<SEC-DOCUMENT>0001539497-23-001700.txt : 20231006
<SEC-HEADER>0001539497-23-001700.hdr.sgml : 20231006
<ACCEPTANCE-DATETIME>20231006172853
ACCESSION NUMBER:		0001539497-23-001700
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		145
CONFORMED PERIOD OF REPORT:	20230630
FILED AS OF DATE:		20231006
DATE AS OF CHANGE:		20231006

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NIOCORP DEVELOPMENTS LTD
		CENTRAL INDEX KEY:			0001512228
		STANDARD INDUSTRIAL CLASSIFICATION:	METAL MINING [1000]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41655
		FILM NUMBER:		231315001

	BUSINESS ADDRESS:	
		STREET 1:		7000 S. YOSEMITE STREET
		STREET 2:		STE. 115
		CITY:			CENTENNIAL
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		720-639-4647

	MAIL ADDRESS:	
		STREET 1:		7000 S. YOSEMITE STREET
		STREET 2:		STE. 115
		CITY:			CENTENNIAL
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QUANTUM RARE EARTH DEVELOPMENTS CORP.
		DATE OF NAME CHANGE:	20110204
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>n2574_x163-10k.htm
<DESCRIPTION>FORM 10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:niobf="http://niocorp.com/20230630">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2022_currency -->
<!-- Field: Set; Name: xdx; ID: xdx_036_niobf_niocorp.com_20230630 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20220701_20230630 -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001512228 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentPeriodEndDate_Jun. 30, 2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DDocumentFiscalYearFocus_2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0wNi0zMA== -->
<!-- Field: Set; Name: xdx; ID: xdx_071_XDX_Z%2D%2D\XBRL JOB\2023\2023\Q3\09 September\NUVO\IXBRL__NioCorp Developments Ltd 10%2DK (n2574__x163)\Out Bound\V8\NUH__n2574__x163__NioCorp Developments Ltd 10%2DK__V8\n2574__x163%2D10k.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_060_USDPShares_0_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_066_NUMBER_5_N -->
<!-- Field: Set; Name: xdx; ID: xdx_061_CADPShares_3_iso4217%2D%2DCAD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityCentralIndexKey">0001512228</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:DocumentPeriodEndDate">2023-06-30</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:DocumentFiscalYearFocus">2023</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:CurrentFiscalYearEndDate">--06-30</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0022" name="dei:EntityIncorporationStateCountryCode">A1</ix:nonNumeric>
  <ix:nonFraction name="niobf:DueToOfficersOrStockholdersOtherCurrent" contextRef="AsOf2023-06-30" id="xdx2ixbrl0093" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2023-06-30" id="xdx2ixbrl0096" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2022-06-30" id="xdx2ixbrl0109" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2022-06-30" id="xdx2ixbrl0112" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:EarnoutLiabilityAtFairValue" contextRef="AsOf2022-06-30" id="xdx2ixbrl0115" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" contextRef="AsOf2022-06-30" id="xdx2ixbrl0127" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0139" name="us-gaap:CommonStockSharesAuthorizedUnlimited">Unlimited</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0141" name="us-gaap:CommonStockSharesAuthorizedUnlimited">Unlimited</ix:nonNumeric>
  <ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutLiability" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0184" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutLiability" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0185" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:ChangeInFairValueOfWarrantLiability" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0188" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:ChangeInFairValueOfWarrantLiability" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0189" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ExtinguishmentOfDebtAmount" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0192" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0204" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0207" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0208" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0220" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0221" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0228" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0229" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0256" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0257" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:AssumptionOfEarnoutLiability" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0284" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:AssumptionOfEarnoutLiability" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0285" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutShareLiability" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0288" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutShareLiability" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0289" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:AssumptionOfPrivateAndPublicWarrants" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0292" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:AssumptionOfPrivateAndPublicWarrants" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0293" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:LossesOnExtinguishmentOfDebt" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0304" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:ChangeInValuationOfWarrantLiabilities" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0308" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:ChangeInValuationOfWarrantLiabilities" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0309" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:FairValueOfCommitmentSharesIssued" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0312" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:FairValueOfCommitmentSharesIssued" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0313" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Depreciation" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0321" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:OtheroperatingGainsLosses" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0332" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0335" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0336" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireMineralRights" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0363" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireMineralRights" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0364" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireBuildings" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0367" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0372" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0373" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0384" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0392" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0393" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0400" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0435" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0436" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0437" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0448" name="niobf:RecognitionOfOperatingLeaseLiabilities" xs:nil="true"></ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0451" name="niobf:DerecognitionOfOperatingLeaseLiabilities" xs:nil="true"></ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0452" name="niobf:DerecognitionOfOperatingLeaseLiabilities" xs:nil="true"></ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0455" name="niobf:AccountsPayableToConvertibleDebtConversion" xs:nil="true"></ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0456" name="niobf:AccountsPayableToConvertibleDebtConversion" xs:nil="true"></ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0460" name="niobf:ValueOfWarrantsIssued" xs:nil="true"></ix:nonNumeric>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0467" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockWarrantExercised" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0472" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockWarrantExercised" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0473" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockWarrantExercised" contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0475" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0480" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0481" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0483" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0488" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0489" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0491" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:PrivatePlacementValueMay2021" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0494" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:PrivatePlacementValueMay2021" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0495" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:PrivatePlacementValueMay2021" contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0497" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0502" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0505" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0510" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0511" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0513" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0516" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0517" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0519" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0521" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0522" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0525" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0527" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0529" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0531" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0537" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockWarrantExercised" contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0542" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockWarrantExercised" contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0543" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockWarrantExercised" contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0545" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0549" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0550" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0552" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0557" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0558" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0560" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:PrivatePlacementSharesMay2021" contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0563" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:PrivatePlacementSharesMay2021" contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0564" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:PrivatePlacementSharesMay2021" contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0566" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0571" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0572" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0574" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0579" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0580" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0582" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0585" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0586" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0588" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0590" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0591" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0594" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0596" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0598" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0600" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0606" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0611" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0612" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0614" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0619" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0620" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0622" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:CommonSharesIssuedInTheGXIITransaction" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0624" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:CommonSharesIssuedInTheGXIITransaction" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0625" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:CommonSharesIssuedInTheGXIITransaction" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0626" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:CommonSharesIssuedInTheGXIITransaction" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0627" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:CommonSharesIssuedInTheGXIITransaction" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0628" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0633" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0634" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0636" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0641" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0642" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0644" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0649" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0650" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0652" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0657" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0658" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0660" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0665" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0666" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0668" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:RedeemableNoncontrollingInterest" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0671" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:RedeemableNoncontrollingInterest" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0672" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0677" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0678" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0680" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0682" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0683" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0686" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0688" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0690" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NumberOfReportableSegments" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0709" decimals="INF" unitRef="NUMBER">1</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0809" decimals="-3" scale="3" unitRef="USD">228</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0811" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0813" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0823" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0825" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-012023-03-31" id="xdx2ixbrl0929" decimals="-3" scale="3" sign="-" unitRef="USD">3877</ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-07-012023-03-31" id="xdx2ixbrl0988" decimals="-3" scale="3" sign="-" unitRef="USD">3877</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl0990" decimals="-3" scale="3" sign="-" unitRef="USD">35741</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember" id="xdx2ixbrl0992" decimals="-3" scale="3" unitRef="USD">665</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-03-31" id="xdx2ixbrl0994" decimals="-3" scale="3" sign="-" unitRef="USD">35076</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember" id="xdx2ixbrl1022" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">665</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl1033" decimals="-3" scale="3" sign="-" unitRef="USD">40308</ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30" id="xdx2ixbrl1091" decimals="INF" unitRef="Shares">31202131</ix:nonFraction>
  <ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="AsOf2022-06-30" id="xdx2ixbrl1168" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" contextRef="AsOf2022-06-30" id="xdx2ixbrl1174" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2023-06-30_custom_ConvertibleSecurityMember" id="xdx2ixbrl1182" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2022-06-30_custom_ConvertibleSecurityMember" id="xdx2ixbrl1187" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2023-06-30" id="xdx2ixbrl1201" name="us-gaap:LongTermDebtTerm">P24M</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember" id="xdx2ixbrl1215" name="us-gaap:IntermediateLifePlantsUsefulLife">P4Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ExtinguishmentOfDebtAmount" contextRef="From2021-07-012022-06-30_custom_ConvertibleSecurityMember" id="xdx2ixbrl1231" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" contextRef="From2021-07-012022-06-30_custom_ConvertibleSecurityMember" id="xdx2ixbrl1243" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2023-06-30_custom_ConvertibleSecurityMember501157812" id="xdx2ixbrl1245" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MinimumMember" id="xdx2ixbrl1346" name="niobf:DebtMaturityPeriod">P6M</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MaximumMember" id="xdx2ixbrl1348" name="niobf:DebtMaturityPeriod">P18M</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl1364" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction>
  <ix:nonNumeric contextRef="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_WarrantMember" id="xdx2ixbrl1444" name="niobf:FairValueAssumptions1ExpectedTerm">P2Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1481" decimals="INF" unitRef="Shares">215</ix:nonFraction>
  <ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_ExercisePrice8.40Member" id="xdx2ixbrl1515" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">2023-09-18</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_ExercisePrice5.40Member" id="xdx2ixbrl1520" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">2023-11-15</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_ExercisePrice7.50Member" id="xdx2ixbrl1525" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">2023-12-14</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_ExercisePrice7.50OneMember" id="xdx2ixbrl1528" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">2023-12-16</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_ExercisePrice13.60Member" id="xdx2ixbrl1531" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">2024-12-17</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_ExercisePrice11.00Member" id="xdx2ixbrl1534" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">2025-05-30</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_ExercisePrice6.95Member" id="xdx2ixbrl1537" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">2026-03-27</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl1569" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P3Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1571" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P3Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2020-07-012021-06-30" id="xdx2ixbrl1572" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P3Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-06-30_custom_ExercisePrice11.00Member" id="xdx2ixbrl1630" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">2024-06-30</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-06-30_custom_ExercisePrice9.70Member" id="xdx2ixbrl1635" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">2025-02-19</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-06-30_custom_ExercisePrice11.50Member" id="xdx2ixbrl1643" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">2028-03-17</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-012023-03-17_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1687" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P5Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1689" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P4Y8M23D</ix:nonNumeric>
  <ix:nonFraction name="niobf:AmountsAdvanced" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1732" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RelatedPartyDepositLiabilities" contextRef="AsOf2023-06-30" id="xdx2ixbrl1737" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-06-30" id="xdx2ixbrl1746" decimals="-3" scale="3" unitRef="USD">252</ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-06-30" id="xdx2ixbrl1747" decimals="-3" scale="3" unitRef="USD">873</ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2023-06-30" id="xdx2ixbrl1775" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm">P3Y7M6D</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2022-06-30" id="xdx2ixbrl1777" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm">P1Y3M19D</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ExplorationCosts" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl1818" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ExplorationCosts" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1819" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:EarnoutSharesLiability" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1887" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:EarnoutSharesLiability" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl1888" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:WarrantLiability" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1891" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:WarrantLiability" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl1892" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:GxiiTransactionCosts" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1895" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:GxiiTransactionCosts" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl1896" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ExtinguishmentOfDebtGainLossIncomeTax" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1907" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ExtinguishmentOfDebtGainLossIncomeTax" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl1908" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl1926" decimals="-3" scale="3" sign="-" unitRef="USD">304</ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1928" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl1930" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:DeferredTaxAssetsStartupAndOorganizationalCosts" contextRef="AsOf2022-06-30" id="xdx2ixbrl1941" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:DeferredTaxAssetsResearchAndDevelopmentCosts" contextRef="AsOf2022-06-30" id="xdx2ixbrl1944" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:DeferredTaxAssetsShareIssuanceCosts" contextRef="AsOf2022-06-30" id="xdx2ixbrl1947" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2023-06-30" id="xdx2ixbrl1961" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2022-06-30" id="xdx2ixbrl1962" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CostsIncurredDevelopmentCosts" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1979" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl2024" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl2025" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl2028" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl2029" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl2032" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl2033" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl2035" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl2036" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl2039" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl2043" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl2049" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl2050" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl2054" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl2055" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl2059" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl2060" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="niobf-20230630.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-07-01to2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_CommonSharesWithoutParValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:CommonSharesWithoutParValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:WarrantsEachExercisableFor1.11829212CommonSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-10-06">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-10-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_Entity0896800BCLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_Entity0896800BCLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_Entity0896800BCLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_Entity0896800BCLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ElkCreekResourcesCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ElkCreekResourcesCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ElkCreekResourcesCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ElkCreekResourcesCorpECRCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ElkCreekResourcesCorpECRCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ElkCreekResourcesCorpECRCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_WarrantAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:WarrantAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_LegacyNioCorpShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LegacyNioCorpShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_LegacyNioCorpShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LegacyNioCorpShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_GXIIClassAShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIClassAShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_GXIIClassAShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIClassAShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-202022-10-22_us-gaap_LandImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-20</xbrli:startDate>
        <xbrli:endDate>2022-10-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_LandImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-06-282011-06-30_custom_Entity0896800BCLtdMember_custom_ShareExchangeAgreementMember_custom_ElkCreekResourcesCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:ElkCreekResourcesCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-06-28</xbrli:startDate>
        <xbrli:endDate>2011-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-06-282011-06-30_custom_Entity0896800BCLtdMember_custom_ShareExchangeAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:ShareExchangeAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-06-28</xbrli:startDate>
        <xbrli:endDate>2011-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-06-282011-06-30_custom_ShareExchangeAgreementMember_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-06-28</xbrli:startDate>
        <xbrli:endDate>2011-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-06-30_custom_ShareExchangeAgreementMember_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-212021-04-23_custom_OptionAgreementMember_custom_ElkCreekResourcesCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:OptionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:ElkCreekResourcesCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-21</xbrli:startDate>
        <xbrli:endDate>2021-04-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-162021-02-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-16</xbrli:startDate>
        <xbrli:endDate>2021-02-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:LindIIIConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember501157062">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">niobf:LindIIIConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_LindIIIConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">niobf:LindIIIConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-172021-02-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-17</xbrli:startDate>
        <xbrli:endDate>2021-02-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_UnsecuredDebtMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-26_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-16_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_MeasurementInputSharePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ConvertibleSecurityMember501157765">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ConvertibleSecurityMember501157812">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-25_us-gaap_MeasurementInputSharePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-25_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-25_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-25_custom_ProbabilityOfIssuanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">niobf:ProbabilityOfIssuanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ProbabilityOfIssuanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">niobf:ProbabilityOfIssuanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-25_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-242022-09-25_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-24</xbrli:startDate>
        <xbrli:endDate>2022-09-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012023-06-30_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-262023-04-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-26</xbrli:startDate>
        <xbrli:endDate>2023-04-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-082023-06-09_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-08</xbrli:startDate>
        <xbrli:endDate>2023-06-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_PrivatePlacementMember_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-032020-11-05_custom_LongTermIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">niobf:LongTermIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-03</xbrli:startDate>
        <xbrli:endDate>2020-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_GXIIPublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIPublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_GXIIPrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIPrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ExercisePrice8.40Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice8.40Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ExercisePrice8.40Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice8.40Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ExercisePrice5.40Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice5.40Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ExercisePrice5.40Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice5.40Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ExercisePrice5.40Member_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice5.40Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ExercisePrice7.50Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice7.50Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ExercisePrice7.50Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice7.50Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ExercisePrice7.50OneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice7.50OneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ExercisePrice7.50OneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice7.50OneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ExercisePrice13.60Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice13.60Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ExercisePrice13.60Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice13.60Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ExercisePrice11.00Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice11.00Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ExercisePrice11.00Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice11.00Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ExercisePrice6.95Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice6.95Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ExercisePrice6.95Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice6.95Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_currency_CAD_custom_ExercisePrice11.00Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice11.00Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ExercisePrice9.70Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice9.70Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_currency_CAD_custom_ExercisePrice9.70Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice9.70Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ExercisePrice8.94Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice8.94Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ExercisePrice11.50Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice11.50Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-17_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-17_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:GeneralSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_custom_AmendedNonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:AmendedNonRevolvingCreditFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_custom_AmendedNonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:AmendedNonRevolvingCreditFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_AmendedNonRevolvingCreditFacilityAgreementMember_custom_MarkSmithMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:AmendedNonRevolvingCreditFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">niobf:MarkSmithMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-22_custom_NonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:NonRevolvingCreditFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-31_custom_MarkSmithMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">niobf:MarkSmithMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_MarkSmithMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">niobf:MarkSmithMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_FeasibilityStudyAndEngineeringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FeasibilityStudyAndEngineeringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_FeasibilityStudyAndEngineeringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FeasibilityStudyAndEngineeringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_FeasibilityStudyAndEngineeringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FeasibilityStudyAndEngineeringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_FieldManagementAndOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldManagementAndOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_FieldManagementAndOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldManagementAndOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_FieldManagementAndOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldManagementAndOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_ExplorationAndProductionEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">us-gaap:ExplorationAndProductionEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_ExplorationAndProductionEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">us-gaap:ExplorationAndProductionEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_ExplorationAndProductionEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">us-gaap:ExplorationAndProductionEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_GeologistsAndFieldStaffMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistsAndFieldStaffMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_GeologistsAndFieldStaffMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistsAndFieldStaffMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_GeologistsAndFieldStaffMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistsAndFieldStaffMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_CorporateOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">niobf:CorporateOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-302023-09-01_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-30</xbrli:startDate>
        <xbrli:endDate>2023-09-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-102023-09-12_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-10</xbrli:startDate>
        <xbrli:endDate>2023-09-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-162023-09-18_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-16</xbrli:startDate>
        <xbrli:endDate>2023-09-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-162023-09-18_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_SubsequentEventMember_custom_FinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:FinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-16</xbrli:startDate>
        <xbrli:endDate>2023-09-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="NUMBER">
      <xbrli:measure>niobf:N</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="CADPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:CAD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000847" toRefs="Footnote000870 Footnote000871"></ix:relationship>
  <ix:relationship fromRefs="Fact000849" toRefs="Footnote000870 Footnote000871"></ix:relationship>
  <ix:relationship fromRefs="Fact000851" toRefs="Footnote000870 Footnote000871"></ix:relationship>
  <ix:relationship fromRefs="Fact000853" toRefs="Footnote000870 Footnote000871"></ix:relationship>
  <ix:relationship fromRefs="Fact000855" toRefs="Footnote000870 Footnote000871"></ix:relationship>
  <ix:relationship fromRefs="Fact000857" toRefs="Footnote000870 Footnote000871"></ix:relationship>
  <ix:relationship fromRefs="Fact000859" toRefs="Footnote000870 Footnote000871"></ix:relationship>
  <ix:relationship fromRefs="Fact000861" toRefs="Footnote000870 Footnote000871"></ix:relationship>
  <ix:relationship fromRefs="Fact000863" toRefs="Footnote000870 Footnote000871"></ix:relationship>
  <ix:relationship fromRefs="Fact000865" toRefs="Footnote000870 Footnote000871"></ix:relationship>
  <ix:relationship fromRefs="Fact000867" toRefs="Footnote000870 Footnote000871"></ix:relationship>
  <ix:relationship fromRefs="Fact000869" toRefs="Footnote000870 Footnote000871"></ix:relationship>
  <ix:relationship fromRefs="Fact001084" toRefs="Footnote001094"></ix:relationship>
  <ix:relationship fromRefs="Fact001086" toRefs="Footnote001094"></ix:relationship>
  <ix:relationship fromRefs="Fact001087" toRefs="Footnote001095"></ix:relationship>
  <ix:relationship fromRefs="Fact001089" toRefs="Footnote001095"></ix:relationship>
  <ix:relationship fromRefs="Fact001264" toRefs="Footnote001267"></ix:relationship>
  <ix:relationship fromRefs="Fact001284" toRefs="Footnote001645"></ix:relationship>
  <ix:relationship fromRefs="Fact001286" toRefs="Footnote001645"></ix:relationship>
  <ix:relationship fromRefs="Fact001288" toRefs="Footnote001645"></ix:relationship>
  <ix:relationship fromRefs="Fact001290" toRefs="Footnote001645"></ix:relationship>
  <ix:relationship fromRefs="Fact001292" toRefs="Footnote001645"></ix:relationship>
  <ix:relationship fromRefs="Fact001294" toRefs="Footnote001645"></ix:relationship>
  <ix:relationship fromRefs="Fact001296" toRefs="Footnote001645"></ix:relationship>
  <ix:relationship fromRefs="Fact001298" toRefs="Footnote001645"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="text-align: center; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNITED
STATES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
AND EXCHANGE COMMISSION </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Washington,
D. C. 20549 </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 16pt"><b>FORM
<span id="xdx_90A_edei--DocumentType_c20220701__20230630_zXDf3zyr6vac"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Mark
One)</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--DocumentAnnualReport_c20220701__20230630_zqhpMnFILioe"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt:booleantrue" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 85%; padding-right: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNUAL
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1in; text-align: center; text-indent: 76.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the fiscal year ended <span id="xdx_90B_edei--DocumentPeriodEndDate_c20220701__20230630_zKfiHIDYZFY3"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June 30, 2023</ix:nonNumeric></span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1in; text-align: center; text-indent: 63pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--DocumentTransitionReport_c20220701__20230630_zmCcepGFr0ud"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRANSITION
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the transition period from to</b></span></p>

<!-- Field: Rule-Page --><div style="text-align: center"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin: 0 auto; width: 40%"><tr style="vertical-align: top; text-align: justify">
<td style="border: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
file number: <span id="xdx_906_edei--EntityFileNumber_c20220701__20230630_zdTLkktSYRue"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityFileNumber">000-55710</ix:nonNumeric></span></b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 45%; padding-top: 18pt">&#160;</td>
    <td rowspan="2" style="width: 10%; text-align: center">&#160;<img src="n257410kimg001.jpg" alt="" style="width: 156px; height: 70px" /></td>
    <td style="border-bottom: Black 1pt solid; width: 45%; padding-top: 18pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 15pt">&#160;</td>
    <td style="padding-bottom: 15pt; white-space: nowrap">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 16pt"><b><span id="xdx_904_edei--EntityRegistrantName_c20220701__20230630_zcOnxi04eKrk"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityRegistrantName">NioCorp
Developments Ltd.</ix:nonNumeric></span></b></span></p>

<!-- Field: Rule-Page --><div style="text-align: center"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 16pt Times New Roman, Times, Serif"><b></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 52%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_dxL_c20220701__20230630_zSuMWT7QXzQf" title="::XDX::A1"><span style="-sec-ix-hidden: xdx2ixbrl0022">British
    Columbia, Canada</span></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 31%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20220701__20230630_zSscRbIqG3dk"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityTaxIdentificationNumber">98-1262185</ix:nonNumeric></span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction
    of incorporation or organization)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer
    Identification No.)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressAddressLine1_c20220701__20230630_zocdph3NnqN8"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityAddressAddressLine1">7000
South Yosemite Street</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressAddressLine2_c20220701__20230630_zhJybQ3DrJua"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityAddressAddressLine2">Suite 115</ix:nonNumeric></span> <span id="xdx_904_edei--EntityAddressCityOrTown_c20220701__20230630_z26m0tTvXkJa"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityAddressCityOrTown">Centennial</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20220701__20230630_zmBHHiqLh268"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityAddressStateOrProvince">CO</ix:nonNumeric></span></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressPostalZipCode_c20220701__20230630_zErozb8dpdz"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityAddressPostalZipCode">80112</ix:nonNumeric></span></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
Code)</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="4" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
    telephone number, including area code: <span id="xdx_905_edei--CityAreaCode_c20220701__20230630_zX4wvYSy8Guh"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:CityAreaCode">(720)</ix:nonNumeric></span> <span id="xdx_90B_edei--LocalPhoneNumber_c20220701__20230630_zDFOkLjRspPi"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:LocalPhoneNumber">334-7066</ix:nonNumeric></span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="4" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 37%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 25%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--Security12bTitle_c20220701__20230630__us-gaap--StatementClassOfStockAxis__custom--CommonSharesWithoutParValueMember_zCRQwwkaCbe7"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_CommonSharesWithoutParValueMember" name="dei:Security12bTitle">Common
    Shares, without par value</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--TradingSymbol_c20220701__20230630__us-gaap--StatementClassOfStockAxis__custom--CommonSharesWithoutParValueMember_zp33aWiryPRl"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_CommonSharesWithoutParValueMember" name="dei:TradingSymbol">NB</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--SecurityExchangeName_c20220701__20230630__us-gaap--StatementClassOfStockAxis__custom--CommonSharesWithoutParValueMember_z6DMlhxDCDXg"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_CommonSharesWithoutParValueMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--Security12bTitle_c20220701__20230630__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableFor1.11829212CommonSharesMember_ztW2Z3BxtpJ7"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember" name="dei:Security12bTitle">Warrants,
    each exercisable for 1.11829212 Common Shares</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--TradingSymbol_c20220701__20230630__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableFor1.11829212CommonSharesMember_zyZEHYCju8Q1"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember" name="dei:TradingSymbol">NIOBW</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--SecurityExchangeName_c20220701__20230630__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableFor1.11829212CommonSharesMember_z1kHsRl4Qei6"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to section 12(g) of the Act: None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Yes
&#9744; <span id="xdx_906_edei--EntityWellKnownSeasonedIssuer_c20220701__20230630_zp2vLM9rxYsc"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Yes
&#9744; <span id="xdx_902_edei--EntityVoluntaryFilers_c20220701__20230630_zQJUt47foWu7"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_edei--EntityCurrentReportingStatus_c20220701__20230630_zgCiKUrdCvB2"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant
to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit such files).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_edei--EntityInteractiveDataCurrent_c20220701__20230630_zLKYm3EeHFG5"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 10%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large Accelerated Filer </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated Filer </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntityFilerCategory_c20220701__20230630_zfaZyShceQd"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-Accelerated
Filer</ix:nonNumeric></span></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#9746;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
Reporting Company</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_edei--EntitySmallBusiness_c20220701__20230630_z2xKJ5OmdX86"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Emerging Growth Company</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20220701__20230630_zHOfvQAbtBYk"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report.  &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the
registrant included in the filing reflect the correction of an error to previously issued financial statements. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).
&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes &#9744; <span id="xdx_904_edei--EntityShellCompany_c20220701__20230630_zxnefrY27aQf"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2022, the aggregate market value of the registrant&#8217;s voting and non-voting common equity held by non-affiliates
of the registrant was $<span id="xdx_909_edei--EntityPublicFloat_iI_dm_c20221231_z1rKmNZ2v7J3"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">190.7</ix:nonFraction> million</span> based on the closing sale price as reported on the Toronto Stock Exchange and the daily exchange
rate as reported by the Bank of Canada for conversion of Canadian dollars into United States dollars. There were <span id="xdx_903_edei--EntityCommonStockSharesOutstanding_iI_pid_uShares_c20231006_z0fOo4GMxdGa"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-10-06" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">32,913,419</ix:nonFraction></span> common shares outstanding on October 6, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DOCUMENTS
INCORPORATED BY REFERENCE </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->








<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contents</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td colspan="2" style="padding-left: 0.125in"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a001">Select Mining Definitions</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td colspan="2" style="padding-left: 0.125in"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a002">Metric Equivalents</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td colspan="2" style="padding-left: 0.125in"><a href="#a067">Mineral Reserves and Resources</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">vi</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td colspan="2" style="padding-left: 0.125in"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a003">Currency and Exchange Rates</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a004">PART I</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a005">ITEM 1.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a005">BUSINESS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="width: 12%; padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 78%; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a006">Introduction</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a007">Historical Development of the Business</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a008">Business Operations</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a009">Competitive Business Conditions</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a010">Cycles</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a011">Economic Dependence</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a012">Government Regulation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a013">Human Capital</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a014">Forward-Looking Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a015">Available Information</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a016">ITEM 1A.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a016">RISK FACTORS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a017">Risks Related to Our Business</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a018">Risks Related to Mining and Development</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a019">Risks Related to Government Regulation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a020">Risks Related to Our Debt</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a021">Risks Related to the Common Shares</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a022">ITEM 1B.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a022">UNRESOLVED STAFF COMMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a023">ITEM 2.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a023">PROPERTIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a024">ITEM 3.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a024">LEGAL PROCEEDINGS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a025">ITEM 4.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a025">MINE SAFETY DISCLOSURES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td colspan="2" style="vertical-align: bottom; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a026">PART II</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a027">ITEM 5.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a027">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a028">Market Information</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a029">Holders</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a030">Dividends</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a031">Securities Authorized for Issuance Under Equity Compensation Plans</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a032">Purchases of Equity Securities by the Company</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a033">Recent Sales of Unregistered Securities</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a034">Exchange Controls</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a035">Certain Canadian Federal Income Tax Considerations for U.S. Residents</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a036">ITEM 6.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><a href="#a036">RESERVED</a></i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a037">ITEM 7.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a037">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a038">Summary of Consolidated Financial and Operating Performance</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a039">Results of Operations</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a040">Liquidity and Capital Resources</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a041">Cash Flow Considerations</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a042">Environmental</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a043">Forward-Looking Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a044">Accounting Developments</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a045">Critical Accounting Estimates and Recent Accounting Pronouncements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a046">Other</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a047">ITEM 7A.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a047">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a048">Interest rate risk</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a049">Foreign currency exchange risk</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a050">Commodity price risk</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a051">ITEM 8.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a051">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a052">ITEM 9.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a052">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a053">ITEM 9A.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a053">CONTROLS AND PROCEDURES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a054">ITEM 9B.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a054">OTHER INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a055">ITEM 9C.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a055">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a056">PART III</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a057">ITEM 10.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a057">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a058">Directors and Executive Officers</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a059">ITEM 11.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a059">EXECUTIVE COMPENSATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a060">ITEM 12.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a060">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">108</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a061">ITEM 13.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a061">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">112</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a062">ITEM 14.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a062">PRINCIPAL ACCOUNTING FEES AND SERVICES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">112</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a063">PART IV</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a064">ITEM 15.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a064">EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a065">ITEM 16.</a></span></td>
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a065">FORM 10&#8211;K SUMMARY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">118</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a066">SIGNATURES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a001"></span>Select
Mining Definitions</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>carbonatite</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72%; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    type of intrusive or extrusive igneous rock defined by mineralogic composition consisting of greater than 50% carbonate minerals.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>cut-off
    grade</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    grade (i.e., the concentration of metal or mineral in rock) that determines the destination of the material during mining.
    For purposes of establishing &#8220;prospects of economic extraction,&#8221; the cut-off grade is the grade that distinguishes
    material deemed to have no economic value (it will not be mined in underground mining or if mined in surface mining, its destination
    will be the waste dump) from material deemed to have economic value (its ultimate destination during mining will be a processing
    facility). Other terms used in similar fashion as cut-off grade include net smelter return, pay limit, and break-even stripping
    ratio.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>deposit</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    mineralized body which has been physically delineated by sufficient drilling, trenching, and/or underground work, and found
    to contain a sufficient average grade of metal or metals to warrant further exploration and/or development expenditures. Such
    a deposit does not qualify as a commercially mineable ore body or as containing reserves or ore, unless final legal, technical,
    and economic factors are resolved.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>development
    stage issuer</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    issuer that is engaged in the preparation of mineral reserves for extraction on at least one material property</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>development
    stage property </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    property that has mineral reserves disclosed, pursuant to Regulation S-K 1300, but no material extraction</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>diamond
    drilling</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    type of rotary drilling in which diamond bits are used as the rock-cutting tool to produce a recoverable drill core sample
    of rock for observation and analysis</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: -5.25pt; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>dysprosium
    or Dy</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    chemical element with an atomic number 66. It is a rare-earth element in the lanthanide series.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: -5.25pt; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>dysprosium
    oxide</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    chemical compound composed of dysprosium and oxygen with the formula Dy<sub>2</sub>O<sub>3</sub></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>economically
    viable</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
    used in the context of mineral reserve determination, means that the qualified person has determined, using a discounted cash
    flow analysis, or has otherwise analytically determined, that extraction of the mineral reserve is economically viable under
    reasonable investment and market assumptions</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>feasibility
    study</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         comprehensive technical and economic study of the selected development option for a mineral
                                         project, which includes detailed assessments of all applicable modifying factors, as
                                         defined under S-K 1300, together with any other relevant operational factors, and detailed
                                         financial analysis that are necessary to demonstrate, at the time of reporting, that
                                         extraction is economically viable. The results of the study may serve as the basis for
                                         a final decision by a proponent or financial institution to proceed with, or finance,
                                         the development of the project.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
        A feasibility study is more comprehensive, and with a higher degree of accuracy, than a pre-feasibility study. It must
        contain mining, infrastructure, and process designs completed with sufficient rigor to serve as the basis for an investment
        decision or to support project financing.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
        The confidence level in the results of a feasibility study is higher than the confidence level in the results of a pre-feasibility
        study. Terms such as <i>full</i>, <i>final</i>,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
</table>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72%; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>comprehensive</i>,
    <i>bankable</i>, or <i>definitive</i> feasibility study are equivalent to feasibility study.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ferroniobium
    or FeNb</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    iron-niobium alloy, with a niobium content of 60-70%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>indicated
    mineral resource</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    part of a mineral resource for which quantity and grade or quality are estimated on the basis of adequate geological evidence
    and sampling. The level of geological certainty associated with an indicated mineral resource is sufficient to allow a qualified
    person to apply modifying factors in sufficient detail to support mine planning and evaluation of the economic viability of
    the deposit. Because an indicated mineral resource has a lower level of confidence than the level of confidence of a measured
    mineral resource, an indicated mineral resource may only be converted to a probable mineral reserve.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>inferred
    mineral resource</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    part of a mineral resource for which quantity and grade or quality are estimated on the basis of limited geological evidence
    and sampling. The level of geological uncertainty associated with an inferred mineral resource is too high to apply relevant
    technical and economic factors likely to influence the prospects of economic extraction in a manner useful for evaluation
    of economic viability. Because an inferred mineral resource has the lowest level of geological confidence of all mineral resources,
    which prevents the application of the modifying factors in a manner useful for evaluation of economic viability, an inferred
    mineral resource may not be considered when assessing the economic viability of a mining project, and may not be converted
    to a mineral reserve.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LoM</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life
    of Mine, the period from the beginning of construction to the end of mine life</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>measured
    mineral resource</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    part of a mineral resource for which quantity and grade or quality are estimated on the basis of conclusive geological evidence
    and sampling. The level of geological certainty associated with a measured mineral resource is sufficient to allow a qualified
    person to apply modifying factors, as defined in this section, in sufficient detail to support detailed mine planning and
    final evaluation of the economic viability of the deposit. Because a measured mineral resource has a higher level of confidence
    than the level of confidence of either an indicated mineral resource or an inferred mineral resource, a measured mineral resource
    may be converted to a proven mineral reserve or to a probable mineral reserve.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>mineral
    reserve</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    estimate of tonnage and grade or quality of indicated and measured mineral resources that, in the opinion of the qualified
    person, can be the basis of an economically viable project. More specifically, it is the economically mineable part of a measured
    or indicated mineral resource, which includes diluting materials and allowances for losses that may occur when the material
    is mined or extracted.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>mineral
    resource</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    concentration or occurrence of material of economic interest in or on the Earth&#8217;s crust in such form, grade or quality,
    and quantity that there are reasonable prospects for economic extraction. A mineral resource is a reasonable estimate of mineralization,
    taking into account relevant factors such as cut-off grade, likely mining dimensions, location or continuity, that, with the
    assumed and justifiable technical and economic conditions, is likely to, in whole or in part, become economically extractable.
    It is not merely an inventory of all mineralization drilled or sampled.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>modifying
    factors</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    factors that a qualified person must apply to indicated and measured mineral resources and then evaluate in order to establish
    the economic viability of mineral reserves. A qualified person must apply and evaluate modifying factors to convert</span></td></tr>
</table>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence -->&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72%; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">measured
    and indicated mineral resources to proven and probable mineral reserves. These factors include, but are not restricted to:
    mining; processing; metallurgical; infrastructure; economic; marketing; legal; environmental compliance; plans, negotiations,
    or agreements with local individuals or groups; and governmental factors. The number, type and specific characteristics of
    the modifying factors applied will necessarily be a function of and depend upon the mineral, mine, property, or project.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>niobium
    or Nb </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    element niobium (atomic number 41), a transition metal primarily used in the production of high-strength, low-alloy steel</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<sub>2</sub>O<sub>5</sub></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Niobium
    pentoxide, a commercial form of refined niobium</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>neodymium
    oxide</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    chemical compound composed of neodymium and oxygen with the formula Nd<sub>2</sub>O<sub>3</sub></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NSR</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Smelter Return, the net revenue that the owner of a mining property receives from the sale of the mine&#8217;s products less
    transportation and refining costs</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>praseodymium
    oxide</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    chemical compound composed of praseodymium and oxygen with the formula Pr<sub>2</sub>O<sub>3</sub></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>probable
    mineral reserve</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    economically mineable part of an indicated and, in some cases, a measured mineral resource</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>production
    stage property</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    property with material extraction of mineral reserves</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>proven
    mineral reserve</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    economically mineable part of a measured mineral resource and can only result from conversion of a measured mineral resource</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>qualified
    person</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                         individual who is:</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&#160;&#160;&#160;A
        mineral industry professional with at least five years of relevant experience in the type of mineralization and type of
        deposit under consideration and in the specific type of activity that person is undertaking on behalf of the registrant;
        and</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&#160;&#160;&#160;An
        eligible member or licensee in good standing of a recognized professional organization at the time the technical report
        is prepared. For an organization to be a recognized professional organization, it must:</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#160;&#160;Be either:</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.5pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)&#160;&#160;An organization recognized within the mining industry as a reputable professional association; or</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.5pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.5pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)&#160;&#160;A board authorized by Unites States federal, state, or foreign statute to regulate professionals in the mining, geoscience,
        or related field;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.5pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&#160;&#160;&#160;Admit eligible members primarily on the basis of their academic qualifications and experience;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&#160;&#160;&#160;&#160;Establish and require compliance with professional standards of competence and ethics;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&#160;&#160;&#160;&#160;Require
        or encourage continuing professional development;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)&#160;&#160;&#160;&#160;&#160;Have
        and apply disciplinary powers, including the power to suspend or expel a member regardless of where the member practices or
        resides; and</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
</table>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence -->&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72%; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)&#160;&#160;&#160;&#160;Provide a public list of members in good standing.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>rare
    earth elements, rare earths or REEs </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    group of 15 elements referred to as the lanthanide series in the periodic table of elements. Scandium and yttrium, while not
    true REEs, are also included in this categorization because they exhibit similar properties to the lanthanides and are found
    in the same ore bodies. Individual mineral deposits may not contain all REEs in economically recoverable quantities.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>rare
    earth products</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercial
    rare earth products currently being examined for production by the Company, including neodymium-praseodymium oxide (sometimes
    referred to as didymium oxide), dysprosium oxide, and terbium oxide. These are the primary rare earths compounds used to manufacture
    the world&#8217;s most powerful permanent magnets.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>relevant
    experience</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         purposes of determining whether a party is a qualified person, that the party has experience
                                         in the specific type of activity that the person is undertaking on behalf of the registrant.
                                         If the qualified person is preparing or supervising the preparation of a technical report
                                         concerning exploration results, the relevant experience must be in exploration. If the
                                         qualified person is estimating, or supervising the estimation of mineral resources, the
                                         relevant experience must be in the estimation, assessment and evaluation of mineral resources
                                         and associated technical and economic factors likely to influence the prospect of economic
                                         extraction. If the qualified person is estimating, or supervising the estimation of mineral
                                         reserves, the relevant experience must be in engineering and other disciplines required
                                         for the estimation, assessment, evaluation, and economic extraction of mineral reserves.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&#160;&#160;&#160;Relevant
        experience also means, for purposes of determining whether a party is a qualified person, that the party has experience
        evaluating the specific type of mineral deposit under consideration (e.g., coal, metal, base metal, industrial mineral,
        or mineral brine). The type of experience necessary to qualify as relevant is a facts and circumstances determination.
        For example, experience in a high-nugget, vein-type mineralization such as tin or tungsten would likely be relevant experience
        for estimating mineral resources for vein-gold mineralization, whereas experience in a low grade disseminated gold deposit
        likely would not be relevant.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Note
        1 to Paragraph (1) of the Definition of Relevant Experience</i>: It is not always necessary for a person to have five
        years&#8217; experience in each and every type of deposit in order to be an eligible qualified person if that person has
        relevant experience in similar deposit types. For example, a person with 20 years&#8217; experience in estimating mineral
        resources for a variety of metalliferous hard-rock deposit types may not require as much as five years of specific experience
        in porphyry-copper deposits to act as a qualified person. Relevant experience in the other deposit types could count towards
        the experience in relation to porphyry-copper deposits.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&#160;&#160;&#160;For a qualified person providing a technical report for exploration results or mineral resource estimates, relevant experience
        also requires, in addition to experience in the type of mineralization, sufficient experience with the sampling and analytical
        techniques, as well as extraction and processing techniques, relevant to the mineral deposit under consideration. Sufficient
        experience means that level of experience necessary to be able to identify, with substantial confidence, problems that
        could affect the reliability of data and issues associated with processing.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
</table>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence -->&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&#160;&#160;&#160;For a qualified person applying the modifying factors, as defined by this section, to
                                         convert mineral resources to mineral reserves, relevant experience also requires:</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#160;&#160;&#160;&#160;Sufficient
        knowledge and experience in the application of these factors to the mineral deposit under consideration; and</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&#160;&#160;&#160;&#160;Experience
        with the geology, geostatistics, mining, extraction, and processing that is applicable to the type of mineral and mining
        under consideration.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>S-K
    1300</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subpart
    1300 of Regulation S-K promulgated by the SEC</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>S-K
    1300 Elk Creek Technical Report Summary</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    technical report summary for the Elk Creek Project that conforms to S-K 1300 reporting standards, with an effective date of
    June 30, 2022, originally filed as Exhibit 96.1 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended
    June 30, 2022, and incorporated by reference into this Annual Report on Form 10-K</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>scandium
    or Sc</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    element scandium (atomic number 21), a transition metal used as an alloying agent with aluminum that provides high strength
    and lower weight for aerospace industry components and other applications that need lightweight metals. It also is used in
    the electrolyte layer of solid oxide fuel cells.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc<sub>2</sub>O<sub>3</sub></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scandium
    trioxide, the primary form of refined scandium</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>terbium
    oxide</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    chemical compound composed of terbium and oxygen with the formula Tb<sub>2</sub>O<sub>3</sub></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>titanium
    or Ti</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    element titanium (atomic number 22), a transition metal which in its oxide form is a common pigment in paper, paint, and plastic.
    In its metallic form, titanium is used in aerospace applications, armor, chemical processing applications, marine hardware
    applications, medical implants, power generation, and in sporting goods.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<sub>2</sub></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Titanium
    dioxide, a commercial form of refined titanium</span></td></tr>
</table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.8in; text-align: center; text-indent: -0.8in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.8in; text-align: center; text-indent: -0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a002"></span>Metric
Equivalents</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.8in; text-align: center; text-indent: -0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
ease of reference, the following factors for converting Imperial measurements into metric equivalents are provided:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 67%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 25%; padding-right: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>To
convert from Imperial</b></span></p></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>To
metric</b></span></p></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Multiply
by</b></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acres</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hectares</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.4047</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Feet
    (&#8220;ft&#8221;)</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Meters
    (&#8220;m&#8221;)</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.3048</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miles</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kilometers
    (&#8220;km&#8221;)</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6093</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tons</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tonnes
    (&#8220;t&#8221;)</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.9072</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
    mile = 1.6093 kilometers</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
    acre = 0.4047 hectares</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,204.62
    pounds = 1 metric tonne = 1 tonne</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2000
    pounds (1 short ton) = 0.9072 tonnes</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence -->&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a067"></span>Mineral
Reserves and Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
concerning our mining property in this Annual Report on Form 10-K has been prepared in accordance with the requirements of S-K
1300, which first became applicable to us for the fiscal year ended June 30, 2022. All mineral resource and mineral reserve estimates
included in this Annual Report on Form 10-K have been prepared in accordance with S-K 1300. Previously, we prepared our estimates
of mineral resources and mineral reserves following only National Instrument 43-101 of the Canadian Securities Administrators
entitled &#8220;Standards of Disclosure for Mineral Projects&#8221; (&#8220;NI 43-101&#8221;) and the Canadian Institute of Mining
and Metallurgy (&#8220;CIM&#8221;) &#8220;Definition Standards &#8211; For Mineral Resources and Mineral Reserves, May 10, 2014.&#8221;
The CIM-compliant NI 43-101 technical report (the &#8220;NI 43-101 Elk Creek Technical Report&#8221;) for the Company&#8217;s
niobium, scandium, and titanium project (the &#8220;Elk Creek Project&#8221;) and S-K 1300 Elk Creek Technical Report Summary,
filed as Exhibit 96.1 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2022 and incorporated by reference into this Annual Report on Form 10-K, are based on a feasibility study prepared by qualified persons (the
&#8220;2022 Elk Creek Feasibility Study&#8221;) and are substantively identical to one another except for internal references
to the regulations under which the report is made, and certain organizational differences. In addition, S-K 1300 requires us to
disclose our mineral resources, in addition to our mineral reserves, as of the end of our most recently completed fiscal year.
You are cautioned that mineral resources are subject to further exploration and development and are subject to additional risks
and no assurance can be given that they will eventually convert to future reserves. Inferred resources, in particular, have a
great amount of uncertainty as to their existence and their economic and legal feasibility. Investors are cautioned not to assume
that any part or all of the inferred resource exists or is economically or legally mineable. See Item 1A, Risk Factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7pt; text-align: center; text-indent: -0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a003"></span>Currency
and Exchange Rates</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7pt; text-align: center; text-indent: -0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
dollar amounts in this Annual Report on Form 10-K are expressed in United States (&#8220;U.S.&#8221;) dollars unless otherwise
indicated. The Company&#8217;s accounts are maintained in U.S. dollars and the Company&#8217;s consolidated financial statements
are prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Some of the Company&#8217;s
significant agreements, as well as certain vendors, use Canadian dollars. As used herein, &#8220;C$&#8221; represents Canadian
dollars.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the rate of exchange for the Canadian dollar, expressed in U.S. dollars in effect at the end of the
periods indicated, the average of exchange rates in effect during such periods, and the high and low exchange rates during such
periods based on the daily rate of exchange as reported by the Bank of Canada for conversion of Canadian dollars into U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
Year Ended June 30,</b></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Canadian
    Dollars to U.S. Dollars</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 31%; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rate
    at end of period </span></td>
    <td style="width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7553</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7760</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.8068</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
    rate for period </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7467</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7900</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7807</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High
    for period </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7841</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.8111</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.8306</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Low
    for period </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7217</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7669</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7344</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence -->&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a004"></span>PART
I</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                                         1.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a005"></span>BUSINESS</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a006"></span>Introduction</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
Developments Ltd. (&#8220;NioCorp,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; or &#8220;the Company&#8221;)
was incorporated under the laws of the Province of British Columbia under the Business Corporations Act (British Columbia) on
February 27, 1987, under the name &#8220;IPC International Prospector Corp.&#8221; On May 22, 1991, we changed our name to &#8220;Kingston
Resources Ltd.&#8221; On June 29, 2001, we changed our name to &#8220;Butler Developments Corp.&#8221; On February 12, 2009, we
changed our name to &#8220;Butler Resource Corp.&#8221; On March 4, 2010, we changed our name to &#8220;Quantum Rare Earth Developments
Corp.&#8221; On March 4, 2013, we changed our name to &#8220;NioCorp Developments Ltd.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
is a reporting issuer in British Columbia, Alberta, Saskatchewan, Ontario, and New Brunswick. Our registered and records office
is located at 595 Burrard Street, Suite 2600, Vancouver, British Columbia V7X 1L3 (ATTN: Blake, Cassels &amp; Graydon LLP). Our
principal executive office is located at 7000 South Yosemite Street, Suite 115, Centennial, Colorado 80112.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a007"></span>Historical
Development of the Business</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2009 and 2010, the Company commenced mineral exploration activities in the Elk Creek, Nebraska area, including negotiations with
local landowners for land access agreements. The acquisition of the carbonatite property located in Southeast Nebraska, USA (the
&#8220;Elk Creek Property&#8221;) was closed in December 2010 and involved the purchase of all of the issued and outstanding common
shares of 0859404 BC Ltd., a private British Columbia company, which in turn held 100% of the issued and outstanding shares of
Elk Creek Resources Corp., a Nebraska corporation (&#8220;Old ECRC&#8221;), and was signatory to the option agreements covering
the Elk Creek Property area. A new Canadian company, 0886338 BC Ltd. was formed to merge with 0859404 BC Ltd., and this merged
entity was subsequently amalgamated into 0896800 B.C. Ltd., a private British Columbia company and a wholly owned subsidiary of
the Company (&#8220;0896800&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company commenced a field exploration program in 2011, which included verification of previous work which was completed on the
Elk Creek Property in the 1970s and 1980s, re-assaying of historic drill core, an airborne geophysical survey and the completion
of five new diamond drillholes. The available data for the Elk Creek Property was compiled into an updated NI 43-101 resource
estimate for the Elk Creek Project, which was issued in April 2012. Additional drilling and NI 43-101 technical reports, including
resource updates and preliminary economic assessments, were completed and issued by the Company in 2014 and 2015.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal years 2016 and 2017, the Company focused on feasibility study development, and on June 30, 2017, we announced the completion
of a NI 43-101 technical report for the Elk Creek Project (the &#8220;2017 NI 43-101 Elk Creek Technical Report&#8221;). In connection
with a review by the Ontario Securities and Exchange Commission, on December 15, 2017, the Company filed a revised 2017 NI 43-101
Elk Creek Technical Report. This revised report contained no changes to any previously reported numbers or forecasted economic
returns of the Elk Creek Project from those contained in the originally filed 2017 NI 43-101 Elk Creek Technical Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2019, we received a new mine design based on detailed underground engineering conducted by The Nordmin Group of Companies
(&#8220;Nordmin&#8221;) along with an updated mineral resource and mineral reserve. On April 16, 2019, we announced the results
of the updated underground mine design and supporting infrastructure, the results of an update to the Elk Creek Project, and the
filing of an NI 43-101 technical report for the Elk Creek Project based on the new mine design. During fiscal year 2020, the Company
focused efforts on advancing detailed engineering of the surface and underground facilities and negotiating the follow-on contracts
associated with the planned construction of the surface and underground features of the project, as well as obtaining a State
of Nebraska permit which describes all the prospective air emissions from a facility (the &#8220;Air Permit&#8221;). The Air Permit
required the completion of an air quality model that demonstrates compliance with the U.S. National Ambient Air Quality Standards
limits on atmospheric concentration of six pollutants that cause smog, acid rain, and other health hazards, as established by
the EPA (&#8220;NAAQS&#8221;). The final Air Permit was issued by the State of Nebraska on June 2, 2020, for the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 11; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2021, we obtained funding which allowed us to purchase land and mineral rights at the Elk Creek Property and continue
early project execution activities. With the acquisition of the land and mineral rights, the Company now owns the surface land
on which the Elk Creek Project&#8217;s mine infrastructure and supporting operations will be located once sufficient project financing
is obtained, along with ownership of the mineral rights to more than 90% of the Elk Creek Project&#8217;s mineral resources and
mineral reserves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2022, we focused efforts towards refining our Elk Creek Project mineral resource and mineral reserve estimates with
respect to REEs. This work included additional assays of historical drill core to fill data gaps in the existing resource database
and re-modeling. Based on this re-interpretation of the geologic data, an update to the mine plan was also completed. Based on
this work, we issued the 2022 NI 43-101 Elk Creek Technical Report on June 28, 2022, and filed the S-K 1300 Elk Creek Technical
Report Summary as an exhibit to our Annual Report on Form 10-K for the year ended June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2022, we also advanced our efforts to optimize our process design to contemplate the recovery and production of REEs,
including completion of bench and pilot scale testing on elements of the current metallurgical flowsheet. This work illustrated
that NioCorp could recover and produce high purity, fully separated magnetic rare earth products, such as neodymium-praseodymium
oxide, dysprosium oxide, and terbium oxide in addition to the niobium, scandium, and titanium products already planned for production
by the Company, once Project financing is secured and additional work has been completed on the technical and economic feasibility
of adding REEs to the Elk Creek Project&#8217;s existing planned product suite. Following the success of this testing, the Company
advanced the construction of a demonstration-scale processing plant located in Trois-Rivieres, Quebec built by the Company and
L3 Process Development (&#8220;L3&#8221;) and operated by L3 (the &#8220;Demonstration Plant&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2023, we completed construction and operated the Demonstration Plant. The Demonstration Plant results showed higher
recoveries for our primary niobium product, much higher recoveries and a higher value titanium product in the form of titanium
tetrachloride, and a high recovery rate for the three planned rare earth oxides of consequence: neodymium/praseodymium oxide,
dysprosium oxide and terbium oxide. In addition, we completed initial site preparation work at the Elk Creek Project, which consisted
of tree and brush clearing. A geotechnical investigation at the project site was also completed, which involved excavated test
pits, geotechnical borings and the installation of shallow groundwater piezometers. The geotechnical program generated valuable
data for the firms that are working on the detailed design of the facilities and infrastructure associated with the Elk Creek
Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
regarding the Elk Creek Project is discussed below under Item 2., &#8220;Properties.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt; text-align: justify; text-indent: -0.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Structure</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt; text-align: justify; text-indent: -0.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s business operations are conducted primarily through ECRC (as defined below). The table below provides an overview
of the Company&#8217;s current subsidiaries and their activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></p></td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>State/Province
of Formation</b></span></p></td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership</b></span></p></td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business</b></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-top: 2pt; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0896800
    B.C. Ltd.</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-top: 2pt; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">British
    Columbia</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-top: 2pt; padding-bottom: 2pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%<br />
    by the Company</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-top: 2pt; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    only business of 0896800 is to hold the shares of Class A common stock of ECRC</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-top: 2pt; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp.</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-top: 2pt; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%
of the Class A common stock through 0896800</span></p></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-top: 2pt; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    business of ECRC is the development of the Elk Creek Project</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt; text-align: justify; text-indent: -0.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt; text-align: justify; text-indent: -0.95pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Recent
Corporate Events</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt; text-align: justify; text-indent: -0.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: -0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Transactions </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: -0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 17, 2023 (the &#8220;Closing Date&#8221;), the Company closed a series of transactions (the &#8220;GXII Transaction&#8221;)
pursuant to the Business Combination Agreement, dated as of September 25, 2022 (the &#8220;Business Combination Agreement&#8221;),
by and among the Company, GX Acquisition Corp. II, a Delaware corporation (&#8220;GXII&#8221;), and Big Red Merger Sub Ltd., a
Delaware corporation and a direct, wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;). Pursuant to the Business
Combination Agreement, the GXII Transaction was accounted for as an equity raise</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">transaction in accordance with U.S. GAAP. At
the Closing of the GXII Transaction (the &#8220;Closing&#8221;), the following transactions occurred:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 96%; padding-right: 2.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    a result of a series of transactions, including, without limitation, the mergers of Merger Sub and Old ECRC with and into
    GXII, with GXII surviving such mergers, GXII became an indirect, majority-owned subsidiary of NioCorp and changed its name
    to &#8220;Elk Creek Resources Corp&#8221;, which we refer to as &#8220;ECRC&#8221;. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; text-align: justify">&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 96%; padding-right: 2.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    the parent company of the merged entity, NioCorp issued 1,753,821 post-Reverse Stock Split common shares of the Corporation
    (the &#8220;Common Shares&#8221;) in exchange for all of the Class A shares of GXII issued and outstanding immediately prior
    to the Closing, including 83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received
    as partial payment for advisory services.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; text-align: justify">&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 96%; padding-right: 2.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    of the Class B shares of GXII issued and outstanding immediately prior to the Closing (after giving effect to the surrender
    of certain Class B shares of GXII in accordance with the Sponsor Support Agreement, dated September 25, 2022 (the &#8220;Sponsor
    Support Agreement&#8221;), among GX Sponsor II LLC (the &#8220;Sponsor&#8221;), GXII, the Company, and the other persons party
    thereto, were converted into 7,957,404 shares of Class B common stock of GXII (now known as ECRC) as the surviving entity
    of the mergers that occurred on the Closing Date as part of the GXII Transaction. Pursuant to the Business Combination Agreement,
    the Sponsor Support Agreement and the Exchange Agreement, dated as of March 17, 2023 (as amended, supplemented or otherwise
    modified, the &#8220;Exchange Agreement&#8221;), by and among NioCorp, ECRC and the Sponsor, after the Closing, the shares
    of Class B common stock of ECRC are exchangeable into Common Shares on a one-for-one basis, subject to certain equitable adjustments,
    under certain conditions. Of the issued and outstanding shares of Class B common stock of ECRC, 4,565,808 shares (the &#8220;Vested
    Shares&#8221;)&#8201;were vested as of the Closing Date and are exchangeable at any time, and from time to time, until the
    tenth anniversary of the Closing Date (the &#8220;Ten-Year Anniversary&#8221;) and 3,391,596 shares (the &#8220;Earnout Shares&#8221;)
    are exchangeable until the Ten-Year Anniversary, subject to certain vesting conditions. See Note 10 to the consolidated financial
    statements included in Part II, Item 8 hereof for additional information regarding the Class B common stock of ECRC.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; text-align: justify">&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 96%; padding-right: 2.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    assumed GXII&#8217;s obligations under the agreement governing the GXII share purchase warrants (the &#8220;GXII Warrants&#8221;)
    and issued an aggregate of 15,666,626 warrants (the &#8220;NioCorp Assumed Warrants&#8221;) to purchase up to an aggregate
    of 17,519,864 Common Shares. The NioCorp Assumed Warrants issued at the Closing consisted of (a) 9,999,959 public NioCorp
    Assumed Warrants (the &#8220;Public Warrants&#8221;) that were issued in respect of the GXII Warrants that were publicly traded
    prior to the Closing and (b) 5,666,667 NioCorp Assumed Warrants (the &#8220;Private Warrants&#8221;) that were issued to the
    Sponsor in respect of the GXII Warrants that it held prior to the Closing, which NioCorp Assumed Warrants were subsequently
    distributed by the Sponsor to its members in connection with the Closing. See Note 11b to the consolidated financial statements
    included in Part II, Item 8 hereof for additional information regarding the NioCorp Assumed Warrants.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; text-align: justify">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the Closing Date, the Company also effected a reverse stock split (the &#8220;Reverse Stock Split&#8221;) based on one (1) post-Reverse
Stock Split Common Share for every ten (10) pre-Reverse Stock Split Common Shares issued and outstanding effectuated by the Company
on the Closing Date. Any fractional shares resulting from the Reverse Stock Split were rounded down to the nearest whole Common
Share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the GXII Transaction, on January 26, 2023, the Company entered into definitive agreements with respect to two separate
financing packages with YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (&#8220;Yorkville&#8221;),
including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         Securities Purchase Agreement, dated January 26, 2023 (as amended, the &#8220;Yorkville
                                         Convertible Debt Financing Agreement&#8221;), between the Company and Yorkville, under
                                         which the Company issued to Yorkville unsecured convertible debentures in the original
                                         aggregate principal amount of $16.0 million (the &#8220;Convertible Debentures&#8221;)
                                         and Common Share purchase warrants, exercisable for up to 1,789,267 Common Shares for
                                         cash or, if at any time there is no effective registration statement registering, or
                                         no current prospectus available for, the resale of the underlying Common Shares, on a
                                         cashless basis, at the option of the holder, at a price per Common Share of approximately
                                         $8.9422, subject to adjustment to give effect to any stock dividend, stock split, reverse
                                         stock split or similar transaction (the &#8220;Financing Warrants&#8221;), on the </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Closing
Date, for gross proceeds of $15.36 million (the &#8220;Yorkville Convertible Debt Facility Financing&#8221;); and.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 19.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         Standby Equity Purchase Agreement, dated January 26, 2023 (the &#8220;Yorkville Equity
                                         Facility Financing Agreement&#8221;), between the Company and Yorkville, under which
                                         Yorkville agreed to purchase up to $65.0 million of Common Shares over the next three
                                         years, at NioCorp&#8217;s direction and subject to certain restrictions (the &#8220;Yorkville
                                         Equity Facility Financing&#8221;).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financing packages are further discussed below under &#8220;<i>Management&#8217;s Discussion and Analysis of Financial Condition
and Results of Operations &#8211; Liquidity and Capital Resources &#8211; Financing Activities</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transactions contemplated by the Business Combination Agreement, including the GXII Transaction, the Yorkville Convertible Debt
Facility Financing, the Yorkville Equity Facility Financing, and the Reverse Stock Split are referred to, collectively, as the
&#8220;Transactions.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="background-color: White">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    Shares</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 2%; background-color: White">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legacy
    NioCorp Shareholders</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,246,621</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93.90</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="background-color: White">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former GXII Class
    A Shareholders<sup>1</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,753,821</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.83</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="background-color: White">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other<sup>2</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,213</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.27</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="background-color: White">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Common Shares
    Outstanding Upon Completion of Transactions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,081,655</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 96%; padding-right: 2.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory
    services.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 96%; padding-right: 2.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    Commitment Shares (as defined below) issued under the Yorkville Equity Facility Financing Agreement.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">After
consideration of GXII expenses incurred in connection with the Transactions, the Company acquired net cash of approximately $2.2
million and assumed net liabilities of approximately $0.4 million. We also assumed Private Warrant liabilities and the Earnout
Shares liability, which were initially recorded at their non-cash fair market value of approximately $3.0 million and approximately
$13.2 million, respectively. The Company incurred expenses related to the Transactions of approximately $6.8 million, all of which
were recorded as other operating expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, in connection with the Transactions, the Common Shares and the NioCorp Assumed Warrants were listed for trading on The
Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;). The Common Shares and the NioCorp Assumed Warrants began trading on the Nasdaq
Global Market and the Nasdaq Capital Market, respectively, on March 21, 2023, under the symbols &#8220;NB&#8221; and &#8220;NIOBW,&#8221;
respectively. The Common Shares continued to trade on the Toronto Stock Exchange (the &#8220;TSX&#8221;) under the symbol &#8220;NB,&#8221;
and began trading on the Nasdaq on a post-Reverse Stock Split basis on March 21, 2023. The Common Shares ceased being quoted on
the U.S. over the counter markets in connection with the commencement of trading on the Nasdaq Global Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a008"></span>Business
Operations</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
is a mineral exploration company engaged in the acquisition, exploration, and development of mineral properties. NioCorp, through
ECRC, is developing a superalloy materials project that, if and when developed, will produce niobium, scandium, titanium, and
potentially, rare earth products. Known as the &#8220;Elk Creek Project,&#8221; it is located near Elk Creek, Nebraska, in the
southeast portion of the state.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Niobium
                                         is used to produce various superalloys that are extensively used in high performance
                                         aircraft and jet turbines. It also is used in high-strength, low-alloy steel, a stronger
                                         steel used in automobiles, bridges, structural systems, buildings, pipelines, and other
                                         applications that generally enables those applications to be stronger and lighter in
                                         mass. This &#8220;lightweighting&#8221; benefit often results in environmental benefits,
                                         including reduced fuel consumption and material usage, which can result in fewer air
                                         emissions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scandium
                                         can be combined with aluminum to make super-high-performance alloys with increased strength
                                         and improved corrosion resistance. Scandium also is a critical component of advanced
                                         solid oxide fuel cells, an environmentally preferred technology for high-reliability,
                                         distributed electricity generation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Titanium
                                         is a component of various superalloys and other applications that are used for aerospace
                                         applications, weapons systems, protective armor, medical implants and many others. It
                                         also is used in pigments for paper, paint, and plastics.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2023, the Company completed work at its Demonstration Plant that confirmed metallurgical recoveries for magnetic rare
earth products. Additional work is needed to modify the design of the proposed surface plant to make these products and to determine
the capital cost of these modifications.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
primary business strategy is to advance our Elk Creek Project to commercial production. We are focused on obtaining additional
funds to carry out our near-term planned work programs associated with securing the project financing necessary to complete detailed
design, development, and construction of the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a009"></span>Competitive
Business Conditions</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is significant competition within the minerals industry to discover and acquire mineral properties considered to have commercial
potential. We compete for the opportunity to participate in promising exploration projects with other entities. In addition, we
compete with others in efforts to obtain financing to acquire and explore mineral properties, acquire and utilize mineral exploration
equipment, and hire qualified mineral exploration personnel. We may compete with other mining companies for mining claims in regions
adjacent to our existing claims, or in other parts of the world should we dedicate resources to doing so in the future. These
companies may be better capitalized than us and we may have difficulty in expanding our holdings through the staking or acquisition
of additional mining claims or other mineral tenures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
competing for qualified mineral exploration personnel, we may be required to pay compensation or benefits relatively higher than
those paid in the past, and the availability of qualified personnel may be limited in high-demand mining periods, such as was
the case in past years when the price of gold and other metals was higher than it is now.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a010"></span>Cycles</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mining business is subject to mineral price cycles. The marketability of minerals and mineral concentrates is also affected by
worldwide economic cycles. At the present time, strong demand for some minerals in many countries is lifting commodity prices,
although it is difficult to assess how long such trends may continue. Fluctuations in supply and demand in various regions throughout
the world are common.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth commodity prices for the last five calendar years for the ferroniobium, scandium trioxide and titanium
dioxide products the Company anticipates extracting from its Elk Creek Project. These pricing surveys may not be representative
of the pricing that the Company anticipates achieving for its products once commercial production begins from its Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 21%; padding-right: 5.75pt; padding-left: 5.75pt"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 27%; padding-right: 5.75pt; padding-left: 5.75pt"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ferroniobium</b></span><br />
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S. Price ($/kg-Nb)<sup>(</sup></b><sup>1)</sup></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 26%; padding-right: 5.75pt; padding-left: 5.75pt"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc<sub>2</sub>O<sub>3</sub></b></span><br />
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S. Price ($/kg)<sup>(</sup></b><sup>2)</sup></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 26%; padding-right: 5.75pt; padding-left: 5.75pt"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<sub>2</sub></b></span><br />
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S. Price ($/kg)<sup>(</sup></b><sup>3)</sup></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$46</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2,100</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1.50</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,200</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.45</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,800</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,900</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,600</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source:
                                         Argus Metal Prices, average annual ending price, 2022. Ferroniobium 65% niobium content,
                                         FOB U.S. warehouse.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source:
                                         United States Geological Service (&#8220;USGS&#8221;) Mineral Commodity Summary, 2022.
                                         Sc<sub>2</sub>O<sub>3</sub>, 99.99% purity, 5-kilogram (&#8220;kg&#8221;) lot size.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source:
                                         USGS Mineral Commodity Summary, 2022. Rutile mineral concentrate, bulk, minimum 95% TiO<sub>2</sub>,
                                         f.o.b. Australia.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on results of the Company&#8217;s Demonstration Plant, a higher value titanium tetrachloride product can be produced with a substantially
higher metallurgical recovery than TiO<sub>2</sub>. The Company is in the process of completing feasibility level cost estimates
to replace the previous TiO<sub>2</sub> production equipment with new equipment that would produce titanium tetrachloride.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
NioCorp is a development stage issuer and has not yet generated any revenue from the operation of the Elk Creek Project, it is
not currently significantly affected by changes in commodity demand and prices, except to the extent that same impact the availability
of capital for mineral exploration and development projects. As it does not carry on production activities, NioCorp&#8217;s ability
to fund ongoing exploration is affected by the availability of financing, which is, in turn, affected by the strength of the economy
and other general economic factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a011"></span>Economic
Dependence</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than land and mineral right option agreements and agreements between NioCorp and third parties for the purchase and sale of products
to be produced from the Elk Creek Project (&#8220;offtake agreements&#8221;), NioCorp&#8217;s business is not substantially dependent
on any contract such as a contract to sell the major part of its product or services or to purchase the major part of its requirements
for goods, services or its raw materials, or any franchise or license or other agreement to use a patent, formula, trade secret,
process or trade name upon which its business depends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a012"></span>Government
Regulation</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exploration and development of a mining prospect is subject to regulation by a number of federal and state government authorities.
These include the United States Environmental Protection Agency (the &#8220;EPA&#8221;) and the United States Army Corps of Engineers
(the &#8220;USACE&#8221;) as well as the various state and local environmental protection agencies. The regulations address many
environmental issues relating to air, soil, and water contamination, and apply to many mining related activities including exploration,
mine construction, mineral extraction, ore milling, water use, waste disposal, and use of toxic substances. In addition, we are
subject to regulations relating to labor standards, occupational health and safety, mine safety, general land use, export of minerals,
taxation, data protection, and data security. Many of the regulations require permits or licenses to be obtained, the absence
of which and/or inability to obtain such permits or licenses will adversely affect our ability to conduct our exploration, development,
and operation activities. The failure to comply with the regulations and terms of permits and licenses may result in fines or
other penalties or in revocation of a permit or license or loss of a prospect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
none of the lands on which the Elk Creek Project is proposed to be built are owned by the U.S. Government, mining rights on public
lands are governed by the General Mining Law of 1872, as amended, which allows for the location of mining claims on certain federal
lands upon the discovery of a valuable mineral deposit and compliance with location requirements. The exploration of mining properties
and development and operation of mines is governed by both federal and state laws. Federal laws that govern mining claim location
and maintenance and mining operations on federal lands are generally administered by the Bureau of Land Management. Additional
federal laws, governing mine safety and health, also apply. State laws also require various permits and approvals before exploration,
development or production operations can begin. Among other things, a reclamation plan must typically be prepared and approved,
with financial assurance provided in the amount of projected reclamation costs. The financial assurance is used to ensure that
proper reclamation takes place and will not be released until that time. Local jurisdictions may also impose permitting requirements,
such as conditional use permits or zoning approvals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental
Regulation</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
mineral projects are subject to various federal, state and local laws and regulations governing protection of the environment.
These laws are continually changing and, in general, are becoming more restrictive. The development, operation, closure, and reclamation
of mining projects in the U.S. requires numerous notifications, permits, authorizations, and public agency decisions. Compliance
with environmental and related laws and regulations requires us to obtain permits issued by regulatory agencies and to file various
reports and keep records of our operations. Certain of these permits require periodic renewal or review of their conditions and
may be subject to a public review process during which opposition to our proposed operations may be encountered. We are currently
operating under various permits for activities connected to mineral exploration, reclamation, and environmental considerations.
Our policy is to conduct business in a way that safeguards public health and the environment. We believe that our operations are
conducted in material compliance with applicable laws and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
to current local, state, or federal laws and regulations in the jurisdictions where we operate could require additional capital
expenditures and increased operating and/or reclamation costs. Although we are unable to predict</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">what additional legislation,
if any, might be proposed or enacted, additional regulatory requirements could impact the economics of our projects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental
Regulation - U.S. Federal Laws</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Comprehensive Environmental, Response, Compensation, and Liability Act (&#8220;CERCLA&#8221;), and comparable state statutes,
impose strict, joint, and several liability on current and former owners and operators of sites and on persons who disposed of
or arranged for the disposal of hazardous substances found at such sites. It is not uncommon for the government to file claims
requiring clean-up actions and/or demands for reimbursement for government-incurred clean-up costs or natural resource damages.
It is also not uncommon for neighboring landowners and other third parties to file claims for personal injury and property damage
allegedly caused by hazardous substances released into the environment. The Resource Conservation and Recovery Act (&#8220;RCRA&#8221;),
and comparable state statutes, govern the disposal of solid waste and hazardous waste and authorize the imposition of substantial
fines and penalties for noncompliance, as well as requirements for corrective actions. CERCLA, RCRA, and comparable state statutes
can impose liability for clean-up of sites and disposal of substances found on exploration, mining and processing sites long after
activities on such sites have been completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Clean Air Act, as amended (&#8220;CAA&#8221;), restricts the emission of air pollutants from many sources, including mining and
processing activities. Any future mining operations by the Company may produce air emissions, including fugitive dust and other
air pollutants from stationary equipment, storage facilities, and the use of mobile sources such as trucks and heavy construction
equipment, which are subject to review, monitoring and/or control requirements under the CAA and state air quality laws. New facilities
may be required to obtain permits before work can begin, and existing facilities may be required to incur capital costs in order
to remain in compliance. In addition, permitting rules may impose limitations on our production levels or result in additional
capital expenditures in order to comply with the rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
National Environmental Policy Act (&#8220;NEPA&#8221;) requires federal agencies to integrate environmental considerations into
their decision-making processes by evaluating the environmental impacts of their proposed actions, including issuance of permits
to mining facilities and assessing alternatives to those actions. If a proposed action could significantly affect the environment,
the agency must prepare either a detailed statement known as an Environmental Impact Statement (&#8220;EIS&#8221;), or a less
detailed statement known as an Environmental Assessment (&#8220;EA&#8221;). The EPA, other federal agencies, and any interested
third parties can review and comment on the scope of the EIS or EA and the adequacy of any findings set forth in the draft and
final EIS or EA. This process can cause delays in issuance of required permits or result in changes to a project to mitigate its
potential environmental impacts, which can in turn impact the economic feasibility of a proposed project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Clean Water Act (&#8220;CWA&#8221;), and comparable state statutes, impose restrictions and controls on the discharge of pollutants
into waters of the U.S. The discharge of pollutants into regulated waters is prohibited, except in accordance with the terms of
a permit issued by the EPA or an analogous state agency. The CWA regulates storm water from mining facilities and requires a storm
water discharge permit or Stormwater Pollution Prevention Plan for certain activities. Such a permit requires the regulated facility
to monitor and sample storm water run-off from its operations. The CWA and regulations implemented thereunder also prohibit discharges
of dredged and fill material in wetlands and other waters of the U.S. unless authorized by an appropriately issued permit. The
CWA and comparable state statutes provide for civil, criminal, and administrative penalties for unauthorized discharges of pollutants,
and impose liability on parties responsible for those discharges for the costs of cleaning up any environmental damage caused
by the release and for natural resource damages resulting from the release.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Safe Drinking Water Act (&#8220;SDWA&#8221;) and the Underground Injection Control (&#8220;UIC&#8221;) program promulgated thereunder,
regulate the drilling and operation of subsurface injection wells. The EPA directly administers the UIC program in some states
and in others the responsibility for the program has been delegated to the state. The program requires that a permit be obtained
before drilling a disposal or injection well. Violation of these regulations and/or contamination of groundwater by mining-related
activities may result in fines, penalties, and remediation costs, among other sanctions and liabilities under the SDWA and state
laws. In addition, third-party claims may be filed by landowners and other parties claiming damages for alternative water supplies,
property damages, and bodily injury.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental
Regulation &#8722; Nebraska</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nebraska
has a well-developed set of environmental regulations and responsible agencies but does not have clearly defined regulations with
respect to permitting mines. As such, review of the project and the issuance of permits by Nebraska agencies and regulatory bodies
could potentially impact the total time to market for our Elk Creek Project. Other Nebraska regulations govern operating and design
standards for the construction and operation of any source of air emissions and landfill operations. Any changes to these laws
and regulations could have an adverse impact on our financial performance and results of operations by, for example, requiring
changes to operating conditions, technical criteria, fees, or surety requirements. The most stringent permit related to air quality
is known as a Prevention of Significant Deterioration (&#8220;PSD&#8221;) permit, which requires the applicant to demonstrate
compliance with NAAQS and Best Available Control Technology (&#8220;BACT&#8221;) for the control of air emissions. If the facility
exceeds the potential to emit thresholds for such a permit and is thus subject to PSD requirements, permanent construction at
the project site may not begin until the responsible agency issues the PSD permit. For facilities in Nebraska with potential emissions
below PSD thresholds, a state air construction permit is needed. The state permit also requires a demonstration of compliance
with NAAQS but does not require a BACT demonstration and further allows construction at a subject facility to proceed ahead of
permit issuance through an established variance process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a013"></span>Human
Capital</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s ability to continue to progress the Elk Creek Project will depend on its ability to attract and retain individuals
with (among other skills) financial, administrative, engineering, geological and mining skills, and knowledge of our industry
and targeted markets. Much of the necessary specialized skills and knowledge required by the Company as a mineral exploration
company are available from the Company&#8217;s current management team and Board of Directors. The Company retains outside consultants
if additional specialized skills and knowledge are required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023, we had seven full-time employees as well as one contract employee. In addition, we use consultants with specific
skills to assist with various aspects of our corporate affairs, project evaluation, due diligence, corporate governance and property
management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
compensation programs are designed to align compensation of our employees with the Company&#8217;s performance and to provide
the proper incentives to attract, retain and motivate employees to achieve superior results. The structure of our compensation
programs balances competitive wages and benefits and incentive earnings for both short-term and long-term performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
priority to maintain a culture of ethical performance as a core value is reflected in the Company&#8217;s Code of Business Conduct
and Ethics (the &#8220;Code of Conduct&#8221;) and other related policies. Oversight is provided by the Company&#8217;s Board
of Directors and, for specific areas of performance, by committees of the Board of Directors. Employees are required to review
the Code of Conduct on a periodic basis. Our compensation programs also include consideration of ethical performance in determining
incentive awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also provides a robust suite of benefits to our employees, including 401(k) participation, medical-insurance options,
and programs to encourage and support the whole person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a014"></span>Forward-Looking
Statements</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annual Report on Form 10-K and the exhibits attached hereto contain &#8220;forward-looking statements&#8221; within the meaning
of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities
Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and &#8220;forward-looking information&#8221; within the meaning
of applicable Canadian securities legislation (collectively, &#8220;forward-looking statements&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements have been based upon our current business and operating plans, as approved by the Company&#8217;s Board of Directors,
and may include statements regarding the anticipated benefits of the Transactions, including NioCorp&#8217;s ability to access
the full amount of the expected net proceeds of the Yorkville Equity Facility Financing Agreement over the next three years; NioCorp&#8217;s
ability to receive a final commitment of financing from the Export-Import Bank of the United States (&#8220;EXIM&#8221;); anticipated
benefits of the listing of the Common Shares on Nasdaq; the financial and business performance of NioCorp; NioCorp&#8217;s anticipated
results and developments in the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">operations of NioCorp in future periods; NioCorp&#8217;s planned exploration activities; the adequacy
of NioCorp&#8217;s financial resources; NioCorp&#8217;s ability to secure sufficient project financing to complete construction
and commence operation of the Elk Creek Project; NioCorp&#8217;s expectation and ability to produce niobium, scandium, and titanium
at the Elk Creek Project; NioCorp&#8217;s plans to produce and supply specific products and market demand for those products;
the outcome of current recovery process improvement testing, and NioCorp&#8217;s expectation that such process improvements could
lead to greater efficiencies and cost savings in the Elk Creek Project; the Elk Creek Project&#8217;s ability to produce multiple
critical metals; the Elk Creek Project&#8217;s projected ore production and mining operations over its expected mine life; the
completion of technical and economic analyses on the potential addition of magnetic rare earth oxides to NioCorp&#8217;s planned
product suite; the exercise of options to purchase additional land parcels; the execution of contracts with engineering, procurement
and construction companies; NioCorp&#8217;s ongoing evaluation of the impact of inflation, supply chain issues and geopolitical
unrest on the Elk Creek Project&#8217;s economic model; and the creation of full time and contract construction jobs over the
construction period of the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements are frequently, but not always, identified by words such as &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221;
&#8220;intends,&#8221; &#8220;estimates,&#8221; &#8220;potential,&#8221; &#8220;possible,&#8221; and similar expressions, or statements
that events, conditions, or results &#8220;will,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; or &#8220;should&#8221; (or the
negative and grammatical variations of any of these terms) occur or be achieved. Any statements that express or involve discussions
with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, or future events or performance
(often, but not always, using words or phrases such as &#8220;expects&#8221; or &#8220;does not expect,&#8221; &#8220;is expected,&#8221;
&#8220;anticipates&#8221; or &#8220;does not anticipate,&#8221; &#8220;plans,&#8221; &#8220;estimates,&#8221; or &#8220;intends,&#8221;
or stating that certain actions, events, or results &#8220;may,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;might,&#8221;
or &#8220;will&#8221; be taken, occur or be achieved) are not statements of historical fact and may be forward-looking statements.
Such forward-looking statements reflect the Company&#8217;s current views with respect to future events and are subject to certain
known and unknown risks, uncertainties, and assumptions. Many factors could cause actual results, performance, or achievements
to be materially different from any future results, performance, or achievements that may be expressed or implied by such forward-looking
statements, including, among others, risks related to the following: NioCorp&#8217;s ability to recognize the anticipated benefits
of the Transactions, including NioCorp&#8217;s ability to access the full amount of the expected net proceeds under the Yorkville
Equity Facility Financing Agreement over the next three years; unexpected costs related to the Transactions; the outcome of any
legal proceedings that may be instituted against NioCorp following closing of the Transactions; NioCorp&#8217;s ability to receive
a final commitment of financing from EXIM on the anticipated timeline, on acceptable terms, or at all; NioCorp&#8217;s ability
to continue to meet Nasdaq listing standards; NioCorp&#8217;s ability to operate as a going concern; risks relating to the Common
Shares, including price volatility, lack of dividend payments and dilution or the perception of the likelihood any of the foregoing;
NioCorp&#8217;s requirement of significant additional capital; the extent to which NioCorp&#8217;s level of indebtedness and/or
the terms contained in agreements governing NioCorp&#8217;s indebtedness or the Yorkville Equity Facility Financing Agreement
may impair NioCorp&#8217;s ability to obtain additional financing; covenants contained in agreements with NioCorp&#8217;s secured
creditors that may affect its assets; NioCorp&#8217;s limited operating history; NioCorp&#8217;s history of losses; the restatement
of NioCorp&#8217;s consolidated financial statements as of and for the fiscal years ended June 30, 2022 and 2021 and the interim
periods ended September 30, 2021, December 31, 2021, March 31, 2022, September 30, 2022 and December 31, 2022 and the impact of
such restatement on NioCorp&#8217;s future financial statements and other financial measures; the material weaknesses in NioCorp&#8217;s
internal control over financial reporting, NioCorp&#8217;s efforts to remediate such material weaknesses and the timing of remediation;
the possibility that NioCorp may qualify as a PFIC under the Code; the potential that the Transactions could result in NioCorp
becoming subject to materially adverse U.S. federal income tax consequences as a result of the application of Section 7874 and
related sections of the Code; cost increases for NioCorp&#8217;s exploration and, if warranted, development projects; a disruption
in, or failure of, NioCorp&#8217;s information technology systems, including those related to cybersecurity; equipment and supply
shortages; variations in the market demand for, and prices of, niobium, scandium, titanium and rare earth products; current and
future offtake agreements, joint ventures, and partnerships; NioCorp&#8217;s ability to attract qualified management; the effects
of global health crises on NioCorp&#8217;s business plans, financial condition and liquidity; estimates of mineral resources and
reserves; mineral exploration and production activities; feasibility study results; the results of metallurgical testing; changes
in demand for and price of commodities (such as fuel and electricity) and currencies; competition in the mining industry; changes
or disruptions in the securities markets; legislative, political or economic developments, including changes in federal and/or
state laws that may significantly affect the mining industry; the impacts of climate change, as well as actions taken or required
by governments related to strengthening resilience in the face of potential impacts from climate change; the need to obtain permits
and comply with laws and regulations and other regulatory requirements; the timing and reliability of sampling and assay data;
the possibility that actual results of work may differ from</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">projections/expectations or may not realize the perceived potential
of NioCorp&#8217;s projects; risks of accidents, equipment breakdowns, and labor disputes or other unanticipated difficulties
or interruptions; the possibility of cost overruns or unanticipated expenses in development programs; operating or technical difficulties
in connection with exploration, mining, or development activities; the management of the water balance at the Elk Creek Project
site; land reclamation requirements related to the Elk Creek Project; the speculative nature of mineral exploration and development,
including the risks of diminishing quantities of grades of reserves and resources; claims on the title to NioCorp&#8217;s properties;
potential future litigation; and NioCorp&#8217;s lack of insurance covering all of NioCorp&#8217;s operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may
vary materially from those described herein. This list is not exhaustive of the factors that may affect any of the Company&#8217;s
forward-looking statements. Forward-looking statements are statements about the future and are inherently uncertain, and actual
achievements of the Company or other future events or conditions may differ materially from those reflected in the forward-looking
statements due to a variety of risks, uncertainties, and other factors, including without limitation those discussed under Item
1A. &#8220;Risk Factors&#8221; below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s forward-looking statements contained in this Annual Report on Form 10-K are based on the beliefs, expectations,
and opinions of management as of the date of this Annual Report on Form 10-K. The Company does not assume any obligation to update
forward-looking statements if circumstances or management&#8217;s beliefs, expectations, or opinions should change, except as
required by law. For the reasons set forth above, investors should not attribute undue certainty to, or place undue reliance on,
forward-looking statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a015"></span>Available
Information</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain a website at http://www.niocorp.com. Our Common Shares are currently registered under Section 12(b) of the Exchange Act,
and we are currently required to file reports on Forms 10-K, 10-Q, or 8-K. Our Annual Report on Form 10-K (which includes our
audited consolidated financial statements), Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to reports
filed or furnished pursuant to Sections 13(a) and 15(d) of the Exchange Act, are available on our website, free of charge, as
soon as reasonably practicable after we electronically file such reports with, or furnish those reports to, the United States
Securities and Exchange Commission (the &#8220;SEC&#8221;). The SEC maintains an internet site that contains reports, proxy and
information statements, and other information regarding issuers that file electronically with the SEC (http://www.sec.gov). We
do not intend to send security holders a printed version of our Annual Report as it will be available online.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain a Code of Conduct, a copy of which may be found on our website in the &#8220;About Us&#8221; section under the main title
&#8220;Corporate Governance.&#8221; Our Code of Conduct contains information regarding whistleblower procedures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not including the information contained on or accessible through our website or the SEC&#8217;s website as a part of, or incorporating
it by reference into, this Annual Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                                         1A.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a016"></span>RISK
                                         FACTORS</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
business activities are subject to significant risks, including those described below. You should carefully consider these risks.
If any of the described risks occurs, our business, financial position, and results of operations could be materially adversely
affected. Such risks are not the only ones we face, and additional risks and uncertainties not presently known to us or that we
currently deem immaterial may also affect our business. This report contains forward-looking statements that involve risks and
uncertainties. Our actual results could differ materially from those anticipated in the forward-looking statements as a result
of a number of factors, including the risks described below. See &#8220;Forward-Looking Statements&#8221; under Item 1., &#8220;Business.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a017"></span>Risks
Related to Our Business</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to operate as a going concern is in doubt.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
notes that accompany our consolidated financial statements for the year ended June 30, 2023, disclose that substantial doubt exists as to our
ability to continue as a going concern. The consolidated financial statements included in this Annual Report</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">on Form 10-K have been prepared
under the assumption that we will continue as a going concern. We are a development stage issuer and we have incurred losses since
our inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have no historical recurring source of revenue and our ability to continue as a going concern is dependent on our ability
to raise capital to fund our future exploration and working capital requirements or our ability to profitably execute our business
plan. Our plans for the long-term return to and continuation as a going concern include financing our future operations through
sales of our Common Shares and/or debt and the potential profitable exploitation of our Elk Creek Project. Additionally, capital
markets and general economic conditions in the U.S. and Canada may impose significant obstacles to raising the required funds.
As discussed further below, while we have been successful in doing so in the past, there can be no assurance we will be able to
raise funds in the future. These factors raise substantial doubt about our ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will require significant additional capital to fund our business plan.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will be required to expend significant funds to develop our existing properties and to identify and acquire additional properties
to diversify our property portfolio. We anticipate that we will be required to make substantial capital expenditures for the development
of our Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023, the Company had cash of $2.3 million and working capital of $0.2 million, compared to cash of $5.3 million and
working capital of $0.6 million on June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023, the Company&#8217;s current planned operational needs are approximately $11.8 million through the end of fiscal
2024. From the date of this Annual Report on Form 10-K, the Company anticipates that it does not have sufficient cash to continue
to fund basic operations for the next twelve months. This includes general overhead costs, expected costs relating to securing
financing necessary for the Elk Creek Project, satisfying outstanding accounts payable, and potential retirement of our short-term
debt obligations. Access to additional funds will be utilized to fund basic operations as well as to further advance the Elk Creek
Project through substantive near-term milestones.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
for the net funds of $1.5 million received from financing transactions closed in September 2023, the potential funding under the
Yorkville Equity Facility Financing, discussed below under &#8220;<i>Management&#8217;s Discussion and Analysis of Financial Condition
and Results of Operations &#8211; Liquidity and Capital Resources &#8211; Financing Activities</i>,&#8221; and the potential exercise
of Options and Warrants, we currently have no further funding commitments or arrangements for additional financing at this time,
and there is no assurance that we will be able to obtain any such additional financing on acceptable terms, if at all. In addition,
pursuant to the Exchange Agreement, NioCorp is restricted from issuing equity or equity-linked securities (other than Common Shares)
or any preferred equity or non-voting equity if such issuance would adversely impact the rights of the holders of the shares of
Class B common stock of ECRC, without the consent of the holders of a majority of the shares of Class B common stock of ECRC.
The Yorkville Convertible Debt Financing Agreement also contains certain covenants that, among other things, limit NioCorp&#8217;s
ability to use the proceeds from the Yorkville Convertible Debt Financing to repay related party debt or to enter into any variable
rate transaction, including issuances of equity or debt securities that are convertible into Common Shares at variable rates and
any equity line of credit, ATM agreement or other continuous offering of Common Shares, other than with Yorkville, subject to
certain exceptions. Notwithstanding the restrictions set forth in the Exchange Agreement and the Yorkville Convertible Debt Financing
Agreement, there is significant uncertainty that we would be able to secure any additional financing in the current equity or
debt markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are actively pursuing additional sources of debt and equity financing, and while we have been successful in doing so in the past,
there can be no assurance we will be able to do so in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to obtain necessary funding for these purposes, in turn, depends upon a number of factors, including the status of the
national and worldwide economy and the price of the products we intend to produce. We may not be successful in obtaining the required
financing or, if we can obtain such financing, such financing may not be on terms that are favorable to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the EXIM Financing discussed below under &#8220;<i>Management&#8217;s Discussion and Analysis of Financial Condition
and Results of Operations &#8211; Liquidity and Capital Resources</i>&#8221; is subject to, among other matters, the satisfactory
completion of due diligence, the negotiation and settlement of final terms, and the negotiation of definitive</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">documentation. There
can be no assurance that the EXIM Financing will be completed on the terms described herein or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
inability to access sufficient capital for our operations could have a material adverse effect on our financial condition, results
of operations, or prospects. Sales of substantial amounts of securities may have a highly dilutive effect on our ownership or
share structure. Sales of a large number of Common Shares in the public markets, or the potential for such sales, could decrease
the trading price of the Common Shares and could impair our ability to raise capital through future sales of Common Shares. We
have not yet commenced commercial production at any of our properties and, as such, have not generated positive cash flows to
date and have no reasonable prospects of doing so unless successful commercial production can be achieved at our Elk Creek Project.
We expect to continue to incur negative investing and operating cash flows until such time as we enter into successful commercial
production. This will require us to deploy our working capital to fund such negative cash flow and to seek additional sources
of financing. There is no assurance that any such financing sources will be available or sufficient to meet our requirements.
There is no assurance that we will be able to continue to raise equity capital or to secure additional debt financing, or that
we will not continue to incur losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>We
have a limited operating history on which to base an evaluation of our business and prospects.</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our inception, we have had no revenue from operations. We have no history of producing products from any of our properties. Our
Elk Creek Project is a development stage property. Advancing our Elk Creek Project from a development stage property to a production
stage property will require significant capital and time, and successful commercial production from the Elk Creek Property will
be subject to permitting and construction of the mine, processing plants, roads, and other related works and infrastructure. As
a result, we are subject to all of the risks associated with developing and establishing new mining operations and business enterprises
including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         timing and cost, which can be considerable, of further exploration, preparing feasibility
                                         studies, permitting, engineering and construction of infrastructure, mining, and processing
                                         facilities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         availability and costs of drilling equipment, exploration personnel, skilled labor, and
                                         mining and processing equipment, if required;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         availability and cost of appropriate smelting and/or refining arrangements, if required;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance
                                         with environmental and other governmental approval and permit requirements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         availability of funds to finance exploration, development, permitting, and construction
                                         activities, as warranted;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                         opposition from non-governmental organizations, local groups, or local residents that
                                         may delay or prevent development activities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                         increases in exploration, construction, and operating costs due to changes in the cost
                                         of fuel, power, materials, and supplies; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                         shortages of mining, mineral processing, hydrometallurgical, pyrometallurgical, construction,
                                         and other facilities-related supplies.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
costs, timing, and complexities of exploration, development, engineering, and construction activities may be increased by the
location of our properties and competition from other mineral exploration and mining companies. It is common for exploration companies
to experience unexpected problems and delays during development, if commenced, including engineering, procurement, construction,
commissioning, and ramp-up. Accordingly, our activities may not result in profitable operations and we may not succeed in establishing
operations or profitably producing products at any of our current or future properties, including our Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a history of losses and expect to continue to incur losses in the future.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have incurred losses since inception, have negative cash flow from operating activities, and expect
to continue to incur losses in the future. We incurred the following net losses attributable to the Company during each
of the following periods:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$40.1
                                         million for the year ended June 30, 2023;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$10.9
                                         million for the year ended June 30, 2022; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.8
                                         million for the year ended June 30, 2021.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to continue to incur losses unless and until such time as one of our properties enters into commercial production and generates
sufficient revenues to fund continuing operations. We recognize that if we are unable to generate significant revenues from operations
and dispositions of our properties, we will not be able to earn profits or continue operations. At this early stage of our operation,
we also expect to face the risks, uncertainties, expenses, and difficulties frequently encountered by companies at the start-up
stage of their business development. We cannot be sure that we will be successful in addressing these risks and uncertainties
and our failure to do so could have a materially adverse effect on our financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increased
costs could affect our financial condition.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that costs at our projects that we may explore or develop will frequently be subject to variation from one year to
the next due to a number of factors, such as changing ore grade, metallurgical performance, and revisions to mine plans, if any,
in response to the physical shape and location of the ore body. In addition, costs are affected by the price of commodities such
as fuel, steel, aluminum, iron, chemicals, natural gas, fresh water, and electricity, as well as by government actions such as
tariffs. Such commodities are at times subject to volatile price movements, including increases that could make production at
certain operations less profitable or not profitable at all. A material increase in costs at any significant location could have
a significant effect on our profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
disruption in, or failure of our third-party service providers&#8217; IT systems, including those related to cybersecurity, could
adversely affect our business operations and financial performance.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on the accuracy, capacity, and security of our third-party service providers&#8217; IT systems for the operations of many
of our business processes and to comply with regulatory, legal, and tax requirements. We are dependent on third parties to provide
important IT services relating to, among other things, operational technology at our facilities, human resources, electronic communications,
and certain finance functions. Despite the security measures that our third-party service providers have implemented, including
those related to cybersecurity, their systems could be breached or damaged by computer viruses, natural or man-made incidents
or disasters, or unauthorized physical or electronic access. Though our third-party service providers have controls in place,
we cannot provide assurance that a cyber-attack will not occur. Furthermore, we may have little or no oversight with respect to
security measures employed by third-party service providers, which may ultimately prove to be ineffective at countering threats.
Failures of our third-party service providers&#8217; IT systems, whether caused maliciously or inadvertently, may result in the
disruption of our business processes, or in the unauthorized release of sensitive, confidential, or otherwise protected information
or result in the corruption of data, which could adversely affect our business operations and financial performance. In addition,
we may be required to incur significant costs to protect against and, if required, remediate the damage caused by such disruptions
or system failures in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
shortage of equipment and supplies could adversely affect our ability to operate our business.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are dependent on various supplies and equipment to carry out our mining exploration and, if warranted, project development operations.
The shortage of such supplies, equipment, and parts could have a material adverse effect on our ability to carry out our operations
and could therefore limit, or increase the cost of, production. Ongoing disruptions to the world&#8217;s economy, including issues
related to supply chains, inflation, and increased raw material and labor costs, may delay our ability to secure supplies and
equipment for the Elk Creek Project on a timely basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint
ventures and other partnerships, including offtake arrangements, may expose us to risks.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into three offtake agreements and one letter of intent related to our Elk Creek Project as well as agreements related
to the supply of natural gas and electricity to the project site, and may enter into joint ventures or partnership arrangements,
including additional offtake agreements, with other parties in relation to the exploration, development, and production of certain
of the properties in which we have an interest. Any failure of such other companies to meet their obligations to us or to third
parties, or any disputes with respect to the parties&#8217; respective rights and obligations, or price fluctuations and termination
provisions related to such agreements, could have a material adverse effect on us, the development and production at our properties,
including the Elk Creek Project, the joint ventures, if any, or their properties and therefore could have a material adverse effect
on our results of operations, financial performance, cash flows, and the price of our Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may experience difficulty attracting and retaining qualified management to meet the needs of our anticipated growth, and the failure
to manage our growth effectively could have a material adverse effect on our business and financial condition.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are dependent on a relatively small number of key employees, including our Chief Executive Officer. The loss of any officer could
have an adverse effect on us. We have no life insurance on any individual, and we may be unable to hire a suitable replacement
for them on favorable terms, should that become necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effect on the capital markets and the economy of recent global events, including inflation, volatility in commodity prices, supply
chain uncertainty, and increases in raw material and labor costs, could have an adverse effect on NioCorp&#8217;s business plans,
financial condition, and liquidity.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
events have effected, and continue to effect, the global and United States economies, including increased inflation, volatility
in commodity prices, supply chain uncertainty, and increases in raw material and labor costs. In addition, in the U.S., the Federal
Reserve has begun raising interest rates sharply, the continuation of which could lead to a recession with uncertain and potentially
severe impacts upon most operating sectors. We cannot predict how this will affect our business, but the impact may be adverse.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
it is not possible to predict the ultimate impact of these factors on NioCorp&#8217;s business plans, financial position, or liquidity,
such impacts that may be material include, but are not limited to: (i) delays in the completion of the mine and surface engineering
designs and uncertainty regarding our ability to finalize necessary Engineering, Procurement, and Construction (&#8220;EPC&#8221;)
agreements as a result of disruptions in the businesses of our engineering consultants and key contractors for the Elk Creek Project,
(ii) reduced availability and increased costs of employees, (iii) a negative impact on our liquidity position, and (iv) increased
costs and less ability to access funds in the capital markets. The full extent to which these factors may continue to impact our
business will depend on future developments, which continue to be highly uncertain and cannot be predicted at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 1pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we cannot predict the impact that recent global events, including inflation, volatility in commodity prices, supply
chain uncertainty, and increases in raw material and labor costs will have on our customers, suppliers, vendors, and other business
partners, and each of their financial conditions; however, any material effect on these parties could adversely impact us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 1pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
may be difficult to enforce judgments or bring actions outside the U.S. against us and certain of our directors.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a Canadian corporation and, as a result, it may be difficult or impossible for an investor to do the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">enforce
                                         in courts outside the U.S. judgments obtained in U.S. courts based upon the civil liability
                                         provisions of U.S. federal securities laws against these persons and the Company; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">bring
                                         in courts outside the U.S. an original action to enforce liabilities based upon U.S.
                                         federal securities laws against these persons and the Company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may not realize all or any of the anticipated benefits expected as a result of the Transactions.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
listing of the Common Shares on Nasdaq may not provide the anticipated benefits of broader access to capital and financing alternatives
or otherwise enhance NioCorp&#8217;s public profile. If the Company is not successful in realizing these anticipated benefits,
including the anticipated benefits of listing the Common Shares on the Nasdaq and the anticipated acceleration of financing efforts
to advance, complete construction, and commence operation of the Elk Creek Project, such consequences may adversely affect the
Company&#8217;s results of operations, cash flows, financial position, and the price of our Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not recognize the full value of the Yorkville Equity Facility Financing Agreement and may not receive any proceeds from the
exercise of the Financing Warrants, the NioCorp Assumed Warrants, and our other outstanding Warrants, and the potential adverse
effect on the prevailing market prices for our Common Shares as a result of sales, or the perception of future sales, of Common
Shares could adversely affect our ability to raise additional capital.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we have entered into the Yorkville Equity Facility Financing Agreement, we may not recognize the full value thereof. Specifically,
our ability to sell Common Shares to Yorkville pursuant to the Yorkville Equity Facility Financing Agreement is subject to certain
restrictions and limitations, which may prevent us from selling the full Commitment Amount prior to the expiration of the Commitment
Period. Our ability to recognize the full value of the Yorkville Equity Facility Financing Agreement may be further impeded by
the potential negative pressure on the market price of our Common Shares as a result of sales, or the perception of future sales,
of Common Shares by us or by other security holders. As a result, there can be no assurance that we will receive all or even a
significant portion of the proceeds that we expect to receive in connection with the Yorkville Equity Facility Financing Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, upon exercise, we will receive the cash exercise price of the Financing Warrants, the NioCorp Assumed Warrants, and
our other outstanding Warrants (assuming, with respect to the Financing Warrants and the NioCorp Assumed Warrants, that they are
not exercised on a cashless basis). We believe the likelihood that holders of the Financing Warrants, the NioCorp Assumed Warrants
or other outstanding Warrants will exercise their Financing Warrants, NioCorp Assumed Warrants, or other outstanding Warrants,
and therefore, the amount of cash proceeds that we would receive, is, among other things, dependent upon the market price of our
Common Shares. For so long as the market price for our Common Shares is less than the applicable exercise price of the Financing
Warrants, NioCorp Assumed Warrants, or other outstanding Warrants, we believe such holders will be unlikely to exercise their
Financing Warrants, NioCorp Assumed Warrants, or other outstanding Warrants. The potential adverse effect on the prevailing market
price of our Common Shares as a result of sales of Common Shares by us or by other security holders, or the perception that such
sales may occur, could keep the market price for our Common Shares below the applicable exercise price of the Financing Warrants,
the NioCorp Assumed Warrants, or other outstanding Warrants. Accordingly, the holders of the Financing Warrants, the NioCorp Assumed
Warrants, or other outstanding Warrants may not exercise their Financing Warrants, NioCorp Assumed Warrants, or other outstanding
Warrants before they expire, and we may not receive any proceeds from the exercise of the Financing Warrants, the NioCorp Assumed
Warrants, or other outstanding Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred significant debt in connection with the Transactions, including upon issuance of the Convertible Debentures, and we require
significant additional capital to operate our business. For example, notwithstanding whether we are able to recognize the full
value of the Yorkville Equity Facility Financing Agreement or receive the cash exercise price of the Financing Warrants, the NioCorp
Assumed Warrants, or other outstanding Warrants, we are obligated to repay or issue Common Shares upon settlement of the full
$16.0 million aggregate principal amount of the Convertible Debentures, plus accrued interest. Such significant additional debt
could adversely affect our business, which may prevent us from fulfilling our obligations with respect to our existing debt or
obtaining future financing. Further, the Yorkville Convertible Debt Financing Agreement restricts us from pursuing certain variable
rate financing transactions, which could impair our ability to obtain additional financing on terms that are favorable, or at
all. In addition, if the market price of the Common Shares were to drop as a result of sales, or the perception of future sales,
of Common Shares by us or by other security holders, this might impede our ability to raise additional capital. Our inability
to obtain additional financing on terms that are favorable, or at all, could have a material adverse effect on our financial condition,
results of operations and prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has identified material weaknesses in its internal control over financial reporting. If not remediated, the Company&#8217;s
failure to establish and maintain effective disclosure controls and procedures and internal control over financial reporting could
result in material misstatements in its financial statements and a failure to meet its reporting and financial obligations, each
of which could have a material adverse effect on the Company&#8217;s financial condition and the trading price of the Common Shares.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management has identified material weaknesses in its internal control over financial reporting relating to its control over the
consideration of all related relevant accounting guidance for non-routine transactions, its control over the design and maintenance
of an effective control environment and risk assessment process, and its monitoring controls over the timely remediation of identified
internal control weaknesses. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial
reporting, such that there is a reasonable possibility that a material misstatement of a company&#8217;s annual or interim financial
statements will not be prevented or detected on a timely basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in Item 9A, &#8220;Controls and Procedures,&#8221; of this Annual Report on Form 10-K, the Company&#8217;s management
has assessed the effectiveness of its internal control over financial reporting and its disclosure controls and procedures and
concluded that they were not effective as of June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is committed to remediating its material weaknesses as promptly as possible. Management is in the process of implementing
its remediation plan. However, there can be no assurance as to when the material weaknesses will be remediated or that additional
material weaknesses will not arise in the future. If the Company is unable to maintain effective internal control over financial
reporting, its ability to record, process and report financial information timely and accurately could be adversely affected,
which could subject the Company to litigation or investigations, require management resources, increase costs, negatively affect
investor confidence and adversely impact the trading price of the Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may face litigation and other risks as a result of the material weaknesses in our internal control over financial reporting.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
identified material weaknesses in our internal control over financial reporting that exist as of June 30, 2023. As a result of
such material weaknesses and other matters raised or that may in the future be raised by the SEC or the Canadian securities regulators,
we face potential for litigation or other disputes, which may include, among others, claims invoking the federal and state securities
laws, contractual claims or other claims arising from the material weaknesses in our internal control over financial reporting
and the preparation of our financial statements. As of the date of this Annual Report on Form 10-K, we have no knowledge of any
such litigation or dispute. However, we can provide no assurance that such litigation or dispute will not arise in the future.
Any such litigation or dispute, whether successful or not, could adversely affect our business, financial condition and results
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a018"></span>Risks
Related to Mining and Development</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face numerous uncertainties in estimating our mineral reserves and resources and inaccuracies in our estimates could result in
lower than expected revenues, higher than expected costs and decreased profitability.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
mineral is economically recoverable when the price at which we may sell the mineral exceeds the costs and expenses of mining and
selling the mineral. Forecasts of our future performance are based on, among other things, estimates of our mineral reserves.
We base our reserve and resource information on engineering, economic and geological data assembled and analyzed by qualified
persons, which include various engineers and geologists on our staff and of third parties. Our estimates are also subject to SEC
regulations regarding classification of reserves and resources, including S-K 1300. Our reserve and resource estimates as to both
quantity and quality are updated from time to time to reflect additional information received. There are numerous uncertainties
inherent in estimating quantities and qualities of mineral reserves and resources, including many factors beyond our control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates
of mineral reserves and resources necessarily depend upon a number of variable factors and assumptions, any one of which may,
if incorrect, result in an estimate that varies considerably from actual results. These factors and assumptions include, but are
not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">geologic
                                         and mining conditions, which may not be fully identified by available exploration data
                                         and may differ from our experience;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">demand
                                         for the minerals that we plan to produce;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">current
                                         and future market prices for minerals and contractual arrangements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">current
                                         and future operating costs and capital expenditures may exceed estimates, notwithstanding
                                         that, under S-K 1300, operating cost and capital expenditure estimates in feasibility
                                         studies must have an accuracy level of at least &#177;15% and a contingency range not
                                         exceeding 10%;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">additional capital expenditures related to the modification of the proposed surface plant related to the potential addition
of rare earth elements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">severance
                                         and excise taxes, royalties and development and reclamation costs;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">future
                                         mining technology improvements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         effects of regulation by governmental agencies;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         ability to obtain, maintain and renew all required permits;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">employee
                                         health and safety; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">historical
                                         production from the area compared with production from other producing areas.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
conversion of reported mineral resources to mineral reserves should not be assumed, and the reclassification of reported mineral
resources from lower to higher levels of geological confidence should not be assumed. As such, actual mineral tonnage recovered
from identified reserves, and revenues and expenditures with respect to our reserves, may vary materially from estimates. Thus,
these estimates may not accurately reflect our actual reserves. Any material inaccuracy in our estimates related to our reserves
could result in lower than expected revenues, higher than expected costs, or decreased profitability, which could materially and
adversely affect our business, results of operations, financial position, and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
nature of mineral exploration and production activities involves a high degree of risk and the possibility of uninsured losses.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exploration
for and the production of minerals is highly speculative and involves much greater risk than many other businesses. Most exploration
programs do not result in the discovery of mineralization, and any mineralization discovered may not be of sufficient quantity
or quality to be profitably mined. Our operations are, and any future development or mining operations we may conduct will be,
subject to all of the operating hazards and risks normally incident to exploring for and developing mineral properties, such as,
but not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">economically
                                         insufficient mineralized material;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuation
                                         in production costs that make production uneconomical;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">labor
                                         disputes;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unanticipated
                                         variations in grade and other geologic problems;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">environmental
                                         hazards;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">water
                                         conditions;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficult
                                         surface or underground conditions;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">industrial
                                         accidents;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">metallurgical,
                                         pyrometallurgical, and other processing problems;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">mechanical
                                         and equipment performance problems;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                         of dams, stockpiles, wastewater transportation systems, or impoundments;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unusual
                                         or unexpected rock formations; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">personal
                                         injury, fire, flooding, cave-ins, and landslides.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of these risks can materially and adversely affect, among other things, the development of properties, production quantities and
rates, costs and expenditures, potential revenues, and production dates. We currently have very limited insurance to guard against
some of these risks. If we determine that capitalized costs associated with any of our mineral interests are not likely to be
recovered, we would incur a write-down of our investment in these interests. All of these factors may result in losses in relation
to amounts spent that are not recoverable, or that result in additional expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no history of producing commercial products from our current mining properties and there can be no assurance that we will
successfully establish mining operations or profitably produce minerals.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no history of producing commercial products from our current mining properties. We do not produce commercial products and
do not currently generate operating earnings. While we seek to move our Elk Creek Project from a development stage property to
a production stage property, such efforts will be subject to all of the risks associated with establishing new mining operations
and business enterprises, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         timing and cost, which are considerable, of the construction of mining and processing
                                         facilities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         availability and costs of skilled labor and equipment;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance
                                         with environmental and other governmental approval and permit requirements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         availability of funds to finance construction and development activities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                         opposition from non-governmental organizations, local groups, or local residents that
                                         may delay or prevent development activities; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                         increases in construction and operating costs due to changes in the cost and availability
                                         of labor, fuel, power, materials, and equipment and supplies, and the time elapsed since
                                         the most recent estimates of cost and availability were made.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is common in new mining and processing operations to experience unexpected problems and delays during engineering, procurement,
construction, commissioning, and initial operations. In addition, our management and workforce will need to be expanded, and sufficient
housing and other support systems for our workforce will have to be established. This could result in delays in the commencement
of production and increased costs of production. Accordingly, we cannot assure you that our activities will result in profitable
operations or that we will successfully establish mining and processing operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Results
of metallurgical testing by us may not be favorable to, or as expected by, us.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have completed significant bench, mini-pilot, and pilot scale metallurgical testing on material from the Elk Creek Project and
will continue to complete necessary metallurgical testing at the bench, mini-pilot, and pilot scale as the exploration and, if
warranted, development of the Elk Creek Project progresses. There can be no assurance that the results of such metallurgical testing
will be favorable to, or will be as expected by, us. Furthermore, there can be no certainty that metallurgical recoveries obtained
in bench or pilot scale tests will be achieved in either subsequent testing or commercial operations. The development of a complete
metallurgical process to produce saleable final products from the Elk Creek Project is a complex and resource-intensive undertaking
that may result in overall schedule delays and increased project costs for us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
volatility could have dramatic effects on our results of operations and our ability to execute our business plan.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
price of commodities varies on a daily basis. Niobium is a specialty metal and not a commonly traded commodity such as copper,
zinc, gold, or iron ore. The price of niobium tends to be set through a limited long-term offtake market, contracted between very
few suppliers and purchasers. The world&#8217;s largest supplier of niobium, Companhia Brasileira de Metalurgia e Minera&#231;&#227;o,
supplies approximately 85% of the world&#8217;s niobium. Any attempt to suppress the price of niobium by such supplier, or an
increase in production by any supplier in excess of any increased demand, would have negative consequences on the price of niobium
and, potentially, on our value. The price of niobium may also be reduced by the discovery of new niobium deposits, which could
not only increase the overall supply of niobium (causing downward pressure on its price) but could draw new firms into the niobium
industry that would compete with us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc<sub>2</sub>O<sub>3
</sub>is used in solid oxide fuel cells and has the potential to become a valuable alloy with aluminum in the aerospace and automotive
industries. Supply of scandium has been sporadic in recent years, and there are no primary scandium mines in the world at present.
Production primarily occurs as a by-product from existing metallurgical plants, primarily in Russia, Canada, the Philippines,
and China. Our management believes the Elk Creek Project would significantly increase the world&#8217;s supply of scandium trioxide.
Although the Company&#8217;s market studies indicate a positive outlook for demand, there is no assurance at present that the
Company could sell all of its production. In addition, the sale of scandium represents a significant portion of the Elk Creek
Project revenue; achieving the revenue projected in the Company&#8217;s studies is subject to market growth in scandium, which
is a developing market with a risk of oversupply and/or undersupply disrupting pricing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Titanium
metal is used in various superalloys and other applications for aerospace applications, armor, and medical implants, and in oxide
form is a key component of pigments used in paper, paint, and plastics. The Elk Creek Project would produce a small quantity of
titanium dioxide relative to other producers. As a small producer, we would be subject to fluctuations in the price of TiO<sub>2
</sub>that would result from normal variations in supply and demand for this commodity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be able to establish a viable recovery process for REEs<span style="font-style: normal">. </span></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market for rare earth products requires particular levels of purity and chemical form, which are achieved through the extraction
and separation of individual REEs from each other as well as from the other constituents in the rare earth ore. At present, the
Company has substantially completed the engineering and testing of a process for producing commercial rare earth products but
has not completed all work necessary to declare a REE reserve estimate for the Elk Creek deposit. The completion of the work necessary
to demonstrate an economically feasible rare earth recovery system will require additional expenditures of cash and time to complete.
There is no guarantee that the Company will be successful in demonstrating positive economics for a rare earth recovery system
tied to the Elk Creek</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Project, nor is there any guarantee that once constructed, the rare earth recovery system will operate as
designed and produce saleable commercial products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates
of resources and reserves are subject to evaluation uncertainties that could result in project failure.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
exploration and future mining operations, if any, are and would be faced with risks associated with being able to accurately predict
the quantity and quality of resources/reserves within the earth using statistical sampling techniques. Estimates of any resources/reserves
on any of our properties would be made using samples obtained from appropriately placed trenches, test pits, underground workings,
and intelligently designed drilling. There is an inherent variability of assays between check and duplicate samples taken adjacent
to each other and between sampling points that cannot be reasonably eliminated. Additionally, there also may be unknown geologic
details that have not been identified or correctly appreciated at the current level of accumulated knowledge about our properties.
This could result in uncertainties that cannot be reasonably eliminated from the process of estimating resources/reserves. If
these estimates were to prove to be unreliable, we could implement an exploitation plan that may not lead to commercially viable
operations in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
material changes in mineral resource/reserve estimates and grades of mineralization will affect the economic viability of placing
a property into production and a property&#8217;s return on capital.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
resource/reserve estimates may require adjustments or downward revisions. In addition, the grade of ore ultimately mined, if any,
may differ from that indicated by our feasibility studies and drill results. Minerals recovered in small scale tests may not be
duplicated in large scale tests under on-site conditions or at commercial production scale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
resource and reserve estimates included in the S-K 1300 Elk Creek Technical Report Summary and contained in this Annual Report
on Form 10-K have been determined based on assumed future prices, cut-off grades, and operating costs that may prove to be inaccurate.
Extended declines in market prices for our products may render portions of our resource/reserve estimates uneconomic and may result
in reduced reported resources/reserves or may adversely affect any commercial viability determinations we may reach. Any material
reductions in estimates of resources/reserves could have a material adverse effect on our Common Share price and on the value
of our properties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face intense competition in the mining industry.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mining industry is intensely competitive in all of its phases. As a result of this competition, some of which is with large established
mining companies with substantial capabilities and with greater financial and technical resources than ours, we may be unable
to acquire additional properties, if any, or financing on terms we consider acceptable. We also compete with other mining companies
in the recruitment and retention of qualified managerial and technical employees. If we are unable to successfully compete for
qualified employees, our exploration and development programs may be slowed down or suspended. We compete with other companies
that produce our planned commercial products for capital. If we are unable to raise sufficient capital, our exploration and development
programs may be jeopardized or we may not be able to acquire, develop, or operate additional mining projects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Difficulties
in water balance management at our Elk Creek Project could negatively affect our potential production and economics at the project.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has conducted three field investigations and two major technical studies into the hydrogeology of the Elk Creek carbonatite,
which is the geologic formation which hosts the mineralized material that would be extracted by the Company&#8217;s mining operations.
The Company expects to encounter significant amounts of water in the carbonatite, which will need to be pumped out of the formation
to facilitate a mining operation. Water quality analyses have demonstrated that this water will have elevated temperature and
salt content when compared to other water resources in the area. While the Company has developed plans to treat water produced
from the mine for use in its operations, there is no guarantee that the permits needed for the treatment of the water or the disposal
of the resultant waste products will be issued by the State of Nebraska, nor is there any guarantee that such permits will be
issued in a timely fashion. Further, based on such plans, the operations will rely on a water treatment system to achieve zero
discharge of wastewater, and there is no guarantee that this system will function as designed or achieve nameplate treatment capacity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
to our properties may be subject to other claims that could affect our property rights and claims.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are risks that title to our properties may be challenged or impugned. Our Elk Creek Project is located in Nebraska and may be
subject to prior unrecorded agreements or transfers or native land claims, and title may be affected by undetected defects. Our
current land and/or mineral rights lease agreements between ECRC and individual landowners give us an option to purchase additional
property (&#8220;OTP&#8221;), which, along with the property we already own, will allow us to construct the Elk Creek Project
once sufficient project financing is obtained. The rights of the current owners to sell the property subject to these options
may be subject to prior unrecorded or unknown claims to title. We have investigated our rights to explore and exploit the Elk
Creek Project resource/reserve and, to the best of our knowledge, our rights in relation to lands covering the Elk Creek Project
resource/reserve are in good standing. However, there may be valid challenges to the title of our properties that, if successful,
could impair development and/or operations. Further, our current OTP agreements, which are important for operations, are of fixed
duration and expire between December 2024 and May 2040.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
properties and operations may be subject to litigation or other claims.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time our properties or operations may be subject to disputes that may result in litigation or other legal claims. We may
be required to assert or defend against these claims, which will divert resources and management time from operations. The costs
of these claims or adverse filings may have a material effect on our business and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not currently insure against all the risks and hazards of mineral exploration, development, and mining operations.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exploration,
development, mining, and surface operations involve various hazards, including environmental hazards, industrial accidents, metallurgical
and other processing problems, unusual or unexpected rock formations, structural cave-ins or slides, flooding, fires, and periodic
interruptions due to inclement or hazardous weather conditions. These risks could result in damage to or destruction of mineral
properties, facilities, or other property, personal injury, environmental damage, delays in operations, increased cost of operations,
monetary losses, and possible legal liability. We may not be able to obtain insurance to cover these risks at economically feasible
premiums or at all. We may elect not to insure where premium costs are disproportionate to our perception of the relevant risks.
The payment of such insurance premiums and of such liabilities would reduce the funds available for exploration and production
activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a019"></span>Risks
Related to Government Regulation</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be able to obtain or renew all required permits and licenses to place any of our properties into production.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current and future operations, including development activities and commencement of production, if warranted, on the Elk Creek
Project, require permits from governmental authorities and such operations are and will be governed by laws and regulations governing
prospecting, development, mining, production, exports, taxes, labor standards, occupational health, waste disposal, toxic substances,
land use, environmental protection, mine safety, and other matters. Companies engaged in mineral property exploration and the
development or operation of mines and related facilities generally experience increased costs, as well as delays in production
and other schedules as a result of the need to comply with applicable laws, regulations, and permits. We cannot predict if all
permits that we may require for continued exploration, development, or construction of mining facilities and conduct of mining
operations will be obtainable or renewable on reasonable terms, if at all. Costs related to applying for and obtaining permits
and licenses may be prohibitive and could delay our planned exploration and development activities. Failure to comply with applicable
laws, regulations, and permitting requirements may result in enforcement actions, including orders issued by regulatory or judicial
authorities causing operations to cease or be curtailed, and may include corrective measures requiring capital expenditures, installation
of additional equipment, or remedial actions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facilities
associated with the Elk Creek Project, such as the mine, surface plant, tailings facilities, stockpiles and supporting infrastructure,
are likely to either temporarily or permanently impact waterbodies and wetlands that are subject to regulation by the USACE as
Waters of the United States (&#8220;WOUS&#8221;). We believe that we have obtained the necessary USACE permits to construct the
project, but changes to the design or layout of the facility may trigger the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">USACE to require us to obtain and maintain additional
permits for the Elk Creek Project. The duration of this permitting exercise is dictated by the USACE and would need to be completed
before facilities that would impact WOUS could be constructed. We may experience delays or additional costs in relation to obtaining
the necessary permits and these delays and additional costs could negatively affect the economics of the Elk Creek Project and
our results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties
engaged in mining operations may be required to compensate those suffering loss or damage by reason of the mining activities and
may have civil or criminal fines or penalties imposed for violations of applicable laws or regulations. Amendments to current
laws, regulations, and permits governing operations and activities of mining companies, or more stringent implementation thereof,
could have a material adverse impact on our operations and cause increases in capital expenditures or production costs or reduction
in levels of production at producing properties or require abandonment or delays in development of new mining properties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to significant governmental regulations that affect our operations and costs of conducting our business.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current and future operations, including development of the Elk Creek Project, are and will be governed by laws and regulations,
including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">laws
                                         and regulations governing mineral concession acquisition, prospecting, development, mining,
                                         and production;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">laws
                                         and regulations related to exports, taxes, and fees;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">labor
                                         standards and regulations related to occupational health and mine safety; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">environmental
                                         standards and regulations related to waste disposal, toxic substances, land use reclamation,
                                         and environmental protection.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies
engaged in development activities often experience increased costs and delays in production and other schedules as a result of
the need to comply with applicable laws, regulations, and permits. Failure to comply with applicable laws, regulations, and permits
may result in enforcement actions, including the forfeiture of mineral claims or other mineral tenures and/or orders issued by
regulatory or judicial authorities requiring operations to cease or be curtailed, and may include corrective measures requiring
capital expenditures, installation of additional equipment, or costly remedial actions. We may be required to compensate those
suffering loss or damage by reason of our development activities and may have civil or criminal fines or penalties imposed for
violations of such laws, regulations, and permits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Existing
and possible future laws, regulations, and permits governing operations and activities of mineral development companies, or more
stringent implementation, could have a material adverse impact on our business and cause increases in capital expenditures or
require abandonment or delays in development. Our Elk Creek Project is located in Nebraska, and while the State does have a comprehensive
and modern set of environmental regulations, it does not have specific regulations with respect to permitting or reclaiming mines
which could potentially impact the total time to market for the project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
activities are subject to environmental laws and regulations that may change, thereby increasing our costs of doing business and
restricting our operations.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
phases of our operations are subject to environmental regulation in the jurisdictions in which we operate. Environmental legislation
is evolving in a manner that may require stricter standards and enforcement, increased fines and penalties for non-compliance,
more stringent environmental assessments of proposed projects, and a heightened degree of responsibility for companies and their
officers, directors, and employees. These laws address emissions into the air, discharges into water, management of waste, management
of hazardous substances, protection of natural resources, antiquities and endangered species, and reclamation of lands disturbed
by mining operations. Compliance with environmental laws and regulations, and future changes in these laws and regulations, may
require significant capital outlays and may cause material changes or delays in our operations and future activities. It is possible
that future changes in these laws or regulations could have a significant adverse impact on our properties or some portion of
our business, causing us to re-evaluate those activities at that time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulations
and pending legislation governing issues involving climate change could result in increased operating costs, which could have
a material adverse effect on our business.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
number of governments or governmental bodies have introduced or are contemplating legislative and/or regulatory changes in response
to concerns about the potential impact of climate change. Legislation and increased regulation regarding climate change could
impose significant costs on us, on our future venture partners, if any, and on our suppliers, including costs related to increased
energy requirements, capital equipment, environmental monitoring and reporting, and other costs necessary to comply with such
regulations. Any adopted future climate change regulations could also negatively impact our ability to compete with companies
situated in areas not subject to such limitations. Given the emotion, political significance, and uncertainty surrounding the
impact of climate change and how it should be dealt with, we cannot predict how legislation and regulation will affect our financial
condition, operating performance, and ability to compete. Furthermore, even without such regulation, increased awareness and any
adverse publicity in the global marketplace about potential impacts on climate change by us or other companies in our industry
could harm our reputation. The potential physical impacts of climate change on our operations are highly uncertain and could be
particular to the geographic circumstances in areas in which we operate and may include changes in rainfall and storm patterns
and intensities, water shortages, changing sea levels, and changing temperatures. These impacts may adversely impact the cost,
production, and financial performance of our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land
reclamation requirements for our properties may be burdensome and expensive.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
variable depending on location and the governing authority, land reclamation requirements are generally imposed on mineral exploration
companies (as well as companies with mining operations) in order to minimize long-term effects of land disturbance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reclamation
may include requirements to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">control
                                         dispersion of potentially deleterious effluents;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">treat
                                         ground and surface water to achieve water quality standards; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonably
                                         re-establish pre-disturbance landforms and vegetation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to carry out reclamation obligations imposed on us in connection with our potential development activities, we must allocate
financial resources that might otherwise be spent on further exploration and development programs. We plan to set up a provision
for our reclamation obligations on our properties, as appropriate, but this provision may not be adequate. If we are required
to carry out unanticipated reclamation work, our financial position could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a020"></span>Risks
Related to Our Debt</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
level of our indebtedness from time to time could impair our ability to obtain additional financing.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we may enter into transactions to acquire assets or the shares of other companies or to fund development of the
Elk Creek Project. These transactions may be financed partially or wholly with debt, which may increase our debt levels above
industry standards. Our articles of incorporation do not limit the amount of indebtedness that we may incur. Our indebtedness
could impair our ability to obtain additional financing in the future on a timely basis to take advantage of business opportunities
that may arise. Our ability to service our debt obligations will depend on our future operations, which are subject to prevailing
industry conditions and other factors, many of which are beyond our control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a021"></span>Risks
Related to the Common Shares</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>NioCorp
may be a &#8220;passive foreign investment company&#8221; for the current taxable year and for one or more future taxable years,
which may result in materially adverse U.S. federal income tax consequences for U.S. investors.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
NioCorp is a passive foreign investment company (&#8220;PFIC&#8221;) for any taxable year, or portion thereof, that is included
in the holding period of a U.S. holder of Common Shares or other securities of NioCorp, such U.S. holder</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">may be subject to certain
adverse U.S. federal income tax consequences. These adverse tax consequences include requirements to treat any gain realized upon
a disposition of Common Shares or other securities, or any &#8220;excess distribution&#8221; received on Common Shares, as ordinary
income, to pay an interest charge on a portion of such gain or distribution, and certain additional reporting requirements. Such
consequences may be mitigated with respect to Common Shares (but not with respect to warrants or other securities of NioCorp)
if the holder thereof makes a timely and effective &#8220;qualified electing fund&#8221; or &#8220;QEF&#8221; election or a &#8220;mark-to-market&#8221;
election. A U.S. holder of Common Shares that makes a QEF election generally must include in income on a current basis for U.S.
federal income tax purposes its share of NioCorp&#8217;s net capital gain and ordinary earnings for any taxable year in which
it is a PFIC, whether or not NioCorp distributes any amount to its shareholders. A U.S. holder of Common Shares that makes a mark-to-market
election generally must include as ordinary income each year the excess of the fair market value of the Common Shares over the
taxpayer&#8217;s basis therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
generally will be classified as a PFIC for a taxable year if (a) 75% or more of its gross income for such year is &#8220;passive
income&#8221; (generally, dividends, interest, rents, royalties, and gains from the disposition of assets producing passive income)
or (b) at least 50% or more of the value of its assets produce, or are held for the production of, passive income, based on the
quarterly average of the fair market value of such assets. NioCorp believes that it may be classified as a PFIC for its taxable
year ended June 30, 2023 and was classified as a PFIC for its taxable year ended June 30, 2022 and, based on the current composition
of its income and assets, as well as current business plans and financial expectations, may be classified as a PFIC for future
taxable years. Any conclusion regarding PFIC status is a factual determination that must be made annually at the close of each
taxable year and, thus, is subject to change. In addition, even if NioCorp concluded it did not qualify as a PFIC, it is possible
that the U.S. Internal Revenue Service (the &#8220;IRS&#8221;) could assert, and that a court could sustain, a determination that
NioCorp is a PFIC. Accordingly, there can be no assurance that NioCorp will not be treated as a PFIC for any taxable year. The
PFIC rules are complex and each holder of Common Shares or other securities of NioCorp should consult its own tax advisors regarding
these rules and the U.S. federal income tax consequences of the acquisition, ownership, and disposition of such securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Transactions could result in NioCorp becoming subject to materially adverse U.S. federal income tax consequences.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7874 and related sections Code, provide for certain adverse tax consequences when the stock of a U.S. corporation is acquired
by a non-U.S. corporation in certain transactions in which former shareholders of the U.S. corporation come to own 60% or more
of the stock of the non-U.S. corporation (by vote or value, and applying certain specific counting and ownership rules). These
adverse tax consequences include (i) potential additional required gain recognition by the U.S. corporation, (ii) treatment of
certain payments to the non-U.S. corporation that reduce gross income as &#8220;base erosion payments,&#8221; (iii) an excise
tax on certain options and stock-based compensation of the U.S. corporation, (iv) disallowance of &#8220;qualified dividend&#8221;
treatment for distributions by the non-U.S. corporation, and (v) if former shareholders of the U.S. corporation come to own 80%
or more of the stock of the non-U.S. corporation, treatment of the non-U.S. corporation as a U.S. corporation subject to U.S.
federal income tax on its worldwide income (in addition to any tax imposed by non-U.S. jurisdictions). If the Transactions result
in the application of any of these, or any other, adverse tax consequences, NioCorp could incur significant additional tax costs.
While NioCorp currently does not believe the Transactions will cause such adverse tax consequences as a result of Section 7874
and related sections of the Code, this determination is subject to significant legal and factual uncertainty. NioCorp has not
sought and will not seek any rulings from the IRS as to the tax treatment of any of the Transactions. Further, there can be no
assurance that your tax advisor, the IRS, or a court, will agree with the position that NioCorp is not subject to these adverse
tax consequences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Share price may be volatile and as a result you could lose all or part of your investment.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to volatility associated with equity securities in general, the value of your investment could decline due to the impact
of any of the following factors upon the market price of the Common Shares:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disappointing
                                         results from our exploration and/or, if warranted, project development efforts;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">decline
                                         in demand for Common Shares;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">downward
                                         revisions in securities analysts&#8217; estimates or changes in general market conditions;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">technological
                                         innovations by competitors or in competing technologies;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investor
                                         perception of our industry or our prospects; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
                                         economic trends.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the past fiscal year, the trading price of our stock on the Nasdaq and TSX has ranged as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 38%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Low</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TSX</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$17.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$6.44</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq<sup>1</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$7.83</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.75</span></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin: 0 auto; width: 50%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>1
</sup>Trading initiated on March 21, 2023.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, stock markets in general have experienced extreme price and volume fluctuations, and the market prices of securities
have been highly volatile. These fluctuations are often unrelated to operating performance and may adversely affect the market
price of the Common Shares. As a result, you may be unable to sell any Common Shares you acquire at a desired price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never paid dividends on the Common Shares.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not paid dividends on the Common Shares to date, and we may not be in a position to pay dividends for the foreseeable future.
Our ability to pay dividends with respect to the Common Shares will depend on our ability to successfully develop one or more
properties and generate earnings from operations. Further, our initial earnings, if any, will likely be retained to finance our
operations. Any future dividends on Common Shares will depend upon our earnings, our then-existing financial requirements, and
other factors, and will be at the discretion of our Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Future
sales, or the perception of future sales, of Common Shares by existing shareholders or by us, or future dilutive issuances of
Common Shares by us, could adversely affect prevailing market prices for the Common Shares and cause investors to suffer dilution
in their net book value per Common Share.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of a substantial number of Common Shares in the public market could occur at any time, including issuances and sales of additional
Common Shares by us and sales by other security holders. These sales, or the market perception that the holders of a large number
of Common Shares or securities convertible, exercisable, or exchangeable into Common Shares intend to sell Common Shares, could
reduce the prevailing market price of the Common Shares. The effect, if any, that future public sales of these securities or the
availability of these securities for sale will have on the market price of the Common Shares is uncertain. If the market price
of the Common Shares were to drop as a result, this might impede our ability to raise additional capital and might cause remaining
shareholders to lose all or part of their investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Articles of NioCorp, as amended in connection with the Transactions, permit us to issue an unlimited number of Common Shares.
Subject to the requirements of the British Columbia Business Corporations Act, Nasdaq and TSX, we will not be required to obtain
the approval of the NioCorp shareholders for the issuance of additional Common Shares. We have issued Common Shares in the past
and will continue to issue Common Shares to finance our activities in the future. In addition, outstanding options, warrants,
and broker warrants to purchase Common Shares may be exercised, resulting in the issuance of additional Common Shares. If we issue
additional Common Shares or decide to enter into joint ventures with other parties in order to raise financing through the sale
of equity securities, investors&#8217; interests in the Company will be diluted and investors may suffer dilution in their net
book value per Common Share depending on the price at which such securities are sold.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
pursuant to the Yorkville Equity Facility Financing Agreement, Yorkville has committed to purchase up to $65.0 million of our
Common Shares, at our direction from time to time during the Commitment Period, subject to certain limitations and the satisfaction
of the conditions in the Yorkville Equity Facility Financing Agreement. We have filed a registration statement under the Securities
Act covering resales by Yorkville of the Common Shares issuable pursuant to the Yorkville Equity Facility Financing Agreement.
Accordingly, any Common Shares that we issue pursuant to the Yorkville Equity Facility Financing Agreement will be available for
sale into the public market, subject to applicable securities laws, which could reduce the prevailing market price for the Common
Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the continued listing criteria of the Nasdaq and TSX and our failure to satisfy these criteria may result in delisting
of the Common Shares.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Shares are currently listed on the Nasdaq Global Market and TSX under the symbol &#8220;NB&#8221;. The public NioCorp Assumed
Warrants are currently listed on the Nasdaq Capital Market under the symbol &#8220;NIOBW.&#8221; Both the Nasdaq Capital Market
and TSX have rules for continued listing. In order to maintain the listings, we must maintain certain financial and share distribution
targets, including maintaining a minimum number of public shareholders. In addition to objective standards, TSX may delist the
securities of any issuer if, in TSX&#8217;s opinion, the issuer&#8217;s financial condition and/or operating results appear unsatisfactory;
if it appears that the extent of public distribution or the aggregate market value of the security has become so reduced as to
make continued listing on TSX inadvisable; if the issuer sells or disposes of principal operating assets or ceases to be an operating
company; if an issuer fails to comply with the listing requirements of TSX; or if any other event occurs or any condition exists
which makes continued listing on TSX, in the opinion of TSX, inadvisable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Nasdaq or TSX delists the Common Shares, investors may face material adverse consequences, including, but not limited to, a lack
of a trading market for the Common Shares, reduced liquidity, a determination that our Common Shares are a &#8220;penny stock,&#8221;
decreased analyst coverage of the Company, and an inability for us to obtain additional financing to fund our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of additional Common Shares may negatively impact the trading price of our securities.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have issued Common Shares in the past and will continue to issue Common Shares to finance our activities in the future. In addition,
outstanding options, warrants, and broker warrants to purchase Common Shares may be exercised, resulting in the issuance of additional
Common Shares. The issuance by us of additional Common Shares would result in dilution to our shareholders, and even the perception
that such an issuance may occur could have a negative impact on the trading price of the Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our Common Shares are considered a penny stock and are subject to the penny stock rules, broker-dealers may be discouraged from
effecting transactions in Common Shares.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Shares has in the past, and may in the future, be considered a &#8220;penny stock.&#8221; The SEC has adopted Rule 15g-9
which generally defines &#8220;penny stock&#8221; to be any equity security that has a market price (as defined) less than $5.00
per share or an exercise price of less than $5.00 per share, subject to certain exceptions. Applicable penny stock rules impose
additional sales practice requirements on broker-dealers who sell to persons other than established customers and &#8220;accredited
investors.&#8221; The term &#8220;accredited investor&#8221; refers generally to institutions with assets in excess of $5.0 million
or individuals with a net worth in excess of $1.0 million or annual income exceeding $200 or $300, jointly with their spouse.
The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from the rules, to
deliver a standardized risk disclosure document in a form prepared by the SEC, which provides information about penny stocks and
the nature and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid and
offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction, and monthly
account statements showing the market value of each penny stock held in the customer&#8217;s account. The bid and offer quotations,
and the broker-dealer and salesperson compensation information, must be given to the customer orally or in writing prior to effecting
the transaction and must be given to the customer in writing before or with the customer&#8217;s confirmation. In addition, the
penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from these rules, the broker-dealer
must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser&#8217;s
written agreement to the transaction. If and when applicable, these disclosure requirements may have the effect of reducing the
level of trading activity in the secondary market for the Common Shares. Consequently, these penny stock rules may affect the
ability of broker-dealers to trade in the Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.0035in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.7465in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                                         1B.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a022"></span>UNRESOLVED
                                         STAFF COMMENTS</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.0035in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.7465in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                                         2.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a023"></span>PROPERTIES</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Elk
Creek Project, Nebraska </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal mineral property is the Elk Creek Property, a niobium, scandium, and titanium development stage property. The Elk Creek
Project has established indicated and inferred resources along with probable reserves and the Company has completed a feasibility
study for the project. The below information is in part summarized or extracted from our S-K 1300 Elk Creek Technical Report Summary,
which was filed as Exhibit 96.1 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2022, and
is incorporated by reference into this Annual Report on Form 10-K. The Company does not have any other material properties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
qualified persons responsible for preparing the S-K 1300 Elk Creek Technical Report Summary are Dahrouge Geological Consulting
USA Ltd.; Understood Mineral Resources Ltd.; Optimize Group; Tetra Tech; Adrian Brown Consultants Inc.; Metallurgy Concept Solutions;
Magemi Mining Inc.; L3 Process Development; A2GC; Scott Honan, M.Sc, SME-RM, NioCorp; Everett Bird, P.E., Cementation; Matt Hales,
P.E., Cementation; Mahmood Khwaja, P.E., CDM Smith; Martin Lepage, P.Eng, Ing., Cementation; and Wynand Marx, M.Eng, BBE Consulting.
A matrix of the sections for which each qualified person is responsible is included in the S-K 1300 Elk Creek Technical Report
Summary. Except for Scott Honan, none of the qualified persons is affiliated with the Company. Mr. Honan is the Chief Operating
Officer of the Company. The technical content disclosed in this Form 10-K was reviewed and approved by Mr. Honan who is a Qualified
Person as defined in NI 43-101.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
Description and Location</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">The Elk Creek Property is a carbonatite deposit located in Johnson County, southeast Nebraska, USA. The carbonatite contains elements
of economic significance, including niobium, titanium, and scandium, as well as potential economic significance for rare earth
products. The Elk Creek Property is situated as shown below and is located within the USGS Tecumseh Quadrangle Nebraska SE (7.5
minute series) mapsheet in Sections 1-6, 9-11; Township 3N; Range 11E and Sections 19-23, 25-36; Township 4N, Range 11E, at approximately
40&#176;16&#8217; north and 96&#176;11&#8217; west in the State of Nebraska, in central USA. The Elk Creek Property is approximately
45 miles southeast of Lincoln, Nebraska, the state capital of Nebraska.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><img src="n257410kimg002.jpg" alt="" />&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
and Ownership</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land
in the project area is exclusively owned by private entities, and there is no federal or state land in the project area. The Company
has secured its rights to the project area by purchasing land from private landowners or by entering into agreements with the
landowners as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently owns one approximately 225-acre parcel of land and associated mineral rights, and an additional 40 acres of
mineral rights, within the carbonatite footprint. The Elk Creek Project&#8217;s mine infrastructure and a portion of the supporting
operations is planned to be located on this land parcel. Ownership of the mineral rights discussed above includes a 2% NSR royalty
and grants us access to more than 90% of the Elk Creek Project&#8217;s mineral resources and mineral reserves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023, the total book value of the Elk Creek Property and associated buildings and equipment was $16.9 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also holds eight OTPs that are associated with the Elk Creek Project and one perpetual easement of a land parcel along
the Missouri River. The current optioned land package covers an area of 1,396 acres and is reflective of the land needed to secure
the remaining mineral resources and mineral reserves held under the OTPs along with the land needed for the development and operations
of the Elk Creek Project for its proposed 38-year operating life.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, exercise of an OTP is accomplished by paying the greater of a fixed amount per acre or a multiple of the appraised value
at the time of purchase. If the land is not purchased by the Company during the term of the OTP and the land in question is needed
for the project, the Company will negotiate a new OTP with the landowner. The OTP is accompanied by a negotiated payment to the
landowner that is paid upon execution of the OTP by the Company and the landowner. As of June 30, 2023, the Company is obligated
to make payments totalling approximately $45,000 over the next 12 years to maintain our rights under these OTPs. Details on the
current OTPs held by the Company are shown in the table below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Active
Lease Agreements (OTP&#8217;s) Covering the Elk Creek Project as of October 2023</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Agreement
    Identifier</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Hectares</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Acres</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 26%; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Agreement
    Expiry</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beethe007</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66.27</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">163.75</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20-Jan-26</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Heidemann005</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79.55</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">196.57</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16-Mar-25</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nielsen001</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100.90</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">249.32</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25-Jun-25</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nielsen002</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.91</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.43</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25-Jun-25</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woltemath80S</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.37</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80.00</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4-Dec-24</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woltemath002</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">152.49</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">376.81</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4-Dec-24</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woltemath003J</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89.03</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">220.00</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25-Mar-25</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shuey001</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.37</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80.00</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27-May-40</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
OTPs are between NioCorp&#8217;s subsidiary ECRC and the individual landowners. Land subject to the OTP agreements is currently
used for agricultural purposes, including growing row crops (corn and soybeans) and pasturing livestock. The land owned by ECRC
houses the company drill core and geological sample repository in two steel core shed buildings and the company maintains a cover
crop (sorghum and rye) on portions of the property that were formerly used for growing row crops. The former landowner maintains
a residence and several outbuildings on the property subject to a life estate that accompanied the purchase of the property by
the Company in fiscal year 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
agreements that involve mineral rights include a 2% NSR royalty attached with the OTP. The OTPs grant the Company an exclusive
right to explore and evaluate the property for the term thereof, with an option to purchase the surface rights or a combination
of the mineral and surface rights at any time during the term. As the Woltemath80S agreement is limited to an option to purchase
the surface rights only, it does not contain an NSR provision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land
Tenure Map as of October 2023</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 18.5pt; text-align: center; text-indent: -18.5pt; color: Red"><img src="n257410kimg003.jpg" alt="" />&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 18.5pt; text-align: center; text-indent: -18.5pt; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current estimated mineral resource and reserve is wholly contained within land owned by the Company and parcel Woltemath003J.
The Company considers these two properties to be the only properties on which the Company&#8217;s development of the Elk Creek
Project is substantially dependent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the OTPs, where required, the Company has also secured surface rights, which allow for access to the land for drilling
activities and associated mineral exploration and project development work.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accessibility,
Physiography, Climate and Infrastructure</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Property is easily accessible year-round as it is situated approximately 45 miles southeast of Lincoln, Nebraska, the
state capital, and approximately 68 miles south of Omaha, Nebraska. Access to the site can be completed via road or from one of
the regional airports. There are several regular flights to both Lincoln and Omaha; however, the Elk Creek Property is most easily
accessible from Lincoln. From Lincoln Municipal Airport, the Elk Creek Property is accessed via paved roads on the main network
and a secondary network of gravel roads. The drive from the Lincoln Municipal Airport to the property is typically 1 hour and
15 minutes, and from Omaha&#8217;s Eppley Airport, the drive is approximately 1 hour and 45 minutes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Property is immediately adjacent to paved Nebraska state highway 50, and the mineral resource and mineral reserve are
centered in Township 4N, Range 11E, Section 33. This section is immediately southwest of the junction of Nebraska state highways
50 and 62. Rail access is available in the town of Elk Creek, which is located 3 miles east of the project area. Water is available
at the project site from a well, as well as from Elk Creek, which crosses Section 33. Water is also available from the Johnson
County Rural Water system, which has distribution infrastructure on the north side of the Section 33 and from the Pawnee County
Rural Water system, which has distribution infrastructure on the south side of Section 33. Electricity is provided at the Company&#8217;s
Core Storage sheds located on the west side of Section 33 on land owned by the Company from the Omaha Public Power District (&#8220;OPPD&#8221;).
Personnel are available from the local surrounding towns, including Elk Creek (3 miles east), Tecumseh</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(6 miles north), Steinauer
(5 miles south), Pawnee City (10 miles south) and Syracuse (20 miles north). Due to the project&#8217;s location in Nebraska,
there are no ports nearby.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Southeast
Nebraska is situated in a humid continental climate (Dfa) on the K&#246;ppen climate classification system. In eastern Nebraska,
this climate is generally characterized by hot humid summers and cold winters. Average winter temperatures vary between 13&#176;F
to 35&#176;F. Average summer temperatures vary between 64&#176;F to 90&#176;F. Exploration, construction and operational activities
may be conducted all year round.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
monthly precipitation (rain and snowfall) varies between 0.9 and 5.0 inches. Average yearly precipitation is between 31 and 33
inches with an average yearly snowfall of approximately 28 inches. Nebraska is located within an area known for tornadoes which
runs through the central U.S. where thunderstorms are common in the spring and summer months. Tornadoes primarily occur during
the spring and summer and may occur into the autumn months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are several local communities near the Elk Creek Property, including Elk Creek and Tecumseh, that will provide local housing for
the Elk Creek Project. There are a number of other communities within driving distance and the large cities of Lincoln and Omaha
are within reasonable driving distance. Mining activities currently taking place in the area are limited to limestone and aggregate
operations to support the local cement manufacturing and construction industries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Project is expected to incorporate surface and underground infrastructure, as well as tailings storage facilities. The
offsite infrastructure is expected to include a new high voltage transmission line constructed by the local utility company and
providing power to an on-site primary sub-station and a natural gas pipeline built by the owner of the interstate pipeline. Water
used for all on-site process needs and activities will be supplied from mine dewatering activities, local groundwater wells and
from a local water utility. See &#8220;<i>2022 Elk Creek Feasibility Study</i>&#8221; below for additional information regarding
proposed infrastructure related to the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
local topography of eastern Nebraska is relatively low-relief with shallow rolling hills intersected by shallow river valleys.
Elevation varies from about 1,066 to 1,280 ft above sea level. Bedrock outcrop exposure is nonexistent in the Elk Creek Project
area.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
majority of the area around the Elk Creek Project is used for cultivation of corn and soybeans, along with uses as grazing land.
Native vegetation typical of eastern Nebraska is upland tall-grass, prairie and upland deciduous forests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Geology
and Mineralization</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Geology</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Property includes a carbonatite that has intruded older Precambrian granitic and low- to medium-grade metamorphic basement
rocks. The carbonatite is an elliptical magmatic body with a northwest-trending long axis perpendicular to the strike of the Midcontinent
Rift System, near the northern part of the Nemaha uplift. The carbonatite consists predominantly of dolomite, calcite and ankerite,
with lesser chlorite, barite, phlogopite, pyrochlore, serpentine, fluorite, sulfides, bastnasite, monazite, and quartz. It is,
however, believed from stratigraphic reconstruction based on drill core observation in the area that the carbonatite is unconformably
overlain by approximately 200 m of essentially flat-lying Palaeozoic marine sedimentary rocks, including carbonates, sandstones
and shales of Pennsylvanian age.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Mineralization</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
property hosts niobium, titanium, and scandium mineralization as well as REE mineralization that occurs within the Elk Creek carbonatite.
The current known extents of the carbonatite unit are approximately 950 m along strike, 300 m wide, and 750 m in dip extent, below
the unconformity. Niobium, titanium, scandium, and rare earths are considered the main elements of interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
deposit contains significant concentrations of niobium. Based on the metallurgical testwork completed to date at a number of laboratories
using QEMSCAN&#174; analysis, the niobium mineralization is known to be fine grained,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">and that 77% of the niobium occurs in the
mineral pyrochlore, while the balance occurs in an iron-titanium-niobium oxide mineral of varying composition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
the Elk Creek carbonatite, a host of other elements exist with varying degrees of concentration. The Company has completed both
whole rock analysis and multi-element analysis on all samples for the 2014 drilling program, described below, plus resampling
of selected historical core/pulps between 2011 and 2014.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Historical
Exploration</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drilling
at the Elk Creek Property was conducted in three phases. The first was during the 1970&#8217;s and 1980&#8217;s by the Molybdenum
Company of America (&#8220;Molycorp&#8221;), the second in 2011 by Quantum Rare Earth Developments Corp (&#8220;Quantum&#8221;
- NioCorp under its former name), and the third and latest program from 2014 to 2016 by NioCorp. To date, 129 diamond core holes
have been completed for a total of 64,981 m over the entire geological complex. Of these, a total of 48 holes (33,909 m) have
been completed to date in the mineralized area and are used in the current mineral resource and reserve estimates. Five additional
holes, with a total length of 3,353.1 m, were drilled for hydrogeologic and geotechnical purposes in 2015. No sampling has been
completed of these five holes to date and therefore they have not been considered for the mineral resource or reserve estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
drilling has been completed using a combination of Tricone, Reverse Circulation (&#8220;RC&#8221;) or Diamond Drilling (&#8220;DDH&#8221;)
in the upper portion of the hole within the Pennsylvanian sediments. All drilling within the underlying carbonatite has been completed
using DDH methods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
of Drilling Database within Elk Creek Deposit Area</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of<br />
Holes</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average
    Depth (m)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sum
    Length<br />
(m)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1970-1980</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">596.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,108.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2011</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quantum</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">772.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,317.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2014-2015</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">845.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,482.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">700.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,908.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Molycorp,
1973-1986</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
1973 and 1974, Molycorp completed six drillholes: EC-1 to EC-4, targeting the Elk Creek anomaly, and two other holes outside the
Elk Creek anomaly area. Drillholes were typically carried out by RC drilling through the overlying sedimentary rocks and diamond
drilling through the Ordovician-Cambrian basement rocks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
continued their drill program from 1977 and, in May 1978, Molycorp made its discovery of the current mineral resource with drillhole
EC-11. EC-11 is located on Section 33, Township 4N, and Range 11. The carbonatite hosting the Elk Creek Project was intersected
at a vertical depth of 203.61 m (668 ft).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
continued its drilling program through to 1984, which mainly centered on the Elk Creek Project within a radius of roughly 2 km.
By 1984, Molycorp had completed 57 drillholes within the Elk Creek gravity anomaly area, which included 25 drillholes over the
Elk Creek Project area.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
1984 to 1986, drilling was focused on the Elk Creek gravity anomaly area. The anomaly area is roughly 7 km in diameter and drilling
was conducted on a grid pattern of approximately 610 m by 610 m (roughly 2,000 ft by 2,000 ft) with some closer spaced drillholes
in selected areas.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
1986, a total of 106 regional drillholes were completed for a total of approximately 46,797 m (153,532 ft). The deepest hole reached
a depth of 1,038 m (3,406 ft) and bottomed in carbonatite.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Quantum,
2010-2011</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2011, Quantum conducted a preliminary drill program (three holes) on the Elk Creek deposit and two REE exploration targets
(two holes), which have been excluded from the current mineral resource and reserve estimation, as they do not intersect the Nb<sub>2</sub>O<sub>5
</sub>anomaly and are located to the east. The objectives of the drill program</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">over the Elk Creek Property were to verify the
presence of higher-grade niobium mineralization at depth, and to infill drill the known niobium deposit in order to upgrade the
resource category of the previous resource estimate and expand the known resource. The drill program was also established to collect
sufficient sample material for metallurgical characterization and process development studies of the niobium mineralization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2011 program consisted of five inclined drillholes, totaling 3,420 m of NQ size diameter core. Inclusive of this total, three
drillholes, totaling 2,318 m, were drilled into the known Elk Creek deposit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">NioCorp,
2014 to Present</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
commenced drilling on the Elk Creek Property using a three-phased program. The three-phased program was originally based on 14
drillholes for approximately 12,150 m (announced in a press release on April 29, 2014), but was subsequently expanded during the
program to 18 drillholes for approximately 15,482 m. Three of the 18 drillholes were drilled for the purpose of metallurgical
characterization and process development studies. Two of these drillholes, NEC14-MET-01 and NEC14-MET-02, were not assayed, while
NEC14-MET-03 was quarter cored with one quarter being assayed and the remainder used for metallurgical testwork. The drilling
has been orientated to intersect the geological model from the southwest and northeast (perpendicular to the strike), with the
exception of NEC14-011 and NEC14-012, which were oriented southeast and northwest, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2022, NioCorp collected a total of 1,095 samples originating from 18 diamond drill holes completed by MolyCorp, as
discussed above. These samples were collected, and subsequently assayed, in order to fill in gaps in our records regarding REE
grades and tonnage that may exist in the deposit. Assaying was conducted at Actlabs in Ancaster, Ontario. The assay results were
subjected to a Quality Assurance and Quality Control (&#8220;QA/QC&#8221;) program consistent with industry best practices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
list of the drillholes, sample storage location, and number of assay results, related to the records gaps noted above, are presented
below and are represented as blue drillhole intervals. Each sample represented a 5-foot section of drill core. All of the holes
noted below were drilled into the Elk Creek carbonatite in the vicinity of the mineral resource for the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pre-2021
Hole Sampling Summary</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 85%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; padding-right: 0.5pt; padding-left: 0.5pt; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resource
    Area<br />
 Drillholes</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; padding-right: 5.4pt; padding-left: 5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-indent: -0.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Source
/ Storage Facility</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 27%; padding-right: 0.5pt; padding-left: 0.5pt; text-indent: -0.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Samples
    selected for<br />
 REE and Sc Assays</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-011</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-014</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-015</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">151</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-016</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-018</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-019</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-020</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-021</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-022</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-026</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-027</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-029</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-030</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-031</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-032</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-034</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-037</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC-054</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
    Samples / Mead Core Warehouse</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; padding-right: 0.5pt; padding-left: 5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,095</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resource
Area Assay Distribution Showing REE Assays (Red) and REE Assay Gaps (Blue).</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt; text-align: center; text-indent: 0.25in; color: Red"><img src="n257410kimg004.jpg" alt="" />&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt; text-align: center; text-indent: 0.25in; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Internal
Controls</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
integrated a series of routine QA/QC procedures throughout the sampling and analytical analysis for drilling programs to ensure
the highest level of quality was maintained throughout the process leading to the estimate of mineral reserves and mineral resources
for the Elk Creek Project. This included the insertion of duplicate samples taken from various stages of the process, insertion
of known control samples (standard reference materials, certified reference materials (&#8220;CRM&#8221;), and blanks) and sending
third-party pulps to the secondary lab (SGS Canada Inc.).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sample
tickets were assigned initially at the core shed using barcodes with duplicate tickets placed inside and on the outside of the
bag. Sample identification was confirmed using barcode labelling and visual sample type comparisons before sample shipment. The
use of barcoded samples ensured both shipment forms and analytical labs used accurate information. Multiple types of QC samples
were inserted at this stage of the process, which includes the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.2535in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.2465in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Field
                                         quartz blanks (1 in 20, or 5%) were inserted within or immediately after samples collected
                                         from mineralized intervals, targeting zones of elevated visual mineralization, where
                                         possible.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.2535in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.2465in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CRMs
                                         (1 in 20, or 5%) were inserted in the field with the sample sequence.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.2535in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.2465in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Field
                                         quarter-core duplicates (1 in 20, or 5%) were inserted to test mineralization and sampling
                                         variability.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
details on the QA/QC program can be found in Section 8 of the S-K 1300 Elk Creek Technical Report Summary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
deposits, including the Elk Creek deposit, are inherently uncertain because of variability at all scales and sparse sampling.
In addition to uncertainty associated with estimation, there are specific risks and sources of uncertainty associated with the
Elk Creek deposit. See Item 1A, Risk Factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-K
1300 and other similarly purposed International Codes (JORC, 2012; NI 43-101, 2014) are designed to require disclosure to the
public of risks relating to mineral resource and reserve estimation as identified and evaluated by a qualified person. The qualified
persons responsible for the S-K 1300 Elk Creek Technical Report Summary address the technical risks in various sections and consider
that no material technical risks are identified. Additional descriptions of the risks and uncertainty associated with reported
mineral reserves and resources can be found in Section 11 of the S-K 1300 Elk Creek Technical Report Summary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022
Elk Creek Feasibility Study</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2022, the Company launched geological, metallurgical, engineering, and other analyses to assess the feasibility of
adding REE production to its plans once sufficient work has been completed. The Company and its consultants were required to complete
additional assays of historical drill core to fill data gaps in the existing resource database to establish an REE mineral resource.
The mine plan was also updated and the S-K 1300 Elk Creek Technical Report Summary was filed with the SEC as an exhibit to the
Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2022. The S-K 1300 Elk Creek Technical Report Summary
was based on the economic and process results of the feasibility study conducted by the qualified persons, which were also presented
in the 2022 NI 43-101 Elk Creek Technical Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Project is planned as an underground mining operation using a long-hole stoping mining method and paste backfill, operating
with a processing rate of 2,764 tonnes per day. Expected total production over the 38-year mine life includes 171,140 tonnes of
payable niobium, 3,676 tonnes of Sc<sub>2</sub>O<sub>3</sub>, and 431,793 tonnes of TiO<sub>2</sub>. Estimated up-front direct
capital costs are $760 million, in addition to indirect costs of $187 million, pre-production capital costs of $92 million, an
overall contingency of $102 million, and pre-production net revenue credit of $257 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Financial
Analysis Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
metrics reported in the S-K 1300 Elk Creek Technical Report Summary are based on the cash flow model results. The metrics are
on both a pre-tax and after-tax basis, on a 100% equity basis with no Elk Creek Project financing inputs and are in first quarter
2019 U.S. constant dollars. Foreign exchange impacts were deemed negligible as most, if not all, costs and revenues are denominated
in U.S. dollars. Key criteria used in the analysis are discussed in detail throughout this section.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Principal
Project Assumptions Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 40%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Production
    Period</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4
    years</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Process
    Plant Life</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38
    years</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mine
    Operating Days per Year</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">365</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mill
    Operating Days per Year</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">365</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discount
    Rate, End of Period</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">@
    8%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercial
    Production Year</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025
    </span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Summary
of Key Evaluation Metrics Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 71%; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 29%; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ore
    Mined (kt)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,655</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ore
    Mining Rate (t/d)</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,764</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Niobium
    Grade</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.81%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scandium
    Grade (parts per million, &#8220;ppm&#8221;)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70.2</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
    </sub>Grade</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.92%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contained
    Nb<sub>2</sub>O<sub>5</sub> (kt)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">297</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contained
    Sc (t)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,573</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contained
    TiO<sub>2</sub> (kt)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,071</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Ore Processed (kt)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,655</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Processing
    Rate (kt/y)</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,009</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
    Recovery, Nb<sub>2</sub>O<sub>5</sub></span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82.4%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
    Recovery Sc</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93.1%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
    Recovery TiO<sub>2</sub></span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.3%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recovered
    Nb<sub>2</sub>O<sub>5</sub> (kt)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">245</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recovered
    Sc (t)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,395</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recovered
    TiO<sub>2</sub> (kt)</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">432</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized
    Market Prices</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nb
    (US$/kg)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$46.55</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
    </sub>(US$/kg)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.99</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc<sub>2</sub>O<sub>3
    </sub>(US$/kg)</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,674</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payable
    Metal</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nb
    (t)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">171,140</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc<sub>2</sub>O<sub>3
    </sub>(t)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,676</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
    </sub>(t)</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">431,793</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Summary
Projected Economic Results Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 71%; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br />
    <b>Description </b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 29%; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
    ($000)</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Gross Revenue </span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$21,899,726</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    Costs:</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
    Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,553,325)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Process
    Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,911,116)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Site
    G&amp;A Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(300,400)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concentrate
    Freight Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,472)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Infrastructure Costs</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(200,407)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Water
    Management Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(609,195)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tailings
    Management Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(73,822)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
    Tax</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(217,540)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalties</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(300,503)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
    Bond Premium</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,500)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Operating Costs</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,182,280)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    Margin (EBITDA<sup>1</sup>)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,717,445</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
    Tax Rate</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.42%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Taxes</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,246,186)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Working
    Capital</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    Cash Flow</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$12,471,258</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 1in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 20%">
<tr style="vertical-align: top; text-align: left">
    <td colspan="2">Totals may not sum due to rounding.</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td style="width: 2%">1
-</td>
    <td style="width: 78%; text-align: justify">The term &#8220;EBITDA&#8221; refers to earnings before interest, taxes depreciation and amortization. See &#8220;Non-GAAP
Financial Performance Measures&#8221; below for a discussion of the use of non-GAAP financial measures.</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 121.5pt; text-align: justify; text-indent: -13.5pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 121.5pt; text-align: justify; text-indent: -13.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Operating
Cost Estimates Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following LoM unit operating costs include the pre-production and first/last years of production.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 71%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 29%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LoM
    US$/t ore </b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
    Cost</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$42.38</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Process
    Cost</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106.70</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Water
    Management Cost</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.62</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Site
    G&amp;A Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.20</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Infrastructure</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.47</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tailings
    Management Cost</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.01</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Expenses</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.22</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subtotal
    </span></td>
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">187.59
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalties/Annual
    Bond Premium</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.35</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    LoM Operating Costs</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$195.94</span></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin: 0 auto; width: 60%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Totals
may not sum due to rounding.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 85.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Capital
Cost Estimates Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the breakout in LoM initial capital and sustaining capital cost estimates (excluding closure and reclamation
of $44 million), which total $1,562 million. This includes a total initial capital cost of $1,141 million, including a 10% contingency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($000,000)</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 54%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sustaining</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
    Preproduction Expenses</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$77</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$77</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Site
    Preparation and Infrastructure</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Processing
    Plant</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">367</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">464</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Water
    Management and Treatment</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
    Infrastructure</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">257</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">198</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">455</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tailings
    Management</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Site
    Wide Indirects</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Processing
    Indirects</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
    Indirects</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commissioning</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owner&#8217;s
    Costs</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mine
    Water Management Indirects</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingency</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Capital Costs</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,141</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$422</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,562</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.75in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin: 0 auto; width: 70%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="text-align: justify; padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Totals
may not sum due to rounding.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Planned
Mining Operations</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Project is planned as an underground mining operation using a long-hole stoping mining method and paste backfill, with
shaft access to minimize development through water bearing horizons. The mine will utilize jumbo drills for lateral development
and tophammer and down-the-hole drills for vertical development and production stoping. Rock bolters will be used for ground support
and probe holes will be used to support mine grouting where required. Ore will be remotely mucked from the bottom stope accesses
using 14 tonne Load-Haul-Dump units (&#8220;LHD&#8221;). The LHDs will transport the ore to an ore pass directly or to remuck
bays to maximize the efficiency of the stope mucking operations. When needed, a second LHD and a fleet of 40 tonne haul trucks
will be used to transport ore from the remuck bays to the grizzly feeding the underground material handling system. Multiple remuck
bays are used on each level to avoid interference between the LHD and the haul trucks. The ore is fed through the grizzlys with
rock breakers into an underground crusher (the &#8220;Primary Crusher&#8221;) and via a material handling system to the surface.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Planned
Processing Operations </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Planned
ore process operations include mineral processing, hydrometallurgical processing (&#8220;Hydromet&#8221;), and pyrometallurgical
processing (&#8220;Pyromet&#8221;) housed in separate buildings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mineral processing building will house all of its equipment within a single large building. Ore from the Primary Crusher (located
in the underground mine) will be fed to the secondary cone crusher system, operating in closed circuit with a double deck screen.
The screen undersize from the cone crusher system will be fed to a high-pressure grinding roll unit (&#8220;HPGR&#8221;), operating
in closed circuit with another double deck screen. The HPGR screen undersize is the comminution product that will report to the
Hydromet process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Hydromet plant building will be a multi-level engineered steel structure, which will house equipment on two levels. Ore from mineral
processing will be fed through 15 individual processes required to separate the three recoverable products. The purpose of the
Hydromet processing steps is to leach the pay metals into solution using two separate acid leaches (Hydrochloric Acid Leach and
Sulfuric Acid Bake), remove impurities, separate the three pay metals, and perform precipitation/processing to final solid oxide
forms. Outputs from the Hydromet Process include saleable TiO<sub>2</sub> and Sc<sub>2</sub>O<sub>3</sub>, with Nb<sub>2</sub>O<sub>5
</sub>reporting to the Pyromet plant for final processing. The Hydromet plant will be supported by a Hydrochloric Acid Regeneration
plant and a Sulfuric Acid Plant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Pyromet building will house most of its equipment within a single building. The purpose of the Pyromet plant is to reduce the
Nb<sub>2</sub>O<sub>5</sub> coming from the Hydromet plant by converting it into a saleable FeNb metal. Aluminum shots and iron
oxide pellets will be introduced to an electric arc furnace on a continuous basis along with fluxing agents and Nb<sub>2</sub>O<sub>5
</sub>to produce a saleable ferroniobium metal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Production Plan and Schedule </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the 2022 Elk Creek Feasibility Study, the operating mine life is approximately 38 years with a nominal processing rate of 2,764
tonnes per day. The Elk Creek Project timeline is based on 39 months to mechanical completion after Authorization to Proceed,
plus an additional six months of commissioning and ramp-up to 100% of production capacity for a total of 45 months and assumes
no financing constraints. The NioCorp board must approve a construction program and budget before construction of the Elk Creek
Project can begin. This approval, along with the receipt of all required governmental permits and approvals and the completion
of project financings, will determine whether and when construction of the Elk Creek Project can begin.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Tailings Storage</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tailings produced by the process plant will consist of filtered water leach residue, calcined excess oxide, and slag. Four engineered
and lined tailings storage facilities (&#8220;TSFs&#8221;) will be constructed sequentially to contain the tailings over the life
of the Elk Creek Project and would contain approximately 14.5 million tonnes of tailings. The tailings facilities have been designed
to incorporate two independent areas: a composite-lined tailings solids storage area; and an area with double lined containment,
including a leak collection and recovery system for management of stormwater runoff and drainage from the tailings solids. The
TSFs will store predominantly dry (i.e., not in a slurry consistency) tailings from the plant with embankment construction based
on a &#8220;downstream&#8221; construction method. Facility closure is considered in the design.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Salt Management</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
crystalline salt produced as a waste product of heating and evaporating brine from the reverse osmosis (&#8220;RO&#8221;) water
treatment plant will be transported by conveyor to the temporary salt staging area and then be transported by truck to the dedicated
salt management cells (&#8220;SMC&#8221;). Two SMCs will be constructed sequentially to contain the salt over the life of the
project and would contain approximately 1.63 million cubic meters of salt. The SMCs design will incorporate a composite-lined
storage area with double-lined containment including a leak collection and recovery system for management of stormwater runoff
and drainage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Water Management</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the first several years of construction, the advancement of the shaft and underground workings will require limited dewatering,
anticipated to be through lower-level sumping and pumping for surface collection and disposal. Initially, water will be stored
in the lined SMC #1 during construction or will be trucked off-site for treatment at a local publicly owned treatment works. Excess
water in the SMCs will be spray evaporated within the footprint of the SMC, to avoid the reintroduction of soluble salts into
the water treatment system. Temporary on-site storage or off-site shipment and disposal of the crystallizer solid waste may be
necessary until construction of SMC #1 is completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
full operations commence, we anticipate a shortfall of approximately 3,700 gallons per minute of operational and processing water,
as the underground mine dewatering is only expected to produce 1,000 gallons per minute. To make up this shortfall, we would purchase
fresh water from a local utility and from local landowners.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
tailings begin being deposited in the TSF, internal contact water (from residual moisture in the tailings and precipitation falling
within the impoundment footprint) will need to be actively managed. This water will be collected and treated using lime softening
to precipitate hydroxide and carbonate solid forms for many of the inorganic constituents. The treated water will be filtered
to remove the solids (which will be returned to the TSF for disposal), and the clean water will be pumped to the process plant
RO system for further treatment. The clean water from the process plant RO unit will be used in the process plant, and the reject
concentrate will be crystallized and deposited into the SMCs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Source of Power </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
local power utility (Omaha Public Power District) will provide power from nearby transmission lines to the site. This will require
that an approximate 18-mile transmission line be installed by the utility to provide the site sub-station with the required site
power demand. The local power utility will also design and install the main substation that will be owned and maintained by the
utility. This infrastructure will be paid back through rate charges on the electrical usage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Source of Natural Gas</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Natural
gas, to be used throughout the Elk Creek Project during the construction and operation phases of the project, will be brought
to the site via pipeline from the local utility company. NioCorp has a natural gas transportation contract with Tallgrass Energy,
which operates the Rockies Express (&#8220;REX&#8221;) pipeline. Tallgrass will construct a 45 kilometer (28 mile) gas pipeline
lateral from the main REX pipeline system in Kansas to the project site. The lateral will be sized to provide a minimum of 27.5
dekatherms of gas per day. Natural gas will be distributed to all on-site facilities utilizing buried high-density polyethylene
natural gas distribution pipe. Natural gas piping above ground and located inside of facilities will consist predominately of
carbon steel pipe. Maximum on-site pipeline distribution pressure will be 100 pounds per square inch gauge. Natural gas will be
used for facility heating, water heating, and for gas-fired process equipment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Markets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
studies for niobium, TiO<sub>2</sub>, and Sc<sub>2</sub>O<sub>3</sub> are an important part of the proposed Elk Creek operation.
These commodities, especially niobium and Sc<sub>2</sub>O<sub>3</sub>, are thinly traded without an established publicly available
price discovery mechanism. Hence, detailed third-party market studies provide the basis for assumptions used in the economic analysis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
economic analysis in the 2022 Elk Creek Feasibility Study used the 2019 U.S. dollar base price of $47/kg Nb as the forward-looking
price for steel grade (65%) ferroniobium based on published independent third-party reports. The base price is adjusted to a realized
price to account for the discount provisions contained in the two ferroniobium offtake agreements that the Company has concluded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
engaged OnG Commodities LLC (&#8220;OnG&#8221;) to produce a market assessment in April 2017. The study examines current scandium
production trends (approximately 20 tons/year) from existing and emerging producers plus an outlook for supply to 2028. The outlook
then reviewed the current and emerging applications for scandium, including fuel cells, aerospace, industrial and other uses,
plus an outlook for demand to 2028. Based on these inputs, OnG provided pricing forecasts and global demand volumes by year to
2028 based estimated production costs and supply-demand balances. The pricing sheet for the OnG Commodities report was updated
for NioCorp in 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
formal market study was done for TiO<sub>2</sub> as it only represents 2% of overall revenue in the economic analysis. All market
information for titanium and TiO<sub>2</sub> is derived from USGS Commodity Market Summaries (Bedinger, 2019).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Taxation
Rates Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes
that may be levied on the Elk Creek Project include corporate income tax rates of 21% for federal and 5.84% for Nebraska. The
Elk Creek Project is eligible for federal depletion allowances and credits, as well as various state incentives. The calculated
effective income tax rate for the Elk Creek Project is 16.42% for the 2022 Feasibility Study.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Design
Considerations for Environmental Performance</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current mine design incorporates these following strategies and technologies designed to minimize environmental impacts of operation:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.2632in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.2368in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zero
                                         Process Liquid Discharge: The Elk Creek facility will now operate as a &#8220;Zero Process
                                         Liquid Discharge&#8221; facility, with no releases of process liquids. Instead, both
                                         naturally occurring, brackish (slightly salty) water produced during mining operations,
                                         and water used in ore processing, will be treated on site for use in operations. A solid
                                         salt will be produced from water treatment operations which will be stored on site.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.2632in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.2368in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
                                         Protection of Groundwater Resources Through Artificial Ground Freezing: The Elk Creek
                                         Project&#8217;s new mine design will utilize artificial ground freezing as part of the
                                         process of sinking the production and ventilation shafts. Artificial ground freezing
                                         creates a temporary frozen barrier that helps to protect groundwater resources in the
                                         area while shaft-sinking operations are underway.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.2632in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.2368in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avoidance
                                         of Permanent Impacts to Federally Jurisdictional Waters: We designed the layout of the
                                         Elk Creek Project to minimize or avoid permanent impacts to any federally jurisdictional
                                         waters and/or wetlands on the property. This reduced the expected environmental impacts
                                         and allowed the Elk Creek Project to secure a Clean Water Act Section 404 permit from
                                         the USACE under the Nationwide Permit Program, a much more efficient and less expensive
                                         process than an individual Section 404 permit. No other NEPA-level federal permits are
                                         now expected to be required for the Elk Creek Project.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.2632in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.2368in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recycling
                                         of Reagents Used in Mineral Processing: Metallurgical and process advances made in 2016
                                         and 2017 are expected to help reduce the volume of material planned for disposal in the
                                         Elk Creek Project&#8217;s tailings storage areas. As more of this material is recycled,
                                         the environmental footprint of the Elk Creek Project is reduced.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.2605in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.2395in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utilizing
                                         Tailings as Underground Mine Backfill: We plan to fill underground voids concurrently
                                         with mining operations using a paste backfill material that contains mine waste material
                                         that typically would be stored in above-ground tailings storage areas.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Company has not identified any significant encumbrances to the property it owns or holds under OTP agreements. The Company has
not had any permit violations or fines since the filing of our Annual Report on Form 10-K for the fiscal year ended June 30, 2022.</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Permitting
requirements for the project have been identified. The Company holds an Air Construction Permit from the State of Nebraska and
a Special Use Permit from Johnson County, both of which are necessary to allow the start of project construction. In addition,
the Elk Creek Project will be required to obtain a series of permits for operations from federal, state, and local agencies. The
majority of these permits are ministerial in nature and present minimal risk to the Company, and typically involve the completion
of an application and the payment of a nominal fee. Three permits from the state of Nebraska are discretionary in nature, where
an application and fee are provided to the state and the state must make a decision as to whether or not the permit will be granted.
While the risk involved in such permits is low, such discretionary permits require more processing time by the state and do require
the state agency to make a decision in favor of issuance of the permit. These three permits include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.2535in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.2465in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solid
                                         Waste Permit;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.2535in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.2465in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Air
                                         Operating Permit; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.257in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.243in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Radioactive
                                         Materials License.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost and schedule for obtaining both the discretionary and ministerial permits is included in the overall execution plan for the
Elk Creek Project. Additional details on the project&#8217;s permitting requirements can be found in Section 17 of the S-K 1300
Elk Creek Technical Report Summary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: normal 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Mineral
Reserves and Resources</span></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The mineral reserves and mineral resources disclosed below are based on the S-K 1300 Elk Creek Technical
Report Summary, which was originally filed as Exhibit 96.1 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year
ended June 30, 2022. Mineral reserves and mineral resources at the Elk Creek Project as of June 30, 2023, are summarized in the
tables below. Further discussion and background regarding the approaches used to establish mineral reserves and mineral resources
is contained in Chapters 11 and 12 of the S-K 1300 Elk Creek Technical Report Summary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
Creek Project In Situ Mineral Resource Estimate (niobium, titanium, and scandium) Excluding Reserves as of June 30,
2023</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NSR
    Cutoff</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tonnage
    (Mt)</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">Indicated</span></td>
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">US$180</span></td>
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">151.7</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<span style="color: black"><sub>2</sub>O<sub>5
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<span style="color: black"><sub>2</sub>O<sub>5
    </sub>(kt)</span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.43</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">649.8</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<span style="color: black"><sub>2
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<span style="color: black"><sub>2
    </sub>(kt)</span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">2.02</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">3,067</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc
    (ppm)</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc
    (t)</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">56.42</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">8,558</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">Inferred</span></td>
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">US$180</span></td>
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">108.3</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<span style="color: black"><sub>2</sub>O<sub>5
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<span style="color: black"><sub>2</sub>O<sub>5
    </sub>(kt)</span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.39</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">426.6</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<span style="color: black"><sub>2
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<span style="color: black"><sub>2
    </sub>(kt)</span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.92</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">2,082</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc
    (ppm)</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc
    (t)</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">52.28</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">5,660</span></td></tr>
</table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.7pt; text-align: center; text-indent: -67.7pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.7pt; text-align: center; text-indent: -67.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
Creek Project In Situ Mineral Resource Estimate (rare earth oxides) Excluding Reserves as of June 30, 2023</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="2" style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class</b></span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NSR
    </b><br />
    <b>Cut-off</b></span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tonnage
    (Mt)</b></span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">Indicated</span></td>
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">US$180</span></td>
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">151.7</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>La<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>La<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ce<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ce<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pr<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pr<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0766</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">116.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.1320</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">200.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0140</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">21.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0511</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">77.5</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0116</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">17.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0040</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">6.0</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dy<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dy<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0096</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">14.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0011</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0044</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">6.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ho<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ho<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Er<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Er<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tm<span style="color: black"><sub>2</sub>O<sub>3</sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0006</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.0</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0015</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">2.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0002</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Yb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Yb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Y<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Y<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0010</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.5</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0001</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0187</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">28.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;LREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;LREO
    (kt) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;HREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;HREO
    (kt) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;TREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;TREO
    (kt) </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.2737</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">415.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0528</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">80.0</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.3265</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">495.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">Inferred</span></td>
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">US$180</span></td>
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">108.3</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>La<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>La<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ce<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ce<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pr<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pr<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0943</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">102.1</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.1576</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">170.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0163</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">17.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0575</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">62.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0116</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">12.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0038</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dy<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dy<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0090</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">9.8</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0010</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.1</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0042</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">4.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ho<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ho<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Er<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Er<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tm<span style="color: black"><sub>2</sub>O<sub>3</sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0006</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.7</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0014</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.5</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0002</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Yb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Yb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Y<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Y<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0010</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.1</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0001</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.1</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0182</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">19.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;LREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;LREO
    (kt) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;HREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;HREO
    (kt) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;TREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;TREO
    (kt) </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.3257</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">352.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0512</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">55.5</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.3769</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">408.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Notes:&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classification
                                         of mineral resources in the above tables is in accordance with the S-K 1300 classification
                                         system. Mineral resources in this table are reported exclusive of mineral reserves.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
                                         resources that are not mineral reserves do not have demonstrated economic viability.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         mineral resources are reported at a Diluted Net Smelter Return (NSR) Cut-off of US$180/tonne.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         diluted NSR is defined as:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 95%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="width: 13pt; text-align: left; vertical-align: middle">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="width: 97pt; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted
    NSR (US$)= </span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
    per block <i>Nb<sub>2</sub>O<sub>5</sub></i> (diluted) + Revenue per block <i>TiO<sub>2</sub></i> (diluted) + Revenue per
    block Sc (diluted)</span></td>
    </tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted tonnes per
    block </span></td>
    </tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 40.75pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         diluted revenue from Nb<sub>2</sub>O<sub>5</sub>, TiO<sub>2</sub>, and Sc per block used
                                         the following factors:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 58.75pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nb<sub>2</sub>O<sub>5
                                         </sub>Revenue: a 94% grade recovery, a 0.696 factor to convert Nb<sub>2</sub>O<sub>5
                                         </sub>to Nb, 82.36% assumption for plant recovery, and a US$39.60 selling price per kg
                                         of ferroniobium as of June 30, 2022.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 58.75pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
                                         </sub>Revenue: a 94% grade recovery, a 40.31% assumption for plant recovery, and an US$0.88
                                         kg selling price per kg of titanium oxide as of June 30, 2022.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 58.75pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc
                                         Revenue: a 94% grade recovery, a 1.534 factor to convert Sc to Sc<sub>2</sub>O<sub>3</sub>,
                                         93.14% assumption for plant recovery, and a US$3,675 selling price per kg of scandium
                                         oxide as of June 30, 2022.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 40.75pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         diluted tonnes are a 6% increase in the total tonnes of the block.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
                                         assumptions for FeNb, Sc<sub>2</sub>O<sub>3</sub>, and TiO<sub>2</sub> as shown in note
                                         d, above, are based upon independent market analyses for each product.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numbers
                                         may not sum due to rounding. The rounding is not considered to be material.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rare
                                         Earth Oxides (REO) were evaluated as a potential by-product to the mining of niobium,
                                         titanium, and scandium; thus, the estimated values of the REOs are reported using the
                                         previously determined diluted NSR as derived from the Nb<sub>2</sub>O<sub>5</sub>, TiO<sub>2</sub>,
                                         and Sc mineral resources and are assigned a price of $0</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         stated Light Rare Earth Oxides (LREO) grade (%) is the summation of La<sub>2</sub>O<sub>3
                                         </sub>(%), Ce<sub>2</sub>O<sub>3</sub> (%), Pr<sub>2</sub>O<sub>3</sub> (%), and Nd<sub>2</sub>O<sub>3
                                         </sub>(%) estimates.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         stated Heavy Rare Earth Oxides (HREO) grade (%) is the summation of Sm<sub>2</sub>O<sub>3
                                         </sub>(%), Eu<sub>2</sub>O<sub>3</sub> (%), Gd<sub>2</sub>O<sub>3</sub> (%), Tb<sub>2</sub>O<sub>3
                                         </sub>(%), Dy<sub>2</sub>O<sub>3</sub> (%), Ho<sub>2</sub>O<sub>3</sub> (%), Er<sub>2</sub>O<sub>3
                                         </sub>(%), Tm<sub>2</sub>O<sub>3</sub> (%), Yb<sub>2</sub>O<sub>3</sub> (%), Lu<sub>2</sub>O<sub>3
                                         </sub>(%), and Y<sub>2</sub>O<sub>3</sub> (%) estimates.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">j.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         stated Total Rare Earth Oxide (TREO) grade (%) is the summation of LREO (%) and HREO
                                         (%).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">k.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         effective date of the mineral resource, including by-products, is June 30, 2023.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: center; text-indent: -49.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Elk
Creek Project Underground In Situ Mineral Reserves Estimate for Elk Creek as of June 30, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: center; text-indent: -0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tonnage</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(kt)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 7%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<sub>2</sub>O<sub>5
</sub>Grade </b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(%)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contained
Nb<sub>2</sub>O<sub>5 </sub></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Payable
Nb </b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<sub>2</sub></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grade</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(%)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contained
TiO<sub>2 </sub></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Payable</b></span><br />
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<sub>2</sub></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 7%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grade
(ppm)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contained<br />
Sc
&#160;</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Payable
Sc<sub>2</sub>O<sub>3</sub></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.75pt; padding-left: 0.125in; text-indent: -3.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proven</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 17.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.75pt; padding-left: 0.125in; text-indent: -3.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Probable</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,656</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 0.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.81</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">297,278</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,409</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.92</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,071,182</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">431,793</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,573</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,677</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.75pt; padding-left: 17.85pt; text-indent: -17.85pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,656</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 0.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.81</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">297,278</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,409</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.92</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,071,182</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">431,793</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,573</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,677</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">All
figures are rounded to reflect the relative accuracy of the estimates. Totals may not sum due to rounding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Qualified Person for the mineral reserve estimate is Optimize Group Inc. The estimate
                                         has an effective date of June 30, 2023.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         mineral reserve is based on the mine design, mine plan, and cash-flow model utilizing
                                         an average cut-off grade of 0.679% Nb<sub>2</sub>O<sub>5</sub> with an NSR of US$180/mt.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         estimate of mineral reserves may be materially affected by metal prices, environmental,
                                         permitting, legal, title, taxation, socio-political, marketing, infrastructure development,
                                         or other relevant issues.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         economic assumptions used to define mineral reserve cut-off grade are as follows:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
                                         life of mine (LoM) production rate of ~7,450 tonnes of FeNb/annum during the years of
                                         full production.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
                                         elevated five-year production rate ~ 7,500 tonnes of FeNb/annum when full production
                                         is reached.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
                                         dilution of ~6% was applied to all stopes and development, based on 3% for the primary
                                         stopes, 9% for the secondary stopes, and 5% for ore development.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
                                         recoveries of 95% were applied in longhole stopes and 62.5% in sill pillar stopes.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 60%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Parameter</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unit</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
    Cost</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.38</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Processing
    </span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106.70</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Water
    Management and Infrastructure </span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.62</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tailings
    Management</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.01</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Infrastructure</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.47</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    and Administrative</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.91</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalties/Annual
    Bond Premium</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.34</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Costs </span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.29</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Cost</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>196.72</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$/t
    mined</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nb<sub>2</sub>O<sub>5
    </sub>to Niobium Conversion</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69.60</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Niobium
    Process Recovery</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82.36</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Niobium
    Price</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.60</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$/kg</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
    </sub>Process Recovery</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.31</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
    </sub>Price</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.88</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$/kg</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc
    Process Recovery</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93.14</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc
    to Sc<sub>2</sub>O<sub>3</sub> Conversion</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153.40</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc
    Price</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,675.00</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$/kg</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
                                         assumptions are as follows: FeNb US$39.60/kg Nb, Sc<sub>2</sub>O<sub>3</sub> US$3,675/kg,
                                         and TiO<sub>2</sub> US$0.88/kg. Price assumptions are based upon independent market analyses
                                         for each product as of June 30, 2022.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
                                         and cost assumptions are based on the pricing of products at the &#8220;mine-gate,&#8221;
                                         with no additional down-stream costs required. The assumed products are ferroniobium
                                         (metallic alloy shots consisting of 65%Nb and 35% Fe), a titanium dioxide product in
                                         powder form, and scandium trioxide in powder form.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         mineral reserve has an average LoM NSR of US$563.06/tonne.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optimize
                                         Group has provided detailed estimates of the expected costs based on the knowledge of
                                         the style of mining (underground) and potential processing methods (by 3rd party Qualified
                                         Persons).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
                                         reserve effective date is June 30, 2023. The financial model was run after the estimate
                                         of the NSR above, which reflects a total cost per tonne of US$196.72 versus US$189.91.
                                         This is not considered a material change.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
                                         variances for commodities are based on independent market studies versus earlier projected
                                         pricing. The independent market studies do not have a negative effect on the reserve.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: normal 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Comparison
of Mineral Resources and Mineral Reserves</span></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no changes in the Elk Creek Project mineral resource or reserve estimates as of June 30, 2023, as compared to the Elk Creek
Project mineral resource and reserve estimates as of June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental
and Social</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
number of key permits and environmental management requirements have been identified for the Elk Creek Project, some of which
need to be implemented as soon as practicable in order to maintain the proposed Elk Creek Project schedule.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.95pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
                                         not necessarily complex, the timing generally required to complete permitting through
                                         any federal regulatory agency requires that NioCorp engage key agencies (in this case
                                         the USACE and possibly the EPA) early on in Elk Creek Project development and consider
                                         the siting and orientation of facilities carefully to minimize the risk of a protracted
                                         National Environmental Policy Act analysis of the Elk Creek Project. At the present time,
                                         the company believes that we have completed the major federal permitting actions needed
                                         for project construction, although changes to the design or location of project facilities
                                         may require that additional federal permits be obtained.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.95pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construction
                                         at the facility requires the Air Permit from the State of Nebraska, which was issued
                                         to the Company on June 2, 2020. The Air Permit describes all the prospective air emissions
                                         from the facility and required the completion of an air quality model that demonstrates
                                         compliance with the NAAQS. On April 15, 2022, the Company announced that the Nebraska
                                         Department of Environment and Energy advised the Company that periodic extensions to
                                         the Elk Creek Project&#8217;s Air Permit are no longer required because the Company has
                                         met the regulatory definition of &#8220;construction, reconstruction, or modification
                                         of the source&#8221; since the permit was issued.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.95pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         radioactive materials license will be needed from the Nebraska Department of Health and
                                         Human Services (&#8220;NDHHS&#8221;), Office of Radiological Health. Because of their
                                         limited experience with hard rock mining in the State of Nebraska, much less mining that
                                         includes Naturally Occurring Radioactive Material, the NDHHS may require additional information
                                         and more time to approve the Elk Creek Project under a Broad Scope License. The Company
                                         has been working with NDHHS on this aspect of project permitting since 2014.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.95pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Documentation
                                         of existing baseline environmental conditions at the Elk Creek Project site was initiated
                                         in 2014 and will continue as needed throughout the permitting process.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.95pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surface
                                         water monitoring will continue throughout the permitting process and extend into construction
                                         and operations as part of the Environmental Management System and likely State of Nebraska
                                         permit requirements.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.95pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         wetland delineation and potential jurisdictional waters assessment was conducted in late
                                         2014 to identify wetland and drainage features within the proposed Elk Creek Project
                                         boundary which resulted in a formal JD being issued by the USACE on September 6, 2016.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 19.2pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         major land-use authorization for the project was received from Johnson County, Nebraska,
                                         on December 24, 2019, in the form of a Special Use Permit for the project. This land-use
                                         permit is a necessary precursor to any project-related construction activities. County
                                         zoning permits will be required for individual buildings constructed at the site, and
                                         the County requirement is that such applications must be submitted five days before construction
                                         commences.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.95pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closure
                                         costs for the Elk Creek Project have been estimated at just over $44 million, including
                                         approximately $13.5 million for reclamation and closure of the TSFs and $16.6 million
                                         for plant and building removal and reclamation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.95pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Community
                                         engagement has occurred in parallel with Nebraska field operations and has included public
                                         meetings, presentations to public agencies, communications with local and state politicians,
                                         meetings with environmental groups, and one-on-one meetings with area landowners.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
Elk Creek Project Activities</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 6, 2022, the Company announced that the Demonstration Plant had commenced processing a three-tonne sample of representative
ore from the Elk Creek Project. The Demonstration Plant project is intended to demonstrate that the Company can extract and separate
rare earth elements from ore that NioCorp expects to mine from the Elk Creek Project site, subject to receipt of necessary project
financing, and that its simplified process for potentially producing niobium, scandium, and titanium is technically and economically
feasible.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 25, 2022, the Company announced that the Demonstration Plant had completed demonstrating its planned process for removing
calcium and magnesium from ore obtained from the Elk Creek Project. This positive result is a key milestone in NioCorp&#8217;s
proposed optimization of its process flow sheet for the Elk Creek Project, which was designed by L3 and NioCorp. Removing carbonate
minerals in this fashion is expected to reduce the size of the follow-on planned production steps and make them more efficient.
Characterization of the calcium and magnesium carbonate from the completed Demonstration Plant production runs has demonstrated
very low levels of impurities, and an overall 99% purity of the mixed calcium-magnesium carbonate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2023, the Company announced that the Demonstration Plant has succeeded in obtaining a rare earth dissolution rate of
86-95% from ore from the Elk Creek Project site through hydrochloric acid leaching and has achieved a loading rate of rare earths
as high as 99% in the follow-on solvent extraction recovery step. These relatively high rates, which were expected, point to potentially
strong rates of overall recovery of separated rare earth oxides, subject to additional demonstration testing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 6, 2023, the Company announced that overall recoveries for praseodymium oxide, neodymium oxide, terbium oxide, and dysprosium
oxide are likely to be greater than 92% and meet commercial purity specifications for magnetic rare earth oxides. These results
are in line with bench- and pilot-scale testing of L3&#8217;s rare earth recovery system, as well as hydrometallurgical performance
models that have been run on the rare earth recovery process upon which the Demonstration Plant is based.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 20, 2023, the Company announced that it had executed a contract with Zachry Group (&#8220;Zachry&#8221;) to develop a
cost for the surface facilities associated with the Elk Creek Project. The contract represents the first phase of EPC contracting
for the Elk Creek Project. NioCorp had previously selected Zachry as its EPC firm for the Elk Creek Project&#8217;s surface facilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 4, 2023, the Company announced a process breakthrough in niobium and titanium recovery achieved at the Demonstration Plant.
The breakthrough points to a potentially more efficient way to process niobium and titanium into higher-purity products, which
may in turn open up new markets for the Elk Creek Project&#8217;s planned products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 25, 2023, the Company announced that it has successfully demonstrated the ability to recover greater amounts of the critical
mineral niobium from each tonne of ore the Company expects to mine at the Elk Creek Project,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">once sufficient financing is obtained
and the project is constructed. Final results from the demonstration show that NioCorp&#8217;s new and improved recovery process
can achieve a 90.7% rate of niobium recovery through the hydrometallurgical process. Overall recovery through the pyrometallurgical
production of the commercial product ferroniobium is expected to be 86.7%. NioCorp&#8217;s previous approach to niobium production
was able to achieve recovery rates through the hydrometallurgical and pyrometallurgical processes of 86.8% and 82.4%, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 26, 2023, the Company announced that it has successfully demonstrated an ability to potentially double the recovery of titanium
from each tonne of ore the Company expects to mine at the Elk Creek Project. The new process is expected to produce a purer form
of titanium that may command a higher price than is assumed in the 2022 Elk Creek Feasibility Study. The Demonstration Plant has
shown that the Company&#8217;s new and improved recovery process can likely achieve an 83.7% rate of overall titanium recovery
to final product. This compares to a 40.3% titanium recovery rate in NioCorp&#8217;s previous process approach. This new result
points to a potentially large increase in the amount of titanium that NioCorp can potentially produce at currently planned rates
of mining.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on results of the Company&#8217;s Demonstration Plant, a higher value titanium tetrachloride product can be produced with a substantially
higher metallurgical recovery than TiO<sub>2</sub>. The Company is in the process of completing feasibility level cost estimates
to replace the previous TiO<sub>2</sub> production equipment with new equipment that would produce titanium tetrachloride.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 1, 2023, the Company announced the successful completion of a geotechnical drilling campaign at the Elk Creek Project, which
was done in advance of the proposed site preparation, grading, heavy construction, and eventual foundation pours for the Elk Creek
Project that are expected to commence once sufficient financing is obtained. The campaign involved drilling 16 boreholes and 20
test pits across the one square mile Elk Creek Project site, analyzing soil samples, and generating data for engineering design
firms that are continuing to finalize plans for the potential construction of the facility. The campaign also involved the installation
of 6 shallow groundwater piezometers to monitor water levels in the soil layer, which will also aid in construction planning.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed
Activities</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
present, the Company is maintaining the Elk Creek property in anticipation of obtaining project financing that will facilitate
the construction, commissioning, and operation of the Elk Creek Project. The property is characterized as a development stage
property and is expected to move to a production stage property should financing be obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
funds become available through the Company&#8217;s fundraising efforts, we expect to undertake the following activities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuation
    of the Company&#8217;s efforts to secure federal, state and local operating permits;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continued
    evaluation of the potential to produce rare earth products and sell such products under offtake agreements;</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Negotiation
    and completion of offtake agreements for the remaining uncommitted production of Nb, Sc, and Ti from the project, including
    the potential sale of Ti as titanium tetrachloride;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Negotiation
    and completion of engineering, procurement, and construction agreements;</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completion
    of the final detailed engineering for the underground portion of the Elk Creek Project;</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initiation
    and completion of the final detailed engineering for surface project facilities;</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construction
    of natural gas and electrical infrastructure under existing agreements to serve the Elk Creek Project site;</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completion
    of water supply agreements and related infrastructure to deliver fresh water to the project site;</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initiation
    of revised mine groundwater investigation and control activities; </span></td>
    </tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initiation of long-lead
    equipment procurement activities; and </span></td>
    </tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a follow-on to
    the Company&#8217;s Demonstration Plant operations, complete characterization and testing of waste materials to support tailings
    impoundment and paste backfill plant designs.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-GAAP
Financial Performance Measures</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-GAAP
financial performance measures are intended to provide additional information only and do not have any standard meaning prescribed
by U.S. GAAP. These measures should not be considered in isolation or as a substitute for performance measures prepared in accordance
with U.S. GAAP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
S-K 1300 Elk Creek Technical Report Summary uses non-GAAP financial performance measures, such as EBITDA, Averaged Annual EBITDA,
and Averaged EBITDA Margin, for purposes of projecting the economic results of the Elk Creek Project. We are unable to provide
a reconciliation of these forward-looking non-GAAP measures to the most comparable U.S. GAAP financial performance measures because
certain information needed to reconcile those non-GAAP measures to the most comparable U.S. GAAP financial performance measures
is dependent on future events, some of which are outside the control of the Company, such as FeNb, Sc<sub>2</sub>O<sub>3,</sub>
and TiO<sub>2</sub> prices, interest rates, and exchange rates. Moreover, estimating such U.S. GAAP measures with the required
precision necessary to provide a meaningful reconciliation is extremely difficult and could not be accomplished without unreasonable
effort.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Headquarters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
lease our principal executive office space at 7000 South Yosemite Street, Suite 115, Centennial, Colorado.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                                         3.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a024"></span>LEGAL
                                        PROCEEDINGS</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 6, 2023, we are not a party to any legal proceedings that could have a material adverse effect on the Company&#8217;s
business, financial condition, or operating results. Further, to the Company&#8217;s knowledge, no such proceedings have been
threatened against the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                                         4.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a025"></span>MINE
                                        SAFETY DISCLOSURES</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 1503(a) of the United States Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the &#8220;Dodd-Frank
Act&#8221;), issuers that are operators, or that have a subsidiary that is an operator, of a coal or other mine in the U.S. are
required to disclose specified information about mine health and safety in their periodic reports. These reporting requirements
are based on the safety and health requirements applicable to mines under the Federal Mine Safety and Health Act of 1977 (the
&#8220;Mine Act&#8221;) which is administered by the U.S. Department of Labor&#8217;s Mine Safety and Health Administration (&#8220;MSHA&#8221;).
During the fiscal year ended June 30, 2023, the Company and its subsidiaries and their properties or operations were not subject
to regulation by MSHA under the Mine Act and thus no disclosure is required under Section 1503(a) of the Dodd-Frank Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a026"></span>PART
II</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                                         5.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a027"></span>MARKET
                                        FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES
                                        OF EQUITY SECURITIES</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a028"></span>Market
Information</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Shares were first listed and posted for trading on the Vancouver Stock Exchange on December 1, 1987. On March 9, 2015,
the Common Shares commenced trading on the TSX under the trading symbol &#8220;NB.&#8221; In addition, the Company traded on the
U.S. Over-the-Counter Bulletin Board and the OTCQX under the symbol &#8220;NIOBF&#8221; until March 21, 2023, at which time the
Common Shares began trading on the Nasdaq exchange under the trading symbol &#8220;NB&#8221;. The Company also trades on the Frankfurt
Stock Exchange as &#8220;BR3.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
over-the-counter market quotations reflect inter-dealer prices without retail mark-up, mark-down, or commission and may not reflect
actual transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a029"></span>Holders</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 6, 2023, we had 20,941 holders of record of the Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a030"></span>Dividends</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not paid any cash dividends on the Common Shares since our inception and do not anticipate paying any cash dividends in the
foreseeable future. We plan to retain our earnings, if any, to provide funds for the expansion of our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a031"></span>Securities
Authorized for Issuance Under Equity Compensation Plans</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
Equity Compensation Plan Information under <i>Item 12.</i>, &#8220;<i>Security Ownership of Certain Beneficial Owners and Management
and Related Stockholder Matters</i>,&#8221; for information on plans approved by our shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a032"></span>Purchases
of Equity Securities by the Company</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
did not make any repurchases in the quarter ended June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a033"></span>Recent
Sales of Unregistered Securities</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 31%; padding-right: 0.25pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross
    Proceeds</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
    Issued</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price/Share</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    30, 2023<sup>(1)</sup></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$362,192</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78,745</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.5995</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    1, 2023<sup>(1)</sup></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$302,164</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,758</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.6660</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    9, 2023<sup>(2)</sup></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$488,080</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.8808</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    12, 2023<sup>(1)</sup></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$275,479</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,446</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.5574</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    13, 2023<sup>(1)</sup></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$502,089</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,939</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.5258</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    20, 2023<sup>(1)</sup></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$514,144</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">112,782</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.5587</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    21, 2023<sup>(1)</sup></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$751,952</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">163,870</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.5887</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    30, 2023<sup>(1)</sup></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$516,644</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114,471</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.5133</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 96%; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued
    in reliance on Section 3(a)(9) of the Securities Act, in connection with the voluntary conversion of a portion of the amount
    outstanding under the Convertible Debentures and based upon representations and warranties of Yorkville in connection therewith.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued
    in reliance on Section 4(a)(2) of the Securities Act in connection with the closing of an advance under the Yorkville Equity
    Facility Financing Agreement and based upon representations and warranties of Yorkville in connection therewith.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a034"></span>Exchange
Controls</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no governmental laws, decrees, or regulations in Canada that restrict the export or import of capital, including foreign exchange
controls, or that affect the remittance of dividends, interest or other payments to non-resident holders of the securities of
NioCorp, other than Canadian withholding tax. See &#8220;Certain Canadian Federal Income Tax Considerations for U.S. Residents&#8221;
below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a035"></span>Certain
Canadian Federal Income Tax Considerations for U.S. Residents</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following generally summarizes certain Canadian federal income tax consequences generally applicable under the Income Tax Act
(Canada) and the regulations enacted thereunder (collectively, the &#8220;Canadian Tax Act&#8221;) and the Canada-United States
Tax Convention (1980) (the &#8220;Convention&#8221;) to the holding and disposition of Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comment
is restricted to holders of Common Shares each of whom, at all material times for the purposes of the Canadian Tax Act and the
Convention, (i) is resident solely in the U.S. for tax purposes, (ii) is a &#8220;qualifying person&#8221; under and entitled
to the benefits of the Convention, (iii) holds all Common Shares as capital property, (iv) holds no Common Shares that are &#8220;taxable
Canadian property&#8221; (as defined in the Canadian Tax Act) of the holder, (v) deals at arm&#8217;s-length with and is not affiliated
with NioCorp, (vi) does not and is not deemed to use or hold any Common Shares in a business carried on in Canada, (vii) is not
an insurer that carries on business in Canada and elsewhere, and (viii) is not an &#8220;authorized foreign bank&#8221; (as defined
in the Canadian Tax Act)(each such holder, a &#8220;U.S. Resident Holder&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
U.S.-resident entities that are fiscally transparent for U.S. federal income tax purposes (including limited liability companies)
may not in all circumstances be entitled to the benefits of the Convention. Members of or holders of an interest in such an entity
that holds Common Shares should consult their own tax advisers regarding the extent, if any, to which the benefits of the Convention
will apply to the entity in respect of its Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
a U.S. Resident Holder&#8217;s Common Shares will be considered to be capital property of such holder provided that the U.S. Resident
Holder is not a trader or dealer in securities, did not acquire, hold, or dispose of the Common Shares in one or more transactions
considered to be an adventure or concern in the nature of trade (i.e. speculation), and does not hold the Common Shares in the
course of carrying on a business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary is based on the current provisions of the Canadian Tax Act and the Convention in effect as of the date prior to the date
hereof, all specific proposals to amend the Canadian Tax Act and Convention publicly announced by or on behalf of the Minister
of Finance (Canada) prior to the date hereof, and the current published administrative policies and assessing practices of the
Canada Revenue Agency (the &#8220;CRA&#8221;). It is assumed that all such amendments will be enacted as currently proposed, and
that there will be no other material change to any applicable law or administrative policy or assessing practice, whether by way
of judicial, legislative or governmental decision or action, although no assurance can be given in these respects. This summary
is not exhaustive of all possible Canadian federal income tax considerations. Except as otherwise expressly provided, this summary
does not take into account any provincial, territorial, or foreign tax considerations, which may differ materially from those
set out herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>This
summary is of a general nature only, is not exhaustive of all possible Canadian federal income tax considerations and is not intended
to be and should not be construed as legal or tax advice to any particular U.S. Resident Holder. U.S. Resident Holders are urged
to consult their own tax advisers for advice with respect to their particular circumstances. The discussion below is qualified
accordingly.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
a U.S. Resident Holder&#8217;s Common Shares will not constitute &#8220;taxable Canadian property&#8221; of such holder at a particular
time at which the Common Shares are listed on a &#8220;designated stock exchange&#8221; (which currently includes the TSX and
Nasdaq) unless both of the following conditions are concurrently met:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 13.75pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                         any time during the 60-month period that ends at the particular time, 25% or more of
                                         the issued shares of any class of the capital stock of NioCorp were owned by or belonged
                                         to one or any combination of:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 31.75pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         U.S. Resident Holder,</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 31.75pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                         with whom the U.S. Resident Holder did not deal at arm&#8217;s length, and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 31.75pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">partnerships
                                         in which the U.S. Resident Holder or a person referred to in clause (b) holds a membership
                                         interest directly or indirectly through one or more partnerships, and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 13.75pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                         any time during the 60-month period that ends at the particular time, more than 50% of
                                         the fair market value of the Common Shares was derived directly or indirectly from, one
                                         or any combination of, real or immovable property situated in Canada, &#8220;Canadian
                                         resource properties&#8221; (as defined in the Canadian Tax Act), &#8220;timber resource
                                         properties&#8221; (as defined in the Canadian Tax Act), or options in respect of, or
                                         interests in any of the foregoing, whether or not the property exists.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Shares may also be deemed to be &#8220;taxable Canadian property&#8221; in certain circumstances set out in the Canadian Tax Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Resident Holder who disposes or is deemed to dispose of one or more Common Shares generally should not thereby incur any
liability for Canadian federal income tax in respect of any capital gain arising as a consequence of the disposition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Resident Holder to whom NioCorp pays or credits or is deemed to pay or credit a dividend on such holder&#8217;s Common Shares
will be subject to Canadian withholding tax, and NioCorp will be required to withhold the tax from the dividend and remit it to
the CRA for the holder&#8217;s account. The rate of withholding tax under the Canadian Tax Act is 25% of the gross amount of the
dividend, but should generally be reduced under the Convention to 15% (or, if the U.S. Resident Holder is a company which is the
beneficial owner of at least 10% of the voting stock of NioCorp, 5%) of the gross amount of the dividend. For this purpose, a
company that is a resident of the United States for purposes of the Canadian Tax Act and the Convention and is entitled to the
benefits of the Convention shall be</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">considered to own the voting stock of NioCorp owned by an entity that is considered fiscally
transparent under the laws of the United States and that is not a resident of Canada, in proportion to such company&#8217;s ownership
interest in that entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                          6.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="a036"></span>RESERVED</i></b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                                         7.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a037"></span>MANAGEMENT&#8217;S
                                        DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following Management&#8217;s Discussion and Analysis (&#8220;MD&amp;A&#8221;) provides information that management believes is
relevant to an assessment and understanding of the consolidated financial condition and results of operations of NioCorp and subsidiaries.
This item should be read in conjunction with our consolidated financial statements and the notes thereto included in this Annual
Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
Item 1, &#8220;<i>Business &#8211; Recent Corporate Events</i>,&#8221; for a description of the Transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a038"></span>Summary
of Consolidated Financial and Operating Performance</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no revenues from mining operations during the fiscal years presented below. Operating expenses incurred related primarily
to performing exploration and feasibility study related activities, as well as the activities necessary to support corporate and
shareholder duties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the year ended June 30,</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="11" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($000)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 4.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,410</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.25pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,796</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 3.9pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,092</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss attributable
    to the Company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 4.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,080</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.25pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,887</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 3.9pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,824</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss per
    share (basic and diluted)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 4.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.34</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.25pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.41</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 3.9pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.20</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 42%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The net loss attributable
to the Company increased to $40.1 million for fiscal year 2023 from $10.9 million for fiscal year 2022. This increased net loss
in fiscal year 2023 as compared to fiscal year 2022 is primarily due to the recognition of Earnout Shares and warrant liabilities
associated with the GXII Transaction as well as an increase in legal and other professional fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The net loss attributable to the Company increased to $10.9 million for fiscal year 2022 from $4.8 million
for fiscal year 2021. This increased net loss in fiscal year 2022 as compared to fiscal year 2021 is primarily due to increased
exploration expenditures associated with process development costs and rare earth review costs, as well increased non-cash costs
of our fiscal year 2022 Option grants, which were fully vested and expensed on the grant dates, and increased loss on partial debt
extinguishment from debt conversions reported as interest expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a039"></span>Results
of Operations</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0.5pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no revenues from mining operations during the fiscal years presented below. Operating expenses incurred related primarily
to costs incurred in connection with the Transactions, as well as performing exploration and feasibility study related activities,
and the activities necessary to support corporate and shareholder duties, as detailed in the following table.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0.5pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 95%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">For the year ended<br /> June 30,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($000)</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; width: 61%">Operating expenses:</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 10%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Employee related costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,323</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,150</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,655</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,581</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">684</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">386</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Exploration expenditures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,348</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,309</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,056</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Other operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">27,158</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,653</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">995</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Total operating expenses</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">37,410</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">7,796</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">4,092</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt">Change in fair value of earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,674</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 9pt">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,414</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt">Loss on debt extinguishment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,922</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">163</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 9pt">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,336</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,827</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,543</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt">Foreign exchange loss (gain)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">216</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">258</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(725</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 8.55pt">Other gains</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(208</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Change in financial instrument fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(32</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Loss (gain) on equity securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Income tax benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(304</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Loss attributable to noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(228</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Net loss attributable to the Company</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2pt solid; font-weight: bold; text-align: right">40,080</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2pt solid; font-weight: bold; text-align: right">10,887</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2pt solid; font-weight: bold; text-align: right">4,824</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fiscal
Year 2023 as Compared to Fiscal Year 2022</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
items affecting operating expenses are noted below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
operating expenses </i>include costs incurred in connection with the Transactions, including direct transaction expenses, and
the fair value of warrant and Earnout Shares liabilities assumed, as well as costs related to investor relations, general office
expenditures, equity offering and proxy expenditures, board-related expenditures, and other miscellaneous costs. These costs increased
in fiscal year 2023 as compared to fiscal year 2022 primarily due to the costs incurred in connection with the Transactions, which
closed on March 17, 2023. A summary of these costs is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 95%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($000)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 86%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
    cash proceeds, net of transaction costs incurred by GXII</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,168</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash costs associated
    with the Transactions:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    liabilities assumed</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">392</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville
    Equity Facility Financing Agreement &#8211; cash costs</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,996</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
    costs expensed</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,715</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-cash
    costs associated with the Transactions:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private
    Warrants assumed at fair value</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,987</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
    Shares assumed at fair value</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,195</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville
    Equity Facility Financing Agreement &#8211; shares issued</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">650</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Total
    transaction related losses incurred</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,767</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, other operating expenses increased due to increased directors and officers insurance premiums associated with our US
stock exchange listing, as well as increased financial and investor relation services performed during 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exploration
expenditures increased </i>in fiscal year 2023 as compared to fiscal year 2022, reflecting work performed in fiscal year 2023
to complete the development of the Demonstration Plant and the subsequent operation of the Demonstration Plant to verify process
improvement efforts and advance the technical and economic analyses on the potential addition of magnetic rare earth oxides to
NioCorp&#8217;s planned product suite. In addition, 2023 costs increased due to costs related to the completion and filing of
the Technical Report Summary </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt; text-align: justify; text-indent: 0">based on the Company&#8217;s 2022 Feasibility Study for the Elk Creek Project, which was filed with
the SEC on September 6, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Professional
fees </i>increased in fiscal year 2023 as compared to fiscal year 2022, primarily due to additional accounting
and legal services related to our March 31, 2023 Form 10-Q SEC filings, as well as legal costs associated with corporate funding
initiatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Employee
related costs</i> for fiscal year 2023 increased as compared to fiscal year 2022 primarily due to the impact of discretionary
bonus payouts totaling $0.2 million, partially offset by the impact of lower employee headcount at the end of fiscal year 2023
as compared to fiscal year 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
significant items impacting the change in the Company&#8217;s net loss are noted below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in fair value of Earnout Shares liability </i>represents the change in fair value related to the Earnout Shares between the Closing Date and the end
of fiscal year 2023, based on the results of Monte Carlo financial modeling.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in fair value of warrant liability </i>represents the change in fair value related to the additional Warrants (the &#8220;Contingent
Consent Warrants&#8221;) that the Company agreed to issue to Lind Global Asset Management III, LLC (&#8220;Lind&#8221;) upon certain
conditions in connection with the Waiver and Consent Agreement, dated September 25, 2022, between the Company and Lind (the &#8220;Lind
Consent&#8221;), as discussed in Note 9 to the consolidated financial statements included in Part II, Item 8 hereof, as well as
the change in the fair value of the Private Warrants based primarily on the impacts of a lower closing Common Share price, which
increases the probability of these Contingent Consent Warrants being issued under the Lind Consent terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loss
on debt extinguishment </i>represents the loss incurred under Accounting Standards Codification (&#8220;ASC&#8221;) Topic 470,
Debt, related to the convertible security issued to Lind (the &#8220;Lind III Convertible Security&#8221;) with a face value of
$11.7 million (representing $10.0 million in funding plus an implied 8.5% interest rate per annum for the term of the Lind III
Convertible Security) pursuant to the Convertible Security Funding Agreement, dated February 16, 2021, as amended by Amendment
#1 to the Convertible Security Funding Agreement, dated December 2, 2021, between the Company and Lind (as amended, the &#8220;Lind
III Agreement&#8221;), as discussed in Note 9 to the consolidated financial statements included in Part II, Item 8 hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest
expense</i> decreased in fiscal year 2023 as compared to fiscal year 2022 due to the impacts of conversions on the outstanding
balance of the Lind III Convertible Security during fiscal year 2022, as well as the impact of debt extinguishment accounting
as discussed in Note 9 to the consolidated financial statements included in Part II, Item 8 hereof, partially offset by Convertible
Debenture interest expense incurred in fiscal year 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loss
attributable to noncontrolling interest</i> represents the portion of net loss in ECRC attributable to the Vested Shares, which
are not owned by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fiscal
Year 2022 as Compared to Fiscal Year 2021</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
items affecting operating expenses are noted below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Employee
related costs</i> for fiscal year 2022 increased as compared to fiscal year 2021 primarily due to increased share-based compensation
costs which primarily reflected the impact of increased Common Share values on the fair value calculations in the Black-Scholes
model, as well as the number of Options granted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Professional
fees </i>increased in fiscal year 2022 as compared to fiscal year 2021, primarily due to additional legal services
related to SEC filings, including our shelf registration statement on Form S-3 filed in November 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exploration
expenditures</i> increased in fiscal year 2022 as compared to fiscal year 2021 reflecting work performed in fiscal year 2022 to
advance the development of a demonstration-scale test plant to verify process improvement efforts as well as to potentially incorporate
REEs into our planned production. Fiscal year 2021 expenditures primarily related to the ongoing personnel costs, as well as ongoing
engineering and metallurgical projects and project advancement activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
operating expenses</i> include investor relations, general office expenditures, equity offering and proxy expenditures, board-related
expenditures, and other miscellaneous costs. These costs increased in fiscal year 2022 as compared to fiscal year 2021 primarily
due to increased financial advisory fees and investor relations fees associated with our ongoing financing efforts. In addition,
share-based compensation for directors and other advisors increased in fiscal year 2022 as compared to fiscal year 2021 due to
increased share-based compensation costs, which primarily reflected the impact of increased Common Share values in the Black Scholes
model. Options issued in both periods were fully vested upon issuance and expensed on the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
significant items impacting the change in the Company&#8217;s net loss are noted below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 18.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
income </i>for fiscal year 2021 represents the one-time forgiveness of the Company&#8217;s U.S. Small Business Administration
Loan, which occurred on November 18, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 18.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 18.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loss
on extinguishment </i>for fiscal year 2021 represents the one-time loss incurred in connection with the December 18, 2020, conversion
of a convertible note in the principal amount of approximately $1.9 million issued by the Company to Nordmin pursuant to a convertible
note and warrant subscription agreement, dated as of December 18, 2020, between NioCorp and Nordmin (the &#8220;Nordmin Note&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 18.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
exchange (gain) loss</i> is primarily due to changes in the U.S. dollar against the Canadian dollar rate as applied to U.S. dollar-denominated
debt instruments, which are carried on the Canadian parent company books, and the fiscal year 2022 loss reflected the impacts
of a strengthened U.S. dollar to Canadian dollar, whereas the fiscal year 2021 gain primarily reflects the impact of a weakened
U.S. dollar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest
expense</i> increased in fiscal year 2022 as compared to fiscal year 2021 primarily due to the accretion of the Nordmin Note,
which was issued in December 2020, as well as accretion of the Lind Convertible Security, which was issued in February 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a040"></span>Liquidity
and Capital Resources</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no revenue generating operations from which we can internally generate funds. To date, our ongoing operations have been financed
by the sale of our equity securities by way of private placements, convertible securities issuances, the exercise of incentive
Options and Warrants, and related party loans. With respect to currently outstanding Options and Warrants, we believe that exercise
of these instruments, and cash proceeds from such exercises, will not occur unless and until the market price for our Common Shares
equals or exceeds the related exercise price of each instrument.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Closing of the Transactions, the Company received net cash proceeds of $8.3 million, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($000)</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 81%; padding-right: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash received from GXII trust account, after payment of direct and incremental transaction costs incurred by GXII</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 3%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,168</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    proceeds from the Yorkville Convertible Debt Financing Agreement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,857</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash costs incurred in connection with Yorkville Equity Facility Financing Agreement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,996)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    direct and incremental transaction costs</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,715)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Net
    proceeds from Transactions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,314</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">The
Transactions delivered to NioCorp several important benefits, including a ready pathway to an up-listing to the Nasdaq, which
is expected to allow additional institutional firms to invest in the Company for the first time. Further, we believe it has given
NioCorp and the Elk Creek Project a much higher profile among institutional investors evaluating projects in the critical materials
space.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Yorkville Convertible Debt Financing has provided, and the Yorkville Equity Facility Financing is expected to provide, near-term
and longer-term access to capital. The ability of the Company to draw down on the Yorkville Equity Facility Financing Agreement,
at its discretion, is subject to certain limitations and the satisfaction of certain conditions. When available, the Yorkville
Equity Facility Financing Agreement provides an opportunity to actively manage the cash needs of the Company more closely. Historically,
cash has generally been available to the Company through private placements of equity for which the timing did not always coincide
with the Company&#8217;s cash needs. The Company may utilize the Yorkville Equity Facility Financing Agreement to potentially
generate funds at a time when they are in need. Alternatively, the Company can also utilize the Yorkville Equity Facility Financing
Agreement for opportunistic share sales.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023, the Company had cash of $2.3 million and working capital of $0.2 million, compared to cash of $5.3 million and
working capital of $0.6 million on June 30, 2022. On September 1, 2023, the Company closed a non-brokered private placement (the
&#8220;September 2023 Private Placement&#8221;) of units of the Company (the &#8220;September 2023 Units&#8221;). A total of 250,000
September 2023 Units were issued at a price per September 2023 Unit of $4.00, for total gross proceeds to the Company of $1.0 million. Each September
2023 Unit consists of one Common Share and one Common Share purchase warrant (&#8220;September 2023 Warrant&#8221;). Each September
2023 Warrant entitles the holder to acquire one Common Share at a price of $4.60 at any time prior to September 1, 2025. In addition,
On September 12 and September 15, 2023, the Company issued 70,000 and 75,000 Common Shares, respectively, under the Yorkville
Equity Facility Financing Agreement in exchange for $0.5 million in gross cash proceeds. NioCorp intends to use the net proceeds
from these September financing transactions for working capital and general corporate purposes, including to advance its efforts
to launch construction of the Elk Creek Project and move it to commercial operation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that the Company will operate at a loss for the foreseeable future. The Company&#8217;s current planned cash needs are
approximately $11.8 million until June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to outstanding accounts payable and short-term liabilities, our average monthly planned expenditures through June 30,
2024 are expected to be approximately $685,000 per month where approximately $390,000 is for corporate overhead and estimated
costs related to securing financing necessary for advancement of the Elk Creek Project. Approximately $295,000 per month is planned
for expenditures relating to the advancement of the Elk Creek Project by NioCorp&#8217;s majority owned subsidiary, ECRC. The
Company&#8217;s ability to continue operations and fund our current work plan is dependent on management&#8217;s ability to secure
additional financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company anticipates that it does not have sufficient cash on hand to continue to fund basic operations for the next twelve months,
and additional funds totaling $8.0 million to $9.0 million, net of funds raised from the September financing transactions discussed
above, are likely to be necessary to continue advancing the project in the areas of financing, permitting, and detailed engineering.
While the Yorkville Equity Facility Financing Agreement may provide the Company with access to additional capital, the Company
may require additional capital to meet its cash need. Management is actively pursuing such additional sources of debt and equity
financing, and while it has been successful in doing so in the past, there can be no assurance it will be able to do so in the
future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
Creek property and lease commitments are $20,000 through June 30, 2024. To maintain our currently held properties and fund our
currently anticipated general and administrative costs and planned exploration and development activities at the Elk Creek Project
for the fiscal year ending June 30, 2024, the Company will likely require additional financing during the current fiscal year.
Should such financing not be available in that timeframe, we will be required to reduce our activities and will not be able to
carry out all our presently planned activities at the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 6, 2023, the Company announced that it had submitted an application to the Export-Import Bank of the United States (&#8220;EXIM&#8221;)
for debt financing (the &#8220;EXIM Financing&#8221;) to fund the project costs for the Elk Creek Project, under EXIM&#8217;s
&#8220;Make More in America&#8221; initiative. The EXIM Financing is subject to, among other matters, the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">satisfactory completion
of due diligence, the negotiation and settlement of final terms, and the negotiation of definitive documentation. There can be
no assurance that the EXIM Financing will be completed on the terms described herein or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
for potential funding under the Yorkville Equity Facility Financing, discussed above, and the potential exercise of Options and
Warrants, we currently have no further funding commitments or arrangements for additional financing at this time, and there is
no assurance that we will be able to obtain any such additional financing on acceptable terms, if at all. Pursuant to the Exchange
Agreement, NioCorp is restricted from issuing equity or equity-linked securities (other than Common Shares) or any preferred equity
or non-voting equity if such issuance would adversely impact the rights of the holders of the shares of Class B common stock of
ECRC, without the consent of the holders of a majority of the shares of Class B common stock of ECRC. The Yorkville Convertible
Debt Financing Agreement also contains certain covenants that, among other things, limit NioCorp&#8217;s ability to use the proceeds
from the Yorkville Convertible Debt Financing to repay related party debt or to enter into any variable rate transaction, including
issuances of equity or debt securities that are convertible into Common Shares at variable rates and any equity line of credit,
ATM agreement or other continuous offering of Common Shares, other than with Yorkville, subject to certain exceptions. Notwithstanding
the restrictions set forth in the Exchange Agreement and the Yorkville Convertible Debt Financing Agreement, there is significant
uncertainty that we would be able to secure any additional financing in the current equity or debt markets. The quantity of funds
to be raised and the terms of any proposed equity or debt financing that may be undertaken will be negotiated by management as
opportunities to raise funds arise. Management may to pursue funding sources of both debt and equity financing, including but
not limited to the issuance of equity securities in the form of Common Shares, Warrants, subscription receipts, or any combination
thereof in units of the Company pursuant to private placements to accredited investors or pursuant to public offerings in the
form of underwritten/brokered offerings, registered direct offerings, or other forms of equity financing and public or private
issuances of debt securities including secured and unsecured convertible debt instruments or secured debt project financing. Management
does not currently know the terms pursuant to which such financings may be completed in the future, but any such financings will
be negotiated at arm&#8217;s-length. Future financings involving the issuance of equity securities or derivatives thereof will
likely be completed at a discount to the then-current market price of the Company&#8217;s securities and will likely be dilutive
to current shareholders. In addition, we could raise funds through the sale of interests in our mineral properties, although current
market conditions and other recent worldwide events have substantially reduced the number of potential buyers/acquirers of any
such interests. However, we cannot provide any assurances that we will be able to be successful in raising such funds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the conditions described within, management has concluded and the audit opinion and notes that accompany our consolidated financial statements
for the year ended June 30, 2023, disclose that substantial doubt exists as to our ability to continue in business. The consolidated financial
statements included in this Annual Report on Form 10-K have been prepared under the assumption that we will continue as a going
concern. As defined under S-K 1300, we are a development stage issuer, and we have incurred losses since our inception. We may
not have sufficient cash, including option and warrant exercises subsequent to June 30, 2023, to fund normal operations and meet
debt obligations for the next twelve months without deferring payment on certain current liabilities and raising additional funds.
Recent worldwide events have created general global economic uncertainty as well as uncertainty in capital markets, supply chain
disruptions, increased interest rates and inflation, and the potential for geographic recessions. During fiscal year 2023, these
events continued to create uncertainty with respect to overall project funding and timelines. We believe that the going concern
uncertainty cannot be alleviated with confidence until the Company has entered into a business climate where funding of its planned
ongoing operating activities is secured. Therefore, these factors raise substantial doubt as to our ability to continue as a going
concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no exposure to any asset-backed commercial paper. Other than cash held by our subsidiaries for their immediate operating
needs in Colorado and Nebraska, all of our cash reserves are on deposit with major U.S. and Canadian chartered banks. We do not
believe that the credit, liquidity, or market risks with respect thereto have increased as a result of the current market conditions.
However, in order to achieve greater security for the preservation of our capital, we have, of necessity, been required to accept
lower rates of interest, which has also lowered our potential interest income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended June 30, 2023, the Company&#8217;s operating activities consumed $17.3 million of cash (2022: $6.2 million and
2021: $4.7 million). The cash used in operating activities for fiscal year 2023 reflects the Company&#8217;s funding of losses
of $40.1 million, the net fair value losses related to the Private Warrants and the Earnout Shares liabilities,
share-based compensation, and other non-cash transactions. Overall, operational outflows during fiscal year 2023 increased from
the corresponding period of 2022 due to cash expenses related to the Transactions and an increase in exploration-related spending
at the Elk Creek Project. Overall, fiscal year 2023 operational outflows were higher than fiscal year 2022 due primarily to increased
exploration expenditures. Going forward, the Company&#8217;s working capital requirements are expected to increase substantially
in connection with the development of the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 18.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investing
Activities </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 18.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had minimal investing activities during the years ended June 30, 2023 and 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 18.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financing
Activities </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 18.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by financing activities was $14.6 million in fiscal year 2023 (2022: $4.3 million and 2021: $18.1 million). This
increase in financing inflows primarily reflects the timing of cash inflows from the financing transactions disclosed below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a discussion of significant financing transactions for fiscal year 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         February 28, 2023, the non-revolving credit facility agreement, dated January 16, 2017,
                                         as amended, with Mark Smith, our Chief Executive Officer, President, and Executive Chairman
                                         (the &#8220;Smith Credit Agreement&#8221;) was amended to increase the borrowing limit
                                         to $4.0 million from the previous limit of $3.5 million. The Company subsequently drew
                                         down $1.13 million under the Smith Credit Agreement. On March 22, 2023, the Company repaid
                                         Mr. Smith $2.0 million, representing $159,000 of interest and $1.84 million of principal
                                         borrowed under the Smith Credit Agreement. This repayment was made out of funds transferred
                                         to the Company from the GXII trust account on the Closing Date. Subsequently, on May
                                         31, 2023, the Company repaid Mr. Smith $1.31 million, representing $24,000 of interest
                                         and the remaining principal balance outstanding of $1.29 million.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         connection with the GXII Transaction, on January 26, 2023, NioCorp and Yorkville entered
                                         into the Yorkville Convertible Debt Financing Agreement, which was subsequently amended
                                         on February 24, 2023.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Yorkville Convertible Debt Financing Agreement, at the Closing, Yorkville advanced a total amount of $15.36 million to
NioCorp in consideration of the issuance by NioCorp to Yorkville of (i) $16.0 million aggregate principal amount of Convertible
Debentures and (ii) the Financing Warrants, which are exercisable for up to 1,789,267 Common Shares for cash or, if at any time
there is no effective registration statement registering, or no current prospectus available for, the resale of the underlying
Common Shares, on a cashless basis, at the option of the holder, at a price per Common Share of approximately $8.9422, subject
to adjustment to give effect to any stock dividend, stock split, reverse stock split or similar transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 36.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Convertible Debenture issued under the Yorkville Convertible Debt Financing Agreement is an unsecured obligation of NioCorp, matures
on September 17, 2024, which maturity may be extended for one six-month period in certain circumstances at the option of NioCorp,
and incurs a simple interest rate obligation of 5.0% per annum (which will increase to 15.0% per annum upon the occurrence of
an event of default). The outstanding principal amount of, accrued and unpaid interest, if any, on, and premium, if any, on the
Convertible Debentures must be paid by NioCorp in cash when the same becomes due and payable under the terms of the Convertible
Debentures at their stated maturity, upon their redemption or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 36.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 36.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain limitations contained within the Yorkville Convertible Debt Financing Agreement and the Convertible Debentures, including
those as described below, holders of the Convertible Debentures will be entitled to convert the principal amount of, and accrued
and unpaid interest, if any, on each Convertible</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 36.25pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 36.25pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 36.25pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> Debenture, in whole or in part, from time to time over their term, into a number
of Common Shares equal to the quotient of the principal amount and accrued and unpaid interest, if any, being converted divided
by the Conversion Price. The &#8220;Conversion Price&#8221; means, as of any Conversion Date (as defined below) or other date
of determination, the greater of (i) 90% of the average of the daily U.S. dollar volume-weighted average price of the Common Shares
on the principal U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading
days immediately preceding the date on which the holder exercises its conversion right in accordance with the requirements of
the Yorkville Convertible Debt Financing Agreement (the &#8220;Conversion Date&#8221;) or other date of determination, but not
lower than the Floor Price (as defined below), and (ii) the five-day volume-weighted average price of the Common Shares on the
TSX (or on the principal U.S. market if the majority of the trading volume and value of the Common Shares occurred on Nasdaq during
the relevant period) for the five consecutive trading days immediately prior to the Conversion Date or other date of determination
less the maximum applicable discount allowed by the TSX. The &#8220;Floor Price&#8221; means a price of $2.1435 per share, which
is equal to the lesser of (a) 30% of the average of the daily volume-weighted average price of the Common Shares on the principal
U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading days immediately
preceding the Debenture Closing and (b) 30% of the average of the volume-weighted average price of the Common Shares on the principal
U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading days immediately
following the Debenture Closing, subject to certain adjustments to give effect to any stock dividend, stock split, reverse stock
split, recapitalization or similar event.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 36.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 36.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Convertible Debentures restrict the number of Convertible Debentures that may be converted during each calendar month
by Yorkville at a Conversion Price below a fixed price equal to approximately $8.9422 (i.e., the quotient of $10.00 divided by
1.11829212 (being the number of Common Shares that were exchanged for each share of GXII at the Closing, after giving effect to
the Reverse Stock Split)), subject to adjustment to give effect to any stock dividend, stock split, reverse stock split, recapitalization
or similar event. The Convertible Debentures are subject to customary anti-dilution adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 36.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 36.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Convertible Debentures restrict the conversion of Convertible Debentures by Yorkville if such a conversion would
cause Yorkville to exceed certain beneficial ownership thresholds in NioCorp or such a conversion would cause the aggregate number
of Common Shares issued pursuant to the Yorkville Convertible Debt Financing Agreement to exceed the thresholds for issuance of
Common Shares under the rules of the TSX and Nasdaq, unless prior shareholder approval is obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 36.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 37pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Convertible Debentures, following certain trigger events, and until a subsequent cure event, NioCorp will
be required to redeem $1.125 million aggregate principal amount of Convertible Debentures (the &#8220;Triggered Principal Amount&#8221;)
each month by making cash payments to the Investors, on a pro rata basis, in an amount equal to the Triggered Principal Amount,
plus accrued and unpaid interest thereon, if any, plus a redemption premium of 7% of the Triggered Principal Amount. Such monthly
prepayments under the terms of the Convertible Debentures are triggered (i) at the time when NioCorp has issued 95% of the total
amount of Common Shares pursuant to the Yorkville Convertible Debt Financing that it may issue under applicable TSX and Nasdaq
rules or (ii) when NioCorp has delayed or suspended the effectiveness or use of the Convertible Debt Financing Registration Statement
for more than 20 consecutive calendar days, and such monthly prepayment obligations will continue until, with respect to (i) above,
shareholder approval is obtained or, with respect to (ii) above, the Investors may once again resell Common Shares under the Convertible
Debt Financing Registration Statement, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 37pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         connection with the GXII Transaction, on January 26, 2023, the Company and Yorkville
                                         entered into the Yorkville Equity Facility Financing Agreement.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 36.5pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Yorkville Equity Facility Financing Agreement, Yorkville has committed to purchase up to $65.0 million of our Common Shares
(the &#8220;Commitment Amount&#8221;), at our direction from time to time for a period commencing upon the Closing Date and ending
on the earliest of (i) the first day of the month next following the 36-month anniversary of the Closing, (ii) the date on which
Yorkville shall have made payment</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 36.5pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 36.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 36.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">of the full Commitment Amount and (iii) the date that the Yorkville Equity Facility Financing
Agreement otherwise terminates in accordance with its terms (the &#8220;Commitment Period&#8221;), subject to certain limitations
and the satisfaction of the conditions in the Yorkville Equity Facility Financing Agreement. Pursuant to the terms of the Yorkville
Equity Facility Financing Agreement, we issued 81,213 of our Common Shares (the &#8220;Commitment Shares&#8221;) to Yorkville
as consideration for its irrevocable commitment to purchase Common Shares under the Yorkville Equity Facility Financing Agreement.
Yorkville has since resold all of the Commitment Shares. On June 9, 2023, we issued and sold 100,000 Common Shares to Yorkville
under the Yorkville Equity Facility Financing Agreement. Additionally, we are required to pay Yorkville an aggregate fee of $1,500,000
in cash (the &#8220;Cash Fee&#8221;), including $500,000 that we paid on the Closing Date and an additional $250,000 we have paid
as of June 30, 2023. We will pay the remaining $750,000 balance in installments over a 12-month period following the Closing Date,
provided that, we will have the right to prepay without penalty all or part of the remaining installments of the Cash Fee at any
time. The Common Shares that may be sold pursuant to the Yorkville Equity Facility Financing Agreement would be purchased by Yorkville
at a purchase price equal to 97% of the daily volume-weighted average price of the Common Shares on Nasdaq or such other principal
U.S. market for the Common Shares if the Common Shares are ever listed or traded on the New York Stock Exchange or the NYSE American
as reported by Bloomberg Financial Markets (or, if not available, a similar service provider of national recognized standing)
during the applicable pricing period, which is a period during a single trading day or a period of three consecutive trading days,
at the Company&#8217;s option and subject to certain restrictions, in each case, defined based on when an Advance Notice (as defined
in the Yorkville Equity Facility Financing Agreement) is submitted, subject to certain limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 36.5pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 36.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023, 100,000 Common Shares, representing $488,080 in net proceeds, had been issued under the Yorkville Equity Facility
Financing Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 36.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.75pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         April 28, 2023, the Company issued and sold 314,465 Common Shares in a registered direct
                                         offering at a price of $6.36 per share. Net proceeds to the Company from the offering
                                         were approximately $1.8 million. NioCorp intends to use the net proceeds from the offering
                                         for working capital and general corporate purposes, including to advance its efforts
                                         to launch construction of the Elk Creek Project and move it to commercial operation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a discussion of significant financing transactions for fiscal year 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         June 30, 2022, the Company closed a non-brokered private placement (the &#8220;June 2022
                                         Private Placement&#8221;) of units (the &#8220;June 2022 Units&#8221;) of the Company.
                                         A total of 4,981,035 June 2022 Units were issued at a price per June 2022 Unit of C$0.96,
                                         for total gross proceeds to the Company of approximately C$4.8 million. Each June 2022
                                         Unit consists of one Common Share and one common share purchase warrant (&#8220;June
                                         2022 Warrant&#8221;). Each June 2022 Warrant entitles the holder to acquire one Common
                                         Share at a price of C$1.10 at any time prior to July 1, 2024. Proceeds of the June 2022
                                         Private Placement will be used for continued advancement of the Company&#8217;s Elk Creek
                                         Critical Minerals Project and for working capital and general corporate purposes. The
                                         Company paid cash commissions of C$62,000 and 65,100 warrants (the &#8220;Finder Warrants&#8221;),
                                         having the same terms as the June 2022 Warrants, to finders outside of the United States.
                                         The Finder Warrants were valued at C$18,000 using a risk-free rate of 3.2%, expected
                                         volatility of 64% and expected life of two years.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         July 23, 2021, the Company repaid $358,000 to Mr. Smith, representing a partial principal
                                         repayment of $318,000 on the Smith Credit Agreement plus accrued interest.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a041"></span>Cash
Flow Considerations</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has historically relied upon debt and equity financings to finance its activities. Subject to the restrictions set forth
in the Yorkville Convertible Debt Financing Agreement, the Company may pursue additional debt and/or equity financing in the medium
term; however, there can be no assurance the Company will be able to obtain any required financing in the future on acceptable
terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has limited financial resources compared to its proposed expenditures, no source of operating income, and no assurance
that additional funding will be available to it for current or future projects, although the Company has been successful in the
past in financing its activities through the sale of equity securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability of the Company to arrange additional financing in the future will depend, in part, on the prevailing capital market conditions,
and its success in developing the Elk Creek Project. Any quoted market for the Common Shares may be subject to market trends generally,
notwithstanding any potential success of the Company in creating revenue, cash flows, or earnings, and any depression of the trading
price of the Common Shares could impact its ability to obtain equity financing on acceptable terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically,
the Company has used net proceeds from issuances of Common Shares to provide sufficient funds to meet its near-term exploration
and development plans and other contractual obligations when due. However, development and construction of the Elk Creek Project
will require substantial additional capital resources. This includes near-term funding and, ultimately, funding for Elk Creek
Project construction and other costs. See &#8220;<i>Liquidity and Capital Resources&#8221; </i>above, for the Company&#8217;s
discussion of arrangements related to possible future financings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Debt
Covenants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Convertible Debentures contain events of default customary for instruments of their type (with customary grace periods, as applicable)
and provide that, upon the occurrence of an event of default arising from certain events of bankruptcy or insolvency with respect
to NioCorp, all outstanding Convertible Debentures will become due and payable immediately without further action or notice. If
any other type of event of default occurs and is continuing, then any holder may declare all of its Convertible Debentures to
be due and payable immediately. The Company obtained a waiver from Yorkville with respect to any acceleration rights it may have
under the Convertible Debentures in connection with the restatements of the Company&#8217;s financial statements for the periods
ended September 30, 2022, and December 31, 2022, and the delay in filing the Company&#8217;s Quarterly Report on Form 10-Q for
the quarterly period ended March 31, 2023. The Yorkville Convertible Debt Financing Agreement also contains certain covenants
that, among other things, limit NioCorp&#8217;s ability to use the proceeds from the Yorkville Convertible Debt Financing to repay
related party debt or to enter into any variable rate transaction other than with Yorkville, subject to certain exceptions. The
Company was in compliance with these covenants as of June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a042"></span>Environmental</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
mining and exploration activities are subject to various federal and state laws and regulations governing the protection of the
environment. We have made, and expect to make in the future, expenditures to comply with such laws and regulations, but cannot
predict the full amount of such future expenditures. As of June 30, 2023 and 2022, we had accrued $48,000 and $48,000, respectively,
related to estimated environmental obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a043"></span>Forward-Looking
Statements</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing discussion and analysis, as well as certain information contained elsewhere in this Annual Report on Form 10-K, contain
&#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange
Act, and are intended to be covered by the safe harbor created thereby. See the discussion in &#8220;Forward-Looking Statements&#8221;
in Item 1., &#8220;Business.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a044"></span>Accounting
Developments</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a discussion of Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements, see Note 3 to the consolidated
financial statements included in this Annual Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a045"></span>Critical
Accounting Estimates and Recent Accounting Pronouncements</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
significant accounting policies are described in Note 3 to the consolidated financial statements included in this Annual Report
on Form 10-K. As described in Note 3, we are required to make estimates and assumptions that affect the reported amounts and related
disclosures of assets, liabilities, revenue, and expenses. Our estimates are based on our experience and our interpretation of
economic, political, regulatory, and other factors that affect our</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">business prospects. Many of the inputs into our estimation
process are subjective and are subject to uncertainty over time and therefore, actual results may differ significantly from our
estimates. Note 3 also discloses recent accounting pronouncements applicable to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We believe that our most critical accounting estimates are related to the carrying value of our long term
assets; accounting for income taxes and the valuation of deferred tax assets; and the valuation of warrants and earnout shares,
as they require us to make assumptions that are highly uncertain at the time the accounting estimates are made and changes in them
are reasonably likely to occur from period to period. Management has discussed the development and selection of these critical
accounting estimates with the Audit Committee of our board of directors, and the Audit Committee has reviewed the disclosures presented
below. In addition, there are other items within our consolidated financial statements that require estimation, but are not deemed to be critical.
However, changes in estimates used in these and other items could have a material impact on our consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Carrying
Value of Long-Lived Assets </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#8217;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. Key inputs include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Many of these inputs are subjective and are subject to uncertainty over time. Such evaluations compare estimated future
net cash flows with our carrying costs and future obligations on an undiscounted basis. If it is determined that the estimated
future undiscounted cash flows are less than the carrying value of the property, an impairment loss will be recorded, measured
by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Where estimates of future net cash
flows are not determinable and where other conditions indicate the potential for impairment, management uses available market
information and/or third-party valuation experts to assess if the carrying value can be recovered and to estimate fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
review and evaluate our long-lived assets, other than mineral properties, for impairment when events or changes in circumstances
indicate that the related carrying amounts may not be recoverable. An impairment loss is measured and recorded based on the estimated
fair value of the long-lived assets being tested for impairment and their carrying amounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
Taxes </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have assets, hold interests, and conduct activities in the U.S. and Canada and are subject to their
tax regimes. Tax laws are complex and continue to evolve. While we have a history of losses, our assumptions made in tax returns
are subject to review and interpretation by taxing authorities and could be modified. <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
judgment is required in determining our provision for income taxes, our deferred tax assets and liabilities, and any valuation
allowance recorded against our deferred tax assets. We consider factors such as the cumulative income or loss in recent years;
reversal of deferred tax liabilities; projected future taxable income exclusive of temporary differences; the character of the
income tax asset, including income tax positions; tax planning strategies and the period over which we expect the deferred tax
assets to be recovered in the determination of the valuation allowance. In the event that actual results differ from these estimates
or we adjust our estimates in the future, we may need to adjust our valuation allowance, which could materially impact our financial
position and results of operations.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Earnout
Shares and Private Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair values of our Earnout Shares liability and Private Warrants liability were determined using various significant unobservable
inputs, including a discount rate and our best estimate of expected volatility and expected holding periods. Changes in the estimated
fair values of these liabilities may have material impacts on our results of operations in any given period, as any increases
in these liabilities have a corresponding negative impact on our U.S. GAAP results of operations. See Note 10 and 11c to our consolidated
financial statements included in this Annual Report on Form 10-K for additional details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a046"></span>Other</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has one class of shares, being Common Shares. A summary of outstanding shares, share options, warrants, and convertible
debt option as of October 6, 2023, is set out below, on a fully diluted basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 95%; border-collapse: collapse; margin-left: 27pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 70%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
                                         Shares Outstanding&#160;</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(fully
        diluted)</b></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">32,913,419</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested
    Shares<sup>1</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> 4,565,808</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    options<sup>2</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">1,319,000</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants<sup>3</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,066,304</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    Debt<sup>4</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,480,900</span>

</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 27.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>1</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 4.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         exchangeable into one Common Share at any time, and from time to time, until the tenth
                                         anniversary of the Closing Date.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 27.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>2</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 22.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         exercisable into one Common Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 27.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>3</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 4.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                         15,666,626 NioCorp Assumed Warrants that are each exercisable into 1.11829212 Common
                                         Shares, and 3,399,678 Warrants that are each exercisable into one Common Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 27.25pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>4</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-right: 9.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                         Common Shares issuable on conversion of Convertible Debentures with an aggregate outstanding
                                         principal and accrued interest balance of $8.16 million as of October 6, 2023, assuming
                                         a market price per Common Share of $3.66 on that date.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                                         7A.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a047"></span>QUANTITATIVE
                                         AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a048"></span>Interest
rate risk</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s exposure to changes in market interest rates, relates primarily to the Company&#8217;s earned interest income
on cash deposits and short-term investments. The Company maintains a balance between the liquidity of cash assets and the interest
rate return thereon. The carrying amount of financial assets, net of any provisions for losses, represents the Company&#8217;s
maximum exposure to credit risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a049"></span>Foreign
currency exchange risk</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company incurs expenditures in both U.S. and Canadian dollars. Canadian dollar expenditures are primarily related to engineering
and metallurgical expenses, as well as certain professional services. As a result, currency exchange fluctuations may impact the
costs of our operating activities. To reduce this risk, we maintain sufficient cash balances in Canadian dollars to fund expected
near-term expenditures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a050"></span>Commodity
price risk</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is exposed to commodity price risk related to the elements associated with the Elk Creek Project. A significant decrease
in the global demand for these elements may have a material adverse effect on our business. The Elk Creek Project is not in production,
and the Company does not currently hold any commodity derivative positions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                                         8.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><b><span id="a051"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL
                                        STATEMENTS AND SUPPLEMENTARY DATA</span></b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="b001"></span>Report
of Independent Registered Public Accounting Firm </b></span></p>





<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Shareholders
and Board of Directors</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">NioCorp
Developments Ltd.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Centennial,
Colorado</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Opinion
on the Consolidated Financial Statements</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">We
have audited the accompanying consolidated balance sheets of NioCorp Developments, Ltd. (the &#8220;Company&#8221;) as of June
30, 2023 and 2022, the related consolidated statements of operations and comprehensive loss, shareholders&#8217; (deficit) equity
and redeemable noncontrolling interest, and cash flows for each of the three years in the period ended June 30, 2023, and the
related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated
financial statements present fairly, in all material respects, the financial position of the Company at June 30, 2023 and 2022,
and the results of its operations and its cash flows for each of the three years in the period ended June 30, 2023<b>,</b> in
conformity with accounting principles generally accepted in the United States of America.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Going
Concern Uncertainty</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0.9pt 0pt 0; text-align: justify; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern.
As discussed in Note 4 to the consolidated financial statements, the Company has an accumulated deficit and suffered recurring
losses without any current revenue generating operations. These conditions raise substantial doubt about the Company&#8217;s ability
to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 4. The consolidated
financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0.9pt 0pt 0; text-align: justify; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Basis
for Opinion</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">These
consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an
opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered
with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with
respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities
and Exchange Commission and the PCAOB.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether
due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over
financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting
but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.
Accordingly, we express no such opinion.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"></span></p>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Our
audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the
accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the
consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Critical
Audit Matters</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The
critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements
that were communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures
that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex
judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements,
taken as a whole, and we are not, by communicating the critical audit matters below, providing a separate opinion on the critical
audit matters or on the accounts or disclosures to which they  relate.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><i>Certain
Financing Transactions</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">As
described in Notes 1 and 9 to the consolidated financial statements, the Company entered into the following financing transactions
during the year ended June 30, 2023:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On
                                         September 25, 2022, the Company and Lind Global Asset Management III, LLC (&#8220;Lind&#8221;)
                                         entered into the waiver and consent agreement (the &#8220;Lind Consent&#8221;). As consideration
                                         for entering into the Lind Consent, Lind received, amongst other things: the right to
                                         receive a cash payment; and the right to receive additional warrants (the &#8220;Contingent
                                         Consent Warrants&#8221;) if certain contingencies are met on the date that is 18 months
                                         following the closing date.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On
                                         January 26, 2023, the Company entered into a definitive agreement with YA II PN, Ltd.,
                                         an investment fund managed by Yorkville Advisors Global, LP (together with YA II PN,
                                         Ltd., &#8220;Yorkville&#8221;). Pursuant to the definitive agreement, at the closing,
                                         Yorkville advanced a total amount of $15.36 million to the Company in consideration for
                                         $16 million aggregate principal amount of unsecured convertible debentures (the &#8220;Yorkville
                                         Convertible Debt&#8221;) and common share purchase warrants (the &#8220;Financing Warrants&#8221;).
                                         </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">We
identified the accounting treatment of these transactions and the inputs and valuation model used in estimating the fair value of
the Contingent Consent Warrants as a critical audit matter. The principal considerations for our determination were: (i) the evaluation
of the accounting treatment for the Lind Consent as to whether this agreement resulted in a debt modification or extinguishment
based on the analysis of cash flows, (ii) the evaluation of the potential derivatives that may require bifurcation from the Yorkville
Convertible Debt and evaluation of the appropriate accounting treatment, and (iii) the evaluation of the inputs and valuation
model used in estimating the fair value of the Contingent Consent Warrants. Auditing these elements involved especially challenging
auditor judgment due to the nature and extent of</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"></span></p>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">audit effort required to address these matters, including the extent of specialized
skills or knowledge needed.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The
primary procedures we performed to address this critical audit matter included:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Reviewing
                                         and analyzing the terms of the agreements associated with each transaction.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Reviewing
                                         and analyzing the changes in cash flows for the Lind financing transaction.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Utilizing
                                         personnel with specialized knowledge and skills in the relevant technical accounting
                                         guidance to assist in: (i) evaluating relevant contract terms of the financing transactions
                                         in relation to the appropriate accounting literature, and (ii) assessing the appropriateness
                                         of conclusions reached by the Company.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Utilizing
                                         personnel with specialized knowledge and skill to assist in analyzing the Company&#8217;s
                                         inputs and valuation model used in estimating the fair value for the Contingent Consent
                                         Warrants.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><i>GX
Acquisition Corp. II Transaction</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">As
discussed in Notes 1, 5, 10, and 11 on March 17, 2023 (the &#8220;Closing Date&#8221;), the Company closed the GXII Transaction
with GX Acquisition Corp. II (&#8220;GXII&#8221;), pursuant to the Business Combination Agreement, dated September 25, 2022 (the
&#8220;Business Combination Agreement&#8221;).</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">In
connection with the closing, pursuant to the Business Combination Agreement, the Company assumed the GXII Warrant Agreement and
each GXII Warrant thereunder that was issued and outstanding immediately prior to the Closing Date was converted into one Company
assumed warrant. The Company&#8217;s private warrants are required to be accounted for as a liability and are subject to remeasurement
at each balance sheet date, with a June 30, 2023 value of $3.3 million.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Certain
shares of Class B common stock of Elk Creek Resource Corporation (&#8220;ECRC&#8221;) (the &#8220;Earnout Shares&#8221;) are subject
to certain vesting conditions. The Earnout Shares are required to be accounted for as a liability and are subject to remeasurement
at each balance sheet date, with a June 30, 2023 value of $10.5 million.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">We
identified the accounting treatment of the GXII Transaction and the inputs and valuation models used in estimating the fair value
of the private warrants and Earnout Shares included in the GXII Transaction as a critical audit matter. The principal considerations
for our determination were: (i) the evaluation of the accounting treatment for the GXII Transaction, including the accounting
for the private warrants and Earnout Shares, and (ii) the evaluation of the inputs and valuation models used in estimating the
fair value of both the private warrants and Earnout Shares. Auditing these elements involved especially challenging auditor judgment</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"></span></p>

<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">due to the nature and extent of audit effort required to address these matters, including the extent of specialized skills or
knowledge needed.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The
primary procedures we performed to address this critical audit matter included:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Reviewing
                                         and analyzing the terms of the agreements associated with the GXII Transaction.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Utilizing
                                         personnel with specialized knowledge and skills in the relevant technical accounting
                                         guidance to assist in: (i) evaluating relevant contract terms in relation to the appropriate
                                         accounting literature, and (ii) assessing the appropriateness of conclusions reached
                                         by the Company.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Utilizing
                                         personnel with specialized knowledge and skill to assist in analyzing the Company&#8217;s
                                         inputs and valuation models used in estimating the fair value for both the private warrants
                                         and Earnout Shares.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">/s/
BDO USA, P.C.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">We
have served as the Company's auditor since 2015.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Spokane,
Washington</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">October
6, 2023&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0"><b>NioCorp Developments Ltd.</b></p>

<p style="margin-top: 0; margin-bottom: 0"><b><span id="b002"></span>Consolidated Balance Sheets</b></p>

<!-- Field: Rule-Page --><div style="text-align: center"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars, except share data)</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_304_111_pn3n3_z0wqPWYSmdGh" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center; text-indent: -0.125in; padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_491_20230630_zpOQGWSo32he" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49D_20220630_zaHWjJrWsP6e" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; text-indent: -0.125in; padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">As of June 30,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; text-indent: -0.125in; padding-left: 0.25in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Note</td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2023</td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2022</td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AssetsAbstract_iB_zM2qrz9Eqhj3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">ASSETS</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--AssetsCurrentAbstract_iB_z6bYOmUOme76" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">Current</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_maACzxmB_maACz02D_z4qkmL7aH881" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; text-indent: -0.125in; padding-left: 0.25in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,341</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,280</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--PrepaidExpenseCurrent_iI_maACzxmB_maACz02D_zNWkcOHWpg12" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in">Prepaid expenses and other</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,385</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">402</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AssetsCurrent_iTI_mtACz02D_maAz78b_zOwTNeramgna" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Total current assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,726</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,682</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--AssetsNoncurrentAbstract_iB_zmtajGwytj73" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">Non-current</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DepositsAssets_iI_maACzxmB_maAz78b_zu1p4km5vprk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in">Deposits</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepositsAssets" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepositsAssets" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--LongTermInvestmentsAndReceivablesNet_iI_maACzxmB_maAz78b_zNaLXV5H61yf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Investment in equity securities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermInvestmentsAndReceivablesNet" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermInvestmentsAndReceivablesNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--FinanceLeaseRightOfUseAsset_iI_maACzxmB_maAz78b_zRqeX3lwn5f9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Right-of-use assets</td><td>&#160;</td>
    <td style="text-align: center">14</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">236</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">94</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_maACzxmB_maAz78b_zD5A3kNpHv97" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Land and buildings, net</td><td>&#160;</td>
    <td style="text-align: center">6</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">839</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">850</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--CapitalizedCostsMineralInterestsInUnprovedProperties_iI_maACzxmB_maAz78b_zKMqd7vZ5c7c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in">Mineral properties</td><td>&#160;</td>
    <td style="text-align: center">7</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,085</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,085</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--Assets_iTI_mtAz78b_zN4gKSr18Dmg" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2pt; text-indent: -0.125in; padding-left: 0.125in">Total assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,930</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,756</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; text-indent: -0.125in; padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--LiabilitiesAbstract_iB_zfmd7ClCLLD9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">LIABILITIES</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LiabilitiesCurrentAbstract_iB_zCp8mHXxQp2i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">Current</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--AccountsPayableCurrent_iI_maLCzohv_maLCzVU7_z1JRVOgngaNl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: center">8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,491</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">817</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--DueToOfficersOrStockholdersOtherCurrent_iI_maLCzohv_maLCzVU7_zy0PGxzZYWr1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Related party loan</td><td>&#160;</td>
    <td style="text-align: center">12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0093">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DueToOfficersOrStockholdersOtherCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--ConvertibleDebtCurrent_iI_maLCzohv_maLCzVU7_zWuqRYmPRPQa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Convertible debt, current portion</td><td>&#160;</td>
    <td style="text-align: center">9</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0096">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,169</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityCurrent_iI_maLCzohv_maLCzVU7_zz6Erk3emqBd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in">Operating lease liability</td><td>&#160;</td>
    <td style="text-align: center">14</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">71</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">82</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--LiabilitiesCurrent_iTI_mtLCzVU7_maLzZD7_z4jfNOYT0rb8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,562</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,068</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--LiabilitiesNoncurrentAbstract_iB_zcoDvgvudBzb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Non-current</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--ConvertibleDebtNoncurrent_iI_maLCzohv_maLzZD7_zPrPAkAsUQKk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Convertible debt</td><td>&#160;</td>
    <td style="text-align: center">9</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,561</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0109">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OtherLiabilitiesNoncurrent_iI_maLCzohv_maLzZD7_zOl1VklVuB5c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Warrant liabilities, at fair value</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9, 11c</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,989</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0112">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--EarnoutLiabilityAtFairValue_iI_maLCzohv_maLzZD7_zboa5YiU48Kj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Earnout liability, at fair value</td><td>&#160;</td>
    <td style="text-align: center">10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:EarnoutLiabilityAtFairValue" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,521</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0115">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_maLCzohv_maLzZD7_zVhBBmkjCrni" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in">Operating lease liability</td><td>&#160;</td>
    <td style="text-align: center">14</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">164</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--Liabilities_iTI_mtLzZD7_maLzjOb_maLASEzSFy_zcBGt1i6IN98" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Total liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,797</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,091</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--CommitmentsAndContingencies_iI_maLCzohv_zcz2Poeaqz37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Commitments and contingencies</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3k, 13</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--RedeemableNoncontrollingInterestEquityOtherCarryingAmount_iI_maLCzohv_maLzcmp_maLzjOb_maLASEzSFy_zt7X09gnOiC9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Redeemable noncontrolling interest</td><td>&#160;</td>
    <td style="text-align: center">10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,100</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0127">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--StockholdersEquityAbstract_iB_zYayjgGi1vk6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">SHAREHOLDERS&#8217; (DEFICIT) EQUITY</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--CommonStockValue_i01I_maSEzLMM_maSEzYH9_maSEzwvr_zrw07TE6Zl7j" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in">Common stock, <span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20220630_zcS4l5ryxaD4" title="Common stock, par value (in dollars per share)"><span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20230630_znVsvugDWsfk" title="Common stock, par value (in dollars per share)"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30" format="ixt-sec:numwordsen" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-06-30" format="ixt-sec:numwordsen" decimals="INF" unitRef="USDPShares">no</ix:nonFraction></ix:nonFraction></span></span>
    par value, <span id="xdx_906_eus-gaap--CommonStockSharesAuthorizedUnlimited_dxL_c20220701__20230630_zDnBBNkQtuQ8" title="Common stock, authorized::XDX::Unlimited"><span id="xdx_900_eus-gaap--CommonStockSharesAuthorizedUnlimited_dxL_c20210701__20220630_z4pwmbE2IXQ4" title="Common stock, authorized::XDX::Unlimited"><span style="-sec-ix-hidden: xdx2ixbrl0139"><span style="-sec-ix-hidden: xdx2ixbrl0141">unlimited</span></span></span></span>
    shares authorized; <span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630_zvLYtJLonPSk" title="Common stock, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,202,131</ix:nonFraction></span> and <span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20220630_z4QXkzjpYfy9" title="Common stock, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,667,060</ix:nonFraction></span>
    shares outstanding as of June 30, 2023 and 2022, respectively</td><td>&#160;</td>
    <td style="text-align: center">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">140,421</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">129,055</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_maSEzLMM_maSEzYH9_maSEzwvr_ztmkKioQGPH5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">150,477</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">110,397</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i01I_maSEzwvr_zuzJXKJK7pu" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in">Accumulated other comprehensive loss</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">911</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">993</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_406_eus-gaap--StockholdersEquity_i01TI_mtSEzwvr_maLASEzSFy_z2UFH3SApgD2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Total shareholders&#8217; (deficit) equity</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,967</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,665</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzSFy_zbSQsx5hMCH7" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Total liabilities, redeemable noncontrolling interest, and shareholders&#8217; (deficit) equity</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,930</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,756</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center">The accompanying notes are an integral part of these consolidated financial statements</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"><b><span id="b003"></span>NioCorp Developments Ltd.</b></p>

<p style="margin-top: 0; margin-bottom: 0"><b>Consolidated Statements of Operations and Comprehensive
Loss</b></p>

<!-- Field: Rule-Page --><div style="text-align: center"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"><b></b></p>

<p style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars,
except share and per share data)</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_303_113_pn3n3_zvSTx7PYnO41" summary="xdx: Statement - Consolidated Statements of Operations and Comprehensive Loss" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_496_20220701__20230630_zm8GX75xhC0g" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_493_20210701__20220630_zYEMEQdxJZG2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_497_20200701__20210630_z1JQi81TmAp4" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ended June 30,</b></span></p></td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Note</b></td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2023</td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2022</td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2021</td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--OperatingExpensesAbstract_iB_zqg9SNvwqg3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0in">Operating expenses</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LaborAndRelatedExpense_maOEzfTN_znQ6oI0rNWrl" style="vertical-align: bottom; background-color: White">
    <td style="width: 49%; text-align: left; text-indent: 10.5pt; padding-left: 0in">Employee related costs</td><td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,323</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,150</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,655</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--ProfessionalFees_maOEzfTN_zAfbz0wFHmD2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0in">Professional fees</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,581</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">684</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">386</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--ExplorationExpenditures_maOEzfTN_zHboZ6EP0Wyg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0in">Exploration expenditures</td><td>&#160;</td>
    <td style="text-align: center">13</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ExplorationExpenditures" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,348</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ExplorationExpenditures" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,309</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ExplorationExpenditures" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,056</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--OtherGeneralExpense_maOEzfTN_zNovwq0kObp2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 10.5pt; padding-left: 0in">Other operating expenses</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">27,158</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,653</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">995</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--OperatingExpenses_iT_mtOEzfTN_msILFCOzVpj_z9YCdtWFWRRi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 1.5pt; padding-left: 0in">Total operating expenses</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37,410</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,796</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,092</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_ecustom--ChangeInFairValueOfEarnoutLiability_iN_di_maILFCOzVpj_zjhLFrda66Ne" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0in">Change in fair value of earnout shares liability</td><td>&#160;</td>
    <td style="text-align: center">10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutLiability" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,674</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0184">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0185">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--ChangeInFairValueOfWarrantLiability_iN_di_maILFCOzVpj_zMZ6icBixqp9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0in">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: center">9,11c</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfWarrantLiability" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,414</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0188">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0189">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ExtinguishmentOfDebtAmount_msILFCOzVpj_zznjkH4gxU19" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0in">Loss on debt extinguishment</td><td>&#160;</td>
    <td style="text-align: center">9</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ExtinguishmentOfDebtAmount" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,922</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0192">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ExtinguishmentOfDebtAmount" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">163</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--InterestExpense_msILFCOzVpj_z2xQMUG1ycQ2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0in">Interest expense</td><td>&#160;</td>
    <td style="text-align: center">9,12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,336</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,827</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,543</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_iN_di_maILFCOzVpj_zqw0RwvXOGh2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0in">Foreign exchange loss (gain)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">216</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">258</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">725</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--OtherIncome_iN_di_maILFCOzVpj_zvNNcOdgc7u3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0in">Other gains</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0204">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">208</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_iN_di_maILFCOzVpj_zqF3aUVe2fKb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0in">Change in financial instrument fair value</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0207">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0208">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_iN_di_maILFCOzVpj_zfm2hAjN3ixi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 10.5pt; padding-left: 0in">Loss (gain) on equity securities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_40D_ecustom--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_iNT_di_mtILFCOzVpj_maPLznQI_z4nan6qw5PAf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0in">Loss before income taxes</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">40,612</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,887</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,824</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--IncomeTaxExpenseBenefit_msPLznQI_zXTaZm4QjWqa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 10.5pt; padding-left: 0in">Income tax benefit</td><td>&#160;</td>
    <td style="text-align: center">15</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">304</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0220">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0221">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--ProfitLoss1_iNT_di_mtPLznQI_maPLz2sq_z1kq9gStS9B6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.75pt; padding-left: 0in">Net loss</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ProfitLoss1" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">40,308</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ProfitLoss1" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,887</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ProfitLoss1" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,824</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_msPLz2sq_zIwPk6IkHg6j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 10.5pt; padding-left: 0in">Net loss attributable to redeemable noncontrolling interest</td><td>&#160;</td>
    <td style="text-align: center">10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">228</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0228">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0229">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--ProfitLoss_iNT_di_mtPLz2sq_zT9rAJ45H9ja" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2pt; padding-left: 0in">Net loss attributable to the Company</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">40,080</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,887</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,824</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract_iB_ztPsM5Tfb7Rb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0in">Other comprehensive loss:</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--NetIncomeLoss_iN_di_zgQo92QHX3ic" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0in">Net loss</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">40,308</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,887</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,824</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_iB_z58APCLCROU9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0in">Other comprehensive (gain) loss:</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_zPW2I3lRKFR3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 10.5pt; padding-left: 0in">Reporting currency translation</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">82</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">166</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">804</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ComprehensiveIncomeNetOfTax_iNT_di_zUx1MyDj0f4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0in">Total comprehensive loss</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">40,226</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,721</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,628</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest_zruM75mBkLXb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 10.5pt; padding-left: 0in">Comprehensive loss attributable to redeemable noncontrolling interest</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">228</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0256">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0257">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_iNT_di_zt4glx8rZ65g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2pt; padding-left: 0in">Comprehensive loss attributable to the Company</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxParent" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39,998</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxParent" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,721</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxParent" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,628</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_zXe5ibv803r9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0in">Loss per common share, basic and diluted</td><td>&#160;</td>
    <td style="text-align: center">3o</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.34</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.41</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.20</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted_z5CqCJoRtpai" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-left: 0in">Weighted average common shares outstanding</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,705,840</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,373,722</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,196,711</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center">The accompanying notes are an integral part of these consolidated financial statements</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"><b><span id="b004"></span>NioCorp Developments Ltd.</b></p>

<p style="margin-top: 0; margin-bottom: 0"><b>Consolidated Statements of Cash Flows</b></p>

<!-- Field: Rule-Page --><div style="text-align: center"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"><b></b></p>

<p style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars)</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_112_pn3n3_zNRAWS3tWtXa" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_499_20220701__20230630_z9H6yFLYDOLg" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_492_20210701__20220630_z1icaTYob0E9" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_491_20200701__20210630_zybqJS6G4oq" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 12.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 12.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ended June 30,</b></span></p></td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; text-align: center">Note</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2023</td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2022</td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2021</td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zmoXnlhmQdJ9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">CASH FLOWS FROM OPERATING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--NetIncomeLoss_maNCPBUzaBc_zTjSzQvqyFOa" style="vertical-align: bottom; background-color: White">
    <td style="width: 57%; text-align: left; text-indent: -0.125in; padding-left: 0.25in">Net loss for the period</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">40,308</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,887</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,824</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB_zwV8Y6rte97c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Adjustments for:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--AssumptionOfEarnoutLiability_maNCPBUzaBc_zFtZHnQ2bK" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Initial valuation of earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:AssumptionOfEarnoutLiability" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,195</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0284">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0285">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--ChangeInFairValueOfEarnoutShareLiability_maNCPBUzaBc_znYrnt2wO7Z6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Change in valuation of earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutShareLiability" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,674</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0288">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0289">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--AssumptionOfPrivateAndPublicWarrants_maNCPBUzaBc_zzePdy2Lv9Hb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Initial valuation of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:AssumptionOfPrivateAndPublicWarrants" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,987</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0292">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0293">-</span></td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_40E_eus-gaap--AccretionExpense_maNCPBUzaBc_zcJlJxU5GSRb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Accretion of convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,157</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,619</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,100</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ShareBasedCompensation_maNCPBUzaBc_zKoOCZEOeqY9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,794</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,745</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">797</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>

<tr id="xdx_403_ecustom--LossesOnExtinguishmentOfDebt_maNCPBUzaBc_z4xk5EUEVKTg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Loss on debt extinguishment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:LossesOnExtinguishmentOfDebt" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,422</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0304">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:LossesOnExtinguishmentOfDebt" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">163</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--ChangeInValuationOfWarrantLiabilities_maNCPBUzaBc_zcmvXjVC9IWd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Change in valuation of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInValuationOfWarrantLiabilities" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,414</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0308">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0309">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--FairValueOfCommitmentSharesIssued_maNCPBUzaBc_z2Xx8T5t8Nol" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.375in">Yorkville share issuances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:FairValueOfCommitmentSharesIssued" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">663</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0312">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0313">-</span></td><td style="text-align: left">&#160;</td></tr>

<tr id="xdx_400_ecustom--ForeignCurrencyTransactionGainLossBeforeTax1_maNCPBUzaBc_zEF3eWI6Zoti" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Foreign exchange loss (gain)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ForeignCurrencyTransactionGainLossBeforeTax1" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ForeignCurrencyTransactionGainLossBeforeTax1" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">329</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ForeignCurrencyTransactionGainLossBeforeTax1" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">661</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_406_eus-gaap--Depreciation_maNCPBUzaBc_zJPK9HWAGmPe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.375in">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0321">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--UnrealizedGainLossOnInvestments_iN_di_msNCPBUzaBc_zUpLXxc9hIY1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Unrealized loss (gain) on equity securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--OperatingLeaseImpairmentLoss_maNCPBUzaBc_zORayizn1Rfk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Noncash lease activity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--OtheroperatingGainsLosses_iN_di_msNCPBUzaBc_zV2Jw5tO7th1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Other gains</td><td style="text-align: center">6</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:OtheroperatingGainsLosses" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0332">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:OtheroperatingGainsLosses" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">196</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_403_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_iN_di_msNCPBUzaBc_zZasjMJt5Vfb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.375in">Change in financial instrument fair value</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0335">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0336">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_zZYBZU6kitI5" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="display: none; visibility: hidden">Total</span></td><td>&#160;</td>

    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">19,171</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,192</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,632</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_iB_zRDNBP2lZL67" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Change in working capital items:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--IncreaseDecreaseInPrepaidExpense_iN_di_msNCPBUzaBc_z3hxA8bBGqnh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">985</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">377</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">9</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_maNCPBUzaBc_zTX4gsMZKYs9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.375in">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,861</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">419</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,103</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iT_mtNCPBUzaBc_maCCERCzXun_z6rvZIe0nKUl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Net cash used in operating activities</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,295</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,150</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,726</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zzDQS3HLsm11" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">CASH FLOWS FROM INVESTING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--PaymentsToAcquireMineralRights_iN_di_msNCPBUzyYt_zrfMNMPzjWml" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Acquisition of mineral rights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0363">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0364">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireMineralRights" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,468</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_403_eus-gaap--PaymentsToAcquireBuildings_iN_di_msNCPBUzyYt_z0KiZW4RAxzl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Acquisition of land and buildings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0367">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireBuildings" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireBuildings" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">837</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--ProceedsFromSaleOfProductiveAssets_maNCPBUzyYt_zK5oAj5DAOSf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in">Proceeds from sale of assets</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0372">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0373">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInInvestingActivities_iT_mtNCPBUzyYt_maCCERCzXun_zHBbjr0mNrNj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Net cash provided by (used in) investing activities</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">16</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,305</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zxmmasyaQ1m6" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">CASH FLOWS FROM FINANCING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--ProceedsFromConvertibleDebt_maNCPBUzfVS_zubTdGi1MlD5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Issuance of convertible debt, net of costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,857</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0384">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,477</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--ProceedsFromIssuanceOfCommonStock_maNCPBUzfVS_zflODJqUOZN" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Proceeds from issuance of capital stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,499</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,737</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,677</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ProceedsFromRelatedPartyDebt_maNCPBUzfVS_zMfiyJe1RLHf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Related party debt draws</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,130</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0392">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0393">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--RepaymentsOfRelatedPartyDebt_iN_di_msNCPBUzfVS_zzsJUUUOvNad" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Related party debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,130</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">318</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,500</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--RepaymentsOfNotesPayable_iN_di_msNCPBUzfVS_z4VHNI8wT55i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Loan repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">515</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0400">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">406</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40C_eus-gaap--PaymentsOfStockIssuanceCosts_iN_di_msNCPBUzfVS_zg9EdJb8jGR9" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in">Share issue costs</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">204</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">118</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">174</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivities_iT_mtNCPBUzfVS_maCCERCzXun_zTZpp9jty7w2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Net cash provided by financing activities</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,637</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,301</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,074</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_maCCERCzXun_zPoz5Z8nKCx3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Exchange rate effect on cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">302</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">172</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzXun_zlF5YoVNGGP5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Change in cash and cash equivalents during period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,939</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,037</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,010</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_zzrt56ktJAQ8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Cash and cash equivalents, beginning of period</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,280</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,317</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">307</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_zTeYXql80Cvd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2pt; text-indent: -0.125in; padding-left: 0.125in">Cash and cash equivalents, end of period</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,341</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,280</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,317</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zoPi5wyPhWd4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Supplemental cash flow information:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--InterestPaidNet_z4D53K2mDfk8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Amounts paid for interest</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">264</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">252</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">873</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--IncomeTaxesPaidNet_zukmTfwyjQng" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Amounts paid for income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0435">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0436">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0437">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_zEbYJey5JM6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Non-cash investing and financing transactions:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--ConversionsOfDebtForCommonShares_z48xpDPqLFjb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.5in">Conversion of debt for common shares</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="niobf:ConversionsOfDebtForCommonShares">5,175</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonNumeric contextRef="From2021-07-012022-06-30" name="niobf:ConversionsOfDebtForCommonShares">8,807</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonNumeric contextRef="From2020-07-012021-06-30" name="niobf:ConversionsOfDebtForCommonShares">3,106</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--RecognitionOfOperatingLeaseLiabilities_zUadIrQsSqFl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.5in">Recognition of operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="niobf:RecognitionOfOperatingLeaseLiabilities">199</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0448">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="From2020-07-012021-06-30" name="niobf:RecognitionOfOperatingLeaseLiabilities">231</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--DerecognitionOfOperatingLeaseLiabilities_zAVrkeHdslYe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.5in">Derecognition of operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0451">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0452">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="From2020-07-012021-06-30" name="niobf:DerecognitionOfOperatingLeaseLiabilities">(22</ix:nonNumeric></td><td style="text-align: left">)</td></tr>
<tr id="xdx_409_ecustom--AccountsPayableToConvertibleDebtConversion_zP2ksAxsRDQa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.5in">Accounts payable to note conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0455">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0456">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="From2020-07-012021-06-30" name="niobf:AccountsPayableToConvertibleDebtConversion">1,640</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_ecustom--ValueOfWarrantsIssued_z7aH8OIWnD18" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.5in">Value of warrants issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="niobf:ValueOfWarrantsIssued">3,337</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0460">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="From2020-07-012021-06-30" name="niobf:ValueOfWarrantsIssued">1,795</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center">The accompanying notes are an integral part of these consolidated financial statements</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>



<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"><b><span id="b005"></span>NioCorp Developments Ltd.</b></p>

<p style="margin-top: 0; margin-bottom: 0"><b>Consolidated Statements of Shareholders&#8217; (Deficit) Equity and Redeemable Noncontrolling Interest</b></p>

<!-- Field: Rule-Page --><div style="text-align: center"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"><b></b></p>

<p style="margin-top: 0; margin-bottom: 0">(expressed in thousands of U.S. dollars, except
share data)</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_114_pn3n3_zBJe1Z0SAq7c" summary="xdx: Statement - Consolidated Statements of Shareholders&apos; (Deficit) Equity and Redeemable Noncontrolling Interest" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; text-align: center">&#160;</td><td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zXb6bCCVoBdi" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; text-align: center">&#160;</td><td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zFdtBWxnCgK8" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; text-align: center">&#160;</td><td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zEqmYoVayyJe" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; text-align: center">&#160;</td><td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" id="xdx_4BD_zbMAXcRIJyN3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; text-align: center">&#160;</td><td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_custom--RedeemableNoncontrollingInterestMember_zOkGpFN2a0Ub" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; text-align: center">&#160;</td><td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">Common Shares Outstanding</td><td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">Common Stock</td><td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">Accumulated
    Deficit</td><td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">Accumulated Other Comprehensive Income</td><td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">Total</td><td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">Redeemable Noncontrolling Interest</td><td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td></tr>
<tr id="xdx_437_c20200701__20210630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zrRkzaRWKNH1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; font-weight: bold; padding-bottom: 1pt; padding-left: 2.15pt">Balance, June 30, 2020</td><td style="border-right: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--CommonStockSharesOutstanding_iS_pid_uShares_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJsknrYihzTd" title="Beginning balance (in shares)" style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,592,571</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">97,682</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">94,686</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 1%; text-align: left">)</td><td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">355</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 1%; text-align: left">)</td><td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,641</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0467">-</span></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_43A_c20200701__20210630_ecustom--StockIssuedDuringPeriodSharesStockWarrantExercised_zYpAXiEyKkU6" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 4.85pt; padding-left: 2.15pt">Exercise of warrants</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesStockWarrantExercisedShares_pid_uShares_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWFdTw2l8Sn9" title="Exercise of warrants (in shares)" style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockWarrantExercisedShares" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">910,628</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockWarrantExercised" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,338</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0472">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0473">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockWarrantExercised" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,338</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0475">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_43B_c20200701__20210630_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zhGuojb5jlfj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 4.85pt; padding-left: 2.15pt">Exercise of options</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_uShares_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUYPhvwo9Sp8" title="Exercise of options (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">295,229</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">215</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0480">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0481">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">215</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0483">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_432_c20200701__20210630_eus-gaap--FairValueAdjustmentOfWarrants_z9Iv7OhuVPV5" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 4.85pt; padding-left: 2.15pt">Fair value of warrants granted</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,795</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0488">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0489">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,795</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0491">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_438_c20200701__20210630_ecustom--PrivatePlacementValueMay2021_z4Enlu3heTm3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 4.85pt; padding-left: 2.15pt">Private placement &#8211; May 2021</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--PrivatePlacementSharesMay2021_pid_uShares_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ4W00qfoK1c" title="Exercise of options (in shares)" style="text-align: right"><ix:nonFraction name="niobf:PrivatePlacementSharesMay2021" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">433,415</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:PrivatePlacementValueMay2021" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,124</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0494">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0495">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:PrivatePlacementValueMay2021" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,124</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0497">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_435_c20200701__20210630_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_zVcW7mJMKQq2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 4.85pt; padding-left: 2.15pt">Debt conversions</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_uShares_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvhZ6hFOcQae" title="Debt conversions (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">406,151</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,106</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0502">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0503">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,106</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0505">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_43D_c20200701__20210630_eus-gaap--StockIssuedDuringPeriodValueNewIssues_z6Em0XSX4txe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 4.85pt; padding-left: 2.15pt">Share issuance costs</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">175</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0510">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0511">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">175</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0513">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_437_c20200701__20210630_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_z7rvFBBGDCej" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 4.85pt; padding-left: 2.15pt">Share-based compensation</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">797</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0516">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0517">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">797</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0519">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_43C_c20200701__20210630_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_zXslu9MpJlkl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 4.85pt; padding-left: 2.15pt">Reporting currency presentation</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0521">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0522">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">804</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">804</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0525">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_43F_c20200701__20210630_eus-gaap--ProfitLoss_zWBLhxWOX8l2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 4.85pt; padding-left: 2.15pt">Loss for the year</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0527">-</span></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,824</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0529">-</span></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,824</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0531">-</span></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_433_c20210701__20220630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zkHXUOu9SHG3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt; padding-left: 2.15pt">Balance, June 30, 2021</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--CommonStockSharesOutstanding_iS_pid_uShares_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z53Wo5UbqMd4" title="Beginning balance (in shares)" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,637,994</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">113,882</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">99,510</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,159</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,213</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0537">-</span></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_43A_c20210701__20220630_ecustom--StockIssuedDuringPeriodSharesStockWarrantExercised_z1ZFkVQe2M7i" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 4.85pt; padding-left: 2.15pt">Exercise of warrants</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--StockIssuedDuringPeriodSharesStockWarrantExercisedShares_pid_uShares_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zL7RcOBGXXs" style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockWarrantExercisedShares" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">87,175</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockWarrantExercised" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">543</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0542">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0543">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockWarrantExercised" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">543</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0545">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_431_c20210701__20220630_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_z9Ow9acZr9db" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 4.85pt; padding-left: 2.15pt">Exercise of options</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_uShares_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zv1kPcyojaLc" title="Exercise of options (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">205,153</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">483</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0549">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0550">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">483</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0552">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_433_c20210701__20220630_eus-gaap--FairValueAdjustmentOfWarrants_zetVrvffH9Z3" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 4.85pt; padding-left: 2.15pt">Fair value of warrants granted</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0557">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0558">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0560">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_434_c20210701__20220630_ecustom--PrivatePlacementSharesMay2021_zoVi6HXRxji" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 4.85pt; padding-left: 2.15pt">Private placement &#8211; June 2022</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--PrivatePlacementSharesMay2022Sahres_pid_uShares_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8pjJawPYAzc" title="Private placement June 2022 (in shares)" style="text-align: right"><ix:nonFraction name="niobf:PrivatePlacementSharesMay2022Sahres" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">498,103</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:PrivatePlacementSharesMay2021" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">3,711</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0563">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0564">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:PrivatePlacementSharesMay2021" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">3,711</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0566">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_439_c20210701__20220630_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_zFcHa6glyU83" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 4.85pt; padding-left: 2.15pt">Debt conversions</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_uShares_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGgMzcAVbEUg" title="Debt conversions (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,238,635</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,807</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0571">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0572">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,807</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0574">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_43F_c20210701__20220630_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zOxgIPudu0B7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 4.85pt; padding-left: 2.15pt">Share issuance costs</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">130</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0579">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0580">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">130</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0582">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_438_c20210701__20220630_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_zMgnHQ7TBbK8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 4.85pt; padding-left: 2.15pt">Share-based compensation</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,745</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0585">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0586">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,745</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0588">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_433_c20210701__20220630_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_zSenPDMbrV93" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 4.85pt; padding-left: 2.15pt">Reporting currency presentation</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0590">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0591">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0594">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_436_c20210701__20220630_eus-gaap--ProfitLoss_zVTg3mtMyUrc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 4.85pt; padding-left: 2.15pt">Loss for the year</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0596">-</span></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,887</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0598">-</span></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,887</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0600">-</span></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_436_c20220701__20230630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zzTydQbpx5kf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt; padding-left: 2.15pt">Balance, June 30, 2022</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--CommonStockSharesOutstanding_iS_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWMVfnX1fV1a" title="Beginning balance (in shares)" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,667,060</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">129,055</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">110,397</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">993</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,665</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0606">-</span></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_439_c20220701__20230630_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zxIrkBqMR2ei" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 4.85pt; padding-left: 2.15pt">Exercise of options</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4fG48jlCIAf" title="Exercise of options (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">265,138</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0611">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0612">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0614">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_439_c20220701__20230630_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_zebjctyVlaD2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 4.85pt; padding-left: 2.15pt">Fair value of warrants granted</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,338</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0619">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0620">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,338</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0622">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_43E_c20220701__20230630_ecustom--CommonSharesIssuedInTheGXIITransaction_zD5XbT4z1dX7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -12.4pt; padding-left: 17.25pt">Common Shares issued in the GXII Transaction</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--CommonSharesIssuedInTheGXIITransactionSahres_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2Ypwno9kw35" title="Common Shares issued in the GXII Transaction (in shares)" style="text-align: right"><ix:nonFraction name="niobf:CommonSharesIssuedInTheGXIITransactionSahres" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,753,821</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0624">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0625">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0626">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0627">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0628">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_434_c20220701__20230630_eus-gaap--StockIssuedDuringPeriodValueOther_zbkzJXZSY2ek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 4.85pt; padding-left: 2.15pt">Commitment shares issued</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNefw8Z6Gqec" title="Commitment shares issued (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">81,213</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0633">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0634">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0636">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_43B_c20220701__20230630_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_zGoN6eh0Dkbh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 4.85pt; padding-left: 2.15pt">Registered direct offering &#8211; May 2023</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwpJlSw3SqSk" title="Registered direct offering May 2023 (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">314,465</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0641">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0642">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0644">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_43C_c20220701__20230630_ecustom--SharesIssuedUnderTheYorkvilleEquityFacility_z4NdG9KzoQa8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12.4pt; padding-left: 17.25pt">Shares issued under the Yorkville equity facility</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--SharesIssuedUnderTheYorkvilleEquityFacilityShares_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZubJ3fgfP5e" title="Shares issued under the Yorkville equity facility (in shares)" style="text-align: right"><ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacilityShares" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">501</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0649">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0650">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">501</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0652">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_431_c20220701__20230630_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_zmLMeV6CgWsj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 4.85pt; padding-left: 2.15pt">Debt conversions</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztckkX8rV3g2" title="Debt conversions (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,020,434</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,604</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0657">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0658">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,604</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0660">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_436_c20220701__20230630_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zW96Q1AhmSe8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 4.85pt; padding-left: 2.15pt">Share issuance costs</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">204</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0665">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0666">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">204</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0668">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_439_c20220701__20230630_ecustom--RedeemableNoncontrollingInterest_zaKOAH8de9P5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 4.85pt; padding-left: 2.15pt">Redeemable noncontrolling interest</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:RedeemableNoncontrollingInterest" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,328</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0671">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0672">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:RedeemableNoncontrollingInterest" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,328</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:RedeemableNoncontrollingInterest" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,328</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_438_c20220701__20230630_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_zVh5hNKKCOmb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 4.85pt; padding-left: 2.15pt">Share-based compensation</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,794</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0677">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0678">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,794</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0680">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_434_c20220701__20230630_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_zZ85czZ9ka7f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 4.85pt; padding-left: 2.15pt">Reporting currency presentation</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0682">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0683">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">82</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">82</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0686">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_432_c20220701__20230630_eus-gaap--ProfitLoss_zMqxgZivBPXf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 4.85pt; padding-left: 2.15pt">Loss for the year</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0688">-</span></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">40,080</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0690">-</span></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">40,080</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">228</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_434_c20220101__20230630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zqTMcjSJ5j3f" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2pt; padding-left: 2.15pt">Balance, June 30, 2023</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--CommonStockSharesOutstanding_iE_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zar5uhiULiKc" title="Ending balance (in shares)" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,202,131</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">140,421</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">150,477</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 2pt solid; text-align: left">)</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">911</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 2pt solid; text-align: left">)</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,967</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 2pt solid; text-align: left">)</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_custom_RedeemableNoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,100</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center">The accompanying notes are an integral part of these consolidated financial statements</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>



<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p id="xdx_235_zihJ1CnDkJv8" style="margin: 0pt 0 0pt 0.25in; text-align: justify"><b><span id="b006"></span>NioCorp Developments Ltd.</b></p>

<p id="xdx_23A_zMs5pi108s0i" style="margin: 0pt 0 0pt 0.25in; text-align: justify"><b>Notes to Consolidated Financial Statements</b></p>

<p id="xdx_237_zt932DFOsSx5" style="margin: 0pt 0 0pt 0.25in; text-align: justify"><b>June 30, 2023</b></p>

<!-- Field: Rule-Page --><div id="xdx_237_z21mLhNmq3Xg" style="text-align: center; margin-left: 0.25in"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0pt 0 0pt 0.25in; text-align: justify"><b></b></p>

<p id="xdx_23A_z0lNOyjlUERf" style="margin: 0pt 0 0pt 0.25in; text-align: justify">(expressed in thousands of U.S. dollars,
except share and per share data)</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:NatureOfOperations"><p id="xdx_80F_eus-gaap--NatureOfOperations_zj6YcLTXPR5l" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td id="xdx_82D_zxkIhqU1ACo6" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
OF BUSINESS</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
Developments Ltd. (the &#8220;Company&#8221; or &#8220;NioCorp&#8221;) was incorporated on February 27, 1987, under the laws of the Province of
British Columbia and currently operates in <span id="xdx_901_eus-gaap--NumberOfReportableSegments_dxL_uNUMBER_c20220701__20230630_zifKldeWzKTc" title="Number of reportable segments::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl0709">one</span></span>
reportable operating segment consisting of exploration and development of mineral deposits in North America, specifically,
the Elk Creek Niobium/Scandium/Titanium property (the &#8220;Elk Creek Project&#8221;) located in southeastern
Nebraska.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
further discussed in Notes 5, 9, 10, and 11, on March 17, 2023 (the &#8220;Closing Date&#8221;), the Company closed the GXII Transaction
(as defined below) with GX Acquisition Corp. II (&#8220;GXII&#8221;), pursuant to the Business Combination Agreement, dated September
25, 2022 (the &#8220;Business Combination Agreement&#8221;), among the Company, GXII and Big Red Merger Sub Ltd (the &#8220;Closing&#8221;).
At the Closing, the Company also closed convertible debt financings (the &#8220;Yorkville Convertible Debt Financing&#8221;) with
YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (together with YA II PN, Ltd., &#8220;Yorkville&#8221;),
and the standby equity purchase facility with Yorkville (the &#8220;Yorkville Equity Facility Financing&#8221; and, together with
the Yorkville Convertible Debt Financing, the &#8220;Yorkville Financings&#8221;) became effective. The transactions contemplated
by the Business Combination Agreement, including the GXII Transaction, the Yorkville Financings and the Reverse Stock Split (as
defined below), are referred to, collectively, as the &#8220;Transactions.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
GXII Transaction is being accounted for as an equity raise transaction in accordance with generally accepted accounting principles
of the United States of America (&#8220;U.S. GAAP&#8221;). Under this method of accounting, GXII is treated as the &#8220;acquired&#8221;
company for financial reporting purposes. Accordingly, the GXII Transaction is treated as the equivalent of NioCorp issuing common
shares, no par value, of the Company (&#8220;Common Shares&#8221;) for the assets and liabilities of GXII. The net assets of GXII
are stated at historical cost, with no goodwill or other intangible assets recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements have been prepared on a going concern basis that contemplates the realization of assets and
discharge of liabilities at their carrying values in the normal course of business for the foreseeable future. These consolidated
financial statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently earns no operating revenues and will require additional capital in order to advance the Elk Creek Project to
construction and commercial operation. As further discussed in Note 4, these matters raised substantial doubt about the Company&#8217;s
ability to continue as a going concern, and the Company is dependent upon the generation of profits from mineral properties, obtaining
additional financing and maintaining continued support from its shareholders and creditors.</span></p>

</ix:nonNumeric><p id="xdx_814_zr5LLoeWYwt5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:BasisOfAccounting"><p id="xdx_80A_eus-gaap--BasisOfAccounting_zQYcL4w1vx82" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82E_zIsB8ZEsQrHd">BASIS
                                         OF PREPARATION</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis
                                         of Preparation and Consolidation</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements have been prepared in conformity with U.S. GAAP and the rules and regulations of the U.S.
Securities and Exchange Commission. The consolidated financial statements include the consolidated accounts of the Company
and its wholly owned subsidiaries with all significant intercompany transactions eliminated. Certain transactions include
reference to Canadian dollars (&#8220;C$&#8221;) where applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_238_zwliu4Uuhn41" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_237_z5sNzh0FHNP9" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_zrENfcOUnHG2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_z2Qde7f0NYl4" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: center; margin-left: 0.25in"><ix:exclude><div id="xdx_238_zTBhneEZUqe2" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_23F_zOv0z8lkCLvk" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;&#160;</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"><p id="xdx_895_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zj4H0tKNxq02" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All
intercompany transactions and balances have been eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span><span id="xdx_8B6_zfL7KyGUoM14" style="display: none; visibility: hidden">Schedule of intercompany transactions and balances</span></span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jurisdiction
    of incorporation</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership
    at June 30,</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 41%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0896800
    BC Ltd. (&#8220;0896800&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zQmMSWJijxzi" title="Country of incorporation"><span id="xdx_908_ecustom--IncorporationStateCountryName_c20210701__20220630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zGlmuRZxB341" title="Country of incorporation"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_Entity0896800BCLtdMember" name="niobf:IncorporationStateCountryName"><ix:nonNumeric contextRef="From2021-07-012022-06-30_custom_Entity0896800BCLtdMember" name="niobf:IncorporationStateCountryName">British
    Columbia, Canada</ix:nonNumeric></ix:nonNumeric></span></span></span></td>
    <td id="xdx_98B_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zzbIweDCVVoa" title="Percentage of ownership" style="font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2023-06-30_custom_Entity0896800BCLtdMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span></td>
    <td id="xdx_981_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zzc9JvGhtq87" title="Percentage of ownership" style="font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2022-06-30_custom_Entity0896800BCLtdMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 0.375in; text-align: justify; text-indent: -23.4pt; width: 41%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zksiovUNC0i9" title="Country of incorporation"><span id="xdx_906_ecustom--IncorporationStateCountryName_c20210701__20220630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zkUMxkHVlFL6" title="Country of incorporation"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_ElkCreekResourcesCorpMember" name="niobf:IncorporationStateCountryName"><ix:nonNumeric contextRef="From2021-07-012022-06-30_custom_ElkCreekResourcesCorpMember" name="niobf:IncorporationStateCountryName">Nebraska,
    USA</ix:nonNumeric></ix:nonNumeric></span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 17%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 17%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_ziAzFfl1yeQ9" title="Percentage of ownership"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2022-06-30_custom_ElkCreekResourcesCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%
    by 0896800</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp. (&#8220;ECRC&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zZnDPIi8PWTd" title="Country of incorporation"><span id="xdx_905_ecustom--IncorporationStateCountryName_c20210701__20220630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zJpRKSrWeSmk" title="Country of incorporation"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_ElkCreekResourcesCorpECRCMember" name="niobf:IncorporationStateCountryName"><ix:nonNumeric contextRef="From2021-07-012022-06-30_custom_ElkCreekResourcesCorpECRCMember" name="niobf:IncorporationStateCountryName">Delaware,
    USA</ix:nonNumeric></ix:nonNumeric></span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zwP0I9QOW6dl" title="Percentage of ownership"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2023-06-30_custom_ElkCreekResourcesCorpECRCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%
    of the Class A common stock by 0896800</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
                                         of Estimates</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date
of the consolidated financial statements, and the reported amounts of expenses during the reporting period. The Company regularly
evaluates estimates and assumptions related to the deferred income tax asset valuations, convertible debt valuations, earnout
valuation, warrant liabilities, and share-based compensation. The Company bases its estimates and assumptions on current facts,
historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which
form the basis for making judgments about the other sources. The actual results experienced by the Company may differ materially
and adversely from the Company&#8217;s estimates. To the extent there are material differences between estimates and the actual
results, future results of operations will be affected.&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric><p id="xdx_816_zG9bN8jinQr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zM2IirnOe0q6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82A_zr2FdprICqU9">SIGNIFICANT
ACCOUNTING POLICIES</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="niobf:DevelopmentStageIssuerPolicyTextBlock"><p id="xdx_848_ecustom--DevelopmentStageIssuerPolicyTextBlock_zJkX4dox3P5g" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_865_zXtCthRZkGJj">Development
                                         Stage Issuer</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is considered to be a development stage issuer under Subpart 1300 of Regulation S-K of the United States Securities Act
of 1933, as amended (&#8220;S-K 1300&#8221;), and it devotes substantially all of its efforts to acquiring and exploring mining
interests that management believes should eventually provide sufficient net profits to sustain the Company&#8217;s existence.
Until such interests are engaged in commercial production, the Company will continue to seek additional funding to support the
completion of its exploration and development activities. The Company&#8217;s activities are subject to significant risks and
uncertainties, including its ability to secure sufficient funding to continue operations, to obtain proven and probable reserves,
to comply with industry regulations and obtain permits necessary for development of the Elk Creek Project, as well as environmental
risks and market conditions.</span></p>

</ix:nonNumeric><p id="xdx_857_zDiwTHECGg9k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zXhSCc1lPCQ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_zlpJd7WiSBI5">Cash
                                         and Cash Equivalents</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents include cash on hand, cash in banks, investments in certificates of deposit with original maturities of
90 days or less, and money market funds. The Company maintains the majority of its cash balances with two financial
institutions. Accounts at banks in the United States (&#8220;U.S.&#8221;) are insured by the Federal Deposit Insurance
Corporation (&#8220;FDIC&#8221;) up to $250, while accounts at banks in Canada are insured by the Canada Deposit Insurance
Corporation (&#8220;CDIC&#8221;) up to C$100. At June 30, 2023 and 2022, the Company had $1,717 and $4,721 in excess of the
FDIC and CDIC insured limits, respectively.</span></p>

</ix:nonNumeric><p id="xdx_85B_zXYY55lo4azj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_843_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zJOG3sB3cbde" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_867_zp6NhYawEyQc">Foreign
                                         Currency Translation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Functional
and reporting currency</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items
included in the financial statements of each of the Company&#8217;s entities are measured using the currency of the primary economic
environment in which the entity operates (&#8220;the functional currency&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reporting currency for these consolidated financial statements is U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in functional currency</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to March 17, 2023, the Company&#8217;s functional currency was the Canadian dollar. The Company re-assessed its functional
currency and determined that on March 17, 2023, its functional currency changed from the Canadian dollar to the U.S. dollar
based on significant changes in economic facts and circumstances in our organization. The change in functional currency was
accounted for prospectively from March 17, 2023 and prior-period consolidated&#160;financial statements were not restated for
the change in functional currency.</span></p>

<ix:exclude><p id="xdx_236_zypyI4Ni7cBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_237_zm7TsTHJEUMj" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zn9gMLJ9SvAe" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zPbF1h05LTB5" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: center; margin-left: 0.25in"><ix:exclude><div id="xdx_238_zSh8la02odBi" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_23A_zWalx97cbpee" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
both monetary and non-monetary assets and liabilities, translated balances as of March 17, 2023 became the new accounting basis.
The exchange rate on the date of change became the historical rate at which non-monetary assets and liabilities were translated
in subsequent periods. There was no effect on the cumulative translation adjustment on the consolidated basis. Previously recorded
cumulative translation adjustments were not reversed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency for the Company&#8217;s Canadian subsidiary, 0896800 BC Ltd., which has no independent operations from its
parent, also changed from the Canadian dollar to the U.S. dollar. The functional currency for Elk Creek Resources Corp. remains
as the U.S. dollar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transactions
in foreign currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
made in a currency other than the functional currency are remeasured to the functional currency at exchange rates at the dates
of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are remeasured to
the functional currency at the exchange rate at that date and non-monetary assets and liabilities are remeasured at historical
rates. Foreign currency translation gains and losses are included in profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Translation
to reporting currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation
gains and losses from the application of the U.S. dollar as the reporting currency for all periods prior to March 17, 2023 (when
the Canadian dollar was the functional currency) are included as part of cumulative currency translation adjustment, which is
reported as a component of shareholders&#8217; equity under accumulated other comprehensive loss.</span></p>

</ix:nonNumeric><p id="xdx_851_z4CznbSjJtAl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="niobf:MineralPropertiesPolicyTextBlock"><p id="xdx_840_ecustom--MineralPropertiesPolicyTextBlock_zn9ko4vXxy8j" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86F_z9HsYAkJsLj5">Mineral
                                         Properties</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
property acquisition costs, including indirectly related acquisition costs, are capitalized when incurred. Acquisition costs include
cash consideration and the fair market value of Common Shares issued as consideration. Properties acquired under option agreements,
whereby payments are made at the sole discretion of the Company, are capitalized as mineral property acquisition costs at such
time as the payments are made. Exploration costs are expensed as incurred. When it is determined that a mining deposit can be
economically and legally extracted or produced based on established proven and probable reserves under S-K 1300, and the Board
of Directors has approved the commencement of formal development activities, development costs related to such reserves and incurred
after such board approval will be considered for capitalization. The establishment of proven and probable reserves is based on
results of feasibility studies, which indicate whether a property is economically feasible. Upon commencement of commercial production,
capitalized costs will be amortized over their estimated useful lives or units of production, whichever is a more reliable measure.
Capitalized amounts relating to a property that is abandoned or otherwise considered uneconomic for the foreseeable future are
written off.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#8217;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. This would include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Such evaluations compare estimated future net cash flows with our carrying costs and future obligations on an undiscounted
basis. If it is determined that the estimated future undiscounted cash flows are less than the carrying value of the property,
an impairment loss will be recorded. Where estimates of future net cash flows are not determinable and where other conditions
indicate the potential for impairment, management uses available market information and/or third-party valuation experts to assess
if the carrying value can be recovered and to estimate fair value. There was no impairment recorded to mineral properties as of
June 30, 2023 or 2022, respectively.</span></p>

</ix:nonNumeric><p id="xdx_85E_zQgYBvzmKOg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zZSrZEJUreb3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_zUmviM3xRkyh">Long
                                         Lived Assets</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets, other than mineral properties, held and used by the Company are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable.</span></p>

<ix:exclude><p id="xdx_232_zMgSL5QFxblb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_233_zORWFeVWB6A7" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zeIOpAA2vbii" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_zaYAWhAGRvwg" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_230_zJlS8LGXnDGe" style="text-align: center; margin-left: 0.25in"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_23F_zylrxHkK2lOh" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For purposes of evaluating the recoverability
of long-lived assets, the recoverability test is performed using undiscounted net cash flows related to the long-lived assets.
If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount
of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount
or fair value less costs to sell. There was no impairment recorded to long-lived assets as of June 30, 2023 or 2022, respectively.</span></p>

</ix:nonNumeric><p id="xdx_858_zh7qSQAu7Gy7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock"><p id="xdx_846_eus-gaap--LesseeLeasesPolicyTextBlock_zKbLNiM7xQV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zlAhXUXUovFl">Leases</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Accounting Standards Codification (&#8220;ASC&#8221;) 842, &#8220;Leases,&#8221; we determine if a contractual arrangement is,
or contains, a lease at the inception date. Right-of-use (&#8220;ROU&#8221;) assets and liabilities related to operating leases
are separately reported in the consolidated balance sheets. The Company currently has no finance leases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU
assets and lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments
over the lease term. When the rate implicit to the lease cannot be readily determined, we utilize our incremental borrowing rate
in determining the present value of the future lease payments. The incremental borrowing rate is derived from information available
at the lease commencement date and represents the rate of interest that a lessee would have to pay to borrow an amount equal to
the lease payments on a collateralized basis over a similar term in a similar economic environment. Operating lease ROU assets
also include any cumulative prepaid or accrued rent when the lease payments are uneven throughout the lease term. The ROU assets
and lease liabilities may include options to extend or terminate the lease when it is reasonably certain that we will exercise
that option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term.
For operating leases, interest on the lease liability and the amortization of the ROU asset result in straight-line rent expense
over the lease term. Variable lease expenses are recorded when incurred.</span></p>

</ix:nonNumeric><p id="xdx_859_zoEY2MYRHgej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="niobf:WarrantsPolicyTextBlock"><p id="xdx_842_ecustom--WarrantsPolicyTextBlock_zmOdMLKAZMp9" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_zkn0gfB4mzZ1">Warrants</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
apply relevant accounting guidance for warrants to purchase our stock based on the nature of the relationship with the counterparty.
For warrants issued to investors or lenders in exchange for cash or other financial assets, we follow guidance issued within ASC
480, Distinguishing Liabilities from Equity, and ASC Topic 815, Derivatives and Hedging, (&#8220;ASC 815&#8221;) to assist in
the determination of whether the warrants should be classified as liabilities or equity. The fair value of warrants is estimated
using Black Scholes modeling or Monte Carlo modeling, depending on the settlement features embedded in the warrant. Inputs under
both models include inputs such as NioCorp&#8217;s Common Share price, the risk-free interest rate, the expected term, the volatility,
and the dividend rate. Warrants that are determined to require liability classifications are measured at fair value upon issuance
and are subsequently remeasured to their then fair value at each subsequent reporting period with changes in fair value recorded
in current earnings. Warrants that are determined to require equity classifications measured at fair value upon issuance and are
not subsequently remeasured unless they are required to be reclassified.</span></p>

</ix:nonNumeric><p id="xdx_850_za5TRCyDd00d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="niobf:EarnoutSharesPolicy"><p id="xdx_841_ecustom--EarnoutSharesPolicy_zPrxAclSfbdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_zFYPbuZ31El8">Earnout
                                         Shares</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
Shares are classified as a liability due to failure to meet the equity classification criteria under ASC 815-40. The fair value
of the Earnout Shares on the date of issuance and on each measurement date is estimated using a Monte Carlo simulation methodology,
which includes inputs such as NioCorp&#8217;s Common Share price, the risk-free interest rate, the expected term, the implied
volatility underlying the Company&#8217;s Public Warrants, the dividend rate, the conversion price, and the number of Earnout
Shares outstanding. Assumptions used in the model are subjective and require significant judgment.</span></p>

</ix:nonNumeric><p id="xdx_85A_zenYl1Yxqa0g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zDNoDDX3pPY3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_865_z6xtqDIfxqBa">Financial
                                         Instruments</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, receivables, equity securities, accounts payable and accrued liabilities,
convertible debt and the related party loan. It is management&#8217;s opinion that the Company is not exposed to significant interest,
currency or credit risks arising from its financial instruments. The fair values of these instruments approximate their carrying
value unless otherwise noted.</span></p>

</ix:nonNumeric><p id="xdx_854_zKAO7T0sPzMl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_z4EOR7m4rotd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_zoVOqAKsMn4c">Concentration
                                         of Credit Risk</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial instrument which potentially subjects the Company to credit risk is cash and cash equivalents, The Company holds investments
or maintains available cash primarily in two commercial banks located in Vancouver,</span></p>

<ix:exclude><p id="xdx_237_z54WHtBdKaYj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_2371_z5sNzh0FHNP9" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_2361_zrENfcOUnHG2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_2351_z2Qde7f0NYl4" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: center; margin-left: 0.25in"><ix:exclude><div id="xdx_2381_zTBhneEZUqe2" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_23F1_zOv0z8lkCLvk" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">British Columbia and Santa Clara, California.
As part of its cash management process, the Company regularly monitors the relative credit standing of these institutions.</span></p>

</ix:nonNumeric><p id="xdx_85A_zJbfMUFd4UO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:AssetRetirementObligationsPolicy"><p id="xdx_84B_eus-gaap--AssetRetirementObligationsPolicy_z6U1pWuF73F1" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zzlbXqlYuAfa">Asset
                                         Retirement Obligation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to various government laws and regulations relating to environmental disturbances caused by exploration and
evaluation activities. The estimated costs associated with environmental remediation obligations are accrued in the period in
which the liability is incurred if it is reasonably estimable or known. Until such time that a project life is established, the
Company records the corresponding cost as an exploration stage expense and has accrued $<span id="xdx_90F_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20230630_zC6yQ1gF29bg"><ix:nonFraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span> as an accrued liability related to
estimated obligations as of June 30, 2023 (2022 - $<span id="xdx_90D_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20220630_zWKK5mFe9WG6" title="Accrued exploration stage expense"><ix:nonFraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
reclamation and environmental-related expenditures are difficult to estimate in many circumstances due to the early-stage nature
of the Elk Creek Project, the uncertainties associated with defining the nature and extent of environmental disturbance, the application
of laws and regulations by regulatory authorities and changes in reclamation or remediation technology. The Company periodically
reviews accrued liabilities for such reclamation and remediation costs as evidence indicating that the liabilities have potentially
changed becomes available. Changes in estimates are reflected in the consolidated statement of operations and comprehensive loss in the period an estimate
is revised.</span></p>

</ix:nonNumeric><p id="xdx_85D_zjpSh9UxA557" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_z8tYU1sa8Ao3" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zs9Rb7gXjoDb">Income
                                         Taxes</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25, <i>&#8220;Income Taxes &#8211; Recognition.&#8221;
</i>Under the approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between
the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded
against deferred tax assets if management does not believe the Company has met the &#8220;more likely than not&#8221; standard
imposed by ASC 740-10-25-5 to allow recognition of such an asset. ASC 740-10-50, &#8220;Income Taxes &#8211; Disclosure,&#8221;
requires the Company to evaluate its income tax positions and recognize a liability for uncertain tax positions that are not more
likely than not to be sustained by tax authorities. As of June 30, 2023 and 2022, the Company believes it had no income tax uncertainties
that required recognition of a liability. If the Company were to determine that uncertain tax positions meet the criteria for
recognition, an estimated liability and related interest and penalties would be recognized as income tax expense.</span></p>

</ix:nonNumeric><p id="xdx_85D_zA6GfYTmwOX7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="niobf:ReverseStockSplitPolicyTextBlock"><p id="xdx_84E_ecustom--ReverseStockSplitPolicyTextBlock_zo8YIoczuktl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reverse
                                         Stock Split</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 17, 2023, the Company effected a reverse stock split (the &#8220;Reverse Stock Split&#8221;) on the basis of one (1) post-Reverse
Stock Split Common Share for every ten (10) pre-Reverse Stock Split Common Shares issued and outstanding, with any fractional
shares resulting from the Reverse Stock Split rounded down to the nearest whole share. Immediately after the Reverse Stock Split,
there were 30,000,442 Common Shares issued and outstanding. All references to share and per share amounts (excluding authorized
shares) in the consolidated financial statements and accompanying notes have been retroactively restated to reflect the Reverse
Stock Split.</span></p>

</ix:nonNumeric><p id="xdx_85C_zQKjGhvx2ZM6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="niobf:RedeemableNoncontrollingInterestPolicyTextBlock"><p id="xdx_842_ecustom--RedeemableNoncontrollingInterestPolicyTextBlock_zVio3UOUdE0a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_z07Nhe4mLBwg">Redeemable
                                         Noncontrolling Interest</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable
Noncontrolling Interest refers to non-controlling interest associated with the Vested Shares that are redeemable upon the occurrence
of an event that is not solely within the Company&#8217;s control and is reported in the mezzanine section between total liabilities
and shareholders&#8217; deficit, as temporary equity in the Company&#8217;s consolidated balance sheets. The
Company&#8217;s non-controlling interest is redeemable at fair value, and no adjustment to the earnings per share numerator is
required because redemption at fair value is not considered an economic distribution different from other common stockholders.</span></p>

</ix:nonNumeric><p id="xdx_85D_zhuVaHmjQsy9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_z4hs6MtuRSEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zHyNOqAYJzI7">Basic
                                         and Diluted Per Share Disclosure</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted
average number of Common Shares outstanding during the period. The Company considers Vested Shares and Released Earnout
Shares (each as defined in Note 10), to be participating securities, requiring the use of the two-class method. Diluted
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted average
number of Common Shares outstanding, inclusive of the dilutive impact of all potentially dilutive securities outstanding
during the period, as applicable.</span></p>

<ix:exclude><p id="xdx_23F_zIr9ieCXNK87" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zoF6TE9XleSh" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zzlJqgvG5GZa" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zICpMNpmNRT4" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: center; margin-left: 0.25in"><ix:exclude><div id="xdx_238_zyAzpctXl3a6" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_233_zLAEW8dUQ2ka" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zGoz269NZLhl" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>


<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z3eruOf1JU9c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. <span id="xdx_8B3_zJC6A6vaTFb8">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share
attributable to common shareholders:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; background-color: #CCECFF; border-collapse: collapse; margin-left: 0.5in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="9" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the year ended June 30,</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20220701__20230630_zFQp4ku0flCa" title="Net loss" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">40,308</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210701__20220630_zIXhZ86d9w65" title="Net loss" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,887</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200701__20210630_zssQC8D0iE53" title="Net loss" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,824</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjust:
    Net loss attributable to noncontrolling interest</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20220701__20230630_zqqNk02gopR" title="Adjust: net loss attributable to noncontrolling interest::XDX::228" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0809">(251</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20210701__20220630_zOyu0YxBliY6" title="Adjust: net loss attributable to noncontrolling interest" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0811">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20200701__20210630_zpWSiN86lFEa" title="Adjust: net loss attributable to noncontrolling interest" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0813">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss available to participating securities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220701__20230630_zV3gNqOmuwTk" title="Net loss available to participating securities" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,057</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20210701__20220630_z9QdtQfKZAgc" title="Net loss available to participating securities" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,887</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20200701__20210630_zv0dpzPPfiY4" title="Net loss available to participating securities" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,824</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss attributable to Vested Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zVLWsnQRhg6j" title="Net loss attributable to vested shares" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,528</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20210701__20220630_z1MBIpPDBSq9" title="Net loss attributable to vested shares" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0823">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20200701__20210630_z2nWNLQPzUU7" title="Net loss attributable to vested shares" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0825">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 9pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss attributed to common shareholders - basic and diluted</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20220701__20230630_z0QxpAAuKBXh" title="Net loss attributed to common shareholders - basic and diluted" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,529</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20210701__20220630_zUGKlTW6sQ8f" title="Net loss attributed to common shareholders - basic and diluted" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,887</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20200701__20210630_zwZFR6TLoOK5" title="Net loss attributed to common shareholders - basic and diluted" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,824</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average shares outstanding &#8211; basic and diluted</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20220701__20230630_zlRgKsVPLbg2" title="Weighted average shares outstanding basic and diluted" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,705,840</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20210701__20220630_zRsagfqjhAD7" title="Weighted average shares outstanding basic and diluted" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">26,373,722</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20200701__20210630_zVMUUNLt4TNl" title="Weighted average shares outstanding basic and diluted" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">24,196,711</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    per Common Share outstanding &#8211; basic and diluted</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230630_z8PCNjjBnWE1" title="Loss per common share outstanding basic and diluted" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.34</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20210701__20220630_zlMXAuzupyke" title="Loss per common share outstanding basic and diluted" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.41</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20200701__20210630_zJ5yF0jIKA72" title="Loss per common share outstanding basic and diluted" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.20</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A5_zDSzIPfVq1a4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following shares underlying options, warrants, and outstanding convertible debt were antidilutive
due to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation for the years
ended June 30, 2023 and 2022, as indicated below.</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zOn3rNY06DWi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BA_zc72BNzqWaDh" style="display: none; visibility: hidden">Schedule of excluded from the dilutive securities</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 89%; border-collapse: collapse; margin-left: 0.75in">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the year ended June 30,</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 61%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excluded
    potentially dilutive securities <sup id="xdx_F6B_zlpIL2QeXlS8">(1)(2)</sup>:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 11%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20230630_fKDEpKDIp_zTxQsQUt6vCi" title="Options" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions" contextRef="From2022-07-01to2023-06-30" id="Fact000847" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,541,500</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20210701__20220630_fKDEpKDIp_zJ8w8jErmrs" title="Options" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions" contextRef="From2021-07-012022-06-30" id="Fact000849" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,446,400</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20200701__20210630_fKDEpKDIp_zkjNk0oBemyg" title="Options" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions" contextRef="From2020-07-012021-06-30" id="Fact000851" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,596,500</ix:nonFraction></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20230630_fKDEpKDIp_zrQbk9S4UKg5" title="Warrants" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2022-07-01to2023-06-30" id="Fact000853" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,816,304</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20210701__20220630_fKDEpKDIp_zDcNxKNdVr4a" title="Warrants" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2021-07-012022-06-30" id="Fact000855" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,851,622</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20200701__20210630_fKDEpKDIp_z0sNl7vkl4B1" title="Warrants" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2020-07-012021-06-30" id="Fact000857" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,434,186</ix:nonFraction></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
debt</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20230630_fKDEpKDIp_z7mNylIwkLa2" title="Convertible debt" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" contextRef="From2022-07-01to2023-06-30" id="Fact000859" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,871,660</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20210701__20220630_fKDEpKDIp_zahcAL52BKfa" title="Convertible debt" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" contextRef="From2021-07-012022-06-30" id="Fact000861" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">415,200</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20200701__20210630_fKDEpKDIp_zgqIxU0aSyua" title="Convertible debt" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" contextRef="From2020-07-012021-06-30" id="Fact000863" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,455,700</ix:nonFraction></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    potentially dilutive securities <sup></sup></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--DilutiveSecurities_c20220701__20230630_fKDEpKDIp_zJ5fgeJjdrLe" title="Total potentially dilutive securities" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DilutiveSecurities" contextRef="From2022-07-01to2023-06-30" id="Fact000865" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,229,464</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--DilutiveSecurities_c20210701__20220630_fKDEpKDIp_z1DA4k0owKD9" title="Total potentially dilutive securities" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DilutiveSecurities" contextRef="From2021-07-012022-06-30" id="Fact000867" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,713,222</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--DilutiveSecurities_c20200701__20210630_fKDEpKDIp_zC4ZPsqKRXjg" title="Total potentially dilutive securities" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DilutiveSecurities" contextRef="From2020-07-012021-06-30" id="Fact000869" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,486,386</ix:nonFraction></span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F0C_z8MpdCdTVJXl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zvlOvhPMsqK8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000870" xml:lang="en-US">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.</ix:footnote></span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F06_zEo1LnpKZiee" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zjFm1EndTiW7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000871" xml:lang="en-US">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period. </ix:footnote></span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AE_zQYsB0CM1Ksf" style="margin-top: 0; margin-bottom: 0"></p>

</ix:nonNumeric><p id="xdx_850_zRMQRCxOQud8" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zXWOk6GWM1Kl" style="margin-top: 0; margin-bottom: 0"></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">p)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zPYfP5GRiaW3">Share
                                         Based Compensation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants stock options to directors, officers, employees, and business advisors. Option terms and vesting conditions
are at the discretion of the Board of Directors. Prior to March 21, 2023, the option exercise price was equal to the closing
market price on The Toronto Stock Exchange (the &#8220;TSX&#8221;) on the day preceding the date of grant. Effective March
21, 2023, the option exercise price is equal to the closing market price on the Nasdaq Stock Market LLC
(&#8220;Nasdaq&#8221;) on the day preceding the date of the grant.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates the fair value of stock options using the Black-Scholes option pricing model. The Company recognizes forfeitures
as they occur.</span></p>

</ix:nonNumeric><p id="xdx_85F_zCFoHEFpDF1g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z9lxU8GlAWhd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">q)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_zhBbIkyvNjb3">Recent
                                         Accounting Standards</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued
and Adopted</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;)
No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s
Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;), which simplifies the accounting for convertible instruments. ASU 2020-06
removes certain accounting models which separate the embedded conversion features from the host contract for convertible instruments.
Either a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption
of this standard. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within
those fiscal</span></p>

<ix:exclude><p id="xdx_239_zuzVaJWIGhYa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_23C_zqEg0U6I3Q27" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_z92whZX8W38g" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_237_zpRdENwp4CH2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_236_z0iBCenAmF2h" style="text-align: center; margin-left: 0.25in"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_238_zfp1SqJk0rZ3" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">years. The Company adopted ASU 2020-06 on July 1, 2022, with no material effect on the Company&#8217;s current financial
position, results of operations or financial statement disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued
and Not Effective</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective
date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a
material impact on the Company&#8217;s consolidated financial statements upon adoption.</span></p>

</ix:nonNumeric><p id="xdx_855_zPyBX9MDZqb1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription"><p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zp4sRsVfdp0h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in">r)</td><td style="text-align: left"><span id="xdx_86D_zfPv1ZxtiDKj">Revision of Financial Statements (Unaudited)</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">During the
fourth quarter of fiscal year 2023, the Company determined that it had used an incorrect strike price while valuing the Private
Warrants (as defined below in Note 11c) at both the March 17, 2023, issuance date and as of March 31, 2023. This resulted in an
overstatement of other operating expenses, at fair value, and an understatement of change in fair value of warrant liabilities
in condensed consolidated statement of operations and comprehensive loss for both the three- and nine-month periods ended March
31, 2023. In addition, warrant liabilities, at fair value and accumulated deficit were overstated and understated, respectively,
as of March 31, 2023. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company determined that
these errors were immaterial to the previously issued consolidated financial statements, and as such no restatement was necessary.
Periods not presented herein will be revised, as applicable, in future filings.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">The effects
of the revision on the previously issued consolidated financial statements are as follows:</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="srt:ScheduleOfCondensedBalanceSheetTableTextBlock"><p id="xdx_896_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zhsVYVtVC4s6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Revision Impacts to the Condensed Consolidated
Balance Sheet (unaudited)</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of March 31, 2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8BB_zqPDmNb9cDEc" style="display: none; visibility: hidden">Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As
of March 31, 2023</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zelflEE9IMBf" style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zWaKgukSfI9" style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230331_zY93igpGJPta" style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">As Previously<br /> Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revision<br /> Impacts</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revised</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--OtherLiabilitiesNoncurrent_iI_pn3n3_zqax1sPZZ8hd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-left: 5.4pt">Warrant liabilities, at fair value</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,303</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">665</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,638</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Total liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Liabilities_iI_pn3n3_c20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zRJ4DvEAlRkk" title="Total liabilities" style="text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,735</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Liabilities_iNI_pn3n3_di_c20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zCy0TdbKQsH" title="Total liabilities" style="text-align: right">(<ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">665</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Liabilities_iI_pn3n3_c20230331_zxCnuRnyJIEi" title="Total liabilities" style="text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,070</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pn3n3_z1kI0YlWdhE3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">146,046</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">665</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">145,381</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--StockholdersEquity_iI_pn3n3_zEeGmVLayfV2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Total shareholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12,512</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">665</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,847</ix:nonFraction></td><td style="text-align: left">)</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A2_zXr0M4XmAGXb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="srt:ScheduleOfCondensedIncomeStatementTableTextBlock"><p id="xdx_89B_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zf4thyh0OZk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Revision Impacts to the Condensed Consolidated
Statement of Operations and Comprehensive Loss (unaudited)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the Three Months Ended March 31,
2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_8B8_zwMYtoPoRhJ1" style="display: none; visibility: hidden">Revision Impacts to
                                            the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For
                                            the Three &amp; Nine Months Ended  March 31,
2023</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">As Previously<br />
 Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revision<br />
 Impacts</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revised</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-left: 5.4pt">Other operating expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OtherGeneralExpense_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zgQOUnHXWm68" title="Other operating expense" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,220</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--OtherGeneralExpense_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpLsguPTVOxc" title="Other operating expense" style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">861</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--OtherGeneralExpense_pn3n3_c20230101__20230331_zasjIfkHG88d" title="Other operating expense" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,359</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Total operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zMubrwz0kZt3" title="Total operating expenses" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,192</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zH8djFst0Oeh" title="Total operating expenses" style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">861</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331_zXe8FrzG6AT7" title="Total operating expenses" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,331</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Change in fair value of warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKTc1llfKIEk" title="Change in fair value of warrant liability" style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfWarrantLiability" contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">784</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zKLUQIW7L7g4" title="Change in fair value of warrant liability" style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfWarrantLiability" contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">196</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331_zBKidsx6iaqj" title="Change in fair value of warrant liability" style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfWarrantLiability" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">980</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Loss before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zkop0E3nssMi" title="Loss before income taxes" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,621</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zefaGBWcanv1" title="Loss before income taxes" style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">665</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_dxL_c20230101__20230331_zTUVmm3EVvbc" title="Loss before income taxes::XDX::-3877" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0929">28,956</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zDEONR6tVaG5" title="Net loss" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,435</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zTzxnU9qsx3d" title="Net loss" style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">665</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331_zTXUUlkWJVU3" title="Net loss" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,770</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Net loss attributable to the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ProfitLoss1_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zzG310e4baTk" title="Net loss attributable to the company" style="text-align: right"><ix:nonFraction name="niobf:ProfitLoss1" contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,343</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ProfitLoss1_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zTNbjnxJqVt6" title="Net loss attributable to the company" style="text-align: right">(<ix:nonFraction name="niobf:ProfitLoss1" contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">665</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ProfitLoss1_pn3n3_c20230101__20230331_zGms76QML6g2" title="Net loss attributable to the company" style="text-align: right"><ix:nonFraction name="niobf:ProfitLoss1" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,678</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Total comprehensive loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zCkWs19aZdeh" title="Total comprehensive loss" style="text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,323</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zPIBX74Xw4Z1" title="Total comprehensive loss" style="text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">665</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331_z9Alax3TgdJ2" title="Total comprehensive loss" style="text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,658</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Comprehensive loss attributable to the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zyDqlX3Y74x6" title="Comprehensive loss attributable to the company" style="text-align: right"><ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxParent" contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,231</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zG6JE1rlwC6a" title="Comprehensive loss attributable to the company" style="text-align: right">(<ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxParent" contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">665</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331_z2L0neTwcTSc" title="Comprehensive loss attributable to the company" style="text-align: right"><ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxParent" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,566</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Loss per common share, basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNILCmuSVGma" title="Loss per common share, basic and diluted" style="text-align: right"><ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zlpch4MOAPo4" title="Loss per common share, basic and diluted" style="text-align: right">(<ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331_z1FzQUrq6b97" title="Loss per common share, basic and diluted" style="text-align: right"><ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.98</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>
<ix:exclude><!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_23C1_zqEg0U6I3Q27" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_2361_z92whZX8W38g" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_2371_zpRdENwp4CH2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_2362_z0iBCenAmF2h" style="text-align: center; margin-left: 0.25in"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_2381_zfp1SqJk0rZ3" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Revision Impacts to the Condensed Consolidated
Statement of Operations and Comprehensive Loss (unaudited)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the Nine Months Ended March 31,
2023&#160; &#160; &#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
    <td style="width: 55%; padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right">&#160;</td>
    <td style="width: 1%; background-color: white; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right">&#160;</td>
    <td style="width: 1%; background-color: white; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right">&#160;</td>
    <td style="width: 1%; background-color: white; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><b>As
    Previously<br />
 Reported</b></span></td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><b>Revision<br />

    Impacts</b></span></td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><b>Revised</b></span></td>
    <td style="background-color: white; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Other operating expense</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--OtherGeneralExpense_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYqCHLJxMxO9" title="Other operating expense" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,888</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_98C_eus-gaap--OtherGeneralExpense_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_z9N7AAiEK2a2" title="Other operating expense" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">861</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--OtherGeneralExpense_pn3n3_c20220701__20230331_zKeufiUYm8qe" title="Other operating expense" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2022-07-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,027</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Total operating expenses</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98B_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zPqhiQylMFh6" title="Total operating expenses" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,475</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zOnwEy7ElEg" title="Total operating expenses" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">861</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_987_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331_z3rjgMQXLo2c" title="Total operating expenses" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-07-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32,614</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Change in fair value of warrant liability</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98E_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zGRArvNXlvyg" title="Change in fair value of warrant liability" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="niobf:ChangeInFairValueOfWarrantLiability" contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">868</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98B_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_ze6iLON1bLq2" title="Change in fair value of warrant liability" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="niobf:ChangeInFairValueOfWarrantLiability" contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">196</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_989_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331_zuXbyNA31H96" title="Change in fair value of warrant liability" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="niobf:ChangeInFairValueOfWarrantLiability" contextRef="From2022-07-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,064</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Loss before income taxes</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYWQlY66Wnz5" title="Loss before income taxes" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,927</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpRhxZjqEyEd" title="Loss before income taxes" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">665</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_dxL_c20220701__20230331_zWnUuOx7nh73" title="Loss before income taxes::XDX::-3877" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0988">35,262</span></span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Net loss</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9qjusG3RCWk" title="Net loss::XDX::-35741" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0990">35,741</span></span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zmIztkbqaAhc" title="Net loss::XDX::665" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0992">(665</span></span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331_z4nx268bQSIk" title="Net loss::XDX::-35076" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0994">35,076</span></span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Net loss attributable to the Company</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_981_ecustom--ProfitLoss1_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zm2e8LNnCqnj" title="Net loss attributable to the company" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="niobf:ProfitLoss1" contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,649</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98A_ecustom--ProfitLoss1_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zYuXfcMAfHIc" title="Net loss attributable to the company" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="niobf:ProfitLoss1" contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">665</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_985_ecustom--ProfitLoss1_pn3n3_c20220701__20230331_z9sJmKZ4oxMk" title="Net loss attributable to the company" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="niobf:ProfitLoss1" contextRef="From2022-07-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,984</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Total comprehensive loss</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKA82dNJQKfk" title="Total comprehensive loss" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,659</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98A_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZ5L3oKr2MW1" title="Total comprehensive loss" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">665</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_986_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331_zcGBegKbF1yh" title="Total comprehensive loss" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2022-07-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,994</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Comprehensive loss attributable to the Company</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98F_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_ze5Cyg3e3j4k" title="Comprehensive loss attributable to the company" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxParent" contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,567</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98B_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zlDk0KhpPKR" title="Comprehensive loss attributable to the company" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxParent" contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">665</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_987_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331_zbMZnDl5gef2" title="Comprehensive loss attributable to the company" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxParent" contextRef="From2022-07-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,902</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Loss per common share, basic and diluted</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zWRnAaJET1i8" title="Loss per common share, basic and diluted" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.26</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zf7OTzzqRKrl" title="Loss per common share, basic and diluted" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331_z8dneKmKuTV7" title="Loss per common share, basic and diluted" style="padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2022-07-012023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.24</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A0_z6LBYNyBTvh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="srt:ScheduleOfCondensedCashFlowStatementTableTextBlock"><p id="xdx_892_esrt--ScheduleOfCondensedCashFlowStatementTableTextBlock_zAD57VdDtUPi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Revision Impacts to the Condensed Consolidated
Statement of Cash Flows (unaudited)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the Nine Months Ended March 31,
2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8B5_z14eJLyY15d8" style="display: none; visibility: hidden">Revision Impacts to the Condensed
Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023</span>&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">As Previously<br />
 Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revision<br />
 Impacts</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revised</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; text-align: left">Net loss for the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zbiFHIIS78Sh" style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">35,741</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zSvmIcP42Hzg" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1022">665</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230331_zfmGaN4AcFT2" style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">35,076</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Initial valuation of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwjsL1DGD204" style="text-align: right"><ix:nonFraction name="niobf:AssumptionOfPrivateAndPublicWarrants" contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,848</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zIqZuI2UrFOg" style="text-align: right">(<ix:nonFraction name="niobf:AssumptionOfPrivateAndPublicWarrants" contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">861</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331_zswoFw4mvRbh" style="text-align: right"><ix:nonFraction name="niobf:AssumptionOfPrivateAndPublicWarrants" contextRef="From2022-07-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,987</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Change in fair value of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zUapaVmlhvAi" style="text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">868</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zbjfLsqFDSz4" style="text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">196</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331_zAf3FS7vazv5" style="text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-07-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,064</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A7_zi5vEHv55UAd" style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>



</ix:nonNumeric><p id="xdx_85D_zcRVC8TinVjf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_815_zSTyPV7DSrrl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock"><p id="xdx_809_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zLcWb8o9mKX" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82C_zWsorQxy2Sw5">GOING
CONCERN ISSUES</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company incurred a net
loss of $<span id="xdx_904_eus-gaap--NetIncomeLoss_iN_pn3n3_dixL_c20220701__20230630_z95LpGxjfJTc" title="Net loss::XDX::40308"><span style="-sec-ix-hidden: xdx2ixbrl1033">40,080</span></span>
for the year ended June 30, 2023 (2022 - $<span id="xdx_90A_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210701__20220630_zm50D2uTuljf"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,887</ix:nonFraction></span>
and 2021 - $<span id="xdx_906_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200701__20210630_zr16DatHZEIa"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,824</ix:nonFraction></span>) and had an
accumulated deficit of $150,477 as of June 30, 2023. As a development stage issuer, the Company has not yet commenced its
mining operations and accordingly does not generate any revenue. As of June 30, 2023, the Company had cash and cash
equivalents of $<span id="xdx_905_ecustom--CashAndCashEquivalentsAtCarryingValue1_pn3n3_c20220701__20230630_zlk3LqB0Ukx3" title="Cash"><ix:nonFraction name="niobf:CashAndCashEquivalentsAtCarryingValue1" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,341</ix:nonFraction></span>
which is not sufficient to fund normal operations for the next twelve months without deferring payment on certain liabilities
or raising additional funds. In addition, the Company will be required to raise additional funds for construction and
commencement of operations. These factors raise substantial doubt about the Company's ability to continue as a going
concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s ability to continue operations and fund its expenditures, which have historically averaged approximately $<span id="xdx_905_eus-gaap--CapitalExpenditureDiscontinuedOperations_pn3n3_c20220701__20230630_zwvALqZIP4rl" title="Capital expenditure of operations"><ix:nonFraction name="us-gaap:CapitalExpenditureDiscontinuedOperations" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,350</ix:nonFraction></span>
per quarter over the preceding three-year period, is dependent on management&#8217;s ability to secure additional financing. NioCorp
expects to have access to up to $62,577 in net proceeds from the Yorkville Equity Facility Financing through April 1, 2026, as
discussed in Note 11d. Management is actively pursuing additional sources of financing, and while it has been successful in doing
so in the past, there can be no assurance it will be able to do so in the future. Other than the potential issuance of Common
Shares under the Yorkville Equity Facility Financing Agreement, the Company did not have any further funding commitments or arrangements
for additional financing as of June 30, 2023. These consolidated financial statements do not give effect to any adjustments required
to realize the Company&#8217;s assets and discharge its liabilities in other than the normal course of business and at amounts
different from those reflected in the accompanying consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent
worldwide events have created general global economic uncertainty as well as uncertainty in capital markets, supply chain disruptions,
increased interest rates and inflation, and the potential for geographic recessions. We believe this could have an adverse impact
on our ability to obtain financing, development plans, results of operations, financial position, and cash flows during the current
fiscal year. The full extent to which these events and our precautionary measures may continue to impact our business will depend
on future developments, which continue to be highly uncertain and cannot be predicted at this time.</span></p>

</ix:nonNumeric><p id="xdx_811_z8khIRXiGgKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:BusinessCombinationDisclosureTextBlock"><p id="xdx_80D_eus-gaap--BusinessCombinationDisclosureTextBlock_z9SfwsdJ3Pub" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_824_z9yZruc9YKJe">GXII
TRANSACTION</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, the following transactions (collectively, the &#8220;GXII Transaction&#8221;) occurred
on the Closing Date:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a
    result of a series of transactions, GXII became an indirect, majority-owned subsidiary of NioCorp and changed its name to
    &#8220;Elk Creek Resources Corp&#8221; (&#8220;ECRC&#8221;).</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As the
    parent company of the merged entity, NioCorp issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zF3WK2UBrCLh" title="Post reverse stock split shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,753,821</ix:nonFraction></span> post-Reverse Stock Split Common Shares in exchange for all of
    the Class A shares of GXII issued and outstanding immediately prior to the Closing, including 83,770 Common Shares issued
    to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory services.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 4%"></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify; width: 94%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the Class B shares of GXII issued and outstanding immediately prior to the Closing (after giving effect to the surrender of
certain Class B shares of GXII in accordance with the Sponsor Support Agreement, dated September 25, 2022 (the &#8220;Sponsor
Support Agreement&#8221;), among GX Sponsor II LLC (the &#8220;Sponsor&#8221;), GXII, NioCorp and the other persons party thereto)
were converted into <span id="xdx_905_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z6QXjdC2aSF4" title="Convertible shares issued upon conversion"><ix:nonFraction name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,957,404</ix:nonFraction></span> shares of Class B common stock of GXII (now known as ECRC) as the surviving entity of the mergers
that occurred on the Closing Date as part of the GXII Transaction. Pursuant to the Business Combination Agreement, the Sponsor
Support Agreement and the Exchange Agreement, dated as of March 17, 2023 (as amended, supplemented or</span></td>
</tr></table>

<ix:exclude><p id="xdx_23C_zhLiBiMMZ1T4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_23F_zNasCfUpyWn1" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zMmWmhHJPg2j" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_234_zM5nroSF2nc6" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_23C_zptQuln7etx5" style="text-align: center; margin-left: 0.25in"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_231_zmUkWS8AV8f6" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 4%"></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="text-align: justify; width: 94%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">otherwise
modified, the &#8220;Exchange Agreement&#8221;), by and among NioCorp, ECRC and the Sponsor, after the Closing, the shares of
Class B common stock of ECRC are exchangeable into Common Shares on a one-for-one basis, subject to certain equitable adjustments,
under certain conditions. See Note 10 for additional information regarding the Class B common stock of ECRC.</span></td>
</tr></table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    assumed GXII&#8217;s obligations under the agreement (the &#8220;GXII Warrant Agreement&#8221;) governing the GXII share purchase
    warrants (the &#8220;GXII Warrants&#8221;) and issued an aggregate of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_uShares_c20220701__20230630__us-gaap--TypeOfArrangementAxis__custom--WarrantAgreementMember_znPigioY0J14" title="Number of shares purchase"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="From2022-07-012023-06-30_custom_WarrantAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,666,626</ix:nonFraction></span> warrants (the &#8220;NioCorp Assumed Warrants&#8221;)
    to purchase up to an aggregate of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zu6Tsga72Ia2" title="Number of shares purchase"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,519,864</ix:nonFraction></span> Common Shares. See Note 11c for additional information regarding the NioCorp
    Assumed Warrants. </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="srt:ScheduleOfCondensedFinancialStatementsTableTextBlock"><p id="xdx_89A_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_z9CjNvrGM0e4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">After the distribution of funds
to GXII redeeming shareholders and prior to paying transaction costs incurred by GXII, $15,676 became available to the Company.
<span id="xdx_8BE_zvhGq16e8iea">The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and
Comprehensive Loss:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_498_20230630_zydPUvNnpwol" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_iI_pn3n3_zi0eb6gtxIYf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 86%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
    cash proceeds, net of transaction costs incurred by GXII</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,168</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB_zqHqMzG2Qip2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash costs associated
    with the Transactions:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn3n3_z24wOkhvP1ji" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    liabilities assumed</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">392</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_iI_pn3n3_z6nv4M3osFH7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville
    Equity Facility Financing Agreement &#8211; cash costs</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,996</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed_iI_pn3n3_zX4CJRueMW81" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
    costs expensed</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,715</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iI_pn3n3_zqR7ry9TQbt" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-cash
    costs associated with the Transactions:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_iI_pn3n3_zy9on14pDKJ1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private
    Warrants assumed at fair value</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,987</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--EarnoutSharesAssumedAtFairValue_iI_pn3n3_zJLWY7ZDo5T4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
    Shares assumed at fair value</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:EarnoutSharesAssumedAtFairValue" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,195</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_iI_pn3n3_zjAL0AcFA0Mj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville
    Equity Facility Financing Agreement &#8211; shares issued</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pn3n3_z5waYAziiy0e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Total
    transaction related losses incurred</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,767</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A7_zjosdUgRMnC8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock"><p id="xdx_899_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_zbKtToD2JDGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BC_zChDr8AQQFsa">The
number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    Shares</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 75%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legacy
    NioCorp Shareholders</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zblr1nfAaEMc" title="Common stock, shares outstanding" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_custom_LegacyNioCorpShareholdersMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,246,621</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zAMBpxdjXG18" title="Number of shares, percentage"><ix:nonFraction name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" contextRef="From2022-07-012023-06-30_custom_LegacyNioCorpShareholdersMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">93.90</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former GXII Class
    A Shareholders<sup id="xdx_F4D_zq4h1nGPSVFe">1</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zuEcaxWXZuc9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_custom_GXIIClassAShareholdersMember" id="Fact001084" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,753,821</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zujXQR4VrIz" title="Number of shares, percentage"><ix:nonFraction name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" contextRef="From2022-07-012023-06-30_custom_GXIIClassAShareholdersMember" id="Fact001086" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.83</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other<sup id="xdx_F46_zjJHsG8GU2Ul">2</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--TransactionTypeAxis__custom--OtherMember_fMg_____zHyFaChf1lsc" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_custom_OtherMember" id="Fact001087" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">81,213</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--OtherMember_fMg_____zHSj89FhogG9" title="Number of shares, percentage"><ix:nonFraction name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" contextRef="From2022-07-012023-06-30_custom_OtherMember" id="Fact001089" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.27</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Common Shares Outstanding Upon Completion of Transactions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--CommonStockSharesOutstanding_iI_pid_dxL_uShares_c20230630_zfZfNceSkSYg" title="Common stock, shares outstanding::XDX::31202131" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1091">30,081,655</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630_z0F1g9xEQJMf" title="Number of shares, percentage"><ix:nonFraction name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F06_zSHFFoRWnGE5" style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"><span id="xdx_F1F_zHUfU4stxzw" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001094" xml:lang="en-US">Includes
    83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory
    services.</ix:footnote></span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span id="xdx_F0F_zbck7w8k0Zlf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"><span id="xdx_F1C_zrGJJauUTbSk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001095" xml:lang="en-US">Represents
    Commitment Shares (as defined in Note 11d) issued under the Yorkville Equity Facility Financing Agreement.</ix:footnote></span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_zXEze9knVenj" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the GXII Transaction, the Company also closed the Yorkville Convertible Debt Financing and the Yorkville Equity
Facility Financing, as discussed in Notes 9 and 11d.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

</ix:nonNumeric><p id="xdx_817_zuQ78NtCKLQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>

<p id="xdx_811_zpBoLVLr3tAf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_804_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zmIs9IX3eWr4" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_822_zucWIc4mFPB">LAND
AND BUILDINGS, NET</span></span></td>
</tr></table>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_89D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zGhFjxhgoaWc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zZiUYWOT9gF9" style="display: none; visibility: hidden">Schedule of properties</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 88%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="22" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">2022</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated <br />
Depreciation</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated <br />
Depreciation</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 22%">Land</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_z42PdFrA4Kb9" title="Cost" style="width: 8%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2023-06-30_us-gaap_LandMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">807</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_ztpb9xlhX1P8" title="Accumulated depreciation" style="width: 8%; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-06-30_us-gaap_LandMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">-</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zOqlHn3igx1h" title="Net" style="width: 8%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-06-30_us-gaap_LandMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">807</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--LandMember_z5iltUQROLHd" style="width: 8%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2022-06-30_us-gaap_LandMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">811</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20220630__srt--ProductOrServiceAxis__us-gaap--LandMember_zLkf8dpBgTlf" title="Accumulated depreciation" style="width: 8%; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-06-30_us-gaap_LandMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">-</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--LandMember_z1C8XJJ5l5Zg" style="width: 8%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30_us-gaap_LandMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">811</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Buildings and other</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zcN1WCL9Ex32" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2023-06-30_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z5i9R6yq5L72" title="Accumulated depreciation" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-06-30_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zPntT9MgMbHi" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-06-30_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zKSFFYWnr9a6" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2022-06-30_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z0pT9THnmUUg" title="Accumulated depreciation" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-06-30_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z0ZyhguGbmci" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630_zDawkaqFIqJi" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">848</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630_zj8WiFxN8mbl" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630_z2xaV7sFhdKi" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">839</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20220630_zAKdMwYKhYO3" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">856</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20220630_zFqpOv0VmhOg" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20220630_zyH0LX1SuAUh" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">850</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A2_zTtYVEODRovi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_23D_zBKowu0UadP7" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_237_z2a5PQestDrj" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_zp25wt704Bv7" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_232_zpVm0evq1Iw2" style="text-align: center; margin-left: 0.25in"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_237_zcwSoSVXTXx6" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p></ix:exclude>

<ix:exclude><p id="xdx_235_zWnC0Z7WseIc" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
October 2022, the Company entered into an agreement with the State of Nebraska (the &#8220;State&#8221;) to sell a strip
of Company-owned land totaling <span id="xdx_905_eus-gaap--LandPurchaseOptionsDescription_c20221020__20221022__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandImprovementsMember_zSll8EhgNDe6" title="Description of owned land"><ix:nonNumeric contextRef="From2022-10-202022-10-22_us-gaap_LandImprovementsMember" name="us-gaap:LandPurchaseOptionsDescription">approximately
1.27 acres located adjacent to State Highway 50</ix:nonNumeric></span> in connection with highway improvements to be completed by the
State, for $<span id="xdx_90D_eus-gaap--LandAndLandImprovements_iI_pn3n3_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandImprovementsMember_ziUHhAaU6mO6" title="Improvements state"><ix:nonFraction name="us-gaap:LandAndLandImprovements" contextRef="AsOf2023-06-30_us-gaap_LandImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21</ix:nonFraction></span>,
inclusive of estimated fence replacement costs. <span id="xdx_90B_eus-gaap--LimitedPartnersCapitalAccountDescriptionOfUnits_c20221020__20221022__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandImprovementsMember_z69bFDbQyZ1c" title="Description of ownership of mineral rights"><ix:nonNumeric contextRef="From2022-10-202022-10-22_us-gaap_LandImprovementsMember" name="us-gaap:LimitedPartnersCapitalAccountDescriptionOfUnits">The Company retained ownership of the mineral rights associated with
this 1.27-acre parcel.</ix:nonNumeric></span> The Company recorded a gain on
this sale of $<span id="xdx_90F_eus-gaap--RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_iI_pn3n3_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandImprovementsMember_zwC5Yrxdzmy1" title="Other gains and comprehensive loss"><ix:nonFraction name="us-gaap:RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" contextRef="AsOf2023-06-30_us-gaap_LandImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></span> in other gains in the consolidated statement of operations and comprehensive loss.</span></p>

</ix:nonNumeric><p id="xdx_81E_zHx1iUOh9Bl7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:MineralIndustriesDisclosuresTextBlock"><p id="xdx_80A_eus-gaap--MineralIndustriesDisclosuresTextBlock_zkV0EgU2ckFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82E_zSEqH8YWgOu1">MINERAL
PROPERTIES</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended June 30, 2011, the Company completed the acquisition of the Elk Creek property through a share exchange agreement
with 0859404 BC Ltd, a Canadian company, which owned all the issued and outstanding shares of ECRC. The Company issued <span id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_uShares_c20110628__20110630__dei--LegalEntityAxis__custom--Entity0896800BCLtdMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ElkCreekResourcesCorpMember_zoA4J4fV08k5" title="Shares issue for acquistion"><ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" contextRef="From2011-06-282011-06-30_custom_Entity0896800BCLtdMember_custom_ShareExchangeAgreementMember_custom_ElkCreekResourcesCorpMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,899,053</ix:nonFraction></span>
Common Shares to acquire all of the issued and outstanding shares of 0859404 BC Ltd. and issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_uShares_c20110628__20110630__dei--LegalEntityAxis__custom--Entity0896800BCLtdMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zskx8stSAGS2" title="Shares issue for acquistion"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2011-06-282011-06-30_custom_Entity0896800BCLtdMember_custom_ShareExchangeAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">103,434</ix:nonFraction></span> Common Shares as a finder&#8217;s
fee with respect to the acquisition. The transaction did not meet the definition of a business acquisition, as set forth in ASC
805, &#8220;Business Combinations,&#8221; and therefore was accounted for as a purchase of assets. The acquisition price was based
on the market value of the Company&#8217;s Common Shares on the closing date and total consideration given was C$<span id="xdx_90A_eus-gaap--BusinessCombinationConsiderationTransferred1_c20110628__20110630__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--CurrencyAxis__currency--CAD_zUTJF5VA8Sul" title="Total consideration"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2011-06-282011-06-30_custom_ShareExchangeAgreementMember_currency_CAD" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,246</ix:nonFraction></span>, including
associated deferred tax impacts of C$<span id="xdx_907_ecustom--DeferredTaxImpacts_iI_c20110630__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--CurrencyAxis__currency--CAD_zGll8ZyVofF6" title="Deferred tax"><ix:nonFraction name="niobf:DeferredTaxImpacts" contextRef="AsOf2011-06-30_custom_ShareExchangeAgreementMember_currency_CAD" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,736</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 23, 2021, ECRC formally closed the purchase of two parcels of land and associated buildings and mineral rights in Johnson
County, Nebraska, associated with the Elk Creek Project, pursuant to an Amended and Restated Option to Purchase, dated as of April
29, 2020 (the &#8220;Option Agreement&#8221;). Pursuant to the terms of the Option Agreement, the Owner sold, transferred, conveyed
and assigned all of the rights, privileges, title and interest in and to the real property to ECRC, including any associated mineral
rights. The Option Agreement provided for a purchase price calculated based on the appraised value per acre of the parcels of
land, the mineral rights and the structures erected on the land. The purchase price was approximately $<span id="xdx_908_eus-gaap--SupplementalDeferredPurchasePrice_pn3n3_c20210421__20210423__us-gaap--TypeOfArrangementAxis__custom--OptionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ElkCreekResourcesCorpMember_zfkr8cnOfgTk" title="Purchase price"><ix:nonFraction name="us-gaap:SupplementalDeferredPurchasePrice" contextRef="From2021-04-212021-04-23_custom_OptionAgreementMember_custom_ElkCreekResourcesCorpMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,300</ix:nonFraction></span>, including indirect
costs of $<span id="xdx_908_eus-gaap--AmortizationOfAcquisitionCosts_pn3n3_c20210421__20210423__us-gaap--TypeOfArrangementAxis__custom--OptionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ElkCreekResourcesCorpMember_z3XUFPDExpha" title="Indirect costs"><ix:nonFraction name="us-gaap:AmortizationOfAcquisitionCosts" contextRef="From2021-04-212021-04-23_custom_OptionAgreementMember_custom_ElkCreekResourcesCorpMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">57</ix:nonFraction></span>. Of this amount, $<span id="xdx_901_eus-gaap--PaymentsToAcquireMineralRights_pn3n3_c20210421__20210423__us-gaap--TypeOfArrangementAxis__custom--OptionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ElkCreekResourcesCorpMember_zMpNOXBDsR6l" title="Other amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireMineralRights" contextRef="From2021-04-212021-04-23_custom_OptionAgreementMember_custom_ElkCreekResourcesCorpMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">837</ix:nonFraction></span> was allocated to land and buildings and the remaining $<span id="xdx_902_eus-gaap--PaymentsToAcquireBuildings_pn3n3_c20210421__20210423__us-gaap--TypeOfArrangementAxis__custom--OptionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ElkCreekResourcesCorpMember_zVBNe7tUA8Mf" title="Remaining balance"><ix:nonFraction name="us-gaap:PaymentsToAcquireBuildings" contextRef="From2021-04-212021-04-23_custom_OptionAgreementMember_custom_ElkCreekResourcesCorpMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,468</ix:nonFraction></span> was allocated to mineral properties
as costs related to mineral rights acquisition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the land and mineral rights currently owned by the Company, the property interests of Elk Creek include eight prepaid
mineral exploration option-to-purchase agreements and include a pre-determined buyout for permanent ownership of the mineral and/or
surface rights. Terms of the agreements require no further significant payments, and the Company may negotiate lease extensions
or elect to purchase the mineral and/or surface rights any time. Agreements that allow for the purchase of mineral rights contain
provisions whereby the landowners would retain a 2% net smelter return.</span></p>

</ix:nonNumeric><p id="xdx_817_zQySQCx7vn83" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_809_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zmTVc3u3wGK4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_820_zcRwatizURve">ACCOUNTS
PAYABLE AND ACCRUED LIABILITIES</span></span></td>
</tr></table>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z1e7O7549m0k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zYDi55cjSCFd" style="display: none; visibility: hidden">Schedule of account payable and accrued liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49F_20230630_zIIEHiJUSMx5" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="3" id="xdx_497_20220630_zjMc309MDUic" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zsNd0OmDJeVk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left">Accounts payable, trade</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,990</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">115</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_z0V4FV6YzPQk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade payable accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,324</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">654</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pn3n3_zep4RcGMjWx5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income taxes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">101</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1168">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_zwATtYBQqDs" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Environmental accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zJ5vNWYcI1ra" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Loan origination fees payable to related party</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1174">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_zFXGY51Hqnme" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Total accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,491</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">817</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AF_zeIf9U2UihB7" style="margin-top: 0; margin-bottom: 0"></p>

</ix:nonNumeric><p id="xdx_81B_zJvzhiIcYq5l" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:LongTermDebtTextBlock"><p id="xdx_809_eus-gaap--LongTermDebtTextBlock_zmuFTRNDSBLd" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_824_zUsEcAkXL1I1">CONVERTIBLE
DEBT</span></span></td>
</tr></table>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock"><p id="xdx_89A_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_zUSiT4NvRe3g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zBH3fghWdisc" style="display: none; visibility: hidden">Schedule of convertible debt</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current Portion:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 74%; text-align: left; padding-bottom: 2pt; padding-left: 0.125in">Lind III convertible security</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 2pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zhnvuGIQ2UWd" style="border-bottom: Black 2pt solid; width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1182">-</span></td><td style="border-bottom: Black 2pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 2pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_z9YihaD2wON3" title="Convertibled debt, current" style="border-bottom: Black 2pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-06-30_custom_ConvertibleSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,169</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Noncurrent Portion:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in">Yorkville convertible debentures</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zNTGr70ljNWl" title="Convertible debt, noncurrent" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2023-06-30_custom_ConvertibleSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,561</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_z4rC220ZElx4" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1187">-</span></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AF_zqmqzEZG3br5" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_231_zbFSdfzJVRih" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_z3n0UZpSgSha" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_237_zoM1q1jywWnk" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_239_zgAI9cSSJvJb" style="text-align: center; margin-left: 0.25in"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_233_zRjlv0igKLLa" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Lind
III Convertible Security</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 16, 2021, the Company issued to Lind Global Asset Management III, LLC (&#8220;Lind&#8221;), an entity managed by The
Lind Partners, the convertible security (the &#8220;Lind III Convertible Security&#8221;) pursuant to the Convertible Security
Funding Agreement, dated February 16, 2021, as amended by Amendment #1 to the Convertible Security Funding Agreement, dated December
2, 2021, between the Company and Lind (as amended, the &#8220;Lind III Agreement&#8221;). The Lind III Convertible Security had
a face value of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_pn3n3_c20210216__20210219_zMs27KE2NSb8" title="Face value"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" contextRef="From2021-02-162021-02-19" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,700</ix:nonFraction></span> (representing $10,000 in funding plus an implied <span id="xdx_90E_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20210219_z8GP56PSQo3h"><ix:nonFraction name="us-gaap:InvestmentInterestRate" contextRef="AsOf2021-02-19" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.5</ix:nonFraction></span>% interest rate per annum for the term of the Lind
III Convertible Security). After deducting a $<span id="xdx_902_eus-gaap--OtherCommitment_iI_pn3n3_c20210219_zcjKoUQMbYP5" title="Commitment fee"><ix:nonFraction name="us-gaap:OtherCommitment" contextRef="AsOf2021-02-19" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">350</ix:nonFraction></span> commitment fee as set forth in the Lind III Agreement, NioCorp received net
proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromInterestReceived_pn3n3_c20210216__20210219_za7FmcpdHEY1" title="Net proceeds"><ix:nonFraction name="us-gaap:ProceedsFromInterestReceived" contextRef="From2021-02-162021-02-19" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,650</ix:nonFraction></span> from the funding of the Lind III Convertible Security. The Company used a portion of the proceeds from the
funding of the Lind III Convertible Security to purchase a key land parcel associated with the Company&#8217;s Elk Creek Project,
with the remainder spent for general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Lind III Convertible Security had a term of (i) <span id="xdx_905_eus-gaap--LongTermDebtTerm_iI_dxL_c20230630_zFOdKmktzaof" title="Long term debt duration::XDX::P24M"><span style="-sec-ix-hidden: xdx2ixbrl1201">24 months</span></span> or (ii) 30 calendar days after the date on which the face value of the
Lind III Convertible Security is nil due to such amount having been fully converted and/or fully repaid (including with any applicable
premium) in accordance with the terms of the Lind III Agreement, whichever is earlier.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--DebtConversionDescription_c20220701__20230630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zvZS5dxwI1th"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember" name="us-gaap:DebtConversionDescription">Pursuant
to the Lind III Agreement, Lind was entitled to convert the Lind III Convertible Security into Common Shares in monthly installments
over its term at a price per Common Share equal to 85% of the volume-weighted average price Common Shares on the TSX for the five
trading days immediately preceding to the date on which Lind provides notice to the Company of its election to convert. The Lind
III Agreement provided that Common Shares issuable upon conversion, together with the number of Common Shares issued upon exercise
of Warrants, shall not exceed 4,358,800 Common Shares.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 19, 2021, in connection with the funding and issuance of the Lind III Convertible Security, the Company issued <span id="xdx_90A_eus-gaap--CommonUnitIssued_iI_uShares_c20210219_zINwzHsfK7M8" title="Common share purchase warrants"><ix:nonFraction name="us-gaap:CommonUnitIssued" contextRef="AsOf2021-02-19" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">855,800</ix:nonFraction></span>
Common Share purchase warrants, exercisable at a price per Common Share of C$<span id="xdx_90A_eus-gaap--AcceleratedShareRepurchasesFinalPricePaidPerShare_uCADPShares_c20220701__20230630_zq4W1bzY2244" title="Exercisable at a price per share"><ix:nonFraction name="us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">9.70</ix:nonFraction></span>, expiring February 19, 2025 (the &#8220;Lind
III Warrants&#8221;), to Lind pursuant to the Lind III Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company identified embedded derivatives in the Lind III Convertible Security that were evaluated to be immaterial at both the
closing date and at June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company allocated the net proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_pn3n3_uUSD_c20220701__20230630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_zL2884ZHBN3h"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" contextRef="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember501157062" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,477</ix:nonFraction></span> from the Lind III Convertible Security as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,712
    was allocated to Common Stock, representing the fair value of the Lind III Warrants based on the Black Scholes pricing model
    using a risk-free interest rate of <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220701__20230630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zndmK0KPqpej" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.40</ix:nonFraction></span>%, an expected dividend yield of <span id="xdx_904_eus-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate_dp_uPure_c20220701__20230630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zisNboMX9e12" title="Expected dividend yield"><ix:nonFraction name="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" contextRef="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="1" unitRef="Pure">0</ix:nonFraction></span>%, a volatility of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20220701__20230630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zdaQRfBBDR6h" title="Volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">51.60</ix:nonFraction></span>%, and an expected life of
    <span id="xdx_90B_eus-gaap--IntermediateLifePlantsUsefulLife_dxL_c20220701__20230630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zkPPzNmd6Dkd" title="Expected life::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl1215">4.0</span></span> years. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_906_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_zg3wzUTExwFb" title="Convertible debt liabilit"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2023-06-30_custom_LindIIIConvertibleSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,938</ix:nonFraction></span>
    was allocated     to the convertible debt liability. Transaction costs of $<span id="xdx_90B_ecustom--TransactionCost_pn3n3_uUSD_c20220701__20230630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_zjh0PQ1UdQf" title="Transaction costs"><ix:nonFraction name="niobf:TransactionCost" contextRef="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember501157062" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">173</ix:nonFraction></span>,
    in addition to a commitment fee of $<span id="xdx_90A_eus-gaap--LineOfCreditFacilityCommitmentFeeAmount_pn3n3_c20210217__20210219_zRt1Br5sH0b9" title="Commitment fee"><ix:nonFraction name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" contextRef="From2021-02-172021-02-19" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">350</ix:nonFraction></span>,
    were recognized as     a direct deduction from the debt liability, resulting in a net opening balance of $7,765. This balance
    was accreted up to the     face value of the Lind III Convertible Security at maturity using the effective interest method
    and recorded as non-cash interest     expense in the consolidated statement of operations and comprehensive loss.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="niobf:ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock"><p id="xdx_89A_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_zyp1AW0UCzuf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BE_zi34CDBBr5Id">Changes
in the Lind III Convertible Security are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 96%; border-collapse: collapse; margin-left: 0.25in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the year ending June 30,</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 76%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
    balance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--ConvertibleDebtNoncurrent_iS_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zCTOxUoUgvF9" title="Beginning balance" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 9%; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2022-06-30_custom_ConvertibleSecurityMember501157765" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,169</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ConvertibleDebtNoncurrent_iS_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_ztl48kYD14fl" title="Beginning balance" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 9%; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2021-06-30_custom_ConvertibleSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,234</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value increase due to debt extinguishment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ExtinguishmentOfDebtAmount_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zPzm8jDMfutc" title="Fair value increase due to debt extinguishment" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ExtinguishmentOfDebtAmount" contextRef="From2022-07-012023-06-30_custom_ConvertibleSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">201</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ExtinguishmentOfDebtAmount_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_z3ND6dZqhpJ5" title="Fair value increase due to debt extinguishment" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1231">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ConversionOfStockAmountIssued1_iN_pn3n3_di_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zXftOjtSPul4" title="Conversions" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2022-07-012023-06-30_custom_ConvertibleSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,950</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--ConversionOfStockAmountIssued1_iN_pn3n3_di_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_z1TaagufMIkj" title="Conversions" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2021-07-012022-06-30_custom_ConvertibleSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,635</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion
    expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--AccretionExpense_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zAvlxooLaGEg" title="Accretion expense" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2022-07-012023-06-30_custom_ConvertibleSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">95</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--AccretionExpense_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zFbeAgOnBgTf" title="Accretion expense" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2021-07-012022-06-30_custom_ConvertibleSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,570</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    at maturity</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--PaymentsToAcquireHeldToMaturitySecurities_iN_pn3n3_di_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zAIIAHMbyiB4" title="Payment at maturity" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" contextRef="From2022-07-012023-06-30_custom_ConvertibleSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">515</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--PaymentsToAcquireHeldToMaturitySecurities_iN_pn3n3_di_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zfuNpY3yvWCf" title="Payment at maturity" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1243">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance,
    end of period</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--ConvertibleDebtCurrent_iE_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zmMhJgGF2gw" title="Ending balance" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1245">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--ConvertibleDebtCurrent_iE_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zGoaMNvaZTp7" title="Ending balance" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-06-30_custom_ConvertibleSecurityMember501157765" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,169</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_zn6WDJAorPbj" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_236_zaKuJFq1G1I8" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_230_znWvpCZmU1cc" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_zQXGUFIGyEj8" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_232_zKoaa2w8OA48" style="text-align: center; margin-left: 0.25in"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_234_zP8QjBZYSly" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-size: 10pt">On
September 25, 2022, the Company and Lind entered into the Waiver and Consent Agreement, dated September 25, 2022, between the
Company and Lind (the &#8220;Lind Consent&#8221;), which included the following principal terms: (i) the consent of Lind to the
GXII Transaction disclosed in Note 5 and Yorkville Financings disclosed below and in Note 11d, including all actions taken by
NioCorp as set out in the Business Combination Agreement to permit the completion of the Transactions; (ii) the consent of Lind
to NioCorp&#8217;s expected cross-listing to the Nasdaq and the consolidation of the Common Shares in order to meet the minimum
listing requirements thereof; (iii) the waiver of Lind of its participation right for up to 15% of the total offering in the Yorkville
Equity Facility Financing; and (iv) the waiver of Lind of certain restrictive covenants in the Lind III Agreement.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As consideration for entering into the
Lind Consent, Lind received, amongst other things: (i) the right to receive a payment of $500, which would have been reduced to
$200 if the Transactions had not been consummated on or before April 30, 2023 (collectively, the &#8220;Consent Payment&#8221;);
(ii) an extension of its existing participation rights under the Lind III Agreement in future financings of NioCorp for a further
two-year period, subject to certain exceptions as well as an extension of such participation rights beyond the additional two-year
period if Yorkville or any affiliate is a party to any such applicable transaction; and (iii) the right to receive additional Warrants
(the &#8220;Contingent Consent Warrants&#8221;) if on the date that is 18 months following the Closing Date, the closing trading
price of the Common Shares on the TSX or such other stock exchange on which such shares may then be listed, is less than C$10.00
(on a post-Reverse Stock Split basis), subject to adjustments. The number of Contingent Consent Warrants to be issued, if any,
is based on the Canadian dollar equivalent (based on the then current Canadian to US dollar exchange rate as reported by Bloomberg,
LP) of $5,000 divided by the five-day volume weighted average price of the Common Shares on the date of issuance. Further, the
number of Contingent Consent Warrants issued will be proportionately adjusted based on the percentage of Warrants currently held
by Lind that are exercised, if any, prior to the issuance of any Contingent Consent Warrants. The Lind Consent was signed as an
amendment to the existing Lind III Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Management determined that the Lind
Consent should be evaluated using ASC 470, which requires an evaluation of the contract amendment under debt modification guidance.
The Company performed a comparison of the discounted cash flows of the Lind III Convertible Security pursuant to the existing Lind
III Agreement and pursuant to the Lind III Agreement as amended by the Lind Consent and determined that a debt extinguishment loss
of $201 had occurred. Further, ASC 470 requires that the minimum estimated Consent Payment of $200 also be included in the calculation
of the initial loss on debt extinguishment. The Company also evaluated the Contingent Consent Warrant feature included in the Lind
Consent and determined that the Contingent Consent Warrants meet the criteria to be considered separate, freestanding instruments,
should be accounted for as a liability under ASC 480, and should be booked at fair value on the date of the Lind Consent, with
subsequent changes in valuation recorded as a non-operating gain or loss in the consolidated statement of operations and comprehensive
loss. The following table summarizes the components of the initial loss and final loss on extinguishment:</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfExtinguishmentOfDebtTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfExtinguishmentOfDebtTextBlock_zYU5vveFJy19" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zZdiXHfZmexk" style="display: none; visibility: hidden">The following table summarizes the components of the initial loss on extinguishment:</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Component of loss</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_496_20220701__20230630_zCQ2gBMelhq1" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--MinimumConsentPaymentAtInception_pn3n3_zxbnNXF91ZK7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 87%; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minimum
    Consent Payment at inception</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:MinimumConsentPaymentAtInception" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--ASC470LossOnExtinguishment_pn3n3_zRQsTefxPyKe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss on debt extinguishment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:ASC470LossOnExtinguishment" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">201</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--AdjustmentOfWarrantsGrantedForServices_pn3n3_zrvjgz1hSOIk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    fair value of Contingent Consent Warrants</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentOfWarrantsGrantedForServices" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,221</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_pn3n3_z21HTd1Pjnw" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    loss on debt extinguishment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,622</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--AdditionalConsentPaymentbooked_pn3n3_z9OTwYiXhEi8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    Consent Payment booked<sup id="xdx_F4E_zLIhWIcwEZ78">1</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:AdditionalConsentPaymentbooked" contextRef="From2022-07-01to2023-06-30" id="Fact001264" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">300</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--GainsLossesOnRestructuringOfDebt_pn3n3_zBCMP29s6eCa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    loss on debt extinguishment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GainsLossesOnRestructuringOfDebt" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,922</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; padding-right: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 5.4pt; text-align: justify"><span id="xdx_F05_zWiHKFp67EBa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 93%; padding-right: 5.4pt; text-align: justify"><span id="xdx_F16_znGdMSE09cad" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001267" xml:lang="en-US">Represents
    the difference between the accrual of the minimum Consent Payment at September 25, 2022 and the actual payment made on March
    17, 2023.</ix:footnote></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify">&#160;</td></tr>
</table>
</ix:nonNumeric><p id="xdx_8AF_z0bggwYdVtoc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="niobf:ScheduleOfWarrantValuationTableTextblock"><p id="xdx_89D_ecustom--ScheduleOfWarrantValuationTableTextblock_z8D7RFLrWh9k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_ztl8jfAUOVqa">The
change in the fair value of the Contingent Consent Warrants is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 76%; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    valuation, September 25, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstanding_iS_c20220701__20230630_zPk9r8SH3Fwh" title="Initial valuation, at beginning" style="font: 10pt Times New Roman, Times, Serif; width: 19%; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,221</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in valuation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_ecustom--ChangeInValuationOfWarrants_c20220701__20230630_zLY1DjA0Htmh" title="Change in valuation" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:ChangeInValuationOfWarrants" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">489</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    at June 30, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--WarrantsAndRightsOutstanding_iE_c20220701__20230630_z5inbWDzyBp3" title="Valuation, at ending" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,710</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A3_ziScyr2L1ku5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_232_zRkJT1jfrE1a" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_ziIRjzgEh987" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zEHqGReAPFqf" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_23C_zW1n6oj7oHO3" style="text-align: center; margin-left: 0.25in"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_23C_zZVLsRnIDEi2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Contingent Consent Warrants are classified as a Level 3 financial instrument and were valued utilizing a Monte Carlo simulation
pricing model, which calculates multiple potential outcomes for future share prices based on historic volatility of the Common
Shares to determine the probability of issuance at 18 months following the applicable valuation date and to determine the value
of the Contingent Consent Warrants. The following table discloses the primary inputs into the Monte Carlo model at each valuation
date, and the probability of issuance calculated by the model.</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="niobf:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock"><p id="xdx_899_ecustom--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_z2e1K9Aadhbf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zZ9UGm3COq19" style="display: none; visibility: hidden">Schedule of valuation date and the probability calculated.</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key Valuation
    Input</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
25,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
30,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 48%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    price on valuation date</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_z7JqcEuX1EIi" title="Share price" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-09-25_us-gaap_MeasurementInputSharePriceMember" id="Fact001284" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.82</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zMIe4TtXk2qh" title="Share price" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-06-30_us-gaap_MeasurementInputSharePriceMember" id="Fact001286" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.03</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 3%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zshyS0ZZK7S7" title="Volatility" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-09-25_us-gaap_MeasurementInputPriceVolatilityMember" id="Fact001288" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="NUMBER">62.4</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zUrf6XHUjH9g" title="Volatility" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-06-30_us-gaap_MeasurementInputPriceVolatilityMember" id="Fact001290" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="NUMBER">63.0</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_zFZFIy8rMQzf" title="Risk free rate" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-09-25_us-gaap_MeasurementInputRiskFreeInterestRateMember" id="Fact001292" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="NUMBER">3.93</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_z10grwww8KFf" title="Risk free rate" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember" id="Fact001294" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="NUMBER">4.11</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Probability of
    issuance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_zNOnUs8ZaMAa" title="Probability of issuance" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-09-25_custom_ProbabilityOfIssuanceMember" id="Fact001296" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="NUMBER">59.4</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_z1FA45HECf56" title="Probability of issuance" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-06-30_custom_ProbabilityOfIssuanceMember" id="Fact001298" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="NUMBER">80.8</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A2_zr93TpQHpcDa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Loss
on debt extinguishment is presented as a non-operating expense in the Company&#8217;s consolidated statements of operations and
comprehensive loss. This accounting also resulted in a decrease in the amount of accretion to be recognized over the remaining
life of the Lind III Convertible Security through February 2023. Accretion expenses are disclosed as a part of interest expense,
which is not included as a component of operating costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Yorkville
Convertible Debentures</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the GXII Transaction, on January 26, 2023, NioCorp entered into definitive agreements with respect to the Yorkville
Financings, including a Securities Purchase Agreement, dated January 26, 2023 (as amended the &#8220;Yorkville Convertible Debt
Financing Agreement&#8221;), between the Company and Yorkville, and a Standby Equity Purchase Agreement, dated January 26, 2023
(the &#8220;Yorkville Equity Facility Financing Agreement&#8221;), between the Company and Yorkville.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Yorkville Convertible Debt Financing Agreement, at the Closing, Yorkville advanced a total amount of $15,360 to NioCorp
in consideration of the issuance by NioCorp to Yorkville of (i) $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20230630__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zhTcUGrB1X94" title="Aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-06-30_us-gaap_UnsecuredDebtMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,000</ix:nonFraction></span> aggregate principal amount of unsecured convertible debentures
(the &#8220;Convertible Debentures&#8221;) and (ii) Common Share purchase warrants, exercisable for up to <span id="xdx_90E_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zefigQNsFKMh" title="Number of shares purchase"><ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockOptionsExercise" contextRef="From2022-07-012023-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,789,267</ix:nonFraction></span> Common Shares
for cash or, if at any time there is no effective registration statement registering, or no current prospectus available for,
the resale of the underlying Common Shares, on a cashless basis, at the option of the holder, at a price per Common Share of approximately
$<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zYRzfWHA9IGg" title="Number of shares purchase"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.9422</ix:nonFraction></span>, subject to adjustment to give effect to any stock dividend, stock split, reverse stock split or similar transaction (the
&#8220;Financing Warrants&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Convertible Debenture issued under the Yorkville Convertible Debt Financing Agreement is an unsecured obligation of NioCorp, has
an <span id="xdx_902_eus-gaap--LongTermDebtMaturitiesRepaymentTerms_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_z7E3vVTS6Vkl" title="Debt term"><ix:nonNumeric contextRef="From2022-07-012023-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember" name="us-gaap:LongTermDebtMaturitiesRepaymentTerms">18-month</ix:nonNumeric></span> term from the Closing Date, which may be extended for one six-month period in certain circumstances at the option
of NioCorp, and incurs a simple interest rate obligation of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MinimumMember_zfEJbFQO9eQc" title="Interest rate obligation"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.0</ix:nonFraction></span>% per annum (which will increase to <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MaximumMember_zyyyqKkneBZk" title="Interest rate obligation"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15.0</ix:nonFraction></span>% per annum upon the occurrence
of an event of default). The outstanding principal amount of, accrued and unpaid interest, if any, on, and premium, if any, on
the Convertible Debentures must be paid by NioCorp in cash when the same becomes due and payable under the terms of the Convertible
Debentures at their stated maturity, upon their redemption or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain limitations contained within the Yorkville Convertible Debt Financing Agreement and the Convertible Debentures, including
those as described below, holders of the Convertible Debentures will be entitled to convert the principal amount of, and accrued and
unpaid interest, if any, on each Convertible Debenture, in whole or in part, from time to time over their term, into a number of
Common Shares equal to the quotient of the principal amount and accrued and unpaid interest, if any, being converted divided by the
Conversion Price. The &#8220;Conversion Price&#8221; means, as of any Conversion Date (as defined below) or other date of
determination, the greater of (i) 90% of the average of the daily U.S. dollar volume-weighted average price of the Common Shares
on the principal U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading
days immediately preceding the date on which the holder exercises its conversion right in accordance with the requirements of
the Yorkville Convertible Debt Financing Agreement (the &#8220;Conversion Date&#8221;) or other date of determination, but not
lower than the Floor Price (as defined below), and (ii) the five-day volume-weighted average price of the Common</span></p>

<ix:exclude><p id="xdx_23C_zMFJY3f8FSK9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_2372_z5sNzh0FHNP9" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_2362_zrENfcOUnHG2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_2352_z2Qde7f0NYl4" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: center; margin-left: 0.25in"><ix:exclude><div id="xdx_2382_zTBhneEZUqe2" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_23F2_zOv0z8lkCLvk" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> Shares on the
TSX (or on the principal U.S. market if the majority of the trading volume and value of the Common Shares occurred on Nasdaq during
the relevant period) for the five consecutive trading days immediately prior to the Conversion Date or other date of determination
less the maximum applicable discount allowed by TSX. The &#8220;Floor Price&#8221; means a price of $2.1435 per share, which is
equal to the lesser of (a) 30% of the average of the daily volume-weighted average price of the Common Shares on the principal
U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading days immediately
preceding the Debenture Closing and (b) 30% of the average of the volume-weighted average price of the Common Shares on the principal
U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading days immediately
following the Debenture Closing, subject to certain adjustments to give effect to any stock dividend, stock split, reverse stock
split, recapitalization or similar event.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Convertible Debentures restrict the number of Convertible Debentures that may be converted during each calendar month
by Yorkville at a Conversion Price below a fixed price equal to approximately $8.9422 (i.e., the quotient of $10.00 divided by
1.11829212 (being the number of Common Shares that were exchanged for each share of GXII at the Closing, after giving effect to
the Reverse Stock Split)), subject to adjustment to give effect to any stock dividend, stock split, reverse stock split, recapitalization
or similar event. The Convertible Debentures are subject to customary anti-dilution adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Convertible Debentures restrict the conversion of Convertible Debentures by Yorkville if such a conversion would
cause Yorkville to exceed certain beneficial ownership thresholds in NioCorp or such a conversion would cause the aggregate number
of Common Shares issued pursuant to the Yorkville Convertible Debt Financing Agreement to exceed the thresholds for issuance of
Common Shares under the rules of the TSX and Nasdaq, unless prior shareholder approval is obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Convertible Debentures, following certain trigger events, and until a subsequent cure event, NioCorp will
be required to redeem $1,125 aggregate principal amount of Convertible Debentures (the &#8220;Triggered Principal Amount&#8221;)
each month by making cash payments to the Investors, on a pro rata basis, in an amount equal to the Triggered Principal Amount,
plus accrued and unpaid interest thereon, if any, plus a redemption premium of 7% of the Triggered Principal Amount. Such monthly
prepayments under the terms of the Convertible Debentures are triggered (i) at the time when NioCorp has issued 95% of the total
amount of Common Shares pursuant to the Yorkville Convertible Debt Financing that it may issue under applicable TSX and Nasdaq
rules or (ii) when NioCorp has delayed or suspended the effectiveness or use of the Convertible Debt Financing Registration Statement
for more than 20 consecutive calendar days, and such monthly prepayment obligations will continue until, with respect to (i) above,
shareholder approval is obtained or, with respect to (ii) above, the Investors may once again resell Common Shares under the Convertible
Debt Financing Registration Statement, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Convertible Debentures may also be redeemed at NioCorp&#8217;s option at any time and from time to time over their term at a redemption
price equal to <span id="xdx_900_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zuhqpqLmDTPf" title="Principal percentage"><ix:nonFraction name="us-gaap:DebtInstrumentRedemptionPricePercentage" contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">110</ix:nonFraction></span>% of the principal amount being redeemed, plus accrued and unpaid interest, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with the issuance of the Convertible Debentures, NioCorp issued to Yorkville <span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zOtAEtQzM43l" title="Issuance of the convertible debentures"><ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockOptionsExercise" contextRef="From2022-07-012023-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,789,267</ix:nonFraction></span> Financing Warrants at an exercise
price of approximately $<span id="xdx_904_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise1_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zxOHOxo8tCDa" title="Issuance of the convertible debentures"><ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockOptionsExercise1" contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">8.9422</ix:nonFraction></span> per Common Share (the &#8220;Financing Warrant Exercise Price&#8221;), subject to adjustment to
give effect to any stock dividend, stock split, reverse stock split recapitalization or similar event.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Financing Warrants are exercisable, in whole or in part, but not in increments of less than $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__srt--RangeAxis__srt--MaximumMember_z6Me60A1ddl2" title="Aggregate exercise price, per shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-06-30_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">50</ix:nonFraction></span> aggregate Financing Warrant Exercise
Price (unless the remaining aggregate Financing Warrant Exercise Price is less than $50), beginning on May 4, 2023, and may be
exercised at any time prior to their expiration. Holders of the Financing Warrants may exercise their Financing Warrants, at their
election, by paying the Financing Warrant Exercise Price in cash or, if at any time there is no effective registration statement
registering, or no current prospectus available for, the resale of the underlying Common Shares, on a cashless exercise basis.
1/12th of the Financing Warrants will expire on each of the first 12 monthly anniversaries of the date that is six months following
the Closing Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Financing Warrants have customary anti-dilution adjustments to be determined in accordance with the requirements of the applicable
stock exchanges, including the TSX. The terms of the Financing Warrants restrict the</span></p>

<ix:exclude><p id="xdx_233_z5kNGCClHEec" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_2373_z5sNzh0FHNP9" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_2363_zrENfcOUnHG2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_2353_z2Qde7f0NYl4" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: center; margin-left: 0.25in"><ix:exclude><div id="xdx_2383_zTBhneEZUqe2" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_23F3_zOv0z8lkCLvk" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">exercise of Financing Warrants by Yorkville
if such an exercise would cause Yorkville to exceed certain beneficial ownership thresholds in NioCorp or such an exercise would
cause the aggregate number of Common Shares issued pursuant to the Yorkville Convertible Debt Financing Agreement to exceed the
thresholds for issuance of Common Shares under the rules of the Nasdaq and the TSX, unless prior shareholder approval is obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Financing Warrants were originally recorded as a $<span id="xdx_903_eus-gaap--LossContingencyAccrualAtCarryingValue_iI_pn3n3_c20230126__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z2QYMy1Bplr3" title="Contingent liability"><ix:nonFraction name="us-gaap:LossContingencyAccrualAtCarryingValue" contextRef="AsOf2023-01-26_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,704</ix:nonFraction></span> contingent liability on January 26, 2023,
and were subsequently marked to market of $<span id="xdx_90E_eus-gaap--ServicingLiability_iI_pn3n3_c20230316__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6MM7nULYP73" title="Contingent liability"><ix:nonFraction name="us-gaap:ServicingLiability" contextRef="AsOf2023-03-16_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,337</ix:nonFraction></span> through March 16, 2023. The change in fair value during this period resulted in
a loss of $<span id="xdx_90E_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230630_z7RVCdMD9Ejj" title="Fair value of warrant liability"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">633</ix:nonFraction></span>, which was booked to change in fair value of warrant liability in the consolidated statement of operations and comprehensive
loss. The Financing Warrants were reclassified to shareholders equity on March 17, 2023, in connection with the closing of the
Convertible Debentures as noted below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company allocated the net proceeds of $15,360 from the Convertible Debentures as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zwaSh4mH3RE2" title="Fair value"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,704</ix:nonFraction></span>
    was booked to Common Shares, representing the initial fair value of the Financing Warrant tranches on January 26, 2023 based
    on the Black Scholes pricing model using a risk-free interest rate <span style="color: #353535">of <span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zIYiUNcJvFSe" title="Fair value"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.33</ix:nonFraction></span>%, an expected dividend
    yield of <span id="xdx_904_ecustom--ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_pid_dp_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zLHMpCmsQbm9" title="Fair value"><ix:nonFraction name="niobf:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputExpectedDividendRateMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span>%, a volatility of <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_c20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zMCrc6Y2rPMk" title="Fair value"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputPriceVolatilityMember" format="ixt:numdotdecimal" decimals="INF" unitRef="NUMBER">64.6</ix:nonFraction></span>%, and an expected life of <span id="xdx_90D_ecustom--DebtMaturityPeriod_dxL_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MinimumMember_zq2jUJ8qOZ6b" title="Expected life::XDX::P6M"><span style="-sec-ix-hidden: xdx2ixbrl1346">6</span></span> months to <span id="xdx_900_ecustom--DebtMaturityPeriod_dxL_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MaximumMember_zjcxBC42lril" title="Expected life::XDX::P18M"><span style="-sec-ix-hidden: xdx2ixbrl1348">18</span></span> months</span>. </span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_901_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zoxAktoyuWxf" title="Convertible debt liability"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,656</ix:nonFraction></span>
    was booked to the convertible debt liability. In addition, transaction costs of $<span id="xdx_90F_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zStNq833Jh1a" title="Transaction costs"><ix:nonFraction name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" contextRef="AsOf2023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">503</ix:nonFraction></span> were recognized as a direct deduction
    from the debt liability, resulting in a net opening balance of $12,153 at an effective interest rate of 18.4%. This balance
    will be accreted to face value of the Convertible Debentures at maturity using the effective interest method and recorded
    as non-cash interest expense in the consolidated statement of operations and comprehensive loss.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
</table>
<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ConvertibleDebtTableTextBlock"><p id="xdx_899_eus-gaap--ConvertibleDebtTableTextBlock_zCePOSCmMlte" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zV8L6A21YcB6">Changes
in the Convertible Debentures are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 86%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opening balance,
    March 17, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$</span></td>
    <td id="xdx_98B_eus-gaap--ConvertibleDebt_iS_pn3n3_c20230315__20230630_z6rOlrdFfvKl" title="Opening balance, March 17, 2023" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2023-03-14" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,153</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20230315__20230630_z1AFoo4i7m14" title="Accretion expense" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccretionExpenseIncludingAssetRetirementObligations" contextRef="From2023-03-152023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,962</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal and accrued
    interest converted</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_98B_ecustom--PrincipalAndAccruedInterestConverted_iN_pn3n3_di_c20230315__20230630_zMvzc22zeyJa" title="Principal and accrued interest converted" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="niobf:PrincipalAndAccruedInterestConverted" contextRef="From2023-03-152023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,554</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30,
    2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--ConvertibleDebt_iS_pn3n3_c20220701__20230630_zhoc7a9NtO6g" title="Balance, June 30, 2023" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,561</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><p style="margin: 0pt 0">Add: Unamortized debt issuance costs</p>


</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt">&#160;</td>
    <td id="xdx_984_eus-gaap--AmortizationOfFinancingCosts_pn3n3_dxL_c20220701__20230630_z72xi07wU049" title="Add: uamortized debt issuance costs::XDX::0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1364">2,439</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><p style="margin: 0pt 0">Remaining principal balance, June 30, 2023</p>


</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt">$</td>
    <td id="xdx_984_eus-gaap--ConvertibleDebt_iE_pn3n3_c20220701__20230630_zc6kgVzCabzc" title="Balance, June 30, 2023" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,000</ix:nonFraction></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A2_z2fKHVgWyB58" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon conversion, the portion of remaining unamortized
issuance costs associated with the conversion are recognized as a component of interest expense. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Convertible Debentures contain events of default customary for instruments of their type (with customary grace periods, as applicable)
and provide that, upon the occurrence of an event of default arising from certain events of bankruptcy or insolvency with respect
to NioCorp, all outstanding Convertible Debentures will become due and payable immediately without further action or notice. If
any other type of event of default occurs and is continuing, then any holder may declare all of its Convertible Debentures to
be due and payable immediately. The Company obtained a waiver from Yorkville with respect to any acceleration rights it may have
under the Convertible Debentures in connection with the restatements of the Company&#8217;s consolidated financial statements for the periods
ended September 30, 2022 and December 31, 2022 and the delay in filing the Company&#8217;s Quarterly Report on Form 10-Q for the
quarterly period ended March 31, 2023. The Yorkville Convertible Debt Financing Agreement also contains certain covenants that,
among other things, limit NioCorp&#8217;s ability to use the proceeds from the Yorkville Convertible Debt Financing to repay related
party debt or to enter into any variable rate transaction other than with Yorkville, subject to certain exceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the Company&#8217;s closing Common Share price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zJgXyJRSh1Bj" title="Common share price, per share"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-06-30_us-gaap_MeasurementInputSharePriceMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.03</ix:nonFraction></span> as of June 30, 2023, conversion of the remaining Convertible Debenture
principal balance of $13.0 million, including accrued interest, would require the issuance of approximately 2,871,660 Common Shares.
For each $0.10 change in the fair value of one Common Share, the total shares the Company would be obligated to issue would change
by approximately <span id="xdx_904_eus-gaap--OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_iI_pid_uShares_c20230630_zvyCG0ZLEmr3" title="Shares issued"><ix:nonFraction name="us-gaap:OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">58,300</ix:nonFraction></span> shares.</span></p>

</ix:nonNumeric><p id="xdx_816_z6ZlTi6N8bud" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p>

<!-- Field: Rule-Page --><div style="text-align: center; margin-left: 0.25in"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock"><p id="xdx_80B_ecustom--ScheduleOfClassBCommonStockOfECRCTableTextBlock_ziTNfX3zNg16" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_824_zvzqmk75ebah">CLASS
B COMMON STOCK OF ECRC</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, the Sponsor Support Agreement, and the Exchange Agreement, after the Closing, the GXII
founders have the right to exchange shares of Class B common stock of ECRC for Common Shares on a one-for-one basis, subject to
certain equitable adjustments, under certain conditions. All <span style="color: #353535"><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zXGpAdsjW0W2" title="Common stock, shares, outstanding"><span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zDDh90q3hYJ2" title="Common stock, shares, issued"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,957,404</ix:nonFraction></ix:nonFraction></span></span> shares of Class B common stock
of ECRC that were issued in connection with the Closing were issued and outstanding as of June 30, 2023. </span>Of the issued
and outstanding shares of Class B common stock of ECRC, <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zI3yg9HKwNY2" title="Earnout shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,565,808</ix:nonFraction></span> shares (the &#8220;Vested Shares&#8221;)&#8201;were vested
as of the Closing Date and are exchangeable at any time, and from time to time, until the tenth anniversary of the Closing Date
(the &#8220;Ten-Year Anniversary&#8221;) and <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20220701__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zdFN2PPVqX05" title="Earnout shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-07-012023-06-30_custom_EarnoutMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,391,596</ix:nonFraction></span> shares (the &#8220;Earnout Shares&#8221;) are exchangeable until the Ten-Year
Anniversary, subject to certain vesting conditions. Under certain circumstances, and subject to certain exceptions, NioCorp may
instead settle all or a portion of any exchange pursuant to the terms of the Exchange Agreement in cash, in lieu of Common Shares,
based on a volume-weighted average price of Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the shares of Class B common stock of ECRC are subject to the Amended and Restated Registration Rights Agreement, dated as
of March 17, 2023 (the &#8220;Registration Rights and Lock-up Agreement&#8221;), among NioCorp, GXII, the Sponsor, the pre-Closing
directors and officers of NioCorp and the other parties thereto, including the members of the Sponsor. Pursuant to Registration
Rights and Lock-up Agreement, all shares of Class B common Stock of ECRC (including the Vested Shares and the Released Earnout
Shares) are subject to certain &#8220;lock-up&#8221; restrictions on transfer beginning upon the Closing and ending upon the earlier
of (i) one year after the Closing and (ii) the date on which the trading price of Common Shares exceeds certain thresholds or
the date on which NioCorp completes a transaction that results in all of NioCorp&#8217;s shareholders having the right to exchange
their Common Shares for cash, securities or other property. Both Vested Shares and Released Earnout Shares may be exchanged by
the holders into Common Shares at any time. Under the Exchange Agreement, all Vested Shares and Earnout Shares must be exchanged
for Common Shares by the Ten-Year Anniversary except for Released Earnout Shares that have been vested for a period of fewer than
twenty-four months as of the Ten-Year Anniversary. Such Released Earnout Shares will be forfeited if not exchanged for Common
Shares by the date that is twenty-four months after the vesting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Vested
Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the exchange of Vested Shares are contingently redeemable at the option of the noncontrolling interest shareholders, the Company
classifies the carrying amount of the redeemable noncontrolling interest in the mezzanine section on the consolidated balance
sheet, which is presented above the equity section and below liabilities. The redeemable noncontrolling interests are classified
as a Level 1 financial instrument and are measured at the fair value of the Company&#8217;s Common Shares at each reporting period.
Adjustments to the carrying value of the redeemable noncontrolling interest are recorded through retained earnings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Earnout
Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--DescriptionOfEarnOutShares_c20220701__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zlelGYyZY4s3" title="Description of earnout shares"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_EarnoutMember" name="niobf:DescriptionOfEarnOutShares">The
Earnout Shares vest (the &#8220;Released Earnout Shares&#8221;) in two equal tranches based upon achieving market share price
milestones of approximately $12.00 per Common Share and approximately $15.00 per Common Share, respectively, prior to the Ten-Year
Anniversary, or upon a change in control as defined in the underlying agreement.</ix:nonNumeric></span> These shares will be forfeited if the market
share price milestones or an acceleration event is not reached prior to the Ten-Year Anniversary. At such time that the Earnout
Shares shall become vested, and therefore, become Released Earnout Shares, the shares will be transferred to the redeemable noncontrolling
interest in the mezzanine section of the Consolidated Balance Sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Earnout Shares were classified as a liability due to failure to meet the equity classification criteria under ASC 815-40, as Level
3 instruments under the fair value hierarchy and are considered a financial liability under ASC 480, Distinguishing Liabilities
from Equity. The Earnout Shares were measured at fair value on the Closing Date with subsequent changes in fair value recorded
in earnings. The Earnout Shares were valued utilizing a Monte Carlo simulation pricing model, which calculates multiple potential
outcomes for future share prices and establishes current fair value based on the most likely outcome. The following table discloses
the primary inputs into the Monte Carlo models.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_23C_zL8018ZxTzbg" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_230_z49R1zOE0WQg" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_zs8MHXg1Vbb2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: center; margin-left: 0.25in"><ix:exclude><div id="xdx_23F_zwkqR4Lbx8vd" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_23F_zrrrZk2lt8P9" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock"><p id="xdx_897_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zhj3jT5sAOh3" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><span id="xdx_8B1_zCYYAonfzRQ9" style="display: none; visibility: hidden">The following table discloses the primary inputs into the Monte Carlo models.</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
    Valuation Input</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
    Close</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 17%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    30, 2023</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing
    Common Share price</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zfLqTFRFUhZe" title="Closing common share price" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-09-25_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.00</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zt5nfwpA88Df" title="Closing Common Share price" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.03</ix:nonFraction></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Term
    (expiry)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220924__20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zzIPd5Pr9Ulf" title="Term (expiry)"><ix:nonNumeric contextRef="From2022-09-242022-09-25_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" format="ixt:datemonthdayyearen" name="niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">March 17, 2033</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zd7S2NhjHeI3" title="Term (expiry)"><ix:nonNumeric contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" format="ixt:datemonthdayyearen" name="niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">March
    17, 2033</ix:nonNumeric></span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Implied
    volatility of Public Warrants</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220924__20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zkyEu3yGwYm2" title="Implied volatility of Public Warrants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-09-242022-09-25_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">19.5</ix:nonFraction></span>%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zDajiz5MaJE" title="Implied volatility of Public Warrants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">33.5</ix:nonFraction></span>%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free
    rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220924__20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIKaow3B86Kd" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-09-242022-09-25_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.39</ix:nonFraction></span>%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zbQ7qDRiyiB9" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.83</ix:nonFraction></span>%</span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A4_zLWPF8Z9XTR4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock"><p id="xdx_890_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_z85NvC16U4xa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zWOytyTvNCya">The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June
30, 2023:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 49%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of March 17, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230301__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zTC4noQBiBD6" title="Fair value at beginning" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ServicingLiabilityAtFairValueAmount" contextRef="AsOf2023-02-28_custom_EarnoutMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,195</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> &#160;</span></td>
    <td id="xdx_98A_eus-gaap--ServicingLiabilityAtFairValueAdditions_iN_pn3n3_di_c20230301__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zwKd8xDGnBd4" title="Change in fair value" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ServicingLiabilityAtFairValueAdditions" contextRef="From2023-03-012023-06-30_custom_EarnoutMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,674</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of June 30, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20230301__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zQLdcdPsHRvk" title="Fair value at ending" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ServicingLiabilityAtFairValueAmount" contextRef="AsOf2023-06-30_custom_EarnoutMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,521</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AD_zF9RWc4mEx9e" style="margin-top: 0; margin-bottom: 0"></p>

</ix:nonNumeric><p id="xdx_812_zMdCgCeoOSGh" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock"><p id="xdx_808_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_zT8B6wABu3Wb" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_827_zqNYCfM9Hyte">COMMON
SHARES</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuances</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fiscal
Year 2023 Issuances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the Common Shares issued in connection with the GXII Transaction, as discussed in Note 5, the following Common Share
issuances occurred during fiscal year 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 28, 2023, the Company closed a registered direct offering and issued <span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20230426__20230428_zCxAl7AhivXa" title="Numberof shares issue"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-04-262023-04-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">314,465</ix:nonFraction></span> Common Shares for $<span id="xdx_909_eus-gaap--OfferingCostsPartnershipInterests_iI_dm_c20230428_zIqj2wdfQ2gk" title="Shares issue price"><ix:nonFraction name="us-gaap:OfferingCostsPartnershipInterests" contextRef="AsOf2023-04-28" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">2.0</ix:nonFraction> million</span>, before deducting
share issuance costs of $<span id="xdx_90D_ecustom--ShareIssuanceCost_iI_pn3n3_c20230428_zXHTbT3noZW" title="Share issuance cost"><ix:nonFraction name="niobf:ShareIssuanceCost" contextRef="AsOf2023-04-28" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">172</ix:nonFraction></span>. The Common Shares were sold pursuant to a securities purchase agreement, dated April 26, 2023, between
the Company and a fund managed by Kingdon Capital Management, LLC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 9, 2023, the Company issued <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20230608__20230609__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_z6Kw3YuvJ9zb" title="Numberof shares issue"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-06-082023-06-09_custom_YorkvilleConvertibleDebtFinancingAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></span> Common Shares under the Yorkville Equity Facility Financing Agreement (discussed below)
in exchange for $488 in cash proceeds. The Company recorded a non-cash operating expense of $<span id="xdx_901_eus-gaap--OperatingLeaseExpense_pn3n3_c20230608__20230609__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zuZ4AkNWNrf1" title="Share issuance cost"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2023-06-082023-06-09_custom_YorkvilleConvertibleDebtFinancingAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></span> which represented the difference between
the proceeds received and the fair value of the Common Shares issued based on Nasdaq closing price per Common Share on the issuance date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fiscal
Year 2022 Issuances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 30, 2022, the Company closed a non-brokered private placement (the &#8220;June 2022 Private Placement&#8221;) of units (the
&#8220;Units&#8221;) of the Company. A total of <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zLxVC65FBqN3" title="Sahares issue"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">498,103</ix:nonFraction></span> Units were issued at a price per Unit of C$<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zfJUXDnIWX9c" title="Price per unit"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2022-06-30_us-gaap_PrivatePlacementMember_currency_CAD" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.96</ix:nonFraction></span>, for total gross proceeds
to the Company of approximately C$<span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_dm_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zcZbVar6yfJj" title="Gross proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">4.8</ix:nonFraction> million</span>. Each Unit consists of one Common Share and one common share purchase warrant (&#8220;June
2022 Warrant&#8221;). Each June 2022 Warrant entitles the holder to acquire one Common Share at a price of C<span id="xdx_90C_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zx7LJDkcNCVf" title="Shares price">$<ix:nonFraction name="niobf:SaleOfStockPricePerShare1" contextRef="AsOf2022-06-30_us-gaap_PrivatePlacementMember_currency_CAD" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.10</ix:nonFraction></span> at any time
prior to July 1, 2024. Proceeds of the June 2022 Private Placement will be used for continued advancement of the Company&#8217;s
Elk Creek Critical Minerals Project and for working capital and general corporate purposes. The Company paid cash commissions
of C$<span id="xdx_90C_eus-gaap--PaymentsForCommissions_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zciHh29u3G38" title="Cash commissions"><ix:nonFraction name="us-gaap:PaymentsForCommissions" contextRef="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62</ix:nonFraction></span> and <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkoxSUUxY2V9" title="Warrants"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,510</ix:nonFraction></span> warrants (the &#8220;Finder Warrants&#8221;), having the same terms as the June 2022 Warrants, to finders outside
of the United States. The Finder Warrants were valued at C$<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zebRdcuxBaf7"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18</ix:nonFraction></span> using a risk-free rate of <span id="xdx_904_ecustom--FairValueAssumptionsRiskFreeInterestRate1_pid_dp_uPure_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZPWKb7PU6Fa" title="Risk-free rate"><ix:nonFraction name="niobf:FairValueAssumptionsRiskFreeInterestRate1" contextRef="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.2</ix:nonFraction></span>%, expected volatility of <span id="xdx_900_ecustom--FairValueAssumptionsExpected1VolatilityRate_pid_dp_uPure_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIavrGTsULta" title="Expected volatility"><ix:nonFraction name="niobf:FairValueAssumptionsExpected1VolatilityRate" contextRef="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">64</ix:nonFraction></span>% and expected
life of <span id="xdx_90A_ecustom--FairValueAssumptions1ExpectedTerm_dxL_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4R2AJ4lczqa" title="Expected life::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1444">two</span></span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
                                         Options</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 5, 2020, the Company&#8217;s shareholders voted to approve an amendment and restatement of its long-term incentive plan
(the &#8220;2017 Amended Long-Term Incentive Plan&#8221;) and the granting of incentive securities thereunder until November 5,
2023. Under the 2017 Amended Long-Term Incentive Plan, the Board may, in its discretion from time to time, grant Options and share
units (in the form of restricted share units and performance</span></p>

<ix:exclude><p id="xdx_238_zM7xtlSCdCJj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_z5Zwex6aofh4" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_2374_z5sNzh0FHNP9" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_2364_zrENfcOUnHG2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_2354_z2Qde7f0NYl4" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: center; margin-left: 0.25in"><ix:exclude><div id="xdx_2384_zTBhneEZUqe2" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_23F4_zOv0z8lkCLvk" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">share units) to directors, employees and certain other service providers
(as defined in the 2017 Amended Long-Term Incentive Plan) of the Company and affiliated entities selected by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--DescriptionOfAmendedPlan_c20201103__20201105__us-gaap--PlanNameAxis__custom--LongTermIncentivePlanMember_zKJ2qmgtamN4" title="Description of amended plan"><ix:nonNumeric contextRef="From2020-11-032020-11-05_custom_LongTermIncentivePlanMember" name="niobf:DescriptionOfAmendedPlan">Subject
to adjustment as described in the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares that may be reserved
for issuance to participants under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation
arrangements of the Company, may not exceed 10% of the issued and outstanding Common Shares from time to time, and the Common
Shares reserved for issuance upon settlement of share units will not exceed 5% of the issued and outstanding Common Shares from
time to time. The 2017 Amended Long-Term Incentive Plan limits the maximum number of Common Shares issued to insiders (as defined
under TSX rules for this purpose) within any one-year period, or issuable to insiders at any time, in the aggregate, under all
security-based compensation arrangements (including the 2017 Amended Long-Term Incentive Plan) to 10% of the then issued and outstanding
Common Shares.</ix:nonNumeric></span> The 2017 Amended Long-Term Incentive Plan also limits the aggregate number of Common Shares that may be reserved
for issuance to any one participant under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation
arrangements of the Company, to 5% of the then issued and outstanding Common Shares (on a non-diluted basis). Subject to the adjustment
provisions of the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares actually issued or transferred
by the Company upon the exercise of Incentive Stock Options will be limited as described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has power over the granting, amendment, administration, or settlement of any award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
option transactions are summarized as follows:</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_zuYtzLMZcVe4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zuYxOKxQMS2j" style="display: none; visibility: hidden">Schedule of stock option</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 73%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Number of <br />
Options</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted <br />
Average <br />
Exercise Price</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 43%; text-align: left; padding-bottom: 1pt">Balance, June 30, 2020</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20200701__20210630_zoDNIIPF27X8" title="Beginning balance" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,912,940</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20200701__20210630_z8dPs5wevkPg" title="Beginning balance" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">6.20</ix:nonFraction> </span></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20200701__20210630_zBzfKgnKuWFa" title="Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">370,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pin3_uCADPShares_c20200701__20210630_zbd08KsT4Dle" title="Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="3" unitRef="CADPShares">7.80</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20200701__20210630_z7wDjX2c9s5j" title="Exercised" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">295,229</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20200701__20210630_zShLAySiqYpk" title="Exercised" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">6.10</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Cancelled/expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20200701__20210630_zVQFmD1UmRw8" title="Cancelled/expired" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">391,212</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20200701__20210630_zY3mzHNSSY3d" title="Cancelled/expired" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">6.40</ix:nonFraction></span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Balance, June 30, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20210701__20220630_zSVKpuzuxfKf" title="Beginning balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,596,499</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20210701__20220630_zItt5cYCitLb" title="Beginning balance" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">6.50</ix:nonFraction></span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210701__20220630_zlq7iko0rNUf" title="Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">447,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20210701__20220630_zURPolnUeojd" title="Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">13.30</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_dxL_uShares_c20210701__20220630_z6xea4C8aqP1" title="Exercised::XDX::215" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1481">(205,153</span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20210701__20220630_zqEJ6WxIdsV" title="Exercised" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">7.00</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Cancelled/expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20210701__20220630_zCaoCdBkQ8Nd" title="Cancelled/expired" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">392,446</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20210701__20220630_zTggmS5N6x29" title="Cancelled/expired" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">7.70</ix:nonFraction></span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Balance, June 30, 2022</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20220701__20230630_zt5wK3mv7Aua" title="Beginning balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,446,400</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20220701__20230630_zK9qtYxshZY" title="Beginning balance" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">8.27</ix:nonFraction></span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220701__20230630_znssPo1te4Ee" title="Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">578,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20220701__20230630_zA72NcOQnmWb" title="Granted" style="text-align: right">$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">6.95</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20220701__20230630_z7R5ve8EMaKf" title="Exercised" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">265,129</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20220701__20230630_zznx1UbVMPr7" title="Exercised" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">4.99</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Cancelled/expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20220701__20230630_zpOj9LgJaFNc" title="Cancelled/expired" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">217,771</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20220701__20230630_zf8lTvy4GLx8" title="Cancelled/expired" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">5.87</ix:nonFraction></span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Balance, June 30, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20220701__20230630_zAdsu9UnmfEk" title="Ending balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,541,500</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCADPShares_c20220701__20230630_z81HeHhfYk8" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">9.64</ix:nonFraction></span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A9_zBKxcpaf33Xj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_8AD_zh3Jx2GKdfk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_2375_z5sNzh0FHNP9" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_2365_zrENfcOUnHG2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_2355_z2Qde7f0NYl4" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: center; margin-left: 0.25in"><ix:exclude><div id="xdx_2385_zTBhneEZUqe2" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_23F5_zOv0z8lkCLvk" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z1ukJujYLRn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B2_zvAfJsmkQWb2">The
following table summarizes information about stock options outstanding at June 30, 2023:</span></span></p>

<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 88%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price </span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 26%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry
    Date</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    Outstanding</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 17%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
    Intrinsic Value </span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    Exercisable</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
    Intrinsic Value </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$8.40</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member_zSzoaElaZqVh" title="::XDX::2023-09-18" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1515">September
    18, 2023</span></span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member_zlXspE7qfR66" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-06-30_custom_ExercisePrice8.40Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">105,000</ix:nonFraction></span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member__srt--CurrencyAxis__currency--CAD_zu8tWcd3RiJ9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$-</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member_zQdR1dvQI25b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-06-30_custom_ExercisePrice8.40Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">105,000</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member__srt--CurrencyAxis__currency--CAD_zpJje8EYO0Qc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$5.40</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member_zNZxnqGb351g" title="::XDX::2023-11-15" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1520">November
    15, 2023</span></span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member_z2nA32ExLyXi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-06-30_custom_ExercisePrice5.40Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">208,500</ix:nonFraction></span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member__srt--CurrencyAxis__currency--CAD_zPNg5FApY9c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-06-30_custom_ExercisePrice5.40Member_currency_CAD" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">263</ix:nonFraction></span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member_zUbZ7qetdcM2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-06-30_custom_ExercisePrice5.40Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">208,500</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member__srt--CurrencyAxis__currency--CAD_zNGPqrHZ2ZX9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1" contextRef="AsOf2023-06-30_custom_ExercisePrice5.40Member_currency_CAD" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">263</ix:nonFraction></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$7.50</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50Member_z3xaFwerOAdc" title="::XDX::2023-12-14" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1525">December
    14, 2023</span></span></td>
    <td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50Member_zaVLP5jERPwe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-06-30_custom_ExercisePrice7.50Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">170,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50Member_zn0uSlTfBEFc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-06-30_custom_ExercisePrice7.50Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">170,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$7.50</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50OneMember_zaijvg3UpkP4" title="::XDX::2023-12-16" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1528">December
    16, 2023</span></span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50OneMember_z5QTQ8gVF6R8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-06-30_custom_ExercisePrice7.50OneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">52,500</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50OneMember_zEb8fFll6vCl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-06-30_custom_ExercisePrice7.50OneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">52,500</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$13.60</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice13.60Member_z4AlqpmAQrT6" title="::XDX::2024-12-17" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1531">December
    17, 2024</span></span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice13.60Member_z9nRYUnhgX4c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-06-30_custom_ExercisePrice13.60Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">377,500</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice13.60Member_zZKddnpfe31" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-06-30_custom_ExercisePrice13.60Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">377,500</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$11.00</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zQOBXzUIcyf8" title="::XDX::2025-05-30" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1534">May
    30, 2025</span></span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_znlYPnkMYpch" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-06-30_custom_ExercisePrice11.00Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zSLGYclGvX2f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-06-30_custom_ExercisePrice11.00Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$6.95</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice6.95Member_zGr64z16HaD6" title="::XDX::2026-03-27" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1537">March
    27, 2026</span></span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice6.95Member_zEmYIbfAAzqi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-06-30_custom_ExercisePrice6.95Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">578,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice6.95Member_ziVA2rajSV8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-06-30_custom_ExercisePrice6.95Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">578,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance,
    June 30, 2023</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630_zZFeF99EiiBl" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,541,500</ix:nonFraction>
    </span></td>
    <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230630__srt--CurrencyAxis__currency--CAD_zgMrHk1tJPLi" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-06-30_currency_CAD" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">263</ix:nonFraction></span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630_zErM3sr9GVOd" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,541,500</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_iI_c20230630__srt--CurrencyAxis__currency--CAD_zZosNnTHqGbh" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<ix:nonFraction name="niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1" contextRef="AsOf2023-06-30_currency_CAD" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">263</ix:nonFraction></span></td>
    </tr>
</table>

</ix:nonNumeric><p id="xdx_8AC_z5btwwz6fulc" style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
aggregate intrinsic value in the preceding table represents the total intrinsic value, based on the Company&#8217;s closing stock
price of C$<span id="xdx_901_eus-gaap--SharePrice_iI_pid_uCADPShares_c20230630_z6Vo4IpNtF41" title="Stock price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">6.68</ix:nonFraction></span> as of June 30, 2023, which would have been received by the option holders had all option holders exercised their
options as of that date. The total number of in-the-money options vested and exercisable as of June 30, 2023, was 208,500. The
total intrinsic value of options exercised during the year ended June 30, 2023, <span style="background-color: white">was C$<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20220701__20230630__srt--CurrencyAxis__currency--CAD_zKHmvPPxjS1d" title="Total intrinsic value"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2022-07-012023-06-30_currency_CAD" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,592</ix:nonFraction></span>.</span></span></p>

<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023, there were no unrecognized compensation costs related to unvested share-based compensation arrangements granted.</span></p>

<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zljymjyaTY77" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BC_zrd9y2ocsX5l">The following table summarizes
the weighted average information and assumptions used to determine option costs:</span></p>

<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 1pt">&#160;</span></td>
    <td id="xdx_490_20220701__20230630_zEsQTkknmuva" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td id="xdx_495_20210701__20220630_zbJKfZneXys3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td id="xdx_495_20200701__20210630_zhb9SG4AtPP4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Year ended June 30,</span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 44%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 12%"><span style="font-size: 10pt">2023</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 12%"><span style="font-size: 10pt">2022</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 12%"><span style="font-size: 10pt">2021</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Fair value per option granted during the period </span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220701__20230630_zSn1kK8HEXL6" title="Fair value per option granted during the period" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.09</ix:nonFraction></span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210701__20220630__srt--CurrencyAxis__currency--CAD_zuB5lSjcmWe4" title="Fair value per option granted during the period" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">C$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-07-012022-06-30_currency_CAD" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">4.90</ix:nonFraction></span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20200701__20210630__srt--CurrencyAxis__currency--CAD_zJMn0yUteG75" title="Fair value per option granted during the period" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">C$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2020-07-012021-06-30_currency_CAD" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">2.50</ix:nonFraction></span></td></tr>
<tr id="xdx_405_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_z7zj6F5aaLF5" style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Risk-free interest rate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.30</ix:nonFraction>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.33</ix:nonFraction>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.26</ix:nonFraction>%</span></td></tr>
<tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_zC9w4HiSTOG1" style="vertical-align: top; background-color: #CCECFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Expected dividend yield</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="1" unitRef="Pure">0</ix:nonFraction>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="1" unitRef="Pure">0</ix:nonFraction>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="1" unitRef="Pure">0</ix:nonFraction>%</span></td></tr>
<tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_zqnp3EAp2RMh" style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Expected stock price volatility (historical basis)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">63.6</ix:nonFraction>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">54.4</ix:nonFraction>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">54.1</ix:nonFraction>%</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Expected option life in years</span></td>
    <td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20220701__20230630_z6RIHeVPKP37" title="Expected option life in years::XDX::P3Y" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1569">3.0</span></span></td>
    <td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20210701__20220630_zdZtSMEn0hL2" title="Expected option life in years::XDX::P3Y" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1571">3.0</span></span></td>
    <td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20200701__20210630_zCY1AHwJbIx7" title="::XDX::P3Y" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1572">3.0</span></span></td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A3_z33xNuo10xNl" style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td></tr></table>

<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z38uyOHtG071" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Warrant transactions are
summarized as follows. <span id="xdx_8B6_zAwhHqU5j7ff">Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S.
dollars using end of period foreign currency exchange rates.</span></p>





<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.25in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Warrants</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted <br />
Average <br />
Exercise Price</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Balance, June 30, 2020</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20200701__20210630_zmlt6i3i2Wmf" title="Balance at beginning" style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,237,645</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20200701__20210630_zWhwu7MyPxA" title="Balance at beginning average price" style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.43</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Granted:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Nordmin warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--NordminWarrants_pid_uShares_c20200701__20210630_zCfxJeGdXhr5" title="Nordmin warrants" style="text-align: right"><ix:nonFraction name="niobf:NordminWarrants" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing_pid_uUSDPShares_c20200701__20210630_zpvIMzS2d7s8" title="Nordmin warrants average price" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.45</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Lind III warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightLindIIIWarrants_pid_uShares_c20200701__20210630_zwToKCCGMf3d" title="Lind III Warrants" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightLindIIIWarrants" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">855,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--ClassOfWarrantOrRightExercisePriceLindWarrants_pid_uUSDPShares_c20200701__20210630_zNzeVOPZslu2" title="Lind III warrants average price" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceLindWarrants" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.83</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">April 2021 private placement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightAprilPrivatePlacement_pid_uShares_c20200701__20210630_zjkMQp0XGIH9" title="April 2021 private placement" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightAprilPrivatePlacement" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">441,211</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements_pid_uUSDPShares_c20200701__20210630_zXeuNz2ovL7l" title="April 2021 private placement average price" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.15</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20200701__20210630_zUWmrD7vFS0k" title="Exercised" style="text-align: right">(<ix:nonFraction name="niobf:ClassOfWarrantOrRightExercised" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">910,628</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uUSDPShares_c20200701__20210630_zARt8P7pEpJa" title="Exercised average price" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceExercised" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.05</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20200701__20210630_zXHnWhRgrQjg" title="Expired" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:ClassOfWarrantOrRightExpired" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">239,845</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20200701__20210630_z42jWS5mWg4f" title="Expired average price" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceExpired" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.89</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Balance, June 30, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20210701__20220630_zXJ9rCjpQE94" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,434,183</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20210701__20220630_zfFpEFCtE7oa" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.36</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;Granted:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.375in; text-indent: -0.125in">June 2022 private placement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightJunePrivatePlacement_pid_uShares_c20210701__20220630_zyCMat9tfbXj" title="June 2022 private placement" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightJunePrivatePlacement" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">504,614</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExercisePriceJunePrivatePlacements_pid_uUSDPShares_c20210701__20220630_zVZQutgXnkW5" title="June 2022 private placement average price" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceJunePrivatePlacements" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.54</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Exercised</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20210701__20220630_z9hvSoKnQyQ5" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:ClassOfWarrantOrRightExercised" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">87,175</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uUSDPShares_c20210701__20220630_z5LcuYqDdIGi" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceExercised" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.05</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Balance, June 30, 2022</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20220701__20230630_zZKpTTLkkXua" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,851,622</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20220701__20230630_zjLJGNwuBCFd" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.99</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;Granted:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Yorkville financing warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--YorkvilleFinancingWarrants_pid_uShares_c20220701__20230630_zDXmddESXRUg" title="Yorkville financing warrants" style="text-align: right"><ix:nonFraction name="niobf:YorkvilleFinancingWarrants" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,789,267</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_pid_uUSDPShares_c20220701__20230630_zxoCsu4gUqu2" title="Yorkville financing warrants average price" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.94</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">GXII warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--GxiiWarrants_pid_uShares_c20220701__20230630_zLdpwi9aUix9" title="GXII warrants" style="text-align: right"><ix:nonFraction name="niobf:GxiiWarrants" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,666,626</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_pid_uUSDPShares_c20220701__20230630_zxRs6xa5uN98" title="GXII warrant average price" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">&#160;Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20220701__20230630_zFo5oT7WZJMh" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:ClassOfWarrantOrRightExpired" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">491,211</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uUSDPShares_c20220701__20230630_zKw3PqcK7Uzk" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceExercised" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.67</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Balance, June 30, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20220701__20230630_zwFCFIqZvM2c" title="Balance at ending" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,816,304</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_uUSDPShares_c20220701__20230630_zIFz5I21f4ei" title="Balance at ending average price" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.98</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A6_zbOIbbTEeAnf" style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="niobf:ScheduleOfOutstandingExercisableWarrantsTableTextBlock"><p id="xdx_89A_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zXusNeJkV6Rg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zmPEwMpPnA1f">At
June 30, 2023, the Company has outstanding exercisable warrants, as follows:</span></span></p>

<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 46%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</span></p></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Exercise
    Price </span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry
Date</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zXPpM1iVegZk" title="Number" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-06-30_custom_ExercisePrice11.00Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">504,611</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230630__srt--CurrencyAxis__currency--CAD__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zYZWnTJ1Gkuk" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-06-30_currency_CAD_custom_ExercisePrice11.00Member" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">11.00</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dxL_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zggTBd5xkmG3" title="Expiry date::XDX::2024-06-30" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1630">June
    30, 2024</span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zN1neMxZXcK2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-06-30_custom_ExercisePrice9.70Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">855,800</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220630__srt--CurrencyAxis__currency--CAD__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zz2ztmA5sLm" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-06-30_currency_CAD_custom_ExercisePrice9.70Member" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">9.70</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dxL_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_z7Y34r2lZCWg" title="Expiry date::XDX::2025-02-19" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1635">February
    19, 2025</span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zq1a1JCJIGzh" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-06-30_custom_ExercisePrice8.94Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,789,267</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zoFJ3LGfZI05" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-06-30_custom_ExercisePrice8.94Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.94</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F2E_zJUo8a8revY3">(1)</sup></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zEnRhgpRCK7c" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-06-30_custom_ExercisePrice11.50Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,666,626</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zlfpLNP0cOWc" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-06-30_custom_ExercisePrice11.50Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dxL_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zCuHofnBpx1b" title="Expiry date::XDX::2028-03-17" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1643">March
    17, 2028</span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630_z6TEA9T9qiLk" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,816,304</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 46%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: left; text-indent: 0in"><span id="xdx_F01_zgLcDmRtSWDe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 93%; text-align: left; text-indent: 0in"><span id="xdx_F17_zx4Jtucrohjg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001645" xml:lang="en-US">Expires
    in 12 equal monthly tranches beginning October 17, 2023</ix:footnote></span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A8_zvrPyojVuAw3" style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_2376_z5sNzh0FHNP9" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_2366_zrENfcOUnHG2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_2356_z2Qde7f0NYl4" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: center; margin-left: 0.25in"><ix:exclude><div id="xdx_2386_zTBhneEZUqe2" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_23F6_zOv0z8lkCLvk" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
connection with the Closing, pursuant to the Business Combination Agreement, the Company assumed the GXII Warrant Agreement and
each GXII Warrant thereunder that was issued and outstanding immediately prior to the Closing Date was converted into one NioCorp
Assumed Warrant pursuant to the GXII Warrant Agreement, as amended by an Assignment, Assumption and Amendment Agreement, dated
March 17, 2023, among the Company, GXII, Continental Stock Transfer &amp; Trust Company, as the existing warrant agent, and Computershare
Inc. and its affiliate, Computershare Trust Company, N.A, together as the successor warrant agent (the &#8220;NioCorp Assumed
Warrant Agreement&#8221;). In connection with the Closing, NioCorp issued (a) <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--GXIIPublicWarrantsMember_zHzzrLldsW5a" title="Warrants traded prior to the closing"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-07-012023-06-30_custom_GXIIPublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,999,959</ix:nonFraction></span> public NioCorp Assumed Warrants (the &#8220;Public
Warrants&#8221;) in respect of the GXII Warrants that were publicly traded prior to the Closing and (b) <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--GXIIPrivateWarrantsMember_zU4jcPu1lC4a" title="Warrants traded prior to the closing"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-07-012023-06-30_custom_GXIIPrivateWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,666,667</ix:nonFraction></span> NioCorp Assumed
Warrants (the &#8220;Private Warrants&#8221;) to the Sponsor in respect of the GXII Warrants that it held prior to the Closing,
which NioCorp Assumed Warrants were subsequently distributed by the Sponsor to its members in connection with the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zS1zYBMQt0P9" title="Description of warrants"><ix:nonNumeric contextRef="From2022-07-012023-06-30_us-gaap_WarrantMember" name="us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees">Each
NioCorp Assumed Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and the
like).</ix:nonNumeric></span> No fractional shares will be issued upon exercise of any NioCorp Assumed Warrants, and fractional shares that would otherwise
be due to the exercising holder will be rounded down to the nearest whole Common Share. In no event will the Company be required
to net cash settle any NioCorp Assumed Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Public
Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20220701__20230630_zefuvIcsPjI6" title="Description of warrants"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees">The
Company may elect to redeem the Public Warrants subject to certain conditions, in whole and not in part, at a price of $0.01 per
Public Warrant if (i) 30 days&#8217; prior written notice of redemption is provided to the holders, (ii) the last reported sale
price of the Common Shares equals or exceeds approximately $16.10 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third business day prior
to the date on which the Company sends the notice of redemption to the warrant holders</ix:nonNumeric></span> and (iii) there is an effective registration
statement covering the Common Shares issuable upon exercise of the Public Warrants, and a current prospectus relating thereto,
available through the redemption date. Upon issuance of a redemption notice by the Company, the warrant holders will have until
the redemption date to exercise for cash, or, at the Company&#8217;s election, on a cashless basis. The Public Warrants are not
precluded from equity classification and are accounted for as such on the date of issuance, and each balance sheet date thereafter.
Because the Transactions resulted in an excess of liabilities over assets acquired, no value was ascribed to the Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Warrants </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Warrants: (i) will be exercisable either for cash or on a cashless basis at the holder&#8217;s option and (ii) will not
be redeemable by the Company, in either case as long as the Private Warrants are held by the Sponsor, its members or any of their
permitted transferees (as prescribed in the NioCorp Assumed Warrant Agreement). In accordance with the NioCorp Assumed Warrant
Agreement, any Private Warrants that are held by someone other than the Sponsor, its members or any their permitted transferees
are treated as Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts for
the Private Warrants assumed in the Transactions in accordance with the guidance contained in ASC 815-40. Such guidance provides
that because the Private Warrants do not meet the criteria for equity treatment thereunder, each Private Warrant must be recorded
as a liability. This liability is carried as a component of Warrant Liabilities on the consolidated balance sheet and is subject
to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to its current
fair value, with the change in fair value recognized in the consolidated statement of operations and comprehensive loss. The Company
will reassess the classification at each balance sheet date. </p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_895_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zHGbgiqtX694" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zNBGleVoOhLc">The
Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a
Black Scholes model with the following assumptions:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_2377_z5sNzh0FHNP9" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_2367_zrENfcOUnHG2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_2357_z2Qde7f0NYl4" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: center; margin-left: 0.25in"><ix:exclude><div id="xdx_2387_zTBhneEZUqe2" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_23F7_zOv0z8lkCLvk" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 1pt">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 1pt">March 17, 2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 1pt">June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: justify">Stock price on valuation date</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zoreS0yoSzEf" title="Stock price on valuation date" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2023-03-17_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.00</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z2HDEv33HTG8" title="Stock price on valuation date" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.03</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Strike price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqYzw8f2t22j" title="Strike price" style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-03-17_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zBewLQd8cik" title="Strike price" style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Implied volatility of Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQyAOb1pWD92" title="Volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-07-012023-03-17_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">19.5</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLgqLMNBoVT5" title="Volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">33.5</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zbyJAsbavZKc" title="Risk free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2022-07-012023-03-17_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.47</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z3NbSUPDeekd" title="Risk free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.18</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zwJhckLCVLMl" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-07-012023-03-17_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="1" unitRef="Pure">0</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7A4lwx69S5f" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="1" unitRef="Pure">0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expected warrant life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zoLtOKC6MfC1" title="Expected warrant life in years::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1687">5.0</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQ8kMrpiUtg6" title="Expected warrant life in years::XDX::P4Y8M23D"><span style="-sec-ix-hidden: xdx2ixbrl1689">4.73</span></span></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AE_znF0FOTOigc7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock"><p id="xdx_89D_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zcRQoEhiDFeh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B1_zH1F9Lfrq6S1">The
change in the Private Warrants liability is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 43%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    valuation, March 17, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20220701__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zToJ5TFGhdP3" title="Initial valuation, at begining" style="font: 10pt Times New Roman, Times, Serif; width: 10%; padding-right: 2.15pt; padding-bottom: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:ChangesInFairValueOfInitialValuation" contextRef="AsOf2022-06-30_us-gaap_NoteWarrantMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,987</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in valuation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20220701__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zYUOPRaUUbA5" title="Change in valuation" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" contextRef="From2022-07-012023-06-30_us-gaap_NoteWarrantMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">292</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    at June 30, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ChangesInFairValueOfInitialValuation_iE_pn3n3_c20220701__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zoiQANZz1QH7" title="Initial valuation, at ending" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:ChangesInFairValueOfInitialValuation" contextRef="AsOf2023-06-30_us-gaap_NoteWarrantMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,279</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A3_zeZGVOq7pVPe" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville
                                         Equity Facility Financing</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrent
with the closing of the GXII Transaction, the Yorkville Equity Facility Financing became effective. Pursuant to the Yorkville
Equity Facility Financing Agreement, Yorkville committed to purchase up to $65,000 of Common Shares (the &#8220;Commitment Amount&#8221;),
at NioCorp&#8217;s direction from time to time for a period commencing upon the Closing Date and ending on the earliest of (i)
the first day of the month next following the 36-month anniversary of the Closing, (ii) the date on which Yorkville shall have
made payment of the full Commitment Amount and (iii) the date that the Yorkville Equity Facility Financing Agreement otherwise
terminates in accordance with its terms (the &#8220;Commitment Period&#8221;), subject to certain limitations and the satisfaction
of the conditions in the Yorkville Equity Facility Financing Agreement. The Common Shares that may be sold pursuant to the Yorkville
Equity Facility Financing Agreement would be purchased by Yorkville at a purchase price equal to 97% of the daily volume-weighted
average price of the Common Shares on Nasdaq or such other principal U.S. market for the Common Shares if the Common Shares are
ever listed or traded on the New York Stock Exchange or the NYSE American as reported by Bloomberg Financial Markets (or, if not
available, a similar service provider of national recognized standing) during the applicable pricing period, which is a period
during a single trading day or a period of three consecutive trading days, at the Company&#8217;s option and subject to certain
restrictions, in each case, defined based on when an Advance Notice (as defined in the Yorkville Equity Facility Financing Agreement)
is submitted, subject to certain limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Pursuant to the terms of
the Yorkville Equity Facility Financing Agreement, NioCorp issued 81,213 of Common Shares (the &#8220;Commitment Shares&#8221;)
valued at $650 to Yorkville as consideration for its irrevocable commitment to purchase Common Shares under the Yorkville Equity
Facility Financing Agreement. On June 9, 2023, NioCorp issued and sold 100,000 Common Shares to Yorkville under the Yorkville Equity
Facility Financing Agreement. Additionally, NioCorp is required to pay Yorkville an aggregate fee of $1,500 in cash (the &#8220;Cash
Fee&#8221;), including $500 that NioCorp paid on the Closing Date and an additional $250 NioCorp was paid as of June 30, 2023.
NioCorp will pay the remaining $750 balance in installments over a 12-month period following the Closing Date, provided that it
will have the right to prepay without penalty all or part of the remaining installments of the Cash Fee at any time. In addition,
legal and other costs of $496 were incurred in connection with the Yorkville Equity Facility Financing and were expensed on the
effective date. The following amounts related to the Yorkville Equity Facility Financing Agreement were expensed as other operating
costs:</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_zFIiTKoD2yAc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_8B7_z2EFGHvCdVF" style="display: none; visibility: hidden">Schedule of expenses as other operating costs</span></span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 43%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_494_20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zk3FqphoJn58" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td>&#160;</td></tr>
<tr id="xdx_40E_ecustom--YorkvilleCashFee_zrPPFBqDaj78" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: justify">Yorkville Cash Fee</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="niobf:YorkvilleCashFee" contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zOKN2XjBb37b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Fair value of Commitment Shares issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--OtherCostAndExpenseOperating_z1H6IAYXhWZh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt">Legal and other related costs</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherCostAndExpenseOperating" contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">496</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--OperatingCostsAndExpenses_zZoDisy4u9y" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2pt">Net costs expensed to other operating expense</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,646</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AC_z0NmmVtly7Ol" style="margin-top: 0; margin-bottom: 0"></p>


</ix:nonNumeric><p id="xdx_81E_zIaLPIniJp31" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_23E_zCpyjRLglp16" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p>

<p id="xdx_232_zKqKhHI0xxUl" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p>

<p id="xdx_236_zIcSkvyxs7f9" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p>

<!-- Field: Rule-Page --><div style="text-align: center; margin-left: 0.25in"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_znO4NFZyAfph" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_820_z4sCjAWx41te">RELATED
PARTY TRANSACTIONS AND BALANCES</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings
under the non-revolving credit facility agreement (the &#8220;Smith Credit Facility&#8221;) with Mark Smith, Chief Executive Officer,
President, and Executive Chairman of NioCorp, bear interest at a rate of <span id="xdx_907_eus-gaap--RelatedPartyTransactionRate_pid_dp_uPure_c20220701__20230630__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_ziDTluNMFdMc" title="Interest at a rate"><ix:nonFraction name="us-gaap:RelatedPartyTransactionRate" contextRef="From2022-07-012023-06-30_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% and drawdowns from the Smith Credit Facility are
subject to a <span id="xdx_906_ecustom--LineOfCreditFacilityPrepaymentFee_pid_dp_uPure_c20220701__20230630__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zDWvTLSNJrK9" title="Prepayment fee"><ix:nonFraction name="niobf:LineOfCreditFacilityPrepaymentFee" contextRef="From2022-07-012023-06-30_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.5</ix:nonFraction></span>% establishment fee. Amounts outstanding under the Smith Credit Facility are secured by all of the Company&#8217;s
assets pursuant to a general security agreement. The Smith Credit Facility contains financial and non-financial covenants customary
for a facility of its size and nature. The maturity date for the Smith Credit Facility was June 30, 2023. On February 28, 2023,
the Smith Credit facility was amended to increase the borrowing limit to $<span id="xdx_907_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230228__us-gaap--TypeOfArrangementAxis__custom--AmendedNonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__srt--RangeAxis__srt--MaximumMember_zb3jXltSYOMj" title="Credit agreement"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" contextRef="AsOf2023-02-28_custom_AmendedNonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,000</ix:nonFraction></span> from the previous limit of $<span id="xdx_909_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230228__us-gaap--TypeOfArrangementAxis__custom--AmendedNonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__srt--RangeAxis__srt--MinimumMember_zpAZNuddzkwa" title="Credit agreement"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" contextRef="AsOf2023-02-28_custom_AmendedNonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,500</ix:nonFraction></span>. The Company
subsequently drew down $<span id="xdx_905_ecustom--AmountPaidToRelatedParty_iI_pn3n3_c20230630_zBixtKViZtK7" title="Amount drew down"><ix:nonFraction name="niobf:AmountPaidToRelatedParty" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,130</ix:nonFraction></span>, leaving an available balance under the Smith Credit Facility of $<span id="xdx_909_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230630__us-gaap--TypeOfArrangementAxis__custom--AmendedNonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember_zDBlzT6bHeA4"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" contextRef="AsOf2023-06-30_custom_AmendedNonRevolvingCreditFacilityAgreementMember_custom_MarkSmithMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zT6epf8Avk78" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zehBT8sBERS1">Changes
in the Smith Credit Agreement principal balance are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ending June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left; padding-bottom: 1pt">Beginning balance</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--RelatedPartyDepositLiabilities_iS_pn3n3_c20220701__20230630_zwHEezuNsSv6" title="Beginning balance" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RelatedPartyDepositLiabilities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--RelatedPartyDepositLiabilities_iS_pn3n3_c20210701__20220630_zwgnGso85md4" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RelatedPartyDepositLiabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,318</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;Amounts advanced</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--AmountsAdvanced_pn3n3_c20220701__20230630_zkFwglwFdpUb" title="Amounts advanced" style="text-align: right"><ix:nonFraction name="niobf:AmountsAdvanced" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,130</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--AmountsAdvanced_pn3n3_c20210701__20220630_zgQObPdwXnV5" title="Amounts advanced" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1732">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;&#160;&#160;Repayments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_pn3n3_c20220701__20230630_zmWVPyMin6R2" title="Repayments" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,130</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_pn3n3_c20210701__20220630_zTZckqQMdsa8" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">318</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Balance, end of period</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--RelatedPartyDepositLiabilities_iE_pn3n3_c20220701__20230630_zMTIL0qtVBd8" title="Balance, end of period" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1737">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--RelatedPartyDepositLiabilities_iE_pn3n3_c20210701__20220630_zTxLrf98i62b" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:RelatedPartyDepositLiabilities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A0_zogHd5mEoNP" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 22, 2023, the Company repaid Mr. Smith $<span id="xdx_901_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230322__us-gaap--TypeOfArrangementAxis__custom--NonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zEwmA6eEKUV9" title="Credit agreement"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" contextRef="AsOf2023-03-22_custom_NonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,841</ix:nonFraction></span> of principal borrowed under the Smith Credit Facility. This repayment was
made out of funds transferred to the Company from the GXII trust account on the Closing Date. The Company repaid the remaining
principal balance of $<span id="xdx_907_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember_zR1v5dsaih68" title="Principal amount outstanding"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" contextRef="AsOf2023-05-31_custom_MarkSmithMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,289</ix:nonFraction></span> on May 31, 2023. The Smith Credit Facility expired on June 30, 2023. Accounts payable and accrued
liabilities as of June 30, 2023 includes $<span id="xdx_901_ecustom--EstablishmentFeesPayable_pn3n3_c20220701__20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember_zX16dvpl82n3" title="Establishment fees payable"><ix:nonFraction name="niobf:EstablishmentFeesPayable" contextRef="From2022-07-012023-06-30_custom_MarkSmithMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span> of origination fees payable under the Smith Credit Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2023 and 2022, the Company paid a total of $<span id="xdx_903_eus-gaap--AccruedLiabilitiesCurrent_iI_pn3n3_dxL_c20230630_ziy9tdU7kGEe" title="Interest paid::XDX::252"><span style="-sec-ix-hidden: xdx2ixbrl1746">183</span></span> and $<span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrent_iI_pn3n3_dxL_c20220630_zEc57w8rquI4" title="::XDX::873"><span style="-sec-ix-hidden: xdx2ixbrl1747">252</span></span>, respectively, representing accrued interest on the Smith
Credit Agreement.</span></p>

</ix:nonNumeric><p id="xdx_81A_zMCUUuQ5kA6i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="niobf:ExplorationExpendituresDisclosuresTextBlock"><p id="xdx_80F_ecustom--ExplorationExpendituresDisclosuresTextBlock_z0dtcmhuBK35" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82D_zurDBRESw9od">EXPLORATION
EXPENDITURES</span></span></td>
</tr></table>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="niobf:ScheduleOfExplorationExpendituresTableTextBlock"><p id="xdx_89F_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zk8FIjT2avH6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zMuxKAi1HCqk" style="display: none; visibility: hidden">Schedule of exploration expenditures</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 70%; margin-left: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2021</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">&#160;Feasibility study and engineering</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zDoRPYqfL0B1" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2022-07-012023-06-30_custom_FeasibilityStudyAndEngineeringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">410</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zqyJlR7KPte4" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2021-07-012022-06-30_custom_FeasibilityStudyAndEngineeringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">334</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zdqIXbvJOf97" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2020-07-012021-06-30_custom_FeasibilityStudyAndEngineeringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;Field management and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zEIjtm0HBAl6" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2022-07-012023-06-30_custom_FieldManagementAndOtherMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">738</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zcDBIKdTU0Ya" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2021-07-012022-06-30_custom_FieldManagementAndOtherMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">569</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zHKeiv5fbv63" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2020-07-012021-06-30_custom_FieldManagementAndOtherMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">656</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;Metallurgical</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__us-gaap--ExplorationAndProductionEquipmentMember_zWMnyMl6Ic2a" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2022-07-012023-06-30_us-gaap_ExplorationAndProductionEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,174</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__us-gaap--ExplorationAndProductionEquipmentMember_z3bptrItMw1b" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2021-07-012022-06-30_us-gaap_ExplorationAndProductionEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,218</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__us-gaap--ExplorationAndProductionEquipmentMember_zwRodmIVAea8" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2020-07-012021-06-30_us-gaap_ExplorationAndProductionEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">272</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;Geologists and field staff</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_zNS0ghMo89Z9" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2022-07-012023-06-30_custom_GeologistsAndFieldStaffMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_zhXYrp3vCw19" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2021-07-012022-06-30_custom_GeologistsAndFieldStaffMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">188</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_zSzKsYwIUAv7" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2020-07-012021-06-30_custom_GeologistsAndFieldStaffMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">&#160;Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630_zP6zjfAPTIgj" title="Exploration expenditures" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,348</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630_zIYOyfyh2Sll" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,309</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630_zND4vnhjVgr6" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,056</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A5_zJl2P4EnLSs9" style="margin-top: 0; margin-bottom: 0"></p>

</ix:nonNumeric><p id="xdx_81B_zzbevRCEF5Tl" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_800_eus-gaap--LesseeOperatingLeasesTextBlock_z4Rp60Gt1JCf" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_822_zsmQYBEN6zid">LEASES</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
February 2023, the Company entered into a <span id="xdx_90F_eus-gaap--LesseeOperatingLeaseOptionToExtend_c20220701__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CorporateOfficeMember_ze67bz4beCNk" title="Other lease description"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_CorporateOfficeMember" name="us-gaap:LesseeOperatingLeaseOptionToExtend">39-month corporate office lease extension and recognized the corresponding ROU asset
and lease liability of $198 associated with this extension, based on a discount rate of <span id="xdx_903_ecustom--DiscountRate_dp_uPure_c20220701__20230630_zsJftga1Ki32" title="Discount rate"><ix:nonFraction name="niobf:DiscountRate" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">16</ix:nonFraction></span>%.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023 and 2022, the Company had one corporate office lease with a remaining lease term of <span id="xdx_909_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dxL_c20230630_zx9UWl74E3be" title="Remaining lease term::XDX::P3Y7M6D"><span style="-sec-ix-hidden: xdx2ixbrl1775">3.6</span></span>
years and <span id="xdx_90E_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dxL_c20220630_zbsNE9HLobVl" title="Remaining lease term::XDX::P1Y3M19D"><span style="-sec-ix-hidden: xdx2ixbrl1777">1.3</span></span> years, respectively. During the year ended June 30, 2023 and 2022, operating cash flows included cash payments of $<span id="xdx_905_eus-gaap--OperatingLeasePayments_c20220701__20230630_z1nSlUQphkg3" title="Cash payment"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93</ix:nonFraction></span>
and $<span id="xdx_905_eus-gaap--OperatingLeasePayments_c20210701__20220630_zipel64MjrVe"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90</ix:nonFraction></span>, respectively related to
the measurement of lease liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_2378_z5sNzh0FHNP9" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_2368_zrENfcOUnHG2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_2358_z2Qde7f0NYl4" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: center; margin-left: 0.25in"><ix:exclude><div id="xdx_2388_zTBhneEZUqe2" style="border-top: Black 1pt solid; text-align: justify; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_23F8_zOv0z8lkCLvk" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<ix:exclude><p id="xdx_234_zVqhTPom9Se8" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:LeaseCostTableTextBlock"><p id="xdx_89D_eus-gaap--LeaseCostTableTextBlock_zSnfQKhwiuh3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zlbAlFFdpoHa">The
Company incurred lease costs as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_499_20220701__20230630_zpmYZ7m6lL3d" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_497_20210701__20220630_zXQcSgepqCo8" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_497_20200701__20210630_zNzI0azPhXl5" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2021</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCostAbstract_iB_zoXpqvRuRPah" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -5.25pt; padding-left: 5.4pt">&#160;Operating Lease Cost:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--FixedRentExpense_z8AcCqN0iHUd" style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; text-align: left; text-indent: 3.75pt; padding-left: 5.4pt">Fixed rent expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="niobf:FixedRentExpense" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">83</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="niobf:FixedRentExpense" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">83</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="niobf:FixedRentExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">106</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--VariableLeaseCost_zr0X1jDo3W73" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 3.75pt; padding-left: 5.4pt">Variable rent expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ShortTermLeaseCost_i_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 3.75pt; padding-left: 5.4pt">Short term lease cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--SubleaseIncome_iN_pn3n3_di_z76UFRZu2Tfa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 3.75pt; padding-left: 5.4pt">Sublease income</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_zcX5cRZwenp8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 5.4pt">Net lease cost</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">73</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">85</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">108</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherCostAndExpenseOperating_i_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 8.25pt; padding-left: 5.4pt">Lease cost &#8211; other operating expense</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherCostAndExpenseOperating" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">73</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherCostAndExpenseOperating" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">85</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherCostAndExpenseOperating" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">89</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ExplorationCosts_i_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 8.25pt; padding-left: 5.4pt">Lease cost &#8211; exploration expenditures</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1818">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1819">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationCosts" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--LeaseCost_iC_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 5.4pt">Net lease cost</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">73</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">85</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">108</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_zKjX3tLg7oj5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><p id="xdx_897_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zD7mmsHKNvfi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zDvJ5ophd4el">The
maturity of lease liabilities is as follows at June 30, 2023:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49C_20230630_z1QWTu6T7T0i" style="text-align: center">&#160;Fiscal Year Lease Maturities</td></tr>
<tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzI5d_zHPDhM5QUv7c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 51%; text-align: left">&#160;&#160;2024</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;$</td>
    <td style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">71</ix:nonFraction></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzI5d_z05KgwjqCgpi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">96</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPzI5d_zvTGZCZz7QY6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;2026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">98</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_maLOLLPzI5d_zqdtbyxaHpE4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;2027</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_mtLOLLPzI5d_zTaKPeQ4hDr2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total lease payments</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">315</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_405_ecustom--LessAmountOfPaymentsRepresentingInterest_iI_pn3n3_zKE9Pp6QS1a2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;Less amount of payments representing interest</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:LessAmountOfPaymentsRepresentingInterest" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">80</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zTgELzjBCtJ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of lease payments</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">235</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_z9MZvrJmbNh1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;Less current portion of operating lease liability</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">71</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zV9dtOQgqg4g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncurrent operating lease liability</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid">$</td>
    <td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">164</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A5_zMOsgEKBhOac" style="margin-top: 0; margin-bottom: 0"></p>

</ix:nonNumeric><p id="xdx_815_zV2VBiI2loze" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_804_eus-gaap--IncomeTaxDisclosureTextBlock_z3QeLREfozB3" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82F_zgFxuyYK0jRi">INCOME
TAXES</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zOwh96xunHZb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zHcHAOhE69tg">Domestic
and foreign components of loss before income taxes for the years ended June 30, 2023, 2022, and 2021 are as follows:</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49A_20220701__20230630_zeb8spq4upv9" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49D_20210701__20220630_zlF7w9Xq9dtk" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_493_20200701__20210630_zDa3CpObDsc7" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2021</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_hus-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zK3uUy9GUwBe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2022-07-012023-06-30_us-gaap_ForeignCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,606</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2021-07-012022-06-30_us-gaap_ForeignCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,918</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-07-012021-06-30_us-gaap_ForeignCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,362</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_hus-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zSnBYF2RA4s3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">United States</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2022-07-012023-06-30_us-gaap_DomesticCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,006</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2021-07-012022-06-30_us-gaap_DomesticCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,969</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-07-012021-06-30_us-gaap_DomesticCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,462</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_zZFNWLHDmeR5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,612</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,887</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,824</ix:nonFraction></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A1_zQzFBiFqZf95" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_2379_z5sNzh0FHNP9" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_2369_zrENfcOUnHG2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_2359_z2Qde7f0NYl4" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: center; margin-left: 0.25in"><ix:exclude><div id="xdx_2389_zTBhneEZUqe2" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_23F9_zOv0z8lkCLvk" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zrbXX9DRFvb9" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zs5HExDBoQV5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_znKJH15Ehw48">The
following table is a reconciliation of income taxes at statutory rates:</span> </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49A_20220701__20230630_znnsNMkmeHA5" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49D_20210701__20220630_zweCFb7u7cH3" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_493_20200701__20210630_zUDfhAo0sfv2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="10" style="text-align: center">For the year ended June 30,</td><td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2021</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_z2WhkTx04cnj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">Loss before income taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,612</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,887</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,824</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zd2HImnVCDA2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Combined federal and provincial statutory income tax rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">27</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">27</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">27</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_zUfrl6WI2bZg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income tax benefit at statutory tax rates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,965</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,940</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,303</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_zG5EZlLuMTAe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Foreign rate differential</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">131</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">72</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">31</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_ecustom--EarnoutSharesLiability_zatK8X6UCRIg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:EarnoutSharesLiability" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,841</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1887">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1888">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--WarrantLiability_ztPKc0T2sA0f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:WarrantLiability" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,518</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1891">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1892">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--GxiiTransactionCosts_zLsZii2oldF8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">GXII transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:GxiiTransactionCosts" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">925</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1895">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1896">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_zKz7PS0iLfNa" style="vertical-align: bottom; background-color: White">
    <td>Share based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">412</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">462</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">212</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_406_eus-gaap--AssetRetirementObligationAccretionExpense_iN_di_zd55MIrI4rN9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AssetRetirementObligationAccretionExpense" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">496</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AssetRetirementObligationAccretionExpense" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">407</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AssetRetirementObligationAccretionExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">158</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--ExtinguishmentOfDebtGainLossIncomeTax_zyvmbEVRRo21" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loss on debt extinguishment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ExtinguishmentOfDebtGainLossIncomeTax" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">54</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1907">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1908">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--EffectOfLegislativeChanges_znHjEoUvZnG1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Capital loss rate differential</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:EffectOfLegislativeChanges" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:EffectOfLegislativeChanges" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">38</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:EffectOfLegislativeChanges" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">182</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_zt23miC8g4Lh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in estimates related to prior years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">274</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">739</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--IncomeTaxReconciliationOtherAdjustments_z9Za1ZpLOYbf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zjGXRlblmnE2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Change in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,341</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,713</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,841</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">Income tax benefit</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20220701__20230630_zr0eMwVRmSl3" title="Income tax benefit::XDX::-304" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1926">304</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20210701__20220630_zYeRGCCQ4tX1" title="Income tax benefit" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1928">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20200701__20210630_zLlWW1B9LwUi" title="Income tax benefit" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1930">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A8_zLgiJwpKP3K5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z9Wm3gH6oO5e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zoPVsgiFNfqf">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_497_20230630_zDhU4uDzfFX" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="3" id="xdx_490_20220630_zFERGbCETe1" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: -0.125in">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0in">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTAGzakr_zFOs3CUB4mza" style="vertical-align: bottom; background-color: White">
    <td style="width: 50%; text-align: left; text-indent: 12.45pt; padding-left: 0in">Net operating losses available for future periods</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,893</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,977</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--DeferredTaxAssetsMineralInterest_iI_pn3n3_maDTAGzakr_zO5arYDMSVR8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 12.45pt; padding-left: 0in">Mineral interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsMineralInterest" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,477</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsMineralInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,477</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--DeferredTaxAssetsStartupAndOorganizationalCosts_iI_pn3n3_maDTAGzakr_znoYOjcmoRZ8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 12.45pt; padding-left: 0in">Startup and organizational costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsStartupAndOorganizationalCosts" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,132</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1941">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--DeferredTaxAssetsResearchAndDevelopmentCosts_iI_pn3n3_maDTAGzakr_zKk5UOLNyXN1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 12.45pt; padding-left: 0in">Research and development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsResearchAndDevelopmentCosts" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,060</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1944">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--DeferredTaxAssetsShareIssuanceCosts_iI_pn3n3_maDTAGzakr_zQd4scgkZIE3" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 12.45pt; padding-left: 0in">Share issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsShareIssuanceCosts" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">446</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1947">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--CapitalLossesAvailableForFuturePeriods_iI_pn3n3_maDTAGzakr_zejWCLKH9Gll" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 12.45pt; padding-left: 0in">Capital losses available for future periods</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:CapitalLossesAvailableForFuturePeriods" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">419</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:CapitalLossesAvailableForFuturePeriods" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">420</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOther_iI_maDTAGzakr_zuwwfEPG5gte" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-indent: 12.45pt; padding-left: 0in">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">74</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iI_mtDTAGzakr_maDTALNz97R_zkKzt0D9EmG5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0in">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,463</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,948</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNz97R_zkL602cJP7R1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 12.45pt; padding-left: 0in">&#160;Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,463</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,948</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNz97R_zFkk3S5gNFpk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0in">Net deferred tax assets</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1961">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1962">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AE_zk1CTyf92846" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended June 30, 2022, we identified errors in the recognition of capital losses related to realized mineral property
write downs and foreign exchange gains and losses in Canada which resulted in changes to capital losses available for future periods
and other of $<span id="xdx_90F_ecustom--IncreasesInCapitalLossesAvailableForFuturePeriods_iI_pn3n3_c20220630_zBi6QNFrDvHk">(<ix:nonFraction name="niobf:IncreasesInCapitalLossesAvailableForFuturePeriods" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">221</ix:nonFraction>)</span> and $<span id="xdx_907_ecustom--OtherIncomeTaxes_pn3n3_c20210701__20220630_zT8rSA3tlFii">(<ix:nonFraction name="niobf:OtherIncomeTaxes" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3</ix:nonFraction>)</span>, respectively. These changes primarily related to adjustments to deferred tax assets recorded during
fiscal year 2021. In addition, during the year ended June 30, 2022, we identified an error in the recognition of net operating
losses related to disallowed interest expense for the prior year which resulted in a decrease to net operating loss carryforwards
of $<span id="xdx_90C_ecustom--CapitalLossCaryforward_iI_pn3n3_c20230630_zPeZDpsZv3Y" title="Operating loss carryforwards"><ix:nonFraction name="niobf:CapitalLossCaryforward" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19</ix:nonFraction></span>. After evaluation and consideration of the full valuation allowance historically applied against total deferred tax assets,
we determined that the impact of the adjustments was not material to the previously issued consolidated financial statements, nor are the out
of period adjustments material to the estimated results for the year ended June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:SummaryOfValuationAllowanceTextBlock"><p id="xdx_89C_eus-gaap--SummaryOfValuationAllowanceTextBlock_zx6ddasQHuG" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zhsSx74uZKO7">Changes
in the valuation allowance are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 50%; text-align: left; text-indent: -5.25pt; padding-left: 5.4pt">Valuation allowance, beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20220701__20230630_z0HmcrsxEO" title="Valuation allowance, beginning of year" style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,948</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20210701__20220630_zWITIePj2yUl" title="Valuation allowance, beginning of year" style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,235</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 4.85pt; padding-left: 5.4pt">Current year additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20220701__20230630_zwPbJS7FO6v9" title="Current year additions" style="text-align: right">(<ix:nonFraction name="niobf:DeferredTaxAssetsValuationAllowanceAdditions" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,341</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20210701__20220630_zar3lEOTceFi" style="text-align: right">(<ix:nonFraction name="niobf:DeferredTaxAssetsValuationAllowanceAdditions" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,713</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 4.85pt; padding-left: 5.4pt">Startup and organizational costs acquired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20220701__20230630_zWrtvp8nFv11" title="Startup and organizational costs acquired" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CostsIncurredDevelopmentCosts" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,174</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20210701__20220630_zwL3jCeNsFHh" title="Startup and organizational costs acquired" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1979">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; text-indent: -5.25pt; padding-left: 5.4pt">Valuation allowance, end of year</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20220701__20230630_zLHAnSv3xxO1" title="Valuation allowance, end of year" style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,463</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20210701__20220630_zMU53NOnfclh" title="Valuation allowance, end of year" style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,948</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">)</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A7_zbh27Din1iOh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><p id="xdx_237A_z5sNzh0FHNP9" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_236A_zrENfcOUnHG2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_235A_z2Qde7f0NYl4" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: center; margin-left: 0.25in"><ix:exclude><div id="xdx_238A_zTBhneEZUqe2" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_23FA_zOv0z8lkCLvk" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acquired a federal income tax payable of $<span id="xdx_907_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_pn3n3_c20220701__20230630_z3PblABOZUtd" title="Federal income tax payable"><ix:nonFraction name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">406</ix:nonFraction></span> in connection with the GXII Transaction. As a result of a post-transaction
loss at ECRC, a partial release of the valuation allowance attributed to the reduction of the acquired federal income tax payable
of $304 has been recorded as an income tax benefit in the consolidated statement of operations and comprehensive loss for the
year ended June 30, 2023. The Company establishes a valuation allowance against future income tax assets if, based on available
information, it is more likely than not that all of the assets will not be realized. The valuation allowance of $<span id="xdx_90D_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pn3n3_c20230630_zwrjHPKNexG6" title="Valuation allowance"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,463</ix:nonFraction></span> at June
30, 2023, relates mainly to net operating loss carryforwards in Canada and mineral interests due to deferred exploration expenditures
in the United States, where the utilization of such attributes is not more likely than not.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock"><p id="xdx_895_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zt7NSQhNdB92" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company has the following cumulative net operating losses for Canadian and U.S. income tax purposes and these carryforwards will
generally expire between 2026 and 2043. As a result of the Tax Cuts and Jobs Act of 2017, U.S. tax losses incurred for tax years
ending on and after June 30, 2019, totaling $<span id="xdx_900_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pn3n3_c20190630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zJv5UtZ5duE5" title="Tax losses incurred"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOtherLossCarryforwards" contextRef="AsOf2019-06-30_us-gaap_DomesticCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,510</ix:nonFraction></span>, have no expiration..&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_8BC_zZs2rzH4nlb7" style="display: none; visibility: hidden">Schedule of cumulative net operating losses</span></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Jurisdiction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zr2FLxoZyhUl" title="Total" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-06-30_us-gaap_ForeignCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,267</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20220630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zhDi5089CG8c" title="Total" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2022-06-30_us-gaap_ForeignCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,551</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zk4iV5YRgr57" title="Total" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-06-30_us-gaap_DomesticCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,491</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20220630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zyv3Wf0uaSG1" title="Total" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2022-06-30_us-gaap_DomesticCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,460</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630_z88s9qWFxcD1" title="Total" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,758</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20220630_z9x1cEazGDhi" title="Total" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,011</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A4_zIP5noOXAsa7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company has a Canadian capital loss carryforward of $<span id="xdx_902_ecustom--CapitalLossCaryforward_iI_c20230630__srt--CurrencyAxis__currency--CAD_z9Q4kEAyjsb4" title="Capital loss carryforward"><ix:nonFraction name="niobf:CapitalLossCaryforward" contextRef="AsOf2023-06-30_currency_CAD" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,375</ix:nonFraction></span> as of June 30, 2023, which has no expiration date and
can be used to offset future capital gains, and U.S. state net operating loss carryforwards of $<span id="xdx_903_ecustom--CapitalLossCaryforward_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z6d9xy17ptD5" title="Net operating loss carryforwards"><ix:nonFraction name="niobf:CapitalLossCaryforward" contextRef="AsOf2023-06-30_us-gaap_DomesticCountryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,943</ix:nonFraction></span> as of June 30, 2023 which
generally expire between 2031 and 2043.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no unrecognized tax benefits as of June 30, 2023 or 2022. The Company recognizes interest accrued related to unrecognized
tax benefits and penalties in its income tax provision. The Company has not recognized any interest or penalties in the fiscal
years presented in these consolidated financial statements. The Company is subject to income tax in the U.S. federal jurisdiction and Canada.
Certain years remain subject to examination but there are currently no ongoing exams in any taxing jurisdictions.</span></p>

</ix:nonNumeric><p id="xdx_818_ztNWVt18biNd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock"><p id="xdx_80B_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_z2JfJREIbHPb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">16.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span><span id="xdx_823_z0Jtaq5xxBC7">FAIR VALUE MEASUREMENTS</span></span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">The Company measures the fair value of
financial assets and liabilities based on U.S. GAAP guidance which defines fair value, establishes a framework for measuring fair
value, and expands disclosures about fair value measurements.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies financial assets and liabilities as held-for-trading, available-for-sale, held-to-maturity, loans and receivables,
or other financial liabilities depending on their nature. Financial assets and financial liabilities are recognized at fair value
on their initial recognition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets and liabilities classified as held-for-trading are measured at fair value, with gains and losses recognized in net income.
Financial assets classified as held-to-maturity, loans and receivables, and financial liabilities other than those classified
as held-for-trading are measured at amortized cost, using the effective interest method of amortization. Financial assets classified
as available-for-sale, including investments in equity securities, are measured at fair value, with unrealized gains and losses
being recognized in income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Financial
instruments including receivables, accounts payable and accrued liabilities, and related party loans are carried at amortized
cost, which management believes approximates fair value due to the short-term nature of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables present information about the assets and liabilities that are measured at fair value on a recurring basis as
of June 30, 2023, and June 30, 2022, respectively, and indicate the fair value hierarchy of the valuation techniques the Company
utilized to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted)
in active markets for identical instruments. Fair values determined by Level 2 inputs utilize data points that are observable,
such as quoted prices, interest rates, and yield curves. Fair values determined by Level 3 inputs are unobservable data points
for the financial instrument and include situations where there is little, if any, market activity for the instrument.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_23F_zT97GARZNUai" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zyyEmkqpKiA1" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>Notes to Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_230_z01aFsuEN048" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b>June 30, 2023</b></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_239_zSP4gASoik4g" style="text-align: center; margin-left: 0.25in"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>

<ix:exclude><p id="xdx_234_zvn0S59sZ5O9" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">(expressed in thousands of U.S. dollars,
except share and per share data)</p></ix:exclude>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock"><p id="xdx_89B_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zNMgNLuWaxM2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><span id="xdx_8B5_z5Btv5rSI5I8" style="display: none; visibility: hidden">Schedule of fair values determined by level 3 inputs are unobservable data</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Note</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 35%; text-align: left; padding-left: 9pt">Cash and cash equivalents</td>
    <td style="width: 9%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630_zBqcN60P3wt7" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,341</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIn4vwrQPf7a" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,341</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7zEhm2YuoQf" style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2024">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zq5aVQK3ovAl" style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2025">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Investment in equity securities</td>
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630_zg5N2PlFUBF4" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zVvWu8ZiBRgi" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhZOTDvsRkxj" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2028">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zXBuHYeUa2Dh" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2029">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td>
    <td>&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20230630_zVAB7hMrEACg" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,350</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zLJ84rQf7Hs2" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,350</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLoa3f7lt5Q6" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2032">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoBfXWj8Caob" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2033">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">Earnout Shares liability</td>
    <td style="text-align: center">10</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630_z0f8wg0zICOe" style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,521</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zU38dtIrpt08" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2035">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4rJ8zi6lceg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2036">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zsYXpvENPoBf" style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,521</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Warrant liabilities</td>
    <td style="text-align: center">9,11c</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630_zBPOAOFwAfj2" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,989</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zomNPdBwqyv8" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2039">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWdcp9yPbOc5" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,279</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmct4EnBaspj" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,710</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt"><p style="margin: 0pt 0">Total</p>


</td>
    <td>&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630_zeRiRuss6wwh" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,510</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z9vJ2MMgp1Cf" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2043">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zpYZRNJVy3m3" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,279</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGxP1J8Qcjoe" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,231</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2022</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 35%; text-align: left; padding-left: 9pt">Cash and cash equivalents</td>
    <td style="width: 9%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20220630_zQii4MSlRlr6" title="Cash and cash equivalents" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,280</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zPVQ35cH5Oxg" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel1Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,280</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhRmHXlSeHA9" style="width: 11%; text-align: right">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2049">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_ztumoy6ys8O2" style="width: 11%; text-align: right">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2050">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Investment in equity securities</td>
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20220630_zKuZXLiBEKi3" title="Cash and cash equivalents" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2O9RdnHokzk" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel1Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zsoypEJ1ICUk" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2054">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoMqkyssNAE9" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2055">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td>
    <td>&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20220630_zcVjOknAjGi9" title="Cash and cash equivalents" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,290</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z30en8wKjpu4" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel1Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,290</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9RUg6IZk7dl" style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2059">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3IbVi7tAKG9" style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2060">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A7_zaS7BfaXvR81" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
<span style="color: #353535">Yorkville Convertible Debt Financing </span>discussed in Note 9 was initially recorded at fair value,
which represented a nonrecurring fair value measurement using a Level 3 input. At June 30, 2023, the estimated fair value of this
instrument approximated carrying value given that the instrument was issued in March 2023 and has a short time period until maturity.&#160;</span></p>

</ix:nonNumeric><p id="xdx_819_z2gLNdxeqvF6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80D_eus-gaap--SubsequentEventsTextBlock_zlsSx7wiCx95" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">17.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="xdx_82F_zpc8DItdVG3e">SUBSEQUENT
EVENTS</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--SubsequentEventDescription_c20230830__20230901__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zNuRxFnAe5v6" title="Subsequent event description"><ix:nonNumeric contextRef="From2023-08-302023-09-01_us-gaap_SubsequentEventMember" name="us-gaap:SubsequentEventDescription">On
September 1, 2023, the Company closed a non-brokered private placement (the &#8220;September 2023 Private Placement&#8221;) of
units of the Company (the &#8220;September 2023 Units&#8221;). A total of 250,000 September 2023 Units were issued at a price per September 2023 Unit of $4.00,
for total gross proceeds to the Company of $1.0 million. Each September 2023 Unit consists of one Common Share and one Common
Share purchase warrant (&#8220;September 2023 Warrant&#8221;). Each September 2023 Warrant entitles the holder to acquire one
Common Share at a price of $4.60 at any time prior to September 1, 2025. Proceeds of the September 2023 Private Placement will
be used for continued advancement of the Company&#8217;s Elk Creek Critical Minerals Project and for working capital and general
corporate purposes.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 12 and September 18, 2023, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20230910__20230912__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zqfBzBeSACc9" title="Shares issued and sold"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-09-102023-09-12_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">70,000</ix:nonFraction></span> and <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20230916__20230918__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUQn6IjkDIke" title="Shares issued and sold"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-09-162023-09-18_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">75,000</ix:nonFraction></span> Common Shares, respectively, under the Yorkville Equity
Facility Financing Agreement in exchange for $<span id="xdx_90F_eus-gaap--DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds_pn5n6_c20230916__20230918__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--FinancingAgreementMember_zqNUyvCQqqJf" title="Gross cash proceeds"><ix:nonFraction name="us-gaap:DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds" contextRef="From2023-09-162023-09-18_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_SubsequentEventMember_custom_FinancingAgreementMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.5</ix:nonFraction></span> million in gross cash proceeds.</span></p>

</ix:nonNumeric><p id="xdx_812_zPGghxM66mb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM&#160;9.</span></td><td style="padding-right: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a052"></span>CHANGES
                                         IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a053"></span>ITEM&#160;9A.</span></td><td style="padding-right: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTROLS
                                         AND PROCEDURES</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Evaluation
of Disclosure Controls and Procedures</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
management of NioCorp Developments Ltd. has evaluated, under the supervision and with the participation of our Chief Executive
Officer (&#8220;CEO&#8221;) and Chief Financial Officer (&#8220;CFO&#8221;), the effectiveness of our disclosure controls and
procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of June 30, 2023. Based on that evaluation,
the CEO and the CFO have concluded that, as of June 30, 2023, our disclosure controls and procedures were not effective due to
the material weaknesses in internal control over financial reporting described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s disclosure controls and procedures have been designed to ensure that: (i) information required to be disclosed
by us in reports that we file or submit to the SEC under the Exchange Act is recorded, processed, summarized, and reported within
the time periods specified in applicable rules and forms and (ii) material information required to be disclosed in our reports
filed under the Exchange Act is accumulated and communicated to management, including the CEO and the CFO, as appropriate, to
allow for accurate and timely decisions regarding required disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not expect that our disclosure controls and procedures will prevent all error and all fraud. The effectiveness of our or
any system of disclosure controls and procedures, however well designed and operated, can provide only reasonable assurance that
the objectives of the system will be met and is subject to certain limitations, including the exercise of judgment in designing,
implementing, and evaluating controls and procedures and the assumptions used in identifying the likelihood of future events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Management&#8217;s
Report on Internal Control over Financial Reporting</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
management of NioCorp Developments Ltd. is responsible for establishing and maintaining adequate internal control over financial
reporting for the Company. Our management assessed the effectiveness of our internal control over financial reporting as of June
30, 2023. In making this assessment, our management used the criteria set forth in the Internal Control -Integrated Framework
(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (the &#8220;COSO Framework&#8221;). Based
on that evaluation, the CEO and the CFO have concluded that, as of the end of the period covered by this Annual Report, our internal
control over financial reporting was not effective due to the material weaknesses in internal control over financial reporting
described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Material
Weaknesses in Internal Control over Financing Reporting Existing as of June 30, 2023</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there
is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be
prevented or detected on a timely basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
concluded that the previously disclosed material weakness relating to the Company&#8217;s controls over the accounting for non-routine
transactions continued to exist as of June 30, 2023. Specifically, such controls were not adequately designed to ensure the consideration
of all related relevant accounting guidance when such transactions were recorded. As disclosed in the Company&#8217;s Amendment
No. 1 on Form 10-K/A to its Annual Report on Form 10-K for the fiscal year ended June 30, 2022, and in the Company&#8217;s Quarterly
Reports on Form 10-Q for the quarterly periods ended September 30, 2022, December 31, 2022 and March 31, 2023, this material weakness
resulted in the restatement of the Company&#8217;s consolidated financial statements as of and for the fiscal years ended June
30, 2022 and 2021, as well as the restatement of the Company&#8217;s condensed consolidated financial statements as of and for
the interim periods ended September 30, 2021, December 31, 2021, and March 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company identified an additional error during the quarter ended March 31, 2023 relating to the accounting treatment of the Lind
Consent. The error required the restatement of the Company&#8217;s condensed consolidated financial statements as of and for the
periods ended September 30, 2022 and December 31, 2022. The Company determined</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">that the error was partially caused by the same
material weakness that existed as of June 30, 2022, September 30, 2022 and December 31, 2022. The material weakness discussed
above continued to exist as of June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the material weakness discussed above, our management concluded that three other material weaknesses in internal control
over financial reporting existed as of June 30, 2023. A cumulative listing of our material weaknesses is disclosed below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 19.25pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify; padding-right: 1.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Control
                                         Environment:</span> Management did not design and maintain an effective control environment
                                         based on the criteria established by the COSO Framework. Specifically, the Company does
                                         not have sufficient personnel with the appropriate levels of knowledge, experience, and
                                         training in accounting and internal control over financial reporting commensurate with
                                         the complexity of the Company&#8217;s business. This material weakness contributed to
                                         additional material weaknesses related to the Company&#8217;s control activities as further
                                         described below.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 19.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify; padding-right: 1.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Risk
                                         Assessment:</span> Management did not design and maintain effective controls over the risk
                                         assessment process. Specifically, management does not have a formal process to identify,
                                         update, and assess risks due to changes in the Company&#8217;s business practices, including
                                         entering into increasingly complex transactions that could significantly impact the design
                                         and operation of the Company&#8217;s control activities.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 19.75pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify; padding-right: 1.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Control
                                         Activities:</span> Management did not design and maintain effective controls, including
                                         management review controls, related to non-routine transactions. Specifically, management
                                         did not maintain effective controls over monitoring and assessing the work of third-party
                                         specialists, including the evaluation of the appropriateness of accounting conclusions
                                         that has resulted in misstatements. In addition, the Company did not design and maintain
                                         effective controls related to the evaluation of certain inputs and assumptions used to
                                         estimate the fair value of instruments and features associated with complex debt and
                                         equity transactions. Finally, management did not have policies and procedures for the
                                         reconsideration of existing agreements when infrequent transactions occur.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 20pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify; padding-right: 1.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Monitoring
                                         Activities:</span> Management did not design and maintain effective monitoring controls
                                         to support timely evaluation of remediation of identified internal control deficiencies.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
these material weaknesses could result in a misstatement of the account balances or disclosures that would result in a material
misstatement to the annual or interim consolidated financial statements that would not be prevented or timely detected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Remediation
Plan for the Material Weakness</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
address our material weaknesses existing as of June 30, 2023, we are currently devising a detailed plan to address each individual
material weakness identified, as well as the overall monitoring process, including the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 19.25pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify; padding-right: 1.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         order to remediate the material weaknesses relating to the Company&#8217;s control environment
                                         and risk assessment process, we plan to develop and implement controls to ensure work
                                         performed by Company personnel and other experts is reviewed by individuals with the
                                         appropriate level of U.S. GAAP knowledge and experience. This may include separating
                                         the performance and review of certain close procedures among current accounting personnel
                                         and/or engaging third party accounting consultants with the requisite U.S. GAAP knowledge
                                         and experience to perform work under the control and oversight of Company personnel.
                                         In addition, we plan to enhance the design of our controls over the consideration of
                                         all related relevant accounting guidance for the initial recording and subsequent measurements
                                         of non-routine transactions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 19.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify; padding-right: 1.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         order to remediate the material weakness relating to the Company&#8217;s controls activities,
                                         we are in the process of designing and implementing controls over the completeness and
                                         accuracy of identifying and adequately assessing the assumptions utilized in the valuation
                                         analysis of complex financial instruments, as well as engaging third party consultants
                                         with the relevant background and expertise to perform the appropriate complex valuation
                                         analyses under the control and oversight of Company personnel.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to remediate the material weakness relating to the Company&#8217;s controls over monitoring activities, we plan to design
and implement controls to manage and monitor our progress towards the remediation of</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"></p>

<!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-indent: 0in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">internal control deficiencies and material
weaknesses, including oversight by, and periodic reporting to, the Audit Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
process of designing and maintaining effective internal control over financial reporting is a continuous effort that requires
management to anticipate and react to changes in our business, economic and regulatory environments and to expend significant
resources. As we continue to evaluate our internal control over financial reporting, we may take additional actions to remediate
the material weaknesses or modify the remediation actions described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we continue to devote significant time and attention to these remediation efforts, the material weaknesses will not be considered
remediated until management completes the design and implementation of the actions described above and the controls operate for
a sufficient period of time, and management has concluded, through testing, that these controls are effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
in Internal Control over Financial Reporting</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as discussed above, there has been no change in our internal control over financial reporting during the quarter ended June
30, 2023, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a054"></span>ITEM&#160;9B.</span></td><td style="padding-right: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
                                         INFORMATION</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the quarter ended June 30, 2023, no director or officer (as defined in Rule 16a-1(f) promulgated under the Exchange Act) of the
Company adopted or terminated a &#8220;Rule 10b5-1 trading arrangement&#8221; or &#8220;non-Rule 10b5-1 trading arrangement&#8221;
(as each term is defined in Item 408 of Regulation S-K).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
                          9C.</span></td><td><span id="a055"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DISCLOSURE
                                         REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTION&#160;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a056"></span>PART
III&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a057"></span>ITEM
                          10.</span></td><td style="padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIRECTORS,
                                         EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a058"></span>Directors
and Executive Officers</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth as of October 6, 2023, the names and ages of, and position or positions held by, our executive officers
and directors, the employment background of these persons, and any directorships held by the current directors during the last
five years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: bottom; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="vertical-align: bottom; width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 3%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="vertical-align: bottom; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td>
    <td style="vertical-align: top; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
    of Appointment</b></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark A. Smith</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer, President, Executive
    Chairman, and Director</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer and Director: September 23, 2013&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
and Executive Chairman: May 31, 2015&#160;</span></p></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neal Shah</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer and Corporate Secretary</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Financial Officer: July 1, 2016&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
Secretary: December 3, 2021&#160;</span></p></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott Honan</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 6, 2014</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jim Sims</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Communications Officer</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 2, 2015</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael J. Morris</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lead Director</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 27, 2014</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David C. Beling</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 6, 2011</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anna Castner Wightman</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 23, 2016</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nilsa Guerrero-Mahon</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 28, 2017</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dean C. Kehler</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 17, 2023</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #353535; background-color: white">Michael
    G. Maselli&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 17, 2023</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter Oliver</span></td>
    <td style="padding-bottom: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 12pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td>
    <td style="padding-bottom: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="padding-bottom: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 25, 2022</span></td></tr>
</table>
<p style="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font: normal 10pt Times New Roman, Times, Serif">The
following sets forth a brief description of the business experience of each executive officer and director of the Company, including
current directorships and directorships held in, at least, the past five years for each director:</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
A. Smith &#8211; Executive Chairman, Director, President, and Chief Executive Officer</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Smith has over 41 years of experience in operating, developing, and financing mining and strategic materials projects in the Americas
and abroad. In September 2013, he was appointed CEO and a Director of NioCorp. From April 2015 to September 2019, Mr. Smith served
as the President and Director for Largo Resources Ltd. (&#8220;Largo&#8221;), a mineral company with an operating property in
Brazil and projects in Brazil and Canada. In addition, from April 2015 to October 2018, Mr. Smith also served as the CEO of Largo.
Mr. Smith has also served on the board of directors of IBC Advanced Alloys Corp., a leading beryllium and copper advanced alloys
company (&#8220;IBC&#8221;), since May 2016 and as CEO of IBC since July 2020. From October 2008 through December 2012, Mr. Smith
served as President, CEO and Director of Molycorp, Inc., a rare earths producer (&#8220;Molycorp&#8221;), where he was instrumentally
involved in taking it from a private company to a publicly traded company with a producing mine. From November 2011 through May
2015, he served on the board of directors at Avanti Mining, a mining company (TSX-V: AVT; Avanti Mining changed its name to AlloyCorp
in early 2015). From December 2012 through September 2013, he served as the Managing Director of KMSmith LLC, a business strategy
and finance advisory firm, where he served as a consultant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to Molycorp, Mr. Smith held numerous engineering, environmental, and legal positions within Unocal Corporation, a former petroleum
explorer and marketer (&#8220;Unocal&#8221;), and later served as the President and CEO of Chevron Mining Inc., a coal and metal
mining company and wholly owned subsidiary of Chevron Corporation (&#8220;Chevron Mining&#8221;). Mr. Smith also served for over
seven years as the shareholder representative of Companhia Brasileira Metal&#250;rgica e Minera&#231;&#227;o (&#8220;CBMM&#8221;),
a private company that currently produces approximately 85% of the world supply of niobium. During his tenure with Chevron Mining,
Mr. Smith was responsible for Chevron Mining&#8217;s three coal mines, one molybdenum mine, a petroleum coke calcining operation
and Molycorp&#8217;s Mountain Pass mine. At Unocal, he served as the Vice-President from June 2000 to April 2006, and managed
the real estate, remediation, mining and carbon divisions. Mr. Smith is a Registered Professional Engineer and serves as an active
member of the State Bars of California and Colorado. He received his Bachelor of Science degree in Agricultural</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 107; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">Engineering from
Colorado State University in 1981 and his Juris Doctor, cum laude, from Western State University, College of Law, in 1990.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neal
Shah &#8211; Chief Financial Officer and Corporate Secretary</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Shah joined NioCorp in September 2014 as Vice President of Finance, and now serves as the Company&#8217;s CFO and Corporate Secretary.
Mr. Shah served as Finance Manager at Covidien Ltd., a medical device company since acquired by Medtronic, from May 2014 through
September 2014. From April 2011 until May 2014, he held the positions of Senior Manager of Corporate Development and M&amp;A and
more recently the Director of Strategy and Business Planning at Molycorp. Mr. Shah graduated from the University of Colorado with
a BSc in Mechanical Engineering in 1996, and from Purdue University with an MBA in 2002. Since the completion of his MBA, Mr.
Shah also held key finance roles with Intel Corporation and IBM.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
Honan &#8211; Chief Operating Officer</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Honan joined NioCorp in May 2014 as Vice President, Business Development, and since July 2020, has served as the Company&#8217;s
Chief Operating Officer (&#8220;COO&#8221;). He also serves as President of Elk Creek Resources Corporation, the NioCorp subsidiary
that is developing the Elk Creek Project in Nebraska. Prior to his work at NioCorp, Mr. Honan served in several leadership capacities
at Molycorp from February 2001 until May 2014, including as Vice President/Director Health, Environment, Safety and Sustainability
and General Manager and Environmental Manager from July 2011 to May 2014. With over 30 years of experience in the gold and rare
earth industries, Mr. Honan is a graduate of Queen&#8217;s University in Mining Engineering in both Mineral Processing (B.Sc.
Honors) and Environmental Management (M.Sc.) disciplines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jim
Sims &#8211; Chief Communications Officer</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Sims has more than 30 years of experience in devising and executing marketing, media relations, public affairs, and investor relations
operations for companies in the mining, chemical, manufacturing, utility, and renewable energy sectors. He joined NioCorp in November
2015 as Vice President, External Affairs, and now serves as its Chief Communications Officer, effective June 7, 2022. Prior to
NioCorp, Mr. Sims served for more than five years as Director (and then Vice President) of Corporate Communications for Molycorp
from March 2010 through November 2015. Since May 2016, Mr. Sims has also served as Director of Investor and Public Relations for
IBC. Mr. Sims was President and CEO of Policy Communications, Inc. from 1998 until 2010, and served as White House Director of
Communications for the Energy Policy Development Group. A former U.S. Senate Chief of Staff, he is the co-founder and former Executive
Director of the Geothermal Energy Association, and he has served as Board Chairman of the Rare Earth Technology Alliance. He is
an honors graduate of Georgetown University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
J. Morris &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Morris was formerly the Chairman of the board of directors of Heritage Oaks Bankcorp (&#8220;Heritage Oaks&#8221;), the holding
company of Heritage Oaks Bank. When Heritage Oaks Bank merged with Pacific Premier Bancorp on April 1, 2017, Mr. Morris became
a member of the Pacific Premier Bancorp&#8217;s board of directors, a position he held until May 31, 2020. He joined Heritage
Oaks&#8217; board of directors in January 2001 and assumed the board&#8217;s chairmanship in 2007. In addition, Mr. Morris has
worked since 1972 at Andre, Morris &amp; Buttery, a professional law corporation, where he serves as Senior Principal and has
served as Chairman of the board since 2005. From 2000 to late 2006, Mr. Morris served on the board of Molycorp, a rare earths
producer, which at the time was a wholly owned subsidiary of Unocal and then Chevron Mining. Mr. Morris was the only independent
director of Molycorp at that time. Mr. Morris is a graduate of Georgetown University and received his law degree from the University
of San Francisco School of Law. He has practiced business and environmental law for over 40 years. Mr. Morris served as a member
of the Board of Governors and Vice President of the State Bar of California. He served as a 1st Lieutenant in the U.S. Army from
1970 to 1972.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
C. Beling &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Beling is a Registered Professional Mining Engineer with 58 years of project and corporate experience. He has served as a director
on the boards of 14 mining companies starting in 1981, including NioCorp since 2011. Mr. Beling is the owner of D.C. Beling &amp;
Assoc., LLC, which provides strategic advisory, project, and corporate development services to the mining industry. His previous
employment and consulting included 14 years with five</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"> major mining companies and then 44 years with 30+ U.S. and Canadian junior
mining companies. He was the President, CEO, and Director of Bullfrog Gold Corp. from 2011 until October 2020; and the Executive
Vice President and COO of Geovic Mining Corp. from 2004 through 2010. Mr. Beling has examined, significantly reviewed, or been
directly involved with 90 underground mines, 136 open pit mines, and 174 process plants in the global metal, energy, and industrial
mineral sectors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anna
Castner Wightman &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
sixth generation Nebraskan and a graduate of Nebraska Wesleyan University, Ms. Wightman serves as a Senior Director of Government
Relations for First National Bank of Omaha, Nebraska, a position she has held since 2000. Prior to that, she worked for the Greater
Omaha Chamber of Commerce and served in the U.S. Congress for former Congressman Bill Barrett and former Congresswoman Virginia
Smith, both of whom represented the 3rd Congressional District of Nebraska. Ms. Wightman serves on the board of directors for
the Nebraska Chamber of Commerce, Rose Theater for Performing Arts, and Joslyn Castle.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nilsa
Guerrero-Mahon &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
former CFO and Controller for global corporations in the technology, energy, and government sectors, Ms. Guerrero-Mahon provides
consulting services to domestic and international corporations as the principal at NG Mahon Business Consulting, LLC. In addition,
Ms. Guerrero-Mahon was appointed to the Board of FinGoal Inc. in April 2022, a finance technology company building artificial
intelligence tools for the financial services industry and other financial technology developers. She also serves on the Board
of the State of Colorado Division of Securities. From 2016 to August 2019, she served on the board of directors of Centura Health
Mountains &amp; North Denver Operating Group, the largest division in the Centura Health Care System. From 2014 to 2016, she served
as the Vice Chair of the board of directors and Chaired the Strategy Committee at St. Anthony Hospital. From 2009 to 2017, Ms.
Guerrero-Mahon served as a gubernatorial appointed Board Member of the State of Colorado Financial Services Commission. Among
other prior positions, from 2004 to 2007, she was the Global Services Controller at Microsoft Corporation, overseeing internal
controls and corporate finance activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Guerrero-Mahon stays current with the latest Corporate Governance practices and the integration of ESG into the strategy. She
is an NACD Board Leadership Fellow, a member of the SASB Alliance, holds a CERT Certificate in Cybersecurity Oversight from the
Carnegie Mellon University and is currently enrolled in the Climate Leadership Certification program with Diligent Corporation.
Ms. Guerrero-Mahon received an Executive MBA from the Daniels College of Business at the University of Denver, a BS in Business
Administration - Accounting from the Interamerican University in San Juan, Puerto Rico, and an AS in Computer Science from the
EDP School of Computer Programming in San Juan, Puerto Rico. She is a Certified Public Accountant registered in the State of Colorado.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
Oliver &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a background in chemistry, Mr. Oliver began working at Greenbushes, Western Australia, for Sons of Gwalia, a mining company, in
May 2003. After Sons of Gwalia went into administration in 2004, Mr. Oliver was hired by Talison Lithium Limited (&#8220;Talison&#8221;),
a mining company, where he served as General Manager of Talison&#8217;s Greenbushes and Wodgina Mines and as Talison&#8217;s COO,
until Mr. Oliver was appointed as the CEO/Managing director. As Talison&#8217;s CEO/Managing director, Mr. Oliver led the listing
of Talison on the Toronto Stock Exchange in September 2010.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Oliver guided Talison through its acquisition in 2013 by Tianqi Lithium Corporation (&#8220;Tianqi&#8221;). He then served as
a corporate adviser to Tianqi, focusing on M&amp;A opportunities and global expansion, including advising on the sale of 49% of
Talison to Albermarle Corp. and the acquisition of 24% of Sociedad Quimica y Minera de Chile S.A., as well as significant expansions
of Talison&#8217;s Greenbushes lithium concentrate production.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Oliver also was a founding member of Tianqi Lithium Energy Australia Pty Ltd, a wholly owned subsidiary of Tianqi, which was established
to build a major Lithium Hydroxide manufacturing facility in Western Australia. Until June 2021, Mr. Oliver remained as a director
of Talison, a joint venture between Tianqi and Albemarle Corp. In September 2022, Mr. Oliver was appointed to the Board of Latin
Resources, a lithium exploration company in Australia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dean
C. Kehler &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Kehler co-founded Trimaran Fund Management, L.L.C. (&#8220;Trimaran Fund&#8221;) in 1998, where he is a Managing Partner, and serves
as a Manager of Trimaran Fund II. Mr. Kehler was also the Co-Chairman and Chief Executive Officer of GX Acquisition Corp. II,
a position he has held from August 2018 to March 2023. From 1995 to 2000, Mr. Kehler held senior positions at Canadian Imperial
Bank of Commerce (&#8220;CIBC&#8221;), including Vice Chairman of CIBC World Markets Corp. Mr. Kehler currently serves on the Boards
of Directors of Portman Ridge Finance Corporation (formerly KCAP Financial Inc.) and Celularity, Inc. Within the last five years,
he has served a director of Inviva Inc., Security First Corp. and Graphene Frontiers, LLC. He holds a bachelor&#8217;s degree from the
Wharton School of the University of Pennsylvania.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
G. Maselli &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Maselli is a managing director of Trimaran Fund, a position he has held since 2006, and was the President of Acquisitions of GX
Acquisition Corp. II from August 2018 to March 2023. Before joining Trimaran Fund in February 2006, Mr. Maselli worked in the
Corporate and Leverage Finance Groups of CIBC World Markets. Prior to joining CIBC in 1997, Mr. Maselli served as a Managing Director
in Bear Stearns&#8217; corporate finance group and, prior to that, as a Vice President at Kidder Peabody &amp; Co. Incorporated.
Since 2010, Mr. Maselli has served on the board of directors of El Pollo Loco Holdings, and he served as their Chairman of the Board from 2011 to 2023. He served on the board of ChanceLight, Inc. (f/k/a Educational Services of America, Inc.) until 2018. From 2013 to 2015,
he served on the board of directors of Norcraft Companies, Inc., and also served on the board of managers of its predecessor company
beginning in 2003. Additionally, Mr. Maselli served on the board of directors of Standard Steel, LLC, and was director as well
as Chairman of the Board of CB Holding Corp. Mr. Maselli received an MBA with distinction from The A.B. Freeman School at Tulane
University and a bachelor&#8217;s degree in economics from the University of Colorado.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
2023 Director Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
at the Closing on March 17, 2023, the Company increased the size of its Board to nine directors and appointed Michael G. Maselli
and Dean C. Kehler. On May 15, 2023, Fernanda Reda Fenga Viana Klamas resigned from the Board. One of the directors serving on
the Board (Mark A. Smith) is also a named executive officer. For a description of the compensation paid to Mr. Smith, see &#8220;Fiscal
2023 Summary Compensation Table&#8221; below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth all compensation the Company granted to our directors, other than Mr. Smith, for the fiscal year ended
June 30, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees Earned or Paid in Cash&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)&#160;</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Option Awards<br /> ($)(1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All Other Compensation&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)(2)&#160;</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total<br /> ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">David C. Beling</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">123,600</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">59,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">182,600</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Michael J. Morris</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">154,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197,700</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Anna Castner Wightman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">123,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">159,100</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Nilsa Guerrero-Mahon</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">139,050</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">166,550</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Fernanda Reda Fenga Viana Klamas</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">123,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">135,100</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Peter Oliver</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">123,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">127,600</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dean C. Kehler</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Michael G. Maselli</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
the grant date fair value of stock options (&#8220;Options&#8221;) granted during the 2023 fiscal year, consisting of 50,000 Options
for Mr. Morris, 45,000 Options for Ms. Guerrero-Mahon, and 40,000 Options each for Ms. Wightman, Ms. Fenga, Mr. Beling, and Mr.
Oliver, in each case at an exercise price of $6.95 per share, computed in accordance with Financial Accounting Standards Board
(&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 718. Assumptions used in the calculation of these
amounts are described in Note 11 in the Company&#8217;s consolidated financial statements included in this Annual Report on Form
10-K. These Options were fully vested on the grant date and generally remain exercisable until three years after the grant date.</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 110; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts in this column reflect a special cash bonus paid to directors equal to $5,000 per year of service or portion thereof,
based on their individual years of service on the Board.</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For
the fiscal year ended June 30, 2023, the directors of the Company did not receive any cash fees for serving on the Board, other
than the special cash bonuses set forth in the table above. The directors of the Company have no standard compensation arrangements,
or any other arrangements, with the Company, except as herein disclosed. Option grants are determined by the Compensation and
Organization Committee of the Board (the &#8220;Compensation Committee&#8221;) on a discretionary basis each year. Executive officers
of the Company who also act as directors of the Company do not receive any additional compensation for services rendered in such
capacity. See &#8220;Fiscal 2023 Summary Compensation Table&#8221; below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate number of Option awards outstanding at the end of fiscal year 2023 for each non-employee director who served during
fiscal 2023 was as follows: Mr. Beling, 122,500 Options; Mr. Morris, 107,500 Options; Ms. Wightman, 122,500 Options; Ms. Guerrero-Mahon,
105,000 Options; Ms. Fenga, 117,500 Options; Mr. Oliver, 90,000 Options; Mr. Kehler, 0 Options; and Mr. Maselli, 0 Options. As
of June 30, 2023, all the above Options were 100% vested.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Directorships</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a list of directorships held over the past five years by our directors. Except as listed below, no directors of the
Company are also directors of reporting issuers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: top">
    <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of Director</b></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 42%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
    Reporting Issuer (or equivalent)</b></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exchange</b></span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    C. Beling</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bullfrog
    Gold</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CSE</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    J. Morris</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pacific
    Premier Bancorp</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    A. Smith</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Largo
    Resources Ltd.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TSX</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IBC
    Advanced Alloys Corp.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TSX-V</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Oliver</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Latin
    Resources</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASX</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dean
    C. Kehler</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">El
Pollo Loco Holdings, Inc.&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Portman
Ridge Finance Corporation&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celularity,
Inc.&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GX
Acquisition Corp. II&#160;</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq&#160;</span></p></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    G. Maselli</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">El
    Pollo Loco Holdings, Inc.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
director or executive officer of the Company is a party adverse to the Company or any of its subsidiaries or has a material interest
adverse to the Company or any of its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the past ten years, none of the persons serving as executive officers and/or directors of the Company and, with respect to promoters
or control persons, for the past five years, none have been the subject matter of any of the legal proceedings that are required
to be disclosed pursuant to Item 401(f) of Regulation S-K. Further, no such legal proceedings are believed to be contemplated
by governmental authorities against any director or executive officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ethical
Business Conduct</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board expects management to operate the business of the Company in a manner that enhances shareholder value and is consistent
with the highest level of integrity. Management is expected to execute the Company&#8217;s business plan and to meet performance
goals and objectives according to the highest ethical standards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, directors and senior officers are bound by the provisions of the Company&#8217;s Articles and the British Columbia Business
Corporations Act (&#8220;BCBCA&#8221;), which set forth how any conflicts of interest are to be dealt with. In particular, any
director who has a material interest in a particular transaction is required to disclose such interest and to refrain from voting
with respect to the approval of any such transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Business Conduct and Ethics</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has adopted a written Code of Business Conduct and Ethics applicable to our employees, officers, and directors, including
those officers responsible for financial reporting. The Code of Business Conduct and Ethics is available on our website at www.niocorp.com.
If the Board amends the Code of Business Conduct and Ethics or grants a waiver, including an implicit waiver, from the Code of
Business Conduct and Ethics, the Company will disclose the information on its internet website. The waiver information will remain
on the website for at least 12 months after the initial disclosure of such waiver. Given the current size of the Company workforce,
and the lack of significant operations, the Board monitors compliance through periodic discussions with executive management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee and Audit Committee Financial Experts</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee is currently comprised of Anna Castner Wightman, Michael J. Morris, and Nilsa Guerrero-Mahon, all of whom are
independent directors. Our Board has determined that Mr. Morris and Ms. Guerrero-Mahon are audit committee financial experts,
as defined by the rules of the SEC. Further, all Audit Committee members are financially literate as defined in NI 52-110. The
Audit Committee was established in accordance with Section 3(a)(58)(A) of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a059"></span>ITEM
                          11.</span></td><td style="padding-right: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTIVE
                                         COMPENSATION</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets out the compensation for the fiscal years ended June 30, 2023 and 2022 for the individual who served as the
Company&#8217;s CEO during fiscal year 2023, as well as the Company&#8217;s two other most highly compensated executive officers
other than the CEO who were serving at the end of the last fiscal year (collectively, the &#8220;named executive officers&#8221;):&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
2023 Summary Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name and Principal Position</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year&#160;</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)&#160;</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bonus&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)&#160;</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards (1)&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)&#160;</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 32%; text-align: left">Mark A. Smith, Chief Executive Officer, President (2)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">2023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">304,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">100,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">216,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">620,300</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="background-color: rgb(204,238,255)">&#160;</td><td style="background-color: rgb(204,238,255)">&#160;</td>
    <td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="text-align: right; background-color: rgb(204,238,255)">2022</td><td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="background-color: rgb(204,238,255)">&#160;</td>
    <td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="text-align: right; background-color: rgb(204,238,255)">297,000</td><td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="background-color: rgb(204,238,255)">&#160;</td>
    <td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="text-align: right; background-color: rgb(204,238,255)">&#8212;</td><td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="background-color: rgb(204,238,255)">&#160;</td>
    <td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="text-align: right; background-color: rgb(204,238,255)">256,471</td><td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="background-color: rgb(204,238,255)">&#160;</td>
    <td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="text-align: right; background-color: rgb(204,238,255)">553,471</td><td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">Scott Honan, Chief Operating Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">265,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">123,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">438,600</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">260,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118,371</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">378,371</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Neal Shah, Chief Financial Officer and Corporate Secretary</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">227,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">123,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">401,100</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="background-color: rgb(204,238,255)">&#160;</td><td style="background-color: rgb(204,238,255)">&#160;</td>
    <td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="text-align: right; background-color: rgb(204,238,255)">2022</td><td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="background-color: rgb(204,238,255)">&#160;</td>
    <td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="text-align: right; background-color: rgb(204,238,255)">220,000</td><td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="background-color: rgb(204,238,255)">&#160;</td>
    <td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="text-align: right; background-color: rgb(204,238,255)">&#8212;</td><td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="background-color: rgb(204,238,255)">&#160;</td>
    <td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="text-align: right; background-color: rgb(204,238,255)">118,371</td><td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="background-color: rgb(204,238,255)">&#160;</td>
    <td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td><td style="text-align: right; background-color: rgb(204,238,255)">338,371</td><td style="text-align: left; background-color: rgb(204,238,255)">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
the grant date fair value of the Options granted during the reported fiscal years. Fiscal year 2023 grants consisted of 70,000
Options for Mr. Smith and 40,000 Options for each of Messrs. Honan and Shah, in each case at an exercise price of $6.95 per share.
Grant date fair values were computed in accordance with FASB ASC Topic 718. Assumptions used in the calculation of these amounts
are described in Note 11 in the Company&#8217;s consolidated financial statements included in this Annual Report on Form 10-K.
These Options were fully vested on the grant date and generally remain exercisable until three years after the grant date.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.25in; text-indent: 0in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
amounts paid to 76 Resources, LLC, an entity controlled by Mr. Smith, as further described below under &#8220;Employment Agreements.&#8221;</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Narrative
Disclosure to Summary Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Governance</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Compensation Committee determines an appropriate amount of compensation for the Company&#8217;s executives, reflecting
the need to provide incentives and compensation for the time and effort expended by the executives while taking into account the
financial and other resources of the Company. The Compensation Committee has the authority to engage and compensate, at the expense
of the Company, any outside advisor that it determines to be necessary to permit it to carry out its duties (including compensation
consultants and advisers)<b>, </b>and utilized information provided by Insperity PEO Services LP (&#8220;Insperity&#8221;), the
Company&#8217;s Professional Employer Organization, in February 2023, to assess employee salaries relative to industry and market
peers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Program Design</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board, in conjunction with the Compensation Committee, determines compensation and rewards to senior management on the basis of
individual and corporate performance, both in the short term and the long term, while at the same time being mindful of the responsibility
that the Company has to its shareholders. In general, the Compensation Committee considers that its compensation program should
be relatively simple in concept, given the current stage of the Company&#8217;s development, and that its focus should be balanced
between reasonable current compensation and longer-term compensation tied to performance of the Company as a whole.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee has not established a formal set of benchmarks or performance criteria to be met by the Company&#8217;s
named executive officers; rather, the members of the Compensation Committee use the information provided by Insperity and their
own subjective assessments of the level of success of the Company to determine, collectively, whether or not the named executive
officers are successfully achieving the Company&#8217;s business plan and strategy and the degree to which they have performed
in that regard. The Compensation Committee has not established any set or formal formula for determining named executive officer
compensation, either as to the amount thereof or the specific mix of compensation elements, and compensation (and adjustments
from time to time) is set through informal discussions at the Compensation Committee level.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Key
Elements of Named Executive Officer Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Base
Salaries</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of the Compensation Committee use their own experience and familiarity with the industry, and consider the factors described
above, to determine what they believe to be reasonable base salaries for our named executive officers. The base salaries of the
named executive officers are set at levels which are considered by the members of the Compensation Committee to be competitive,
thereby enabling the Company to compete for and retain executives critical to the long-term success of the Company. Initially,
base salaries (or, for Mr. Smith, base consulting fees) are set through negotiation when executive officers join the Company (with
direct input from the Compensation Committee) and are subsequently reviewed each fiscal year to determine if adjustments are required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
April 1, 2023, the Compensation Committee approved the following increases to the named executive officers&#8217; base salaries
to reflect each executive&#8217;s experience, contribution, responsibilities and pay relative to market and among senior executives
at the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">NEO</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Prior Base</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Salary Rate ($)</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">New Base</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Salary Rate ($)</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Mark A. Smith</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">297,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">325,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Scott Honan</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">260,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">280,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Neal Shah</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">220,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">250,000</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Bonus
Compensation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has discretion, where deemed appropriate and financially affordable for the Company, to grant a cash bonus to a named executive
officer based on the performance of both the individual named executive officer and the Company. In March 2023, the Compensation
Committee approved the following discretionary bonuses for the named executive officers, each of which was paid in April 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 30%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">NEO</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Bonus Amount ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 15%; text-align: left">Mark A. Smith</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">100,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Scott Honan</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Neal Shah</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
one-time bonuses were intended to reflect the Compensation Committee&#8217;s desire to reward individual performance and teamwork
across the senior leadership level.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Option-Based
Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
incentive portion of each named executive officer&#8217;s compensation package consists primarily of Options awarded under the
2017 Amended Long-Term Incentive Plan. Share ownership opportunities through the grant of Options are provided to align the interests
of senior management of the Company with the longer-term interests of the shareholders of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2017 Amended Long-Term Incentive Plan is administered by the Compensation Committee, and is intended to advance the interests
of the Company through the motivation, attraction and retention of officers and other key employees, directors and consultants
of the Company and affiliates of the Company and to secure for the Company and its shareholders the benefits inherent in the ownership
of Common Shares of the Company by officers and other key employees, directors and consultants of the Company and affiliates of
the Company. Grants of Options under the 2017 Amended Long-Term Incentive Plan are proposed/recommended by the CEO, and reviewed
by the Compensation Committee. The Compensation Committee can approve, modify, or reject any proposed grants, in whole or in part.
In general, the allocation of available Options among the eligible participants in the 2017 Amended Long-Term Incentive Plan is
on an ad hoc basis, and there is no set formula for allocating available Options, nor is there any fixed benchmark or performance
criteria to be achieved in order to receive an award of or vest in Options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee does not consider the accounting value of any such Option grants in determining the number of Options to
award to any individual, as any such &#8220;value&#8221; is an accounting measure that is not relevant to incentivizing the individual.
The timing of the grants of Options is determined by the Compensation Committee, and there is no regular interval for the awarding
of Option grants. In general, a higher level of responsibility will result in a larger grant of Options. Because the number of
Options available is limited, in general, the Compensation Committee aims to have individuals at what it subjectively considers
to be the same levels of responsibility holding equivalent numbers of Options, with additional grants being allocated for individuals
who the Compensation Committee believes are in a position to more directly affect the success of the Company through their efforts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee looks at the overall number of Options held by an individual (plus the exercise prices and remaining terms
of existing Options and whether any previously granted Options have expired out of the money or were exercised) and takes such
information into consideration when reviewing proposed new grants. After considering the CEO&#8217;s recommendations and the foregoing
factors, the resulting proposed Option grant (if any) is then submitted to the Board for approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended June 30, 2023, the Compensation Committee approved all recommendations for the grant of Options proposed
by management, and the named executive officers were granted the following number of Options effective March 27, 2023, each with
an exercise price per share of $6.95 per share: Mr. Smith, 70,000 Options; Mr. Honan, 40,000 Options; and Mr. Shah, 40,000 Options.
These Options were fully vested on the grant date and generally remain exercisable until three years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employment
Agreements and Severance Arrangements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and KMSmith, LLC (&#8220;KMSmith&#8221;), an entity controlled by Mark A. Smith, entered into a Consulting Agreement effective
September 23, 2013 (as amended, the &#8220;Smith Agreement&#8221;). On August 31, 2020, the Company, KMSmith and 76 Resources,
Inc., an entity controlled by Mr. Smith, entered into a Contract Assignment and Novation Agreement, pursuant to which KMSmith
assigned all of its rights under the Smith Agreement to 76 Resources, Inc. and 76 Resources, Inc. assumed all of KMSmith&#8217;s
obligations under the Smith Agreement by novation. On August 1, 2021, the Company, 76 Resources, Inc. and 76 Resources, LLC, an
entity controlled by Mr. Smith, entered into a Contract Assignment and Novation Agreement, pursuant to which 76 Resources, Inc.
assigned all of its rights under the Smith Agreement to 76 Resources, LLC and 76 Resources, LLC assumed all of 76 Resources, Inc.&#8217;s
obligations</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">under the Smith Agreement by novation. Under the terms of the Smith Agreement, 76 Resources, LLC (as ultimate successor
in interest to KMSmith), through Mr. Smith, performs the duties and responsibilities of the CEO of the Company and related services,
for an indefinite term at a base rate of $297,000 per year, generally payable in equal monthly installments of $24,750. During
fiscal 2023, the Smith Agreement was amended to increase the base rate to $325,000 per year. Any bonuses and incentive payments
are payable at the discretion of the Board. Mr. Smith is eligible to receive Options under the 2017 Amended Long-Term Incentive
Plan, as determined by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may terminate the Smith Agreement at any time without notice or payment if (1) 76 Resources, LLC commits a material breach
of the Smith Agreement (subject to a cure period in certain circumstances), (2) Mr. Smith dies or becomes permanently disabled,
or (3) certain other &#8220;for cause&#8221; scenarios occur (as further described in the Smith Agreement). In the event the Smith
Agreement is terminated by the Company for any other reason or if 76 Resources, LLC terminates the Smith Agreement on the occurrence
of a Triggering Event, the Company shall pay 76 Resources, LLC a lump sum termination fee equal to the base fee in effect at the
termination date as well as the average of any annual bonuses or other cash incentive payments for two calendar years immediately
preceding the year the termination occurs. A Triggering Event is defined as: a substantial change in the nature of services to
be performed by 76 Resources, LLC; a material breach by the Company of the Smith Agreement that is not remedied within 30 days
of notice; the cessation of the Company as a going concern; the failure of the Company to pay a material amount due pursuant to
the Smith Agreement within 30 days of the due date; or a material reduction in base fee or any other form of compensation payable
by the Company to 76 Resources, LLC, except where all senior executives or consultants of the Company are subject to relatively
similar reductions in such values. 76 Resources, LLC may terminate the Smith Agreement for a reason other than a Triggering Event
on 90 days&#8217; written notice and, should the Company immediately accept such termination notice, it shall pay 76 Resources,
LLC the sum of $69,904. Should a change of control of the Company occur (as that term is defined in the Smith Agreement) and,
within one year, either a Triggering Event occurs and 76 Resources, LLC terminates the Smith Agreement or 76 Resources, LLC&#8217;s
engagement is terminated by the Company under circumstances that would give rise to a termination payment in the absence of a
change of control, then 76 Resources, LLC shall be entitled to receive an amount equal to the base fee in effect at the termination
date as well as the average of any annual bonuses or other cash payments for two calendar years immediately preceding the year
the termination occurs. In the event 76 Resources, LLC is entitled to a termination payment with respect to a change of control,
any Options previously granted to Mr. Smith shall become fully vested and shall remain exercisable for the original term of grant
despite a termination of 76 Resources, LLC. Termination payments under the Smith Agreement are generally contingent on a release
of claims by 76 Resources, LLC. The Smith Agreement also includes customary confidentiality and six-month employee non-solicitation
provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Smith Agreement is terminated by the Company for any reason other than as set out in the Smith Agreement, if 76 Resources,
LLC terminates the Smith Agreement on the occurrence of a Triggering Event, or should a change of control of the Company occur
and within one year, either a Triggering Event occurs and 76 Resources, LLC terminates the Smith Agreement or 76 Resources, LLC&#8217;s
engagement is terminated without the occurrence of a Triggering Event, effective as of June 30, 2023, 76 Resources, LLC (as ultimate
successor in interest to KMSmith) would have been entitled to a payment of $325,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously disclosed, on September 25, 2022, in connection with our entry into the Business Combination Agreement, Messrs. Shah
and Honan (the &#8220;Covered Officers&#8221;) entered into employment agreements with a United States affiliate (the &#8220;U.S.
Affiliate&#8221;) of the Company (the &#8220;Employment Agreements&#8221;). The Employment Agreements became effective upon the
closing of the GXII Transaction, and will continue until either the Covered Officer or the U.S. Affiliate terminates the Covered
Officer&#8217;s employment for any reason. Pursuant to the Employment Agreements, Mr. Shah continues to serve as Chief Financial
Officer of the Company, and Mr. Honan continues to serve as the COO of the Company and serves as President of the U.S. Affiliate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Employment Agreement for Mr. Shah provides for an annual base salary of $220,000 per year, and Mr. Honan&#8217;s Employment Agreement
provides for an annual base salary of $260,000 per year. The annual base salary rates for the Covered Officers will be reviewed
at least annually for potential increases. As described above, the base salary rates of Messrs. Shah and Honan were increased
in fiscal 2023. The Employment Agreements also provide each of the Covered Officers with eligibility to participate in (1) any
annual cash bonus plan and/or any long-term incentive compensation plan as may be established by the U.S. Affiliate or its affiliates,
and (2) any employee benefit plan, program, or policy of the U.S. Affiliate or its affiliates as may be in effect for senior executives
of the U.S. Affiliate or its affiliates generally. The Employment Agreements also include the following additional features: (1)
severance benefits upon certain qualifying terminations of employment, consisting of: (a) for a qualifying termination of the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Covered Officer&#8217;s employment by the U.S. Affiliate without Cause (as such term is defined in the Employment Agreements)
that does not occur within two years after a Change in Control of the U.S. Affiliate (as defined in the Employment Agreements),
certain accrued obligations, plus 12 months of salary continuation, and (b) for a qualifying termination of the Covered Officer&#8217;s
employment by the U.S. Affiliate without Cause or by the Covered Officer for Good Reason (as such term is defined in the Employment
Agreements) that occurs within two years after a Change in Control (a &#8220;Change in Control Termination&#8221;), certain accrued
obligations, and a lump sum cash amount equal to two times the Covered Officer&#8217;s annual base salary as in effect at the
time of such termination; and (2) a requirement that each Covered Executive execute a customary release of claims in favor of
the U.S. Affiliate to receive severance compensation. In connection with the Covered Officers entering into the Employment Agreements
each Covered Officer also entered into a restrictive covenant agreement (a &#8220;Restrictive Covenant Agreement&#8221;). The
Restrictive Covenant Agreements will include customary restrictive covenants, including non-competition and non-solicitation obligations
that remain in effect both during the employment term and for one year following termination of the Covered Officer&#8217;s employment
other than a Change in Control Termination (in which case the period will be two years following such Change in Control Termination),
as well as other customary restrictive covenants, such as confidentiality provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock
Options Under the 2017 Amended Long-Term Incentive Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the 2017 Amended Long-Term Incentive Plan, the Company granted Options to its named executive officers during
the Company&#8217;s 2023 fiscal year; no other equity-based awards were granted to the named executive officers during the 2023
fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the outstanding equity awards for each named executive officer at June 30, 2023. The Company has not
granted full value stock-based awards to any of its named executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Equity Awards at 2023 Fiscal Year-End</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="15" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option Awards<sup>(1)</sup></b></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Grant Date</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
of&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underlying&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercised&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(#)&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercisable&#160;</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
of&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underlying&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercised&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(#)&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercisable&#160;</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price
($)&#160;</b></span></p></td><td style="padding-bottom: 1pt"><sup>&#160;</sup></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiration&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date&#160;</b></span></p></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 16%; text-align: left">Mark A. Smith</td><td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: center">12/14/2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">50,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">5.66</td><td style="width: 1%; text-align: left"><sup>(2)</sup></td><td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: center">12/14/2023</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">12/17/2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.27</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: center">12/17/2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">03/27/2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.95</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: center">03/27/2026</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Scott Honan</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">11/15/2018</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.08</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: center">11/15/2023</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">12/14/2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.66</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: center">12/14/2023</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">12/17/2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.27</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: center">12/17/2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">03/27/2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.95</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: center">03/27/2026</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Neal Shah</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">11/15/2018</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.08</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: center">11/15/2023</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">12/14/2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.66</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: center">12/14/2023</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">12/17/2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.27</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: center">12/17/2024</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">03/27/2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.95</td><td style="text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: center">03/27/2026</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with a reverse stock split effected by the Company on March 17, 2023, each then-outstanding Option then held by our
named executive officers was adjusted as follows:&#160;&#160;(a) the number of shares subject to each such Option was divided
by ten, with the resulting number rounded down to the nearest whole share; and (b) the exercise price applicable to each such
outstanding Option was multiplied by ten, with the resulting price rounded up to the nearest whole cent. The amounts set forth
in the table above with respect to options granted prior to March 27, 2023 reflect such adjustments.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
exercise price based on a spot exchange rate of C$1.324 to US$1.00 on June 30, 2023.</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Retirement
Plan Benefits</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Messrs.
Honan and Shah are each eligible to participate in the Company&#8217;s 401(k) savings plan, which is designed to reward continued
employment with the Company and assist participants with financial preparation for retirement. All amounts credited under the
401(k) savings plan relate to participant contributions. The Company does not currently make matching or other contributions to
the 401(k) savings plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Termination
and Change of Control Benefits</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as described above, the Company has not entered into any plans or arrangements in respect of remuneration received or that may
be received by the named executive officers in respect of compensating such officers or directors in the event of a change of
control, termination of employment (as a result of resignation, retirement, change of control, etc.) or a change in responsibilities
following a change of control. Options are generally subject to clawback provisions, and provide for post-employment exercise
periods, pursuant to the terms of such awards and the 2017 Amended Long-Term Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EQUITY
COMPENSATION PLANS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has maintained equity compensation plans under which Options have been granted. Option grants have been determined by
the Company&#8217;s directors and are only provided in compliance with applicable laws and regulatory policy. The following information
is provided with respect to compensation plans (including individual compensation arrangements) under which equity securities
were authorized for issuance as of June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="13" style="font-weight: bold; text-align: center">Equity Compensation Plan Information</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">Plan Category</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Securities</b></span><br /> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>to be Issued Upon</b></span><br /> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise of</b></span><br /> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding Options,</b></span><br /> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants, and Rights&#160;</b></span></p></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-Average Exercise Price of Outstanding</b></span><br /> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options, Warrants,</b></span><br /> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and Rights&#160;</b></span></p></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right; padding-bottom: 1pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Second Column)&#160;</b></span></p></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; text-indent: -7.6pt; padding-left: 7.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity Compensation Plans Approved by Security Holders&#160;<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: right">1,541,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">7.28</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,578,713</span></td><td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top"><sup>(2)</sup></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt; padding-bottom: 1pt">Equity Compensation Plans Not Approved by Security Holders</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; padding-bottom: 1pt">-</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total<sup>(3)</sup></span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,541,500</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7.28</td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,578,713</span></td><td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top"><sup>(3)</sup></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    Options granted pursuant to the 2017 Amended Long-Term Incentive Plan.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
    the aggregate number of Common Shares reserved for issuance to participants under the 2017 Amended Long-Term Incentive Plan,
    together with all other security-based compensation arrangements of the Company may not exceed 10% of the issued and outstanding
    Common Shares from time to time, and the Common Shares reserved for issuance upon settlement of share units shall not exceed
    5% of the issued and outstanding Common Shares from time to time. Common Shares subject to any grant (or any portion thereof)
    that are issued upon exercise or settlement, forfeited, surrendered, cancelled, unearned, or otherwise terminated will again
    be available for grant under the 2017 Amended Long-Term Incentive Plan.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><p style="margin: 0pt 0">As of the date of this report there are: (i) 1,319,000 outstanding securities awarded under the 2017
Amended Long-Term Incentive Plan representing 4.01% of the Company&#8217;s currently issued and outstanding Common Shares; and
(ii) 1,972,341 remaining securities available for grant representing 5.99% of the Company&#8217;s currently issued and outstanding
Common Shares.</p>


</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
of the 2017 Amended Long-Term Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 5, 2020, NioCorp&#8217;s shareholders approved the adoption of the 2017 Amended Long-Term Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the burn rates for the 2017 Amended Long-Term Incentive Plan since inception:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fiscal Year<br /> Ending June 30</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of awards granted (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted average number of Common Shares outstanding (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Burn rate</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 24%; text-align: center">2023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 22%; text-align: right">578,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 22%; text-align: right">28,705,840</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 22%; text-align: right">2.0</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">447,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,373,722</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.7</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">370,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,196,711</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.5</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,461,012</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    noted above, the Company completed a Reverse Stock Split. For purposes of comparability across fiscal years in this table,
    amounts in these columns with respect to fiscal years prior to 2023 represent the original amounts adjusted to reflect the
    Reverse Stock Split. With respect to the number of awards granted in fiscal 2023, any actual grants made prior to the Reverse
    Stock Split have also been adjusted.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PERFORMANCE
GRAPH</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following graph compares total cumulative shareholder return for $100 invested in Common Shares from July 1, 2018, to June 30,
2023, with cumulative total returns for the S&amp;P/TSX Composite Index and S&amp;P/TSX Mining Index:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.25in; color: Red"><img src="n257410kimg005.jpg" alt="" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.25in; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overall,
the Company&#8217;s cumulative return for the five-year period ended slightly below the range of returns for the two selected
indices. As an exploration stage company, executive officer compensation has not historically been adjusted to reflect share performance
trends. Compensation to executive officers remained flat from 2013 through February 2023, except for increases supported by additional
job responsibilities and/or job promotions. Effective September 1, 2019, the Board approved a 10% base rate increase for all NioCorp
employees and effective April 1, 2023, the Compensation Committee approved a base rate average increase of 12% for all NioCorp
employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a060"></span>ITEM
                          12.</span></td><td style="padding-right: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITY
                                         OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the beneficial ownership of Common Shares of NioCorp for the following: (1) each person who is known
by NioCorp to beneficially own more than 5% of the outstanding shares of NioCorp&#8217;s Common</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 118; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Shares; (2) each of the named
executive officers (as defined in the &#8220;Fiscal 2023 Summary Compensation Table,&#8221; above); (3) each of NioCorp&#8217;s
directors; and (4) all directors and executive officers of NioCorp as a group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
ownership of Common Shares in the table below is determined in accordance with the rules of the SEC and includes voting or investment
power with respect to the Common Shares. Common Shares that may be acquired by an individual or group within 60 days of October 6, 2023, pursuant to the exercise of options to purchase Common Shares (&#8220;Options&#8221;), the exercise of Common Share
purchase warrants (&#8220;Warrants&#8221;) or the exchange of shares of Class B common stock of ECRC (formerly known as GXII),
are deemed to be outstanding for the purpose of computing the percentage ownership of such individual or group but are not deemed
to be outstanding for the purpose of computing the percentage ownership of any other person shown in the table. Percentage of
ownership is based on 32,913,419 Common Shares outstanding as of October 6, 2023. Unless otherwise noted in the table below,
Options vested at the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as indicated in footnotes to this table, we believe that the shareholders named in this table have sole voting and investment
power with respect to all Common Shares shown to be beneficially owned by them, based on information provided to us by such shareholders.
Unless otherwise indicated, the address for each director and executive officer listed is: c/o NioCorp Developments Ltd., 7000
South Yosemite Street, Suite 115, Centennial, CO 80112.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name and Address of<br /> Beneficial Owner</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Position</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount and Nature of Beneficial Ownership<br /> (1)(2)</td>
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Percent
                                         of</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Common
                                         Shares</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left; padding-left: 5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mark A. Smith, PE, Esq.&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Highlands Ranch, Colorado, USA&#160;</span></p></td><td style="width: 1%">&#160;</td>
    <td style="width: 34%; text-align: left">Chief Executive Officer, President, Executive Chairman and Director</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">2,226,795</td>
    <td style="width: 1%; text-align: left">(3)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">6.73</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neal Shah&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Superior, Colorado, USA&#160;</span></p></td><td>&#160;</td>
    <td style="text-align: left">Chief Financial Officer and Corporate Secretary</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">185,000</td>
    <td style="text-align: left">(4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Scott Honan&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Centennial, Colorado, USA&#160;</span></p></td><td>&#160;</td>
    <td style="text-align: left">Chief Operating Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">184,452</td>
    <td style="text-align: left">(5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jim Sims&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Golden Colorado, USA&#160;</span></p></td><td>&#160;</td>
    <td style="text-align: left">VP &#8211; External Affairs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">152,928</td>
    <td style="text-align: left">(6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Michael J. Morris&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San Luis Obispo, California, USA&#160;</span></p></td><td>&#160;</td>
    <td style="text-align: left">Lead Director</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">144,698</td>
    <td style="text-align: left">(7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>David C. Beling&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grand Junction, Colorado, USA&#160;</span></p></td><td>&#160;</td>
    <td>Director</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168,391</td>
    <td style="text-align: left">(8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anna Castner Wightman&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Omaha, Nebraska, USA&#160;</span></p></td><td>&#160;</td>
    <td>Director</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">127,462</td>
    <td style="text-align: left">(9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nilsa Guerrero-Mahon&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brighton, Colorado, USA&#160;</span></p></td><td>&#160;</td>
    <td>Director</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">121,068</td>
    <td style="text-align: left">(10)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5pt">Dean Kehler<br /> New York, New York, USA</td><td>&#160;</td>
    <td>Director <br /></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,364,991</td>
    <td style="text-align: left">(11)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13.26</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Michael Maselli&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pelham, New York, USA&#160;</span></p></td><td>&#160;</td>
    <td>Director</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">778,231</td>
    <td style="text-align: left">(12)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.36</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Peter Oliver&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bunbury, Western Australia, Australia&#160;</span></p></td><td>&#160;</td>
    <td>Director</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,000</td>
    <td style="text-align: left">(13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td colspan="3" style="text-align: left">All current directors, executive officers and named executive officers as a group (11 persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,544,016</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25.21</td><td style="text-align: left">%</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Represents ownership of less than 1%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated
                                         in accordance with Rule 13d-3 of the Exchange Act.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 119; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                         March 17, 2023, NioCorp effected a 1-to-10 Reverse Stock Split of the Common Shares,
                                         with any fractional shares resulting from the Reverse Stock Split rounded down to the
                                         nearest whole share. All Options and Warrants outstanding as of March 17, 2023 were adjusted
                                         to reflect the Reverse Stock Split. Such Options and Warrants initially covered a number
                                         of shares equal to the amount reported herein times 10 (and at an exercise price equal
                                         to the amount reported herein divided by 10). Class B common stock of ECRC, which may
                                         be exchanged for Common Shares upon certain conditions, were issued on a post-Reverse
                                         Stock Split basis.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of October 6, 2023, Mr. Smith beneficially owns 2,041,795 outstanding Common Shares.
                                         In addition, he beneficially owns 185,000 vested Options comprised of the following:
                                         (i) on December 14, 2020, Mr. Smith was granted 50,000 Options for a period of three
                                         years at a price of C$7.50 per Common share; (ii) on December 17, 2021, Mr. Smith was
                                         granted 65,000 Options for a period of three years at a price of C$13.60 per Common Share;
                                         and (iii) on March 27, 2023, Mr. Smith was granted 70,000 Options for a period of three
                                         years at a price of $6.95 per Common Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of October 6, 2023, Mr. Shah beneficially owns 55,000 outstanding Common Shares. In
                                         addition, he beneficially owns 130,000 vested Options comprised of the following: (i)
                                         on November 15, 2018, Mr. Shah was granted 35,000 Options for a period of five years
                                         at a price of C$5.40 per Common Share, which vest over a period of 18 months with 100%
                                         having vested at this time; (ii) on December 14, 2020, Mr. Shah was granted 25,000 Options
                                         for a period of three years at a price of C$7.50 per Common share; (iii) on December
                                         17, 2021, Mr. Shah was granted 30,000 Options for a period of three years at a price
                                         of C$13.60 per Common Share; and (iv) on March 27, 2023, Mr. Shah was granted 40,000
                                         Options for a period of three years at a price of $6.95 per Common Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of October 6, 2023, Mr. Honan beneficially owns 54,452 outstanding Common Shares.
                                         In addition, he beneficially owns 130,000 vested Options comprised of the following:
                                         (i) on November 15, 2018, Mr. Honan was granted 35,000 Options for a period of five years
                                         at a price of C$5.40 per Common Share, which vest over a period of 18 months with 100%
                                         having vested at this time; (ii) on December 14, 2020, Mr. Honan was granted 25,000 Options
                                         for a period of three years at a price of C$7.50 per Common share; (iii) on December
                                         17, 2021, Mr. Honan was granted 30,000 Options for a period of three years at a price
                                         of C$13.60 per Common Share; and (iv) on March 27, 2023, Mr. Honan was granted 40,000
                                         Options for a period of three years at a price of $6.95 per Common Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of October 6, 2023, Mr. Sims beneficially owns 57,928 outstanding Common Shares. In
                                         addition, he beneficially owns 95,000 vested Options comprised of the following: (i)
                                         on December 14, 2020, Mr. Sims was granted 25,000 Options for a period of three years
                                         at a price of C$7.50 per Common share; (ii) on December 17, 2021, Mr. Sims was granted
                                         30,000 Options for a period of three years at a price of C$13.60 per Common Share; and
                                         (iii) on March 27, 2023, Mr. Sims was granted 40,000 Options for a period of three years
                                         at a price of $6.95 per Common Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of October 6, 2023, Mr. Morris beneficially owns 62,198 outstanding Common Shares.
                                         He shares both voting and investment power with respect to 5,525 of such Common Shares
                                         with his wife as the only trustees of the Michael and Sandra Morris Trust. In addition,
                                         he beneficially owns 82,500 vested Options comprised of the following: (i) on December
                                         17, 2021, Mr. Morris was granted 32,500 Options for a period of three years at a price
                                         of C$13.60 per Common Share; and (ii) on March 27, 2023, Mr. Morris was granted 50,000
                                         Options for a period of three years at a price of $6.95 per Common Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of October 6, 2023, Mr. Beling beneficially owns 70,891 outstanding Common Shares.
                                         In addition, he beneficially owns 97,500 vested Options comprised of the following: (i)
                                         on November 15, 2018, Mr. Beling was granted 30,000 Options for a period of five years
                                         at a price of C$5.40 per Common Share, which vest over a period of 18 months with 100%
                                         having vested at this time; (ii) on December 17, 2021, Mr. Beling was granted 27,500
                                         Options for a period of three years at a price of C$13.60 per Common Share; and (iii)
                                         on March 27, 2023, Mr. Beling was granted 40,000 Options for a period of three years
                                         at a price of $6.95 per Common Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 6, 2023, Ms. Wightman beneficially owns 29,562 outstanding Common Shares. She shares both voting and investment
power with respect to (i) 100 such Common Shares with her husband, (ii) 50</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.25in; text-indent: 0in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.25in; text-indent: 0in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 120; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-indent: 0in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">such Common Shares with a minor child and (iii) 50
such Common Shares with a minor child. In addition, she beneficially owns 97,500 vested Options comprised of the following: (i)
on November 15, 2018, Ms. Wightman was granted 30,000 Options for a period of five years at a price of C$5.40 per Common Share,
which vest over a period of 18 months with 100% having vested at this time; (ii) on December 17, 2021, Ms. Wightman was granted
27,500 Options for a period of three years at a price of C$13.60 per Common Share; and (iii) on March 27, 2023, Ms. Wightman was
granted 40,000 Options for a period of three years at a price of $6.95 per Common Share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of October 6, 2023, Ms. Guerrero-Mahon beneficially owns 46,068 Common Shares. In
                                         addition, she beneficially owns 75,000 vested Options comprised of the following: (i)
                                         on December 17, 2021, Ms. Guerrero-Mahon was granted 30,000 Options for a period of three
                                         years at a price of C$13.60 per Common Share; and (ii) on March 27, 2023, Ms. Guerrero-Mahon
                                         was granted 45,000 Options for a period of three years at a price of $6.95 per Common
                                         Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of October 6, 2023, Mr. Kehler beneficially owns 2,511,918 Common Shares issuable
                                         upon the exchange of shares of Class B common stock of ECRC comprised of the following:
                                         (i) 1,441,290 Common Shares issuable up issuable upon the exchange of shares of Class
                                         B common stock of ECRC that are vested as of the date hereof (&#8220;Vested Shares&#8221;);
                                         (ii) 535,314 Common Shares issuable upon the exchange of shares of Class B common stock
                                         of ECRC that will vest when the volume-weighted average price of the Common Shares on
                                         the principal exchange of the Common Shares as reported by Bloomberg (&#8220;VWAP&#8221;)
                                         equals or exceeds approximately $12.00 per share for 20 of any 30 consecutive trading
                                         days during from March 17, 2023 to March 17, 2033 (such period, the &#8220;Earnout Share
                                         Period&#8221;) on any stock exchange on which the Common Shares are then trading (such
                                         Common Shares, the &#8220;Tranche I Earnout Shares&#8221;); and (iii) 535,314 Common
                                         Shares issuable upon the exchange of shares of Class B common stock of ECRC that will
                                         vest when the VWAP of the Common Shares equals or exceeds approximately $15.00 per share
                                         for 20 of any 30 consecutive trading days during the Earnout Share Period on any stock
                                         exchange on which the Common Shares are then trading (such Common Shares, the &#8220;Tranche
                                         II Earnout Shares&#8221;). He shares both voting and investment power with respect to
                                         (i) 318,480 such Vested Shares with U.S. Trust Company of Delaware, as co-trustee of
                                         the Elizabeth Kehler 2012 Family Trust under Declaration of Trust dated December 12,
                                         2012 (the &#8220;Elizabeth Kehler Trust&#8221;); (ii) 118,284 such Tranche I Earnout
                                         Shares with U.S. Trust Company of Delaware, as co-trustee of the Elizabeth Kehler Trust;
                                         and (iii) 118,284 such Tranche II Earnout Shares with U.S. Trust Company of Delaware,
                                         as co-trustee of the Elizabeth Kehler Trust. In addition, Mr. Kehler beneficially owns
                                         1,853,073 Common Shares issuable upon exercise of 1,657,057 Warrants issued in connection
                                         with the transactions contemplated by the Business Combination Agreement, dated as of
                                         September 25, 2022, among the Company, GX Acquisition Corp. II and Big Red Merger Sub
                                         Ltd. (the &#8220;NioCorp Assumed Warrants&#8221;), held by Mr. Kehler.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of October 6, 2023, Mr. Maselli beneficially owns 563,081 Common Shares issuable upon
                                         the exchange of shares of Class B common stock of ECRC comprised of the following: (i)
                                         323,085 Vested Shares; (ii) 119,998 Tranche I Earnout Shares; and (iii) 119,998 Tranche
                                         II Earnout Shares. In addition, Mr. Maselli beneficially owns 215,150 Common Shares issuable
                                         upon exercise of 192,392 NioCorp Assumed Warrants held by Mr. Maselli.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         of October 6, 2023, Mr. Oliver beneficially owns 90,000 vested Options comprised of
                                         the following: (i) on May 30, 2022, Mr. Oliver was granted 50,000 Options for a period
                                         of three years at a price of C$11.00; and (ii) on March 27, 2023, Mr. Oliver was granted
                                         40,000 Options for a period of three years at a price of $6.95 per Common Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Security
Ownership of Certain Beneficial Owners</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 6, 2023, the Company is not aware of any persons that beneficially own more than 5% of its outstanding Common Shares
who does not serve as an executive officer or director of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 121; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
                          13.</span></td><td style="padding-right: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a061"></span>CERTAIN
                                         RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following sets forth certain information regarding transactions between the Company (and its subsidiaries) and its officers, directors,
and significant shareholders. There have been no other transactions since the end of the Company&#8217;s most recently completed
fiscal year and there are no currently proposed transactions in which the Company was or is to be a participant and the amount
involved exceeds $120,000, and in which any related person (for purposes of Item 404 of Regulation S-K) had or will have a direct
or indirect material interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loan
Transactions:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Smith is our Chief Executive Officer, President, Executive Chairman, and Director. On January 16, 2017, the Company and Mr. Smith
entered into a credit agreement (the &#8220;Smith Credit Agreement&#8221;) pursuant to which Mr. Smith agreed to make available
to the Company a credit facility of initially up to $2,000,000. On January 17, 2020, the Company entered into an amending agreement
to the Smith Credit Agreement, increasing the limit of the credit facility to $2,500,000 from the previous limit of $2,000,000.
On April 3, 2020, the Smith Credit Agreement was amended to increase the limit of the credit facility to $3,000,000 and on June
10, 2020, the Smith Credit Agreement was amended to increase the limit of the credit facility to $3,500,000. In addition, on June
10, 2020, the maturity date for the Smith Credit Agreement was extended to December 15, 2020. On December 14, 2020, the maturity
date for the Smith Credit Agreement was extended to December 15, 2021. On December 13, 2021, the maturity date for the Smith Credit
Agreement was extended to June 30, 2022. On June 29, 2022, the maturity date for the Smith Credit Agreement was extended to June
30, 2023. On February 28, 2023, the Smith Credit Agreement was amended to increase the borrowing limit to $4,000,000 from the
previous limit of $3,500,000. The Company subsequently drew down $1,130,000, leaving an available balance under the Smith Credit
Agreement of $52,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
largest aggregate amount of principal outstanding under the Smith Credit Agreement during the years ended June 30, 2023 and 2022
was $3,130,000 and $2,318,000, respectively. Principal repayments of $3,130,000 and $318,000 were made under the Smith Credit
Agreement during the years ended June 30, 2023 and 2022, respectively. In addition, interest payments of $183,343 and $251,741
were paid under the Smith Credit Agreement during the years ended June 30, 2023 and 2022, respectively, and $0 of interest remained
payable as of June 30, 2023. As of June 30, 2023, all principal and accrued interest outstanding under the Smith Credit Agreement
had been repaid and the Smith Credit Agreement expired on June 30, 2023. Accounts payable and accrued liabilities as of June 30,
2023, includes $28,250 of origination fees payable under the Smith Credit Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Review,
Approval or Ratification of Related Person Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as described below, the Company does not currently have in place any specific policy or procedure in respect of the review,
approval or ratification of any transaction required to be reported under Item 404(a) of Regulation S-K. Sections 147-153 of the
BCBCA set out rules and procedures applicable to all British Columbia corporations, pursuant to which a director presented with
a resolution in respect of any matter (including an equity issuance) in respect of which he/she has an interest must disclose
that interest in writing to the corporation&#8217;s board of directors prior to the approval of such matter. This procedure ensures
that each equity issuance to a director or officer of the Company is approved by all directors of the Company not involved in
such sale. All loan transactions from directors and officers are subject to review and approval by the Board prior to acceptance
and are documented in the meeting minutes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
                          14.</span></td><td style="padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a062"></span>PRINCIPAL
                                         ACCOUNTING FEES AND SERVICES</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents fees for
professional services rendered by BDO USA, P.C. (formerly known as BDO USA, LLP) Certified Public Accountants (&#8220;BDO&#8221;)
for each of the last two fiscal years for the audit of the Company&#8217;s annual consolidated financial statements and review of consolidated financial
statements included in the Company&#8217;s filings and fees billed for other services rendered by BDO during those periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
    Year Ending June 30,</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
    Fees<sup>(1)</sup> ($)</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit-Related
    Fees<sup>(2)</sup> ($)</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tax
    Fees<sup>(3)</sup> ($)</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
    Other Fees<sup>(4)</sup> ($)</b></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,205,765</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,356</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">181,920</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,551</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 122; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Audit
                                         Fees&#8221; include fees necessary to perform the annual audit and quarterly reviews
                                         of the Company&#8217;s consolidated financial statements. Audit Fees include fees for
                                         review of tax provisions and for accounting consultations on matters reflected in the
                                         consolidated financial statements. Audit Fees also include audit or other attest services required
                                         by legislation or regulation, such as comfort letters, consents, reviews of securities
                                         filings and statutory audits.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Audit-Related
                                         Fees&#8221; include services that are traditionally performed by the auditor. These audit-related
                                         services include employee benefit audits, due diligence assistance, accounting consultations
                                         on proposed transactions, internal control reviews and audit or attest services not required
                                         by legislation or regulation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Tax
                                         Fees&#8221; include fees for all tax services other than those included in &#8220;Audit
                                         Fees&#8221; and &#8220;Audit-Related Fees.&#8221; This category includes fees for tax
                                         compliance, tax planning and tax advice. Tax planning and tax advice includes assistance
                                         with tax audits and appeals, tax advice related to mergers and acquisitions, and requests
                                         for rulings or technical advice from tax authorities. For the financial years ended June
                                         30, 2023 and 2022, these tax services included the preparation of Canadian and U.S. federal
                                         and state tax returns and tax planning and tax advice services.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;All
                                         Other Fees&#8221; includes all other non-audit services.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pre-approval
Policies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The policy of the Audit Committee of the
Board (the &#8220;Audit Committee&#8221;) has been to pre-approve all audit, audit-related and non-audit services performed by
our independent auditors and to subsequently review the actual fees and expenses paid to our independent auditors. Accordingly,
the Audit Committee pre-approved all audit, audit-related and non-audit services performed by BDO and subsequently reviewed the
actual fees and expenses paid to BDO. The Audit Committee has determined that the fees paid to BDO for services are compatible
with maintaining BDO&#8217;s independence as our auditors. All of the services provided by BDO during the year ended June 30,
2023, were approved by the Audit Committee pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 123; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>


<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a063"></span>PART
IV</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM&#160;
                          15.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a064"></span>EXHIBITS
                                         AND FINANCIAL STATEMENT SCHEDULES&#160;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following documents are filed as a part of this report:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0pt"></td><td style="width: 17.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financial
                                         Statements</i>&#160;</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.45pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Consolidated Financial Statements, together with the report thereon of BDO USA, P.C. dated October 6, 2023, are included as part of Item&#160;8, &#8220;Financial Statements and Supplementary Data,&#8221; commencing on page 60
above. </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 90%; background-color: white; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="width: 92%; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b001">Report of Independent Registered Public Accounting Firms<br /> &#160;(<span id="xdx_90F_edei--AuditorName_c20220701__20230630_zJdqfhKfChLh"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:AuditorName">BDO USA, P.C.; <span id="xdx_907_edei--AuditorLocation_c20220701__20230630_zJxTBBomYN0a"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:AuditorLocation">Spokane, Washington</ix:nonNumeric></span>; PCAOB ID#</ix:nonNumeric></span><span id="xdx_900_edei--AuditorFirmId_c20220701__20230630_zVfwB2x4saR3"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:AuditorFirmId">243</ix:nonNumeric></span>)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b002">Consolidated Balance Sheets</a>&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b003">Consolidated Statements of Operations and Comprehensive Loss</a>&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b004">Consolidated Statements of Cash Flows</a>&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b005">Consolidated
    Statements of Shareholders&#8217; (Deficit) Equity&#160;and Redeemable Noncontrolling Interest</a>&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b006">Notes to Consolidated Financial Statements</a>&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0pt"></td><td style="width: 17.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(a)</i></b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exhibits</i></b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 15%"><p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
No.</b></span></p></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 83%"><p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></p></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh2-1.htm"><span style="color: #0000EE">2.1(1)***</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh2-1.htm">Business
    Combination Agreement, dated September 25, 2022, by and among NioCorp Developments Ltd., GX Acquisition Corp. II and Big Red
    Merger Sub Ltd</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename2.htm"><span style="color: #0000EE">3.1(2)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename2.htm"><span style="color: #0000EE">Notice
    of Articles of NioCorp Developments Ltd., dated April 5, 2016</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename3.htm"><span style="color: #0000EE">3.2(2)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename3.htm"><span style="color: #0000EE">Articles
    of NioCorp Developments Ltd., as amended, effective as of January 27, 2015</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh3-1.htm"><span style="color: #0000EE">3.3(3)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh3-1.htm"><span style="color: #0000EE">Amendment
    to Articles, effective March 17, 2023</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598221000044/sf0095h_ex4-1.htm">4.1(4)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598221000044/sf0095h_ex4-1.htm">Convertible
    Security Funding Agreement, dated February 16, 2021, between the Company and Lind Global Asset Management III, LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598221000044/sf0095h_ex4-2.htm">4.2(4)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598221000044/sf0095h_ex4-2.htm">Form
    of Lind III Warrant Certificate</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722000259/n2574_x23exh10-2.htm">4.3(5)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722000259/n2574_x23exh10-2.htm">Amendment
    #1 to Convertible Security Funding Agreement, dated December 2, 2021, between the Company and Lind Global Asset Management
    III, LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001757/n2574s4_ex4-17waiveconsent.htm">4.4(6)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001757/n2574s4_ex4-17waiveconsent.htm">Waiver
    and Consent Agreement, dated September 25, 2022, between NioCorp Developments Ltd. and Lind Global Asset Management III, LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001237/exh4-2.htm">4.5(7)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001237/exh4-2.htm">Form
    of Subscription Agreement in respect of units of the Company issued in June 2022</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001237/exh4-1.htm">4.6(7)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001237/exh4-1.htm">Form
    of Warrants issued in June 2022</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001510/n2574_x36exh4-13.htm">4.7(8)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001510/n2574_x36exh4-13.htm">Non-Transferable
    Broker Warrant Certificate, dated June 30, 2022, in respect of non-transferable broker warrants issued to Research Capital
    Corporation</a></span></td></tr>
<tr style="vertical-align: top">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001510/n2574_x36exh4-14.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8(8)</span></a></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001510/n2574_x36exh4-14.htm">Non-Transferable
    Broker Warrant Certificate, dated June 30, 2022, in respect of non-transferable broker warrants issued to Red Cloud Securities,
    Inc.</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-1.htm"><span style="color: #0000EE">4.9(1)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-1.htm"><span style="color: #0000EE">Sponsor
    Support Agreement, dated as of September 25, 2022, by and among GX Acquisition Corp. II, NioCorp Developments Ltd., GX Sponsor
    II LLC, in its capacity as a shareholder of GX Acquisition Corp. II, and certain other shareholders of GX Acquisition Corp.
    II</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000670/exh4-5.htm">4.10(9)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000670/exh4-5.htm"><span style="color: #0000EE">Joinder
    to Sponsor Support Agreement, dated as of March 17, 2023, by and among NioCorp Developments Ltd. and each of the Holders party
    thereto</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-1.htm"><span style="color: #0000EE">4.11(3)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-1.htm">Amended
    and Restated Registration Rights Agreement, dated as of March 17, 2023, by and among NioCorp Developments Ltd., GX Acquisition
    Corp. II, GX Sponsor II LLC, certain holders of the common shares of the NioCorp Developments Ltd. listed on Schedule 1 thereto,
    </a></span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 124; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 83%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-1.htm">certain current and former stockholders of GX Acquisition Corp. II, and other persons and entities listed on Schedule 2 thereto</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-2.htm"><span style="color: #0000EE">4.12(3)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-2.htm"><span style="color: #0000EE">Registration
    Rights Agreement Joinder, dated as of March 17, 2023, by and among NioCorp Developments Ltd. and each of the parties listed
    on Schedule A thereto</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-3.htm"><span style="color: #0000EE">4.13(3)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-3.htm"><span style="color: #0000EE">Exchange
    Agreement, dated as of March 17, 2023, by and among NioCorp Developments Ltd., GX Acquisition Corp. II and GX Sponsor II LLC</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000670/exh4-9.htm">4.14(9)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000670/exh4-9.htm"><span style="color: #0000EE">Joinder
    to Exchange Agreement, dated as of March 17, 2023, by and among NioCorp Developments Ltd., Elk Creek Resources Corp (f/k/a
    GX Acquisition Corp. II) and each of the Holders party thereto</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1826669/000121390021017023/ea138188ex4-1gxacquisit2.htm"><span style="color: #0000EE">4.15(10)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1826669/000121390021017023/ea138188ex4-1gxacquisit2.htm"><span style="color: #0000EE">Warrant
    Agreement, dated March 17, 2021, by and between GX Acquisition Corp. II and Continental Stock Transfer &amp; Trust Company</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh4-2.htm"><span style="color: #0000EE">4.16(3)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh4-2.htm"><span style="color: #0000EE">Assignment,
    Assumption and Amendment Agreement, dated as of March 17, 2023, by and among GX Acquisition Corp. II, NioCorp Developments
    Ltd., Continental Stock Transfer &amp; Trust Company, as the existing Warrant Agent, and Computershare Inc. and its affiliate
    Computershare Trust Company, N.A., as the successor Warrant Agent</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh4-2.htm"><span style="color: #0000EE">4.17(3)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh4-2.htm"><span style="color: #0000EE">Form
    of Warrant (included in Exhibit 4.16)</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh4-1.htm">4.18(11)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh4-1.htm">Securities
    Purchase Agreement, dated as of January 26, 2023, by and between NioCorp Developments Ltd. and each of the investors listed
    on the Schedule of Buyers attached thereto</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000339/exh4-1.htm">4.19(12)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000339/exh4-1.htm">Amendment
    No. 1 to Securities Purchase Agreement, dated February 24, 2023, by and between NioCorp Developments Ltd. and YA II PN, Ltd.</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh4-1.htm#a_001">4.20(12)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh4-1.htm#a_001">Form
    of Convertible Debenture (included in Exhibit 4.19)</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh4-1.htm#a_002">4.21(11)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh4-1.htm#a_002">Form
    of Financing Warrants (included in Exhibit 4.18)</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh4-4.htm"><span style="background-color: white">4.22(11)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh4-4.htm">Registration
    Rights Agreement, dated as of January 26, 2023, by and between NioCorp Developments Ltd. and YA II PN, Ltd.</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-2subscription.htm"><span style="background-color: white">4.23(13)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-2subscription.htm"><span style="background-color: white">Form
    of Subscription Agreement in respect of units issued in September 2023</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-1warrant.htm"><span style="background-color: white">4.24(13)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-1warrant.htm"><span style="background-color: white">Form
    of Warrants issued in September 2023</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="background-color: white"><a href="n2574_x163ex4-25.htm">4.25</a></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="background-color: white"><a href="n2574_x163ex4-25.htm">Description of Securities</a></span></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000161577417006460/s108109_ex10-1.htm">10.1(14)#</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000161577417006460/s108109_ex10-1.htm">NioCorp
    Developments Ltd. Long Term Incentive Plan, effective as of November 9, 2017</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename9.htm">10.2(2)#</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename9.htm">Consulting
    Agreement, dated May 13, 2014, between the Company and KMSmith, LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-3.htm">10.3(15)#</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-3.htm">Amendment
    to Contract, dated September 1, 2019, between the Company and KMSmith, LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-4.htm">10.4(15)#</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-4.htm">Contract
    Assignment and Novation Agreement, dated as of August 31, 2020, among the Company, KMSmith, LLC and 76 Resources, Inc.</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949721001306/exh10-5agreement.htm">10.5(16)#</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949721001306/exh10-5agreement.htm">Contract
    Assignment and Novation Agreement, dated as of August 1, 2021, among the Company, 76 Resources, Inc. and 76 Resources, LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001504/exh10-6_amndtmnt.htm">10.6(17)#</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001504/exh10-6_amndtmnt.htm">Amendment
    to Contract, dated April 1, 2023, between the Company and 76 Resources, LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416122587/v448164_ex10-3.htm">10.7(18)*</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416122587/v448164_ex10-3.htm">Offtake
    agreement, dated June 13, 2006, between the Company and CMC Cometals, a division of Commercial Metals Company</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001717/n2574_x60ex10-7.htm">10.8(19)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001717/n2574_x60ex10-7.htm">Amendment
    No. 1 to Offtake Agreement, dated April 13, 2020, between the Company and Traxys North America LLC, as assignee</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000161577417004839/s107345_ex10-4.htm">10.9(20)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000161577417004839/s107345_ex10-4.htm">Offtake
    agreement with ThyssenKrupp Metallurgical Products GmbH</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-8.htm">10.10(15)**,
    ***</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-8.htm">Woltemath
    003J Amended and Restated Option to Purchase, dated January 4, 2017, among ECRC and Victor L. and Juanita E. Woltemath</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-9.htm">10.11(15)**,
    ***</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-9.htm">Woltemath
    003J Extension to Option to Purchase, dated December 23, 2019, among ECRC and Victor L. and Juanita E. Woltemath</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000161577417001651/s105842_ex10-8.htm">10.12(21)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000161577417001651/s105842_ex10-8.htm">Security
    Agreement, dated June 17, 2015, from the Company to Mark Smith</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000953/sf0045h_ex10-1.htm">10.13(22)#</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000953/sf0045h_ex10-1.htm">NioCorp
    Developments Ltd. Long Term Incentive Plan, as amended</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh10-1.htm"><span style="color: #0000EE">10.14(11)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh10-1.htm"><span style="color: #0000EE">Standby
    Equity Purchase Agreement, dated as of January 26, 2023, by and between NioCorp Developments Ltd. and YA II PN, Ltd.</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949723000458/exh10-4.htm">10.15(3)#</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949723000458/exh10-4.htm"><span style="background-color: white">Form
    of Director and Officer Indemnification Agreement</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-3.htm"><span style="background-color: white">10.16(1)#</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-3.htm"><span style="background-color: white">Employment
    Agreement, dated as of September 25, 2022, by and between Elk Creek Resources Corporation and Neal Shah</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-4.htm"><span style="background-color: white">10.17(1)#</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-4.htm"><span style="background-color: white">Employment
    Agreement, dated as of September 25, 2022, by and between Elk Creek Resources Corporation and Scott Honan</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-5.htm"><span style="background-color: white">10.18(1)#</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-5.htm"><span style="background-color: white">Employment
    Agreement, dated as of September 25, 2022, by and between Elk Creek Resources Corporation and Jim Sims</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-6.htm"><span style="background-color: white">10.19(1)#</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-6.htm"><span style="background-color: white">Form
    of Restrictive Covenant Agreement</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x163ex21-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x163ex21-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries of NioCorp Developments Ltd.</span></a></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 125; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-1.htm">23.1</a></span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 83%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-1.htm">Consent of BDO USA, P.C.</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-2.htm">23.2</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-2.htm">Consent of Dahrouge Geological Consulting USA Ltd.</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-3.htm">23.3</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-3.htm">Consent of Understood Mineral Resources Ltd.</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-4.htm">23.4</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-4.htm">Consent of Optimize Group Inc.</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-5.htm">23.5</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-5.htm">Consent of Tetra Tech</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-6.htm">23.6</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-6.htm">Consent of Adrian Brown Consultants Inc.</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-7.htm">23.7</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-7.htm">Consent of Magemi Mining Inc.</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-8.htm">23.8</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-8.htm">Consent of L3 Process Development</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-9.htm">23.9</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-9.htm">Consent of Olsson</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-10.htm">23.10</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-10.htm">Consent of A2GC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-11.htm">23.11</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-11.htm">Consent of Metallurgy Concept Solutions</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-12.htm">23.12</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-12.htm">Consent of Scott Honan, M.Sc., SME-RM, NioCorp</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-13.htm">23.13</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-13.htm">Consent of Everett Bird, P.E., Cementation</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-14.htm">23.14</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-14.htm">Consent of Matt Hales, P.E., Cementation</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-15.htm">23.15</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-15.htm">Consent of Mahmood Khwaja, P.E., CDM Smith</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-16.htm">23.16</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-16.htm">Consent of Martin Lepage, P.Eng., Cementation</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-17.htm">23.17</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex23-17.htm">Consent of Wynand Marx, M.Eng., BBE Consulting</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex31-1.htm">31.1</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex31-1.htm">Certification of the Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex31-2.htm">31.2</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex31-2.htm">Certification of the Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex32-1.htm">32.1</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex32-1.htm">Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex32-2.htm">32.2</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x163ex32-2.htm">Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001510/n2574_x36exh96-1.htm"><span style="color: #0000EE">96.1(8)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001510/n2574_x36exh96-1.htm"><span style="color: #0000EE">S-K
    1300 Elk Creek Technical Report Summary</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS(23)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Instance Document</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH(23)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension &#8211; Schema</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL(23)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension &#8211; Calculations</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF(23)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension &#8211; Definitions</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB(23)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension &#8211; Labels</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE(23)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension &#8211; Presentations</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (formatted
    as Inline XBRL and contained in Exhibit 101)</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
compensation plan, arrangement or agreement.</span></td>
</tr></table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Portions
of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, which portions will be furnished to the Securities
and Exchange Commission upon request.</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt; text-align: justify; text-indent: -27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">***</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted exhibit will
be furnished to the Securities and Exchange Commission upon request.</span></td>
</tr></table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0; text-align: justify; text-indent: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
        filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on September
        29, 2022 and incorporated herein by reference.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0; text-align: justify; text-indent: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Draft Registration Statement on Form S-1 (Registration No. 377-01354) submitted to the
    SEC on July 26, 2016 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on March 17,
    2023 and incorporated herein by reference. </span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on February
    17, 2021 and incorporated herein by reference.</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 126; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed as an exhibit to the Company&#8217;s Current Report on Form 10-Q (File No. 000-55710) filed with the SEC on February
    4, 2022 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Registration Statement on Form S-4 (Registration No. 333-268227) filed with the SEC on
    November 7, 2022 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on June 30,
    2022 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed as an exhibit to the Company&#8217;s Annual Report on Form 10-K (File No. 000-55710) filed with the SEC on September
    6, 2022 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Registration Statement on Form S-3 (File No. 333-271268) filed with the SEC on April
    14, 2023 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to Elk Creek Resources Corp.&#8217;s (f/k/a GX Acquisition Corp. II) Current Report on Form 8-K (File No. 001-40226)
    filed with the SEC on March 22, 2021 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on January 27, 2023
    and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on February 24, 2023
    and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
        filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on September
        1, 2023 and incorporated herein by reference.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on November 13, 2017
    and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Annual Report on Form 10-K (File No. 000-55710) filed with the SEC on September 16, 2020
    and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Annual Report on Form 10-K (File No. 000-55710) filed with the SEC on September 8, 2021
    and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17)</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
        filed as an exhibit to the Company&#8217;s Post-Effective Amendment No. 1 to the Registration Statement on Form S-3 on
        Form S-1 (File No. 333-271268) filed with the SEC on August 22, 2023 and incorporated herein by reference.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Registration Statement on Form S-1 (Registration No. 333-213451) filed with the SEC on
    September 2, 2016 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed as an exhibit to Amendment No. 1 to the Company&#8217;s Annual Report on Form 10-K/A (File No. 000-55710) filed with
    the SEC on October 31, 2022 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Annual Report on Form 10-K (File No. 000-55710) filed with the SEC on August 29, 2017
    and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Registration Statement on Form S-1 (Registration No. 333-217272) filed with the SEC on
    April 12, 2017 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22)</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0; text-align: justify; text-indent: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
        filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on November
        6, 2020 and incorporated herein by reference.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0; text-align: justify; text-indent: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(23)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Submitted
    Electronically Herewith. Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting
    Language): (i) the Consolidated Balance Sheets at June 30, 2023 and June 30, </span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 127; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022, (ii) the Consolidated Statements of Operations
    and Comprehensive Loss for the years ended June 30, 2023, 2022 and 2021, (iii) the Consolidated Statements of Cash Flows for
    the years ended June 30, 2023, 2022 and 2021, (iv) the Consolidated Statements of Changes in Equity for the years ended June
    30, 2023, 2022 and 2021, (v) the Notes to the Consolidated Financial Statements.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM&#160;16.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a065"></span>FORM
                                         10&#8211;K SUMMARY&#160;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 128; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a066"></span>SIGNATURES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report
to be signed on its behalf by the undersigned, thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NIOCORP DEVELOPMENTS LTD.</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Neal
    Shah</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neal
Shah&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Financial Officer&#160;</span></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 6, 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf
of the registrant and in the capacities indicated on October 6, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Mark
    A. Smith</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, Chief Executive Officer
    (Principal</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark A. Smith</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Officer and Authorized
    U.S. Representative)</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and Chairman of the Board of Directors</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Neal
    Shah</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer (Principal
    Financial and</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neal Shah</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting Officer)</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Michael Morris</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael Morris</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
David C. Beling</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David C. Beling</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Anna Castner Wightman</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anna Castner Wightman</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Nilsa
    Guerrero-Mahon</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nilsa Guerrero-Mahon</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Dean
    C. Kehler</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dean C. Kehler</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Michael G. Maselli</span></td>
    <td style="vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael G. Maselli</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Peter
    Oliver</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter Oliver</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 129; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></p></div>

    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.25
<SEQUENCE>2
<FILENAME>n2574_x163ex4-25.htm
<DESCRIPTION>DESCRIPTION OF SECURITIES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 4.25</B></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>DESCRIPTION
OF Securities</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Shares</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
authorized capital of NioCorp Developments Ltd., a British Columbia corporation (the &ldquo;Company&rdquo;), consists of an unlimited
number of Common Shares, without par value. The holders of Common Shares are entitled to receive notice of and attend all meetings
of shareholders, with each Common Share held entitling the holder to one vote on any resolution to be passed at such shareholder
meetings. The holders of Common Shares are entitled to dividends if, as and when declared by the Company&rsquo;s Board of Directors.
The Common Shares are entitled, upon liquidation, dissolution, or winding up of the Company, to receive the remaining assets of
the Company available for distribution to shareholders. There are no pre-emptive, conversion, or redemption rights attached to
the Common Shares.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Exchange
Controls</I></B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no governmental laws, decrees, or regulations in Canada that restrict the export or import of capital, including foreign exchange
controls, or that affect the remittance of dividends, interest or other payments to non-resident holders of the securities of
the Company, other than as discussed below and Canadian withholding tax. See &ldquo;<I>Certain Canadian Federal Income Tax Considerations
for U.S. Residents</I>&rdquo; below.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Competition
Act</I></B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Limitations
on the ability to acquire and hold Common Shares may be imposed by the Competition Act (Canada). This legislation permits the
Commissioner of Competition of Canada (the &ldquo;Commissioner&rdquo;) to review any acquisition of a significant interest in
the Company. This legislation grants the Commissioner jurisdiction to challenge such an acquisition before the Canadian Competition
Tribunal if the Commissioner believes that it would, or would be likely to, result in a substantial lessening or prevention of
competition in any market in Canada.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Investment
Canada Act</I></B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Canada Act subjects an acquisition of control of a company by a non-Canadian to government review if the enterprise
value (or in some cases, asset value) of such company, as calculated pursuant to the legislation, exceeds a threshold amount.
A reviewable acquisition may not proceed unless the relevant minister is satisfied that the investment is likely to result in
a net benefit to Canada. Under the national-security-review regime in the Investment Canada Act, review on a discretionary basis
may also be undertaken by the federal government in respect of a broad range of investments by a non-Canadian. No financial threshold
applies to a national security review. The relevant test is whether such investment by a non-Canadian could be &ldquo;injurious
to national security.&rdquo;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
Canadian Federal Income Tax Considerations for U.S. Residents</I></B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following generally summarizes certain Canadian federal income tax consequences generally applicable under the&nbsp;<I>Income
Tax Act</I>&nbsp;(Canada) and the regulations enacted thereunder (collectively, the &ldquo;Canadian Tax Act&rdquo;) and the&nbsp;<I>Canada-United
States Tax Convention (1980)</I>&nbsp;(the &ldquo;Convention&rdquo;) to the holding and disposition of Common Shares.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comment
is restricted to holders of Common Shares each of whom, at all material times for the purposes of the Canadian Tax Act and the
Convention, (i) is resident solely in the United States for tax purposes, (ii) is a &ldquo;qualifying person&rdquo; under and
entitled to the benefits of the Convention, (iii) holds all Common Shares as capital property, (iv) holds no Common Shares that
are &ldquo;taxable Canadian property&rdquo; (as defined in the Canadian Tax Act) of the holder, (v) deals at arm&rsquo;s length
with and is not affiliated with the Company, (vi) does not and is not deemed to use or hold any Common Shares in a business carried
on in Canada, (vii) is not an insurer that carries on business in Canada and elsewhere, and (viii) is not an &ldquo;authorized
foreign bank&rdquo; (as defined in the Canadian Tax Act) (each such holder, a &ldquo;U.S. Resident Holder&rdquo;).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
U.S.-resident entities that are fiscally transparent for United States federal income tax purposes (including limited liability
companies) may not in all circumstances be entitled to the benefits of the Convention.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Members of or holders of an interest in
such an entity that holds Common Shares should consult their own tax advisers regarding the extent, if any, to which the benefits
of the Convention will apply to the entity in respect of its Common Shares.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
a U.S. Resident Holder&rsquo;s Common Shares will be considered to be capital property of such holder provided that the U.S. Resident
Holder is not a trader or dealer in securities, did not acquire, hold, or dispose of the Common Shares in one or more transactions
considered to be an adventure or concern in the nature of trade (<I>i.e.</I>, speculation) and does not hold the Common Shares
in the course of carrying on a business.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary is based on the current provisions of the Canadian Tax Act and the Convention in effect as of the date prior to the date
hereof, all specific proposals to amend the Canadian Tax Act and Convention publicly announced by or on behalf of the Minister
of Finance (Canada) prior to the date hereof, and the current published administrative policies and assessing practices of the
Canada Revenue Agency (the &ldquo;CRA&rdquo;). It is assumed that all such amendments will be enacted as currently proposed, and
that there will be no other material change to any applicable law or administrative policy or assessing practice, whether by way
of judicial, legislative or governmental decision or action, although no assurance can be given in these respects. This summary
is not exhaustive of all possible Canadian federal income tax considerations. Except as otherwise expressly provided, this summary
does not take into account any provincial, territorial, or foreign tax considerations, which may differ materially from those
set out herein.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary is of a general nature only, is not exhaustive of all possible Canadian federal income tax considerations, and is not
intended to be and should not be construed as legal or tax advice to any particular U.S. Resident Holder. U.S. Resident Holders
are urged to consult their own tax advisers for advice with respect to their particular circumstances. The discussion below is
qualified accordingly.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
a U.S. Resident Holder&rsquo;s Common Shares will not constitute &ldquo;taxable Canadian property&rdquo; of such holder at a particular
time at which the Common Shares are listed on a &ldquo;designated stock exchange&rdquo; (which currently includes the Toronto
Stock Exchange (the &ldquo;TSX&rdquo;) and the Nasdaq) unless both of the following conditions are concurrently met:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 22.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                         any time during the 60-month period that ends at the particular time, 25% or more of
                                         the issued shares of any class of the capital stock of the Company were owned by or belonged
                                         to one or any combination of:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         U.S. Resident Holder;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                         with whom the U.S. Resident Holder did not deal at arm&rsquo;s length; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">partnerships
                                         in which the U.S. Resident Holder or a person referred to in clause (B) holds a membership
                                         interest directly or indirectly through one or more partnerships; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 22.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                         any time during the 60-month period that ends at the particular time, more than 50% of
                                         the fair market value of the Common Shares was derived directly or indirectly from, one
                                         or any combination of, real or immovable property situated in Canada, &ldquo;Canadian
                                         resource properties&rdquo; (as defined in the Canadian Tax Act), &ldquo;timber resource
                                         properties&rdquo; (as defined in the Canadian Tax Act), or options in respect of, or
                                         interests in any of the foregoing, whether or not the property exists.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Shares may also be deemed to be &ldquo;taxable Canadian property&rdquo; in certain circumstances set out in the Canadian Tax Act.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Resident Holder who disposes or is deemed to dispose of one or more Common Shares generally should not thereby incur any
liability for Canadian federal income tax in respect of any capital gain arising as a consequence of the disposition.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Resident Holder to whom the Company pays or credits or is deemed to pay or credit a dividend on such holder&rsquo;s Common
Shares will be subject to Canadian withholding tax, and the Company will be required to</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">withhold the tax from the dividend and
remit it to the CRA for the holder&rsquo;s account. The rate of withholding tax under the Canadian Tax Act is 25% of the gross
amount of the dividend, but should generally be reduced under the Convention to 15% (or, if the U.S. Resident Holder is a company
which is the beneficial owner of at least 10% of the voting stock of the Company, 5%) of the gross amount of the dividend. For
this purpose, a company that is a resident of the United States for purposes of the Canadian Tax Act and the Convention and is
entitled to the benefits of the Convention shall be considered to own the voting stock of the Company owned by an entity that
is considered fiscally transparent under the laws of the United States and that is not a resident of Canada, in proportion to
such company&rsquo;s ownership interest in that entity.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrants</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company has outstanding Common Share purchase warrants, with each Common Share purchase warrant exercisable
for one Common Share. The exercise price per Common Share and the number of Common Shares issuable upon exercise of Common Share
purchase warrants is subject to adjustment upon the occurrence of certain events, including, but not limited to, the following:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in; text-align: left"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         subdivision or re-division of the outstanding Common Shares into a greater number of
                                         Common Shares;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in; text-align: left"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         reduction, combination or consolidation of the outstanding Common Shares into a lesser
                                         number of Common Shares;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in; text-align: left"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         issuance of Common Shares or securities exchangeable for, or convertible into, Common
                                         Shares to all or substantially all of the holders of Common Shares by way of stock dividend
                                         or other distribution (other than a distribution of Common Shares upon the exercise of
                                         Common Share purchase warrants or any outstanding options);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in; text-align: left"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         reorganization of the Company or the consolidation or merger or amalgamation of the Company
                                         with or into another corporate body; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in; text-align: left"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         reclassification or other similar change to the outstanding Common Shares.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will issue the Common Shares issuable upon exercise of Common Share purchase warrants within five business days following
its receipt of notice of exercise and payment of the exercise price, subject to surrender of the Common Share purchase warrants.
Prior to the exercise of any Common Share purchase warrants, holders of the Common Share purchase warrants will not have any of
the rights of holders of the Common Shares issuable upon exercise, including the right to vote or to receive any payments of dividends
on the Common Shares issuable upon exercise.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NioCorp
Assumed Warrants</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 17, 2023 (the &ldquo;Closing Date&rdquo;), the Company closed a series of transactions (the &ldquo;GXII Transaction&rdquo;)
pursuant to the Business Combination Agreement, dated as of September 25, 2022 (the &ldquo;Business Combination Agreement&rdquo;),
by and among the Company, GX Acquisition Corp. II, a Delaware corporation (&ldquo;GXII&rdquo;), and Big Red Merger Sub Ltd., a
Delaware corporation and a direct, wholly owned subsidiary of the Company. In connection with the closing of the GXII Transaction
(the &ldquo;Closing&rdquo;), pursuant to the Business Combination Agreement, the Company assumed GXII&rsquo;s obligations under
the Warrant Agreement, dated as of March 17, 2021 (the &ldquo;GXII Warrant Agreement&rdquo;), by and between GXII and Continental
Stock Transfer &amp; Trust Company (&ldquo;CST&rdquo;), as warrant agent, and each share purchase warrant of GXII thereunder (the
&ldquo;GXII Warrants&rdquo;) that was issued and outstanding immediately prior to the Closing Date was converted into one Common
Share purchase warrant (the &ldquo;NioCorp Assumed Warrants&rdquo;) pursuant to the GXII Warrant Agreement, as amended by an Assignment,
Assumption and Amendment Agreement, dated the Closing Date (the GXII Warrant Agreement, as so amended, the &ldquo;NioCorp Assumed
Warrant Agreement&rdquo;), among the Company, GXII, CST, as existing warrant agent, and Computershare Inc. and its affiliate Computershare
Trust Company, N.A, together as successor warrant agent (the &ldquo;NioCorp Assumed Warrant Agent&rdquo;). In connection with
the Closing, NioCorp issued (a) 9,999,959 public NioCorp Assumed Warrants in respect of the GXII Warrants that were publicly traded
prior to the Closing and (b) 5,666,667 NioCorp Assumed Warrants to GX Sponsor II LLC (the &ldquo;Sponsor&rdquo;) in respect of
the GXII Warrants that it held prior to the</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Closing, which NioCorp Assumed Warrants were subsequently distributed by the Sponsor
to its members in connection with the Closing.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
the public NioCorp Assumed Warrants and the NioCorp Assumed Warrants issued to the Sponsor are subject to the terms of the NioCorp
Assumed Warrant Agreement and are identical, with certain exceptions applicable to the NioCorp Assumed Warrants issued to the
Sponsor for so long as such NioCorp Assumed Warrants are held by the Sponsor, its members, or their respective affiliates and
other permitted transferees. In accordance with the NioCorp Assumed Warrant Agreement, any NioCorp Assumed Warrants issued to
the Sponsor that are held by someone other than the Sponsor, its members, or their respective affiliates and other permitted transferees,
are treated as public NioCorp Assumed Warrants.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
NioCorp Assumed Warrant is exercisable on and after April 16, 2023 until its expiration for 1.11829212 Common Shares at a price
of $11.50 per 1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations
and the like). Under the terms of NioCorp Assumed Warrant Agreement, for so long as the NioCorp Assumed Warrants issued to the
Sponsor are held by the Sponsor, its members, or their respective affiliates and other permitted transferees, such holders have
the right to elect to exercise those NioCorp Assumed Warrants on a cashless basis. For such NioCorp Assumed Warrants exercised
on a cashless basis after the Closing, the holder will be entitled to pay the exercise price for those NioCorp Assumed Warrants
by surrendering all or portion of the cash and/or Common Shares (valued at their fair market value) into which those NioCorp Assumed
Warrants are exercisable as shall be elected by the holder. For this purpose, Common Shares so surrendered will be deemed to have
a &ldquo;fair market value&rdquo; equal to the average reported last sale price of the Common Shares for the 10 trading days ending
on the third trading day prior to the date of exercise of the applicable NioCorp Assumed Warrants.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NioCorp Assumed Warrants will expire at 5:00 p.m., New York City time, on March 17, 2028 or earlier upon redemption or liquidation.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will not be obligated to deliver any Common Shares pursuant to the exercise of a NioCorp Assumed Warrant and will have
no obligation to settle such exercise unless a registration statement under the Securities Act with respect to the Common Shares
underlying the NioCorp Assumed Warrants is then effective and a prospectus relating thereto is current, subject to the Company
satisfying its obligations described below with respect to registration. No NioCorp Assumed Warrant will be exercisable and the
Company will not be obligated to issue Common Shares upon exercise of a NioCorp Assumed Warrant unless Common Shares issuable
upon such exercise have been registered, qualified or deemed to be exempt under the securities laws of the state of residence
of the registered holder of the NioCorp Assumed Warrants. In the event that the conditions in the two immediately preceding sentences
are not satisfied with respect to a NioCorp Assumed Warrant, the holder of such NioCorp Assumed Warrant will not be entitled to
exercise such NioCorp Assumed Warrant and such NioCorp Assumed Warrant may have no value and expire worthless. In no event will
the Company be required to net cash settle any NioCorp Assumed Warrant.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NioCorp Assumed Warrants, and the underlying Common Shares issuable upon the exercise thereof, were registered under the Securities
Act pursuant to the Company&rsquo;s registration statement on Form S-4, originally filed on November 7, 2022, as subsequently
amended, which was declared effective by the SEC on February 8, 2023. The Company expects the ongoing registered offering of the
Common Shares underlying the NioCorp Assumed Warrants to be conducted pursuant to the Company&rsquo;s registration statement on
Form S-3, which was filed on April 14, 2023 and which the Company expects to post-effectively amend to convert such registration
statement to Form S-1.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will have the right to call the public NioCorp Assumed Warrants for redemption at any time following the Closing Date:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 30px; font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in whole and not in
    part;</FONT></TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 30px; font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at a price of $0.01
    per NioCorp Assumed Warrant;</FONT></TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 30px; font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon not less than 30
    days&rsquo; prior written notice of redemption (the &ldquo;30-day redemption period&rdquo;) to each public NioCorp Assumed
    Warrant holder;</FONT></TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 30px; font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if, and only if, the
    reported last sale price of the Common Shares equals or exceeds approximately $16.10 per share (subject to certain adjustments)
    for any 20 trading days within a 30-trading day period commencing once the NioCorp Assumed Warrants become exercisable and
    ending three business days before the Company sends the notice of redemption to the public NioCorp Assumed Warrant holders;
    and</FONT></TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 30px; font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if there is an effective
    registration statement covering the Common Shares issuable upon exercise of the NioCorp Assumed Warrants, and a current prospectus
    relating thereto, available throughout the 30-day redemption period.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NioCorp Assumed Warrants issued to the Sponsor are not redeemable by the Company for so long as such NioCorp Assumed Warrants
are held by the Sponsor, its members, or their respective affiliates or other permitted transferees. In addition, the Company
may not exercise its redemption right if the issuance of Common Shares upon exercise of the NioCorp Assumed Warrants is not exempt
from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or
qualification.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company calls the public NioCorp Assumed Warrants for redemption as described above, the Company will have the option to require
any holder that wishes to exercise its public NioCorp Assumed Warrant to do so on a &ldquo;cashless basis.&rdquo; In determining
whether to require all holders to exercise their public NioCorp Assumed Warrants on a &ldquo;cashless basis,&rdquo; the Company
will consider, among other factors, its cash position, the number of NioCorp Assumed Warrants that are outstanding and the dilutive
effect on the Company&rsquo;s shareholders of issuing the maximum number of Common Shares issuable upon the exercise of the NioCorp
Assumed Warrants. If the Company takes advantage of this option, all holders of public NioCorp Assumed Warrants would pay the
exercise price by surrendering their NioCorp Assumed Warrants for that number of Common Shares equal to the quotient obtained
by dividing (x) the product of the number of Common Shares underlying the public NioCorp Assumed Warrants, multiplied by the difference
between the exercise price of the NioCorp Assumed Warrants and the &ldquo;fair market value&rdquo; (defined below) by (y) the
fair market value. The &ldquo;fair market value&rdquo; shall mean the average reported last sale price of the Common Shares for
the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders
of public NioCorp Assumed Warrants. If the Company takes advantage of this option, the notice of redemption will contain the information
necessary to calculate the number of Common Shares to be received upon exercise of the NioCorp Assumed Warrants, including the
&ldquo;fair market value&rdquo; in such case. Requiring a cashless exercise in this manner will reduce the number of Common Shares
to be issued and thereby lessen the dilutive effect of a redemption of the public NioCorp Assumed Warrants. If the Company calls
the public NioCorp Assumed Warrants for redemption and does not take advantage of this option, the Sponsor, its members, and their
respective affiliates and other permitted transferees would still be entitled to exercise their NioCorp Assumed Warrants for cash
or on a cashless basis using the same formula described above that other NioCorp Assumed Warrant holders would have been required
to use had all NioCorp Assumed Warrant holders been required to exercise their NioCorp Assumed Warrants on a cashless basis, as
described in more detail below.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
holder of a NioCorp Assumed Warrant may notify the Company in writing in the event it elects to be subject to a requirement that
such holder will not have the right to exercise such NioCorp Assumed Warrant, to the extent that after giving effect to such exercise,
such holder (together with such holder&rsquo;s affiliates), to the NioCorp Assumed Warrant Agent&rsquo;s actual knowledge, would
beneficially own in excess of 4.9% or 9.8% (or such other amount as a holder may specify) of the Common Shares outstanding immediately
after giving effect to such exercise.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NioCorp Assumed Warrants have certain anti-dilution and adjustments rights upon certain events.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NioCorp Assumed Warrants may be exercised upon surrender of the certificate representing such NioCorp Assumed Warrants on or prior
to the expiration date at the offices of the NioCorp Assumed Warrant Agent, with the exercise form on the reverse side of such
certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless basis, if
applicable), by certified or official bank check payable to the order of the NioCorp Assumed Warrant Agent or by wire transfer,
for the number of NioCorp Assumed Warrants being exercised. The NioCorp Assumed Warrant holders will not have the rights or privileges
of holders of Common Shares or any attendant voting rights until they exercise their NioCorp Assumed Warrants and receive Common
Shares. After the issuance of Common Shares upon exercise of the NioCorp Assumed Warrants, each</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">holder will be entitled to one
vote for each Common Share held of record on all matters to be voted on by NioCorp shareholders.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
upon exercise of the NioCorp Assumed Warrants, a holder would be entitled to receive a fractional interest in a share, the Company
will, upon exercise, round down to the nearest whole number of Common Shares to be issued to the NioCorp Assumed Warrant holder.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NioCorp Assumed Warrants were issued in registered form under the NioCorp Assumed Warrant Agreement. The NioCorp Assumed Warrant
Agreement may be amended by the parties thereto without the consent of any registered holder (i) for the purpose of curing any
ambiguity, or curing, correcting or supplementing any mistake, or adding or changing any other provisions with respect to matters
or questions arising under NioCorp Assumed Warrant Agreement as the parties may deem necessary or desirable and that the parties
deem shall not adversely affect the interest of the registered holders of the NioCorp Assumed Warrants, and (ii) to provide for
the delivery of such kind and amount of Common Shares or other securities or property (including cash) receivable upon a reclassification,
reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of NioCorp
Assumed Warrants would have received if such holder had exercised his, her or its NioCorp Assumed Warrants immediately prior to
such event. All other modifications or amendments, including any amendment to increase the warrant price or shorten the exercise
period, shall require the vote or written consent of the registered holders of a majority of the then outstanding public NioCorp
Assumed Warrants. Any amendment solely to the NioCorp Assumed Warrants issued to the Sponsor and that are held by the Sponsor,
its members, or their respective affiliates or other permitted transferees, shall require the vote or written consent of a majority
of the holders of the then outstanding NioCorp Assumed Warrants issued to the Sponsor.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Convertible
Debentures</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2023, NioCorp entered into a Securities Purchase Agreement (as amended, the &ldquo;Yorkville Convertible Debt Financing
Agreement&rdquo;) with YA II PN, Ltd. (&ldquo;YA&rdquo;). Pursuant to the Yorkville Convertible Debt Financing Agreement, YA advanced
a total amount of $15,360,000 to NioCorp in consideration of the issuance by NioCorp to YA of $16,000,000 aggregate principal
amount of unsecured convertible debentures (the &ldquo;Convertible Debentures&rdquo;) at the time of Closing (the &ldquo;Debenture
Closing&rdquo;). As of [September [27]], 2023, there was $8,000,000 aggregate principal amount of Convertible Debentures outstanding.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Convertible Debenture issued under the Yorkville Convertible Debt Financing Agreement is an unsecured obligation of NioCorp, matures
on September 17, 2024, which maturity may be extended for one six-month period in certain circumstances at the option of NioCorp,
and incurs a simple interest rate obligation of 5.0% per annum (which will increase to 15.0% per annum upon the occurrence of
an event of default). The outstanding principal amount of, accrued and unpaid interest, if any, on, and premium, if any, on the
Convertible Debentures must be paid by NioCorp in cash when the same becomes due and payable under the terms of the Convertible
Debentures at their stated maturity, upon their redemption or otherwise.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain limitations contained within the Yorkville Convertible Debt Financing Agreement and the Convertible Debentures, including
those as described below, holders of the Convertible Debentures will be entitled to convert the principal amount of, and accrued
and unpaid interest, if any, on each Convertible Debenture, in whole or in part, from time to time over their term, into a number
of Common Shares equal to the quotient of the principal amount and accrued and unpaid interest, if any, being converted divided
by the Conversion Price. The &ldquo;Conversion Price&rdquo; means, as of any Conversion Date (as defined below) or other date
of determination, the greater of (i) 90% of the average of the daily U.S. dollar volume-weighted average price of the Common Shares
on the principal U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading
days</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">immediately preceding the date on which the holder exercises its conversion right in accordance with the requirements of
the Yorkville Convertible Debt Financing Agreement (the &ldquo;Conversion Date&rdquo;) or other date of determination, but not
lower than the Floor Price (as defined below), and (ii) the five-day volume-weighted average price of the Common Shares on the
TSX (or on the principal U.S. market if the majority of the trading volume and value of the Common Shares occurred on Nasdaq during
the relevant period) for the five consecutive trading days immediately prior to the Conversion Date or other date of determination
less the maximum applicable discount allowed by the TSX. The &ldquo;Floor Price&rdquo; means a price of $2.1435 per share, which
is equal to the lesser of (a) 30% of the average of the daily volume-weighted average price of the Common Shares on the principal
U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading days immediately
preceding the Debenture Closing and (b) 30% of the average of the volume-weighted average price of the Common Shares on the principal
U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading days immediately
following the Debenture Closing, subject to certain adjustments to give effect to any stock dividend, stock split, reverse stock
split, recapitalization or similar event.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Convertible Debentures restrict the number of Convertible Debentures that may be converted during each calendar month
by YA at a Conversion Price below a fixed price equal to approximately $8.9422 (i.e., the quotient of $10.00 divided by 1.11829212
(being the number of Common Shares that were exchanged for each share of GXII at the Closing, after giving effect to the Reverse
Stock Split)), subject to adjustment to give effect to any stock dividend, stock split, reverse stock split, recapitalization
or similar event. The Convertible Debentures are subject to customary anti-dilution adjustments.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Convertible Debentures restrict the conversion of Convertible Debentures by YA if such a conversion would cause YA
to exceed certain beneficial ownership thresholds in NioCorp or such a conversion would cause the aggregate number of Common Shares
issued pursuant to the Yorkville Convertible Debt Financing Agreement to exceed the thresholds for issuance of Common Shares under
the rules of the TSX and Nasdaq, unless prior shareholder approval is obtained.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financing
Warrants</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with the Debenture Closing, NioCorp issued to YA Common Share purchase warrants (the &ldquo;Financing Warrants&rdquo;)
to purchase 1,789,267 Common Shares, which is equal to the quotient of the principal amount of Convertible Debentures issued in
such Debenture Closing divided by the &ldquo;Exercise Price,&rdquo; which is equal to approximately $8.9422 (i.e., the quotient
of $10.00 divided by 1.11829212 (being the number of Common Shares that were exchanged for each share of GXII at the Closing,
after giving effect to the Reverse Stock Split)), in each case, subject to adjustment to give effect to any stock dividend, stock
split, reverse stock split, recapitalization or similar event.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Financing Warrants are exercisable, in whole or in part, but not in increments of less than $50,000 aggregate Exercise Price (unless
the remaining aggregate Exercise Price is less than $50,000), beginning on May 4, 2023, and may be exercised at any time prior
to their expiration. Holders of the Financing Warrants may exercise their Financing Warrants, at their election, by paying the
Exercise Price in cash or, if at any time there is no effective registration statement registering, or no current prospectus available
for, the resale of the underlying Common Shares, on a cashless exercise basis. On each of the first 12 monthly anniversaries of
September 17, 2023, 1/12th of the Financing Warrants will expire.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Financing Warrants have customary anti-dilution adjustments to be determined in accordance with the requirements of the applicable
stock exchanges, including the TSX.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Financing Warrants restrict the exercise of Financing Warrants by YA if such an exercise would cause YA to exceed
certain beneficial ownership thresholds in NioCorp or such an exercise would cause the aggregate number of Common Shares issued
pursuant to the Yorkville Convertible Debt Financing Agreement to exceed the thresholds for issuance of Common Shares under the
rules of the TSX and Nasdaq, unless prior shareholder approval is obtained.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>n2574_x163ex21-1.htm
<DESCRIPTION>SUBSIDIARIES OF NIOCORP DEVELOPMENTS LTD.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
21.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List
of Subsidiaries of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: #DBDBDB">
    <TD STYLE="width: 30%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; padding-bottom: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Name</U></B></FONT></TD>
    <TD STYLE="width: 28%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; padding-bottom: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>State/Province
    of Formation</U></B></FONT></TD>
    <TD STYLE="width: 42%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; padding-bottom: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Ownership</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0896800
        B.C. Ltd. (&ldquo;0896800&rdquo;) </FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">British
    Columbia </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%
    by the Company</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
        Creek Resources Corp.  </FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%
        of the Class A common stock by 0896800</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
</TABLE>


<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>n2574_x163ex23-1.htm
<DESCRIPTION>CONSENT OF BDO USA, P.C.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.1</B></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: fuchsia"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><U>Consent
of Independent Registered Public Accounting Firm</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: fuchsia"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">NioCorp
Developments Ltd.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Centennial,
Colorado</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">We
hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-254511, 333-260673, 333-270541,
333-270542, 333-271266 and 333-271268) and Form S-8 (No. 333-222313) of NioCorp Developments Ltd. of our report dated October
6, 2023, relating to the consolidated financial statements, which appears in this Form 10-K. Our report contains an explanatory
paragraph regarding the Company&rsquo;s ability to continue as a going concern.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">/s/
BDO USA, P.C.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Spokane,
Washington</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: fuchsia"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">October
6, 2023</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>5
<FILENAME>n2574_x163ex23-2.htm
<DESCRIPTION>CONSENT OF DAHROUGE GEOLOGICAL CONSULTING USA LTD.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 23.2</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="n2574ex232img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge
Geological Consulting USA Ltd. hereby consents to the public filing of Sections 1.1 to 1.5, 1.9 to 1.11, 2 to 6, 7.1 to 7.2, 8,
9.2, 9.3, 16, 18 to 21, 22.1, 22.3, 22.9 to 22.12, 23.1.1, and 23.1.9 (the &ldquo;Covered Sections&rdquo;) of the Technical Report
Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022 (the
&ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30, 2023
(the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge
Geological Consulting USA Ltd. also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s
Registration Statement on Form S-8 (Registration No. 333-222313) and Registration Statements on Form S-3 (Registration Nos. 333-254511,
333-260673, 333-270541, 333-270542, 333-271266 and 333-271268) (collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge
Geological Consulting USA Ltd. also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified
person&rdquo; (as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection
with the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge
Geological Consulting USA Ltd. also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated
by reference in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge
Geological Consulting USA Ltd. certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately
represents the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 6<SUP>th</SUP> day of October 2023 at Centennial, Colorado.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Trevor
Mills</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trevor Mills, P.G., SME-RM</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Geologist /  US Operations
    Manager</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge Geological Consulting USA Ltd.</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>6
<FILENAME>n2574_x163ex23-3.htm
<DESCRIPTION>CONSENT OF UNDERSTOOD MINERAL RESOURCES LTD.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.3</B></FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="n2574ex233img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Understood
Mineral Resources Ltd. hereby consents to the public filing of Sections 1.6, 9.1, 11 and 22.2 (the &ldquo;Covered Sections&rdquo;)
of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date
of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year
ended June 30, 2023 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Understood
Mineral Resources Ltd. also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration
Statement on Form S-8 (Registration No. 333-222313) and Registration Statements on Form S-3 (Registration Nos. 333-254511, 333-260673,
333-270541, 333-270542, 333-271266 and 333-271268) (collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Understood
Mineral Resources Ltd. also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified
person&rdquo; (as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection
with the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Understood
Mineral Resources Ltd. also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated
by reference in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Understood
Mineral Resources Ltd. certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately
represents the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 6<SUP>th</SUP> day of October 2023 at 22 Middleton Crescent, Saskatoon, Saskatchewan, Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">                                                                                                                                        <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify; border-bottom: Black 1pt solid">/s/ <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Matt
Batty</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Matt Batty, MSc, P.Geo</FONT></TD>
</TR>                                                                           <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Owner
and Geostatistican</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Understood
Mineral Resources Ltd.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.4
<SEQUENCE>7
<FILENAME>n2574_x163ex23-4.htm
<DESCRIPTION>CONSENT OF OPTIMIZE GROUP INC.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.4</B></FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: left">&nbsp;<IMG SRC="n2574ex234img001.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optimize
Group Inc. hereby consents to the public filing of Sections 1.7, 12, 13.3 to 13.5, 15.7, 22.5 and 23.1.4 (the &ldquo;Covered Sections&rdquo;)
of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date
of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year
ended June 30, 2023 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optimize
Group Inc. also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement
on Form S-8 (Registration No. 333-222313) and Registration Statements on Form S-3 (Registration Nos. 333-254511, 333-260673, 333-270541,
333-270542, 333-271266 and 333-271268) (collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optimize
Group Inc. also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo;
(as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with
the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optimize
Group Inc. also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference
in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optimize
Group Inc. certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents
the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 6<SUP>th</SUP> day of October 2023 at Toronto, Ontario, Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">                                                                                                                                        <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify; border-bottom: Black 1pt solid">/s/ <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Gavin
Clow</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gavin
Clow, P.Eng.</FONT></TD>
</TR>                                                                           <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mining
Manager - Canada</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Optimize
Group Inc.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.5
<SEQUENCE>8
<FILENAME>n2574_x163ex23-5.htm
<DESCRIPTION>CONSENT OF TETRA TECH
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.5</B></FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="n2574ex235img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tetra
Tech hereby consents to the public filing of Sections 14.5, 15.1.1, 15.1.2, 15.2 to 15.4, 22.7 and 23.1.6 (the &ldquo;Covered
Sections&rdquo;) of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with
an Effective Date of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K
for the fiscal year ended June 30, 2023 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tetra
Tech also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement on
Form S-8 (Registration No. 333-222313) and Registration Statements on Form S-3 (Registration Nos. 333-254511, 333-260673, 333-270541,
333-270542, 333-271266 and 333-271268) (collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tetra
Tech also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo;
(as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with
the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tetra
Tech also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in
the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tetra
Tech certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 6<SUP>th</SUP> day of October 2023 at Salt Lake City, Utah.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">                                                                                                                                        <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify; border-bottom: Black 1pt solid">/s/ <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
R. Winters</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
R. Winters, SE, PE</FONT></TD>
</TR>                                                                                                                                                           <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Senior
Principal Engineer</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Tetra
Tech</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.6
<SEQUENCE>9
<FILENAME>n2574_x163ex23-6.htm
<DESCRIPTION>CONSENT OF ADRIAN BROWN CONSULTANTS INC.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.6</B>&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="n2574ex236img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
Brown Consultants Inc. hereby consents to the public filing of Sections 7.4.1, 7.4.2 and 13.2 (the &ldquo;Covered Sections&rdquo;)
of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date
of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year
ended June 30, 2023 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
Brown Consultants Inc. also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration
Statement on Form S-8 (Registration No. 333-222313) and Registration Statements on Form S-3 (Registration Nos. 333-254511, 333-260673,
333-270541, 333-270542, 333-271266 and 333-271268) (collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
Brown Consultants Inc. also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified
person&rdquo; (as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection
with the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
Brown Consultants Inc. also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated
by reference in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
Brown Consultants Inc. certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately
represents the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 6<SUP>th </SUP>day of October 2023 at Denver, Colorado, USA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Adrian Brown</FONT></TD>
    <TD STYLE="width: 15%; text-align: center; vertical-align: top">&nbsp;<IMG SRC="n2574ex236img002.jpg" ALT=""></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian Brown, P.E.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Engineer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian Brown Consultants Inc.</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.7
<SEQUENCE>10
<FILENAME>n2574_x163ex23-7.htm
<DESCRIPTION>CONSENT OF MAGEMI MINING INC.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.7</B>&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="n2574ex237img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi
Mining Inc. hereby consents to the public filing of Sections 10.1, 14.1.1, 14.2.1, 14.3.1, and 14.4.1 (the &ldquo;Covered Sections&rdquo;)
of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date
of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year
ended June 30, 2023 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi
Mining Inc. also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement
on Form S-8 (Registration No. 333-222313) and Registration Statements on Form S-3 (Registration Nos. 333-254511, 333-260673, 333-270541,
333-270542, 333-271266 and 333-271268) (collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi
Mining Inc. also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo;
(as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with
the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi
Mining Inc. also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference
in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi
Mining Inc. certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents
the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 6<SUP>th</SUP> day of October 2023 at North York, Ontario, Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Georgi Doundarov</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Georgi Doundarov, M.SC, P.Eng.,
    PMP, CCP</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi Mining Inc.</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.8
<SEQUENCE>11
<FILENAME>n2574_x163ex23-8.htm
<DESCRIPTION>CONSENT OF L3 PROCESS DEVELOPMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 23.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="n2574ex238img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT
OF QUALIFIED PERSON</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3
Process Development hereby consents to the public filing of Sections 10.2, 10.2.1 to 10.2.3, 14.1.2, 14.1.4, 14.2.2, 14.2.4, 14.3.2,
14.3.4, 14.4.2, 14.4.4, 22.4, 22.6, 23.1.2, and 23.1.5 (the &ldquo;Covered Sections&rdquo;) of the Technical Report Summary titled
&ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022 (the &ldquo;Technical
Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30, 2023 (the &ldquo;Form
10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3
Process Development also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration
Statement on Form S-8 (Registration No. 333-222313) and Registration Statements on Form S-3 (Registration Nos. 333-254511, 333-260673,
333-270541, 333-270542, 333-271266 and 333-271268) (collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3
Process Development also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified
person&rdquo; (as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection
with the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3
Process Development also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated
by reference in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3
Process Development certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents
the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 6<SUP>th</SUP> day of October 2023 at Salt Lake City.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Eric
    Larochelle Ing.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric Larochelle Ing.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Co-Owner - CEO</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3 Process Development</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.9
<SEQUENCE>12
<FILENAME>n2574_x163ex23-9.htm
<DESCRIPTION>CONSENT OF OLSSON
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.9</B></FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left">&nbsp;<IMG SRC="n2574ex239img001.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olsson
hereby consents to the public filing of Sections 1.8, 17, 22.8 and 23.1.7 (the &ldquo;Covered Sections&rdquo;) of the Technical
Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022
(the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30,
2023 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olsson
also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement on Form
S-8 (Registration No. 333-222313) and Registration Statements on Form S-3 (Registration Nos. 333-254511, 333-260673, 333-270541,
333-270542, 333-271266 and 333-271268) (collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olsson
also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo; (as
defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the
Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olsson
also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in the
Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olsson
certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 6<SUP>th</SUP> day of October 2023 at Omaha, Nebraska.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">                                                                                                                                        <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify; border-bottom: Black 1pt solid">/s/ <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Brian
Osborn</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
Osborn</FONT></TD>
</TR>                                                                           <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Senior Vice
President</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Olsson</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.10
<SEQUENCE>13
<FILENAME>n2574_x163ex23-10.htm
<DESCRIPTION>CONSENT OF A2GC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 23.10</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left">&nbsp;<IMG SRC="n2574ex2310img001.jpg" ALT=""></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC
hereby consents to the public filing of Sections 7.3, 13.1 and 23.1.3 (the &ldquo;Covered Sections&rdquo;) of the Technical Report
Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022 (the
&ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30, 2023
(the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC
also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement on Form
S-8 (Registration No. 333-222313) and Registration Statements on Form S-3 (Registration Nos. 333-254511, 333-260673, 333-270541,
333-270542, 333-271266 and 333-271268) (collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC
also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo; (as
defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the
Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC
also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in the
Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC
certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 6<SUP>th </SUP>day of October 2023 in Montreal, Quebec, Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Patrick Andrieux</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patrick Andrieux, Ph.D., P.Eng., Eng.</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Engineer</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC</FONT></TD>
    </TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.11
<SEQUENCE>14
<FILENAME>n2574_x163ex23-11.htm
<DESCRIPTION>CONSENT OF METALLURGY CONCEPT SOLUTIONS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.11</B></FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="n2574ex2311img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metallurgy
Concept Solutions LLC hereby consents to the public filing of Sections 10.3, 14.1.3, 14.2.3, 14.3.3, and 14.4.3 (the &ldquo;Covered
Sections&rdquo;) of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with
an Effective Date of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K
for the fiscal year ended June 30, 2023 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metallurgy
Concept Solutions LLC also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration
Statement on Form S-8 (Registration No. 333-222313) and Registration Statements on Form S-3 (Registration Nos. 333-254511, 333-260673,
333-270541, 333-270542, 333-271266 and 333-271268) (collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metallurgy
Concept Solutions LLC also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified
person&rdquo; (as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection
with the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metallurgy
Concept Solutions LLC also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated
by reference in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metallurgy
Concept Solutions LLC certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately
represents the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 6<SUP>th</SUP> day of October 2023 at 32 Rue Provost apt C, St-Remi, Quebec, Canada, J0L 2L0.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">                                                                                                                                        <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify">/s/ <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Sylvain
Harton</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="text-align: justify; width: 50%; border-top: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sylvain
Harton, P. Eng.</FONT></TD>
</TR>                                   <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Senior
Metallurgist Engineer</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Metallurgy
Concept Solutions LLC</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.12
<SEQUENCE>15
<FILENAME>n2574_x163ex23-12.htm
<DESCRIPTION>CONSENT OF SCOTT HONAN, M.SC., SME-RM, NIOCORP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.12</B></FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="n2574ex2312img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Scott Honan, M.Sc., SME-RM, consent to the public filing of Sections 13.7.5, 13.7.6, 13.7.7, 13.7.8, 13.7.15, 15.5, 15.6 and 22.7.1
(the &ldquo;Covered Sections&rdquo;) of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project,
Nebraska&rdquo; with an Effective Date of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual
Report on Form 10-K for the fiscal year ended June 30, 2023 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement on Form S-8
(Registration No. 333-222313) and Registration Statements on Form S-3 (Registration Nos. 333-254511, 333-260673, 333-270541, 333-270542,
333-271266 and 333-271268) (collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the use of and references to my name, including my status as an expert or &ldquo;qualified person&rdquo; (as defined
in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the Form 10-K,
the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in the Registration
Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
certify that I have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 6<SUP>th</SUP> day of October 2023 at Centennial, Colorado, USA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">                                                                                                                                        <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify; border-bottom: Black 1pt solid">/s/ <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Scott
Honan</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
Honan, M.Sc., SME-RM</FONT></TD>
</TR>                                                                           <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief
Operating Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">NioCorp
Developments Ltd.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.13
<SEQUENCE>16
<FILENAME>n2574_x163ex23-13.htm
<DESCRIPTION>CONSENT OF EVERETT BIRD, P.E., CEMENTATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.13</B>&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="n2574ex2313img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Everett Bird, P.E., consent to the public filing of Sections 13.7.1, 13.7.2, 13.7.3, 13.7.4 and 13.7.13 (the &ldquo;Covered Sections&rdquo;)
of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date
of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year
ended June 30, 2023 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement on Form S-8
(Registration No. 333-222313) and Registration Statements on Form S-3 (Registration Nos. 333-254511, 333-260673, 333-270541, 333-270542,
333-271266 and 333-271268) (collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the use of and references to my name, including my status as an expert or &ldquo;qualified person&rdquo; (as defined
in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the Form 10-K,
the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in the Registration
Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
certify that I have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 6<SUP>th</SUP> day of October 2023 at Salt Lake City, Utah.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Everett Bird</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Everett Bird, P.E.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Engineering Manager</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cementation</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.14
<SEQUENCE>17
<FILENAME>n2574_x163ex23-14.htm
<DESCRIPTION>CONSENT OF MATT HALES, P.E., CEMENTATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.14</B></FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="n2574ex2314img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Matt Hales, P.E., consent to the public filing of Sections 13.7.9, 13.7.10, 13.7.11, 13.7.14, 15.1.3, and 15.1.4 (the &ldquo;Covered
Sections&rdquo;) of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with
an Effective Date of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K
for the fiscal year ended June 30, 2022 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement on Form S-8
(Registration No. 333-222313) and Registration Statements on Form S-3 (Registration Nos. 333-254511, 333-260673, 333-270541, 333-270542,
333-271266 and 333-271268) (collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the use of and references to my name, including my status as an expert or &ldquo;qualified person&rdquo; (as defined
in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the Form 10-K,
the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in the Registration
Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
certify that I have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 6<SUP>th</SUP> day of October 2023 at Salt Lake City, Utah.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="text-align: justify; width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
                            Matt Hales</FONT></TD>
</TR>                                                                           <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Matt
Hales, P.E.</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Electrical
Engineering Lead</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Cementation</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.15
<SEQUENCE>18
<FILENAME>n2574_x163ex23-15.htm
<DESCRIPTION>CONSENT OF MAHMOOD KHWAJA, P.E., CDM SMITH
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.15</B>&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="n2574ex2315img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Mahmood Khwaja, P.E., consent to the public filing of Section 15.8 (the &ldquo;Covered Section&rdquo;) of the Technical Report
Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022 (the
&ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30, 2023
(the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the incorporation by reference of the Covered Section in the Company&rsquo;s Registration Statement on Form S-8
(Registration No. 333-222313) and Registration Statements on Form S-3 (Registration Nos. 333-254511, 333-260673, 333-270541, 333-270542,
333-271266 and 333-271268) (collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the use of and references to my name, including my status as an expert or &ldquo;qualified person&rdquo; (as defined
in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the Form 10-K,
the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to any extracts from or a summary of the Covered Section in the Form 10-K and incorporated by reference in the Registration
Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
certify that I have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 6<SUP>th</SUP> day of October 2023 at Boston, Massachusetts, USA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 35%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Mahmood Khwaja</FONT></TD>
    <TD ROWSPAN="5" STYLE="width: 15%; text-align: center; vertical-align: bottom"><IMG SRC="n2574ex2315img002.jpg" ALT="">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mahmood Khwaja, PE</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice President / Senior Geotechnical Engineer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Technical Services Unit &#9474; ISG</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDM Smith</FONT></P>
        <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.16
<SEQUENCE>19
<FILENAME>n2574_x163ex23-16.htm
<DESCRIPTION>CONSENT OF MARTIN LEPAGE, P.ENG., CEMENTATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 23.16</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="n2574ex2316img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Martin Lepage, P.Eng., Ing., consent to the public filing of Sections 13.7.12 and 23.1.8 (the &ldquo;Covered Sections&rdquo;)
of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date
of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year
ended June 30, 2023 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement on Form S-8
(Registration No. 333-222313) and Registration Statements on Form S-3 (Registration Nos. 333-254511, 333-260673, 333-270541, 333-270542,
333-271266 and 333-271268) (collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the use of and references to my name, including my status as an expert or &ldquo;qualified person&rdquo; (as defined
in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the Form 10-K,
the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in the Registration
Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
certify that I have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 6<SUP>th</SUP> day of October 2023 at North Bay, Ontario, Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 25%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Martin Lepage</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 25%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Martin
Lepage, P. Eng.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lead Technical
    Engineer - Hoisting</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cementation</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.17
<SEQUENCE>20
<FILENAME>n2574_x163ex23-17.htm
<DESCRIPTION>CONSENT OF WYNAND MARX, M.ENG., BBE CONSULTING
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.17</B></FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="n2574ex2317img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">CONSENT
OF QUALIFIED PERSON</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I, Wynand Marx, M.Eng.,
consent to the public filing of Section 13.6 (the &ldquo;Covered Section&rdquo;) of the Technical Report Summary titled &ldquo;Technical
Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;)
as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30, 2023 (the &ldquo;Form 10-K&rdquo;) of NioCorp
Developments Ltd. (the &ldquo;Company&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I also consent to the
incorporation by reference of the Covered Section in the Company&rsquo;s Registration Statement on Form S-8 (Registration No. 333-222313)
and Registration Statements on Form S-3 (Registration Nos. 333-254511, 333-260673, 333-270541, 333-270542, 333-271266 and 333-271268)
(collectively, the &ldquo;Registration Statements&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I also consent to the
use of and references to my name, including my status as an expert or &ldquo;qualified person&rdquo; (as defined in Subpart 1300
of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the Form 10-K, the Registration
Statements and the Technical Report Summary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I also consent to any
extracts from or a summary of the Covered Section in the Form 10-K and incorporated by reference in the Registration Statements
(the &ldquo;Disclosure&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I certify that I have
read the Disclosure being filed by the Company and that it fairly and accurately represents the information in the Covered Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Signed and dated this
6<SUP>th</SUP> day of October 2023 at Johannesburg, South Africa.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="text-align: justify; width: 50%; border-bottom: Black 1pt solid">/s/ Wynand Marx</TD>
</TR>                                                                                                                                                                                                                                                                                                                           <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify">Wynand Marx, M.Eng.</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify">Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: justify">BBE Consulting</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>21
<FILENAME>n2574_x163ex31-1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Mark A. Smith, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed this Annual Report on Form 10-K of NioCorp Developments Ltd.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make&nbsp;the&nbsp;statements made, in light of&nbsp;the&nbsp;circumstances under which such statements were made, not misleading
with respect to&nbsp;the&nbsp;period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge,&nbsp;the&nbsp;financial statements, and other financial information included in this report, fairly present
in all material respects the&nbsp;financial condition, results of operations and cash flows of&nbsp;the&nbsp;registrant as of,
and for,&nbsp;the&nbsp;periods presented in this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&nbsp;The&nbsp;registrant&rsquo;s
other&nbsp;certifying&nbsp;officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for&nbsp;the&nbsp;registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to&nbsp;the&nbsp;registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during&nbsp;the&nbsp;period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding&nbsp;the&nbsp;reliability of financial reporting and&nbsp;the&nbsp;preparation
of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Evaluated&nbsp;the&nbsp;effectiveness of&nbsp;the&nbsp;registrant&rsquo;s disclosure controls and procedures and presented in this report
our conclusions about&nbsp;the effectiveness of&nbsp;the&nbsp;disclosure controls and procedures, as of&nbsp;the&nbsp;end of&nbsp;the&nbsp;period
covered by this report based on such evaluation; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Disclosed in this report any change in&nbsp;the&nbsp;registrant&rsquo;s internal control over financial reporting that occurred during&nbsp;the&nbsp;registrant&rsquo;s
most recent fiscal quarter (the&nbsp;registrant&rsquo;s fourth fiscal quarter in&nbsp;the&nbsp;case of an annual report) that has materially
affected, or is reasonably likely to materially affect,&nbsp;the&nbsp;registrant&rsquo;s internal control over financial reporting;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&nbsp;The&nbsp;registrant&rsquo;s
other&nbsp;certifying&nbsp;officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to&nbsp;the&nbsp;registrant&rsquo;s auditors and&nbsp;the&nbsp;audit committee of&nbsp;the&nbsp;registrant&rsquo;s board of directors
(or persons performing&nbsp;the&nbsp;equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All significant deficiencies and material weaknesses in&nbsp;the&nbsp;design or operation of internal control over financial reporting
which are reasonably likely to adversely affect&nbsp;the&nbsp;registrant&rsquo;s ability to record, process, summarize and report financial
information; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in&nbsp;the&nbsp;registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 52%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
October 6, 2023</FONT></P></TD>
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 34%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/S/
    Mark A. Smith</FONT></TD>
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark A. Smith</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
Executive Officer)</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>22
<FILENAME>n2574_x163ex31-2.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
31.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Neal Shah, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed this Annual Report on Form 10-K of NioCorp Developments Ltd.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make&nbsp;the&nbsp;statements made, in light of&nbsp;the&nbsp;circumstances under which such statements were made, not misleading
with respect to&nbsp;the&nbsp;period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge,&nbsp;the&nbsp;financial statements, and other financial information included in this report, fairly present
in all material respects the&nbsp;financial condition, results of operations and cash flows of&nbsp;the&nbsp;registrant as of,
and for,&nbsp;the&nbsp;periods presented in this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&nbsp;The&nbsp;registrant&rsquo;s
other&nbsp;certifying&nbsp;officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for&nbsp;the&nbsp;registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to&nbsp;the&nbsp;registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during&nbsp;the&nbsp;period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding&nbsp;the&nbsp;reliability of financial reporting and&nbsp;the&nbsp;preparation
of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Evaluated&nbsp;the&nbsp;effectiveness of&nbsp;the&nbsp;registrant&rsquo;s disclosure controls and procedures and presented in this report
our conclusions about&nbsp;the effectiveness of&nbsp;the&nbsp;disclosure controls and procedures, as of&nbsp;the&nbsp;end of&nbsp;the&nbsp;period
covered by this report based on such evaluation; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Disclosed in this report any change in&nbsp;the&nbsp;registrant&rsquo;s internal control over financial reporting that occurred during&nbsp;the&nbsp;registrant&rsquo;s
most recent fiscal quarter (the&nbsp;registrant&rsquo;s fourth fiscal quarter in&nbsp;the&nbsp;case of an annual report) that has materially
affected, or is reasonably likely to materially affect,&nbsp;the&nbsp;registrant&rsquo;s internal control over financial reporting;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&nbsp;The&nbsp;registrant&rsquo;s
other&nbsp;certifying&nbsp;officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to&nbsp;the&nbsp;registrant&rsquo;s auditors and&nbsp;the&nbsp;audit committee of&nbsp;the&nbsp;registrant&rsquo;s board of directors
(or persons performing&nbsp;the&nbsp;equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All significant deficiencies and material weaknesses in&nbsp;the&nbsp;design or operation of internal control over financial reporting
which are reasonably likely to adversely affect&nbsp;the&nbsp;registrant&rsquo;s ability to record, process, summarize and report financial
information; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in&nbsp;the&nbsp;registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
October 6, 2023</FONT></P></TD>
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 36%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/S/
    Neal Shah</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neal Shah</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Financial Officer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
Financial and Accounting Officer)</FONT></P></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>23
<FILENAME>n2574_x163ex32-1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Annual Report on Form 10-K of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;), for the year ended June
30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Mark Smith, Chief
Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to my knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 52%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
October 6, 2023</FONT></P></TD>
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 34%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/S/
    Mark A. Smith</FONT></TD>
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark A. Smith</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
Executive Officer)</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>24
<FILENAME>n2574_x163ex32-2.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
32.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Annual Report on Form 10-K of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;), for the year ended June
30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Neal Shah, Chief
Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to my knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 52%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
October 6, 2023</FONT></P></TD>
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 34%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/S/
    Neal Shah</FONT></TD>
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neal Shah</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
        Financial Officer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
Financial and Accounting Officer)</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>25
<FILENAME>niobf-20230630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!--XBRL Document Created By The Nuvo Group-->
<!-- -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:niobf="http://niocorp.com/20230630" elementFormDefault="qualified" targetNamespace="http://niocorp.com/20230630">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://niocorp.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" id="StatementsOfOperationsAndComprehensiveLoss">
          <link:definition>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000005 - Statement - Consolidated Statements of Cash Flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" id="StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest">
          <link:definition>00000006 - Statement - Consolidated Statements of Shareholders' (Deficit) Equity and Redeemable Noncontrolling Interest</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/DescriptionOfBusiness" id="DescriptionOfBusiness">
          <link:definition>00000007 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BasisOfPreparation" id="BasisOfPreparation">
          <link:definition>00000008 - Disclosure - BASIS OF PREPARATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
          <link:definition>00000009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/GoingConcernIssues" id="GoingConcernIssues">
          <link:definition>00000010 - Disclosure - GOING CONCERN ISSUES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/GxiiTransaction" id="GxiiTransaction">
          <link:definition>00000011 - Disclosure - GXII TRANSACTION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/LandAndBuildingsNet" id="LandAndBuildingsNet">
          <link:definition>00000012 - Disclosure - LAND AND BUILDINGS, NET</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/MineralProperties" id="MineralProperties">
          <link:definition>00000013 - Disclosure - MINERAL PROPERTIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
          <link:definition>00000014 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ConvertibleDebt" id="ConvertibleDebt">
          <link:definition>00000015 - Disclosure - CONVERTIBLE DEBT</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrc" id="ClassBCommonStockOfEcrc">
          <link:definition>00000016 - Disclosure - CLASS B COMMON STOCK OF ECRC</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonShares" id="CommonShares">
          <link:definition>00000017 - Disclosure - COMMON SHARES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" id="RelatedPartyTransactionsAndBalances">
          <link:definition>00000018 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ExplorationExpenditures" id="ExplorationExpenditures">
          <link:definition>00000019 - Disclosure - EXPLORATION EXPENDITURES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/Leases" id="Leases">
          <link:definition>00000020 - Disclosure - LEASES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>00000021 - Disclosure - INCOME TAXES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FairValueMeasurements" id="FairValueMeasurements">
          <link:definition>00000022 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>00000023 - Disclosure - SUBSEQUENT EVENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
          <link:definition>00000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BasisOfPreparationTables" id="BasisOfPreparationTables">
          <link:definition>00000025 - Disclosure - BASIS OF PREPARATION (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SignificantAccountingPoliciesTables" id="SignificantAccountingPoliciesTables">
          <link:definition>00000026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/GxiiTransactionTables" id="GxiiTransactionTables">
          <link:definition>00000027 - Disclosure - GXII TRANSACTION (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/LandAndBuildingsNetTables" id="LandAndBuildingsNetTables">
          <link:definition>00000028 - Disclosure - LAND AND BUILDINGS, NET (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" id="AccountsPayableAndAccruedLiabilitiesTables">
          <link:definition>00000029 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ConvertibleDebtTables" id="ConvertibleDebtTables">
          <link:definition>00000030 - Disclosure - CONVERTIBLE DEBT (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" id="ClassBCommonStockOfEcrcTables">
          <link:definition>00000031 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesTables" id="CommonSharesTables">
          <link:definition>00000032 - Disclosure - COMMON SHARES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables" id="RelatedPartyTransactionsAndBalancesTables">
          <link:definition>00000033 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ExplorationExpendituresTables" id="ExplorationExpendituresTables">
          <link:definition>00000034 - Disclosure - EXPLORATION EXPENDITURES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/LeasesTables" id="LeasesTables">
          <link:definition>00000035 - Disclosure - LEASES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
          <link:definition>00000036 - Disclosure - INCOME TAXES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
          <link:definition>00000037 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails" id="ScheduleOfIntercompanyTransactionsAndBalancesDetails">
          <link:definition>00000038 - Disclosure - Schedule of intercompany transactions and balances (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" id="DescriptionOfBusinessDetailsNarrative">
          <link:definition>00000039 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" id="FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails">
          <link:definition>00000040 - Disclosure - The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" id="ScheduleOfExcludedFromDilutiveSecuritiesDetails">
          <link:definition>00000041 - Disclosure - Schedule of excluded from the dilutive securities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details" id="RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details">
          <link:definition>00000042 - Disclosure - Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As of March 31, 2023 (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details" id="RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details">
          <link:definition>00000043 - Disclosure - Revision Impacts to the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For the Three &amp; Nine Months Ended March 31, 2023 (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details" id="RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details">
          <link:definition>00000044 - Disclosure - Revision Impacts to the Condensed Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023 (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" id="SignificantAccountingPoliciesDetailsNarrative">
          <link:definition>00000045 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" id="GoingConcernIssuesDetailsNarrative">
          <link:definition>00000046 - Disclosure - GOING CONCERN ISSUES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" id="FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails">
          <link:definition>00000047 - Disclosure - The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails" id="NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails">
          <link:definition>00000048 - Disclosure - The number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/GxiiTransactionDetailsNarrative" id="GxiiTransactionDetailsNarrative">
          <link:definition>00000049 - Disclosure - GXII TRANSACTION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfPropertiesDetails" id="ScheduleOfPropertiesDetails">
          <link:definition>00000050 - Disclosure - Schedule of properties (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative" id="LandAndBuildingsNetDetailsNarrative">
          <link:definition>00000051 - Disclosure - LAND AND BUILDINGS, NET (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/MineralPropertiesDetailsNarrative" id="MineralPropertiesDetailsNarrative">
          <link:definition>00000052 - Disclosure - MINERAL PROPERTIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" id="ScheduleOfAccountPayableAndAccruedLiabilitiesDetails">
          <link:definition>00000053 - Disclosure - Schedule of account payable and accrued liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfConvertibleDebtDetails" id="ScheduleOfConvertibleDebtDetails">
          <link:definition>00000054 - Disclosure - Schedule of convertible debt (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" id="ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails">
          <link:definition>00000055 - Disclosure - Changes in the Lind III Convertible Security are as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails" id="FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails">
          <link:definition>00000056 - Disclosure - The following table summarizes the components of the initial loss on extinguishment: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" id="ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails">
          <link:definition>00000057 - Disclosure - The change in the fair value of the Contingent Consent Warrants is presented below: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details" id="ScheduleOfValuationDateAndProbabilityCalculated.Details">
          <link:definition>00000058 - Disclosure - Schedule of valuation date and the probability calculated. (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails" id="ChangesInConvertibleDebenturesAreAsFollowsDetails">
          <link:definition>00000059 - Disclosure - Changes in the Convertible Debentures are as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" id="ConvertibleDebtDetailsNarrative">
          <link:definition>00000060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" id="FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details">
          <link:definition>00000061 - Disclosure - The following table discloses the primary inputs into the Monte Carlo models. (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details" id="FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details">
          <link:definition>00000062 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2023: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" id="ClassBCommonStockOfEcrcDetailsNarrative">
          <link:definition>00000063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfStockOptionDetails" id="ScheduleOfStockOptionDetails">
          <link:definition>00000064 - Disclosure - Schedule of stock option (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details" id="FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details">
          <link:definition>00000065 - Disclosure - The following table summarizes information about stock options outstanding at June 30, 2023: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" id="FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails">
          <link:definition>00000066 - Disclosure - The following table summarizes the weighted average information and assumptions used to determine option costs: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" id="WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details">
          <link:definition>00000067 - Disclosure - Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" id="AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails">
          <link:definition>00000068 - Disclosure - At June 30, 2023, the Company has outstanding exercisable warrants, as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" id="CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails">
          <link:definition>00000069 - Disclosure - The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" id="ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails">
          <link:definition>00000070 - Disclosure - The change in the Private Warrants liability is presented below: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails" id="ScheduleOfExpensesAsOtherOperatingCostsDetails">
          <link:definition>00000071 - Disclosure - Schedule of expenses as other operating costs (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesDetailsNarrative" id="CommonSharesDetailsNarrative">
          <link:definition>00000072 - Disclosure - COMMON SHARES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" id="ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails">
          <link:definition>00000073 - Disclosure - Changes in the Smith Credit Agreement principal balance are as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" id="RelatedPartyTransactionsAndBalancesDetailsNarrative">
          <link:definition>00000074 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" id="ScheduleOfExplorationExpendituresDetails">
          <link:definition>00000075 - Disclosure - Schedule of exploration expenditures (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" id="CompanyIncurredLeaseCostsAsFollowsDetails">
          <link:definition>00000076 - Disclosure - The Company incurred lease costs as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details" id="MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details">
          <link:definition>00000077 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2023: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/LeasesDetailsNarrative" id="LeasesDetailsNarrative">
          <link:definition>00000078 - Disclosure - LEASES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails" id="DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails">
          <link:definition>00000079 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2023, 2022, and 2021 are as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" id="FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails">
          <link:definition>00000080 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" id="DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails">
          <link:definition>00000081 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" id="ChangesInValuationAllowanceAreAsFollowsDetails">
          <link:definition>00000082 - Disclosure - Changes in the valuation allowance are as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" id="ScheduleOfCumulativeNetOperatingLossesDetails">
          <link:definition>00000083 - Disclosure - Schedule of cumulative net operating losses (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>00000084 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" id="ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails">
          <link:definition>00000085 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>00000086 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="niobf-20230630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="niobf-20230630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="niobf-20230630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="niobf-20230630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="niobf_CommonSharesWithoutParValueMember" name="CommonSharesWithoutParValueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" name="WarrantsEachExercisableFor1.11829212CommonSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_RedeemableNoncontrollingInterestMember" name="RedeemableNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_Entity0896800BCLtdMember" name="Entity0896800BCLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ElkCreekResourcesCorpMember" name="ElkCreekResourcesCorpMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ElkCreekResourcesCorpECRCMember" name="ElkCreekResourcesCorpECRCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_WarrantAgreementMember" name="WarrantAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LegacyNioCorpShareholdersMember" name="LegacyNioCorpShareholdersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GXIIClassAShareholdersMember" name="GXIIClassAShareholdersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_OtherMember" name="OtherMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ShareExchangeAgreementMember" name="ShareExchangeAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_OptionAgreementMember" name="OptionAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ConvertibleSecurityMember" name="ConvertibleSecurityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LindIIIConvertibleSecurityMember" name="LindIIIConvertibleSecurityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_YorkvilleConvertibleDebtFinancingAgreementMember" name="YorkvilleConvertibleDebtFinancingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ProbabilityOfIssuanceMember" name="ProbabilityOfIssuanceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarnoutMember" name="EarnoutMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LongTermIncentivePlanMember" name="LongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GXIIPublicWarrantsMember" name="GXIIPublicWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GXIIPrivateWarrantsMember" name="GXIIPrivateWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice8.40Member" name="ExercisePrice8.40Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice5.40Member" name="ExercisePrice5.40Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice7.50Member" name="ExercisePrice7.50Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice7.50OneMember" name="ExercisePrice7.50OneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice13.60Member" name="ExercisePrice13.60Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice11.00Member" name="ExercisePrice11.00Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice6.95Member" name="ExercisePrice6.95Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice9.70Member" name="ExercisePrice9.70Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice8.94Member" name="ExercisePrice8.94Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice11.50Member" name="ExercisePrice11.50Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GeneralSecurityAgreementMember" name="GeneralSecurityAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AmendedNonRevolvingCreditFacilityAgreementMember" name="AmendedNonRevolvingCreditFacilityAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_MarkSmithMember" name="MarkSmithMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_NonRevolvingCreditFacilityAgreementMember" name="NonRevolvingCreditFacilityAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FeasibilityStudyAndEngineeringMember" name="FeasibilityStudyAndEngineeringMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FieldManagementAndOtherMember" name="FieldManagementAndOtherMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GeologistsAndFieldStaffMember" name="GeologistsAndFieldStaffMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CorporateOfficeMember" name="CorporateOfficeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FinancingAgreementMember" name="FinancingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DueToOfficersOrStockholdersOtherCurrent" name="DueToOfficersOrStockholdersOtherCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarnoutLiabilityAtFairValue" name="EarnoutLiabilityAtFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExplorationExpenditures" name="ExplorationExpenditures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfEarnoutLiability" name="ChangeInFairValueOfEarnoutLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfWarrantLiability" name="ChangeInFairValueOfWarrantLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" name="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ProfitLoss1" name="ProfitLoss1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarningsLossPerShareBasicAndDiluted" name="EarningsLossPerShareBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" name="TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AssumptionOfEarnoutLiability" name="AssumptionOfEarnoutLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfEarnoutShareLiability" name="ChangeInFairValueOfEarnoutShareLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AssumptionOfPrivateAndPublicWarrants" name="AssumptionOfPrivateAndPublicWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LossesOnExtinguishmentOfDebt" name="LossesOnExtinguishmentOfDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInValuationOfWarrantLiabilities" name="ChangeInValuationOfWarrantLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FairValueOfCommitmentSharesIssued" name="FairValueOfCommitmentSharesIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ForeignCurrencyTransactionGainLossBeforeTax1" name="ForeignCurrencyTransactionGainLossBeforeTax1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_OtheroperatingGainsLosses" name="OtheroperatingGainsLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ConversionsOfDebtForCommonShares" name="ConversionsOfDebtForCommonShares" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_RecognitionOfOperatingLeaseLiabilities" name="RecognitionOfOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DerecognitionOfOperatingLeaseLiabilities" name="DerecognitionOfOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AccountsPayableToConvertibleDebtConversion" name="AccountsPayableToConvertibleDebtConversion" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ValueOfWarrantsIssued" name="ValueOfWarrantsIssued" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodSharesStockWarrantExercised" name="StockIssuedDuringPeriodSharesStockWarrantExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodSharesStockWarrantExercisedShares" name="StockIssuedDuringPeriodSharesStockWarrantExercisedShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PrivatePlacementValueMay2021" name="PrivatePlacementValueMay2021" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PrivatePlacementSharesMay2021" name="PrivatePlacementSharesMay2021" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PrivatePlacementSharesMay2022Sahres" name="PrivatePlacementSharesMay2022Sahres" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CommonSharesIssuedInTheGXIITransaction" name="CommonSharesIssuedInTheGXIITransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CommonSharesIssuedInTheGXIITransactionSahres" name="CommonSharesIssuedInTheGXIITransactionSahres" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_SharesIssuedUnderTheYorkvilleEquityFacility" name="SharesIssuedUnderTheYorkvilleEquityFacility" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" name="SharesIssuedUnderTheYorkvilleEquityFacilityShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_RedeemableNoncontrollingInterest" name="RedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DisclosureClassBCommonStockOfEcrcAbstract" name="DisclosureClassBCommonStockOfEcrcAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" name="ScheduleOfClassBCommonStockOfECRCTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DisclosureExplorationExpendituresAbstract" name="DisclosureExplorationExpendituresAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExplorationExpendituresDisclosuresTextBlock" name="ExplorationExpendituresDisclosuresTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DisclosureLeasesAbstract" name="DisclosureLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DevelopmentStageIssuerPolicyTextBlock" name="DevelopmentStageIssuerPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_MineralPropertiesPolicyTextBlock" name="MineralPropertiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_WarrantsPolicyTextBlock" name="WarrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarnoutSharesPolicy" name="EarnoutSharesPolicy" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ReverseStockSplitPolicyTextBlock" name="ReverseStockSplitPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_RedeemableNoncontrollingInterestPolicyTextBlock" name="RedeemableNoncontrollingInterestPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" name="ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" name="ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfWarrantValuationTableTextblock" name="ScheduleOfWarrantValuationTableTextblock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" name="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" name="ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" name="ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" name="ScheduleOfOutstandingExercisableWarrantsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" name="ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfExplorationExpendituresTableTextBlock" name="ScheduleOfExplorationExpendituresTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_IncorporationStateCountryName" name="IncorporationStateCountryName" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CashAndCashEquivalentsAtCarryingValue1" name="CashAndCashEquivalentsAtCarryingValue1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" name="BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarnoutSharesAssumedAtFairValue" name="EarnoutSharesAssumedAtFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DeferredTaxImpacts" name="DeferredTaxImpacts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_MinimumConsentPaymentAtInception" name="MinimumConsentPaymentAtInception" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ASC470LossOnExtinguishment" name="ASC470LossOnExtinguishment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AdditionalConsentPaymentbooked" name="AdditionalConsentPaymentbooked" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInValuationOfWarrants" name="ChangeInValuationOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PrincipalAndAccruedInterestConverted" name="PrincipalAndAccruedInterestConverted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_TransactionCost" name="TransactionCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" name="StockIssuedDuringPeriodSharesStockOptionsExercise" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1" name="StockIssuedDuringPeriodSharesStockOptionsExercise1" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" name="ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DebtMaturityPeriod" name="DebtMaturityPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" name="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DescriptionOfEarnOutShares" name="DescriptionOfEarnOutShares" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_NordminWarrants" name="NordminWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing" name="ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightLindIIIWarrants" name="ClassOfWarrantOrRightLindIIIWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceLindWarrants" name="ClassOfWarrantOrRightExercisePriceLindWarrants" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightAprilPrivatePlacement" name="ClassOfWarrantOrRightAprilPrivatePlacement" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements" name="ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercised" name="ClassOfWarrantOrRightExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceExercised" name="ClassOfWarrantOrRightExercisePriceExercised" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExpired" name="ClassOfWarrantOrRightExpired" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceExpired" name="ClassOfWarrantOrRightExercisePriceExpired" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightJunePrivatePlacement" name="ClassOfWarrantOrRightJunePrivatePlacement" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceJunePrivatePlacements" name="ClassOfWarrantOrRightExercisePriceJunePrivatePlacements" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_YorkvilleFinancingWarrants" name="YorkvilleFinancingWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" name="ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GxiiWarrants" name="GxiiWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" name="ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangesInFairValueOfInitialValuation" name="ChangesInFairValueOfInitialValuation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_YorkvilleCashFee" name="YorkvilleCashFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ShareIssuanceCost" name="ShareIssuanceCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_SaleOfStockPricePerShare1" name="SaleOfStockPricePerShare1" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FairValueAssumptionsRiskFreeInterestRate1" name="FairValueAssumptionsRiskFreeInterestRate1" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FairValueAssumptionsExpected1VolatilityRate" name="FairValueAssumptionsExpected1VolatilityRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FairValueAssumptions1ExpectedTerm" name="FairValueAssumptions1ExpectedTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DescriptionOfAmendedPlan" name="DescriptionOfAmendedPlan" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AmountsAdvanced" name="AmountsAdvanced" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LineOfCreditFacilityPrepaymentFee" name="LineOfCreditFacilityPrepaymentFee" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AmountPaidToRelatedParty" name="AmountPaidToRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EstablishmentFeesPayable" name="EstablishmentFeesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CostCentreAxis" name="CostCentreAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="niobf_CostCentreDomain" name="CostCentreDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FixedRentExpense" name="FixedRentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LessAmountOfPaymentsRepresentingInterest" name="LessAmountOfPaymentsRepresentingInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DiscountRate" name="DiscountRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarnoutSharesLiability" name="EarnoutSharesLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_WarrantLiability" name="WarrantLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GxiiTransactionCosts" name="GxiiTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EffectOfLegislativeChanges" name="EffectOfLegislativeChanges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DeferredTaxAssetsMineralInterest" name="DeferredTaxAssetsMineralInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" name="DeferredTaxAssetsStartupAndOorganizationalCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" name="DeferredTaxAssetsResearchAndDevelopmentCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DeferredTaxAssetsShareIssuanceCosts" name="DeferredTaxAssetsShareIssuanceCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CapitalLossesAvailableForFuturePeriods" name="CapitalLossesAvailableForFuturePeriods" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DeferredTaxAssetsValuationAllowanceAdditions" name="DeferredTaxAssetsValuationAllowanceAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_IncreasesInCapitalLossesAvailableForFuturePeriods" name="IncreasesInCapitalLossesAvailableForFuturePeriods" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_OtherIncomeTaxes" name="OtherIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CapitalLossCaryforward" name="CapitalLossCaryforward" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" name="AvailableForSaleSecuritiesEquitySecuritiesOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ReverseStockSplitPolicy" name="ReverseStockSplitPolicy" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_TransactionCosts" name="TransactionCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PrivatePlacementSharesMay2022" name="PrivatePlacementSharesMay2022" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LindConvertibleSecurityMember" name="LindConvertibleSecurityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>26
<FILENAME>niobf-20230630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!--XBRL Document Created By The Nuvo Group-->
<!-- -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://niocorp.com/role/Cover" xlink:href="niobf-20230630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheets" xlink:href="niobf-20230630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:href="niobf-20230630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="niobf-20230630.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfCashFlows" xlink:href="niobf-20230630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:href="niobf-20230630.xsd#StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusiness" xlink:href="niobf-20230630.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPreparation" xlink:href="niobf-20230630.xsd#BasisOfPreparation" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPolicies" xlink:href="niobf-20230630.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcernIssues" xlink:href="niobf-20230630.xsd#GoingConcernIssues" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransaction" xlink:href="niobf-20230630.xsd#GxiiTransaction" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LandAndBuildingsNet" xlink:href="niobf-20230630.xsd#LandAndBuildingsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MineralProperties" xlink:href="niobf-20230630.xsd#MineralProperties" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="niobf-20230630.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebt" xlink:href="niobf-20230630.xsd#ConvertibleDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:href="niobf-20230630.xsd#ClassBCommonStockOfEcrc" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonShares" xlink:href="niobf-20230630.xsd#CommonShares" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" xlink:href="niobf-20230630.xsd#RelatedPartyTransactionsAndBalances" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpenditures" xlink:href="niobf-20230630.xsd#ExplorationExpenditures" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/Leases" xlink:href="niobf-20230630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxes" xlink:href="niobf-20230630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurements" xlink:href="niobf-20230630.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEvents" xlink:href="niobf-20230630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" xlink:href="niobf-20230630.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPreparationTables" xlink:href="niobf-20230630.xsd#BasisOfPreparationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesTables" xlink:href="niobf-20230630.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransactionTables" xlink:href="niobf-20230630.xsd#GxiiTransactionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LandAndBuildingsNetTables" xlink:href="niobf-20230630.xsd#LandAndBuildingsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="niobf-20230630.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebtTables" xlink:href="niobf-20230630.xsd#ConvertibleDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:href="niobf-20230630.xsd#ClassBCommonStockOfEcrcTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesTables" xlink:href="niobf-20230630.xsd#CommonSharesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:href="niobf-20230630.xsd#RelatedPartyTransactionsAndBalancesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpendituresTables" xlink:href="niobf-20230630.xsd#ExplorationExpendituresTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LeasesTables" xlink:href="niobf-20230630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxesTables" xlink:href="niobf-20230630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurementsTables" xlink:href="niobf-20230630.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails" xlink:href="niobf-20230630.xsd#ScheduleOfIntercompanyTransactionsAndBalancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:href="niobf-20230630.xsd#DescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:href="niobf-20230630.xsd#FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:href="niobf-20230630.xsd#ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details" xlink:href="niobf-20230630.xsd#RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details" xlink:href="niobf-20230630.xsd#RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details" xlink:href="niobf-20230630.xsd#RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="niobf-20230630.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" xlink:href="niobf-20230630.xsd#GoingConcernIssuesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" xlink:href="niobf-20230630.xsd#FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails" xlink:href="niobf-20230630.xsd#NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransactionDetailsNarrative" xlink:href="niobf-20230630.xsd#GxiiTransactionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfPropertiesDetails" xlink:href="niobf-20230630.xsd#ScheduleOfPropertiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative" xlink:href="niobf-20230630.xsd#LandAndBuildingsNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MineralPropertiesDetailsNarrative" xlink:href="niobf-20230630.xsd#MineralPropertiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:href="niobf-20230630.xsd#ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfConvertibleDebtDetails" xlink:href="niobf-20230630.xsd#ScheduleOfConvertibleDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:href="niobf-20230630.xsd#ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails" xlink:href="niobf-20230630.xsd#FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:href="niobf-20230630.xsd#ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details" xlink:href="niobf-20230630.xsd#ScheduleOfValuationDateAndProbabilityCalculated.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:href="niobf-20230630.xsd#ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" xlink:href="niobf-20230630.xsd#ConvertibleDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:href="niobf-20230630.xsd#FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details" xlink:href="niobf-20230630.xsd#FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" xlink:href="niobf-20230630.xsd#ClassBCommonStockOfEcrcDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:href="niobf-20230630.xsd#ScheduleOfStockOptionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details" xlink:href="niobf-20230630.xsd#FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:href="niobf-20230630.xsd#FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:href="niobf-20230630.xsd#WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:href="niobf-20230630.xsd#AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:href="niobf-20230630.xsd#CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:href="niobf-20230630.xsd#ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:href="niobf-20230630.xsd#ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:href="niobf-20230630.xsd#CommonSharesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:href="niobf-20230630.xsd#ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:href="niobf-20230630.xsd#RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:href="niobf-20230630.xsd#ScheduleOfExplorationExpendituresDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:href="niobf-20230630.xsd#CompanyIncurredLeaseCostsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details" xlink:href="niobf-20230630.xsd#MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LeasesDetailsNarrative" xlink:href="niobf-20230630.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails" xlink:href="niobf-20230630.xsd#DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:href="niobf-20230630.xsd#FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:href="niobf-20230630.xsd#DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" xlink:href="niobf-20230630.xsd#ChangesInValuationAllowanceAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" xlink:href="niobf-20230630.xsd#ScheduleOfCumulativeNetOperatingLossesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxesDetailsNarrative" xlink:href="niobf-20230630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:href="niobf-20230630.xsd#ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:href="niobf-20230630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssets" xlink:label="loc_us-gaapDepositsAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDepositsAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:label="loc_us-gaapLongTermInvestmentsAndReceivablesNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapLongTermInvestmentsAndReceivablesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" xlink:label="loc_us-gaapCapitalizedCostsMineralInterestsInUnprovedProperties" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapCapitalizedCostsMineralInterestsInUnprovedProperties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DueToOfficersOrStockholdersOtherCurrent" xlink:label="loc_niobfDueToOfficersOrStockholdersOtherCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_niobfDueToOfficersOrStockholdersOtherCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarnoutLiabilityAtFairValue" xlink:label="loc_niobfEarnoutLiabilityAtFairValue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_niobfEarnoutLiabilityAtFairValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityOtherCarryingAmount" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExplorationExpenditures" xlink:label="loc_niobfExplorationExpenditures" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_niobfExplorationExpenditures" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOtherGeneralExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:label="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangeInFairValueOfEarnoutLiability" xlink:label="loc_niobfChangeInFairValueOfEarnoutLiability" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_niobfChangeInFairValueOfEarnoutLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangeInFairValueOfWarrantLiability" xlink:label="loc_niobfChangeInFairValueOfWarrantLiability" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_niobfChangeInFairValueOfWarrantLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount" xlink:label="loc_us-gaapExtinguishmentOfDebtAmount" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_us-gaapExtinguishmentOfDebtAmount" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ProfitLoss1" xlink:label="loc_niobfProfitLoss1" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfProfitLoss1" xlink:to="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfProfitLoss1" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_niobfProfitLoss1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AssumptionOfEarnoutLiability" xlink:label="loc_niobfAssumptionOfEarnoutLiability" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfAssumptionOfEarnoutLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:label="loc_niobfChangeInFairValueOfEarnoutShareLiability" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfChangeInFairValueOfEarnoutShareLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AssumptionOfPrivateAndPublicWarrants" xlink:label="loc_niobfAssumptionOfPrivateAndPublicWarrants" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfAssumptionOfPrivateAndPublicWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAccretionExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LossesOnExtinguishmentOfDebt" xlink:label="loc_niobfLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangeInValuationOfWarrantLiabilities" xlink:label="loc_niobfChangeInValuationOfWarrantLiabilities" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfChangeInValuationOfWarrantLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FairValueOfCommitmentSharesIssued" xlink:label="loc_niobfFairValueOfCommitmentSharesIssued" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfFairValueOfCommitmentSharesIssued" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ForeignCurrencyTransactionGainLossBeforeTax1" xlink:label="loc_niobfForeignCurrencyTransactionGainLossBeforeTax1" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfForeignCurrencyTransactionGainLossBeforeTax1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="loc_us-gaapOperatingLeaseImpairmentLoss" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseImpairmentLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_OtheroperatingGainsLosses" xlink:label="loc_niobfOtheroperatingGainsLosses" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfOtheroperatingGainsLosses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMineralRights" xlink:label="loc_us-gaapPaymentsToAcquireMineralRights" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireMineralRights" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBuildings" xlink:label="loc_us-gaapPaymentsToAcquireBuildings" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireBuildings" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_us-gaapProceedsFromSaleOfProductiveAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfProductiveAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:title="00000006 - Statement - Consolidated Statements of Shareholders&apos; (Deficit) Equity and Redeemable Noncontrolling Interest" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusiness" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparation" xlink:title="00000008 - Disclosure - BASIS OF PREPARATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssues" xlink:title="00000010 - Disclosure - GOING CONCERN ISSUES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransaction" xlink:title="00000011 - Disclosure - GXII TRANSACTION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNet" xlink:title="00000012 - Disclosure - LAND AND BUILDINGS, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MineralProperties" xlink:title="00000013 - Disclosure - MINERAL PROPERTIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000014 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebt" xlink:title="00000015 - Disclosure - CONVERTIBLE DEBT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:title="00000016 - Disclosure - CLASS B COMMON STOCK OF ECRC" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonShares" xlink:title="00000017 - Disclosure - COMMON SHARES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" xlink:title="00000018 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpenditures" xlink:title="00000019 - Disclosure - EXPLORATION EXPENDITURES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Leases" xlink:title="00000020 - Disclosure - LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurements" xlink:title="00000022 - Disclosure - FAIR VALUE MEASUREMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEvents" xlink:title="00000023 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparationTables" xlink:title="00000025 - Disclosure - BASIS OF PREPARATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransactionTables" xlink:title="00000027 - Disclosure - GXII TRANSACTION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNetTables" xlink:title="00000028 - Disclosure - LAND AND BUILDINGS, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000029 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtTables" xlink:title="00000030 - Disclosure - CONVERTIBLE DEBT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:title="00000031 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesTables" xlink:title="00000032 - Disclosure - COMMON SHARES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:title="00000033 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpendituresTables" xlink:title="00000034 - Disclosure - EXPLORATION EXPENDITURES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesTables" xlink:title="00000035 - Disclosure - LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesTables" xlink:title="00000036 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurementsTables" xlink:title="00000037 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails" xlink:title="00000038 - Disclosure - Schedule of intercompany transactions and balances (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="00000039 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:title="00000040 - Disclosure - The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:title="00000041 - Disclosure - Schedule of excluded from the dilutive securities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details" xlink:title="00000042 - Disclosure - Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As of March 31, 2023 (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details" xlink:title="00000043 - Disclosure - Revision Impacts to the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For the Three &amp; Nine Months Ended March 31, 2023 (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details" xlink:title="00000044 - Disclosure - Revision Impacts to the Condensed Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023 (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000045 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" xlink:title="00000046 - Disclosure - GOING CONCERN ISSUES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" xlink:title="00000047 - Disclosure - The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails" xlink:title="00000048 - Disclosure - The number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransactionDetailsNarrative" xlink:title="00000049 - Disclosure - GXII TRANSACTION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfPropertiesDetails" xlink:title="00000050 - Disclosure - Schedule of properties (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative" xlink:title="00000051 - Disclosure - LAND AND BUILDINGS, NET (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MineralPropertiesDetailsNarrative" xlink:title="00000052 - Disclosure - MINERAL PROPERTIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:title="00000053 - Disclosure - Schedule of account payable and accrued liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfConvertibleDebtDetails" xlink:title="00000054 - Disclosure - Schedule of convertible debt (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:title="00000055 - Disclosure - Changes in the Lind III Convertible Security are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails" xlink:title="00000056 - Disclosure - The following table summarizes the components of the initial loss on extinguishment: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:title="00000057 - Disclosure - The change in the fair value of the Contingent Consent Warrants is presented below: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details" xlink:title="00000058 - Disclosure - Schedule of valuation date and the probability calculated. (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:title="00000059 - Disclosure - Changes in the Convertible Debentures are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" xlink:title="00000060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:title="00000061 - Disclosure - The following table discloses the primary inputs into the Monte Carlo models. (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details" xlink:title="00000062 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2023: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" xlink:title="00000063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:title="00000064 - Disclosure - Schedule of stock option (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details" xlink:title="00000065 - Disclosure - The following table summarizes information about stock options outstanding at June 30, 2023: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:title="00000066 - Disclosure - The following table summarizes the weighted average information and assumptions used to determine option costs: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:title="00000067 - Disclosure - Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:title="00000068 - Disclosure - At June 30, 2023, the Company has outstanding exercisable warrants, as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:title="00000069 - Disclosure - The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:title="00000070 - Disclosure - The change in the Private Warrants liability is presented below: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:title="00000071 - Disclosure - Schedule of expenses as other operating costs (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:title="00000072 - Disclosure - COMMON SHARES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:title="00000073 - Disclosure - Changes in the Smith Credit Agreement principal balance are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:title="00000074 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:title="00000075 - Disclosure - Schedule of exploration expenditures (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:title="00000076 - Disclosure - The Company incurred lease costs as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details" xlink:title="00000077 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2023: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesDetailsNarrative" xlink:title="00000078 - Disclosure - LEASES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails" xlink:title="00000079 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2023, 2022, and 2021 are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:title="00000080 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:title="00000081 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DeferredTaxAssetsMineralInterest" xlink:label="loc_niobfDeferredTaxAssetsMineralInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_niobfDeferredTaxAssetsMineralInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" xlink:label="loc_niobfDeferredTaxAssetsStartupAndOorganizationalCosts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_niobfDeferredTaxAssetsStartupAndOorganizationalCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" xlink:label="loc_niobfDeferredTaxAssetsResearchAndDevelopmentCosts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_niobfDeferredTaxAssetsResearchAndDevelopmentCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DeferredTaxAssetsShareIssuanceCosts" xlink:label="loc_niobfDeferredTaxAssetsShareIssuanceCosts" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_niobfDeferredTaxAssetsShareIssuanceCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CapitalLossesAvailableForFuturePeriods" xlink:label="loc_niobfCapitalLossesAvailableForFuturePeriods" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_niobfCapitalLossesAvailableForFuturePeriods" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" xlink:title="00000082 - Disclosure - Changes in the valuation allowance are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" xlink:title="00000083 - Disclosure - Schedule of cumulative net operating losses (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000084 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:title="00000085 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000086 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>27
<FILENAME>niobf-20230630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!--XBRL Document Created By The Nuvo Group-->
<!-- -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://niocorp.com/role/Cover" xlink:href="niobf-20230630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheets" xlink:href="niobf-20230630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:href="niobf-20230630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="niobf-20230630.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfCashFlows" xlink:href="niobf-20230630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:href="niobf-20230630.xsd#StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusiness" xlink:href="niobf-20230630.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPreparation" xlink:href="niobf-20230630.xsd#BasisOfPreparation" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPolicies" xlink:href="niobf-20230630.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcernIssues" xlink:href="niobf-20230630.xsd#GoingConcernIssues" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransaction" xlink:href="niobf-20230630.xsd#GxiiTransaction" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LandAndBuildingsNet" xlink:href="niobf-20230630.xsd#LandAndBuildingsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MineralProperties" xlink:href="niobf-20230630.xsd#MineralProperties" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="niobf-20230630.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebt" xlink:href="niobf-20230630.xsd#ConvertibleDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:href="niobf-20230630.xsd#ClassBCommonStockOfEcrc" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonShares" xlink:href="niobf-20230630.xsd#CommonShares" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" xlink:href="niobf-20230630.xsd#RelatedPartyTransactionsAndBalances" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpenditures" xlink:href="niobf-20230630.xsd#ExplorationExpenditures" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/Leases" xlink:href="niobf-20230630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxes" xlink:href="niobf-20230630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurements" xlink:href="niobf-20230630.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEvents" xlink:href="niobf-20230630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" xlink:href="niobf-20230630.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPreparationTables" xlink:href="niobf-20230630.xsd#BasisOfPreparationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesTables" xlink:href="niobf-20230630.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransactionTables" xlink:href="niobf-20230630.xsd#GxiiTransactionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LandAndBuildingsNetTables" xlink:href="niobf-20230630.xsd#LandAndBuildingsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="niobf-20230630.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebtTables" xlink:href="niobf-20230630.xsd#ConvertibleDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:href="niobf-20230630.xsd#ClassBCommonStockOfEcrcTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesTables" xlink:href="niobf-20230630.xsd#CommonSharesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:href="niobf-20230630.xsd#RelatedPartyTransactionsAndBalancesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpendituresTables" xlink:href="niobf-20230630.xsd#ExplorationExpendituresTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LeasesTables" xlink:href="niobf-20230630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxesTables" xlink:href="niobf-20230630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurementsTables" xlink:href="niobf-20230630.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails" xlink:href="niobf-20230630.xsd#ScheduleOfIntercompanyTransactionsAndBalancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:href="niobf-20230630.xsd#DescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:href="niobf-20230630.xsd#FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:href="niobf-20230630.xsd#ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details" xlink:href="niobf-20230630.xsd#RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details" xlink:href="niobf-20230630.xsd#RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details" xlink:href="niobf-20230630.xsd#RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="niobf-20230630.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" xlink:href="niobf-20230630.xsd#GoingConcernIssuesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" xlink:href="niobf-20230630.xsd#FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails" xlink:href="niobf-20230630.xsd#NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransactionDetailsNarrative" xlink:href="niobf-20230630.xsd#GxiiTransactionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfPropertiesDetails" xlink:href="niobf-20230630.xsd#ScheduleOfPropertiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative" xlink:href="niobf-20230630.xsd#LandAndBuildingsNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MineralPropertiesDetailsNarrative" xlink:href="niobf-20230630.xsd#MineralPropertiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:href="niobf-20230630.xsd#ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfConvertibleDebtDetails" xlink:href="niobf-20230630.xsd#ScheduleOfConvertibleDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:href="niobf-20230630.xsd#ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails" xlink:href="niobf-20230630.xsd#FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:href="niobf-20230630.xsd#ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details" xlink:href="niobf-20230630.xsd#ScheduleOfValuationDateAndProbabilityCalculated.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:href="niobf-20230630.xsd#ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" xlink:href="niobf-20230630.xsd#ConvertibleDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:href="niobf-20230630.xsd#FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details" xlink:href="niobf-20230630.xsd#FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" xlink:href="niobf-20230630.xsd#ClassBCommonStockOfEcrcDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:href="niobf-20230630.xsd#ScheduleOfStockOptionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details" xlink:href="niobf-20230630.xsd#FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:href="niobf-20230630.xsd#FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:href="niobf-20230630.xsd#WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:href="niobf-20230630.xsd#AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:href="niobf-20230630.xsd#CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:href="niobf-20230630.xsd#ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:href="niobf-20230630.xsd#ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:href="niobf-20230630.xsd#CommonSharesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:href="niobf-20230630.xsd#ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:href="niobf-20230630.xsd#RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:href="niobf-20230630.xsd#ScheduleOfExplorationExpendituresDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:href="niobf-20230630.xsd#CompanyIncurredLeaseCostsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details" xlink:href="niobf-20230630.xsd#MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LeasesDetailsNarrative" xlink:href="niobf-20230630.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails" xlink:href="niobf-20230630.xsd#DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:href="niobf-20230630.xsd#FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:href="niobf-20230630.xsd#DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" xlink:href="niobf-20230630.xsd#ChangesInValuationAllowanceAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" xlink:href="niobf-20230630.xsd#ScheduleOfCumulativeNetOperatingLossesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxesDetailsNarrative" xlink:href="niobf-20230630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:href="niobf-20230630.xsd#ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:href="niobf-20230630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CommonSharesWithoutParValueMember" xlink:label="loc_niobfCommonSharesWithoutParValueMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfCommonSharesWithoutParValueMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:label="loc_niobfWarrantsEachExercisableFor1.11829212CommonSharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfWarrantsEachExercisableFor1.11829212CommonSharesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_60" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_60" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_60" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_60" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_60" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_60" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_60" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_60" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_60" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_60" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_60" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_60" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_60" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_60" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_60" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_60" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_60" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_60" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_60" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_60" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_60" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_60" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_60" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_60" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_60" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_60" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_60" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_60" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_60" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_60" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_60" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorName_60" xlink:type="arc" order="58" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorLocation_60" xlink:type="arc" order="59" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorFirmId_60" xlink:type="arc" order="60" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:title="00000006 - Statement - Consolidated Statements of Shareholders&apos; (Deficit) Equity and Redeemable Noncontrolling Interest">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_RedeemableNoncontrollingInterestMember" xlink:label="loc_niobfRedeemableNoncontrollingInterestMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfRedeemableNoncontrollingInterestMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:label="loc_niobfStockIssuedDuringPeriodSharesStockWarrantExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodSharesStockWarrantExercised_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_StockIssuedDuringPeriodSharesStockWarrantExercisedShares" xlink:label="loc_niobfStockIssuedDuringPeriodSharesStockWarrantExercisedShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodSharesStockWarrantExercisedShares_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_PrivatePlacementValueMay2021" xlink:label="loc_niobfPrivatePlacementValueMay2021_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfPrivatePlacementValueMay2021_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_PrivatePlacementSharesMay2021" xlink:label="loc_niobfPrivatePlacementSharesMay2021_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfPrivatePlacementSharesMay2021_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_PrivatePlacementSharesMay2022Sahres" xlink:label="loc_niobfPrivatePlacementSharesMay2022Sahres_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfPrivatePlacementSharesMay2022Sahres_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CommonSharesIssuedInTheGXIITransaction" xlink:label="loc_niobfCommonSharesIssuedInTheGXIITransaction_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfCommonSharesIssuedInTheGXIITransaction_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CommonSharesIssuedInTheGXIITransactionSahres" xlink:label="loc_niobfCommonSharesIssuedInTheGXIITransactionSahres_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfCommonSharesIssuedInTheGXIITransactionSahres_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacility" xlink:label="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacility_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacility_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:label="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacilityShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacilityShares_60" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_RedeemableNoncontrollingInterest" xlink:label="loc_niobfRedeemableNoncontrollingInterest_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfRedeemableNoncontrollingInterest_60" xlink:type="arc" order="26" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusiness" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparation" xlink:title="00000008 - Disclosure - BASIS OF PREPARATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssues" xlink:title="00000010 - Disclosure - GOING CONCERN ISSUES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransaction" xlink:title="00000011 - Disclosure - GXII TRANSACTION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNet" xlink:title="00000012 - Disclosure - LAND AND BUILDINGS, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/MineralProperties" xlink:title="00000013 - Disclosure - MINERAL PROPERTIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000014 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebt" xlink:title="00000015 - Disclosure - CONVERTIBLE DEBT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:title="00000016 - Disclosure - CLASS B COMMON STOCK OF ECRC" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonShares" xlink:title="00000017 - Disclosure - COMMON SHARES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" xlink:title="00000018 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpenditures" xlink:title="00000019 - Disclosure - EXPLORATION EXPENDITURES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/Leases" xlink:title="00000020 - Disclosure - LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurements" xlink:title="00000022 - Disclosure - FAIR VALUE MEASUREMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEvents" xlink:title="00000023 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparationTables" xlink:title="00000025 - Disclosure - BASIS OF PREPARATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransactionTables" xlink:title="00000027 - Disclosure - GXII TRANSACTION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNetTables" xlink:title="00000028 - Disclosure - LAND AND BUILDINGS, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000029 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtTables" xlink:title="00000030 - Disclosure - CONVERTIBLE DEBT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:title="00000031 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesTables" xlink:title="00000032 - Disclosure - COMMON SHARES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:title="00000033 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpendituresTables" xlink:title="00000034 - Disclosure - EXPLORATION EXPENDITURES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesTables" xlink:title="00000035 - Disclosure - LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesTables" xlink:title="00000036 - Disclosure - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurementsTables" xlink:title="00000037 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails" xlink:title="00000038 - Disclosure - Schedule of intercompany transactions and balances (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_Entity0896800BCLtdMember" xlink:label="loc_niobfEntity0896800BCLtdMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfEntity0896800BCLtdMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ElkCreekResourcesCorpMember" xlink:label="loc_niobfElkCreekResourcesCorpMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfElkCreekResourcesCorpMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ElkCreekResourcesCorpECRCMember" xlink:label="loc_niobfElkCreekResourcesCorpECRCMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfElkCreekResourcesCorpECRCMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_IncorporationStateCountryName" xlink:label="loc_niobfIncorporationStateCountryName_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_niobfIncorporationStateCountryName_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent_110" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="00000039 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:title="00000040 - Disclosure - The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:title="00000041 - Disclosure - Schedule of excluded from the dilutive securities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details" xlink:title="00000042 - Disclosure - Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As of March 31, 2023 (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember" xlink:label="loc_srtRestatementAdjustmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRestatementAdjustmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilities_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_40" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details" xlink:title="00000043 - Disclosure - Revision Impacts to the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For the Three &amp; Nine Months Ended March 31, 2023 (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember" xlink:label="loc_srtRestatementAdjustmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRestatementAdjustmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherGeneralExpense_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpenses_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangeInFairValueOfWarrantLiability" xlink:label="loc_niobfChangeInFairValueOfWarrantLiability_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfChangeInFairValueOfWarrantLiability_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ProfitLoss1" xlink:label="loc_niobfProfitLoss1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfProfitLoss1_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:label="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarningsLossPerShareBasicAndDiluted" xlink:label="loc_niobfEarningsLossPerShareBasicAndDiluted_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfEarningsLossPerShareBasicAndDiluted_70" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details" xlink:title="00000044 - Disclosure - Revision Impacts to the Condensed Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023 (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember" xlink:label="loc_srtRestatementAdjustmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRestatementAdjustmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AssumptionOfPrivateAndPublicWarrants" xlink:label="loc_niobfAssumptionOfPrivateAndPublicWarrants_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfAssumptionOfPrivateAndPublicWarrants_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000045 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" xlink:title="00000046 - Disclosure - GOING CONCERN ISSUES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" xlink:title="00000047 - Disclosure - The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails" xlink:title="00000048 - Disclosure - The number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="loc_us-gaapOffsettingAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapOffsettingAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LegacyNioCorpShareholdersMember" xlink:label="loc_niobfLegacyNioCorpShareholdersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfLegacyNioCorpShareholdersMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GXIIClassAShareholdersMember" xlink:label="loc_niobfGXIIClassAShareholdersMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIClassAShareholdersMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_OtherMember" xlink:label="loc_niobfOtherMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfOtherMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_90" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransactionDetailsNarrative" xlink:title="00000049 - Disclosure - GXII TRANSACTION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_WarrantAgreementMember" xlink:label="loc_niobfWarrantAgreementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfWarrantAgreementMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfPropertiesDetails" xlink:title="00000050 - Disclosure - Schedule of properties (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember" xlink:label="loc_us-gaapLandMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapLandMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapBuildingMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOther" xlink:label="loc_us-gaapPropertyPlantAndEquipmentOther_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentOther_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative" xlink:title="00000051 - Disclosure - LAND AND BUILDINGS, NET (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandImprovementsMember" xlink:label="loc_us-gaapLandImprovementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandImprovementsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandPurchaseOptionsDescription" xlink:label="loc_us-gaapLandPurchaseOptionsDescription_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapLandPurchaseOptionsDescription_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAndLandImprovements" xlink:label="loc_us-gaapLandAndLandImprovements_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapLandAndLandImprovements_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnersCapitalAccountDescriptionOfUnits" xlink:label="loc_us-gaapLimitedPartnersCapitalAccountDescriptionOfUnits_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapLimitedPartnersCapitalAccountDescriptionOfUnits_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" xlink:label="loc_us-gaapRealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapRealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_30" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/MineralPropertiesDetailsNarrative" xlink:title="00000052 - Disclosure - MINERAL PROPERTIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReserveQuantitiesLineItems" xlink:label="loc_srtReserveQuantitiesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:label="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_Entity0896800BCLtdMember" xlink:label="loc_niobfEntity0896800BCLtdMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_niobfEntity0896800BCLtdMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ShareExchangeAgreementMember" xlink:label="loc_niobfShareExchangeAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfShareExchangeAgreementMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_OptionAgreementMember" xlink:label="loc_niobfOptionAgreementMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfOptionAgreementMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ElkCreekResourcesCorpMember" xlink:label="loc_niobfElkCreekResourcesCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfElkCreekResourcesCorpMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD" xlink:label="loc_currencyCAD_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DeferredTaxImpacts" xlink:label="loc_niobfDeferredTaxImpacts_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_niobfDeferredTaxImpacts_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalDeferredPurchasePrice" xlink:label="loc_us-gaapSupplementalDeferredPurchasePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_us-gaapSupplementalDeferredPurchasePrice_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfAcquisitionCosts" xlink:label="loc_us-gaapAmortizationOfAcquisitionCosts_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_us-gaapAmortizationOfAcquisitionCosts_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMineralRights" xlink:label="loc_us-gaapPaymentsToAcquireMineralRights_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_us-gaapPaymentsToAcquireMineralRights_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBuildings" xlink:label="loc_us-gaapPaymentsToAcquireBuildings_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBuildings_60" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:title="00000053 - Disclosure - Schedule of account payable and accrued liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfConvertibleDebtDetails" xlink:title="00000054 - Disclosure - Schedule of convertible debt (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ConvertibleSecurityMember" xlink:label="loc_niobfConvertibleSecurityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfConvertibleSecurityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtCurrent_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtNoncurrent_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:title="00000055 - Disclosure - Changes in the Lind III Convertible Security are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ConvertibleSecurityMember" xlink:label="loc_niobfConvertibleSecurityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_niobfConvertibleSecurityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtNoncurrent_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount" xlink:label="loc_us-gaapExtinguishmentOfDebtAmount_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapExtinguishmentOfDebtAmount_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaapConversionOfStockAmountIssued1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConversionOfStockAmountIssued1_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAccretionExpense_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:label="loc_us-gaapPaymentsToAcquireHeldToMaturitySecurities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapPaymentsToAcquireHeldToMaturitySecurities_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtCurrent_60" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails" xlink:title="00000056 - Disclosure - The following table summarizes the components of the initial loss on extinguishment: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:title="00000057 - Disclosure - The change in the fair value of the Contingent Consent Warrants is presented below: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details" xlink:title="00000058 - Disclosure - Schedule of valuation date and the probability calculated. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaapMeasurementInputSharePriceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputSharePriceMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ProbabilityOfIssuanceMember" xlink:label="loc_niobfProbabilityOfIssuanceMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_niobfProbabilityOfIssuanceMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_90" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:title="00000059 - Disclosure - Changes in the Convertible Debentures are as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" xlink:title="00000060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LindIIIConvertibleSecurityMember" xlink:label="loc_niobfLindIIIConvertibleSecurityMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfLindIIIConvertibleSecurityMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LindIIIConvertibleSecurityMember" xlink:label="loc_niobfLindIIIConvertibleSecurityMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_niobfLindIIIConvertibleSecurityMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember" xlink:label="loc_us-gaapUnsecuredDebtMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapUnsecuredDebtMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_180" xlink:type="arc" order="182" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_190" xlink:type="arc" order="192" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_200" xlink:type="arc" order="202" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaapMeasurementInputSharePriceMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputSharePriceMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_230" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInterestRate" xlink:label="loc_us-gaapInvestmentInterestRate_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapInvestmentInterestRate_230" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment" xlink:label="loc_us-gaapOtherCommitment_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapOtherCommitment_230" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInterestReceived" xlink:label="loc_us-gaapProceedsFromInterestReceived_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromInterestReceived_230" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTerm" xlink:label="loc_us-gaapLongTermDebtTerm_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtTerm_230" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionDescription" xlink:label="loc_us-gaapDebtConversionDescription_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtConversionDescription_230" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonUnitIssued" xlink:label="loc_us-gaapCommonUnitIssued_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapCommonUnitIssued_230" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:label="loc_us-gaapAcceleratedShareRepurchasesFinalPricePaidPerShare_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapAcceleratedShareRepurchasesFinalPricePaidPerShare_230" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_230" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate_230" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_230" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntermediateLifePlantsUsefulLife" xlink:label="loc_us-gaapIntermediateLifePlantsUsefulLife_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapIntermediateLifePlantsUsefulLife_230" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapConvertibleDebtCurrent_230" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_TransactionCost" xlink:label="loc_niobfTransactionCost_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfTransactionCost_230" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:label="loc_us-gaapLineOfCreditFacilityCommitmentFeeAmount_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityCommitmentFeeAmount_230" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_230" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" xlink:label="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise_230" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_230" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentTerms" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentTerms_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentTerms_230" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_230" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaapDebtInstrumentRedemptionPricePercentage_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentRedemptionPricePercentage_230" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1" xlink:label="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise1_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise1_230" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="loc_us-gaapLossContingencyAccrualAtCarryingValue_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLossContingencyAccrualAtCarryingValue_230" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingLiability" xlink:label="loc_us-gaapServicingLiability_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapServicingLiability_230" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_230" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_230" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" xlink:label="loc_niobfShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_230" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DebtMaturityPeriod" xlink:label="loc_niobfDebtMaturityPeriod_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfDebtMaturityPeriod_230" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts_230" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" xlink:label="loc_us-gaapOptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapOptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_230" xlink:type="arc" order="29" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:title="00000061 - Disclosure - The following table discloses the primary inputs into the Monte Carlo models. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharePrice_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details" xlink:title="00000062 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2023: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingLiabilityAtFairValueAmount" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAmount_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAmount_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingLiabilityAtFairValueAdditions" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAdditions_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAdditions_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" xlink:title="00000063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DescriptionOfEarnOutShares" xlink:label="loc_niobfDescriptionOfEarnOutShares_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfDescriptionOfEarnOutShares_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:title="00000064 - Disclosure - Schedule of stock option (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details" xlink:title="00000065 - Disclosure - The following table summarizes information about stock options outstanding at June 30, 2023: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice8.40Member" xlink:label="loc_niobfExercisePrice8.40Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice8.40Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice5.40Member" xlink:label="loc_niobfExercisePrice5.40Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice5.40Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice7.50Member" xlink:label="loc_niobfExercisePrice7.50Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice7.50Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice7.50OneMember" xlink:label="loc_niobfExercisePrice7.50OneMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice7.50OneMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice13.60Member" xlink:label="loc_niobfExercisePrice13.60Member_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice13.60Member_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice11.00Member" xlink:label="loc_niobfExercisePrice11.00Member_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice11.00Member_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice6.95Member" xlink:label="loc_niobfExercisePrice6.95Member_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice6.95Member_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD" xlink:label="loc_currencyCAD_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1" xlink:label="loc_niobfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_niobfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_190" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:title="00000066 - Disclosure - The following table summarizes the weighted average information and assumptions used to determine option costs: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD" xlink:label="loc_currencyCAD_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_60" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:title="00000067 - Disclosure - Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:title="00000068 - Disclosure - At June 30, 2023, the Company has outstanding exercisable warrants, as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice11.00Member" xlink:label="loc_niobfExercisePrice11.00Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice11.00Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice9.70Member" xlink:label="loc_niobfExercisePrice9.70Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice9.70Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice8.94Member" xlink:label="loc_niobfExercisePrice8.94Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice8.94Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice11.50Member" xlink:label="loc_niobfExercisePrice11.50Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice11.50Member_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD" xlink:label="loc_currencyCAD_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate_80" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:title="00000069 - Disclosure - The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapSharePrice_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_50" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:title="00000070 - Disclosure - The change in the Private Warrants liability is presented below: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoteWarrantMember" xlink:label="loc_us-gaapNoteWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapNoteWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangesInFairValueOfInitialValuation" xlink:label="loc_niobfChangesInFairValueOfInitialValuation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:label="loc_us-gaapServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:title="00000071 - Disclosure - Schedule of expenses as other operating costs (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_YorkvilleCashFee" xlink:label="loc_niobfYorkvilleCashFee_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_niobfYorkvilleCashFee_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaapOtherCostAndExpenseOperating_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOtherCostAndExpenseOperating_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOperatingCostsAndExpenses_20" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:title="00000072 - Disclosure - COMMON SHARES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD" xlink:label="loc_currencyCAD_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LongTermIncentivePlanMember" xlink:label="loc_niobfLongTermIncentivePlanMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_niobfLongTermIncentivePlanMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GXIIPublicWarrantsMember" xlink:label="loc_niobfGXIIPublicWarrantsMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIPublicWarrantsMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GXIIPrivateWarrantsMember" xlink:label="loc_niobfGXIIPrivateWarrantsMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIPrivateWarrantsMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfferingCostsPartnershipInterests" xlink:label="loc_us-gaapOfferingCostsPartnershipInterests_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapOfferingCostsPartnershipInterests_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ShareIssuanceCost" xlink:label="loc_niobfShareIssuanceCost_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfShareIssuanceCost_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_140" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_SaleOfStockPricePerShare1" xlink:label="loc_niobfSaleOfStockPricePerShare1_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfSaleOfStockPricePerShare1_140" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForCommissions" xlink:label="loc_us-gaapPaymentsForCommissions_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPaymentsForCommissions_140" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FairValueAssumptionsRiskFreeInterestRate1" xlink:label="loc_niobfFairValueAssumptionsRiskFreeInterestRate1_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfFairValueAssumptionsRiskFreeInterestRate1_140" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FairValueAssumptionsExpected1VolatilityRate" xlink:label="loc_niobfFairValueAssumptionsExpected1VolatilityRate_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfFairValueAssumptionsExpected1VolatilityRate_140" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FairValueAssumptions1ExpectedTerm" xlink:label="loc_niobfFairValueAssumptions1ExpectedTerm_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfFairValueAssumptions1ExpectedTerm_140" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DescriptionOfAmendedPlan" xlink:label="loc_niobfDescriptionOfAmendedPlan_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfDescriptionOfAmendedPlan_140" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharePrice_140" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_140" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_140" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees_140" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:title="00000073 - Disclosure - Changes in the Smith Credit Agreement principal balance are as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:title="00000074 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GeneralSecurityAgreementMember" xlink:label="loc_niobfGeneralSecurityAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfGeneralSecurityAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AmendedNonRevolvingCreditFacilityAgreementMember" xlink:label="loc_niobfAmendedNonRevolvingCreditFacilityAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfAmendedNonRevolvingCreditFacilityAgreementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_NonRevolvingCreditFacilityAgreementMember" xlink:label="loc_niobfNonRevolvingCreditFacilityAgreementMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfNonRevolvingCreditFacilityAgreementMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_srtChiefExecutiveOfficerMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_MarkSmithMember" xlink:label="loc_niobfMarkSmithMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_niobfMarkSmithMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="loc_us-gaapRelatedPartyTransactionRate_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionRate_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LineOfCreditFacilityPrepaymentFee" xlink:label="loc_niobfLineOfCreditFacilityPrepaymentFee_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_niobfLineOfCreditFacilityPrepaymentFee_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaapLongTermLineOfCredit_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLongTermLineOfCredit_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AmountPaidToRelatedParty" xlink:label="loc_niobfAmountPaidToRelatedParty_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_niobfAmountPaidToRelatedParty_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EstablishmentFeesPayable" xlink:label="loc_niobfEstablishmentFeesPayable_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_niobfEstablishmentFeesPayable_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_100" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:title="00000075 - Disclosure - Schedule of exploration expenditures (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CostCentreAxis" xlink:label="loc_niobfCostCentreAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_niobfCostCentreAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CostCentreDomain" xlink:label="loc_niobfCostCentreDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_niobfCostCentreAxis" xlink:to="loc_niobfCostCentreDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CostCentreDomain" xlink:label="loc_niobfCostCentreDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_niobfCostCentreAxis" xlink:to="loc_niobfCostCentreDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FeasibilityStudyAndEngineeringMember" xlink:label="loc_niobfFeasibilityStudyAndEngineeringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfFeasibilityStudyAndEngineeringMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FieldManagementAndOtherMember" xlink:label="loc_niobfFieldManagementAndOtherMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfFieldManagementAndOtherMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExplorationAndProductionEquipmentMember" xlink:label="loc_us-gaapExplorationAndProductionEquipmentMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_us-gaapExplorationAndProductionEquipmentMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GeologistsAndFieldStaffMember" xlink:label="loc_niobfGeologistsAndFieldStaffMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfGeologistsAndFieldStaffMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExplorationExpense" xlink:label="loc_us-gaapExplorationExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapExplorationExpense_160" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:title="00000076 - Disclosure - The Company incurred lease costs as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details" xlink:title="00000077 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2023: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesDetailsNarrative" xlink:title="00000078 - Disclosure - LEASES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CorporateOfficeMember" xlink:label="loc_niobfCorporateOfficeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_niobfCorporateOfficeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="loc_us-gaapLesseeOperatingLeaseOptionToExtend_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseOptionToExtend_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DiscountRate" xlink:label="loc_niobfDiscountRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_niobfDiscountRate_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="loc_us-gaapLesseeOperatingLeaseRemainingLeaseTerm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseRemainingLeaseTerm_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapOperatingLeasePayments_60" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails" xlink:title="00000079 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2023, 2022, and 2021 are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_100" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:title="00000080 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:title="00000081 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" xlink:title="00000082 - Disclosure - Changes in the valuation allowance are as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" xlink:title="00000083 - Disclosure - Schedule of cumulative net operating losses (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOtherLossCarryforwards_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOtherLossCarryforwards_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_80" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000084 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD" xlink:label="loc_currencyCAD_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_IncreasesInCapitalLossesAvailableForFuturePeriods" xlink:label="loc_niobfIncreasesInCapitalLossesAvailableForFuturePeriods_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_niobfIncreasesInCapitalLossesAvailableForFuturePeriods_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_OtherIncomeTaxes" xlink:label="loc_niobfOtherIncomeTaxes_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_niobfOtherIncomeTaxes_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CapitalLossCaryforward" xlink:label="loc_niobfCapitalLossCaryforward_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_niobfCapitalLossCaryforward_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:title="00000085 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:label="loc_niobfAvailableForSaleSecuritiesEquitySecuritiesOther_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_niobfAvailableForSaleSecuritiesEquitySecuritiesOther_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapOtherLiabilitiesFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapOtherLiabilitiesFairValueDisclosure_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapFinancialLiabilitiesFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFinancialLiabilitiesFairValueDisclosure_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" xlink:label="loc_us-gaapMortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapMortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_90" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000086 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FinancingAgreementMember" xlink:label="loc_niobfFinancingAgreementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfFinancingAgreementMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventDescription" xlink:label="loc_us-gaapSubsequentEventDescription_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventDescription_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds" xlink:label="loc_us-gaapDemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds_50" xlink:type="arc" order="2" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>28
<FILENAME>niobf-20230630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!--XBRL Document Created By The Nuvo Group-->
<!-- -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CommonSharesWithoutParValueMember" xlink:label="niobf_CommonSharesWithoutParValueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonSharesWithoutParValueMember" xlink:to="niobf_CommonSharesWithoutParValueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CommonSharesWithoutParValueMember_lbl" xml:lang="en-US">Common Shares Without Par Value [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:label="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:to="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember_lbl" xml:lang="en-US">Warrants Each Exercisable for 1.11829212 Common Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_RedeemableNoncontrollingInterestMember" xlink:label="niobf_RedeemableNoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterestMember" xlink:to="niobf_RedeemableNoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_RedeemableNoncontrollingInterestMember_lbl" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_Entity0896800BCLtdMember" xlink:label="niobf_Entity0896800BCLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_Entity0896800BCLtdMember" xlink:to="niobf_Entity0896800BCLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_Entity0896800BCLtdMember_lbl" xml:lang="en-US">Entity 0896800 B C Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ElkCreekResourcesCorpMember" xlink:label="niobf_ElkCreekResourcesCorpMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ElkCreekResourcesCorpMember" xlink:to="niobf_ElkCreekResourcesCorpMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ElkCreekResourcesCorpMember_lbl" xml:lang="en-US">Elk Creek Resources Corp [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ElkCreekResourcesCorpECRCMember" xlink:label="niobf_ElkCreekResourcesCorpECRCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ElkCreekResourcesCorpECRCMember" xlink:to="niobf_ElkCreekResourcesCorpECRCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ElkCreekResourcesCorpECRCMember_lbl" xml:lang="en-US">Elk Creek Resources Corp ECRC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAxis_lbl" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xml:lang="en-US">Previously Reported [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember" xlink:label="srt_RestatementAdjustmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAdjustmentMember" xlink:to="srt_RestatementAdjustmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAdjustmentMember_lbl" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_WarrantAgreementMember" xlink:label="niobf_WarrantAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantAgreementMember" xlink:to="niobf_WarrantAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_WarrantAgreementMember_lbl" xml:lang="en-US">Warrant Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis" xlink:label="us-gaap_TransactionTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransactionTypeAxis_lbl" xml:lang="en-US">Transaction Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LegacyNioCorpShareholdersMember" xlink:label="niobf_LegacyNioCorpShareholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LegacyNioCorpShareholdersMember" xlink:to="niobf_LegacyNioCorpShareholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LegacyNioCorpShareholdersMember_lbl" xml:lang="en-US">Legacy Nio Corp Shareholders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GXIIClassAShareholdersMember" xlink:label="niobf_GXIIClassAShareholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIClassAShareholdersMember" xlink:to="niobf_GXIIClassAShareholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GXIIClassAShareholdersMember_lbl" xml:lang="en-US">GXII Class A Shareholders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_OtherMember" xlink:label="niobf_OtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtherMember" xlink:to="niobf_OtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_OtherMember_lbl" xml:lang="en-US">Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember" xlink:label="us-gaap_LandMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandMember" xlink:to="us-gaap_LandMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LandMember_lbl" xml:lang="en-US">Land [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US">Building [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandImprovementsMember" xlink:label="us-gaap_LandImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandImprovementsMember" xlink:to="us-gaap_LandImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LandImprovementsMember_lbl" xml:lang="en-US">Land Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ShareExchangeAgreementMember" xlink:label="niobf_ShareExchangeAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareExchangeAgreementMember" xlink:to="niobf_ShareExchangeAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ShareExchangeAgreementMember_lbl" xml:lang="en-US">Share Exchange Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CurrencyAxis" xlink:to="srt_CurrencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CurrencyAxis_lbl" xml:lang="en-US">Currency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD" xlink:label="currency_CAD" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_CAD" xlink:to="currency_CAD_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_CAD_lbl" xml:lang="en-US">Canada, Dollars</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_OptionAgreementMember" xlink:label="niobf_OptionAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OptionAgreementMember" xlink:to="niobf_OptionAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_OptionAgreementMember_lbl" xml:lang="en-US">Option Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ConvertibleSecurityMember" xlink:label="niobf_ConvertibleSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConvertibleSecurityMember" xlink:to="niobf_ConvertibleSecurityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ConvertibleSecurityMember_lbl" xml:lang="en-US">Convertible Security [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LindIIIConvertibleSecurityMember" xlink:label="niobf_LindIIIConvertibleSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LindIIIConvertibleSecurityMember" xlink:to="niobf_LindIIIConvertibleSecurityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LindIIIConvertibleSecurityMember_lbl" xml:lang="en-US">Lind I I I Convertible Security [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember" xlink:label="us-gaap_UnsecuredDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnsecuredDebtMember" xlink:to="us-gaap_UnsecuredDebtMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnsecuredDebtMember_lbl" xml:lang="en-US">Unsecured Debt [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="niobf_YorkvilleConvertibleDebtFinancingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:to="niobf_YorkvilleConvertibleDebtFinancingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_YorkvilleConvertibleDebtFinancingAgreementMember_lbl" xml:lang="en-US">Yorkville Convertible Debt Financing Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputSharePriceMember" xlink:to="us-gaap_MeasurementInputSharePriceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl" xml:lang="en-US">Measurement Input, Share Price [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ProbabilityOfIssuanceMember" xlink:label="niobf_ProbabilityOfIssuanceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ProbabilityOfIssuanceMember" xlink:to="niobf_ProbabilityOfIssuanceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ProbabilityOfIssuanceMember_lbl" xml:lang="en-US">Probability of Issuance [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarnoutMember" xlink:label="niobf_EarnoutMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutMember" xlink:to="niobf_EarnoutMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarnoutMember_lbl" xml:lang="en-US">Earnout [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="us-gaap_MeasurementInputExercisePriceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExercisePriceMember" xlink:to="us-gaap_MeasurementInputExercisePriceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExercisePriceMember_lbl" xml:lang="en-US">Measurement Input, Exercise Price [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:to="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xml:lang="en-US">Valuation Technique, Option Pricing Model [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LongTermIncentivePlanMember" xlink:label="niobf_LongTermIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LongTermIncentivePlanMember" xlink:to="niobf_LongTermIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LongTermIncentivePlanMember_lbl" xml:lang="en-US">Long TermIncentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GXIIPublicWarrantsMember" xlink:label="niobf_GXIIPublicWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIPublicWarrantsMember" xlink:to="niobf_GXIIPublicWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GXIIPublicWarrantsMember_lbl" xml:lang="en-US">GXII Public Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GXIIPrivateWarrantsMember" xlink:label="niobf_GXIIPrivateWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIPrivateWarrantsMember" xlink:to="niobf_GXIIPrivateWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GXIIPrivateWarrantsMember_lbl" xml:lang="en-US">GXII Private Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice8.40Member" xlink:label="niobf_ExercisePrice8.40Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice8.40Member" xlink:to="niobf_ExercisePrice8.40Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice8.40Member_lbl" xml:lang="en-US">Exercise Price 8.40 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice5.40Member" xlink:label="niobf_ExercisePrice5.40Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice5.40Member" xlink:to="niobf_ExercisePrice5.40Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice5.40Member_lbl" xml:lang="en-US">Exercise Price 5.40 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice7.50Member" xlink:label="niobf_ExercisePrice7.50Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice7.50Member" xlink:to="niobf_ExercisePrice7.50Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice7.50Member_lbl" xml:lang="en-US">Exercise Price 7.50 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice7.50OneMember" xlink:label="niobf_ExercisePrice7.50OneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice7.50OneMember" xlink:to="niobf_ExercisePrice7.50OneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice7.50OneMember_lbl" xml:lang="en-US">Exercise Price 7.50 One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice13.60Member" xlink:label="niobf_ExercisePrice13.60Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice13.60Member" xlink:to="niobf_ExercisePrice13.60Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice13.60Member_lbl" xml:lang="en-US">Exercise Price 13.60 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice11.00Member" xlink:label="niobf_ExercisePrice11.00Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice11.00Member" xlink:to="niobf_ExercisePrice11.00Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice11.00Member_lbl" xml:lang="en-US">Exercise Price 11.00 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice6.95Member" xlink:label="niobf_ExercisePrice6.95Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice6.95Member" xlink:to="niobf_ExercisePrice6.95Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice6.95Member_lbl" xml:lang="en-US">Exercise Price 6.95 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice9.70Member" xlink:label="niobf_ExercisePrice9.70Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice9.70Member" xlink:to="niobf_ExercisePrice9.70Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice9.70Member_lbl" xml:lang="en-US">Exercise Price 9.70 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice8.94Member" xlink:label="niobf_ExercisePrice8.94Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice8.94Member" xlink:to="niobf_ExercisePrice8.94Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice8.94Member_lbl" xml:lang="en-US">Exercise Price 8.94 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice11.50Member" xlink:label="niobf_ExercisePrice11.50Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice11.50Member" xlink:to="niobf_ExercisePrice11.50Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice11.50Member_lbl" xml:lang="en-US">Exercise Price11.50 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoteWarrantMember" xlink:label="us-gaap_NoteWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoteWarrantMember" xlink:to="us-gaap_NoteWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoteWarrantMember_lbl" xml:lang="en-US">Note Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GeneralSecurityAgreementMember" xlink:label="niobf_GeneralSecurityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GeneralSecurityAgreementMember" xlink:to="niobf_GeneralSecurityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GeneralSecurityAgreementMember_lbl" xml:lang="en-US">General Security Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AmendedNonRevolvingCreditFacilityAgreementMember" xlink:label="niobf_AmendedNonRevolvingCreditFacilityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AmendedNonRevolvingCreditFacilityAgreementMember" xlink:to="niobf_AmendedNonRevolvingCreditFacilityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_AmendedNonRevolvingCreditFacilityAgreementMember_lbl" xml:lang="en-US">Amended Non Revolving Credit Facility Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_MarkSmithMember" xlink:label="niobf_MarkSmithMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MarkSmithMember" xlink:to="niobf_MarkSmithMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_MarkSmithMember_lbl" xml:lang="en-US">Mark Smith [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_NonRevolvingCreditFacilityAgreementMember" xlink:label="niobf_NonRevolvingCreditFacilityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NonRevolvingCreditFacilityAgreementMember" xlink:to="niobf_NonRevolvingCreditFacilityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_NonRevolvingCreditFacilityAgreementMember_lbl" xml:lang="en-US">Non Revolving Credit Facility Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CostCentreAxis" xlink:label="niobf_CostCentreAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CostCentreAxis" xlink:to="niobf_CostCentreAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CostCentreAxis_lbl" xml:lang="en-US">Cost Centre [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FeasibilityStudyAndEngineeringMember" xlink:label="niobf_FeasibilityStudyAndEngineeringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FeasibilityStudyAndEngineeringMember" xlink:to="niobf_FeasibilityStudyAndEngineeringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FeasibilityStudyAndEngineeringMember_lbl" xml:lang="en-US">Feasibility Study and Engineering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FieldManagementAndOtherMember" xlink:label="niobf_FieldManagementAndOtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FieldManagementAndOtherMember" xlink:to="niobf_FieldManagementAndOtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FieldManagementAndOtherMember_lbl" xml:lang="en-US">Field Management and Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExplorationAndProductionEquipmentMember" xlink:label="us-gaap_ExplorationAndProductionEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExplorationAndProductionEquipmentMember" xlink:to="us-gaap_ExplorationAndProductionEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExplorationAndProductionEquipmentMember_lbl" xml:lang="en-US">Exploration and Production Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GeologistsAndFieldStaffMember" xlink:label="niobf_GeologistsAndFieldStaffMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GeologistsAndFieldStaffMember" xlink:to="niobf_GeologistsAndFieldStaffMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GeologistsAndFieldStaffMember_lbl" xml:lang="en-US">Geologists and Field Staff [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CorporateOfficeMember" xlink:label="niobf_CorporateOfficeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CorporateOfficeMember" xlink:to="niobf_CorporateOfficeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CorporateOfficeMember_lbl" xml:lang="en-US">Corporate Office [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FinancingAgreementMember" xlink:label="niobf_FinancingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FinancingAgreementMember" xlink:to="niobf_FinancingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FinancingAgreementMember_lbl" xml:lang="en-US">Financing Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssets" xlink:label="us-gaap_DepositsAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssets" xlink:to="us-gaap_DepositsAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssets_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:label="us-gaap_LongTermInvestmentsAndReceivablesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:to="us-gaap_LongTermInvestmentsAndReceivablesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermInvestmentsAndReceivablesNet_lbl" xml:lang="en-US">Investment in equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Land and buildings, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" xlink:label="us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" xlink:to="us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties_lbl" xml:lang="en-US">Mineral properties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DueToOfficersOrStockholdersOtherCurrent" xlink:label="niobf_DueToOfficersOrStockholdersOtherCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DueToOfficersOrStockholdersOtherCurrent" xlink:to="niobf_DueToOfficersOrStockholdersOtherCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DueToOfficersOrStockholdersOtherCurrent_lbl" xml:lang="en-US">Related party loan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="us-gaap_ConvertibleDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtCurrent_lbl" xml:lang="en-US">Convertible debt, current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="us-gaap_ConvertibleDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtNoncurrent" xlink:to="us-gaap_ConvertibleDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtNoncurrent_lbl" xml:lang="en-US">Convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Warrant liabilities, at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarnoutLiabilityAtFairValue" xlink:label="niobf_EarnoutLiabilityAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutLiabilityAtFairValue" xlink:to="niobf_EarnoutLiabilityAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarnoutLiabilityAtFairValue_lbl" xml:lang="en-US">Earnout liability, at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_lbl" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; (DEFICIT) EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, no par value, unlimited shares authorized; 31,202,131 and 27,667,060 shares outstanding as of June 30, 2023 and 2022, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total shareholders&#8217; (deficit) equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities, redeemable noncontrolling interest, and shareholders&#8217; (deficit) equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorizedUnlimited" xlink:label="us-gaap_CommonStockSharesAuthorizedUnlimited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorizedUnlimited" xlink:to="us-gaap_CommonStockSharesAuthorizedUnlimited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorizedUnlimited_lbl" xml:lang="en-US">Common stock, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="us-gaap_LaborAndRelatedExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xml:lang="en-US">Employee related costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExplorationExpenditures" xlink:label="niobf_ExplorationExpenditures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExplorationExpenditures" xlink:to="niobf_ExplorationExpenditures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExplorationExpenditures_lbl" xml:lang="en-US">Exploration expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherGeneralExpense" xlink:label="us-gaap_OtherGeneralExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralExpense" xlink:to="us-gaap_OtherGeneralExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherGeneralExpense_lbl" xml:lang="en-US">Other operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangeInFairValueOfEarnoutLiability" xlink:label="niobf_ChangeInFairValueOfEarnoutLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_ChangeInFairValueOfEarnoutLiability_lbl" xml:lang="en-US">Change in fair value of earnout shares liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangeInFairValueOfWarrantLiability" xlink:label="niobf_ChangeInFairValueOfWarrantLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfWarrantLiability" xlink:to="niobf_ChangeInFairValueOfWarrantLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_ChangeInFairValueOfWarrantLiability_lbl" xml:lang="en-US">Change in fair value of warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount" xlink:label="us-gaap_ExtinguishmentOfDebtAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtAmount" xlink:to="us-gaap_ExtinguishmentOfDebtAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtinguishmentOfDebtAmount_lbl" xml:lang="en-US">Loss on debt extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Foreign exchange loss (gain)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Other gains</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xml:lang="en-US">Change in financial instrument fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_lbl" xml:lang="en-US">Loss (gain) on equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:label="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_lbl" xml:lang="en-US">Loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ProfitLoss1" xlink:label="niobf_ProfitLoss1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ProfitLoss1" xlink:to="niobf_ProfitLoss1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="niobf_ProfitLoss1_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net loss attributable to redeemable noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net loss attributable to the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">Other comprehensive loss:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">Other comprehensive (gain) loss:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US">Reporting currency translation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Total comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" xlink:label="us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" xlink:to="us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest_lbl" xml:lang="en-US">Comprehensive loss attributable to redeemable noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:label="us-gaap_OciEquityMethodInvestmentBeforeTaxParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:to="us-gaap_OciEquityMethodInvestmentBeforeTaxParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_OciEquityMethodInvestmentBeforeTaxParent_lbl" xml:lang="en-US">Comprehensive loss attributable to the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarningsLossPerShareBasicAndDiluted" xlink:label="niobf_EarningsLossPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarningsLossPerShareBasicAndDiluted" xlink:to="niobf_EarningsLossPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarningsLossPerShareBasicAndDiluted_lbl" xml:lang="en-US">Loss per common share, basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average common shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments for:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AssumptionOfEarnoutLiability" xlink:label="niobf_AssumptionOfEarnoutLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AssumptionOfEarnoutLiability" xlink:to="niobf_AssumptionOfEarnoutLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_AssumptionOfEarnoutLiability_lbl" xml:lang="en-US">Initial valuation of earnout shares liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:label="niobf_ChangeInFairValueOfEarnoutShareLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutShareLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfEarnoutShareLiability_lbl" xml:lang="en-US">Change in valuation of earnout shares liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AssumptionOfPrivateAndPublicWarrants" xlink:label="niobf_AssumptionOfPrivateAndPublicWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AssumptionOfPrivateAndPublicWarrants" xlink:to="niobf_AssumptionOfPrivateAndPublicWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_AssumptionOfPrivateAndPublicWarrants_lbl" xml:lang="en-US">Initial valuation of warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionExpense" xlink:label="us-gaap_AccretionExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionExpense" xlink:to="us-gaap_AccretionExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccretionExpense_lbl" xml:lang="en-US">Accretion of convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LossesOnExtinguishmentOfDebt" xlink:label="niobf_LossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LossesOnExtinguishmentOfDebt" xlink:to="niobf_LossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_LossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Loss on debt extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangeInValuationOfWarrantLiabilities" xlink:label="niobf_ChangeInValuationOfWarrantLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInValuationOfWarrantLiabilities" xlink:to="niobf_ChangeInValuationOfWarrantLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInValuationOfWarrantLiabilities_lbl" xml:lang="en-US">Change in valuation of warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FairValueOfCommitmentSharesIssued" xlink:label="niobf_FairValueOfCommitmentSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueOfCommitmentSharesIssued" xlink:to="niobf_FairValueOfCommitmentSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FairValueOfCommitmentSharesIssued_lbl" xml:lang="en-US">Yorkville share issuances</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ForeignCurrencyTransactionGainLossBeforeTax1" xlink:label="niobf_ForeignCurrencyTransactionGainLossBeforeTax1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ForeignCurrencyTransactionGainLossBeforeTax1" xlink:to="niobf_ForeignCurrencyTransactionGainLossBeforeTax1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ForeignCurrencyTransactionGainLossBeforeTax1_lbl" xml:lang="en-US">Foreign exchange loss (gain)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xml:lang="en-US">Unrealized loss (gain) on equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="us-gaap_OperatingLeaseImpairmentLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseImpairmentLoss" xlink:to="us-gaap_OperatingLeaseImpairmentLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseImpairmentLoss_lbl" xml:lang="en-US">Noncash lease activity</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_OtheroperatingGainsLosses" xlink:label="niobf_OtheroperatingGainsLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtheroperatingGainsLosses" xlink:to="niobf_OtheroperatingGainsLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_OtheroperatingGainsLosses_lbl" xml:lang="en-US">Other gains</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_lbl" xml:lang="en-US">Change in financial instrument fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Change in working capital items:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMineralRights" xlink:label="us-gaap_PaymentsToAcquireMineralRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMineralRights" xlink:to="us-gaap_PaymentsToAcquireMineralRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireMineralRights_lbl" xml:lang="en-US">Acquisition of mineral rights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBuildings" xlink:label="us-gaap_PaymentsToAcquireBuildings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBuildings" xlink:to="us-gaap_PaymentsToAcquireBuildings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireBuildings_lbl" xml:lang="en-US">Acquisition of land and buildings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl" xml:lang="en-US">Proceeds from sale of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Issuance of convertible debt, net of costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of capital stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Related party debt draws</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Related party debt repayments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Loan repayments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Share issue costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Exchange rate effect on cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Change in cash and cash equivalents during period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Amounts paid for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Amounts paid for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Non-cash investing and financing transactions:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ConversionsOfDebtForCommonShares" xlink:label="niobf_ConversionsOfDebtForCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConversionsOfDebtForCommonShares" xlink:to="niobf_ConversionsOfDebtForCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ConversionsOfDebtForCommonShares_lbl" xml:lang="en-US">Conversion of debt for common shares</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_RecognitionOfOperatingLeaseLiabilities" xlink:label="niobf_RecognitionOfOperatingLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RecognitionOfOperatingLeaseLiabilities" xlink:to="niobf_RecognitionOfOperatingLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_RecognitionOfOperatingLeaseLiabilities_lbl" xml:lang="en-US">Recognition of operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DerecognitionOfOperatingLeaseLiabilities" xlink:label="niobf_DerecognitionOfOperatingLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DerecognitionOfOperatingLeaseLiabilities" xlink:to="niobf_DerecognitionOfOperatingLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DerecognitionOfOperatingLeaseLiabilities_lbl" xml:lang="en-US">Derecognition of operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AccountsPayableToConvertibleDebtConversion" xlink:label="niobf_AccountsPayableToConvertibleDebtConversion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AccountsPayableToConvertibleDebtConversion" xlink:to="niobf_AccountsPayableToConvertibleDebtConversion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_AccountsPayableToConvertibleDebtConversion_lbl" xml:lang="en-US">Accounts payable to note conversion</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ValueOfWarrantsIssued" xlink:label="niobf_ValueOfWarrantsIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ValueOfWarrantsIssued" xlink:to="niobf_ValueOfWarrantsIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ValueOfWarrantsIssued_lbl" xml:lang="en-US">Value of warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Beginning balance (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:label="niobf_StockIssuedDuringPeriodSharesStockWarrantExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:to="niobf_StockIssuedDuringPeriodSharesStockWarrantExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodSharesStockWarrantExercised_lbl" xml:lang="en-US">Exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_StockIssuedDuringPeriodSharesStockWarrantExercisedShares" xlink:label="niobf_StockIssuedDuringPeriodSharesStockWarrantExercisedShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodSharesStockWarrantExercisedShares" xlink:to="niobf_StockIssuedDuringPeriodSharesStockWarrantExercisedShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodSharesStockWarrantExercisedShares_lbl" xml:lang="en-US">Exercise of warrants (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercise of options (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Fair value of warrants granted</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_PrivatePlacementValueMay2021" xlink:label="niobf_PrivatePlacementValueMay2021" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivatePlacementValueMay2021" xlink:to="niobf_PrivatePlacementValueMay2021_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PrivatePlacementValueMay2021_lbl" xml:lang="en-US">Private placement &#8211; May 2021</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_PrivatePlacementSharesMay2021" xlink:label="niobf_PrivatePlacementSharesMay2021" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivatePlacementSharesMay2021" xlink:to="niobf_PrivatePlacementSharesMay2021_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PrivatePlacementSharesMay2021_lbl" xml:lang="en-US">Private placement &#8211; June 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_lbl" xml:lang="en-US">Debt conversions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Debt conversions (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Share issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Reporting currency presentation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Loss for the year</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_PrivatePlacementSharesMay2022Sahres" xlink:label="niobf_PrivatePlacementSharesMay2022Sahres" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivatePlacementSharesMay2022Sahres" xlink:to="niobf_PrivatePlacementSharesMay2022Sahres_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PrivatePlacementSharesMay2022Sahres_lbl" xml:lang="en-US">Private placement June 2022 (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_lbl" xml:lang="en-US">Fair value of warrants granted</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CommonSharesIssuedInTheGXIITransaction" xlink:label="niobf_CommonSharesIssuedInTheGXIITransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonSharesIssuedInTheGXIITransaction" xlink:to="niobf_CommonSharesIssuedInTheGXIITransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CommonSharesIssuedInTheGXIITransaction_lbl" xml:lang="en-US">Common Shares issued in the GXII Transaction</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CommonSharesIssuedInTheGXIITransactionSahres" xlink:label="niobf_CommonSharesIssuedInTheGXIITransactionSahres" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonSharesIssuedInTheGXIITransactionSahres" xlink:to="niobf_CommonSharesIssuedInTheGXIITransactionSahres_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CommonSharesIssuedInTheGXIITransactionSahres_lbl" xml:lang="en-US">Common Shares issued in the GXII Transaction (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Commitment shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Commitment shares issued (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xml:lang="en-US">Registered direct offering &#8211; May 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xml:lang="en-US">Registered direct offering May 2023 (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacility" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacility" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharesIssuedUnderTheYorkvilleEquityFacility" xlink:to="niobf_SharesIssuedUnderTheYorkvilleEquityFacility_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacility_lbl" xml:lang="en-US">Shares issued under the Yorkville equity facility</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:to="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares_lbl" xml:lang="en-US">Shares issued under the Yorkville equity facility (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_RedeemableNoncontrollingInterest" xlink:label="niobf_RedeemableNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterest" xlink:to="niobf_RedeemableNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_RedeemableNoncontrollingInterest_lbl" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_3_lbl" xml:lang="en-US">Ending balance (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccounting" xlink:label="us-gaap_BasisOfAccounting" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccounting" xlink:to="us-gaap_BasisOfAccounting_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccounting_lbl" xml:lang="en-US">BASIS OF PREPARATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">GOING CONCERN ISSUES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">GXII TRANSACTION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">LAND AND BUILDINGS, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExtractiveIndustriesAbstract" xlink:label="srt_ExtractiveIndustriesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ExtractiveIndustriesAbstract" xlink:to="srt_ExtractiveIndustriesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ExtractiveIndustriesAbstract_lbl" xml:lang="en-US">Extractive Industries [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MineralIndustriesDisclosuresTextBlock" xlink:label="us-gaap_MineralIndustriesDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MineralIndustriesDisclosuresTextBlock" xlink:to="us-gaap_MineralIndustriesDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MineralIndustriesDisclosuresTextBlock_lbl" xml:lang="en-US">MINERAL PROPERTIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">CONVERTIBLE DEBT</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="niobf_DisclosureClassBCommonStockOfEcrcAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:to="niobf_DisclosureClassBCommonStockOfEcrcAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DisclosureClassBCommonStockOfEcrcAbstract_lbl" xml:lang="en-US">Class B Common Stock Of Ecrc</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" xlink:label="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" xlink:to="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock_lbl" xml:lang="en-US">CLASS B COMMON STOCK OF ECRC</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">COMMON SHARES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS AND BALANCES</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DisclosureExplorationExpendituresAbstract" xlink:label="niobf_DisclosureExplorationExpendituresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureExplorationExpendituresAbstract" xlink:to="niobf_DisclosureExplorationExpendituresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DisclosureExplorationExpendituresAbstract_lbl" xml:lang="en-US">Exploration Expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExplorationExpendituresDisclosuresTextBlock" xlink:label="niobf_ExplorationExpendituresDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExplorationExpendituresDisclosuresTextBlock" xlink:to="niobf_ExplorationExpendituresDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExplorationExpendituresDisclosuresTextBlock_lbl" xml:lang="en-US">EXPLORATION EXPENDITURES</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="niobf_DisclosureLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureLeasesAbstract" xlink:to="niobf_DisclosureLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DisclosureLeasesAbstract_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="us-gaap_FairValueMeasurementInputsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="us-gaap_FairValueMeasurementInputsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementInputsDisclosureTextBlock_lbl" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DevelopmentStageIssuerPolicyTextBlock" xlink:label="niobf_DevelopmentStageIssuerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DevelopmentStageIssuerPolicyTextBlock" xlink:to="niobf_DevelopmentStageIssuerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DevelopmentStageIssuerPolicyTextBlock_lbl" xml:lang="en-US">Development Stage Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Translation</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_MineralPropertiesPolicyTextBlock" xlink:label="niobf_MineralPropertiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MineralPropertiesPolicyTextBlock" xlink:to="niobf_MineralPropertiesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_MineralPropertiesPolicyTextBlock_lbl" xml:lang="en-US">Mineral Properties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Long Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_WarrantsPolicyTextBlock" xlink:label="niobf_WarrantsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantsPolicyTextBlock" xlink:to="niobf_WarrantsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_WarrantsPolicyTextBlock_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarnoutSharesPolicy" xlink:label="niobf_EarnoutSharesPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutSharesPolicy" xlink:to="niobf_EarnoutSharesPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarnoutSharesPolicy_lbl" xml:lang="en-US">Earnout Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetRetirementObligationsPolicy" xlink:label="us-gaap_AssetRetirementObligationsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationsPolicy" xlink:to="us-gaap_AssetRetirementObligationsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetRetirementObligationsPolicy_lbl" xml:lang="en-US">Asset Retirement Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ReverseStockSplitPolicyTextBlock" xlink:label="niobf_ReverseStockSplitPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ReverseStockSplitPolicyTextBlock" xlink:to="niobf_ReverseStockSplitPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ReverseStockSplitPolicyTextBlock_lbl" xml:lang="en-US">Reverse Stock Split [Policy Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:label="niobf_RedeemableNoncontrollingInterestPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:to="niobf_RedeemableNoncontrollingInterestPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_RedeemableNoncontrollingInterestPolicyTextBlock_lbl" xml:lang="en-US">Redeemable Noncontrolling Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and Diluted Per Share Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Revision of Financial Statements (Unaudited)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_lbl" xml:lang="en-US">Schedule of intercompany transactions and balances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_lbl" xml:lang="en-US">Schedule of excluded from the dilutive securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:to="srt_ScheduleOfCondensedBalanceSheetTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock_lbl" xml:lang="en-US">Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As of March 31, 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:to="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl" xml:lang="en-US">Revision Impacts to the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For the Three &amp; Nine Months Ended March 31, 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:label="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:to="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_lbl" xml:lang="en-US">Revision Impacts to the Condensed Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:to="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock_lbl" xml:lang="en-US">The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_lbl" xml:lang="en-US">The number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of properties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of account payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" xlink:label="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" xlink:to="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_lbl" xml:lang="en-US">Schedule of convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" xlink:label="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" xlink:to="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_lbl" xml:lang="en-US">Changes in the Lind III Convertible Security are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" xlink:label="us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" xlink:to="us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock_lbl" xml:lang="en-US">The following table summarizes the components of the initial loss on extinguishment:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfWarrantValuationTableTextblock" xlink:label="niobf_ScheduleOfWarrantValuationTableTextblock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfWarrantValuationTableTextblock" xlink:to="niobf_ScheduleOfWarrantValuationTableTextblock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfWarrantValuationTableTextblock_lbl" xml:lang="en-US">The change in the fair value of the Contingent Consent Warrants is presented below:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" xlink:label="niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" xlink:to="niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_lbl" xml:lang="en-US">Schedule of valuation date and the probability calculated.</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl" xml:lang="en-US">Changes in the Convertible Debentures are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:label="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:to="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_lbl" xml:lang="en-US">The following table discloses the primary inputs into the Monte Carlo models.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:label="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:to="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_lbl" xml:lang="en-US">The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2023:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl" xml:lang="en-US">Schedule of stock option</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xml:lang="en-US">The following table summarizes information about stock options outstanding at June 30, 2023:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">The following table summarizes the weighted average information and assumptions used to determine option costs:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:label="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock_lbl" xml:lang="en-US">At June 30, 2023, the Company has outstanding exercisable warrants, as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_lbl" xml:lang="en-US">The change in the Private Warrants liability is presented below:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" xlink:label="us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" xlink:to="us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_lbl" xml:lang="en-US">Schedule of expenses as other operating costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xml:lang="en-US">Changes in the Smith Credit Agreement principal balance are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfExplorationExpendituresTableTextBlock" xlink:label="niobf_ScheduleOfExplorationExpendituresTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfExplorationExpendituresTableTextBlock" xlink:to="niobf_ScheduleOfExplorationExpendituresTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfExplorationExpendituresTableTextBlock_lbl" xml:lang="en-US">Schedule of exploration expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">The Company incurred lease costs as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">The maturity of lease liabilities is as follows at June 30, 2023:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">Domestic and foreign components of loss before income taxes for the years ended June 30, 2023, 2022, and 2021 are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">The following table is a reconciliation of income taxes at statutory rates:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="us-gaap_SummaryOfValuationAllowanceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock_lbl" xml:lang="en-US">Changes in the valuation allowance are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:to="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl" xml:lang="en-US">Schedule of cumulative net operating losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock_lbl" xml:lang="en-US">Schedule of fair values determined by level 3 inputs are unobservable data</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_IncorporationStateCountryName" xlink:label="niobf_IncorporationStateCountryName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncorporationStateCountryName" xlink:to="niobf_IncorporationStateCountryName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_IncorporationStateCountryName_lbl" xml:lang="en-US">Country of incorporation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xml:lang="en-US">Percentage of ownership</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US">Number of reportable segments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Adjust: net loss attributable to noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net loss available to participating securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net loss attributable to vested shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:label="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:to="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_lbl" xml:lang="en-US">Net loss attributed to common shareholders - basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average shares outstanding basic and diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarningsLossPerShareBasicAndDiluted" xlink:to="niobf_EarningsLossPerShareBasicAndDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_EarningsLossPerShareBasicAndDiluted_2_lbl" xml:lang="en-US">Loss per common share outstanding basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions" xlink:label="us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions" xlink:to="us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions_lbl" xml:lang="en-US">Options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xml:lang="en-US">Convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecurities" xlink:label="us-gaap_DilutiveSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DilutiveSecurities" xlink:to="us-gaap_DilutiveSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DilutiveSecurities_lbl" xml:lang="en-US">Total potentially dilutive securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_Liabilities_3_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Total shareholders&#8217; deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralExpense" xlink:to="us-gaap_OtherGeneralExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherGeneralExpense_2_lbl" xml:lang="en-US">Other operating expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralExpense" xlink:to="us-gaap_OtherGeneralExpense_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherGeneralExpense_3_lbl" xml:lang="en-US">Other operating expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfWarrantLiability" xlink:to="niobf_ChangeInFairValueOfWarrantLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="niobf_ChangeInFairValueOfWarrantLiability_2_lbl" xml:lang="en-US">Change in fair value of warrant liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before income taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ProfitLoss1" xlink:to="niobf_ProfitLoss1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ProfitLoss1_2_lbl" xml:lang="en-US">Net loss attributable to the company</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Total comprehensive loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:to="us-gaap_OciEquityMethodInvestmentBeforeTaxParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OciEquityMethodInvestmentBeforeTaxParent_2_lbl" xml:lang="en-US">Comprehensive loss attributable to the company</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_4_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AssumptionOfPrivateAndPublicWarrants" xlink:to="niobf_AssumptionOfPrivateAndPublicWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_AssumptionOfPrivateAndPublicWarrants_2_lbl" xml:lang="en-US">Assumption of Private and Public Warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xml:lang="en-US">Fair Value Adjustment of Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xml:lang="en-US">Accrued exploration stage expense</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CashAndCashEquivalentsAtCarryingValue1" xlink:label="niobf_CashAndCashEquivalentsAtCarryingValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CashAndCashEquivalentsAtCarryingValue1" xlink:to="niobf_CashAndCashEquivalentsAtCarryingValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CashAndCashEquivalentsAtCarryingValue1_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:label="us-gaap_CapitalExpenditureDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:to="us-gaap_CapitalExpenditureDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalExpenditureDiscontinuedOperations_lbl" xml:lang="en-US">Capital expenditure of operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_lbl" xml:lang="en-US">Gross cash proceeds, net of transaction costs incurred by GXII</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_lbl" xml:lang="en-US">Less:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Net liabilities assumed</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" xlink:label="niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" xlink:to="niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_lbl" xml:lang="en-US">Yorkville Equity Facility Financing Agreement &#8211; cash costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed_lbl" xml:lang="en-US">Transaction costs expensed</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_lbl" xml:lang="en-US">Non-cash costs associated with the Transactions:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_lbl" xml:lang="en-US">Private Warrants assumed at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarnoutSharesAssumedAtFairValue" xlink:label="niobf_EarnoutSharesAssumedAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutSharesAssumedAtFairValue" xlink:to="niobf_EarnoutSharesAssumedAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarnoutSharesAssumedAtFairValue_lbl" xml:lang="en-US">Earnout Shares assumed at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_lbl" xml:lang="en-US">Yorkville Equity Facility Financing Agreement &#8211; shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xml:lang="en-US">&#160;Total transaction related losses incurred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable" xlink:label="us-gaap_OffsettingAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingAssetsTable" xlink:to="us-gaap_OffsettingAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingAssetsTable_lbl" xml:lang="en-US">Offsetting Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="us-gaap_OffsettingAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingAssetsLineItems" xlink:to="us-gaap_OffsettingAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingAssetsLineItems_lbl" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_4_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_lbl" xml:lang="en-US">Number of shares, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xml:lang="en-US">Post reverse stock split shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xml:lang="en-US">Convertible shares issued upon conversion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xml:lang="en-US">Number of shares purchase</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOther" xlink:label="us-gaap_PropertyPlantAndEquipmentOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentOther" xlink:to="us-gaap_PropertyPlantAndEquipmentOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentOther_lbl" xml:lang="en-US">Cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandPurchaseOptionsDescription" xlink:label="us-gaap_LandPurchaseOptionsDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandPurchaseOptionsDescription" xlink:to="us-gaap_LandPurchaseOptionsDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LandPurchaseOptionsDescription_lbl" xml:lang="en-US">Description of owned land</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAndLandImprovements" xlink:label="us-gaap_LandAndLandImprovements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandAndLandImprovements" xlink:to="us-gaap_LandAndLandImprovements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LandAndLandImprovements_lbl" xml:lang="en-US">Improvements state</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnersCapitalAccountDescriptionOfUnits" xlink:label="us-gaap_LimitedPartnersCapitalAccountDescriptionOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LimitedPartnersCapitalAccountDescriptionOfUnits" xlink:to="us-gaap_LimitedPartnersCapitalAccountDescriptionOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LimitedPartnersCapitalAccountDescriptionOfUnits_lbl" xml:lang="en-US">Description of ownership of mineral rights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" xlink:label="us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" xlink:to="us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_lbl" xml:lang="en-US">Other gains and comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:label="srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable_lbl" xml:lang="en-US">Proved Developed and Undeveloped Oil and Gas Reserve Quantities [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReserveQuantitiesLineItems" xlink:label="srt_ReserveQuantitiesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ReserveQuantitiesLineItems" xlink:to="srt_ReserveQuantitiesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ReserveQuantitiesLineItems_lbl" xml:lang="en-US">Reserve Quantities [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xml:lang="en-US">Shares issue for acquistion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Shares issue for acquistion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US">Total consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DeferredTaxImpacts" xlink:label="niobf_DeferredTaxImpacts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxImpacts" xlink:to="niobf_DeferredTaxImpacts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DeferredTaxImpacts_lbl" xml:lang="en-US">Deferred tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalDeferredPurchasePrice" xlink:label="us-gaap_SupplementalDeferredPurchasePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalDeferredPurchasePrice" xlink:to="us-gaap_SupplementalDeferredPurchasePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalDeferredPurchasePrice_lbl" xml:lang="en-US">Purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfAcquisitionCosts" xlink:label="us-gaap_AmortizationOfAcquisitionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfAcquisitionCosts" xlink:to="us-gaap_AmortizationOfAcquisitionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfAcquisitionCosts_lbl" xml:lang="en-US">Indirect costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMineralRights" xlink:to="us-gaap_PaymentsToAcquireMineralRights_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireMineralRights_2_lbl" xml:lang="en-US">Other amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBuildings" xlink:to="us-gaap_PaymentsToAcquireBuildings_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBuildings_2_lbl" xml:lang="en-US">Remaining balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="us-gaap_AccountsPayableTradeCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US">Accounts payable, trade</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Trade payable accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="us-gaap_TaxesPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:to="us-gaap_TaxesPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxesPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Environmental accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Loan origination fees payable to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Total accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleDebtCurrent_2_lbl" xml:lang="en-US">Convertibled debt, current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtNoncurrent" xlink:to="us-gaap_ConvertibleDebtNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleDebtNoncurrent_2_lbl" xml:lang="en-US">Convertible debt, noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtNoncurrent" xlink:to="us-gaap_ConvertibleDebtNoncurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ConvertibleDebtNoncurrent_3_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtAmount" xlink:to="us-gaap_ExtinguishmentOfDebtAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ExtinguishmentOfDebtAmount_2_lbl" xml:lang="en-US">Fair value increase due to debt extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="us-gaap_ConversionOfStockAmountIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountIssued1" xlink:to="us-gaap_ConversionOfStockAmountIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ConversionOfStockAmountIssued1_lbl" xml:lang="en-US">Conversions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionExpense" xlink:to="us-gaap_AccretionExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccretionExpense_2_lbl" xml:lang="en-US">Accretion expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:to="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_lbl" xml:lang="en-US">Payment at maturity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ConvertibleDebtCurrent_3_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_MinimumConsentPaymentAtInception" xlink:label="niobf_MinimumConsentPaymentAtInception" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MinimumConsentPaymentAtInception" xlink:to="niobf_MinimumConsentPaymentAtInception_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_MinimumConsentPaymentAtInception_lbl" xml:lang="en-US">Minimum Consent Payment at inception</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ASC470LossOnExtinguishment" xlink:label="niobf_ASC470LossOnExtinguishment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ASC470LossOnExtinguishment" xlink:to="niobf_ASC470LossOnExtinguishment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_ASC470LossOnExtinguishment_lbl" xml:lang="en-US">Loss on debt extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl" xml:lang="en-US">Initial fair value of Contingent Consent Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_lbl" xml:lang="en-US">Initial loss on debt extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AdditionalConsentPaymentbooked" xlink:label="niobf_AdditionalConsentPaymentbooked" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AdditionalConsentPaymentbooked" xlink:to="niobf_AdditionalConsentPaymentbooked_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_AdditionalConsentPaymentbooked_lbl" xml:lang="en-US">Additional Consent Payment booked</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnRestructuringOfDebt" xlink:label="us-gaap_GainsLossesOnRestructuringOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnRestructuringOfDebt" xlink:to="us-gaap_GainsLossesOnRestructuringOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnRestructuringOfDebt_lbl" xml:lang="en-US">Total loss on debt extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Initial valuation, at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangeInValuationOfWarrants" xlink:label="niobf_ChangeInValuationOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInValuationOfWarrants" xlink:to="niobf_ChangeInValuationOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInValuationOfWarrants_lbl" xml:lang="en-US">Change in valuation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_2_lbl" xml:lang="en-US">Valuation, at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Share price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xml:lang="en-US">Probability of issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebt" xlink:label="us-gaap_ConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ConvertibleDebt_lbl" xml:lang="en-US">Balance, June 30, 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionExpenseIncludingAssetRetirementObligations" xlink:label="us-gaap_AccretionExpenseIncludingAssetRetirementObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionExpenseIncludingAssetRetirementObligations" xlink:to="us-gaap_AccretionExpenseIncludingAssetRetirementObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccretionExpenseIncludingAssetRetirementObligations_lbl" xml:lang="en-US">Accretion expense</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_PrincipalAndAccruedInterestConverted" xlink:label="niobf_PrincipalAndAccruedInterestConverted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrincipalAndAccruedInterestConverted" xlink:to="niobf_PrincipalAndAccruedInterestConverted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_PrincipalAndAccruedInterestConverted_lbl" xml:lang="en-US">Principal and accrued interest converted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US">Add: uamortized debt issuance costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ConvertibleDebt_2_lbl" xml:lang="en-US">Balance, June 30, 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl" xml:lang="en-US">Face value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInterestRate" xlink:label="us-gaap_InvestmentInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInterestRate" xlink:to="us-gaap_InvestmentInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentInterestRate_lbl" xml:lang="en-US">Investment Interest Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment" xlink:label="us-gaap_OtherCommitment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitment" xlink:to="us-gaap_OtherCommitment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitment_lbl" xml:lang="en-US">Commitment fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInterestReceived" xlink:label="us-gaap_ProceedsFromInterestReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromInterestReceived" xlink:to="us-gaap_ProceedsFromInterestReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromInterestReceived_lbl" xml:lang="en-US">Net proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTerm" xlink:label="us-gaap_LongTermDebtTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTerm" xlink:to="us-gaap_LongTermDebtTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTerm_lbl" xml:lang="en-US">Long term debt duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionDescription" xlink:label="us-gaap_DebtConversionDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionDescription" xlink:to="us-gaap_DebtConversionDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionDescription_lbl" xml:lang="en-US">Debt Conversion, Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonUnitIssued" xlink:label="us-gaap_CommonUnitIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonUnitIssued" xlink:to="us-gaap_CommonUnitIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonUnitIssued_lbl" xml:lang="en-US">Common share purchase warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:label="us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:to="us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_lbl" xml:lang="en-US">Exercisable at a price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntermediateLifePlantsUsefulLife" xlink:label="us-gaap_IntermediateLifePlantsUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntermediateLifePlantsUsefulLife" xlink:to="us-gaap_IntermediateLifePlantsUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntermediateLifePlantsUsefulLife_lbl" xml:lang="en-US">Expected life</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleDebtCurrent_4_lbl" xml:lang="en-US">Convertible debt liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_TransactionCost" xlink:label="niobf_TransactionCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TransactionCost" xlink:to="niobf_TransactionCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_TransactionCost_lbl" xml:lang="en-US">Transaction costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="us-gaap_LineOfCreditFacilityCommitmentFeeAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount_lbl" xml:lang="en-US">Commitment fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" xlink:label="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" xlink:to="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise_lbl" xml:lang="en-US">Issuance of the convertible debentures</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Common share price, per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentTerms" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentTerms" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentTerms_lbl" xml:lang="en-US">Debt term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Interest rate obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xml:lang="en-US">Principal percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1" xlink:label="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1" xlink:to="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1_lbl" xml:lang="en-US">Issuance of the convertible debentures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xml:lang="en-US">Contingent liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingLiability" xlink:label="us-gaap_ServicingLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiability" xlink:to="us-gaap_ServicingLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ServicingLiability_lbl" xml:lang="en-US">Contingent liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_3_lbl" xml:lang="en-US">Fair value of warrant liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_2_lbl" xml:lang="en-US">Fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" xlink:label="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" xlink:to="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_lbl" xml:lang="en-US">Fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DebtMaturityPeriod" xlink:label="niobf_DebtMaturityPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DebtMaturityPeriod" xlink:to="niobf_DebtMaturityPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_DebtMaturityPeriod_lbl" xml:lang="en-US">Expected life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xml:lang="en-US">Transaction costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" xlink:label="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" xlink:to="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_lbl" xml:lang="en-US">Shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Closing Common Share price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:to="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_lbl" xml:lang="en-US">Term (expiry)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Implied volatility of Public Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_lbl" xml:lang="en-US">Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_lbl" xml:lang="en-US">Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingLiabilityAtFairValueAmount" xlink:label="us-gaap_ServicingLiabilityAtFairValueAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiabilityAtFairValueAmount" xlink:to="us-gaap_ServicingLiabilityAtFairValueAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ServicingLiabilityAtFairValueAmount_lbl" xml:lang="en-US">Fair value at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingLiabilityAtFairValueAdditions" xlink:label="us-gaap_ServicingLiabilityAtFairValueAdditions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiabilityAtFairValueAdditions" xlink:to="us-gaap_ServicingLiabilityAtFairValueAdditions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ServicingLiabilityAtFairValueAdditions_lbl" xml:lang="en-US">Change in fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiabilityAtFairValueAmount" xlink:to="us-gaap_ServicingLiabilityAtFairValueAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ServicingLiabilityAtFairValueAmount_2_lbl" xml:lang="en-US">Fair value at ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_5_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_5_lbl" xml:lang="en-US">Common stock, shares, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares, issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xml:lang="en-US">Earnout shares</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DescriptionOfEarnOutShares" xlink:label="niobf_DescriptionOfEarnOutShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DescriptionOfEarnOutShares" xlink:to="niobf_DescriptionOfEarnOutShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DescriptionOfEarnOutShares_lbl" xml:lang="en-US">Description of earnout shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Cancelled/expired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Cancelled/expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xml:lang="en-US">Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1" xlink:label="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1" xlink:to="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_lbl" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Options Outstanding Intrinsic Value 1</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Fair value per option granted during the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_lbl" xml:lang="en-US">Expected stock price volatility (historical basis)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected option life in years</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Balance at beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xml:lang="en-US">Balance at beginning average price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_NordminWarrants" xlink:label="niobf_NordminWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NordminWarrants" xlink:to="niobf_NordminWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_NordminWarrants_lbl" xml:lang="en-US">Nordmin warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing_lbl" xml:lang="en-US">Nordmin warrants average price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightLindIIIWarrants" xlink:label="niobf_ClassOfWarrantOrRightLindIIIWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightLindIIIWarrants" xlink:to="niobf_ClassOfWarrantOrRightLindIIIWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightLindIIIWarrants_lbl" xml:lang="en-US">Lind III Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercisePriceLindWarrants" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceLindWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceLindWarrants" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceLindWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceLindWarrants_lbl" xml:lang="en-US">Lind III warrants average price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightAprilPrivatePlacement" xlink:label="niobf_ClassOfWarrantOrRightAprilPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightAprilPrivatePlacement" xlink:to="niobf_ClassOfWarrantOrRightAprilPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightAprilPrivatePlacement_lbl" xml:lang="en-US">April 2021 private placement</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements_lbl" xml:lang="en-US">April 2021 private placement average price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercised" xlink:label="niobf_ClassOfWarrantOrRightExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercised" xlink:to="niobf_ClassOfWarrantOrRightExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_ClassOfWarrantOrRightExercised_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercisePriceExercised" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExercised" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExercised_lbl" xml:lang="en-US">Exercised average price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExpired" xlink:label="niobf_ClassOfWarrantOrRightExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExpired" xlink:to="niobf_ClassOfWarrantOrRightExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExpired_lbl" xml:lang="en-US">Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExpired_lbl" xml:lang="en-US">Expired average price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightJunePrivatePlacement" xlink:label="niobf_ClassOfWarrantOrRightJunePrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightJunePrivatePlacement" xlink:to="niobf_ClassOfWarrantOrRightJunePrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightJunePrivatePlacement_lbl" xml:lang="en-US">June 2022 private placement</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercisePriceJunePrivatePlacements" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceJunePrivatePlacements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceJunePrivatePlacements" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceJunePrivatePlacements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceJunePrivatePlacements_lbl" xml:lang="en-US">June 2022 private placement average price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_YorkvilleFinancingWarrants" xlink:label="niobf_YorkvilleFinancingWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleFinancingWarrants" xlink:to="niobf_YorkvilleFinancingWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_YorkvilleFinancingWarrants_lbl" xml:lang="en-US">Yorkville financing warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_lbl" xml:lang="en-US">Yorkville financing warrants average price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GxiiWarrants" xlink:label="niobf_GxiiWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GxiiWarrants" xlink:to="niobf_GxiiWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GxiiWarrants_lbl" xml:lang="en-US">GXII warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_lbl" xml:lang="en-US">GXII warrant average price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Balance at ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4_lbl" xml:lang="en-US">Balance at ending average price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xml:lang="en-US">Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xml:lang="en-US">Expiry date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Stock price on valuation date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharePrice_2_lbl" xml:lang="en-US">Strike price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_lbl" xml:lang="en-US">Volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Risk free rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xml:lang="en-US">Expected warrant life in years</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangesInFairValueOfInitialValuation" xlink:label="niobf_ChangesInFairValueOfInitialValuation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation" xlink:to="niobf_ChangesInFairValueOfInitialValuation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="niobf_ChangesInFairValueOfInitialValuation_lbl" xml:lang="en-US">Initial valuation, at begining</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:label="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:to="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_lbl" xml:lang="en-US">Change in valuation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation" xlink:to="niobf_ChangesInFairValueOfInitialValuation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="niobf_ChangesInFairValueOfInitialValuation_2_lbl" xml:lang="en-US">Initial valuation, at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCostAndReserveLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_YorkvilleCashFee" xlink:label="niobf_YorkvilleCashFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleCashFee" xlink:to="niobf_YorkvilleCashFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_YorkvilleCashFee_lbl" xml:lang="en-US">Yorkville Cash Fee</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Fair value of Commitment Shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="us-gaap_OtherCostAndExpenseOperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostAndExpenseOperating" xlink:to="us-gaap_OtherCostAndExpenseOperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostAndExpenseOperating_lbl" xml:lang="en-US">Legal and other related costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xml:lang="en-US">Net costs expensed to other operating expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfferingCostsPartnershipInterests" xlink:label="us-gaap_OfferingCostsPartnershipInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfferingCostsPartnershipInterests" xlink:to="us-gaap_OfferingCostsPartnershipInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfferingCostsPartnershipInterests_lbl" xml:lang="en-US">Shares issue price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ShareIssuanceCost" xlink:label="niobf_ShareIssuanceCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareIssuanceCost" xlink:to="niobf_ShareIssuanceCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ShareIssuanceCost_lbl" xml:lang="en-US">Share issuance cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Share issuance cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Price per unit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Gross proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_SaleOfStockPricePerShare1" xlink:label="niobf_SaleOfStockPricePerShare1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SaleOfStockPricePerShare1" xlink:to="niobf_SaleOfStockPricePerShare1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_SaleOfStockPricePerShare1_lbl" xml:lang="en-US">Shares price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForCommissions" xlink:label="us-gaap_PaymentsForCommissions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForCommissions" xlink:to="us-gaap_PaymentsForCommissions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForCommissions_lbl" xml:lang="en-US">Cash commissions</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FairValueAssumptionsRiskFreeInterestRate1" xlink:label="niobf_FairValueAssumptionsRiskFreeInterestRate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueAssumptionsRiskFreeInterestRate1" xlink:to="niobf_FairValueAssumptionsRiskFreeInterestRate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_FairValueAssumptionsRiskFreeInterestRate1_lbl" xml:lang="en-US">Risk-free rate</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FairValueAssumptionsExpected1VolatilityRate" xlink:label="niobf_FairValueAssumptionsExpected1VolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueAssumptionsExpected1VolatilityRate" xlink:to="niobf_FairValueAssumptionsExpected1VolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FairValueAssumptionsExpected1VolatilityRate_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FairValueAssumptions1ExpectedTerm" xlink:label="niobf_FairValueAssumptions1ExpectedTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueAssumptions1ExpectedTerm" xlink:to="niobf_FairValueAssumptions1ExpectedTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_FairValueAssumptions1ExpectedTerm_lbl" xml:lang="en-US">Expected life</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DescriptionOfAmendedPlan" xlink:label="niobf_DescriptionOfAmendedPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DescriptionOfAmendedPlan" xlink:to="niobf_DescriptionOfAmendedPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DescriptionOfAmendedPlan_lbl" xml:lang="en-US">Description of amended plan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_3_lbl" xml:lang="en-US">Stock price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Total intrinsic value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_3_lbl" xml:lang="en-US">Warrants traded prior to the closing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:to="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees_lbl" xml:lang="en-US">Description of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDepositLiabilities" xlink:label="us-gaap_RelatedPartyDepositLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDepositLiabilities" xlink:to="us-gaap_RelatedPartyDepositLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_RelatedPartyDepositLiabilities_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AmountsAdvanced" xlink:label="niobf_AmountsAdvanced" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AmountsAdvanced" xlink:to="niobf_AmountsAdvanced_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_AmountsAdvanced_lbl" xml:lang="en-US">Amounts advanced</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Repayments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDepositLiabilities" xlink:to="us-gaap_RelatedPartyDepositLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_RelatedPartyDepositLiabilities_2_lbl" xml:lang="en-US">Balance, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="us-gaap_RelatedPartyTransactionRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionRate" xlink:to="us-gaap_RelatedPartyTransactionRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionRate_lbl" xml:lang="en-US">Interest at a rate</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LineOfCreditFacilityPrepaymentFee" xlink:label="niobf_LineOfCreditFacilityPrepaymentFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LineOfCreditFacilityPrepaymentFee" xlink:to="niobf_LineOfCreditFacilityPrepaymentFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LineOfCreditFacilityPrepaymentFee_lbl" xml:lang="en-US">Prepayment fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit" xlink:label="us-gaap_LongTermLineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermLineOfCredit_lbl" xml:lang="en-US">Principal amount outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AmountPaidToRelatedParty" xlink:label="niobf_AmountPaidToRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AmountPaidToRelatedParty" xlink:to="niobf_AmountPaidToRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_AmountPaidToRelatedParty_lbl" xml:lang="en-US">Amount drew down</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EstablishmentFeesPayable" xlink:label="niobf_EstablishmentFeesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EstablishmentFeesPayable" xlink:to="niobf_EstablishmentFeesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EstablishmentFeesPayable_lbl" xml:lang="en-US">Establishment fees payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExplorationExpense" xlink:label="us-gaap_ExplorationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExplorationExpense" xlink:to="us-gaap_ExplorationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ExplorationExpense_lbl" xml:lang="en-US">Exploration expenditures</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureLeasesAbstract" xlink:to="niobf_DisclosureLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_DisclosureLeasesAbstract_2_lbl" xml:lang="en-US">Company Incurred Lease Costs As Follows</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract" xlink:label="us-gaap_LeaseCostAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostAbstract_lbl" xml:lang="en-US">&#160;Operating Lease Cost:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FixedRentExpense" xlink:label="niobf_FixedRentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FixedRentExpense" xlink:to="niobf_FixedRentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FixedRentExpense_lbl" xml:lang="en-US">Fixed rent expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableLeaseCost_lbl" xml:lang="en-US">Variable rent expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xml:lang="en-US">Short term lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome" xlink:label="us-gaap_SubleaseIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SubleaseIncome_lbl" xml:lang="en-US">Sublease income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCost_lbl" xml:lang="en-US">Net lease cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostAndExpenseOperating" xlink:to="us-gaap_OtherCostAndExpenseOperating_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherCostAndExpenseOperating_2_lbl" xml:lang="en-US">Lease cost &#8211; other operating expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExplorationCosts" xlink:label="us-gaap_ExplorationCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExplorationCosts" xlink:to="us-gaap_ExplorationCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExplorationCosts_lbl" xml:lang="en-US">Lease cost &#8211; exploration expenditures</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureLeasesAbstract" xlink:to="niobf_DisclosureLeasesAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="niobf_DisclosureLeasesAbstract_3_lbl" xml:lang="en-US">Maturity Of Lease Liabilities Is As Follows At June 30 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">&#160;&#160;2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">&#160;&#160;2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">&#160;&#160;2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">&#160;&#160;2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LessAmountOfPaymentsRepresentingInterest" xlink:label="niobf_LessAmountOfPaymentsRepresentingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LessAmountOfPaymentsRepresentingInterest" xlink:to="niobf_LessAmountOfPaymentsRepresentingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LessAmountOfPaymentsRepresentingInterest_lbl" xml:lang="en-US">&#160;&#160;Less amount of payments representing interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Present value of lease payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">&#160;&#160;Less current portion of operating lease liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Noncurrent operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xml:lang="en-US">Other lease description</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DiscountRate" xlink:label="niobf_DiscountRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DiscountRate" xlink:to="niobf_DiscountRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DiscountRate_lbl" xml:lang="en-US">Discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xml:lang="en-US">Remaining lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Cash payment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_lbl" xml:lang="en-US">Loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Combined federal and provincial statutory income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Income tax benefit at statutory tax rates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Foreign rate differential</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarnoutSharesLiability" xlink:label="niobf_EarnoutSharesLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutSharesLiability" xlink:to="niobf_EarnoutSharesLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarnoutSharesLiability_lbl" xml:lang="en-US">Earnout shares liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_WarrantLiability" xlink:label="niobf_WarrantLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantLiability" xlink:to="niobf_WarrantLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_WarrantLiability_lbl" xml:lang="en-US">Warrant liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GxiiTransactionCosts" xlink:label="niobf_GxiiTransactionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GxiiTransactionCosts" xlink:to="niobf_GxiiTransactionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GxiiTransactionCosts_lbl" xml:lang="en-US">GXII transaction costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl" xml:lang="en-US">Share based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetRetirementObligationAccretionExpense" xlink:label="us-gaap_AssetRetirementObligationAccretionExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationAccretionExpense" xlink:to="us-gaap_AssetRetirementObligationAccretionExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AssetRetirementObligationAccretionExpense_lbl" xml:lang="en-US">Accretion expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtGainLossIncomeTax" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossIncomeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtGainLossIncomeTax" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossIncomeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossIncomeTax_lbl" xml:lang="en-US">Loss on debt extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EffectOfLegislativeChanges" xlink:label="niobf_EffectOfLegislativeChanges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EffectOfLegislativeChanges" xlink:to="niobf_EffectOfLegislativeChanges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EffectOfLegislativeChanges_lbl" xml:lang="en-US">Capital loss rate differential</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" xml:lang="en-US">Change in estimates related to prior years</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating losses available for future periods</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DeferredTaxAssetsMineralInterest" xlink:label="niobf_DeferredTaxAssetsMineralInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsMineralInterest" xlink:to="niobf_DeferredTaxAssetsMineralInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DeferredTaxAssetsMineralInterest_lbl" xml:lang="en-US">Mineral interests</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" xlink:label="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" xlink:to="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts_lbl" xml:lang="en-US">Startup and organizational costs</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" xlink:label="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" xlink:to="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts_lbl" xml:lang="en-US">Research and development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DeferredTaxAssetsShareIssuanceCosts" xlink:label="niobf_DeferredTaxAssetsShareIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsShareIssuanceCosts" xlink:to="niobf_DeferredTaxAssetsShareIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_DeferredTaxAssetsShareIssuanceCosts_lbl" xml:lang="en-US">Share issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CapitalLossesAvailableForFuturePeriods" xlink:label="niobf_CapitalLossesAvailableForFuturePeriods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CapitalLossesAvailableForFuturePeriods" xlink:to="niobf_CapitalLossesAvailableForFuturePeriods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CapitalLossesAvailableForFuturePeriods_lbl" xml:lang="en-US">Capital losses available for future periods</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">&#160;Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Valuation allowance, beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DeferredTaxAssetsValuationAllowanceAdditions" xlink:label="niobf_DeferredTaxAssetsValuationAllowanceAdditions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsValuationAllowanceAdditions" xlink:to="niobf_DeferredTaxAssetsValuationAllowanceAdditions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_DeferredTaxAssetsValuationAllowanceAdditions_lbl" xml:lang="en-US">Current year additions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsIncurredDevelopmentCosts" xlink:label="us-gaap_CostsIncurredDevelopmentCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsIncurredDevelopmentCosts" xlink:to="us-gaap_CostsIncurredDevelopmentCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostsIncurredDevelopmentCosts_lbl" xml:lang="en-US">Startup and organizational costs acquired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_3_lbl" xml:lang="en-US">Valuation allowance, end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOtherLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOtherLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOtherLossCarryforwards_lbl" xml:lang="en-US">Tax losses incurred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_IncreasesInCapitalLossesAvailableForFuturePeriods" xlink:label="niobf_IncreasesInCapitalLossesAvailableForFuturePeriods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncreasesInCapitalLossesAvailableForFuturePeriods" xlink:to="niobf_IncreasesInCapitalLossesAvailableForFuturePeriods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_IncreasesInCapitalLossesAvailableForFuturePeriods_lbl" xml:lang="en-US">Increases in Capital Losses Available for Future Periods</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_OtherIncomeTaxes" xlink:label="niobf_OtherIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtherIncomeTaxes" xlink:to="niobf_OtherIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_OtherIncomeTaxes_lbl" xml:lang="en-US">Other Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CapitalLossCaryforward" xlink:label="niobf_CapitalLossCaryforward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CapitalLossCaryforward" xlink:to="niobf_CapitalLossCaryforward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CapitalLossCaryforward_lbl" xml:lang="en-US">Net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl" xml:lang="en-US">Federal income tax payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_4_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:label="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:to="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="us-gaap_OtherLiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:to="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xml:lang="en-US">Warrants Not Settleable in Cash, Fair Value Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" xlink:label="us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" xlink:to="us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_lbl" xml:lang="en-US">Mortgage-Backed Securities Available-for-Sale, Fair Value Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventDescription" xlink:label="us-gaap_SubsequentEventDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventDescription" xlink:to="us-gaap_SubsequentEventDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventDescription_lbl" xml:lang="en-US">Subsequent event description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Shares issued and sold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds" xlink:label="us-gaap_DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds" xlink:to="us-gaap_DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds_lbl" xml:lang="en-US">Gross cash proceeds</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:to="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember_doc" xml:lang="en-US">The element represents warrants each exercisable for 1.11829212 common shares member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonSharesWithoutParValueMember" xlink:to="niobf_CommonSharesWithoutParValueMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CommonSharesWithoutParValueMember_doc" xml:lang="en-US">The element represents common shares without par value member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncorporationStateCountryName" xlink:to="niobf_IncorporationStateCountryName_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_IncorporationStateCountryName_doc" xml:lang="en-US">The element represents incorporation state country name.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_Entity0896800BCLtdMember" xlink:to="niobf_Entity0896800BCLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_Entity0896800BCLtdMember_doc" xml:lang="en-US">The element represents entity 0896800 b c ltd member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ElkCreekResourcesCorpMember" xlink:to="niobf_ElkCreekResourcesCorpMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ElkCreekResourcesCorpMember_doc" xml:lang="en-US">The element represents elk creek resources corp member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ElkCreekResourcesCorpECRCMember" xlink:to="niobf_ElkCreekResourcesCorpECRCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ElkCreekResourcesCorpECRCMember_doc" xml:lang="en-US">The element represents elk creek resources corp ecrc member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DevelopmentStageIssuerPolicyTextBlock" xlink:to="niobf_DevelopmentStageIssuerPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DevelopmentStageIssuerPolicyTextBlock_doc" xml:lang="en-US">The element represents development stage issuer policy text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MineralPropertiesPolicyTextBlock" xlink:to="niobf_MineralPropertiesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_MineralPropertiesPolicyTextBlock_doc" xml:lang="en-US">The element represents mineral properties policy text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantsPolicyTextBlock" xlink:to="niobf_WarrantsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_WarrantsPolicyTextBlock_doc" xml:lang="en-US">The element represents warrants policy text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutSharesPolicy" xlink:to="niobf_EarnoutSharesPolicy_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarnoutSharesPolicy_doc" xml:lang="en-US">The element represents earnout shares policy.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ReverseStockSplitPolicy" xlink:label="niobf_ReverseStockSplitPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ReverseStockSplitPolicy" xlink:to="niobf_ReverseStockSplitPolicy_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ReverseStockSplitPolicy_doc" xml:lang="en-US">The element represents reverse stock split policy.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ReverseStockSplitPolicyTextBlock" xlink:to="niobf_ReverseStockSplitPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ReverseStockSplitPolicyTextBlock_doc" xml:lang="en-US">The element represents reverse stock split policy text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:to="niobf_RedeemableNoncontrollingInterestPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_RedeemableNoncontrollingInterestPolicyTextBlock_doc" xml:lang="en-US">The element represents redeemable noncontrolling interest policy text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarningsLossPerShareBasicAndDiluted" xlink:to="niobf_EarningsLossPerShareBasicAndDiluted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarningsLossPerShareBasicAndDiluted_doc" xml:lang="en-US">The element represents earnings loss per share basic and diluted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantAgreementMember" xlink:to="niobf_WarrantAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_WarrantAgreementMember_doc" xml:lang="en-US">The element represents warrant agreement member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_TransactionCosts" xlink:label="niobf_TransactionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TransactionCosts" xlink:to="niobf_TransactionCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_TransactionCosts_doc" xml:lang="en-US">The element represents transaction costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutSharesAssumedAtFairValue" xlink:to="niobf_EarnoutSharesAssumedAtFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarnoutSharesAssumedAtFairValue_doc" xml:lang="en-US">The element represents earnout shares assumed at fair value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LegacyNioCorpShareholdersMember" xlink:to="niobf_LegacyNioCorpShareholdersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LegacyNioCorpShareholdersMember_doc" xml:lang="en-US">The element represents legacy nio corp shareholders member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIClassAShareholdersMember" xlink:to="niobf_GXIIClassAShareholdersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GXIIClassAShareholdersMember_doc" xml:lang="en-US">The element represents gxii class a shareholders member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtherMember" xlink:to="niobf_OtherMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_OtherMember_doc" xml:lang="en-US">The element represents other member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareExchangeAgreementMember" xlink:to="niobf_ShareExchangeAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ShareExchangeAgreementMember_doc" xml:lang="en-US">The element represents share exchange agreement member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxImpacts" xlink:to="niobf_DeferredTaxImpacts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DeferredTaxImpacts_doc" xml:lang="en-US">The element represents deferred taximpacts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OptionAgreementMember" xlink:to="niobf_OptionAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_OptionAgreementMember_doc" xml:lang="en-US">The element represents option agreement member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConvertibleSecurityMember" xlink:to="niobf_ConvertibleSecurityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ConvertibleSecurityMember_doc" xml:lang="en-US">The element represents convertible security member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LindIIIConvertibleSecurityMember" xlink:to="niobf_LindIIIConvertibleSecurityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LindIIIConvertibleSecurityMember_doc" xml:lang="en-US">The element represents lind i i i convertible security member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TransactionCost" xlink:to="niobf_TransactionCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_TransactionCost_doc" xml:lang="en-US">The element represents transaction cost.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" xlink:to="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_doc" xml:lang="en-US">The element represents schedule of changes in lind iii convertible security text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" xlink:to="niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_doc" xml:lang="en-US">The element represents business combination separately recognized transactions additional disclosures acquisition cash costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MinimumConsentPaymentAtInception" xlink:to="niobf_MinimumConsentPaymentAtInception_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_MinimumConsentPaymentAtInception_doc" xml:lang="en-US">The element represents minimum consent payment at inception.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ASC470LossOnExtinguishment" xlink:to="niobf_ASC470LossOnExtinguishment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ASC470LossOnExtinguishment_doc" xml:lang="en-US">The element represents as c470 loss on extinguishment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AdditionalConsentPaymentbooked" xlink:to="niobf_AdditionalConsentPaymentbooked_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AdditionalConsentPaymentbooked_doc" xml:lang="en-US">The element represents additional consent paymentbooked.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfWarrantValuationTableTextblock" xlink:to="niobf_ScheduleOfWarrantValuationTableTextblock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfWarrantValuationTableTextblock_doc" xml:lang="en-US">The element represents schedule of warrant valuation table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInValuationOfWarrants" xlink:to="niobf_ChangeInValuationOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInValuationOfWarrants_doc" xml:lang="en-US">The element represents change in valuation of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" xlink:to="niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_doc" xml:lang="en-US">The element represents fair value assets and liabilities measured on recurring and nonrecurring monte carlo techniques table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ProbabilityOfIssuanceMember" xlink:to="niobf_ProbabilityOfIssuanceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ProbabilityOfIssuanceMember_doc" xml:lang="en-US">The element represents probability of issuance member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:to="niobf_YorkvilleConvertibleDebtFinancingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_YorkvilleConvertibleDebtFinancingAgreementMember_doc" xml:lang="en-US">The element represents yorkville convertible debt financing agreement member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" xlink:to="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise_doc" xml:lang="en-US">The element represents stock issued during period shares stock options exercise.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1" xlink:to="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1_doc" xml:lang="en-US">The element represents stock issued during period shares stock options exercise1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" xlink:to="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_doc" xml:lang="en-US">The element represents share based goods and nonemployee services transaction valuation method expected dividend yield rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DebtMaturityPeriod" xlink:to="niobf_DebtMaturityPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DebtMaturityPeriod_doc" xml:lang="en-US">The element represents debt maturity period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrincipalAndAccruedInterestConverted" xlink:to="niobf_PrincipalAndAccruedInterestConverted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PrincipalAndAccruedInterestConverted_doc" xml:lang="en-US">The element represents principal and accrued interest converted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" xlink:to="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock_doc" xml:lang="en-US">The element represents schedule of class b common stock of ecrc table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutMember" xlink:to="niobf_EarnoutMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarnoutMember_doc" xml:lang="en-US">The element represents earnout member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DescriptionOfEarnOutShares" xlink:to="niobf_DescriptionOfEarnOutShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DescriptionOfEarnOutShares_doc" xml:lang="en-US">The element represents description of earn out shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:to="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_doc" xml:lang="en-US">The element represents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:to="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_doc" xml:lang="en-US">The element represents sharebased compensation arrangement by sharebased payment award fair value assumptions expected term2.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DescriptionOfAmendedPlan" xlink:to="niobf_DescriptionOfAmendedPlan_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DescriptionOfAmendedPlan_doc" xml:lang="en-US">The element represents description of amended plan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LongTermIncentivePlanMember" xlink:to="niobf_LongTermIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LongTermIncentivePlanMember_doc" xml:lang="en-US">The element represents long termincentive plan member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueAssumptionsRiskFreeInterestRate1" xlink:to="niobf_FairValueAssumptionsRiskFreeInterestRate1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FairValueAssumptionsRiskFreeInterestRate1_doc" xml:lang="en-US">The element represents fair value assumptions risk free interest rate 1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueAssumptionsExpected1VolatilityRate" xlink:to="niobf_FairValueAssumptionsExpected1VolatilityRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FairValueAssumptionsExpected1VolatilityRate_doc" xml:lang="en-US">The element represents fair value assumptions expected 1 volatility rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueAssumptions1ExpectedTerm" xlink:to="niobf_FairValueAssumptions1ExpectedTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FairValueAssumptions1ExpectedTerm_doc" xml:lang="en-US">The element represents fair value assumptions 1 expected term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1" xlink:to="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_doc" xml:lang="en-US">The element represents share based compensation arrangement by share based payment award options outstanding intrinsic value 1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice8.40Member" xlink:to="niobf_ExercisePrice8.40Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice8.40Member_doc" xml:lang="en-US">The element represents exercise price 8.40 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice5.40Member" xlink:to="niobf_ExercisePrice5.40Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice5.40Member_doc" xml:lang="en-US">The element represents exercise price 5.40 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice7.50Member" xlink:to="niobf_ExercisePrice7.50Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice7.50Member_doc" xml:lang="en-US">The element represents exercise price 7.50 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice7.50OneMember" xlink:to="niobf_ExercisePrice7.50OneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice7.50OneMember_doc" xml:lang="en-US">The element represents exercise price 7.50 one member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice13.60Member" xlink:to="niobf_ExercisePrice13.60Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice13.60Member_doc" xml:lang="en-US">The element represents exercise price 13.60 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice11.00Member" xlink:to="niobf_ExercisePrice11.00Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice11.00Member_doc" xml:lang="en-US">The element represents exercise price 11.00 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice6.95Member" xlink:to="niobf_ExercisePrice6.95Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice6.95Member_doc" xml:lang="en-US">The element represents exercise price 6.95 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NordminWarrants" xlink:to="niobf_NordminWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_NordminWarrants_doc" xml:lang="en-US">The element represents nordmin warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightLindIIIWarrants" xlink:to="niobf_ClassOfWarrantOrRightLindIIIWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightLindIIIWarrants_doc" xml:lang="en-US">The element represents class of warrant or right lind i i i warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightAprilPrivatePlacement" xlink:to="niobf_ClassOfWarrantOrRightAprilPrivatePlacement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightAprilPrivatePlacement_doc" xml:lang="en-US">The element represents class of warrant or right april private placement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercised" xlink:to="niobf_ClassOfWarrantOrRightExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercised_doc" xml:lang="en-US">The element represents class of warrant or right exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExpired" xlink:to="niobf_ClassOfWarrantOrRightExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExpired_doc" xml:lang="en-US">The element represents class of warrant or right expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing_doc" xml:lang="en-US">The element represents class of warrant or right exercise price warrants november financing.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceLindWarrants" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceLindWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceLindWarrants_doc" xml:lang="en-US">The element represents class of warrant or right exercise price lind warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements_doc" xml:lang="en-US">The element represents class of warrant or right exercise price april private placements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExercised" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExercised_doc" xml:lang="en-US">The element represents class of warrant or right exercise price exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExpired_doc" xml:lang="en-US">The element represents class of warrant or right exercise price expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceJunePrivatePlacements" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceJunePrivatePlacements_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceJunePrivatePlacements_doc" xml:lang="en-US">The element represents class of warrant or right exercise price june private placements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_doc" xml:lang="en-US">The element represents class of warrant or right exercise price warrants yorkville financing warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_doc" xml:lang="en-US">The element represents class of warrant or right exercise price warrants gxii warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightJunePrivatePlacement" xlink:to="niobf_ClassOfWarrantOrRightJunePrivatePlacement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightJunePrivatePlacement_doc" xml:lang="en-US">The element represents class of warrant or right june private placement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleFinancingWarrants" xlink:to="niobf_YorkvilleFinancingWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_YorkvilleFinancingWarrants_doc" xml:lang="en-US">The element represents yorkville financing warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GxiiWarrants" xlink:to="niobf_GxiiWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GxiiWarrants_doc" xml:lang="en-US">The element represents gxii warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock_doc" xml:lang="en-US">The element represents schedule of outstanding exercisable warrants table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIPublicWarrantsMember" xlink:to="niobf_GXIIPublicWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GXIIPublicWarrantsMember_doc" xml:lang="en-US">The element represents gxii public warrants member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIPrivateWarrantsMember" xlink:to="niobf_GXIIPrivateWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GXIIPrivateWarrantsMember_doc" xml:lang="en-US">The element represents gxii private warrants member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_doc" xml:lang="en-US">The elements represents schedule of changes in the fair value of the private warrants table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation" xlink:to="niobf_ChangesInFairValueOfInitialValuation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangesInFairValueOfInitialValuation_doc" xml:lang="en-US">The element represents changes in fair value of initial valuation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GeneralSecurityAgreementMember" xlink:to="niobf_GeneralSecurityAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GeneralSecurityAgreementMember_doc" xml:lang="en-US">The element represents general security agreement member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LineOfCreditFacilityPrepaymentFee" xlink:to="niobf_LineOfCreditFacilityPrepaymentFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LineOfCreditFacilityPrepaymentFee_doc" xml:lang="en-US">The element represents line of credit facility prepayment fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AmendedNonRevolvingCreditFacilityAgreementMember" xlink:to="niobf_AmendedNonRevolvingCreditFacilityAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AmendedNonRevolvingCreditFacilityAgreementMember_doc" xml:lang="en-US">The element represents amended non revolving credit facility agreement member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AmountPaidToRelatedParty" xlink:to="niobf_AmountPaidToRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AmountPaidToRelatedParty_doc" xml:lang="en-US">The element represents amount paid to related party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NonRevolvingCreditFacilityAgreementMember" xlink:to="niobf_NonRevolvingCreditFacilityAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_NonRevolvingCreditFacilityAgreementMember_doc" xml:lang="en-US">The element represents non revolving credit facility agreement member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MarkSmithMember" xlink:to="niobf_MarkSmithMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_MarkSmithMember_doc" xml:lang="en-US">The element represents mark smith member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EstablishmentFeesPayable" xlink:to="niobf_EstablishmentFeesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EstablishmentFeesPayable_doc" xml:lang="en-US">The element represents establishment fees payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AmountsAdvanced" xlink:to="niobf_AmountsAdvanced_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AmountsAdvanced_doc" xml:lang="en-US">The element represents amounts advanced.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExplorationExpendituresDisclosuresTextBlock" xlink:to="niobf_ExplorationExpendituresDisclosuresTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExplorationExpendituresDisclosuresTextBlock_doc" xml:lang="en-US">The element represents exploration expenditures disclosures text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CostCentreAxis" xlink:to="niobf_CostCentreAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CostCentreAxis_doc" xml:lang="en-US">The element represents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FeasibilityStudyAndEngineeringMember" xlink:to="niobf_FeasibilityStudyAndEngineeringMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FeasibilityStudyAndEngineeringMember_doc" xml:lang="en-US">The element represents feasibility study and engineering member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FieldManagementAndOtherMember" xlink:to="niobf_FieldManagementAndOtherMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FieldManagementAndOtherMember_doc" xml:lang="en-US">The element represents field management and other member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GeologistsAndFieldStaffMember" xlink:to="niobf_GeologistsAndFieldStaffMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GeologistsAndFieldStaffMember_doc" xml:lang="en-US">The element represents geologists and field staff member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CorporateOfficeMember" xlink:to="niobf_CorporateOfficeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CorporateOfficeMember_doc" xml:lang="en-US">The element represents corporate office member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FixedRentExpense" xlink:to="niobf_FixedRentExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FixedRentExpense_doc" xml:lang="en-US">The element represents fixed rent expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LessAmountOfPaymentsRepresentingInterest" xlink:to="niobf_LessAmountOfPaymentsRepresentingInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LessAmountOfPaymentsRepresentingInterest_doc" xml:lang="en-US">The element represents less amount of payments representing interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExplorationExpenditures" xlink:to="niobf_ExplorationExpenditures_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExplorationExpenditures_doc" xml:lang="en-US">The element represents exploration expenditures.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted_doc" xml:lang="en-US">The element represents total weighted average number of share outstanding basic and diluted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ValueOfWarrantsIssued" xlink:to="niobf_ValueOfWarrantsIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ValueOfWarrantsIssued_doc" xml:lang="en-US">The element represents value of warrants issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AccountsPayableToConvertibleDebtConversion" xlink:to="niobf_AccountsPayableToConvertibleDebtConversion_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AccountsPayableToConvertibleDebtConversion_doc" xml:lang="en-US">The element represents accounts payable to convertible debt conversion.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DerecognitionOfOperatingLeaseLiabilities" xlink:to="niobf_DerecognitionOfOperatingLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DerecognitionOfOperatingLeaseLiabilities_doc" xml:lang="en-US">The element represents derecognition of operating lease liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RecognitionOfOperatingLeaseLiabilities" xlink:to="niobf_RecognitionOfOperatingLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_RecognitionOfOperatingLeaseLiabilities_doc" xml:lang="en-US">The element represents recognition of operating lease liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConversionsOfDebtForCommonShares" xlink:to="niobf_ConversionsOfDebtForCommonShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ConversionsOfDebtForCommonShares_doc" xml:lang="en-US">The element represents conversions of debt for common shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtheroperatingGainsLosses" xlink:to="niobf_OtheroperatingGainsLosses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_OtheroperatingGainsLosses_doc" xml:lang="en-US">The element represents otheroperating gains losses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ForeignCurrencyTransactionGainLossBeforeTax1" xlink:to="niobf_ForeignCurrencyTransactionGainLossBeforeTax1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ForeignCurrencyTransactionGainLossBeforeTax1_doc" xml:lang="en-US">The element represents foreign currency transaction gain loss before tax 1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LossesOnExtinguishmentOfDebt" xlink:to="niobf_LossesOnExtinguishmentOfDebt_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LossesOnExtinguishmentOfDebt_doc" xml:lang="en-US">The element represents losses on extinguishment of debt.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:to="niobf_StockIssuedDuringPeriodSharesStockWarrantExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodSharesStockWarrantExercised_doc" xml:lang="en-US">The element represents stock issued during period shares stock warrant exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivatePlacementSharesMay2021" xlink:to="niobf_PrivatePlacementSharesMay2021_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PrivatePlacementSharesMay2021_doc" xml:lang="en-US">The element represents private placement shares may 2021.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterestMember" xlink:to="niobf_RedeemableNoncontrollingInterestMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_RedeemableNoncontrollingInterestMember_doc" xml:lang="en-US">The element represents redeemable noncontrolling interest member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EffectOfLegislativeChanges" xlink:to="niobf_EffectOfLegislativeChanges_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EffectOfLegislativeChanges_doc" xml:lang="en-US">The element represents effect of legislative changes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsMineralInterest" xlink:to="niobf_DeferredTaxAssetsMineralInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DeferredTaxAssetsMineralInterest_doc" xml:lang="en-US">The element represents deferred tax assets mineral interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CapitalLossesAvailableForFuturePeriods" xlink:to="niobf_CapitalLossesAvailableForFuturePeriods_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CapitalLossesAvailableForFuturePeriods_doc" xml:lang="en-US">The element represents capital losses available for future periods.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" xlink:to="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts_doc" xml:lang="en-US">The element represents deferred tax assets startup and oorganizational costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" xlink:to="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts_doc" xml:lang="en-US">The element represents deferred tax assets research and development costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsShareIssuanceCosts" xlink:to="niobf_DeferredTaxAssetsShareIssuanceCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DeferredTaxAssetsShareIssuanceCosts_doc" xml:lang="en-US">The element represents deferred tax assets share issuance costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncreasesInCapitalLossesAvailableForFuturePeriods" xlink:to="niobf_IncreasesInCapitalLossesAvailableForFuturePeriods_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_IncreasesInCapitalLossesAvailableForFuturePeriods_doc" xml:lang="en-US">The element represents increases in capital losses available for future periods.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtherIncomeTaxes" xlink:to="niobf_OtherIncomeTaxes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_OtherIncomeTaxes_doc" xml:lang="en-US">The element represents Other Income Taxes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsValuationAllowanceAdditions" xlink:to="niobf_DeferredTaxAssetsValuationAllowanceAdditions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DeferredTaxAssetsValuationAllowanceAdditions_doc" xml:lang="en-US">The element represents deferred tax assets valuation allowance additions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CapitalLossCaryforward" xlink:to="niobf_CapitalLossCaryforward_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CapitalLossCaryforward_doc" xml:lang="en-US">The element represents Capital Loss Caryforward.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutLiabilityAtFairValue" xlink:to="niobf_EarnoutLiabilityAtFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarnoutLiabilityAtFairValue_doc" xml:lang="en-US">The element represents earnout liability at fair value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfEarnoutLiability_doc" xml:lang="en-US">The element represents change in fair value of earnout liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfWarrantLiability" xlink:to="niobf_ChangeInFairValueOfWarrantLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfWarrantLiability_doc" xml:lang="en-US">The element represents change in fair value of warrant liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AssumptionOfPrivateAndPublicWarrants" xlink:to="niobf_AssumptionOfPrivateAndPublicWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AssumptionOfPrivateAndPublicWarrants_doc" xml:lang="en-US">The element represents assumption of private and public warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutShareLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfEarnoutShareLiability_doc" xml:lang="en-US">The element represents change in fair value of earnout share liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AssumptionOfEarnoutLiability" xlink:to="niobf_AssumptionOfEarnoutLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AssumptionOfEarnoutLiability_doc" xml:lang="en-US">The element represents assumption of earnout liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueOfCommitmentSharesIssued" xlink:to="niobf_FairValueOfCommitmentSharesIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FairValueOfCommitmentSharesIssued_doc" xml:lang="en-US">The element represents fair value of commitment shares issued.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_PrivatePlacementSharesMay2022" xlink:label="niobf_PrivatePlacementSharesMay2022" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivatePlacementSharesMay2022" xlink:to="niobf_PrivatePlacementSharesMay2022_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PrivatePlacementSharesMay2022_doc" xml:lang="en-US">The element represents private placement shares may 2022.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleCashFee" xlink:to="niobf_YorkvilleCashFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_YorkvilleCashFee_doc" xml:lang="en-US">The element represents yorkville cash fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharesIssuedUnderTheYorkvilleEquityFacility" xlink:to="niobf_SharesIssuedUnderTheYorkvilleEquityFacility_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacility_doc" xml:lang="en-US">The element represents shares issued under the yorkville equity facility.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:to="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares_doc" xml:lang="en-US">The element represents shares issued under the yorkville equity facility shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GxiiTransactionCosts" xlink:to="niobf_GxiiTransactionCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GxiiTransactionCosts_doc" xml:lang="en-US">The element represents gxii transaction costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantLiability" xlink:to="niobf_WarrantLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_WarrantLiability_doc" xml:lang="en-US">The element represents warrant liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutSharesLiability" xlink:to="niobf_EarnoutSharesLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarnoutSharesLiability_doc" xml:lang="en-US">The element represents earnout shares liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivatePlacementValueMay2021" xlink:to="niobf_PrivatePlacementValueMay2021_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PrivatePlacementValueMay2021_doc" xml:lang="en-US">The element represents private placement value may 2021.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DiscountRate" xlink:to="niobf_DiscountRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DiscountRate_doc" xml:lang="en-US">The element represents discount rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice9.70Member" xlink:to="niobf_ExercisePrice9.70Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice9.70Member_doc" xml:lang="en-US">The element represents exercise price 9.70 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice8.94Member" xlink:to="niobf_ExercisePrice8.94Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice8.94Member_doc" xml:lang="en-US">The element represents exercise price 8.94 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice11.50Member" xlink:to="niobf_ExercisePrice11.50Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice11.50Member_doc" xml:lang="en-US">The element represents exercise price11.50 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SaleOfStockPricePerShare1" xlink:to="niobf_SaleOfStockPricePerShare1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_SaleOfStockPricePerShare1_doc" xml:lang="en-US">The element represents sale of stock price per share 1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:to="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_doc" xml:lang="en-US">The element represents schedule ofsummary of the changes in the fair value of the earnout share liability table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonSharesIssuedInTheGXIITransaction" xlink:to="niobf_CommonSharesIssuedInTheGXIITransaction_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CommonSharesIssuedInTheGXIITransaction_doc" xml:lang="en-US">The element represents common shares issued in the gxii transaction.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonSharesIssuedInTheGXIITransactionSahres" xlink:to="niobf_CommonSharesIssuedInTheGXIITransactionSahres_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CommonSharesIssuedInTheGXIITransactionSahres_doc" xml:lang="en-US">The element represents common shares issued in the gxii transaction sahres,</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" xlink:to="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_doc" xml:lang="en-US">The element represents schedule of changes in lind iii convertible security one text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfExplorationExpendituresTableTextBlock" xlink:to="niobf_ScheduleOfExplorationExpendituresTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfExplorationExpendituresTableTextBlock_doc" xml:lang="en-US">The element represents schedule of exploration expenditures table text block..</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodSharesStockWarrantExercisedShares" xlink:to="niobf_StockIssuedDuringPeriodSharesStockWarrantExercisedShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodSharesStockWarrantExercisedShares_doc" xml:lang="en-US">The element represents stock issued during period shares stock warrant exercised shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivatePlacementSharesMay2022Sahres" xlink:to="niobf_PrivatePlacementSharesMay2022Sahres_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PrivatePlacementSharesMay2022Sahres_doc" xml:lang="en-US">The element represents private placement shares may 2022 sahres.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DueToOfficersOrStockholdersOtherCurrent" xlink:to="niobf_DueToOfficersOrStockholdersOtherCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DueToOfficersOrStockholdersOtherCurrent_doc" xml:lang="en-US">The element represents due to officers or stockholders other current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:to="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_doc" xml:lang="en-US">The element represents available for sale securities equity securities other.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInValuationOfWarrantLiabilities" xlink:to="niobf_ChangeInValuationOfWarrantLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInValuationOfWarrantLiabilities_doc" xml:lang="en-US">The element represents change in valuation of warrant liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ProfitLoss1" xlink:to="niobf_ProfitLoss1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ProfitLoss1_doc" xml:lang="en-US">The element represents profit loss 2.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_doc" xml:lang="en-US">The element represents income loss from continuing operations before income taxes extraordinary items noncontrolling interest 1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareIssuanceCost" xlink:to="niobf_ShareIssuanceCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ShareIssuanceCost_doc" xml:lang="en-US">The element represents share issuance cost.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LindConvertibleSecurityMember" xlink:label="niobf_LindConvertibleSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LindConvertibleSecurityMember" xlink:to="niobf_LindConvertibleSecurityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LindConvertibleSecurityMember_doc" xml:lang="en-US">The element represents lind convertible security member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FinancingAgreementMember" xlink:to="niobf_FinancingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FinancingAgreementMember_doc" xml:lang="en-US">The element represents financing agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CashAndCashEquivalentsAtCarryingValue1" xlink:to="niobf_CashAndCashEquivalentsAtCarryingValue1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CashAndCashEquivalentsAtCarryingValue1_doc" xml:lang="en-US">The element represents cash and cash equivalents at carrying value1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterest" xlink:to="niobf_RedeemableNoncontrollingInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_RedeemableNoncontrollingInterest_doc" xml:lang="en-US">The element represents redeemable noncontrolling interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutLiability_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfEarnoutLiability_3_lbl" xml:lang="en-US">Change in Fair Value of Earnout Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfWarrantLiability" xlink:to="niobf_ChangeInFairValueOfWarrantLiability_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfWarrantLiability_4_lbl" xml:lang="en-US">Change in Fair Value of Warrant Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_2_lbl" xml:lang="en-US">Other Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_2_lbl" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_3_lbl" xml:lang="en-US">Income Loss from Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LossesOnExtinguishmentOfDebt" xlink:to="niobf_LossesOnExtinguishmentOfDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LossesOnExtinguishmentOfDebt_3_lbl" xml:lang="en-US">Losses on Extinguishment of Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_2_lbl" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtheroperatingGainsLosses" xlink:to="niobf_OtheroperatingGainsLosses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_OtheroperatingGainsLosses_3_lbl" xml:lang="en-US">Otheroperating Gains Losses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_2_lbl" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xml:lang="en-US">Repayments of Related Party Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_2_lbl" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_2_lbl" xml:lang="en-US">Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterest" xlink:to="niobf_RedeemableNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_RedeemableNoncontrollingInterest_3_lbl" xml:lang="en-US">Redeemable Noncontrolling Interest [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_2_lbl" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_2_lbl" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2_lbl" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountIssued1" xlink:to="us-gaap_ConversionOfStockAmountIssued1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountIssued1_2_lbl" xml:lang="en-US">Conversion of Stock, Amount Issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:to="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_2_lbl" xml:lang="en-US">Payments to Acquire Held-to-Maturity Securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ASC470LossOnExtinguishment" xlink:to="niobf_ASC470LossOnExtinguishment_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ASC470LossOnExtinguishment_3_lbl" xml:lang="en-US">AS C470 Loss on Extinguishment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_3_lbl" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebt_3_lbl" xml:lang="en-US">Convertible Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrincipalAndAccruedInterestConverted" xlink:to="niobf_PrincipalAndAccruedInterestConverted_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PrincipalAndAccruedInterestConverted_3_lbl" xml:lang="en-US">Principal and Accrued Interest Converted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="us-gaap_LineOfCreditFacilityCommitmentFeeAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount_2_lbl" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1" xlink:to="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1_3_lbl" xml:lang="en-US">Stock Issued During Period Shares Stock Options Exercise1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiability" xlink:to="us-gaap_ServicingLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ServicingLiability_2_lbl" xml:lang="en-US">Servicing Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" xlink:to="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_3_lbl" xml:lang="en-US">Share-Based Goods and Nonemployee Services Transaction Valuation Method Expected Dividend Yield Rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DebtMaturityPeriod" xlink:to="niobf_DebtMaturityPeriod_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DebtMaturityPeriod_3_lbl" xml:lang="en-US">Debt Maturity Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_2_lbl" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiabilityAtFairValueAmount" xlink:to="us-gaap_ServicingLiabilityAtFairValueAmount_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ServicingLiabilityAtFairValueAmount_3_lbl" xml:lang="en-US">Servicing Liability at Fair Value, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiabilityAtFairValueAdditions" xlink:to="us-gaap_ServicingLiabilityAtFairValueAdditions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ServicingLiabilityAtFairValueAdditions_2_lbl" xml:lang="en-US">Servicing Liability at Fair Value, Additions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercised" xlink:to="niobf_ClassOfWarrantOrRightExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercised_3_lbl" xml:lang="en-US">Class of Warrant or Right Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation" xlink:to="niobf_ChangesInFairValueOfInitialValuation_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangesInFairValueOfInitialValuation_4_lbl" xml:lang="en-US">Changes in Fair Value of initial Valuation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:to="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_2_lbl" xml:lang="en-US">Servicing Asset at Fair Value, Changes in Fair Value Resulting from Changes in Valuation Inputs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2_lbl" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_2_lbl" xml:lang="en-US">Operating Lease, Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueAssumptionsRiskFreeInterestRate1" xlink:to="niobf_FairValueAssumptionsRiskFreeInterestRate1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FairValueAssumptionsRiskFreeInterestRate1_3_lbl" xml:lang="en-US">Fair Value Assumptions Risk Free Interest Rate 1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueAssumptions1ExpectedTerm" xlink:to="niobf_FairValueAssumptions1ExpectedTerm_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FairValueAssumptions1ExpectedTerm_3_lbl" xml:lang="en-US">Fair Value Assumptions 1 Expected Term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDepositLiabilities" xlink:to="us-gaap_RelatedPartyDepositLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDepositLiabilities_3_lbl" xml:lang="en-US">Related Party Deposit Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExplorationExpense" xlink:to="us-gaap_ExplorationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExplorationExpense_2_lbl" xml:lang="en-US">Exploration Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubleaseIncome_2_lbl" xml:lang="en-US">Sublease Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_2_lbl" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationAccretionExpense" xlink:to="us-gaap_AssetRetirementObligationAccretionExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetRetirementObligationAccretionExpense_2_lbl" xml:lang="en-US">Asset Retirement Obligation, Accretion Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtGainLossIncomeTax" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossIncomeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossIncomeTax_2_lbl" xml:lang="en-US">Extinguishment of Debt, Gain (Loss), Income Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsShareIssuanceCosts" xlink:to="niobf_DeferredTaxAssetsShareIssuanceCosts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DeferredTaxAssetsShareIssuanceCosts_3_lbl" xml:lang="en-US">Deferred Tax Assets Share Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_2_lbl" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsValuationAllowanceAdditions" xlink:to="niobf_DeferredTaxAssetsValuationAllowanceAdditions_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DeferredTaxAssetsValuationAllowanceAdditions_3_lbl" xml:lang="en-US">Deferred Tax Assets Valuation Allowance Additions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsIncurredDevelopmentCosts" xlink:to="us-gaap_CostsIncurredDevelopmentCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsIncurredDevelopmentCosts_2_lbl" xml:lang="en-US">Costs Incurred, Development Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_2_lbl" xml:lang="en-US">Operating Loss Carryforwards</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:to="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_3_lbl" xml:lang="en-US">Available for Sale Securities Equity Securities Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_2_lbl" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>29
<FILENAME>niobf-20230630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!--XBRL Document Created By The Nuvo Group-->
<!-- -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://niocorp.com/role/Cover" xlink:href="niobf-20230630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheets" xlink:href="niobf-20230630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:href="niobf-20230630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="niobf-20230630.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfCashFlows" xlink:href="niobf-20230630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:href="niobf-20230630.xsd#StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusiness" xlink:href="niobf-20230630.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPreparation" xlink:href="niobf-20230630.xsd#BasisOfPreparation" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPolicies" xlink:href="niobf-20230630.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcernIssues" xlink:href="niobf-20230630.xsd#GoingConcernIssues" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransaction" xlink:href="niobf-20230630.xsd#GxiiTransaction" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LandAndBuildingsNet" xlink:href="niobf-20230630.xsd#LandAndBuildingsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MineralProperties" xlink:href="niobf-20230630.xsd#MineralProperties" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="niobf-20230630.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebt" xlink:href="niobf-20230630.xsd#ConvertibleDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:href="niobf-20230630.xsd#ClassBCommonStockOfEcrc" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonShares" xlink:href="niobf-20230630.xsd#CommonShares" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" xlink:href="niobf-20230630.xsd#RelatedPartyTransactionsAndBalances" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpenditures" xlink:href="niobf-20230630.xsd#ExplorationExpenditures" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/Leases" xlink:href="niobf-20230630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxes" xlink:href="niobf-20230630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurements" xlink:href="niobf-20230630.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEvents" xlink:href="niobf-20230630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" xlink:href="niobf-20230630.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPreparationTables" xlink:href="niobf-20230630.xsd#BasisOfPreparationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesTables" xlink:href="niobf-20230630.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransactionTables" xlink:href="niobf-20230630.xsd#GxiiTransactionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LandAndBuildingsNetTables" xlink:href="niobf-20230630.xsd#LandAndBuildingsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="niobf-20230630.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebtTables" xlink:href="niobf-20230630.xsd#ConvertibleDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:href="niobf-20230630.xsd#ClassBCommonStockOfEcrcTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesTables" xlink:href="niobf-20230630.xsd#CommonSharesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:href="niobf-20230630.xsd#RelatedPartyTransactionsAndBalancesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpendituresTables" xlink:href="niobf-20230630.xsd#ExplorationExpendituresTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LeasesTables" xlink:href="niobf-20230630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxesTables" xlink:href="niobf-20230630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurementsTables" xlink:href="niobf-20230630.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails" xlink:href="niobf-20230630.xsd#ScheduleOfIntercompanyTransactionsAndBalancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:href="niobf-20230630.xsd#DescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:href="niobf-20230630.xsd#FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:href="niobf-20230630.xsd#ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details" xlink:href="niobf-20230630.xsd#RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details" xlink:href="niobf-20230630.xsd#RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details" xlink:href="niobf-20230630.xsd#RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="niobf-20230630.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" xlink:href="niobf-20230630.xsd#GoingConcernIssuesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" xlink:href="niobf-20230630.xsd#FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails" xlink:href="niobf-20230630.xsd#NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GxiiTransactionDetailsNarrative" xlink:href="niobf-20230630.xsd#GxiiTransactionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfPropertiesDetails" xlink:href="niobf-20230630.xsd#ScheduleOfPropertiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative" xlink:href="niobf-20230630.xsd#LandAndBuildingsNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MineralPropertiesDetailsNarrative" xlink:href="niobf-20230630.xsd#MineralPropertiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:href="niobf-20230630.xsd#ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfConvertibleDebtDetails" xlink:href="niobf-20230630.xsd#ScheduleOfConvertibleDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:href="niobf-20230630.xsd#ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails" xlink:href="niobf-20230630.xsd#FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:href="niobf-20230630.xsd#ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details" xlink:href="niobf-20230630.xsd#ScheduleOfValuationDateAndProbabilityCalculated.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:href="niobf-20230630.xsd#ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" xlink:href="niobf-20230630.xsd#ConvertibleDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:href="niobf-20230630.xsd#FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details" xlink:href="niobf-20230630.xsd#FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" xlink:href="niobf-20230630.xsd#ClassBCommonStockOfEcrcDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:href="niobf-20230630.xsd#ScheduleOfStockOptionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details" xlink:href="niobf-20230630.xsd#FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:href="niobf-20230630.xsd#FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:href="niobf-20230630.xsd#WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:href="niobf-20230630.xsd#AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:href="niobf-20230630.xsd#CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:href="niobf-20230630.xsd#ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:href="niobf-20230630.xsd#ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:href="niobf-20230630.xsd#CommonSharesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:href="niobf-20230630.xsd#ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:href="niobf-20230630.xsd#RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:href="niobf-20230630.xsd#ScheduleOfExplorationExpendituresDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:href="niobf-20230630.xsd#CompanyIncurredLeaseCostsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details" xlink:href="niobf-20230630.xsd#MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LeasesDetailsNarrative" xlink:href="niobf-20230630.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails" xlink:href="niobf-20230630.xsd#DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:href="niobf-20230630.xsd#FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:href="niobf-20230630.xsd#DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" xlink:href="niobf-20230630.xsd#ChangesInValuationAllowanceAreAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" xlink:href="niobf-20230630.xsd#ScheduleOfCumulativeNetOperatingLossesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/IncomeTaxesDetailsNarrative" xlink:href="niobf-20230630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:href="niobf-20230630.xsd#ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:href="niobf-20230630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CommonSharesWithoutParValueMember" xlink:label="loc_niobfCommonSharesWithoutParValueMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfCommonSharesWithoutParValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:label="loc_niobfWarrantsEachExercisableFor1.11829212CommonSharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfWarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssets" xlink:label="loc_us-gaapDepositsAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapDepositsAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:label="loc_us-gaapLongTermInvestmentsAndReceivablesNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLongTermInvestmentsAndReceivablesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" xlink:label="loc_us-gaapCapitalizedCostsMineralInterestsInUnprovedProperties" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCapitalizedCostsMineralInterestsInUnprovedProperties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DueToOfficersOrStockholdersOtherCurrent" xlink:label="loc_niobfDueToOfficersOrStockholdersOtherCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_niobfDueToOfficersOrStockholdersOtherCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarnoutLiabilityAtFairValue" xlink:label="loc_niobfEarnoutLiabilityAtFairValue" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_niobfEarnoutLiabilityAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityOtherCarryingAmount" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorizedUnlimited" xlink:label="loc_us-gaapCommonStockSharesAuthorizedUnlimited" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorizedUnlimited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExplorationExpenditures" xlink:label="loc_niobfExplorationExpenditures" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_niobfExplorationExpenditures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherGeneralExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangeInFairValueOfEarnoutLiability" xlink:label="loc_niobfChangeInFairValueOfEarnoutLiability" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_niobfChangeInFairValueOfEarnoutLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangeInFairValueOfWarrantLiability" xlink:label="loc_niobfChangeInFairValueOfWarrantLiability" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_niobfChangeInFairValueOfWarrantLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount" xlink:label="loc_us-gaapExtinguishmentOfDebtAmount" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapExtinguishmentOfDebtAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:label="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ProfitLoss1" xlink:label="loc_niobfProfitLoss1" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_niobfProfitLoss1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" xlink:label="loc_us-gaapOciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOciEquityMethodInvestmentBeforeTaxNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:label="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarningsLossPerShareBasicAndDiluted" xlink:label="loc_niobfEarningsLossPerShareBasicAndDiluted" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_niobfEarningsLossPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_niobfTotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_niobfTotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AssumptionOfEarnoutLiability" xlink:label="loc_niobfAssumptionOfEarnoutLiability" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_niobfAssumptionOfEarnoutLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:label="loc_niobfChangeInFairValueOfEarnoutShareLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_niobfChangeInFairValueOfEarnoutShareLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AssumptionOfPrivateAndPublicWarrants" xlink:label="loc_niobfAssumptionOfPrivateAndPublicWarrants" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_niobfAssumptionOfPrivateAndPublicWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAccretionExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LossesOnExtinguishmentOfDebt" xlink:label="loc_niobfLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_niobfLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangeInValuationOfWarrantLiabilities" xlink:label="loc_niobfChangeInValuationOfWarrantLiabilities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_niobfChangeInValuationOfWarrantLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FairValueOfCommitmentSharesIssued" xlink:label="loc_niobfFairValueOfCommitmentSharesIssued" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_niobfFairValueOfCommitmentSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ForeignCurrencyTransactionGainLossBeforeTax1" xlink:label="loc_niobfForeignCurrencyTransactionGainLossBeforeTax1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_niobfForeignCurrencyTransactionGainLossBeforeTax1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="loc_us-gaapOperatingLeaseImpairmentLoss" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapOperatingLeaseImpairmentLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_OtheroperatingGainsLosses" xlink:label="loc_niobfOtheroperatingGainsLosses" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_niobfOtheroperatingGainsLosses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMineralRights" xlink:label="loc_us-gaapPaymentsToAcquireMineralRights" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapPaymentsToAcquireMineralRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBuildings" xlink:label="loc_us-gaapPaymentsToAcquireBuildings" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapPaymentsToAcquireBuildings" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_us-gaapProceedsFromSaleOfProductiveAssets" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfProductiveAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ConversionsOfDebtForCommonShares" xlink:label="loc_niobfConversionsOfDebtForCommonShares" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_niobfConversionsOfDebtForCommonShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_RecognitionOfOperatingLeaseLiabilities" xlink:label="loc_niobfRecognitionOfOperatingLeaseLiabilities" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_niobfRecognitionOfOperatingLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DerecognitionOfOperatingLeaseLiabilities" xlink:label="loc_niobfDerecognitionOfOperatingLeaseLiabilities" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_niobfDerecognitionOfOperatingLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AccountsPayableToConvertibleDebtConversion" xlink:label="loc_niobfAccountsPayableToConvertibleDebtConversion" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_niobfAccountsPayableToConvertibleDebtConversion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ValueOfWarrantsIssued" xlink:label="loc_niobfValueOfWarrantsIssued" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_niobfValueOfWarrantsIssued" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:title="00000006 - Statement - Consolidated Statements of Shareholders&apos; (Deficit) Equity and Redeemable Noncontrolling Interest">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_RedeemableNoncontrollingInterestMember" xlink:label="loc_niobfRedeemableNoncontrollingInterestMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_niobfRedeemableNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:label="loc_niobfStockIssuedDuringPeriodSharesStockWarrantExercised" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodSharesStockWarrantExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_StockIssuedDuringPeriodSharesStockWarrantExercisedShares" xlink:label="loc_niobfStockIssuedDuringPeriodSharesStockWarrantExercisedShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodSharesStockWarrantExercisedShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_PrivatePlacementValueMay2021" xlink:label="loc_niobfPrivatePlacementValueMay2021" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfPrivatePlacementValueMay2021" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_PrivatePlacementSharesMay2021" xlink:label="loc_niobfPrivatePlacementSharesMay2021" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfPrivatePlacementSharesMay2021" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_PrivatePlacementSharesMay2022Sahres" xlink:label="loc_niobfPrivatePlacementSharesMay2022Sahres" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfPrivatePlacementSharesMay2022Sahres" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CommonSharesIssuedInTheGXIITransaction" xlink:label="loc_niobfCommonSharesIssuedInTheGXIITransaction" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfCommonSharesIssuedInTheGXIITransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CommonSharesIssuedInTheGXIITransactionSahres" xlink:label="loc_niobfCommonSharesIssuedInTheGXIITransactionSahres" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfCommonSharesIssuedInTheGXIITransactionSahres" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacility" xlink:label="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacility" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacility" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:label="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacilityShares" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_RedeemableNoncontrollingInterest" xlink:label="loc_niobfRedeemableNoncontrollingInterest" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfRedeemableNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_2" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusiness" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparation" xlink:title="00000008 - Disclosure - BASIS OF PREPARATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccounting" xlink:label="loc_us-gaapBasisOfAccounting" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapBasisOfAccounting" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssues" xlink:title="00000010 - Disclosure - GOING CONCERN ISSUES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransaction" xlink:title="00000011 - Disclosure - GXII TRANSACTION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNet" xlink:title="00000012 - Disclosure - LAND AND BUILDINGS, NET">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MineralProperties" xlink:title="00000013 - Disclosure - MINERAL PROPERTIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExtractiveIndustriesAbstract" xlink:label="loc_srtExtractiveIndustriesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MineralIndustriesDisclosuresTextBlock" xlink:label="loc_us-gaapMineralIndustriesDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtExtractiveIndustriesAbstract" xlink:to="loc_us-gaapMineralIndustriesDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000014 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebt" xlink:title="00000015 - Disclosure - CONVERTIBLE DEBT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaapLongTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:title="00000016 - Disclosure - CLASS B COMMON STOCK OF ECRC">
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" xlink:label="loc_niobfScheduleOfClassBCommonStockOfECRCTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_niobfScheduleOfClassBCommonStockOfECRCTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonShares" xlink:title="00000017 - Disclosure - COMMON SHARES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapShareholdersEquityAndShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" xlink:title="00000018 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpenditures" xlink:title="00000019 - Disclosure - EXPLORATION EXPENDITURES">
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DisclosureExplorationExpendituresAbstract" xlink:label="loc_niobfDisclosureExplorationExpendituresAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExplorationExpendituresDisclosuresTextBlock" xlink:label="loc_niobfExplorationExpendituresDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureExplorationExpendituresAbstract" xlink:to="loc_niobfExplorationExpendituresDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Leases" xlink:title="00000020 - Disclosure - LEASES">
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurements" xlink:title="00000022 - Disclosure - FAIR VALUE MEASUREMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaapFairValueMeasurementInputsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEvents" xlink:title="00000023 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DevelopmentStageIssuerPolicyTextBlock" xlink:label="loc_niobfDevelopmentStageIssuerPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfDevelopmentStageIssuerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_MineralPropertiesPolicyTextBlock" xlink:label="loc_niobfMineralPropertiesPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfMineralPropertiesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_WarrantsPolicyTextBlock" xlink:label="loc_niobfWarrantsPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfWarrantsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarnoutSharesPolicy" xlink:label="loc_niobfEarnoutSharesPolicy" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfEarnoutSharesPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetRetirementObligationsPolicy" xlink:label="loc_us-gaapAssetRetirementObligationsPolicy" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAssetRetirementObligationsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ReverseStockSplitPolicyTextBlock" xlink:label="loc_niobfReverseStockSplitPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfReverseStockSplitPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:label="loc_niobfRedeemableNoncontrollingInterestPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfRedeemableNoncontrollingInterestPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparationTables" xlink:title="00000025 - Disclosure - BASIS OF PREPARATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:label="loc_srtScheduleOfCondensedBalanceSheetTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_srtScheduleOfCondensedBalanceSheetTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:label="loc_srtScheduleOfCondensedIncomeStatementTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_srtScheduleOfCondensedIncomeStatementTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:label="loc_srtScheduleOfCondensedCashFlowStatementTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_srtScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransactionTables" xlink:title="00000027 - Disclosure - GXII TRANSACTION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:label="loc_srtScheduleOfCondensedFinancialStatementsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_srtScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNetTables" xlink:title="00000028 - Disclosure - LAND AND BUILDINGS, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000029 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtTables" xlink:title="00000030 - Disclosure - CONVERTIBLE DEBT (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" xlink:label="loc_niobfScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" xlink:label="loc_niobfScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" xlink:label="loc_us-gaapScheduleOfExtinguishmentOfDebtTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfExtinguishmentOfDebtTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfWarrantValuationTableTextblock" xlink:label="loc_niobfScheduleOfWarrantValuationTableTextblock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfScheduleOfWarrantValuationTableTextblock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" xlink:label="loc_niobfFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="loc_us-gaapConvertibleDebtTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapConvertibleDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:title="00000031 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)">
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:label="loc_niobfScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_niobfScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:label="loc_niobfScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_niobfScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesTables" xlink:title="00000032 - Disclosure - COMMON SHARES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="loc_us-gaapScheduleOfStockOptionsRollForwardTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockOptionsRollForwardTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:label="loc_niobfScheduleOfOutstandingExercisableWarrantsTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:label="loc_niobfScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" xlink:label="loc_us-gaapScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:title="00000033 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpendituresTables" xlink:title="00000034 - Disclosure - EXPLORATION EXPENDITURES (Tables)">
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DisclosureExplorationExpendituresAbstract" xlink:label="loc_niobfDisclosureExplorationExpendituresAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ScheduleOfExplorationExpendituresTableTextBlock" xlink:label="loc_niobfScheduleOfExplorationExpendituresTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureExplorationExpendituresAbstract" xlink:to="loc_niobfScheduleOfExplorationExpendituresTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesTables" xlink:title="00000035 - Disclosure - LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesTables" xlink:title="00000036 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="loc_us-gaapSummaryOfValuationAllowanceTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapSummaryOfValuationAllowanceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:label="loc_us-gaapSummaryOfOperatingLossCarryforwardsTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapSummaryOfOperatingLossCarryforwardsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurementsTables" xlink:title="00000037 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="loc_us-gaapFairValueByBalanceSheetGroupingTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails" xlink:title="00000038 - Disclosure - Schedule of intercompany transactions and balances (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtOwnershipAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_Entity0896800BCLtdMember" xlink:label="loc_niobfEntity0896800BCLtdMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfEntity0896800BCLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ElkCreekResourcesCorpMember" xlink:label="loc_niobfElkCreekResourcesCorpMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfElkCreekResourcesCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ElkCreekResourcesCorpECRCMember" xlink:label="loc_niobfElkCreekResourcesCorpECRCMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfElkCreekResourcesCorpECRCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_IncorporationStateCountryName" xlink:label="loc_niobfIncorporationStateCountryName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_niobfIncorporationStateCountryName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="00000039 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaapNumberOfReportableSegments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNumberOfReportableSegments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:title="00000040 - Disclosure - The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:label="loc_us-gaapNetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarningsLossPerShareBasicAndDiluted" xlink:label="loc_niobfEarningsLossPerShareBasicAndDiluted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfEarningsLossPerShareBasicAndDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:title="00000041 - Disclosure - Schedule of excluded from the dilutive securities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToWrittenPutOptions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToWrittenPutOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecurities" xlink:label="loc_us-gaapDilutiveSecurities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDilutiveSecurities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details" xlink:title="00000042 - Disclosure - Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As of March 31, 2023 (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember" xlink:label="loc_srtRestatementAdjustmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRestatementAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilities_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details" xlink:title="00000043 - Disclosure - Revision Impacts to the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For the Three &amp; Nine Months Ended March 31, 2023 (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember" xlink:label="loc_srtRestatementAdjustmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRestatementAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherGeneralExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense_2" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherGeneralExpense_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangeInFairValueOfWarrantLiability" xlink:label="loc_niobfChangeInFairValueOfWarrantLiability" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfChangeInFairValueOfWarrantLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ProfitLoss1" xlink:label="loc_niobfProfitLoss1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfProfitLoss1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:label="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarningsLossPerShareBasicAndDiluted" xlink:label="loc_niobfEarningsLossPerShareBasicAndDiluted" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfEarningsLossPerShareBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details" xlink:title="00000044 - Disclosure - Revision Impacts to the Condensed Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023 (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember" xlink:label="loc_srtRestatementAdjustmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRestatementAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AssumptionOfPrivateAndPublicWarrants" xlink:label="loc_niobfAssumptionOfPrivateAndPublicWarrants" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfAssumptionOfPrivateAndPublicWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000045 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" xlink:title="00000046 - Disclosure - GOING CONCERN ISSUES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CashAndCashEquivalentsAtCarryingValue1" xlink:label="loc_niobfCashAndCashEquivalentsAtCarryingValue1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_niobfCashAndCashEquivalentsAtCarryingValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:label="loc_us-gaapCapitalExpenditureDiscontinuedOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapCapitalExpenditureDiscontinuedOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" xlink:title="00000047 - Disclosure - The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" xlink:label="loc_niobfBusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_niobfBusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarnoutSharesAssumedAtFairValue" xlink:label="loc_niobfEarnoutSharesAssumedAtFairValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_niobfEarnoutSharesAssumedAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails" xlink:title="00000048 - Disclosure - The number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapOffsettingAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="loc_us-gaapOffsettingAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapOffsettingAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LegacyNioCorpShareholdersMember" xlink:label="loc_niobfLegacyNioCorpShareholdersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfLegacyNioCorpShareholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GXIIClassAShareholdersMember" xlink:label="loc_niobfGXIIClassAShareholdersMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIClassAShareholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_OtherMember" xlink:label="loc_niobfOtherMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GxiiTransactionDetailsNarrative" xlink:title="00000049 - Disclosure - GXII TRANSACTION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_WarrantAgreementMember" xlink:label="loc_niobfWarrantAgreementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfWarrantAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfPropertiesDetails" xlink:title="00000050 - Disclosure - Schedule of properties (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember" xlink:label="loc_us-gaapLandMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapLandMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOther" xlink:label="loc_us-gaapPropertyPlantAndEquipmentOther" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative" xlink:title="00000051 - Disclosure - LAND AND BUILDINGS, NET (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandImprovementsMember" xlink:label="loc_us-gaapLandImprovementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandPurchaseOptionsDescription" xlink:label="loc_us-gaapLandPurchaseOptionsDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapLandPurchaseOptionsDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAndLandImprovements" xlink:label="loc_us-gaapLandAndLandImprovements" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapLandAndLandImprovements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnersCapitalAccountDescriptionOfUnits" xlink:label="loc_us-gaapLimitedPartnersCapitalAccountDescriptionOfUnits" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapLimitedPartnersCapitalAccountDescriptionOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" xlink:label="loc_us-gaapRealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapRealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MineralPropertiesDetailsNarrative" xlink:title="00000052 - Disclosure - MINERAL PROPERTIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExtractiveIndustriesAbstract" xlink:label="loc_srtExtractiveIndustriesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:label="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtExtractiveIndustriesAbstract" xlink:to="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ReserveQuantitiesLineItems" xlink:label="loc_srtReserveQuantitiesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="loc_srtReserveQuantitiesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_Entity0896800BCLtdMember" xlink:label="loc_niobfEntity0896800BCLtdMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_niobfEntity0896800BCLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ShareExchangeAgreementMember" xlink:label="loc_niobfShareExchangeAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfShareExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_OptionAgreementMember" xlink:label="loc_niobfOptionAgreementMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfOptionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ElkCreekResourcesCorpMember" xlink:label="loc_niobfElkCreekResourcesCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfElkCreekResourcesCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="loc_srtCurrencyAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD" xlink:label="loc_currencyCAD" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DeferredTaxImpacts" xlink:label="loc_niobfDeferredTaxImpacts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_niobfDeferredTaxImpacts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalDeferredPurchasePrice" xlink:label="loc_us-gaapSupplementalDeferredPurchasePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_us-gaapSupplementalDeferredPurchasePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfAcquisitionCosts" xlink:label="loc_us-gaapAmortizationOfAcquisitionCosts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_us-gaapAmortizationOfAcquisitionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMineralRights" xlink:label="loc_us-gaapPaymentsToAcquireMineralRights" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_us-gaapPaymentsToAcquireMineralRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBuildings" xlink:label="loc_us-gaapPaymentsToAcquireBuildings" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBuildings" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:title="00000053 - Disclosure - Schedule of account payable and accrued liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableTradeCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapTaxesPayableCurrentAndNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapTaxesPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfConvertibleDebtDetails" xlink:title="00000054 - Disclosure - Schedule of convertible debt (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ConvertibleSecurityMember" xlink:label="loc_niobfConvertibleSecurityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfConvertibleSecurityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails" xlink:title="00000055 - Disclosure - Changes in the Lind III Convertible Security are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ConvertibleSecurityMember" xlink:label="loc_niobfConvertibleSecurityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_niobfConvertibleSecurityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount" xlink:label="loc_us-gaapExtinguishmentOfDebtAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapExtinguishmentOfDebtAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaapConversionOfStockAmountIssued1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConversionOfStockAmountIssued1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAccretionExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:label="loc_us-gaapPaymentsToAcquireHeldToMaturitySecurities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapPaymentsToAcquireHeldToMaturitySecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails" xlink:title="00000056 - Disclosure - The following table summarizes the components of the initial loss on extinguishment: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_MinimumConsentPaymentAtInception" xlink:label="loc_niobfMinimumConsentPaymentAtInception" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfMinimumConsentPaymentAtInception" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ASC470LossOnExtinguishment" xlink:label="loc_niobfASC470LossOnExtinguishment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfASC470LossOnExtinguishment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:label="loc_us-gaapAdjustmentOfWarrantsGrantedForServices" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapAdjustmentOfWarrantsGrantedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AdditionalConsentPaymentbooked" xlink:label="loc_niobfAdditionalConsentPaymentbooked" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfAdditionalConsentPaymentbooked" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnRestructuringOfDebt" xlink:label="loc_us-gaapGainsLossesOnRestructuringOfDebt" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapGainsLossesOnRestructuringOfDebt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails" xlink:title="00000057 - Disclosure - The change in the fair value of the Contingent Consent Warrants is presented below: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangeInValuationOfWarrants" xlink:label="loc_niobfChangeInValuationOfWarrants" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfChangeInValuationOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details" xlink:title="00000058 - Disclosure - Schedule of valuation date and the probability calculated. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaapMeasurementInputSharePriceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputSharePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ProbabilityOfIssuanceMember" xlink:label="loc_niobfProbabilityOfIssuanceMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_niobfProbabilityOfIssuanceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails" xlink:title="00000059 - Disclosure - Changes in the Convertible Debentures are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionExpenseIncludingAssetRetirementObligations" xlink:label="loc_us-gaapAccretionExpenseIncludingAssetRetirementObligations" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapAccretionExpenseIncludingAssetRetirementObligations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_PrincipalAndAccruedInterestConverted" xlink:label="loc_niobfPrincipalAndAccruedInterestConverted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfPrincipalAndAccruedInterestConverted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapConvertibleDebt_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" xlink:title="00000060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LindIIIConvertibleSecurityMember" xlink:label="loc_niobfLindIIIConvertibleSecurityMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfLindIIIConvertibleSecurityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LindIIIConvertibleSecurityMember" xlink:label="loc_niobfLindIIIConvertibleSecurityMember_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_niobfLindIIIConvertibleSecurityMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember" xlink:label="loc_us-gaapUnsecuredDebtMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapUnsecuredDebtMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtRangeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaapMeasurementInputSharePriceMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputSharePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInterestRate" xlink:label="loc_us-gaapInvestmentInterestRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapInvestmentInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment" xlink:label="loc_us-gaapOtherCommitment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapOtherCommitment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInterestReceived" xlink:label="loc_us-gaapProceedsFromInterestReceived" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromInterestReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTerm" xlink:label="loc_us-gaapLongTermDebtTerm" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionDescription" xlink:label="loc_us-gaapDebtConversionDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtConversionDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonUnitIssued" xlink:label="loc_us-gaapCommonUnitIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapCommonUnitIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:label="loc_us-gaapAcceleratedShareRepurchasesFinalPricePaidPerShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapAcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntermediateLifePlantsUsefulLife" xlink:label="loc_us-gaapIntermediateLifePlantsUsefulLife" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapIntermediateLifePlantsUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_TransactionCost" xlink:label="loc_niobfTransactionCost" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfTransactionCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:label="loc_us-gaapLineOfCreditFacilityCommitmentFeeAmount" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityCommitmentFeeAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" xlink:label="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentTerms" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentTerms" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaapDebtInstrumentRedemptionPricePercentage" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentRedemptionPricePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1" xlink:label="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise1" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="loc_us-gaapLossContingencyAccrualAtCarryingValue" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLossContingencyAccrualAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingLiability" xlink:label="loc_us-gaapServicingLiability" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapServicingLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" xlink:label="loc_niobfShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DebtMaturityPeriod" xlink:label="loc_niobfDebtMaturityPeriod" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_niobfDebtMaturityPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" xlink:label="loc_us-gaapOptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapOptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details" xlink:title="00000061 - Disclosure - The following table discloses the primary inputs into the Monte Carlo models. (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details" xlink:title="00000062 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2023: (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingLiabilityAtFairValueAmount" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingLiabilityAtFairValueAdditions" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAdditions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAdditions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingLiabilityAtFairValueAmount" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAmount_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAmount_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" xlink:title="00000063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DescriptionOfEarnOutShares" xlink:label="loc_niobfDescriptionOfEarnOutShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfDescriptionOfEarnOutShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:title="00000064 - Disclosure - Schedule of stock option (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details" xlink:title="00000065 - Disclosure - The following table summarizes information about stock options outstanding at June 30, 2023: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice8.40Member" xlink:label="loc_niobfExercisePrice8.40Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice8.40Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice5.40Member" xlink:label="loc_niobfExercisePrice5.40Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice5.40Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice7.50Member" xlink:label="loc_niobfExercisePrice7.50Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice7.50Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice7.50OneMember" xlink:label="loc_niobfExercisePrice7.50OneMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice7.50OneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice13.60Member" xlink:label="loc_niobfExercisePrice13.60Member" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice13.60Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice11.00Member" xlink:label="loc_niobfExercisePrice11.00Member" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice11.00Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice6.95Member" xlink:label="loc_niobfExercisePrice6.95Member" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice6.95Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_srtCurrencyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD" xlink:label="loc_currencyCAD" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1" xlink:label="loc_niobfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_niobfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails" xlink:title="00000066 - Disclosure - The following table summarizes the weighted average information and assumptions used to determine option costs: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCurrencyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD" xlink:label="loc_currencyCAD" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details" xlink:title="00000067 - Disclosure - Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_NordminWarrants" xlink:label="loc_niobfNordminWarrants" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfNordminWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightLindIIIWarrants" xlink:label="loc_niobfClassOfWarrantOrRightLindIIIWarrants" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightLindIIIWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercisePriceLindWarrants" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceLindWarrants" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceLindWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightAprilPrivatePlacement" xlink:label="loc_niobfClassOfWarrantOrRightAprilPrivatePlacement" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightAprilPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceAprilPrivatePlacements" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceAprilPrivatePlacements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercised" xlink:label="loc_niobfClassOfWarrantOrRightExercised" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercisePriceExercised" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceExercised" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExpired" xlink:label="loc_niobfClassOfWarrantOrRightExpired" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceExpired" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightJunePrivatePlacement" xlink:label="loc_niobfClassOfWarrantOrRightJunePrivatePlacement" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightJunePrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercisePriceJunePrivatePlacements" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceJunePrivatePlacements" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceJunePrivatePlacements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_YorkvilleFinancingWarrants" xlink:label="loc_niobfYorkvilleFinancingWarrants" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfYorkvilleFinancingWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GxiiWarrants" xlink:label="loc_niobfGxiiWarrants" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfGxiiWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails" xlink:title="00000068 - Disclosure - At June 30, 2023, the Company has outstanding exercisable warrants, as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice11.00Member" xlink:label="loc_niobfExercisePrice11.00Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice11.00Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice9.70Member" xlink:label="loc_niobfExercisePrice9.70Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice9.70Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice8.94Member" xlink:label="loc_niobfExercisePrice8.94Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice8.94Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ExercisePrice11.50Member" xlink:label="loc_niobfExercisePrice11.50Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice11.50Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_srtCurrencyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD" xlink:label="loc_currencyCAD" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails" xlink:title="00000069 - Disclosure - The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:title="00000070 - Disclosure - The change in the Private Warrants liability is presented below: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoteWarrantMember" xlink:label="loc_us-gaapNoteWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapNoteWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangesInFairValueOfInitialValuation" xlink:label="loc_niobfChangesInFairValueOfInitialValuation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:label="loc_us-gaapServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ChangesInFairValueOfInitialValuation" xlink:label="loc_niobfChangesInFairValueOfInitialValuation_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails" xlink:title="00000071 - Disclosure - Schedule of expenses as other operating costs (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_YorkvilleCashFee" xlink:label="loc_niobfYorkvilleCashFee" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_niobfYorkvilleCashFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaapOtherCostAndExpenseOperating" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOtherCostAndExpenseOperating" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOperatingCostsAndExpenses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:title="00000072 - Disclosure - COMMON SHARES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtCurrencyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD" xlink:label="loc_currencyCAD" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapPlanNameAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LongTermIncentivePlanMember" xlink:label="loc_niobfLongTermIncentivePlanMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_niobfLongTermIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GXIIPublicWarrantsMember" xlink:label="loc_niobfGXIIPublicWarrantsMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GXIIPrivateWarrantsMember" xlink:label="loc_niobfGXIIPrivateWarrantsMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIPrivateWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfferingCostsPartnershipInterests" xlink:label="loc_us-gaapOfferingCostsPartnershipInterests" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapOfferingCostsPartnershipInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_ShareIssuanceCost" xlink:label="loc_niobfShareIssuanceCost" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfShareIssuanceCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_SaleOfStockPricePerShare1" xlink:label="loc_niobfSaleOfStockPricePerShare1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfSaleOfStockPricePerShare1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForCommissions" xlink:label="loc_us-gaapPaymentsForCommissions" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPaymentsForCommissions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FairValueAssumptionsRiskFreeInterestRate1" xlink:label="loc_niobfFairValueAssumptionsRiskFreeInterestRate1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfFairValueAssumptionsRiskFreeInterestRate1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FairValueAssumptionsExpected1VolatilityRate" xlink:label="loc_niobfFairValueAssumptionsExpected1VolatilityRate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfFairValueAssumptionsExpected1VolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FairValueAssumptions1ExpectedTerm" xlink:label="loc_niobfFairValueAssumptions1ExpectedTerm" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfFairValueAssumptions1ExpectedTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DescriptionOfAmendedPlan" xlink:label="loc_niobfDescriptionOfAmendedPlan" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfDescriptionOfAmendedPlan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails" xlink:title="00000073 - Disclosure - Changes in the Smith Credit Agreement principal balance are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDepositLiabilities" xlink:label="loc_us-gaapRelatedPartyDepositLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyDepositLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AmountsAdvanced" xlink:label="loc_niobfAmountsAdvanced" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_niobfAmountsAdvanced" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDepositLiabilities" xlink:label="loc_us-gaapRelatedPartyDepositLiabilities_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyDepositLiabilities_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:title="00000074 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GeneralSecurityAgreementMember" xlink:label="loc_niobfGeneralSecurityAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfGeneralSecurityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AmendedNonRevolvingCreditFacilityAgreementMember" xlink:label="loc_niobfAmendedNonRevolvingCreditFacilityAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfAmendedNonRevolvingCreditFacilityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_NonRevolvingCreditFacilityAgreementMember" xlink:label="loc_niobfNonRevolvingCreditFacilityAgreementMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfNonRevolvingCreditFacilityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_srtChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_MarkSmithMember" xlink:label="loc_niobfMarkSmithMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_niobfMarkSmithMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="loc_us-gaapRelatedPartyTransactionRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LineOfCreditFacilityPrepaymentFee" xlink:label="loc_niobfLineOfCreditFacilityPrepaymentFee" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_niobfLineOfCreditFacilityPrepaymentFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaapLongTermLineOfCredit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLongTermLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AmountPaidToRelatedParty" xlink:label="loc_niobfAmountPaidToRelatedParty" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_niobfAmountPaidToRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EstablishmentFeesPayable" xlink:label="loc_niobfEstablishmentFeesPayable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_niobfEstablishmentFeesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:title="00000075 - Disclosure - Schedule of exploration expenditures (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DisclosureExplorationExpendituresAbstract" xlink:label="loc_niobfDisclosureExplorationExpendituresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureExplorationExpendituresAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CostCentreAxis" xlink:label="loc_niobfCostCentreAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_niobfCostCentreAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CostCentreDomain" xlink:label="loc_niobfCostCentreDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreAxis" xlink:to="loc_niobfCostCentreDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FeasibilityStudyAndEngineeringMember" xlink:label="loc_niobfFeasibilityStudyAndEngineeringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfFeasibilityStudyAndEngineeringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FieldManagementAndOtherMember" xlink:label="loc_niobfFieldManagementAndOtherMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfFieldManagementAndOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExplorationAndProductionEquipmentMember" xlink:label="loc_us-gaapExplorationAndProductionEquipmentMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_us-gaapExplorationAndProductionEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GeologistsAndFieldStaffMember" xlink:label="loc_niobfGeologistsAndFieldStaffMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfGeologistsAndFieldStaffMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExplorationExpense" xlink:label="loc_us-gaapExplorationExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapExplorationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:title="00000076 - Disclosure - The Company incurred lease costs as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract" xlink:label="loc_us-gaapLeaseCostAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLeaseCostAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FixedRentExpense" xlink:label="loc_niobfFixedRentExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_niobfFixedRentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaapVariableLeaseCost" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapVariableLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaapShortTermLeaseCost" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapShortTermLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome" xlink:label="loc_us-gaapSubleaseIncome" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapSubleaseIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaapLeaseCost" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaapOtherCostAndExpenseOperating" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapOtherCostAndExpenseOperating" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExplorationCosts" xlink:label="loc_us-gaapExplorationCosts" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapExplorationCosts" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details" xlink:title="00000077 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2023: (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_LessAmountOfPaymentsRepresentingInterest" xlink:label="loc_niobfLessAmountOfPaymentsRepresentingInterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_niobfLessAmountOfPaymentsRepresentingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesDetailsNarrative" xlink:title="00000078 - Disclosure - LEASES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CorporateOfficeMember" xlink:label="loc_niobfCorporateOfficeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_niobfCorporateOfficeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="loc_us-gaapLesseeOperatingLeaseOptionToExtend" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseOptionToExtend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DiscountRate" xlink:label="loc_niobfDiscountRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_niobfDiscountRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="loc_us-gaapLesseeOperatingLeaseRemainingLeaseTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails" xlink:title="00000079 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2023, 2022, and 2021 are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapOperatingLossCarryforwardsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:title="00000080 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EarnoutSharesLiability" xlink:label="loc_niobfEarnoutSharesLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfEarnoutSharesLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_WarrantLiability" xlink:label="loc_niobfWarrantLiability" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfWarrantLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_GxiiTransactionCosts" xlink:label="loc_niobfGxiiTransactionCosts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfGxiiTransactionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetRetirementObligationAccretionExpense" xlink:label="loc_us-gaapAssetRetirementObligationAccretionExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapAssetRetirementObligationAccretionExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtGainLossIncomeTax" xlink:label="loc_us-gaapExtinguishmentOfDebtGainLossIncomeTax" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapExtinguishmentOfDebtGainLossIncomeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_EffectOfLegislativeChanges" xlink:label="loc_niobfEffectOfLegislativeChanges" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfEffectOfLegislativeChanges" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationPriorYearIncomeTaxes" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:title="00000081 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DeferredTaxAssetsMineralInterest" xlink:label="loc_niobfDeferredTaxAssetsMineralInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfDeferredTaxAssetsMineralInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" xlink:label="loc_niobfDeferredTaxAssetsStartupAndOorganizationalCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfDeferredTaxAssetsStartupAndOorganizationalCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" xlink:label="loc_niobfDeferredTaxAssetsResearchAndDevelopmentCosts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfDeferredTaxAssetsResearchAndDevelopmentCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DeferredTaxAssetsShareIssuanceCosts" xlink:label="loc_niobfDeferredTaxAssetsShareIssuanceCosts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfDeferredTaxAssetsShareIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CapitalLossesAvailableForFuturePeriods" xlink:label="loc_niobfCapitalLossesAvailableForFuturePeriods" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfCapitalLossesAvailableForFuturePeriods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" xlink:title="00000082 - Disclosure - Changes in the valuation allowance are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_DeferredTaxAssetsValuationAllowanceAdditions" xlink:label="loc_niobfDeferredTaxAssetsValuationAllowanceAdditions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfDeferredTaxAssetsValuationAllowanceAdditions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsIncurredDevelopmentCosts" xlink:label="loc_us-gaapCostsIncurredDevelopmentCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCostsIncurredDevelopmentCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" xlink:title="00000083 - Disclosure - Schedule of cumulative net operating losses (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapOperatingLossCarryforwardsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOtherLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOtherLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000084 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapOperatingLossCarryforwardsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_srtCurrencyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD" xlink:label="loc_currencyCAD" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_IncreasesInCapitalLossesAvailableForFuturePeriods" xlink:label="loc_niobfIncreasesInCapitalLossesAvailableForFuturePeriods" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_niobfIncreasesInCapitalLossesAvailableForFuturePeriods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_OtherIncomeTaxes" xlink:label="loc_niobfOtherIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_niobfOtherIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_CapitalLossCaryforward" xlink:label="loc_niobfCapitalLossCaryforward" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_niobfCapitalLossCaryforward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:title="00000085 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:label="loc_niobfAvailableForSaleSecuritiesEquitySecuritiesOther" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_niobfAvailableForSaleSecuritiesEquitySecuritiesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapOtherLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapOtherLiabilitiesFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapFinancialLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFinancialLiabilitiesFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" xlink:label="loc_us-gaapMortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapMortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000086 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20230630.xsd#niobf_FinancingAgreementMember" xlink:label="loc_niobfFinancingAgreementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfFinancingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventDescription" xlink:label="loc_us-gaapSubsequentEventDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds" xlink:label="loc_us-gaapDemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>n257410kimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 1@"< P$1  (1 0,1 ?_$ +8   $$ P$
M      < ! 4& 0(( P$  04! 0                $#! 4& @<0  $# P$$
M! <(#0L%      $" P0 $042(1,&!S$B%'1!,K*S-C<(46%Q@2-S%361L<%"
M@L(S0S2T=187H5)B<M*#TT24&#B3)%15A1$  0,!!@0""00" P       0 1
M @,A07$2! 4Q43(S@2+P89&A4F(3-!6QP=$4X4*B(R3_V@ , P$  A$#$0 _
M +5E<]/Q/'\V:RZLB-/<46M1TJ1K(4FU_"FA"/,*8Q,B,RXZM;#Z$N-J]U*A
M<4(53YM..-\&O*;44*WS5E))!\;W10A>'+68ZUR_,M1+KC)D.#62;Z"2 2?@
MI)%@ZYG)HDIERXRW$^=S<O+Y(+[ 6"W'L"EE*BL'2V/#L&TU!TLYSD92X*HV
MZK5JS,Y=+(C"IZN4J$)4(0,Y^<9<00,U#P^.F.PHHC=H?+"BVIQ2U$ %2;*L
M GHK0;/I82B92#VK-[UJYQF(1+!1,7EGSEDQF9+>37NWD)<0#/=!TK%Q?;[]
M/2UVD!;+[DQ';]60^;_DH/B,<S>!I\0S\O(1(>276-$I;R"$$ A25&WQ$5(H
M?U]1$Y8CV*-7_L::0S2-OK72V R"\C@\?D%@)7+CM/+2.@*<0%&WQFLK5AEF
M8\BM?1GG@)<PG]-IU*A"5"$J$)4(2H0E0A*A"Y[S6+>R?&^:BL_EM]+=;3TZ
MBU=>GXP*$*^<FN(NTXQ["OJN]"^4CWZ2RL[1^"K[="%*<W?0M[YYGRJ$+PY9
MK0CEX5N(#K:#)4ML]"@"24GX:&2$.HOEOQ9E,_Q3($@I8A,Q#V6"R-+38UI&
MP>$V\-( R   P7IQCS6G8K-/8O&1&W3&(0ZZ]J)4LBY"4I(Z+VI4JA?XP<8?
M^N8_Z3W]JA"G>"N:<W,9IK%9**VTJ1J#+S.H66D%6E25$]-J$(<>T3Z:L=P1
MY:ZU.R]HXK);YWA@N@<#]1X[NK/FTUF:O6<5J:/1' *I\Q.5L7C65#D/9!R$
M8C:VPE#:5ZM9!N;D>Y4W1[A*@" '=0M=MPU!!)9EMQ?Q.WR[X)@AMOMTAE+4
M&(E9T!:D(\==KV&E%["DTU ZJJ;KRC5:@:6B+[@ABGV@>.W+K:QD12"=A2T^
MH?!<+JW_  ]$<9'W*G&]5CPB%LCVAN,V'4F7BXA;/2@I>:)'O**C]JD_#4B/
M+(H_-U0;8A%#/<P51>7*.,,='2[O6V7$1WB;#>K"%))3_-)-5%'1YJ_TB5<U
MM;EH?5B$-?\ <CG=S88:-OM7C;QS1IMT6Z;_ !U:_A(/U%5 WZ;=(5NX+YN9
M/.\/<0Y>5CV6E85H.MLM*6 Y="E$**KV\6H.IVZ-.<8@]2GZ7<I5(2E(-E59
M_P!RLNP)P3?^H/\ AU,_!?,H7Y\_"LCVE9-_J)OXI)_PZ/P7S^Y+^?/PJQ_Q
M[P?[J_3/87>V]H[+]':QX^C7KWEO$T^&UZB_B)_4R/9Q=2OS4/I9VMY*+X?]
M<<GO4OR554*Z3;,-.\#\PT3&4D07%[Y"1T%ATV<1^";_ ,E"%>.:[K;W RWF
ME!;;CC"T*'04J5<&A"\.7/JV=^"5]VA"JG)/TCE=S/EIH0FLOUO?_3;^V*$(
MYT(0*P7K8'[0?_'H0H7VB?35CN"/+76IV7LG%9+?.\,%T#@?J/'=U9\VFLS5
MZCBM31Z(X!/JX3B$7M(>C>*[Z?-*J[V/N2P5#OW;CBI_D<!_#C'[/SC_ )U5
M1=U/_>?!2MH'_G'BJG[2@'9,";;=Y(V_@HJ;L75+P4'?QY8K&3_XX1?FF?UF
MDI??'TN2U?L!Z7IQ[.<:,]@,N7FD.$2TV*TA7YH>Z*3>Y$3C;<EV*(-.3B]7
M_CR-'9X&SVY:0WJA/7T)";]0^Y5;I"36B_-6FLB!1FPN0B]G6%"EY3,IE1VY
M"4L,E(=0E8!*U=&H&KO>YF,8L65%L4(RE)PZ(_-7"X=GE[FW6H,=MU# *'$-
M(2H'>)V@@7JJV^K,UHN3Q5ON-& H2( ]BYBU*[!IN=.^O;P7T=-:]K5BWL1Q
MX?\ 7')[U+\E58!>C*X<U^'?I3APS&4:I>-)>3;I+1_*)^QUOBH0J*GB!60Y
M62<<ZK5(QC["4D])96KJ?8VIH0KERY]6SOP2ONT(54Y)^D<KN9\M-"$UE^MX
M?M-'VQ0A'.A"!6"]; _:#_X]"%"^T3Z:L=P1Y:ZU.R]DXK);YWA@N@<#]1X[
MNK/FTUF:O4<5J:/1' )]7"<0B]I#T:Q7?3YI57>Q]R6"H=^[<<58.1WJXQW]
M=_SJJB[KWSX*7L_VX\54O:4_0\#\[(\E%3=BZI8!0=_Z8K&3_P".$7YIG]9I
M*7WQ]+D5?L!Z7IY[-WH_E^^)\T*YWSKC@N]@[<L5?^8/H/G>Y/\ D&JW1]Z.
M*M-=V98(2>S7];9ON['EJJZWWICXJBV#JG@B;S:]7.=^8'G$U4;=WXXJYW+[
M>>"Y5_R7][^+6TO6'N1RX?\ 7')[U+\E5>?KT9&5:$+0I"P%(4"E23T$'810
MA<[<68J1P[G,CBD7$21935^A3)5K1\:2+4(1,Y<^K9WX)7W:$*J<D_2.5W,^
M6FA":R_6\/VFC[8H0CG0A K!^MD?M!_\>A"A?:)]-6.X(\M=:G9>T<5DM\[P
MP70."^H\=W5GS8K,U>LXK4T>@8!"[GCQQQ1PWD<6UA9IB-R&'5O)"$+NI*@
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3KV&WARX(@55*_2H0E0A*A"__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>n257410kimg002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg002.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@!PP)' P$1  (1 0,1 ?_$ +X   (" P$!
M       %! 8" P<!" $! 0$! 0$!              $# @0%!A   0,# @,#
M PP,"@@#!@4% 0(#!  1!1(&(1,',4$B410687&Q,M(CD[05E5<(@9'10C-S
MTS1T51<WH5)BDB24-74V5L%R@K)3LU34HD,EPH.C1(0GX6-E1ACQ9$6%M1$!
M  ("  8! P4  @,       $"$0,A,5$2$P1!(C(487%2(P6!8I&A,__:  P#
M 0 "$0,1 #\ LNWNO'6#=+T[T7V3#R,> M#3[IE\HA;B L"SA3W'NH'7I_\
M63^CB'\X-^[H#T_^LG]'$/YP;]W0'I_]9/Z.(?S@W[N@/3_ZR?T<0_G!OW=
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M?NZ ]/\ ZR?T<0_G!OW= >G_ -9/Z.(?S@W[N@/3_P"LG]'$/YP;]W0'I_\
M63^CB'\X-^[H#T_^LG]'$/YP;]W0'I_]9/Z.(?S@W[N@/3_ZR?T<0_G!OW=
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M/JSM&!,EPU/.R'X2BF2(Z-83H05NG5< AI(\=N_AQ/"@D,=2]MNQ9\E*G@W
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M0IHDLN,APEM>DJ\:O-UZ0F][>M06O!9N+F8 FQDN(1S'65MN@)6AQAU3+B%
M%0NE;:AP- PH"@* H"@*!9N'/,8/%2,E(9=>CQDZW4L)2I83WJLI2!8#B>-!
M64]7]K^(+;EMN: MME;(2M:KI"VT@J]NV5^.]K<?(:"=D^I6V,:F Y*>6EF>
MPF4AX(NEME8NA;O&Z0JQ X4&C%]5-M9.9&A1A(\YD+#;C:VM)84I2DH#USX=
M90=-K^K:@N0[* H"@* H"@#V4%/RG5#;>.S,O#O<]<Z&E)<;;0%74O1I0GQ
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M86<)!U $!7F[=P#V\=-!EZ$;/_4L+X!O[E![Z$;/_4L+X!O[E >A&S_U+"^
M;^Y0'H1L_P#4L+X!O[E >A&S_P!2PO@&_N4!Z$;/_4L+X!O[E >A&S_U+"^
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M28(4M#1)0IISBA2+DGAQ2?5% [H"@* O0% 4!0% 4!0% 4!0% 4!0% 4!0%
M4!0% 4!0% 4!0% 4!0% 4!0% 4!0< WIDMW8KJ!O/(X#&IRQ;;QJ'(20ZJ05
M*8(2IM* 00/OKV]>F1%@XSZPF;:;DN/8S QWBE:6E(4J2A!/B#B%!U.K3W7[
M:N1:H_3?<;DL3,ENJ4N3&1RH?FC;;#2AVZI+)YB'%7[;::9$3,[;ZOORFW,9
MD\9&9C!'O)0M0E*UC67-2%*:&CL"">/?3(;Q=L;I:9>EKEP8LEPJ<5%:C%:+
M]VIW6VM9L.)TBF0O:;W#F-N1GI^!CSH>190X[$;?25:%I"@"AY+:;\>S73(Y
M3G-D[KQ^?F9!:,^UBG-2(8C2$1_-&QXE\Q]:WT); [%:AV=E01]L9/;<R2\G
M(;\SFW789"2Y,F-J#A!*2F_+0"O2D*!-_"10=)@]0MC1GHK<K><G+-X]0>2X
MN+J2XHA24ZGVF$I/MO+:@C2/K*[9E.)BX"&Y+G%91RI;C,5*N!(#:RI25*41
MI'=?M-! W1U+VYNV'/Q:8,C'[EQ7,Y3$EM.L.)%@D+:<0\D*4;70?5[*#GST
M_?<D24[MCS&-J8]QA2X+#<HR)#BP2TW&=>NZ2E0\2M8M5%NE]8ILG(QL'C&V
M\)-,<.).62M];BE-!32 F/K*0J_B6Y;UJ9"S:_4;/8O/[A<A?)DYI2#-,F.I
M^2@K)&MI!U-I:)MQ24@^6]0;&]R;FZCY>+E,?+B;0W%'/)Q\5?.<=GZ2M2F7
M+I2E2$ <0$FUR;T'L+?S66RLC:^^<4S\M8Q]TM2 ^VTD)3<.*9<6&DCLX!1
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MZ2H_R:!WG^HC6&GR4C&KDXG'MQ',ED6G$#D^>K*6_>E64NR;*5I[B*"7 W_
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M;.N(,>>W^;Y&/9$EKC?P.6)MY0;@]XH%S&3R^#(8SY$K'IL&\XV-/D']*:2
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MB_%10?0- BW=^:8_^\X'QE% ]H"@* H"@* H"@* H"@* H"@* H"@* H"@*
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M&5Q0>:A0>W% 7% 7% 7% 4!<4!0% 7% 4!0% 4!0% 4!0% 4!0% 7% 4!0%
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M_KZU+H)D#I#BA'#L'>&XE,N>-+B<F7$GU02E5!'B;&Q^7<?8Q74;/.OQ5Z)
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M@S(JT O,+6CF,)<2XII6E2>W3P5VB@9;J0$0<<D"P3DH 'V)**!_0% 4!0%
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M@V%PH"XH)Q[*!%M=I+;N9 &D'(O*MZJD(43]F]!.^2D?*2YY?>)6URC&*[L
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M(;RSKG47(XQN0&L- ,5DZ9$5A0<4CFO+T/(6X[X5I%D6[**7;)ZC;NR.Y<;
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MCO[@MT?C<[[#E!$^J1^9[O\ TZ+\5%!] %"3VB@1[N%H>/\ [S@?&44#V@*
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M4'/.C9=;:W+"\XYL>'FYGF[.D!*&Y:_/T$*L%<42TW![+4'1Z H"@* H"@*
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MSF'<?,#&06(SZ4:(PE.V04ZB>)8/:54#N%D9YG-PIS;3<A4<OJ#2U+3<.:;
MJ2DVL1W4#:@\500#G,4,F,4938R)3K$74.9IM>^GR5UV3C/PF81RVD;K;=^^
M,%:3ZP>2?]-<J;ZA0>%Q [2!4RN""06_3*"]S$Z3!D([>\.M'_33NA>R>AX9
M+ 4$E:;J]J+BYMY*9A.V68<0>P@TR8D*4FW$U<IA6)D/"X9T[@1SEM1]27&6
M5<QMM#A2A:DMWLE*--SH]6BQ&5C9E,.M)<;6E2%"Z5 W%JF8.V2S<6<BXS'N
M.+'.><!1&BI\2WG%#PH2GM-ZXO>(AIJU3:7$#T!@9M63B*DKQ>55R9ZPS=3
MD/:U:=-]20FVFZ%#AVWKG3><XEZ?9BL1$U5S:YA;-WQCW&F6\/CXHDX?<4I3
M3LAEJ1^&0MY?!&G6+(65#PD7KV;:4F,P\5=M^67T#AG7\Q$;G8;<465CU$@.
MPF6G$*([1K"U@$5C$8)MDU&,R]B#EG+^4,LC_P!DT1@G%Y)"U+=S4DH/WO+C
M) ^SRC0*\CC'I.0;Q,B7DWXTII:G74A@1P!]XM26@05=UJ#-G#HVRWFLP9+T
MUMY'G"X[NBX+2#?Q "]QY:!%T^;R2>H>_ERW>8R](@.Q@   A4-(3P O<)2
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MUO/R=^JOQE7X^V6GE/M2)64SZBI7F[4CFL1TJ[%%3G@!%_\ \!2-'64M[?\
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MF7JMMC5&*\^KJ+<5EL@H2E) ">  X#L'K5O$8>&9RV\!WU45&5'C(ZKXZ2
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M;UQVCC06MMA#$0,MBR&T:$@DFP2+#B>)H.(='?W!;H_&YWV'*")]4C\SW?\
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M:2U$W*EAYIQ<@>;2]2G$EM*#Q'<FXX4#=C?>*Q[C:'H.;0P_J+DN9$E+0T$
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M1<]O 4%,Z**4KIKB&UCQL!YE?^LV^M)H+U0% 4!0% 4!0% 4!0% 4!0(\_\
MVQMW].=^)2*!X.R@Q=_!J]8^Q0<+Z._N"W1^-SOL.4$3ZI'YGN_].B_%10?0
M- BW=^9P/[R@?&44&S:B0G'/6[Y4DGU^<J@<T!0%!4I<@GJEC8_<G#S'+=_&
M1''^B@MM 4&J4PU(96PZD+:=24+2>PI4+$&K%L3D?/&:Z2[CV1*;&R\,YG8;
M\UB:4N2&T!E;#I6D<M020=!T:M1%NZ]?<U_Z$;8QLG&(933H:X?:.Z]OPW-S
M8AAM66A1V<*<<KW]UN-'6%+*74@)6M:E75X;6X ]]?)]KV;6Y?:].FE9X3S=
M7VUNO'YF(DH46IB0 _$=\#J%=X4DUY*[(EIM]>U)_0^"A:M'G94!0%J"(]'F
M*FQW6Y&B,V%A]C2#S"1X?%][IH.>9Z5);ZCX5AI@.-NYLJ<=U :-.&='9WW"
MB?L4'3AV4 >R@@P,/$A2I<ID'G37 Y(4I1-R!86!X  4$ZPH/-(H(4C),-96
M-CU)47I3;KB%BVD!HIN#_/H)FE-!6,_TZVOF9OG\AIZ-,*=#DB$^[%6M/<'"
MRI&NW=>@X[O.)(QFZHV*3ELODL3!4)\3$,N)EJ4]'+9905.C78*UE6I1 X5E
M.V,XAZJ^O/;W3P.-K0\<^[.R>2C+QN(89;*,<E85YR6W%I2'%6&OWS@+<#7,
M4M:>/)I;92E<5Y]75,'!7(6WEI+K3JE-Z8K+%BPRA7MM"OOR;"ZJVB,/%,S)
M\+#A50%:0">P"@4JE85.;2I<I"<@6"E+16![UJ!)MZ]J!AY_"_X[?\]/W:#F
M6ZM_[2Q'4W$O3YP;$:'+B.I0AQU7,=Y#J+!M*B04@\10,AU?Z8HF"2)C@EO!
M+ <\SE:E"]THORO*>R@SR_6/:N-GPF7D3.3+*TEXPI:;+2!H2E):\15?NH-H
MZP[;/ 8[-?-4S\G0:<AU:Q4;$R\C$PV7?\W&I:%0'V ?+=;J4I%AWF@<;<W3
M/=V8G<&>B*A.AMQ]Z,A"E+2TDDI\ *B3HMV4"?*=5^F"GH3[NX(P?84I^,UK
ML5*4TM&E=P=/!1[:#"'U6Z9YJ#&<R.4A-N)6AU3+K@*&7DDZ+N$!%^' F@E9
M;J3LB7AYK,3),S@XP\V3']]0#H(LI2?"+G@+GC053$]:<,SL+%LX!E60S2(D
M9CS1T\AIE2DH:0Y(=5P0@K6 FW%1X"@<8O;DA>Y\5E-S/IG[D2''9+'MHD)"
MT*Y7FJ%#P<46U\5'O-!T5N7'4MQM"TJ6U;F)!%TW%Q>@TN9;'IFM8]3Z!,D-
M+>98OXE-ME(6L#R K3]NI*PJ>QLK 8R.5Q6M7G+L^2\RV$J*=%P3XP-/;?OK
M+4]/LSG'[+S6SRJ,XA<7J]&N^Z\,CB)*TM+(+;/(?8!" !?Q:[F@0=-I^9D;
MHWAC,));5MF%DEN,2WF5+5YU))<EL((6W=+;AX'U;4$K?L'=*M[;#<;FL^;)
MR,E#CB62E25*@OGL*UA5T)5]F@L\^)N9,Z(TUD'UL/E27W66HX2T +A2@L*)
MU'APH)CN"R;K)0<Y+3?[Y"8Z3]CWN@K_ $>;$7;<W%<TO'$9;(P2\192^7*6
MH*4!PN4K%Z"]T!0% 4!0% 4!0% 4!0% 4"//_P!L;=_3G?B4B@>"@Q=_!J]8
M^Q0<+Z._N"W1^-SOL.4$3ZI'YGN_].B_%10?0- BW?\ F<#^\H'QE%! QSF6
M?VK(7@G&A/5(D&.M\$MFSZKA0''B.%!:(X=#2.;8NZ1S"GLU6XVOW7H-E 4%
M/DMWZL0G;^TPDA-O+JE-?<H+A0% 4'A'"@2[;*5IR1'9\H2!]D* -!EE=KX?
M)K#TB.!*3^#E-DMO)_U7$656=M<2VU[[55F/CMZ;;RCLGSI_<&$6G3YLM8\Z
M:.J^I(4 %V'JBL_KK/6&\VU[(_C;_P!+/BMS8C)*+3#VB2C\)%=!;>3_ *S:
M[*K2NR)8;-%J_L;!0O:M&+*XH"@YEGE!'43$+5X4#-*45'R#".WXT&&$Z];=
MR@B?T20PY)4Z'&".8ZVD*;$=0;0"I?G"7TJ1IH'$KK#LUN&[(C.R)JF4H4XU
M'C/J4E3KJF$(62@)0M3J"G2H@WH)&U.I>$W#*E1&DN1Y+*I2V4N)6$O18D@Q
ME2$+*4HTE:>R]!6<7UYA9!PE&)=$9QQMN)*0ZEQ"R[)\W2%V3X%E(+FGCX10
M.Y76;9;+/.;<DR$(7)1(Y49Z[7FD;SIU2PI*2!RRFWJJ'JV#1AM]X'<F[,08
M;BVI3<*0M^(^A;;C:EAE1;)(TE:+C6 >%#"S9+=V!@/B,])"Y:[Z(S(4ZZ;?
MR&PHUG;;6&]/7O/'!)-&\-RZFHBG-NXSA_2%I!F.V-[)3>S:3V&_B]:N,VM^
MD-<4U_\ :5>W;T_V\]O/9D(1PF,IW(.RD77J>*8Z3[XL*"R;]Y-:5UQ7DPV;
MK7YRE*Z3[;3NLIQ3TO"-M0FU\N \$I*RZX-5G4O64!?BFW;7;(ZB]-1&;2TS
MN;.):2"$M)E-I2+^0)9'9VT$?,=/)(P\T-[ISA=Y2E-K7*!TE U< VALF]K'
MC09X;8T3([<@B=DLNZW(C-*?8<GR$WUH!4E106U'ML:!>YTFZ=(W/"9.!BO(
M,1W4I])>4HH4@)*UN%2E$#O)H'S/2GIRPO6WMV %%6NY80KC_M T%1S.S]KP
MNK^T_-,6Q%2Y%G.$,,MMH+C(04*.D)-QJ-!U8LMD#4D&W$7'?0(\W!+^X,&\
M6PXTPX_KNG4$E3)TJ/<.(H&N0>ELPW7(; E24)NU'*PV%GR:R#:@R+2),3ER
MFDD.HL\RNRT\1Q2>XT&U*$!(2+:1P 'DH*AO*1C(>2P)+(<=3-*UQV&^:\I!
M8=3?EH!41<^2@JO5+>SD3:>0\PVC*EMH25R%SH.F*$-@K"E)78J\0 X@4%"?
MV[)@X[;KL7-HEL;V4RC-X;#PH+;JVTLJ?'F>E*5)0WI"%%:B>^] UG;==BY1
MO!;/VQ)QV/C.0<E*Q[Z6E)?5%=4M&NT@JXK2DWX]G&@W;IQ.Z\M,?DYB+,A_
M*:E)0QI:3'0XB MED75) *4.+<=.KMX4$>5A]PM-NMI3I&0Y)9ERI482/-6B
MW[R\H3K+CN!DILCQ>(GRW"1!VX%OH?R.2C1&6M#*8JGF>5R#*=EN,-<I]Q26
MBLLI"3]XCLXVHL).V]W[EVACV<%CL1$SC,9U,5617/,916&TZEJ;$=XANXX*
MU=E9:[9>C?3&/V63([RZAY*"ZSBHV'A2B$V?\]F/E!"@3<#'A)N!:M7F0H>8
MW0SU4Q4C=K4)@?),QJ(C%B;))*W8ZU%96PWW 6T_9H&G2ITY#;>Y&\6\6-6:
MR@AS^7X3S'BM+B4JTZ@DKMQ\E!)ZAMYC&8/ 9E;GGQVY/9G9=T)T+<C!EUAY
M:$ *%P'M5O(#07]"DJ2".-Z#U1X4'->F.7Q\;/;KPJI*%RWLY.F1TH]J6W V
ML@*["I.KQ"@Z6#0% 4!0% 4!0% 4!0% 4!0(\_\ VQMW].=^)2*!X*#%W\&K
MUC[%!POH[^X+='XW.^PY01/JD?F>[_TZ+\5%!] T"'>)M"@_WE ^,HH#9;;;
M6!:">Q2WE'UU.J- ^N/+0>:D^6@-0\M!2=_\_"RH6](Q)3B_Z/E6;72O'ON)
MYJ_*%,D!P>H#075MQ*T)6D@I4 01W@T&5Q0%Q0>$BU BVFH%O*<?_P#)2_\
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MJ?OK,9&)>=C,SIAN-N.-A'+&@'2A02;\L$W%!W0"PM0% 4!0% 4!0% 4!0%
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MZV1C-WX?Y/FN.1UH6'8TQ@@.M+'>DD$$$<% \#1'(=M=-G,#T^]+MMS)8W1
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MG":J4VZ8^+B/OLQHR$(0.6@!Q*G+JOJ5;C06R)T<Z8Q9"9#6W8BG4^U+J2\
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MWUFN?@[)SAI<ST/Y+<R+2M;"!P)"DW-["UQ?B:XGV([<KV3G!@PM2VD+(L5
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MGHU3=X8!B(Z\S/BR74))0PB0R%+(^]!4H"G9;H=D]"+.[HP;LO;SHR,1"O/
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M8Y4B,XT'$NA3@4XHJ4GE,A+:T*<%D^%2TWU"U XW4O7 QRK$:LE -CVB\E%
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M#W&PSCVG()A87#) ==1%=<#P>D.7*>:JWM4]@-!TY*$)%D@#UJ#V@* H"@*
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MQO-\KDSB669(R2AE9)#;Z2R60L\VZ3I*Z!BG:6W%>US&2-V^<+9:6?>S]_\
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M*6L+#9+BVG';#Q.'F!OA[5*>T]E K>Z);B(D%C(QV"\T^XTE&L)9=D%_7%:
M2-#"D2;%8\5T@Z:#I^SL&O"8-J YH#G,??6VS^";,E];Y:;N$^!OF:$\!P%
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MGP+7NZ _;;GOHXW)\"U[N@/VVY[Z.-R? ->[H,7.M>>4@I'3C<@)!'X!KW=
MIZ687<..Z$;BASL5)CY20,P\QC7$6?7ST+4T@)_C+O84':D]GW*#*@* H"@*
M H"@* H"@* H"@* H"@* H"@* H"@* H"@* H"@* H"@* H"@* H"@* H"@*
L H"@* H"@* H"@* H"@* H"@* H"@* H"@* H"@* H"@* H"@\-!X.^@_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>n257410kimg003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg003.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@!NP*\ P$1  (1 0,1 ?_$ ,L   (# 0$!
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MR 1^[.?; 4_5*V3KJ$C 8 ^!6CW33M/]SYO9Y%9_=WN#:?2R5W$:72,@'O\
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MC)&K$:NQ.YV_0*;GVYO2S.9=FR\>!#<*07Z 7[7JXUUOA-H;J+C0]1W%!Y>
MI!+ :7&A[&F<>BC2+(,@<E;$$$=#>]J:X6G;$R'VS1[3?RLIM]M!4]C$!=HU
M"Z#Y=NM PGD,:%L4,3N82W _D^4=*"VU)-'ZL>UNE[_'2E4W5#1(5"G6U[CL
M;^-*%-0S!&BLZ+YE4A5[?DJE8)%-\>_;YAI:^OSH+K.SH/H4EV@R#:;GK\:0
MQ8JJ_DZCY4*$D73Y=:!@O,O[)S\*(BLZ]NM:I%B8 W\.U!*^H?4N!;72E1&N
MV=+'(L>0!E12.NU)3J@ ZHW;Y5+?5U69%@9O!K)@R^I) 55\=@!)N%[D>.GA
M27F.>Y)Y8I,=$0%C$ -"!>YTH9TAC+-'D;'W ->Z]A23*G/2/?&C@>FQ.X_&
MU"JRL6RIM!%@?+>JK.&4B:20(1Y3;<UJDZUL,P;#"" ZFP!-*KU$VM<]J0=!
MQ16.&-MH%P-Q(L:7"Z>7#,Q)?<RW!.AJI%L>?$B^H>][WN1?2ACOJ,&LA/8"
MF,L^=MSGX]"*2,%9=XZ"[=A33@QA-;*A?NKKI\R+TSCLMO\ _).W_3[?[-7S
MO^5]E\G\E\\]TX^3)SW)$1L5^IDVL+?RC7N=W^)'RO?9]]MXV:ADB)C"L[#4
M _>O6\<TIPMFG[V))T OI_'3RKB3Z&81KBR)&>DC6"G[;T97*MQ:RID2RRH1
MMBDVBXL;K:C+.[&L2?&0".5"H0DV!8GIXT9)Y^5>-R,>,+%<[;WZ'X5*OM,%
MLG/E;8=%(T  TM52%G*^'([[BUM.M+"X7S(O3EZZZ'\M5!0L7(>-MI%U_7-M
M/LI;3*9UC9<T4J+Z9\H.OC2FN%@!@O0W/8T\'EZ^X"_76F658W_:*#H-P_32
MH:W, ?CD0_E"(_F%2N-OE<.20.XR9<<1Q$@QD 7L>MP:7PC=@X/N+E%6-)(8
M'2P!D+'>;?K$5I65W.Y$$V;'!E;D:6S(J'0#SD!OR5%3TTCRW!Y&#D9$<CB6
M,$-!*H\K(;$_;XU6#D*D.8[+J;:#^*C*Y4P12&96E.U^IOX =Z :$D-P#*!?
MN0:6 O(N(T3[IT+ >7K<-U\*14Q'Q.5)$CKM96 (-_$4' 9<<HYC++<&Q(UI
M958I]*N_<""!WM4VLYKTO-"-+.&O\]*%V!S8<S;63)2-5-V O<@?93B++ ./
MR/2CVS9*.K7(9C=KW^54C[21J8G*8T;7,R[3U&M"_M88_&<*3R^J 3HHU_BH
M'VTK/Y%MLTNOS-,V4%UT_CIF(J$ &C %4WI4Q8RPO_%2@1(;J/&^M/)*("Q8
M6U'2G2HL6+)*2$6^W[Q^/A2E&M/8AF@PYR65+&T0/WMQZT9&UPKA9&1*7037
MBA 0@ ;K_.D)<DN1ARX\DMC&/S*+[[G6],(7Z]86=O3-AT4-28[=9'(F,Q!(
ML0-:J,Z?]M@GEL?M=K?F-/9?+RZ!,3(T(*[1;4G6LG3KJ+/C$?=<'QOIK1E7
M"1DPWL2"/B152Y9;:ELOZR"39&T9T!#$$]?E4<+';2T!\G-6)I/6BN@)*[6U
MMX4^%'V(:YV:<=)!+"@?4*X:]O&G(?V<+'#RGG.49(W\Z[UU&O:U-IAK)"K
M^;7]72@<+SP;1<M?X4'PH9-P'FUH+!23U!(YC(U87!H/!63#G(("JU_$GO06
M*NWXH"!<*JZ*%/84&TH%G;!GD>-6;U4L+_W-CK]E "#RW-\52.WG% S$>M("
M",2X.E@XO^FA70](TIC8+B%20?-O&GQZT#H,F- 03]ZP)H&) Y(XW8!M XL/
MG4IV".&T8/I"Z]QUH #2,+B0;>USW% 4=MR%5[BUC3D*P@<.8:L%!^8JN)G=
M7EA:VZUSVL13XBFKRQ*'#RD*JD7%]33SDY.D7DMCM#ML+M?=\*5:5KPL KJ6
MVM<.A&EG7H:E'$/-S&3*H.;MG":;Y!9A;MN%J#R7CY'B\EFW.^(Y-HB5,D9
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M+%57DB<H T9[7)\V@%Z>*RQ$<OR#1^E%$J)&Z+(I46T;6UC4Q5Z"\'-R6V9
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M^9)N:K".-XRQVML-O#<:.$^-/J0V%HM!\33X1Q/*8&.L8![7)[:T83GI$RC
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MH#1X[(EP\U)D)(%P8[:6[FXI'+AU4?N/BW"J\VQVT L00?"EAK-N@#D?<V'
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MZW UZT&]%$@L);[')&\6 8?QT"0T8S! LF.X+/IYOO"W0$4K3ZBV9N'H3(A
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M>O$JEG5=J]K=Z1E$@CRB)9"I5+C8@L03XT$+/ B.%4 QE0 #_P"GC0<4$*M
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M%=%.(?RF0U6WP(V<NKOOU\:EEE[)D<$,MK,!>_C>A63>'!%-!D(CEI!&C/\
M#S4'UJYG'R8\FUI5V[0P/3J.GSH&&;/$TK1("=C7+>&ATI'#<<4<:;(P% Z_
M$T*QE=L.27($@-ELM(2&F7'$9VIO=#9OA\:>%6%RZD*RG8G6PTZ]C02SQ;E5
M@+K)=3WTZ4A)D."T<X%BJL-C7\.QH@A?*_IB H-M+U2=J2D-CHH%/*,+1QLW
M464];5%+!D !!8"G*6"FYSN7;WZCO1:L+(#!5O\ &G$[A$DJ0=5/45;/6@/
MR*+$[;_EH;-7A&/[2*]@^@'SJ:<3B9^3QF<WIFX1K,E_*PJD7H;&1A0<QBMF
M<<OIY2_TN+X^-J#QE@20R@[2+$=1WHR6%E"]"=:>$H(O?M2",>/=,B,UMQM>
M@W2\;P483ZP9)5HV\L) NUM+7^-ZGB;33H8G)9_K2+C[0LH:[H?$=!4R,[UC
MXN-D-&Y8H"V@.OEM150ROU(N0X)O=].NEJ<&797/]@[]_K;_  _S6OG?\K[3
MY/Y+A_<,^_GN20H0$R9 "1U.X]*][N\^[CY;OOMMO&6CC#+91U[UKERAY?I8
M^%.=UV*VL.Q)HR,@X$:11;68KY  S?RCJ:H-;/6+ZJ%(AY5BC5OBUB34T]9F
MH>) HUN3II2RVVTQ$Q1QM(%>[#4Z=@/&E*-=2&, )& Z;B?C5%8=V,WF7IX4
MD5YG55UZCM0.%5((#*TD-RK&[;O&F6,#A=NH^RDJ @CU".]Z$_"LP)-M*#PE
M9H821(;=-+>-*GAF9N>))&]!5V_K=[_.B)H/&Q1O(SR#SGK<]:K)R'IL0C)B
MDB'EUWV[4'ACR*),EYA81QZ+\2:;.KB-B3(+AE%@>U3@PY9-X50"=MBQ^-,4
MS@*'#:6&ZQ;[.U-%7C"_5.VZ^P63YU)? ;C&[4]:$94S,@P1%5(#OH+_ *::
MY68%<FYU(&I[?8*:XM%C6W ."6MJVO3M2R:^UTF1A(04U(!M<_&F+74\)[AA
MEA2/)<>NQVE@+#\]"M:S>;G,G*2D7 0*MSW%NM-9#UDM<L#\J<&1N.,<O*X@
M# A)5+7%*D^@N(1*3L%NQ(K"UKDKD\;QT_\ 30J6/ZP\I_-3E%I.3VWAA?)*
MR@_RK'\]&4DLKVSE[;PR*XMT(L?RT\E@MA\/R$0R()8F'JIY'ZBZF]OMIRC#
M-V%7*LI4CJ/"J@PAP#J:::L^YHE?=<*=A_2*61 PH(%SJIUM0*5DQDE<RZOY
MKA.@!OX4X4,X88.6<V[?  52=C0$LN9'+$5:*,%7UU-]=*BB'8XPO3I\*1R'
MN)AFDY"%DC9PKC<P!('7K0=*9F2\\PMHB@ +^F])%N0Y#< 'K3( 0R&4L.EJ
M0AG&0HAOXDWHBQE0RH!T)U!I@OMG5F610MCY2-;KXT"-3V]N'.<>1_\ Q,5_
MRT3KB_@;.:CC*R0$-_5D_5-B-QH9%@K#RJC;>NMZ0264]"?M% +>\6.WB /N
MG#U)_P#>&KV^!.SFO2(8$5+.K2%2 I["U!P;BR8I,QE-F]%;?+<*%128R3,3
M*Y;N0WPZ4*+/$Y86TVFZI00]CU(VGN*57#KEEQE*KN)L=/"D X"Z@NZFS:6'
MQ-4<JY6-E8N"PM<"VE*G86:5(D$*+Y7-VDOH!\*2)439,#0GTV-TL0W4]=#3
M,OF$F9B.AM8CO0BE&OKMU^=,/1S,-&^RII44S'4 7THB5L)G24J#Y7Z@ZTME
M@<F!^S([D]*>M1N1UM6B)$H^S3JG<'I35*?XYSCAY]H 5?O?'L*FJUK.;)+S
M,\Q D<DW[?95%L<PLW(Q95F@?:Z]+=#\"*5/.'0;>/YR'U]8,U%_:J@'F/7I
M_#0.')-.&XTXV69<WZ?+A56@@DLI<DZJ;T9' 1CQ)QMW C>P%]+6/>],YJ/%
M@I&/J);EH7N NH(#:7H/#1,PES0L;':9%<^7: +@[14GDCR7'1#-EC1E6S-9
MP;BQ/6]&$X:O$<#G3LS1R"7&*%D%K=.IW4JN0%N,=Y6+Y/IQ#I;4VI1&W0ZO
M8/[![-VGUNW?_JMKU\]_E?:?(_)<AS^$C\WR$@WW^HD)LVGWC7N]WOW<?+]]
M]MMXROTT 39N=NURW2M<.4O-QG[-E)+&]PN[K\[T#"N/QT;$*S/ZCL#M)N+]
M-*JC#0R<=6Y*=B3L1MEQW90!45OK%YDC]+:#<D]/"D:((VV2E& <*=H)T)HB
MB@C]!U++?<+MMULQZVJT8%:0E/)]E PHX8@;A:FE>'< 0OSI6!YI/,%#&[&[
M4L)P\19M3>@68$07[4#!!(99R2X-P6N/'72G@84RH\3$Q&0>6>2QTUM;K3)3
MBXEWAV%PHMKH;FE2:Q:-48L0 %)OX6I*KE]P,@11NC O?IK0BC-=8;L;$Z#P
M^-J#":W2U@=*<*@P&*0&.0F]B18VT-JNIU,PP0O,GI,01;N0-*E5U::L1H.E
M&$X!GC260,XW6%OAUIX&&;GS$9!CAT706'C\Z N'=(]64R >4$=#4X,)2R1E
MI2"_BM7@46(J?,+D"VSX$]:#BTK@WDFF8J0 >IO:DK(7K(I98CZC6-E46 !&
MFM$I6M#AOV>;C>MH%8,]M3<"BG*Z3.]Q)GK'C<5(WK2G:9"+;0I\U1AK;DM/
MR#8LN1AY^0YC"J^+/:[;SU&E/K&0ES<M8]^-R>XK8F&86Z^%Z6!EK8_+\Q%C
M--+''/%%I,8R+K4X.;#0>Z>-=5,H:,WUN+C\HHP=I;-Q./Y)FFX^=#,?,Z$V
M_)>G*67/943JC",@2#77QJ\Y9[0G).9,(AR4E;7:AU8KUM]E/A1=^@7&6.1$
M9 Z[D)_:7NW3MT%J+U%K5O3LX(O^TU)[7I1H3G:8SO&C!5V_;J*=J=FMQ:,F
M/YM3?KXU&1JT%8@?HH4U>#Y!H9!BA6(GD5]R,5(:,'\HUIZ[X3MKEC-(68N-
M"VMOG2NV:G&$ DGXT!<7!^-!4PK>G"Y/;7XVM2:? 2XS-DR$MJ/3)#/XZZ"G
ML6IUI&[V)J0\F1D8Q^HA<QS1^:)QV8:@TX+MB'3^\/WH1?\ $V)/6Z(>O^#5
M\=9\=0?WB^\$4L<\FW_[<?\ -I<>PXZ]+[_]YE#-#R(>,"[#THMR_P#5I\=/
MBK"Y3W#SG.9<<N9,9YT7TX[*J^6][66PI6VB])[&X^7Z9&D7]O:[K27->@S%
MB\;(EWC <?>!OK0>!8\;CH%G**"S1_=ZZ7%";&5N6YM$ +Z=303PE! .U.XT
M&M!6I4%G545=S$#4:4J<K0S0R9#(BA46P"#ITI+H!9M!I5!6\H(UO:Y8GL*F
MPLLWE,R 1,L>V1WL"NMK'7M52)M+P3RI L:J %-[ :4%D1LF1F4,JV L!T%C
MK0$(Z]T%N]C0J/9#Q!0RQ#XW-2FT$9(/ZBC\M&$Y0N8B,&V@,.EKTL"4-\B)
M[!D[W-C5:S!Y6:/"<W164_R;W%/)<+PPXB"4D !'W6T- DP:P,,YG'S8R$?5
M![[7(5=H'QH,I-Q,<8$3R[I#J%4%@#3R, Q?302M!D.Z[#Y;J=1\#0,'!(N/
MLS<"2Z@VN.H/76F6<-J"+A^>9\J9 >1V:XU]HD9!H5_A%2N4Q#+CG!R9 P,C
M;$B0)Y(Q]UMU];:T2'83_80Y_H_4!L9F"I,HL&7Y>%.WI3--]NIT_"2<7B8^
M0F<89)#(2LK@G]G9;$?];3QHQ'3R<27+EE,#9N1D$JL)\H!-P5)N:+6&9GH:
M^%S6=A1%() D 4>DMKJNI.X?EJ<E=L%5BD>(E7\XULWZRTTWI=-8_P!A[6U^
MNZ?ZK7SO^5]KCS?R7)<H6CY[DU8D(^1(RGL;L017M=WOF1\OWV??;>,LD?F\
M1X5TWJ<T+YDHEF&,"+CS2 ?JJ/&E"M&PWME1#H RV\;7J\"=(CSD,[]=[%C\
MR:SK< RS,WE 5.](&%"K"\A-Y%TL*(>6<TCLVK$.=01T%6C!B!9U0F3J#Y&'
M0@T%,O,DA-RVE,)C8V-C^2@5Z*.[EVI)$8C7;25'MSJ;'IVM35AZ+]FDA N5
MNX'\%"-F4$DRLD%E"V\UCX4TM&*,1KY?'6]!)R@1B2'=9MMKG70Z&EA583.J
M"[FRFP"^/RIR(JADDDM=0%!.AZ@TL'*ID.RI=5!(/?PHD%+X*L7# J0Q-QWJ
MZC5KX\1!#'XV7I4GD2:01;;@Z]+4X _K85)2S%SI:GD9(NC_ %&YS^L6V#_T
MZ4B#)+.YN&%]"/C0>07?>NU1:P-AU-4+1,61B.]QI2HE'$F]BM[V%S:C 0K1
M+(=JG<=">QJ:#N P3($Y.ZRG<H^1HAM+VEC1_4/,AN(@5V@==VM[TMFFC=S\
M3#S-GJH5D0Z.O7Y7J95V(G]MX$V((H5$;]0^I)/QJLC!'&Q!@Y/(8D;,8SC;
MGW:@L1J:29& DK  =JJ4UTELP9;JP(U&E*P.E?%XSF("V*OH9:  @Z G^&IG
M0+.@OC1<5Q<0Q\G&*YJ/N+, ZV(ZAJOB8<-+Y,L3[O3MZ=RUOB?"E6NNN"&0
M$6)FL;+J+=?LHAWH9.4'>9F;RJUK"^O2JRSMRV>%D+XI4DDJU@?A4T]6FD18
M7)L!UI0\FN)V_C..BBP5K"_RI'&>%.T::6H9U&X@WIED42;E#;1<4&]'DM>5
MMPW);: /$4CXAH@VS4*"3<D #4T6G'G6[6O^6D'LI=L;"]KK3+;J9RQV%B1;
MPHRQ5FBW1D*;GPIGDG'+(MRC%6'<4*E-<5F)Z]G13*= X%OLH5&\N:L26ET/
M2XUM2M:VXA=VEENRD(AZ-W(I<2)<BPP(%F9;DB)NIZ]#3E%U9JRNO?X_;32\
M&!.@Z4)L$C.WS=QJ*5."/F$;G(('4MUI+R)')%+>RGU"NY3V-/)TEG<DT:6C
MB8NUQN(\NE.(VKGBTAD]3<02=3?O\130-+F3QBZ.=.YI!)*1E'N;L TIZ@W\
M*!DWY0+?"ZGX&E59#R!^S\:432E[#O\  52<()+'Y4'A#!=+4 5>PO;P-2,B
M."%L>].'E6.5U=?.;*=-!<?;3P>1A(QD+%V9F_68ZTA*]D0#(%W8!OU7[U4.
MET=X>/R(0EWC;<WB0>XJL%)EV&3[0Q./]TGB8,V4R8V+#E/.I0G?+)&MMH^[
M82=#6G"J:8;XACA]Q9'M;*B5.4DVQIDN!:1)""I('1F74VJ;&ELPS>6XOD,+
MCYY>%3#P8<=]W(3\@ YDBW!4CB4 VW%J5Y4KTN[\R:8Q)3\OLKEU63CH6AC&
M(6FF5Y!MC!<(BN3\384M>58Y>]W7;;,<WRG"/A8.!R$,:1\9RBZJYN3,EPX#
M?R5TI[:X<EUP"N4L>.B,J/< ,4.E_$ UFG"BY\K+:P;33L;4##L=Q_L%N[_6
MWM_JM?._Y7VGR?R7-<ZM^8S>]IY/^T:]WN\^[CY?OOMMO&0+JH.YMJCJ?A6U
M<Q/)R%AAEG50S]B.K&]A3D35_;O&Y7UBSSF^X%K7)(VB]4>IJ*$[59QNW#[I
MK%T"R1'>$46;K;M0"F5+)_1*UT4Z'I>G"I(3%I&MH!H150I3:.R[8KV#>;0Z
MVIIVVP,;GI0CC>3:O2@Y<ID?2RC0=:#@:V[&Y[BD:U[@6H5JK<E&0Z%M+T(V
M"BQQ%D2-U#*H!_332:7;;II01/D<AC&(BH"G4->V@\:%5B2.C[Y2OE3[@\;5
M415X&$BA[#76QJ1 )I%2-N^Z^V_QIP]@L)+ENUK?/Y"KJ-6A&I!M<@'K<FIP
M%II"-JF]@.@-Z0*O+M;?;L-.MZ $9[,9GL;^6P/?K:@*(+KY7V,YM;N* A9G
M$Z7 #QFQ;N?G5BM"9?V$LVV[W VKT^=33B,.!F C7RNVOFI95@S+@KCQJ W4
MW;YU(P$JLZR$ ^5"P TIGAO^T4D$,S ;(W("GL0!4[KTCIXX;)TW7TU[5,:2
M,[E,[,P'1<>/U@X)))VJH'B:I&SGY.4RH9)LK(VN^0AA9EU55/2]J>$39EP%
M9$W)<K>P)[GX4*XLK]!TM3,:#)F@D26%BKH;@@^%'67$ZC&R<3G\;TIU$>:G
M0]S\?E4V86R)L9\;(>!^JW%K:$?"ED9*3+<$*>NE_ FG"VC&56\NX[FMM-SK
MI5,&QPK-^U4,MA;R^%3MU"+<R[HD;*Q!!-]K=+]*4%K:]O1S^OBSN HTV*;E
MFL.]Z:Y2J!BH%]+:BAG0_LH V/$9&4%K7O?Y4*UU%GQHX&8(UR]B;^(I'MKA
M0 D@7I""EE.@-C0"^42T# ?>MU-!;=14M:FQ1<]?&F">EC?K>A45C_9RJPTL
M;T&Z,@2JCVNIM>IK6=,6V-UL;?FJ%2+HUDE7QC:WY*K7K+;J9%U[UHS&0@+T
MZ=Z1/$:Z=*5$2H_9NP7?M/E6_4TEPP"H4?'J/"@ZR>?EC6"-&-B6T777\E.,
MJSHXE:&6PT0(1V)-[=Z9 3 *-=2 +7[WH3E+,/26WVB@VA XFB5C86%B/T4J
MN!SC0CP-*%0 !<U24%?A2H5*G2PN*G(6%KTPEI#MVGIXTP@54-=9EUW$:?&G
M@E3/N^([ '2B07I'BG(OHK BS ZZ>%,]=L#YO*\UD9#Y@S)QEQ($8LPWO&""
MHW#[P&T57VB\DWY?/SLA,K)S)9\J/[LKO^T4WOUZZ'I1G*+UNGXCW$N=D8N)
MRH&69IH8Y6R&+(T>[==E%M00#2RZ.1S<YCI??&-)B<RK8&9*9#CGZI-]Q)$3
M<*3T)Z$"G;2VZW-<G!DM[0Q,I9G7"7+,"XK.3MVH6#6/0>;M2MS"KGEE"@$$
M6/36LT03U"1J?C0'T*__ ./;_P"E]?\ 5*^=_P K[/Y/Y+E.>S<H<[GQ+B.Z
M?42 27 'WCK7N]W]G'R_?/;;>-F39.09#&,9F4?KW%C\+5O& 1FD8JKXD@ 8
M,2".@UI]#/:5L<-E,\N01"8D2%RI8ZW(-ZBJU'BS\13L%V(MN[U+:;$L[/B:
M=H8V.]ET%M=M5(5W)B-U0@@D6T'QH+*,?#<[C?0^-,"K'Z;JK?:U&4["R$BQ
MM]@ICAB8O/>XMX"C(P(46]C1DL/;!:U2J= 97;IVH7-@F'FIL]NM<':+GK3+
M"D^0RQ'T@=ZZG2^E,6,5S'*QW2'>39=YTN==*53E23B<Z2PW*% MMO:EQ%TI
MDQI<-4@E4@[='O<6)[4\J,X_%IEXP8L1<_K#I:C(QD/\.6(DHX*CI>X^W2C*
M>'"FV7U-H()(Z"YIY*0/T)6+V( 31EOK>C*L(FP99 @9T4!;(HTZTLC <?%6
M.]V "G:MS<W'6GDN%<8$BC<I!UL033E&*E\:?>K':S#H;:T6C%-PQY!B(;T]
M3=MS6I9*Q= 5VF,1[M==UQ13RKD39Q4"5$](:W7J?"I.5[!5'D:.[#>K7/V5
M<&70\?RF-C0101JQ""Q/QJ+&G&>/N1;@>D;#KJ*5@^T9_*^Y<&4>B5*J+F5S
MK8$4Y"WVR6]L<;ASX<K/O:(N=JMI<'N:+2TF3N1[5QE4'&F*#??TR;@5.5<#
M.R^#Y2(^0"6,=7&I^=J>1;2+P2(&]12+6M8&QO3R(O!Z\,JRQL5==584E.EP
M>0PN218N0'IY"K82?=#5-,KR?"R8SW0%X&U#@=/G:G"L<\^,QRVB4@$D;5(Z
MWZ"]4RVG29_#\SC721E_I/)MN-1U'Y*6R;&A[7BQCRICRBAAG4AVE!*AKZ7^
M-*''6\;PK)/COER;)"TFU8[/&%CU%V'W=P(TK6:S!W+F!#+Z>] 6BO;>.FE8
M_"GAJH7H+=*I-R:P8R9CWT_32K;03DO3$T08>=$'J(.MR=+U,A<PJY%_AV T
MTIH07'C0I65?4C< @>72].%MU$9<B%"8SU Z]J;$N9SZ@])EV^!O1@T(#KZ@
MM<^4+K0<IS$X^&>+=ZA%F(8=Z%S7+7C@$<*QI?8O>IK::X-1PEQ85"I,@^F(
M@ZM_):WVJ:>K/9C[;:6O>M&/PCQPR/?:- -;U.507T)$(Z7ZWO1E4U$2-O3U
MVW)OI0IXQ( +V'B:96,W*QL/*E 9V+*Q1P-0.GZ:$8!DX^&#%^G5F(F<!F&N
MT#51KTHR6"^;@X>.JEY68M:PMK\Z9<,6_#<=L9I8I3)M%P+ :_&@74E!*\88
M!2;C4?*BG#+D$!M+FU[4L%:"5-]!UII-3Q8RQHT3%F(\X/8T%2QZ5%+54I;Y
M4XJAN?+TH"P ,;7\#^6U5 ['+SN)^EX>.%X!BQ\7(N404_SIHR K);?OOW-=
M,D:XC,]YP\"3QN9QF4D[3X\:9\,1(=)(U 8!;6Z=#XTMI$[2'<D\1F<\\.?D
M0_@,,$K\8N.XCNRQ Q1N5&\,6T-^IHD@L@R\?[&6?BXX\J1TF@,V9D&2RB81
M7] C[R>?2_2EB*DCW+X'M+D?:V'%QF2,;F,7)F&)AR.+^C-/:\LH%F(TM<]*
M+C![8PSO9$_ Q<A/A>X0BPY.3B1IDC5H?39B9%MU2^C_  HUP6LD=*G(\5)%
MQ>/*Z28HRIVRV5PI $[>E=2-UB+=[6I;6-)AJ\FO R9?'N\J8^)!/'*8YM89
M"8Y?4#BVGFV@-?N*>MF#LCG,3+X:3W3R+F2&#C\O %C.4>.&;T=%8*/VK;M+
MIWI7">@+#G]IHG +CRKN@R)Y.07(CV,W[!&\SZBS2#;&>@IR0NATGJQ?V,];
M:WH_B&_9N7?M^FO;=]V_QZ5\O\/YK['Y/Y3DN6E5N?SU5P0L\@.NH;>=+5[G
M=_9Q\OWN??;>,DNC-N\;BMO@8SK+39J>J\"*?536Y-@0>M+"=Z:XP7Q\R[%@
M4L;_ !8"U"(M%$MKA;(-/C1A51Z0$K-I>PL>XM3+#TFUAH;>-)4JBC;TZ=:%
M+2J "Y.O\F@J'<FVE,8%B(!-Z5"6UZ=:"66_?2@LA,RZ@TU0(ZD4@OT&O2C(
M>,/D;M<&YIY*LY<.%MH9""S67X4T0UM*^5FN5T)Z:UEM&DH^5$N1Q;,JAIHA
MY6;M;_HJI24XGRXA=AW)!M:]J8C*RV+LB*3YQJ1VIIVN5A&VWTT)"W!UZGXF
M@]8M*8XT+,+(38BW6A5D1EL66%G4"0NJFW8 :6HB0T"A;@EE+L!?QZFJ&1@0
M!;\M"UD"WUZ4 #.G@B%P+R..GC29;!ICYM][N(D(_HU TO\ $490=2.%L3(C
M):13:SZW6W46I #%@DC9]Y(V1DHO3<.FAJZ<,P#SV%P:DS(4]#U!M>E2K&E\
MV6\+1JY).XGRD@?IJH'8<!&?HFV: M;Y6J*VY;7VJH ;5V!N?$U*[2\[,DBV
M:Q*ZVH"8S%(ACD4/&VC*0*HL,#E^+7C295N<64DHYZ*?Y)I$2C;>@93<-JI%
M&%1M\9S1B_8Y(:2/;M![C^.F&') &\X;;.IT;X#I3B+!>1RYY,. 3>?T2"9A
MKU\116>RBYS8TPFB0!KZJ>FG0TDY=%PO.?6\C"I8I*S#<GZI!ZTL--=B''<E
M$DL^/*=L=[KX ]*6%9/28D,A#H=JMK<=#?PH%D0<C$P)H RL[SL(UVV.OB?A
M2&N"3"<Y>8V1_2EU(-[^6QL*<3L\0";G[::</ 6N ;4C01:*06N=IM06W4QI
M4)G95'8 ^'3QJF*@C$36<@MV0&F*(LJV.A^% E:&%N2!773<32;2C>O/N'F)
M'SI8'%3G&Y<HG=;[]P\H)[BHN&NFU%R/49[D!;@G0^ -&O6GF99$DC+=@NZV
MNV_7[:T8K8&?ZURJE;74J3?6IPK4Q+DE5U1FMU.G2AIQ5,.1NC!Z'Q-+)95,
MLQ1E9 K#[AO<$=J9@XZ[4:/U+N!>0CK<ZWI4L)DC9(1O;>P96=K6\M[54+:)
MR^/CRF!8>5.ECV\**C"D^*T&!+'BQ@LP)VWU/C1*,N<647U!\+U942.<>6(W
MW#KX4DF0I"!R#8FU(/.!;3H:!5#:EA,6&VUCTI*@$R  D&R^-,]BWK&^FE5(
MC+PF[GOU-:X-(:]& LCA?XJ0R;BV%MUNO6E@!+IJIL;WT^%(<5,>EBS)YCZ4
MHU##47I+E,863*[M'*5FVV!=>J_.]JSNIRNBQLY)<9..R@SK*Q$-]0"O4&B=
M#67H8_)\0V.[62R@W '84)NK,('?[151#Z/8?_;O^Y^J_-])7SO^5]I\G\ER
M6>P;W%S"O&@VY4FUEZVW'[WQKW>1[./F.]^VV\82%=S'J:V^!C.MGY;A,@OZ
M>]V%@!8';\2>U#/=J<0ROQ\[[=A8HI2]^Y/7[*105KA;CI^:A02V6Y/FO0%3
MM+:#KU% BXC'SH4]Z8(.E!H""^@H/"P2]Q0FO;3X4BJX0;>ES2(M( 3H/MJH
MH-5Z7H CFW;3N*0>+7730TTJ0(3)<ZV.M/(1F1.=K*MR.HJ;$U['>2)9MRFV
MQB 1W H@7@B*8"J2;E+L3U)(N:=IQA*SRY<=T** 2MS8@+U-K=^U,'D4/J-&
M%)8!$OU#EB"BVV+;OWIIM"S9+-$.C,38WZ:4(RNK@MLO<=CVOX_;5+B-UM#U
MH6+&2; 4@'DXX>6"ZC>#8$]A?6AC>MH1QAM2+7.I^532(\Q#DQF7($A1&4*J
MJV@'<FB4J>X?#2:+)F>5G(QR+,+CM:QJZ<$CPX[%]0W0D&H5PA0S*GJ,[VC5
MB S?#YT)K.GR=W()*(BJD>4M877I>JA.R]O$?1Z&XWD@^-371H?EF03*O<WV
MGL*E5*9DK>JH0@V'G'\%!*0RR6NZ!1>UUUM\Z>1DXI@*F.?:\3=58W!^-+)N
M3YA<?C>1,4+K)#,?41 ?,@/46JDY>60$7O24@DMTZ7ZU>J:LS*L4AV[P4-U\
M>U*LMBV:&!CC8$%5 -_E22=]J*1SN/KH2:9ZLO*GD.1(0Q&I% M57)G*[2[%
M1VO1@N)J\"<I\AI8X5EV@ 2R'^CN=2!W-3T+Y?2T\A3]9,0WE&VWCWI'0GU7
M:!TUO03PT&M!I"@H]_"A.W4PLHNN2=3:VBBJ8P";<I#'OVH%71&8:=#TIE&]
MBH#QQVF_I&Q'QI-I "XMN&@O00L:90=6Q(S+.")%1>I4=:5D7K<&6Y'/R9U5
M\'TXR'W.&!MY32FN#VMK/4BP\*;(;&0%B5 'C0K5*2-([$+= ;7\;4JH54N"
M?T5)A1L#-(+EK$7!&@T[561E;:%>^@OUI&M-&KPMKY3:X_)50;+WN!;[:*S6
M8 +8Z7ZTH>'&N"LI1@;W(/Y:J5E4."%6QUUV^)^VJ#0QV!Q4N;L!TO<V^-33
MCQ0'[GY+T%0B&!LP^PT$L=$I8,K-N?\ O1VJI$@NHM>M($! 1I5!-B%I6!Y0
M;WO1@',0C>H/6]2'F(#L/B: NNTBU&!E5XV8@J=DJ_=?I]AI6'*U,;.$:XV6
MZLSXS'UXQU(L1<?"HPVUKJH)L7-QU>X>"07%K%EO0VDS&#RW S0OZD2[HVO:
MW2WPH9;S#K=I_P#M]MMK]7:W^J5\[_E?8_(_)<?S(:'W+R.XJ5FFD*@:$ .>
MM>YW?XD?+=]]MMXP4:.+'9ISM5FL&.EZV<TN"T?'R3QY6:+:-^S3=8O&"%\O
MB%ZFJ@MRT\+CYH,)PY #RBUC?0*:D*2LJRB,$FVK?#YT&AKVT-!K(#H?#K0(
M(I\O84+B6/333N:#Z V<1JS6! !T.@H++T)8JI:UR =.FM!)8&_72@#8\7K2
M)&&L6-B:FB0'(QFAF:*2]U.GQIP; K;72F<0X\I-(*[A:F0^(H\QZV% @Y"@
MW[GM0>(AENIN#8Z4#H#9"$T![ 4BN H8\>;/"75PILXZVTJI!T-=.,PMOEC4
M'M3P,('&8-R#$+T'AA>X\+&@"RQH%E/DN/"A-UC)AB9A>VGC35CH039B*102
M%['X4"B)/'>RWOT-#'%R.)P?V: D]O\ UTK!=:S^3R9LJ-<2*$CS^:7J++UI
M8*-+BLFPDA.YD$97=V-75R'T<JNE9RK9DJHRL60.ID+*I\:>&5ZV?R$/E28G
M1'NH;33PIPG9\ 1]$%(LI8FE6VE.9#Q(K2,0%C%_A:ID7EG1.9+2W\LOF47'
M2G@9'EY"'"Q_4D-@2%7OJ:,';(33G./4[&R(U)U-M1]MJ.%,W@DPX?D$)=XW
M.VX92-P'C3%PY=LL(Y17+P]$<BQ(IR(XL!KRQ#21;+L"0@!UZ=3VM58*[EGS
MLOU=S-MO;RC4:481=CT'/Y[!TE2.< [AO77[+4L)RU/:_(\>_.8A])X7,EBM
M[K:U[WM27"\O'&9Y)8)8W2]S=K$7\;T0J ./R6UC57']RRG^&F%8>3S..SM0
M"%&UD'Z#:C UVPUN/SY,\Y$[HL6W:-BW(-K^-3M%<1MI%MKUJ1E6_774]:#R
MD.%5@?#2@MNIF9@(B]4 ;NA/PH8LZ-U-[G_UU4,PLR(IM][HM%36Y[<4R8>3
M?H6L1]E#HTZBTT;12.CBP74CX4)LZ1(L'U0DF3=4T("^%]/^FI.QH+BX.'D-
MCKDM(SB^JG:#L.B_"J&>AFI!D22[5CLM]"2!2J)K;3OT)APY)9FV[3>R$;B#
M\Z37&%+HR*R@J"/NGJ*<.6(/>VGP%38,P%#YG:]A?H?R4\)B\@+ ;!=A>P\:
M5BEE9O3LR^G<7*G4@^%*!>,J=;Z5HSHIU%Z56S,GB<=Y"[+YFZD&AG=2&?QZ
M0*@BW=]!K593AGA)EENBFXZ C2U!Q[ZB0OYH]"1TN#\Z*6QY%]90QT*Z'Y=J
M22T@;<1^J*J09"(/V514,ZWNM!(V^%/)H*FC(0 P[49 V-*RRH;=Q4T#3Z3R
M?WQI2A16 -/)#!AXWHR(U."QILF<B$E98@65UMH.X(/45-:ZM:+)7"EFEGVP
MP$ %XEMZC_WNH'Q/2AM,P^)3-Q[S&598PPW0W"F,=GCOU^(K.W%9W=K^7^Q7
MWO+]?]ZW;Z;K:O _R/L_D_DN7YV*(\SF,5N1/)K_ (1KW.[_ !(^=[WK/M=O
M&1FFF5W56C:#;98Y4W:D:F]ZV<&Z(N4AQH71]MF 4V6X^2T929>?TL''2!++
M(SNS$GJ386^%"B<<01W8L69]6/QH"Z@L=HZ#6@QU6Z=>G:A6%=VU@"=>P- "
MRI)442H20GWHQW7O;XT%:'.PR\)#&C!9"-RL+&U^]!9-HMEOVI546NIM0>!8
M#MEC/@PI4S_*QXTBE]ZK*N@UZ_ U/2-F((^YZ=ZLH'-;[@^9-!5$:7ZTRB&D
M$64A.MU95 [FG"M%\S+UL>GQH6%OE6,;G.GB:25),ER+!R/D:$T3A\"99%R@
M T>X^>YW"^FH_AIY&L;;QNI+PGS'J#TIY:#XLR.+D68:,#UO0&3[F2(B'=H&
M8W% PQI J)M30VLH-!DE4[O/IKU[4R-+&@4E=3X]J I(ZK8"Q8Z?*D,!RH#'
MM)(OX&QH&'HU.QK&PV[1\!1A.(;XD;$R6\(M/M-,7H.Q D7/Y:RP4I)I(L?'
M,TI) )U^)-5&=9<<65FS%\@!(%L8XAU%CW^=4&S%DL@LI*GJ0+VL:6!+@/D)
MY'0Q*YLUBVNFATHD/BI9))UC=?4.GAT5?A0,TS#*)\S&QV'JQJ;ON.FJFVG>
ML>\?$Z.S^;I[G<\R9Z>B_P JV(\#CO,3BPK?J0BZ_FK+W?TMOK5TSO7H:?5A
MSC>!Q\UYDQ881)!CRY,JLH6\<(W.%L#<V[43NV?E;?6I^]^CI]6&^1]DY^%E
MQ8IPHI\J=Q'CP0)ZKNQB6;RC:-%1QN^-7[I?G;?6I>]^CI]6!XOL?D)L.;-7
MCHA'"DLN4"EI$6"41.'4KUW'IX4>Z^EM]:CWKT-/JQ7^QG)R9+XR\'(^1"@F
MDB]#S+&PNKD6Z&E[M?#OY:GWKT-/JQ ]H<E']5?AB/HPOU5H2/3+_=WZ:7I>
M[7YV_EH]Z]#3ZL:6%[!YO$SQZW&!8HIV@R)(4(])D":LP  #>J-IIWNE\.WE
MISO?HZ?5CTO[N\U?580XC(CF$,";/*K.AB7R E@T3=?+\:?N?I;?6HO>_0T^
MK&=-[9Q\;CDY&),:7$EE,'J07-I@@D9#N502 W5;B^EZF]VQT\6WUJ/>_0T^
MK&?+QV$5+KCQWZM=%-_S5/N_I;?6I>]>AI]6/-%#%'>-%C4GS6&V_ATI\K6S
M;:9MZNOI\*>\[3;37;$ESMU3'@9^3,\><H9B(E4$@$=ZZ'!1]REK@W5M5I%*
M](" ;GKJ*J*"GF"XKN )&VW.EA?Y4,ZR1$&U(\Q\*9BY\(5$9%MM%G^7C0F=
M+9]JS1IC3(;[G<;3]E*M^2VACHS;V4%E^[\/XZCBK7AA7-&P*0!?PJI4;D\=
M)GRH/4(:SVWZWL=+:^%4RA694$H1)6TN'L>AOVJ+E<N"&7ES1ML1R_8D_HIQ
M-H)GF:V]S>W8_FJDHO/<,78"^@N:!DZ<Z^*8^K[?,Q%CH?$4*R'%S61 ;J!K
M8'QL.FM$/B>AG+S%MQ\QW$7)_318O7I:\1_9B_4T(VZQ""#<:4&]+-M2[@&E
M@6E7R\>/<[DA5'AN.OA2I? S6YV(2*#"0ESN8@'0]#21Q07,AQ\N)9,<CU#J
MMM+BG%69)I/&1]+(0DXT50/O#O5,NI5HRKA"#O.@'C:JE+"TN%D("[1D+:]/
M*L$B.H\:$U)2PIA7;02-MNM!I31A;QHH:<\$;S%M+L >_A665X4&/;]44\EA
MY4!Z!?MI6E(VN)G;C(9LIKJ'78S*.@)[7\:-;EIK<'4YKVS-"8Y)3J-K!E--
MM-X4S,-X,=LK%?ZC#VV21+'8/!AUI<,9[:2]3J=__P"/O4_TO=UT_P T\:^>
M_P K[+'F_DN?YI?^,9O_ +^3_M&O;[O\2/G>^7[W9CRG=(==+UN\[:7(>P,U
MM+7O1"Q6KEH(H<:+LL*M_CW:A94> Z]J#$"D"W?O0<CQ8]NO:A52&W* 1M?0
M[NH^5"< /$JY?K2O:,FT<1Z;K=10DP6O"92/+<;:#>]57NHT(ZZ6I4Y1% (&
MG3O2IRBBVT=S>B16092"IW&P^-5@MJ$IM'<_$T8*4'86NW76C!6B* JT% )L
M6:3*CE!VI&NO>Y/:G!UB--:XV6/2FO(94M'LZD_IJ,DU<3"Q,O&0L@#$68C0
M@_93*0^<6/%B6)  OZMJ;2Q[:U[]!TID%)!()-\-@_ZP/1A0,,;W%,)8X/[X
M@CN#03&\Q.NI[48/+P7347IDGU2H  ^= >V;]1UI 01C9KJ11@%W9V0[1H>M
M,CW$J6@RS8V$8_[5!;&  1;MXWM4X1"LDD+IL<[XU:]AW-$B*3'([Y71<<ML
M-F;<!K^2G@S<39&0P$6,R_RFN#:@DR\?RTFX;%3MN#:_HH/"AXW+9Q$T9!5;
MLP.A8]-.]&!@W@<=E+FQS-'M"D^&I*D7-8=Y^)_K/YNON>OWG^FW\JWHX69?
M,H Z$5=09X/DCP?-X_(- ,F"$E9<8G:)(74H\=[-]X-X4];BGAIK^\ O)CQY
M.$94CQ<S$SF2;TY9!F,OFCD"'8T:(JWL;BM/M"PT9/>^5D2RYV1QRJTR2!$$
MIL"<F/(BW73S;?1 :^K:]*+S#P+!^\YFYP<@./988W1U@]<7N)9)W!81*+%Y
M=!MTMK<T7F_"D$>^8?0SE?C2\^9A#"2?ZC51]*N.S$&)K^9-VA'@2:7VA+\-
M[L2+E9),?#=1EG,.QY]P$F<(;MI&NB&'0?&U^]+[14B,OWZ57)CCX[TH6)R,
M-#.6,64[RN\C'TQO0F8V33I]ZG]J3*Y?E\3-P\'#Q()L;&P4"10-,CPWV@/(
M$6*,[Y&\S,S-X=*SWVS R'6P([=ZD,/G'$0@"EKC<5-[:Z5/+^/MXI_5IS_9
M:>/;^C+R,UY-NXD2*NTCY:@UOAPVB8^6T 4LWJ1MU'\F]+!1I@^I&"#IUO2R
MTA+'R9'R9\62%M@8E)+>4@]C3+:&/01;$6'@*$94FFC12C+N#=10)3/#2 EP
M %5"+6J=KT->373JHL7O=66]0Z<,O*(E+$=$ L/MHC+9,  R8;BPW+^FM(,=
M#"RALE<C^6=/MI6L[2$P!/37K1$H0$CQ\*H6BBVVS=?"@E ]PR@ZC3[!0 7@
M8FQ.E]:(!L6R9 \=115Z[8;L((A4CK2R=% 8@:TR>&/ZA\QN/C0, 9,&VP%K
M=*5@I8X\3@JZ*5^(H3B,Z;CGBW21FR@7!O8V\*<+I+_5?4K9T5V5K;T\CFWQ
MHP=Q4PLRYD>UC+/N'I DFU5@1W/-\?-B\;'%F(R9DL6^P (V@7\UOND]A2L5
MM.AP4ILV@JI6-KVM,E66VM 1L)U)H"=H((Z4O@+X6@'TC8G3:/T5C6J_JLP(
M6YOH/MHA&<?$N@=M!'KTZU5A+\I--^$O<_LGF5=@Z A;W'Y:>L5*Y[53855@
M:G"<O/QTEA^TQW-IH#T(Z&UZ6%S?#Z+O@_L-ZGI_Y/\ 7;O2T^Y]+?;^2OG/
M\K[3/FY_!<US,L8YC.4L+^O)I?7[QKV^[_$CYWO=^]V/8V- \:%HUU )\HK5
MSX@LF)CJ+B)/G84:WI+AC(Y%O4R6M]U0JC_!%4SP#'%;S=Z!(]I>W?Y4#*C2
MPHX1W4.WW 3J?LH+(65FP0#;?=*1Y8QJ;]KVZ4%:I"D[1GZC;N)N46Y4#L+T
M(R8CCZ "P'2A:Q\G>YI5*ZZZ7TI*%TTM3@R4SW]- UP;D:=Z9;4K(IY'#"7:
M$LPW1WMNUZ7\*<&>@ICX^-BYLJA!ZZ* H6X0D]@2312R8^KY$DIZ$:RJ"=I8
MGH=*1FD:1H[NOF+BX7I3BH]. "G0EM3XZ4S1^K:H@;$$/HX\+K<!@N^W8^-5
M!DU*Q=%#==P'Y::K14"D;;_;0'BFUMS&_A0'/>Z4B3)QW2PW*6>W<WH2PGMN
MW7Z]J9O6%KT!X_>Z'47H"REKACHOA0'IV.C7L/"@)6Y%[Z6H!_B],?,_O%'_
M %J$;O%@JDFU@*3*5S<LQ.6K( EV "J!J;ZT0-C<'&W:JR:"1E[6[4UR-?@E
MOC-T(,A-_E25,-0E!U M1#N 7<&<%1IMM?XTQD51YUOW-8=Y^)_K/YNGNGM/
M^W;^1I?+55B6S8[JTO\ W@L$\*4,E% !/T(%]U[]#WIDV'EAE@%]X2/0[A:X
M/RZT\'"$2HI=ETN=!;M49*BA=!U'YZ$-'A@K<AC+:P$@I+C+SI9"1= "- +W
M/SJBJT;,0&/?4U-"S$D6 N:<#F_<$C2- 8UT*N+DVM8BIY7Q]O\ 3^J^\^RT
M_P"[^C+(/HQAM2!K\[UT//M>4E3< $_&G84IW SBEXG%T/<=1>HPTFS;A"-A
M2,OF5E^W3J;4LM/@(3&[!1TM396!YF+*RI(@W#N!0,#<2C1>IO%AU^-16O+;
M)RG&.%#':>BU+HST%Q;T9#?P_31&.]%L/4A8'HR_IK2*EZ&)R) S9EOT<_IJ
M?A9?"6!2Y/4]A3&%&:Y^[:G"JID\M@ 3XGPIDK&H))(U*]* \?AYC0$0DB9"
M="#TI".@QGWQ!>_A26."%%C3.//,+:&U,4!IU?R'OWH(%[ D=J1 SQF2/TP5
M!;LY(N/@>U$!9N!>%?(X6_4=1]C4\C  P6$Y!(%K:I][["*.(\.B@ED L[%M
MZ;&#$F]Q:Y^-&<EERDZ><CI;2WRJHQO6&.MK_;3R:Q4G^.B$@@CO>F'@OY?"
ME\!-&-"8(2 6%M1\JQK60Y!A,6#/]W^3:U!X&R7!"HJV0: T\HH/)'_@RCM]
M5_\ ZZO4XP?&K-9=S=3<@:&D'TZY_P#MQ?O]3_NE?-_Y7VWR/R7.<M!&O-\@
MV^-0<B5FNP!ON[WKVN[_ !(^<[U<<W;QM&/D\!HE].9&N-"&4C]-:L/M,B'/
MQWBV!U);RKYAWT\:<*[LO,@D7)D&Y?*[ V=3T-O&FC"I&GWD_P =?XZ !) L
MKH2ZC8=PLXM?XZT(JBXQEG:1=F[4??%OLH.1+8$Z/&JA0-=UB+_EO0+J+]*X
M\Y9 !U)-!<*!)"@UR(C_ (8I2"A^K$6'[>(C^^JL%E=IX+6$T5^YW4L'E8-#
M;6>(#QN?XJ>#P&V-C3*Q,\1$?G/F-Z,%@%)\*$H!,/,+;-2%MWT%&"PKDXL$
MD32KDPDJ/*!N(O?2]AUHP*G$QL2/SOE*'(M]V0]?\&@H)]1@D;1.K"_W@&!N
M/LH5Q+,V#*0PRMI'0>FU,N,*.;#DF>),@@I<$^F>O<=:.$3=J/R^-%$H(8J
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MQ6S&>B>%T=W[M--KMMMKPS6YQTWIZ.HT./F.OJ1?XQ_BK?[+G_-T^M_LS_\
M&^?M]3_=Z3CY&7:9(K'^Z/\ %1]ES_!I];_8?^-\_;ZG^ZAXAFVGUXALU&I[
M_93^QY_@T^M_L6>[?.W^K_N-D8,V%!'!ESHID!*L=S76_P#<J:X>\<_G<OF7
M2Z2W7'5?#,L?>>ZYLFV]QZ,_^Q3Z'&N;9D5QU&V3O_@UC[YSO_S_ (HO>N[?
MB>37_P"PBX< ('UD0OWVR?S:7OG._P#S_BGWGNWXGDU_^QWBL5$Y"!HLF&:7
M>/3C(D4%NVNVIV[]SI+;IU=I7OO=I,V<SH[-?_LP\CEL2.1@1N*D@D#30_&N
M^?;>#7RUV7;NWAW\D_N#^+03PK+&C[+[-P%P3?I3QSO!K_$N/NWAW\D_NH.0
M@W:NR*/O&VEJ,<[T?XCC[MZ?\&5RDN-D9<:#U$B4']MM\IOKI>Q[5IR=-I;=
ML=..IAWKFZ;3773.-<]?:"N/B/BK-)*4\Q3X_DUKH<>%?I>./_?M;X?^JD)H
ME,3CUD4K.QL>A &M*JFKHQB9C1*D</D(L+'M\*YIWG6S,FU_T=^W<-];C:ZR
M_2@#\3/(X4)^T7JJ]A\:/>/1V\C/W&_.T^L\>(RK:DV\+Z4>\7YNQSN7IZ>5
M5L27"5I2+[M+=:6G>,[36RRU>W<^'2[S;7:3P=J/K&M]T7^5=#FX@I.0D"B(
MQ@K(=652>E)-Z1H)PT\(<@+N6]ATUJQQ= N;@MD9<K"#U C6W*IZ5-.:L^7
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M<6H&!)Y^*8^I)$(R1=HSJ0?F*<3=2:S<'O%WNNMUV'O_ !48(5LG@]ME-OB
MU 2LW!#4 #_!:C(4EEX223<&93\ ;:?93+!S'R>#C@6T\@?4;=NX?P5-BH(W
M)\0;$RR:=;1C^$TL!3\3X<@JSRL+_P @#^&C@"'RN&GP3C%YE;U1(C[!8>6Q
M!%ZJ3!,QHN*OI-+I_P#MC7\]4$"/BAUGF'_PQ_.H#Z-9/_MW:Y]/ZO[UM;?2
M=;5\W_E?;?)_)<?[AD>3G>2CCW62=_492!8EC8:_"O:[O\2/F.^[?>[>,*&/
M:H"Z!1;\E:L->@> ;\J,=5# '\M/(,N+F1K:L22?MIM"^@T T- 7C'E/8=Z"
MQ#7$QKZDEO ?IH$AN=3Z\=NUS0K"[0CTV#KY3U% PP9N$S9I2T84HYT8Z:?*
MG*FQ3)X?-PH_6(61!^LNNWXD54J>%F@,7!/4F^GQH+!J9MJ*ATMJ2:,@..4+
M#*;:V"W/>]&06*E%+7(N#H.M&4T3#DB6(QEB+D6N>A/:C)8R+(ZHOW22=+CM
M4Y30 @&@%A_'1EG1AM"%FN-H)/R%&1A3!WEE9_O27<"UM.U&5ZZM"11Z)ZZ6
M_31EO80<&^G;M5)RE7L+'K0:0"P_@I4QX"J#776@CD.6T#6L6B8W911@VE#E
M8TI\C6/\DZ$5%AS819HH\R-)&"^JAM<Z7!!%.1-O28.?B;SOE0;38BXJSZ&1
MR?(-*L@A7=CJ=K2 K9F(T [U-3:PLN<0D1E2WE&]N@ ^)HPFMOVMC2YCSP06
M>5E&Q;@:*"QZ_ 5R=ZF;I/2=W<KT<S__ #K?S/;?,X>",[(@$>,8H9@Y9;E,
M@D1Z WN;=*Z;K8\[%#Q/;_+YG'2<AC0>IBQ&02/N4%?24.]P3?0&EPVG(1C4
MJ@)!\PO2=.FN%&CVG2^TB_RH7AHYW \MQ^$<S+@]* 2"$L2MPY0/;;>_W358
ML&8='LKW$0I]! C1F3<9H@ 1_P!VQW:2?W!\WPJN"CBAC'X;E<&'$R,N()%,
MUXAO4N T19=Z EDW#4;AK4S6SF:?2_\ C6NEG!O]#^L+B0 :UVO.5!WZ_DHH
M>%P";=!2 GNXVDPO_='3X[J\OO\ _P"SS/\ M_X1YO+^/OXY_)B0[C)(0;:C
M]%<MJME?I3($,CL2IN"#:A)WB(7'+X)W,0DR:7ZZUCWCV>WT:CG3S-O%7&28
M^7+(Y:8(FY[V&O4Z5[$ZGI',8_3XRX\9T74MXGQIGE$LT4:$3.$+#[O<_(4L
MGAGSRB:*)]18]#X=JJ)2H_R,Z=)!K]AIB]"B7M2P(NNDB^!(N?MI;=337KCO
ML=]D$;'L-.W:N'N=^ZU>K^H>WV_Z^!2,;8[IHTA]1S\^U=+@R(QZ7U)[T!G\
MP",?Y$5AO/O=/]77R_\ U^9X]6/&VO\ '74\U56.\CH+48.+ _ME/3S+;\M%
MK/;K=;A^XN+Q&EQ\B(K<$/M!.I[@U-=.NW0YKD'C;*FDB-X7<^F;$>6J8[4E
M,?/H-.U ACCG_P K3L+&_P"2A4:TSQAE*D:]J&O$%DQN8G91Y@IVV\;4)V<9
M($GF#!O.3Y@Y[WUM51SW.76^TLK%P?JX,O',WU43(JH5L0&'FW$]J;37I:N)
MA-CN_EVQS><V-]1T(J-G1K.A9TW+=C9O$>%([EE9HRXXY1(0R:%6)L0/[T=Z
M>&&VNS&2. R>N8P9K_TA^]:U4C)B012P-"XT<6N*,GA[B,;C\19TS4,KR ^B
M8[D*UM&(%J$W57EXD?#QF"[70,GE)(-C?O0,89B0RZM'U47(/@*5H)9DA9]O
MY;54(NH JAA8&YM0,)W&CH"6-A\:0RF/:VMS\J \S$D6[=Z \&;QI@168&F$
M-?=>@81VI%A]0_\ +?\ UG_<Z^;_ ,K[;Y/Y+F.;B#<[R!\<B30>.X]:]KN_
MQ(^7[[K]]MXP7 B4C]9NGPK9S\0G%INS(AU\U_R4EZKY$A"[0=2=2.E4H!-+
M7-]: )LW+Y2 3KKTH![C_P!G!+("-UP+]J!&BP! /<=Z%!HS,&4B[*;,.M 6
M<$(=NAVFQ\#067-P<WEP2LD]YX2;.C:D?*G(F[)S9.+E9),2(K)^L-0OY*,#
M+/R9Y$(W)='Z-H?R7IINR!*# Y)!4$*?Y5^HL*$R@V$A!864=3X?&A>.A  N
M3;<5U6VE]*$V8,8ZEX4=FU(UM\^])-CRQA6M8D$TF=@7($Q[;M^SL2RC6Y[4
M")XHS22-)(-J@#9?[Q!ZZ>%#33I:4ND1(_6M0TI!V#,P!^[][[:N(HC1(8?4
M0V(T(H5%0?LI53R2GZB,&VTG6ACGI:<L812Y-P-+"FTI7TRZ7)(OW7K1@I&7
MEX.5$R2R9;R7:T0;H._6C"-H6EGE$B[[.6\Q(T[T);'&9*R0F%8MJ1M=6[7[
MVI*XNA?*AWRQG=H+DK;0FA+>]J94?'YL69)&9(H)4>2-;!F0:,HZ=0:Y.\WS
M^7])Z/<OB<V^A_5UDO[P8I8O2;$GC7ZF>6-U]-FA@*;<9$5C8O#U\/C7;>9'
M!Q"8_P"\/%@XG)Q!#F&;(ADB?+ B$KL\0C]60![;B1=K'I4SF0Y1$_>-CK!*
MHPI$+)%%CLD4:F-8Y%=UW-+(6#*"- O7I3^TC>:A0^_,!<-Q+AY,N>\;1//Y
M"A0JP4%0\>JEA8FX%NE+CA\*<[]XN+D8L^,^-DR?4,[2^H(V4AL<0JNK'17&
MZGQP<(1]\\8V&V-]!DE3FCDF?;$2<@&X0#?JGB_7^YHXX.$FG*\7(,'"XZ'(
MB*>K/R$LRK_E&048>IN#L=J+Y46U3+/M-/I?_&MM)YG,^C_\H7(N0H/WM23V
M%=;SUPNUK#I10LX*@^!%*!7W@W[?# [0G_M&O+[_ /\ L\S_ +?^&KSN5\??
MQS^4946'-(NY)0H?H"M[5RUIMJO&3L /7H?LI,\'.*!_$\76W[9#_P!85EWC
MV>WT:CG>SV\5<<"HN #U8F_S->Q.IZ(D9%C;[W:F ,K%QOIWDE\TH!VMUN34
MQ<5X/!/)9V+QR6625MMV(4#3J3\ZM.IOEH..QA/A0JPGA<!WW7!*BU_RTSVC
M,B (^5"8!E,Z[=IL=PU'SJ=NI<O3'>RM?#A12!(VW;?77Y5P]S]EJ]7]1]OM
M_P!? .UMY^P6KI<*[^72VOZ*8I#EO-BZ>-8<SVFG^KJY/L>9_P!O\V"0-+UT
MO.JL3$C5KZG6@1>6P*D=K'\]-.Q_,<KF.&.A L?F+T85GH*2MN(4'04D[ SJ
M2_V4*E>BW>JH!MH;F@9-P;7F4#[PU))OTH/6B\GS"848!C,DC:*HZ:=S0TWV
MQ''M(7=G8"[&]A51R79N>V2&E8G]5;*3V!(IUOR>EUL4UELQZ=*G#JP\W734
M'I2P1?D41\24_K!3<^-J61M>ARR"4W8-Y1VHRYL=)S8HO=^AOIX495@,H6)&
M_4_=!T-OLHR)%,V-DXN, ;=LC=R=3\ZJ(WU9ZNZ'<&MIJ**C&&<U[ECW-ZO4
M91<6^-,T#1KVH"=: ]KWH(1= 3;YT'$[=.E >VT!8=Z EA<BPMIK0$6H#Z?_
M .6_^L_[I7S?^5]K\G\ERW-SL><Y(!=I3(D%_P#".M>WW?V<?*]_V^]V\9.-
MF9-;EC<$UK7+JTN(LF6I.NU7;\BFG&W$1B$P7]K*'+:KY;;1?I08A87^[;L*
M%+ DFPTH(+ZX8T,N-&BC>V\-W+=S0F[-+"YN.5+3C9)^8_&@:[K+S&-]5(JF
MX.T"WB=-*!QJYW*G'DDBVW8#2_QH&V_0Y]O,=_ZQ/FIQCKS$J+.MKD7UHJ[N
MF97,BI%&[L;65020+ZFJ^!&VPC0%PL;$HPUMV\-:DM.M$F#. 1IM)T4?IIN@
M";!;TU4'4G5QT^VC(P%CK+C2%&(,7<];D^%")T4Z)4])S_)%S^2AGM23(S2F
M0W%P#8ZVM01CCHR9&8];6-^M2TY<6YAV&,J*-7;:#TMH>]->U+X*AHR5:ZL>
MI_)]M#.4VL;K&4L"#KK1*L#2UO"F<H4EU9;=A<?EH8;WI-+F12+YB5<^-#37
M8S#L<>4WMUM35-LBLD<P$;+=?CXT*PRN4XTI9X1< ;?3[#XFDC:#\7K"MF"[
M ?4C'8^--",8RRYTDYN(S<(I.EAI<4!N\:"Z2)T\P /V5Q]Y^/R_'_1Z/=9]
MUS?HS^8[8LFZP()K9Y_ @X\JKTO\J2YHOZ;>E;PH;R*(+&_YJI55E@&TNG0]
M5[B@C?M^6.+FL(R!&C>41.' *VE_9DD'33=>GKUBN]S<O@IL?Z+!@@:1)Y>*
MC,6Q99DP(99?4#6)!F9T4M6O%-=M<=>?Z4:ZVZ[?1_K!H,#B\;VFZ)C*V:PE
MD;$DD5YHI3B1MZ?J!-QVDG3;^>NAR:SH4?@O:\.(LBR2Y$JQQG^D6-)-\D*;
MT.UC;]JW8].O6D>!1[:X.7;(&9<=HV#?MMSJX>=%:RQVVD0J3NL!?K3&%_?>
M/PL_$XT+0QQEI&:&2-T5U$?&M,"3M)93*EMNFO>]<'.UEWWSU\4_X1RZZS.W
MC_\ C'R6'FYHD55B1@FER3K7GX8[;"X63DYA9(T4%!=B3;J:53.EK<1!E)R>
M,9-I3UH[$&Y^\*QY]^[V\51S]?,V\5<A*")7^9T^VO9G4]+X'K7 %J8$2]@"
M+Z=2.GRJ83%E,N'E;T;]H-;J>O?6KA&)IOJ+9>[=Z@%_[DCJ*84!*D$&@\HE
MC68J"; $$V^=*]1R],=HI7?$/&VOA:N'N?LM7J_J/M]O^O@:GHJ7U^VNAR\(
M+&TA%OMH12G)BV(?"]8\SX^GC='(]GS/%/YL"9?,!V\:Z7#41BPU T^[:@H]
M+<@GX4XG9H\K8Y+-_<(?^J*:O@96)E&:63<!N[?*BA>8WD/RJ0&#9@2-==!0
M#V$P2<,>ATN?C0K6'LF"&:*SA7TU!UZT--IF.-R8$2:15(!4VMUO;PJHX]M3
M?"Y#0F5EM?P-"M-FO^)Y'PH7]JVN/+S8J2WL3]ZE71I<P?(C(QY0/-=3V^%2
MN]3D8F*LRD6!H8B&ZW++N5A]X:BA0:2EYM+V.@/0:?"A,IO,<#B96L&9'6RC
MMNHU3S&$QWJ>S6Z57PLR)^Z:N$\B@TS3= =;VH"00: M:F$A38VI$DF@\I \
M:#P]I>@+E" ";@$:&@K4'\OQIIR^F_\ EQ_K/^Z5\U_E?;_(_)<OSK,.;Y%&
M^]Z\K  _J[C8U[?=_9Q\IW_VVWC+0_=UZ#O6U8:[#8<SL\^W1/2<7\=+:?EH
MD.=-# .B@W(&M#7"ZA>A^\#K\Z#$4*6UH#/GN&<V"ZD$^-"-ND!'>_P'0T,K
MT+@_M%E4]"#\*"R;Y25)<LNA#!U4@CY4*NTI/8 ->M-AC%5FW>@P!M;6_A0U
M:?'13XK/,92?4CVV4VN#\Q35PJ"+$^JD:)6  &CFYUUO>@I!+,WQ%*MXB1%V
ME;66D;-R(88XW$GF(!(O^:JB-HS(YG/IJ[$IN!('C\Z&.&WQRXTLS+*-Q87'
MQMVH::-(8D2M>!0@Z6J52,GFD8/!%O%MV]@?R4T; 8JFYW=SY;4)D'R)#Z\,
M2EKW)(7KH*CJ:)W ZG[W<U4H&GQ<=N+;)M^U1[!OAI589;:LUBAL1V[T83DS
M@Y"JQ4BY;H?E0K6GF>?=^S7:3IK0WE0<261&+,>ANW8^(H1=65FPR8TBC&#+
M&R_M''>_:A.#./)##Z#![12CTP"= PUHR,.BXK;YB/Y7\%<?/OWFG^O\GH]S
M]ES/%/YGB1OO6V8PX;X$G:-;TN*>%7!MX ]P!(\>E+CU\*M=-K\%"E&TFW7X
M4OMM?#%_8;WX*&KN#T^5'V_+^=#G=N9\V^1YD#:VL2/,*7O'+^=#]TYOS=O(
M/Q<2#*%T%A'(.@Z;&TI\GG:;<[2:V7IO_&KV[OS-.5S+MK9.&?\ *-3VM[;@
MY?ZV%7B@&)"9RKI<;;%B2 /*OE\S=!I7I/&U;7$^RAG+!)!-&6D1I,B-(BTB
ML(DE544"\K-'*+;?C0N1DY?'XT&5D8Q5)3CR-'NVVN5TO8BXH3DI[RAA.;B6
MC7^@N387/[1OXJ\OOW_L\SQZ_P##5Y_*^-MX_P"D<S#BR&>0,+!6/VW)TKFI
M[P[P*6RIQW %_E>II\INQ[HW1P2"KKM;X@Z5ASOB;>*NC36;;27JM)IQ>"P#
M&,$D DGQ-=^G)SK+G;RO<YO-QO9-=.B^#_=<\3@VN(A>J^PGAV\J/M[\W3ZJ
M^7[4Y2)G5<0!8YDQV)9;>I+%ZRB]^A36]/W7MV\J?>KX-/JLG%X6?,E48^$"
M\L33H&3:6C47++N^]]E+W:7X=O*4[YMX-?JQ.5P6;Q^=+AY&!Z;PR>C,@CN!
M(?U;C2].]UU]+RT_?-_!K]6"2\9(K!/HR'+;%5HB"3UL!;K2]UU]+RT>_;^#
M7ZL-8?MOD<E5:/"&UA*5)4*3Z%C( #W6_2CW/6^'RTYW_F>C]6?V-8OM[F<P
MPMC8H/J[A!&759F](VD81L=VU#]XVL*VY?)X=9-9T.?F\W;?:[;==.8/"<\\
M\T<D:.8P2+2(=X5=Y,=C^T 74[:K[.E-BS*CZC\M2+"/*Q@8AMTT%8\SKU^D
MVY/Q-_H_U<^PNVWK<Z5T.*I566&[(P:Y&HT/A:@DF.20[%%VMJ*<+&36?&7
M#DQLT2@GY*!35AF8&%LD>0.'0*5%NMZ"&F7H>EQ4F7F;;8ZZ$=_B*,D.[HHV
MDZ@:CO3+(N/F#Z.<@6>,7_-I0J7H<\ZD&Y!OXTV(V!<32#Q7^&@^H_\ IH2Z
M;A"/PY==0Q%C2=G+ZCN\-"XZD@B]+"K7(R>5GN+$7M;YTD(CWVVJ& /6^E[^
M% !]':Y !O?[10S^%I0KNQ)K]POYC3U/?J9\V#C[7=8[2,.NM&6=8;!E8J:N
M4GE.UP1U!N*H9>D.YBQZG4VH&4@"U!QZ@QHC;4=;4%4,#?04,ZD!NXH&1H<:
M60Z)<>(I6JAU_6:)(_NA!8"U&3P WKQL4<%3X$"G*BOH7_EY_K?^Z5\W_E?<
M?(_)<OSQC_&\V_WS/*!_C&O;[O[./E>_^VV\9!V!C:,?K"Q^5;.;4S@Q@13^
MF-L:QA0/"[BG%ZA9#B"-BS /8D=_MI+R]!+&_P!QBXTU^?>A4&#@&X^0H,D5
M7U)'D7>=QV*>@H@I>9'D8M)M!'11H/S541=<EU>0%KFRWU(Z#X"]#*Z"8WJF
M2^[<K: 6Z5)<.!IY!'8.+#Q%S0,!I+<E;'3KIU%!QO95OIH]I\SVOKVM1EKT
M89\#[LV<;K@ "WA84T&DNHO^:BM8L+-J.OA2!/DUB^FD9DW.!86\3H*>2V<^
M4 ((T(()_P#50P:6),N/,LSD[$/G('8_"FK2NCC?U%#(?*;$5+5S^2QGSY&)
M5D0[ IZ^47)H1M!4VE@1]E D5G6))X2P.X[@"/@+ZTJ:JLI5BITO^>C4X?P8
MQD<)D(#<EW(^8M6D3M.ABA"5';QH8)C-CI2$K5PLQ+K'*;J2-A/4&AMK6CD%
MVC*[@H4$4+K&R\E(85=@3(UQ$AZD^)I(+<:!ZH650S#S*>P8]; T%73\0BE'
M7H+WTKA[SR9S-]9>K%>IW'O&W*Y>VVN,YDZ3TD*!;@DUG^W\OM\K?;]5YWH^
M1Z.%&/>U/W#E>#^)3]4Y_AGD2\*#I]MZ?N')^:-OU3O'SOX!2+M'2WQISN/)
M^:B?J7>+\M2QZ7UZT_<N3\V*]_Y_SZ\ QO;K8VI^Z<KYL1>_<_Y]-<;M:=2!
MH8Y/^P:TY')TUYVEUF/C?\:F]YYG,Y/,FVULQ/YF>*]P\KP4DQX^*&5LM-C>
MN"0C*K!9!M^]8.WE/E/?I7IQX\N#F#[OSL>#%A;"QWAQXRDFXNLDS%$B#LZF
M\;(D2A2E!\3'Y;E<K,RLO/R3_E.4[2$1WL-+*H)U( '4ZFA-N3GNN1!G82L;
M$XX-C_[QZ\OOW_L\SQS_ (:N#EWSMO'_ $CG99"<F5@=RDW3PO:W:N9=-^W;
M'+F)Z[!^FIV/E-Z0CR6_E+^FL.;\3;Q5T\GX^OC@"J0B_(?HKU>7\6>)ZW.^
M/MX[_-Z?U?3+1&S6Z'I5,G097[QN(D@;&."[RIQWT_J>6S9P"HDYUZ+&EK]:
MV^TF&=A/DO?F#+G-+BPY.UA(X61E_8,\*Q+!C[3Y81MW=OE1>9$G,W]Y&%/,
M7A7+]/Z\YKPN(B'5G1]6+$[D"%5L/M%.\R -_P!XO'9?)03YD&9-!CR"4(7
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M]EGB58FN5N6![TYWS3TO(7[?S?#K]:$4@9D;UB-Q%@HJO?=/2\@_;N9Z/UH
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M2@8$8L&L/NCO5&\&/A02P;\_6D'D0/F8Y(Z."#\17/WKV=='<_;:^-J-$ ;
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M)IH%&X'345UO.L6ZBDE6QH--C0%@* L0;4 ^0/P;'?N))!;[0:FJE*@^:]+
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M+#7I084[V=1WJX%TN1>B!YU5AM874Z44J+&%AC)-PHT514,K4@F_]]3 MO\
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MZ=+W-/ 23?M0 W)V,-VTGI:FQW4B$R'=#(RLOW3X4)E;7"\MD394,,A9YO5
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M*-@Q"?U+NK@^5U-C^:F<E/+FY\",8\EI-B[MLH# 6^-3A;4]'&Y7!6>,J92
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MMU_JY\\OR%[GTP1_^S&/_9KM>7PO#F,Z]RT?_P J/^;0.%X<KG$_?7_Y<?\
M%0.%8<KEE=62_?\ 9I_%3.ZJCD)P21L!/?TT_BH3PBP<G#ZZOEP1S)T)5520
M7[JRVJ1PF)9(H0'PM(7-ED8#??J0?"B]!\(7U?( %FEL.]PM_P!%$I<!=>0Y
M!(U<?KDLI(!TZ=+49/@:>//)+LG:4B/:6"*H%V7]6]1;TKFHF%F9<^0Z>H2E
MB54VJA)TB/D9 &VY0WUZ:T#:=*T>3*G0V)\ !K1@Y%H<N9I7#&[#I>E1(GW!
MD92K@N)-J-$;V U*GPIC9GP<SGC]F'_9C6VGVT%-K2F?RV1)',_K'TW<*M@
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M7]43&JKTDCB]/3XW8]!THF^5P/"_>FV-[YP_=GX9O^@X^/ &'ZUM_IP-!O\
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MT$3",LUBUA<#O:A-9KJ1>YT.IDZ:#M52ETAJ\0;T@B@VOI8^7XU60A5?(<B
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MGG92UHU! 4C4GX46DW\'#BQ83K^TDU8_#L*DX))L]-B=+#QH;5ES-=5( Z6
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M%R88@&E:4, I'W%'QI$W8U (^ L/LJ@KE8P=?50#U(]0?&W:@+0F/*@ Z/\
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M3H5/B;5IR=[M+Q=<N&'/Y>NFTX<XLSTB1N HTN/$5JB+^8=M#06 VCVM<]*
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MW+C:]U&,BL]R?Y5D.E1PT<+1]J_N\ARN?X'$YG/Q88>;1,F#%6;_ "J2!U+
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M,2IXS(ERN2CCN5COHJT%-ND63#F?DS-(RE4)*%="1X&DHR)(%F= 2KL 1?\
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M>_QHC/:+XF-&(BA9F/8DT\+UTRN,(,?OZ#]6WA2.:8-1I9?GJ:&D@@*A&#$
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MW7\!?6@\!R.3]P%/CW-,Q_I'9+F0W:Q^0I'A=<-59'/FMH0:"P1S0%R"H&@
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MQE2>YM3D!)\R1XA&[%E"!0.B_.PI@!@&B$=V 4WL#1 JS9:W*OO6VB-U_+3
MASHP@ONCN;;6%^E3PGE49L<DH0$AQ]UB-&^5&!D27-6%]DBEFMJ!VO1@96AS
MH)(I%7=N-KW&FAHP,O"6QNMP?C0*-BP/.65=2-3VZFE5Z1I^N(LA,=S82+:.
MP_67K4X7AV%C_8:U]?KNO^JU\_\ Y'V'R?RG+^[O5?F)HE0N%9VTUM>1C>O=
M[O[./E.^S[[;QN?D.VYM=1]XV.E:X<U@:9"LP6,DD]  =?S48+I,K&74K)&3
M;H2+48&&[[>B48O*>6S#'4"_@)5-J[.[?%W\7]6>_P  D<1<W&@(U(ZWH.0<
M"]E(W?*D,+HALQ%R .HU%"H6]P0NW(@ 7_R>+Y?=-3WKXW^D7R^I]$]M\KQ4
M'%80Y7G^*S^!AQRN7@<E%;/QM#NCQRHW,/Y.M3KU+)>TL[A,W"]F99Y3$XZ'
MV_R&1)E8N4YCE,4KEH3&MCN\MKZZ4M?@-@\C[CF7V_PV%Q_*- 7Y_D,G,2"4
MHQA,X,;/;]0]11;CRAT?*\KQF9[S]U\E%[@1'B.-]'')F28N+)#& 7;U8@SO
ML/\ W:]:K/25*YV;'RN9[DQ^ ]R8O$9<_+P9XSS,8(I\/T%&Q)5!/DD!8H>M
M'B(][)]P\;C>WI(/Q/#S^4P^4GR<O-SLF;!3(0_<E4HI,R_J[&%&M...]M>]
M>*XKW^GN+*A6+!3+FD?'Q07")(&4&,-M) W7^59YQMDVWA\A[6]ER^X?<;<]
MC<RG,P9,/'8.*';*D;+.Y3D*WW GZQ-7.BY)LXON[#DY?#QART;<0GM-L>:
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M8<B*4VN-Z=5%M*!Q"JB"20A0IN-*FM(F3:5*D"WA2RK'07LNW:+6_-1E,U,
M+L4$7L;T958SFBEDC+*[ ;W-EU)N=/LJF=1+%,V/'!N\\C %K6('4B@FOA1*
MGF M%':WQ8=Z%R.EX3-Y/"P<A,7*DQ3FH4R'B\KM&UQMOU%Z7%9U-,%\3&CA
MD.*B;8$ 9.][]OLI9([Z"G6P^5&3P@XT!'W%4GP%&1AE\QC)]#,"HMH;@:Z&
MG$[:N</FL.@^%6P-QHGTKRN09%^XG2@F3E'()4(K2&,B0.187^(^%/!91BY;
M+)L860F\G8W(OTH5K6HMOY1!-K&AMA<M&5*%K]Z,%=2N?E3+L,2:7 OV4#^.
MA*@D1>-D.7.5NZMCJ 6):]B+?*G"K+1BS'9]T-99' N?LIIPT.,AR?7:<R$@
MMY]+"UM+#PI6KFC3D>9<W'6)]B.&:07U-JF*X5,K)9_+I<C[UM;TTV$P[N?/
M(6(/0^-"(S>46^2L84!MFYF-B;7H7 G"A060>F+=M;FEE-&ESX%D$8:X%BVT
M$JI'0&U--6Y+(Q3%C)$Q:24>I)M;I9R!^:C UJD&),[,5L4!T).MCWJL*^%L
M<?CG(E02:QP(5E9]$$=QJ;];&E@]DYXC^NF]*QAOY&M;3MIVJ:QG6GD;AHS_
M '(_10-NBE;D#YT8)I>WV)Y&(DV(;3\E%7K4P$6E9NE[5E:TD+R%1\?G3E2]
MZBLP*]0+CMK5##0Q)%,,I+2EBMF+CR WZ"@8 RLF.!"SDD=!;4F_2@F0O[4"
M>4;8Y9-GD-MK W\U,1TD\7K11,&NT+;A?N+6J<M[KF,SZ48[;%)._7;UM>FR
MX<"28N88SM0@GN0=/LH*T1$>- &-R.K#O0BT#.(^EDW'H/X:!TO<7+'D<AB1
MAU2)6#O*6VJ+:GYT'*>YC_)WE9<B!T5NFH)W=+:BA;/C9DDC-[);SZ$6/SI(
M.QMJ@OW'?XT*,YH RY;DZL=: 78 @>/PI4!Y*03XZ0L2+2 FU[D4X0T?$>E@
M*LPC4,28T?5K'7<>_6F:=T;8YZ^I&.A-AH-=:#99Y: R%?3:X_54AM/&XH3:
MIDY\$L$@C))'30V^V@97AR6,(>,AS^L#TUI4/!63?(6+JUK*>WPTI&E%5VM:
M@&\3'.\E$OVIG(V>"XEL[G^.XYW/HYDZQRVZA.K6^-A5Z]:\,_WCR;<GS,TP
MB^GQL=FQ\/#2ZI%#&=H  [GJ31M4;%H^1Y_D\/ ]LQRODPI.3@X0(),LIM;<
M=;42I'QO;_#R>X#P&5R4F'D>H<8YHC5L<9'3TR/O[=WEW7JL9!GD/;F5A0&?
ME2<7\,<\?,EKO+D;KJD=]+%?-N/:E=,*D,CVK-F<#'S'#&3,B^H7#R<.0*L\
M4SFT>HLK(_8U,TRO)O@_8T7(^X>0]OR\@8>9P$=A!%&&26:,;I(%9C]Y?&G.
M7FCB9_*13<G["]L8>-&QR)>:S,>*-B =QVIK;\]:683MTB\;PO&/CYT)SW@D
MP%<Q9,T:IC3R1:-$I^^&)^[UK/A.:L[CH!EN1)+]+!'"9LK(E4L(E&AT74W)
M %+A%D,R\/&(\7*Q\V*7C\MVB&6RF(1.@NZR(23>QTMUHX"PKE<*LD$<V'D&
M=!DPP2[X7A*&<[8VLQ.Y2;]*.$8;'#^VL#']Y?AN;F19/I0Y8R&2)FC$B0N
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K^&_V1_\ H;?7_P"G=?I_R_P6^-8>;P?!\?TL]7\W5YW'\/L_1Q__  __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>n257410kimg004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg004.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@!W '! P$1  (1 0,1 ?_$ -P   (#  ,!
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M!7*)U5'IWNFCK&PJ\C-S)=RWZ5H=WP?+A>+;DE,XQ7G20:)4?S'75+(5"(H
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M:0,>VSM>_4=I%[4E.K%3,\JWK$Y9Q;?=IQM4<F;"PCF':DLDL>0Q:X74->.
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M/=^^7YQ0#OH H H H H H H!-;M_XGY#_F!_PL%3,YJM_AK^:1C':=-0S(*
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M?M- -7:?3?<,' ?.WW<CEY"1%QAQ(J0JVG[Y[:VTGV6H!E4 4 4 4 4 4 4
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M]+2R#QJ_&=[!#[NVL*\[Z3>U,*@* * B8?X[G_6)_9)0$N@(F\?DO*^K;YJ
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M^5=+UR/*GTEOGEBR]F?)*/0_I/.?K C8:[WLSBQP=TRI(U4DQJD\\#H!?O\
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MXL&9ZC[;NC:ER(MOD0)<6M(')U"W;7SO@O$;EJ,\HJ>'.>)O;6*HJ<GD.O\
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MHV[3;5I[3:K_ (1!6K-W,O7!88_%+1U(U7'5J(WHXXXHUCC4)&@"HBBP  L
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MFH"70!0!0!0!0!0!0%%QC\:W_P#S-_\ #P5.SO=M_A_U2,8[2]J"9!0$2?\
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MS&?!(8LW!<OF-%Q-P_%MF<=C8.,1\1A6M^75+<?A781,ZZWYOZ\NTM:W$4*
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M$V+ H7V>5EL2?E\T5 ^68?\ W-A_5N?R,N(S_P#K[T?K0?6.7U7Q3D^G.]J
M3Y6.,DA2 ;8SK,>WNM'UJDSL,5J2Y#5PV[X>8A+=)&4]0\R/<O3SB.2WX1,C
M/P#*&46;\!)JNO9:_=4+-3Q96+WX2SR%MV\]*.['V,5GJ1LDN1ZX[H<:08YD
M@EPU"IK)6;:XH45$%AVS&K6UQB%FU?RDHM^/@IN36_H2--G(RG:MWT_N\3YZ
M-?2/7T:W0;CZ=[7(=7F0J\4FL6L0Q8 >T*K 5!X:_L4O=JNAFGC4:9F3]ZCZ
M4CSAR3;H\SU0W8O&TLF'B[AF8X2]P\.;.=7A[0JZB:GY.&+A6=7^]$FW+F',
M95_47:.G!RXHO4/A^^7#_G!LPQI&E\$GFP $RR,;ZV?S%07ZU4*Y]I:G[T:=
M1Y*S]EF+>KPYI];1F_77<,+>?5C@?%)XO-Q8LN-\XFX#>]30KY8(/[1+GIWB
MNWX!)2AFH/\ _P \NLH)PE!0N+W]'D,#O.T;7A\2X]RR;5'E<;Y(NWY4-KRK
MA"3SD#WLW@>)M.H==1J+\EYIPE=RM:*]CBOB<:KSECQV#FX7*?Z<6^FGH/76
M/D09,$>1CR++!,H>*5#=65A<,".T$552BTZ/65@J>50-!Z]<<F6)E3+PQJF
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MV24!+H")O'Y+ROJV^:@)= % % % % % % 47&/QK?_\ ,W_P\%3L[W;?X?\
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M7)O=;G_*,@   #H!T J<4X4 4 4 4!$P_P =S_K$_LDH"70$3>/R7E?5M\U
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MRUMW]&M7T7)3_,Y"YE]<[;\2/-JEU:3BI:))[]!FO7&;)DYX\C6./M^+A ]
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MU-8]37LLQ-IIO0Q0L)_RIB?5S?/'6D])= % % % % % % % +_U36+(W+B6
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ML2&"Q822Y(,4:$!D.DLWBLPLMZPS%U0@Y/4;<G8E=NQC'6V8W]''&@@X=F!
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M:W__ #-_\/!4[.]VW^'_ %2,8[2]J"9!0$2?\J8GU<WSQT!+H H H H H H
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M(X].=[2(DMDPKC)H :_O,B0V^(^98_!7F<N8;4I<A!X?:QWX1Y2L]"=U]_\
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MJ!TOUJ9">*">]%;=MX+CCNE3K*/T@%O3O:%]B./_ (K5#X5]PN>7\S+'CO\
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M/-'W)G%.%?X\?+VL\XZJ9N7D_E1L:L2H%+R('_ZE.*'N&R98^Z9?V*OLG_\
MGW_BM]IJEWT-JJ$VA0!0!0!0$3#_ !W/^L3^R2@)= 1-X_)>5]6WS4!+H H
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M_F6OQ)&J/?8XJYTVA0!0!0!0$':NW-_WJ3]:@)U 1-X_)>5]6WS4!+H H H
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MN7,]K!#^Y[O*?, T@^:[MIT]VFU1<FJ7;B^LGTF7$I8K-F7U6NA_23?6C?\
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M&$5^@Z597\].>5MV7%*,')J6--NN^.N-.769RM6TE)2K)ZXX:4\NT:-5I@%
M% % % 0=J[<W_>I/UJ G4!$WC\EY7U;?-0$N@"@"@"@"@"@"@*+C'XUO_P#F
M;_X>"IV=[MO\/^J1C':7M03(* B3_E3$^KF^>.@)= % % % % % % % % %
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M8N?W4O5G\,M!S_A^(FEWM:YT8OU7Y*W,>#>GO*-OR$BSURO>&"#5HS(E3S$
MN2-,BD]>ZMN;ST>#W;]MQ<U.$X1?Q+U9=#1)X=D?S<DJTI1]>D=7IIQH<=X;
MM^ T/DY+)YV4A'B\R3K9O:5%E^2N<R5EV[23[STOG9MXGF5>OR:[JT1YD47
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M@   "P'0 50FT* * * * * * * @[5VYO^]2?K4!.H")O'Y+ROJV^:@)= %
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M/V*HT:G/?T%7\)5BF]QR-V%)N*V.@N/2L?G#RWD7.;NV)F,,3;'?O@2UK#L
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M6:KW=&S5 ;0H H H H H H H"#M7;F_[U)^M0$Z@(F\?DO*^K;YJ ET 4 4
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M+\,4''>BJREWP[L9;FA90[S&.-^G?+HK%<.3[.W"4 $QQ.+6E*JQ"J(CIO\
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M=;M6.?NN-ND>]+0C;PG+J=[%+N0]:7D-9Q;8X]BX]@;2A#>Z0JCLH"AG[78
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M*FTK>00H H H H H H H"#M7;F_[U)^M0$Z@(F\?DO*^K;YJ ET 4 4 4 4
M4 4!1<8_&M__ ,S?_#P5.SO=M_A_U2,8[2]J"9!0$2?\J8GU<WSQT!+H H H
M H H H H H H H H H H"/N+,FWY3*2&6)R".A!"FO&>K68'T%Q,J'@:Y$[*
MZYN0T\+!BS%1%'$==Q]+7&U5O"8TLUWREVEW\P2KF*;H1757SC&JS*,1^V;>
M?S,YWQ6.\C;!ERY> '"DZ(9#*EV079F$/7P]+U2Q@IQO6?TTG37;N">7S"VJ
MC_9T=C.O@G'L;D7I/R'$1/-F,\F7@.1=Q.L2S1$$@FY)TDCVFM'#+;N6+D9:
MZ^9$KC-Y6,U9G'4H]6)C0].=_7?>%;3N(?7(\"I,223KC\#$DEC<VOU-7&3N
M8[2;UZGSHY[BEA6LQ**[M:KF>E&7F;%@]8]TVG)L(N1[1'8>*SN \1# "Q/E
MP'O'3XZCND<U3WX=A*C661JO].Y7R/Z:'9Z#Y4HXED[3D!ER]HS)L:971D;H
M;78&_B+!C;NIPU88RA[LGUZ3WC;QSA=]^"Z5H.O?X6VWUOX_N15DQMUP),-Y
M0;AY8B^E-/: /-4DU[?6&_;EOJNHQRCQ92[#=AEUDCT@AR,E=^Y!D3-*^ZY\
MAC_")(@B5V>+25 /1)0O7N KS(>M*Y/?*G09<6>"%JU[L*^61&]3$^V^:\7X
MN\NC$9VS<R-7*M)])$6P9>FA)3V=H%NPUAQ"6.<+7O.KYD;.$1\.U=S&V$:+
MGEH&:    + = !5H4)F=QX1'G\WV_D^1EEDVZ$Q08!C!4.=1,@?5TZL#]'[T
M5%N9;'=C-ON["=9SOAV)VDM,Z:>1;#35*((4 4!"WW%7+V3<,1B57(QIHBP[
M0'C*W'W:\DJHR@Z-,PWH%GG,].,0DM>&61"C?>E@LFD?UEZK^%Z+6'W9-%U\
MPZ<QB]Z$7U4\PQJL2C%?LQCV[UVWK$  ^T\*/)6[F]RB ^$CJ;X[=/956EAS
MGQ0["]D\?#EOMW.IC0JT*(* * * * * * * * * @[5VYO\ O4GZU 3J B;Q
M^2\KZMOFH"70!0!0!0!0!0!0%%QC\:W_ /S-_P##P5.SO=M_A_U2,8[2]J"9
M!0$2?\J8GU<WSQT!+H H H H H H H H H H H H H"-N?Y-R_J9/XAKQGJU
MF2]&!I].-H6][+(+_P#O&J!PS[E<\NUEQQ[_ "I<T?Y4;:K IA:[/$=J]<-[
M@EN(=\P(LK&+ G5)&%C=5(Z!0L))OWU7I*&:K[\>PMW)W,C3^W/JE7SD'T2R
MRN\<NVB*'RL+"SY?)B5-,:*)YHT"DCJ#'&H[;#36GA]8W;L5W<5?22.+4EE[
M$WW\-.=;&2O3'%R-BYOR[C0CD3;HY4S<&ZVC"3>*R:0$'20+8=R]U;<M%PO3
MC[+];TF&?N1O96U/VXU@_-YS1<IXGN&Y\KXWO6#,L'V7+(,UBS!F@?2VE0.A
MU:"I^!JVYG+RG.$DZ87U$3)YN%NW=A)5QQHN?84''O+VOUGY#MZQK%%NF/'F
M1@*PNVE2Q'=XW\UF/MJ/!X,W);)QKY43+J\3A\9;;<VO(R+Z_9,^T;9LG)<*
M5X=RVW+DBQ)%59%4Y$#,69&!#>*!;?+67$JJ,9+6I(PX)%3G.V]4X-&K]+]M
M.!PG;HV0H\J&5@R*ALQLA(7]P%K9PVVXV8UUO3TFCC%S%F94]GU>CZ3+>G3K
MRCGG(N5SM=<"=L#;XPQ952.\=R-;:6TIJMI'T[]MZUV%XF8E-K1'U5YR7G7X
M&4MVD]-SUY>9#3JR*$* * * * * 5WH?KV_\YN.39$4TVW;KD.NGH[!W*LQ!
M-]/@ '2H&3E2=R.Z7:BZXK2=NS<6V%.AOTC1J>4HK?4*)]H]5.&\E7S/(RO,
MVG*T*K %S>(=>]_-?X@M0<UZLX3Y:=)><+7B6+UKZF+]UU&E4XHPH H H H
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MYW_+9OX<'^LIB>X>##WX]$O09CE\NYMN>PY<'%WW*;'S/%,S0WA1D,9?H7N
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M"DPX^6JJ)& N421&=2UNH'0FO)6Y1UF4;L9:C?UK-@4 4 4 4 4 4 4 4 4
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'D2O4Y#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>n257410kimg005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg005.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!.0)P P$1  (1 0,1 ?_$ -D  0 !! ,! 0
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M;%4E%K'N.2@Z4O%4S6&KMPQC.%FWE$)(R%FF*QLPC)5N9HDDW=LE'!3J-A
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MEJ\'B%EM27V$G]6\R+ZW;3KDA!.DY?65?D*IOOJI"Z-Q#K(9FBXL3) RJH%
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MR*[#TK"I.;?;X[E,MNKHE".3.J\M%D::>D*FP28I*]%11S-2B9 2*;@83J@
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MB;B3)9>G*9/4,]:RM$84T47[M-%,3..$4TUQ$1C,SA$=<KN  *
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M)@,!@1I*?C%1_P M-J?:G3F1VLOJSYX^5S&?C#=_RUU9]J-Q9*.STI*P@P&
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MP8G548Q4:C)/WJ,-"LC+FZEDS*@T2 >!$P  X!+V P& P& P& P& P(BU/\
M[1M;\W;-_NJO9$,ZNSS)=R6!@,#R _8F%8"O6AA;NDV+@ <HB*#Y4$3),U@
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M%BH02]>9V"!C-@2' S8P& P& P&!$6^/PGMW_DQ7^_HK(GJ94?22[DL3 8#
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M<#SI59TA(QDNA2]:HRT+&$A8>32143D8F'2(8B43&/25X'+",3(<0*@D8B0
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M.@)A,8P2$2&FDRB0E9H)""M'N!*0[LI1<1!$$XI<2A!  K1B;9,K<W[2()E
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M P& P(TE/QBH_P"6FU/M3IS([67U9\\?*YC/QAN_Y:ZL^U&XLE'9Z4E808#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M-LM$E<W5J&?;.#1THSG:TY%)>8@6LND=NG+,BJ-3* "2X-G8*-4PV;X# 8#
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M2(<D0EZM:H@RI4WL8_10>-5!X')P$IC!/?IBS^IY^WHSXL!Z8L_J>?MZ,^+
M>F+/ZGG[>C/BP'IBS^IY^WHSXL!Z8L_J>?MZ,^+ >F+/ZGG[>C/BP'IBS^IY
M^WHSXL!Z8L_J>?MZ,^+ >F+/ZGG[>C/BP'IBS^IY^WHSXL!Z8L_J>?MZ,^+
M>F+/ZGG[>C/BP'IBS^IY^WHSXL!Z8L_J>?MZ,^+ >F+/ZGG[>C/BP'IBS^IY
M^WHSXL!Z8L_J>?MZ,^+ N%DJY7:HJNV@L7)RB*K05TW(HB!C !>O1_T:G$H
M/$/U\,#U8# 8# C24_&*C_EIM3[4Z<R.UE]6?/'RN8S\8;O^6NK/M1N+)1V>
ME)6$& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P/*
M^?,HQD\DI)XUCHZ.:N'TA(/G"31DQ9-$CN'3QXZ<'30;-6R"9CJ*',4A"%$1
M$  1P/EUYD?%4YI?$HW!:^0[P,$63R-K[ONWS.>)K.M%5-):+CGHG;R,5I:1
M%!=O=[^JT!7S)^W*N=4Y14C$CH@,PS#:IX:/A.<L_ADT::;:T0E]E;XV.;TG
MO?FCV:IZ<W)N*R.7 R,HYE9QXL^=0=:6EU#N$8ANN9(%!!9RJ[>"H[4#:!@,
M!@,!@,!@,!@,!@,#SO&;20:.F#]JW?,7S==F]9/$$G+1XT<I&1<M7398IT7#
M=PB<Q#D.42G*(@(" X'S(<SG@W[_ .2_<%FY\O GM\1I?:LJN$SNWD*L[CJN
M5?F68('4</F=?@7#QE$Z\N#@JBGFB2:S%BDJH/F#N&$5?. SC\-+QF]&<^\K
M-Z$O]9GN5#GTUD#J-W+R<[B*M!7N)F(<A?34GKQ>7:Q2M^JR0""XBD@E),VY
MRJ.6I$3(N%PW*8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8$:2GXQ4?\M-J?:G3
MF1VLOJSYX^5S&?C#=_RUU9]J-Q9*.STI*P@P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P(*YDN9C1/*'IZV[[YC]EUO5.J:4U!Q-VF
MRNQ12.Y6 X,(6&8($7D[#9)A8G5,8UBBX>O%AZ"21S>3 ^7\0YZ_[DB:'C_B
M3R%>"2:2^#@%>YF.?6#8.OA^!RWJVJ)@Z/\ _9B0#Z9<%_\ 3P^H#ENY9]$\
MH>GJGH7EPUI6M4:II;46\+5JRSZA([E4""_FIE^L9:2L-DF%B=:^DGRSAZ\6
M^6LJ<WEP)UP& P& P& P& P& P& P& P-3GB6^#]RT^)%%0EOG%Y[1/-;K@S
M:1TGS?:>5-7-QZZFHHYG4*D^DXUS&.+A56;[@IZ/=.$UFPB<[!TR6.980UC:
M,\6;FQ\,G9]6Y-/'<@FK*LSKXM7Y>_$\HL6X<:/W$@T'JF+'=?F3!LG1;F5@
M4AWCTS=LJB/%5^T(V TNN'U$0DW"V6'BK%7)>+L%?G8YG+PD["/VDK#S,3(M
MTW<?*14FP5792$<^:JE5171.=-5,P&*80$!P*I@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@1I*?C%1_RTVI]J=.9':R^K/GCY7,9^,-W_ "UU9]J-Q9*.STI*P@P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!J_\2[Q8^6?P
MR*-"N=EKR^R]\;''T;HCE;UF3TWN3<=C=.0C8QM$P;-!^Z@ZTM,*$;+2[E Z
M0*"*+9)V\%-HH&JKEN\*KFD\2?<%5Y\O'058OXZ =&L7+)X94&Y54TEHJ.?B
M1Q&RNYXXKE=O>+\HS!+SU@Y,N=50H$DU3H@$.S#ZBV+%E&,F<;&LVL?'1[5N
MQ8,&+=)HR8LFB1$&K-FU0(F@V:MD$RD33(4I"$*    &!ZL!@,!@,!@,!@,!
M@,!@,!@,!@,")-YZ&TUS,:OM.EM_:VJ>V=671B9A9*5<XI&5B'Z?E%!RD!^B
MYC99@J(*M'S51!ZS7*55!5-0I3@'R[3?+CXB']OC,2NQN2!.^^(!X4QI!W/[
M&Y,[/*NYSF!Y6X91P9Y-6/0\Z9N]>V.IQ34RJZK9)(Q!(4POV0GZZ<('T'\B
MOB$<J7B.:;9[LY5-FQUW@"BU9VRKO.JBMAZUGW"'7C6-BTY1PM(5N8(4INK.
M(JLGI""JS<.$."HAFK@,!@,!@,!@,!@,!@,!@,!@,!@,"-)3\8J/^6FU/M3I
MS([67U9\\?*YC/QAN_Y:ZL^U&XLE'9Z4E808# 8%.F%%48B450DF4.LE'/5$
MI>11*YCXM0C90Q)%\W.[8%79LC!UJI!71 Q"B G)^T :WX7F2V*VUAH[9\K>
M8R],']4FFEO@*"OKUM=;_?R7F(KE>5BZ>[BYAW)P2Z)EDW[*!<M7[8S@#$,<
M2E# \K#?N^)!O"R=3MU>V%')1FFK1/MVD= ,I-[<MA,Y]:P:1@2L(AXBZ1@T
MH#SA=$W53\2W>)N';LR"*O3#-+0&R@VKK2)M2CQ9_(F<O64RZ.PCX]F:534*
MZ71B"1<A*LE8=HD\31;F%PJY*5/JW?0>$<)$"37\E+-7 I,ZZZDD.K(8'2,A
M%MB"<W2Z2?5.W2*W$G /+PX#Q\F!XO35@]3G_:\#_/X#TU8/4Y_VO _S^ ]-
M6#U.?]KP/\_@/35@]3G_ &O _P _@/35@]3G_:\#_/X#TU8/4Y_VO _S^ ]-
M6#U.?]KP/\_@/35@]3G_ &O _P _@/35@]3G_:\#_/X#TU8/4Y_VO _S^ ]-
M6#U.?]KP/\_@/35@]3G_ &O _P _@/35@]3G_:\#_/X#TU8/4Y_VO _S^ ]-
M6#U.?]KP/\_@/35@]3G_ &O _P _@/35@]3G_:\#_/X#TU8/4Y_VO _S^ ]-
M6#U.?]KP/\_@/35@]3G_ &O _P _@/35@]3G_:\#_/X#TU8/4Y_VO _S^ ]-
M6#U.?]KP/\_@/35@]3G_ &O _P _@/35@]3G_:\#_/X&@+GX\:BZQ>Y%_#O\
M+G4B/-GXBMA0<,)TS!_&S.B^59J=0C-_;MVW"/?E@_358%8%%HD[M%LR6%,C
M]<JYDXYT%\^&MX/+/E.O4QSA\W,W.<['B2[+)Z2V#S*WZ1AW\3KQ9\V,DXI6
MA8&4<HIU&N1C17S(L@5LU>*MBB@V2CV!@8@&\3TU8/4Y_P!KP/\ /X#TU8/4
MY_VO _S^ ]-6#U.?]KP/\_@/35@]3G_:\#_/X#TU8/4Y_P!KP/\ /X#TU8/4
MY_VO _S^ ]-6#U.?]KP/\_@/35@]3G_:\#_/X#TU8/4Y_P!KP/\ /X%@[+W7
M7].U)]>=EM@J=78*(-U9)_+Q"AEWCHPD:1\>S:NEWLC(NS /5H(IG4,!1'@!
M2F$+;1-"U?B/4*=+T2Q7F,]7$S%-.$81'7555,Q333';5,Q'9US"JUG6]*X>
MR%6IZS>IL9*F8B:JL9QF>JFF(B9JJGLB(F?1#P:JW_4=W5HENU:4EL@Q<K,E
MUFLM$M7C!^W AEF$G&/G+:0CWB9%"&Z"B9>D0Y3%$2F 1^VO<-ZYPQG9T[7<
MO7E\UNQ5$3A,54SU54U4S--4=$QC$]<3$X2^6A\0Z+Q)DHU#1,Q1?RV]-,S&
M,335'73535$54STQT3'5,3'1*3?35@]3G_:\#_/Y1KH]-6#U.?\ :\#_ #^
M]-6#U.?]KP/\_@/35@]3G_:\#_/X#TU8/4Y_VO _S^ ]-6#U.?\ :\#_ #^
M]-6#U.?]KP/\_@/35@]3G_:\#_/X#TU8/4Y_VO _S^ ]-6#U.?\ :\#_ #^!
M\\O/#X+]S<;F><_GA/V57D8Y^8SKI2PQ\2]@V_+GS/)"X&0E*QN:ALCOHAI)
MV14@ I()L%V;MP/7/6QG70D$ C30G]RMKZI[)U9RC>)5IASRB\Y<I<;!K3:D
M>RME8L.H*G88@K!K6+=(3K:=E'=-J^S95RHDQ0D%W LR)@X,Y78K-WBH?2-7
M=B-[@Q-)U)G'VF-(NHV/(URWU&;8E<(F$JJ!G<;+N4"K)&#@8@FZ11^$,"O^
MFK!ZG/\ M>!_G\!Z:L'J<_[7@?Y_ >FK!ZG/^UX'^?P'IJP>IS_M>!_G\!Z:
ML'J<_P"UX'^?P'IJP>IS_M>!_G\!Z:L'J<_[7@?Y_ >FK!ZG/^UX'^?P'IJP
M>IS_ +7@?Y_ >FK!ZG/^UX'^?P'IJP>IS_M>!_G\#MK5K@[4W<*1$K#OW$>N
M9I+,XJ:BII2)> 90/,Y!6)=.T6[G@F(] P@8/+Y/(.;.9R6<R>[^+LW;6_3C
M3OTU4[T;:=Z(QCRQT-;+YS*9O>_"W;=W<G"K<JIJW9V3A,X3Y)Z5R9K-DP&
MP(TE/QBH_P"6FU/M3IS([67U9\\?*YC/QAN_Y:ZL^U&XLE'9Z4E808# 8'X5
M23634163(JBJ0Z2J2I"J)J)J%$ITU"& 2G(<HB @(" @.!X$8:';F:F;Q4:@
M9D==1D9%BU2,T4<D!-RHU$B11;G<$ "G$G 3@' >.!Z$63)MTO-VC5#IN5GA
M^I;I)=)XX P.'1N@0O2<K@<>F<?E&XCQ$>.!VH-T&J8(MD46Z)3*&*D@F1),
M#*J&55,!$RE*!E%3F,8>'E,(B/E' [<!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,#ROGS*,9N9"2>-8]@S1.X=OGSA%HS:MTPZ2B[ERN=-%!%,H<3&,8"@'P
MC@:CN9WQY?"<Y2W+N(V9SE:RL=N9N$V:M%TRX?[PMQ'JAB$!B\8:N:6=I#NR
MBH'2(_<-1+\ ^4.&!\L$SXO/BQ>*+X@FY?#OTK$[.Y4=/[P:52N0-@UI3HV;
MVIHC2;-ZG+26[I&Y23RND)%;6I4QTW3]C(QRJ*;AF2,<=80Q'(?9-X?/AN\K
M/AHZ80T]RUTKS!:2.C)['VA9#H3.U=O6D"G%Q9]A6X6Z#J37%990S9DB5"-C
MB*&(U;I 8_2#/3 8# 8%GV'85!J)#GM=WJ-9(GTNF,_9(>'Z/1#B8!](/&X\
M0_5\.6.3TC5M0G#(97,7YG_=VZZ_V8EH9O5=+R$8Y[,V+,1^G<HH_:F&.-IY
M]^4"HF52D][4QXY2 >+6NJO[2N<2CP$J85UC)IF,'ZNEG99'E1S$U"(JL:5F
M::)[;D4VH_\ ,JIGN<AGN:/ .GS--[4\O57'9;FJ[/\ Y<5(F5\2S4LN<S?6
M>K>8#:[L3 5#NEJ^2*Q7$W[!@>R2[4Y$SC_WA2\GZLZ"GDKQ!EXW];SVD9"W
MV^]S-.]'HIB?:HJN<6A7YW-&R6JYZOL]UEJMV?35,>QUCS3\XEOX):YY%K/$
M K_J9':]\A:JB'$1Z)EXT[=HZ3*(<!_UODR?]"<NM.^=K/%-BYAUTY6Q7=GT
M58S'<C_6W,#/]&D<,W[>/55F;]%J/33A$]X"'B@74W$[[EHTNV,/'H(M[!=I
M1(@_"'%8LI&JK$_1Y0(.-[D=ID813K>I5^6;=FF?5NU1'>;O.C49QFK1M.H\
MD5WJN_>IQ[C_ )2N:^W<5=D\]U_: KY'$;JRGPU*;=$1\I47[9TBNF'#R?ZD
M<?Q X!T_YNB\*Y2K#JJS5ZN]/IIF)CO/]"<<Y_YVL<3YJG'KIRUJBS'HJB8G
MN1KM?PL8"X4UV6 W9M6;V6FZ;O(^?VU:G=NKBPDZ9';)S$-FK96.!VFH/1<H
MBJJB8/V3E,8HW6@<]LWIVI4SF],R%K1)IF*K>4M1:N1LF*YF8JPP^C.$3MB8
MB5/KG)+*ZAI]4974<]<UF)B::\U=F[;G;$TQ$33C'UHQF-DQ,P\^FO">UG 5
M$Z>Y++8+-?74BJZ-*:_LD]4(:(8E231:QK B9DG,DJ4Q3*J.7"9#&,<"%3(4
MGRL^).?NMYO4-[ARS9L:331$;N8MV[U==6.,U5=<4QU1%-,S'1C,S,]&'#W(
MS1\KD-WB&]=O:G57CO6+E=JBFG#"*:>J:MLU51'7A$1$=,KF\-C6;$0/5]V<
MSM54* ]6$;MYXJ@F/'B'!%S&',/1$/)\O*".=&MW>C/:9H=^.W>RD1/KBKY%
MY_!_1K73DM2UJQ,?HYJ</5-/RN Y%]G1@B%7YY^9R)3  !)"3FV=A03 !\@"
MDY.U*8.'P_!QQ_%+0[_Y[A;0[D]LTT3;GUQB?PTUFS^2XFUFW&RJN+D=^!_R
MM<Y$./2KG/M9G_#RD);=65F1 /T !S^D'(J>0/AX>4<G_77+C,]&=X3L4?X6
M:NT_^&#_ $3S!R_3E.*+U?\ BY:W5_XI<_X6^)3&%Z,?S/Z0L?1_9[R:H&+$
MX_\ \AH2/6,7CP_1D?OWDM?G&]H>J6?\/-;W[=4'[DYPV8PM:UIM[_$RV[^Q
M3+\C_P#*+"#Y Y4KJ4H^43=](0ZH!Y1Z/ 69"&,'D#B' ,G_ /AF:_\ S^6_
MR:\/:?\ ]JRW_P"#S/\ G4>#]#M/Q*(L0&0Y8-)V-(G^L/7-K!&G. < XI)3
M$@H?B;_,/#(_<7):_P#=:YJ=FJ?]YE=[US12?OOG#8^]T73;T1_N\SN^J*ZG
M <TO.1$#T;%R$V=Z4@!UBU3VE69,##Y0'JD/,%E!#B'ZQ\F3/ O+C,1CD^*[
M%,SV7<K<I]<[T01QMS!L=&;X7O5>6UF;=7JC=D_YZ=F1O$;3R,\S<.F4>!U8
MZ$9SZ?   1$AVY&A5 #R_ /Z,?PMT2]T9#BG0[D[*JYMSWXG\3-9L_G>&=9M
MQMIHBOV8'_R4:S8%$;3I/F=J8EX]9Z5U"],1/H_#TCMI-0>B >7B #Y,?P7U
MN[^0U/0\Q'ZF;CY:8/XP:-:_.Z;K5B?ULK/R5/>T\3WE+4Z(2MCN]9$> "%A
MUO;VG0$1X<%!;1KPI> _#Y>&?&YR/Y@1]Q9RM^/[O,V9]M4/K;YS\"3]_>S-
MG_$R]V/93*]H[Q$.3&2Z )[XJ[0ZGD!.3862+.'DX_*%_"H$+_TFRLO<G^9-
MG''2K]41VTU6ZOV:Y65GFQR\O8;NJ6:9G]*FY3^U1#03SI\C?@C\QWB&:?YO
M]ADE9VPLC>E-OP.LH,KS2^W[  (-Z78]M+M1;/3RM950ZR1&,354D6Q$4WO'
MJ^!M[(<E>/\ /Y&YG9RM%BJWCA:O5Q1=N81C\RG"8Z>J)KFF*IZMK2SW.+@7
M(YVWDXS-=^FYAC=M437:HQG#Y]6,3T=<Q3%4Q'7L6=M3P;?!-96FP;%Y;^>'
MF+Y)]G3LLZL#FU\N7-%=GI%YU\[%^Z?R3:TMKK-O_.'JPJ'(E)MC=(1X&#AP
M"GL\J^8E_P"[TC.>FF*?VIA;7N9W %C[S5<IZ*IJ_9B42O5/$TY7Q<K\J/\
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M/[NU<K]E34_B!QC=_+<*ZCC^O<HH]M(',+SYRO#T/R/QD5TN'1[R;FKA>CQ
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M(#( 7I&$> 9O6-*U3,_ELMF+GV;==7LB6E>U/3<O^8S%BW]JY13[9A2&?/\
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MIWKF2G,7/TKURY<GTQ-6'<R.JV@-&T@J1:EJ'6\ 9'@*2T=3(!%T00_2#SS
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M_'X"IE:PBO3-^L \H?IS1N?$1R7M_P#W_*53LIHO53/FW;4XMZW\-?/*Y_\
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MGS431<B)V33)_P CEYN/ =T<W.]+PBK\IU"UB0;4&#,8WE.F1HP-(EZKC\'
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M+BSQIP;F/R^L:57YLWEY[O>8J2_P/QOEOS&BZO1'ER>8B-O7[O!<[79M??@
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MX PA<F!P)0,' P 8!^$! ! ?^@?)D3$3&$]28F8G&.M3'$'".P$'4/%N0$.
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M!@,"-)3\8J/^6FU/M3IS([67U9\\?*YC/QAN_P"6NK/M1N+)1V>E)6$& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M& [T_P!.6KLCYQ@.]/\ 3EJ[(^<8#O3_ $Y:NR/G& [T_P!.6KLCYQ@.]/\
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MU&XLE'9Z4E808# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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',!@,!@?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>n2574ex2310img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2310img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ @ !@ P$1  (1 0,1 ?_$ ,8   (" @,! 0
M       )" H$!P$#!@4" 0$   <! 0$              0(#! 4("0<&"A
M 0,# P("!@0'# 8+     0(%!@,$!P 1""$2,0E!(A,4%191<9$78:'1TE24
M)L$R8C,D-566EQ@968'A0B-7"K%28T1T)66%E=9'$0 ! @0$ P4$!@8+
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M&VGWS)N-$.TNA'L*(%^ZE%K[5[A2*@/\5,Z5'V)_A%'AMU^-Z@[*D[AM?S(
M\UOZ<_U]QYK9_P!,W6JMZ&[N&XM9-HFL@]D<(@$L=QRQ;PQ<#CI2J<1XIN<'
M8K;(0X-=U9SN7_!I?E?8[_#GC9/R[C\[I 'R3%O1N?V@<AJ7IMLVGV]1FI</
M&,<N.*RWJ;ZP5_6^[G=7F0L[< P'A 1PPAC'#$0 /$@>T]A<_H]Y]FO2:"O-
MYJG4\S!K081^G8M2:9CO-_,'?^=EI[<OM1["Y_1[S[#^35!P@XCD56)!,1DG
M@<:\N+ROCJUNG%9^;H\0Q2D>T2E2KA"1VNR0H;&G72GN\=]P?I&I5!24T18?
MN5G^B6OZK3_-T1'N5G^B6OZK3_-T1'N5G^B6OZK3_-T1=E"A0H@BB !]>_T:
M(LC1%QL/H'V:@6@Y@%.$.".U.^^PW^G8;_;J)Q$#DHQ,(<%B>YVOZ-:_JB=!
MX1 8!1UOTZ(G1RCA[D>Y6?Z):_JM/\W1H#3%N![%+PT_AY(]RL_T2U_5:?YN
MB+FC;T+8;4:%O;GP]4)'XP ?QZ(HS\J>./\ >BQ1=8G^]G*N&4W;ZROGSKA^
M0F*RU(8*U19917]EZT?NE+2:E/<]R@D[^E1$LW_!(H?YAO/'^UQ7YFB(_P $
MBA_F&\\?[7%?F:(C_!(H?YAO/'^UQ7YFB(_P2*'^8;SQ_M<5^9HBWUQA\L>V
MXUY;8LK_ -\3EUEA30W/%BJ$90R8MYA]^9&0HK>V)5'MJU:2@"GH/6'HVT1-
M;T1&B(T1&B(T1&B(T15[N8WG7HXK\VVOC.WXVC$FQW'7+'%GEK(=Z^NU-YC"
MI14IUI08[';9'LU&(1M^;JB]RKN545OT( (K %O<6]W1M[BWK"YMKH>]VMS;
M;*IJ00"DA2>X$*"MNOCU!T15Z\B^;;S*H-V:,XXKX165UQ)X^ROX)+IGE:8O
M4"R-*&2D*2*S_&(U4I) H(752%&FA[&ZAX$Z(FF7G-O"L9X?,G-28.ES%L5.
MV.8_D*I9N*BN34OF.E:TF:+4Z([R^2A4A*6M%-*AWU#N?5W)(DTQ3S=?,IY&
M6#GD?BGY=?S;A2TO75OL7YYOW]R='%5(#UJ=)2H4),D+.^S*5^/4G;1%/?RY
MO-*AO.:\F6+Y- G7"O(?'#>MRF&.I$X!U4X-=.K2C[R_1]5.AL+=$G2I!:U!
M51 "5$J.Z@19/F)^:1 N#%:,8YC\&=<R<B)[3^(1'%L:<54ZE@UUJRV!L?Y
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&B(T1?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>n2574ex2311img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2311img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ H0#2 P$1  (1 0,1 ?_$ ),   $% 0$!
M       #! 4&!P(( 0$! 0$! 0$               $" P0%$  ! @4" P0(
M! ((!04    ! @, $00%!B$2,4$'46$B$W&!H3)"4A0(D;$C%6*"P='A<I*B
M)!;PLC-#-/'24R47$0$!  ,  P # 0$          1$" R$Q$D$3!#(4_]H
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MR-07;'>L'3O("$4%X9#JAHTZ?+7^"Y1:+C2N(=!6AP.(($BDZ?\ 'KB!> (
M@" ( @" ( @" ( @.%$A4RJ29:B 972]6VUTBZJX5**6F;!*G'%!( '>8#'L
MC^XWZFJ7;<#M+E\K$S2:Q<T4R>^?.)1F.59+D57N>SS,OH4JU_9;5(KE\I4(
MSD5NVW:W..^5AV&NW-\'2XW)2G5$GGR$,BQLXKUKNJ2FJKZ:QTQXL4Z$@I[A
MMAD.VNA"ZI07><GKJQ1U6$G8)^LPR)*GZ"=/V2 Z*FI4>*G'3(_A&?H2+?13
MIJA.MM*CVJ<489 >B/35P$?MRTG^%Q0A]!A4] ,"<)\DU5,KM;=)D?08?0C5
M]"JNC5NLV4UM*OY5F:1^$,AK58[UMLR?T*REOU*-"R^A))'\TS&I16KA>+$7
MRSF>&N6JJ!DJOH"IL@]H TBVBR8K=L@HRE[IYFGUJ!(FS70@*D/A$XF1HUA^
MX^JH:M-LZ@69RS5!.U%:S-5.H?,29^R+*-ELE_M-YHVZRUU;=73.":5MJ!'K
MC0DAQGKKR@/L 0! $ 0! $ 0'"U$$G=(#MX0&5]2>N=IQNH%FL;'[_DS^C-$
MUJAL_,\H<NX2],!AF671ZH?%TZI7IRMJEG?18G;U;&TD\ [+L_&):$[;0=2<
MR8%/:*=K$<9G(!M.U:D]I)_469=XC*6INLZ1XIBN-U%UDNZ7I "D55<=Z-TP
M"0V)"7]Z<<MMJZ:QI%E*$6>DVMMH*V4+6AM"4H!*03M $,W"6%ENJ'/3F(2F
M"2GSS]NL:,$WZ]AA.YUS8GMW2]DC&3!F<JLR5J0JH5-/Q>6J4#!Y0WVU5A_T
MU2A1YIF K\"$P#JL>4FD>6A6U26UJ09[C-*21P"8Q;6I(K'3G(KI>K"JIN+J
M77TO+02D!(D)R$A"6Y9L6DN"7*.R8(U+-+5LJ8JF6WVCIM>2%I]HB97"AY'T
M2Q"Z*-5;O.LMQXI?IC-O=V;"?Z8N4PJE6YU)PYE5%D=&SE6,$[2I8*W&T]RP
M 4J_&+*4YQ=:DOJO72F\N4=<GQ5>,5J@6C_"$GC/N(,;E1L_3CK[;K[5_L62
MTYL62MZ%AT_HO$:$M+,I:_"9_P!XQ1K:7-Y!!!!$]/ZXF0I#((H( @" (!"I
MJ44[2W75);:;!4I:C(!(YF \_P"=]8;[E-?48U@ZQ3TC0/[K?UZ(;0GW@V>'
MK@,K1>O*K7,;Z<L&NO-297')'AO=)^,MJ.B$]IB6B\8;TCL]H=%UOBU7>^+\
M2GG_ !H0KGM29S]<<[1H:'P4A &UL<$ "7]GJAK6:KW4%95B5P)^5('=J(Y;
M.VJ4LZ9V>A[ PW_RB'X2E'@4F>DN/'E%B&^_>G<B12=0H<)=QYQN#DM-3FI"
M2KYE *_.<7 Z"&E:*0F7,2$H8#>ILMEK!)^E1N'N+0-BTGM"DR,+&,HJHI\B
MLN]VC<5=K=*;U&[(OI0/_C6);M.4<['24ZQ)6.+H7%60>4TXX5/TRB=S;AXS
M!U$9GLJ9*B!(<.V.WX0D7% CNUC,'0?(]/&*%?.0M)2O5!'B00"#RU!B5*SW
M+NC]%6/"\8RZ;1?6SO06B0TXKCP' QJ;(JW[_1WJH1B_4:F-OO["A^W7UD>6
MN? ;B.4XWD:)@_5;(L"N+.,9PY]99W2!:[Z-?">&\\X#T)2W!NJIVJBF6EYE
MU(6AQ&J5)5J)& >1H$ 0! (N/E"2J0D 3,F0T@/-_4WJ3=.H%]?PS&*@TF/4
MDU9#=DF0\M!FI"5<AI+OA!FZW*K)ZI.%82/H<=I2/W"XC3S2#(K4H<1V"&W@
M:_BF)6;%;5]!;60A:@//?4)N.*YE1Y]T<;LN$JI9/=*,F'UHDD1K4^4)U !3
MAMP4> 2/^81G:-Q,VQZEI,>HZFK>2PRBF:+CJS) \$^,1FY4NGS)>5Y,S9;2
MA35K2DO5E4=%K2G3:/E"E [>T1G+<U7=;*4S"0$I3() T  [H]&LS'/:X(+3
M.!EQK R[0)09P701("6@U'IC.%4W,;+6VQ__ '/8$[*U@3KJ0>Y4,_$-HTW#
MMC-UPWK,IRP7VDOEK37TYENT=2?A7V&,_L:VUP>*W2GP$65SE< RXZQJ*^A>
MU05S'"%B4NT\D<2=8F$0^9878LNMRJ:L;"*ML?Z6L3HXCNGV1J49?;KB_9ZQ
M[IYU!1Y]J=,K=<7-2B?N*2YQVQN"Z=/\]O/2_)6\1RA]55BU<M)L]S49I;"S
MX1/Y>T<HU@>FF:GS4)<04J;5JE:3,$'L@%X @./,XZ?^D!AOW"]1KA3H8P3&
MUE607Q09<=1JIIA?OD$>ZHB8]$X#%[ZE5 W2=,<2(76U:D&_W%&JG#.:D*6-
M9),2C7L0Q.U8I9F[=0H3OGOJGI34ZY+WE$]G*.=VR)-:S/B3WGCZXPL? "KA
M!3IAI1(D(92H;J.E"<)N8,BI 1N3SF5"42UTTBA=5GW_ -MQ>C4ZL43M('':
M:?@6H 2W#G'.[8>C76%^B@:;N-XJ'@E*6*=L%SY4S4>/&7IX1=?+&_AI%5>+
M.E#:_JVRAY'FM$'WD@R*AW3YQWFV'DLS4>[?+.3_ .2F1$T]I[AWQ,MX?5W.
MWMH*UO)2E*4K42?A6)I,,F'TW*A;4L+="?+1YK@/%*)3W$=D,F'TWNUMA&^H
M0"L IUTUX:]\,F"RKQ9D@I74MJ;D2H>\""/RE"^FIX9K3U3>&9QL8=\W';LI
M(* 9I;6Z9((_F(CA^3.6GN<SQGPE'2)9@T5Q,;B.09G6-5*Z&ATC*%F7#,S)
M$^8XP$1G.%V[+K&JC>0E%8P-]#4 :H7V3^4]D649MBKXR:VUO33, $W6WE9M
M-:[HX"@>$!7/EZ1'3(U#[>.HUS;?J.G>4+G=K4?*H77/>=:3[J >>U,I11Z
M!T@"9[("(R6]TMCL5==JM013T;2WE3X>%,P/Q@/(5MR"I8M]^ZI7=6^YW%2F
M+)NXH*S+<@?PI@++T1Q!RBM;F2W,$W>\%:D.*$RVT?$3K\_ QSWV7#1EK"I*
M(E,<(Y2&'S8DB<O1$VV\M37P=M4HE,B0 F8TSE1,SZITEM6JVV IJKCP=?\
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M9^D^7Q3J>$Y'T3ADP3*E@R*!(:[E&0C4U:NN"#2':ISZ=EM=2\L>)II)4?\
M+,1TD<[MALW3.R9@[:G;+DU$%8W4-E#**I0+J)C0;1N('Y1UY^'#I<N:[%E5
M[U1A=T<WW*E:54XQ=G1,NM)&C:R=5;.8CIT])R]LB<:>8<<8?;\I]A7EOMJ/
MB2H:&/'O/#U3WDZL]F?OE[HK0QXC5NI;<_A;GO6YZDH(]<9Y:^6NNWAZ3<:9
MI:-JE92$-LH#:4=FT2CW/GU$5/&<0,U1K5*3/&-(Z3 +M)\7JB5H]81PC%&0
MYDHY#UNM%J9\;5N2WYH'PJ22I4=(RFK&C_<?W-L^5XJ>RI\?<6T_UQT@]6[4
M_+%'GG[L<?J&Z.S9C2 ^;9JA(>(&H;4J<_48@S//JY%MRC&>HE%K0UX;^K*>
M7)P'O*28Q1M3;[-6PU4LJ"V7DA:%#@0H3$<ZT;J3*9B#D+D8)3^GJ0D>KQ>B
M&$16887;,LI 5*33W!A)-+6H$SW(6D:D1FZ9=->N&)WW%\CQU];=VIE)93XA
M6L^-A85PVE(.WAJ%1QVYN^O5$JJVMQ 4-R0"0V0L2/ E0.T>LQQNKM-W)J0'
MDM%"5E0F"RH+4/2E.X_A%UT9VW62S=/LVO@0Y1VXTU(K5557%+ /H:!4Y^($
M=IS<;UPO]HZ%V=HA[(:]RX.D:T[8\IE'<)ZK]4;FJ7OE?K98[%:&4M6ZB:ID
M)]R2)*]9(C<U<KOE(I=4KTQ/29RI_4Y8H6+)?VP156ZO92E2>):=6&W4?S!1
MBY;GACV=O,/9I>'$-^6%O'33C+NCS[3R]FG^<K9T(M#;MWNEX<&YVF;33T_\
M.XS4?\*8WIJ\W79K-;,I)[3I'9PB(?09P4T<21PC6J4C(QI':4F 7:"BOLTB
M5HO55M-;[>_751"664%UQ1,N TC R#I&OZBOR?J-<AL9!=53J7IVF29]@D(Z
MLKO]J5EJ+A<<@S>J22JN>+;*U"4QNW%0GV1N#TEY0^8Q1!9SB]+DV+7.R5$O
M+K&%M@G62B)@CUQ!Y*QBV.W2QWSI?>_TKO0E;ML*]#O;/:8F!8NBF5ONTCV(
MW8^7=;5N2RE>BG&QHI(GS1QC%@TAY$IRX1BP-W!+40@$.&44.FJM0,38D.EU
M+3S):>0EQM7O)4 H'\8PTA*W!\&KEA51:V=W\$TCURB87ZI]:\=Q:U2-!;F6
MB."@D$_B88/JI@UFX^R-:^V: Z"9\N:CP$8Z[8IIKE$U^4VJC205EUP<0F7M
MGH(U>DPUMSJ .=WJK66K=3)W*,D  N'V:1PQM7281F;5>4/6!"KU3%BD;JJ=
M:'%23^HAQ)&D63:-_,K*JYWZBLJZG<%&H=6L]TS&;MY>KCKX7WI*O)&Z&[+L
M;:5)#H%2'")J&Q6B9Q?+S]\2K6YE624'@O%N,N;B04CN\1\,7-U]N6VLN,']
M'D=JN 2 YY3W-"^'^(:0U[8OE;QMAXXT)S'!7#^SNCU:]M=O$<-N.VOFD%-&
M+E'U#9B6A=I*I\(DR,MZT9+45U12X-99N7"L6CZQ"-=J5<$$C\3&Y RZB3LN
M-V;IC8QYEPJ0@5>SCO<5,SE\RB3Z(W@>H>F^'4^)85:[&A/CIV4IJ".;BM5S
M]<46CS'/E@%-B>SC ><ON+Z>W6W7*GZCXRV?K;<L+N+2>);3Q7IQ3+14!FV2
MH%]H:3J?AQVW&D*1>*)/OHEQ7(<1V]T,#4,+S&VY99164J@BI; %53$S4VYV
M:?">V.=@EG$?VCL,9"4I<(#F:@8+'7G$")A2J*H@2G# [14;N,,!RT2I4AZH
M>A5,IR524.-LE26$:;4>^M9TVB/!UWSL[Z:X/L>P#S@BNOQ+KKB=Z:).C;0Y
M)4>*U]L>G]=L7;>1=:.AIJ9M**=E+24\$!(3^<H[Z:N.TQY4GKLL#! DR"C6
M4\BHRXK Y3Y1.DPWRW8,'$>62I0DH3"^7KG*/%C-R]NG3RV+[?G-MNOA*D_]
M=$U'1(3L5\7*/5SU>'^G;-:=5TZ76RVZ@*2L?$)@S[=([W25RML4V^X"RXA=
M3:1]-6)$PQQ8<,_=',*/*./3A&].U16+7UY3@H:Q!20HMJ2LS4VM,P4DQY?\
MUZ,_46E;"I#27+TQ[.?F/)T\5\;86=!"^R>E<Z@9O1XA9EO+DY<GQMHZ8>\5
MGG+L'MC<B*'B-"UB%DK.HN8$JO=<A:J"D5[\UZI3K\2N/<(W(+A]O'3^X9'>
MJGJ7DC9*JEQ2K8VJ?;(KD?A3[J?1%'ID)$O5* -B8#[ -ZRAIJNG=IWT!QEY
M)0ZVK4*2H24#W$0'E//,(O/2#*W,@L3*JS#KB2BOHN):2LZ@CAI\)B9%;K[8
MO'ZI&?\ 3YTU-E?UN%L3\ 5JI"D]D0:AAV:67+;9]71*V/MB531*(\QM1T'I
M$9L$PMA:21Q[9<(S0BI!B2A,IVF<5<@'6*9*HGRB6J>TXF=I,ICC&+<^!G=S
M2_35WG%L.KHZI-06AQ4EI4RD=Y CYG2_.^*]_+3ZTS?9[F_65RFJOH\;;0\H
MB;E>[/:E1XI0B6JOFX2C['7I-=,ZO!RTN^V*B\$R>]7VIN*;]<%N4[2!/9-"
M4;N:9&>GICAIO7JZZ3&#?$\0>7?;G_N:I=J;?1/>31MU"UJ0^X[JE8':D1KI
M+8\TF*CJFAL>.4E7=:BW-W5U^L6Q14CJE(9:3,RG($\HYZ:8C?W93S%KM8:A
MRMJ[1;FZ6[.@)3:GJA::=1E-2TE(GJ!(>$R[HW+6=O*,K,]S.AO%2:2I=MHF
M)6]X^<A/;M5H2D\C&=^EE=N>LL7[!NL'U[OT61);I:A7AIJUJ9;6H:D*!'A5
M(:<8MZ>&?CRC6*QE_(ZJNEY3576)^G:&FZ<D@ZZS5MG'FDFU=O,C4'*?7@3/
MA(=WICU\[8\W3653\]Z@6/#J'=4J%3<70?IJ!'_44K@"H"<DQU^<^7+/X9Q8
ML?>N%0]U%ZD/ANF;DN@MRYB8&J1M[!R$:$GBF*WSK5F;=WN*%T6%6Y80PR=/
M,"#[HY;E?$K@(N1ZRH;;14-$S14C09I6$);::1H$I2) :10Y D)=D 0! $ R
MNMGH+K1/T5>TE^EJ$['6E@$$1*/,F<=,\HZ6W9Z_8FE5SQ=\GZZTK&[RPKB9
M<P.V(*D;%17Q2LJZ;5@H;TR0NML2CMF?BV]L7 M&(=7Z2L=_:,G:_:;PV=BE
M. I;6KTG@8Q8-"\I#B XTH+0H32I)!'LC. BMD#B=>Z 34@06/J$Q*I[3^'Q
M&,SV*;E5,::_;@9)K$^9/EN DJ4>#^WE;<Q[_P"??QA6+OBM+6J+YG3OK_[S
M<I%1YE/?SCGIVN,5UUY36Y1]MLUUM-OO%*P&ZMRXTY;97O+9:6.!,P9QZ.?6
M./37)\]D66./VA3MO4MNW.I=J&PX 'U!.T[3+3776/7^Z.,Y4S9K+JXJK9N]
MA57VRH>4^TP'0AQHJ,P-_.4<[VBWD<TZJ!VI0M[#4L)IU)72/-5)0N:>2U2U
M!YQ/W1/U&UQQV\WN[+N-7Y-$E20VA""5[4I[XX]>F7;GI@JU0V>Q-!XA56^D
MGRW%"8"R-9#@-.<<OJUU^9$A@3:[WF N%8M#5NM+1J7-YDE*U^% ).D]#'?A
MSN<N'?>82F9]:DKJOV+"J<W6[O30'T@EMLGL[8]DU>.[*TSC5IQ/=EO4>N_<
M;^^-]+:P=Q2I/(CTGT"-QE+XG@>7]8;PS><B2NV8>P0*6B3-)6D'0#M_O11Z
MALV/VNRVUBVVUE--24R0EIM   E_7S@)*- @" ( @"43 2J*9M]"D+ *5C:H
M$ Z>@S$,#"^I?VYAVX*R; :LV:_HFMRF2=K#Q[I3V'U$&+!DMTOMKKZ@6#JK
M95VN[-22U?*=.U6X:;E#@H?CZ(E@7IK?U(PYOZ[%J]K*L9)W^03O4$]X!"A_
M*?5&;J+%8.MN,7!T4=Z:<LEQ)DIIT39G_"HA*A_,(GR+W2/T-<UYM'4-5#9X
M*:4%_E# 62Q+@!Z](S8N2S:)2GX>\B?Y1C!E%YE9C668U#0'U5&//:$C/:/>
M3_,(;^)Y=..V*IU([YK*%-&:I CF=A_ICXW77R^G]_4.UMM$'<A)$YCCQ[3&
M==ELA(4K&I[1IJ?;RC=N?R22!-.T@]BNP3/L5,1/*7:9)5*0@@)F-W;K[.$:
MDI]0UJZJGI&]]6ZEAL<%J4 /PG&]>>U9N\BD9/FU#4K;H+*V[=:@$C8TD[)J
MTG,"?LCU\OY[^7#IW/<>Z99I<J%ZJRJZ)QO'75)<J&B0EUQ*>&FG+M_"/?KK
M)'AVVS4@QF%ELZSCG26R*N=T<FAV\O)WJF=)@RE&L(T;IU]N;]37-Y+U&JE7
M2[K(6U;YDL-\QO),U'^$2$3 WVEHF:5E#-.A#3+8 0VA.U( [ .$7 <0P"*"
M ( @" ( @.5(W&?LY0$!E>!8ME="JBOE W5-$>%9 #B3VI7[P@,*O_VYYGBM
M0NX].[VYY(.[]LJ3,2XRG[I_ 1**%?<B <-!U,PLH>3X57*E0IM1_BYCVQ S
MMV,8G5*#V$YD[;'CJFCJ5;)=VDOR@+ U7==;,GW*2_TZ?=<2 24]LTRB6!PC
MK9D5"=MYQ*H84G1;C15M/J(C/R)*E^X;#U BKHJRG5P*5(W ]QAOIEK7PJ+O
M4[$6:]]VC><+"G5N,)4V1)*S/:9<A'CW_FM>G7K@N>K&([ "ZZ52X!LQQ_X:
MW^X@OJU89;:>DJJE?()3*-S^&G[G",\R:N4$VK&JE[Y5.;@/8(W/Y,)>IR,<
MZSWI,W_IK)3G7S')!0'I,_RCT:?SQY]NU,ZC".GUI5]1F>6+NCR3-5%2F<SZ
M9G\H[SE(Y?MM/[1G"4+^@Z6X9N>)V"XU""X=><S_ %P^#ZM6ZR?;UG^952;C
MU%O3C=/,*3;6#+0_"9:"+!NN(=.<4Q&A326.@;I@!XGI3<6?XE'6*+(EL@S/
M'N@.X @" ( @" ( @" ( @.5I*I2B4,;C9+=<F2S7TK54TK12'4!8(]<,#-<
MD^V7IA>5*>:H#;:I4_U:1Q38$^81/;""CU7VP9C:9JQ3,:EE*?<:J"92[)HV
MQ:(]_"ON7M.@=HKRRG0!Q*%$CUB<9P(VIJ>M3 VW' :.K/SI8_\ ;*-+DP-[
MRS=^OTL96OM2RH#\X8B9KH7S+9_H=+&DKY%;*B/SB>3-/J:KZU5$A;, I*$G
MW7"Q+_FG&I3-23&(_<W=4^67J.T-*XAM+:5#\$SC7@S3VE^V+.;NKS,IS%]:
M5:J9IR1ZO$2(Q1=<;^U_IE9U(>?I'+I4HU\RK<4L$_W1X8GE9(TRU6"V6MH,
MV^D9I&4\$-("?RBB12"#,B4$=0! $ 0! $ 0! $ 0! $ 0! $ 0! <J]Q7H@
C&Q]V <GWA 'Q0'"OB@.VO<$!U $ 0! $ 0! $ 0! $!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>n2574ex2312img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2312img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ B $L P$1  (1 0,1 ?_$ *P    ' 0$
M       "! 4&!P@! P$!  (# 0$               (& 0,%! <0  $"! ($
M!@P)" H# 0    $" P 1! 4A!C&Q$@=!46$3<S9Q@9&A(C)RLA0T-0C!T4*2
M(S,5%A?A4F+"4U15)O!#8X.3PR1TA$;Q@B5$$0 " 0,$ 0,$ P$!
M 0(1 P0A,1(%,D$3,U%A(A1Q@2,5\/_:  P# 0 "$0,1 #\ LO>O=JZCOC#;
M#G-@LB:1(SQ/&( 2;N,WU;=[32U+FTS5_1@J &ROY.(Y<( NA'BCA$ =@#BN
M[R0!26\B\W&ES.\TP^4-X224IPPXY0!+-T==55ELK7*A>TH.( T2T'B$*&43
M&Y5]#;V%5-4X$( F28UW[G&)IN7U;W*XNN\A^ONM+0V](;I5O("G%B:E#:&C
MDCQ0R5+0Y3SE.XDBT*8S0)F9XX]EM'4MNI[S$;3=0[  @ 0 ( \7 "O'0,8C
M+70Q[M"H=Y6]ZILMQ5:+,RVNH:P<>=FH \(2 1C':Z_K?<17^PSZ.A7WXQ9\
M))]-2GDYM'Q1U'U$5N<M]BT<_&//G#7)_P -'Q0_Y,"7_39W\7\]SPKT]GFT
M?%$EU$)&M=E),6VS??G"GJ$&L4U64\_I I&PLCD*3*-,^GXH],.RJ]2^LHY@
MIK]9Z:YT^"'T^&GB4,"F*YD6W"="RXEQ2A4?HU'I!  @ 0 ( $ " !  @ 0
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M5$7[[O[RW,JOI)FE%00D<7@B*MVT4KA9>HDW M*.2=H$ " !  @ 0 ( $ "
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MXQPOT/S.K_TW0YOE]OL="-9CB%G%6YE)545^. 2F79G,& ([O&R]]CYA<YI
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M]OL="-9B@GT86;E?6JWR1K@"UTIF >0#M0! ][.7_3;0+@VF;M'BX>-OA[D
M51EJZO6J]TU6,%-J3M<NT9*2>U #QO)=0]F1QY!FEQ"5A7 04P!-MR_LJX=(
MWJ5 "S?#U;:Z<:H I^S>UJ3ID:X THOU%71?JP!FFX^O/]*?A@"Z=TG5-'3+
M^" )K $-WJ=57_*3K@"BV/K4=F --T?J+7D)U1F.Y"[XF1<V]9+CTR]<77!\
M"BYOR%O^[I[.N72)U1Q.Y\D=_IO%EQ)\6.% [TSJR!*<9;HR/&H4KD91CDR:
MHCNT#W(FB,D9BWT]?:SR&_,$6OI?B94>W\A^]WGV_7=%\4:.Y\$>CI30/#%:
M6Q97N([O[-JNB7YL+.Y"_L8VK_6ZCI%:S%]M_'_10;GR?V:4W']0Z;RW//,5
M'LOD9;^L\$5+OPZ\5'D)U1W.H^-'#[?Y6.?N^=:*OH/UA&GN-C=T^YH<:(J\
M]BU>@57P1E^)GT,X[_.MS/0#7%NZ?P14NVW";A^O'_&7YR8CW?@0Z;S-)<,5
M2);Y[!*GZAWR?@C%KR(7O!F.,P^W;A_N'//,7S$\"BY?F*O^O?WG^;&P\Q;V
M^7V^QT(UF*"?1A9N5]:K?)&N +91XH[$ >-93M5##C#J=MIU)0XCC2H2.N ,
MY9EL[]GO;]$X">:40VK\\#Q50 DK[D[7%I3@DIIOF_FB0@"U]R_LJX=(WJ5
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M.@H /;$ 9ZSC8*ZUWRI0ZT0VIQ1;> )!"SM#N R@!F:?JVO$4X@<'!,\<@8
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MI2>Y'F5FKU/=<S'*.@WY!2357D'0*A0$S/"<;\J59'FPHMIU$MF1*Y9C$I>
MN1X#X)XHRVM#5;4N;3V$EGJJ<9%N+ <'.A+RN;$I@=B,W8UDJ"VW22?U$P=9
M::RZXLA+:'%%Q6@?TG&Q6]S1&5)(F%=FVC;J*:DIE!Y52E9*TJF$E 'QQY8V
M&WJ=*YD+BJ$6L3%GK*>K<NCZE5)=4$I4\M/+@D$"/0TXO0\;:EN-M,E"<JU2
M&?$%P($\<)#AC?;TFJGGN6ZQH6C3B5I0.#F1C_ZQQIQ7NU.[:35FA75-3E>6
M[@\02:>X%T%)QDE*)1T;\ZM?P<:W9?)O[GNR_P#:%LO=T,E\Z$MM$\ "1.?;
MC/)1:2,<FU<;]&J'7$_294EXW-HD. @"(\EJ)R?&W]VZCKDY ^W;V0G^LTX"
M>)XHCER5(T^B-^'!MNOW&&HVR<T8$$<Y(\,@=/:CT69+C$\F1&?)KT%ELMUG
MJK,PS4WAY*2V NGYT;(( \&1$>62;E5'KM;<7L**AABFSK96V22TVVHH5@?Z
MLC48V:N#J8X1A)<4<N_HU3G!=/<75)HTLS2GG%-B<OT2(A:32JC=?O-R28CI
MZ:WL9MJ4T*MIGT):@=HK,SRJ)CT\Y..IX9VXQERBM20[NY_8JC_;.'CX8\&;
M!R:.GUTG&+7H>U7F:E:S JV5;24MAK;#[DM,P)#NQBU"5-R<KRJTQDJGZ9[.
MC2Z125H]'6/ ,QH/"(]JY>W1G)G#_9.(WY;IJ%VFJ4U%T>HYO*!92Z$)([!$
M9OII)K?ZFS%DE6#\7Z"F_6^V6ZU6YN@?4]2>EAQ3JE!1)(D25"0X(QB.4F^7
MT&;&,>*@OQK4DE;FVW4:*1#1%0MXI;DA0)$^&.?*P^=3I?MQX4&:QUU)29PO
M"ZAU+27=D)VC+1ITQ[\JURM(\>+D*,QLJ'4O5.9W&5;25LN$*^2?!PE$[5%"
M/\GDOR<IU)+9C_(R9"8YA0[4C'D=/>K]SIN7^/\ 1%WTSW;H2!H5P<&,A'HN
M23NL\CF_9BA]S&JEN&4"^PYM^CI0LE!T #&<HTQ3YT-_*#MU:U$>4:C[6S(N
MO)V_1J=+>URJE\4;K[<8<?1GFPY^[.K]"PT@$F8T&4<F7T+)L@Z4B9B9&B.[
M">*,/4)) "4C0(PE0E4[&3 ( $ --;8K;7I3Z53I>*,$E8F9:8E9R&>;(Q8R
M/.ARQ8Z)\/4]&VV\-"TC&(SONI"UAI(64EMH*-;IIF4M*=.TZ4X;1XS$W-RU
M9O5I16@5JVT#+CCC3*4K=F'5 8JGQQGDR,[*2J>#>6[&DN*11MI4X"EP@2F#
MIG!WVC$<:+7\G7LO6=YE##E,A33<]A!& G!93(2P8GG295L=(_S]/2-MNC0H
M#1V(P\ED?U$=7EBP+>+RZ-HND[17LXSXX?LLFL2)Z_8%G%.6$TJ RI6V4 8;
M7YW9@LEU)?K1%J64!L-@> !(#DB#=74VTHJ"5JS6UIARG;IT)9=)4ZV!@HF4
MR>Y$_<J:XV$%:L=L:I5TC=.A-,YBMH#P3VHRYLPL6.OW.FRVY0IP:=)%++T<
M2\27YL1=P/%C1+Z'K36RCIW7'F6DH<=,W%#A/+&)2<C,;2B>0L=N!>(81_J9
M\_AX\],XDKK2H0EC)NHE.3\MSF;>R2,0=GAA[K1F&-&HL-HMY>:?YE/.LX-J
MEB !+"'OO8S+&C4\JZP6BO=2Y5TR'E(! 4L3,C&%?:,3Q(MH#%@M#"^<8ID-
MJV=B8'R3P1G]EF)XD1124%)1-ENF;#2"2H@<9TQAW7(WV[48(2UU@M%>YSE5
M3(=6!+:4)F495YHTW<5-U!19=LU O;I*1#2U"14D<$)9+:H2MXT5J>+N4\NN
MN\XY1-*6=)(B2R9-4-;P8UJ*5V"T*HTT:J5!I4XI:EX(.G1$5?<6;'BQ:U/!
MC*>7V%I<:HFTK3BDRQ$2E>>YJ_4A6@:HRY8ZIXNU%&VXZ=*U#&'[,FJ5)/"@
MM3U18;2VEQ**9"0ZG8< 'C)XC&'>:,_IQ8H;M]&U2"E;:":<#9#8&$CP1K4G
M6IM]F-*'B+/;11>AAA/HO[*7@Z9Z(FKCJ0_5C2@W7&DI;3;5M4-N+Z',%4[(
M&,^.<;(W/R/+?QTHT$>1;._1L53[]/Z,I]PJ0UPA/ #&[*NJ37\&GK\?C7^2
75IP$>)HZ\V'3 PMCL#(( $ " ! '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>n2574ex2313img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2313img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ (0"Q P$1  (1 0,1 ?_$ *L    & P$!
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MFA1L9=9;\6.1^6;VSDFM,L<%59.;L=1I9+*J5-4/A?+:WNOKG<%4X@5>* &
M!  +L(ATWZ'DUAQ7A_=/%\/;A:._)TW.<X.8%(H@C=U)0AH,R![!#?G.(6:#
MVF+!9?Y=<OV)P1XA/1O2"M6\USN^)+AE5F 2[N9.;T3KE5 J5 71W_Y$ZR 0
M 5 V\_;KRO#=I>!YCO1?\<RUJ;=M"WIN9;[]S757?,<YVX:(QE-&Z*YQUBT;
MP?*#5.Y3/V2_YB'E239YQ3<\!SK@Z[^4"29.%93+S(UO9!1 ]$^,W]3,#?\
M7?1P,4 !O=PCT#<-MM=0>/<1RK<EAN086VM<?:%PHU*=5SW.8!Z2\(TAZ@GT
MJ H"R4I^:"C87+U]_LB>O(1(65$Z<W>-./<09&2ECHGSK#L9FO;1)6%8$UJ
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M*X*QE_X8/<P@!@((F((;@'757F7=R]Y6<1>FR(K8YS7)\P3VEI&J_P!,^OA
M,6@+NB'[X;[''@FL<>^/3+3 ZCD0HN.VR><E1Q'D,6,1.JLXYOE[MI@A4W#5
M(OB<4(-^ZI3 -P\? .BY)WXO^2=S,5S6XQY^58,0CY@GZ Q)Z+_&4(,7(A9F
M-NC\#4.JO&6U>.V29*77;283O=3^8LS);=MFXZ&PZ' NK*\2XHI)*]0@%H^M
MG*)1V$WU;!W3N[_//=.KW'Q%C\FTJL#'T#4^)&["X/()!U]A$I2(B_UXT/U_
M7#1LK@YRL6G/%J9DWR>3!,,&PY>)51J1BU$46,IN%/1"=E-(<2_3<%03@($
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:T*V#'\OS#14_!^J$$)#4E7\,PZ,FEAD?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>n2574ex2314img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2314img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ (P"T P$1  (1 0,1 ?_$ (P   (# 0$! 0
M       !!08'! (#" $! 0$! 0$               $" P0%$  ! @4# P$'
M @4%       ! @, $00%!C$2!R%!$U%A@9$B,A050A=QP3,E%E)B(S0($0 "
M 00! P,$ P           0(1$@,$(3%!$S(4!5&!(D*14A7_V@ , P$  A$#
M$0 _ /U3 ! "E&9<@<5K@"@HE'!T($4! ! ! ! ! ! ! !WC-J 1H",$B@1&
M8]0$5\ (J XB9 B@( ( ^3Q<#2_&1Y9'9NTG[900,OXSY-R3*<IO=IK:>G9I
M[.X6EN-;MRC.0E,F/?LZJQQ3^ISJ:H#'SZU.B(/*\SL&+6Y5?>:I-.R.B9GJ
MH^@$=<&O+(Z(RY%*LO\ Z*XYNM>BB%4NG6Z=J%NIVI)G+6/7D^*R15:"\T]I
MQ+K:5H(*5 %*@9B/"U3@T>X@" " " " " " *_>,XQFTWFEL]?7(8N%9+[9A
M6JYF0E[XZ+7E)50)])F)QR2H!$R@P0-MSG&;E>JFRT-:AZY4DP_3@_,F6LX[
M3UY156*G'1<D8]69>]BC*UFZ,;BM)20GY1,]8T\#MN!:Q'GJ!B"0"* @#Y//
MM,,J==6$-H$U+4>@$2%9!F3UO,=TN-]7:\<L;MRM[;A9J:_J&]#/:1'TX:*M
MK)T9EE0Q)S*L<N^17:APQ2*AWYV)%4UB?4:]?6/7M8XSM5QE&G\=<G(RERHM
M];1.6N\T@F]1NS!*3^I,]1'S-C7LY1M&.\R W_FZSX_<W"+4"RD-DD).X@D_
MRC[/QZLP.=.3F^II6?\ #G&5;9V4U**>Q(84D(JVMC)Z:))Z3]\?.U_D,T9/
M]ZFN"K<C\C5F"V*PXQC=Q#SE4A*!=W2'-K((&_<.D>C6UO(WDFOL&R L/+^2
MXYF%MH*S(D9/:;BH-OK3U+2UF0DHZ=8[9M6&2#E&-M"*1WW?.N4+IRK<L6Q^
MY!ICQJ4R%@;6TR'4'UZPA@PQPJ4ER1R(3%\RYHOK]XQJFO.VJM&]Q^M6?^22
M9C:E6LND=,NK@A&,FO42YEGXZYKOR./;]<;ZO[RMLCGB0ZK5:E?3NCS[&A#R
MJ*X3*I%-5RSGCUI.4#+6FZS=N3CXTV;M"G32.[T<496-?<7%IY!YGR@X)C5]
MLCYHZJX.!%2B0DI4I$?&.&OI0\CB^4C5W!%Y!FW,.(Y!C]PO-T#M)=W$#[),
MO'L,MR2G0&1UCLM?#EA)17,3*D0_+]#D[G+-D\U>E=57>-RUN2 \"2OY1TUD
M8[:GC>%I+TARY-,Y&O?(%GH+-;47^EMH4W_<;FM:4.K7_L2>LI>D?.UL>.;;
M:97(J> \EYB]G#^*)R#\W25+"OMKBL$[7):@GTCTYM/&L2R4H8N97N-;1F#G
M,=UIZ:Z!JX4[JC<*@@2=2%?,!_&/1MO&M=2H5,O5FS&Z)YWO%N>\9H:5IYPR
M;2%R0B?U2G'@GB3UTT6XB:#+^6N0GKQ=\>NOXRTVE2O"PGIY-LR)RUZ#O':>
M'#@M4E<Y"XD+?S/DMSXDOUP+P8R&R*;;<?2!UW+"9R]8YO2CYU'M(MQ6*[,^
M:U8!2YJJ\^*@96$%MOY5.;E2"ERUCTQUL-[QT_(7&L_N-=?V4_R^8_)>">[I
M+?NV3EI'R_:KW%G:I:\%^R*TJNMBK;<A?C55-%L+/:?>/%AR4:9MF3XK:4V.
MZ4E!=D%%"TT[2+(F 'PK>%]/]2>\>[+-RC5,RSARMR^4V07.DM+SGV%[:9:3
M4!1/C"3*:?0JCIAA&U2?8RBZ8_C"6<V8K*=)#5IH$43SA^I;JAN()[RG'FS9
M4X?<VB+YDX?J,P=IKS9GQ27RCEXW--P29CKZQW^/WO'^,_01Q*#7<4<VYBJD
MMF55Z&[53*25*"PHD)/4R'U&4>][NOBK+&OR,4+;R1P8[<;99%XVIM-=84I0
MPT]]#B4R,E3]2(\FM\C1N[]C3B<V/8#R1<LBHJF]T=!:;;2$*>;IT(*W2GJ)
M2'K&\V[%0<8MRJ11)2Q\99%0\RU^6.^/\54-+;:((WS.V73W1Y\NXI85#Z"T
MYN/N*\FL68Y5=:T-BEN[;B:0I4"J:BJ4Q[XZ;7R$9XX1_J+#@P+A"\TN-919
M;[XT)O+A73+;5NVD?23'3:WH2G!Q[$M(:W<8<M6FV#'J2@MSE.A12U=5I07
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A/5F@]-(+JP,:=HG8C%T]D;0'\(Q$!V[18E'V[1.Y#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>n2574ex2315img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2315img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 'P!% P$1  (1 0,1 ?_$ )X   (!! ,
M      <("00%!@H" PL!  $% 0$               4"! 8'" ,)$   !00!
M @0$! <!       ! @4&!Q$#! @) !(B$Q46(4$4%S%183)Q@:&Q,R4F&!$
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M73U$:]A@$1ZK2\\/N5 8ZJMC<R$@$.4$$. (T/14(SSTRSQH2Q<RHJJC?&'
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M8[B;8M*4'K$<5M=$9ZDR_;[?)CG*E/A*<#:,[#77,WE:VJ$N%6>XHY9:=HE
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)^143?KT3'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>n2574ex2315img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2315img002.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ >0!X P$1  (1 0,1 ?_$ )8   $%  ,  P
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M%PS6L,G:"QH^<Z1J.RNA;L36JX4?7U:M<>0(X\&;('NXH))(\Y*$3>6),?\
MQRG[0$GBY\"_^:=<.\B\\([LK1"=J8G6.TS85JW(EA[:N*:FL%5]EJB:EQ]J
M<%*ERX4E21,_\))QHCNBYS@N_=]?@#M!=.C)W7%>3K;>9,<Z JK81F2C,W,!
M,5,/<JBD^MK-0QQRHZU6Z:))NNF*.O*;<PR8R;(D3*0X.B-P;OT"@<3'\"BM
MA>:_B+H:)K4K#%+3PH;*&2+S*3ET[,WY%1@%SMIR09_S@GM2OUALIIN7S&Z+
M00'&1B/":Q+UZ-.H"$10 &#-"NVU_/O;<5C$HDE[PNJO4>&R&3J*Y/WU'XN\
M6#;&#L\M1@8M+DM!^=4(>8Q6C#/ZQ<8L<YB=H:Z*EQ;T#O%:/[418"P?F.O7
MB[LZ08$R8+!?-YXV6_Q4?I"D+3L2)S3V"=V6*/ZB$6/9[?5=.1=Y2'5XU/2-
M2L*8K 4M,B3H$X2P. C.ED&FOQ]>_M_#7#0>@*BTY6#!<%)3-OFT%D'[*<I<
MD H1N+.\MQOZSW%94PN!25ZBDPCB[@DSDU.!"=>A4!Z6<4 7/AE,GP%\!? H
M-Z+^B=$^:^:YCH6X%1[^L;#1QRO*IC"I(;/+7LI2U#=VF"1I"+III)O&P/7)
MS6"*,+:64DY<8 80!+,#$PIMK9FHO0VH9ZY0M'HGT_.N+&FO<9Q]C=I$DRS2
M^ ;@S'.[!F47<GPWAS9!8#"YK83 6^OA[<ID4E<FD ROJ8I* (MV<#PY"R+B
MCR(LW/E<W8\S78'I=8\!&F8+J'4T\L:/YNJ=RE1L69P,:!A0RM/EO*;?;$V$
MP\D/2PJ3%CT>8M.(1"&4C'E?:[DGT5VF.A]W3J(Q*+:JKK4[SHZ(6-/U)<7'
MGV-T72=]PYUI66-VS_/.MG:OK?L4BWI,LSZ!^GM,2AZ9T*R3.\:1!#^,SHN&
M$6G(\]KNT@P4M [JK6KZTC^6LYUU7C9K5Z*C\GB6JF*F[AINQ<RN$@I5Y4-$
MTC+0PUK"Y/R8L,M)1$-3O-7%"W_N(S35'0KZR-'^7<Q?(9_$[$W'"+9>4I3P
MCJF& GYUPRC-\.[>;II1JB-,2:KVF53=ED4=M!Y"<F<QNHWDXA"D3F"&(@8A
MK<FB8:D]4/#^CXC9, B]BZDEE-7JDDZ>21ZP:EV3:M*(8[)E4E<97%(8U2Z'
MO$:B$3=BYPY#7HV@HI)U,+O%'>!**YSE_P!OAN<_L.7'=C^%1L_HX%%>BQ<@
MFE>V&QS&-0_05^OALO<6>MJNM"IZ5I-2ENY*QNL?K.CFVV'9=&65, A5US-+
M//.5F"^X6YY2S3*^]U^?>BL89MKV1Y<,?]8+:;<K8T?(N(61GEEI7?J*Q%J6
MM,PRIDA:Y&\(A4WA6 6*_3-EC[>N/-='./-)21-^V:<L!H$)D6GLR>8WFA5T
MUKY)(I;#62N$#73<2/BT@8+$MB<+69RF$MEEA1M0PII1#UP5A3W,[-=G)N*.
MCR5.\."XK\Q(B1@*NP,9/&L_W+-H.QZJ\TO72T(C(+#=QXRT*:OI/T:S$Q.D
M.=4%U*7>M^L=A,U16R\2-"4V310W(Y4TN)J@M0%U"$@WY+N<=0/#/.N)=B6]
M+4E].U' LHZ+KU=.6;5/D.RD;?T[=.N5C8!H>F2W5UT#8Y] &.P'QN,4N,1G
MA:']-X3.O$KVL4D'DF)TWOU&V/-VB:IUA2-=Z"I21DR>NK+827ME6!YPEP;E
M(##$3W&9$W]$(]EED3>TRAM=4!WT/0N"4TDSG! [\HG'X'6O+PUQUG=9 ^+T
MK4R,;:N>'AT7&@3HFUJ;$IJUP<%AX^\ 2E1I"!F&#[WZ! 'O>_ \^C7&Q;<V
M-N2);8CC66^.-;O]&+?&+(DR3F$PS?U V_;%JY<TRK7M!HSES/94X$-.^'JE
MY:(3'#T:7]LD "_SF2\<K^.3K[;]L'$RGGZF_".C,Y9[6.9LKVCO*1K(7.-"
MNRIJ3Q"IV.KZT72N3NW]]V@J31EMH'(-?I!"C,17.1+C*SBQ 1)N&*3P)*OE
M9;QT#[K)T%/CX!DC1$#KG0^AIRWQ)[PW?#N1HR]^[_8=#R!YLN]]@6-9$0G%
M<LL,PB^0)*E!+:IZ)Q*@3@G2F@3N'XF5.J,K2JW[//EM)Z@I6#T<R^A?M:_)
MYP]UM2=)*YH6PTS#K 7R12P<=7B</<K(J^F:-JM6FAS+(Y%^::*X:W)DQJ@A
M ?T1)<XU::/^1NGMO.S3:?L;K*4V,UJQ)'HK 67G^0U+D*%G]X TJ/3!W;7$
MN?W(H;R#!$*%"E8F 8=]_0G'D]!]'/V06NDL'8KS>UM;11.4\_U<F9P "@51
M.JX<WO1?0! '\Y\BZTF/ZU69T'!&'GJ3#C#.]&,71"[WLF[=Z=EX3!8%H5-3
M+?"$U@26-PEMGU@1&F8$B<.%IDTAL2?*1-L.@;,B3D#"-T?S0#"23P 2^%@$
M(?0EA$+E1#-U8&Q%HY*O3WIDK.]HB=#P*EZ^85'"'1[4*BP& +4BD V<+X!4
M4$X70&!4<&$7>"YWG><[Q;Y9QU7;F=@@; \E-?8C4N=J^,6LI?#D+<O4/PO/
M_4,H>+0RI*4P^&?GB=>O3ZM'+*D"-.+I:$'[AA(#NA[U8E+#]W,Y^6[4?NHK
M2=!^JEN5G&+38[-PCZS80D#I(WZA9 X 0R,,4<U#(GM.'D_RC:OB=TY<OUE3
MH"GKB,H+L!"(DY*J($42L.T!]S;/^H\R[@M&:R;KJ\O"ZJ*_3.U[&3;E&,]Q
M5G00DVA]$R5U,B/)H_9L\T,XN$^B<741N.IS97*/[>;HT@_(%T>G?H6YNVA[
MS]'Z@F^DJZ=VW.7H5FN>6! \\:&R!9$BJJ->@6;FN+U[8KK7\8L%W!V6.M-6
M/R1EM#6]F'/;3'9<W<=F\\]&,\DX*2>5&E9]D"W62XU%&Z"I_P Y=XV&XQ6U
ME>F=+5/<LOH+<(;$=:SY/7<EO4QVRHR@M:;I.1R9IGUD2JDCSQ$X&F<3EF=&
M6S+C:?\ ",\/^81TG:C33U.>?V:X^USC16^GR>,Y,'62DB**I/15&0Y3;5T0
M)J<SC"0ER.\6=E)@S:GZ84<NX^*BTHOV0E]"%"_$ZLJ%F4XOOT;>EBV(^=N&
M'"[HIYOLUW1]%$NY>B%K)&V[-C']4.AA[]QJJ*6NRV%M*Q>H5\1H$SBG(%P7
M!\X$/:TM:'Z&A6Y[*M?4-M:*@EDR"36'BBJD4#FMZ8.T93C?$(\HKW'DUH>'
MP?\ Q0S1J5KFZ42(,G/4Q67!7.[?(VE:L3#.0%@2.Z].Z"Q#CO%&)\ZI7R]O
M3S5$130[+\%O%/&#YYE^K'B-$.<FE-UR.-,#0UOL;RPPD$,9KPL2HCI(K:2U
M"PI6-.M","->:7F-5/G;7C\81('>[M.6ZN'+-*:LL0DAPM2XYLYC*7NH3WM3
MQ2\-<$0NOWC;&<2H\*?@NF'&'J!#.$!-O@+X&?7UZ\9)KZ16=75RU=;K!04W
MJ""J^-2T@<Y3O%M3UJE[<[P9KF<@C#XF*KV.1%B*=2FN3,:%1+FQ8_FC)'^%
M. @T#N0&',E>PF)P:-H5+8PQ*/M,?:&]:_O<J5HD#6B)2)TRJ3298X2*0*"@
M%<X-:N/.5JA?4PT8AB%WX#N^ *3TU\O('NJ-QJTJ_?5%#;IH$XN896U5#.\:
M9A"9FPB.<V6)3)8F*$9*ZHD#G_R'-L4A."24>8:1S@NFEG!1>AI!$_:K.DAK
M'6D#;J4]-,&S"3UI<]=DO\TAR>/S=V9BT0U+VBA<CCTSG&.M0,*1(.01TAS*
M0R)O(.1 6<_$E7? HG KOL[-6V:NK!.W];[?C499U5D==*Q17CNV:YLC3H2E
M@6;,JX_I]2X9K\^:-N=Z;>)V2.%.IK@PPMN_N64+T9X4HCP:'JKEC*E=:)7:
M9E4<RTT9L]3ZW?VFPIUH"$3ZUT]$;2@L; 2RJJALO,CP\.%/R^V8V>XF.CLB
M_GT!DKAXSN?D&IYSH'E\3]>/NJL6LS-8LWC]C7=F63N&;[<L*,/(GQ@M1P@;
M>V&0RZ&!>J3-[PJ9K8@#BVNG3%Z1$M_DA+2CR"CB3"PAFX]B-#2"P-B^D=@M
MC VVG&\4U=1&;XI'Z^?4S-JC)U\K!L%\YVWM4JT2,I4.LVS4,O20:;)FY2)?
M^$E+Q2$2482^ 5?4T.A^'O++$OFU.*9KVR8??C"16.@9W<MJ6I16;:Z<F"*+
M] V_9%JW_7L/EDQ@KS/+F)Z5&QJ$H!.3PX?51T991Y)@<WG)DZ%V-,(QZZSR
M5L]A5_>5>MNGS+=O61+(OLBAY1$:[C, 9J^?K2H5QAM'75EULJV-KE/4#['V
MPXHXXM<I3'*#S>)@>OB;&1[,M75/M5:;*I-F.H9Y**0R.2[ <.@K+$]0/A$9
MCZ*,)UY:8M(=:DOCASL['@(#T]0FX,L00'G!&%P[&](W*K?5F/X8E,9BZ*CG
M;'+U?S_<1ZYQX[PRRFERL5]21)]X#Z,;9''FIZFD3L3T_P#]4<8TGB+%PLH8
M>A2:,_Y@%0KQ;'M7/F398HD\QT??D*9Z29I,<W2B-YASBK*D5PZ0G2U]CH.M
M*6KZK4%.#L@XFYPQP5)DY9@ '?> +X3[UMSQ6KSOYFE2<Y&HP4Q5X].284LA
M29YO;MB4LU76W(J>8%[VD<78Q,T/B5#PPSGXE*PWGXA=#SOTFS<V:.0GU_R:
MGA?HI.)*9-XNV^8LM50[1B->U,2AQ7N06@2]F'7)2.2&D2 N6.Y![.V 6&-Q
MI[J3TH82P="9VAKR#VUQ;'%S6:<AOYY@B&MZPLVZ[CB-'RR9U!E5IN".L$LA
M#%IF:Q;CLGKF6G1N3(USDA)*<>L:$X*IR&D3""<(+-/?I#B*.6:YU(]Z#BC?
M+F.<1:LG]::V2PROH[8\V:6][B<!D5O$1XVI6"8O[:\(Q)FU8]DK#!K4Y7"_
MRGE 'F^4ER[R'_ =JY*M*SGNEJ^T14TKMF.OTHB[M7C7,F@<L(DD)6*4$P8B
M&<Y02J<':+JD1P5Z=,$XU+PH8C A"'O>: =?5UL3>?\ L3)?LE!4W\<P!ED3
MQ5OQL2B,3MTQS3;[XG00:TG8I.(A.=(Z,GX4IQ:@[[C%:4U,E$8 E.$/08GJ
M-GN$M>AI6\R^V)G5]3; J>.**VB6:XA)I9;=N;4I&0D2]])F],TRQMLOUK7$
MZS8R$D.+=*WT488&Z.'=_"6->%00$ 1IKH;66 -MY6Q'4%UTBL?*Y0>M> P2
MUW@13<ROLRG\LEU<.&>&>K#W$NDFEBOJDUO_ -).!PG5K.DIP# %)E ""P97
MC[L>4RS>F?)_(IG8,MYZ<8W4G3Q!969T6?)(1;>84']UQNQO\0H:A*IS33/(
M6*03!B2OK,-(_E$MI '1$#I?U+ 4O^'!>E-P5+*WV,U)/6R^?=FTF$RXZRF2
MQFN^A2(CH:5O5EY$UE&49:$FQZ]N&L:28YU6:H01ELIJ9:3^3I9@R.AZ-"U&
MB<$:E XI$R] L(,3+$2Q.6K2*TQX>EG)U*8X!A)Y!H!="( @]"+G?IWGT^2V
M>,V]!GW]JX!4.)?*/=ZK*M1PBFY_KM9 *>=B*MCC7#D\TG=ZS2,TZJ='!H9R
M$C8-R5P^1KBE)Q! 3SRNB$/\@^?+EO'<&<R]1[!F?-]$9ZBZ5&C8J5J2 5D@
M*0?EZE,Y#HPVLBA86,_@3S1."M&8>,8^?>8,SHA?[W>_)++T%.M4^3V9]=SR
MP;%LURLI%(K159B)F!D8DJ%I3&Q;+S_:3NQPUK^C,8M;F2RVFYI"R2SZGG#<
M65;U.3U-W[C!)=MGP*LHO$'%=BCG[_<=I2_2E?V27HA#3D<E4J9&^&U Z:AM
MV;6_=+A6CG7 XPJ?W>2.:] U""K5*2BV.+)$?2^@"HZ.B+?_ .!$?><CZ2IF
MVK4KO16D+M/J,R)ZRMFC&,Z?UB"J*II6H&\#.MX\O<B($='ZD&M+ZD<4G"UC
MH9SO!<YTP<R;N31%UQ>"-M3M=;BMFOJNST-XO6U[/N-I<H\\LO+BM.;3FQ+!
MP<?/E"!([<7L%!OEEJ@/Y@N&_LIT*4M*G,YSG2J.SAGG+Z!YBH_9F#Z!B.?I
MS2VZ$2%R*TE++ <64_-SU8^=ZTSCH)NDU2GQE:^7(A;&&N..,)_34HN*3502
MG<PL/!]X#0'BO8=<YDT!X[1++O\ >U;WS=DSFD$W<KF,1_P>C-$6#;<6L!Z?
MKACR]W*L\S2-7MP5+:S,Z!L4(74YM;E!3@2G+/Z5-YS*&W4V>]-V;6F;<7=Q
M;<=.V13WIW*-R6!J6W6R&):>@U?Q784\N,APJJ?,,G>)58=J7)6[PC8 -Z9O
M1?82[+Q.!Y20GO3:-!N]Z!8]2XIU1GN0MI;JBM>B;)BJ-,,OAHR)$HC#@IB3
MJD#TE1T+BQRI*B6I1\ (1:A. 0>?=SGP!"9 >EVN_$CS_P!$/<Z*B5[YFB\,
MFD4MURJ>>WV^P"UZ813#.4P=@4U6\CBTLLN22""N;VV?Q'5!A1RAS"<>0=TG
M[/@.CS8,]!3[DKUNL*(73"Z)BZ'3J"RDMKTE1&;JD?H6ZS]"LR8]413%:HU-
M@1"RGEG X.$P;'E5Q*V!5'A/Z)6:F#\#/_0\@<<H65 X#VYM11)NSQ[OOU:1
MNL)7'0SO%MQ1AXT"_5RYQ6B9R3%EBRA;Z@$-NI<J>&92ZM;8_-_#C"2E9B@
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M"X3I#+'A\;G<3<Q)U"03C&I8SHWYC7_K*RB5)'%;8O*,X$8 BYP7]>? >?\
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M;DOA$-KA>.#L:6-)%T+KTY[.A+(L;&D*5L5 C0I&N"E/&2)2 M2(O\G0?0/
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9?_*9Q_[ZW_,]VJ+O\(7P%\!? 7P%\#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>n2574ex2316img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2316img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ' "M P$1  (1 0,1 ?_$ *\    %!0$
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M3!VK_M!CV7;Q_P"* 7;X<T$[(.BJ*M1^'341*8FHQ#D$Q@(8#B0A1$P%KVJ
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MNV)$R^>ZRA\4*GDA_2I09LEZ(8?_ $O"9'T1<J*(.%JFF=O<&VCH)>H*6@+
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M?Z1YG<L\KT#4O?*WEM4!<:Y!8UX/># 2)F(XRXX8;PD0^7J4ZA<TN+<=_O\
MI%/'?P=Y=WU/>3WR!9JPC<N&YSDO@O.%D8GPJ\93+.ZI-W?H2LKOJPC9NDY2
M39.6Z94!,8XN5'JGN)\/I.9.J]!9;G6G-&Y/>.KT\HN*7'J3TW4PT.8]TI5"
MXRR[,"20A A]*TJ!2Z;88S?C#XI<EK \$GD2P_?&#,FV9EF_BYM;V5CR>M27
MC+KGVLICR.C8M>+MT['<=$?/6ZNV<H&U%[]A]M3S>YBZ1S?GMEN895<KEUK)
M.06E)F-&!W+B#TP[RM4-(Q3^OTADB?"GEY_\[#O"7]MV80S$//F/O<,7#:D]
M]XFL\MM2<>::+""TWOIA')@*8P$V]1@ 1KIZT1W,#0)_=&W/Q<CT096YA<K?
M]PTV)CL0@$]BQ*+6IY<LQFG'S$=UF9OTE^EVG^KVQ].^_+6^T?7^HU?J)ZS_
M ,6^G>D^;]2W-VE/RNSN;_R^O@G(O5)SZ5_[,F/]TN_XI_ET831<U))#-#%8
M7_UJ_8MX_2=G[!V+M^Z-O]3/H'HOO"XONG;V_P#MWI/O3ZAJVNVYJV_D:>K*
MC^L_6;?T[S?J*N7A3+L_[GRBOJ^6^^985W&/]D/VA;/Z<_1?M3^X]Q]O;/UW
MT?\ <-]$-Z?1]0_*_4/H6UZ75^1T[>GYE>@,\_5?Z@=ZOYOSO#[RJDB'ME\7
M4LW7!%+A82JJ_&'P)?3OFZ?9L$KJT:_1T/73_P!1M;^[JU_'N:J]J=4)\UYY
MRS[EV2*F'5^&[J@ZFN,OQ]OXQZS[/SM?JM>CO3?I2@UV-/RMW37^G\RG[^@6
M_P"W6X'$V[O^GY_6(ZDOW(D$1]/N'T:]_0G^+:WM&V;9U5^97\6G>^*NJG:O
M4E.:6WXLZ][Q*N_Q[EZ$_BL-I28\-$BX;;TGKZK3H&NG>W*^_;I^8U5_EZG;
MQO.X+(F^7A_2(QPN)UK[=< -K3VW_P *=-.KV:S4II[5_F]]*5]W7>[YWO)Q
M)2B[.M.N"]^Y(JGZ?:';KHIWV:4_$?V[/:NO57]]:]1CR?YDG"E^]$3?M^/7
M#2BX)%L?3[R>GU%:!HV=STNC435KT_DZT_F^.E=/4)\OP:' E\HI21).U-R]
MBKO6&/DE"I%XGIZ%VZ[6DOLIL[=#Z/Q_#IK[-/?V?P]']]<.Q$^40_EIN3LB
MR7T?J$_P>LI\7_*^JV=*^WO:/F;%*Z:>_P#U=,?+,WB)-]J_%/FD2TT0RI%%
M-C4%=[<VR[FFFYMZ34K3_?\ Y.^JE>W4E/A\=TG#X^"]*;NSWX;=\-;PN(=D
M_7V[( >GWS;F[K]071KI37Z7MHT?%M:-7XNVK5[J=!VZ^6H<.:3O^_Q.6?KZ
M$W2[X(<LNZ"&]/J+7U/\-='[=\NUN;7S=%?V_+T5U=J]%-X?F#P^'QT[R(J)
M]W7MEWJJ;HK/R>-A-,L4+Z?1V]3N[9*TIN4V4M.C;_+Z--/P?*UZJ>_JJ?Y#
M]0MDE]0E=,BHG^:X_P"E<>V+!R()D2 /IJ&_K_U5=6U[=STXZZ;7\5=5:=]R
MO[NC+A/4;7;/^8B>'9C.OP_K#FHO<EW;.V/0GL56_%IW24KM:->VWT[>W\=*
MT_%WK7W:>H^YYFHJ\1/EBG7T]<,JH@F1/YQ9'TWSM7J:[(Z]W<V-.Z.O3ZC\
MCKU?L[Z?9VZ,LUX-/AHBE/[MN].]$7Y:X[>R#$V-(;6JFAO^#T_]+6/\_;;I
M75I[TKI[]5[.'ZU7GF\U(SQ;-Z2[U55ZXE=*N*+V14OI=P/;O4'3N5W]%?CT
MZ_G[.KV_PT_=3J2WX'J5Q*GFD9-LV2X)U=/7#L-Z08-&P;^O726O]/>IJ/2G
;_#U::_Z>I1P?4W>'C=WI3PN[=BQW[MRK'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>n2574ex2317img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2317img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ /@#Z P$1  (1 0,1 ?_$ *,   $$ P$
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M[BNMR$M/IO98XD^@BMA3RCEMSBW$]=02% % % % % % % % % % % % % %
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MLJ"PRDBY(J8P1K<CN6ZVDBP41E#+3;38LAL!(] %;&$CE?=WML]%00% % %
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6R/!PG=;MO0Q!'!8\%O2* 2R>^@/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>n2574ex232img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex232img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 2P#= P$1  (1 0,1 ?_$ ,D   $#!0 #
M      @'"0H#! 4&"P ! @$!   ' 0$               (#! 4&!P@) 1
M  4# @0#!00&!0L% 0   0(#! 41!@<2"  A$PDQ(A1!4146%S(C& IA<8%"
M,S2A4D,D&9'!8G*"HE-$-38WL6.4)3@F$0 ! @0$ P0&!P0'!@<    ! @,
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MNPS-L0"MK?RF<QEWJP%*1O,HG$PZ7):H1%;( U$3"4:DJ \N=0*8H@-.=2F
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MZ?LB! FTO_Q!]D%3O1!N7>3N4.H J &394Y=-0,7J1D08VH \ * <<6=3?\
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M)W6&0;XW=8OGY/;K(VJK,?*UWV'C-%X_F@4>LDB-X-S$=9PET%2IJ$.D9,0
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M>SKBC(J,!#(WF_[\BY@O K%N2ZB).LP.2';'GR(C.*CT6Y$U$Q731,"0 ):
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M?Y(O_4*\_3?\"O\ 8TXSZ.?8P ZO2J?_ )HI0/#I^C\?[2OFI[N$(M35Y_\
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8,=?'V>[Z2B^'5K3[4^2>S5+R^C[\H__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>n2574ex233img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex233img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 7 %> P$1  (1 0,1 ?_$ *D   $$ P$
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MO\!!_H4?S1^JLWU^/_Q_LOGLU7CX?@RC^:/U5QY?4UNO28)R7Y-V&0A$R>E
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M]/.IFK@MGN/8;/03CLQ#1,AJ*5EIP73O3T)L;U)T,%\3BL?BL:UCL='3%B,
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M7$OD^\T0E* JPUZ"F!TY#(\IY%S'(X7&9;\$BX9MLN.LMH==><<3N%_5"DA
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M<Y<S:9#,:;*0]B766]BF(\I; #:T;%A6U'B3K2B[84L/QF7TC:'VTNA)ZC>
M;?GJ#JWZ7_-0:6TTIJFW285SW1Q4QAV'R7'H*Y>*4%.H2-7&2;J KT:7,?7^
MMY9X^&W:IAQOD,3,XB//C+2M#R1:QO8^1KCR:XKQ>SP73:R'=*[^%8G5Y-;<
MLW)K35@HS1>H2M?5L3Y#J:3J6V=T,YYF%R2SQZ"=TR<0ES;U0W?WB?*O5Q:^
M/6OE^Y['E9KJDV'QK4#&LPV=&VDA(_)7#FY/*O;Z7'X:N]L6)K+T>/7+>HIL
MS_'H&<CL,3-VR.^W);VFWOM&Z:LHYYO$,3*RN,R2DJ;D8E3JXNP[4W?2$KW
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M/(P:^.=N,1@\BYDD294Z<MGX82)CI=4EJ]]B=!II3R4<A[<8;,Y!.2#\G'Y
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' H"@*#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>n2574ex234img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex234img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ :@$. P$1  (1 0,1 ?_$ +0   $% 0$!
M       "! 4&!P,!" $!  (# 0$               ($ 0,%!@<0  $# P,"
M P4!"P0,#P$   $" P0 $04A$@8Q!T%1$V%Q(C(4"(&1H;%"4G+2(Q46P=$S
M5>%B@I*R4W.3)#47&/&B0X.CL^,T5'24)29&5B@1 0 " @$# @0$!04
M   ! A$#!"$2!3$&06$B$U%Q,A3P@9'!(Z'1X5)B_]H # ,!  (1 Q$ /P#Z
MIH"@* H$*&M_93#%K="=/&LY-<24V=2*PQ%\R71(4!0% 4!0% 4!0% 4!0%
M4!0% 4!0% 4!0% 4!0% 4!0% 4!0% UR$QF(PY(>4$--IW*438 "L3.(3UZI
MO;#$L[WKDIY&@8_X\8RJSH\5B^NWW53MR.KUG'\%W:L_%KO&.18_.0$3(C@6
MA8%QXI/D:LZ[Y>9Y7%G3?$IJ^MJV*PH"@* H"@* H"@* H"@* H"@* H"@*
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M=?X5YL1KRH@^?T;?Z] TRN)YSB<=(R*.0(F_2MJ=5%>BI0E:4BY&Y*B1I03
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MZ8J&>G6.U^K0*3Q["-+2XQC8K3J3=*T,-I(]MPF@=^@KR&GW^O2_E0.* H/
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M-.E![84!86M;2@* H"@*#P]?"C,#[U$9 H0]HR* H"@* H"@* H"@* H"@*
2H"@* H"@* H"@* H"@* H/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>n2574ex235img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex235img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 2@#Z P$1  (1 0,1 ?_$ *(  0 " P$! 0
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#!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>n2574ex236img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex236img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 6@"> P$1  (1 0,1 ?_$ +0  0 ! P4!
M       '!@@) 0,$!0H" 0$  04! 0               0(#! 4'!@@0   $
M!0($ P4$!@4-      $%!@< $0($""$#,4$2%106"5%A<8$BL<$3)9&A,C4F
M%_#Q-$4G8G*"<],D1&6%5I;F&1$  0,"!0($ P<# @<      0 1 @,$(3$2
M!09!!U%A(A/PL3)Q@9&AP4(4X2,ST?%B<H*2)#05_]H # ,!  (1 Q$ /P#W
M\01((D$2")!$@B01((D$2(+-CDBL;ROS*1N)Y017BD1BL6IHH+H!V2Q.6/X5
MD6E(3"\/5"H*P\OV--/QUUX!&/3HU9WL;?9 ]6X(!;)_)_-7)392/C5D@W^4
M396;H-WNF6T2W!Z;IXPLSC9I"_+CXFN@I-B2K4)C1+B'NC;;YQJXX@!M6]@^
M]6 DW_,Y#M]A6+.IC@KG-!TC7PD,A]RO^:#"47R4+6*T2")!$@B01((D$2")
M!$@B01((D$2")!^O1%I$82PS"+#3ZAN5.0[(6IE;4,*0'N.AL3 F52HE1?\
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M UD(3C,XMV]M-PM:=_PO?96]_3C'7 5/1*9&$I0$H8RZZ90!P4WM0TB3(/\
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M#(XE( ,U$EQ#I#JU$:B.H?NS+SBW<KC4!8T=]A><<(.LRTF0CT <R)\S*1.
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M\+5C([/A3  726 J"0=FF(<Q'48PCRG9[?A5_L/OU*U>O4C(:S(^H3! B^#
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>n2574ex236img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex236img002.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ <P!X P$1  (1 0,1 ?_$ '4   (" @,! 0
M      D*  @%!P0&"P," 0$                     $  !! ("  4# @8"
M  <    & P0%!P(( 0D $A,4%1$6"A<8(2(C)349020Q4V,T928H$0$
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ME'C/8P$"G,E$1\MA._)U9:^H$\!-4F9NNORY0XFXO!WFAPX3=).E%.40?4U
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MMDAJ"D"@<;/<)-N/D3R+:N)N$;R*?'"<@A%2:BJ&"^/''"N*?&7'\.? =E\
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MQ+?#4GHIJ?9J.BHZ'&9*G:8B$1DMV%V""!B-3@AII%9X9*)JI2C*-=,4^<<
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*D_ 3P$\!/ ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>n2574ex237img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex237img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 0 "9 P$1  (1 0,1 ?_$ +,    %!0$
M       &!P@) @,$!0H! 0 ! P4!               '  4( 0(#! 8)$
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M.1PC77-]WVJQ^C*<X9IS3Y%L>/.*7,BS5;KWY=0*06/H8P_S+R:%,_S#H@>
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MH1ZWGVS%KH%]6=BNN/\ ^46]/]\V):4]F,XDGT7ZM^XMBMEWLCV17(*5+*0
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??OX?"-$Q63P^W]P:HW^7QBU&45ZOBZ!I0H&E"C__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>n2574ex238img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex238img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 90%? P$1  (1 0,1 ?_$ /   0 !! (# 0
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MPTKKR.CJC0RJN B"(XR"KAF#'#8 X=-4<IM\W'86XNXK7%U&XN;,!P =P<!
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M6PC&+/JU1]45XJ;?MMJ9P8US8@^;ZE&QQ[;X"<:PS&#,M^N&<#)F5P.=KO\
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MKW E,!1V\"LK=U6X+F[O.G=Q_>'\6U26[KM:*#:OQ>XA+GU4AI>T !I+F@P
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M']7,80'NY>8 DXJ5;LY>&^[GF5TL=EH'U>14IEL?#&:#;X9.A9/+A'=KBDY
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61$HB41*(E$2B)1$HB41*(E$2B+__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>n2574ex239img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex239img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 0 #2 P$1  (1 0,1 ?_$ )L   $% 0$!
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M7H2\C8V4V9M#ON\[;N,DF+++ >XLV.]Q\K&K%7;N/&*;Y.&=UIFO<=Y.F_\
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7_E4<K28#J@'0"U+&VD!(&G@*XI /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162157307488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Oct. 06, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-55710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NioCorp
Developments Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001512228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1262185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">A1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7000
South Yosemite Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Centennial<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(720)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">334-7066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 190,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,913,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">BDO USA, P.C.; Spokane, Washington; PCAOB ID#<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Spokane, Washington<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=niobf_CommonSharesWithoutParValueMember', window );">Common Shares Without Par Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Shares, without par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember', window );">Warrants Each Exercisable for 1.11829212 Common Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants,
    each exercisable for 1.11829212 Common Shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NIOBW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=niobf_CommonSharesWithoutParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=niobf_CommonSharesWithoutParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162163422096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,341<span></span>
</td>
<td class="nump">$ 5,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">1,385<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,726<span></span>
</td>
<td class="nump">5,682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssets', window );">Deposits</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestmentsAndReceivablesNet', window );">Investment in equity securities</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Land and buildings, net</a></td>
<td class="nump">839<span></span>
</td>
<td class="nump">850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties', window );">Mineral properties</a></td>
<td class="nump">16,085<span></span>
</td>
<td class="nump">16,085<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">20,930<span></span>
</td>
<td class="nump">22,756<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">3,491<span></span>
</td>
<td class="nump">817<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DueToOfficersOrStockholdersOtherCurrent', window );">Related party loan</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible debt, current portion</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,562<span></span>
</td>
<td class="nump">5,068<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible debt</a></td>
<td class="nump">10,561<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Warrant liabilities, at fair value</a></td>
<td class="nump">4,989<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarnoutLiabilityAtFairValue', window );">Earnout liability, at fair value</a></td>
<td class="nump">10,521<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability</a></td>
<td class="nump">164<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">29,797<span></span>
</td>
<td class="nump">5,091<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS&#8217; (DEFICIT) EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, no par value, unlimited shares authorized; 31,202,131 and 27,667,060 shares outstanding as of June 30, 2023 and 2022, respectively</a></td>
<td class="nump">140,421<span></span>
</td>
<td class="nump">129,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(150,477)<span></span>
</td>
<td class="num">(110,397)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(911)<span></span>
</td>
<td class="num">(993)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; (deficit) equity</a></td>
<td class="num">(10,967)<span></span>
</td>
<td class="nump">17,665<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interest, and shareholders&#8217; (deficit) equity</a></td>
<td class="nump">$ 20,930<span></span>
</td>
<td class="nump">$ 22,756<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DueToOfficersOrStockholdersOtherCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents due to officers or stockholders other current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DueToOfficersOrStockholdersOtherCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarnoutLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnout liability at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarnoutLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized costs of unproven properties that include fee ownership or a lease, concession, or other interest representing the right to extract oil or gas subject to such terms as may be imposed by the conveyance of that interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 235<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126939881&amp;loc=d3e61926-109447<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -URI https://asc.fasb.org/topic&amp;trid=2145477<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 235<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126939881&amp;loc=d3e61901-109447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestmentsAndReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle) and amount due to the Entity from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such investments and receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestmentsAndReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncontrolling interests which are redeemable by the parent entity, classified as other equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164186128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorizedUnlimited', window );">Common stock, authorized</a></td>
<td class="text">Unlimited<span></span>
</td>
<td class="text">Unlimited<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="nump">31,202,131<span></span>
</td>
<td class="nump">27,667,060<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorizedUnlimited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the number of common shares permitted to be issued by an entity's charter and bylaws is unlimited. The acceptable value is "Unlimited".</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorizedUnlimited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:authorizedUnlimitedItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162157127408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Employee related costs</a></td>
<td class="nump">$ 2,323<span></span>
</td>
<td class="nump">$ 2,150<span></span>
</td>
<td class="nump">$ 1,655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="nump">2,581<span></span>
</td>
<td class="nump">684<span></span>
</td>
<td class="nump">386<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ExplorationExpenditures', window );">Exploration expenditures</a></td>
<td class="nump">5,348<span></span>
</td>
<td class="nump">3,309<span></span>
</td>
<td class="nump">1,056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Other operating expenses</a></td>
<td class="nump">27,158<span></span>
</td>
<td class="nump">1,653<span></span>
</td>
<td class="nump">995<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">37,410<span></span>
</td>
<td class="nump">7,796<span></span>
</td>
<td class="nump">4,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfEarnoutLiability', window );">Change in fair value of earnout shares liability</a></td>
<td class="num">(2,674)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfWarrantLiability', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">1,414<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Loss on debt extinguishment</a></td>
<td class="nump">1,922<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">2,336<span></span>
</td>
<td class="nump">2,827<span></span>
</td>
<td class="nump">1,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange loss (gain)</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">258<span></span>
</td>
<td class="num">(725)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other gains</a></td>
<td class="num">(13)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(208)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in financial instrument fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Loss (gain) on equity securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1', window );">Loss before income taxes</a></td>
<td class="nump">40,612<span></span>
</td>
<td class="nump">10,887<span></span>
</td>
<td class="nump">4,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">(304)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ProfitLoss1', window );">Net loss</a></td>
<td class="nump">40,308<span></span>
</td>
<td class="nump">10,887<span></span>
</td>
<td class="nump">4,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to redeemable noncontrolling interest</a></td>
<td class="nump">228<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss attributable to the Company</a></td>
<td class="nump">40,080<span></span>
</td>
<td class="nump">10,887<span></span>
</td>
<td class="nump">4,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">40,308<span></span>
</td>
<td class="nump">10,887<span></span>
</td>
<td class="nump">4,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive (gain) loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Reporting currency translation</a></td>
<td class="num">(82)<span></span>
</td>
<td class="num">(166)<span></span>
</td>
<td class="nump">804<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="nump">40,226<span></span>
</td>
<td class="nump">10,721<span></span>
</td>
<td class="nump">5,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest', window );">Comprehensive loss attributable to redeemable noncontrolling interest</a></td>
<td class="nump">228<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciEquityMethodInvestmentBeforeTaxParent', window );">Comprehensive loss attributable to the Company</a></td>
<td class="nump">$ 39,998<span></span>
</td>
<td class="nump">$ 10,721<span></span>
</td>
<td class="nump">$ 5,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarningsLossPerShareBasicAndDiluted', window );">Loss per common share, basic and diluted</a></td>
<td class="nump">$ 1.34<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common shares outstanding</a></td>
<td class="nump">$ 28,705,840<span></span>
</td>
<td class="nump">$ 26,373,722<span></span>
</td>
<td class="nump">$ 24,196,711<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfEarnoutLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of earnout liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfEarnoutLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarningsLossPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnings loss per share basic and diluted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarningsLossPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ExplorationExpenditures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents exploration expenditures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ExplorationExpenditures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents income loss from continuing operations before income taxes extraordinary items noncontrolling interest 1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ProfitLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents profit loss 2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ProfitLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents total weighted average number of share outstanding basic and diluted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126903467&amp;loc=d3e32472-111569<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciEquityMethodInvestmentBeforeTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126903467&amp;loc=d3e32472-111569<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciEquityMethodInvestmentBeforeTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general expenses not normally included in Other Operating Costs and Expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.6)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162163497536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period</a></td>
<td class="num">$ (40,308)<span></span>
</td>
<td class="num">$ (10,887)<span></span>
</td>
<td class="num">$ (4,824)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AssumptionOfEarnoutLiability', window );">Initial valuation of earnout shares liability</a></td>
<td class="nump">13,195<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfEarnoutShareLiability', window );">Change in valuation of earnout shares liability</a></td>
<td class="num">(2,674)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AssumptionOfPrivateAndPublicWarrants', window );">Initial valuation of warrant liabilities</a></td>
<td class="nump">2,987<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion of convertible debt</a></td>
<td class="nump">2,157<span></span>
</td>
<td class="nump">2,619<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">1,794<span></span>
</td>
<td class="nump">1,745<span></span>
</td>
<td class="nump">797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_LossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="nump">1,422<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInValuationOfWarrantLiabilities', window );">Change in valuation of warrant liabilities</a></td>
<td class="nump">1,414<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FairValueOfCommitmentSharesIssued', window );">Yorkville share issuances</a></td>
<td class="nump">663<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ForeignCurrencyTransactionGainLossBeforeTax1', window );">Foreign exchange loss (gain)</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="num">(661)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss (gain) on equity securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Noncash lease activity</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_OtheroperatingGainsLosses', window );">Other gains</a></td>
<td class="num">(13)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(196)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Change in financial instrument fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities', window );">Total</a></td>
<td class="num">(19,171)<span></span>
</td>
<td class="num">(6,192)<span></span>
</td>
<td class="num">(3,632)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in working capital items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="num">(985)<span></span>
</td>
<td class="num">(377)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">2,861<span></span>
</td>
<td class="nump">419<span></span>
</td>
<td class="num">(1,103)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(17,295)<span></span>
</td>
<td class="num">(6,150)<span></span>
</td>
<td class="num">(4,726)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMineralRights', window );">Acquisition of mineral rights</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,468)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBuildings', window );">Acquisition of land and buildings</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(837)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from sale of assets</a></td>
<td class="nump">21<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">21<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(6,305)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Issuance of convertible debt, net of costs</a></td>
<td class="nump">14,857<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of capital stock</a></td>
<td class="nump">2,499<span></span>
</td>
<td class="nump">4,737<span></span>
</td>
<td class="nump">10,677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Related party debt draws</a></td>
<td class="nump">1,130<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Related party debt repayments</a></td>
<td class="num">(3,130)<span></span>
</td>
<td class="num">(318)<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Loan repayments</a></td>
<td class="num">(515)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(406)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Share issue costs</a></td>
<td class="num">(204)<span></span>
</td>
<td class="num">(118)<span></span>
</td>
<td class="num">(174)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">14,637<span></span>
</td>
<td class="nump">4,301<span></span>
</td>
<td class="nump">18,074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Exchange rate effect on cash and cash equivalents</a></td>
<td class="num">(302)<span></span>
</td>
<td class="num">(172)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash and cash equivalents during period</a></td>
<td class="num">(2,939)<span></span>
</td>
<td class="num">(2,037)<span></span>
</td>
<td class="nump">7,010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">5,280<span></span>
</td>
<td class="nump">7,317<span></span>
</td>
<td class="nump">307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">2,341<span></span>
</td>
<td class="nump">5,280<span></span>
</td>
<td class="nump">7,317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Amounts paid for interest</a></td>
<td class="nump">264<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="nump">873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Amounts paid for income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash investing and financing transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ConversionsOfDebtForCommonShares', window );">Conversion of debt for common shares</a></td>
<td class="text">5,175<span></span>
</td>
<td class="text">8,807<span></span>
</td>
<td class="text">3,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_RecognitionOfOperatingLeaseLiabilities', window );">Recognition of operating lease liabilities</a></td>
<td class="text">199<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">231<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DerecognitionOfOperatingLeaseLiabilities', window );">Derecognition of operating lease liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">(22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AccountsPayableToConvertibleDebtConversion', window );">Accounts payable to note conversion</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">1,640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ValueOfWarrantsIssued', window );">Value of warrants issued</a></td>
<td class="text">3,337<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">1,795<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_AccountsPayableToConvertibleDebtConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents accounts payable to convertible debt conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_AccountsPayableToConvertibleDebtConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_AssumptionOfEarnoutLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents assumption of earnout liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_AssumptionOfEarnoutLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_AssumptionOfPrivateAndPublicWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents assumption of private and public warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_AssumptionOfPrivateAndPublicWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfEarnoutShareLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of earnout share liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfEarnoutShareLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInValuationOfWarrantLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in valuation of warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInValuationOfWarrantLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ConversionsOfDebtForCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents conversions of debt for common shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ConversionsOfDebtForCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DerecognitionOfOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents derecognition of operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DerecognitionOfOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_FairValueOfCommitmentSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents fair value of commitment shares issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_FairValueOfCommitmentSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ForeignCurrencyTransactionGainLossBeforeTax1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents foreign currency transaction gain loss before tax 1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ForeignCurrencyTransactionGainLossBeforeTax1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_LossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents losses on extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_LossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_OtheroperatingGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents otheroperating gains losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_OtheroperatingGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_RecognitionOfOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents recognition of operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_RecognitionOfOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ValueOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents value of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ValueOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6394232&amp;loc=d3e17558-110866<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3) and still held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of buildings (properties) whether for investment or use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMineralRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the acquisition of a mineral right which is the right to extract a mineral from the earth or to receive payment, in the form of royalty, for the extraction of minerals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMineralRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162152546176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' (Deficit) Equity and Redeemable Noncontrolling Interest - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Redeemable Noncontrolling Interest [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Jun. 30, 2020</a></td>
<td class="nump">$ 97,682<span></span>
</td>
<td class="num">$ (94,686)<span></span>
</td>
<td class="num">$ (355)<span></span>
</td>
<td class="nump">$ 2,641<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2020</a></td>
<td class="nump">23,592,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodSharesStockWarrantExercised', window );">Exercise of warrants</a></td>
<td class="nump">$ 5,338<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,338<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodSharesStockWarrantExercisedShares', window );">Exercise of warrants (in shares)</a></td>
<td class="nump">910,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">$ 215<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 215<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="nump">295,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants granted</a></td>
<td class="nump">$ 1,795<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,795<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_PrivatePlacementValueMay2021', window );">Private placement &#8211; May 2021</a></td>
<td class="nump">$ 5,124<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,124<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_PrivatePlacementSharesMay2021', window );">Private placement &#8211; June 2022</a></td>
<td class="nump">433,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Debt conversions</a></td>
<td class="nump">$ 3,106<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,106<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Debt conversions (in shares)</a></td>
<td class="nump">406,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Share issuance costs</a></td>
<td class="num">$ (175)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Share-based compensation</a></td>
<td class="nump">797<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">797<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Reporting currency presentation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(804)<span></span>
</td>
<td class="num">(804)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(4,824)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,824)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2021</a></td>
<td class="nump">$ 113,882<span></span>
</td>
<td class="num">(99,510)<span></span>
</td>
<td class="num">(1,159)<span></span>
</td>
<td class="nump">13,213<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="nump">25,637,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodSharesStockWarrantExercised', window );">Exercise of warrants</a></td>
<td class="nump">$ 543<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">543<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodSharesStockWarrantExercisedShares', window );">Exercise of warrants (in shares)</a></td>
<td class="nump">87,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">$ 483<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 483<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="nump">205,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants granted</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_PrivatePlacementSharesMay2021', window );">Private placement &#8211; June 2022</a></td>
<td class="nump">3,711,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,711,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Debt conversions</a></td>
<td class="nump">$ 8,807<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 8,807<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Debt conversions (in shares)</a></td>
<td class="nump">1,238,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Share issuance costs</a></td>
<td class="num">$ (130)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(130)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Share-based compensation</a></td>
<td class="nump">1,745<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,745<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Reporting currency presentation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(10,887)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(10,887)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_PrivatePlacementSharesMay2022Sahres', window );">Private placement June 2022 (in shares)</a></td>
<td class="nump">498,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2022</a></td>
<td class="nump">$ 129,055<span></span>
</td>
<td class="num">(110,397)<span></span>
</td>
<td class="num">(993)<span></span>
</td>
<td class="nump">$ 17,665<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="nump">27,667,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,667,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="nump">265,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Debt conversions</a></td>
<td class="nump">$ 5,604<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,604<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Debt conversions (in shares)</a></td>
<td class="nump">1,020,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Share issuance costs</a></td>
<td class="num">$ (204)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(204)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Share-based compensation</a></td>
<td class="nump">1,794<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,794<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Reporting currency presentation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(40,080)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(40,080)<span></span>
</td>
<td class="num">(228)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Fair value of warrants granted</a></td>
<td class="nump">3,338<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,338<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CommonSharesIssuedInTheGXIITransaction', window );">Common Shares issued in the GXII Transaction</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CommonSharesIssuedInTheGXIITransactionSahres', window );">Common Shares issued in the GXII Transaction (in shares)</a></td>
<td class="nump">1,753,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Commitment shares issued</a></td>
<td class="nump">$ 650<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Commitment shares issued (in shares)</a></td>
<td class="nump">81,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Registered direct offering &#8211; May 2023</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Registered direct offering May 2023 (in shares)</a></td>
<td class="nump">314,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SharesIssuedUnderTheYorkvilleEquityFacility', window );">Shares issued under the Yorkville equity facility</a></td>
<td class="nump">$ 501<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">501<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares', window );">Shares issued under the Yorkville equity facility (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_RedeemableNoncontrollingInterest', window );">Redeemable noncontrolling interest</a></td>
<td class="num">$ (2,328)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,328)<span></span>
</td>
<td class="nump">2,328<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2023</a></td>
<td class="nump">$ 140,421<span></span>
</td>
<td class="num">$ (150,477)<span></span>
</td>
<td class="num">$ (911)<span></span>
</td>
<td class="num">$ (10,967)<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="nump">31,202,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,202,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CommonSharesIssuedInTheGXIITransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents common shares issued in the gxii transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CommonSharesIssuedInTheGXIITransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CommonSharesIssuedInTheGXIITransactionSahres">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents common shares issued in the gxii transaction sahres,</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CommonSharesIssuedInTheGXIITransactionSahres</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_PrivatePlacementSharesMay2021">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents private placement shares may 2021.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_PrivatePlacementSharesMay2021</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_PrivatePlacementSharesMay2022Sahres">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents private placement shares may 2022 sahres.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_PrivatePlacementSharesMay2022Sahres</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_PrivatePlacementValueMay2021">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents private placement value may 2021.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_PrivatePlacementValueMay2021</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_RedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_RedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_SharesIssuedUnderTheYorkvilleEquityFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents shares issued under the yorkville equity facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_SharesIssuedUnderTheYorkvilleEquityFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents shares issued under the yorkville equity facility shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodSharesStockWarrantExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period shares stock warrant exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodSharesStockWarrantExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodSharesStockWarrantExercisedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period shares stock warrant exercised shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodSharesStockWarrantExercisedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 30<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=128088960&amp;loc=d3e3913-113898<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126965701&amp;loc=d3e15009-113911<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164880448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--NatureOfOperations_zj6YcLTXPR5l" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td id="xdx_82D_zxkIhqU1ACo6" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
OF BUSINESS</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
Developments Ltd. (the &#8220;Company&#8221; or &#8220;NioCorp&#8221;) was incorporated on February 27, 1987, under the laws of the Province of
British Columbia and currently operates in <span id="xdx_901_eus-gaap--NumberOfReportableSegments_dxL_uNUMBER_c20220701__20230630_zifKldeWzKTc" title="Number of reportable segments::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl0709">one</span></span>
reportable operating segment consisting of exploration and development of mineral deposits in North America, specifically,
the Elk Creek Niobium/Scandium/Titanium property (the &#8220;Elk Creek Project&#8221;) located in southeastern
Nebraska.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
further discussed in Notes 5, 9, 10, and 11, on March 17, 2023 (the &#8220;Closing Date&#8221;), the Company closed the GXII Transaction
(as defined below) with GX Acquisition Corp. II (&#8220;GXII&#8221;), pursuant to the Business Combination Agreement, dated September
25, 2022 (the &#8220;Business Combination Agreement&#8221;), among the Company, GXII and Big Red Merger Sub Ltd (the &#8220;Closing&#8221;).
At the Closing, the Company also closed convertible debt financings (the &#8220;Yorkville Convertible Debt Financing&#8221;) with
YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (together with YA II PN, Ltd., &#8220;Yorkville&#8221;),
and the standby equity purchase facility with Yorkville (the &#8220;Yorkville Equity Facility Financing&#8221; and, together with
the Yorkville Convertible Debt Financing, the &#8220;Yorkville Financings&#8221;) became effective. The transactions contemplated
by the Business Combination Agreement, including the GXII Transaction, the Yorkville Financings and the Reverse Stock Split (as
defined below), are referred to, collectively, as the &#8220;Transactions.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
GXII Transaction is being accounted for as an equity raise transaction in accordance with generally accepted accounting principles
of the United States of America (&#8220;U.S. GAAP&#8221;). Under this method of accounting, GXII is treated as the &#8220;acquired&#8221;
company for financial reporting purposes. Accordingly, the GXII Transaction is treated as the equivalent of NioCorp issuing common
shares, no par value, of the Company (&#8220;Common Shares&#8221;) for the assets and liabilities of GXII. The net assets of GXII
are stated at historical cost, with no goodwill or other intangible assets recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements have been prepared on a going concern basis that contemplates the realization of assets and
discharge of liabilities at their carrying values in the normal course of business for the foreseeable future. These consolidated
financial statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently earns no operating revenues and will require additional capital in order to advance the Elk Creek Project to
construction and commercial operation. As further discussed in Note 4, these matters raised substantial doubt about the Company&#8217;s
ability to continue as a going concern, and the Company is dependent upon the generation of profits from mineral properties, obtaining
additional financing and maintaining continued support from its shareholders and creditors.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162162048192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PREPARATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">BASIS OF PREPARATION</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--BasisOfAccounting_zQYcL4w1vx82" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82E_zIsB8ZEsQrHd">BASIS
                                         OF PREPARATION</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis
                                         of Preparation and Consolidation</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements have been prepared in conformity with U.S. GAAP and the rules and regulations of the U.S.
Securities and Exchange Commission. The consolidated financial statements include the consolidated accounts of the Company
and its wholly owned subsidiaries with all significant intercompany transactions eliminated. Certain transactions include
reference to Canadian dollars (&#8220;C$&#8221;) where applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<div style="text-align: center; margin-left: 0.25in"></div>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;&#160;</p>

<p id="xdx_895_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zj4H0tKNxq02" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All
intercompany transactions and balances have been eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span><span id="xdx_8B6_zfL7KyGUoM14" style="display: none; visibility: hidden">Schedule of intercompany transactions and balances</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jurisdiction
    of incorporation</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership
    at June 30,</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 41%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0896800
    BC Ltd. (&#8220;0896800&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zQmMSWJijxzi" title="Country of incorporation"><span id="xdx_908_ecustom--IncorporationStateCountryName_c20210701__20220630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zGlmuRZxB341" title="Country of incorporation">British
    Columbia, Canada</span></span></span></td>
    <td id="xdx_98B_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zzbIweDCVVoa" style="font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Percentage of ownership"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td id="xdx_981_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zzc9JvGhtq87" style="font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Percentage of ownership"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 0.375in; text-align: justify; text-indent: -23.4pt; width: 41%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zksiovUNC0i9" title="Country of incorporation"><span id="xdx_906_ecustom--IncorporationStateCountryName_c20210701__20220630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zkUMxkHVlFL6" title="Country of incorporation">Nebraska,
    USA</span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 17%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 17%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_ziAzFfl1yeQ9" title="Percentage of ownership">100</span>%
    by 0896800</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp. (&#8220;ECRC&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zZnDPIi8PWTd" title="Country of incorporation"><span id="xdx_905_ecustom--IncorporationStateCountryName_c20210701__20220630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zJpRKSrWeSmk" title="Country of incorporation">Delaware,
    USA</span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zwP0I9QOW6dl" title="Percentage of ownership">100</span>%
    of the Class A common stock by 0896800</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
                                         of Estimates</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date
of the consolidated financial statements, and the reported amounts of expenses during the reporting period. The Company regularly
evaluates estimates and assumptions related to the deferred income tax asset valuations, convertible debt valuations, earnout
valuation, warrant liabilities, and share-based compensation. The Company bases its estimates and assumptions on current facts,
historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which
form the basis for making judgments about the other sources. The actual results experienced by the Company may differ materially
and adversely from the Company&#8217;s estimates. To the extent there are material differences between estimates and the actual
results, future results of operations will be affected.&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162165879136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zM2IirnOe0q6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82A_zr2FdprICqU9">SIGNIFICANT
ACCOUNTING POLICIES</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_ecustom--DevelopmentStageIssuerPolicyTextBlock_zJkX4dox3P5g" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_865_zXtCthRZkGJj">Development
                                         Stage Issuer</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is considered to be a development stage issuer under Subpart 1300 of Regulation S-K of the United States Securities Act
of 1933, as amended (&#8220;S-K 1300&#8221;), and it devotes substantially all of its efforts to acquiring and exploring mining
interests that management believes should eventually provide sufficient net profits to sustain the Company&#8217;s existence.
Until such interests are engaged in commercial production, the Company will continue to seek additional funding to support the
completion of its exploration and development activities. The Company&#8217;s activities are subject to significant risks and
uncertainties, including its ability to secure sufficient funding to continue operations, to obtain proven and probable reserves,
to comply with industry regulations and obtain permits necessary for development of the Elk Creek Project, as well as environmental
risks and market conditions.</span></p>

<p id="xdx_857_zDiwTHECGg9k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zXhSCc1lPCQ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_zlpJd7WiSBI5">Cash
                                         and Cash Equivalents</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents include cash on hand, cash in banks, investments in certificates of deposit with original maturities of
90 days or less, and money market funds. The Company maintains the majority of its cash balances with two financial
institutions. Accounts at banks in the United States (&#8220;U.S.&#8221;) are insured by the Federal Deposit Insurance
Corporation (&#8220;FDIC&#8221;) up to $250, while accounts at banks in Canada are insured by the Canada Deposit Insurance
Corporation (&#8220;CDIC&#8221;) up to C$100. At June 30, 2023 and 2022, the Company had $1,717 and $4,721 in excess of the
FDIC and CDIC insured limits, respectively.</span></p>

<p id="xdx_85B_zXYY55lo4azj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zJOG3sB3cbde" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_867_zp6NhYawEyQc">Foreign
                                         Currency Translation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Functional
and reporting currency</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items
included in the financial statements of each of the Company&#8217;s entities are measured using the currency of the primary economic
environment in which the entity operates (&#8220;the functional currency&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reporting currency for these consolidated financial statements is U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in functional currency</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to March 17, 2023, the Company&#8217;s functional currency was the Canadian dollar. The Company re-assessed its functional
currency and determined that on March 17, 2023, its functional currency changed from the Canadian dollar to the U.S. dollar
based on significant changes in economic facts and circumstances in our organization. The change in functional currency was
accounted for prospectively from March 17, 2023 and prior-period consolidated&#160;financial statements were not restated for
the change in functional currency.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<div style="text-align: center; margin-left: 0.25in"></div>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
both monetary and non-monetary assets and liabilities, translated balances as of March 17, 2023 became the new accounting basis.
The exchange rate on the date of change became the historical rate at which non-monetary assets and liabilities were translated
in subsequent periods. There was no effect on the cumulative translation adjustment on the consolidated basis. Previously recorded
cumulative translation adjustments were not reversed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency for the Company&#8217;s Canadian subsidiary, 0896800 BC Ltd., which has no independent operations from its
parent, also changed from the Canadian dollar to the U.S. dollar. The functional currency for Elk Creek Resources Corp. remains
as the U.S. dollar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transactions
in foreign currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
made in a currency other than the functional currency are remeasured to the functional currency at exchange rates at the dates
of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are remeasured to
the functional currency at the exchange rate at that date and non-monetary assets and liabilities are remeasured at historical
rates. Foreign currency translation gains and losses are included in profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Translation
to reporting currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation
gains and losses from the application of the U.S. dollar as the reporting currency for all periods prior to March 17, 2023 (when
the Canadian dollar was the functional currency) are included as part of cumulative currency translation adjustment, which is
reported as a component of shareholders&#8217; equity under accumulated other comprehensive loss.</span></p>

<p id="xdx_851_z4CznbSjJtAl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_ecustom--MineralPropertiesPolicyTextBlock_zn9ko4vXxy8j" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86F_z9HsYAkJsLj5">Mineral
                                         Properties</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
property acquisition costs, including indirectly related acquisition costs, are capitalized when incurred. Acquisition costs include
cash consideration and the fair market value of Common Shares issued as consideration. Properties acquired under option agreements,
whereby payments are made at the sole discretion of the Company, are capitalized as mineral property acquisition costs at such
time as the payments are made. Exploration costs are expensed as incurred. When it is determined that a mining deposit can be
economically and legally extracted or produced based on established proven and probable reserves under S-K 1300, and the Board
of Directors has approved the commencement of formal development activities, development costs related to such reserves and incurred
after such board approval will be considered for capitalization. The establishment of proven and probable reserves is based on
results of feasibility studies, which indicate whether a property is economically feasible. Upon commencement of commercial production,
capitalized costs will be amortized over their estimated useful lives or units of production, whichever is a more reliable measure.
Capitalized amounts relating to a property that is abandoned or otherwise considered uneconomic for the foreseeable future are
written off.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#8217;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. This would include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Such evaluations compare estimated future net cash flows with our carrying costs and future obligations on an undiscounted
basis. If it is determined that the estimated future undiscounted cash flows are less than the carrying value of the property,
an impairment loss will be recorded. Where estimates of future net cash flows are not determinable and where other conditions
indicate the potential for impairment, management uses available market information and/or third-party valuation experts to assess
if the carrying value can be recovered and to estimate fair value. There was no impairment recorded to mineral properties as of
June 30, 2023 or 2022, respectively.</span></p>

<p id="xdx_85E_zQgYBvzmKOg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zZSrZEJUreb3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_zUmviM3xRkyh">Long
                                         Lived Assets</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets, other than mineral properties, held and used by the Company are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>









<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For purposes of evaluating the recoverability
of long-lived assets, the recoverability test is performed using undiscounted net cash flows related to the long-lived assets.
If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount
of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount
or fair value less costs to sell. There was no impairment recorded to long-lived assets as of June 30, 2023 or 2022, respectively.</span></p>

<p id="xdx_858_zh7qSQAu7Gy7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_eus-gaap--LesseeLeasesPolicyTextBlock_zKbLNiM7xQV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zlAhXUXUovFl">Leases</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Accounting Standards Codification (&#8220;ASC&#8221;) 842, &#8220;Leases,&#8221; we determine if a contractual arrangement is,
or contains, a lease at the inception date. Right-of-use (&#8220;ROU&#8221;) assets and liabilities related to operating leases
are separately reported in the consolidated balance sheets. The Company currently has no finance leases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU
assets and lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments
over the lease term. When the rate implicit to the lease cannot be readily determined, we utilize our incremental borrowing rate
in determining the present value of the future lease payments. The incremental borrowing rate is derived from information available
at the lease commencement date and represents the rate of interest that a lessee would have to pay to borrow an amount equal to
the lease payments on a collateralized basis over a similar term in a similar economic environment. Operating lease ROU assets
also include any cumulative prepaid or accrued rent when the lease payments are uneven throughout the lease term. The ROU assets
and lease liabilities may include options to extend or terminate the lease when it is reasonably certain that we will exercise
that option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term.
For operating leases, interest on the lease liability and the amortization of the ROU asset result in straight-line rent expense
over the lease term. Variable lease expenses are recorded when incurred.</span></p>

<p id="xdx_859_zoEY2MYRHgej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_ecustom--WarrantsPolicyTextBlock_zmOdMLKAZMp9" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_zkn0gfB4mzZ1">Warrants</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
apply relevant accounting guidance for warrants to purchase our stock based on the nature of the relationship with the counterparty.
For warrants issued to investors or lenders in exchange for cash or other financial assets, we follow guidance issued within ASC
480, Distinguishing Liabilities from Equity, and ASC Topic 815, Derivatives and Hedging, (&#8220;ASC 815&#8221;) to assist in
the determination of whether the warrants should be classified as liabilities or equity. The fair value of warrants is estimated
using Black Scholes modeling or Monte Carlo modeling, depending on the settlement features embedded in the warrant. Inputs under
both models include inputs such as NioCorp&#8217;s Common Share price, the risk-free interest rate, the expected term, the volatility,
and the dividend rate. Warrants that are determined to require liability classifications are measured at fair value upon issuance
and are subsequently remeasured to their then fair value at each subsequent reporting period with changes in fair value recorded
in current earnings. Warrants that are determined to require equity classifications measured at fair value upon issuance and are
not subsequently remeasured unless they are required to be reclassified.</span></p>

<p id="xdx_850_za5TRCyDd00d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_ecustom--EarnoutSharesPolicy_zPrxAclSfbdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_zFYPbuZ31El8">Earnout
                                         Shares</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
Shares are classified as a liability due to failure to meet the equity classification criteria under ASC 815-40. The fair value
of the Earnout Shares on the date of issuance and on each measurement date is estimated using a Monte Carlo simulation methodology,
which includes inputs such as NioCorp&#8217;s Common Share price, the risk-free interest rate, the expected term, the implied
volatility underlying the Company&#8217;s Public Warrants, the dividend rate, the conversion price, and the number of Earnout
Shares outstanding. Assumptions used in the model are subjective and require significant judgment.</span></p>

<p id="xdx_85A_zenYl1Yxqa0g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zDNoDDX3pPY3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_865_z6xtqDIfxqBa">Financial
                                         Instruments</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, receivables, equity securities, accounts payable and accrued liabilities,
convertible debt and the related party loan. It is management&#8217;s opinion that the Company is not exposed to significant interest,
currency or credit risks arising from its financial instruments. The fair values of these instruments approximate their carrying
value unless otherwise noted.</span></p>

<p id="xdx_854_zKAO7T0sPzMl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_z4EOR7m4rotd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_zoVOqAKsMn4c">Concentration
                                         of Credit Risk</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial instrument which potentially subjects the Company to credit risk is cash and cash equivalents, The Company holds investments
or maintains available cash primarily in two commercial banks located in Vancouver,</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<div style="text-align: center; margin-left: 0.25in"></div>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">British Columbia and Santa Clara, California.
As part of its cash management process, the Company regularly monitors the relative credit standing of these institutions.</span></p>

<p id="xdx_85A_zJbfMUFd4UO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--AssetRetirementObligationsPolicy_z6U1pWuF73F1" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zzlbXqlYuAfa">Asset
                                         Retirement Obligation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to various government laws and regulations relating to environmental disturbances caused by exploration and
evaluation activities. The estimated costs associated with environmental remediation obligations are accrued in the period in
which the liability is incurred if it is reasonably estimable or known. Until such time that a project life is established, the
Company records the corresponding cost as an exploration stage expense and has accrued $<span id="xdx_90F_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20230630_zC6yQ1gF29bg">48</span> as an accrued liability related to
estimated obligations as of June 30, 2023 (2022 - $<span id="xdx_90D_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20220630_zWKK5mFe9WG6" title="Accrued exploration stage expense">48</span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
reclamation and environmental-related expenditures are difficult to estimate in many circumstances due to the early-stage nature
of the Elk Creek Project, the uncertainties associated with defining the nature and extent of environmental disturbance, the application
of laws and regulations by regulatory authorities and changes in reclamation or remediation technology. The Company periodically
reviews accrued liabilities for such reclamation and remediation costs as evidence indicating that the liabilities have potentially
changed becomes available. Changes in estimates are reflected in the consolidated statement of operations and comprehensive loss in the period an estimate
is revised.</span></p>

<p id="xdx_85D_zjpSh9UxA557" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_z8tYU1sa8Ao3" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zs9Rb7gXjoDb">Income
                                         Taxes</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25, <i>&#8220;Income Taxes &#8211; Recognition.&#8221;
</i>Under the approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between
the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded
against deferred tax assets if management does not believe the Company has met the &#8220;more likely than not&#8221; standard
imposed by ASC 740-10-25-5 to allow recognition of such an asset. ASC 740-10-50, &#8220;Income Taxes &#8211; Disclosure,&#8221;
requires the Company to evaluate its income tax positions and recognize a liability for uncertain tax positions that are not more
likely than not to be sustained by tax authorities. As of June 30, 2023 and 2022, the Company believes it had no income tax uncertainties
that required recognition of a liability. If the Company were to determine that uncertain tax positions meet the criteria for
recognition, an estimated liability and related interest and penalties would be recognized as income tax expense.</span></p>

<p id="xdx_85D_zA6GfYTmwOX7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_ecustom--ReverseStockSplitPolicyTextBlock_zo8YIoczuktl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reverse
                                         Stock Split</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 17, 2023, the Company effected a reverse stock split (the &#8220;Reverse Stock Split&#8221;) on the basis of one (1) post-Reverse
Stock Split Common Share for every ten (10) pre-Reverse Stock Split Common Shares issued and outstanding, with any fractional
shares resulting from the Reverse Stock Split rounded down to the nearest whole share. Immediately after the Reverse Stock Split,
there were 30,000,442 Common Shares issued and outstanding. All references to share and per share amounts (excluding authorized
shares) in the consolidated financial statements and accompanying notes have been retroactively restated to reflect the Reverse
Stock Split.</span></p>

<p id="xdx_85C_zQKjGhvx2ZM6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_ecustom--RedeemableNoncontrollingInterestPolicyTextBlock_zVio3UOUdE0a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_z07Nhe4mLBwg">Redeemable
                                         Noncontrolling Interest</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable
Noncontrolling Interest refers to non-controlling interest associated with the Vested Shares that are redeemable upon the occurrence
of an event that is not solely within the Company&#8217;s control and is reported in the mezzanine section between total liabilities
and shareholders&#8217; deficit, as temporary equity in the Company&#8217;s consolidated balance sheets. The
Company&#8217;s non-controlling interest is redeemable at fair value, and no adjustment to the earnings per share numerator is
required because redemption at fair value is not considered an economic distribution different from other common stockholders.</span></p>

<p id="xdx_85D_zhuVaHmjQsy9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_z4hs6MtuRSEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zHyNOqAYJzI7">Basic
                                         and Diluted Per Share Disclosure</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted
average number of Common Shares outstanding during the period. The Company considers Vested Shares and Released Earnout
Shares (each as defined in Note 10), to be participating securities, requiring the use of the two-class method. Diluted
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted average
number of Common Shares outstanding, inclusive of the dilutive impact of all potentially dilutive securities outstanding
during the period, as applicable.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>









<div style="text-align: center; margin-left: 0.25in"></div>





<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>


<p id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z3eruOf1JU9c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. <span id="xdx_8B3_zJC6A6vaTFb8">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share
attributable to common shareholders:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; background-color: #CCECFF; border-collapse: collapse; margin-left: 0.5in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="9" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the year ended June 30,</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20220701__20230630_zFQp4ku0flCa" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,308</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210701__20220630_zIXhZ86d9w65" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,887</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200701__20210630_zssQC8D0iE53" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,824</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjust:
    Net loss attributable to noncontrolling interest</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20220701__20230630_zqqNk02gopR" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::228"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0809">(251</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20210701__20220630_zOyu0YxBliY6" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0811">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20200701__20210630_zpWSiN86lFEa" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0813">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss available to participating securities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220701__20230630_zV3gNqOmuwTk" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,057</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20210701__20220630_z9QdtQfKZAgc" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,887</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20200701__20210630_zv0dpzPPfiY4" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,824</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss attributable to Vested Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zVLWsnQRhg6j" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,528</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20210701__20220630_z1MBIpPDBSq9" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0823">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20200701__20210630_z2nWNLQPzUU7" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0825">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 9pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss attributed to common shareholders - basic and diluted</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20220701__20230630_z0QxpAAuKBXh" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,529</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20210701__20220630_zUGKlTW6sQ8f" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,887</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20200701__20210630_zwZFR6TLoOK5" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,824</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average shares outstanding &#8211; basic and diluted</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20220701__20230630_zlRgKsVPLbg2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,705,840</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20210701__20220630_zRsagfqjhAD7" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,373,722</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20200701__20210630_zVMUUNLt4TNl" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,196,711</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    per Common Share outstanding &#8211; basic and diluted</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230630_z8PCNjjBnWE1" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.34</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20210701__20220630_zlMXAuzupyke" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.41</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20200701__20210630_zJ5yF0jIKA72" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.20</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p id="xdx_8A5_zDSzIPfVq1a4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following shares underlying options, warrants, and outstanding convertible debt were antidilutive
due to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation for the years
ended June 30, 2023 and 2022, as indicated below.</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zOn3rNY06DWi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BA_zc72BNzqWaDh" style="display: none; visibility: hidden">Schedule of excluded from the dilutive securities</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 89%; border-collapse: collapse; margin-left: 0.75in">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the year ended June 30,</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 61%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excluded
    potentially dilutive securities <sup id="xdx_F6B_zlpIL2QeXlS8">(1)(2)</sup>:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 11%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20230630_fKDEpKDIp_zTxQsQUt6vCi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,541,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20210701__20220630_fKDEpKDIp_zJ8w8jErmrs" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,446,400</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20200701__20210630_fKDEpKDIp_zkjNk0oBemyg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,596,500</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20230630_fKDEpKDIp_zrQbk9S4UKg5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,816,304</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20210701__20220630_fKDEpKDIp_zDcNxKNdVr4a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,851,622</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20200701__20210630_fKDEpKDIp_z0sNl7vkl4B1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,434,186</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
debt</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20230630_fKDEpKDIp_z7mNylIwkLa2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,871,660</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20210701__20220630_fKDEpKDIp_zahcAL52BKfa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">415,200</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20200701__20210630_fKDEpKDIp_zgqIxU0aSyua" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,455,700</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    potentially dilutive securities <sup></sup></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--DilutiveSecurities_c20220701__20230630_fKDEpKDIp_zJ5fgeJjdrLe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,229,464</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--DilutiveSecurities_c20210701__20220630_fKDEpKDIp_z1DA4k0owKD9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,713,222</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--DilutiveSecurities_c20200701__20210630_fKDEpKDIp_zC4ZPsqKRXjg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,486,386</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F0C_z8MpdCdTVJXl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zvlOvhPMsqK8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F06_zEo1LnpKZiee" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zjFm1EndTiW7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period. </span></td></tr>
</table>

<p id="xdx_8AE_zQYsB0CM1Ksf" style="margin-top: 0; margin-bottom: 0"></p>

<p id="xdx_850_zRMQRCxOQud8" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zXWOk6GWM1Kl" style="margin-top: 0; margin-bottom: 0"></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">p)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zPYfP5GRiaW3">Share
                                         Based Compensation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants stock options to directors, officers, employees, and business advisors. Option terms and vesting conditions
are at the discretion of the Board of Directors. Prior to March 21, 2023, the option exercise price was equal to the closing
market price on The Toronto Stock Exchange (the &#8220;TSX&#8221;) on the day preceding the date of grant. Effective March
21, 2023, the option exercise price is equal to the closing market price on the Nasdaq Stock Market LLC
(&#8220;Nasdaq&#8221;) on the day preceding the date of the grant.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates the fair value of stock options using the Black-Scholes option pricing model. The Company recognizes forfeitures
as they occur.</span></p>

<p id="xdx_85F_zCFoHEFpDF1g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z9lxU8GlAWhd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">q)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_zhBbIkyvNjb3">Recent
                                         Accounting Standards</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued
and Adopted</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;)
No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s
Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;), which simplifies the accounting for convertible instruments. ASU 2020-06
removes certain accounting models which separate the embedded conversion features from the host contract for convertible instruments.
Either a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption
of this standard. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within
those fiscal</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>









<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">years. The Company adopted ASU 2020-06 on July 1, 2022, with no material effect on the Company&#8217;s current financial
position, results of operations or financial statement disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued
and Not Effective</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective
date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a
material impact on the Company&#8217;s consolidated financial statements upon adoption.</span></p>

<p id="xdx_855_zPyBX9MDZqb1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zp4sRsVfdp0h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in">r)</td><td style="text-align: left"><span id="xdx_86D_zfPv1ZxtiDKj">Revision of Financial Statements (Unaudited)</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">During the
fourth quarter of fiscal year 2023, the Company determined that it had used an incorrect strike price while valuing the Private
Warrants (as defined below in Note 11c) at both the March 17, 2023, issuance date and as of March 31, 2023. This resulted in an
overstatement of other operating expenses, at fair value, and an understatement of change in fair value of warrant liabilities
in condensed consolidated statement of operations and comprehensive loss for both the three- and nine-month periods ended March
31, 2023. In addition, warrant liabilities, at fair value and accumulated deficit were overstated and understated, respectively,
as of March 31, 2023. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company determined that
these errors were immaterial to the previously issued consolidated financial statements, and as such no restatement was necessary.
Periods not presented herein will be revised, as applicable, in future filings.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">The effects
of the revision on the previously issued consolidated financial statements are as follows:</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p id="xdx_896_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zhsVYVtVC4s6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Revision Impacts to the Condensed Consolidated
Balance Sheet (unaudited)</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of March 31, 2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8BB_zqPDmNb9cDEc" style="display: none; visibility: hidden">Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As
of March 31, 2023</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zelflEE9IMBf" style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zWaKgukSfI9" style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230331_zY93igpGJPta" style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">As Previously<br/> Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revision<br/> Impacts</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revised</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--OtherLiabilitiesNoncurrent_iI_pn3n3_zqax1sPZZ8hd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-left: 5.4pt">Warrant liabilities, at fair value</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,303</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(665</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,638</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Total liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Liabilities_iI_pn3n3_c20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zRJ4DvEAlRkk" style="text-align: right" title="Total liabilities">34,735</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Liabilities_iNI_pn3n3_di_c20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zCy0TdbKQsH" style="text-align: right" title="Total liabilities">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Liabilities_iI_pn3n3_c20230331_zxCnuRnyJIEi" style="text-align: right" title="Total liabilities">34,070</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pn3n3_z1kI0YlWdhE3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(146,046</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">665</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(145,381</td><td style="text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--StockholdersEquity_iI_pn3n3_zEeGmVLayfV2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Total shareholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,512</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">665</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,847</td><td style="text-align: left">)</td></tr>
</table>

<p id="xdx_8A2_zXr0M4XmAGXb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"></p>

<p id="xdx_89B_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zf4thyh0OZk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Revision Impacts to the Condensed Consolidated
Statement of Operations and Comprehensive Loss (unaudited)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the Three Months Ended March 31,
2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_8B8_zwMYtoPoRhJ1" style="display: none; visibility: hidden">Revision Impacts to
                                            the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For
                                            the Three &amp; Nine Months Ended  March 31,
2023</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">As Previously<br/>
 Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revision<br/>
 Impacts</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revised</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-left: 5.4pt">Other operating expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OtherGeneralExpense_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zgQOUnHXWm68" style="width: 12%; text-align: right" title="Other operating expense">26,220</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--OtherGeneralExpense_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpLsguPTVOxc" style="width: 12%; text-align: right" title="Other operating expense">(861</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--OtherGeneralExpense_pn3n3_c20230101__20230331_zasjIfkHG88d" style="width: 12%; text-align: right" title="Other operating expense">25,359</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Total operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zMubrwz0kZt3" style="text-align: right" title="Total operating expenses">29,192</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zH8djFst0Oeh" style="text-align: right" title="Total operating expenses">(861</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331_zXe8FrzG6AT7" style="text-align: right" title="Total operating expenses">28,331</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Change in fair value of warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKTc1llfKIEk" style="text-align: right" title="Change in fair value of warrant liability">784</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zKLUQIW7L7g4" style="text-align: right" title="Change in fair value of warrant liability">196</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331_zBKidsx6iaqj" style="text-align: right" title="Change in fair value of warrant liability">980</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Loss before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zkop0E3nssMi" style="text-align: right" title="Loss before income taxes">29,621</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zefaGBWcanv1" style="text-align: right" title="Loss before income taxes">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_dxL_c20230101__20230331_zTUVmm3EVvbc" style="text-align: right" title="Loss before income taxes::XDX::-3877"><span style="-sec-ix-hidden: xdx2ixbrl0929">28,956</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zDEONR6tVaG5" style="text-align: right" title="Net loss">29,435</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zTzxnU9qsx3d" style="text-align: right" title="Net loss">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331_zTXUUlkWJVU3" style="text-align: right" title="Net loss">28,770</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Net loss attributable to the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ProfitLoss1_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zzG310e4baTk" style="text-align: right" title="Net loss attributable to the company">29,343</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ProfitLoss1_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zTNbjnxJqVt6" style="text-align: right" title="Net loss attributable to the company">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ProfitLoss1_pn3n3_c20230101__20230331_zGms76QML6g2" style="text-align: right" title="Net loss attributable to the company">28,678</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Total comprehensive loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zCkWs19aZdeh" style="text-align: right" title="Total comprehensive loss">29,323</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zPIBX74Xw4Z1" style="text-align: right" title="Total comprehensive loss">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331_z9Alax3TgdJ2" style="text-align: right" title="Total comprehensive loss">28,658</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Comprehensive loss attributable to the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zyDqlX3Y74x6" style="text-align: right" title="Comprehensive loss attributable to the company">29,231</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zG6JE1rlwC6a" style="text-align: right" title="Comprehensive loss attributable to the company">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331_z2L0neTwcTSc" style="text-align: right" title="Comprehensive loss attributable to the company">28,566</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Loss per common share, basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNILCmuSVGma" style="text-align: right" title="Loss per common share, basic and diluted">1.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zlpch4MOAPo4" style="text-align: right" title="Loss per common share, basic and diluted">(0.02</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331_z1FzQUrq6b97" style="text-align: right" title="Loss per common share, basic and diluted">0.98</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>




<p style="margin-top: 0; margin-bottom: 0">&#160;</p>









<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Revision Impacts to the Condensed Consolidated
Statement of Operations and Comprehensive Loss (unaudited)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the Nine Months Ended March 31,
2023&#160; &#160; &#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
    <td style="width: 55%; padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right">&#160;</td>
    <td style="width: 1%; background-color: white; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right">&#160;</td>
    <td style="width: 1%; background-color: white; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right">&#160;</td>
    <td style="width: 1%; background-color: white; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><b>As
    Previously<br/>
 Reported</b></span></td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><b>Revision<br/>

    Impacts</b></span></td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><b>Revised</b></span></td>
    <td style="background-color: white; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Other operating expense</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--OtherGeneralExpense_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYqCHLJxMxO9" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"><span style="font-size: 10pt">26,888</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_98C_eus-gaap--OtherGeneralExpense_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_z9N7AAiEK2a2" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"><span style="font-size: 10pt">(861</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--OtherGeneralExpense_pn3n3_c20220701__20230331_zKeufiUYm8qe" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"><span style="font-size: 10pt">26,027</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Total operating expenses</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98B_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zPqhiQylMFh6" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"><span style="font-size: 10pt">33,475</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zOnwEy7ElEg" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"><span style="font-size: 10pt">(861</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_987_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331_z3rjgMQXLo2c" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"><span style="font-size: 10pt">32,614</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Change in fair value of warrant liability</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98E_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zGRArvNXlvyg" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"><span style="font-size: 10pt">868</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98B_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_ze6iLON1bLq2" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"><span style="font-size: 10pt">196</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_989_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331_zuXbyNA31H96" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"><span style="font-size: 10pt">1,064</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Loss before income taxes</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYWQlY66Wnz5" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes"><span style="font-size: 10pt">35,927</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpRhxZjqEyEd" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes"><span style="font-size: 10pt">(665</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_dxL_c20220701__20230331_zWnUuOx7nh73" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes::XDX::-3877"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0988">35,262</span></span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Net loss</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9qjusG3RCWk" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::-35741"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0990">35,741</span></span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zmIztkbqaAhc" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::665"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0992">(665</span></span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331_z4nx268bQSIk" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::-35076"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0994">35,076</span></span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Net loss attributable to the Company</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_981_ecustom--ProfitLoss1_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zm2e8LNnCqnj" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"><span style="font-size: 10pt">35,649</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98A_ecustom--ProfitLoss1_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zYuXfcMAfHIc" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"><span style="font-size: 10pt">(665</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_985_ecustom--ProfitLoss1_pn3n3_c20220701__20230331_z9sJmKZ4oxMk" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"><span style="font-size: 10pt">34,984</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Total comprehensive loss</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKA82dNJQKfk" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"><span style="font-size: 10pt">35,659</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98A_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZ5L3oKr2MW1" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"><span style="font-size: 10pt">(665</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_986_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331_zcGBegKbF1yh" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"><span style="font-size: 10pt">34,994</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Comprehensive loss attributable to the Company</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98F_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_ze5Cyg3e3j4k" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"><span style="font-size: 10pt">35,567</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98B_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zlDk0KhpPKR" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"><span style="font-size: 10pt">(665</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_987_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331_zbMZnDl5gef2" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"><span style="font-size: 10pt">34,902</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Loss per common share, basic and diluted</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zWRnAaJET1i8" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"><span style="font-size: 10pt">1.26</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zf7OTzzqRKrl" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"><span style="font-size: 10pt">(0.02</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331_z8dneKmKuTV7" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"><span style="font-size: 10pt">1.24</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
</table>
<p id="xdx_8A0_z6LBYNyBTvh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"></p>

<p id="xdx_892_esrt--ScheduleOfCondensedCashFlowStatementTableTextBlock_zAD57VdDtUPi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Revision Impacts to the Condensed Consolidated
Statement of Cash Flows (unaudited)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the Nine Months Ended March 31,
2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8B5_z14eJLyY15d8" style="display: none; visibility: hidden">Revision Impacts to the Condensed
Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023</span>&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">As Previously<br/>
 Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revision<br/>
 Impacts</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revised</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; text-align: left">Net loss for the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zbiFHIIS78Sh" style="width: 12%; text-align: right">(35,741</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zSvmIcP42Hzg" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1022">665</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230331_zfmGaN4AcFT2" style="width: 12%; text-align: right">(35,076</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Initial valuation of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwjsL1DGD204" style="text-align: right">3,848</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zIqZuI2UrFOg" style="text-align: right">(861</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331_zswoFw4mvRbh" style="text-align: right">2,987</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Change in fair value of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zUapaVmlhvAi" style="text-align: right">868</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zbjfLsqFDSz4" style="text-align: right">196</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331_zAf3FS7vazv5" style="text-align: right">1,064</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A7_zi5vEHv55UAd" style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>



<p id="xdx_85D_zcRVC8TinVjf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164867120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOING CONCERN ISSUES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">GOING CONCERN ISSUES</a></td>
<td class="text"><p id="xdx_809_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zLcWb8o9mKX" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82C_zWsorQxy2Sw5">GOING
CONCERN ISSUES</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company incurred a net
loss of $<span id="xdx_904_eus-gaap--NetIncomeLoss_iN_pn3n3_dixL_c20220701__20230630_z95LpGxjfJTc" title="Net loss::XDX::40308"><span style="-sec-ix-hidden: xdx2ixbrl1033">40,080</span></span>
for the year ended June 30, 2023 (2022 - $<span id="xdx_90A_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210701__20220630_zm50D2uTuljf">10,887</span>
and 2021 - $<span id="xdx_906_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200701__20210630_zr16DatHZEIa">4,824</span>) and had an
accumulated deficit of $150,477 as of June 30, 2023. As a development stage issuer, the Company has not yet commenced its
mining operations and accordingly does not generate any revenue. As of June 30, 2023, the Company had cash and cash
equivalents of $<span id="xdx_905_ecustom--CashAndCashEquivalentsAtCarryingValue1_pn3n3_c20220701__20230630_zlk3LqB0Ukx3" title="Cash">2,341</span>
which is not sufficient to fund normal operations for the next twelve months without deferring payment on certain liabilities
or raising additional funds. In addition, the Company will be required to raise additional funds for construction and
commencement of operations. These factors raise substantial doubt about the Company's ability to continue as a going
concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s ability to continue operations and fund its expenditures, which have historically averaged approximately $<span id="xdx_905_eus-gaap--CapitalExpenditureDiscontinuedOperations_pn3n3_c20220701__20230630_zwvALqZIP4rl" title="Capital expenditure of operations">2,350</span>
per quarter over the preceding three-year period, is dependent on management&#8217;s ability to secure additional financing. NioCorp
expects to have access to up to $62,577 in net proceeds from the Yorkville Equity Facility Financing through April 1, 2026, as
discussed in Note 11d. Management is actively pursuing additional sources of financing, and while it has been successful in doing
so in the past, there can be no assurance it will be able to do so in the future. Other than the potential issuance of Common
Shares under the Yorkville Equity Facility Financing Agreement, the Company did not have any further funding commitments or arrangements
for additional financing as of June 30, 2023. These consolidated financial statements do not give effect to any adjustments required
to realize the Company&#8217;s assets and discharge its liabilities in other than the normal course of business and at amounts
different from those reflected in the accompanying consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent
worldwide events have created general global economic uncertainty as well as uncertainty in capital markets, supply chain disruptions,
increased interest rates and inflation, and the potential for geographic recessions. We believe this could have an adverse impact
on our ability to obtain financing, development plans, results of operations, financial position, and cash flows during the current
fiscal year. The full extent to which these events and our precautionary measures may continue to impact our business will depend
on future developments, which continue to be highly uncertain and cannot be predicted at this time.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 40<br> -URI https://asc.fasb.org/subtopic&amp;trid=51888271<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164829376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GXII TRANSACTION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">GXII TRANSACTION</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--BusinessCombinationDisclosureTextBlock_z9SfwsdJ3Pub" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_824_z9yZruc9YKJe">GXII
TRANSACTION</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, the following transactions (collectively, the &#8220;GXII Transaction&#8221;) occurred
on the Closing Date:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a
    result of a series of transactions, GXII became an indirect, majority-owned subsidiary of NioCorp and changed its name to
    &#8220;Elk Creek Resources Corp&#8221; (&#8220;ECRC&#8221;).</span></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As the
    parent company of the merged entity, NioCorp issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zF3WK2UBrCLh" title="Post reverse stock split shares">1,753,821</span> post-Reverse Stock Split Common Shares in exchange for all of
    the Class A shares of GXII issued and outstanding immediately prior to the Closing, including 83,770 Common Shares issued
    to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory services.</span></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 4%"></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify; width: 94%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the Class B shares of GXII issued and outstanding immediately prior to the Closing (after giving effect to the surrender of
certain Class B shares of GXII in accordance with the Sponsor Support Agreement, dated September 25, 2022 (the &#8220;Sponsor
Support Agreement&#8221;), among GX Sponsor II LLC (the &#8220;Sponsor&#8221;), GXII, NioCorp and the other persons party thereto)
were converted into <span id="xdx_905_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z6QXjdC2aSF4" title="Convertible shares issued upon conversion">7,957,404</span> shares of Class B common stock of GXII (now known as ECRC) as the surviving entity of the mergers
that occurred on the Closing Date as part of the GXII Transaction. Pursuant to the Business Combination Agreement, the Sponsor
Support Agreement and the Exchange Agreement, dated as of March 17, 2023 (as amended, supplemented or</span></td>
</tr></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>









<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 4%"></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="text-align: justify; width: 94%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">otherwise
modified, the &#8220;Exchange Agreement&#8221;), by and among NioCorp, ECRC and the Sponsor, after the Closing, the shares of
Class B common stock of ECRC are exchangeable into Common Shares on a one-for-one basis, subject to certain equitable adjustments,
under certain conditions. See Note 10 for additional information regarding the Class B common stock of ECRC.</span></td>
</tr></table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    assumed GXII&#8217;s obligations under the agreement (the &#8220;GXII Warrant Agreement&#8221;) governing the GXII share purchase
    warrants (the &#8220;GXII Warrants&#8221;) and issued an aggregate of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_uShares_c20220701__20230630__us-gaap--TypeOfArrangementAxis__custom--WarrantAgreementMember_znPigioY0J14" title="Number of shares purchase">15,666,626</span> warrants (the &#8220;NioCorp Assumed Warrants&#8221;)
    to purchase up to an aggregate of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zu6Tsga72Ia2" title="Number of shares purchase">17,519,864</span> Common Shares. See Note 11c for additional information regarding the NioCorp
    Assumed Warrants. </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p id="xdx_89A_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_z9CjNvrGM0e4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">After the distribution of funds
to GXII redeeming shareholders and prior to paying transaction costs incurred by GXII, $15,676 became available to the Company.
<span id="xdx_8BE_zvhGq16e8iea">The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and
Comprehensive Loss:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_498_20230630_zydPUvNnpwol" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_iI_pn3n3_zi0eb6gtxIYf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 86%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
    cash proceeds, net of transaction costs incurred by GXII</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,168</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB_zqHqMzG2Qip2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash costs associated
    with the Transactions:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn3n3_z24wOkhvP1ji" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    liabilities assumed</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">392</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_iI_pn3n3_z6nv4M3osFH7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville
    Equity Facility Financing Agreement &#8211; cash costs</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,996</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed_iI_pn3n3_zX4CJRueMW81" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
    costs expensed</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,715</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iI_pn3n3_zqR7ry9TQbt" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-cash
    costs associated with the Transactions:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_iI_pn3n3_zy9on14pDKJ1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private
    Warrants assumed at fair value</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,987</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--EarnoutSharesAssumedAtFairValue_iI_pn3n3_zJLWY7ZDo5T4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
    Shares assumed at fair value</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,195</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_iI_pn3n3_zjAL0AcFA0Mj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville
    Equity Facility Financing Agreement &#8211; shares issued</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">650</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pn3n3_z5waYAziiy0e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Total
    transaction related losses incurred</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,767</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p id="xdx_8A7_zjosdUgRMnC8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_899_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_zbKtToD2JDGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BC_zChDr8AQQFsa">The
number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    Shares</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 75%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legacy
    NioCorp Shareholders</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zblr1nfAaEMc" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Common stock, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,246,621</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zAMBpxdjXG18" title="Number of shares, percentage">93.90</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former GXII Class
    A Shareholders<sup id="xdx_F4D_zq4h1nGPSVFe">1</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zuEcaxWXZuc9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,753,821</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zujXQR4VrIz" title="Number of shares, percentage">5.83</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other<sup id="xdx_F46_zjJHsG8GU2Ul">2</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--TransactionTypeAxis__custom--OtherMember_fMg_____zHyFaChf1lsc" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,213</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--OtherMember_fMg_____zHSj89FhogG9" title="Number of shares, percentage">0.27</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Common Shares Outstanding Upon Completion of Transactions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--CommonStockSharesOutstanding_iI_pid_dxL_uShares_c20230630_zfZfNceSkSYg" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Common stock, shares outstanding::XDX::31202131"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1091">30,081,655</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630_z0F1g9xEQJMf" title="Number of shares, percentage">100</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F06_zSHFFoRWnGE5" style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"><span id="xdx_F1F_zHUfU4stxzw" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory
    services.</span></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span id="xdx_F0F_zbck7w8k0Zlf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"><span id="xdx_F1C_zrGJJauUTbSk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    Commitment Shares (as defined in Note 11d) issued under the Yorkville Equity Facility Financing Agreement.</span></td></tr>
</table>

<p id="xdx_8A9_zXEze9knVenj" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the GXII Transaction, the Company also closed the Yorkville Convertible Debt Financing and the Yorkville Equity
Facility Financing, as discussed in Notes 9 and 11d.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164832960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LAND AND BUILDINGS, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">LAND AND BUILDINGS, NET</a></td>
<td class="text"><p id="xdx_804_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zmIs9IX3eWr4" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_822_zucWIc4mFPB">LAND
AND BUILDINGS, NET</span></span></td>
</tr></table>

<p id="xdx_89D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zGhFjxhgoaWc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zZiUYWOT9gF9" style="display: none; visibility: hidden">Schedule of properties</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 88%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="22" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">2022</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated <br/>
Depreciation</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated <br/>
Depreciation</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 22%">Land</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_z42PdFrA4Kb9" style="width: 8%; text-align: right" title="Cost">807</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_ztpb9xlhX1P8" style="width: 8%; text-align: right" title="Accumulated depreciation">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zOqlHn3igx1h" style="width: 8%; text-align: right" title="Net">807</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--LandMember_z5iltUQROLHd" style="width: 8%; text-align: right">811</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20220630__srt--ProductOrServiceAxis__us-gaap--LandMember_zLkf8dpBgTlf" style="width: 8%; text-align: right" title="Accumulated depreciation">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--LandMember_z1C8XJJ5l5Zg" style="width: 8%; text-align: right">811</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Buildings and other</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zcN1WCL9Ex32" style="border-bottom: Black 1pt solid; text-align: right">41</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z5i9R6yq5L72" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">9</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zPntT9MgMbHi" style="border-bottom: Black 1pt solid; text-align: right">32</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zKSFFYWnr9a6" style="border-bottom: Black 1pt solid; text-align: right">45</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z0pT9THnmUUg" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">6</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z0ZyhguGbmci" style="border-bottom: Black 1pt solid; text-align: right">39</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630_zDawkaqFIqJi" style="border-bottom: Black 2pt solid; text-align: right">848</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630_zj8WiFxN8mbl" style="border-bottom: Black 2pt solid; text-align: right">9</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630_z2xaV7sFhdKi" style="border-bottom: Black 2pt solid; text-align: right">839</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20220630_zAKdMwYKhYO3" style="border-bottom: Black 2pt solid; text-align: right">856</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20220630_zFqpOv0VmhOg" style="border-bottom: Black 2pt solid; text-align: right">6</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20220630_zyH0LX1SuAUh" style="border-bottom: Black 2pt solid; text-align: right">850</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A2_zTtYVEODRovi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>













<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
October 2022, the Company entered into an agreement with the State of Nebraska (the &#8220;State&#8221;) to sell a strip
of Company-owned land totaling <span id="xdx_905_eus-gaap--LandPurchaseOptionsDescription_c20221020__20221022__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandImprovementsMember_zSll8EhgNDe6" title="Description of owned land">approximately
1.27 acres located adjacent to State Highway 50</span> in connection with highway improvements to be completed by the
State, for $<span id="xdx_90D_eus-gaap--LandAndLandImprovements_iI_pn3n3_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandImprovementsMember_ziUHhAaU6mO6" title="Improvements state">21</span>,
inclusive of estimated fence replacement costs. <span id="xdx_90B_eus-gaap--LimitedPartnersCapitalAccountDescriptionOfUnits_c20221020__20221022__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandImprovementsMember_z69bFDbQyZ1c" title="Description of ownership of mineral rights">The Company retained ownership of the mineral rights associated with
this 1.27-acre parcel.</span> The Company recorded a gain on
this sale of $<span id="xdx_90F_eus-gaap--RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_iI_pn3n3_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandImprovementsMember_zwC5Yrxdzmy1" title="Other gains and comprehensive loss">13</span> in other gains in the consolidated statement of operations and comprehensive loss.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164858832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MINERAL PROPERTIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ExtractiveIndustriesAbstract', window );"><strong>Extractive Industries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MineralIndustriesDisclosuresTextBlock', window );">MINERAL PROPERTIES</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--MineralIndustriesDisclosuresTextBlock_zkV0EgU2ckFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82E_zSEqH8YWgOu1">MINERAL
PROPERTIES</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended June 30, 2011, the Company completed the acquisition of the Elk Creek property through a share exchange agreement
with 0859404 BC Ltd, a Canadian company, which owned all the issued and outstanding shares of ECRC. The Company issued <span id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_uShares_c20110628__20110630__dei--LegalEntityAxis__custom--Entity0896800BCLtdMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ElkCreekResourcesCorpMember_zoA4J4fV08k5" title="Shares issue for acquistion">1,899,053</span>
Common Shares to acquire all of the issued and outstanding shares of 0859404 BC Ltd. and issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_uShares_c20110628__20110630__dei--LegalEntityAxis__custom--Entity0896800BCLtdMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zskx8stSAGS2" title="Shares issue for acquistion">103,434</span> Common Shares as a finder&#8217;s
fee with respect to the acquisition. The transaction did not meet the definition of a business acquisition, as set forth in ASC
805, &#8220;Business Combinations,&#8221; and therefore was accounted for as a purchase of assets. The acquisition price was based
on the market value of the Company&#8217;s Common Shares on the closing date and total consideration given was C$<span id="xdx_90A_eus-gaap--BusinessCombinationConsiderationTransferred1_c20110628__20110630__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--CurrencyAxis__currency--CAD_zUTJF5VA8Sul" title="Total consideration">13,246</span>, including
associated deferred tax impacts of C$<span id="xdx_907_ecustom--DeferredTaxImpacts_iI_c20110630__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--CurrencyAxis__currency--CAD_zGll8ZyVofF6" title="Deferred tax">4,736</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 23, 2021, ECRC formally closed the purchase of two parcels of land and associated buildings and mineral rights in Johnson
County, Nebraska, associated with the Elk Creek Project, pursuant to an Amended and Restated Option to Purchase, dated as of April
29, 2020 (the &#8220;Option Agreement&#8221;). Pursuant to the terms of the Option Agreement, the Owner sold, transferred, conveyed
and assigned all of the rights, privileges, title and interest in and to the real property to ECRC, including any associated mineral
rights. The Option Agreement provided for a purchase price calculated based on the appraised value per acre of the parcels of
land, the mineral rights and the structures erected on the land. The purchase price was approximately $<span id="xdx_908_eus-gaap--SupplementalDeferredPurchasePrice_pn3n3_c20210421__20210423__us-gaap--TypeOfArrangementAxis__custom--OptionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ElkCreekResourcesCorpMember_zfkr8cnOfgTk" title="Purchase price">6,300</span>, including indirect
costs of $<span id="xdx_908_eus-gaap--AmortizationOfAcquisitionCosts_pn3n3_c20210421__20210423__us-gaap--TypeOfArrangementAxis__custom--OptionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ElkCreekResourcesCorpMember_z3XUFPDExpha" title="Indirect costs">57</span>. Of this amount, $<span id="xdx_901_eus-gaap--PaymentsToAcquireMineralRights_pn3n3_c20210421__20210423__us-gaap--TypeOfArrangementAxis__custom--OptionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ElkCreekResourcesCorpMember_zMpNOXBDsR6l" title="Other amount">837</span> was allocated to land and buildings and the remaining $<span id="xdx_902_eus-gaap--PaymentsToAcquireBuildings_pn3n3_c20210421__20210423__us-gaap--TypeOfArrangementAxis__custom--OptionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ElkCreekResourcesCorpMember_zVBNe7tUA8Mf" title="Remaining balance">5,468</span> was allocated to mineral properties
as costs related to mineral rights acquisition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the land and mineral rights currently owned by the Company, the property interests of Elk Creek include eight prepaid
mineral exploration option-to-purchase agreements and include a pre-determined buyout for permanent ownership of the mineral and/or
surface rights. Terms of the agreements require no further significant payments, and the Company may negotiate lease extensions
or elect to purchase the mineral and/or surface rights any time. Agreements that allow for the purchase of mineral rights contain
provisions whereby the landowners would retain a 2% net smelter return.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ExtractiveIndustriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ExtractiveIndustriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MineralIndustriesDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for mineral industries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -URI https://asc.fasb.org/topic&amp;trid=2145477<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 930<br> -SubTopic 715<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473690&amp;loc=d3e23744-110275<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 930<br> -URI https://asc.fasb.org/topic&amp;trid=2155974<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MineralIndustriesDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164722800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</a></td>
<td class="text"><p id="xdx_809_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zmTVc3u3wGK4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_820_zcRwatizURve">ACCOUNTS
PAYABLE AND ACCRUED LIABILITIES</span></span></td>
</tr></table>

<p id="xdx_89F_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z1e7O7549m0k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zYDi55cjSCFd" style="display: none; visibility: hidden">Schedule of account payable and accrued liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49F_20230630_zIIEHiJUSMx5" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="3" id="xdx_497_20220630_zjMc309MDUic" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zsNd0OmDJeVk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left">Accounts payable, trade</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,990</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">115</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_z0V4FV6YzPQk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade payable accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,324</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">654</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pn3n3_zep4RcGMjWx5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income taxes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1168">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_zwATtYBQqDs" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Environmental accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zJ5vNWYcI1ra" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Loan origination fees payable to related party</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1174">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_zFXGY51Hqnme" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Total accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">3,491</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">817</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AF_zeIf9U2UihB7" style="margin-top: 0; margin-bottom: 0"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164867120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">CONVERTIBLE DEBT</a></td>
<td class="text"><p id="xdx_809_eus-gaap--LongTermDebtTextBlock_zmuFTRNDSBLd" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_824_zUsEcAkXL1I1">CONVERTIBLE
DEBT</span></span></td>
</tr></table>

<p id="xdx_89A_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_zUSiT4NvRe3g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zBH3fghWdisc" style="display: none; visibility: hidden">Schedule of convertible debt</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current Portion:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 74%; text-align: left; padding-bottom: 2pt; padding-left: 0.125in">Lind III convertible security</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 2pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zhnvuGIQ2UWd" style="border-bottom: Black 2pt solid; width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1182">-</span></td><td style="border-bottom: Black 2pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 2pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_z9YihaD2wON3" style="border-bottom: Black 2pt solid; width: 10%; text-align: right" title="Convertibled debt, current">2,169</td><td style="border-bottom: Black 2pt solid; width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Noncurrent Portion:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in">Yorkville convertible debentures</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zNTGr70ljNWl" style="border-bottom: Black 2pt solid; text-align: right" title="Convertible debt, noncurrent">10,561</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_z4rC220ZElx4" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1187">-</span></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AF_zqmqzEZG3br5" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>









<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Lind
III Convertible Security</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 16, 2021, the Company issued to Lind Global Asset Management III, LLC (&#8220;Lind&#8221;), an entity managed by The
Lind Partners, the convertible security (the &#8220;Lind III Convertible Security&#8221;) pursuant to the Convertible Security
Funding Agreement, dated February 16, 2021, as amended by Amendment #1 to the Convertible Security Funding Agreement, dated December
2, 2021, between the Company and Lind (as amended, the &#8220;Lind III Agreement&#8221;). The Lind III Convertible Security had
a face value of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_pn3n3_c20210216__20210219_zMs27KE2NSb8" title="Face value">11,700</span> (representing $10,000 in funding plus an implied <span id="xdx_90E_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20210219_z8GP56PSQo3h">8.5</span>% interest rate per annum for the term of the Lind
III Convertible Security). After deducting a $<span id="xdx_902_eus-gaap--OtherCommitment_iI_pn3n3_c20210219_zcjKoUQMbYP5" title="Commitment fee">350</span> commitment fee as set forth in the Lind III Agreement, NioCorp received net
proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromInterestReceived_pn3n3_c20210216__20210219_za7FmcpdHEY1" title="Net proceeds">9,650</span> from the funding of the Lind III Convertible Security. The Company used a portion of the proceeds from the
funding of the Lind III Convertible Security to purchase a key land parcel associated with the Company&#8217;s Elk Creek Project,
with the remainder spent for general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Lind III Convertible Security had a term of (i) <span id="xdx_905_eus-gaap--LongTermDebtTerm_iI_dxL_c20230630_zFOdKmktzaof" title="Long term debt duration::XDX::P24M"><span style="-sec-ix-hidden: xdx2ixbrl1201">24 months</span></span> or (ii) 30 calendar days after the date on which the face value of the
Lind III Convertible Security is nil due to such amount having been fully converted and/or fully repaid (including with any applicable
premium) in accordance with the terms of the Lind III Agreement, whichever is earlier.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--DebtConversionDescription_c20220701__20230630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zvZS5dxwI1th">Pursuant
to the Lind III Agreement, Lind was entitled to convert the Lind III Convertible Security into Common Shares in monthly installments
over its term at a price per Common Share equal to 85% of the volume-weighted average price Common Shares on the TSX for the five
trading days immediately preceding to the date on which Lind provides notice to the Company of its election to convert. The Lind
III Agreement provided that Common Shares issuable upon conversion, together with the number of Common Shares issued upon exercise
of Warrants, shall not exceed 4,358,800 Common Shares.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 19, 2021, in connection with the funding and issuance of the Lind III Convertible Security, the Company issued <span id="xdx_90A_eus-gaap--CommonUnitIssued_iI_uShares_c20210219_zINwzHsfK7M8" title="Common share purchase warrants">855,800</span>
Common Share purchase warrants, exercisable at a price per Common Share of C$<span id="xdx_90A_eus-gaap--AcceleratedShareRepurchasesFinalPricePaidPerShare_uCADPShares_c20220701__20230630_zq4W1bzY2244" title="Exercisable at a price per share">9.70</span>, expiring February 19, 2025 (the &#8220;Lind
III Warrants&#8221;), to Lind pursuant to the Lind III Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company identified embedded derivatives in the Lind III Convertible Security that were evaluated to be immaterial at both the
closing date and at June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company allocated the net proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_pn3n3_uUSD_c20220701__20230630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_zL2884ZHBN3h">9,477</span> from the Lind III Convertible Security as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,712
    was allocated to Common Stock, representing the fair value of the Lind III Warrants based on the Black Scholes pricing model
    using a risk-free interest rate of <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220701__20230630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zndmK0KPqpej" title="Risk-free interest rate">0.40</span>%, an expected dividend yield of <span id="xdx_904_eus-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate_dp_uPure_c20220701__20230630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zisNboMX9e12" title="Expected dividend yield">0</span>%, a volatility of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20220701__20230630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zdaQRfBBDR6h" title="Volatility">51.60</span>%, and an expected life of
    <span id="xdx_90B_eus-gaap--IntermediateLifePlantsUsefulLife_dxL_c20220701__20230630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zkPPzNmd6Dkd" title="Expected life::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl1215">4.0</span></span> years. </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_906_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_zg3wzUTExwFb" title="Convertible debt liabilit">7,938</span>
    was allocated     to the convertible debt liability. Transaction costs of $<span id="xdx_90B_ecustom--TransactionCost_pn3n3_uUSD_c20220701__20230630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_zjh0PQ1UdQf" title="Transaction costs">173</span>,
    in addition to a commitment fee of $<span id="xdx_90A_eus-gaap--LineOfCreditFacilityCommitmentFeeAmount_pn3n3_c20210217__20210219_zRt1Br5sH0b9" title="Commitment fee">350</span>,
    were recognized as     a direct deduction from the debt liability, resulting in a net opening balance of $7,765. This balance
    was accreted up to the     face value of the Lind III Convertible Security at maturity using the effective interest method
    and recorded as non-cash interest     expense in the consolidated statement of operations and comprehensive loss.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89A_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_zyp1AW0UCzuf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BE_zi34CDBBr5Id">Changes
in the Lind III Convertible Security are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 96%; border-collapse: collapse; margin-left: 0.25in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the year ending June 30,</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 76%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
    balance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--ConvertibleDebtNoncurrent_iS_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zCTOxUoUgvF9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 9%; padding-right: 2.15pt; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,169</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ConvertibleDebtNoncurrent_iS_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_ztl48kYD14fl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 9%; padding-right: 2.15pt; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,234</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value increase due to debt extinguishment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ExtinguishmentOfDebtAmount_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zPzm8jDMfutc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Fair value increase due to debt extinguishment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">201</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ExtinguishmentOfDebtAmount_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_z3ND6dZqhpJ5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Fair value increase due to debt extinguishment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1231">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ConversionOfStockAmountIssued1_iN_pn3n3_di_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zXftOjtSPul4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Conversions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,950</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--ConversionOfStockAmountIssued1_iN_pn3n3_di_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_z1TaagufMIkj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Conversions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,635</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion
    expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--AccretionExpense_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zAvlxooLaGEg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Accretion expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--AccretionExpense_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zFbeAgOnBgTf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Accretion expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,570</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    at maturity</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--PaymentsToAcquireHeldToMaturitySecurities_iN_pn3n3_di_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zAIIAHMbyiB4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Payment at maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(515</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--PaymentsToAcquireHeldToMaturitySecurities_iN_pn3n3_di_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zfuNpY3yvWCf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Payment at maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1243">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance,
    end of period</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--ConvertibleDebtCurrent_iE_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zmMhJgGF2gw" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1245">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--ConvertibleDebtCurrent_iE_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zGoaMNvaZTp7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,169</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p id="xdx_8A9_zn6WDJAorPbj" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>









<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-size: 10pt">On
September 25, 2022, the Company and Lind entered into the Waiver and Consent Agreement, dated September 25, 2022, between the
Company and Lind (the &#8220;Lind Consent&#8221;), which included the following principal terms: (i) the consent of Lind to the
GXII Transaction disclosed in Note 5 and Yorkville Financings disclosed below and in Note 11d, including all actions taken by
NioCorp as set out in the Business Combination Agreement to permit the completion of the Transactions; (ii) the consent of Lind
to NioCorp&#8217;s expected cross-listing to the Nasdaq and the consolidation of the Common Shares in order to meet the minimum
listing requirements thereof; (iii) the waiver of Lind of its participation right for up to 15% of the total offering in the Yorkville
Equity Facility Financing; and (iv) the waiver of Lind of certain restrictive covenants in the Lind III Agreement.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As consideration for entering into the
Lind Consent, Lind received, amongst other things: (i) the right to receive a payment of $500, which would have been reduced to
$200 if the Transactions had not been consummated on or before April 30, 2023 (collectively, the &#8220;Consent Payment&#8221;);
(ii) an extension of its existing participation rights under the Lind III Agreement in future financings of NioCorp for a further
two-year period, subject to certain exceptions as well as an extension of such participation rights beyond the additional two-year
period if Yorkville or any affiliate is a party to any such applicable transaction; and (iii) the right to receive additional Warrants
(the &#8220;Contingent Consent Warrants&#8221;) if on the date that is 18 months following the Closing Date, the closing trading
price of the Common Shares on the TSX or such other stock exchange on which such shares may then be listed, is less than C$10.00
(on a post-Reverse Stock Split basis), subject to adjustments. The number of Contingent Consent Warrants to be issued, if any,
is based on the Canadian dollar equivalent (based on the then current Canadian to US dollar exchange rate as reported by Bloomberg,
LP) of $5,000 divided by the five-day volume weighted average price of the Common Shares on the date of issuance. Further, the
number of Contingent Consent Warrants issued will be proportionately adjusted based on the percentage of Warrants currently held
by Lind that are exercised, if any, prior to the issuance of any Contingent Consent Warrants. The Lind Consent was signed as an
amendment to the existing Lind III Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Management determined that the Lind
Consent should be evaluated using ASC 470, which requires an evaluation of the contract amendment under debt modification guidance.
The Company performed a comparison of the discounted cash flows of the Lind III Convertible Security pursuant to the existing Lind
III Agreement and pursuant to the Lind III Agreement as amended by the Lind Consent and determined that a debt extinguishment loss
of $201 had occurred. Further, ASC 470 requires that the minimum estimated Consent Payment of $200 also be included in the calculation
of the initial loss on debt extinguishment. The Company also evaluated the Contingent Consent Warrant feature included in the Lind
Consent and determined that the Contingent Consent Warrants meet the criteria to be considered separate, freestanding instruments,
should be accounted for as a liability under ASC 480, and should be booked at fair value on the date of the Lind Consent, with
subsequent changes in valuation recorded as a non-operating gain or loss in the consolidated statement of operations and comprehensive
loss. The following table summarizes the components of the initial loss and final loss on extinguishment:</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p id="xdx_89C_eus-gaap--ScheduleOfExtinguishmentOfDebtTextBlock_zYU5vveFJy19" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zZdiXHfZmexk" style="display: none; visibility: hidden">The following table summarizes the components of the initial loss on extinguishment:</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Component of loss</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_496_20220701__20230630_zCQ2gBMelhq1" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--MinimumConsentPaymentAtInception_pn3n3_zxbnNXF91ZK7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 87%; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minimum
    Consent Payment at inception</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--ASC470LossOnExtinguishment_pn3n3_zRQsTefxPyKe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss on debt extinguishment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">201</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--AdjustmentOfWarrantsGrantedForServices_pn3n3_zrvjgz1hSOIk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    fair value of Contingent Consent Warrants</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,221</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_pn3n3_z21HTd1Pjnw" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    loss on debt extinguishment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,622</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--AdditionalConsentPaymentbooked_pn3n3_z9OTwYiXhEi8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    Consent Payment booked<sup id="xdx_F4E_zLIhWIcwEZ78">1</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--GainsLossesOnRestructuringOfDebt_pn3n3_zBCMP29s6eCa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    loss on debt extinguishment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,922</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; padding-right: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 5.4pt; text-align: justify"><span id="xdx_F05_zWiHKFp67EBa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 93%; padding-right: 5.4pt; text-align: justify"><span id="xdx_F16_znGdMSE09cad" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the difference between the accrual of the minimum Consent Payment at September 25, 2022 and the actual payment made on March
    17, 2023.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify">&#160;</td></tr>
</table>
<p id="xdx_8AF_z0bggwYdVtoc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89D_ecustom--ScheduleOfWarrantValuationTableTextblock_z8D7RFLrWh9k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_ztl8jfAUOVqa">The
change in the fair value of the Contingent Consent Warrants is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 76%; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    valuation, September 25, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstanding_iS_c20220701__20230630_zPk9r8SH3Fwh" style="font: 10pt Times New Roman, Times, Serif; width: 19%; padding-right: 2.15pt; text-align: right" title="Initial valuation, at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,221</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in valuation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_ecustom--ChangeInValuationOfWarrants_c20220701__20230630_zLY1DjA0Htmh" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right" title="Change in valuation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">489</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    at June 30, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--WarrantsAndRightsOutstanding_iE_c20220701__20230630_z5inbWDzyBp3" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right" title="Valuation, at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,710</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p id="xdx_8A3_ziScyr2L1ku5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>









<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Contingent Consent Warrants are classified as a Level 3 financial instrument and were valued utilizing a Monte Carlo simulation
pricing model, which calculates multiple potential outcomes for future share prices based on historic volatility of the Common
Shares to determine the probability of issuance at 18 months following the applicable valuation date and to determine the value
of the Contingent Consent Warrants. The following table discloses the primary inputs into the Monte Carlo model at each valuation
date, and the probability of issuance calculated by the model.</span></p>

<p id="xdx_899_ecustom--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_z2e1K9Aadhbf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zZ9UGm3COq19" style="display: none; visibility: hidden">Schedule of valuation date and the probability calculated.</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key Valuation
    Input</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
25,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
30,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 48%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    price on valuation date</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_z7JqcEuX1EIi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: right" title="Share price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.82</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zMIe4TtXk2qh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: right" title="Share price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.03</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 3%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zshyS0ZZK7S7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Volatility"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zUrf6XHUjH9g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Volatility"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.0</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_zFZFIy8rMQzf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Risk free rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.93</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_z10grwww8KFf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Risk free rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Probability of
    issuance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_zNOnUs8ZaMAa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Probability of issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_z1FA45HECf56" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Probability of issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
</table>
<p id="xdx_8A2_zr93TpQHpcDa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Loss
on debt extinguishment is presented as a non-operating expense in the Company&#8217;s consolidated statements of operations and
comprehensive loss. This accounting also resulted in a decrease in the amount of accretion to be recognized over the remaining
life of the Lind III Convertible Security through February 2023. Accretion expenses are disclosed as a part of interest expense,
which is not included as a component of operating costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Yorkville
Convertible Debentures</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the GXII Transaction, on January 26, 2023, NioCorp entered into definitive agreements with respect to the Yorkville
Financings, including a Securities Purchase Agreement, dated January 26, 2023 (as amended the &#8220;Yorkville Convertible Debt
Financing Agreement&#8221;), between the Company and Yorkville, and a Standby Equity Purchase Agreement, dated January 26, 2023
(the &#8220;Yorkville Equity Facility Financing Agreement&#8221;), between the Company and Yorkville.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Yorkville Convertible Debt Financing Agreement, at the Closing, Yorkville advanced a total amount of $15,360 to NioCorp
in consideration of the issuance by NioCorp to Yorkville of (i) $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20230630__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zhTcUGrB1X94" title="Aggregate principal amount">16,000</span> aggregate principal amount of unsecured convertible debentures
(the &#8220;Convertible Debentures&#8221;) and (ii) Common Share purchase warrants, exercisable for up to <span id="xdx_90E_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zefigQNsFKMh" title="Number of shares purchase">1,789,267</span> Common Shares
for cash or, if at any time there is no effective registration statement registering, or no current prospectus available for,
the resale of the underlying Common Shares, on a cashless basis, at the option of the holder, at a price per Common Share of approximately
$<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zYRzfWHA9IGg" title="Number of shares purchase">8.9422</span>, subject to adjustment to give effect to any stock dividend, stock split, reverse stock split or similar transaction (the
&#8220;Financing Warrants&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Convertible Debenture issued under the Yorkville Convertible Debt Financing Agreement is an unsecured obligation of NioCorp, has
an <span id="xdx_902_eus-gaap--LongTermDebtMaturitiesRepaymentTerms_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_z7E3vVTS6Vkl" title="Debt term">18-month</span> term from the Closing Date, which may be extended for one six-month period in certain circumstances at the option
of NioCorp, and incurs a simple interest rate obligation of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MinimumMember_zfEJbFQO9eQc" title="Interest rate obligation">5.0</span>% per annum (which will increase to <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MaximumMember_zyyyqKkneBZk" title="Interest rate obligation">15.0</span>% per annum upon the occurrence
of an event of default). The outstanding principal amount of, accrued and unpaid interest, if any, on, and premium, if any, on
the Convertible Debentures must be paid by NioCorp in cash when the same becomes due and payable under the terms of the Convertible
Debentures at their stated maturity, upon their redemption or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain limitations contained within the Yorkville Convertible Debt Financing Agreement and the Convertible Debentures, including
those as described below, holders of the Convertible Debentures will be entitled to convert the principal amount of, and accrued and
unpaid interest, if any, on each Convertible Debenture, in whole or in part, from time to time over their term, into a number of
Common Shares equal to the quotient of the principal amount and accrued and unpaid interest, if any, being converted divided by the
Conversion Price. The &#8220;Conversion Price&#8221; means, as of any Conversion Date (as defined below) or other date of
determination, the greater of (i) 90% of the average of the daily U.S. dollar volume-weighted average price of the Common Shares
on the principal U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading
days immediately preceding the date on which the holder exercises its conversion right in accordance with the requirements of
the Yorkville Convertible Debt Financing Agreement (the &#8220;Conversion Date&#8221;) or other date of determination, but not
lower than the Floor Price (as defined below), and (ii) the five-day volume-weighted average price of the Common</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<div style="text-align: center; margin-left: 0.25in"></div>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> Shares on the
TSX (or on the principal U.S. market if the majority of the trading volume and value of the Common Shares occurred on Nasdaq during
the relevant period) for the five consecutive trading days immediately prior to the Conversion Date or other date of determination
less the maximum applicable discount allowed by TSX. The &#8220;Floor Price&#8221; means a price of $2.1435 per share, which is
equal to the lesser of (a) 30% of the average of the daily volume-weighted average price of the Common Shares on the principal
U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading days immediately
preceding the Debenture Closing and (b) 30% of the average of the volume-weighted average price of the Common Shares on the principal
U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading days immediately
following the Debenture Closing, subject to certain adjustments to give effect to any stock dividend, stock split, reverse stock
split, recapitalization or similar event.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Convertible Debentures restrict the number of Convertible Debentures that may be converted during each calendar month
by Yorkville at a Conversion Price below a fixed price equal to approximately $8.9422 (i.e., the quotient of $10.00 divided by
1.11829212 (being the number of Common Shares that were exchanged for each share of GXII at the Closing, after giving effect to
the Reverse Stock Split)), subject to adjustment to give effect to any stock dividend, stock split, reverse stock split, recapitalization
or similar event. The Convertible Debentures are subject to customary anti-dilution adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Convertible Debentures restrict the conversion of Convertible Debentures by Yorkville if such a conversion would
cause Yorkville to exceed certain beneficial ownership thresholds in NioCorp or such a conversion would cause the aggregate number
of Common Shares issued pursuant to the Yorkville Convertible Debt Financing Agreement to exceed the thresholds for issuance of
Common Shares under the rules of the TSX and Nasdaq, unless prior shareholder approval is obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Convertible Debentures, following certain trigger events, and until a subsequent cure event, NioCorp will
be required to redeem $1,125 aggregate principal amount of Convertible Debentures (the &#8220;Triggered Principal Amount&#8221;)
each month by making cash payments to the Investors, on a pro rata basis, in an amount equal to the Triggered Principal Amount,
plus accrued and unpaid interest thereon, if any, plus a redemption premium of 7% of the Triggered Principal Amount. Such monthly
prepayments under the terms of the Convertible Debentures are triggered (i) at the time when NioCorp has issued 95% of the total
amount of Common Shares pursuant to the Yorkville Convertible Debt Financing that it may issue under applicable TSX and Nasdaq
rules or (ii) when NioCorp has delayed or suspended the effectiveness or use of the Convertible Debt Financing Registration Statement
for more than 20 consecutive calendar days, and such monthly prepayment obligations will continue until, with respect to (i) above,
shareholder approval is obtained or, with respect to (ii) above, the Investors may once again resell Common Shares under the Convertible
Debt Financing Registration Statement, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Convertible Debentures may also be redeemed at NioCorp&#8217;s option at any time and from time to time over their term at a redemption
price equal to <span id="xdx_900_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zuhqpqLmDTPf" title="Principal percentage">110</span>% of the principal amount being redeemed, plus accrued and unpaid interest, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with the issuance of the Convertible Debentures, NioCorp issued to Yorkville <span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zOtAEtQzM43l" title="Issuance of the convertible debentures">1,789,267</span> Financing Warrants at an exercise
price of approximately $<span id="xdx_904_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise1_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zxOHOxo8tCDa" title="Issuance of the convertible debentures">8.9422</span> per Common Share (the &#8220;Financing Warrant Exercise Price&#8221;), subject to adjustment to
give effect to any stock dividend, stock split, reverse stock split recapitalization or similar event.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Financing Warrants are exercisable, in whole or in part, but not in increments of less than $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__srt--RangeAxis__srt--MaximumMember_z6Me60A1ddl2" title="Aggregate exercise price, per shares">50</span> aggregate Financing Warrant Exercise
Price (unless the remaining aggregate Financing Warrant Exercise Price is less than $50), beginning on May 4, 2023, and may be
exercised at any time prior to their expiration. Holders of the Financing Warrants may exercise their Financing Warrants, at their
election, by paying the Financing Warrant Exercise Price in cash or, if at any time there is no effective registration statement
registering, or no current prospectus available for, the resale of the underlying Common Shares, on a cashless exercise basis.
1/12th of the Financing Warrants will expire on each of the first 12 monthly anniversaries of the date that is six months following
the Closing Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Financing Warrants have customary anti-dilution adjustments to be determined in accordance with the requirements of the applicable
stock exchanges, including the TSX. The terms of the Financing Warrants restrict the</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<div style="text-align: center; margin-left: 0.25in"></div>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">exercise of Financing Warrants by Yorkville
if such an exercise would cause Yorkville to exceed certain beneficial ownership thresholds in NioCorp or such an exercise would
cause the aggregate number of Common Shares issued pursuant to the Yorkville Convertible Debt Financing Agreement to exceed the
thresholds for issuance of Common Shares under the rules of the Nasdaq and the TSX, unless prior shareholder approval is obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Financing Warrants were originally recorded as a $<span id="xdx_903_eus-gaap--LossContingencyAccrualAtCarryingValue_iI_pn3n3_c20230126__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z2QYMy1Bplr3" title="Contingent liability">2,704</span> contingent liability on January 26, 2023,
and were subsequently marked to market of $<span id="xdx_90E_eus-gaap--ServicingLiability_iI_pn3n3_c20230316__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6MM7nULYP73" title="Contingent liability">3,337</span> through March 16, 2023. The change in fair value during this period resulted in
a loss of $<span id="xdx_90E_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230630_z7RVCdMD9Ejj" title="Fair value of warrant liability">633</span>, which was booked to change in fair value of warrant liability in the consolidated statement of operations and comprehensive
loss. The Financing Warrants were reclassified to shareholders equity on March 17, 2023, in connection with the closing of the
Convertible Debentures as noted below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company allocated the net proceeds of $15,360 from the Convertible Debentures as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zwaSh4mH3RE2" title="Fair value">2,704</span>
    was booked to Common Shares, representing the initial fair value of the Financing Warrant tranches on January 26, 2023 based
    on the Black Scholes pricing model using a risk-free interest rate <span style="color: #353535">of <span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zIYiUNcJvFSe" title="Fair value">4.33</span>%, an expected dividend
    yield of <span id="xdx_904_ecustom--ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_pid_dp_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zLHMpCmsQbm9" title="Fair value">0</span>%, a volatility of <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_c20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zMCrc6Y2rPMk" title="Fair value">64.6</span>%, and an expected life of <span id="xdx_90D_ecustom--DebtMaturityPeriod_dxL_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MinimumMember_zq2jUJ8qOZ6b" title="Expected life::XDX::P6M"><span style="-sec-ix-hidden: xdx2ixbrl1346">6</span></span> months to <span id="xdx_900_ecustom--DebtMaturityPeriod_dxL_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MaximumMember_zjcxBC42lril" title="Expected life::XDX::P18M"><span style="-sec-ix-hidden: xdx2ixbrl1348">18</span></span> months</span>. </span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_901_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zoxAktoyuWxf" title="Convertible debt liability">12,656</span>
    was booked to the convertible debt liability. In addition, transaction costs of $<span id="xdx_90F_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zStNq833Jh1a" title="Transaction costs">503</span> were recognized as a direct deduction
    from the debt liability, resulting in a net opening balance of $12,153 at an effective interest rate of 18.4%. This balance
    will be accreted to face value of the Convertible Debentures at maturity using the effective interest method and recorded
    as non-cash interest expense in the consolidated statement of operations and comprehensive loss.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
</table>
<p id="xdx_899_eus-gaap--ConvertibleDebtTableTextBlock_zCePOSCmMlte" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zV8L6A21YcB6">Changes
in the Convertible Debentures are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 86%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opening balance,
    March 17, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$</span></td>
    <td id="xdx_98B_eus-gaap--ConvertibleDebt_iS_pn3n3_c20230315__20230630_z6rOlrdFfvKl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Opening balance, March 17, 2023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,153</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20230315__20230630_z1AFoo4i7m14" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,962</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal and accrued
    interest converted</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_98B_ecustom--PrincipalAndAccruedInterestConverted_iN_pn3n3_di_c20230315__20230630_zMvzc22zeyJa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal and accrued interest converted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,554</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30,
    2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--ConvertibleDebt_iS_pn3n3_c20220701__20230630_zhoc7a9NtO6g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, June 30, 2023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,561</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><p style="margin: 0pt 0">Add: Unamortized debt issuance costs</p>


</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt">&#160;</td>
    <td id="xdx_984_eus-gaap--AmortizationOfFinancingCosts_pn3n3_dxL_c20220701__20230630_z72xi07wU049" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Add: uamortized debt issuance costs::XDX::0"><span style="-sec-ix-hidden: xdx2ixbrl1364">2,439</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><p style="margin: 0pt 0">Remaining principal balance, June 30, 2023</p>


</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt">$</td>
    <td id="xdx_984_eus-gaap--ConvertibleDebt_iE_pn3n3_c20220701__20230630_zc6kgVzCabzc" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, June 30, 2023">13,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
</table>

<p id="xdx_8A2_z2fKHVgWyB58" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon conversion, the portion of remaining unamortized
issuance costs associated with the conversion are recognized as a component of interest expense. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Convertible Debentures contain events of default customary for instruments of their type (with customary grace periods, as applicable)
and provide that, upon the occurrence of an event of default arising from certain events of bankruptcy or insolvency with respect
to NioCorp, all outstanding Convertible Debentures will become due and payable immediately without further action or notice. If
any other type of event of default occurs and is continuing, then any holder may declare all of its Convertible Debentures to
be due and payable immediately. The Company obtained a waiver from Yorkville with respect to any acceleration rights it may have
under the Convertible Debentures in connection with the restatements of the Company&#8217;s consolidated financial statements for the periods
ended September 30, 2022 and December 31, 2022 and the delay in filing the Company&#8217;s Quarterly Report on Form 10-Q for the
quarterly period ended March 31, 2023. The Yorkville Convertible Debt Financing Agreement also contains certain covenants that,
among other things, limit NioCorp&#8217;s ability to use the proceeds from the Yorkville Convertible Debt Financing to repay related
party debt or to enter into any variable rate transaction other than with Yorkville, subject to certain exceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the Company&#8217;s closing Common Share price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zJgXyJRSh1Bj" title="Common share price, per share">5.03</span> as of June 30, 2023, conversion of the remaining Convertible Debenture
principal balance of $13.0 million, including accrued interest, would require the issuance of approximately 2,871,660 Common Shares.
For each $0.10 change in the fair value of one Common Share, the total shares the Company would be obligated to issue would change
by approximately <span id="xdx_904_eus-gaap--OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_iI_pid_uShares_c20230630_zvyCG0ZLEmr3" title="Shares issued">58,300</span> shares.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164864688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CLASS B COMMON STOCK OF ECRC<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureClassBCommonStockOfEcrcAbstract', window );"><strong>Class B Common Stock Of Ecrc</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock', window );">CLASS B COMMON STOCK OF ECRC</a></td>
<td class="text"><p id="xdx_80B_ecustom--ScheduleOfClassBCommonStockOfECRCTableTextBlock_ziTNfX3zNg16" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_824_zvzqmk75ebah">CLASS
B COMMON STOCK OF ECRC</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, the Sponsor Support Agreement, and the Exchange Agreement, after the Closing, the GXII
founders have the right to exchange shares of Class B common stock of ECRC for Common Shares on a one-for-one basis, subject to
certain equitable adjustments, under certain conditions. All <span style="color: #353535"><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zXGpAdsjW0W2" title="Common stock, shares, outstanding"><span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zDDh90q3hYJ2" title="Common stock, shares, issued">7,957,404</span></span> shares of Class B common stock
of ECRC that were issued in connection with the Closing were issued and outstanding as of June 30, 2023. </span>Of the issued
and outstanding shares of Class B common stock of ECRC, <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zI3yg9HKwNY2" title="Earnout shares">4,565,808</span> shares (the &#8220;Vested Shares&#8221;)&#8201;were vested
as of the Closing Date and are exchangeable at any time, and from time to time, until the tenth anniversary of the Closing Date
(the &#8220;Ten-Year Anniversary&#8221;) and <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20220701__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zdFN2PPVqX05" title="Earnout shares">3,391,596</span> shares (the &#8220;Earnout Shares&#8221;) are exchangeable until the Ten-Year
Anniversary, subject to certain vesting conditions. Under certain circumstances, and subject to certain exceptions, NioCorp may
instead settle all or a portion of any exchange pursuant to the terms of the Exchange Agreement in cash, in lieu of Common Shares,
based on a volume-weighted average price of Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the shares of Class B common stock of ECRC are subject to the Amended and Restated Registration Rights Agreement, dated as
of March 17, 2023 (the &#8220;Registration Rights and Lock-up Agreement&#8221;), among NioCorp, GXII, the Sponsor, the pre-Closing
directors and officers of NioCorp and the other parties thereto, including the members of the Sponsor. Pursuant to Registration
Rights and Lock-up Agreement, all shares of Class B common Stock of ECRC (including the Vested Shares and the Released Earnout
Shares) are subject to certain &#8220;lock-up&#8221; restrictions on transfer beginning upon the Closing and ending upon the earlier
of (i) one year after the Closing and (ii) the date on which the trading price of Common Shares exceeds certain thresholds or
the date on which NioCorp completes a transaction that results in all of NioCorp&#8217;s shareholders having the right to exchange
their Common Shares for cash, securities or other property. Both Vested Shares and Released Earnout Shares may be exchanged by
the holders into Common Shares at any time. Under the Exchange Agreement, all Vested Shares and Earnout Shares must be exchanged
for Common Shares by the Ten-Year Anniversary except for Released Earnout Shares that have been vested for a period of fewer than
twenty-four months as of the Ten-Year Anniversary. Such Released Earnout Shares will be forfeited if not exchanged for Common
Shares by the date that is twenty-four months after the vesting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Vested
Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the exchange of Vested Shares are contingently redeemable at the option of the noncontrolling interest shareholders, the Company
classifies the carrying amount of the redeemable noncontrolling interest in the mezzanine section on the consolidated balance
sheet, which is presented above the equity section and below liabilities. The redeemable noncontrolling interests are classified
as a Level 1 financial instrument and are measured at the fair value of the Company&#8217;s Common Shares at each reporting period.
Adjustments to the carrying value of the redeemable noncontrolling interest are recorded through retained earnings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Earnout
Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--DescriptionOfEarnOutShares_c20220701__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zlelGYyZY4s3" title="Description of earnout shares">The
Earnout Shares vest (the &#8220;Released Earnout Shares&#8221;) in two equal tranches based upon achieving market share price
milestones of approximately $12.00 per Common Share and approximately $15.00 per Common Share, respectively, prior to the Ten-Year
Anniversary, or upon a change in control as defined in the underlying agreement.</span> These shares will be forfeited if the market
share price milestones or an acceleration event is not reached prior to the Ten-Year Anniversary. At such time that the Earnout
Shares shall become vested, and therefore, become Released Earnout Shares, the shares will be transferred to the redeemable noncontrolling
interest in the mezzanine section of the Consolidated Balance Sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Earnout Shares were classified as a liability due to failure to meet the equity classification criteria under ASC 815-40, as Level
3 instruments under the fair value hierarchy and are considered a financial liability under ASC 480, Distinguishing Liabilities
from Equity. The Earnout Shares were measured at fair value on the Closing Date with subsequent changes in fair value recorded
in earnings. The Earnout Shares were valued utilizing a Monte Carlo simulation pricing model, which calculates multiple potential
outcomes for future share prices and establishes current fair value based on the most likely outcome. The following table discloses
the primary inputs into the Monte Carlo models.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<div style="text-align: center; margin-left: 0.25in"></div>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p id="xdx_897_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zhj3jT5sAOh3" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><span id="xdx_8B1_zCYYAonfzRQ9" style="display: none; visibility: hidden">The following table discloses the primary inputs into the Monte Carlo models.</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
    Valuation Input</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
    Close</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 17%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    30, 2023</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing
    Common Share price</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zfLqTFRFUhZe" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Closing common share price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$7.00</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zt5nfwpA88Df" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Closing Common Share price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$5.03</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Term
    (expiry)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220924__20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zzIPd5Pr9Ulf" title="Term (expiry)">March 17, 2033</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zd7S2NhjHeI3" title="Term (expiry)">March
    17, 2033</span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Implied
    volatility of Public Warrants</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220924__20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zkyEu3yGwYm2" title="Implied volatility of Public Warrants">19.5</span>%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zDajiz5MaJE" title="Implied volatility of Public Warrants">33.5</span>%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free
    rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220924__20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIKaow3B86Kd" title="Risk-free rate">3.39</span>%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zbQ7qDRiyiB9" title="Risk-free rate">3.83</span>%</span></td></tr>
</table>
<p id="xdx_8A4_zLWPF8Z9XTR4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p id="xdx_890_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_z85NvC16U4xa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zWOytyTvNCya">The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June
30, 2023:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 49%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of March 17, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230301__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zTC4noQBiBD6" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Fair value at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,195</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> &#160;</span></td>
    <td id="xdx_98A_eus-gaap--ServicingLiabilityAtFairValueAdditions_iN_pn3n3_di_c20230301__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zwKd8xDGnBd4" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,674</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of June 30, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20230301__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zQLdcdPsHRvk" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,521</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p id="xdx_8AD_zF9RWc4mEx9e" style="margin-top: 0; margin-bottom: 0"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureClassBCommonStockOfEcrcAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureClassBCommonStockOfEcrcAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of class b common stock of ecrc table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164829376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">COMMON SHARES</a></td>
<td class="text"><p id="xdx_808_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_zT8B6wABu3Wb" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_827_zqNYCfM9Hyte">COMMON
SHARES</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuances</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fiscal
Year 2023 Issuances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the Common Shares issued in connection with the GXII Transaction, as discussed in Note 5, the following Common Share
issuances occurred during fiscal year 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 28, 2023, the Company closed a registered direct offering and issued <span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20230426__20230428_zCxAl7AhivXa" title="Numberof shares issue">314,465</span> Common Shares for $<span id="xdx_909_eus-gaap--OfferingCostsPartnershipInterests_iI_dm_c20230428_zIqj2wdfQ2gk" title="Shares issue price">2.0 million</span>, before deducting
share issuance costs of $<span id="xdx_90D_ecustom--ShareIssuanceCost_iI_pn3n3_c20230428_zXHTbT3noZW" title="Share issuance cost">172</span>. The Common Shares were sold pursuant to a securities purchase agreement, dated April 26, 2023, between
the Company and a fund managed by Kingdon Capital Management, LLC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 9, 2023, the Company issued <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20230608__20230609__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_z6Kw3YuvJ9zb" title="Numberof shares issue">100,000</span> Common Shares under the Yorkville Equity Facility Financing Agreement (discussed below)
in exchange for $488 in cash proceeds. The Company recorded a non-cash operating expense of $<span id="xdx_901_eus-gaap--OperatingLeaseExpense_pn3n3_c20230608__20230609__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zuZ4AkNWNrf1" title="Share issuance cost">13</span> which represented the difference between
the proceeds received and the fair value of the Common Shares issued based on Nasdaq closing price per Common Share on the issuance date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fiscal
Year 2022 Issuances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 30, 2022, the Company closed a non-brokered private placement (the &#8220;June 2022 Private Placement&#8221;) of units (the
&#8220;Units&#8221;) of the Company. A total of <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zLxVC65FBqN3" title="Sahares issue">498,103</span> Units were issued at a price per Unit of C$<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zfJUXDnIWX9c" title="Price per unit">0.96</span>, for total gross proceeds
to the Company of approximately C$<span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_dm_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zcZbVar6yfJj" title="Gross proceeds">4.8 million</span>. Each Unit consists of one Common Share and one common share purchase warrant (&#8220;June
2022 Warrant&#8221;). Each June 2022 Warrant entitles the holder to acquire one Common Share at a price of C<span id="xdx_90C_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zx7LJDkcNCVf" title="Shares price">$1.10</span> at any time
prior to July 1, 2024. Proceeds of the June 2022 Private Placement will be used for continued advancement of the Company&#8217;s
Elk Creek Critical Minerals Project and for working capital and general corporate purposes. The Company paid cash commissions
of C$<span id="xdx_90C_eus-gaap--PaymentsForCommissions_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zciHh29u3G38" title="Cash commissions">62</span> and <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkoxSUUxY2V9" title="Warrants">6,510</span> warrants (the &#8220;Finder Warrants&#8221;), having the same terms as the June 2022 Warrants, to finders outside
of the United States. The Finder Warrants were valued at C$<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zebRdcuxBaf7">18</span> using a risk-free rate of <span id="xdx_904_ecustom--FairValueAssumptionsRiskFreeInterestRate1_pid_dp_uPure_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZPWKb7PU6Fa" title="Risk-free rate">3.2</span>%, expected volatility of <span id="xdx_900_ecustom--FairValueAssumptionsExpected1VolatilityRate_pid_dp_uPure_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIavrGTsULta" title="Expected volatility">64</span>% and expected
life of <span id="xdx_90A_ecustom--FairValueAssumptions1ExpectedTerm_dxL_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4R2AJ4lczqa" title="Expected life::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1444">two</span></span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
                                         Options</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 5, 2020, the Company&#8217;s shareholders voted to approve an amendment and restatement of its long-term incentive plan
(the &#8220;2017 Amended Long-Term Incentive Plan&#8221;) and the granting of incentive securities thereunder until November 5,
2023. Under the 2017 Amended Long-Term Incentive Plan, the Board may, in its discretion from time to time, grant Options and share
units (in the form of restricted share units and performance</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>











<div style="text-align: center; margin-left: 0.25in"></div>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">share units) to directors, employees and certain other service providers
(as defined in the 2017 Amended Long-Term Incentive Plan) of the Company and affiliated entities selected by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--DescriptionOfAmendedPlan_c20201103__20201105__us-gaap--PlanNameAxis__custom--LongTermIncentivePlanMember_zKJ2qmgtamN4" title="Description of amended plan">Subject
to adjustment as described in the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares that may be reserved
for issuance to participants under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation
arrangements of the Company, may not exceed 10% of the issued and outstanding Common Shares from time to time, and the Common
Shares reserved for issuance upon settlement of share units will not exceed 5% of the issued and outstanding Common Shares from
time to time. The 2017 Amended Long-Term Incentive Plan limits the maximum number of Common Shares issued to insiders (as defined
under TSX rules for this purpose) within any one-year period, or issuable to insiders at any time, in the aggregate, under all
security-based compensation arrangements (including the 2017 Amended Long-Term Incentive Plan) to 10% of the then issued and outstanding
Common Shares.</span> The 2017 Amended Long-Term Incentive Plan also limits the aggregate number of Common Shares that may be reserved
for issuance to any one participant under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation
arrangements of the Company, to 5% of the then issued and outstanding Common Shares (on a non-diluted basis). Subject to the adjustment
provisions of the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares actually issued or transferred
by the Company upon the exercise of Incentive Stock Options will be limited as described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has power over the granting, amendment, administration, or settlement of any award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
option transactions are summarized as follows:</span></p>

<p id="xdx_89F_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_zuYtzLMZcVe4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zuYxOKxQMS2j" style="display: none; visibility: hidden">Schedule of stock option</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 73%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Number of <br/>
Options</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted <br/>
Average <br/>
Exercise Price</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 43%; text-align: left; padding-bottom: 1pt">Balance, June 30, 2020</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20200701__20210630_zoDNIIPF27X8" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance">1,912,940</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20200701__20210630_z8dPs5wevkPg" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$6.20 </span></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20200701__20210630_zBzfKgnKuWFa" style="text-align: right" title="Granted">370,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pin3_uCADPShares_c20200701__20210630_zbd08KsT4Dle" style="text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$7.80</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20200701__20210630_z7wDjX2c9s5j" style="text-align: right" title="Exercised">(295,229</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20200701__20210630_zShLAySiqYpk" style="text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$6.10</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Cancelled/expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20200701__20210630_zVQFmD1UmRw8" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired">(391,212</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20200701__20210630_zY3mzHNSSY3d" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$6.40</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Balance, June 30, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20210701__20220630_zSVKpuzuxfKf" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance">1,596,499</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20210701__20220630_zItt5cYCitLb" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$6.50</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210701__20220630_zlq7iko0rNUf" style="text-align: right" title="Granted">447,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20210701__20220630_zURPolnUeojd" style="text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$13.30</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_dxL_uShares_c20210701__20220630_z6xea4C8aqP1" style="text-align: right" title="Exercised::XDX::215"><span style="-sec-ix-hidden: xdx2ixbrl1481">(205,153</span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20210701__20220630_zqEJ6WxIdsV" style="text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$7.00</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Cancelled/expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20210701__20220630_zCaoCdBkQ8Nd" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired">(392,446</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20210701__20220630_zTggmS5N6x29" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$7.70</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Balance, June 30, 2022</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20220701__20230630_zt5wK3mv7Aua" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance">1,446,400</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20220701__20230630_zK9qtYxshZY" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$8.27</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220701__20230630_znssPo1te4Ee" style="text-align: right" title="Granted">578,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20220701__20230630_zA72NcOQnmWb" style="text-align: right" title="Granted">$6.95</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20220701__20230630_z7R5ve8EMaKf" style="text-align: right" title="Exercised">(265,129</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20220701__20230630_zznx1UbVMPr7" style="text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$4.99</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Cancelled/expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20220701__20230630_zpOj9LgJaFNc" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired">(217,771</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20220701__20230630_zf8lTvy4GLx8" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$5.87</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Balance, June 30, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20220701__20230630_zAdsu9UnmfEk" style="border-bottom: Black 1pt solid; text-align: right" title="Ending balance">1,541,500</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCADPShares_c20220701__20230630_z81HeHhfYk8" style="border-bottom: Black 1pt solid; text-align: right" title="Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$9.64</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A9_zBKxcpaf33Xj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_8AD_zh3Jx2GKdfk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<div style="text-align: center; margin-left: 0.25in"></div>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z1ukJujYLRn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B2_zvAfJsmkQWb2">The
following table summarizes information about stock options outstanding at June 30, 2023:</span></span></p>

<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 88%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price </span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 26%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry
    Date</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    Outstanding</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 17%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
    Intrinsic Value </span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    Exercisable</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
    Intrinsic Value </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$8.40</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member_zSzoaElaZqVh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2023-09-18"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1515">September
    18, 2023</span></span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member_zlXspE7qfR66" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,000</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member__srt--CurrencyAxis__currency--CAD_zu8tWcd3RiJ9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$-</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member_zQdR1dvQI25b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,000</span></td>
    <td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member__srt--CurrencyAxis__currency--CAD_zpJje8EYO0Qc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$5.40</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member_zNZxnqGb351g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2023-11-15"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1520">November
    15, 2023</span></span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member_z2nA32ExLyXi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">208,500</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member__srt--CurrencyAxis__currency--CAD_zPNg5FApY9c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">263</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member_zUbZ7qetdcM2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">208,500</span></td>
    <td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member__srt--CurrencyAxis__currency--CAD_zNGPqrHZ2ZX9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">263</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$7.50</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50Member_z3xaFwerOAdc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2023-12-14"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1525">December
    14, 2023</span></span></td>
    <td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50Member_zaVLP5jERPwe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50Member_zn0uSlTfBEFc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$7.50</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50OneMember_zaijvg3UpkP4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2023-12-16"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1528">December
    16, 2023</span></span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50OneMember_z5QTQ8gVF6R8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50OneMember_zEb8fFll6vCl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$13.60</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice13.60Member_z4AlqpmAQrT6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2024-12-17"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1531">December
    17, 2024</span></span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice13.60Member_z9nRYUnhgX4c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">377,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice13.60Member_zZKddnpfe31" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">377,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$11.00</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zQOBXzUIcyf8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2025-05-30"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1534">May
    30, 2025</span></span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_znlYPnkMYpch" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zSLGYclGvX2f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$6.95</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice6.95Member_zGr64z16HaD6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2026-03-27"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1537">March
    27, 2026</span></span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice6.95Member_zEmYIbfAAzqi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">578,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice6.95Member_ziVA2rajSV8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">578,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance,
    June 30, 2023</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630_zZFeF99EiiBl" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,541,500
    </span></td>
    <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230630__srt--CurrencyAxis__currency--CAD_zgMrHk1tJPLi" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$263</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630_zErM3sr9GVOd" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,541,500</span></td>
    <td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_iI_c20230630__srt--CurrencyAxis__currency--CAD_zZosNnTHqGbh" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$263</span></td>
    </tr>
</table>

<p id="xdx_8AC_z5btwwz6fulc" style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
aggregate intrinsic value in the preceding table represents the total intrinsic value, based on the Company&#8217;s closing stock
price of C$<span id="xdx_901_eus-gaap--SharePrice_iI_pid_uCADPShares_c20230630_z6Vo4IpNtF41" title="Stock price">6.68</span> as of June 30, 2023, which would have been received by the option holders had all option holders exercised their
options as of that date. The total number of in-the-money options vested and exercisable as of June 30, 2023, was 208,500. The
total intrinsic value of options exercised during the year ended June 30, 2023, <span style="background-color: white">was C$<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20220701__20230630__srt--CurrencyAxis__currency--CAD_zKHmvPPxjS1d" title="Total intrinsic value">1,592</span>.</span></span></p>

<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023, there were no unrecognized compensation costs related to unvested share-based compensation arrangements granted.</span></p>

<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p id="xdx_896_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zljymjyaTY77" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BC_zrd9y2ocsX5l">The following table summarizes
the weighted average information and assumptions used to determine option costs:</span></p>

<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 1pt">&#160;</span></td>
    <td id="xdx_490_20220701__20230630_zEsQTkknmuva" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td id="xdx_495_20210701__20220630_zbJKfZneXys3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td id="xdx_495_20200701__20210630_zhb9SG4AtPP4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Year ended June 30,</span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 44%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 12%"><span style="font-size: 10pt">2023</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 12%"><span style="font-size: 10pt">2022</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 12%"><span style="font-size: 10pt">2021</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Fair value per option granted during the period </span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220701__20230630_zSn1kK8HEXL6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Fair value per option granted during the period"><span style="font-size: 10pt">$3.09</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210701__20220630__srt--CurrencyAxis__currency--CAD_zuB5lSjcmWe4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Fair value per option granted during the period"><span style="font-size: 10pt">C$4.90</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20200701__20210630__srt--CurrencyAxis__currency--CAD_zJMn0yUteG75" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Fair value per option granted during the period"><span style="font-size: 10pt">C$2.50</span></td></tr>
<tr id="xdx_405_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_z7zj6F5aaLF5" style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Risk-free interest rate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">3.30%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">1.33%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">0.26%</span></td></tr>
<tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_zC9w4HiSTOG1" style="vertical-align: top; background-color: #CCECFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Expected dividend yield</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">0%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">0%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">0%</span></td></tr>
<tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_zqnp3EAp2RMh" style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Expected stock price volatility (historical basis)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">63.6%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">54.4%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">54.1%</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Expected option life in years</span></td>
    <td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20220701__20230630_z6RIHeVPKP37" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expected option life in years::XDX::P3Y"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1569">3.0</span></span></td>
    <td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20210701__20220630_zdZtSMEn0hL2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expected option life in years::XDX::P3Y"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1571">3.0</span></span></td>
    <td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20200701__20210630_zCY1AHwJbIx7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P3Y"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1572">3.0</span></span></td></tr>
</table>


<p id="xdx_8A3_z33xNuo10xNl" style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td></tr></table>

<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z38uyOHtG071" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Warrant transactions are
summarized as follows. <span id="xdx_8B6_zAwhHqU5j7ff">Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S.
dollars using end of period foreign currency exchange rates.</span></p>





<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.25in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Warrants</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted <br/>
Average <br/>
Exercise Price</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Balance, June 30, 2020</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20200701__20210630_zmlt6i3i2Wmf" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Balance at beginning">1,237,645</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20200701__20210630_zWhwu7MyPxA" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Balance at beginning average price">5.43</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Granted:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Nordmin warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--NordminWarrants_pid_uShares_c20200701__20210630_zCfxJeGdXhr5" style="text-align: right" title="Nordmin warrants">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing_pid_uUSDPShares_c20200701__20210630_zpvIMzS2d7s8" style="text-align: right" title="Nordmin warrants average price">6.45</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Lind III warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightLindIIIWarrants_pid_uShares_c20200701__20210630_zwToKCCGMf3d" style="text-align: right" title="Lind III Warrants">855,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--ClassOfWarrantOrRightExercisePriceLindWarrants_pid_uUSDPShares_c20200701__20210630_zNzeVOPZslu2" style="text-align: right" title="Lind III warrants average price">7.83</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">April 2021 private placement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightAprilPrivatePlacement_pid_uShares_c20200701__20210630_zjkMQp0XGIH9" style="text-align: right" title="April 2021 private placement">441,211</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements_pid_uUSDPShares_c20200701__20210630_zXeuNz2ovL7l" style="text-align: right" title="April 2021 private placement average price">13.15</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20200701__20210630_zUWmrD7vFS0k" style="text-align: right" title="Exercised">(910,628</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uUSDPShares_c20200701__20210630_zARt8P7pEpJa" style="text-align: right" title="Exercised average price">6.05</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20200701__20210630_zXHnWhRgrQjg" style="border-bottom: Black 1pt solid; text-align: right" title="Expired">(239,845</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20200701__20210630_z42jWS5mWg4f" style="border-bottom: Black 1pt solid; text-align: right" title="Expired average price">5.89</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Balance, June 30, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20210701__20220630_zXJ9rCjpQE94" style="border-bottom: Black 1pt solid; text-align: right">1,434,183</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20210701__20220630_zfFpEFCtE7oa" style="border-bottom: Black 1pt solid; text-align: right">9.36</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;Granted:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.375in; text-indent: -0.125in">June 2022 private placement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightJunePrivatePlacement_pid_uShares_c20210701__20220630_zyCMat9tfbXj" style="text-align: right" title="June 2022 private placement">504,614</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExercisePriceJunePrivatePlacements_pid_uUSDPShares_c20210701__20220630_zVZQutgXnkW5" style="text-align: right" title="June 2022 private placement average price">8.54</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Exercised</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20210701__20220630_z9hvSoKnQyQ5" style="border-bottom: Black 1pt solid; text-align: right">(87,175</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uUSDPShares_c20210701__20220630_z5LcuYqDdIGi" style="border-bottom: Black 1pt solid; text-align: right">6.05</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Balance, June 30, 2022</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20220701__20230630_zZKpTTLkkXua" style="border-bottom: Black 1pt solid; text-align: right">1,851,622</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20220701__20230630_zjLJGNwuBCFd" style="border-bottom: Black 1pt solid; text-align: right">8.99</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;Granted:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Yorkville financing warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--YorkvilleFinancingWarrants_pid_uShares_c20220701__20230630_zDXmddESXRUg" style="text-align: right" title="Yorkville financing warrants">1,789,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_pid_uUSDPShares_c20220701__20230630_zxoCsu4gUqu2" style="text-align: right" title="Yorkville financing warrants average price">8.94</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">GXII warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--GxiiWarrants_pid_uShares_c20220701__20230630_zLdpwi9aUix9" style="text-align: right" title="GXII warrants">15,666,626</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_pid_uUSDPShares_c20220701__20230630_zxRs6xa5uN98" style="text-align: right" title="GXII warrant average price">11.50</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">&#160;Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20220701__20230630_zFo5oT7WZJMh" style="border-bottom: Black 1pt solid; text-align: right">(491,211</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uUSDPShares_c20220701__20230630_zKw3PqcK7Uzk" style="border-bottom: Black 1pt solid; text-align: right">11.67</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Balance, June 30, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20220701__20230630_zwFCFIqZvM2c" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending">18,816,304</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_uUSDPShares_c20220701__20230630_zIFz5I21f4ei" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending average price">10.98</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A6_zbOIbbTEeAnf" style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p id="xdx_89A_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zXusNeJkV6Rg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zmPEwMpPnA1f">At
June 30, 2023, the Company has outstanding exercisable warrants, as follows:</span></span></p>

<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 46%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</span></p></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Exercise
    Price </span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry
Date</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zXPpM1iVegZk" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Number"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">504,611</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230630__srt--CurrencyAxis__currency--CAD__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zYZWnTJ1Gkuk" title="Exercise price">11.00</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dxL_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zggTBd5xkmG3" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expiry date::XDX::2024-06-30"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1630">June
    30, 2024</span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zN1neMxZXcK2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">855,800</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220630__srt--CurrencyAxis__currency--CAD__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zz2ztmA5sLm" title="Exercise price">9.70</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dxL_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_z7Y34r2lZCWg" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expiry date::XDX::2025-02-19"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1635">February
    19, 2025</span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zq1a1JCJIGzh" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,789,267</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zoFJ3LGfZI05" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$8.94</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F2E_zJUo8a8revY3">(1)</sup></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zEnRhgpRCK7c" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,666,626</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zlfpLNP0cOWc" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$11.50</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dxL_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zCuHofnBpx1b" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expiry date::XDX::2028-03-17"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1643">March
    17, 2028</span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630_z6TEA9T9qiLk" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,816,304</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 46%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: left; text-indent: 0in"><span id="xdx_F01_zgLcDmRtSWDe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 93%; text-align: left; text-indent: 0in"><span id="xdx_F17_zx4Jtucrohjg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expires
    in 12 equal monthly tranches beginning October 17, 2023</span></td></tr>
</table>
<p id="xdx_8A8_zvrPyojVuAw3" style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<div style="text-align: center; margin-left: 0.25in"></div>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
connection with the Closing, pursuant to the Business Combination Agreement, the Company assumed the GXII Warrant Agreement and
each GXII Warrant thereunder that was issued and outstanding immediately prior to the Closing Date was converted into one NioCorp
Assumed Warrant pursuant to the GXII Warrant Agreement, as amended by an Assignment, Assumption and Amendment Agreement, dated
March 17, 2023, among the Company, GXII, Continental Stock Transfer &amp; Trust Company, as the existing warrant agent, and Computershare
Inc. and its affiliate, Computershare Trust Company, N.A, together as the successor warrant agent (the &#8220;NioCorp Assumed
Warrant Agreement&#8221;). In connection with the Closing, NioCorp issued (a) <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--GXIIPublicWarrantsMember_zHzzrLldsW5a" title="Warrants traded prior to the closing">9,999,959</span> public NioCorp Assumed Warrants (the &#8220;Public
Warrants&#8221;) in respect of the GXII Warrants that were publicly traded prior to the Closing and (b) <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--GXIIPrivateWarrantsMember_zU4jcPu1lC4a" title="Warrants traded prior to the closing">5,666,667</span> NioCorp Assumed
Warrants (the &#8220;Private Warrants&#8221;) to the Sponsor in respect of the GXII Warrants that it held prior to the Closing,
which NioCorp Assumed Warrants were subsequently distributed by the Sponsor to its members in connection with the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zS1zYBMQt0P9" title="Description of warrants">Each
NioCorp Assumed Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and the
like).</span> No fractional shares will be issued upon exercise of any NioCorp Assumed Warrants, and fractional shares that would otherwise
be due to the exercising holder will be rounded down to the nearest whole Common Share. In no event will the Company be required
to net cash settle any NioCorp Assumed Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Public
Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20220701__20230630_zefuvIcsPjI6" title="Description of warrants">The
Company may elect to redeem the Public Warrants subject to certain conditions, in whole and not in part, at a price of $0.01 per
Public Warrant if (i) 30 days&#8217; prior written notice of redemption is provided to the holders, (ii) the last reported sale
price of the Common Shares equals or exceeds approximately $16.10 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third business day prior
to the date on which the Company sends the notice of redemption to the warrant holders</span> and (iii) there is an effective registration
statement covering the Common Shares issuable upon exercise of the Public Warrants, and a current prospectus relating thereto,
available through the redemption date. Upon issuance of a redemption notice by the Company, the warrant holders will have until
the redemption date to exercise for cash, or, at the Company&#8217;s election, on a cashless basis. The Public Warrants are not
precluded from equity classification and are accounted for as such on the date of issuance, and each balance sheet date thereafter.
Because the Transactions resulted in an excess of liabilities over assets acquired, no value was ascribed to the Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Warrants </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Warrants: (i) will be exercisable either for cash or on a cashless basis at the holder&#8217;s option and (ii) will not
be redeemable by the Company, in either case as long as the Private Warrants are held by the Sponsor, its members or any of their
permitted transferees (as prescribed in the NioCorp Assumed Warrant Agreement). In accordance with the NioCorp Assumed Warrant
Agreement, any Private Warrants that are held by someone other than the Sponsor, its members or any their permitted transferees
are treated as Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts for
the Private Warrants assumed in the Transactions in accordance with the guidance contained in ASC 815-40. Such guidance provides
that because the Private Warrants do not meet the criteria for equity treatment thereunder, each Private Warrant must be recorded
as a liability. This liability is carried as a component of Warrant Liabilities on the consolidated balance sheet and is subject
to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to its current
fair value, with the change in fair value recognized in the consolidated statement of operations and comprehensive loss. The Company
will reassess the classification at each balance sheet date. </p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zHGbgiqtX694" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zNBGleVoOhLc">The
Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a
Black Scholes model with the following assumptions:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<div style="text-align: center; margin-left: 0.25in"></div>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 1pt">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 1pt">March 17, 2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 1pt">June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: justify">Stock price on valuation date</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zoreS0yoSzEf" style="width: 10%; text-align: right" title="Stock price on valuation date">7.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z2HDEv33HTG8" style="width: 10%; text-align: right" title="Stock price on valuation date">5.03</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Strike price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqYzw8f2t22j" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zBewLQd8cik" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Implied volatility of Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQyAOb1pWD92" title="Volatility">19.5</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLgqLMNBoVT5" title="Volatility">33.5</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zbyJAsbavZKc" title="Risk free rate">3.47</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z3NbSUPDeekd" title="Risk free rate">4.18</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zwJhckLCVLMl" title="Dividend yield">0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7A4lwx69S5f" title="Dividend yield">0</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expected warrant life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zoLtOKC6MfC1" title="Expected warrant life in years::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1687">5.0</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQ8kMrpiUtg6" title="Expected warrant life in years::XDX::P4Y8M23D"><span style="-sec-ix-hidden: xdx2ixbrl1689">4.73</span></span></td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AE_znF0FOTOigc7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89D_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zcRQoEhiDFeh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B1_zH1F9Lfrq6S1">The
change in the Private Warrants liability is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 43%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    valuation, March 17, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20220701__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zToJ5TFGhdP3" style="font: 10pt Times New Roman, Times, Serif; width: 10%; padding-right: 2.15pt; padding-bottom: 2.15pt; text-align: right" title="Initial valuation, at begining"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,987</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in valuation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20220701__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zYUOPRaUUbA5" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right" title="Change in valuation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">292</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    at June 30, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ChangesInFairValueOfInitialValuation_iE_pn3n3_c20220701__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zoiQANZz1QH7" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt; text-align: right" title="Initial valuation, at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,279</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p id="xdx_8A3_zeZGVOq7pVPe" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville
                                         Equity Facility Financing</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrent
with the closing of the GXII Transaction, the Yorkville Equity Facility Financing became effective. Pursuant to the Yorkville
Equity Facility Financing Agreement, Yorkville committed to purchase up to $65,000 of Common Shares (the &#8220;Commitment Amount&#8221;),
at NioCorp&#8217;s direction from time to time for a period commencing upon the Closing Date and ending on the earliest of (i)
the first day of the month next following the 36-month anniversary of the Closing, (ii) the date on which Yorkville shall have
made payment of the full Commitment Amount and (iii) the date that the Yorkville Equity Facility Financing Agreement otherwise
terminates in accordance with its terms (the &#8220;Commitment Period&#8221;), subject to certain limitations and the satisfaction
of the conditions in the Yorkville Equity Facility Financing Agreement. The Common Shares that may be sold pursuant to the Yorkville
Equity Facility Financing Agreement would be purchased by Yorkville at a purchase price equal to 97% of the daily volume-weighted
average price of the Common Shares on Nasdaq or such other principal U.S. market for the Common Shares if the Common Shares are
ever listed or traded on the New York Stock Exchange or the NYSE American as reported by Bloomberg Financial Markets (or, if not
available, a similar service provider of national recognized standing) during the applicable pricing period, which is a period
during a single trading day or a period of three consecutive trading days, at the Company&#8217;s option and subject to certain
restrictions, in each case, defined based on when an Advance Notice (as defined in the Yorkville Equity Facility Financing Agreement)
is submitted, subject to certain limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Pursuant to the terms of
the Yorkville Equity Facility Financing Agreement, NioCorp issued 81,213 of Common Shares (the &#8220;Commitment Shares&#8221;)
valued at $650 to Yorkville as consideration for its irrevocable commitment to purchase Common Shares under the Yorkville Equity
Facility Financing Agreement. On June 9, 2023, NioCorp issued and sold 100,000 Common Shares to Yorkville under the Yorkville Equity
Facility Financing Agreement. Additionally, NioCorp is required to pay Yorkville an aggregate fee of $1,500 in cash (the &#8220;Cash
Fee&#8221;), including $500 that NioCorp paid on the Closing Date and an additional $250 NioCorp was paid as of June 30, 2023.
NioCorp will pay the remaining $750 balance in installments over a 12-month period following the Closing Date, provided that it
will have the right to prepay without penalty all or part of the remaining installments of the Cash Fee at any time. In addition,
legal and other costs of $496 were incurred in connection with the Yorkville Equity Facility Financing and were expensed on the
effective date. The following amounts related to the Yorkville Equity Facility Financing Agreement were expensed as other operating
costs:</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p id="xdx_892_eus-gaap--ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_zFIiTKoD2yAc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_8B7_z2EFGHvCdVF" style="display: none; visibility: hidden">Schedule of expenses as other operating costs</span></span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 43%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_494_20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zk3FqphoJn58" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td>&#160;</td></tr>
<tr id="xdx_40E_ecustom--YorkvilleCashFee_zrPPFBqDaj78" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: justify">Yorkville Cash Fee</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zOKN2XjBb37b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Fair value of Commitment Shares issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">650</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--OtherCostAndExpenseOperating_z1H6IAYXhWZh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt">Legal and other related costs</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">496</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--OperatingCostsAndExpenses_zZoDisy4u9y" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2pt">Net costs expensed to other operating expense</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">2,646</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AC_z0NmmVtly7Ol" style="margin-top: 0; margin-bottom: 0"></p>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162163503696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS AND BALANCES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS AND BALANCES</a></td>
<td class="text"><p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_znO4NFZyAfph" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_820_z4sCjAWx41te">RELATED
PARTY TRANSACTIONS AND BALANCES</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings
under the non-revolving credit facility agreement (the &#8220;Smith Credit Facility&#8221;) with Mark Smith, Chief Executive Officer,
President, and Executive Chairman of NioCorp, bear interest at a rate of <span id="xdx_907_eus-gaap--RelatedPartyTransactionRate_pid_dp_uPure_c20220701__20230630__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_ziDTluNMFdMc" title="Interest at a rate">10</span>% and drawdowns from the Smith Credit Facility are
subject to a <span id="xdx_906_ecustom--LineOfCreditFacilityPrepaymentFee_pid_dp_uPure_c20220701__20230630__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zDWvTLSNJrK9" title="Prepayment fee">2.5</span>% establishment fee. Amounts outstanding under the Smith Credit Facility are secured by all of the Company&#8217;s
assets pursuant to a general security agreement. The Smith Credit Facility contains financial and non-financial covenants customary
for a facility of its size and nature. The maturity date for the Smith Credit Facility was June 30, 2023. On February 28, 2023,
the Smith Credit facility was amended to increase the borrowing limit to $<span id="xdx_907_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230228__us-gaap--TypeOfArrangementAxis__custom--AmendedNonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__srt--RangeAxis__srt--MaximumMember_zb3jXltSYOMj" title="Credit agreement">4,000</span> from the previous limit of $<span id="xdx_909_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230228__us-gaap--TypeOfArrangementAxis__custom--AmendedNonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__srt--RangeAxis__srt--MinimumMember_zpAZNuddzkwa" title="Credit agreement">3,500</span>. The Company
subsequently drew down $<span id="xdx_905_ecustom--AmountPaidToRelatedParty_iI_pn3n3_c20230630_zBixtKViZtK7" title="Amount drew down">1,130</span>, leaving an available balance under the Smith Credit Facility of $<span id="xdx_909_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230630__us-gaap--TypeOfArrangementAxis__custom--AmendedNonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember_zDBlzT6bHeA4">52</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zT6epf8Avk78" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zehBT8sBERS1">Changes
in the Smith Credit Agreement principal balance are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ending June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left; padding-bottom: 1pt">Beginning balance</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--RelatedPartyDepositLiabilities_iS_pn3n3_c20220701__20230630_zwHEezuNsSv6" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance">2,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--RelatedPartyDepositLiabilities_iS_pn3n3_c20210701__20220630_zwgnGso85md4" style="border-bottom: Black 1pt solid; width: 12%; text-align: right">2,318</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;Amounts advanced</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--AmountsAdvanced_pn3n3_c20220701__20230630_zkFwglwFdpUb" style="text-align: right" title="Amounts advanced">1,130</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--AmountsAdvanced_pn3n3_c20210701__20220630_zgQObPdwXnV5" style="text-align: right" title="Amounts advanced"><span style="-sec-ix-hidden: xdx2ixbrl1732">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;&#160;&#160;Repayments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_pn3n3_c20220701__20230630_zmWVPyMin6R2" style="border-bottom: Black 1pt solid; text-align: right" title="Repayments">(3,130</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_pn3n3_c20210701__20220630_zTZckqQMdsa8" style="border-bottom: Black 1pt solid; text-align: right">(318</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Balance, end of period</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--RelatedPartyDepositLiabilities_iE_pn3n3_c20220701__20230630_zMTIL0qtVBd8" style="border-bottom: Black 2pt solid; text-align: right" title="Balance, end of period"><span style="-sec-ix-hidden: xdx2ixbrl1737">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--RelatedPartyDepositLiabilities_iE_pn3n3_c20210701__20220630_zTxLrf98i62b" style="border-bottom: Black 2pt solid; text-align: right">2,000</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A0_zogHd5mEoNP" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 22, 2023, the Company repaid Mr. Smith $<span id="xdx_901_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230322__us-gaap--TypeOfArrangementAxis__custom--NonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zEwmA6eEKUV9" title="Credit agreement">1,841</span> of principal borrowed under the Smith Credit Facility. This repayment was
made out of funds transferred to the Company from the GXII trust account on the Closing Date. The Company repaid the remaining
principal balance of $<span id="xdx_907_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember_zR1v5dsaih68" title="Principal amount outstanding">1,289</span> on May 31, 2023. The Smith Credit Facility expired on June 30, 2023. Accounts payable and accrued
liabilities as of June 30, 2023 includes $<span id="xdx_901_ecustom--EstablishmentFeesPayable_pn3n3_c20220701__20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember_zX16dvpl82n3" title="Establishment fees payable">28</span> of origination fees payable under the Smith Credit Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2023 and 2022, the Company paid a total of $<span id="xdx_903_eus-gaap--AccruedLiabilitiesCurrent_iI_pn3n3_dxL_c20230630_ziy9tdU7kGEe" title="Interest paid::XDX::252"><span style="-sec-ix-hidden: xdx2ixbrl1746">183</span></span> and $<span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrent_iI_pn3n3_dxL_c20220630_zEc57w8rquI4" title="::XDX::873"><span style="-sec-ix-hidden: xdx2ixbrl1747">252</span></span>, respectively, representing accrued interest on the Smith
Credit Agreement.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164861264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EXPLORATION EXPENDITURES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureExplorationExpendituresAbstract', window );"><strong>Exploration Expenditures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ExplorationExpendituresDisclosuresTextBlock', window );">EXPLORATION EXPENDITURES</a></td>
<td class="text"><p id="xdx_80F_ecustom--ExplorationExpendituresDisclosuresTextBlock_z0dtcmhuBK35" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82D_zurDBRESw9od">EXPLORATION
EXPENDITURES</span></span></td>
</tr></table>

<p id="xdx_89F_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zk8FIjT2avH6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zMuxKAi1HCqk" style="display: none; visibility: hidden">Schedule of exploration expenditures</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 70%; margin-left: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2021</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">&#160;Feasibility study and engineering</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zDoRPYqfL0B1" style="width: 12%; text-align: right">410</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zqyJlR7KPte4" style="width: 12%; text-align: right">334</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zdqIXbvJOf97" style="width: 12%; text-align: right">79</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;Field management and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zEIjtm0HBAl6" style="text-align: right">738</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zcDBIKdTU0Ya" style="text-align: right">569</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zHKeiv5fbv63" style="text-align: right">656</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;Metallurgical</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__us-gaap--ExplorationAndProductionEquipmentMember_zWMnyMl6Ic2a" style="text-align: right">4,174</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__us-gaap--ExplorationAndProductionEquipmentMember_z3bptrItMw1b" style="text-align: right">2,218</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__us-gaap--ExplorationAndProductionEquipmentMember_zwRodmIVAea8" style="text-align: right">272</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;Geologists and field staff</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_zNS0ghMo89Z9" style="border-bottom: Black 1pt solid; text-align: right">26</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_zhXYrp3vCw19" style="border-bottom: Black 1pt solid; text-align: right">188</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_zSzKsYwIUAv7" style="border-bottom: Black 1pt solid; text-align: right">49</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">&#160;Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630_zP6zjfAPTIgj" style="border-bottom: Black 2pt solid; text-align: right" title="Exploration expenditures">5,348</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630_zIYOyfyh2Sll" style="border-bottom: Black 2pt solid; text-align: right">3,309</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630_zND4vnhjVgr6" style="border-bottom: Black 2pt solid; text-align: right">1,056</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A5_zJl2P4EnLSs9" style="margin-top: 0; margin-bottom: 0"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureExplorationExpendituresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureExplorationExpendituresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ExplorationExpendituresDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents exploration expenditures disclosures text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ExplorationExpendituresDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164867120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text"><p id="xdx_800_eus-gaap--LesseeOperatingLeasesTextBlock_z4Rp60Gt1JCf" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_822_zsmQYBEN6zid">LEASES</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
February 2023, the Company entered into a <span id="xdx_90F_eus-gaap--LesseeOperatingLeaseOptionToExtend_c20220701__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CorporateOfficeMember_ze67bz4beCNk" title="Other lease description">39-month corporate office lease extension and recognized the corresponding ROU asset
and lease liability of $198 associated with this extension, based on a discount rate of <span id="xdx_903_ecustom--DiscountRate_dp_uPure_c20220701__20230630_zsJftga1Ki32" title="Discount rate">16</span>%.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023 and 2022, the Company had one corporate office lease with a remaining lease term of <span id="xdx_909_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dxL_c20230630_zx9UWl74E3be" title="Remaining lease term::XDX::P3Y7M6D"><span style="-sec-ix-hidden: xdx2ixbrl1775">3.6</span></span>
years and <span id="xdx_90E_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dxL_c20220630_zbsNE9HLobVl" title="Remaining lease term::XDX::P1Y3M19D"><span style="-sec-ix-hidden: xdx2ixbrl1777">1.3</span></span> years, respectively. During the year ended June 30, 2023 and 2022, operating cash flows included cash payments of $<span id="xdx_905_eus-gaap--OperatingLeasePayments_c20220701__20230630_z1nSlUQphkg3" title="Cash payment">93</span>
and $<span id="xdx_905_eus-gaap--OperatingLeasePayments_c20210701__20220630_zipel64MjrVe">90</span>, respectively related to
the measurement of lease liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<div style="text-align: center; margin-left: 0.25in"></div>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>





<p id="xdx_89D_eus-gaap--LeaseCostTableTextBlock_zSnfQKhwiuh3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zlbAlFFdpoHa">The
Company incurred lease costs as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_499_20220701__20230630_zpmYZ7m6lL3d" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_497_20210701__20220630_zXQcSgepqCo8" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_497_20200701__20210630_zNzI0azPhXl5" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2021</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCostAbstract_iB_zoXpqvRuRPah" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -5.25pt; padding-left: 5.4pt">&#160;Operating Lease Cost:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--FixedRentExpense_z8AcCqN0iHUd" style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; text-align: left; text-indent: 3.75pt; padding-left: 5.4pt">Fixed rent expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">83</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">83</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">106</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--VariableLeaseCost_zr0X1jDo3W73" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 3.75pt; padding-left: 5.4pt">Variable rent expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ShortTermLeaseCost_i_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 3.75pt; padding-left: 5.4pt">Short term lease cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--SubleaseIncome_iN_pn3n3_di_z76UFRZu2Tfa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 3.75pt; padding-left: 5.4pt">Sublease income</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(33</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(26</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(18</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_zcX5cRZwenp8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 5.4pt">Net lease cost</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">73</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">85</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">108</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherCostAndExpenseOperating_i_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 8.25pt; padding-left: 5.4pt">Lease cost &#8211; other operating expense</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">73</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">85</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">89</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ExplorationCosts_i_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 8.25pt; padding-left: 5.4pt">Lease cost &#8211; exploration expenditures</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1818">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1819">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">19</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--LeaseCost_iC_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 5.4pt">Net lease cost</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">73</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">85</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">108</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AA_zKjX3tLg7oj5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p id="xdx_897_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zD7mmsHKNvfi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zDvJ5ophd4el">The
maturity of lease liabilities is as follows at June 30, 2023:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49C_20230630_z1QWTu6T7T0i" style="text-align: center">&#160;Fiscal Year Lease Maturities</td></tr>
<tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzI5d_zHPDhM5QUv7c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 51%; text-align: left">&#160;&#160;2024</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;$</td>
    <td style="width: 15%; text-align: right">71</td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzI5d_z05KgwjqCgpi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">96</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPzI5d_zvTGZCZz7QY6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;2026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">98</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_maLOLLPzI5d_zqdtbyxaHpE4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;2027</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">50</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_mtLOLLPzI5d_zTaKPeQ4hDr2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total lease payments</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">315</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_405_ecustom--LessAmountOfPaymentsRepresentingInterest_iI_pn3n3_zKE9Pp6QS1a2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;Less amount of payments representing interest</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(80</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zTgELzjBCtJ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of lease payments</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">235</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_z9MZvrJmbNh1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;Less current portion of operating lease liability</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(71</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zV9dtOQgqg4g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncurrent operating lease liability</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid">$</td>
    <td style="border-bottom: Black 2pt solid; text-align: right">164</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
</table>

<p id="xdx_8A5_zMOsgEKBhOac" style="margin-top: 0; margin-bottom: 0"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164855104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_804_eus-gaap--IncomeTaxDisclosureTextBlock_z3QeLREfozB3" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82F_zgFxuyYK0jRi">INCOME
TAXES</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zOwh96xunHZb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zHcHAOhE69tg">Domestic
and foreign components of loss before income taxes for the years ended June 30, 2023, 2022, and 2021 are as follows:</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49A_20220701__20230630_zeb8spq4upv9" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49D_20210701__20220630_zlF7w9Xq9dtk" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_493_20200701__20210630_zDa3CpObDsc7" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2021</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_hus-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zK3uUy9GUwBe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">34,606</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">6,918</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,362</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_hus-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zSnBYF2RA4s3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">United States</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,006</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,969</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,462</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_zZFNWLHDmeR5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">40,612</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">10,887</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">4,824</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A1_zQzFBiFqZf95" style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<div style="text-align: center; margin-left: 0.25in"></div>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>





<p id="xdx_890_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zs5HExDBoQV5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_znKJH15Ehw48">The
following table is a reconciliation of income taxes at statutory rates:</span> </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49A_20220701__20230630_znnsNMkmeHA5" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49D_20210701__20220630_zweCFb7u7cH3" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_493_20200701__20210630_zUDfhAo0sfv2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="10" style="text-align: center">For the year ended June 30,</td><td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2021</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_z2WhkTx04cnj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">Loss before income taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">40,612</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">10,887</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,824</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zd2HImnVCDA2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Combined federal and provincial statutory income tax rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27</td><td style="text-align: left">%</td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_zUfrl6WI2bZg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income tax benefit at statutory tax rates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,965</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,940</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,303</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_zG5EZlLuMTAe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Foreign rate differential</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(131</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(72</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(31</td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_ecustom--EarnoutSharesLiability_zatK8X6UCRIg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,841</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1887">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1888">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--WarrantLiability_ztPKc0T2sA0f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,518</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1891">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1892">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--GxiiTransactionCosts_zLsZii2oldF8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">GXII transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(925</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1895">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1896">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_zKz7PS0iLfNa" style="vertical-align: bottom; background-color: White">
    <td>Share based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(412</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(462</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(212</td><td style="text-align: left">)</td></tr>
<tr id="xdx_406_eus-gaap--AssetRetirementObligationAccretionExpense_iN_di_zd55MIrI4rN9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(496</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(407</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(158</td><td style="text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--ExtinguishmentOfDebtGainLossIncomeTax_zyvmbEVRRo21" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loss on debt extinguishment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(54</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1907">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1908">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--EffectOfLegislativeChanges_znHjEoUvZnG1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Capital loss rate differential</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(38</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">182</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_zt23miC8g4Lh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in estimates related to prior years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(274</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">739</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--IncomeTaxReconciliationOtherAdjustments_z9Za1ZpLOYbf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zjGXRlblmnE2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Change in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,341</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,713</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,841</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">Income tax benefit</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20220701__20230630_zr0eMwVRmSl3" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit::XDX::-304"><span style="-sec-ix-hidden: xdx2ixbrl1926">304</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20210701__20220630_zYeRGCCQ4tX1" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit"><span style="-sec-ix-hidden: xdx2ixbrl1928">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20200701__20210630_zLlWW1B9LwUi" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit"><span style="-sec-ix-hidden: xdx2ixbrl1930">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A8_zLgiJwpKP3K5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p id="xdx_896_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z9Wm3gH6oO5e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zoPVsgiFNfqf">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_497_20230630_zDhU4uDzfFX" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="3" id="xdx_490_20220630_zFERGbCETe1" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: -0.125in">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0in">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTAGzakr_zFOs3CUB4mza" style="vertical-align: bottom; background-color: White">
    <td style="width: 50%; text-align: left; text-indent: 12.45pt; padding-left: 0in">Net operating losses available for future periods</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">11,893</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">8,977</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--DeferredTaxAssetsMineralInterest_iI_pn3n3_maDTAGzakr_zO5arYDMSVR8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 12.45pt; padding-left: 0in">Mineral interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,477</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,477</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--DeferredTaxAssetsStartupAndOorganizationalCosts_iI_pn3n3_maDTAGzakr_znoYOjcmoRZ8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 12.45pt; padding-left: 0in">Startup and organizational costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,132</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1941">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--DeferredTaxAssetsResearchAndDevelopmentCosts_iI_pn3n3_maDTAGzakr_zKk5UOLNyXN1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 12.45pt; padding-left: 0in">Research and development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,060</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1944">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--DeferredTaxAssetsShareIssuanceCosts_iI_pn3n3_maDTAGzakr_zQd4scgkZIE3" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 12.45pt; padding-left: 0in">Share issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">446</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1947">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--CapitalLossesAvailableForFuturePeriods_iI_pn3n3_maDTAGzakr_zejWCLKH9Gll" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 12.45pt; padding-left: 0in">Capital losses available for future periods</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">419</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">420</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOther_iI_maDTAGzakr_zuwwfEPG5gte" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-indent: 12.45pt; padding-left: 0in">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">36</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">74</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iI_mtDTAGzakr_maDTALNz97R_zkKzt0D9EmG5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0in">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,463</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,948</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNz97R_zkL602cJP7R1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 12.45pt; padding-left: 0in">&#160;Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(25,463</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(18,948</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNz97R_zFkk3S5gNFpk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0in">Net deferred tax assets</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1961">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1962">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AE_zk1CTyf92846" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended June 30, 2022, we identified errors in the recognition of capital losses related to realized mineral property
write downs and foreign exchange gains and losses in Canada which resulted in changes to capital losses available for future periods
and other of $<span id="xdx_90F_ecustom--IncreasesInCapitalLossesAvailableForFuturePeriods_iI_pn3n3_c20220630_zBi6QNFrDvHk">(221)</span> and $<span id="xdx_907_ecustom--OtherIncomeTaxes_pn3n3_c20210701__20220630_zT8rSA3tlFii">(3)</span>, respectively. These changes primarily related to adjustments to deferred tax assets recorded during
fiscal year 2021. In addition, during the year ended June 30, 2022, we identified an error in the recognition of net operating
losses related to disallowed interest expense for the prior year which resulted in a decrease to net operating loss carryforwards
of $<span id="xdx_90C_ecustom--CapitalLossCaryforward_iI_pn3n3_c20230630_zPeZDpsZv3Y" title="Operating loss carryforwards">19</span>. After evaluation and consideration of the full valuation allowance historically applied against total deferred tax assets,
we determined that the impact of the adjustments was not material to the previously issued consolidated financial statements, nor are the out
of period adjustments material to the estimated results for the year ended June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_eus-gaap--SummaryOfValuationAllowanceTextBlock_zx6ddasQHuG" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zhsSx74uZKO7">Changes
in the valuation allowance are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 50%; text-align: left; text-indent: -5.25pt; padding-left: 5.4pt">Valuation allowance, beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20220701__20230630_z0HmcrsxEO" style="width: 12%; text-align: right" title="Valuation allowance, beginning of year">(18,948</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20210701__20220630_zWITIePj2yUl" style="width: 12%; text-align: right" title="Valuation allowance, beginning of year">(17,235</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 4.85pt; padding-left: 5.4pt">Current year additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20220701__20230630_zwPbJS7FO6v9" style="text-align: right" title="Current year additions">(4,341</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20210701__20220630_zar3lEOTceFi" style="text-align: right">(1,713</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 4.85pt; padding-left: 5.4pt">Startup and organizational costs acquired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20220701__20230630_zWrtvp8nFv11" style="border-bottom: Black 1pt solid; text-align: right" title="Startup and organizational costs acquired">(2,174</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20210701__20220630_zwL3jCeNsFHh" style="border-bottom: Black 1pt solid; text-align: right" title="Startup and organizational costs acquired"><span style="-sec-ix-hidden: xdx2ixbrl1979">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; text-indent: -5.25pt; padding-left: 5.4pt">Valuation allowance, end of year</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20220701__20230630_zLHAnSv3xxO1" style="border-bottom: Black 2pt solid; text-align: right" title="Valuation allowance, end of year">(25,463</td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20210701__20220630_zMU53NOnfclh" style="border-bottom: Black 2pt solid; text-align: right" title="Valuation allowance, end of year">(18,948</td><td style="padding-bottom: 2pt; text-align: left">)</td></tr>
</table>

<p id="xdx_8A7_zbh27Din1iOh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<div style="text-align: center; margin-left: 0.25in"></div>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acquired a federal income tax payable of $<span id="xdx_907_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_pn3n3_c20220701__20230630_z3PblABOZUtd" title="Federal income tax payable">406</span> in connection with the GXII Transaction. As a result of a post-transaction
loss at ECRC, a partial release of the valuation allowance attributed to the reduction of the acquired federal income tax payable
of $304 has been recorded as an income tax benefit in the consolidated statement of operations and comprehensive loss for the
year ended June 30, 2023. The Company establishes a valuation allowance against future income tax assets if, based on available
information, it is more likely than not that all of the assets will not be realized. The valuation allowance of $<span id="xdx_90D_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pn3n3_c20230630_zwrjHPKNexG6" title="Valuation allowance">25,463</span> at June
30, 2023, relates mainly to net operating loss carryforwards in Canada and mineral interests due to deferred exploration expenditures
in the United States, where the utilization of such attributes is not more likely than not.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<p id="xdx_895_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zt7NSQhNdB92" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company has the following cumulative net operating losses for Canadian and U.S. income tax purposes and these carryforwards will
generally expire between 2026 and 2043. As a result of the Tax Cuts and Jobs Act of 2017, U.S. tax losses incurred for tax years
ending on and after June 30, 2019, totaling $<span id="xdx_900_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pn3n3_c20190630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zJv5UtZ5duE5" title="Tax losses incurred">2,510</span>, have no expiration..&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_8BC_zZs2rzH4nlb7" style="display: none; visibility: hidden">Schedule of cumulative net operating losses</span></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Jurisdiction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zr2FLxoZyhUl" style="width: 12%; text-align: right" title="Total">40,267</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20220630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zhDi5089CG8c" style="width: 12%; text-align: right" title="Total">31,551</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zk4iV5YRgr57" style="border-bottom: Black 1pt solid; text-align: right" title="Total">3,491</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20220630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zyv3Wf0uaSG1" style="border-bottom: Black 1pt solid; text-align: right" title="Total">2,460</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630_z88s9qWFxcD1" style="border-bottom: Black 2pt solid; text-align: right" title="Total">43,758</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20220630_z9x1cEazGDhi" style="border-bottom: Black 2pt solid; text-align: right" title="Total">34,011</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A4_zIP5noOXAsa7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company has a Canadian capital loss carryforward of $<span id="xdx_902_ecustom--CapitalLossCaryforward_iI_c20230630__srt--CurrencyAxis__currency--CAD_z9Q4kEAyjsb4" title="Capital loss carryforward">3,375</span> as of June 30, 2023, which has no expiration date and
can be used to offset future capital gains, and U.S. state net operating loss carryforwards of $<span id="xdx_903_ecustom--CapitalLossCaryforward_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z6d9xy17ptD5" title="Net operating loss carryforwards">4,943</span> as of June 30, 2023 which
generally expire between 2031 and 2043.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no unrecognized tax benefits as of June 30, 2023 or 2022. The Company recognizes interest accrued related to unrecognized
tax benefits and penalties in its income tax provision. The Company has not recognized any interest or penalties in the fiscal
years presented in these consolidated financial statements. The Company is subject to income tax in the U.S. federal jurisdiction and Canada.
Certain years remain subject to examination but there are currently no ongoing exams in any taxing jurisdictions.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164883056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_z2JfJREIbHPb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">16.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span><span id="xdx_823_z0Jtaq5xxBC7">FAIR VALUE MEASUREMENTS</span></span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify">The Company measures the fair value of
financial assets and liabilities based on U.S. GAAP guidance which defines fair value, establishes a framework for measuring fair
value, and expands disclosures about fair value measurements.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies financial assets and liabilities as held-for-trading, available-for-sale, held-to-maturity, loans and receivables,
or other financial liabilities depending on their nature. Financial assets and financial liabilities are recognized at fair value
on their initial recognition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets and liabilities classified as held-for-trading are measured at fair value, with gains and losses recognized in net income.
Financial assets classified as held-to-maturity, loans and receivables, and financial liabilities other than those classified
as held-for-trading are measured at amortized cost, using the effective interest method of amortization. Financial assets classified
as available-for-sale, including investments in equity securities, are measured at fair value, with unrealized gains and losses
being recognized in income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Financial
instruments including receivables, accounts payable and accrued liabilities, and related party loans are carried at amortized
cost, which management believes approximates fair value due to the short-term nature of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables present information about the assets and liabilities that are measured at fair value on a recurring basis as
of June 30, 2023, and June 30, 2022, respectively, and indicate the fair value hierarchy of the valuation techniques the Company
utilized to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted)
in active markets for identical instruments. Fair values determined by Level 2 inputs utilize data points that are observable,
such as quoted prices, interest rates, and yield curves. Fair values determined by Level 3 inputs are unobservable data points
for the financial instrument and include situations where there is little, if any, market activity for the instrument.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>









<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p id="xdx_89B_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zNMgNLuWaxM2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><span id="xdx_8B5_z5Btv5rSI5I8" style="display: none; visibility: hidden">Schedule of fair values determined by level 3 inputs are unobservable data</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Note</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 35%; text-align: left; padding-left: 9pt">Cash and cash equivalents</td>
    <td style="width: 9%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630_zBqcN60P3wt7" style="width: 11%; text-align: right">2,341</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIn4vwrQPf7a" style="width: 11%; text-align: right">2,341</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7zEhm2YuoQf" style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2024">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zq5aVQK3ovAl" style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2025">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Investment in equity securities</td>
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630_zg5N2PlFUBF4" style="border-bottom: Black 1pt solid; text-align: right">9</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zVvWu8ZiBRgi" style="border-bottom: Black 1pt solid; text-align: right">9</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhZOTDvsRkxj" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2028">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zXBuHYeUa2Dh" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2029">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td>
    <td>&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20230630_zVAB7hMrEACg" style="border-bottom: Black 2pt solid; text-align: right">2,350</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zLJ84rQf7Hs2" style="border-bottom: Black 2pt solid; text-align: right">2,350</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLoa3f7lt5Q6" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2032">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoBfXWj8Caob" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2033">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">Earnout Shares liability</td>
    <td style="text-align: center">10</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630_z0f8wg0zICOe" style="text-align: right">10,521</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zU38dtIrpt08" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2035">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4rJ8zi6lceg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2036">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zsYXpvENPoBf" style="text-align: right">10,521</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Warrant liabilities</td>
    <td style="text-align: center">9,11c</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630_zBPOAOFwAfj2" style="border-bottom: Black 1pt solid; text-align: right">4,989</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zomNPdBwqyv8" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2039">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWdcp9yPbOc5" style="border-bottom: Black 1pt solid; text-align: right">3,279</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmct4EnBaspj" style="border-bottom: Black 1pt solid; text-align: right">1,710</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt"><p style="margin: 0pt 0">Total</p>


</td>
    <td>&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630_zeRiRuss6wwh" style="border-bottom: Black 2pt solid; text-align: right">15,510</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z9vJ2MMgp1Cf" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2043">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zpYZRNJVy3m3" style="border-bottom: Black 2pt solid; text-align: right">3,279</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGxP1J8Qcjoe" style="border-bottom: Black 2pt solid; text-align: right">12,231</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2022</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 35%; text-align: left; padding-left: 9pt">Cash and cash equivalents</td>
    <td style="width: 9%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20220630_zQii4MSlRlr6" style="width: 11%; text-align: right" title="Cash and cash equivalents">5,280</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zPVQ35cH5Oxg" style="width: 11%; text-align: right">5,280</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhRmHXlSeHA9" style="width: 11%; text-align: right">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2049">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_ztumoy6ys8O2" style="width: 11%; text-align: right">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2050">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Investment in equity securities</td>
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20220630_zKuZXLiBEKi3" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents">10</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2O9RdnHokzk" style="border-bottom: Black 1pt solid; text-align: right">10</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zsoypEJ1ICUk" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2054">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoMqkyssNAE9" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2055">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td>
    <td>&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20220630_zcVjOknAjGi9" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents">5,290</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z30en8wKjpu4" style="border-bottom: Black 2pt solid; text-align: right">5,290</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9RUg6IZk7dl" style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2059">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3IbVi7tAKG9" style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2060">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A7_zaS7BfaXvR81" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
<span style="color: #353535">Yorkville Convertible Debt Financing </span>discussed in Note 9 was initially recorded at fair value,
which represented a nonrecurring fair value measurement using a Level 3 input. At June 30, 2023, the estimated fair value of this
instrument approximated carrying value given that the instrument was issued in March 2023 and has a short time period until maturity.&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI https://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164829376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--SubsequentEventsTextBlock_zlsSx7wiCx95" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">17.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="xdx_82F_zpc8DItdVG3e">SUBSEQUENT
EVENTS</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--SubsequentEventDescription_c20230830__20230901__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zNuRxFnAe5v6" title="Subsequent event description">On
September 1, 2023, the Company closed a non-brokered private placement (the &#8220;September 2023 Private Placement&#8221;) of
units of the Company (the &#8220;September 2023 Units&#8221;). A total of 250,000 September 2023 Units were issued at a price per September 2023 Unit of $4.00,
for total gross proceeds to the Company of $1.0 million. Each September 2023 Unit consists of one Common Share and one Common
Share purchase warrant (&#8220;September 2023 Warrant&#8221;). Each September 2023 Warrant entitles the holder to acquire one
Common Share at a price of $4.60 at any time prior to September 1, 2025. Proceeds of the September 2023 Private Placement will
be used for continued advancement of the Company&#8217;s Elk Creek Critical Minerals Project and for working capital and general
corporate purposes.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 12 and September 18, 2023, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20230910__20230912__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zqfBzBeSACc9" title="Shares issued and sold">70,000</span> and <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20230916__20230918__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUQn6IjkDIke" title="Shares issued and sold">75,000</span> Common Shares, respectively, under the Yorkville Equity
Facility Financing Agreement in exchange for $<span id="xdx_90F_eus-gaap--DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds_pn5n6_c20230916__20230918__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--FinancingAgreementMember_zqNUyvCQqqJf" title="Gross cash proceeds">0.5</span> million in gross cash proceeds.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162154457488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DevelopmentStageIssuerPolicyTextBlock', window );">Development Stage Issuer</a></td>
<td class="text"><p id="xdx_848_ecustom--DevelopmentStageIssuerPolicyTextBlock_zJkX4dox3P5g" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_865_zXtCthRZkGJj">Development
                                         Stage Issuer</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is considered to be a development stage issuer under Subpart 1300 of Regulation S-K of the United States Securities Act
of 1933, as amended (&#8220;S-K 1300&#8221;), and it devotes substantially all of its efforts to acquiring and exploring mining
interests that management believes should eventually provide sufficient net profits to sustain the Company&#8217;s existence.
Until such interests are engaged in commercial production, the Company will continue to seek additional funding to support the
completion of its exploration and development activities. The Company&#8217;s activities are subject to significant risks and
uncertainties, including its ability to secure sufficient funding to continue operations, to obtain proven and probable reserves,
to comply with industry regulations and obtain permits necessary for development of the Elk Creek Project, as well as environmental
risks and market conditions.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zXhSCc1lPCQ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_zlpJd7WiSBI5">Cash
                                         and Cash Equivalents</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents include cash on hand, cash in banks, investments in certificates of deposit with original maturities of
90 days or less, and money market funds. The Company maintains the majority of its cash balances with two financial
institutions. Accounts at banks in the United States (&#8220;U.S.&#8221;) are insured by the Federal Deposit Insurance
Corporation (&#8220;FDIC&#8221;) up to $250, while accounts at banks in Canada are insured by the Canada Deposit Insurance
Corporation (&#8220;CDIC&#8221;) up to C$100. At June 30, 2023 and 2022, the Company had $1,717 and $4,721 in excess of the
FDIC and CDIC insured limits, respectively.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><p id="xdx_843_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zJOG3sB3cbde" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_867_zp6NhYawEyQc">Foreign
                                         Currency Translation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Functional
and reporting currency</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items
included in the financial statements of each of the Company&#8217;s entities are measured using the currency of the primary economic
environment in which the entity operates (&#8220;the functional currency&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reporting currency for these consolidated financial statements is U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in functional currency</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to March 17, 2023, the Company&#8217;s functional currency was the Canadian dollar. The Company re-assessed its functional
currency and determined that on March 17, 2023, its functional currency changed from the Canadian dollar to the U.S. dollar
based on significant changes in economic facts and circumstances in our organization. The change in functional currency was
accounted for prospectively from March 17, 2023 and prior-period consolidated&#160;financial statements were not restated for
the change in functional currency.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<div style="text-align: center; margin-left: 0.25in"></div>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
both monetary and non-monetary assets and liabilities, translated balances as of March 17, 2023 became the new accounting basis.
The exchange rate on the date of change became the historical rate at which non-monetary assets and liabilities were translated
in subsequent periods. There was no effect on the cumulative translation adjustment on the consolidated basis. Previously recorded
cumulative translation adjustments were not reversed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency for the Company&#8217;s Canadian subsidiary, 0896800 BC Ltd., which has no independent operations from its
parent, also changed from the Canadian dollar to the U.S. dollar. The functional currency for Elk Creek Resources Corp. remains
as the U.S. dollar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transactions
in foreign currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
made in a currency other than the functional currency are remeasured to the functional currency at exchange rates at the dates
of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are remeasured to
the functional currency at the exchange rate at that date and non-monetary assets and liabilities are remeasured at historical
rates. Foreign currency translation gains and losses are included in profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Translation
to reporting currency&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation
gains and losses from the application of the U.S. dollar as the reporting currency for all periods prior to March 17, 2023 (when
the Canadian dollar was the functional currency) are included as part of cumulative currency translation adjustment, which is
reported as a component of shareholders&#8217; equity under accumulated other comprehensive loss.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_MineralPropertiesPolicyTextBlock', window );">Mineral Properties</a></td>
<td class="text"><p id="xdx_840_ecustom--MineralPropertiesPolicyTextBlock_zn9ko4vXxy8j" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86F_z9HsYAkJsLj5">Mineral
                                         Properties</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
property acquisition costs, including indirectly related acquisition costs, are capitalized when incurred. Acquisition costs include
cash consideration and the fair market value of Common Shares issued as consideration. Properties acquired under option agreements,
whereby payments are made at the sole discretion of the Company, are capitalized as mineral property acquisition costs at such
time as the payments are made. Exploration costs are expensed as incurred. When it is determined that a mining deposit can be
economically and legally extracted or produced based on established proven and probable reserves under S-K 1300, and the Board
of Directors has approved the commencement of formal development activities, development costs related to such reserves and incurred
after such board approval will be considered for capitalization. The establishment of proven and probable reserves is based on
results of feasibility studies, which indicate whether a property is economically feasible. Upon commencement of commercial production,
capitalized costs will be amortized over their estimated useful lives or units of production, whichever is a more reliable measure.
Capitalized amounts relating to a property that is abandoned or otherwise considered uneconomic for the foreseeable future are
written off.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#8217;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. This would include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Such evaluations compare estimated future net cash flows with our carrying costs and future obligations on an undiscounted
basis. If it is determined that the estimated future undiscounted cash flows are less than the carrying value of the property,
an impairment loss will be recorded. Where estimates of future net cash flows are not determinable and where other conditions
indicate the potential for impairment, management uses available market information and/or third-party valuation experts to assess
if the carrying value can be recovered and to estimate fair value. There was no impairment recorded to mineral properties as of
June 30, 2023 or 2022, respectively.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long Lived Assets</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zZSrZEJUreb3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_zUmviM3xRkyh">Long
                                         Lived Assets</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets, other than mineral properties, held and used by the Company are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>









<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For purposes of evaluating the recoverability
of long-lived assets, the recoverability test is performed using undiscounted net cash flows related to the long-lived assets.
If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount
of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount
or fair value less costs to sell. There was no impairment recorded to long-lived assets as of June 30, 2023 or 2022, respectively.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p id="xdx_846_eus-gaap--LesseeLeasesPolicyTextBlock_zKbLNiM7xQV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zlAhXUXUovFl">Leases</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Accounting Standards Codification (&#8220;ASC&#8221;) 842, &#8220;Leases,&#8221; we determine if a contractual arrangement is,
or contains, a lease at the inception date. Right-of-use (&#8220;ROU&#8221;) assets and liabilities related to operating leases
are separately reported in the consolidated balance sheets. The Company currently has no finance leases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU
assets and lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments
over the lease term. When the rate implicit to the lease cannot be readily determined, we utilize our incremental borrowing rate
in determining the present value of the future lease payments. The incremental borrowing rate is derived from information available
at the lease commencement date and represents the rate of interest that a lessee would have to pay to borrow an amount equal to
the lease payments on a collateralized basis over a similar term in a similar economic environment. Operating lease ROU assets
also include any cumulative prepaid or accrued rent when the lease payments are uneven throughout the lease term. The ROU assets
and lease liabilities may include options to extend or terminate the lease when it is reasonably certain that we will exercise
that option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term.
For operating leases, interest on the lease liability and the amortization of the ROU asset result in straight-line rent expense
over the lease term. Variable lease expenses are recorded when incurred.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_WarrantsPolicyTextBlock', window );">Warrants</a></td>
<td class="text"><p id="xdx_842_ecustom--WarrantsPolicyTextBlock_zmOdMLKAZMp9" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_zkn0gfB4mzZ1">Warrants</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
apply relevant accounting guidance for warrants to purchase our stock based on the nature of the relationship with the counterparty.
For warrants issued to investors or lenders in exchange for cash or other financial assets, we follow guidance issued within ASC
480, Distinguishing Liabilities from Equity, and ASC Topic 815, Derivatives and Hedging, (&#8220;ASC 815&#8221;) to assist in
the determination of whether the warrants should be classified as liabilities or equity. The fair value of warrants is estimated
using Black Scholes modeling or Monte Carlo modeling, depending on the settlement features embedded in the warrant. Inputs under
both models include inputs such as NioCorp&#8217;s Common Share price, the risk-free interest rate, the expected term, the volatility,
and the dividend rate. Warrants that are determined to require liability classifications are measured at fair value upon issuance
and are subsequently remeasured to their then fair value at each subsequent reporting period with changes in fair value recorded
in current earnings. Warrants that are determined to require equity classifications measured at fair value upon issuance and are
not subsequently remeasured unless they are required to be reclassified.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarnoutSharesPolicy', window );">Earnout Shares</a></td>
<td class="text"><p id="xdx_841_ecustom--EarnoutSharesPolicy_zPrxAclSfbdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_zFYPbuZ31El8">Earnout
                                         Shares</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
Shares are classified as a liability due to failure to meet the equity classification criteria under ASC 815-40. The fair value
of the Earnout Shares on the date of issuance and on each measurement date is estimated using a Monte Carlo simulation methodology,
which includes inputs such as NioCorp&#8217;s Common Share price, the risk-free interest rate, the expected term, the implied
volatility underlying the Company&#8217;s Public Warrants, the dividend rate, the conversion price, and the number of Earnout
Shares outstanding. Assumptions used in the model are subjective and require significant judgment.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Financial Instruments</a></td>
<td class="text"><p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zDNoDDX3pPY3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_865_z6xtqDIfxqBa">Financial
                                         Instruments</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, receivables, equity securities, accounts payable and accrued liabilities,
convertible debt and the related party loan. It is management&#8217;s opinion that the Company is not exposed to significant interest,
currency or credit risks arising from its financial instruments. The fair values of these instruments approximate their carrying
value unless otherwise noted.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_z4EOR7m4rotd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_zoVOqAKsMn4c">Concentration
                                         of Credit Risk</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial instrument which potentially subjects the Company to credit risk is cash and cash equivalents, The Company holds investments
or maintains available cash primarily in two commercial banks located in Vancouver,</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<div style="text-align: center; margin-left: 0.25in"></div>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">British Columbia and Santa Clara, California.
As part of its cash management process, the Company regularly monitors the relative credit standing of these institutions.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationsPolicy', window );">Asset Retirement Obligation</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--AssetRetirementObligationsPolicy_z6U1pWuF73F1" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zzlbXqlYuAfa">Asset
                                         Retirement Obligation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to various government laws and regulations relating to environmental disturbances caused by exploration and
evaluation activities. The estimated costs associated with environmental remediation obligations are accrued in the period in
which the liability is incurred if it is reasonably estimable or known. Until such time that a project life is established, the
Company records the corresponding cost as an exploration stage expense and has accrued $<span id="xdx_90F_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20230630_zC6yQ1gF29bg">48</span> as an accrued liability related to
estimated obligations as of June 30, 2023 (2022 - $<span id="xdx_90D_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20220630_zWKK5mFe9WG6" title="Accrued exploration stage expense">48</span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
reclamation and environmental-related expenditures are difficult to estimate in many circumstances due to the early-stage nature
of the Elk Creek Project, the uncertainties associated with defining the nature and extent of environmental disturbance, the application
of laws and regulations by regulatory authorities and changes in reclamation or remediation technology. The Company periodically
reviews accrued liabilities for such reclamation and remediation costs as evidence indicating that the liabilities have potentially
changed becomes available. Changes in estimates are reflected in the consolidated statement of operations and comprehensive loss in the period an estimate
is revised.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_z8tYU1sa8Ao3" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zs9Rb7gXjoDb">Income
                                         Taxes</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25, <i>&#8220;Income Taxes &#8211; Recognition.&#8221;
</i>Under the approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between
the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded
against deferred tax assets if management does not believe the Company has met the &#8220;more likely than not&#8221; standard
imposed by ASC 740-10-25-5 to allow recognition of such an asset. ASC 740-10-50, &#8220;Income Taxes &#8211; Disclosure,&#8221;
requires the Company to evaluate its income tax positions and recognize a liability for uncertain tax positions that are not more
likely than not to be sustained by tax authorities. As of June 30, 2023 and 2022, the Company believes it had no income tax uncertainties
that required recognition of a liability. If the Company were to determine that uncertain tax positions meet the criteria for
recognition, an estimated liability and related interest and penalties would be recognized as income tax expense.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ReverseStockSplitPolicyTextBlock', window );">Reverse Stock Split [Policy Text Block]</a></td>
<td class="text"><p id="xdx_84E_ecustom--ReverseStockSplitPolicyTextBlock_zo8YIoczuktl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reverse
                                         Stock Split</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 17, 2023, the Company effected a reverse stock split (the &#8220;Reverse Stock Split&#8221;) on the basis of one (1) post-Reverse
Stock Split Common Share for every ten (10) pre-Reverse Stock Split Common Shares issued and outstanding, with any fractional
shares resulting from the Reverse Stock Split rounded down to the nearest whole share. Immediately after the Reverse Stock Split,
there were 30,000,442 Common Shares issued and outstanding. All references to share and per share amounts (excluding authorized
shares) in the consolidated financial statements and accompanying notes have been retroactively restated to reflect the Reverse
Stock Split.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_RedeemableNoncontrollingInterestPolicyTextBlock', window );">Redeemable Noncontrolling Interest</a></td>
<td class="text"><p id="xdx_842_ecustom--RedeemableNoncontrollingInterestPolicyTextBlock_zVio3UOUdE0a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_z07Nhe4mLBwg">Redeemable
                                         Noncontrolling Interest</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable
Noncontrolling Interest refers to non-controlling interest associated with the Vested Shares that are redeemable upon the occurrence
of an event that is not solely within the Company&#8217;s control and is reported in the mezzanine section between total liabilities
and shareholders&#8217; deficit, as temporary equity in the Company&#8217;s consolidated balance sheets. The
Company&#8217;s non-controlling interest is redeemable at fair value, and no adjustment to the earnings per share numerator is
required because redemption at fair value is not considered an economic distribution different from other common stockholders.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Per Share Disclosure</a></td>
<td class="text"><p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_z4hs6MtuRSEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zHyNOqAYJzI7">Basic
                                         and Diluted Per Share Disclosure</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted
average number of Common Shares outstanding during the period. The Company considers Vested Shares and Released Earnout
Shares (each as defined in Note 10), to be participating securities, requiring the use of the two-class method. Diluted
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted average
number of Common Shares outstanding, inclusive of the dilutive impact of all potentially dilutive securities outstanding
during the period, as applicable.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>









<div style="text-align: center; margin-left: 0.25in"></div>





<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>


<p id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z3eruOf1JU9c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. <span id="xdx_8B3_zJC6A6vaTFb8">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share
attributable to common shareholders:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; background-color: #CCECFF; border-collapse: collapse; margin-left: 0.5in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="9" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the year ended June 30,</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20220701__20230630_zFQp4ku0flCa" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,308</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210701__20220630_zIXhZ86d9w65" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,887</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200701__20210630_zssQC8D0iE53" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,824</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjust:
    Net loss attributable to noncontrolling interest</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20220701__20230630_zqqNk02gopR" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::228"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0809">(251</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20210701__20220630_zOyu0YxBliY6" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0811">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20200701__20210630_zpWSiN86lFEa" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0813">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss available to participating securities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220701__20230630_zV3gNqOmuwTk" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,057</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20210701__20220630_z9QdtQfKZAgc" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,887</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20200701__20210630_zv0dpzPPfiY4" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,824</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss attributable to Vested Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zVLWsnQRhg6j" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,528</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20210701__20220630_z1MBIpPDBSq9" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0823">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20200701__20210630_z2nWNLQPzUU7" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0825">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 9pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss attributed to common shareholders - basic and diluted</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20220701__20230630_z0QxpAAuKBXh" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,529</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20210701__20220630_zUGKlTW6sQ8f" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,887</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20200701__20210630_zwZFR6TLoOK5" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,824</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average shares outstanding &#8211; basic and diluted</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20220701__20230630_zlRgKsVPLbg2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,705,840</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20210701__20220630_zRsagfqjhAD7" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,373,722</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20200701__20210630_zVMUUNLt4TNl" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,196,711</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    per Common Share outstanding &#8211; basic and diluted</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230630_z8PCNjjBnWE1" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.34</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20210701__20220630_zlMXAuzupyke" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.41</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20200701__20210630_zJ5yF0jIKA72" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.20</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p id="xdx_8A5_zDSzIPfVq1a4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following shares underlying options, warrants, and outstanding convertible debt were antidilutive
due to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation for the years
ended June 30, 2023 and 2022, as indicated below.</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zOn3rNY06DWi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BA_zc72BNzqWaDh" style="display: none; visibility: hidden">Schedule of excluded from the dilutive securities</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 89%; border-collapse: collapse; margin-left: 0.75in">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the year ended June 30,</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 61%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excluded
    potentially dilutive securities <sup id="xdx_F6B_zlpIL2QeXlS8">(1)(2)</sup>:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 11%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20230630_fKDEpKDIp_zTxQsQUt6vCi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,541,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20210701__20220630_fKDEpKDIp_zJ8w8jErmrs" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,446,400</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20200701__20210630_fKDEpKDIp_zkjNk0oBemyg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,596,500</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20230630_fKDEpKDIp_zrQbk9S4UKg5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,816,304</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20210701__20220630_fKDEpKDIp_zDcNxKNdVr4a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,851,622</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20200701__20210630_fKDEpKDIp_z0sNl7vkl4B1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,434,186</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
debt</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20230630_fKDEpKDIp_z7mNylIwkLa2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,871,660</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20210701__20220630_fKDEpKDIp_zahcAL52BKfa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">415,200</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20200701__20210630_fKDEpKDIp_zgqIxU0aSyua" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,455,700</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    potentially dilutive securities <sup></sup></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--DilutiveSecurities_c20220701__20230630_fKDEpKDIp_zJ5fgeJjdrLe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,229,464</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--DilutiveSecurities_c20210701__20220630_fKDEpKDIp_z1DA4k0owKD9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,713,222</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--DilutiveSecurities_c20200701__20210630_fKDEpKDIp_zC4ZPsqKRXjg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,486,386</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F0C_z8MpdCdTVJXl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zvlOvhPMsqK8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F06_zEo1LnpKZiee" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zjFm1EndTiW7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period. </span></td></tr>
</table>

<p id="xdx_8AE_zQYsB0CM1Ksf" style="margin-top: 0; margin-bottom: 0"></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share Based Compensation</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zXWOk6GWM1Kl" style="margin-top: 0; margin-bottom: 0"></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">p)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zPYfP5GRiaW3">Share
                                         Based Compensation</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants stock options to directors, officers, employees, and business advisors. Option terms and vesting conditions
are at the discretion of the Board of Directors. Prior to March 21, 2023, the option exercise price was equal to the closing
market price on The Toronto Stock Exchange (the &#8220;TSX&#8221;) on the day preceding the date of grant. Effective March
21, 2023, the option exercise price is equal to the closing market price on the Nasdaq Stock Market LLC
(&#8220;Nasdaq&#8221;) on the day preceding the date of the grant.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates the fair value of stock options using the Black-Scholes option pricing model. The Company recognizes forfeitures
as they occur.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z9lxU8GlAWhd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">q)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_zhBbIkyvNjb3">Recent
                                         Accounting Standards</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued
and Adopted</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;)
No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s
Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;), which simplifies the accounting for convertible instruments. ASU 2020-06
removes certain accounting models which separate the embedded conversion features from the host contract for convertible instruments.
Either a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption
of this standard. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within
those fiscal</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>









<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">years. The Company adopted ASU 2020-06 on July 1, 2022, with no material effect on the Company&#8217;s current financial
position, results of operations or financial statement disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued
and Not Effective</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective
date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a
material impact on the Company&#8217;s consolidated financial statements upon adoption.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Revision of Financial Statements (Unaudited)</a></td>
<td class="text"><p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zp4sRsVfdp0h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in">r)</td><td style="text-align: left"><span id="xdx_86D_zfPv1ZxtiDKj">Revision of Financial Statements (Unaudited)</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">During the
fourth quarter of fiscal year 2023, the Company determined that it had used an incorrect strike price while valuing the Private
Warrants (as defined below in Note 11c) at both the March 17, 2023, issuance date and as of March 31, 2023. This resulted in an
overstatement of other operating expenses, at fair value, and an understatement of change in fair value of warrant liabilities
in condensed consolidated statement of operations and comprehensive loss for both the three- and nine-month periods ended March
31, 2023. In addition, warrant liabilities, at fair value and accumulated deficit were overstated and understated, respectively,
as of March 31, 2023. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company determined that
these errors were immaterial to the previously issued consolidated financial statements, and as such no restatement was necessary.
Periods not presented herein will be revised, as applicable, in future filings.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">The effects
of the revision on the previously issued consolidated financial statements are as follows:</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p id="xdx_896_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zhsVYVtVC4s6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Revision Impacts to the Condensed Consolidated
Balance Sheet (unaudited)</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of March 31, 2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8BB_zqPDmNb9cDEc" style="display: none; visibility: hidden">Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As
of March 31, 2023</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zelflEE9IMBf" style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zWaKgukSfI9" style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230331_zY93igpGJPta" style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">As Previously<br/> Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revision<br/> Impacts</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revised</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--OtherLiabilitiesNoncurrent_iI_pn3n3_zqax1sPZZ8hd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-left: 5.4pt">Warrant liabilities, at fair value</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,303</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(665</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,638</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Total liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Liabilities_iI_pn3n3_c20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zRJ4DvEAlRkk" style="text-align: right" title="Total liabilities">34,735</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Liabilities_iNI_pn3n3_di_c20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zCy0TdbKQsH" style="text-align: right" title="Total liabilities">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Liabilities_iI_pn3n3_c20230331_zxCnuRnyJIEi" style="text-align: right" title="Total liabilities">34,070</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pn3n3_z1kI0YlWdhE3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(146,046</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">665</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(145,381</td><td style="text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--StockholdersEquity_iI_pn3n3_zEeGmVLayfV2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Total shareholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,512</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">665</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,847</td><td style="text-align: left">)</td></tr>
</table>

<p id="xdx_8A2_zXr0M4XmAGXb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"></p>

<p id="xdx_89B_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zf4thyh0OZk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Revision Impacts to the Condensed Consolidated
Statement of Operations and Comprehensive Loss (unaudited)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the Three Months Ended March 31,
2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_8B8_zwMYtoPoRhJ1" style="display: none; visibility: hidden">Revision Impacts to
                                            the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For
                                            the Three &amp; Nine Months Ended  March 31,
2023</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">As Previously<br/>
 Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revision<br/>
 Impacts</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revised</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-left: 5.4pt">Other operating expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OtherGeneralExpense_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zgQOUnHXWm68" style="width: 12%; text-align: right" title="Other operating expense">26,220</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--OtherGeneralExpense_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpLsguPTVOxc" style="width: 12%; text-align: right" title="Other operating expense">(861</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--OtherGeneralExpense_pn3n3_c20230101__20230331_zasjIfkHG88d" style="width: 12%; text-align: right" title="Other operating expense">25,359</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Total operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zMubrwz0kZt3" style="text-align: right" title="Total operating expenses">29,192</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zH8djFst0Oeh" style="text-align: right" title="Total operating expenses">(861</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331_zXe8FrzG6AT7" style="text-align: right" title="Total operating expenses">28,331</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Change in fair value of warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKTc1llfKIEk" style="text-align: right" title="Change in fair value of warrant liability">784</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zKLUQIW7L7g4" style="text-align: right" title="Change in fair value of warrant liability">196</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331_zBKidsx6iaqj" style="text-align: right" title="Change in fair value of warrant liability">980</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Loss before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zkop0E3nssMi" style="text-align: right" title="Loss before income taxes">29,621</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zefaGBWcanv1" style="text-align: right" title="Loss before income taxes">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_dxL_c20230101__20230331_zTUVmm3EVvbc" style="text-align: right" title="Loss before income taxes::XDX::-3877"><span style="-sec-ix-hidden: xdx2ixbrl0929">28,956</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zDEONR6tVaG5" style="text-align: right" title="Net loss">29,435</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zTzxnU9qsx3d" style="text-align: right" title="Net loss">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331_zTXUUlkWJVU3" style="text-align: right" title="Net loss">28,770</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Net loss attributable to the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ProfitLoss1_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zzG310e4baTk" style="text-align: right" title="Net loss attributable to the company">29,343</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ProfitLoss1_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zTNbjnxJqVt6" style="text-align: right" title="Net loss attributable to the company">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ProfitLoss1_pn3n3_c20230101__20230331_zGms76QML6g2" style="text-align: right" title="Net loss attributable to the company">28,678</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Total comprehensive loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zCkWs19aZdeh" style="text-align: right" title="Total comprehensive loss">29,323</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zPIBX74Xw4Z1" style="text-align: right" title="Total comprehensive loss">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331_z9Alax3TgdJ2" style="text-align: right" title="Total comprehensive loss">28,658</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Comprehensive loss attributable to the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zyDqlX3Y74x6" style="text-align: right" title="Comprehensive loss attributable to the company">29,231</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zG6JE1rlwC6a" style="text-align: right" title="Comprehensive loss attributable to the company">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331_z2L0neTwcTSc" style="text-align: right" title="Comprehensive loss attributable to the company">28,566</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Loss per common share, basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNILCmuSVGma" style="text-align: right" title="Loss per common share, basic and diluted">1.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zlpch4MOAPo4" style="text-align: right" title="Loss per common share, basic and diluted">(0.02</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331_z1FzQUrq6b97" style="text-align: right" title="Loss per common share, basic and diluted">0.98</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>




<p style="margin-top: 0; margin-bottom: 0">&#160;</p>









<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Revision Impacts to the Condensed Consolidated
Statement of Operations and Comprehensive Loss (unaudited)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the Nine Months Ended March 31,
2023&#160; &#160; &#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
    <td style="width: 55%; padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right">&#160;</td>
    <td style="width: 1%; background-color: white; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right">&#160;</td>
    <td style="width: 1%; background-color: white; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right">&#160;</td>
    <td style="width: 1%; background-color: white; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><b>As
    Previously<br/>
 Reported</b></span></td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><b>Revision<br/>

    Impacts</b></span></td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><b>Revised</b></span></td>
    <td style="background-color: white; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Other operating expense</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--OtherGeneralExpense_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYqCHLJxMxO9" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"><span style="font-size: 10pt">26,888</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_98C_eus-gaap--OtherGeneralExpense_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_z9N7AAiEK2a2" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"><span style="font-size: 10pt">(861</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--OtherGeneralExpense_pn3n3_c20220701__20230331_zKeufiUYm8qe" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"><span style="font-size: 10pt">26,027</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Total operating expenses</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98B_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zPqhiQylMFh6" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"><span style="font-size: 10pt">33,475</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zOnwEy7ElEg" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"><span style="font-size: 10pt">(861</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_987_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331_z3rjgMQXLo2c" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"><span style="font-size: 10pt">32,614</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Change in fair value of warrant liability</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98E_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zGRArvNXlvyg" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"><span style="font-size: 10pt">868</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98B_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_ze6iLON1bLq2" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"><span style="font-size: 10pt">196</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_989_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331_zuXbyNA31H96" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"><span style="font-size: 10pt">1,064</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Loss before income taxes</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYWQlY66Wnz5" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes"><span style="font-size: 10pt">35,927</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpRhxZjqEyEd" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes"><span style="font-size: 10pt">(665</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_dxL_c20220701__20230331_zWnUuOx7nh73" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes::XDX::-3877"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0988">35,262</span></span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Net loss</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9qjusG3RCWk" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::-35741"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0990">35,741</span></span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zmIztkbqaAhc" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::665"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0992">(665</span></span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331_z4nx268bQSIk" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::-35076"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0994">35,076</span></span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Net loss attributable to the Company</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_981_ecustom--ProfitLoss1_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zm2e8LNnCqnj" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"><span style="font-size: 10pt">35,649</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98A_ecustom--ProfitLoss1_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zYuXfcMAfHIc" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"><span style="font-size: 10pt">(665</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_985_ecustom--ProfitLoss1_pn3n3_c20220701__20230331_z9sJmKZ4oxMk" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"><span style="font-size: 10pt">34,984</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Total comprehensive loss</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKA82dNJQKfk" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"><span style="font-size: 10pt">35,659</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98A_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZ5L3oKr2MW1" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"><span style="font-size: 10pt">(665</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_986_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331_zcGBegKbF1yh" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"><span style="font-size: 10pt">34,994</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Comprehensive loss attributable to the Company</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98F_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_ze5Cyg3e3j4k" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"><span style="font-size: 10pt">35,567</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98B_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zlDk0KhpPKR" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"><span style="font-size: 10pt">(665</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_987_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331_zbMZnDl5gef2" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"><span style="font-size: 10pt">34,902</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Loss per common share, basic and diluted</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zWRnAaJET1i8" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"><span style="font-size: 10pt">1.26</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zf7OTzzqRKrl" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"><span style="font-size: 10pt">(0.02</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331_z8dneKmKuTV7" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"><span style="font-size: 10pt">1.24</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
</table>
<p id="xdx_8A0_z6LBYNyBTvh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"></p>

<p id="xdx_892_esrt--ScheduleOfCondensedCashFlowStatementTableTextBlock_zAD57VdDtUPi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Revision Impacts to the Condensed Consolidated
Statement of Cash Flows (unaudited)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the Nine Months Ended March 31,
2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8B5_z14eJLyY15d8" style="display: none; visibility: hidden">Revision Impacts to the Condensed
Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023</span>&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">As Previously<br/>
 Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revision<br/>
 Impacts</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revised</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; text-align: left">Net loss for the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zbiFHIIS78Sh" style="width: 12%; text-align: right">(35,741</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zSvmIcP42Hzg" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1022">665</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230331_zfmGaN4AcFT2" style="width: 12%; text-align: right">(35,076</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Initial valuation of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwjsL1DGD204" style="text-align: right">3,848</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zIqZuI2UrFOg" style="text-align: right">(861</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331_zswoFw4mvRbh" style="text-align: right">2,987</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Change in fair value of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zUapaVmlhvAi" style="text-align: right">868</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zbjfLsqFDSz4" style="text-align: right">196</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331_zAf3FS7vazv5" style="text-align: right">1,064</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A7_zi5vEHv55UAd" style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DevelopmentStageIssuerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents development stage issuer policy text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DevelopmentStageIssuerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarnoutSharesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnout shares policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarnoutSharesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_MineralPropertiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents mineral properties policy text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_MineralPropertiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_RedeemableNoncontrollingInterestPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents redeemable noncontrolling interest policy text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_RedeemableNoncontrollingInterestPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ReverseStockSplitPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents reverse stock split policy text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ReverseStockSplitPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_WarrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents warrants policy text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_WarrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for legal obligation associated with retirement of long-lived asset that results from acquisition, construction, or development or from normal operation of long-lived asset. Excludes environmental remediation liability from improper or other-than-normal operation of long-lived asset, obligation arising in connection with leased property that meets definition of lease payments or variable lease payments and from plan to sell or otherwise dispose of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2175671<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162162059936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PREPARATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock', window );">Schedule of intercompany transactions and balances</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zj4H0tKNxq02" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All
intercompany transactions and balances have been eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span><span id="xdx_8B6_zfL7KyGUoM14" style="display: none; visibility: hidden">Schedule of intercompany transactions and balances</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jurisdiction
    of incorporation</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership
    at June 30,</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 41%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0896800
    BC Ltd. (&#8220;0896800&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zQmMSWJijxzi" title="Country of incorporation"><span id="xdx_908_ecustom--IncorporationStateCountryName_c20210701__20220630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zGlmuRZxB341" title="Country of incorporation">British
    Columbia, Canada</span></span></span></td>
    <td id="xdx_98B_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zzbIweDCVVoa" style="font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Percentage of ownership"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td id="xdx_981_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zzc9JvGhtq87" style="font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Percentage of ownership"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 0.375in; text-align: justify; text-indent: -23.4pt; width: 41%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zksiovUNC0i9" title="Country of incorporation"><span id="xdx_906_ecustom--IncorporationStateCountryName_c20210701__20220630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zkUMxkHVlFL6" title="Country of incorporation">Nebraska,
    USA</span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 17%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 17%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_ziAzFfl1yeQ9" title="Percentage of ownership">100</span>%
    by 0896800</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp. (&#8220;ECRC&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zZnDPIi8PWTd" title="Country of incorporation"><span id="xdx_905_ecustom--IncorporationStateCountryName_c20210701__20220630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zJpRKSrWeSmk" title="Country of incorporation">Delaware,
    USA</span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zwP0I9QOW6dl" title="Percentage of ownership">100</span>%
    of the Class A common stock by 0896800</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
                                         of Estimates</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date
of the consolidated financial statements, and the reported amounts of expenses during the reporting period. The Company regularly
evaluates estimates and assumptions related to the deferred income tax asset valuations, convertible debt valuations, earnout
valuation, warrant liabilities, and share-based compensation. The Company bases its estimates and assumptions on current facts,
historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which
form the basis for making judgments about the other sources. The actual results experienced by the Company may differ materially
and adversely from the Company&#8217;s estimates. To the extent there are material differences between estimates and the actual
results, future results of operations will be affected.&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162152607520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders:</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z3eruOf1JU9c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. <span id="xdx_8B3_zJC6A6vaTFb8">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share
attributable to common shareholders:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; background-color: #CCECFF; border-collapse: collapse; margin-left: 0.5in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="9" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the year ended June 30,</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20220701__20230630_zFQp4ku0flCa" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,308</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210701__20220630_zIXhZ86d9w65" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,887</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200701__20210630_zssQC8D0iE53" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,824</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjust:
    Net loss attributable to noncontrolling interest</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20220701__20230630_zqqNk02gopR" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::228"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0809">(251</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20210701__20220630_zOyu0YxBliY6" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0811">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20200701__20210630_zpWSiN86lFEa" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0813">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss available to participating securities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220701__20230630_zV3gNqOmuwTk" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,057</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20210701__20220630_z9QdtQfKZAgc" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,887</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20200701__20210630_zv0dpzPPfiY4" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,824</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss attributable to Vested Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zVLWsnQRhg6j" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,528</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20210701__20220630_z1MBIpPDBSq9" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0823">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20200701__20210630_z2nWNLQPzUU7" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0825">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 9pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss attributed to common shareholders - basic and diluted</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20220701__20230630_z0QxpAAuKBXh" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,529</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20210701__20220630_zUGKlTW6sQ8f" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,887</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20200701__20210630_zwZFR6TLoOK5" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,824</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average shares outstanding &#8211; basic and diluted</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20220701__20230630_zlRgKsVPLbg2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,705,840</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20210701__20220630_zRsagfqjhAD7" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,373,722</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20200701__20210630_zVMUUNLt4TNl" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,196,711</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    per Common Share outstanding &#8211; basic and diluted</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230630_z8PCNjjBnWE1" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.34</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20210701__20220630_zlMXAuzupyke" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.41</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20200701__20210630_zJ5yF0jIKA72" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.20</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock', window );">Schedule of excluded from the dilutive securities</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zOn3rNY06DWi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BA_zc72BNzqWaDh" style="display: none; visibility: hidden">Schedule of excluded from the dilutive securities</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 89%; border-collapse: collapse; margin-left: 0.75in">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the year ended June 30,</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 61%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excluded
    potentially dilutive securities <sup id="xdx_F6B_zlpIL2QeXlS8">(1)(2)</sup>:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 11%; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20230630_fKDEpKDIp_zTxQsQUt6vCi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,541,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20210701__20220630_fKDEpKDIp_zJ8w8jErmrs" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,446,400</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20200701__20210630_fKDEpKDIp_zkjNk0oBemyg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,596,500</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20230630_fKDEpKDIp_zrQbk9S4UKg5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,816,304</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20210701__20220630_fKDEpKDIp_zDcNxKNdVr4a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,851,622</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20200701__20210630_fKDEpKDIp_z0sNl7vkl4B1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,434,186</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
debt</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20230630_fKDEpKDIp_z7mNylIwkLa2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,871,660</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20210701__20220630_fKDEpKDIp_zahcAL52BKfa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">415,200</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20200701__20210630_fKDEpKDIp_zgqIxU0aSyua" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,455,700</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    potentially dilutive securities <sup></sup></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--DilutiveSecurities_c20220701__20230630_fKDEpKDIp_zJ5fgeJjdrLe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,229,464</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--DilutiveSecurities_c20210701__20220630_fKDEpKDIp_z1DA4k0owKD9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,713,222</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--DilutiveSecurities_c20200701__20210630_fKDEpKDIp_zC4ZPsqKRXjg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,486,386</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F0C_z8MpdCdTVJXl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zvlOvhPMsqK8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F06_zEo1LnpKZiee" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zjFm1EndTiW7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period. </span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock', window );">Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As of March 31, 2023</a></td>
<td class="text"><p id="xdx_896_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zhsVYVtVC4s6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Revision Impacts to the Condensed Consolidated
Balance Sheet (unaudited)</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of March 31, 2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8BB_zqPDmNb9cDEc" style="display: none; visibility: hidden">Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As
of March 31, 2023</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zelflEE9IMBf" style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zWaKgukSfI9" style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230331_zY93igpGJPta" style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">As Previously<br/> Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revision<br/> Impacts</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revised</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--OtherLiabilitiesNoncurrent_iI_pn3n3_zqax1sPZZ8hd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-left: 5.4pt">Warrant liabilities, at fair value</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,303</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(665</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,638</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Total liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Liabilities_iI_pn3n3_c20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zRJ4DvEAlRkk" style="text-align: right" title="Total liabilities">34,735</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Liabilities_iNI_pn3n3_di_c20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zCy0TdbKQsH" style="text-align: right" title="Total liabilities">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Liabilities_iI_pn3n3_c20230331_zxCnuRnyJIEi" style="text-align: right" title="Total liabilities">34,070</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pn3n3_z1kI0YlWdhE3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(146,046</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">665</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(145,381</td><td style="text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--StockholdersEquity_iI_pn3n3_zEeGmVLayfV2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Total shareholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,512</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">665</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,847</td><td style="text-align: left">)</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedIncomeStatementTableTextBlock', window );">Revision Impacts to the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For the Three &amp; Nine Months Ended March 31, 2023</a></td>
<td class="text"><p id="xdx_89B_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zf4thyh0OZk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Revision Impacts to the Condensed Consolidated
Statement of Operations and Comprehensive Loss (unaudited)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the Three Months Ended March 31,
2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_8B8_zwMYtoPoRhJ1" style="display: none; visibility: hidden">Revision Impacts to
                                            the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For
                                            the Three &amp; Nine Months Ended  March 31,
2023</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">As Previously<br/>
 Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revision<br/>
 Impacts</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revised</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-left: 5.4pt">Other operating expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OtherGeneralExpense_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zgQOUnHXWm68" style="width: 12%; text-align: right" title="Other operating expense">26,220</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--OtherGeneralExpense_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpLsguPTVOxc" style="width: 12%; text-align: right" title="Other operating expense">(861</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--OtherGeneralExpense_pn3n3_c20230101__20230331_zasjIfkHG88d" style="width: 12%; text-align: right" title="Other operating expense">25,359</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Total operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zMubrwz0kZt3" style="text-align: right" title="Total operating expenses">29,192</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zH8djFst0Oeh" style="text-align: right" title="Total operating expenses">(861</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331_zXe8FrzG6AT7" style="text-align: right" title="Total operating expenses">28,331</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Change in fair value of warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKTc1llfKIEk" style="text-align: right" title="Change in fair value of warrant liability">784</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zKLUQIW7L7g4" style="text-align: right" title="Change in fair value of warrant liability">196</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331_zBKidsx6iaqj" style="text-align: right" title="Change in fair value of warrant liability">980</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Loss before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zkop0E3nssMi" style="text-align: right" title="Loss before income taxes">29,621</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zefaGBWcanv1" style="text-align: right" title="Loss before income taxes">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_dxL_c20230101__20230331_zTUVmm3EVvbc" style="text-align: right" title="Loss before income taxes::XDX::-3877"><span style="-sec-ix-hidden: xdx2ixbrl0929">28,956</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zDEONR6tVaG5" style="text-align: right" title="Net loss">29,435</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zTzxnU9qsx3d" style="text-align: right" title="Net loss">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331_zTXUUlkWJVU3" style="text-align: right" title="Net loss">28,770</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Net loss attributable to the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ProfitLoss1_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zzG310e4baTk" style="text-align: right" title="Net loss attributable to the company">29,343</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ProfitLoss1_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zTNbjnxJqVt6" style="text-align: right" title="Net loss attributable to the company">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ProfitLoss1_pn3n3_c20230101__20230331_zGms76QML6g2" style="text-align: right" title="Net loss attributable to the company">28,678</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Total comprehensive loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zCkWs19aZdeh" style="text-align: right" title="Total comprehensive loss">29,323</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zPIBX74Xw4Z1" style="text-align: right" title="Total comprehensive loss">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331_z9Alax3TgdJ2" style="text-align: right" title="Total comprehensive loss">28,658</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Comprehensive loss attributable to the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zyDqlX3Y74x6" style="text-align: right" title="Comprehensive loss attributable to the company">29,231</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zG6JE1rlwC6a" style="text-align: right" title="Comprehensive loss attributable to the company">(665</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331_z2L0neTwcTSc" style="text-align: right" title="Comprehensive loss attributable to the company">28,566</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Loss per common share, basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNILCmuSVGma" style="text-align: right" title="Loss per common share, basic and diluted">1.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zlpch4MOAPo4" style="text-align: right" title="Loss per common share, basic and diluted">(0.02</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331_z1FzQUrq6b97" style="text-align: right" title="Loss per common share, basic and diluted">0.98</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>




<p style="margin-top: 0; margin-bottom: 0">&#160;</p>









<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Revision Impacts to the Condensed Consolidated
Statement of Operations and Comprehensive Loss (unaudited)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the Nine Months Ended March 31,
2023&#160; &#160; &#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
    <td style="width: 55%; padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right">&#160;</td>
    <td style="width: 1%; background-color: white; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right">&#160;</td>
    <td style="width: 1%; background-color: white; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right">&#160;</td>
    <td style="width: 1%; background-color: white; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><b>As
    Previously<br/>
 Reported</b></span></td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><b>Revision<br/>

    Impacts</b></span></td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"><span style="font-size: 10pt"><b>Revised</b></span></td>
    <td style="background-color: white; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Other operating expense</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--OtherGeneralExpense_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYqCHLJxMxO9" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"><span style="font-size: 10pt">26,888</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_98C_eus-gaap--OtherGeneralExpense_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_z9N7AAiEK2a2" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"><span style="font-size: 10pt">(861</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--OtherGeneralExpense_pn3n3_c20220701__20230331_zKeufiUYm8qe" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"><span style="font-size: 10pt">26,027</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Total operating expenses</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98B_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zPqhiQylMFh6" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"><span style="font-size: 10pt">33,475</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zOnwEy7ElEg" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"><span style="font-size: 10pt">(861</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_987_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331_z3rjgMQXLo2c" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"><span style="font-size: 10pt">32,614</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Change in fair value of warrant liability</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98E_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zGRArvNXlvyg" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"><span style="font-size: 10pt">868</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98B_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_ze6iLON1bLq2" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"><span style="font-size: 10pt">196</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_989_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331_zuXbyNA31H96" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"><span style="font-size: 10pt">1,064</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Loss before income taxes</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYWQlY66Wnz5" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes"><span style="font-size: 10pt">35,927</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpRhxZjqEyEd" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes"><span style="font-size: 10pt">(665</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_dxL_c20220701__20230331_zWnUuOx7nh73" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes::XDX::-3877"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0988">35,262</span></span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Net loss</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9qjusG3RCWk" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::-35741"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0990">35,741</span></span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zmIztkbqaAhc" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::665"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0992">(665</span></span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331_z4nx268bQSIk" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::-35076"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0994">35,076</span></span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Net loss attributable to the Company</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_981_ecustom--ProfitLoss1_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zm2e8LNnCqnj" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"><span style="font-size: 10pt">35,649</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98A_ecustom--ProfitLoss1_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zYuXfcMAfHIc" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"><span style="font-size: 10pt">(665</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_985_ecustom--ProfitLoss1_pn3n3_c20220701__20230331_z9sJmKZ4oxMk" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"><span style="font-size: 10pt">34,984</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Total comprehensive loss</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKA82dNJQKfk" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"><span style="font-size: 10pt">35,659</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98A_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZ5L3oKr2MW1" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"><span style="font-size: 10pt">(665</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_986_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331_zcGBegKbF1yh" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"><span style="font-size: 10pt">34,994</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Comprehensive loss attributable to the Company</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98F_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_ze5Cyg3e3j4k" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"><span style="font-size: 10pt">35,567</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_98B_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zlDk0KhpPKR" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"><span style="font-size: 10pt">(665</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td id="xdx_987_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331_zbMZnDl5gef2" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"><span style="font-size: 10pt">34,902</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 5.4pt"><span style="font-size: 10pt">Loss per common share, basic and diluted</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zWRnAaJET1i8" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"><span style="font-size: 10pt">1.26</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zf7OTzzqRKrl" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"><span style="font-size: 10pt">(0.02</span></td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">)</span></td>
    <td style="padding-right: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt"><span style="font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331_z8dneKmKuTV7" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"><span style="font-size: 10pt">1.24</span></td>
    <td style="padding-right: 1.45pt">&#160;</td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock', window );">Revision Impacts to the Condensed Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023</a></td>
<td class="text"><p id="xdx_892_esrt--ScheduleOfCondensedCashFlowStatementTableTextBlock_zAD57VdDtUPi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Revision Impacts to the Condensed Consolidated
Statement of Cash Flows (unaudited)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the Nine Months Ended March 31,
2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8B5_z14eJLyY15d8" style="display: none; visibility: hidden">Revision Impacts to the Condensed
Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023</span>&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">As Previously<br/>
 Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revision<br/>
 Impacts</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">Revised</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; text-align: left">Net loss for the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zbiFHIIS78Sh" style="width: 12%; text-align: right">(35,741</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zSvmIcP42Hzg" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1022">665</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230331_zfmGaN4AcFT2" style="width: 12%; text-align: right">(35,076</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Initial valuation of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwjsL1DGD204" style="text-align: right">3,848</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zIqZuI2UrFOg" style="text-align: right">(861</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331_zswoFw4mvRbh" style="text-align: right">2,987</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Change in fair value of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zUapaVmlhvAi" style="text-align: right">868</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zbjfLsqFDSz4" style="text-align: right">196</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331_zAf3FS7vazv5" style="text-align: right">1,064</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Paragraph (a)<br> -Subsection 04<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Paragraph (a)<br> -Subsection 04<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedCashFlowStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedIncomeStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Paragraph (a)<br> -Subsection 04<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedIncomeStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164849840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GXII TRANSACTION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedFinancialStatementsTableTextBlock', window );">The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss:</a></td>
<td class="text"><p id="xdx_89A_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_z9CjNvrGM0e4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">After the distribution of funds
to GXII redeeming shareholders and prior to paying transaction costs incurred by GXII, $15,676 became available to the Company.
<span id="xdx_8BE_zvhGq16e8iea">The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and
Comprehensive Loss:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_498_20230630_zydPUvNnpwol" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_iI_pn3n3_zi0eb6gtxIYf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 86%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
    cash proceeds, net of transaction costs incurred by GXII</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,168</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB_zqHqMzG2Qip2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash costs associated
    with the Transactions:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn3n3_z24wOkhvP1ji" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    liabilities assumed</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">392</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_iI_pn3n3_z6nv4M3osFH7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville
    Equity Facility Financing Agreement &#8211; cash costs</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,996</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed_iI_pn3n3_zX4CJRueMW81" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
    costs expensed</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,715</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iI_pn3n3_zqR7ry9TQbt" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-cash
    costs associated with the Transactions:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_iI_pn3n3_zy9on14pDKJ1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private
    Warrants assumed at fair value</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,987</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--EarnoutSharesAssumedAtFairValue_iI_pn3n3_zJLWY7ZDo5T4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
    Shares assumed at fair value</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,195</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_iI_pn3n3_zjAL0AcFA0Mj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville
    Equity Facility Financing Agreement &#8211; shares issued</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">650</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pn3n3_z5waYAziiy0e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Total
    transaction related losses incurred</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,767</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock', window );">The number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows:</a></td>
<td class="text"><p id="xdx_899_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_zbKtToD2JDGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BC_zChDr8AQQFsa">The
number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    Shares</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 75%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legacy
    NioCorp Shareholders</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zblr1nfAaEMc" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Common stock, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,246,621</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zAMBpxdjXG18" title="Number of shares, percentage">93.90</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former GXII Class
    A Shareholders<sup id="xdx_F4D_zq4h1nGPSVFe">1</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zuEcaxWXZuc9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,753,821</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zujXQR4VrIz" title="Number of shares, percentage">5.83</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other<sup id="xdx_F46_zjJHsG8GU2Ul">2</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--TransactionTypeAxis__custom--OtherMember_fMg_____zHyFaChf1lsc" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,213</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--OtherMember_fMg_____zHSj89FhogG9" title="Number of shares, percentage">0.27</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Common Shares Outstanding Upon Completion of Transactions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--CommonStockSharesOutstanding_iI_pid_dxL_uShares_c20230630_zfZfNceSkSYg" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Common stock, shares outstanding::XDX::31202131"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1091">30,081,655</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630_z0F1g9xEQJMf" title="Number of shares, percentage">100</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F06_zSHFFoRWnGE5" style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"><span id="xdx_F1F_zHUfU4stxzw" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory
    services.</span></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span id="xdx_F0F_zbck7w8k0Zlf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"><span id="xdx_F1C_zrGJJauUTbSk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    Commitment Shares (as defined in Note 11d) issued under the Yorkville Equity Facility Financing Agreement.</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedFinancialStatementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Paragraph (a)<br> -Subsection 04<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedFinancialStatementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164937648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LAND AND BUILDINGS, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of properties</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zGhFjxhgoaWc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zZiUYWOT9gF9" style="display: none; visibility: hidden">Schedule of properties</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 88%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="22" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">2022</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated <br/>
Depreciation</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="border-bottom: Black 1pt solid">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated <br/>
Depreciation</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 22%">Land</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_z42PdFrA4Kb9" style="width: 8%; text-align: right" title="Cost">807</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_ztpb9xlhX1P8" style="width: 8%; text-align: right" title="Accumulated depreciation">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zOqlHn3igx1h" style="width: 8%; text-align: right" title="Net">807</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--LandMember_z5iltUQROLHd" style="width: 8%; text-align: right">811</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20220630__srt--ProductOrServiceAxis__us-gaap--LandMember_zLkf8dpBgTlf" style="width: 8%; text-align: right" title="Accumulated depreciation">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--LandMember_z1C8XJJ5l5Zg" style="width: 8%; text-align: right">811</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Buildings and other</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zcN1WCL9Ex32" style="border-bottom: Black 1pt solid; text-align: right">41</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z5i9R6yq5L72" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">9</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zPntT9MgMbHi" style="border-bottom: Black 1pt solid; text-align: right">32</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zKSFFYWnr9a6" style="border-bottom: Black 1pt solid; text-align: right">45</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z0pT9THnmUUg" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">6</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z0ZyhguGbmci" style="border-bottom: Black 1pt solid; text-align: right">39</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630_zDawkaqFIqJi" style="border-bottom: Black 2pt solid; text-align: right">848</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630_zj8WiFxN8mbl" style="border-bottom: Black 2pt solid; text-align: right">9</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630_z2xaV7sFhdKi" style="border-bottom: Black 2pt solid; text-align: right">839</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20220630_zAKdMwYKhYO3" style="border-bottom: Black 2pt solid; text-align: right">856</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20220630_zFqpOv0VmhOg" style="border-bottom: Black 2pt solid; text-align: right">6</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20220630_zyH0LX1SuAUh" style="border-bottom: Black 2pt solid; text-align: right">850</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162162148928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of account payable and accrued liabilities</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z1e7O7549m0k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zYDi55cjSCFd" style="display: none; visibility: hidden">Schedule of account payable and accrued liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49F_20230630_zIIEHiJUSMx5" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="3" id="xdx_497_20220630_zjMc309MDUic" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zsNd0OmDJeVk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left">Accounts payable, trade</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,990</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">115</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_z0V4FV6YzPQk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade payable accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,324</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">654</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pn3n3_zep4RcGMjWx5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income taxes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1168">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_zwATtYBQqDs" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Environmental accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zJ5vNWYcI1ra" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Loan origination fees payable to related party</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1174">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_zFXGY51Hqnme" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Total accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">3,491</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">817</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162158882432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock', window );">Schedule of convertible debt</a></td>
<td class="text"><p id="xdx_89A_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_zUSiT4NvRe3g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zBH3fghWdisc" style="display: none; visibility: hidden">Schedule of convertible debt</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current Portion:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 74%; text-align: left; padding-bottom: 2pt; padding-left: 0.125in">Lind III convertible security</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 2pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zhnvuGIQ2UWd" style="border-bottom: Black 2pt solid; width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1182">-</span></td><td style="border-bottom: Black 2pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 2pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_z9YihaD2wON3" style="border-bottom: Black 2pt solid; width: 10%; text-align: right" title="Convertibled debt, current">2,169</td><td style="border-bottom: Black 2pt solid; width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Noncurrent Portion:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in">Yorkville convertible debentures</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zNTGr70ljNWl" style="border-bottom: Black 2pt solid; text-align: right" title="Convertible debt, noncurrent">10,561</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_z4rC220ZElx4" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1187">-</span></td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock', window );">Changes in the Lind III Convertible Security are as follows:</a></td>
<td class="text"><p id="xdx_89A_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_zyp1AW0UCzuf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BE_zi34CDBBr5Id">Changes
in the Lind III Convertible Security are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 96%; border-collapse: collapse; margin-left: 0.25in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the year ending June 30,</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 76%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
    balance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--ConvertibleDebtNoncurrent_iS_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zCTOxUoUgvF9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 9%; padding-right: 2.15pt; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,169</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ConvertibleDebtNoncurrent_iS_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_ztl48kYD14fl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 9%; padding-right: 2.15pt; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,234</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value increase due to debt extinguishment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ExtinguishmentOfDebtAmount_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zPzm8jDMfutc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Fair value increase due to debt extinguishment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">201</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ExtinguishmentOfDebtAmount_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_z3ND6dZqhpJ5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Fair value increase due to debt extinguishment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1231">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ConversionOfStockAmountIssued1_iN_pn3n3_di_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zXftOjtSPul4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Conversions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,950</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--ConversionOfStockAmountIssued1_iN_pn3n3_di_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_z1TaagufMIkj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Conversions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,635</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion
    expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--AccretionExpense_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zAvlxooLaGEg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Accretion expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--AccretionExpense_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zFbeAgOnBgTf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Accretion expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,570</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    at maturity</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--PaymentsToAcquireHeldToMaturitySecurities_iN_pn3n3_di_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zAIIAHMbyiB4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Payment at maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(515</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--PaymentsToAcquireHeldToMaturitySecurities_iN_pn3n3_di_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zfuNpY3yvWCf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Payment at maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1243">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance,
    end of period</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_eus-gaap--ConvertibleDebtCurrent_iE_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zmMhJgGF2gw" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1245">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--ConvertibleDebtCurrent_iE_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zGoaMNvaZTp7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,169</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock', window );">The following table summarizes the components of the initial loss on extinguishment:</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfExtinguishmentOfDebtTextBlock_zYU5vveFJy19" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zZdiXHfZmexk" style="display: none; visibility: hidden">The following table summarizes the components of the initial loss on extinguishment:</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Component of loss</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_496_20220701__20230630_zCQ2gBMelhq1" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--MinimumConsentPaymentAtInception_pn3n3_zxbnNXF91ZK7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 87%; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minimum
    Consent Payment at inception</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--ASC470LossOnExtinguishment_pn3n3_zRQsTefxPyKe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss on debt extinguishment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">201</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--AdjustmentOfWarrantsGrantedForServices_pn3n3_zrvjgz1hSOIk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    fair value of Contingent Consent Warrants</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,221</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_pn3n3_z21HTd1Pjnw" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    loss on debt extinguishment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,622</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--AdditionalConsentPaymentbooked_pn3n3_z9OTwYiXhEi8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    Consent Payment booked<sup id="xdx_F4E_zLIhWIcwEZ78">1</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--GainsLossesOnRestructuringOfDebt_pn3n3_zBCMP29s6eCa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    loss on debt extinguishment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,922</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; padding-right: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 5.4pt; text-align: justify"><span id="xdx_F05_zWiHKFp67EBa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 93%; padding-right: 5.4pt; text-align: justify"><span id="xdx_F16_znGdMSE09cad" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the difference between the accrual of the minimum Consent Payment at September 25, 2022 and the actual payment made on March
    17, 2023.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify">&#160;</td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfWarrantValuationTableTextblock', window );">The change in the fair value of the Contingent Consent Warrants is presented below:</a></td>
<td class="text"><p id="xdx_89D_ecustom--ScheduleOfWarrantValuationTableTextblock_z8D7RFLrWh9k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_ztl8jfAUOVqa">The
change in the fair value of the Contingent Consent Warrants is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 76%; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    valuation, September 25, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstanding_iS_c20220701__20230630_zPk9r8SH3Fwh" style="font: 10pt Times New Roman, Times, Serif; width: 19%; padding-right: 2.15pt; text-align: right" title="Initial valuation, at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,221</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in valuation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_ecustom--ChangeInValuationOfWarrants_c20220701__20230630_zLY1DjA0Htmh" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right" title="Change in valuation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">489</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    at June 30, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--WarrantsAndRightsOutstanding_iE_c20220701__20230630_z5inbWDzyBp3" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right" title="Valuation, at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,710</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock', window );">Schedule of valuation date and the probability calculated.</a></td>
<td class="text"><p id="xdx_899_ecustom--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_z2e1K9Aadhbf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zZ9UGm3COq19" style="display: none; visibility: hidden">Schedule of valuation date and the probability calculated.</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key Valuation
    Input</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
25,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
30,</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 48%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    price on valuation date</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_z7JqcEuX1EIi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: right" title="Share price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.82</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zMIe4TtXk2qh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: right" title="Share price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.03</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 3%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zshyS0ZZK7S7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Volatility"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zUrf6XHUjH9g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Volatility"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.0</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_zFZFIy8rMQzf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Risk free rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.93</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_z10grwww8KFf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Risk free rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Probability of
    issuance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_zNOnUs8ZaMAa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Probability of issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_z1FA45HECf56" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Probability of issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Changes in the Convertible Debentures are as follows:</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ConvertibleDebtTableTextBlock_zCePOSCmMlte" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zV8L6A21YcB6">Changes
in the Convertible Debentures are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 86%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opening balance,
    March 17, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$</span></td>
    <td id="xdx_98B_eus-gaap--ConvertibleDebt_iS_pn3n3_c20230315__20230630_z6rOlrdFfvKl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Opening balance, March 17, 2023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,153</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20230315__20230630_z1AFoo4i7m14" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,962</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal and accrued
    interest converted</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td id="xdx_98B_ecustom--PrincipalAndAccruedInterestConverted_iN_pn3n3_di_c20230315__20230630_zMvzc22zeyJa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal and accrued interest converted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,554</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30,
    2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--ConvertibleDebt_iS_pn3n3_c20220701__20230630_zhoc7a9NtO6g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, June 30, 2023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,561</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><p style="margin: 0pt 0">Add: Unamortized debt issuance costs</p>


</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt">&#160;</td>
    <td id="xdx_984_eus-gaap--AmortizationOfFinancingCosts_pn3n3_dxL_c20220701__20230630_z72xi07wU049" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Add: uamortized debt issuance costs::XDX::0"><span style="-sec-ix-hidden: xdx2ixbrl1364">2,439</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><p style="margin: 0pt 0">Remaining principal balance, June 30, 2023</p>


</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt">$</td>
    <td id="xdx_984_eus-gaap--ConvertibleDebt_iE_pn3n3_c20220701__20230630_zc6kgVzCabzc" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, June 30, 2023">13,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents fair value assets and liabilities measured on recurring and nonrecurring monte carlo techniques table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of changes in lind iii convertible security one text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of changes in lind iii convertible security text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfWarrantValuationTableTextblock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of warrant valuation table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfWarrantValuationTableTextblock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of debt extinguished which may include, amount of gain (loss), the income tax effect and the per share amount of the aggregate gain (loss), net of the related income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7516071&amp;loc=d3e13374-112631<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164766592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CLASS B COMMON STOCK OF ECRC (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureClassBCommonStockOfEcrcAbstract', window );"><strong>Class B Common Stock Of Ecrc</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock', window );">The following table discloses the primary inputs into the Monte Carlo models.</a></td>
<td class="text"><p id="xdx_897_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zhj3jT5sAOh3" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><span id="xdx_8B1_zCYYAonfzRQ9" style="display: none; visibility: hidden">The following table discloses the primary inputs into the Monte Carlo models.</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
    Valuation Input</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
    Close</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 17%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    30, 2023</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing
    Common Share price</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zfLqTFRFUhZe" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Closing common share price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$7.00</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zt5nfwpA88Df" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Closing Common Share price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$5.03</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Term
    (expiry)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220924__20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zzIPd5Pr9Ulf" title="Term (expiry)">March 17, 2033</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zd7S2NhjHeI3" title="Term (expiry)">March
    17, 2033</span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Implied
    volatility of Public Warrants</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220924__20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zkyEu3yGwYm2" title="Implied volatility of Public Warrants">19.5</span>%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zDajiz5MaJE" title="Implied volatility of Public Warrants">33.5</span>%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free
    rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220924__20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIKaow3B86Kd" title="Risk-free rate">3.39</span>%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zbQ7qDRiyiB9" title="Risk-free rate">3.83</span>%</span></td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock', window );">The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2023:</a></td>
<td class="text"><p id="xdx_890_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_z85NvC16U4xa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zWOytyTvNCya">The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June
30, 2023:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 49%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of March 17, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230301__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zTC4noQBiBD6" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Fair value at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,195</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> &#160;</span></td>
    <td id="xdx_98A_eus-gaap--ServicingLiabilityAtFairValueAdditions_iN_pn3n3_di_c20230301__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zwKd8xDGnBd4" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,674</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value as of June 30, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20230301__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zQLdcdPsHRvk" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,521</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureClassBCommonStockOfEcrcAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureClassBCommonStockOfEcrcAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule ofsummary of the changes in the fair value of the earnout share liability table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162163409392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock', window );">Schedule of stock option</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_zuYtzLMZcVe4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zuYxOKxQMS2j" style="display: none; visibility: hidden">Schedule of stock option</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 73%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Number of <br/>
Options</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted <br/>
Average <br/>
Exercise Price</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 43%; text-align: left; padding-bottom: 1pt">Balance, June 30, 2020</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20200701__20210630_zoDNIIPF27X8" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance">1,912,940</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20200701__20210630_z8dPs5wevkPg" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$6.20 </span></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20200701__20210630_zBzfKgnKuWFa" style="text-align: right" title="Granted">370,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pin3_uCADPShares_c20200701__20210630_zbd08KsT4Dle" style="text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$7.80</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20200701__20210630_z7wDjX2c9s5j" style="text-align: right" title="Exercised">(295,229</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20200701__20210630_zShLAySiqYpk" style="text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$6.10</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Cancelled/expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20200701__20210630_zVQFmD1UmRw8" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired">(391,212</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20200701__20210630_zY3mzHNSSY3d" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$6.40</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Balance, June 30, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20210701__20220630_zSVKpuzuxfKf" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance">1,596,499</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20210701__20220630_zItt5cYCitLb" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$6.50</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210701__20220630_zlq7iko0rNUf" style="text-align: right" title="Granted">447,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20210701__20220630_zURPolnUeojd" style="text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$13.30</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_dxL_uShares_c20210701__20220630_z6xea4C8aqP1" style="text-align: right" title="Exercised::XDX::215"><span style="-sec-ix-hidden: xdx2ixbrl1481">(205,153</span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20210701__20220630_zqEJ6WxIdsV" style="text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$7.00</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Cancelled/expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20210701__20220630_zCaoCdBkQ8Nd" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired">(392,446</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20210701__20220630_zTggmS5N6x29" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$7.70</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Balance, June 30, 2022</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20220701__20230630_zt5wK3mv7Aua" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance">1,446,400</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20220701__20230630_zK9qtYxshZY" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$8.27</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220701__20230630_znssPo1te4Ee" style="text-align: right" title="Granted">578,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20220701__20230630_zA72NcOQnmWb" style="text-align: right" title="Granted">$6.95</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20220701__20230630_z7R5ve8EMaKf" style="text-align: right" title="Exercised">(265,129</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20220701__20230630_zznx1UbVMPr7" style="text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$4.99</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Cancelled/expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20220701__20230630_zpOj9LgJaFNc" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired">(217,771</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20220701__20230630_zf8lTvy4GLx8" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$5.87</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Balance, June 30, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20220701__20230630_zAdsu9UnmfEk" style="border-bottom: Black 1pt solid; text-align: right" title="Ending balance">1,541,500</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCADPShares_c20220701__20230630_z81HeHhfYk8" style="border-bottom: Black 1pt solid; text-align: right" title="Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$9.64</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">The following table summarizes information about stock options outstanding at June 30, 2023:</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z1ukJujYLRn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B2_zvAfJsmkQWb2">The
following table summarizes information about stock options outstanding at June 30, 2023:</span></span></p>

<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 88%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price </span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 26%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry
    Date</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    Outstanding</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 17%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
    Intrinsic Value </span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    Exercisable</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
    Intrinsic Value </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$8.40</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member_zSzoaElaZqVh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2023-09-18"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1515">September
    18, 2023</span></span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member_zlXspE7qfR66" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,000</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member__srt--CurrencyAxis__currency--CAD_zu8tWcd3RiJ9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$-</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member_zQdR1dvQI25b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,000</span></td>
    <td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member__srt--CurrencyAxis__currency--CAD_zpJje8EYO0Qc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$5.40</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member_zNZxnqGb351g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2023-11-15"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1520">November
    15, 2023</span></span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member_z2nA32ExLyXi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">208,500</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member__srt--CurrencyAxis__currency--CAD_zPNg5FApY9c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">263</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member_zUbZ7qetdcM2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">208,500</span></td>
    <td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member__srt--CurrencyAxis__currency--CAD_zNGPqrHZ2ZX9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">263</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$7.50</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50Member_z3xaFwerOAdc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2023-12-14"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1525">December
    14, 2023</span></span></td>
    <td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50Member_zaVLP5jERPwe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50Member_zn0uSlTfBEFc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$7.50</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50OneMember_zaijvg3UpkP4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2023-12-16"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1528">December
    16, 2023</span></span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50OneMember_z5QTQ8gVF6R8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50OneMember_zEb8fFll6vCl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$13.60</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice13.60Member_z4AlqpmAQrT6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2024-12-17"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1531">December
    17, 2024</span></span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice13.60Member_z9nRYUnhgX4c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">377,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice13.60Member_zZKddnpfe31" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">377,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$11.00</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zQOBXzUIcyf8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2025-05-30"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1534">May
    30, 2025</span></span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_znlYPnkMYpch" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zSLGYclGvX2f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$6.95</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice6.95Member_zGr64z16HaD6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2026-03-27"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1537">March
    27, 2026</span></span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice6.95Member_zEmYIbfAAzqi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">578,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice6.95Member_ziVA2rajSV8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">578,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance,
    June 30, 2023</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630_zZFeF99EiiBl" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,541,500
    </span></td>
    <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230630__srt--CurrencyAxis__currency--CAD_zgMrHk1tJPLi" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$263</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630_zErM3sr9GVOd" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,541,500</span></td>
    <td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_iI_c20230630__srt--CurrencyAxis__currency--CAD_zZosNnTHqGbh" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$263</span></td>
    </tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">The following table summarizes the weighted average information and assumptions used to determine option costs:</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zljymjyaTY77" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BC_zrd9y2ocsX5l">The following table summarizes
the weighted average information and assumptions used to determine option costs:</span></p>

<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 1pt">&#160;</span></td>
    <td id="xdx_490_20220701__20230630_zEsQTkknmuva" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td id="xdx_495_20210701__20220630_zbJKfZneXys3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td id="xdx_495_20200701__20210630_zhb9SG4AtPP4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Year ended June 30,</span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 44%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 12%"><span style="font-size: 10pt">2023</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 12%"><span style="font-size: 10pt">2022</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 12%"><span style="font-size: 10pt">2021</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Fair value per option granted during the period </span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220701__20230630_zSn1kK8HEXL6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Fair value per option granted during the period"><span style="font-size: 10pt">$3.09</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210701__20220630__srt--CurrencyAxis__currency--CAD_zuB5lSjcmWe4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Fair value per option granted during the period"><span style="font-size: 10pt">C$4.90</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20200701__20210630__srt--CurrencyAxis__currency--CAD_zJMn0yUteG75" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Fair value per option granted during the period"><span style="font-size: 10pt">C$2.50</span></td></tr>
<tr id="xdx_405_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_z7zj6F5aaLF5" style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Risk-free interest rate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">3.30%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">1.33%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">0.26%</span></td></tr>
<tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_zC9w4HiSTOG1" style="vertical-align: top; background-color: #CCECFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Expected dividend yield</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">0%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">0%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">0%</span></td></tr>
<tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_zqnp3EAp2RMh" style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Expected stock price volatility (historical basis)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">63.6%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">54.4%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 10pt">54.1%</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Expected option life in years</span></td>
    <td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20220701__20230630_z6RIHeVPKP37" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expected option life in years::XDX::P3Y"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1569">3.0</span></span></td>
    <td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20210701__20220630_zdZtSMEn0hL2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expected option life in years::XDX::P3Y"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1571">3.0</span></span></td>
    <td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20200701__20210630_zCY1AHwJbIx7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P3Y"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1572">3.0</span></span></td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates.</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z38uyOHtG071" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Warrant transactions are
summarized as follows. <span id="xdx_8B6_zAwhHqU5j7ff">Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S.
dollars using end of period foreign currency exchange rates.</span></p>





<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.25in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Warrants</td><td style="border-bottom: Black 1pt solid">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted <br/>
Average <br/>
Exercise Price</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Balance, June 30, 2020</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20200701__20210630_zmlt6i3i2Wmf" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Balance at beginning">1,237,645</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20200701__20210630_zWhwu7MyPxA" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Balance at beginning average price">5.43</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Granted:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Nordmin warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--NordminWarrants_pid_uShares_c20200701__20210630_zCfxJeGdXhr5" style="text-align: right" title="Nordmin warrants">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing_pid_uUSDPShares_c20200701__20210630_zpvIMzS2d7s8" style="text-align: right" title="Nordmin warrants average price">6.45</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Lind III warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightLindIIIWarrants_pid_uShares_c20200701__20210630_zwToKCCGMf3d" style="text-align: right" title="Lind III Warrants">855,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--ClassOfWarrantOrRightExercisePriceLindWarrants_pid_uUSDPShares_c20200701__20210630_zNzeVOPZslu2" style="text-align: right" title="Lind III warrants average price">7.83</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">April 2021 private placement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightAprilPrivatePlacement_pid_uShares_c20200701__20210630_zjkMQp0XGIH9" style="text-align: right" title="April 2021 private placement">441,211</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements_pid_uUSDPShares_c20200701__20210630_zXeuNz2ovL7l" style="text-align: right" title="April 2021 private placement average price">13.15</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20200701__20210630_zUWmrD7vFS0k" style="text-align: right" title="Exercised">(910,628</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uUSDPShares_c20200701__20210630_zARt8P7pEpJa" style="text-align: right" title="Exercised average price">6.05</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20200701__20210630_zXHnWhRgrQjg" style="border-bottom: Black 1pt solid; text-align: right" title="Expired">(239,845</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20200701__20210630_z42jWS5mWg4f" style="border-bottom: Black 1pt solid; text-align: right" title="Expired average price">5.89</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Balance, June 30, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20210701__20220630_zXJ9rCjpQE94" style="border-bottom: Black 1pt solid; text-align: right">1,434,183</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20210701__20220630_zfFpEFCtE7oa" style="border-bottom: Black 1pt solid; text-align: right">9.36</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;Granted:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.375in; text-indent: -0.125in">June 2022 private placement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightJunePrivatePlacement_pid_uShares_c20210701__20220630_zyCMat9tfbXj" style="text-align: right" title="June 2022 private placement">504,614</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExercisePriceJunePrivatePlacements_pid_uUSDPShares_c20210701__20220630_zVZQutgXnkW5" style="text-align: right" title="June 2022 private placement average price">8.54</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Exercised</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20210701__20220630_z9hvSoKnQyQ5" style="border-bottom: Black 1pt solid; text-align: right">(87,175</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uUSDPShares_c20210701__20220630_z5LcuYqDdIGi" style="border-bottom: Black 1pt solid; text-align: right">6.05</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Balance, June 30, 2022</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20220701__20230630_zZKpTTLkkXua" style="border-bottom: Black 1pt solid; text-align: right">1,851,622</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20220701__20230630_zjLJGNwuBCFd" style="border-bottom: Black 1pt solid; text-align: right">8.99</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">&#160;Granted:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Yorkville financing warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--YorkvilleFinancingWarrants_pid_uShares_c20220701__20230630_zDXmddESXRUg" style="text-align: right" title="Yorkville financing warrants">1,789,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_pid_uUSDPShares_c20220701__20230630_zxoCsu4gUqu2" style="text-align: right" title="Yorkville financing warrants average price">8.94</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">GXII warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--GxiiWarrants_pid_uShares_c20220701__20230630_zLdpwi9aUix9" style="text-align: right" title="GXII warrants">15,666,626</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_pid_uUSDPShares_c20220701__20230630_zxRs6xa5uN98" style="text-align: right" title="GXII warrant average price">11.50</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">&#160;Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20220701__20230630_zFo5oT7WZJMh" style="border-bottom: Black 1pt solid; text-align: right">(491,211</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uUSDPShares_c20220701__20230630_zKw3PqcK7Uzk" style="border-bottom: Black 1pt solid; text-align: right">11.67</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Balance, June 30, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20220701__20230630_zwFCFIqZvM2c" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending">18,816,304</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_uUSDPShares_c20220701__20230630_zIFz5I21f4ei" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending average price">10.98</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock', window );">At June 30, 2023, the Company has outstanding exercisable warrants, as follows:</a></td>
<td class="text"><p id="xdx_89A_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zXusNeJkV6Rg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zmPEwMpPnA1f">At
June 30, 2023, the Company has outstanding exercisable warrants, as follows:</span></span></p>

<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 46%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</span></p></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Exercise
    Price </span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry
Date</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zXPpM1iVegZk" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Number"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">504,611</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230630__srt--CurrencyAxis__currency--CAD__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zYZWnTJ1Gkuk" title="Exercise price">11.00</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dxL_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zggTBd5xkmG3" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expiry date::XDX::2024-06-30"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1630">June
    30, 2024</span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zN1neMxZXcK2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">855,800</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C$<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220630__srt--CurrencyAxis__currency--CAD__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zz2ztmA5sLm" title="Exercise price">9.70</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dxL_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_z7Y34r2lZCWg" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expiry date::XDX::2025-02-19"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1635">February
    19, 2025</span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zq1a1JCJIGzh" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,789,267</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zoFJ3LGfZI05" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$8.94</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F2E_zJUo8a8revY3">(1)</sup></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zEnRhgpRCK7c" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,666,626</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zlfpLNP0cOWc" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$11.50</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dxL_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zCuHofnBpx1b" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expiry date::XDX::2028-03-17"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1643">March
    17, 2028</span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630_z6TEA9T9qiLk" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,816,304</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 46%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: left; text-indent: 0in"><span id="xdx_F01_zgLcDmRtSWDe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 93%; text-align: left; text-indent: 0in"><span id="xdx_F17_zx4Jtucrohjg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expires
    in 12 equal monthly tranches beginning October 17, 2023</span></td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions:</a></td>
<td class="text"><p id="xdx_895_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zHGbgiqtX694" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zNBGleVoOhLc">The
Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a
Black Scholes model with the following assumptions:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<div style="text-align: center; margin-left: 0.25in"></div>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><b></b></p>



<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 1pt">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 1pt">March 17, 2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 1pt">June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: justify">Stock price on valuation date</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zoreS0yoSzEf" style="width: 10%; text-align: right" title="Stock price on valuation date">7.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z2HDEv33HTG8" style="width: 10%; text-align: right" title="Stock price on valuation date">5.03</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Strike price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqYzw8f2t22j" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zBewLQd8cik" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Implied volatility of Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQyAOb1pWD92" title="Volatility">19.5</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLgqLMNBoVT5" title="Volatility">33.5</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zbyJAsbavZKc" title="Risk free rate">3.47</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z3NbSUPDeekd" title="Risk free rate">4.18</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zwJhckLCVLMl" title="Dividend yield">0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7A4lwx69S5f" title="Dividend yield">0</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expected warrant life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zoLtOKC6MfC1" title="Expected warrant life in years::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1687">5.0</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQ8kMrpiUtg6" title="Expected warrant life in years::XDX::P4Y8M23D"><span style="-sec-ix-hidden: xdx2ixbrl1689">4.73</span></span></td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock', window );">The change in the Private Warrants liability is presented below:</a></td>
<td class="text"><p id="xdx_89D_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zcRQoEhiDFeh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B1_zH1F9Lfrq6S1">The
change in the Private Warrants liability is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 43%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    valuation, March 17, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20220701__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zToJ5TFGhdP3" style="font: 10pt Times New Roman, Times, Serif; width: 10%; padding-right: 2.15pt; padding-bottom: 2.15pt; text-align: right" title="Initial valuation, at begining"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,987</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in valuation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20220701__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zYUOPRaUUbA5" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right" title="Change in valuation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">292</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    at June 30, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ChangesInFairValueOfInitialValuation_iE_pn3n3_c20220701__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zoiQANZz1QH7" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt; text-align: right" title="Initial valuation, at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,279</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock', window );">Schedule of expenses as other operating costs</a></td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_zFIiTKoD2yAc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_8B7_z2EFGHvCdVF" style="display: none; visibility: hidden">Schedule of expenses as other operating costs</span></span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 43%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_494_20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zk3FqphoJn58" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td>&#160;</td></tr>
<tr id="xdx_40E_ecustom--YorkvilleCashFee_zrPPFBqDaj78" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: justify">Yorkville Cash Fee</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zOKN2XjBb37b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Fair value of Commitment Shares issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">650</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--OtherCostAndExpenseOperating_z1H6IAYXhWZh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt">Legal and other related costs</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">496</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--OperatingCostsAndExpenses_zZoDisy4u9y" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2pt">Net costs expensed to other operating expense</td><td>&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">2,646</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The elements represents schedule of changes in the fair value of the private warrants table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of outstanding exercisable warrants table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of each detailed component of other operating costs and expenses that are applicable to sales and revenues, but not included in the cost of sales in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164953360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS AND BALANCES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Changes in the Smith Credit Agreement principal balance are as follows:</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zT6epf8Avk78" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zehBT8sBERS1">Changes
in the Smith Credit Agreement principal balance are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ending June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left; padding-bottom: 1pt">Beginning balance</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--RelatedPartyDepositLiabilities_iS_pn3n3_c20220701__20230630_zwHEezuNsSv6" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance">2,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--RelatedPartyDepositLiabilities_iS_pn3n3_c20210701__20220630_zwgnGso85md4" style="border-bottom: Black 1pt solid; width: 12%; text-align: right">2,318</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;Amounts advanced</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--AmountsAdvanced_pn3n3_c20220701__20230630_zkFwglwFdpUb" style="text-align: right" title="Amounts advanced">1,130</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--AmountsAdvanced_pn3n3_c20210701__20220630_zgQObPdwXnV5" style="text-align: right" title="Amounts advanced"><span style="-sec-ix-hidden: xdx2ixbrl1732">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;&#160;&#160;Repayments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_pn3n3_c20220701__20230630_zmWVPyMin6R2" style="border-bottom: Black 1pt solid; text-align: right" title="Repayments">(3,130</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_pn3n3_c20210701__20220630_zTZckqQMdsa8" style="border-bottom: Black 1pt solid; text-align: right">(318</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Balance, end of period</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--RelatedPartyDepositLiabilities_iE_pn3n3_c20220701__20230630_zMTIL0qtVBd8" style="border-bottom: Black 2pt solid; text-align: right" title="Balance, end of period"><span style="-sec-ix-hidden: xdx2ixbrl1737">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--RelatedPartyDepositLiabilities_iE_pn3n3_c20210701__20220630_zTxLrf98i62b" style="border-bottom: Black 2pt solid; text-align: right">2,000</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162162158176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EXPLORATION EXPENDITURES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureExplorationExpendituresAbstract', window );"><strong>Exploration Expenditures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfExplorationExpendituresTableTextBlock', window );">Schedule of exploration expenditures</a></td>
<td class="text"><p id="xdx_89F_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zk8FIjT2avH6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zMuxKAi1HCqk" style="display: none; visibility: hidden">Schedule of exploration expenditures</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 70%; margin-left: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2021</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">&#160;Feasibility study and engineering</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zDoRPYqfL0B1" style="width: 12%; text-align: right">410</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zqyJlR7KPte4" style="width: 12%; text-align: right">334</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zdqIXbvJOf97" style="width: 12%; text-align: right">79</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;Field management and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zEIjtm0HBAl6" style="text-align: right">738</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zcDBIKdTU0Ya" style="text-align: right">569</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zHKeiv5fbv63" style="text-align: right">656</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;Metallurgical</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__us-gaap--ExplorationAndProductionEquipmentMember_zWMnyMl6Ic2a" style="text-align: right">4,174</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__us-gaap--ExplorationAndProductionEquipmentMember_z3bptrItMw1b" style="text-align: right">2,218</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__us-gaap--ExplorationAndProductionEquipmentMember_zwRodmIVAea8" style="text-align: right">272</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;Geologists and field staff</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_zNS0ghMo89Z9" style="border-bottom: Black 1pt solid; text-align: right">26</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_zhXYrp3vCw19" style="border-bottom: Black 1pt solid; text-align: right">188</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_zSzKsYwIUAv7" style="border-bottom: Black 1pt solid; text-align: right">49</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">&#160;Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630_zP6zjfAPTIgj" style="border-bottom: Black 2pt solid; text-align: right" title="Exploration expenditures">5,348</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630_zIYOyfyh2Sll" style="border-bottom: Black 2pt solid; text-align: right">3,309</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630_zND4vnhjVgr6" style="border-bottom: Black 2pt solid; text-align: right">1,056</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureExplorationExpendituresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureExplorationExpendituresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfExplorationExpendituresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of exploration expenditures table text block..</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfExplorationExpendituresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162154441024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">The Company incurred lease costs as follows:</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--LeaseCostTableTextBlock_zSnfQKhwiuh3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zlbAlFFdpoHa">The
Company incurred lease costs as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_499_20220701__20230630_zpmYZ7m6lL3d" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_497_20210701__20220630_zXQcSgepqCo8" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_497_20200701__20210630_zNzI0azPhXl5" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2021</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCostAbstract_iB_zoXpqvRuRPah" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -5.25pt; padding-left: 5.4pt">&#160;Operating Lease Cost:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--FixedRentExpense_z8AcCqN0iHUd" style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; text-align: left; text-indent: 3.75pt; padding-left: 5.4pt">Fixed rent expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">83</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">83</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">106</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--VariableLeaseCost_zr0X1jDo3W73" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 3.75pt; padding-left: 5.4pt">Variable rent expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ShortTermLeaseCost_i_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 3.75pt; padding-left: 5.4pt">Short term lease cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--SubleaseIncome_iN_pn3n3_di_z76UFRZu2Tfa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 3.75pt; padding-left: 5.4pt">Sublease income</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(33</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(26</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(18</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_zcX5cRZwenp8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 5.4pt">Net lease cost</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">73</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">85</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">108</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherCostAndExpenseOperating_i_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 8.25pt; padding-left: 5.4pt">Lease cost &#8211; other operating expense</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">73</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">85</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">89</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ExplorationCosts_i_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 8.25pt; padding-left: 5.4pt">Lease cost &#8211; exploration expenditures</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1818">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1819">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">19</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--LeaseCost_iC_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 5.4pt">Net lease cost</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">73</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">85</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">108</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">The maturity of lease liabilities is as follows at June 30, 2023:</a></td>
<td class="text"><p id="xdx_897_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zD7mmsHKNvfi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zDvJ5ophd4el">The
maturity of lease liabilities is as follows at June 30, 2023:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49C_20230630_z1QWTu6T7T0i" style="text-align: center">&#160;Fiscal Year Lease Maturities</td></tr>
<tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzI5d_zHPDhM5QUv7c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 51%; text-align: left">&#160;&#160;2024</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;$</td>
    <td style="width: 15%; text-align: right">71</td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzI5d_z05KgwjqCgpi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">96</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPzI5d_zvTGZCZz7QY6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;2026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">98</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_maLOLLPzI5d_zqdtbyxaHpE4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;2027</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">50</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_mtLOLLPzI5d_zTaKPeQ4hDr2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total lease payments</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">315</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_405_ecustom--LessAmountOfPaymentsRepresentingInterest_iI_pn3n3_zKE9Pp6QS1a2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;Less amount of payments representing interest</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(80</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zTgELzjBCtJ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of lease payments</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">235</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_z9MZvrJmbNh1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;Less current portion of operating lease liability</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(71</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zV9dtOQgqg4g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncurrent operating lease liability</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid">$</td>
    <td style="border-bottom: Black 2pt solid; text-align: right">164</td><td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162157221984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Domestic and foreign components of loss before income taxes for the years ended June 30, 2023, 2022, and 2021 are as follows:</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zOwh96xunHZb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zHcHAOhE69tg">Domestic
and foreign components of loss before income taxes for the years ended June 30, 2023, 2022, and 2021 are as follows:</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49A_20220701__20230630_zeb8spq4upv9" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49D_20210701__20220630_zlF7w9Xq9dtk" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_493_20200701__20210630_zDa3CpObDsc7" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2021</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_hus-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zK3uUy9GUwBe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">34,606</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">6,918</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,362</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_hus-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zSnBYF2RA4s3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">United States</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,006</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,969</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,462</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_zZFNWLHDmeR5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">40,612</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">10,887</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">4,824</td><td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">The following table is a reconciliation of income taxes at statutory rates:</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zs5HExDBoQV5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_znKJH15Ehw48">The
following table is a reconciliation of income taxes at statutory rates:</span> </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49A_20220701__20230630_znnsNMkmeHA5" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_49D_20210701__20220630_zweCFb7u7cH3" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_493_20200701__20210630_zUDfhAo0sfv2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="10" style="text-align: center">For the year ended June 30,</td><td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2021</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_z2WhkTx04cnj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">Loss before income taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">40,612</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">10,887</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,824</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zd2HImnVCDA2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Combined federal and provincial statutory income tax rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27</td><td style="text-align: left">%</td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_zUfrl6WI2bZg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income tax benefit at statutory tax rates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,965</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,940</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,303</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_zG5EZlLuMTAe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Foreign rate differential</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(131</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(72</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(31</td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_ecustom--EarnoutSharesLiability_zatK8X6UCRIg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,841</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1887">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1888">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--WarrantLiability_ztPKc0T2sA0f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,518</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1891">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1892">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--GxiiTransactionCosts_zLsZii2oldF8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">GXII transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(925</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1895">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1896">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_zKz7PS0iLfNa" style="vertical-align: bottom; background-color: White">
    <td>Share based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(412</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(462</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(212</td><td style="text-align: left">)</td></tr>
<tr id="xdx_406_eus-gaap--AssetRetirementObligationAccretionExpense_iN_di_zd55MIrI4rN9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(496</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(407</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(158</td><td style="text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--ExtinguishmentOfDebtGainLossIncomeTax_zyvmbEVRRo21" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loss on debt extinguishment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(54</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1907">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1908">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--EffectOfLegislativeChanges_znHjEoUvZnG1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Capital loss rate differential</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(38</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">182</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_zt23miC8g4Lh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in estimates related to prior years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(274</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">739</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--IncomeTaxReconciliationOtherAdjustments_z9Za1ZpLOYbf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zjGXRlblmnE2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Change in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,341</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,713</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,841</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">Income tax benefit</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20220701__20230630_zr0eMwVRmSl3" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit::XDX::-304"><span style="-sec-ix-hidden: xdx2ixbrl1926">304</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20210701__20220630_zYeRGCCQ4tX1" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit"><span style="-sec-ix-hidden: xdx2ixbrl1928">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20200701__20210630_zLlWW1B9LwUi" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit"><span style="-sec-ix-hidden: xdx2ixbrl1930">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z9Wm3gH6oO5e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zoPVsgiFNfqf">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_497_20230630_zDhU4uDzfFX" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="3" id="xdx_490_20220630_zFERGbCETe1" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: -0.125in">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0in">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTAGzakr_zFOs3CUB4mza" style="vertical-align: bottom; background-color: White">
    <td style="width: 50%; text-align: left; text-indent: 12.45pt; padding-left: 0in">Net operating losses available for future periods</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">11,893</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">8,977</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--DeferredTaxAssetsMineralInterest_iI_pn3n3_maDTAGzakr_zO5arYDMSVR8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 12.45pt; padding-left: 0in">Mineral interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,477</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,477</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--DeferredTaxAssetsStartupAndOorganizationalCosts_iI_pn3n3_maDTAGzakr_znoYOjcmoRZ8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 12.45pt; padding-left: 0in">Startup and organizational costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,132</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1941">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--DeferredTaxAssetsResearchAndDevelopmentCosts_iI_pn3n3_maDTAGzakr_zKk5UOLNyXN1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 12.45pt; padding-left: 0in">Research and development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,060</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1944">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--DeferredTaxAssetsShareIssuanceCosts_iI_pn3n3_maDTAGzakr_zQd4scgkZIE3" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 12.45pt; padding-left: 0in">Share issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">446</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1947">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--CapitalLossesAvailableForFuturePeriods_iI_pn3n3_maDTAGzakr_zejWCLKH9Gll" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 12.45pt; padding-left: 0in">Capital losses available for future periods</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">419</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">420</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOther_iI_maDTAGzakr_zuwwfEPG5gte" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-indent: 12.45pt; padding-left: 0in">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">36</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">74</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iI_mtDTAGzakr_maDTALNz97R_zkKzt0D9EmG5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0in">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,463</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,948</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNz97R_zkL602cJP7R1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 12.45pt; padding-left: 0in">&#160;Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(25,463</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(18,948</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNz97R_zFkk3S5gNFpk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0in">Net deferred tax assets</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1961">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1962">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Changes in the valuation allowance are as follows:</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--SummaryOfValuationAllowanceTextBlock_zx6ddasQHuG" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zhsSx74uZKO7">Changes
in the valuation allowance are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 50%; text-align: left; text-indent: -5.25pt; padding-left: 5.4pt">Valuation allowance, beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20220701__20230630_z0HmcrsxEO" style="width: 12%; text-align: right" title="Valuation allowance, beginning of year">(18,948</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20210701__20220630_zWITIePj2yUl" style="width: 12%; text-align: right" title="Valuation allowance, beginning of year">(17,235</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 4.85pt; padding-left: 5.4pt">Current year additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20220701__20230630_zwPbJS7FO6v9" style="text-align: right" title="Current year additions">(4,341</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20210701__20220630_zar3lEOTceFi" style="text-align: right">(1,713</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 4.85pt; padding-left: 5.4pt">Startup and organizational costs acquired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20220701__20230630_zWrtvp8nFv11" style="border-bottom: Black 1pt solid; text-align: right" title="Startup and organizational costs acquired">(2,174</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20210701__20220630_zwL3jCeNsFHh" style="border-bottom: Black 1pt solid; text-align: right" title="Startup and organizational costs acquired"><span style="-sec-ix-hidden: xdx2ixbrl1979">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt; text-indent: -5.25pt; padding-left: 5.4pt">Valuation allowance, end of year</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20220701__20230630_zLHAnSv3xxO1" style="border-bottom: Black 2pt solid; text-align: right" title="Valuation allowance, end of year">(25,463</td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20210701__20220630_zMU53NOnfclh" style="border-bottom: Black 2pt solid; text-align: right" title="Valuation allowance, end of year">(18,948</td><td style="padding-bottom: 2pt; text-align: left">)</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock', window );">Schedule of cumulative net operating losses</a></td>
<td class="text"><p id="xdx_895_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zt7NSQhNdB92" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company has the following cumulative net operating losses for Canadian and U.S. income tax purposes and these carryforwards will
generally expire between 2026 and 2043. As a result of the Tax Cuts and Jobs Act of 2017, U.S. tax losses incurred for tax years
ending on and after June 30, 2019, totaling $<span id="xdx_900_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pn3n3_c20190630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zJv5UtZ5duE5" title="Tax losses incurred">2,510</span>, have no expiration..&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_8BC_zZs2rzH4nlb7" style="display: none; visibility: hidden">Schedule of cumulative net operating losses</span></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Jurisdiction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zr2FLxoZyhUl" style="width: 12%; text-align: right" title="Total">40,267</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20220630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zhDi5089CG8c" style="width: 12%; text-align: right" title="Total">31,551</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zk4iV5YRgr57" style="border-bottom: Black 1pt solid; text-align: right" title="Total">3,491</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20220630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zyv3Wf0uaSG1" style="border-bottom: Black 1pt solid; text-align: right" title="Total">2,460</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630_z88s9qWFxcD1" style="border-bottom: Black 2pt solid; text-align: right" title="Total">43,758</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20220630_z9x1cEazGDhi" style="border-bottom: Black 2pt solid; text-align: right" title="Total">34,011</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162162130528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of fair values determined by level 3 inputs are unobservable data</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zNMgNLuWaxM2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"><span id="xdx_8B5_z5Btv5rSI5I8" style="display: none; visibility: hidden">Schedule of fair values determined by level 3 inputs are unobservable data</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Note</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 35%; text-align: left; padding-left: 9pt">Cash and cash equivalents</td>
    <td style="width: 9%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630_zBqcN60P3wt7" style="width: 11%; text-align: right">2,341</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIn4vwrQPf7a" style="width: 11%; text-align: right">2,341</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7zEhm2YuoQf" style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2024">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zq5aVQK3ovAl" style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2025">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Investment in equity securities</td>
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630_zg5N2PlFUBF4" style="border-bottom: Black 1pt solid; text-align: right">9</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zVvWu8ZiBRgi" style="border-bottom: Black 1pt solid; text-align: right">9</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhZOTDvsRkxj" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2028">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zXBuHYeUa2Dh" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2029">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td>
    <td>&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20230630_zVAB7hMrEACg" style="border-bottom: Black 2pt solid; text-align: right">2,350</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zLJ84rQf7Hs2" style="border-bottom: Black 2pt solid; text-align: right">2,350</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLoa3f7lt5Q6" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2032">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoBfXWj8Caob" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2033">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">Earnout Shares liability</td>
    <td style="text-align: center">10</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630_z0f8wg0zICOe" style="text-align: right">10,521</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zU38dtIrpt08" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2035">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4rJ8zi6lceg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2036">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zsYXpvENPoBf" style="text-align: right">10,521</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Warrant liabilities</td>
    <td style="text-align: center">9,11c</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630_zBPOAOFwAfj2" style="border-bottom: Black 1pt solid; text-align: right">4,989</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zomNPdBwqyv8" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2039">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWdcp9yPbOc5" style="border-bottom: Black 1pt solid; text-align: right">3,279</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmct4EnBaspj" style="border-bottom: Black 1pt solid; text-align: right">1,710</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt"><p style="margin: 0pt 0">Total</p>


</td>
    <td>&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630_zeRiRuss6wwh" style="border-bottom: Black 2pt solid; text-align: right">15,510</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z9vJ2MMgp1Cf" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2043">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zpYZRNJVy3m3" style="border-bottom: Black 2pt solid; text-align: right">3,279</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGxP1J8Qcjoe" style="border-bottom: Black 2pt solid; text-align: right">12,231</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2022</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 35%; text-align: left; padding-left: 9pt">Cash and cash equivalents</td>
    <td style="width: 9%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20220630_zQii4MSlRlr6" style="width: 11%; text-align: right" title="Cash and cash equivalents">5,280</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zPVQ35cH5Oxg" style="width: 11%; text-align: right">5,280</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhRmHXlSeHA9" style="width: 11%; text-align: right">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2049">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_ztumoy6ys8O2" style="width: 11%; text-align: right">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2050">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Investment in equity securities</td>
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20220630_zKuZXLiBEKi3" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents">10</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2O9RdnHokzk" style="border-bottom: Black 1pt solid; text-align: right">10</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zsoypEJ1ICUk" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2054">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoMqkyssNAE9" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2055">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td>
    <td>&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20220630_zcVjOknAjGi9" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents">5,290</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z30en8wKjpu4" style="border-bottom: Black 2pt solid; text-align: right">5,290</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9RUg6IZk7dl" style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2059">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3IbVi7tAKG9" style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2060">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162152638112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of intercompany transactions and balances (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=niobf_Entity0896800BCLtdMember', window );">Entity 0896800 B C Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_IncorporationStateCountryName', window );">Country of incorporation</a></td>
<td class="text">British
    Columbia, Canada<span></span>
</td>
<td class="text">British
    Columbia, Canada<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of ownership</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=niobf_ElkCreekResourcesCorpMember', window );">Elk Creek Resources Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_IncorporationStateCountryName', window );">Country of incorporation</a></td>
<td class="text">Nebraska,
    USA<span></span>
</td>
<td class="text">Nebraska,
    USA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=niobf_ElkCreekResourcesCorpECRCMember', window );">Elk Creek Resources Corp ECRC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_IncorporationStateCountryName', window );">Country of incorporation</a></td>
<td class="text">Delaware,
    USA<span></span>
</td>
<td class="text">Delaware,
    USA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of ownership</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_IncorporationStateCountryName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents incorporation state country name.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_IncorporationStateCountryName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=niobf_Entity0896800BCLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=niobf_Entity0896800BCLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=niobf_ElkCreekResourcesCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=niobf_ElkCreekResourcesCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=niobf_ElkCreekResourcesCorpECRCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=niobf_ElkCreekResourcesCorpECRCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162164831376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>N</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162152623088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders: (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (28,770)<span></span>
</td>
<td class="nump">$ 35,076<span></span>
</td>
<td class="nump">$ 40,308<span></span>
</td>
<td class="nump">$ 10,887<span></span>
</td>
<td class="nump">$ 4,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Adjust: net loss attributable to noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss available to participating securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,057<span></span>
</td>
<td class="nump">10,887<span></span>
</td>
<td class="nump">4,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Net loss attributable to vested shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,528)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic', window );">Net loss attributed to common shareholders - basic and diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,529<span></span>
</td>
<td class="nump">$ 10,887<span></span>
</td>
<td class="nump">$ 4,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding basic and diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,705,840<span></span>
</td>
<td class="nump">26,373,722<span></span>
</td>
<td class="nump">24,196,711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarningsLossPerShareBasicAndDiluted', window );">Loss per common share outstanding basic and diluted</a></td>
<td class="nump">$ 0.98<span></span>
</td>
<td class="nump">$ 1.24<span></span>
</td>
<td class="nump">$ 1.34<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarningsLossPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnings loss per share basic and diluted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarningsLossPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162157169296">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of excluded from the dilutive securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions', window );">Options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">1,541,500<span></span>
</td>
<td class="nump">1,446,400<span></span>
</td>
<td class="nump">1,596,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">18,816,304<span></span>
</td>
<td class="nump">1,851,622<span></span>
</td>
<td class="nump">1,434,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Convertible debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">2,871,660<span></span>
</td>
<td class="nump">415,200<span></span>
</td>
<td class="nump">1,455,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecurities', window );">Total potentially dilutive securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">$ 23,229,464<span></span>
</td>
<td class="nump">$ 3,713,222<span></span>
</td>
<td class="nump">$ 4,486,386<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1828-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of outstanding written put options using the reverse treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 36<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2398-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 35<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2366-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162156563376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As of March 31, 2023 (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Warrant liabilities, at fair value</a></td>
<td class="nump">$ 4,989<span></span>
</td>
<td class="nump">$ 4,638<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">29,797<span></span>
</td>
<td class="nump">34,070<span></span>
</td>
<td class="nump">5,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="num">(29,797)<span></span>
</td>
<td class="num">(34,070)<span></span>
</td>
<td class="num">(5,091)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(150,477)<span></span>
</td>
<td class="num">(145,381)<span></span>
</td>
<td class="num">(110,397)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; deficit</a></td>
<td class="num">$ (10,967)<span></span>
</td>
<td class="num">(11,847)<span></span>
</td>
<td class="nump">$ 17,665<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Warrant liabilities, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,735)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(146,046)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,512)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Revision of Prior Period, Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Warrant liabilities, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(665)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(665)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162152499296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revision Impacts to the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For the Three &amp; Nine Months Ended March 31, 2023 (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Other operating expense</a></td>
<td class="nump">$ 25,359<span></span>
</td>
<td class="nump">$ 26,027<span></span>
</td>
<td class="nump">$ 27,158<span></span>
</td>
<td class="nump">$ 1,653<span></span>
</td>
<td class="nump">$ 995<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Other operating expense</a></td>
<td class="num">(25,359)<span></span>
</td>
<td class="num">(26,027)<span></span>
</td>
<td class="num">(27,158)<span></span>
</td>
<td class="num">(1,653)<span></span>
</td>
<td class="num">(995)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">28,331<span></span>
</td>
<td class="nump">32,614<span></span>
</td>
<td class="nump">37,410<span></span>
</td>
<td class="nump">7,796<span></span>
</td>
<td class="nump">4,092<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfWarrantLiability', window );">Change in fair value of warrant liability</a></td>
<td class="nump">980<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(3,877)<span></span>
</td>
<td class="num">(3,877)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">28,770<span></span>
</td>
<td class="num">(35,076)<span></span>
</td>
<td class="num">(40,308)<span></span>
</td>
<td class="num">(10,887)<span></span>
</td>
<td class="num">(4,824)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ProfitLoss1', window );">Net loss attributable to the company</a></td>
<td class="nump">28,678<span></span>
</td>
<td class="nump">34,984<span></span>
</td>
<td class="num">(40,308)<span></span>
</td>
<td class="num">(10,887)<span></span>
</td>
<td class="num">(4,824)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="nump">28,658<span></span>
</td>
<td class="nump">34,994<span></span>
</td>
<td class="num">(40,226)<span></span>
</td>
<td class="num">(10,721)<span></span>
</td>
<td class="num">(5,628)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciEquityMethodInvestmentBeforeTaxParent', window );">Comprehensive loss attributable to the company</a></td>
<td class="nump">$ 28,566<span></span>
</td>
<td class="nump">$ 34,902<span></span>
</td>
<td class="num">$ (39,998)<span></span>
</td>
<td class="num">$ (10,721)<span></span>
</td>
<td class="num">$ (5,628)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarningsLossPerShareBasicAndDiluted', window );">Loss per common share, basic and diluted</a></td>
<td class="nump">$ 0.98<span></span>
</td>
<td class="nump">$ 1.24<span></span>
</td>
<td class="nump">$ 1.34<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Other operating expense</a></td>
<td class="nump">$ 26,220<span></span>
</td>
<td class="nump">$ 26,888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Other operating expense</a></td>
<td class="num">(26,220)<span></span>
</td>
<td class="num">(26,888)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">29,192<span></span>
</td>
<td class="nump">33,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfWarrantLiability', window );">Change in fair value of warrant liability</a></td>
<td class="nump">784<span></span>
</td>
<td class="nump">868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="nump">29,621<span></span>
</td>
<td class="nump">35,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">29,435<span></span>
</td>
<td class="num">(35,741)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ProfitLoss1', window );">Net loss attributable to the company</a></td>
<td class="nump">29,343<span></span>
</td>
<td class="nump">35,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="nump">29,323<span></span>
</td>
<td class="nump">35,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciEquityMethodInvestmentBeforeTaxParent', window );">Comprehensive loss attributable to the company</a></td>
<td class="nump">$ 29,231<span></span>
</td>
<td class="nump">$ 35,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarningsLossPerShareBasicAndDiluted', window );">Loss per common share, basic and diluted</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Revision of Prior Period, Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Other operating expense</a></td>
<td class="nump">$ 861<span></span>
</td>
<td class="nump">$ 861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Other operating expense</a></td>
<td class="num">(861)<span></span>
</td>
<td class="num">(861)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="num">(861)<span></span>
</td>
<td class="num">(861)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfWarrantLiability', window );">Change in fair value of warrant liability</a></td>
<td class="nump">196<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(665)<span></span>
</td>
<td class="num">(665)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(665)<span></span>
</td>
<td class="nump">665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ProfitLoss1', window );">Net loss attributable to the company</a></td>
<td class="num">(665)<span></span>
</td>
<td class="num">(665)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">(665)<span></span>
</td>
<td class="num">(665)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciEquityMethodInvestmentBeforeTaxParent', window );">Comprehensive loss attributable to the company</a></td>
<td class="num">$ (665)<span></span>
</td>
<td class="num">$ (665)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarningsLossPerShareBasicAndDiluted', window );">Loss per common share, basic and diluted</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarningsLossPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnings loss per share basic and diluted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarningsLossPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ProfitLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents profit loss 2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ProfitLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciEquityMethodInvestmentBeforeTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126903467&amp;loc=d3e32472-111569<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciEquityMethodInvestmentBeforeTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general expenses not normally included in Other Operating Costs and Expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.6)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162158720592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revision Impacts to the Condensed Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023 (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">$ 28,770<span></span>
</td>
<td class="num">$ (35,076)<span></span>
</td>
<td class="num">$ (40,308)<span></span>
</td>
<td class="num">$ (10,887)<span></span>
</td>
<td class="num">$ (4,824)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AssumptionOfPrivateAndPublicWarrants', window );">Assumption of Private and Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,987<span></span>
</td>
<td class="nump">2,987<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair Value Adjustment of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
<td class="nump">$ 633<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 1,795<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">29,435<span></span>
</td>
<td class="num">(35,741)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AssumptionOfPrivateAndPublicWarrants', window );">Assumption of Private and Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair Value Adjustment of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Revision of Prior Period, Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="num">$ (665)<span></span>
</td>
<td class="nump">665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AssumptionOfPrivateAndPublicWarrants', window );">Assumption of Private and Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(861)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair Value Adjustment of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_AssumptionOfPrivateAndPublicWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents assumption of private and public warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_AssumptionOfPrivateAndPublicWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162157356464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued exploration stage expense</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162163370736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOING CONCERN ISSUES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (28,770)<span></span>
</td>
<td class="nump">$ 35,076<span></span>
</td>
<td class="nump">$ 40,308<span></span>
</td>
<td class="nump">$ 10,887<span></span>
</td>
<td class="nump">$ 4,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CashAndCashEquivalentsAtCarryingValue1', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpenditureDiscontinuedOperations', window );">Capital expenditure of operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CashAndCashEquivalentsAtCarryingValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents cash and cash equivalents at carrying value1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CashAndCashEquivalentsAtCarryingValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpenditureDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of capital expenditure attributable to discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpenditureDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162154469440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss: (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts', window );">Gross cash proceeds, net of transaction costs incurred by GXII</a></td>
<td class="nump">$ 2,168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Less:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net liabilities assumed</a></td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts', window );">Yorkville Equity Facility Financing Agreement &#8211; cash costs</a></td>
<td class="nump">1,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed', window );">Transaction costs expensed</a></td>
<td class="nump">6,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Private Warrants assumed at fair value</a></td>
<td class="nump">2,987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarnoutSharesAssumedAtFairValue', window );">Earnout Shares assumed at fair value</a></td>
<td class="nump">13,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities', window );">Yorkville Equity Facility Financing Agreement &#8211; shares issued</a></td>
<td class="nump">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">&#160;Total transaction related losses incurred</a></td>
<td class="nump">$ 23,767<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents business combination separately recognized transactions additional disclosures acquisition cash costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarnoutSharesAssumedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnout shares assumed at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarnoutSharesAssumedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease obligation assumed in business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities assumed (as defined) which have been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of any issuance related costs which have not been expensed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162161406560">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>The number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows: (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">31,202,131<span></span>
</td>
<td class="nump">27,667,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Number of shares, percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=niobf_LegacyNioCorpShareholdersMember', window );">Legacy Nio Corp Shareholders [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,246,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Number of shares, percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">93.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=niobf_GXIIClassAShareholdersMember', window );">GXII Class A Shareholders [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,753,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Number of shares, percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">5.83%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=niobf_OtherMember', window );">Other [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">81,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Number of shares, percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0.27%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes
    83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory
    services.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Represents
    Commitment Shares (as defined in Note 11d) issued under the Yorkville Equity Facility Financing Agreement.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_LegacyNioCorpShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_LegacyNioCorpShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_GXIIClassAShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_GXIIClassAShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162161234096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GXII TRANSACTION (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_WarrantAgreementMember', window );">Warrant Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Number of shares purchase</a></td>
<td class="nump">15,666,626<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible shares issued upon conversion</a></td>
<td class="nump">7,957,404<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits', window );">Post reverse stock split shares</a></td>
<td class="nump">1,753,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Number of shares purchase</a></td>
<td class="nump">17,519,864<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares purchased for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction in the number of shares during the period as a result of a reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_WarrantAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_WarrantAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162158925232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of properties (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOther', window );">Cost</a></td>
<td class="nump">$ 848<span></span>
</td>
<td class="nump">$ 856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net</a></td>
<td class="nump">839<span></span>
</td>
<td class="nump">850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LandMember', window );">Land [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOther', window );">Cost</a></td>
<td class="nump">807<span></span>
</td>
<td class="nump">811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net</a></td>
<td class="nump">807<span></span>
</td>
<td class="nump">811<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_BuildingMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOther', window );">Cost</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162161182144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LAND AND BUILDINGS, NET (Details Narrative) - Land Improvements [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Oct. 22, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LandPurchaseOptionsDescription', window );">Description of owned land</a></td>
<td class="text">approximately
1.27 acres located adjacent to State Highway 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LandAndLandImprovements', window );">Improvements state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedPartnersCapitalAccountDescriptionOfUnits', window );">Description of ownership of mineral rights</a></td>
<td class="text">The Company retained ownership of the mineral rights associated with
this 1.27-acre parcel.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale', window );">Other gains and comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LandAndLandImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation and depletion of real estate held for productive use and additions or improvements to real estate held for productive use, examples include, but are not limited to, walkways, driveways, fences, and parking lots. Excludes land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LandAndLandImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LandPurchaseOptionsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes contracts, agreements and arrangements that give the entity unilateral rights to purchase the land covered by the option for a specified period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 970<br> -SubTopic 340<br> -Section 25<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126944050&amp;loc=d3e29293-110302<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LandPurchaseOptionsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedPartnersCapitalAccountDescriptionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the various rights, preferences, and privileges of the limited partners' ownership units including: redemption, conversion, liquidation, tax status of distribution per unit and the sharing in distributions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 4.F)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187171-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedPartnersCapitalAccountDescriptionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For banks, amount of all liabilities for which a financial institution is required to include in its calculation of net investment in real estate assets held for development or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162152905296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MINERAL PROPERTIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 23, 2021</div></th>
<th class="th"><div>Jun. 30, 2011</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ReserveQuantitiesLineItems', window );"><strong>Reserve Quantities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMineralRights', window );">Other amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 5,468,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBuildings', window );">Remaining balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">$ 837,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_ShareExchangeAgreementMember', window );">Share Exchange Agreement [Member] | Canada, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ReserveQuantitiesLineItems', window );"><strong>Reserve Quantities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DeferredTaxImpacts', window );">Deferred tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_OptionAgreementMember', window );">Option Agreement [Member] | Elk Creek Resources Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ReserveQuantitiesLineItems', window );"><strong>Reserve Quantities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalDeferredPurchasePrice', window );">Purchase price</a></td>
<td class="nump">$ 6,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfAcquisitionCosts', window );">Indirect costs</a></td>
<td class="nump">57,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMineralRights', window );">Other amount</a></td>
<td class="nump">837,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBuildings', window );">Remaining balance</a></td>
<td class="nump">$ 5,468,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=niobf_Entity0896800BCLtdMember', window );">Entity 0896800 B C Ltd [Member] | Share Exchange Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ReserveQuantitiesLineItems', window );"><strong>Reserve Quantities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issue for acquistion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=niobf_Entity0896800BCLtdMember', window );">Entity 0896800 B C Ltd [Member] | Share Exchange Agreement [Member] | Elk Creek Resources Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ReserveQuantitiesLineItems', window );"><strong>Reserve Quantities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issue for acquistion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,899,053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DeferredTaxImpacts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred taximpacts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DeferredTaxImpacts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ReserveQuantitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ReserveQuantitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of buildings (properties) whether for investment or use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMineralRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the acquisition of a mineral right which is the right to extract a mineral from the earth or to receive payment, in the form of royalty, for the extraction of minerals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMineralRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalDeferredPurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A device of credit enhancement where a part of the purchase price for the receivable/ payable is retained to serve as a cash collateral.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalDeferredPurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_ShareExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_ShareExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_OptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_OptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=niobf_ElkCreekResourcesCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=niobf_ElkCreekResourcesCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=niobf_Entity0896800BCLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=niobf_Entity0896800BCLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162152863504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of account payable and accrued liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable, trade</a></td>
<td class="nump">$ 1,990<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Trade payable accruals</a></td>
<td class="nump">1,324<span></span>
</td>
<td class="nump">654<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Income taxes payable</a></td>
<td class="nump">101<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Environmental accruals</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure', window );">Loan origination fees payable to related party</a></td>
<td class="nump">28<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total accounts payable and accrued liabilities</a></td>
<td class="nump">$ 3,491<span></span>
</td>
<td class="nump">$ 817<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of trade and related party payables and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162152863088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of convertible debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertibled debt, current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible debt, noncurrent</a></td>
<td class="nump">10,561<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=niobf_ConvertibleSecurityMember', window );">Convertible Security [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertibled debt, current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible debt, noncurrent</a></td>
<td class="nump">$ 10,561<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=niobf_ConvertibleSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=niobf_ConvertibleSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162152580256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in the Lind III Convertible Security are as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Beginning balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Fair value increase due to debt extinguishment</a></td>
<td class="nump">1,922<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion expense</a></td>
<td class="nump">2,157<span></span>
</td>
<td class="nump">2,619<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Ending balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=niobf_ConvertibleSecurityMember', window );">Convertible Security [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Beginning balance</a></td>
<td class="nump">2,169<span></span>
</td>
<td class="nump">7,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Fair value increase due to debt extinguishment</a></td>
<td class="nump">201<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Conversions</a></td>
<td class="num">(1,950)<span></span>
</td>
<td class="num">(7,635)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion expense</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">2,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities', window );">Payment at maturity</a></td>
<td class="num">(515)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Ending balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6394232&amp;loc=d3e17558-110866<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow through purchase of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=niobf_ConvertibleSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=niobf_ConvertibleSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162157256352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table summarizes the components of the initial loss on extinguishment: (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_MinimumConsentPaymentAtInception', window );">Minimum Consent Payment at inception</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ASC470LossOnExtinguishment', window );">Loss on debt extinguishment</a></td>
<td class="nump">201<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentOfWarrantsGrantedForServices', window );">Initial fair value of Contingent Consent Warrants</a></td>
<td class="nump">1,221<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost', window );">Initial loss on debt extinguishment</a></td>
<td class="nump">1,622<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AdditionalConsentPaymentbooked', window );">Additional Consent Payment booked</a></td>
<td class="nump">300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnRestructuringOfDebt', window );">Total loss on debt extinguishment</a></td>
<td class="nump">$ 1,922<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents
    the difference between the accrual of the minimum Consent Payment at September 25, 2022 and the actual payment made on March
    17, 2023.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ASC470LossOnExtinguishment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents as c470 loss on extinguishment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ASC470LossOnExtinguishment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_AdditionalConsentPaymentbooked">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents additional consent paymentbooked.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_AdditionalConsentPaymentbooked</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_MinimumConsentPaymentAtInception">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents minimum consent payment at inception.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_MinimumConsentPaymentAtInception</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentOfWarrantsGrantedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment for noncash service expenses paid for by granting of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentOfWarrantsGrantedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnRestructuringOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For a debtor, the aggregate gain (loss) recognized on the restructuring of payables arises from the difference between the book value of the debt before the restructuring and the fair value of the payments on the debt after restructuring is complete.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6402221&amp;loc=d3e15743-112638<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnRestructuringOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162161337744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The change in the fair value of the Contingent Consent Warrants is presented below: (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Initial valuation, at beginning</a></td>
<td class="nump">$ 1,221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInValuationOfWarrants', window );">Change in valuation</a></td>
<td class="nump">489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Valuation, at ending</a></td>
<td class="nump">$ 1,710<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInValuationOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in valuation of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInValuationOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162152928976">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Schedule of valuation date and the probability calculated. (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>N </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 25, 2022 </div>
<div>N </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Share price | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 10.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.99<span></span>
</td>
<td class="nump">$ 9.36<span></span>
</td>
<td class="nump">$ 5.43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Measurement Input, Share Price [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Share price | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 5.03<span></span>
</td>
<td class="nump">$ 7.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Probability of issuance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.630<span></span>
</td>
<td class="nump">0.624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Probability of issuance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.0411<span></span>
</td>
<td class="nump">0.0393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=niobf_ProbabilityOfIssuanceMember', window );">Probability of Issuance [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Probability of issuance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.808<span></span>
</td>
<td class="nump">0.594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Expires
    in 12 equal monthly tranches beginning October 17, 2023</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=niobf_ProbabilityOfIssuanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=niobf_ProbabilityOfIssuanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162161148576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in the Convertible Debentures are as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Balance, June 30, 2023</a></td>
<td class="nump">$ 12,153<span></span>
</td>
<td class="nump">$ 10,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpenseIncludingAssetRetirementObligations', window );">Accretion expense</a></td>
<td class="nump">1,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_PrincipalAndAccruedInterestConverted', window );">Principal and accrued interest converted</a></td>
<td class="num">(3,554)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Add: uamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Balance, June 30, 2023</a></td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_PrincipalAndAccruedInterestConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents principal and accrued interest converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_PrincipalAndAccruedInterestConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpenseIncludingAssetRetirementObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion expense, which includes, but is not limited to, accretion expense from asset retirement obligations, environmental remediation obligations, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6392676&amp;loc=d3e7480-110848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpenseIncludingAssetRetirementObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162150638912">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE DEBT (Details Narrative)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 19, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 19, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>N </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>N </div>
<div>$ / shares </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 16, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 26, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 25, 2022 </div>
<div>N </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Face value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Investment Interest Rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8.50%<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Commitment fee</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 350<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromInterestReceived', window );">Net proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTerm', window );">Long term debt duration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonUnitIssued', window );">Common share purchase warrants | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">855,800<span></span>
</td>
<td class="nump">855,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare', window );">Exercisable at a price per share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible debt liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount', window );">Commitment fee</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Common share price, per share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.98<span></span>
</td>
<td class="nump">$ 10.98<span></span>
</td>
<td class="nump">$ 8.99<span></span>
</td>
<td class="nump">$ 9.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrant liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,064<span></span>
</td>
<td class="nump">$ 633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 1,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare', window );">Shares issued | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,300<span></span>
</td>
<td class="nump">58,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value | N</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0411<span></span>
</td>
<td class="nump">0.0411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value | N</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.630<span></span>
</td>
<td class="nump">0.630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Measurement Input, Share Price [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Common share price, per share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.03<span></span>
</td>
<td class="nump">$ 5.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Common share price, per share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Contingent liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingLiability', window );">Contingent liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible debt liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,656<span></span>
</td>
<td class="nump">$ 12,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,704<span></span>
</td>
<td class="nump">$ 2,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Principal percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1', window );">Issuance of the convertible debentures | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.9422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 503<span></span>
</td>
<td class="nump">$ 503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member] | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.33<span></span>
</td>
<td class="nump">4.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member] | Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate', window );">Fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member] | Measurement Input, Price Volatility [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value | N</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64.6<span></span>
</td>
<td class="nump">64.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member] | Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate obligation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DebtMaturityPeriod', window );">Expected life</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate obligation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DebtMaturityPeriod', window );">Expected life</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member] | Warrant [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodSharesStockOptionsExercise', window );">Issuance of the convertible debentures | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,789,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Common share price, per share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.9422<span></span>
</td>
<td class="nump">$ 8.9422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentTerms', window );">Debt term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18-month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt [Member] | Yorkville Convertible Debt Financing Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=niobf_LindIIIConvertibleSecurityMember', window );">Lind I I I Convertible Security [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Face value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible debt liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,938<span></span>
</td>
<td class="nump">$ 7,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_TransactionCost', window );">Transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=niobf_LindIIIConvertibleSecurityMember', window );">Lind I I I Convertible Security [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionDescription', window );">Debt Conversion, Description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Pursuant
to the Lind III Agreement, Lind was entitled to convert the Lind III Convertible Security into Common Shares in monthly installments
over its term at a price per Common Share equal to 85% of the volume-weighted average price Common Shares on the TSX for the five
trading days immediately preceding to the date on which Lind provides notice to the Company of its election to convert. The Lind
III Agreement provided that Common Shares issuable upon conversion, together with the number of Common Shares issued upon exercise
of Warrants, shall not exceed 4,358,800 Common Shares.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Volatility</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntermediateLifePlantsUsefulLife', window );">Expected life</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="12"></td></tr>
<tr><td colspan="12"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Expires
    in 12 equal monthly tranches beginning October 17, 2023</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DebtMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents debt maturity period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DebtMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents share based goods and nonemployee services transaction valuation method expected dividend yield rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodSharesStockOptionsExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period shares stock options exercise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodSharesStockOptionsExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period shares stock options exercise1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_TransactionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents transaction cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_TransactionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonUnitIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common units issued of limited liability company (LLC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonUnitIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntermediateLifePlantsUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of intermediate-life plants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 905<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471048&amp;loc=d3e5272-110052<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntermediateLifePlantsUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of interest on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of timing of required repayments, sinking fund requirements, and other redeemable securities at fixed or determinable prices and dates in the five years immediately following the date of the latest balance sheet presented in the financial statements, and the amount thereafter to fully repay the principal of long-term debt. These disclosures may be made either on an individual debt or security basis, by type of debt or security basis, or on a combined basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in number of shares that would be issued upon settlement from change in fair value of share for option contract indexed to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromInterestReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest received on loans and other debt instruments during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3337-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromInterestReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ServicingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of servicing liabilities that are subsequently measured at fair value and servicing liabilities that are subsequently measured using the amortization method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6469459&amp;loc=d3e122501-111745<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ServicingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the expected term of a nonvested share or option award issued to other than an employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=niobf_LindIIIConvertibleSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=niobf_LindIIIConvertibleSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=niobf_LindIIIConvertibleSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=niobf_LindIIIConvertibleSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162157080992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table discloses the primary inputs into the Monte Carlo models. (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 25, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares</div>
</th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing Common Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Implied volatility of Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63.60%<span></span>
</td>
<td class="nump">54.40%<span></span>
</td>
<td class="nump">54.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">1.33%<span></span>
</td>
<td class="nump">0.26%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Measurement Input, Exercise Price [Member] | Valuation Technique, Option Pricing Model [Member] | Earnout [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing Common Share price</a></td>
<td class="nump">$ 7.00<span></span>
</td>
<td class="nump">$ 5.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2', window );">Term (expiry)</a></td>
<td class="text">Mar. 17,  2033<span></span>
</td>
<td class="text">Mar. 17,  2033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Implied volatility of Public Warrants</a></td>
<td class="nump">19.50%<span></span>
</td>
<td class="nump">33.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">3.39%<span></span>
</td>
<td class="nump">3.83%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents sharebased compensation arrangement by sharebased payment award fair value assumptions expected term2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162249469280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2023: (Details) - Earnout [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingLiabilityAtFairValueAmount', window );">Fair value at beginning</a></td>
<td class="nump">$ 13,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingLiabilityAtFairValueAdditions', window );">Change in fair value</a></td>
<td class="num">(2,674)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingLiabilityAtFairValueAmount', window );">Fair value at ending</a></td>
<td class="nump">$ 10,521<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ServicingLiabilityAtFairValueAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of new servicing liabilities, that are subsequently measured at fair value, acquired or created during the current period through assumptions of servicing obligations and servicing obligations that result from transfers of financial assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128311188&amp;loc=d3e122625-111746<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ServicingLiabilityAtFairValueAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ServicingLiabilityAtFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of a liability representing servicing arrangements under which the estimated future revenue from contractually specified servicing fees, late charges, and other ancillary revenues are not expected to adequately compensate the servicer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6469459&amp;loc=d3e122492-111745<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6469459&amp;loc=d3e122501-111745<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128311188&amp;loc=d3e122625-111746<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6469459&amp;loc=d3e122501-111745<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ServicingLiabilityAtFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162152869456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CLASS B COMMON STOCK OF ECRC (Details Narrative) - shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="nump">31,202,131<span></span>
</td>
<td class="nump">27,667,060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember', window );">Earnout [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Earnout shares</a></td>
<td class="nump">3,391,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DescriptionOfEarnOutShares', window );">Description of earnout shares</a></td>
<td class="text">The
Earnout Shares vest (the &#8220;Released Earnout Shares&#8221;) in two equal tranches based upon achieving market share price
milestones of approximately $12.00 per Common Share and approximately $15.00 per Common Share, respectively, prior to the Ten-Year
Anniversary, or upon a change in control as defined in the underlying agreement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="nump">7,957,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares, issued</a></td>
<td class="nump">7,957,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Earnout shares</a></td>
<td class="nump">4,565,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DescriptionOfEarnOutShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents description of earn out shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DescriptionOfEarnOutShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162156974432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of stock option (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance</a></td>
<td class="nump">1,446,400<span></span>
</td>
<td class="nump">1,596,499<span></span>
</td>
<td class="nump">1,912,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance</a></td>
<td class="nump">$ 8.27<span></span>
</td>
<td class="nump">$ 6.50<span></span>
</td>
<td class="nump">$ 6.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">578,000<span></span>
</td>
<td class="nump">447,500<span></span>
</td>
<td class="nump">370,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">$ 6.95<span></span>
</td>
<td class="nump">$ 13.30<span></span>
</td>
<td class="nump">$ 7,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(265,129)<span></span>
</td>
<td class="num">(215)<span></span>
</td>
<td class="num">(295,229)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="nump">$ 4.99<span></span>
</td>
<td class="nump">$ 7.00<span></span>
</td>
<td class="nump">$ 6.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled/expired</a></td>
<td class="num">(217,771)<span></span>
</td>
<td class="num">(392,446)<span></span>
</td>
<td class="num">(391,212)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled/expired</a></td>
<td class="nump">$ 5.87<span></span>
</td>
<td class="nump">$ 7.70<span></span>
</td>
<td class="nump">$ 6.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="nump">265,129<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="nump">295,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance</a></td>
<td class="nump">1,541,500<span></span>
</td>
<td class="nump">1,446,400<span></span>
</td>
<td class="nump">1,596,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending Balance</a></td>
<td class="nump">$ 9.64<span></span>
</td>
<td class="nump">$ 8.27<span></span>
</td>
<td class="nump">$ 6.50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162153360656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table summarizes information about stock options outstanding at June 30, 2023: (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</a></td>
<td class="nump">1,541,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</a></td>
<td class="nump">1,541,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CAD', window );">Canada, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value | $</a></td>
<td class="nump">$ 263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1', window );">Share Based Compensation Arrangement by Share Based Payment Award Options Outstanding Intrinsic Value 1 | $</a></td>
<td class="nump">$ 263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice8.40Member', window );">Exercise Price 8.40 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date</a></td>
<td class="text">Sep. 18,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</a></td>
<td class="nump">105,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</a></td>
<td class="nump">105,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice5.40Member', window );">Exercise Price 5.40 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date</a></td>
<td class="text">Nov. 15,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</a></td>
<td class="nump">208,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</a></td>
<td class="nump">208,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice5.40Member', window );">Exercise Price 5.40 [Member] | Canada, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value | $</a></td>
<td class="nump">$ 263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1', window );">Share Based Compensation Arrangement by Share Based Payment Award Options Outstanding Intrinsic Value 1 | $</a></td>
<td class="nump">$ 263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice7.50Member', window );">Exercise Price 7.50 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date</a></td>
<td class="text">Dec. 14,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</a></td>
<td class="nump">170,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</a></td>
<td class="nump">170,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice7.50OneMember', window );">Exercise Price 7.50 One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date</a></td>
<td class="text">Dec. 16,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</a></td>
<td class="nump">52,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</a></td>
<td class="nump">52,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice13.60Member', window );">Exercise Price 13.60 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date</a></td>
<td class="text">Dec. 17,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</a></td>
<td class="nump">377,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</a></td>
<td class="nump">377,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.00Member', window );">Exercise Price 11.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date</a></td>
<td class="text">May 30,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice6.95Member', window );">Exercise Price 6.95 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date</a></td>
<td class="text">Mar. 27,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</a></td>
<td class="nump">578,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</a></td>
<td class="nump">578,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents share based compensation arrangement by share based payment award options outstanding intrinsic value 1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the equity-based award expires, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice8.40Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice8.40Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice5.40Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice5.40Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice7.50Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice7.50Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice7.50OneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice7.50OneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice13.60Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice13.60Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice6.95Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice6.95Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162161443392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table summarizes the weighted average information and assumptions used to determine option costs: (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value per option granted during the period</a></td>
<td class="nump">$ 3.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">1.33%<span></span>
</td>
<td class="nump">0.26%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility (historical basis)</a></td>
<td class="nump">63.60%<span></span>
</td>
<td class="nump">54.40%<span></span>
</td>
<td class="nump">54.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected option life in years</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CAD', window );">Canada, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value per option granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.90<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162150083488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Balance at beginning</a></td>
<td class="nump">1,851,622<span></span>
</td>
<td class="nump">1,434,183<span></span>
</td>
<td class="nump">1,237,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Balance at beginning average price</a></td>
<td class="nump">$ 8.99<span></span>
</td>
<td class="nump">$ 9.36<span></span>
</td>
<td class="nump">$ 5.43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_NordminWarrants', window );">Nordmin warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing', window );">Nordmin warrants average price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightLindIIIWarrants', window );">Lind III Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">855,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceLindWarrants', window );">Lind III warrants average price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightAprilPrivatePlacement', window );">April 2021 private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">441,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements', window );">April 2021 private placement average price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercised', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(87,175)<span></span>
</td>
<td class="num">(910,628)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceExercised', window );">Exercised average price</a></td>
<td class="nump">$ 11.67<span></span>
</td>
<td class="nump">$ 6.05<span></span>
</td>
<td class="nump">$ 6.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExpired', window );">Expired</a></td>
<td class="num">(491,211)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(239,845)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceExpired', window );">Expired average price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightJunePrivatePlacement', window );">June 2022 private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">504,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceJunePrivatePlacements', window );">June 2022 private placement average price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_YorkvilleFinancingWarrants', window );">Yorkville financing warrants</a></td>
<td class="nump">1,789,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants', window );">Yorkville financing warrants average price</a></td>
<td class="nump">$ 8.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_GxiiWarrants', window );">GXII warrants</a></td>
<td class="nump">15,666,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants', window );">GXII warrant average price</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Balance at ending</a></td>
<td class="nump">18,816,304<span></span>
</td>
<td class="nump">1,851,622<span></span>
</td>
<td class="nump">1,434,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Balance at ending average price</a></td>
<td class="nump">$ 10.98<span></span>
</td>
<td class="nump">$ 8.99<span></span>
</td>
<td class="nump">$ 9.36<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightAprilPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right april private placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightAprilPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price april private placements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceJunePrivatePlacements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price june private placements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceJunePrivatePlacements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceLindWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price lind warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceLindWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price warrants gxii warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price warrants november financing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price warrants yorkville financing warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightJunePrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right june private placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightJunePrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightLindIIIWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right lind i i i warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightLindIIIWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_GxiiWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents gxii warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_GxiiWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_NordminWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents nordmin warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_NordminWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_YorkvilleFinancingWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents yorkville financing warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_YorkvilleFinancingWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162152942912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>At June 30, 2023, the Company has outstanding exercisable warrants, as follows: (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number | shares</a></td>
<td class="nump">18,816,304<span></span>
</td>
<td class="nump">18,816,304<span></span>
</td>
<td class="nump">1,851,622<span></span>
</td>
<td class="nump">1,851,622<span></span>
</td>
<td class="nump">1,434,183<span></span>
</td>
<td class="nump">1,237,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 10.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.36<span></span>
</td>
<td class="nump">$ 5.43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.00Member', window );">Exercise Price 11.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number | shares</a></td>
<td class="nump">504,611<span></span>
</td>
<td class="nump">504,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="text">Jun. 30,  2024<span></span>
</td>
<td class="text">Jun. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.00Member', window );">Exercise Price 11.00 [Member] | Canada, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice9.70Member', window );">Exercise Price 9.70 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number | shares</a></td>
<td class="nump">855,800<span></span>
</td>
<td class="nump">855,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="text">Feb. 19,  2025<span></span>
</td>
<td class="text">Feb. 19,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice9.70Member', window );">Exercise Price 9.70 [Member] | Canada, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice8.94Member', window );">Exercise Price 8.94 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number | shares</a></td>
<td class="nump">1,789,267<span></span>
</td>
<td class="nump">1,789,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 8.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.50Member', window );">Exercise Price11.50 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number | shares</a></td>
<td class="nump">15,666,626<span></span>
</td>
<td class="nump">15,666,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="text">Mar. 17,  2028<span></span>
</td>
<td class="text">Mar. 17,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice9.70Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice9.70Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice8.94Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice8.94Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.50Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.50Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162157044480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 17, 2023 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares</div>
</th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Strike price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63.60%<span></span>
</td>
<td class="nump">54.40%<span></span>
</td>
<td class="nump">54.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected warrant life in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Stock price on valuation date</a></td>
<td class="nump">$ 7.00<span></span>
</td>
<td class="nump">$ 5.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Strike price</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">19.50%<span></span>
</td>
<td class="nump">33.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free rate</a></td>
<td class="nump">3.47%<span></span>
</td>
<td class="nump">4.18%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected warrant life in years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">4 years 8 months 23 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162161313184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The change in the Private Warrants liability is presented below: (Details) - Note Warrant [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangesInFairValueOfInitialValuation', window );">Initial valuation, at begining</a></td>
<td class="nump">$ 2,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs', window );">Change in valuation</a></td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangesInFairValueOfInitialValuation', window );">Initial valuation, at ending</a></td>
<td class="nump">$ 3,279<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangesInFairValueOfInitialValuation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents changes in fair value of initial valuation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangesInFairValueOfInitialValuation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in fair value from changes in the inputs used to calculate the fair value of contract to service financial assets under which the benefits of servicing are expected to more than adequately compensate the servicer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(4)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128311188&amp;loc=d3e122625-111746<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162152660208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of expenses as other operating costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Fair value of Commitment Shares issued</a></td>
<td class="num">$ (204)<span></span>
</td>
<td class="num">$ (130)<span></span>
</td>
<td class="num">$ (175)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Legal and other related costs</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_YorkvilleCashFee', window );">Yorkville Cash Fee</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Fair value of Commitment Shares issued</a></td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Legal and other related costs</a></td>
<td class="nump">496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Net costs expensed to other operating expense</a></td>
<td class="nump">$ 2,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_YorkvilleCashFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents yorkville cash fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_YorkvilleCashFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162156825696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 09, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 28, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th"><div>Nov. 05, 2020</div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Warrants | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">314,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OfferingCostsPartnershipInterests', window );">Shares issue price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ShareIssuanceCost', window );">Share issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees', window );">Description of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
Company may elect to redeem the Public Warrants subject to certain conditions, in whole and not in part, at a price of $0.01 per
Public Warrant if (i) 30 days&#8217; prior written notice of redemption is provided to the holders, (ii) the last reported sale
price of the Common Shares equals or exceeds approximately $16.10 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third business day prior
to the date on which the Company sends the notice of redemption to the warrant holders<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=niobf_GXIIPublicWarrantsMember', window );">GXII Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Warrants traded prior to the closing | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,999,959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=niobf_GXIIPrivateWarrantsMember', window );">GXII Private Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Warrants traded prior to the closing | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=niobf_LongTermIncentivePlanMember', window );">Long TermIncentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DescriptionOfAmendedPlan', window );">Description of amended plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Subject
to adjustment as described in the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares that may be reserved
for issuance to participants under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation
arrangements of the Company, may not exceed 10% of the issued and outstanding Common Shares from time to time, and the Common
Shares reserved for issuance upon settlement of share units will not exceed 5% of the issued and outstanding Common Shares from
time to time. The 2017 Amended Long-Term Incentive Plan limits the maximum number of Common Shares issued to insiders (as defined
under TSX rules for this purpose) within any one-year period, or issuable to insiders at any time, in the aggregate, under all
security-based compensation arrangements (including the 2017 Amended Long-Term Incentive Plan) to 10% of the then issued and outstanding
Common Shares.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees', window );">Description of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each
NioCorp Assumed Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and the
like).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CAD', window );">Canada, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Canada, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Warrants | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">498,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SaleOfStockPricePerShare1', window );">Shares price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Canada, Dollars | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Warrants | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForCommissions', window );">Cash commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FairValueAssumptionsRiskFreeInterestRate1', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FairValueAssumptionsExpected1VolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FairValueAssumptions1ExpectedTerm', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Warrants | shares</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Share issuance cost</a></td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DescriptionOfAmendedPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents description of amended plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DescriptionOfAmendedPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_FairValueAssumptions1ExpectedTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents fair value assumptions 1 expected term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_FairValueAssumptions1ExpectedTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_FairValueAssumptionsExpected1VolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents fair value assumptions expected 1 volatility rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_FairValueAssumptionsExpected1VolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_FairValueAssumptionsRiskFreeInterestRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents fair value assumptions risk free interest rate 1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_FairValueAssumptionsRiskFreeInterestRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_SaleOfStockPricePerShare1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents sale of stock price per share 1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_SaleOfStockPricePerShare1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ShareIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents share issuance cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ShareIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of reason for issuing warrant or right.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OfferingCostsPartnershipInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred in connection with the offering and selling of additional partner interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 5.D.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126898976&amp;loc=d3e600348-122990<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OfferingCostsPartnershipInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for commissions during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_GXIIPublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_GXIIPublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_GXIIPrivateWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_GXIIPrivateWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=niobf_LongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=niobf_LongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162161156240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in the Smith Credit Agreement principal balance are as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyDepositLiabilities', window );">Beginning balance</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 2,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AmountsAdvanced', window );">Amounts advanced</a></td>
<td class="nump">1,130<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt', window );">Repayments</a></td>
<td class="num">(3,130)<span></span>
</td>
<td class="num">(318)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyDepositLiabilities', window );">Balance, end of period</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_AmountsAdvanced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents amounts advanced.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_AmountsAdvanced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyDepositLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deposits held by the entity for a related party (entity, shareholder, employee).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyDepositLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162157027952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Mar. 22, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AmountPaidToRelatedParty', window );">Amount drew down</a></td>
<td class="nump">$ 1,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Interest paid</a></td>
<td class="nump">252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=niobf_MarkSmithMember', window );">Mark Smith [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Principal amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EstablishmentFeesPayable', window );">Establishment fees payable</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_GeneralSecurityAgreementMember', window );">General Security Agreement [Member] | Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionRate', window );">Interest at a rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_LineOfCreditFacilityPrepaymentFee', window );">Prepayment fee</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_AmendedNonRevolvingCreditFacilityAgreementMember', window );">Amended Non Revolving Credit Facility Agreement [Member] | Chief Executive Officer [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Principal amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_AmendedNonRevolvingCreditFacilityAgreementMember', window );">Amended Non Revolving Credit Facility Agreement [Member] | Chief Executive Officer [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Principal amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_AmendedNonRevolvingCreditFacilityAgreementMember', window );">Amended Non Revolving Credit Facility Agreement [Member] | Mark Smith [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Principal amount outstanding</a></td>
<td class="nump">$ 52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_NonRevolvingCreditFacilityAgreementMember', window );">Non Revolving Credit Facility Agreement [Member] | Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Principal amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_AmountPaidToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents amount paid to related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_AmountPaidToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EstablishmentFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents establishment fees payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EstablishmentFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_LineOfCreditFacilityPrepaymentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents line of credit facility prepayment fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_LineOfCreditFacilityPrepaymentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1336-112600<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1314-112600<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=niobf_MarkSmithMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=niobf_MarkSmithMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_GeneralSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_GeneralSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_AmendedNonRevolvingCreditFacilityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_AmendedNonRevolvingCreditFacilityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_NonRevolvingCreditFacilityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_NonRevolvingCreditFacilityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162158855248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of exploration expenditures (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration expenditures</a></td>
<td class="nump">$ 5,348<span></span>
</td>
<td class="nump">$ 3,309<span></span>
</td>
<td class="nump">$ 1,056<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CostCentreAxis=niobf_FeasibilityStudyAndEngineeringMember', window );">Feasibility Study and Engineering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration expenditures</a></td>
<td class="nump">410<span></span>
</td>
<td class="nump">334<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CostCentreAxis=niobf_FieldManagementAndOtherMember', window );">Field Management and Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration expenditures</a></td>
<td class="nump">738<span></span>
</td>
<td class="nump">569<span></span>
</td>
<td class="nump">656<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CostCentreAxis=us-gaap_ExplorationAndProductionEquipmentMember', window );">Exploration and Production Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration expenditures</a></td>
<td class="nump">4,174<span></span>
</td>
<td class="nump">2,218<span></span>
</td>
<td class="nump">272<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CostCentreAxis=niobf_GeologistsAndFieldStaffMember', window );">Geologists and Field Staff [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration expenditures</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExplorationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exploration expenses (including prospecting) related to oil and gas producing entities and would be included in operating expenses of that entity. Costs incurred in identifying areas that may warrant examination and in examining specific areas that are considered to have prospects of containing oil and gas reserves, including costs of drilling exploratory wells and exploratory-type stratigraphic test wells. Exploration costs may be incurred both before acquiring the related property (sometimes referred to in part as prospecting costs) and after acquiring the property. Principal types of exploration costs, which include depreciation and applicable operating costs of support equipment and facilities and other costs of exploration activities, are: (i) Costs of topographical, geographical and geophysical studies, rights of access to properties to conduct those studies, and salaries and other expenses of geologists, geophysical crews, and others conducting those studies. Collectively, these are sometimes referred to as geological and geophysical or "G&amp;G" costs. (ii) Costs of carrying and retaining undeveloped properties, such as delay rentals, ad valorem taxes on properties, legal costs for title defense, and the maintenance of land and lease records. (iii) Dry hole contributions and bottom hole contributions. (iv) Costs of drilling and equipping exploratory wells. (v) Costs of drilling exploratory-type stratigraphic test wells.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 235<br> -Section 50<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126939881&amp;loc=d3e62136-109447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExplorationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CostCentreAxis=niobf_FeasibilityStudyAndEngineeringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CostCentreAxis=niobf_FeasibilityStudyAndEngineeringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CostCentreAxis=niobf_FieldManagementAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CostCentreAxis=niobf_FieldManagementAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CostCentreAxis=us-gaap_ExplorationAndProductionEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CostCentreAxis=us-gaap_ExplorationAndProductionEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CostCentreAxis=niobf_GeologistsAndFieldStaffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CostCentreAxis=niobf_GeologistsAndFieldStaffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162152941120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company incurred lease costs as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>&#160;Operating Lease Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FixedRentExpense', window );">Fixed rent expense</a></td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">$ 106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable rent expense</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short term lease cost</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(33)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net lease cost</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Lease cost &#8211; other operating expense</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationCosts', window );">Lease cost &#8211; exploration expenditures</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_FixedRentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents fixed rent expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_FixedRentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExplorationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The capitalized costs incurred during the period (excluded from amortization) in identifying areas that may warrant examination and in examining specific areas that are considered to have prospects of containing oil and gas reserves, including costs of drilling exploratory wells and exploratory-type stratigraphic test wells. Exploration costs may be incurred both before acquiring the related property (sometimes referred to in part as prospecting costs) and after acquiring the property. Principal types of exploration costs, which include depreciation and applicable operating costs of support equipment and facilities and other costs of exploration activities, are: costs of topographical, geographical and geophysical studies, rights of access to properties to conduct those studies, and salaries and other expenses of geologists, geophysical crews, and others conducting those studies. Collectively, these are sometimes referred to as geological and geophysical or "G&amp;G" costs. Exploration costs also include costs of carrying and retaining undeveloped properties, such as delay rentals, ad valorem taxes on properties, legal costs for title defense, the maintenance of land and lease records, dry hole contributions and bottom hole contributions, costs of drilling and equipping exploratory wells and costs of drilling exploratory-type stratigraphic test wells.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(7)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126954596&amp;loc=d3e511914-122862<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExplorationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162157057232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The maturity of lease liabilities is as follows at June 30, 2023: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">&#160;&#160;2024</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">&#160;&#160;2025</a></td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">&#160;&#160;2026</a></td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">&#160;&#160;2027</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_LessAmountOfPaymentsRepresentingInterest', window );">&#160;&#160;Less amount of payments representing interest</a></td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease payments</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">&#160;&#160;Less current portion of operating lease liability</a></td>
<td class="num">(71)<span></span>
</td>
<td class="num">$ (82)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Noncurrent operating lease liability</a></td>
<td class="nump">$ 164<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_LessAmountOfPaymentsRepresentingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents less amount of payments representing interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_LessAmountOfPaymentsRepresentingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162157221984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DiscountRate', window );">Discount rate</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">3 years 7 months 6 days<span></span>
</td>
<td class="text">1 year 3 months 19 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash payment</a></td>
<td class="nump">$ 93<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=niobf_CorporateOfficeMember', window );">Corporate Office [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Other lease description</a></td>
<td class="text">39-month corporate office lease extension and recognized the corresponding ROU asset
and lease liability of $198 associated with this extension, based on a discount rate of 16%.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=niobf_CorporateOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=niobf_CorporateOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162162584512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Domestic and foreign components of loss before income taxes for the years ended June 30, 2023, 2022, and 2021 are as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Total</a></td>
<td class="nump">$ 40,612<span></span>
</td>
<td class="nump">$ 10,887<span></span>
</td>
<td class="nump">$ 4,824<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Total</a></td>
<td class="nump">34,606<span></span>
</td>
<td class="nump">6,918<span></span>
</td>
<td class="nump">3,362<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Total</a></td>
<td class="nump">$ 6,006<span></span>
</td>
<td class="nump">$ 3,969<span></span>
</td>
<td class="nump">$ 1,462<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162150055904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table is a reconciliation of income taxes at statutory rates: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax', window );">Loss before income taxes</a></td>
<td class="nump">$ 40,612<span></span>
</td>
<td class="nump">$ 10,887<span></span>
</td>
<td class="nump">$ 4,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Combined federal and provincial statutory income tax rate</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax benefit at statutory tax rates</a></td>
<td class="nump">$ 10,965<span></span>
</td>
<td class="nump">$ 2,940<span></span>
</td>
<td class="nump">$ 1,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="num">(131)<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarnoutSharesLiability', window );">Earnout shares liability</a></td>
<td class="num">(2,841)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_WarrantLiability', window );">Warrant liability</a></td>
<td class="num">(1,518)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_GxiiTransactionCosts', window );">GXII transaction costs</a></td>
<td class="num">(925)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Share based compensation</a></td>
<td class="num">(412)<span></span>
</td>
<td class="num">(462)<span></span>
</td>
<td class="num">(212)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationAccretionExpense', window );">Accretion expense</a></td>
<td class="num">(496)<span></span>
</td>
<td class="num">(407)<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossIncomeTax', window );">Loss on debt extinguishment</a></td>
<td class="num">(54)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EffectOfLegislativeChanges', window );">Capital loss rate differential</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Change in estimates related to prior years</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(274)<span></span>
</td>
<td class="nump">739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(4,341)<span></span>
</td>
<td class="num">(1,713)<span></span>
</td>
<td class="num">(1,841)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">$ (304)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarnoutSharesLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnout shares liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarnoutSharesLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EffectOfLegislativeChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents effect of legislative changes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EffectOfLegislativeChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_GxiiTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents gxii transaction costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_GxiiTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_WarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_WarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationAccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6392676&amp;loc=d3e7480-110848<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationAccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtGainLossIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current period income tax expense or benefit pertaining to a gain (loss) on an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtGainLossIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162157174752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses available for future periods</a></td>
<td class="nump">$ 11,893<span></span>
</td>
<td class="nump">$ 8,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DeferredTaxAssetsMineralInterest', window );">Mineral interests</a></td>
<td class="nump">9,477<span></span>
</td>
<td class="nump">9,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DeferredTaxAssetsStartupAndOorganizationalCosts', window );">Startup and organizational costs</a></td>
<td class="nump">2,132<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DeferredTaxAssetsResearchAndDevelopmentCosts', window );">Research and development costs</a></td>
<td class="nump">1,060<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DeferredTaxAssetsShareIssuanceCosts', window );">Share issuance costs</a></td>
<td class="nump">446<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CapitalLossesAvailableForFuturePeriods', window );">Capital losses available for future periods</a></td>
<td class="nump">419<span></span>
</td>
<td class="nump">420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">25,463<span></span>
</td>
<td class="nump">18,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">&#160;Valuation allowance</a></td>
<td class="num">(25,463)<span></span>
</td>
<td class="num">(18,948)<span></span>
</td>
<td class="num">$ (17,235)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CapitalLossesAvailableForFuturePeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents capital losses available for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CapitalLossesAvailableForFuturePeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DeferredTaxAssetsMineralInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax assets mineral interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DeferredTaxAssetsMineralInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DeferredTaxAssetsResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax assets research and development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DeferredTaxAssetsResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DeferredTaxAssetsShareIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax assets share issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DeferredTaxAssetsShareIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DeferredTaxAssetsStartupAndOorganizationalCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax assets startup and oorganizational costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DeferredTaxAssetsStartupAndOorganizationalCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162153337632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in the valuation allowance are as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance, beginning of year</a></td>
<td class="num">$ (18,948)<span></span>
</td>
<td class="num">$ (17,235)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DeferredTaxAssetsValuationAllowanceAdditions', window );">Current year additions</a></td>
<td class="num">(4,341)<span></span>
</td>
<td class="num">(1,713)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsIncurredDevelopmentCosts', window );">Startup and organizational costs acquired</a></td>
<td class="num">(2,174)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance, end of year</a></td>
<td class="num">$ (25,463)<span></span>
</td>
<td class="num">$ (18,948)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DeferredTaxAssetsValuationAllowanceAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax assets valuation allowance additions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DeferredTaxAssetsValuationAllowanceAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsIncurredDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Development costs incurred, including capitalized costs and costs charged to expense, in oil and gas activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 235<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126939881&amp;loc=d3e62014-109447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsIncurredDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162156974960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of cumulative net operating losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Total</a></td>
<td class="nump">$ 43,758<span></span>
</td>
<td class="nump">$ 34,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOtherLossCarryforwards', window );">Tax losses incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Total</a></td>
<td class="nump">3,491<span></span>
</td>
<td class="nump">2,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Total</a></td>
<td class="nump">$ 40,267<span></span>
</td>
<td class="nump">$ 31,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOtherLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible loss carryforwards, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOtherLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162150055824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_IncreasesInCapitalLossesAvailableForFuturePeriods', window );">Increases in Capital Losses Available for Future Periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (221,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_OtherIncomeTaxes', window );">Other Income Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CapitalLossCaryforward', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations', window );">Federal income tax payable</a></td>
<td class="nump">406,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">25,463,000<span></span>
</td>
<td class="nump">$ 18,948,000<span></span>
</td>
<td class="nump">$ 17,235,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CapitalLossCaryforward', window );">Net operating loss carryforwards</a></td>
<td class="nump">4,943,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CAD', window );">Canada, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CapitalLossCaryforward', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 3,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CapitalLossCaryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents Capital Loss Caryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CapitalLossCaryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_IncreasesInCapitalLossesAvailableForFuturePeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents increases in capital losses available for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_IncreasesInCapitalLossesAvailableForFuturePeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_OtherIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents Other Income Taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_OtherIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162157450784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of fair values determined by level 3 inputs are unobservable data (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,341<span></span>
</td>
<td class="nump">$ 5,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther', window );">Cash and cash equivalents</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">2,350<span></span>
</td>
<td class="nump">5,290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other Liabilities, Fair Value Disclosure</a></td>
<td class="nump">10,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Warrants Not Settleable in Cash, Fair Value Disclosure</a></td>
<td class="nump">4,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liabilities Fair Value Disclosure</a></td>
<td class="nump">15,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">2,341<span></span>
</td>
<td class="nump">5,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther', window );">Cash and cash equivalents</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">2,350<span></span>
</td>
<td class="nump">5,290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other Liabilities, Fair Value Disclosure</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Warrants Not Settleable in Cash, Fair Value Disclosure</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liabilities Fair Value Disclosure</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other Liabilities, Fair Value Disclosure</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Warrants Not Settleable in Cash, Fair Value Disclosure</a></td>
<td class="nump">3,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liabilities Fair Value Disclosure</a></td>
<td class="nump">3,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure', window );">Mortgage-Backed Securities Available-for-Sale, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other Liabilities, Fair Value Disclosure</a></td>
<td class="nump">10,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Warrants Not Settleable in Cash, Fair Value Disclosure</a></td>
<td class="nump">1,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liabilities Fair Value Disclosure</a></td>
<td class="nump">$ 12,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure', window );">Mortgage-Backed Securities Available-for-Sale, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents available for sale securities equity securities other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_AvailableForSaleSecuritiesEquitySecuritiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of securitized, pay-through debt securities collateralized by real estate mortgage loans classified as available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of warrants not settleable in cash classified as equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsNotSettleableInCashFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140162157315600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 18, 2023</div></th>
<th class="th"><div>Sep. 12, 2023</div></th>
<th class="th"><div>Sep. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventDescription', window );">Subsequent event description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On
September 1, 2023, the Company closed a non-brokered private placement (the &#8220;September 2023 Private Placement&#8221;) of
units of the Company (the &#8220;September 2023 Units&#8221;). A total of 250,000 September 2023 Units were issued at a price per September 2023 Unit of $4.00,
for total gross proceeds to the Company of $1.0 million. Each September 2023 Unit consists of one Common Share and one Common
Share purchase warrant (&#8220;September 2023 Warrant&#8221;). Each September 2023 Warrant entitles the holder to acquire one
Common Share at a price of $4.60 at any time prior to September 1, 2025. Proceeds of the September 2023 Private Placement will
be used for continued advancement of the Company&#8217;s Elk Creek Critical Minerals Project and for working capital and general
corporate purposes.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Yorkville Convertible Debt Financing Agreement [Member] | Financing Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds', window );">Gross cash proceeds</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Common Stock [Member] | Yorkville Convertible Debt Financing Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued and sold</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share or unit times the number of shares or units issued in an insurance entity stock offering in connection with its conversion from a mutual form of ownership to a stock entity. Amount is gross, before offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 805<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505872&amp;loc=d3e30785-158569<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_FinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_FinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>n2574_x163-10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:currency="http://xbrl.sec.gov/currency/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:niobf="http://niocorp.com/20230630"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="niobf-20230630.xsd" xlink:type="simple"/>
    <context id="From2022-07-01to2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_CommonSharesWithoutParValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:CommonSharesWithoutParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:WarrantsEachExercisableFor1.11829212CommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-10-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2023-10-06</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_Entity0896800BCLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_Entity0896800BCLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_Entity0896800BCLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_Entity0896800BCLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ElkCreekResourcesCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ElkCreekResourcesCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ElkCreekResourcesCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ElkCreekResourcesCorpECRCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ElkCreekResourcesCorpECRCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ElkCreekResourcesCorpECRCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_srt_RestatementAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_srt_RestatementAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_srt_RestatementAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_WarrantAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:WarrantAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_LegacyNioCorpShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LegacyNioCorpShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_LegacyNioCorpShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LegacyNioCorpShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_GXIIClassAShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIClassAShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_GXIIClassAShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIClassAShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-10-202022-10-22_us-gaap_LandImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-20</startDate>
            <endDate>2022-10-22</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_LandImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2011-06-282011-06-30_custom_Entity0896800BCLtdMember_custom_ShareExchangeAgreementMember_custom_ElkCreekResourcesCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:ElkCreekResourcesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:ShareExchangeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2011-06-28</startDate>
            <endDate>2011-06-30</endDate>
        </period>
    </context>
    <context id="From2011-06-282011-06-30_custom_Entity0896800BCLtdMember_custom_ShareExchangeAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:ShareExchangeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2011-06-28</startDate>
            <endDate>2011-06-30</endDate>
        </period>
    </context>
    <context id="From2011-06-282011-06-30_custom_ShareExchangeAgreementMember_currency_CAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2011-06-28</startDate>
            <endDate>2011-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2011-06-30_custom_ShareExchangeAgreementMember_currency_CAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2011-06-30</instant>
        </period>
    </context>
    <context id="From2021-04-212021-04-23_custom_OptionAgreementMember_custom_ElkCreekResourcesCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:ElkCreekResourcesCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:OptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-21</startDate>
            <endDate>2021-04-23</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2021-02-162021-02-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2021-02-16</startDate>
            <endDate>2021-02-19</endDate>
        </period>
    </context>
    <context id="AsOf2021-02-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2021-02-19</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:LindIIIConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember501157062">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">niobf:LindIIIConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_LindIIIConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">niobf:LindIIIConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2021-02-172021-02-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2021-02-17</startDate>
            <endDate>2021-02-19</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_UnsecuredDebtMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-01-26_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-26</instant>
        </period>
    </context>
    <context id="AsOf2023-03-16_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-16</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ConvertibleSecurityMember501157765">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ConvertibleSecurityMember501157812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:ConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-25_us-gaap_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-25</instant>
        </period>
    </context>
    <context id="AsOf2022-09-25_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-25</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-25_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-25</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-25_custom_ProbabilityOfIssuanceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">niobf:ProbabilityOfIssuanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-25</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ProbabilityOfIssuanceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">niobf:ProbabilityOfIssuanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="From2023-03-152023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-25_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-25</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-09-242022-09-25_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-24</startDate>
            <endDate>2022-09-25</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-28_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="From2023-03-012023-06-30_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-04-262023-04-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2023-04-26</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="From2023-06-082023-06-09_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-08</startDate>
            <endDate>2023-06-09</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_PrivatePlacementMember_currency_CAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-11-032020-11-05_custom_LongTermIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">niobf:LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-03</startDate>
            <endDate>2020-11-05</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_currency_CAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_GXIIPublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIPublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_GXIIPrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIPrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ExercisePrice8.40Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice8.40Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ExercisePrice8.40Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice8.40Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ExercisePrice5.40Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice5.40Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ExercisePrice5.40Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice5.40Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ExercisePrice5.40Member_currency_CAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice5.40Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ExercisePrice7.50Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice7.50Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ExercisePrice7.50Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice7.50Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ExercisePrice7.50OneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice7.50OneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ExercisePrice7.50OneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice7.50OneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ExercisePrice13.60Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice13.60Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ExercisePrice13.60Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice13.60Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ExercisePrice11.00Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice11.00Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ExercisePrice11.00Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice11.00Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ExercisePrice6.95Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice6.95Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ExercisePrice6.95Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice6.95Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_currency_CAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_currency_CAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_currency_CAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_currency_CAD_custom_ExercisePrice11.00Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice11.00Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ExercisePrice9.70Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice9.70Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_currency_CAD_custom_ExercisePrice9.70Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice9.70Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ExercisePrice8.94Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice8.94Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ExercisePrice11.50Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice11.50Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-17_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-17</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-03-17_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-17</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:GeneralSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-28_custom_AmendedNonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:AmendedNonRevolvingCreditFacilityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_custom_AmendedNonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:AmendedNonRevolvingCreditFacilityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_AmendedNonRevolvingCreditFacilityAgreementMember_custom_MarkSmithMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">niobf:MarkSmithMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:AmendedNonRevolvingCreditFacilityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-22_custom_NonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:NonRevolvingCreditFacilityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-22</instant>
        </period>
    </context>
    <context id="AsOf2023-05-31_custom_MarkSmithMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">niobf:MarkSmithMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_MarkSmithMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">niobf:MarkSmithMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_FeasibilityStudyAndEngineeringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FeasibilityStudyAndEngineeringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_FeasibilityStudyAndEngineeringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FeasibilityStudyAndEngineeringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_FeasibilityStudyAndEngineeringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FeasibilityStudyAndEngineeringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_FieldManagementAndOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldManagementAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_FieldManagementAndOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldManagementAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_FieldManagementAndOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldManagementAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_ExplorationAndProductionEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">us-gaap:ExplorationAndProductionEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_ExplorationAndProductionEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">us-gaap:ExplorationAndProductionEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_ExplorationAndProductionEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">us-gaap:ExplorationAndProductionEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_GeologistsAndFieldStaffMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistsAndFieldStaffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_GeologistsAndFieldStaffMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistsAndFieldStaffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_GeologistsAndFieldStaffMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistsAndFieldStaffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_CorporateOfficeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">niobf:CorporateOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2023-08-302023-09-01_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-30</startDate>
            <endDate>2023-09-01</endDate>
        </period>
    </context>
    <context id="From2023-09-102023-09-12_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-10</startDate>
            <endDate>2023-09-12</endDate>
        </period>
    </context>
    <context id="From2023-09-162023-09-18_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-16</startDate>
            <endDate>2023-09-18</endDate>
        </period>
    </context>
    <context id="From2023-09-162023-09-18_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_SubsequentEventMember_custom_FinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:FinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-16</startDate>
            <endDate>2023-09-18</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="NUMBER">
        <measure>niobf:N</measure>
    </unit>
    <unit id="CADPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:CAD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-07-01to2023-06-30">0001512228</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-07-01to2023-06-30">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2022-07-01to2023-06-30">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentPeriodEndDate contextRef="From2022-07-01to2023-06-30">2023-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2022-07-01to2023-06-30">2023</dei:DocumentFiscalYearFocus>
    <dei:CurrentFiscalYearEndDate contextRef="From2022-07-01to2023-06-30">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0022">A1</dei:EntityIncorporationStateCountryCode>
    <niobf:DueToOfficersOrStockholdersOtherCurrent
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl0093"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl0096"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl0109"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl0112"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:EarnoutLiabilityAtFairValue
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl0115"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl0127"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesAuthorizedUnlimited contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0139">Unlimited</us-gaap:CommonStockSharesAuthorizedUnlimited>
    <us-gaap:CommonStockSharesAuthorizedUnlimited contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0141">Unlimited</us-gaap:CommonStockSharesAuthorizedUnlimited>
    <niobf:ChangeInFairValueOfEarnoutLiability
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0184"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:ChangeInFairValueOfEarnoutLiability
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0185"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:ChangeInFairValueOfWarrantLiability
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0188"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:ChangeInFairValueOfWarrantLiability
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0189"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0192"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherIncome
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0204"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-07-01to2023-06-30"
      id="xdx2ixbrl0207"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0208"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0220"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0221"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0228"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0229"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0256"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0257"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AssumptionOfEarnoutLiability
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0284"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AssumptionOfEarnoutLiability
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0285"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:ChangeInFairValueOfEarnoutShareLiability
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0288"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:ChangeInFairValueOfEarnoutShareLiability
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0289"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AssumptionOfPrivateAndPublicWarrants
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0292"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AssumptionOfPrivateAndPublicWarrants
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0293"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:LossesOnExtinguishmentOfDebt
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0304"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:ChangeInValuationOfWarrantLiabilities
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0308"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:ChangeInValuationOfWarrantLiabilities
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0309"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:FairValueOfCommitmentSharesIssued
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0312"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:FairValueOfCommitmentSharesIssued
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0313"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Depreciation
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0321"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:OtheroperatingGainsLosses
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0332"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="From2022-07-01to2023-06-30"
      id="xdx2ixbrl0335"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0336"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireMineralRights
      contextRef="From2022-07-01to2023-06-30"
      id="xdx2ixbrl0363"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireMineralRights
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0364"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="From2022-07-01to2023-06-30"
      id="xdx2ixbrl0367"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0372"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0373"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0384"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0392"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0393"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0400"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2022-07-01to2023-06-30"
      id="xdx2ixbrl0435"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0436"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0437"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:RecognitionOfOperatingLeaseLiabilities
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0448"
      xsi:nil="true"/>
    <niobf:DerecognitionOfOperatingLeaseLiabilities
      contextRef="From2022-07-01to2023-06-30"
      id="xdx2ixbrl0451"
      xsi:nil="true"/>
    <niobf:DerecognitionOfOperatingLeaseLiabilities
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0452"
      xsi:nil="true"/>
    <niobf:AccountsPayableToConvertibleDebtConversion
      contextRef="From2022-07-01to2023-06-30"
      id="xdx2ixbrl0455"
      xsi:nil="true"/>
    <niobf:AccountsPayableToConvertibleDebtConversion
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0456"
      xsi:nil="true"/>
    <niobf:ValueOfWarrantsIssued
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0460"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0467"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodSharesStockWarrantExercised
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0472"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodSharesStockWarrantExercised
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0473"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodSharesStockWarrantExercised
      contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0475"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0480"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0481"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0483"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0488"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0489"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0491"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:PrivatePlacementValueMay2021
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0494"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:PrivatePlacementValueMay2021
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0495"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:PrivatePlacementValueMay2021
      contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0497"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0502"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0505"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0510"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0511"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0513"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0516"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0517"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0519"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0521"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0522"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0525"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0527"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0529"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0531"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0537"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodSharesStockWarrantExercised
      contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0542"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodSharesStockWarrantExercised
      contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0543"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodSharesStockWarrantExercised
      contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0545"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0549"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0550"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0552"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0557"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0558"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0560"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:PrivatePlacementSharesMay2021
      contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0563"
      unitRef="Shares"
      xsi:nil="true"/>
    <niobf:PrivatePlacementSharesMay2021
      contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0564"
      unitRef="Shares"
      xsi:nil="true"/>
    <niobf:PrivatePlacementSharesMay2021
      contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0566"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0571"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0572"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0574"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0579"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0580"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0582"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0585"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0586"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0588"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0590"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0591"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0594"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0596"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0598"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0600"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0606"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0611"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0612"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0614"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0619"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0620"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0622"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:CommonSharesIssuedInTheGXIITransaction
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0624"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:CommonSharesIssuedInTheGXIITransaction
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0625"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:CommonSharesIssuedInTheGXIITransaction
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0626"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:CommonSharesIssuedInTheGXIITransaction
      contextRef="From2022-07-01to2023-06-30"
      id="xdx2ixbrl0627"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:CommonSharesIssuedInTheGXIITransaction
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0628"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0633"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0634"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0636"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0641"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0642"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0644"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0649"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0650"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0652"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0657"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0658"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0660"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0665"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0666"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0668"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:RedeemableNoncontrollingInterest
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0671"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:RedeemableNoncontrollingInterest
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0672"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0677"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0678"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0680"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0682"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0683"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0686"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0688"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0690"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NumberOfReportableSegments
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      id="xdx2ixbrl0709"
      unitRef="NUMBER">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      id="xdx2ixbrl0809"
      unitRef="USD">228000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0811"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0813"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0823"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0825"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      id="xdx2ixbrl0929"
      unitRef="USD">-3877000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-07-012023-03-31"
      decimals="-3"
      id="xdx2ixbrl0988"
      unitRef="USD">-3877000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="xdx2ixbrl0990"
      unitRef="USD">-35741000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      id="xdx2ixbrl0992"
      unitRef="USD">665000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-03-31"
      decimals="-3"
      id="xdx2ixbrl0994"
      unitRef="USD">-35076000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      id="xdx2ixbrl1022"
      unitRef="USD">665000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      id="xdx2ixbrl1033"
      unitRef="USD">-40308000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="xdx2ixbrl1091"
      unitRef="Shares">31202131</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl1168"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl1174"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-06-30_custom_ConvertibleSecurityMember"
      id="xdx2ixbrl1182"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2022-06-30_custom_ConvertibleSecurityMember"
      id="xdx2ixbrl1187"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtTerm contextRef="AsOf2023-06-30" id="xdx2ixbrl1201">P24M</us-gaap:LongTermDebtTerm>
    <us-gaap:IntermediateLifePlantsUsefulLife
      contextRef="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember"
      id="xdx2ixbrl1215">P4Y</us-gaap:IntermediateLifePlantsUsefulLife>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="From2021-07-012022-06-30_custom_ConvertibleSecurityMember"
      id="xdx2ixbrl1231"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="From2021-07-012022-06-30_custom_ConvertibleSecurityMember"
      id="xdx2ixbrl1243"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-06-30_custom_ConvertibleSecurityMember501157812"
      id="xdx2ixbrl1245"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:DebtMaturityPeriod
      contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MinimumMember"
      id="xdx2ixbrl1346">P6M</niobf:DebtMaturityPeriod>
    <niobf:DebtMaturityPeriod
      contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MaximumMember"
      id="xdx2ixbrl1348">P18M</niobf:DebtMaturityPeriod>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      id="xdx2ixbrl1364"
      unitRef="USD">0</us-gaap:AmortizationOfFinancingCosts>
    <niobf:FairValueAssumptions1ExpectedTerm
      contextRef="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_WarrantMember"
      id="xdx2ixbrl1444">P2Y</niobf:FairValueAssumptions1ExpectedTerm>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      id="xdx2ixbrl1481"
      unitRef="Shares">215</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-07-012023-06-30_custom_ExercisePrice8.40Member"
      id="xdx2ixbrl1515">2023-09-18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-07-012023-06-30_custom_ExercisePrice5.40Member"
      id="xdx2ixbrl1520">2023-11-15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-07-012023-06-30_custom_ExercisePrice7.50Member"
      id="xdx2ixbrl1525">2023-12-14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-07-012023-06-30_custom_ExercisePrice7.50OneMember"
      id="xdx2ixbrl1528">2023-12-16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-07-012023-06-30_custom_ExercisePrice13.60Member"
      id="xdx2ixbrl1531">2024-12-17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-07-012023-06-30_custom_ExercisePrice11.00Member"
      id="xdx2ixbrl1534">2025-05-30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2022-07-012023-06-30_custom_ExercisePrice6.95Member"
      id="xdx2ixbrl1537">2026-03-27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl1569">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1571">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2020-07-012021-06-30" id="xdx2ixbrl1572">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2023-06-30_custom_ExercisePrice11.00Member"
      id="xdx2ixbrl1630">2024-06-30</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2023-06-30_custom_ExercisePrice9.70Member"
      id="xdx2ixbrl1635">2025-02-19</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2023-06-30_custom_ExercisePrice11.50Member"
      id="xdx2ixbrl1643">2028-03-17</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-07-012023-03-17_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1687">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1689">P4Y8M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <niobf:AmountsAdvanced
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1732"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RelatedPartyDepositLiabilities
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl1737"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="xdx2ixbrl1746"
      unitRef="USD">252000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2022-06-30"
      decimals="-3"
      id="xdx2ixbrl1747"
      unitRef="USD">873000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="AsOf2023-06-30" id="xdx2ixbrl1775">P3Y7M6D</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="AsOf2022-06-30" id="xdx2ixbrl1777">P1Y3M19D</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:ExplorationCosts
      contextRef="From2022-07-01to2023-06-30"
      id="xdx2ixbrl1818"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ExplorationCosts
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1819"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:EarnoutSharesLiability
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1887"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:EarnoutSharesLiability
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl1888"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:WarrantLiability
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1891"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:WarrantLiability
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl1892"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:GxiiTransactionCosts
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1895"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:GxiiTransactionCosts
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl1896"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ExtinguishmentOfDebtGainLossIncomeTax
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1907"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ExtinguishmentOfDebtGainLossIncomeTax
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl1908"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      id="xdx2ixbrl1926"
      unitRef="USD">-304000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1928"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl1930"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:DeferredTaxAssetsStartupAndOorganizationalCosts
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl1941"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:DeferredTaxAssetsResearchAndDevelopmentCosts
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl1944"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:DeferredTaxAssetsShareIssuanceCosts
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl1947"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl1961"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl1962"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CostsIncurredDevelopmentCosts
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1979"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2024"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl2025"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2028"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl2029"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2032"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl2033"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl2035"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2036"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl2039"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl2043"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2049"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl2050"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure
      contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2054"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure
      contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl2055"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2059"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl2060"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2022-07-01to2023-06-30">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2022-07-01to2023-06-30">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2022-07-01to2023-06-30">2023-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2022-07-01to2023-06-30">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2022-07-01to2023-06-30">000-55710</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2022-07-01to2023-06-30">NioCorp Developments Ltd.</dei:EntityRegistrantName>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-07-01to2023-06-30">98-1262185</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-07-01to2023-06-30">7000 South Yosemite Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-07-01to2023-06-30">Suite 115</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-07-01to2023-06-30">Centennial</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-07-01to2023-06-30">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-07-01to2023-06-30">80112</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-07-01to2023-06-30">(720)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-07-01to2023-06-30">334-7066</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2022-07-012023-06-30_custom_CommonSharesWithoutParValueMember">Common     Shares, without par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-07-012023-06-30_custom_CommonSharesWithoutParValueMember">NB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-07-012023-06-30_custom_CommonSharesWithoutParValueMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-07-012023-06-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember">Warrants,     each exercisable for 1.11829212 Common Shares</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-07-012023-06-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember">NIOBW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-07-012023-06-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2022-07-01to2023-06-30">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2022-07-01to2023-06-30">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2022-07-01to2023-06-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2022-07-01to2023-06-30">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2022-07-01to2023-06-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2022-07-01to2023-06-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-07-01to2023-06-30">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2022-07-01to2023-06-30">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">190700000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2023-10-06" decimals="INF" unitRef="Shares">32913419</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">2341000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">5280000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">1385000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">402000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">3726000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">5682000</us-gaap:AssetsCurrent>
    <us-gaap:DepositsAssets contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">35000</us-gaap:DepositsAssets>
    <us-gaap:DepositsAssets contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">35000</us-gaap:DepositsAssets>
    <us-gaap:LongTermInvestmentsAndReceivablesNet contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">9000</us-gaap:LongTermInvestmentsAndReceivablesNet>
    <us-gaap:LongTermInvestmentsAndReceivablesNet contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">10000</us-gaap:LongTermInvestmentsAndReceivablesNet>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">236000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">94000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">839000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">850000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">16085000</us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties>
    <us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">16085000</us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties>
    <us-gaap:Assets contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">20930000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">22756000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">3491000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">817000</us-gaap:AccountsPayableCurrent>
    <niobf:DueToOfficersOrStockholdersOtherCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">2000000</niobf:DueToOfficersOrStockholdersOtherCurrent>
    <us-gaap:ConvertibleDebtCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">2169000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">71000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">82000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">3562000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">5068000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">10561000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">4989000</us-gaap:OtherLiabilitiesNoncurrent>
    <niobf:EarnoutLiabilityAtFairValue contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">10521000</niobf:EarnoutLiabilityAtFairValue>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">164000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">23000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">29797000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">5091000</us-gaap:Liabilities>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">2100000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30"
      decimals="INF"
      unitRef="USDPShares">0</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-06-30"
      decimals="INF"
      unitRef="USDPShares">0</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2023-06-30" decimals="INF" unitRef="Shares">31202131</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">27667060</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">140421000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">129055000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">-150477000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">-110397000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">-911000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">-993000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">-10967000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">17665000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">20930000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">22756000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">2323000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">2150000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">1655000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ProfessionalFees
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">2581000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">684000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">386000</us-gaap:ProfessionalFees>
    <niobf:ExplorationExpenditures
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">5348000</niobf:ExplorationExpenditures>
    <niobf:ExplorationExpenditures
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">3309000</niobf:ExplorationExpenditures>
    <niobf:ExplorationExpenditures
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">1056000</niobf:ExplorationExpenditures>
    <us-gaap:OtherGeneralExpense
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">27158000</us-gaap:OtherGeneralExpense>
    <us-gaap:OtherGeneralExpense
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">1653000</us-gaap:OtherGeneralExpense>
    <us-gaap:OtherGeneralExpense
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">995000</us-gaap:OtherGeneralExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">37410000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">7796000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">4092000</us-gaap:OperatingExpenses>
    <niobf:ChangeInFairValueOfEarnoutLiability
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">2674000</niobf:ChangeInFairValueOfEarnoutLiability>
    <niobf:ChangeInFairValueOfWarrantLiability
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-1414000</niobf:ChangeInFairValueOfWarrantLiability>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">1922000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">163000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:InterestExpense
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">2336000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">2827000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">1543000</us-gaap:InterestExpense>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-216000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-258000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">725000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:OtherIncome
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">13000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">208000</us-gaap:OtherIncome>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">32000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-1000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-6000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">9000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-40612000</niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1>
    <niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-10887000</niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1>
    <niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-4824000</niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-304000</us-gaap:IncomeTaxExpenseBenefit>
    <niobf:ProfitLoss1
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-40308000</niobf:ProfitLoss1>
    <niobf:ProfitLoss1
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-10887000</niobf:ProfitLoss1>
    <niobf:ProfitLoss1
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-4824000</niobf:ProfitLoss1>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">228000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-40080000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-10887000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-4824000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-40308000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-10887000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-4824000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-82000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-166000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">804000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-40226000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-10721000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-5628000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">228000</us-gaap:OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxParent
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-39998000</us-gaap:OciEquityMethodInvestmentBeforeTaxParent>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxParent
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-10721000</us-gaap:OciEquityMethodInvestmentBeforeTaxParent>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxParent
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-5628000</us-gaap:OciEquityMethodInvestmentBeforeTaxParent>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="USDPShares">1.34</niobf:EarningsLossPerShareBasicAndDiluted>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.41</niobf:EarningsLossPerShareBasicAndDiluted>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">0.20</niobf:EarningsLossPerShareBasicAndDiluted>
    <niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">28705840000</niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">26373722000</niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">24196711000</niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-40308000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-10887000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-4824000</us-gaap:NetIncomeLoss>
    <niobf:AssumptionOfEarnoutLiability
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">13195000</niobf:AssumptionOfEarnoutLiability>
    <niobf:ChangeInFairValueOfEarnoutShareLiability
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-2674000</niobf:ChangeInFairValueOfEarnoutShareLiability>
    <niobf:AssumptionOfPrivateAndPublicWarrants
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">2987000</niobf:AssumptionOfPrivateAndPublicWarrants>
    <us-gaap:AccretionExpense
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">2157000</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">2619000</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">1100000</us-gaap:AccretionExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">1794000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">1745000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">797000</us-gaap:ShareBasedCompensation>
    <niobf:LossesOnExtinguishmentOfDebt
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">1422000</niobf:LossesOnExtinguishmentOfDebt>
    <niobf:LossesOnExtinguishmentOfDebt
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">163000</niobf:LossesOnExtinguishmentOfDebt>
    <niobf:ChangeInValuationOfWarrantLiabilities
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">1414000</niobf:ChangeInValuationOfWarrantLiabilities>
    <niobf:FairValueOfCommitmentSharesIssued
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">663000</niobf:FairValueOfCommitmentSharesIssued>
    <niobf:ForeignCurrencyTransactionGainLossBeforeTax1
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">200000</niobf:ForeignCurrencyTransactionGainLossBeforeTax1>
    <niobf:ForeignCurrencyTransactionGainLossBeforeTax1
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">329000</niobf:ForeignCurrencyTransactionGainLossBeforeTax1>
    <niobf:ForeignCurrencyTransactionGainLossBeforeTax1
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-661000</niobf:ForeignCurrencyTransactionGainLossBeforeTax1>
    <us-gaap:Depreciation
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">3000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">3000</us-gaap:Depreciation>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-1000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-6000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">9000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-12000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-7000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">30000</us-gaap:OperatingLeaseImpairmentLoss>
    <niobf:OtheroperatingGainsLosses
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">13000</niobf:OtheroperatingGainsLosses>
    <niobf:OtheroperatingGainsLosses
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">196000</niobf:OtheroperatingGainsLosses>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">32000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-19171000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-6192000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-3632000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">985000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">377000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-9000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">2861000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">419000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-1103000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-17295000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-6150000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-4726000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMineralRights
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">5468000</us-gaap:PaymentsToAcquireMineralRights>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">16000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">837000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">21000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">21000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-16000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-6305000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">14857000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">9477000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">2499000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">4737000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">10677000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">1130000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">3130000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">318000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">1500000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">515000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">406000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">204000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">118000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">174000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">14637000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">4301000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">18074000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-302000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-172000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-33000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-2939000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-2037000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">7010000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">5280000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">7317000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2020-06-30" decimals="-3" unitRef="USD">307000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">2341000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">5280000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">7317000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">264000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">252000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">873000</us-gaap:InterestPaidNet>
    <niobf:ConversionsOfDebtForCommonShares contextRef="From2022-07-01to2023-06-30">5,175</niobf:ConversionsOfDebtForCommonShares>
    <niobf:ConversionsOfDebtForCommonShares contextRef="From2021-07-012022-06-30">8,807</niobf:ConversionsOfDebtForCommonShares>
    <niobf:ConversionsOfDebtForCommonShares contextRef="From2020-07-012021-06-30">3,106</niobf:ConversionsOfDebtForCommonShares>
    <niobf:RecognitionOfOperatingLeaseLiabilities contextRef="From2022-07-01to2023-06-30">199</niobf:RecognitionOfOperatingLeaseLiabilities>
    <niobf:RecognitionOfOperatingLeaseLiabilities contextRef="From2020-07-012021-06-30">231</niobf:RecognitionOfOperatingLeaseLiabilities>
    <niobf:DerecognitionOfOperatingLeaseLiabilities contextRef="From2020-07-012021-06-30">(22</niobf:DerecognitionOfOperatingLeaseLiabilities>
    <niobf:AccountsPayableToConvertibleDebtConversion contextRef="From2020-07-012021-06-30">1,640</niobf:AccountsPayableToConvertibleDebtConversion>
    <niobf:ValueOfWarrantsIssued contextRef="From2022-07-01to2023-06-30">3,337</niobf:ValueOfWarrantsIssued>
    <niobf:ValueOfWarrantsIssued contextRef="From2020-07-012021-06-30">1,795</niobf:ValueOfWarrantsIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">23592571</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">97682000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-94686000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-355000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-06-30" decimals="-3" unitRef="USD">2641000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <niobf:StockIssuedDuringPeriodSharesStockWarrantExercisedShares
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">910628</niobf:StockIssuedDuringPeriodSharesStockWarrantExercisedShares>
    <niobf:StockIssuedDuringPeriodSharesStockWarrantExercised
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">5338000</niobf:StockIssuedDuringPeriodSharesStockWarrantExercised>
    <niobf:StockIssuedDuringPeriodSharesStockWarrantExercised
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">5338000</niobf:StockIssuedDuringPeriodSharesStockWarrantExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">295229</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">215000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">215000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1795000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">1795000</us-gaap:FairValueAdjustmentOfWarrants>
    <niobf:PrivatePlacementSharesMay2021
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">433415</niobf:PrivatePlacementSharesMay2021>
    <niobf:PrivatePlacementValueMay2021
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">5124000</niobf:PrivatePlacementValueMay2021>
    <niobf:PrivatePlacementValueMay2021
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">5124000</niobf:PrivatePlacementValueMay2021>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">406151</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">3106000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">3106000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">-175000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-175000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">797000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">797000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-804000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-804000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-4824000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-4824000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">25637994</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">113882000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-99510000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-1159000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">13213000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <niobf:StockIssuedDuringPeriodSharesStockWarrantExercisedShares
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">87175</niobf:StockIssuedDuringPeriodSharesStockWarrantExercisedShares>
    <niobf:StockIssuedDuringPeriodSharesStockWarrantExercised
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">543000</niobf:StockIssuedDuringPeriodSharesStockWarrantExercised>
    <niobf:StockIssuedDuringPeriodSharesStockWarrantExercised
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">543000</niobf:StockIssuedDuringPeriodSharesStockWarrantExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">205153</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">483000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">483000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">14000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">14000</us-gaap:FairValueAdjustmentOfWarrants>
    <niobf:PrivatePlacementSharesMay2022Sahres
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">498103</niobf:PrivatePlacementSharesMay2022Sahres>
    <niobf:PrivatePlacementSharesMay2021
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">3711000</niobf:PrivatePlacementSharesMay2021>
    <niobf:PrivatePlacementSharesMay2021
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="Shares">3711000</niobf:PrivatePlacementSharesMay2021>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1238635</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">8807000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">8807000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">-130000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-130000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1745000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">1745000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-07-012022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">166000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">166000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-10887000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-10887000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">27667060</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">129055000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-110397000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-993000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">17665000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">265138</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">11000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">11000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">3338000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">3338000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <niobf:CommonSharesIssuedInTheGXIITransactionSahres
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1753821</niobf:CommonSharesIssuedInTheGXIITransactionSahres>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">81213</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">650000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">650000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">314465</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">2000000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">2000000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacilityShares
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">100000</niobf:SharesIssuedUnderTheYorkvilleEquityFacilityShares>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">501000</niobf:SharesIssuedUnderTheYorkvilleEquityFacility>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">501000</niobf:SharesIssuedUnderTheYorkvilleEquityFacility>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1020434</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">5604000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">5604000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">-204000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-204000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <niobf:RedeemableNoncontrollingInterest
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">-2328000</niobf:RedeemableNoncontrollingInterest>
    <niobf:RedeemableNoncontrollingInterest
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-2328000</niobf:RedeemableNoncontrollingInterest>
    <niobf:RedeemableNoncontrollingInterest
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">2328000</niobf:RedeemableNoncontrollingInterest>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1794000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">1794000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">82000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">82000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-40080000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-40080000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-228000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">31202131</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">140421000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-150477000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      unitRef="USD">-911000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">-10967000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">2100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NatureOfOperations contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_80F_eus-gaap--NatureOfOperations_zj6YcLTXPR5l" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_82D_zxkIhqU1ACo6" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;DESCRIPTION
OF BUSINESS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NioCorp
Developments Ltd. (the &#x201c;Company&#x201d; or &#x201c;NioCorp&#x201d;) was incorporated on February 27, 1987, under the laws of the Province of
British Columbia and currently operates in &lt;span id="xdx_901_eus-gaap--NumberOfReportableSegments_dxL_uNUMBER_c20220701__20230630_zifKldeWzKTc" title="Number of reportable segments::XDX::1"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0709"&gt;one&lt;/span&gt;&lt;/span&gt;
reportable operating segment consisting of exploration and development of mineral deposits in North America, specifically,
the Elk Creek Niobium/Scandium/Titanium property (the &#x201c;Elk Creek Project&#x201d;) located in southeastern
Nebraska.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
further discussed in Notes 5, 9, 10, and 11, on March 17, 2023 (the &#x201c;Closing Date&#x201d;), the Company closed the GXII Transaction
(as defined below) with GX Acquisition Corp. II (&#x201c;GXII&#x201d;), pursuant to the Business Combination Agreement, dated September
25, 2022 (the &#x201c;Business Combination Agreement&#x201d;), among the Company, GXII and Big Red Merger Sub Ltd (the &#x201c;Closing&#x201d;).
At the Closing, the Company also closed convertible debt financings (the &#x201c;Yorkville Convertible Debt Financing&#x201d;) with
YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (together with YA II PN, Ltd., &#x201c;Yorkville&#x201d;),
and the standby equity purchase facility with Yorkville (the &#x201c;Yorkville Equity Facility Financing&#x201d; and, together with
the Yorkville Convertible Debt Financing, the &#x201c;Yorkville Financings&#x201d;) became effective. The transactions contemplated
by the Business Combination Agreement, including the GXII Transaction, the Yorkville Financings and the Reverse Stock Split (as
defined below), are referred to, collectively, as the &#x201c;Transactions.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
GXII Transaction is being accounted for as an equity raise transaction in accordance with generally accepted accounting principles
of the United States of America (&#x201c;U.S. GAAP&#x201d;). Under this method of accounting, GXII is treated as the &#x201c;acquired&#x201d;
company for financial reporting purposes. Accordingly, the GXII Transaction is treated as the equivalent of NioCorp issuing common
shares, no par value, of the Company (&#x201c;Common Shares&#x201d;) for the assets and liabilities of GXII. The net assets of GXII
are stated at historical cost, with no goodwill or other intangible assets recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
consolidated financial statements have been prepared on a going concern basis that contemplates the realization of assets and
discharge of liabilities at their carrying values in the normal course of business for the foreseeable future. These consolidated
financial statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company currently earns no operating revenues and will require additional capital in order to advance the Elk Creek Project to
construction and commercial operation. As further discussed in Note 4, these matters raised substantial doubt about the Company&#x2019;s
ability to continue as a going concern, and the Company is dependent upon the generation of profits from mineral properties, obtaining
additional financing and maintaining continued support from its shareholders and creditors.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NatureOfOperations>
    <us-gaap:BasisOfAccounting contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_80A_eus-gaap--BasisOfAccounting_zQYcL4w1vx82" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82E_zIsB8ZEsQrHd"&gt;BASIS
                                         OF PREPARATION&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basis
                                         of Preparation and Consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
consolidated financial statements have been prepared in conformity with U.S. GAAP and the rules and regulations of the U.S.
Securities and Exchange Commission. The consolidated financial statements include the consolidated accounts of the Company
and its wholly owned subsidiaries with all significant intercompany transactions eliminated. Certain transactions include
reference to Canadian dollars (&#x201c;C$&#x201d;) where applicable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;

&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&#160;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zj4H0tKNxq02" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All
intercompany transactions and balances have been eliminated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span&gt;&lt;span id="xdx_8B6_zfL7KyGUoM14" style="display: none; visibility: hidden"&gt;Schedule of intercompany transactions and balances&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td rowspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Jurisdiction
    of incorporation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ownership
    at June 30,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 41%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0896800
    BC Ltd. (&#x201c;0896800&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zQmMSWJijxzi" title="Country of incorporation"&gt;&lt;span id="xdx_908_ecustom--IncorporationStateCountryName_c20210701__20220630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zGlmuRZxB341" title="Country of incorporation"&gt;British
    Columbia, Canada&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zzbIweDCVVoa" style="font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Percentage of ownership"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100%&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zzc9JvGhtq87" style="font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Percentage of ownership"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 0.375in; text-align: justify; text-indent: -23.4pt; width: 41%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Elk
    Creek Resources Corp.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 25%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zksiovUNC0i9" title="Country of incorporation"&gt;&lt;span id="xdx_906_ecustom--IncorporationStateCountryName_c20210701__20220630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zkUMxkHVlFL6" title="Country of incorporation"&gt;Nebraska,
    USA&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 17%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 17%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_ziAzFfl1yeQ9" title="Percentage of ownership"&gt;100&lt;/span&gt;%
    by 0896800&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Elk
    Creek Resources Corp. (&#x201c;ECRC&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zZnDPIi8PWTd" title="Country of incorporation"&gt;&lt;span id="xdx_905_ecustom--IncorporationStateCountryName_c20210701__20220630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zJpRKSrWeSmk" title="Country of incorporation"&gt;Delaware,
    USA&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zwP0I9QOW6dl" title="Percentage of ownership"&gt;100&lt;/span&gt;%
    of the Class A common stock by 0896800&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Use
                                         of Estimates&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date
of the consolidated financial statements, and the reported amounts of expenses during the reporting period. The Company regularly
evaluates estimates and assumptions related to the deferred income tax asset valuations, convertible debt valuations, earnout
valuation, warrant liabilities, and share-based compensation. The Company bases its estimates and assumptions on current facts,
historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which
form the basis for making judgments about the other sources. The actual results experienced by the Company may differ materially
and adversely from the Company&#x2019;s estimates. To the extent there are material differences between estimates and the actual
results, future results of operations will be affected.&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccounting>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_895_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zj4H0tKNxq02" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All
intercompany transactions and balances have been eliminated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span&gt;&lt;span id="xdx_8B6_zfL7KyGUoM14" style="display: none; visibility: hidden"&gt;Schedule of intercompany transactions and balances&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td rowspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Jurisdiction
    of incorporation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ownership
    at June 30,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 41%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0896800
    BC Ltd. (&#x201c;0896800&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zQmMSWJijxzi" title="Country of incorporation"&gt;&lt;span id="xdx_908_ecustom--IncorporationStateCountryName_c20210701__20220630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zGlmuRZxB341" title="Country of incorporation"&gt;British
    Columbia, Canada&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zzbIweDCVVoa" style="font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Percentage of ownership"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100%&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zzc9JvGhtq87" style="font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Percentage of ownership"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 0.375in; text-align: justify; text-indent: -23.4pt; width: 41%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Elk
    Creek Resources Corp.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 25%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zksiovUNC0i9" title="Country of incorporation"&gt;&lt;span id="xdx_906_ecustom--IncorporationStateCountryName_c20210701__20220630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_zkUMxkHVlFL6" title="Country of incorporation"&gt;Nebraska,
    USA&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 17%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 17%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpMember_ziAzFfl1yeQ9" title="Percentage of ownership"&gt;100&lt;/span&gt;%
    by 0896800&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Elk
    Creek Resources Corp. (&#x201c;ECRC&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--IncorporationStateCountryName_c20220701__20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zZnDPIi8PWTd" title="Country of incorporation"&gt;&lt;span id="xdx_905_ecustom--IncorporationStateCountryName_c20210701__20220630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zJpRKSrWeSmk" title="Country of incorporation"&gt;Delaware,
    USA&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_zwP0I9QOW6dl" title="Percentage of ownership"&gt;100&lt;/span&gt;%
    of the Class A common stock by 0896800&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Use
                                         of Estimates&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date
of the consolidated financial statements, and the reported amounts of expenses during the reporting period. The Company regularly
evaluates estimates and assumptions related to the deferred income tax asset valuations, convertible debt valuations, earnout
valuation, warrant liabilities, and share-based compensation. The Company bases its estimates and assumptions on current facts,
historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which
form the basis for making judgments about the other sources. The actual results experienced by the Company may differ materially
and adversely from the Company&#x2019;s estimates. To the extent there are material differences between estimates and the actual
results, future results of operations will be affected.&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock>
    <niobf:IncorporationStateCountryName contextRef="From2022-07-012023-06-30_custom_Entity0896800BCLtdMember">British
    Columbia, Canada</niobf:IncorporationStateCountryName>
    <niobf:IncorporationStateCountryName contextRef="From2021-07-012022-06-30_custom_Entity0896800BCLtdMember">British
    Columbia, Canada</niobf:IncorporationStateCountryName>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2023-06-30_custom_Entity0896800BCLtdMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2022-06-30_custom_Entity0896800BCLtdMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <niobf:IncorporationStateCountryName contextRef="From2022-07-012023-06-30_custom_ElkCreekResourcesCorpMember">Nebraska,
    USA</niobf:IncorporationStateCountryName>
    <niobf:IncorporationStateCountryName contextRef="From2021-07-012022-06-30_custom_ElkCreekResourcesCorpMember">Nebraska,
    USA</niobf:IncorporationStateCountryName>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2022-06-30_custom_ElkCreekResourcesCorpMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <niobf:IncorporationStateCountryName contextRef="From2022-07-012023-06-30_custom_ElkCreekResourcesCorpECRCMember">Delaware,
    USA</niobf:IncorporationStateCountryName>
    <niobf:IncorporationStateCountryName contextRef="From2021-07-012022-06-30_custom_ElkCreekResourcesCorpECRCMember">Delaware,
    USA</niobf:IncorporationStateCountryName>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2023-06-30_custom_ElkCreekResourcesCorpECRCMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zM2IirnOe0q6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82A_zr2FdprICqU9"&gt;SIGNIFICANT
ACCOUNTING POLICIES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_ecustom--DevelopmentStageIssuerPolicyTextBlock_zJkX4dox3P5g" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_865_zXtCthRZkGJj"&gt;Development
                                         Stage Issuer&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is considered to be a development stage issuer under Subpart 1300 of Regulation S-K of the United States Securities Act
of 1933, as amended (&#x201c;S-K 1300&#x201d;), and it devotes substantially all of its efforts to acquiring and exploring mining
interests that management believes should eventually provide sufficient net profits to sustain the Company&#x2019;s existence.
Until such interests are engaged in commercial production, the Company will continue to seek additional funding to support the
completion of its exploration and development activities. The Company&#x2019;s activities are subject to significant risks and
uncertainties, including its ability to secure sufficient funding to continue operations, to obtain proven and probable reserves,
to comply with industry regulations and obtain permits necessary for development of the Elk Creek Project, as well as environmental
risks and market conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_857_zDiwTHECGg9k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zXhSCc1lPCQ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86B_zlpJd7WiSBI5"&gt;Cash
                                         and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents include cash on hand, cash in banks, investments in certificates of deposit with original maturities of
90 days or less, and money market funds. The Company maintains the majority of its cash balances with two financial
institutions. Accounts at banks in the United States (&#x201c;U.S.&#x201d;) are insured by the Federal Deposit Insurance
Corporation (&#x201c;FDIC&#x201d;) up to $250, while accounts at banks in Canada are insured by the Canada Deposit Insurance
Corporation (&#x201c;CDIC&#x201d;) up to C$100. At June 30, 2023 and 2022, the Company had $1,717 and $4,721 in excess of the
FDIC and CDIC insured limits, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85B_zXYY55lo4azj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zJOG3sB3cbde" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_867_zp6NhYawEyQc"&gt;Foreign
                                         Currency Translation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Functional
and reporting currency&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Items
included in the financial statements of each of the Company&#x2019;s entities are measured using the currency of the primary economic
environment in which the entity operates (&#x201c;the functional currency&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
reporting currency for these consolidated financial statements is U.S. dollars.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Change
in functional currency&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to March 17, 2023, the Company&#x2019;s functional currency was the Canadian dollar. The Company re-assessed its functional
currency and determined that on March 17, 2023, its functional currency changed from the Canadian dollar to the U.S. dollar
based on significant changes in economic facts and circumstances in our organization. The change in functional currency was
accounted for prospectively from March 17, 2023 and prior-period consolidated&#160;financial statements were not restated for
the change in functional currency.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;

&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
both monetary and non-monetary assets and liabilities, translated balances as of March 17, 2023 became the new accounting basis.
The exchange rate on the date of change became the historical rate at which non-monetary assets and liabilities were translated
in subsequent periods. There was no effect on the cumulative translation adjustment on the consolidated basis. Previously recorded
cumulative translation adjustments were not reversed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
functional currency for the Company&#x2019;s Canadian subsidiary, 0896800 BC Ltd., which has no independent operations from its
parent, also changed from the Canadian dollar to the U.S. dollar. The functional currency for Elk Creek Resources Corp. remains
as the U.S. dollar.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Transactions
in foreign currency&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transactions
made in a currency other than the functional currency are remeasured to the functional currency at exchange rates at the dates
of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are remeasured to
the functional currency at the exchange rate at that date and non-monetary assets and liabilities are remeasured at historical
rates. Foreign currency translation gains and losses are included in profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Translation
to reporting currency&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Translation
gains and losses from the application of the U.S. dollar as the reporting currency for all periods prior to March 17, 2023 (when
the Canadian dollar was the functional currency) are included as part of cumulative currency translation adjustment, which is
reported as a component of shareholders&#x2019; equity under accumulated other comprehensive loss.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_851_z4CznbSjJtAl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--MineralPropertiesPolicyTextBlock_zn9ko4vXxy8j" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86F_z9HsYAkJsLj5"&gt;Mineral
                                         Properties&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mineral
property acquisition costs, including indirectly related acquisition costs, are capitalized when incurred. Acquisition costs include
cash consideration and the fair market value of Common Shares issued as consideration. Properties acquired under option agreements,
whereby payments are made at the sole discretion of the Company, are capitalized as mineral property acquisition costs at such
time as the payments are made. Exploration costs are expensed as incurred. When it is determined that a mining deposit can be
economically and legally extracted or produced based on established proven and probable reserves under S-K 1300, and the Board
of Directors has approved the commencement of formal development activities, development costs related to such reserves and incurred
after such board approval will be considered for capitalization. The establishment of proven and probable reserves is based on
results of feasibility studies, which indicate whether a property is economically feasible. Upon commencement of commercial production,
capitalized costs will be amortized over their estimated useful lives or units of production, whichever is a more reliable measure.
Capitalized amounts relating to a property that is abandoned or otherwise considered uneconomic for the foreseeable future are
written off.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#x2019;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. This would include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Such evaluations compare estimated future net cash flows with our carrying costs and future obligations on an undiscounted
basis. If it is determined that the estimated future undiscounted cash flows are less than the carrying value of the property,
an impairment loss will be recorded. Where estimates of future net cash flows are not determinable and where other conditions
indicate the potential for impairment, management uses available market information and/or third-party valuation experts to assess
if the carrying value can be recovered and to estimate fair value. There was no impairment recorded to mineral properties as of
June 30, 2023 or 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85E_zQgYBvzmKOg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zZSrZEJUreb3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;e)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_862_zUmviM3xRkyh"&gt;Long
                                         Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-lived
assets, other than mineral properties, held and used by the Company are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;









&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For purposes of evaluating the recoverability
of long-lived assets, the recoverability test is performed using undiscounted net cash flows related to the long-lived assets.
If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount
of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount
or fair value less costs to sell. There was no impairment recorded to long-lived assets as of June 30, 2023 or 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_858_zh7qSQAu7Gy7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--LesseeLeasesPolicyTextBlock_zKbLNiM7xQV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;f)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_zlAhXUXUovFl"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
Accounting Standards Codification (&#x201c;ASC&#x201d;) 842, &#x201c;Leases,&#x201d; we determine if a contractual arrangement is,
or contains, a lease at the inception date. Right-of-use (&#x201c;ROU&#x201d;) assets and liabilities related to operating leases
are separately reported in the consolidated balance sheets. The Company currently has no finance leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ROU
assets and lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments
over the lease term. When the rate implicit to the lease cannot be readily determined, we utilize our incremental borrowing rate
in determining the present value of the future lease payments. The incremental borrowing rate is derived from information available
at the lease commencement date and represents the rate of interest that a lessee would have to pay to borrow an amount equal to
the lease payments on a collateralized basis over a similar term in a similar economic environment. Operating lease ROU assets
also include any cumulative prepaid or accrued rent when the lease payments are uneven throughout the lease term. The ROU assets
and lease liabilities may include options to extend or terminate the lease when it is reasonably certain that we will exercise
that option.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term.
For operating leases, interest on the lease liability and the amortization of the ROU asset result in straight-line rent expense
over the lease term. Variable lease expenses are recorded when incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_859_zoEY2MYRHgej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_ecustom--WarrantsPolicyTextBlock_zmOdMLKAZMp9" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;g)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_862_zkn0gfB4mzZ1"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
apply relevant accounting guidance for warrants to purchase our stock based on the nature of the relationship with the counterparty.
For warrants issued to investors or lenders in exchange for cash or other financial assets, we follow guidance issued within ASC
480, Distinguishing Liabilities from Equity, and ASC Topic 815, Derivatives and Hedging, (&#x201c;ASC 815&#x201d;) to assist in
the determination of whether the warrants should be classified as liabilities or equity. The fair value of warrants is estimated
using Black Scholes modeling or Monte Carlo modeling, depending on the settlement features embedded in the warrant. Inputs under
both models include inputs such as NioCorp&#x2019;s Common Share price, the risk-free interest rate, the expected term, the volatility,
and the dividend rate. Warrants that are determined to require liability classifications are measured at fair value upon issuance
and are subsequently remeasured to their then fair value at each subsequent reporting period with changes in fair value recorded
in current earnings. Warrants that are determined to require equity classifications measured at fair value upon issuance and are
not subsequently remeasured unless they are required to be reclassified.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_850_za5TRCyDd00d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_ecustom--EarnoutSharesPolicy_zPrxAclSfbdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;h)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86D_zFYPbuZ31El8"&gt;Earnout
                                         Shares&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
Shares are classified as a liability due to failure to meet the equity classification criteria under ASC 815-40. The fair value
of the Earnout Shares on the date of issuance and on each measurement date is estimated using a Monte Carlo simulation methodology,
which includes inputs such as NioCorp&#x2019;s Common Share price, the risk-free interest rate, the expected term, the implied
volatility underlying the Company&#x2019;s Public Warrants, the dividend rate, the conversion price, and the number of Earnout
Shares outstanding. Assumptions used in the model are subjective and require significant judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85A_zenYl1Yxqa0g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zDNoDDX3pPY3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_865_z6xtqDIfxqBa"&gt;Financial
                                         Instruments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments consist of cash and cash equivalents, receivables, equity securities, accounts payable and accrued liabilities,
convertible debt and the related party loan. It is management&#x2019;s opinion that the Company is not exposed to significant interest,
currency or credit risks arising from its financial instruments. The fair values of these instruments approximate their carrying
value unless otherwise noted.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_854_zKAO7T0sPzMl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_z4EOR7m4rotd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;j)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86D_zoVOqAKsMn4c"&gt;Concentration
                                         of Credit Risk&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial instrument which potentially subjects the Company to credit risk is cash and cash equivalents, The Company holds investments
or maintains available cash primarily in two commercial banks located in Vancouver,&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;

&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;British Columbia and Santa Clara, California.
As part of its cash management process, the Company regularly monitors the relative credit standing of these institutions.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85A_zJbfMUFd4UO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--AssetRetirementObligationsPolicy_z6U1pWuF73F1" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;k)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_860_zzlbXqlYuAfa"&gt;Asset
                                         Retirement Obligation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is subject to various government laws and regulations relating to environmental disturbances caused by exploration and
evaluation activities. The estimated costs associated with environmental remediation obligations are accrued in the period in
which the liability is incurred if it is reasonably estimable or known. Until such time that a project life is established, the
Company records the corresponding cost as an exploration stage expense and has accrued $&lt;span id="xdx_90F_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20230630_zC6yQ1gF29bg"&gt;48&lt;/span&gt; as an accrued liability related to
estimated obligations as of June 30, 2023 (2022 - $&lt;span id="xdx_90D_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20220630_zWKK5mFe9WG6" title="Accrued exploration stage expense"&gt;48&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
reclamation and environmental-related expenditures are difficult to estimate in many circumstances due to the early-stage nature
of the Elk Creek Project, the uncertainties associated with defining the nature and extent of environmental disturbance, the application
of laws and regulations by regulatory authorities and changes in reclamation or remediation technology. The Company periodically
reviews accrued liabilities for such reclamation and remediation costs as evidence indicating that the liabilities have potentially
changed becomes available. Changes in estimates are reflected in the consolidated statement of operations and comprehensive loss in the period an estimate
is revised.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85D_zjpSh9UxA557" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_z8tYU1sa8Ao3" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;l)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_zs9Rb7gXjoDb"&gt;Income
                                         Taxes&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25, &lt;i&gt;&#x201c;Income Taxes &#x2013; Recognition.&#x201d;
&lt;/i&gt;Under the approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between
the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded
against deferred tax assets if management does not believe the Company has met the &#x201c;more likely than not&#x201d; standard
imposed by ASC 740-10-25-5 to allow recognition of such an asset. ASC 740-10-50, &#x201c;Income Taxes &#x2013; Disclosure,&#x201d;
requires the Company to evaluate its income tax positions and recognize a liability for uncertain tax positions that are not more
likely than not to be sustained by tax authorities. As of June 30, 2023 and 2022, the Company believes it had no income tax uncertainties
that required recognition of a liability. If the Company were to determine that uncertain tax positions meet the criteria for
recognition, an estimated liability and related interest and penalties would be recognized as income tax expense.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85D_zA6GfYTmwOX7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--ReverseStockSplitPolicyTextBlock_zo8YIoczuktl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;m)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Reverse
                                         Stock Split&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 17, 2023, the Company effected a reverse stock split (the &#x201c;Reverse Stock Split&#x201d;) on the basis of one (1) post-Reverse
Stock Split Common Share for every ten (10) pre-Reverse Stock Split Common Shares issued and outstanding, with any fractional
shares resulting from the Reverse Stock Split rounded down to the nearest whole share. Immediately after the Reverse Stock Split,
there were 30,000,442 Common Shares issued and outstanding. All references to share and per share amounts (excluding authorized
shares) in the consolidated financial statements and accompanying notes have been retroactively restated to reflect the Reverse
Stock Split.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85C_zQKjGhvx2ZM6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_ecustom--RedeemableNoncontrollingInterestPolicyTextBlock_zVio3UOUdE0a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;n)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_860_z07Nhe4mLBwg"&gt;Redeemable
                                         Noncontrolling Interest&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable
Noncontrolling Interest refers to non-controlling interest associated with the Vested Shares that are redeemable upon the occurrence
of an event that is not solely within the Company&#x2019;s control and is reported in the mezzanine section between total liabilities
and shareholders&#x2019; deficit, as temporary equity in the Company&#x2019;s consolidated balance sheets. The
Company&#x2019;s non-controlling interest is redeemable at fair value, and no adjustment to the earnings per share numerator is
required because redemption at fair value is not considered an economic distribution different from other common stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85D_zhuVaHmjQsy9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_z4hs6MtuRSEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;o)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_860_zHyNOqAYJzI7"&gt;Basic
                                         and Diluted Per Share Disclosure&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted
average number of Common Shares outstanding during the period. The Company considers Vested Shares and Released Earnout
Shares (each as defined in Note 10), to be participating securities, requiring the use of the two-class method. Diluted
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted average
number of Common Shares outstanding, inclusive of the dilutive impact of all potentially dilutive securities outstanding
during the period, as applicable.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;









&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;





&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;


&lt;p id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z3eruOf1JU9c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. &lt;span id="xdx_8B3_zJC6A6vaTFb8"&gt;The following table sets forth the computation of the Company&#x2019;s basic and diluted net loss per share
attributable to common shareholders:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; background-color: #CCECFF; border-collapse: collapse; margin-left: 0.5in"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="9" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the year ended June 30,&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 56%; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    loss&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20220701__20230630_zFQp4ku0flCa" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,308&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210701__20220630_zIXhZ86d9w65" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,887&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200701__20210630_zssQC8D0iE53" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,824&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Adjust:
    Net loss attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20220701__20230630_zqqNk02gopR" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::228"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0809"&gt;(251&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20210701__20220630_zOyu0YxBliY6" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0811"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20200701__20210630_zpWSiN86lFEa" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0813"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    loss available to participating securities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220701__20230630_zV3gNqOmuwTk" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,057&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20210701__20220630_z9QdtQfKZAgc" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,887&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20200701__20210630_zv0dpzPPfiY4" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,824&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    loss attributable to Vested Shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zVLWsnQRhg6j" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,528&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20210701__20220630_z1MBIpPDBSq9" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0823"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20200701__20210630_z2nWNLQPzUU7" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0825"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 9pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
loss attributed to common shareholders - basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20220701__20230630_z0QxpAAuKBXh" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;38,529&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20210701__20220630_zUGKlTW6sQ8f" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,887&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20200701__20210630_zwZFR6TLoOK5" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,824&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    average shares outstanding &#x2013; basic and diluted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20220701__20230630_zlRgKsVPLbg2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;28,705,840&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20210701__20220630_zRsagfqjhAD7" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,373,722&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20200701__20210630_zVMUUNLt4TNl" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,196,711&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
    per Common Share outstanding &#x2013; basic and diluted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230630_z8PCNjjBnWE1" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.34&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20210701__20220630_zlMXAuzupyke" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$0.41&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20200701__20210630_zJ5yF0jIKA72" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$0.20&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A5_zDSzIPfVq1a4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The following shares underlying options, warrants, and outstanding convertible debt were antidilutive
due to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation for the years
ended June 30, 2023 and 2022, as indicated below.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zOn3rNY06DWi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BA_zc72BNzqWaDh" style="display: none; visibility: hidden"&gt;Schedule of excluded from the dilutive securities&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 89%; border-collapse: collapse; margin-left: 0.75in"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 61%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Excluded
    potentially dilutive securities &lt;sup id="xdx_F6B_zlpIL2QeXlS8"&gt;(1)(2)&lt;/sup&gt;:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 11%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Options
&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20230630_fKDEpKDIp_zTxQsQUt6vCi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,541,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20210701__20220630_fKDEpKDIp_zJ8w8jErmrs" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,446,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20200701__20210630_fKDEpKDIp_zkjNk0oBemyg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,596,500&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20230630_fKDEpKDIp_zrQbk9S4UKg5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,816,304&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20210701__20220630_fKDEpKDIp_zDcNxKNdVr4a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,851,622&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20200701__20210630_fKDEpKDIp_z0sNl7vkl4B1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,434,186&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Convertible
debt&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20230630_fKDEpKDIp_z7mNylIwkLa2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,871,660&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20210701__20220630_fKDEpKDIp_zahcAL52BKfa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;415,200&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20200701__20210630_fKDEpKDIp_zgqIxU0aSyua" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,455,700&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    potentially dilutive securities &lt;sup&gt;&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--DilutiveSecurities_c20220701__20230630_fKDEpKDIp_zJ5fgeJjdrLe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23,229,464&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--DilutiveSecurities_c20210701__20220630_fKDEpKDIp_z1DA4k0owKD9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,713,222&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DilutiveSecurities_c20200701__20210630_fKDEpKDIp_zC4ZPsqKRXjg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,486,386&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span id="xdx_F0C_z8MpdCdTVJXl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1A_zvlOvhPMsqK8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span id="xdx_F06_zEo1LnpKZiee" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_zjFm1EndTiW7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AE_zQYsB0CM1Ksf" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;p id="xdx_850_zRMQRCxOQud8" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zXWOk6GWM1Kl" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;p)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_860_zPYfP5GRiaW3"&gt;Share
                                         Based Compensation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company grants stock options to directors, officers, employees, and business advisors. Option terms and vesting conditions
are at the discretion of the Board of Directors. Prior to March 21, 2023, the option exercise price was equal to the closing
market price on The Toronto Stock Exchange (the &#x201c;TSX&#x201d;) on the day preceding the date of grant. Effective March
21, 2023, the option exercise price is equal to the closing market price on the Nasdaq Stock Market LLC
(&#x201c;Nasdaq&#x201d;) on the day preceding the date of the grant.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company estimates the fair value of stock options using the Black-Scholes option pricing model. The Company recognizes forfeitures
as they occur.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85F_zCFoHEFpDF1g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z9lxU8GlAWhd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;q)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_864_zhBbIkyvNjb3"&gt;Recent
                                         Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Issued
and Adopted&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August 2020, the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;)
No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s
Own Equity (Subtopic 815-40) (&#x201c;ASU 2020-06&#x201d;), which simplifies the accounting for convertible instruments. ASU 2020-06
removes certain accounting models which separate the embedded conversion features from the host contract for convertible instruments.
Either a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption
of this standard. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within
those fiscal&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;









&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;years. The Company adopted ASU 2020-06 on July 1, 2022, with no material effect on the Company&#x2019;s current financial
position, results of operations or financial statement disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Issued
and Not Effective&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective
date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a
material impact on the Company&#x2019;s consolidated financial statements upon adoption.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_855_zPyBX9MDZqb1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zp4sRsVfdp0h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;r)&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span id="xdx_86D_zfPv1ZxtiDKj"&gt;Revision of Financial Statements (Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;During the
fourth quarter of fiscal year 2023, the Company determined that it had used an incorrect strike price while valuing the Private
Warrants (as defined below in Note 11c) at both the March 17, 2023, issuance date and as of March 31, 2023. This resulted in an
overstatement of other operating expenses, at fair value, and an understatement of change in fair value of warrant liabilities
in condensed consolidated statement of operations and comprehensive loss for both the three- and nine-month periods ended March
31, 2023. In addition, warrant liabilities, at fair value and accumulated deficit were overstated and understated, respectively,
as of March 31, 2023. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;The Company determined that
these errors were immaterial to the previously issued consolidated financial statements, and as such no restatement was necessary.
Periods not presented herein will be revised, as applicable, in future filings.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;The effects
of the revision on the previously issued consolidated financial statements are as follows:&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_896_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zhsVYVtVC4s6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Revision Impacts to the Condensed Consolidated
Balance Sheet (unaudited)&lt;/b&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;As of March 31, 2023&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BB_zqPDmNb9cDEc" style="display: none; visibility: hidden"&gt;Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As
of March 31, 2023&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zelflEE9IMBf" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zWaKgukSfI9" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230331_zY93igpGJPta" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;As Previously&lt;br/&gt; Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revision&lt;br/&gt; Impacts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revised&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--OtherLiabilitiesNoncurrent_iI_pn3n3_zqax1sPZZ8hd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; padding-left: 5.4pt"&gt;Warrant liabilities, at fair value&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;5,303&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(665&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;4,638&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Total liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Liabilities_iI_pn3n3_c20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zRJ4DvEAlRkk" style="text-align: right" title="Total liabilities"&gt;34,735&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Liabilities_iNI_pn3n3_di_c20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zCy0TdbKQsH" style="text-align: right" title="Total liabilities"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Liabilities_iI_pn3n3_c20230331_zxCnuRnyJIEi" style="text-align: right" title="Total liabilities"&gt;34,070&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pn3n3_z1kI0YlWdhE3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Accumulated deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(146,046&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;665&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(145,381&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--StockholdersEquity_iI_pn3n3_zEeGmVLayfV2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Total shareholders&#x2019; deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,512&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;665&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,847&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A2_zXr0M4XmAGXb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&lt;/p&gt;

&lt;p id="xdx_89B_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zf4thyh0OZk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Revision Impacts to the Condensed Consolidated
Statement of Operations and Comprehensive Loss (unaudited)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;For the Three Months Ended March 31,
2023&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&lt;span id="xdx_8B8_zwMYtoPoRhJ1" style="display: none; visibility: hidden"&gt;Revision Impacts to
                                            the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For
                                            the Three &amp;amp; Nine Months Ended  March 31,
2023&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;As Previously&lt;br/&gt;
 Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revision&lt;br/&gt;
 Impacts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revised&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; padding-left: 5.4pt"&gt;Other operating expense&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OtherGeneralExpense_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zgQOUnHXWm68" style="width: 12%; text-align: right" title="Other operating expense"&gt;26,220&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OtherGeneralExpense_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpLsguPTVOxc" style="width: 12%; text-align: right" title="Other operating expense"&gt;(861&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherGeneralExpense_pn3n3_c20230101__20230331_zasjIfkHG88d" style="width: 12%; text-align: right" title="Other operating expense"&gt;25,359&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Total operating expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zMubrwz0kZt3" style="text-align: right" title="Total operating expenses"&gt;29,192&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zH8djFst0Oeh" style="text-align: right" title="Total operating expenses"&gt;(861&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331_zXe8FrzG6AT7" style="text-align: right" title="Total operating expenses"&gt;28,331&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Change in fair value of warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKTc1llfKIEk" style="text-align: right" title="Change in fair value of warrant liability"&gt;784&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zKLUQIW7L7g4" style="text-align: right" title="Change in fair value of warrant liability"&gt;196&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331_zBKidsx6iaqj" style="text-align: right" title="Change in fair value of warrant liability"&gt;980&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Loss before income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zkop0E3nssMi" style="text-align: right" title="Loss before income taxes"&gt;29,621&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zefaGBWcanv1" style="text-align: right" title="Loss before income taxes"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_dxL_c20230101__20230331_zTUVmm3EVvbc" style="text-align: right" title="Loss before income taxes::XDX::-3877"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0929"&gt;28,956&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Net loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zDEONR6tVaG5" style="text-align: right" title="Net loss"&gt;29,435&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zTzxnU9qsx3d" style="text-align: right" title="Net loss"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331_zTXUUlkWJVU3" style="text-align: right" title="Net loss"&gt;28,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Net loss attributable to the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ProfitLoss1_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zzG310e4baTk" style="text-align: right" title="Net loss attributable to the company"&gt;29,343&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ProfitLoss1_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zTNbjnxJqVt6" style="text-align: right" title="Net loss attributable to the company"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ProfitLoss1_pn3n3_c20230101__20230331_zGms76QML6g2" style="text-align: right" title="Net loss attributable to the company"&gt;28,678&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Total comprehensive loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zCkWs19aZdeh" style="text-align: right" title="Total comprehensive loss"&gt;29,323&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zPIBX74Xw4Z1" style="text-align: right" title="Total comprehensive loss"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331_z9Alax3TgdJ2" style="text-align: right" title="Total comprehensive loss"&gt;28,658&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Comprehensive loss attributable to the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zyDqlX3Y74x6" style="text-align: right" title="Comprehensive loss attributable to the company"&gt;29,231&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zG6JE1rlwC6a" style="text-align: right" title="Comprehensive loss attributable to the company"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331_z2L0neTwcTSc" style="text-align: right" title="Comprehensive loss attributable to the company"&gt;28,566&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Loss per common share, basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNILCmuSVGma" style="text-align: right" title="Loss per common share, basic and diluted"&gt;1.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zlpch4MOAPo4" style="text-align: right" title="Loss per common share, basic and diluted"&gt;(0.02&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331_z1FzQUrq6b97" style="text-align: right" title="Loss per common share, basic and diluted"&gt;0.98&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&#160;&lt;/p&gt;




&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;









&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Revision Impacts to the Condensed Consolidated
Statement of Operations and Comprehensive Loss (unaudited)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;For the Nine Months Ended March 31,
2023&#160; &#160; &#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 55%; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;As
    Previously&lt;br/&gt;
 Reported&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Revision&lt;br/&gt;

    Impacts&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Revised&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Other operating expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--OtherGeneralExpense_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYqCHLJxMxO9" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"&gt;&lt;span style="font-size: 10pt"&gt;26,888&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--OtherGeneralExpense_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_z9N7AAiEK2a2" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"&gt;&lt;span style="font-size: 10pt"&gt;(861&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--OtherGeneralExpense_pn3n3_c20220701__20230331_zKeufiUYm8qe" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"&gt;&lt;span style="font-size: 10pt"&gt;26,027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zPqhiQylMFh6" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"&gt;&lt;span style="font-size: 10pt"&gt;33,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zOnwEy7ElEg" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"&gt;&lt;span style="font-size: 10pt"&gt;(861&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331_z3rjgMQXLo2c" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"&gt;&lt;span style="font-size: 10pt"&gt;32,614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Change in fair value of warrant liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zGRArvNXlvyg" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"&gt;&lt;span style="font-size: 10pt"&gt;868&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_ze6iLON1bLq2" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"&gt;&lt;span style="font-size: 10pt"&gt;196&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331_zuXbyNA31H96" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"&gt;&lt;span style="font-size: 10pt"&gt;1,064&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYWQlY66Wnz5" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes"&gt;&lt;span style="font-size: 10pt"&gt;35,927&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpRhxZjqEyEd" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes"&gt;&lt;span style="font-size: 10pt"&gt;(665&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_dxL_c20220701__20230331_zWnUuOx7nh73" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes::XDX::-3877"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0988"&gt;35,262&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Net loss&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9qjusG3RCWk" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::-35741"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0990"&gt;35,741&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zmIztkbqaAhc" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::665"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0992"&gt;(665&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331_z4nx268bQSIk" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::-35076"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0994"&gt;35,076&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Net loss attributable to the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ProfitLoss1_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zm2e8LNnCqnj" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;35,649&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ProfitLoss1_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zYuXfcMAfHIc" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;(665&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ProfitLoss1_pn3n3_c20220701__20230331_z9sJmKZ4oxMk" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;34,984&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Total comprehensive loss&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKA82dNJQKfk" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"&gt;&lt;span style="font-size: 10pt"&gt;35,659&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZ5L3oKr2MW1" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"&gt;&lt;span style="font-size: 10pt"&gt;(665&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331_zcGBegKbF1yh" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"&gt;&lt;span style="font-size: 10pt"&gt;34,994&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Comprehensive loss attributable to the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_ze5Cyg3e3j4k" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;35,567&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zlDk0KhpPKR" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;(665&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331_zbMZnDl5gef2" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;34,902&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Loss per common share, basic and diluted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zWRnAaJET1i8" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"&gt;&lt;span style="font-size: 10pt"&gt;1.26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zf7OTzzqRKrl" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"&gt;&lt;span style="font-size: 10pt"&gt;(0.02&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331_z8dneKmKuTV7" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"&gt;&lt;span style="font-size: 10pt"&gt;1.24&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A0_z6LBYNyBTvh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&lt;/p&gt;

&lt;p id="xdx_892_esrt--ScheduleOfCondensedCashFlowStatementTableTextBlock_zAD57VdDtUPi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Revision Impacts to the Condensed Consolidated
Statement of Cash Flows (unaudited)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;For the Nine Months Ended March 31,
2023&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B5_z14eJLyY15d8" style="display: none; visibility: hidden"&gt;Revision Impacts to the Condensed
Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023&lt;/span&gt;&#160;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;As Previously&lt;br/&gt;
 Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revision&lt;br/&gt;
 Impacts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revised&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;CASH FLOWS FROM OPERATING ACTIVITIES&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Net loss for the period&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zbiFHIIS78Sh" style="width: 12%; text-align: right"&gt;(35,741&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zSvmIcP42Hzg" style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1022"&gt;665&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230331_zfmGaN4AcFT2" style="width: 12%; text-align: right"&gt;(35,076&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Initial valuation of warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwjsL1DGD204" style="text-align: right"&gt;3,848&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zIqZuI2UrFOg" style="text-align: right"&gt;(861&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331_zswoFw4mvRbh" style="text-align: right"&gt;2,987&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Change in fair value of warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zUapaVmlhvAi" style="text-align: right"&gt;868&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zbjfLsqFDSz4" style="text-align: right"&gt;196&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331_zAf3FS7vazv5" style="text-align: right"&gt;1,064&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A7_zi5vEHv55UAd" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_85D_zcRVC8TinVjf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <niobf:DevelopmentStageIssuerPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_848_ecustom--DevelopmentStageIssuerPolicyTextBlock_zJkX4dox3P5g" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_865_zXtCthRZkGJj"&gt;Development
                                         Stage Issuer&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is considered to be a development stage issuer under Subpart 1300 of Regulation S-K of the United States Securities Act
of 1933, as amended (&#x201c;S-K 1300&#x201d;), and it devotes substantially all of its efforts to acquiring and exploring mining
interests that management believes should eventually provide sufficient net profits to sustain the Company&#x2019;s existence.
Until such interests are engaged in commercial production, the Company will continue to seek additional funding to support the
completion of its exploration and development activities. The Company&#x2019;s activities are subject to significant risks and
uncertainties, including its ability to secure sufficient funding to continue operations, to obtain proven and probable reserves,
to comply with industry regulations and obtain permits necessary for development of the Elk Creek Project, as well as environmental
risks and market conditions.&lt;/span&gt;&lt;/p&gt;

</niobf:DevelopmentStageIssuerPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zXhSCc1lPCQ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86B_zlpJd7WiSBI5"&gt;Cash
                                         and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents include cash on hand, cash in banks, investments in certificates of deposit with original maturities of
90 days or less, and money market funds. The Company maintains the majority of its cash balances with two financial
institutions. Accounts at banks in the United States (&#x201c;U.S.&#x201d;) are insured by the Federal Deposit Insurance
Corporation (&#x201c;FDIC&#x201d;) up to $250, while accounts at banks in Canada are insured by the Canada Deposit Insurance
Corporation (&#x201c;CDIC&#x201d;) up to C$100. At June 30, 2023 and 2022, the Company had $1,717 and $4,721 in excess of the
FDIC and CDIC insured limits, respectively.&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_843_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zJOG3sB3cbde" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_867_zp6NhYawEyQc"&gt;Foreign
                                         Currency Translation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Functional
and reporting currency&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Items
included in the financial statements of each of the Company&#x2019;s entities are measured using the currency of the primary economic
environment in which the entity operates (&#x201c;the functional currency&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
reporting currency for these consolidated financial statements is U.S. dollars.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Change
in functional currency&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to March 17, 2023, the Company&#x2019;s functional currency was the Canadian dollar. The Company re-assessed its functional
currency and determined that on March 17, 2023, its functional currency changed from the Canadian dollar to the U.S. dollar
based on significant changes in economic facts and circumstances in our organization. The change in functional currency was
accounted for prospectively from March 17, 2023 and prior-period consolidated&#160;financial statements were not restated for
the change in functional currency.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;

&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
both monetary and non-monetary assets and liabilities, translated balances as of March 17, 2023 became the new accounting basis.
The exchange rate on the date of change became the historical rate at which non-monetary assets and liabilities were translated
in subsequent periods. There was no effect on the cumulative translation adjustment on the consolidated basis. Previously recorded
cumulative translation adjustments were not reversed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
functional currency for the Company&#x2019;s Canadian subsidiary, 0896800 BC Ltd., which has no independent operations from its
parent, also changed from the Canadian dollar to the U.S. dollar. The functional currency for Elk Creek Resources Corp. remains
as the U.S. dollar.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Transactions
in foreign currency&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transactions
made in a currency other than the functional currency are remeasured to the functional currency at exchange rates at the dates
of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are remeasured to
the functional currency at the exchange rate at that date and non-monetary assets and liabilities are remeasured at historical
rates. Foreign currency translation gains and losses are included in profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Translation
to reporting currency&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Translation
gains and losses from the application of the U.S. dollar as the reporting currency for all periods prior to March 17, 2023 (when
the Canadian dollar was the functional currency) are included as part of cumulative currency translation adjustment, which is
reported as a component of shareholders&#x2019; equity under accumulated other comprehensive loss.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <niobf:MineralPropertiesPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_840_ecustom--MineralPropertiesPolicyTextBlock_zn9ko4vXxy8j" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86F_z9HsYAkJsLj5"&gt;Mineral
                                         Properties&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mineral
property acquisition costs, including indirectly related acquisition costs, are capitalized when incurred. Acquisition costs include
cash consideration and the fair market value of Common Shares issued as consideration. Properties acquired under option agreements,
whereby payments are made at the sole discretion of the Company, are capitalized as mineral property acquisition costs at such
time as the payments are made. Exploration costs are expensed as incurred. When it is determined that a mining deposit can be
economically and legally extracted or produced based on established proven and probable reserves under S-K 1300, and the Board
of Directors has approved the commencement of formal development activities, development costs related to such reserves and incurred
after such board approval will be considered for capitalization. The establishment of proven and probable reserves is based on
results of feasibility studies, which indicate whether a property is economically feasible. Upon commencement of commercial production,
capitalized costs will be amortized over their estimated useful lives or units of production, whichever is a more reliable measure.
Capitalized amounts relating to a property that is abandoned or otherwise considered uneconomic for the foreseeable future are
written off.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#x2019;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. This would include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Such evaluations compare estimated future net cash flows with our carrying costs and future obligations on an undiscounted
basis. If it is determined that the estimated future undiscounted cash flows are less than the carrying value of the property,
an impairment loss will be recorded. Where estimates of future net cash flows are not determinable and where other conditions
indicate the potential for impairment, management uses available market information and/or third-party valuation experts to assess
if the carrying value can be recovered and to estimate fair value. There was no impairment recorded to mineral properties as of
June 30, 2023 or 2022, respectively.&lt;/span&gt;&lt;/p&gt;

</niobf:MineralPropertiesPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zZSrZEJUreb3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;e)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_862_zUmviM3xRkyh"&gt;Long
                                         Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-lived
assets, other than mineral properties, held and used by the Company are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;









&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For purposes of evaluating the recoverability
of long-lived assets, the recoverability test is performed using undiscounted net cash flows related to the long-lived assets.
If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount
of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount
or fair value less costs to sell. There was no impairment recorded to long-lived assets as of June 30, 2023 or 2022, respectively.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_846_eus-gaap--LesseeLeasesPolicyTextBlock_zKbLNiM7xQV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;f)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_zlAhXUXUovFl"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
Accounting Standards Codification (&#x201c;ASC&#x201d;) 842, &#x201c;Leases,&#x201d; we determine if a contractual arrangement is,
or contains, a lease at the inception date. Right-of-use (&#x201c;ROU&#x201d;) assets and liabilities related to operating leases
are separately reported in the consolidated balance sheets. The Company currently has no finance leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ROU
assets and lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments
over the lease term. When the rate implicit to the lease cannot be readily determined, we utilize our incremental borrowing rate
in determining the present value of the future lease payments. The incremental borrowing rate is derived from information available
at the lease commencement date and represents the rate of interest that a lessee would have to pay to borrow an amount equal to
the lease payments on a collateralized basis over a similar term in a similar economic environment. Operating lease ROU assets
also include any cumulative prepaid or accrued rent when the lease payments are uneven throughout the lease term. The ROU assets
and lease liabilities may include options to extend or terminate the lease when it is reasonably certain that we will exercise
that option.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term.
For operating leases, interest on the lease liability and the amortization of the ROU asset result in straight-line rent expense
over the lease term. Variable lease expenses are recorded when incurred.&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <niobf:WarrantsPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_842_ecustom--WarrantsPolicyTextBlock_zmOdMLKAZMp9" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;g)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_862_zkn0gfB4mzZ1"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
apply relevant accounting guidance for warrants to purchase our stock based on the nature of the relationship with the counterparty.
For warrants issued to investors or lenders in exchange for cash or other financial assets, we follow guidance issued within ASC
480, Distinguishing Liabilities from Equity, and ASC Topic 815, Derivatives and Hedging, (&#x201c;ASC 815&#x201d;) to assist in
the determination of whether the warrants should be classified as liabilities or equity. The fair value of warrants is estimated
using Black Scholes modeling or Monte Carlo modeling, depending on the settlement features embedded in the warrant. Inputs under
both models include inputs such as NioCorp&#x2019;s Common Share price, the risk-free interest rate, the expected term, the volatility,
and the dividend rate. Warrants that are determined to require liability classifications are measured at fair value upon issuance
and are subsequently remeasured to their then fair value at each subsequent reporting period with changes in fair value recorded
in current earnings. Warrants that are determined to require equity classifications measured at fair value upon issuance and are
not subsequently remeasured unless they are required to be reclassified.&lt;/span&gt;&lt;/p&gt;

</niobf:WarrantsPolicyTextBlock>
    <niobf:EarnoutSharesPolicy contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_841_ecustom--EarnoutSharesPolicy_zPrxAclSfbdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;h)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86D_zFYPbuZ31El8"&gt;Earnout
                                         Shares&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
Shares are classified as a liability due to failure to meet the equity classification criteria under ASC 815-40. The fair value
of the Earnout Shares on the date of issuance and on each measurement date is estimated using a Monte Carlo simulation methodology,
which includes inputs such as NioCorp&#x2019;s Common Share price, the risk-free interest rate, the expected term, the implied
volatility underlying the Company&#x2019;s Public Warrants, the dividend rate, the conversion price, and the number of Earnout
Shares outstanding. Assumptions used in the model are subjective and require significant judgment.&lt;/span&gt;&lt;/p&gt;

</niobf:EarnoutSharesPolicy>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zDNoDDX3pPY3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_865_z6xtqDIfxqBa"&gt;Financial
                                         Instruments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments consist of cash and cash equivalents, receivables, equity securities, accounts payable and accrued liabilities,
convertible debt and the related party loan. It is management&#x2019;s opinion that the Company is not exposed to significant interest,
currency or credit risks arising from its financial instruments. The fair values of these instruments approximate their carrying
value unless otherwise noted.&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_z4EOR7m4rotd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;j)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86D_zoVOqAKsMn4c"&gt;Concentration
                                         of Credit Risk&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial instrument which potentially subjects the Company to credit risk is cash and cash equivalents, The Company holds investments
or maintains available cash primarily in two commercial banks located in Vancouver,&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;

&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;British Columbia and Santa Clara, California.
As part of its cash management process, the Company regularly monitors the relative credit standing of these institutions.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:AssetRetirementObligationsPolicy contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_84B_eus-gaap--AssetRetirementObligationsPolicy_z6U1pWuF73F1" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;k)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_860_zzlbXqlYuAfa"&gt;Asset
                                         Retirement Obligation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is subject to various government laws and regulations relating to environmental disturbances caused by exploration and
evaluation activities. The estimated costs associated with environmental remediation obligations are accrued in the period in
which the liability is incurred if it is reasonably estimable or known. Until such time that a project life is established, the
Company records the corresponding cost as an exploration stage expense and has accrued $&lt;span id="xdx_90F_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20230630_zC6yQ1gF29bg"&gt;48&lt;/span&gt; as an accrued liability related to
estimated obligations as of June 30, 2023 (2022 - $&lt;span id="xdx_90D_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20220630_zWKK5mFe9WG6" title="Accrued exploration stage expense"&gt;48&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
reclamation and environmental-related expenditures are difficult to estimate in many circumstances due to the early-stage nature
of the Elk Creek Project, the uncertainties associated with defining the nature and extent of environmental disturbance, the application
of laws and regulations by regulatory authorities and changes in reclamation or remediation technology. The Company periodically
reviews accrued liabilities for such reclamation and remediation costs as evidence indicating that the liabilities have potentially
changed becomes available. Changes in estimates are reflected in the consolidated statement of operations and comprehensive loss in the period an estimate
is revised.&lt;/span&gt;&lt;/p&gt;

</us-gaap:AssetRetirementObligationsPolicy>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">48000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">48000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_z8tYU1sa8Ao3" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;l)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_zs9Rb7gXjoDb"&gt;Income
                                         Taxes&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25, &lt;i&gt;&#x201c;Income Taxes &#x2013; Recognition.&#x201d;
&lt;/i&gt;Under the approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between
the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded
against deferred tax assets if management does not believe the Company has met the &#x201c;more likely than not&#x201d; standard
imposed by ASC 740-10-25-5 to allow recognition of such an asset. ASC 740-10-50, &#x201c;Income Taxes &#x2013; Disclosure,&#x201d;
requires the Company to evaluate its income tax positions and recognize a liability for uncertain tax positions that are not more
likely than not to be sustained by tax authorities. As of June 30, 2023 and 2022, the Company believes it had no income tax uncertainties
that required recognition of a liability. If the Company were to determine that uncertain tax positions meet the criteria for
recognition, an estimated liability and related interest and penalties would be recognized as income tax expense.&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <niobf:ReverseStockSplitPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_84E_ecustom--ReverseStockSplitPolicyTextBlock_zo8YIoczuktl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;m)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Reverse
                                         Stock Split&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 17, 2023, the Company effected a reverse stock split (the &#x201c;Reverse Stock Split&#x201d;) on the basis of one (1) post-Reverse
Stock Split Common Share for every ten (10) pre-Reverse Stock Split Common Shares issued and outstanding, with any fractional
shares resulting from the Reverse Stock Split rounded down to the nearest whole share. Immediately after the Reverse Stock Split,
there were 30,000,442 Common Shares issued and outstanding. All references to share and per share amounts (excluding authorized
shares) in the consolidated financial statements and accompanying notes have been retroactively restated to reflect the Reverse
Stock Split.&lt;/span&gt;&lt;/p&gt;

</niobf:ReverseStockSplitPolicyTextBlock>
    <niobf:RedeemableNoncontrollingInterestPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_842_ecustom--RedeemableNoncontrollingInterestPolicyTextBlock_zVio3UOUdE0a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;n)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_860_z07Nhe4mLBwg"&gt;Redeemable
                                         Noncontrolling Interest&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable
Noncontrolling Interest refers to non-controlling interest associated with the Vested Shares that are redeemable upon the occurrence
of an event that is not solely within the Company&#x2019;s control and is reported in the mezzanine section between total liabilities
and shareholders&#x2019; deficit, as temporary equity in the Company&#x2019;s consolidated balance sheets. The
Company&#x2019;s non-controlling interest is redeemable at fair value, and no adjustment to the earnings per share numerator is
required because redemption at fair value is not considered an economic distribution different from other common stockholders.&lt;/span&gt;&lt;/p&gt;

</niobf:RedeemableNoncontrollingInterestPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_z4hs6MtuRSEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;o)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_860_zHyNOqAYJzI7"&gt;Basic
                                         and Diluted Per Share Disclosure&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted
average number of Common Shares outstanding during the period. The Company considers Vested Shares and Released Earnout
Shares (each as defined in Note 10), to be participating securities, requiring the use of the two-class method. Diluted
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted average
number of Common Shares outstanding, inclusive of the dilutive impact of all potentially dilutive securities outstanding
during the period, as applicable.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;









&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;





&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;


&lt;p id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z3eruOf1JU9c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. &lt;span id="xdx_8B3_zJC6A6vaTFb8"&gt;The following table sets forth the computation of the Company&#x2019;s basic and diluted net loss per share
attributable to common shareholders:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; background-color: #CCECFF; border-collapse: collapse; margin-left: 0.5in"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="9" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the year ended June 30,&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 56%; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    loss&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20220701__20230630_zFQp4ku0flCa" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,308&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210701__20220630_zIXhZ86d9w65" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,887&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200701__20210630_zssQC8D0iE53" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,824&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Adjust:
    Net loss attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20220701__20230630_zqqNk02gopR" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::228"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0809"&gt;(251&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20210701__20220630_zOyu0YxBliY6" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0811"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20200701__20210630_zpWSiN86lFEa" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0813"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    loss available to participating securities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220701__20230630_zV3gNqOmuwTk" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,057&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20210701__20220630_z9QdtQfKZAgc" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,887&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20200701__20210630_zv0dpzPPfiY4" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,824&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    loss attributable to Vested Shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zVLWsnQRhg6j" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,528&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20210701__20220630_z1MBIpPDBSq9" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0823"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20200701__20210630_z2nWNLQPzUU7" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0825"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 9pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
loss attributed to common shareholders - basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20220701__20230630_z0QxpAAuKBXh" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;38,529&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20210701__20220630_zUGKlTW6sQ8f" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,887&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20200701__20210630_zwZFR6TLoOK5" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,824&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    average shares outstanding &#x2013; basic and diluted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20220701__20230630_zlRgKsVPLbg2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;28,705,840&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20210701__20220630_zRsagfqjhAD7" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,373,722&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20200701__20210630_zVMUUNLt4TNl" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,196,711&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
    per Common Share outstanding &#x2013; basic and diluted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230630_z8PCNjjBnWE1" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.34&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20210701__20220630_zlMXAuzupyke" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$0.41&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20200701__20210630_zJ5yF0jIKA72" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$0.20&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A5_zDSzIPfVq1a4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The following shares underlying options, warrants, and outstanding convertible debt were antidilutive
due to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation for the years
ended June 30, 2023 and 2022, as indicated below.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zOn3rNY06DWi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BA_zc72BNzqWaDh" style="display: none; visibility: hidden"&gt;Schedule of excluded from the dilutive securities&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 89%; border-collapse: collapse; margin-left: 0.75in"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 61%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Excluded
    potentially dilutive securities &lt;sup id="xdx_F6B_zlpIL2QeXlS8"&gt;(1)(2)&lt;/sup&gt;:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 11%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Options
&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20230630_fKDEpKDIp_zTxQsQUt6vCi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,541,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20210701__20220630_fKDEpKDIp_zJ8w8jErmrs" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,446,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20200701__20210630_fKDEpKDIp_zkjNk0oBemyg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,596,500&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20230630_fKDEpKDIp_zrQbk9S4UKg5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,816,304&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20210701__20220630_fKDEpKDIp_zDcNxKNdVr4a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,851,622&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20200701__20210630_fKDEpKDIp_z0sNl7vkl4B1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,434,186&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Convertible
debt&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20230630_fKDEpKDIp_z7mNylIwkLa2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,871,660&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20210701__20220630_fKDEpKDIp_zahcAL52BKfa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;415,200&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20200701__20210630_fKDEpKDIp_zgqIxU0aSyua" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,455,700&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    potentially dilutive securities &lt;sup&gt;&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--DilutiveSecurities_c20220701__20230630_fKDEpKDIp_zJ5fgeJjdrLe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23,229,464&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--DilutiveSecurities_c20210701__20220630_fKDEpKDIp_z1DA4k0owKD9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,713,222&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DilutiveSecurities_c20200701__20210630_fKDEpKDIp_zC4ZPsqKRXjg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,486,386&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span id="xdx_F0C_z8MpdCdTVJXl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1A_zvlOvhPMsqK8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span id="xdx_F06_zEo1LnpKZiee" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_zjFm1EndTiW7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AE_zQYsB0CM1Ksf" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z3eruOf1JU9c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. &lt;span id="xdx_8B3_zJC6A6vaTFb8"&gt;The following table sets forth the computation of the Company&#x2019;s basic and diluted net loss per share
attributable to common shareholders:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; background-color: #CCECFF; border-collapse: collapse; margin-left: 0.5in"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="9" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the year ended June 30,&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 56%; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    loss&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20220701__20230630_zFQp4ku0flCa" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,308&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210701__20220630_zIXhZ86d9w65" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,887&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200701__20210630_zssQC8D0iE53" style="font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 1.45pt; text-align: right" title="Net loss"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,824&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Adjust:
    Net loss attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20220701__20230630_zqqNk02gopR" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::228"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0809"&gt;(251&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20210701__20220630_zOyu0YxBliY6" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0811"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20200701__20210630_zpWSiN86lFEa" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Adjust: net loss attributable to noncontrolling interest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0813"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    loss available to participating securities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220701__20230630_zV3gNqOmuwTk" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,057&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20210701__20220630_z9QdtQfKZAgc" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,887&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20200701__20210630_zv0dpzPPfiY4" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss available to participating securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,824&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    loss attributable to Vested Shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20220701__20230630_zVLWsnQRhg6j" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,528&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20210701__20220630_z1MBIpPDBSq9" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0823"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20200701__20210630_z2nWNLQPzUU7" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributable to vested shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0825"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 9pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
loss attributed to common shareholders - basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20220701__20230630_z0QxpAAuKBXh" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;38,529&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20210701__20220630_zUGKlTW6sQ8f" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,887&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20200701__20210630_zwZFR6TLoOK5" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Net loss attributed to common shareholders - basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,824&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    average shares outstanding &#x2013; basic and diluted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20220701__20230630_zlRgKsVPLbg2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;28,705,840&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20210701__20220630_zRsagfqjhAD7" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,373,722&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20200701__20210630_zVMUUNLt4TNl" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,196,711&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
    per Common Share outstanding &#x2013; basic and diluted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230630_z8PCNjjBnWE1" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.34&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20210701__20220630_zlMXAuzupyke" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$0.41&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20200701__20210630_zJ5yF0jIKA72" style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt; text-align: right" title="Loss per common share outstanding basic and diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$0.20&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-40308000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-10887000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-4824000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">40057000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">10887000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">4824000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-1528000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">38529000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">10887000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">4824000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Shares">28705840</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Shares">26373722</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">24196711</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="USDPShares">1.34</niobf:EarningsLossPerShareBasicAndDiluted>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.41</niobf:EarningsLossPerShareBasicAndDiluted>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">0.20</niobf:EarningsLossPerShareBasicAndDiluted>
    <us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zOn3rNY06DWi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BA_zc72BNzqWaDh" style="display: none; visibility: hidden"&gt;Schedule of excluded from the dilutive securities&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 89%; border-collapse: collapse; margin-left: 0.75in"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 61%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Excluded
    potentially dilutive securities &lt;sup id="xdx_F6B_zlpIL2QeXlS8"&gt;(1)(2)&lt;/sup&gt;:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 11%; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Options
&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20230630_fKDEpKDIp_zTxQsQUt6vCi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,541,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20210701__20220630_fKDEpKDIp_zJ8w8jErmrs" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,446,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20200701__20210630_fKDEpKDIp_zkjNk0oBemyg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,596,500&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20230630_fKDEpKDIp_zrQbk9S4UKg5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,816,304&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20210701__20220630_fKDEpKDIp_zDcNxKNdVr4a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,851,622&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20200701__20210630_fKDEpKDIp_z0sNl7vkl4B1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,434,186&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Convertible
debt&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20230630_fKDEpKDIp_z7mNylIwkLa2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,871,660&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20210701__20220630_fKDEpKDIp_zahcAL52BKfa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;415,200&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20200701__20210630_fKDEpKDIp_zgqIxU0aSyua" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Convertible debt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,455,700&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    potentially dilutive securities &lt;sup&gt;&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--DilutiveSecurities_c20220701__20230630_fKDEpKDIp_zJ5fgeJjdrLe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23,229,464&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--DilutiveSecurities_c20210701__20220630_fKDEpKDIp_z1DA4k0owKD9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,713,222&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DilutiveSecurities_c20200701__20210630_fKDEpKDIp_zC4ZPsqKRXjg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 1.45pt; text-align: right" title="Total potentially dilutive securities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,486,386&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span id="xdx_F0C_z8MpdCdTVJXl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1A_zvlOvhPMsqK8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span id="xdx_F06_zEo1LnpKZiee" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_zjFm1EndTiW7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      id="Fact000847"
      unitRef="Shares">1541500</us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions>
    <us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      id="Fact000849"
      unitRef="Shares">1446400</us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions>
    <us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      id="Fact000851"
      unitRef="Shares">1596500</us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      id="Fact000853"
      unitRef="Shares">18816304</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      id="Fact000855"
      unitRef="Shares">1851622</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      id="Fact000857"
      unitRef="Shares">1434186</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      id="Fact000859"
      unitRef="Shares">2871660</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      id="Fact000861"
      unitRef="Shares">415200</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      id="Fact000863"
      unitRef="Shares">1455700</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      id="Fact000865"
      unitRef="USD">23229464000</us-gaap:DilutiveSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      id="Fact000867"
      unitRef="USD">3713222000</us-gaap:DilutiveSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      id="Fact000869"
      unitRef="USD">4486386000</us-gaap:DilutiveSecurities>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zXWOk6GWM1Kl" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;p)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_860_zPYfP5GRiaW3"&gt;Share
                                         Based Compensation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company grants stock options to directors, officers, employees, and business advisors. Option terms and vesting conditions
are at the discretion of the Board of Directors. Prior to March 21, 2023, the option exercise price was equal to the closing
market price on The Toronto Stock Exchange (the &#x201c;TSX&#x201d;) on the day preceding the date of grant. Effective March
21, 2023, the option exercise price is equal to the closing market price on the Nasdaq Stock Market LLC
(&#x201c;Nasdaq&#x201d;) on the day preceding the date of the grant.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company estimates the fair value of stock options using the Black-Scholes option pricing model. The Company recognizes forfeitures
as they occur.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z9lxU8GlAWhd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;q)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_864_zhBbIkyvNjb3"&gt;Recent
                                         Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Issued
and Adopted&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August 2020, the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;)
No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s
Own Equity (Subtopic 815-40) (&#x201c;ASU 2020-06&#x201d;), which simplifies the accounting for convertible instruments. ASU 2020-06
removes certain accounting models which separate the embedded conversion features from the host contract for convertible instruments.
Either a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption
of this standard. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within
those fiscal&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;









&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;years. The Company adopted ASU 2020-06 on July 1, 2022, with no material effect on the Company&#x2019;s current financial
position, results of operations or financial statement disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Issued
and Not Effective&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective
date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a
material impact on the Company&#x2019;s consolidated financial statements upon adoption.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zp4sRsVfdp0h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;r)&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span id="xdx_86D_zfPv1ZxtiDKj"&gt;Revision of Financial Statements (Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;During the
fourth quarter of fiscal year 2023, the Company determined that it had used an incorrect strike price while valuing the Private
Warrants (as defined below in Note 11c) at both the March 17, 2023, issuance date and as of March 31, 2023. This resulted in an
overstatement of other operating expenses, at fair value, and an understatement of change in fair value of warrant liabilities
in condensed consolidated statement of operations and comprehensive loss for both the three- and nine-month periods ended March
31, 2023. In addition, warrant liabilities, at fair value and accumulated deficit were overstated and understated, respectively,
as of March 31, 2023. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;The Company determined that
these errors were immaterial to the previously issued consolidated financial statements, and as such no restatement was necessary.
Periods not presented herein will be revised, as applicable, in future filings.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;The effects
of the revision on the previously issued consolidated financial statements are as follows:&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_896_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zhsVYVtVC4s6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Revision Impacts to the Condensed Consolidated
Balance Sheet (unaudited)&lt;/b&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;As of March 31, 2023&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BB_zqPDmNb9cDEc" style="display: none; visibility: hidden"&gt;Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As
of March 31, 2023&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zelflEE9IMBf" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zWaKgukSfI9" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230331_zY93igpGJPta" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;As Previously&lt;br/&gt; Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revision&lt;br/&gt; Impacts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revised&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--OtherLiabilitiesNoncurrent_iI_pn3n3_zqax1sPZZ8hd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; padding-left: 5.4pt"&gt;Warrant liabilities, at fair value&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;5,303&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(665&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;4,638&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Total liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Liabilities_iI_pn3n3_c20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zRJ4DvEAlRkk" style="text-align: right" title="Total liabilities"&gt;34,735&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Liabilities_iNI_pn3n3_di_c20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zCy0TdbKQsH" style="text-align: right" title="Total liabilities"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Liabilities_iI_pn3n3_c20230331_zxCnuRnyJIEi" style="text-align: right" title="Total liabilities"&gt;34,070&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pn3n3_z1kI0YlWdhE3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Accumulated deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(146,046&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;665&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(145,381&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--StockholdersEquity_iI_pn3n3_zEeGmVLayfV2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Total shareholders&#x2019; deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,512&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;665&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,847&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A2_zXr0M4XmAGXb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&lt;/p&gt;

&lt;p id="xdx_89B_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zf4thyh0OZk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Revision Impacts to the Condensed Consolidated
Statement of Operations and Comprehensive Loss (unaudited)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;For the Three Months Ended March 31,
2023&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&lt;span id="xdx_8B8_zwMYtoPoRhJ1" style="display: none; visibility: hidden"&gt;Revision Impacts to
                                            the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For
                                            the Three &amp;amp; Nine Months Ended  March 31,
2023&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;As Previously&lt;br/&gt;
 Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revision&lt;br/&gt;
 Impacts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revised&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; padding-left: 5.4pt"&gt;Other operating expense&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OtherGeneralExpense_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zgQOUnHXWm68" style="width: 12%; text-align: right" title="Other operating expense"&gt;26,220&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OtherGeneralExpense_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpLsguPTVOxc" style="width: 12%; text-align: right" title="Other operating expense"&gt;(861&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherGeneralExpense_pn3n3_c20230101__20230331_zasjIfkHG88d" style="width: 12%; text-align: right" title="Other operating expense"&gt;25,359&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Total operating expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zMubrwz0kZt3" style="text-align: right" title="Total operating expenses"&gt;29,192&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zH8djFst0Oeh" style="text-align: right" title="Total operating expenses"&gt;(861&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331_zXe8FrzG6AT7" style="text-align: right" title="Total operating expenses"&gt;28,331&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Change in fair value of warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKTc1llfKIEk" style="text-align: right" title="Change in fair value of warrant liability"&gt;784&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zKLUQIW7L7g4" style="text-align: right" title="Change in fair value of warrant liability"&gt;196&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331_zBKidsx6iaqj" style="text-align: right" title="Change in fair value of warrant liability"&gt;980&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Loss before income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zkop0E3nssMi" style="text-align: right" title="Loss before income taxes"&gt;29,621&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zefaGBWcanv1" style="text-align: right" title="Loss before income taxes"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_dxL_c20230101__20230331_zTUVmm3EVvbc" style="text-align: right" title="Loss before income taxes::XDX::-3877"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0929"&gt;28,956&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Net loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zDEONR6tVaG5" style="text-align: right" title="Net loss"&gt;29,435&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zTzxnU9qsx3d" style="text-align: right" title="Net loss"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331_zTXUUlkWJVU3" style="text-align: right" title="Net loss"&gt;28,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Net loss attributable to the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ProfitLoss1_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zzG310e4baTk" style="text-align: right" title="Net loss attributable to the company"&gt;29,343&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ProfitLoss1_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zTNbjnxJqVt6" style="text-align: right" title="Net loss attributable to the company"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ProfitLoss1_pn3n3_c20230101__20230331_zGms76QML6g2" style="text-align: right" title="Net loss attributable to the company"&gt;28,678&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Total comprehensive loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zCkWs19aZdeh" style="text-align: right" title="Total comprehensive loss"&gt;29,323&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zPIBX74Xw4Z1" style="text-align: right" title="Total comprehensive loss"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331_z9Alax3TgdJ2" style="text-align: right" title="Total comprehensive loss"&gt;28,658&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Comprehensive loss attributable to the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zyDqlX3Y74x6" style="text-align: right" title="Comprehensive loss attributable to the company"&gt;29,231&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zG6JE1rlwC6a" style="text-align: right" title="Comprehensive loss attributable to the company"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331_z2L0neTwcTSc" style="text-align: right" title="Comprehensive loss attributable to the company"&gt;28,566&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Loss per common share, basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNILCmuSVGma" style="text-align: right" title="Loss per common share, basic and diluted"&gt;1.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zlpch4MOAPo4" style="text-align: right" title="Loss per common share, basic and diluted"&gt;(0.02&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331_z1FzQUrq6b97" style="text-align: right" title="Loss per common share, basic and diluted"&gt;0.98&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&#160;&lt;/p&gt;




&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;









&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Revision Impacts to the Condensed Consolidated
Statement of Operations and Comprehensive Loss (unaudited)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;For the Nine Months Ended March 31,
2023&#160; &#160; &#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 55%; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;As
    Previously&lt;br/&gt;
 Reported&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Revision&lt;br/&gt;

    Impacts&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Revised&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Other operating expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--OtherGeneralExpense_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYqCHLJxMxO9" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"&gt;&lt;span style="font-size: 10pt"&gt;26,888&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--OtherGeneralExpense_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_z9N7AAiEK2a2" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"&gt;&lt;span style="font-size: 10pt"&gt;(861&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--OtherGeneralExpense_pn3n3_c20220701__20230331_zKeufiUYm8qe" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"&gt;&lt;span style="font-size: 10pt"&gt;26,027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zPqhiQylMFh6" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"&gt;&lt;span style="font-size: 10pt"&gt;33,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zOnwEy7ElEg" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"&gt;&lt;span style="font-size: 10pt"&gt;(861&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331_z3rjgMQXLo2c" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"&gt;&lt;span style="font-size: 10pt"&gt;32,614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Change in fair value of warrant liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zGRArvNXlvyg" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"&gt;&lt;span style="font-size: 10pt"&gt;868&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_ze6iLON1bLq2" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"&gt;&lt;span style="font-size: 10pt"&gt;196&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331_zuXbyNA31H96" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"&gt;&lt;span style="font-size: 10pt"&gt;1,064&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYWQlY66Wnz5" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes"&gt;&lt;span style="font-size: 10pt"&gt;35,927&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpRhxZjqEyEd" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes"&gt;&lt;span style="font-size: 10pt"&gt;(665&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_dxL_c20220701__20230331_zWnUuOx7nh73" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes::XDX::-3877"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0988"&gt;35,262&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Net loss&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9qjusG3RCWk" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::-35741"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0990"&gt;35,741&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zmIztkbqaAhc" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::665"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0992"&gt;(665&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331_z4nx268bQSIk" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::-35076"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0994"&gt;35,076&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Net loss attributable to the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ProfitLoss1_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zm2e8LNnCqnj" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;35,649&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ProfitLoss1_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zYuXfcMAfHIc" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;(665&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ProfitLoss1_pn3n3_c20220701__20230331_z9sJmKZ4oxMk" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;34,984&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Total comprehensive loss&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKA82dNJQKfk" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"&gt;&lt;span style="font-size: 10pt"&gt;35,659&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZ5L3oKr2MW1" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"&gt;&lt;span style="font-size: 10pt"&gt;(665&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331_zcGBegKbF1yh" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"&gt;&lt;span style="font-size: 10pt"&gt;34,994&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Comprehensive loss attributable to the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_ze5Cyg3e3j4k" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;35,567&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zlDk0KhpPKR" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;(665&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331_zbMZnDl5gef2" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;34,902&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Loss per common share, basic and diluted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zWRnAaJET1i8" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"&gt;&lt;span style="font-size: 10pt"&gt;1.26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zf7OTzzqRKrl" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"&gt;&lt;span style="font-size: 10pt"&gt;(0.02&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331_z8dneKmKuTV7" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"&gt;&lt;span style="font-size: 10pt"&gt;1.24&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A0_z6LBYNyBTvh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"&gt;&lt;/p&gt;

&lt;p id="xdx_892_esrt--ScheduleOfCondensedCashFlowStatementTableTextBlock_zAD57VdDtUPi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Revision Impacts to the Condensed Consolidated
Statement of Cash Flows (unaudited)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;For the Nine Months Ended March 31,
2023&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B5_z14eJLyY15d8" style="display: none; visibility: hidden"&gt;Revision Impacts to the Condensed
Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023&lt;/span&gt;&#160;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;As Previously&lt;br/&gt;
 Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revision&lt;br/&gt;
 Impacts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revised&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;CASH FLOWS FROM OPERATING ACTIVITIES&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Net loss for the period&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zbiFHIIS78Sh" style="width: 12%; text-align: right"&gt;(35,741&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zSvmIcP42Hzg" style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1022"&gt;665&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230331_zfmGaN4AcFT2" style="width: 12%; text-align: right"&gt;(35,076&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Initial valuation of warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwjsL1DGD204" style="text-align: right"&gt;3,848&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zIqZuI2UrFOg" style="text-align: right"&gt;(861&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331_zswoFw4mvRbh" style="text-align: right"&gt;2,987&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Change in fair value of warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zUapaVmlhvAi" style="text-align: right"&gt;868&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zbjfLsqFDSz4" style="text-align: right"&gt;196&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331_zAf3FS7vazv5" style="text-align: right"&gt;1,064&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A7_zi5vEHv55UAd" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <srt:ScheduleOfCondensedBalanceSheetTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_896_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zhsVYVtVC4s6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Revision Impacts to the Condensed Consolidated
Balance Sheet (unaudited)&lt;/b&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;As of March 31, 2023&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BB_zqPDmNb9cDEc" style="display: none; visibility: hidden"&gt;Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As
of March 31, 2023&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zelflEE9IMBf" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zWaKgukSfI9" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230331_zY93igpGJPta" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;As Previously&lt;br/&gt; Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revision&lt;br/&gt; Impacts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revised&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--OtherLiabilitiesNoncurrent_iI_pn3n3_zqax1sPZZ8hd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; padding-left: 5.4pt"&gt;Warrant liabilities, at fair value&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;5,303&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(665&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;4,638&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Total liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Liabilities_iI_pn3n3_c20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zRJ4DvEAlRkk" style="text-align: right" title="Total liabilities"&gt;34,735&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Liabilities_iNI_pn3n3_di_c20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zCy0TdbKQsH" style="text-align: right" title="Total liabilities"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Liabilities_iI_pn3n3_c20230331_zxCnuRnyJIEi" style="text-align: right" title="Total liabilities"&gt;34,070&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pn3n3_z1kI0YlWdhE3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Accumulated deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(146,046&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;665&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(145,381&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--StockholdersEquity_iI_pn3n3_zEeGmVLayfV2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Total shareholders&#x2019; deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,512&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;665&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,847&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</srt:ScheduleOfCondensedBalanceSheetTableTextBlock>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">5303000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">-665000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">4638000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">34735000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">665000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">34070000</us-gaap:Liabilities>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">-146046000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">665000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">-145381000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">-12512000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">665000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">-11847000</us-gaap:StockholdersEquity>
    <srt:ScheduleOfCondensedIncomeStatementTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_89B_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zf4thyh0OZk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Revision Impacts to the Condensed Consolidated
Statement of Operations and Comprehensive Loss (unaudited)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;For the Three Months Ended March 31,
2023&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&lt;span id="xdx_8B8_zwMYtoPoRhJ1" style="display: none; visibility: hidden"&gt;Revision Impacts to
                                            the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For
                                            the Three &amp;amp; Nine Months Ended  March 31,
2023&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;As Previously&lt;br/&gt;
 Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revision&lt;br/&gt;
 Impacts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revised&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; padding-left: 5.4pt"&gt;Other operating expense&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OtherGeneralExpense_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zgQOUnHXWm68" style="width: 12%; text-align: right" title="Other operating expense"&gt;26,220&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OtherGeneralExpense_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpLsguPTVOxc" style="width: 12%; text-align: right" title="Other operating expense"&gt;(861&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherGeneralExpense_pn3n3_c20230101__20230331_zasjIfkHG88d" style="width: 12%; text-align: right" title="Other operating expense"&gt;25,359&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Total operating expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zMubrwz0kZt3" style="text-align: right" title="Total operating expenses"&gt;29,192&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zH8djFst0Oeh" style="text-align: right" title="Total operating expenses"&gt;(861&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20230101__20230331_zXe8FrzG6AT7" style="text-align: right" title="Total operating expenses"&gt;28,331&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Change in fair value of warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKTc1llfKIEk" style="text-align: right" title="Change in fair value of warrant liability"&gt;784&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zKLUQIW7L7g4" style="text-align: right" title="Change in fair value of warrant liability"&gt;196&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20230101__20230331_zBKidsx6iaqj" style="text-align: right" title="Change in fair value of warrant liability"&gt;980&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Loss before income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zkop0E3nssMi" style="text-align: right" title="Loss before income taxes"&gt;29,621&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zefaGBWcanv1" style="text-align: right" title="Loss before income taxes"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_dxL_c20230101__20230331_zTUVmm3EVvbc" style="text-align: right" title="Loss before income taxes::XDX::-3877"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0929"&gt;28,956&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Net loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zDEONR6tVaG5" style="text-align: right" title="Net loss"&gt;29,435&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zTzxnU9qsx3d" style="text-align: right" title="Net loss"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331_zTXUUlkWJVU3" style="text-align: right" title="Net loss"&gt;28,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Net loss attributable to the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ProfitLoss1_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zzG310e4baTk" style="text-align: right" title="Net loss attributable to the company"&gt;29,343&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ProfitLoss1_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zTNbjnxJqVt6" style="text-align: right" title="Net loss attributable to the company"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ProfitLoss1_pn3n3_c20230101__20230331_zGms76QML6g2" style="text-align: right" title="Net loss attributable to the company"&gt;28,678&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Total comprehensive loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zCkWs19aZdeh" style="text-align: right" title="Total comprehensive loss"&gt;29,323&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zPIBX74Xw4Z1" style="text-align: right" title="Total comprehensive loss"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20230101__20230331_z9Alax3TgdJ2" style="text-align: right" title="Total comprehensive loss"&gt;28,658&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Comprehensive loss attributable to the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zyDqlX3Y74x6" style="text-align: right" title="Comprehensive loss attributable to the company"&gt;29,231&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zG6JE1rlwC6a" style="text-align: right" title="Comprehensive loss attributable to the company"&gt;(665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20230101__20230331_z2L0neTwcTSc" style="text-align: right" title="Comprehensive loss attributable to the company"&gt;28,566&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Loss per common share, basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNILCmuSVGma" style="text-align: right" title="Loss per common share, basic and diluted"&gt;1.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zlpch4MOAPo4" style="text-align: right" title="Loss per common share, basic and diluted"&gt;(0.02&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331_z1FzQUrq6b97" style="text-align: right" title="Loss per common share, basic and diluted"&gt;0.98&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&#160;&lt;/p&gt;




&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;









&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Revision Impacts to the Condensed Consolidated
Statement of Operations and Comprehensive Loss (unaudited)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;For the Nine Months Ended March 31,
2023&#160; &#160; &#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 55%; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;As
    Previously&lt;br/&gt;
 Reported&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Revision&lt;br/&gt;

    Impacts&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; background-color: white; padding-right: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Revised&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: white; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Other operating expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--OtherGeneralExpense_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYqCHLJxMxO9" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"&gt;&lt;span style="font-size: 10pt"&gt;26,888&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--OtherGeneralExpense_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_z9N7AAiEK2a2" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"&gt;&lt;span style="font-size: 10pt"&gt;(861&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--OtherGeneralExpense_pn3n3_c20220701__20230331_zKeufiUYm8qe" style="padding-right: 1.45pt; text-align: right" title="Other operating expense"&gt;&lt;span style="font-size: 10pt"&gt;26,027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zPqhiQylMFh6" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"&gt;&lt;span style="font-size: 10pt"&gt;33,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zOnwEy7ElEg" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"&gt;&lt;span style="font-size: 10pt"&gt;(861&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--OperatingExpenses_pn3n3_c20220701__20230331_z3rjgMQXLo2c" style="padding-right: 1.45pt; text-align: right" title="Total operating expenses"&gt;&lt;span style="font-size: 10pt"&gt;32,614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Change in fair value of warrant liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zGRArvNXlvyg" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"&gt;&lt;span style="font-size: 10pt"&gt;868&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_ze6iLON1bLq2" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"&gt;&lt;span style="font-size: 10pt"&gt;196&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ChangeInFairValueOfWarrantLiability_iN_pn3n3_di_c20220701__20230331_zuXbyNA31H96" style="padding-right: 1.45pt; text-align: right" title="Change in fair value of warrant liability"&gt;&lt;span style="font-size: 10pt"&gt;1,064&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYWQlY66Wnz5" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes"&gt;&lt;span style="font-size: 10pt"&gt;35,927&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpRhxZjqEyEd" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes"&gt;&lt;span style="font-size: 10pt"&gt;(665&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_dxL_c20220701__20230331_zWnUuOx7nh73" style="padding-right: 1.45pt; text-align: right" title="Loss before income taxes::XDX::-3877"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0988"&gt;35,262&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Net loss&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9qjusG3RCWk" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::-35741"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0990"&gt;35,741&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zmIztkbqaAhc" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::665"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0992"&gt;(665&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331_z4nx268bQSIk" style="padding-right: 1.45pt; text-align: right" title="Net loss::XDX::-35076"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0994"&gt;35,076&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Net loss attributable to the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ProfitLoss1_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zm2e8LNnCqnj" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;35,649&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ProfitLoss1_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zYuXfcMAfHIc" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;(665&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ProfitLoss1_pn3n3_c20220701__20230331_z9sJmKZ4oxMk" style="padding-right: 1.45pt; text-align: right" title="Net loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;34,984&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Total comprehensive loss&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKA82dNJQKfk" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"&gt;&lt;span style="font-size: 10pt"&gt;35,659&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZ5L3oKr2MW1" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"&gt;&lt;span style="font-size: 10pt"&gt;(665&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220701__20230331_zcGBegKbF1yh" style="padding-right: 1.45pt; text-align: right" title="Total comprehensive loss"&gt;&lt;span style="font-size: 10pt"&gt;34,994&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Comprehensive loss attributable to the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_ze5Cyg3e3j4k" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;35,567&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zlDk0KhpPKR" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;(665&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_pn3n3_c20220701__20230331_zbMZnDl5gef2" style="padding-right: 1.45pt; text-align: right" title="Comprehensive loss attributable to the company"&gt;&lt;span style="font-size: 10pt"&gt;34,902&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Loss per common share, basic and diluted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zWRnAaJET1i8" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"&gt;&lt;span style="font-size: 10pt"&gt;1.26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zf7OTzzqRKrl" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"&gt;&lt;span style="font-size: 10pt"&gt;(0.02&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331_z8dneKmKuTV7" style="padding-right: 1.45pt; text-align: right" title="Loss per common share, basic and diluted"&gt;&lt;span style="font-size: 10pt"&gt;1.24&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</srt:ScheduleOfCondensedIncomeStatementTableTextBlock>
    <us-gaap:OtherGeneralExpense
      contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">26220000</us-gaap:OtherGeneralExpense>
    <us-gaap:OtherGeneralExpense
      contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">861000</us-gaap:OtherGeneralExpense>
    <us-gaap:OtherGeneralExpense
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">25359000</us-gaap:OtherGeneralExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">29192000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">-861000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">28331000</us-gaap:OperatingExpenses>
    <niobf:ChangeInFairValueOfWarrantLiability
      contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">-784000</niobf:ChangeInFairValueOfWarrantLiability>
    <niobf:ChangeInFairValueOfWarrantLiability
      contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">-196000</niobf:ChangeInFairValueOfWarrantLiability>
    <niobf:ChangeInFairValueOfWarrantLiability
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">-980000</niobf:ChangeInFairValueOfWarrantLiability>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">29621000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">-665000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">29435000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">-665000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">28770000</us-gaap:NetIncomeLoss>
    <niobf:ProfitLoss1
      contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">29343000</niobf:ProfitLoss1>
    <niobf:ProfitLoss1
      contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">-665000</niobf:ProfitLoss1>
    <niobf:ProfitLoss1
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">28678000</niobf:ProfitLoss1>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">29323000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">-665000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">28658000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxParent
      contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">29231000</us-gaap:OciEquityMethodInvestmentBeforeTaxParent>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxParent
      contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">-665000</us-gaap:OciEquityMethodInvestmentBeforeTaxParent>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxParent
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">28566000</us-gaap:OciEquityMethodInvestmentBeforeTaxParent>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2023-01-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="USDPShares">1.00</niobf:EarningsLossPerShareBasicAndDiluted>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2023-01-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="INF"
      unitRef="USDPShares">-0.02</niobf:EarningsLossPerShareBasicAndDiluted>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2023-01-012023-03-31"
      decimals="INF"
      unitRef="USDPShares">0.98</niobf:EarningsLossPerShareBasicAndDiluted>
    <us-gaap:OtherGeneralExpense
      contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">26888000</us-gaap:OtherGeneralExpense>
    <us-gaap:OtherGeneralExpense
      contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">861000</us-gaap:OtherGeneralExpense>
    <us-gaap:OtherGeneralExpense
      contextRef="From2022-07-012023-03-31"
      decimals="-3"
      unitRef="USD">26027000</us-gaap:OtherGeneralExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">33475000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">-861000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-07-012023-03-31"
      decimals="-3"
      unitRef="USD">32614000</us-gaap:OperatingExpenses>
    <niobf:ChangeInFairValueOfWarrantLiability
      contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">-868000</niobf:ChangeInFairValueOfWarrantLiability>
    <niobf:ChangeInFairValueOfWarrantLiability
      contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">-196000</niobf:ChangeInFairValueOfWarrantLiability>
    <niobf:ChangeInFairValueOfWarrantLiability
      contextRef="From2022-07-012023-03-31"
      decimals="-3"
      unitRef="USD">-1064000</niobf:ChangeInFairValueOfWarrantLiability>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">35927000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">-665000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <niobf:ProfitLoss1
      contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">35649000</niobf:ProfitLoss1>
    <niobf:ProfitLoss1
      contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">-665000</niobf:ProfitLoss1>
    <niobf:ProfitLoss1
      contextRef="From2022-07-012023-03-31"
      decimals="-3"
      unitRef="USD">34984000</niobf:ProfitLoss1>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">35659000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">-665000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2022-07-012023-03-31"
      decimals="-3"
      unitRef="USD">34994000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxParent
      contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">35567000</us-gaap:OciEquityMethodInvestmentBeforeTaxParent>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxParent
      contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">-665000</us-gaap:OciEquityMethodInvestmentBeforeTaxParent>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxParent
      contextRef="From2022-07-012023-03-31"
      decimals="-3"
      unitRef="USD">34902000</us-gaap:OciEquityMethodInvestmentBeforeTaxParent>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="USDPShares">1.26</niobf:EarningsLossPerShareBasicAndDiluted>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="INF"
      unitRef="USDPShares">-0.02</niobf:EarningsLossPerShareBasicAndDiluted>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2022-07-012023-03-31"
      decimals="INF"
      unitRef="USDPShares">1.24</niobf:EarningsLossPerShareBasicAndDiluted>
    <srt:ScheduleOfCondensedCashFlowStatementTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_892_esrt--ScheduleOfCondensedCashFlowStatementTableTextBlock_zAD57VdDtUPi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Revision Impacts to the Condensed Consolidated
Statement of Cash Flows (unaudited)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;For the Nine Months Ended March 31,
2023&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B5_z14eJLyY15d8" style="display: none; visibility: hidden"&gt;Revision Impacts to the Condensed
Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023&lt;/span&gt;&#160;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;As Previously&lt;br/&gt;
 Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revision&lt;br/&gt;
 Impacts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Revised&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;CASH FLOWS FROM OPERATING ACTIVITIES&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Net loss for the period&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zbiFHIIS78Sh" style="width: 12%; text-align: right"&gt;(35,741&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zSvmIcP42Hzg" style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1022"&gt;665&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230331_zfmGaN4AcFT2" style="width: 12%; text-align: right"&gt;(35,076&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Initial valuation of warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwjsL1DGD204" style="text-align: right"&gt;3,848&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zIqZuI2UrFOg" style="text-align: right"&gt;(861&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AssumptionOfPrivateAndPublicWarrants_pn3n3_c20220701__20230331_zswoFw4mvRbh" style="text-align: right"&gt;2,987&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Change in fair value of warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zUapaVmlhvAi" style="text-align: right"&gt;868&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zbjfLsqFDSz4" style="text-align: right"&gt;196&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230331_zAf3FS7vazv5" style="text-align: right"&gt;1,064&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</srt:ScheduleOfCondensedCashFlowStatementTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">-35741000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-03-31"
      decimals="-3"
      unitRef="USD">-35076000</us-gaap:NetIncomeLoss>
    <niobf:AssumptionOfPrivateAndPublicWarrants
      contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">3848000</niobf:AssumptionOfPrivateAndPublicWarrants>
    <niobf:AssumptionOfPrivateAndPublicWarrants
      contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">-861000</niobf:AssumptionOfPrivateAndPublicWarrants>
    <niobf:AssumptionOfPrivateAndPublicWarrants
      contextRef="From2022-07-012023-03-31"
      decimals="-3"
      unitRef="USD">2987000</niobf:AssumptionOfPrivateAndPublicWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      unitRef="USD">868000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-07-012023-03-31_srt_RestatementAdjustmentMember"
      decimals="-3"
      unitRef="USD">196000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-07-012023-03-31"
      decimals="-3"
      unitRef="USD">1064000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_809_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zLcWb8o9mKX" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82C_zWsorQxy2Sw5"&gt;GOING
CONCERN ISSUES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;The Company incurred a net
loss of $&lt;span id="xdx_904_eus-gaap--NetIncomeLoss_iN_pn3n3_dixL_c20220701__20230630_z95LpGxjfJTc" title="Net loss::XDX::40308"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1033"&gt;40,080&lt;/span&gt;&lt;/span&gt;
for the year ended June 30, 2023 (2022 - $&lt;span id="xdx_90A_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20210701__20220630_zm50D2uTuljf"&gt;10,887&lt;/span&gt;
and 2021 - $&lt;span id="xdx_906_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20200701__20210630_zr16DatHZEIa"&gt;4,824&lt;/span&gt;) and had an
accumulated deficit of $150,477 as of June 30, 2023. As a development stage issuer, the Company has not yet commenced its
mining operations and accordingly does not generate any revenue. As of June 30, 2023, the Company had cash and cash
equivalents of $&lt;span id="xdx_905_ecustom--CashAndCashEquivalentsAtCarryingValue1_pn3n3_c20220701__20230630_zlk3LqB0Ukx3" title="Cash"&gt;2,341&lt;/span&gt;
which is not sufficient to fund normal operations for the next twelve months without deferring payment on certain liabilities
or raising additional funds. In addition, the Company will be required to raise additional funds for construction and
commencement of operations. These factors raise substantial doubt about the Company's ability to continue as a going
concern.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s ability to continue operations and fund its expenditures, which have historically averaged approximately $&lt;span id="xdx_905_eus-gaap--CapitalExpenditureDiscontinuedOperations_pn3n3_c20220701__20230630_zwvALqZIP4rl" title="Capital expenditure of operations"&gt;2,350&lt;/span&gt;
per quarter over the preceding three-year period, is dependent on management&#x2019;s ability to secure additional financing. NioCorp
expects to have access to up to $62,577 in net proceeds from the Yorkville Equity Facility Financing through April 1, 2026, as
discussed in Note 11d. Management is actively pursuing additional sources of financing, and while it has been successful in doing
so in the past, there can be no assurance it will be able to do so in the future. Other than the potential issuance of Common
Shares under the Yorkville Equity Facility Financing Agreement, the Company did not have any further funding commitments or arrangements
for additional financing as of June 30, 2023. These consolidated financial statements do not give effect to any adjustments required
to realize the Company&#x2019;s assets and discharge its liabilities in other than the normal course of business and at amounts
different from those reflected in the accompanying consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Recent
worldwide events have created general global economic uncertainty as well as uncertainty in capital markets, supply chain disruptions,
increased interest rates and inflation, and the potential for geographic recessions. We believe this could have an adverse impact
on our ability to obtain financing, development plans, results of operations, financial position, and cash flows during the current
fiscal year. The full extent to which these events and our precautionary measures may continue to impact our business will depend
on future developments, which continue to be highly uncertain and cannot be predicted at this time.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-10887000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-4824000</us-gaap:NetIncomeLoss>
    <niobf:CashAndCashEquivalentsAtCarryingValue1
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">2341000</niobf:CashAndCashEquivalentsAtCarryingValue1>
    <us-gaap:CapitalExpenditureDiscontinuedOperations
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">2350000</us-gaap:CapitalExpenditureDiscontinuedOperations>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_80D_eus-gaap--BusinessCombinationDisclosureTextBlock_z9SfwsdJ3Pub" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_824_z9yZruc9YKJe"&gt;GXII
TRANSACTION&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Business Combination Agreement, the following transactions (collectively, the &#x201c;GXII Transaction&#x201d;) occurred
on the Closing Date:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As a
    result of a series of transactions, GXII became an indirect, majority-owned subsidiary of NioCorp and changed its name to
    &#x201c;Elk Creek Resources Corp&#x201d; (&#x201c;ECRC&#x201d;).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As the
    parent company of the merged entity, NioCorp issued &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zF3WK2UBrCLh" title="Post reverse stock split shares"&gt;1,753,821&lt;/span&gt; post-Reverse Stock Split Common Shares in exchange for all of
    the Class A shares of GXII issued and outstanding immediately prior to the Closing, including 83,770 Common Shares issued
    to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory services.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 4%"&gt;&lt;/td&gt;&lt;td style="width: 2%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 94%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
of the Class B shares of GXII issued and outstanding immediately prior to the Closing (after giving effect to the surrender of
certain Class B shares of GXII in accordance with the Sponsor Support Agreement, dated September 25, 2022 (the &#x201c;Sponsor
Support Agreement&#x201d;), among GX Sponsor II LLC (the &#x201c;Sponsor&#x201d;), GXII, NioCorp and the other persons party thereto)
were converted into &lt;span id="xdx_905_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z6QXjdC2aSF4" title="Convertible shares issued upon conversion"&gt;7,957,404&lt;/span&gt; shares of Class B common stock of GXII (now known as ECRC) as the surviving entity of the mergers
that occurred on the Closing Date as part of the GXII Transaction. Pursuant to the Business Combination Agreement, the Sponsor
Support Agreement and the Exchange Agreement, dated as of March 17, 2023 (as amended, supplemented or&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;









&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 4%"&gt;&lt;/td&gt;&lt;td style="width: 2%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 94%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;otherwise
modified, the &#x201c;Exchange Agreement&#x201d;), by and among NioCorp, ECRC and the Sponsor, after the Closing, the shares of
Class B common stock of ECRC are exchangeable into Common Shares on a one-for-one basis, subject to certain equitable adjustments,
under certain conditions. See Note 10 for additional information regarding the Class B common stock of ECRC.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NioCorp
    assumed GXII&#x2019;s obligations under the agreement (the &#x201c;GXII Warrant Agreement&#x201d;) governing the GXII share purchase
    warrants (the &#x201c;GXII Warrants&#x201d;) and issued an aggregate of &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_uShares_c20220701__20230630__us-gaap--TypeOfArrangementAxis__custom--WarrantAgreementMember_znPigioY0J14" title="Number of shares purchase"&gt;15,666,626&lt;/span&gt; warrants (the &#x201c;NioCorp Assumed Warrants&#x201d;)
    to purchase up to an aggregate of &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zu6Tsga72Ia2" title="Number of shares purchase"&gt;17,519,864&lt;/span&gt; Common Shares. See Note 11c for additional information regarding the NioCorp
    Assumed Warrants. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_89A_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_z9CjNvrGM0e4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;After the distribution of funds
to GXII redeeming shareholders and prior to paying transaction costs incurred by GXII, $15,676 became available to the Company.
&lt;span id="xdx_8BE_zvhGq16e8iea"&gt;The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and
Comprehensive Loss:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20230630_zydPUvNnpwol" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_iI_pn3n3_zi0eb6gtxIYf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 86%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Gross
    cash proceeds, net of transaction costs incurred by GXII&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,168&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB_zqHqMzG2Qip2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash costs associated
    with the Transactions:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn3n3_z24wOkhvP1ji" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    liabilities assumed&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;392&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_iI_pn3n3_z6nv4M3osFH7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Yorkville
    Equity Facility Financing Agreement &#x2013; cash costs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,996&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed_iI_pn3n3_zX4CJRueMW81" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transaction
    costs expensed&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,715&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iI_pn3n3_zqR7ry9TQbt" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-cash
    costs associated with the Transactions:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_iI_pn3n3_zy9on14pDKJ1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Private
    Warrants assumed at fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,987&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--EarnoutSharesAssumedAtFairValue_iI_pn3n3_zJLWY7ZDo5T4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
    Shares assumed at fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,195&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_iI_pn3n3_zjAL0AcFA0Mj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Yorkville
    Equity Facility Financing Agreement &#x2013; shares issued&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;650&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pn3n3_z5waYAziiy0e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Total
    transaction related losses incurred&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23,767&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A7_zjosdUgRMnC8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_zbKtToD2JDGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8BC_zChDr8AQQFsa"&gt;The
number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Common
    Shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Percentage&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Legacy
    NioCorp Shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zblr1nfAaEMc" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Common stock, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;28,246,621&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zAMBpxdjXG18" title="Number of shares, percentage"&gt;93.90&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Former GXII Class
    A Shareholders&lt;sup id="xdx_F4D_zq4h1nGPSVFe"&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zuEcaxWXZuc9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,753,821&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zujXQR4VrIz" title="Number of shares, percentage"&gt;5.83&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other&lt;sup id="xdx_F46_zjJHsG8GU2Ul"&gt;2&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--TransactionTypeAxis__custom--OtherMember_fMg_____zHyFaChf1lsc" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;81,213&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--OtherMember_fMg_____zHSj89FhogG9" title="Number of shares, percentage"&gt;0.27&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Common Shares Outstanding Upon Completion of Transactions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--CommonStockSharesOutstanding_iI_pid_dxL_uShares_c20230630_zfZfNceSkSYg" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Common stock, shares outstanding::XDX::31202131"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1091"&gt;30,081,655&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630_z0F1g9xEQJMf" title="Number of shares, percentage"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F06_zSHFFoRWnGE5" style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"&gt;&lt;span id="xdx_F1F_zHUfU4stxzw" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory
    services.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span id="xdx_F0F_zbck7w8k0Zlf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"&gt;&lt;span id="xdx_F1C_zrGJJauUTbSk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    Commitment Shares (as defined in Note 11d) issued under the Yorkville Equity Facility Financing Agreement.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zXEze9knVenj" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the GXII Transaction, the Company also closed the Yorkville Convertible Debt Financing and the Yorkville Equity
Facility Financing, as discussed in Notes 9 and 11d.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1753821</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">7957404</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="From2022-07-012023-06-30_custom_WarrantAgreementMember"
      decimals="INF"
      unitRef="Shares">15666626</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">17519864</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <srt:ScheduleOfCondensedFinancialStatementsTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_89A_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_z9CjNvrGM0e4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;After the distribution of funds
to GXII redeeming shareholders and prior to paying transaction costs incurred by GXII, $15,676 became available to the Company.
&lt;span id="xdx_8BE_zvhGq16e8iea"&gt;The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and
Comprehensive Loss:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20230630_zydPUvNnpwol" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_iI_pn3n3_zi0eb6gtxIYf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 86%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Gross
    cash proceeds, net of transaction costs incurred by GXII&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,168&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB_zqHqMzG2Qip2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash costs associated
    with the Transactions:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn3n3_z24wOkhvP1ji" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    liabilities assumed&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;392&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts_iI_pn3n3_z6nv4M3osFH7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Yorkville
    Equity Facility Financing Agreement &#x2013; cash costs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,996&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed_iI_pn3n3_zX4CJRueMW81" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transaction
    costs expensed&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,715&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iI_pn3n3_zqR7ry9TQbt" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-cash
    costs associated with the Transactions:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_iI_pn3n3_zy9on14pDKJ1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Private
    Warrants assumed at fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,987&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--EarnoutSharesAssumedAtFairValue_iI_pn3n3_zJLWY7ZDo5T4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
    Shares assumed at fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,195&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_iI_pn3n3_zjAL0AcFA0Mj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Yorkville
    Equity Facility Financing Agreement &#x2013; shares issued&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;650&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pn3n3_z5waYAziiy0e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Total
    transaction related losses incurred&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23,767&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</srt:ScheduleOfCondensedFinancialStatementsTableTextBlock>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">2168000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">392000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <niobf:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">1996000</niobf:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">6715000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">2987000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <niobf:EarnoutSharesAssumedAtFairValue contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">13195000</niobf:EarnoutSharesAssumedAtFairValue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">650000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">23767000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_899_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_zbKtToD2JDGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8BC_zChDr8AQQFsa"&gt;The
number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Common
    Shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Percentage&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Legacy
    NioCorp Shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zblr1nfAaEMc" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Common stock, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;28,246,621&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--LegacyNioCorpShareholdersMember_zAMBpxdjXG18" title="Number of shares, percentage"&gt;93.90&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Former GXII Class
    A Shareholders&lt;sup id="xdx_F4D_zq4h1nGPSVFe"&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zuEcaxWXZuc9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,753,821&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--GXIIClassAShareholdersMember_fKDEp_zujXQR4VrIz" title="Number of shares, percentage"&gt;5.83&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other&lt;sup id="xdx_F46_zjJHsG8GU2Ul"&gt;2&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--TransactionTypeAxis__custom--OtherMember_fMg_____zHyFaChf1lsc" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;81,213&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--OtherMember_fMg_____zHSj89FhogG9" title="Number of shares, percentage"&gt;0.27&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Common Shares Outstanding Upon Completion of Transactions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--CommonStockSharesOutstanding_iI_pid_dxL_uShares_c20230630_zfZfNceSkSYg" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Common stock, shares outstanding::XDX::31202131"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1091"&gt;30,081,655&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_pid_dp_uPure_c20220701__20230630_z0F1g9xEQJMf" title="Number of shares, percentage"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F06_zSHFFoRWnGE5" style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"&gt;&lt;span id="xdx_F1F_zHUfU4stxzw" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory
    services.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span id="xdx_F0F_zbck7w8k0Zlf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"&gt;&lt;span id="xdx_F1C_zrGJJauUTbSk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    Commitment Shares (as defined in Note 11d) issued under the Yorkville Equity Facility Financing Agreement.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_custom_LegacyNioCorpShareholdersMember"
      decimals="INF"
      unitRef="Shares">28246621</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="From2022-07-012023-06-30_custom_LegacyNioCorpShareholdersMember"
      decimals="INF"
      unitRef="Pure">0.9390</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_custom_GXIIClassAShareholdersMember"
      decimals="INF"
      id="Fact001084"
      unitRef="Shares">1753821</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="From2022-07-012023-06-30_custom_GXIIClassAShareholdersMember"
      decimals="INF"
      id="Fact001086"
      unitRef="Pure">0.0583</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_custom_OtherMember"
      decimals="INF"
      id="Fact001087"
      unitRef="Shares">81213</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="From2022-07-012023-06-30_custom_OtherMember"
      decimals="INF"
      id="Fact001089"
      unitRef="Pure">0.0027</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">1</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_804_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zmIs9IX3eWr4" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_822_zucWIc4mFPB"&gt;LAND
AND BUILDINGS, NET&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_89D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zGhFjxhgoaWc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zZiUYWOT9gF9" style="display: none; visibility: hidden"&gt;Schedule of properties&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 88%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Accumulated &lt;br/&gt;
Depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Net&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Accumulated &lt;br/&gt;
Depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Net&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 22%"&gt;Land&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_z42PdFrA4Kb9" style="width: 8%; text-align: right" title="Cost"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_ztpb9xlhX1P8" style="width: 8%; text-align: right" title="Accumulated depreciation"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zOqlHn3igx1h" style="width: 8%; text-align: right" title="Net"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--LandMember_z5iltUQROLHd" style="width: 8%; text-align: right"&gt;811&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20220630__srt--ProductOrServiceAxis__us-gaap--LandMember_zLkf8dpBgTlf" style="width: 8%; text-align: right" title="Accumulated depreciation"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--LandMember_z1C8XJJ5l5Zg" style="width: 8%; text-align: right"&gt;811&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Buildings and other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zcN1WCL9Ex32" style="border-bottom: Black 1pt solid; text-align: right"&gt;41&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z5i9R6yq5L72" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"&gt;9&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zPntT9MgMbHi" style="border-bottom: Black 1pt solid; text-align: right"&gt;32&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zKSFFYWnr9a6" style="border-bottom: Black 1pt solid; text-align: right"&gt;45&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z0pT9THnmUUg" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"&gt;6&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z0ZyhguGbmci" style="border-bottom: Black 1pt solid; text-align: right"&gt;39&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630_zDawkaqFIqJi" style="border-bottom: Black 2pt solid; text-align: right"&gt;848&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630_zj8WiFxN8mbl" style="border-bottom: Black 2pt solid; text-align: right"&gt;9&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630_z2xaV7sFhdKi" style="border-bottom: Black 2pt solid; text-align: right"&gt;839&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20220630_zAKdMwYKhYO3" style="border-bottom: Black 2pt solid; text-align: right"&gt;856&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20220630_zFqpOv0VmhOg" style="border-bottom: Black 2pt solid; text-align: right"&gt;6&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20220630_zyH0LX1SuAUh" style="border-bottom: Black 2pt solid; text-align: right"&gt;850&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A2_zTtYVEODRovi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;













&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
October 2022, the Company entered into an agreement with the State of Nebraska (the &#x201c;State&#x201d;) to sell a strip
of Company-owned land totaling &lt;span id="xdx_905_eus-gaap--LandPurchaseOptionsDescription_c20221020__20221022__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandImprovementsMember_zSll8EhgNDe6" title="Description of owned land"&gt;approximately
1.27 acres located adjacent to State Highway 50&lt;/span&gt; in connection with highway improvements to be completed by the
State, for $&lt;span id="xdx_90D_eus-gaap--LandAndLandImprovements_iI_pn3n3_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandImprovementsMember_ziUHhAaU6mO6" title="Improvements state"&gt;21&lt;/span&gt;,
inclusive of estimated fence replacement costs. &lt;span id="xdx_90B_eus-gaap--LimitedPartnersCapitalAccountDescriptionOfUnits_c20221020__20221022__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandImprovementsMember_z69bFDbQyZ1c" title="Description of ownership of mineral rights"&gt;The Company retained ownership of the mineral rights associated with
this 1.27-acre parcel.&lt;/span&gt; The Company recorded a gain on
this sale of $&lt;span id="xdx_90F_eus-gaap--RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_iI_pn3n3_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandImprovementsMember_zwC5Yrxdzmy1" title="Other gains and comprehensive loss"&gt;13&lt;/span&gt; in other gains in the consolidated statement of operations and comprehensive loss.&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_89D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zGhFjxhgoaWc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zZiUYWOT9gF9" style="display: none; visibility: hidden"&gt;Schedule of properties&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 88%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Accumulated &lt;br/&gt;
Depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Net&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Accumulated &lt;br/&gt;
Depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Net&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 22%"&gt;Land&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_z42PdFrA4Kb9" style="width: 8%; text-align: right" title="Cost"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_ztpb9xlhX1P8" style="width: 8%; text-align: right" title="Accumulated depreciation"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--LandMember_zOqlHn3igx1h" style="width: 8%; text-align: right" title="Net"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--LandMember_z5iltUQROLHd" style="width: 8%; text-align: right"&gt;811&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20220630__srt--ProductOrServiceAxis__us-gaap--LandMember_zLkf8dpBgTlf" style="width: 8%; text-align: right" title="Accumulated depreciation"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--LandMember_z1C8XJJ5l5Zg" style="width: 8%; text-align: right"&gt;811&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Buildings and other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zcN1WCL9Ex32" style="border-bottom: Black 1pt solid; text-align: right"&gt;41&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z5i9R6yq5L72" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"&gt;9&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zPntT9MgMbHi" style="border-bottom: Black 1pt solid; text-align: right"&gt;32&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zKSFFYWnr9a6" style="border-bottom: Black 1pt solid; text-align: right"&gt;45&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z0pT9THnmUUg" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"&gt;6&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20220630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z0ZyhguGbmci" style="border-bottom: Black 1pt solid; text-align: right"&gt;39&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20230630_zDawkaqFIqJi" style="border-bottom: Black 2pt solid; text-align: right"&gt;848&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230630_zj8WiFxN8mbl" style="border-bottom: Black 2pt solid; text-align: right"&gt;9&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20230630_z2xaV7sFhdKi" style="border-bottom: Black 2pt solid; text-align: right"&gt;839&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20220630_zAKdMwYKhYO3" style="border-bottom: Black 2pt solid; text-align: right"&gt;856&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20220630_zFqpOv0VmhOg" style="border-bottom: Black 2pt solid; text-align: right"&gt;6&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20220630_zyH0LX1SuAUh" style="border-bottom: Black 2pt solid; text-align: right"&gt;850&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2023-06-30_us-gaap_LandMember"
      decimals="-3"
      unitRef="USD">807000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-06-30_us-gaap_LandMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-06-30_us-gaap_LandMember"
      decimals="-3"
      unitRef="USD">807000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2022-06-30_us-gaap_LandMember"
      decimals="-3"
      unitRef="USD">811000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-06-30_us-gaap_LandMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-06-30_us-gaap_LandMember"
      decimals="-3"
      unitRef="USD">811000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2023-06-30_us-gaap_BuildingMember"
      decimals="-3"
      unitRef="USD">41000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-06-30_us-gaap_BuildingMember"
      decimals="-3"
      unitRef="USD">9000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-06-30_us-gaap_BuildingMember"
      decimals="-3"
      unitRef="USD">32000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2022-06-30_us-gaap_BuildingMember"
      decimals="-3"
      unitRef="USD">45000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-06-30_us-gaap_BuildingMember"
      decimals="-3"
      unitRef="USD">6000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-06-30_us-gaap_BuildingMember"
      decimals="-3"
      unitRef="USD">39000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentOther contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">848000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">9000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">839000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentOther contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">856000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">6000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">850000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:LandPurchaseOptionsDescription contextRef="From2022-10-202022-10-22_us-gaap_LandImprovementsMember">approximately
1.27 acres located adjacent to State Highway 50</us-gaap:LandPurchaseOptionsDescription>
    <us-gaap:LandAndLandImprovements
      contextRef="AsOf2023-06-30_us-gaap_LandImprovementsMember"
      decimals="-3"
      unitRef="USD">21000</us-gaap:LandAndLandImprovements>
    <us-gaap:LimitedPartnersCapitalAccountDescriptionOfUnits contextRef="From2022-10-202022-10-22_us-gaap_LandImprovementsMember">The Company retained ownership of the mineral rights associated with
this 1.27-acre parcel.</us-gaap:LimitedPartnersCapitalAccountDescriptionOfUnits>
    <us-gaap:RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale
      contextRef="AsOf2023-06-30_us-gaap_LandImprovementsMember"
      decimals="-3"
      unitRef="USD">13000</us-gaap:RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale>
    <us-gaap:MineralIndustriesDisclosuresTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_80A_eus-gaap--MineralIndustriesDisclosuresTextBlock_zkV0EgU2ckFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82E_zSEqH8YWgOu1"&gt;MINERAL
PROPERTIES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended June 30, 2011, the Company completed the acquisition of the Elk Creek property through a share exchange agreement
with 0859404 BC Ltd, a Canadian company, which owned all the issued and outstanding shares of ECRC. The Company issued &lt;span id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_uShares_c20110628__20110630__dei--LegalEntityAxis__custom--Entity0896800BCLtdMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ElkCreekResourcesCorpMember_zoA4J4fV08k5" title="Shares issue for acquistion"&gt;1,899,053&lt;/span&gt;
Common Shares to acquire all of the issued and outstanding shares of 0859404 BC Ltd. and issued &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_uShares_c20110628__20110630__dei--LegalEntityAxis__custom--Entity0896800BCLtdMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zskx8stSAGS2" title="Shares issue for acquistion"&gt;103,434&lt;/span&gt; Common Shares as a finder&#x2019;s
fee with respect to the acquisition. The transaction did not meet the definition of a business acquisition, as set forth in ASC
805, &#x201c;Business Combinations,&#x201d; and therefore was accounted for as a purchase of assets. The acquisition price was based
on the market value of the Company&#x2019;s Common Shares on the closing date and total consideration given was C$&lt;span id="xdx_90A_eus-gaap--BusinessCombinationConsiderationTransferred1_c20110628__20110630__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--CurrencyAxis__currency--CAD_zUTJF5VA8Sul" title="Total consideration"&gt;13,246&lt;/span&gt;, including
associated deferred tax impacts of C$&lt;span id="xdx_907_ecustom--DeferredTaxImpacts_iI_c20110630__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--CurrencyAxis__currency--CAD_zGll8ZyVofF6" title="Deferred tax"&gt;4,736&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 23, 2021, ECRC formally closed the purchase of two parcels of land and associated buildings and mineral rights in Johnson
County, Nebraska, associated with the Elk Creek Project, pursuant to an Amended and Restated Option to Purchase, dated as of April
29, 2020 (the &#x201c;Option Agreement&#x201d;). Pursuant to the terms of the Option Agreement, the Owner sold, transferred, conveyed
and assigned all of the rights, privileges, title and interest in and to the real property to ECRC, including any associated mineral
rights. The Option Agreement provided for a purchase price calculated based on the appraised value per acre of the parcels of
land, the mineral rights and the structures erected on the land. The purchase price was approximately $&lt;span id="xdx_908_eus-gaap--SupplementalDeferredPurchasePrice_pn3n3_c20210421__20210423__us-gaap--TypeOfArrangementAxis__custom--OptionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ElkCreekResourcesCorpMember_zfkr8cnOfgTk" title="Purchase price"&gt;6,300&lt;/span&gt;, including indirect
costs of $&lt;span id="xdx_908_eus-gaap--AmortizationOfAcquisitionCosts_pn3n3_c20210421__20210423__us-gaap--TypeOfArrangementAxis__custom--OptionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ElkCreekResourcesCorpMember_z3XUFPDExpha" title="Indirect costs"&gt;57&lt;/span&gt;. Of this amount, $&lt;span id="xdx_901_eus-gaap--PaymentsToAcquireMineralRights_pn3n3_c20210421__20210423__us-gaap--TypeOfArrangementAxis__custom--OptionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ElkCreekResourcesCorpMember_zMpNOXBDsR6l" title="Other amount"&gt;837&lt;/span&gt; was allocated to land and buildings and the remaining $&lt;span id="xdx_902_eus-gaap--PaymentsToAcquireBuildings_pn3n3_c20210421__20210423__us-gaap--TypeOfArrangementAxis__custom--OptionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--ElkCreekResourcesCorpMember_zVBNe7tUA8Mf" title="Remaining balance"&gt;5,468&lt;/span&gt; was allocated to mineral properties
as costs related to mineral rights acquisition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition to the land and mineral rights currently owned by the Company, the property interests of Elk Creek include eight prepaid
mineral exploration option-to-purchase agreements and include a pre-determined buyout for permanent ownership of the mineral and/or
surface rights. Terms of the agreements require no further significant payments, and the Company may negotiate lease extensions
or elect to purchase the mineral and/or surface rights any time. Agreements that allow for the purchase of mineral rights contain
provisions whereby the landowners would retain a 2% net smelter return.&lt;/span&gt;&lt;/p&gt;

</us-gaap:MineralIndustriesDisclosuresTextBlock>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2011-06-282011-06-30_custom_Entity0896800BCLtdMember_custom_ShareExchangeAgreementMember_custom_ElkCreekResourcesCorpMember"
      decimals="INF"
      unitRef="Shares">1899053</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2011-06-282011-06-30_custom_Entity0896800BCLtdMember_custom_ShareExchangeAgreementMember"
      decimals="INF"
      unitRef="Shares">103434</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2011-06-282011-06-30_custom_ShareExchangeAgreementMember_currency_CAD"
      decimals="0"
      unitRef="USD">13246</us-gaap:BusinessCombinationConsiderationTransferred1>
    <niobf:DeferredTaxImpacts
      contextRef="AsOf2011-06-30_custom_ShareExchangeAgreementMember_currency_CAD"
      decimals="0"
      unitRef="USD">4736</niobf:DeferredTaxImpacts>
    <us-gaap:SupplementalDeferredPurchasePrice
      contextRef="From2021-04-212021-04-23_custom_OptionAgreementMember_custom_ElkCreekResourcesCorpMember"
      decimals="-3"
      unitRef="USD">6300000</us-gaap:SupplementalDeferredPurchasePrice>
    <us-gaap:AmortizationOfAcquisitionCosts
      contextRef="From2021-04-212021-04-23_custom_OptionAgreementMember_custom_ElkCreekResourcesCorpMember"
      decimals="-3"
      unitRef="USD">57000</us-gaap:AmortizationOfAcquisitionCosts>
    <us-gaap:PaymentsToAcquireMineralRights
      contextRef="From2021-04-212021-04-23_custom_OptionAgreementMember_custom_ElkCreekResourcesCorpMember"
      decimals="-3"
      unitRef="USD">837000</us-gaap:PaymentsToAcquireMineralRights>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="From2021-04-212021-04-23_custom_OptionAgreementMember_custom_ElkCreekResourcesCorpMember"
      decimals="-3"
      unitRef="USD">5468000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_809_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zmTVc3u3wGK4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_820_zcRwatizURve"&gt;ACCOUNTS
PAYABLE AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z1e7O7549m0k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zYDi55cjSCFd" style="display: none; visibility: hidden"&gt;Schedule of account payable and accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20230630_zIIEHiJUSMx5" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20220630_zjMc309MDUic" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zsNd0OmDJeVk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: left"&gt;Accounts payable, trade&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,990&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;115&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_z0V4FV6YzPQk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade payable accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,324&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;654&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pn3n3_zep4RcGMjWx5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Income taxes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1168"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_zwATtYBQqDs" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Environmental accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zJ5vNWYcI1ra" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Loan origination fees payable to related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;28&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1174"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_zFXGY51Hqnme" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;Total accounts payable and accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;3,491&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;817&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AF_zeIf9U2UihB7" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_89F_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z1e7O7549m0k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zYDi55cjSCFd" style="display: none; visibility: hidden"&gt;Schedule of account payable and accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20230630_zIIEHiJUSMx5" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20220630_zjMc309MDUic" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zsNd0OmDJeVk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: left"&gt;Accounts payable, trade&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,990&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;115&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_z0V4FV6YzPQk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade payable accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,324&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;654&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pn3n3_zep4RcGMjWx5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Income taxes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1168"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_zwATtYBQqDs" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Environmental accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zJ5vNWYcI1ra" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Loan origination fees payable to related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;28&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1174"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_zFXGY51Hqnme" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;Total accounts payable and accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;3,491&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;817&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableTradeCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">1990000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">115000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">1324000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">654000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">101000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">48000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">48000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">28000</us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">3491000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">817000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_809_eus-gaap--LongTermDebtTextBlock_zmuFTRNDSBLd" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_824_zUsEcAkXL1I1"&gt;CONVERTIBLE
DEBT&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_89A_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_zUSiT4NvRe3g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zBH3fghWdisc" style="display: none; visibility: hidden"&gt;Schedule of convertible debt&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Current Portion:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 74%; text-align: left; padding-bottom: 2pt; padding-left: 0.125in"&gt;Lind III convertible security&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zhnvuGIQ2UWd" style="border-bottom: Black 2pt solid; width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1182"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_z9YihaD2wON3" style="border-bottom: Black 2pt solid; width: 10%; text-align: right" title="Convertibled debt, current"&gt;2,169&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Noncurrent Portion:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in"&gt;Yorkville convertible debentures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zNTGr70ljNWl" style="border-bottom: Black 2pt solid; text-align: right" title="Convertible debt, noncurrent"&gt;10,561&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_z4rC220ZElx4" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1187"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AF_zqmqzEZG3br5" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;









&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Lind
III Convertible Security&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 16, 2021, the Company issued to Lind Global Asset Management III, LLC (&#x201c;Lind&#x201d;), an entity managed by The
Lind Partners, the convertible security (the &#x201c;Lind III Convertible Security&#x201d;) pursuant to the Convertible Security
Funding Agreement, dated February 16, 2021, as amended by Amendment #1 to the Convertible Security Funding Agreement, dated December
2, 2021, between the Company and Lind (as amended, the &#x201c;Lind III Agreement&#x201d;). The Lind III Convertible Security had
a face value of $&lt;span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_pn3n3_c20210216__20210219_zMs27KE2NSb8" title="Face value"&gt;11,700&lt;/span&gt; (representing $10,000 in funding plus an implied &lt;span id="xdx_90E_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20210219_z8GP56PSQo3h"&gt;8.5&lt;/span&gt;% interest rate per annum for the term of the Lind
III Convertible Security). After deducting a $&lt;span id="xdx_902_eus-gaap--OtherCommitment_iI_pn3n3_c20210219_zcjKoUQMbYP5" title="Commitment fee"&gt;350&lt;/span&gt; commitment fee as set forth in the Lind III Agreement, NioCorp received net
proceeds of $&lt;span id="xdx_907_eus-gaap--ProceedsFromInterestReceived_pn3n3_c20210216__20210219_za7FmcpdHEY1" title="Net proceeds"&gt;9,650&lt;/span&gt; from the funding of the Lind III Convertible Security. The Company used a portion of the proceeds from the
funding of the Lind III Convertible Security to purchase a key land parcel associated with the Company&#x2019;s Elk Creek Project,
with the remainder spent for general corporate purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Lind III Convertible Security had a term of (i) &lt;span id="xdx_905_eus-gaap--LongTermDebtTerm_iI_dxL_c20230630_zFOdKmktzaof" title="Long term debt duration::XDX::P24M"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1201"&gt;24 months&lt;/span&gt;&lt;/span&gt; or (ii) 30 calendar days after the date on which the face value of the
Lind III Convertible Security is nil due to such amount having been fully converted and/or fully repaid (including with any applicable
premium) in accordance with the terms of the Lind III Agreement, whichever is earlier.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--DebtConversionDescription_c20220701__20230630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zvZS5dxwI1th"&gt;Pursuant
to the Lind III Agreement, Lind was entitled to convert the Lind III Convertible Security into Common Shares in monthly installments
over its term at a price per Common Share equal to 85% of the volume-weighted average price Common Shares on the TSX for the five
trading days immediately preceding to the date on which Lind provides notice to the Company of its election to convert. The Lind
III Agreement provided that Common Shares issuable upon conversion, together with the number of Common Shares issued upon exercise
of Warrants, shall not exceed 4,358,800 Common Shares.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 19, 2021, in connection with the funding and issuance of the Lind III Convertible Security, the Company issued &lt;span id="xdx_90A_eus-gaap--CommonUnitIssued_iI_uShares_c20210219_zINwzHsfK7M8" title="Common share purchase warrants"&gt;855,800&lt;/span&gt;
Common Share purchase warrants, exercisable at a price per Common Share of C$&lt;span id="xdx_90A_eus-gaap--AcceleratedShareRepurchasesFinalPricePaidPerShare_uCADPShares_c20220701__20230630_zq4W1bzY2244" title="Exercisable at a price per share"&gt;9.70&lt;/span&gt;, expiring February 19, 2025 (the &#x201c;Lind
III Warrants&#x201d;), to Lind pursuant to the Lind III Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company identified embedded derivatives in the Lind III Convertible Security that were evaluated to be immaterial at both the
closing date and at June 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company allocated the net proceeds of $&lt;span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_pn3n3_uUSD_c20220701__20230630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_zL2884ZHBN3h"&gt;9,477&lt;/span&gt; from the Lind III Convertible Security as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 92%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$1,712
    was allocated to Common Stock, representing the fair value of the Lind III Warrants based on the Black Scholes pricing model
    using a risk-free interest rate of &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220701__20230630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zndmK0KPqpej" title="Risk-free interest rate"&gt;0.40&lt;/span&gt;%, an expected dividend yield of &lt;span id="xdx_904_eus-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate_dp_uPure_c20220701__20230630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zisNboMX9e12" title="Expected dividend yield"&gt;0&lt;/span&gt;%, a volatility of &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20220701__20230630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zdaQRfBBDR6h" title="Volatility"&gt;51.60&lt;/span&gt;%, and an expected life of
    &lt;span id="xdx_90B_eus-gaap--IntermediateLifePlantsUsefulLife_dxL_c20220701__20230630__us-gaap--DebtInstrumentAxis__custom--LindIIIConvertibleSecurityMember_zkPPzNmd6Dkd" title="Expected life::XDX::P4Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1215"&gt;4.0&lt;/span&gt;&lt;/span&gt; years. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_906_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_zg3wzUTExwFb" title="Convertible debt liabilit"&gt;7,938&lt;/span&gt;
    was allocated     to the convertible debt liability. Transaction costs of $&lt;span id="xdx_90B_ecustom--TransactionCost_pn3n3_uUSD_c20220701__20230630__dei--LegalEntityAxis__custom--LindIIIConvertibleSecurityMember_zjh0PQ1UdQf" title="Transaction costs"&gt;173&lt;/span&gt;,
    in addition to a commitment fee of $&lt;span id="xdx_90A_eus-gaap--LineOfCreditFacilityCommitmentFeeAmount_pn3n3_c20210217__20210219_zRt1Br5sH0b9" title="Commitment fee"&gt;350&lt;/span&gt;,
    were recognized as     a direct deduction from the debt liability, resulting in a net opening balance of $7,765. This balance
    was accreted up to the     face value of the Lind III Convertible Security at maturity using the effective interest method
    and recorded as non-cash interest     expense in the consolidated statement of operations and comprehensive loss.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_zyp1AW0UCzuf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8BE_zi34CDBBr5Id"&gt;Changes
in the Lind III Convertible Security are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 96%; border-collapse: collapse; margin-left: 0.25in"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the year ending June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 76%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Beginning
    balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ConvertibleDebtNoncurrent_iS_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zCTOxUoUgvF9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 9%; padding-right: 2.15pt; text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,169&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ConvertibleDebtNoncurrent_iS_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_ztl48kYD14fl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 9%; padding-right: 2.15pt; text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,234&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value increase due to debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ExtinguishmentOfDebtAmount_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zPzm8jDMfutc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Fair value increase due to debt extinguishment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;201&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ExtinguishmentOfDebtAmount_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_z3ND6dZqhpJ5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Fair value increase due to debt extinguishment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1231"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Conversions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ConversionOfStockAmountIssued1_iN_pn3n3_di_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zXftOjtSPul4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Conversions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,950&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ConversionOfStockAmountIssued1_iN_pn3n3_di_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_z1TaagufMIkj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Conversions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(7,635&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accretion
    expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--AccretionExpense_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zAvlxooLaGEg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Accretion expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;95&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--AccretionExpense_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zFbeAgOnBgTf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Accretion expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,570&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payment
    at maturity&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--PaymentsToAcquireHeldToMaturitySecurities_iN_pn3n3_di_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zAIIAHMbyiB4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Payment at maturity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(515&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--PaymentsToAcquireHeldToMaturitySecurities_iN_pn3n3_di_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zfuNpY3yvWCf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Payment at maturity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1243"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance,
    end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ConvertibleDebtCurrent_iE_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zmMhJgGF2gw" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1245"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertibleDebtCurrent_iE_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zGoaMNvaZTp7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,169&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zn6WDJAorPbj" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;


&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;









&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;On
September 25, 2022, the Company and Lind entered into the Waiver and Consent Agreement, dated September 25, 2022, between the
Company and Lind (the &#x201c;Lind Consent&#x201d;), which included the following principal terms: (i) the consent of Lind to the
GXII Transaction disclosed in Note 5 and Yorkville Financings disclosed below and in Note 11d, including all actions taken by
NioCorp as set out in the Business Combination Agreement to permit the completion of the Transactions; (ii) the consent of Lind
to NioCorp&#x2019;s expected cross-listing to the Nasdaq and the consolidation of the Common Shares in order to meet the minimum
listing requirements thereof; (iii) the waiver of Lind of its participation right for up to 15% of the total offering in the Yorkville
Equity Facility Financing; and (iv) the waiver of Lind of certain restrictive covenants in the Lind III Agreement.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;As consideration for entering into the
Lind Consent, Lind received, amongst other things: (i) the right to receive a payment of $500, which would have been reduced to
$200 if the Transactions had not been consummated on or before April 30, 2023 (collectively, the &#x201c;Consent Payment&#x201d;);
(ii) an extension of its existing participation rights under the Lind III Agreement in future financings of NioCorp for a further
two-year period, subject to certain exceptions as well as an extension of such participation rights beyond the additional two-year
period if Yorkville or any affiliate is a party to any such applicable transaction; and (iii) the right to receive additional Warrants
(the &#x201c;Contingent Consent Warrants&#x201d;) if on the date that is 18 months following the Closing Date, the closing trading
price of the Common Shares on the TSX or such other stock exchange on which such shares may then be listed, is less than C$10.00
(on a post-Reverse Stock Split basis), subject to adjustments. The number of Contingent Consent Warrants to be issued, if any,
is based on the Canadian dollar equivalent (based on the then current Canadian to US dollar exchange rate as reported by Bloomberg,
LP) of $5,000 divided by the five-day volume weighted average price of the Common Shares on the date of issuance. Further, the
number of Contingent Consent Warrants issued will be proportionately adjusted based on the percentage of Warrants currently held
by Lind that are exercised, if any, prior to the issuance of any Contingent Consent Warrants. The Lind Consent was signed as an
amendment to the existing Lind III Agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;Management determined that the Lind
Consent should be evaluated using ASC 470, which requires an evaluation of the contract amendment under debt modification guidance.
The Company performed a comparison of the discounted cash flows of the Lind III Convertible Security pursuant to the existing Lind
III Agreement and pursuant to the Lind III Agreement as amended by the Lind Consent and determined that a debt extinguishment loss
of $201 had occurred. Further, ASC 470 requires that the minimum estimated Consent Payment of $200 also be included in the calculation
of the initial loss on debt extinguishment. The Company also evaluated the Contingent Consent Warrant feature included in the Lind
Consent and determined that the Contingent Consent Warrants meet the criteria to be considered separate, freestanding instruments,
should be accounted for as a liability under ASC 480, and should be booked at fair value on the date of the Lind Consent, with
subsequent changes in valuation recorded as a non-operating gain or loss in the consolidated statement of operations and comprehensive
loss. The following table summarizes the components of the initial loss and final loss on extinguishment:&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfExtinguishmentOfDebtTextBlock_zYU5vveFJy19" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zZdiXHfZmexk" style="display: none; visibility: hidden"&gt;The following table summarizes the components of the initial loss on extinguishment:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Component of loss&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220701__20230630_zCQ2gBMelhq1" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--MinimumConsentPaymentAtInception_pn3n3_zxbnNXF91ZK7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 87%; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Minimum
    Consent Payment at inception&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;200&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--ASC470LossOnExtinguishment_pn3n3_zRQsTefxPyKe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;201&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--AdjustmentOfWarrantsGrantedForServices_pn3n3_zrvjgz1hSOIk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
    fair value of Contingent Consent Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,221&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_pn3n3_z21HTd1Pjnw" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
    loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,622&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--AdditionalConsentPaymentbooked_pn3n3_z9OTwYiXhEi8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additional
    Consent Payment booked&lt;sup id="xdx_F4E_zLIhWIcwEZ78"&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;300&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--GainsLossesOnRestructuringOfDebt_pn3n3_zBCMP29s6eCa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,922&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 5%; padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 5.4pt; text-align: justify"&gt;&lt;span id="xdx_F05_zWiHKFp67EBa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 93%; padding-right: 5.4pt; text-align: justify"&gt;&lt;span id="xdx_F16_znGdMSE09cad" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    the difference between the accrual of the minimum Consent Payment at September 25, 2022 and the actual payment made on March
    17, 2023.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8AF_z0bggwYdVtoc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfWarrantValuationTableTextblock_z8D7RFLrWh9k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B9_ztl8jfAUOVqa"&gt;The
change in the fair value of the Contingent Consent Warrants is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 76%; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
    valuation, September 25, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--WarrantsAndRightsOutstanding_iS_c20220701__20230630_zPk9r8SH3Fwh" style="font: 10pt Times New Roman, Times, Serif; width: 19%; padding-right: 2.15pt; text-align: right" title="Initial valuation, at beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,221&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in valuation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ChangeInValuationOfWarrants_c20220701__20230630_zLY1DjA0Htmh" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right" title="Change in valuation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;489&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Valuation
    at June 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--WarrantsAndRightsOutstanding_iE_c20220701__20230630_z5inbWDzyBp3" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right" title="Valuation, at ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,710&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A3_ziScyr2L1ku5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;









&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Contingent Consent Warrants are classified as a Level 3 financial instrument and were valued utilizing a Monte Carlo simulation
pricing model, which calculates multiple potential outcomes for future share prices based on historic volatility of the Common
Shares to determine the probability of issuance at 18 months following the applicable valuation date and to determine the value
of the Contingent Consent Warrants. The following table discloses the primary inputs into the Monte Carlo model at each valuation
date, and the probability of issuance calculated by the model.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_ecustom--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_z2e1K9Aadhbf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zZ9UGm3COq19" style="display: none; visibility: hidden"&gt;Schedule of valuation date and the probability calculated.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Key Valuation
    Input&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
25,&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
30,&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 48%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
    price on valuation date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_z7JqcEuX1EIi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: right" title="Share price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.82&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zMIe4TtXk2qh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: right" title="Share price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.03&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 3%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Volatility&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zshyS0ZZK7S7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Volatility"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;62.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zUrf6XHUjH9g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Volatility"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk free rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_zFZFIy8rMQzf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Risk free rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.93&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_z10grwww8KFf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Risk free rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.11&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Probability of
    issuance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_zNOnUs8ZaMAa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Probability of issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;59.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_z1FA45HECf56" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Probability of issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;80.8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A2_zr93TpQHpcDa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Loss
on debt extinguishment is presented as a non-operating expense in the Company&#x2019;s consolidated statements of operations and
comprehensive loss. This accounting also resulted in a decrease in the amount of accretion to be recognized over the remaining
life of the Lind III Convertible Security through February 2023. Accretion expenses are disclosed as a part of interest expense,
which is not included as a component of operating costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Yorkville
Convertible Debentures&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the GXII Transaction, on January 26, 2023, NioCorp entered into definitive agreements with respect to the Yorkville
Financings, including a Securities Purchase Agreement, dated January 26, 2023 (as amended the &#x201c;Yorkville Convertible Debt
Financing Agreement&#x201d;), between the Company and Yorkville, and a Standby Equity Purchase Agreement, dated January 26, 2023
(the &#x201c;Yorkville Equity Facility Financing Agreement&#x201d;), between the Company and Yorkville.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Yorkville Convertible Debt Financing Agreement, at the Closing, Yorkville advanced a total amount of $15,360 to NioCorp
in consideration of the issuance by NioCorp to Yorkville of (i) $&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20230630__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zhTcUGrB1X94" title="Aggregate principal amount"&gt;16,000&lt;/span&gt; aggregate principal amount of unsecured convertible debentures
(the &#x201c;Convertible Debentures&#x201d;) and (ii) Common Share purchase warrants, exercisable for up to &lt;span id="xdx_90E_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zefigQNsFKMh" title="Number of shares purchase"&gt;1,789,267&lt;/span&gt; Common Shares
for cash or, if at any time there is no effective registration statement registering, or no current prospectus available for,
the resale of the underlying Common Shares, on a cashless basis, at the option of the holder, at a price per Common Share of approximately
$&lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zYRzfWHA9IGg" title="Number of shares purchase"&gt;8.9422&lt;/span&gt;, subject to adjustment to give effect to any stock dividend, stock split, reverse stock split or similar transaction (the
&#x201c;Financing Warrants&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
Convertible Debenture issued under the Yorkville Convertible Debt Financing Agreement is an unsecured obligation of NioCorp, has
an &lt;span id="xdx_902_eus-gaap--LongTermDebtMaturitiesRepaymentTerms_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_z7E3vVTS6Vkl" title="Debt term"&gt;18-month&lt;/span&gt; term from the Closing Date, which may be extended for one six-month period in certain circumstances at the option
of NioCorp, and incurs a simple interest rate obligation of &lt;span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MinimumMember_zfEJbFQO9eQc" title="Interest rate obligation"&gt;5.0&lt;/span&gt;% per annum (which will increase to &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MaximumMember_zyyyqKkneBZk" title="Interest rate obligation"&gt;15.0&lt;/span&gt;% per annum upon the occurrence
of an event of default). The outstanding principal amount of, accrued and unpaid interest, if any, on, and premium, if any, on
the Convertible Debentures must be paid by NioCorp in cash when the same becomes due and payable under the terms of the Convertible
Debentures at their stated maturity, upon their redemption or otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subject
to certain limitations contained within the Yorkville Convertible Debt Financing Agreement and the Convertible Debentures, including
those as described below, holders of the Convertible Debentures will be entitled to convert the principal amount of, and accrued and
unpaid interest, if any, on each Convertible Debenture, in whole or in part, from time to time over their term, into a number of
Common Shares equal to the quotient of the principal amount and accrued and unpaid interest, if any, being converted divided by the
Conversion Price. The &#x201c;Conversion Price&#x201d; means, as of any Conversion Date (as defined below) or other date of
determination, the greater of (i) 90% of the average of the daily U.S. dollar volume-weighted average price of the Common Shares
on the principal U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading
days immediately preceding the date on which the holder exercises its conversion right in accordance with the requirements of
the Yorkville Convertible Debt Financing Agreement (the &#x201c;Conversion Date&#x201d;) or other date of determination, but not
lower than the Floor Price (as defined below), and (ii) the five-day volume-weighted average price of the Common&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;

&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt; Shares on the
TSX (or on the principal U.S. market if the majority of the trading volume and value of the Common Shares occurred on Nasdaq during
the relevant period) for the five consecutive trading days immediately prior to the Conversion Date or other date of determination
less the maximum applicable discount allowed by TSX. The &#x201c;Floor Price&#x201d; means a price of $2.1435 per share, which is
equal to the lesser of (a) 30% of the average of the daily volume-weighted average price of the Common Shares on the principal
U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading days immediately
preceding the Debenture Closing and (b) 30% of the average of the volume-weighted average price of the Common Shares on the principal
U.S. market for the Common Shares as reported by Bloomberg Financial Markets during the five consecutive trading days immediately
following the Debenture Closing, subject to certain adjustments to give effect to any stock dividend, stock split, reverse stock
split, recapitalization or similar event.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms of the Convertible Debentures restrict the number of Convertible Debentures that may be converted during each calendar month
by Yorkville at a Conversion Price below a fixed price equal to approximately $8.9422 (i.e., the quotient of $10.00 divided by
1.11829212 (being the number of Common Shares that were exchanged for each share of GXII at the Closing, after giving effect to
the Reverse Stock Split)), subject to adjustment to give effect to any stock dividend, stock split, reverse stock split, recapitalization
or similar event. The Convertible Debentures are subject to customary anti-dilution adjustments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms of the Convertible Debentures restrict the conversion of Convertible Debentures by Yorkville if such a conversion would
cause Yorkville to exceed certain beneficial ownership thresholds in NioCorp or such a conversion would cause the aggregate number
of Common Shares issued pursuant to the Yorkville Convertible Debt Financing Agreement to exceed the thresholds for issuance of
Common Shares under the rules of the TSX and Nasdaq, unless prior shareholder approval is obtained.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the terms of the Convertible Debentures, following certain trigger events, and until a subsequent cure event, NioCorp will
be required to redeem $1,125 aggregate principal amount of Convertible Debentures (the &#x201c;Triggered Principal Amount&#x201d;)
each month by making cash payments to the Investors, on a pro rata basis, in an amount equal to the Triggered Principal Amount,
plus accrued and unpaid interest thereon, if any, plus a redemption premium of 7% of the Triggered Principal Amount. Such monthly
prepayments under the terms of the Convertible Debentures are triggered (i) at the time when NioCorp has issued 95% of the total
amount of Common Shares pursuant to the Yorkville Convertible Debt Financing that it may issue under applicable TSX and Nasdaq
rules or (ii) when NioCorp has delayed or suspended the effectiveness or use of the Convertible Debt Financing Registration Statement
for more than 20 consecutive calendar days, and such monthly prepayment obligations will continue until, with respect to (i) above,
shareholder approval is obtained or, with respect to (ii) above, the Investors may once again resell Common Shares under the Convertible
Debt Financing Registration Statement, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Convertible Debentures may also be redeemed at NioCorp&#x2019;s option at any time and from time to time over their term at a redemption
price equal to &lt;span id="xdx_900_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zuhqpqLmDTPf" title="Principal percentage"&gt;110&lt;/span&gt;% of the principal amount being redeemed, plus accrued and unpaid interest, if any.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
conjunction with the issuance of the Convertible Debentures, NioCorp issued to Yorkville &lt;span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise_pid_uShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zOtAEtQzM43l" title="Issuance of the convertible debentures"&gt;1,789,267&lt;/span&gt; Financing Warrants at an exercise
price of approximately $&lt;span id="xdx_904_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise1_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zxOHOxo8tCDa" title="Issuance of the convertible debentures"&gt;8.9422&lt;/span&gt; per Common Share (the &#x201c;Financing Warrant Exercise Price&#x201d;), subject to adjustment to
give effect to any stock dividend, stock split, reverse stock split recapitalization or similar event.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Financing Warrants are exercisable, in whole or in part, but not in increments of less than $&lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__srt--RangeAxis__srt--MaximumMember_z6Me60A1ddl2" title="Aggregate exercise price, per shares"&gt;50&lt;/span&gt; aggregate Financing Warrant Exercise
Price (unless the remaining aggregate Financing Warrant Exercise Price is less than $50), beginning on May 4, 2023, and may be
exercised at any time prior to their expiration. Holders of the Financing Warrants may exercise their Financing Warrants, at their
election, by paying the Financing Warrant Exercise Price in cash or, if at any time there is no effective registration statement
registering, or no current prospectus available for, the resale of the underlying Common Shares, on a cashless exercise basis.
1/12th of the Financing Warrants will expire on each of the first 12 monthly anniversaries of the date that is six months following
the Closing Date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Financing Warrants have customary anti-dilution adjustments to be determined in accordance with the requirements of the applicable
stock exchanges, including the TSX. The terms of the Financing Warrants restrict the&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;

&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;exercise of Financing Warrants by Yorkville
if such an exercise would cause Yorkville to exceed certain beneficial ownership thresholds in NioCorp or such an exercise would
cause the aggregate number of Common Shares issued pursuant to the Yorkville Convertible Debt Financing Agreement to exceed the
thresholds for issuance of Common Shares under the rules of the Nasdaq and the TSX, unless prior shareholder approval is obtained.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Financing Warrants were originally recorded as a $&lt;span id="xdx_903_eus-gaap--LossContingencyAccrualAtCarryingValue_iI_pn3n3_c20230126__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z2QYMy1Bplr3" title="Contingent liability"&gt;2,704&lt;/span&gt; contingent liability on January 26, 2023,
and were subsequently marked to market of $&lt;span id="xdx_90E_eus-gaap--ServicingLiability_iI_pn3n3_c20230316__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6MM7nULYP73" title="Contingent liability"&gt;3,337&lt;/span&gt; through March 16, 2023. The change in fair value during this period resulted in
a loss of $&lt;span id="xdx_90E_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20220701__20230630_z7RVCdMD9Ejj" title="Fair value of warrant liability"&gt;633&lt;/span&gt;, which was booked to change in fair value of warrant liability in the consolidated statement of operations and comprehensive
loss. The Financing Warrants were reclassified to shareholders equity on March 17, 2023, in connection with the closing of the
Convertible Debentures as noted below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company allocated the net proceeds of $15,360 from the Convertible Debentures as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zwaSh4mH3RE2" title="Fair value"&gt;2,704&lt;/span&gt;
    was booked to Common Shares, representing the initial fair value of the Financing Warrant tranches on January 26, 2023 based
    on the Black Scholes pricing model using a risk-free interest rate &lt;span style="color: #353535"&gt;of &lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zIYiUNcJvFSe" title="Fair value"&gt;4.33&lt;/span&gt;%, an expected dividend
    yield of &lt;span id="xdx_904_ecustom--ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate_pid_dp_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zLHMpCmsQbm9" title="Fair value"&gt;0&lt;/span&gt;%, a volatility of &lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_c20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zMCrc6Y2rPMk" title="Fair value"&gt;64.6&lt;/span&gt;%, and an expected life of &lt;span id="xdx_90D_ecustom--DebtMaturityPeriod_dxL_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MinimumMember_zq2jUJ8qOZ6b" title="Expected life::XDX::P6M"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1346"&gt;6&lt;/span&gt;&lt;/span&gt; months to &lt;span id="xdx_900_ecustom--DebtMaturityPeriod_dxL_c20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__srt--RangeAxis__srt--MaximumMember_zjcxBC42lril" title="Expected life::XDX::P18M"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1348"&gt;18&lt;/span&gt;&lt;/span&gt; months&lt;/span&gt;. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_901_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zoxAktoyuWxf" title="Convertible debt liability"&gt;12,656&lt;/span&gt;
    was booked to the convertible debt liability. In addition, transaction costs of $&lt;span id="xdx_90F_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zStNq833Jh1a" title="Transaction costs"&gt;503&lt;/span&gt; were recognized as a direct deduction
    from the debt liability, resulting in a net opening balance of $12,153 at an effective interest rate of 18.4%. This balance
    will be accreted to face value of the Convertible Debentures at maturity using the effective interest method and recorded
    as non-cash interest expense in the consolidated statement of operations and comprehensive loss.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_899_eus-gaap--ConvertibleDebtTableTextBlock_zCePOSCmMlte" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zV8L6A21YcB6"&gt;Changes
in the Convertible Debentures are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 86%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Opening balance,
    March 17, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_iS_pn3n3_c20230315__20230630_z6rOlrdFfvKl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Opening balance, March 17, 2023"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,153&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accretion expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20230315__20230630_z1AFoo4i7m14" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,962&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal and accrued
    interest converted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalAndAccruedInterestConverted_iN_pn3n3_di_c20230315__20230630_zMvzc22zeyJa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal and accrued interest converted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,554&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30,
    2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ConvertibleDebt_iS_pn3n3_c20220701__20230630_zhoc7a9NtO6g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, June 30, 2023"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,561&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;p style="margin: 0pt 0"&gt;Add: Unamortized debt issuance costs&lt;/p&gt;


&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--AmortizationOfFinancingCosts_pn3n3_dxL_c20220701__20230630_z72xi07wU049" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Add: uamortized debt issuance costs::XDX::0"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1364"&gt;2,439&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;p style="margin: 0pt 0"&gt;Remaining principal balance, June 30, 2023&lt;/p&gt;


&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;$&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_iE_pn3n3_c20220701__20230630_zc6kgVzCabzc" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, June 30, 2023"&gt;13,000&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A2_z2fKHVgWyB58" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon conversion, the portion of remaining unamortized
issuance costs associated with the conversion are recognized as a component of interest expense. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Convertible Debentures contain events of default customary for instruments of their type (with customary grace periods, as applicable)
and provide that, upon the occurrence of an event of default arising from certain events of bankruptcy or insolvency with respect
to NioCorp, all outstanding Convertible Debentures will become due and payable immediately without further action or notice. If
any other type of event of default occurs and is continuing, then any holder may declare all of its Convertible Debentures to
be due and payable immediately. The Company obtained a waiver from Yorkville with respect to any acceleration rights it may have
under the Convertible Debentures in connection with the restatements of the Company&#x2019;s consolidated financial statements for the periods
ended September 30, 2022 and December 31, 2022 and the delay in filing the Company&#x2019;s Quarterly Report on Form 10-Q for the
quarterly period ended March 31, 2023. The Yorkville Convertible Debt Financing Agreement also contains certain covenants that,
among other things, limit NioCorp&#x2019;s ability to use the proceeds from the Yorkville Convertible Debt Financing to repay related
party debt or to enter into any variable rate transaction other than with Yorkville, subject to certain exceptions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based
on the Company&#x2019;s closing Common Share price of $&lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zJgXyJRSh1Bj" title="Common share price, per share"&gt;5.03&lt;/span&gt; as of June 30, 2023, conversion of the remaining Convertible Debenture
principal balance of $13.0 million, including accrued interest, would require the issuance of approximately 2,871,660 Common Shares.
For each $0.10 change in the fair value of one Common Share, the total shares the Company would be obligated to issue would change
by approximately &lt;span id="xdx_904_eus-gaap--OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_iI_pid_uShares_c20230630_zvyCG0ZLEmr3" title="Shares issued"&gt;58,300&lt;/span&gt; shares.&lt;/span&gt;&lt;/p&gt;

</us-gaap:LongTermDebtTextBlock>
    <niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_89A_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_zUSiT4NvRe3g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zBH3fghWdisc" style="display: none; visibility: hidden"&gt;Schedule of convertible debt&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Current Portion:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 74%; text-align: left; padding-bottom: 2pt; padding-left: 0.125in"&gt;Lind III convertible security&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zhnvuGIQ2UWd" style="border-bottom: Black 2pt solid; width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1182"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iI_pn3n3_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_z9YihaD2wON3" style="border-bottom: Black 2pt solid; width: 10%; text-align: right" title="Convertibled debt, current"&gt;2,169&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Noncurrent Portion:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in"&gt;Yorkville convertible debentures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20230630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_zNTGr70ljNWl" style="border-bottom: Black 2pt solid; text-align: right" title="Convertible debt, noncurrent"&gt;10,561&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ConvertibleDebtNoncurrent_iI_pn3n3_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleSecurityMember_z4rC220ZElx4" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1187"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2022-06-30_custom_ConvertibleSecurityMember"
      decimals="-3"
      unitRef="USD">2169000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2023-06-30_custom_ConvertibleSecurityMember"
      decimals="-3"
      unitRef="USD">10561000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="From2021-02-162021-02-19"
      decimals="-3"
      unitRef="USD">11700000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:InvestmentInterestRate contextRef="AsOf2021-02-19" decimals="INF" unitRef="Pure">0.085</us-gaap:InvestmentInterestRate>
    <us-gaap:OtherCommitment contextRef="AsOf2021-02-19" decimals="-3" unitRef="USD">350000</us-gaap:OtherCommitment>
    <us-gaap:ProceedsFromInterestReceived
      contextRef="From2021-02-162021-02-19"
      decimals="-3"
      unitRef="USD">9650000</us-gaap:ProceedsFromInterestReceived>
    <us-gaap:DebtConversionDescription contextRef="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember">Pursuant
to the Lind III Agreement, Lind was entitled to convert the Lind III Convertible Security into Common Shares in monthly installments
over its term at a price per Common Share equal to 85% of the volume-weighted average price Common Shares on the TSX for the five
trading days immediately preceding to the date on which Lind provides notice to the Company of its election to convert. The Lind
III Agreement provided that Common Shares issuable upon conversion, together with the number of Common Shares issued upon exercise
of Warrants, shall not exceed 4,358,800 Common Shares.</us-gaap:DebtConversionDescription>
    <us-gaap:CommonUnitIssued contextRef="AsOf2021-02-19" decimals="INF" unitRef="Shares">855800</us-gaap:CommonUnitIssued>
    <us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="CADPShares">9.70</us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember501157062"
      decimals="-3"
      unitRef="USD">9477000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember"
      decimals="INF"
      unitRef="Pure">0.0040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate
      contextRef="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember"
      decimals="-3"
      unitRef="Pure">0</us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember"
      decimals="INF"
      unitRef="Pure">0.5160</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-06-30_custom_LindIIIConvertibleSecurityMember"
      decimals="-3"
      unitRef="USD">7938000</us-gaap:ConvertibleDebtCurrent>
    <niobf:TransactionCost
      contextRef="From2022-07-012023-06-30_custom_LindIIIConvertibleSecurityMember501157062"
      decimals="-3"
      unitRef="USD">173000</niobf:TransactionCost>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="From2021-02-172021-02-19"
      decimals="-3"
      unitRef="USD">350000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <niobf:ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_89A_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock_zyp1AW0UCzuf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8BE_zi34CDBBr5Id"&gt;Changes
in the Lind III Convertible Security are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 96%; border-collapse: collapse; margin-left: 0.25in"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the year ending June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 76%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Beginning
    balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ConvertibleDebtNoncurrent_iS_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zCTOxUoUgvF9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 9%; padding-right: 2.15pt; text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,169&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 2.15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ConvertibleDebtNoncurrent_iS_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_ztl48kYD14fl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 9%; padding-right: 2.15pt; text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,234&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value increase due to debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ExtinguishmentOfDebtAmount_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zPzm8jDMfutc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Fair value increase due to debt extinguishment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;201&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ExtinguishmentOfDebtAmount_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_z3ND6dZqhpJ5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Fair value increase due to debt extinguishment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1231"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Conversions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ConversionOfStockAmountIssued1_iN_pn3n3_di_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zXftOjtSPul4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Conversions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,950&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ConversionOfStockAmountIssued1_iN_pn3n3_di_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_z1TaagufMIkj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Conversions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(7,635&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accretion
    expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--AccretionExpense_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zAvlxooLaGEg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Accretion expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;95&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--AccretionExpense_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zFbeAgOnBgTf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Accretion expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,570&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payment
    at maturity&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--PaymentsToAcquireHeldToMaturitySecurities_iN_pn3n3_di_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zAIIAHMbyiB4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Payment at maturity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(515&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--PaymentsToAcquireHeldToMaturitySecurities_iN_pn3n3_di_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zfuNpY3yvWCf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Payment at maturity"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1243"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance,
    end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ConvertibleDebtCurrent_iE_pn3n3_c20220701__20230630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zmMhJgGF2gw" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1245"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertibleDebtCurrent_iE_pn3n3_c20210701__20220630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleSecurityMember_zGoaMNvaZTp7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 2.15pt; text-align: right" title="Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,169&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2022-06-30_custom_ConvertibleSecurityMember501157765"
      decimals="-3"
      unitRef="USD">2169000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2021-06-30_custom_ConvertibleSecurityMember"
      decimals="-3"
      unitRef="USD">7234000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="From2022-07-012023-06-30_custom_ConvertibleSecurityMember"
      decimals="-3"
      unitRef="USD">201000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="From2022-07-012023-06-30_custom_ConvertibleSecurityMember"
      decimals="-3"
      unitRef="USD">1950000</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="From2021-07-012022-06-30_custom_ConvertibleSecurityMember"
      decimals="-3"
      unitRef="USD">7635000</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:AccretionExpense
      contextRef="From2022-07-012023-06-30_custom_ConvertibleSecurityMember"
      decimals="-3"
      unitRef="USD">95000</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="From2021-07-012022-06-30_custom_ConvertibleSecurityMember"
      decimals="-3"
      unitRef="USD">2570000</us-gaap:AccretionExpense>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="From2022-07-012023-06-30_custom_ConvertibleSecurityMember"
      decimals="-3"
      unitRef="USD">515000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2022-06-30_custom_ConvertibleSecurityMember501157765"
      decimals="-3"
      unitRef="USD">2169000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ScheduleOfExtinguishmentOfDebtTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_89C_eus-gaap--ScheduleOfExtinguishmentOfDebtTextBlock_zYU5vveFJy19" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zZdiXHfZmexk" style="display: none; visibility: hidden"&gt;The following table summarizes the components of the initial loss on extinguishment:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Component of loss&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220701__20230630_zCQ2gBMelhq1" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--MinimumConsentPaymentAtInception_pn3n3_zxbnNXF91ZK7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 87%; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Minimum
    Consent Payment at inception&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;200&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--ASC470LossOnExtinguishment_pn3n3_zRQsTefxPyKe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;201&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--AdjustmentOfWarrantsGrantedForServices_pn3n3_zrvjgz1hSOIk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
    fair value of Contingent Consent Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,221&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_pn3n3_z21HTd1Pjnw" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
    loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,622&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--AdditionalConsentPaymentbooked_pn3n3_z9OTwYiXhEi8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additional
    Consent Payment booked&lt;sup id="xdx_F4E_zLIhWIcwEZ78"&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;300&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--GainsLossesOnRestructuringOfDebt_pn3n3_zBCMP29s6eCa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,922&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 5%; padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 5.4pt; text-align: justify"&gt;&lt;span id="xdx_F05_zWiHKFp67EBa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 93%; padding-right: 5.4pt; text-align: justify"&gt;&lt;span id="xdx_F16_znGdMSE09cad" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    the difference between the accrual of the minimum Consent Payment at September 25, 2022 and the actual payment made on March
    17, 2023.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfExtinguishmentOfDebtTextBlock>
    <niobf:MinimumConsentPaymentAtInception
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">200000</niobf:MinimumConsentPaymentAtInception>
    <niobf:ASC470LossOnExtinguishment
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">201000</niobf:ASC470LossOnExtinguishment>
    <us-gaap:AdjustmentOfWarrantsGrantedForServices
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">1221000</us-gaap:AdjustmentOfWarrantsGrantedForServices>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">1622000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <niobf:AdditionalConsentPaymentbooked
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      id="Fact001264"
      unitRef="USD">300000</niobf:AdditionalConsentPaymentbooked>
    <us-gaap:GainsLossesOnRestructuringOfDebt
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">1922000</us-gaap:GainsLossesOnRestructuringOfDebt>
    <niobf:ScheduleOfWarrantValuationTableTextblock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_89D_ecustom--ScheduleOfWarrantValuationTableTextblock_z8D7RFLrWh9k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B9_ztl8jfAUOVqa"&gt;The
change in the fair value of the Contingent Consent Warrants is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 76%; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
    valuation, September 25, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--WarrantsAndRightsOutstanding_iS_c20220701__20230630_zPk9r8SH3Fwh" style="font: 10pt Times New Roman, Times, Serif; width: 19%; padding-right: 2.15pt; text-align: right" title="Initial valuation, at beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,221&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in valuation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ChangeInValuationOfWarrants_c20220701__20230630_zLY1DjA0Htmh" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right" title="Change in valuation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;489&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Valuation
    at June 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--WarrantsAndRightsOutstanding_iE_c20220701__20230630_z5inbWDzyBp3" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right" title="Valuation, at ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,710&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</niobf:ScheduleOfWarrantValuationTableTextblock>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">1221000</us-gaap:WarrantsAndRightsOutstanding>
    <niobf:ChangeInValuationOfWarrants
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">489000</niobf:ChangeInValuationOfWarrants>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">1710000</us-gaap:WarrantsAndRightsOutstanding>
    <niobf:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_899_ecustom--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock_z2e1K9Aadhbf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zZ9UGm3COq19" style="display: none; visibility: hidden"&gt;Schedule of valuation date and the probability calculated.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Key Valuation
    Input&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
25,&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
30,&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 48%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
    price on valuation date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_z7JqcEuX1EIi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: right" title="Share price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.82&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_fKDEp_zMIe4TtXk2qh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: right" title="Share price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.03&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 3%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Volatility&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zshyS0ZZK7S7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Volatility"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;62.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_fKDEp_zUrf6XHUjH9g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Volatility"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk free rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_zFZFIy8rMQzf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Risk free rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.93&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_fKDEp_z10grwww8KFf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Risk free rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.11&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Probability of
    issuance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20220925__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_zNOnUs8ZaMAa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Probability of issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;59.4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_c20230630__us-gaap--MeasurementInputTypeAxis__custom--ProbabilityOfIssuanceMember_fKDEp_z1FA45HECf56" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Probability of issuance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;80.8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</niobf:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-09-25_us-gaap_MeasurementInputSharePriceMember"
      decimals="INF"
      id="Fact001284"
      unitRef="USDPShares">7.82</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-06-30_us-gaap_MeasurementInputSharePriceMember"
      decimals="INF"
      id="Fact001286"
      unitRef="USDPShares">5.03</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-09-25_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact001288"
      unitRef="NUMBER">0.624</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-06-30_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact001290"
      unitRef="NUMBER">0.630</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-09-25_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact001292"
      unitRef="NUMBER">0.0393</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact001294"
      unitRef="NUMBER">0.0411</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-09-25_custom_ProbabilityOfIssuanceMember"
      decimals="INF"
      id="Fact001296"
      unitRef="NUMBER">0.594</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-06-30_custom_ProbabilityOfIssuanceMember"
      decimals="INF"
      id="Fact001298"
      unitRef="NUMBER">0.808</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-06-30_us-gaap_UnsecuredDebtMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      unitRef="USD">16000000</us-gaap:DebtInstrumentFaceAmount>
    <niobf:StockIssuedDuringPeriodSharesStockOptionsExercise
      contextRef="From2022-07-012023-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="INF"
      unitRef="Shares">1789267</niobf:StockIssuedDuringPeriodSharesStockOptionsExercise>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="INF"
      unitRef="USDPShares">8.9422</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:LongTermDebtMaturitiesRepaymentTerms contextRef="From2022-07-012023-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">18-month</us-gaap:LongTermDebtMaturitiesRepaymentTerms>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.050</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">0.150</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="INF"
      unitRef="Pure">1.10</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <niobf:StockIssuedDuringPeriodSharesStockOptionsExercise
      contextRef="From2022-07-012023-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="INF"
      unitRef="Shares">1789267</niobf:StockIssuedDuringPeriodSharesStockOptionsExercise>
    <niobf:StockIssuedDuringPeriodSharesStockOptionsExercise1
      contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="INF"
      unitRef="CADPShares">8.9422</niobf:StockIssuedDuringPeriodSharesStockOptionsExercise1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-06-30_srt_MaximumMember"
      decimals="INF"
      unitRef="USDPShares">50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="AsOf2023-01-26_us-gaap_WarrantMember"
      decimals="-3"
      unitRef="USD">2704000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:ServicingLiability
      contextRef="AsOf2023-03-16_us-gaap_WarrantMember"
      decimals="-3"
      unitRef="USD">3337000</us-gaap:ServicingLiability>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">633000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      unitRef="USD">2704000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      unitRef="Pure">4.33</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <niobf:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate
      contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      decimals="INF"
      unitRef="Pure">0</niobf:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      unitRef="NUMBER">64.6</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      unitRef="USD">12656000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      unitRef="USD">503000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_899_eus-gaap--ConvertibleDebtTableTextBlock_zCePOSCmMlte" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zV8L6A21YcB6"&gt;Changes
in the Convertible Debentures are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 86%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Opening balance,
    March 17, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_iS_pn3n3_c20230315__20230630_z6rOlrdFfvKl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Opening balance, March 17, 2023"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,153&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accretion expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20230315__20230630_z1AFoo4i7m14" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,962&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal and accrued
    interest converted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalAndAccruedInterestConverted_iN_pn3n3_di_c20230315__20230630_zMvzc22zeyJa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal and accrued interest converted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,554&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30,
    2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ConvertibleDebt_iS_pn3n3_c20220701__20230630_zhoc7a9NtO6g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, June 30, 2023"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,561&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;p style="margin: 0pt 0"&gt;Add: Unamortized debt issuance costs&lt;/p&gt;


&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--AmortizationOfFinancingCosts_pn3n3_dxL_c20220701__20230630_z72xi07wU049" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Add: uamortized debt issuance costs::XDX::0"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1364"&gt;2,439&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;p style="margin: 0pt 0"&gt;Remaining principal balance, June 30, 2023&lt;/p&gt;


&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;$&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_iE_pn3n3_c20220701__20230630_zc6kgVzCabzc" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, June 30, 2023"&gt;13,000&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:ConvertibleDebt contextRef="AsOf2023-03-14" decimals="-3" unitRef="USD">12153000</us-gaap:ConvertibleDebt>
    <us-gaap:AccretionExpenseIncludingAssetRetirementObligations
      contextRef="From2023-03-152023-06-30"
      decimals="-3"
      unitRef="USD">1962000</us-gaap:AccretionExpenseIncludingAssetRetirementObligations>
    <niobf:PrincipalAndAccruedInterestConverted
      contextRef="From2023-03-152023-06-30"
      decimals="-3"
      unitRef="USD">3554000</niobf:PrincipalAndAccruedInterestConverted>
    <us-gaap:ConvertibleDebt contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">10561000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">13000000</us-gaap:ConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-06-30_us-gaap_MeasurementInputSharePriceMember"
      decimals="INF"
      unitRef="USDPShares">5.03</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare contextRef="AsOf2023-06-30" decimals="INF" unitRef="Shares">58300</us-gaap:OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare>
    <niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_80B_ecustom--ScheduleOfClassBCommonStockOfECRCTableTextBlock_ziTNfX3zNg16" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_824_zvzqmk75ebah"&gt;CLASS
B COMMON STOCK OF ECRC&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Business Combination Agreement, the Sponsor Support Agreement, and the Exchange Agreement, after the Closing, the GXII
founders have the right to exchange shares of Class B common stock of ECRC for Common Shares on a one-for-one basis, subject to
certain equitable adjustments, under certain conditions. All &lt;span style="color: #353535"&gt;&lt;span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zXGpAdsjW0W2" title="Common stock, shares, outstanding"&gt;&lt;span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zDDh90q3hYJ2" title="Common stock, shares, issued"&gt;7,957,404&lt;/span&gt;&lt;/span&gt; shares of Class B common stock
of ECRC that were issued in connection with the Closing were issued and outstanding as of June 30, 2023. &lt;/span&gt;Of the issued
and outstanding shares of Class B common stock of ECRC, &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zI3yg9HKwNY2" title="Earnout shares"&gt;4,565,808&lt;/span&gt; shares (the &#x201c;Vested Shares&#x201d;)&#x2009;were vested
as of the Closing Date and are exchangeable at any time, and from time to time, until the tenth anniversary of the Closing Date
(the &#x201c;Ten-Year Anniversary&#x201d;) and &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20220701__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zdFN2PPVqX05" title="Earnout shares"&gt;3,391,596&lt;/span&gt; shares (the &#x201c;Earnout Shares&#x201d;) are exchangeable until the Ten-Year
Anniversary, subject to certain vesting conditions. Under certain circumstances, and subject to certain exceptions, NioCorp may
instead settle all or a portion of any exchange pursuant to the terms of the Exchange Agreement in cash, in lieu of Common Shares,
based on a volume-weighted average price of Common Shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
of the shares of Class B common stock of ECRC are subject to the Amended and Restated Registration Rights Agreement, dated as
of March 17, 2023 (the &#x201c;Registration Rights and Lock-up Agreement&#x201d;), among NioCorp, GXII, the Sponsor, the pre-Closing
directors and officers of NioCorp and the other parties thereto, including the members of the Sponsor. Pursuant to Registration
Rights and Lock-up Agreement, all shares of Class B common Stock of ECRC (including the Vested Shares and the Released Earnout
Shares) are subject to certain &#x201c;lock-up&#x201d; restrictions on transfer beginning upon the Closing and ending upon the earlier
of (i) one year after the Closing and (ii) the date on which the trading price of Common Shares exceeds certain thresholds or
the date on which NioCorp completes a transaction that results in all of NioCorp&#x2019;s shareholders having the right to exchange
their Common Shares for cash, securities or other property. Both Vested Shares and Released Earnout Shares may be exchanged by
the holders into Common Shares at any time. Under the Exchange Agreement, all Vested Shares and Earnout Shares must be exchanged
for Common Shares by the Ten-Year Anniversary except for Released Earnout Shares that have been vested for a period of fewer than
twenty-four months as of the Ten-Year Anniversary. Such Released Earnout Shares will be forfeited if not exchanged for Common
Shares by the date that is twenty-four months after the vesting date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Vested
Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
the exchange of Vested Shares are contingently redeemable at the option of the noncontrolling interest shareholders, the Company
classifies the carrying amount of the redeemable noncontrolling interest in the mezzanine section on the consolidated balance
sheet, which is presented above the equity section and below liabilities. The redeemable noncontrolling interests are classified
as a Level 1 financial instrument and are measured at the fair value of the Company&#x2019;s Common Shares at each reporting period.
Adjustments to the carrying value of the redeemable noncontrolling interest are recorded through retained earnings.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Earnout
Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfEarnOutShares_c20220701__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zlelGYyZY4s3" title="Description of earnout shares"&gt;The
Earnout Shares vest (the &#x201c;Released Earnout Shares&#x201d;) in two equal tranches based upon achieving market share price
milestones of approximately $12.00 per Common Share and approximately $15.00 per Common Share, respectively, prior to the Ten-Year
Anniversary, or upon a change in control as defined in the underlying agreement.&lt;/span&gt; These shares will be forfeited if the market
share price milestones or an acceleration event is not reached prior to the Ten-Year Anniversary. At such time that the Earnout
Shares shall become vested, and therefore, become Released Earnout Shares, the shares will be transferred to the redeemable noncontrolling
interest in the mezzanine section of the Consolidated Balance Sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Earnout Shares were classified as a liability due to failure to meet the equity classification criteria under ASC 815-40, as Level
3 instruments under the fair value hierarchy and are considered a financial liability under ASC 480, Distinguishing Liabilities
from Equity. The Earnout Shares were measured at fair value on the Closing Date with subsequent changes in fair value recorded
in earnings. The Earnout Shares were valued utilizing a Monte Carlo simulation pricing model, which calculates multiple potential
outcomes for future share prices and establishes current fair value based on the most likely outcome. The following table discloses
the primary inputs into the Monte Carlo models.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;

&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p id="xdx_897_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zhj3jT5sAOh3" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;span id="xdx_8B1_zCYYAonfzRQ9" style="display: none; visibility: hidden"&gt;The following table discloses the primary inputs into the Monte Carlo models.&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Key
    Valuation Input&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transaction
    Close&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 17%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Closing
    Common Share price&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zfLqTFRFUhZe" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Closing common share price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$7.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zt5nfwpA88Df" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Closing Common Share price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$5.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Term
    (expiry)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220924__20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zzIPd5Pr9Ulf" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zd7S2NhjHeI3" title="Term (expiry)"&gt;March
    17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Implied
    volatility of Public Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220924__20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zkyEu3yGwYm2" title="Implied volatility of Public Warrants"&gt;19.5&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zDajiz5MaJE" title="Implied volatility of Public Warrants"&gt;33.5&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-free
    rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220924__20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIKaow3B86Kd" title="Risk-free rate"&gt;3.39&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zbQ7qDRiyiB9" title="Risk-free rate"&gt;3.83&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A4_zLWPF8Z9XTR4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_z85NvC16U4xa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BE_zWOytyTvNCya"&gt;The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June
30, 2023:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 49%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value as of March 17, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230301__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zTC4noQBiBD6" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Fair value at beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,195&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; &#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ServicingLiabilityAtFairValueAdditions_iN_pn3n3_di_c20230301__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zwKd8xDGnBd4" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,674&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value as of June 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20230301__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zQLdcdPsHRvk" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value at ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,521&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AD_zF9RWc4mEx9e" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

</niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">7957404</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">7957404</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">4565808</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-07-012023-06-30_custom_EarnoutMember"
      decimals="INF"
      unitRef="Shares">3391596</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <niobf:DescriptionOfEarnOutShares contextRef="From2022-07-012023-06-30_custom_EarnoutMember">The
Earnout Shares vest (the &#x201c;Released Earnout Shares&#x201d;) in two equal tranches based upon achieving market share price
milestones of approximately $12.00 per Common Share and approximately $15.00 per Common Share, respectively, prior to the Ten-Year
Anniversary, or upon a change in control as defined in the underlying agreement.</niobf:DescriptionOfEarnOutShares>
    <niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_897_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zhj3jT5sAOh3" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;span id="xdx_8B1_zCYYAonfzRQ9" style="display: none; visibility: hidden"&gt;The following table discloses the primary inputs into the Monte Carlo models.&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Key
    Valuation Input&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transaction
    Close&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 17%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Closing
    Common Share price&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zfLqTFRFUhZe" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Closing common share price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$7.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zt5nfwpA88Df" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Closing Common Share price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$5.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Term
    (expiry)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220924__20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zzIPd5Pr9Ulf" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zd7S2NhjHeI3" title="Term (expiry)"&gt;March
    17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Implied
    volatility of Public Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220924__20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zkyEu3yGwYm2" title="Implied volatility of Public Warrants"&gt;19.5&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zDajiz5MaJE" title="Implied volatility of Public Warrants"&gt;33.5&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-free
    rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220924__20220925__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIKaow3B86Kd" title="Risk-free rate"&gt;3.39&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zbQ7qDRiyiB9" title="Risk-free rate"&gt;3.83&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2022-09-25_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      unitRef="USDPShares">7.00</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      unitRef="USDPShares">5.03</us-gaap:SharePrice>
    <niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2 contextRef="From2022-09-242022-09-25_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">2033-03-17</niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2 contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">2033-03-17</niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-09-242022-09-25_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      unitRef="Pure">0.195</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      unitRef="Pure">0.335</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-09-242022-09-25_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      unitRef="Pure">0.0339</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      unitRef="Pure">0.0383</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_890_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_z85NvC16U4xa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BE_zWOytyTvNCya"&gt;The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June
30, 2023:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 49%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value as of March 17, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230301__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zTC4noQBiBD6" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Fair value at beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,195&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; &#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ServicingLiabilityAtFairValueAdditions_iN_pn3n3_di_c20230301__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zwKd8xDGnBd4" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,674&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value as of June 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20230301__20230630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zQLdcdPsHRvk" style="border-bottom: black 2.25pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value at ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,521&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock>
    <us-gaap:ServicingLiabilityAtFairValueAmount
      contextRef="AsOf2023-02-28_custom_EarnoutMember"
      decimals="-3"
      unitRef="USD">13195000</us-gaap:ServicingLiabilityAtFairValueAmount>
    <us-gaap:ServicingLiabilityAtFairValueAdditions
      contextRef="From2023-03-012023-06-30_custom_EarnoutMember"
      decimals="-3"
      unitRef="USD">2674000</us-gaap:ServicingLiabilityAtFairValueAdditions>
    <us-gaap:ServicingLiabilityAtFairValueAmount
      contextRef="AsOf2023-06-30_custom_EarnoutMember"
      decimals="-3"
      unitRef="USD">10521000</us-gaap:ServicingLiabilityAtFairValueAmount>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_808_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_zT8B6wABu3Wb" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_827_zqNYCfM9Hyte"&gt;COMMON
SHARES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issuances&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Fiscal
Year 2023 Issuances&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition to the Common Shares issued in connection with the GXII Transaction, as discussed in Note 5, the following Common Share
issuances occurred during fiscal year 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 28, 2023, the Company closed a registered direct offering and issued &lt;span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20230426__20230428_zCxAl7AhivXa" title="Numberof shares issue"&gt;314,465&lt;/span&gt; Common Shares for $&lt;span id="xdx_909_eus-gaap--OfferingCostsPartnershipInterests_iI_dm_c20230428_zIqj2wdfQ2gk" title="Shares issue price"&gt;2.0 million&lt;/span&gt;, before deducting
share issuance costs of $&lt;span id="xdx_90D_ecustom--ShareIssuanceCost_iI_pn3n3_c20230428_zXHTbT3noZW" title="Share issuance cost"&gt;172&lt;/span&gt;. The Common Shares were sold pursuant to a securities purchase agreement, dated April 26, 2023, between
the Company and a fund managed by Kingdon Capital Management, LLC.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 9, 2023, the Company issued &lt;span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20230608__20230609__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_z6Kw3YuvJ9zb" title="Numberof shares issue"&gt;100,000&lt;/span&gt; Common Shares under the Yorkville Equity Facility Financing Agreement (discussed below)
in exchange for $488 in cash proceeds. The Company recorded a non-cash operating expense of $&lt;span id="xdx_901_eus-gaap--OperatingLeaseExpense_pn3n3_c20230608__20230609__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zuZ4AkNWNrf1" title="Share issuance cost"&gt;13&lt;/span&gt; which represented the difference between
the proceeds received and the fair value of the Common Shares issued based on Nasdaq closing price per Common Share on the issuance date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Fiscal
Year 2022 Issuances&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 30, 2022, the Company closed a non-brokered private placement (the &#x201c;June 2022 Private Placement&#x201d;) of units (the
&#x201c;Units&#x201d;) of the Company. A total of &lt;span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zLxVC65FBqN3" title="Sahares issue"&gt;498,103&lt;/span&gt; Units were issued at a price per Unit of C$&lt;span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zfJUXDnIWX9c" title="Price per unit"&gt;0.96&lt;/span&gt;, for total gross proceeds
to the Company of approximately C$&lt;span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_dm_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zcZbVar6yfJj" title="Gross proceeds"&gt;4.8 million&lt;/span&gt;. Each Unit consists of one Common Share and one common share purchase warrant (&#x201c;June
2022 Warrant&#x201d;). Each June 2022 Warrant entitles the holder to acquire one Common Share at a price of C&lt;span id="xdx_90C_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zx7LJDkcNCVf" title="Shares price"&gt;$1.10&lt;/span&gt; at any time
prior to July 1, 2024. Proceeds of the June 2022 Private Placement will be used for continued advancement of the Company&#x2019;s
Elk Creek Critical Minerals Project and for working capital and general corporate purposes. The Company paid cash commissions
of C$&lt;span id="xdx_90C_eus-gaap--PaymentsForCommissions_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zciHh29u3G38" title="Cash commissions"&gt;62&lt;/span&gt; and &lt;span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkoxSUUxY2V9" title="Warrants"&gt;6,510&lt;/span&gt; warrants (the &#x201c;Finder Warrants&#x201d;), having the same terms as the June 2022 Warrants, to finders outside
of the United States. The Finder Warrants were valued at C$&lt;span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zebRdcuxBaf7"&gt;18&lt;/span&gt; using a risk-free rate of &lt;span id="xdx_904_ecustom--FairValueAssumptionsRiskFreeInterestRate1_pid_dp_uPure_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZPWKb7PU6Fa" title="Risk-free rate"&gt;3.2&lt;/span&gt;%, expected volatility of &lt;span id="xdx_900_ecustom--FairValueAssumptionsExpected1VolatilityRate_pid_dp_uPure_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIavrGTsULta" title="Expected volatility"&gt;64&lt;/span&gt;% and expected
life of &lt;span id="xdx_90A_ecustom--FairValueAssumptions1ExpectedTerm_dxL_c20210701__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4R2AJ4lczqa" title="Expected life::XDX::P2Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1444"&gt;two&lt;/span&gt;&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock
                                         Options&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 5, 2020, the Company&#x2019;s shareholders voted to approve an amendment and restatement of its long-term incentive plan
(the &#x201c;2017 Amended Long-Term Incentive Plan&#x201d;) and the granting of incentive securities thereunder until November 5,
2023. Under the 2017 Amended Long-Term Incentive Plan, the Board may, in its discretion from time to time, grant Options and share
units (in the form of restricted share units and performance&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;











&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;

&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;share units) to directors, employees and certain other service providers
(as defined in the 2017 Amended Long-Term Incentive Plan) of the Company and affiliated entities selected by the Board.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--DescriptionOfAmendedPlan_c20201103__20201105__us-gaap--PlanNameAxis__custom--LongTermIncentivePlanMember_zKJ2qmgtamN4" title="Description of amended plan"&gt;Subject
to adjustment as described in the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares that may be reserved
for issuance to participants under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation
arrangements of the Company, may not exceed 10% of the issued and outstanding Common Shares from time to time, and the Common
Shares reserved for issuance upon settlement of share units will not exceed 5% of the issued and outstanding Common Shares from
time to time. The 2017 Amended Long-Term Incentive Plan limits the maximum number of Common Shares issued to insiders (as defined
under TSX rules for this purpose) within any one-year period, or issuable to insiders at any time, in the aggregate, under all
security-based compensation arrangements (including the 2017 Amended Long-Term Incentive Plan) to 10% of the then issued and outstanding
Common Shares.&lt;/span&gt; The 2017 Amended Long-Term Incentive Plan also limits the aggregate number of Common Shares that may be reserved
for issuance to any one participant under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation
arrangements of the Company, to 5% of the then issued and outstanding Common Shares (on a non-diluted basis). Subject to the adjustment
provisions of the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares actually issued or transferred
by the Company upon the exercise of Incentive Stock Options will be limited as described above.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Board has power over the granting, amendment, administration, or settlement of any award.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock
option transactions are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_zuYtzLMZcVe4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B8_zuYxOKxQMS2j" style="display: none; visibility: hidden"&gt;Schedule of stock option&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 73%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Number of &lt;br/&gt;
Options&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted &lt;br/&gt;
Average &lt;br/&gt;
Exercise Price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 43%; text-align: left; padding-bottom: 1pt"&gt;Balance, June 30, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20200701__20210630_zoDNIIPF27X8" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance"&gt;1,912,940&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20200701__20210630_z8dPs5wevkPg" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$6.20 &lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20200701__20210630_zBzfKgnKuWFa" style="text-align: right" title="Granted"&gt;370,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pin3_uCADPShares_c20200701__20210630_zbd08KsT4Dle" style="text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$7.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20200701__20210630_z7wDjX2c9s5j" style="text-align: right" title="Exercised"&gt;(295,229&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20200701__20210630_zShLAySiqYpk" style="text-align: right" title="Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$6.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Cancelled/expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20200701__20210630_zVQFmD1UmRw8" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"&gt;(391,212&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20200701__20210630_zY3mzHNSSY3d" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$6.40&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Balance, June 30, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20210701__20220630_zSVKpuzuxfKf" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"&gt;1,596,499&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20210701__20220630_zItt5cYCitLb" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$6.50&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210701__20220630_zlq7iko0rNUf" style="text-align: right" title="Granted"&gt;447,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20210701__20220630_zURPolnUeojd" style="text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$13.30&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_dxL_uShares_c20210701__20220630_z6xea4C8aqP1" style="text-align: right" title="Exercised::XDX::215"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1481"&gt;(205,153&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20210701__20220630_zqEJ6WxIdsV" style="text-align: right" title="Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$7.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Cancelled/expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20210701__20220630_zCaoCdBkQ8Nd" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"&gt;(392,446&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20210701__20220630_zTggmS5N6x29" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$7.70&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Balance, June 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20220701__20230630_zt5wK3mv7Aua" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"&gt;1,446,400&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20220701__20230630_zK9qtYxshZY" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$8.27&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220701__20230630_znssPo1te4Ee" style="text-align: right" title="Granted"&gt;578,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20220701__20230630_zA72NcOQnmWb" style="text-align: right" title="Granted"&gt;$6.95&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20220701__20230630_z7R5ve8EMaKf" style="text-align: right" title="Exercised"&gt;(265,129&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20220701__20230630_zznx1UbVMPr7" style="text-align: right" title="Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$4.99&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Cancelled/expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20220701__20230630_zpOj9LgJaFNc" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"&gt;(217,771&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20220701__20230630_zf8lTvy4GLx8" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$5.87&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Balance, June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20220701__20230630_zAdsu9UnmfEk" style="border-bottom: Black 1pt solid; text-align: right" title="Ending balance"&gt;1,541,500&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCADPShares_c20220701__20230630_z81HeHhfYk8" style="border-bottom: Black 1pt solid; text-align: right" title="Ending Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$9.64&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A9_zBKxcpaf33Xj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8AD_zh3Jx2GKdfk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;

&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z1ukJujYLRn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B2_zvAfJsmkQWb2"&gt;The
following table summarizes information about stock options outstanding at June 30, 2023:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 88%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; width: 11%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    Price &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 26%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expiry
    Date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    Outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 17%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Aggregate
    Intrinsic Value &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    Exercisable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 16%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Aggregate
    Intrinsic Value &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$8.40&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member_zSzoaElaZqVh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2023-09-18"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1515"&gt;September
    18, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member_zlXspE7qfR66" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;105,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member__srt--CurrencyAxis__currency--CAD_zu8tWcd3RiJ9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member_zQdR1dvQI25b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;105,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member__srt--CurrencyAxis__currency--CAD_zpJje8EYO0Qc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$5.40&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member_zNZxnqGb351g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2023-11-15"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1520"&gt;November
    15, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member_z2nA32ExLyXi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;208,500&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member__srt--CurrencyAxis__currency--CAD_zPNg5FApY9c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;263&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member_zUbZ7qetdcM2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;208,500&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member__srt--CurrencyAxis__currency--CAD_zNGPqrHZ2ZX9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;263&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$7.50&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50Member_z3xaFwerOAdc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2023-12-14"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1525"&gt;December
    14, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50Member_zaVLP5jERPwe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;170,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50Member_zn0uSlTfBEFc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;170,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$7.50&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50OneMember_zaijvg3UpkP4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2023-12-16"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1528"&gt;December
    16, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50OneMember_z5QTQ8gVF6R8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;52,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50OneMember_zEb8fFll6vCl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;52,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$13.60&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice13.60Member_z4AlqpmAQrT6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2024-12-17"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1531"&gt;December
    17, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice13.60Member_z9nRYUnhgX4c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;377,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice13.60Member_zZKddnpfe31" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;377,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$11.00&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zQOBXzUIcyf8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2025-05-30"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1534"&gt;May
    30, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_znlYPnkMYpch" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zSLGYclGvX2f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$6.95&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice6.95Member_zGr64z16HaD6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2026-03-27"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1537"&gt;March
    27, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice6.95Member_zEmYIbfAAzqi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;578,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice6.95Member_ziVA2rajSV8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;578,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance,
    June 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630_zZFeF99EiiBl" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,541,500
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230630__srt--CurrencyAxis__currency--CAD_zgMrHk1tJPLi" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$263&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630_zErM3sr9GVOd" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,541,500&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_iI_c20230630__srt--CurrencyAxis__currency--CAD_zZosNnTHqGbh" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$263&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AC_z5btwwz6fulc" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
aggregate intrinsic value in the preceding table represents the total intrinsic value, based on the Company&#x2019;s closing stock
price of C$&lt;span id="xdx_901_eus-gaap--SharePrice_iI_pid_uCADPShares_c20230630_z6Vo4IpNtF41" title="Stock price"&gt;6.68&lt;/span&gt; as of June 30, 2023, which would have been received by the option holders had all option holders exercised their
options as of that date. The total number of in-the-money options vested and exercisable as of June 30, 2023, was 208,500. The
total intrinsic value of options exercised during the year ended June 30, 2023, &lt;span style="background-color: white"&gt;was C$&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20220701__20230630__srt--CurrencyAxis__currency--CAD_zKHmvPPxjS1d" title="Total intrinsic value"&gt;1,592&lt;/span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2023, there were no unrecognized compensation costs related to unvested share-based compensation arrangements granted.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zljymjyaTY77" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BC_zrd9y2ocsX5l"&gt;The following table summarizes
the weighted average information and assumptions used to determine option costs:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_490_20220701__20230630_zEsQTkknmuva" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_495_20210701__20220630_zbJKfZneXys3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_495_20200701__20210630_zhb9SG4AtPP4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 44%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 12%"&gt;&lt;span style="font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 12%"&gt;&lt;span style="font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 12%"&gt;&lt;span style="font-size: 10pt"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: #CCECFF"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Fair value per option granted during the period &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220701__20230630_zSn1kK8HEXL6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Fair value per option granted during the period"&gt;&lt;span style="font-size: 10pt"&gt;$3.09&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210701__20220630__srt--CurrencyAxis__currency--CAD_zuB5lSjcmWe4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Fair value per option granted during the period"&gt;&lt;span style="font-size: 10pt"&gt;C$4.90&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20200701__20210630__srt--CurrencyAxis__currency--CAD_zJMn0yUteG75" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Fair value per option granted during the period"&gt;&lt;span style="font-size: 10pt"&gt;C$2.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_z7zj6F5aaLF5" style="vertical-align: top; background-color: white"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3.30%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1.33%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0.26%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_zC9w4HiSTOG1" style="vertical-align: top; background-color: #CCECFF"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_zqnp3EAp2RMh" style="vertical-align: top; background-color: white"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Expected stock price volatility (historical basis)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;63.6%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;54.4%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;54.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: #CCECFF"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Expected option life in years&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20220701__20230630_z6RIHeVPKP37" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expected option life in years::XDX::P3Y"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1569"&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20210701__20220630_zdZtSMEn0hL2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expected option life in years::XDX::P3Y"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1571"&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20200701__20210630_zCY1AHwJbIx7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P3Y"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1572"&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A3_z33xNuo10xNl" style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 6pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z38uyOHtG071" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Warrant transactions are
summarized as follows. &lt;span id="xdx_8B6_zAwhHqU5j7ff"&gt;Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S.
dollars using end of period foreign currency exchange rates.&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted &lt;br/&gt;
Average &lt;br/&gt;
Exercise Price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance, June 30, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20200701__20210630_zmlt6i3i2Wmf" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Balance at beginning"&gt;1,237,645&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20200701__20210630_zWhwu7MyPxA" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Balance at beginning average price"&gt;5.43&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Granted:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in"&gt;Nordmin warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--NordminWarrants_pid_uShares_c20200701__20210630_zCfxJeGdXhr5" style="text-align: right" title="Nordmin warrants"&gt;50,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing_pid_uUSDPShares_c20200701__20210630_zpvIMzS2d7s8" style="text-align: right" title="Nordmin warrants average price"&gt;6.45&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in"&gt;Lind III warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ClassOfWarrantOrRightLindIIIWarrants_pid_uShares_c20200701__20210630_zwToKCCGMf3d" style="text-align: right" title="Lind III Warrants"&gt;855,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ClassOfWarrantOrRightExercisePriceLindWarrants_pid_uUSDPShares_c20200701__20210630_zNzeVOPZslu2" style="text-align: right" title="Lind III warrants average price"&gt;7.83&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.375in; text-indent: -0.125in"&gt;April 2021 private placement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ClassOfWarrantOrRightAprilPrivatePlacement_pid_uShares_c20200701__20210630_zjkMQp0XGIH9" style="text-align: right" title="April 2021 private placement"&gt;441,211&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements_pid_uUSDPShares_c20200701__20210630_zXeuNz2ovL7l" style="text-align: right" title="April 2021 private placement average price"&gt;13.15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20200701__20210630_zUWmrD7vFS0k" style="text-align: right" title="Exercised"&gt;(910,628&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uUSDPShares_c20200701__20210630_zARt8P7pEpJa" style="text-align: right" title="Exercised average price"&gt;6.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20200701__20210630_zXHnWhRgrQjg" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;(239,845&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20200701__20210630_z42jWS5mWg4f" style="border-bottom: Black 1pt solid; text-align: right" title="Expired average price"&gt;5.89&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance, June 30, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20210701__20220630_zXJ9rCjpQE94" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,434,183&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20210701__20220630_zfFpEFCtE7oa" style="border-bottom: Black 1pt solid; text-align: right"&gt;9.36&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;Granted:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.375in; text-indent: -0.125in"&gt;June 2022 private placement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ClassOfWarrantOrRightJunePrivatePlacement_pid_uShares_c20210701__20220630_zyCMat9tfbXj" style="text-align: right" title="June 2022 private placement"&gt;504,614&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ClassOfWarrantOrRightExercisePriceJunePrivatePlacements_pid_uUSDPShares_c20210701__20220630_zVZQutgXnkW5" style="text-align: right" title="June 2022 private placement average price"&gt;8.54&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20210701__20220630_z9hvSoKnQyQ5" style="border-bottom: Black 1pt solid; text-align: right"&gt;(87,175&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uUSDPShares_c20210701__20220630_z5LcuYqDdIGi" style="border-bottom: Black 1pt solid; text-align: right"&gt;6.05&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance, June 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20220701__20230630_zZKpTTLkkXua" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,851,622&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20220701__20230630_zjLJGNwuBCFd" style="border-bottom: Black 1pt solid; text-align: right"&gt;8.99&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;Granted:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in"&gt;Yorkville financing warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--YorkvilleFinancingWarrants_pid_uShares_c20220701__20230630_zDXmddESXRUg" style="text-align: right" title="Yorkville financing warrants"&gt;1,789,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_pid_uUSDPShares_c20220701__20230630_zxoCsu4gUqu2" style="text-align: right" title="Yorkville financing warrants average price"&gt;8.94&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in"&gt;GXII warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--GxiiWarrants_pid_uShares_c20220701__20230630_zLdpwi9aUix9" style="text-align: right" title="GXII warrants"&gt;15,666,626&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_pid_uUSDPShares_c20220701__20230630_zxRs6xa5uN98" style="text-align: right" title="GXII warrant average price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;Expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20220701__20230630_zFo5oT7WZJMh" style="border-bottom: Black 1pt solid; text-align: right"&gt;(491,211&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uUSDPShares_c20220701__20230630_zKw3PqcK7Uzk" style="border-bottom: Black 1pt solid; text-align: right"&gt;11.67&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance, June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20220701__20230630_zwFCFIqZvM2c" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending"&gt;18,816,304&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_uUSDPShares_c20220701__20230630_zIFz5I21f4ei" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending average price"&gt;10.98&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A6_zbOIbbTEeAnf" style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zXusNeJkV6Rg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zmPEwMpPnA1f"&gt;At
June 30, 2023, the Company has outstanding exercisable warrants, as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 46%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Exercise
    Price &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expiry
Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF"&gt;
    &lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zXPpM1iVegZk" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Number"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;504,611&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$&lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230630__srt--CurrencyAxis__currency--CAD__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zYZWnTJ1Gkuk" title="Exercise price"&gt;11.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dxL_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zggTBd5xkmG3" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expiry date::XDX::2024-06-30"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1630"&gt;June
    30, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zN1neMxZXcK2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;855,800&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220630__srt--CurrencyAxis__currency--CAD__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zz2ztmA5sLm" title="Exercise price"&gt;9.70&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dxL_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_z7Y34r2lZCWg" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expiry date::XDX::2025-02-19"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1635"&gt;February
    19, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF"&gt;
    &lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zq1a1JCJIGzh" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,789,267&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zoFJ3LGfZI05" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$8.94&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F2E_zJUo8a8revY3"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zEnRhgpRCK7c" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,666,626&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zlfpLNP0cOWc" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$11.50&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dxL_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zCuHofnBpx1b" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expiry date::XDX::2028-03-17"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1643"&gt;March
    17, 2028&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF"&gt;
    &lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630_z6TEA9T9qiLk" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,816,304&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 46%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: left; text-indent: 0in"&gt;&lt;span id="xdx_F01_zgLcDmRtSWDe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 93%; text-align: left; text-indent: 0in"&gt;&lt;span id="xdx_F17_zx4Jtucrohjg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expires
    in 12 equal monthly tranches beginning October 17, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A8_zvrPyojVuAw3" style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;

&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
connection with the Closing, pursuant to the Business Combination Agreement, the Company assumed the GXII Warrant Agreement and
each GXII Warrant thereunder that was issued and outstanding immediately prior to the Closing Date was converted into one NioCorp
Assumed Warrant pursuant to the GXII Warrant Agreement, as amended by an Assignment, Assumption and Amendment Agreement, dated
March 17, 2023, among the Company, GXII, Continental Stock Transfer &amp;amp; Trust Company, as the existing warrant agent, and Computershare
Inc. and its affiliate, Computershare Trust Company, N.A, together as the successor warrant agent (the &#x201c;NioCorp Assumed
Warrant Agreement&#x201d;). In connection with the Closing, NioCorp issued (a) &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--GXIIPublicWarrantsMember_zHzzrLldsW5a" title="Warrants traded prior to the closing"&gt;9,999,959&lt;/span&gt; public NioCorp Assumed Warrants (the &#x201c;Public
Warrants&#x201d;) in respect of the GXII Warrants that were publicly traded prior to the Closing and (b) &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20220701__20230630__us-gaap--TransactionTypeAxis__custom--GXIIPrivateWarrantsMember_zU4jcPu1lC4a" title="Warrants traded prior to the closing"&gt;5,666,667&lt;/span&gt; NioCorp Assumed
Warrants (the &#x201c;Private Warrants&#x201d;) to the Sponsor in respect of the GXII Warrants that it held prior to the Closing,
which NioCorp Assumed Warrants were subsequently distributed by the Sponsor to its members in connection with the Closing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zS1zYBMQt0P9" title="Description of warrants"&gt;Each
NioCorp Assumed Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and the
like).&lt;/span&gt; No fractional shares will be issued upon exercise of any NioCorp Assumed Warrants, and fractional shares that would otherwise
be due to the exercising holder will be rounded down to the nearest whole Common Share. In no event will the Company be required
to net cash settle any NioCorp Assumed Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Public
Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20220701__20230630_zefuvIcsPjI6" title="Description of warrants"&gt;The
Company may elect to redeem the Public Warrants subject to certain conditions, in whole and not in part, at a price of $0.01 per
Public Warrant if (i) 30 days&#x2019; prior written notice of redemption is provided to the holders, (ii) the last reported sale
price of the Common Shares equals or exceeds approximately $16.10 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third business day prior
to the date on which the Company sends the notice of redemption to the warrant holders&lt;/span&gt; and (iii) there is an effective registration
statement covering the Common Shares issuable upon exercise of the Public Warrants, and a current prospectus relating thereto,
available through the redemption date. Upon issuance of a redemption notice by the Company, the warrant holders will have until
the redemption date to exercise for cash, or, at the Company&#x2019;s election, on a cashless basis. The Public Warrants are not
precluded from equity classification and are accounted for as such on the date of issuance, and each balance sheet date thereafter.
Because the Transactions resulted in an excess of liabilities over assets acquired, no value was ascribed to the Public Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Private
Warrants &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Private Warrants: (i) will be exercisable either for cash or on a cashless basis at the holder&#x2019;s option and (ii) will not
be redeemable by the Company, in either case as long as the Private Warrants are held by the Sponsor, its members or any of their
permitted transferees (as prescribed in the NioCorp Assumed Warrant Agreement). In accordance with the NioCorp Assumed Warrant
Agreement, any Private Warrants that are held by someone other than the Sponsor, its members or any their permitted transferees
are treated as Public Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company accounts for
the Private Warrants assumed in the Transactions in accordance with the guidance contained in ASC 815-40. Such guidance provides
that because the Private Warrants do not meet the criteria for equity treatment thereunder, each Private Warrant must be recorded
as a liability. This liability is carried as a component of Warrant Liabilities on the consolidated balance sheet and is subject
to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to its current
fair value, with the change in fair value recognized in the consolidated statement of operations and comprehensive loss. The Company
will reassess the classification at each balance sheet date. &lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zHGbgiqtX694" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B5_zNBGleVoOhLc"&gt;The
Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a
Black Scholes model with the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;

&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 1pt"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 1pt"&gt;March 17, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 1pt"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-align: justify"&gt;Stock price on valuation date&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zoreS0yoSzEf" style="width: 10%; text-align: right" title="Stock price on valuation date"&gt;7.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z2HDEv33HTG8" style="width: 10%; text-align: right" title="Stock price on valuation date"&gt;5.03&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Strike price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqYzw8f2t22j" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zBewLQd8cik" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Implied volatility of Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQyAOb1pWD92" title="Volatility"&gt;19.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLgqLMNBoVT5" title="Volatility"&gt;33.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zbyJAsbavZKc" title="Risk free rate"&gt;3.47&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z3NbSUPDeekd" title="Risk free rate"&gt;4.18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zwJhckLCVLMl" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7A4lwx69S5f" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Expected warrant life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zoLtOKC6MfC1" title="Expected warrant life in years::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1687"&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQ8kMrpiUtg6" title="Expected warrant life in years::XDX::P4Y8M23D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1689"&gt;4.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AE_znF0FOTOigc7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zcRQoEhiDFeh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B1_zH1F9Lfrq6S1"&gt;The
change in the Private Warrants liability is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 43%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30%; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
    valuation, March 17, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt; padding-bottom: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt; padding-bottom: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20220701__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zToJ5TFGhdP3" style="font: 10pt Times New Roman, Times, Serif; width: 10%; padding-right: 2.15pt; padding-bottom: 2.15pt; text-align: right" title="Initial valuation, at begining"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,987&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt; padding-bottom: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in valuation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20220701__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zYUOPRaUUbA5" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right" title="Change in valuation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Valuation
    at June 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ChangesInFairValueOfInitialValuation_iE_pn3n3_c20220701__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zoiQANZz1QH7" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt; text-align: right" title="Initial valuation, at ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,279&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A3_zeZGVOq7pVPe" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Yorkville
                                         Equity Facility Financing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Concurrent
with the closing of the GXII Transaction, the Yorkville Equity Facility Financing became effective. Pursuant to the Yorkville
Equity Facility Financing Agreement, Yorkville committed to purchase up to $65,000 of Common Shares (the &#x201c;Commitment Amount&#x201d;),
at NioCorp&#x2019;s direction from time to time for a period commencing upon the Closing Date and ending on the earliest of (i)
the first day of the month next following the 36-month anniversary of the Closing, (ii) the date on which Yorkville shall have
made payment of the full Commitment Amount and (iii) the date that the Yorkville Equity Facility Financing Agreement otherwise
terminates in accordance with its terms (the &#x201c;Commitment Period&#x201d;), subject to certain limitations and the satisfaction
of the conditions in the Yorkville Equity Facility Financing Agreement. The Common Shares that may be sold pursuant to the Yorkville
Equity Facility Financing Agreement would be purchased by Yorkville at a purchase price equal to 97% of the daily volume-weighted
average price of the Common Shares on Nasdaq or such other principal U.S. market for the Common Shares if the Common Shares are
ever listed or traded on the New York Stock Exchange or the NYSE American as reported by Bloomberg Financial Markets (or, if not
available, a similar service provider of national recognized standing) during the applicable pricing period, which is a period
during a single trading day or a period of three consecutive trading days, at the Company&#x2019;s option and subject to certain
restrictions, in each case, defined based on when an Advance Notice (as defined in the Yorkville Equity Facility Financing Agreement)
is submitted, subject to certain limitations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Pursuant to the terms of
the Yorkville Equity Facility Financing Agreement, NioCorp issued 81,213 of Common Shares (the &#x201c;Commitment Shares&#x201d;)
valued at $650 to Yorkville as consideration for its irrevocable commitment to purchase Common Shares under the Yorkville Equity
Facility Financing Agreement. On June 9, 2023, NioCorp issued and sold 100,000 Common Shares to Yorkville under the Yorkville Equity
Facility Financing Agreement. Additionally, NioCorp is required to pay Yorkville an aggregate fee of $1,500 in cash (the &#x201c;Cash
Fee&#x201d;), including $500 that NioCorp paid on the Closing Date and an additional $250 NioCorp was paid as of June 30, 2023.
NioCorp will pay the remaining $750 balance in installments over a 12-month period following the Closing Date, provided that it
will have the right to prepay without penalty all or part of the remaining installments of the Cash Fee at any time. In addition,
legal and other costs of $496 were incurred in connection with the Yorkville Equity Facility Financing and were expensed on the
effective date. The following amounts related to the Yorkville Equity Facility Financing Agreement were expensed as other operating
costs:&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_zFIiTKoD2yAc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;&lt;span id="xdx_8B7_z2EFGHvCdVF" style="display: none; visibility: hidden"&gt;Schedule of expenses as other operating costs&lt;/span&gt;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 43%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zk3FqphoJn58" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--YorkvilleCashFee_zrPPFBqDaj78" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 30%; text-align: justify"&gt;Yorkville Cash Fee&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zOKN2XjBb37b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Fair value of Commitment Shares issued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;650&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--OtherCostAndExpenseOperating_z1H6IAYXhWZh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Legal and other related costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;496&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--OperatingCostsAndExpenses_zZoDisy4u9y" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt"&gt;Net costs expensed to other operating expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;2,646&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AC_z0NmmVtly7Ol" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;


</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-04-262023-04-28"
      decimals="INF"
      unitRef="Shares">314465</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:OfferingCostsPartnershipInterests contextRef="AsOf2023-04-28" decimals="0" unitRef="USD">2000000.0</us-gaap:OfferingCostsPartnershipInterests>
    <niobf:ShareIssuanceCost contextRef="AsOf2023-04-28" decimals="-3" unitRef="USD">172000</niobf:ShareIssuanceCost>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-06-082023-06-09_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="INF"
      unitRef="Shares">100000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2023-06-082023-06-09_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      unitRef="USD">13000</us-gaap:OperatingLeaseExpense>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD"
      decimals="INF"
      unitRef="Shares">498103</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2022-06-30_us-gaap_PrivatePlacementMember_currency_CAD"
      decimals="INF"
      unitRef="USDPShares">0.96</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD"
      decimals="0"
      unitRef="USD">4800000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <niobf:SaleOfStockPricePerShare1
      contextRef="AsOf2022-06-30_us-gaap_PrivatePlacementMember_currency_CAD"
      decimals="INF"
      unitRef="USDPShares">1.10</niobf:SaleOfStockPricePerShare1>
    <us-gaap:PaymentsForCommissions
      contextRef="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_WarrantMember"
      decimals="0"
      unitRef="USD">62</us-gaap:PaymentsForCommissions>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Shares">6510</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_WarrantMember"
      decimals="0"
      unitRef="USD">18</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <niobf:FairValueAssumptionsRiskFreeInterestRate1
      contextRef="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Pure">0.032</niobf:FairValueAssumptionsRiskFreeInterestRate1>
    <niobf:FairValueAssumptionsExpected1VolatilityRate
      contextRef="From2021-07-012022-06-30_us-gaap_PrivatePlacementMember_currency_CAD_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Pure">0.64</niobf:FairValueAssumptionsExpected1VolatilityRate>
    <niobf:DescriptionOfAmendedPlan contextRef="From2020-11-032020-11-05_custom_LongTermIncentivePlanMember">Subject
to adjustment as described in the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares that may be reserved
for issuance to participants under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation
arrangements of the Company, may not exceed 10% of the issued and outstanding Common Shares from time to time, and the Common
Shares reserved for issuance upon settlement of share units will not exceed 5% of the issued and outstanding Common Shares from
time to time. The 2017 Amended Long-Term Incentive Plan limits the maximum number of Common Shares issued to insiders (as defined
under TSX rules for this purpose) within any one-year period, or issuable to insiders at any time, in the aggregate, under all
security-based compensation arrangements (including the 2017 Amended Long-Term Incentive Plan) to 10% of the then issued and outstanding
Common Shares.</niobf:DescriptionOfAmendedPlan>
    <us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_89F_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_zuYtzLMZcVe4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B8_zuYxOKxQMS2j" style="display: none; visibility: hidden"&gt;Schedule of stock option&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 73%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Number of &lt;br/&gt;
Options&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted &lt;br/&gt;
Average &lt;br/&gt;
Exercise Price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 43%; text-align: left; padding-bottom: 1pt"&gt;Balance, June 30, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20200701__20210630_zoDNIIPF27X8" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance"&gt;1,912,940&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20200701__20210630_z8dPs5wevkPg" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$6.20 &lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20200701__20210630_zBzfKgnKuWFa" style="text-align: right" title="Granted"&gt;370,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pin3_uCADPShares_c20200701__20210630_zbd08KsT4Dle" style="text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$7.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20200701__20210630_z7wDjX2c9s5j" style="text-align: right" title="Exercised"&gt;(295,229&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20200701__20210630_zShLAySiqYpk" style="text-align: right" title="Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$6.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Cancelled/expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20200701__20210630_zVQFmD1UmRw8" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"&gt;(391,212&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20200701__20210630_zY3mzHNSSY3d" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$6.40&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Balance, June 30, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20210701__20220630_zSVKpuzuxfKf" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"&gt;1,596,499&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20210701__20220630_zItt5cYCitLb" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$6.50&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20210701__20220630_zlq7iko0rNUf" style="text-align: right" title="Granted"&gt;447,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20210701__20220630_zURPolnUeojd" style="text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$13.30&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_dxL_uShares_c20210701__20220630_z6xea4C8aqP1" style="text-align: right" title="Exercised::XDX::215"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1481"&gt;(205,153&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20210701__20220630_zqEJ6WxIdsV" style="text-align: right" title="Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$7.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Cancelled/expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20210701__20220630_zCaoCdBkQ8Nd" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"&gt;(392,446&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20210701__20220630_zTggmS5N6x29" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$7.70&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Balance, June 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20220701__20230630_zt5wK3mv7Aua" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"&gt;1,446,400&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20220701__20230630_zK9qtYxshZY" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$8.27&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20220701__20230630_znssPo1te4Ee" style="text-align: right" title="Granted"&gt;578,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20220701__20230630_zA72NcOQnmWb" style="text-align: right" title="Granted"&gt;$6.95&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20220701__20230630_z7R5ve8EMaKf" style="text-align: right" title="Exercised"&gt;(265,129&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20220701__20230630_zznx1UbVMPr7" style="text-align: right" title="Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$4.99&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Cancelled/expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20220701__20230630_zpOj9LgJaFNc" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"&gt;(217,771&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20220701__20230630_zf8lTvy4GLx8" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$5.87&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Balance, June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20220701__20230630_zAdsu9UnmfEk" style="border-bottom: Black 1pt solid; text-align: right" title="Ending balance"&gt;1,541,500&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCADPShares_c20220701__20230630_z81HeHhfYk8" style="border-bottom: Black 1pt solid; text-align: right" title="Ending Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$9.64&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-06-30" decimals="INF" unitRef="Shares">1912940</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-06-30"
      decimals="INF"
      unitRef="CADPShares">6.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">370000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="CADPShares">7800</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">295229</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="CADPShares">6.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">391212</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="CADPShares">6.40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">1596499</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="CADPShares">6.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Shares">447500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="CADPShares">13.30</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="CADPShares">7.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Shares">392446</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="CADPShares">7.70</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">1446400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-06-30"
      decimals="INF"
      unitRef="CADPShares">8.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Shares">578000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="CADPShares">6.95</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Shares">265129</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="CADPShares">4.99</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Shares">217771</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="CADPShares">5.87</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2023-06-30" decimals="INF" unitRef="Shares">1541500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-06-30"
      decimals="INF"
      unitRef="CADPShares">9.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z1ukJujYLRn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B2_zvAfJsmkQWb2"&gt;The
following table summarizes information about stock options outstanding at June 30, 2023:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 88%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; width: 11%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    Price &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 26%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expiry
    Date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    Outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 17%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Aggregate
    Intrinsic Value &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    Exercisable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 16%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Aggregate
    Intrinsic Value &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$8.40&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member_zSzoaElaZqVh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2023-09-18"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1515"&gt;September
    18, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member_zlXspE7qfR66" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;105,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member__srt--CurrencyAxis__currency--CAD_zu8tWcd3RiJ9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member_zQdR1dvQI25b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;105,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.40Member__srt--CurrencyAxis__currency--CAD_zpJje8EYO0Qc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$5.40&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member_zNZxnqGb351g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2023-11-15"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1520"&gt;November
    15, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member_z2nA32ExLyXi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;208,500&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member__srt--CurrencyAxis__currency--CAD_zPNg5FApY9c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;263&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member_zUbZ7qetdcM2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;208,500&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5.40Member__srt--CurrencyAxis__currency--CAD_zNGPqrHZ2ZX9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;263&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$7.50&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50Member_z3xaFwerOAdc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2023-12-14"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1525"&gt;December
    14, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50Member_zaVLP5jERPwe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;170,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50Member_zn0uSlTfBEFc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;170,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$7.50&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50OneMember_zaijvg3UpkP4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2023-12-16"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1528"&gt;December
    16, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50OneMember_z5QTQ8gVF6R8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;52,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice7.50OneMember_zEb8fFll6vCl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;52,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$13.60&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice13.60Member_z4AlqpmAQrT6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2024-12-17"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1531"&gt;December
    17, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice13.60Member_z9nRYUnhgX4c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;377,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice13.60Member_zZKddnpfe31" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;377,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$11.00&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zQOBXzUIcyf8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2025-05-30"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1534"&gt;May
    30, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_znlYPnkMYpch" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zSLGYclGvX2f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$6.95&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dxL_c20220701__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice6.95Member_zGr64z16HaD6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::2026-03-27"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1537"&gt;March
    27, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice6.95Member_zEmYIbfAAzqi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;578,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice6.95Member_ziVA2rajSV8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;578,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance,
    June 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_uShares_c20230630_zZFeF99EiiBl" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,541,500
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230630__srt--CurrencyAxis__currency--CAD_zgMrHk1tJPLi" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$263&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_uShares_c20230630_zErM3sr9GVOd" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,541,500&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1_iI_c20230630__srt--CurrencyAxis__currency--CAD_zZosNnTHqGbh" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$263&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-06-30_custom_ExercisePrice8.40Member"
      decimals="INF"
      unitRef="Shares">105000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2023-06-30_custom_ExercisePrice8.40Member"
      decimals="INF"
      unitRef="Shares">105000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-06-30_custom_ExercisePrice5.40Member"
      decimals="INF"
      unitRef="Shares">208500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-06-30_custom_ExercisePrice5.40Member_currency_CAD"
      decimals="-3"
      unitRef="USD">263000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2023-06-30_custom_ExercisePrice5.40Member"
      decimals="INF"
      unitRef="Shares">208500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1
      contextRef="AsOf2023-06-30_custom_ExercisePrice5.40Member_currency_CAD"
      decimals="-3"
      unitRef="USD">263000</niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-06-30_custom_ExercisePrice7.50Member"
      decimals="INF"
      unitRef="Shares">170000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2023-06-30_custom_ExercisePrice7.50Member"
      decimals="INF"
      unitRef="Shares">170000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-06-30_custom_ExercisePrice7.50OneMember"
      decimals="INF"
      unitRef="Shares">52500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2023-06-30_custom_ExercisePrice7.50OneMember"
      decimals="INF"
      unitRef="Shares">52500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-06-30_custom_ExercisePrice13.60Member"
      decimals="INF"
      unitRef="Shares">377500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2023-06-30_custom_ExercisePrice13.60Member"
      decimals="INF"
      unitRef="Shares">377500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-06-30_custom_ExercisePrice11.00Member"
      decimals="INF"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2023-06-30_custom_ExercisePrice11.00Member"
      decimals="INF"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-06-30_custom_ExercisePrice6.95Member"
      decimals="INF"
      unitRef="Shares">578000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2023-06-30_custom_ExercisePrice6.95Member"
      decimals="INF"
      unitRef="Shares">578000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2023-06-30" decimals="INF" unitRef="Shares">1541500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-06-30_currency_CAD"
      decimals="-3"
      unitRef="USD">263000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2023-06-30" decimals="INF" unitRef="Shares">1541500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1
      contextRef="AsOf2023-06-30_currency_CAD"
      decimals="-3"
      unitRef="USD">263000</niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1>
    <us-gaap:SharePrice
      contextRef="AsOf2023-06-30"
      decimals="INF"
      unitRef="CADPShares">6.68</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2022-07-012023-06-30_currency_CAD"
      decimals="0"
      unitRef="USD">1592</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_896_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zljymjyaTY77" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BC_zrd9y2ocsX5l"&gt;The following table summarizes
the weighted average information and assumptions used to determine option costs:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_490_20220701__20230630_zEsQTkknmuva" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_495_20210701__20220630_zbJKfZneXys3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_495_20200701__20210630_zhb9SG4AtPP4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 44%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 12%"&gt;&lt;span style="font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 12%"&gt;&lt;span style="font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 12%"&gt;&lt;span style="font-size: 10pt"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: #CCECFF"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Fair value per option granted during the period &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_c20220701__20230630_zSn1kK8HEXL6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Fair value per option granted during the period"&gt;&lt;span style="font-size: 10pt"&gt;$3.09&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210701__20220630__srt--CurrencyAxis__currency--CAD_zuB5lSjcmWe4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Fair value per option granted during the period"&gt;&lt;span style="font-size: 10pt"&gt;C$4.90&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20200701__20210630__srt--CurrencyAxis__currency--CAD_zJMn0yUteG75" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Fair value per option granted during the period"&gt;&lt;span style="font-size: 10pt"&gt;C$2.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_z7zj6F5aaLF5" style="vertical-align: top; background-color: white"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3.30%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1.33%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0.26%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_zC9w4HiSTOG1" style="vertical-align: top; background-color: #CCECFF"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_zqnp3EAp2RMh" style="vertical-align: top; background-color: white"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Expected stock price volatility (historical basis)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;63.6%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;54.4%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;54.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: #CCECFF"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Expected option life in years&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20220701__20230630_z6RIHeVPKP37" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expected option life in years::XDX::P3Y"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1569"&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20210701__20220630_zdZtSMEn0hL2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expected option life in years::XDX::P3Y"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1571"&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20200701__20210630_zCY1AHwJbIx7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P3Y"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1572"&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="USDPShares">3.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-07-012022-06-30_currency_CAD"
      decimals="INF"
      unitRef="CADPShares">4.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2020-07-012021-06-30_currency_CAD"
      decimals="INF"
      unitRef="CADPShares">2.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">0.0330</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">0.0133</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.0026</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">0.636</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">0.544</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.541</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_897_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z38uyOHtG071" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Warrant transactions are
summarized as follows. &lt;span id="xdx_8B6_zAwhHqU5j7ff"&gt;Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S.
dollars using end of period foreign currency exchange rates.&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted &lt;br/&gt;
Average &lt;br/&gt;
Exercise Price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance, June 30, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20200701__20210630_zmlt6i3i2Wmf" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Balance at beginning"&gt;1,237,645&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20200701__20210630_zWhwu7MyPxA" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Balance at beginning average price"&gt;5.43&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Granted:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in"&gt;Nordmin warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--NordminWarrants_pid_uShares_c20200701__20210630_zCfxJeGdXhr5" style="text-align: right" title="Nordmin warrants"&gt;50,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing_pid_uUSDPShares_c20200701__20210630_zpvIMzS2d7s8" style="text-align: right" title="Nordmin warrants average price"&gt;6.45&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in"&gt;Lind III warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ClassOfWarrantOrRightLindIIIWarrants_pid_uShares_c20200701__20210630_zwToKCCGMf3d" style="text-align: right" title="Lind III Warrants"&gt;855,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ClassOfWarrantOrRightExercisePriceLindWarrants_pid_uUSDPShares_c20200701__20210630_zNzeVOPZslu2" style="text-align: right" title="Lind III warrants average price"&gt;7.83&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.375in; text-indent: -0.125in"&gt;April 2021 private placement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ClassOfWarrantOrRightAprilPrivatePlacement_pid_uShares_c20200701__20210630_zjkMQp0XGIH9" style="text-align: right" title="April 2021 private placement"&gt;441,211&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements_pid_uUSDPShares_c20200701__20210630_zXeuNz2ovL7l" style="text-align: right" title="April 2021 private placement average price"&gt;13.15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20200701__20210630_zUWmrD7vFS0k" style="text-align: right" title="Exercised"&gt;(910,628&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uUSDPShares_c20200701__20210630_zARt8P7pEpJa" style="text-align: right" title="Exercised average price"&gt;6.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20200701__20210630_zXHnWhRgrQjg" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;(239,845&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20200701__20210630_z42jWS5mWg4f" style="border-bottom: Black 1pt solid; text-align: right" title="Expired average price"&gt;5.89&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance, June 30, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20210701__20220630_zXJ9rCjpQE94" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,434,183&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20210701__20220630_zfFpEFCtE7oa" style="border-bottom: Black 1pt solid; text-align: right"&gt;9.36&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;Granted:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.375in; text-indent: -0.125in"&gt;June 2022 private placement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ClassOfWarrantOrRightJunePrivatePlacement_pid_uShares_c20210701__20220630_zyCMat9tfbXj" style="text-align: right" title="June 2022 private placement"&gt;504,614&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ClassOfWarrantOrRightExercisePriceJunePrivatePlacements_pid_uUSDPShares_c20210701__20220630_zVZQutgXnkW5" style="text-align: right" title="June 2022 private placement average price"&gt;8.54&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20210701__20220630_z9hvSoKnQyQ5" style="border-bottom: Black 1pt solid; text-align: right"&gt;(87,175&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uUSDPShares_c20210701__20220630_z5LcuYqDdIGi" style="border-bottom: Black 1pt solid; text-align: right"&gt;6.05&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance, June 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20220701__20230630_zZKpTTLkkXua" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,851,622&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20220701__20230630_zjLJGNwuBCFd" style="border-bottom: Black 1pt solid; text-align: right"&gt;8.99&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;Granted:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in"&gt;Yorkville financing warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--YorkvilleFinancingWarrants_pid_uShares_c20220701__20230630_zDXmddESXRUg" style="text-align: right" title="Yorkville financing warrants"&gt;1,789,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants_pid_uUSDPShares_c20220701__20230630_zxoCsu4gUqu2" style="text-align: right" title="Yorkville financing warrants average price"&gt;8.94&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in"&gt;GXII warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--GxiiWarrants_pid_uShares_c20220701__20230630_zLdpwi9aUix9" style="text-align: right" title="GXII warrants"&gt;15,666,626&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants_pid_uUSDPShares_c20220701__20230630_zxRs6xa5uN98" style="text-align: right" title="GXII warrant average price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"&gt;&#160;Expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20220701__20230630_zFo5oT7WZJMh" style="border-bottom: Black 1pt solid; text-align: right"&gt;(491,211&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uUSDPShares_c20220701__20230630_zKw3PqcK7Uzk" style="border-bottom: Black 1pt solid; text-align: right"&gt;11.67&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Balance, June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20220701__20230630_zwFCFIqZvM2c" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending"&gt;18,816,304&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_uUSDPShares_c20220701__20230630_zIFz5I21f4ei" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending average price"&gt;10.98&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-06-30" decimals="INF" unitRef="Shares">1237645</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-06-30"
      decimals="INF"
      unitRef="USDPShares">5.43</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <niobf:NordminWarrants
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">50000</niobf:NordminWarrants>
    <niobf:ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">6.45</niobf:ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing>
    <niobf:ClassOfWarrantOrRightLindIIIWarrants
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">855800</niobf:ClassOfWarrantOrRightLindIIIWarrants>
    <niobf:ClassOfWarrantOrRightExercisePriceLindWarrants
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">7.83</niobf:ClassOfWarrantOrRightExercisePriceLindWarrants>
    <niobf:ClassOfWarrantOrRightAprilPrivatePlacement
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">441211</niobf:ClassOfWarrantOrRightAprilPrivatePlacement>
    <niobf:ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">13.15</niobf:ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements>
    <niobf:ClassOfWarrantOrRightExercised
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">-910628</niobf:ClassOfWarrantOrRightExercised>
    <niobf:ClassOfWarrantOrRightExercisePriceExercised
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">6.05</niobf:ClassOfWarrantOrRightExercisePriceExercised>
    <niobf:ClassOfWarrantOrRightExpired
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">-239845</niobf:ClassOfWarrantOrRightExpired>
    <niobf:ClassOfWarrantOrRightExercisePriceExpired
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">5.89</niobf:ClassOfWarrantOrRightExercisePriceExpired>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">1434183</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="USDPShares">9.36</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <niobf:ClassOfWarrantOrRightJunePrivatePlacement
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Shares">504614</niobf:ClassOfWarrantOrRightJunePrivatePlacement>
    <niobf:ClassOfWarrantOrRightExercisePriceJunePrivatePlacements
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="USDPShares">8.54</niobf:ClassOfWarrantOrRightExercisePriceJunePrivatePlacements>
    <niobf:ClassOfWarrantOrRightExercised
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Shares">-87175</niobf:ClassOfWarrantOrRightExercised>
    <niobf:ClassOfWarrantOrRightExercisePriceExercised
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="USDPShares">6.05</niobf:ClassOfWarrantOrRightExercisePriceExercised>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">1851622</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-06-30"
      decimals="INF"
      unitRef="USDPShares">8.99</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <niobf:YorkvilleFinancingWarrants
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Shares">1789267</niobf:YorkvilleFinancingWarrants>
    <niobf:ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="USDPShares">8.94</niobf:ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants>
    <niobf:GxiiWarrants
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Shares">15666626</niobf:GxiiWarrants>
    <niobf:ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="USDPShares">11.50</niobf:ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants>
    <niobf:ClassOfWarrantOrRightExpired
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Shares">-491211</niobf:ClassOfWarrantOrRightExpired>
    <niobf:ClassOfWarrantOrRightExercisePriceExercised
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="USDPShares">11.67</niobf:ClassOfWarrantOrRightExercisePriceExercised>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2023-06-30" decimals="INF" unitRef="Shares">18816304</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-06-30"
      decimals="INF"
      unitRef="USDPShares">10.98</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <niobf:ScheduleOfOutstandingExercisableWarrantsTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_89A_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zXusNeJkV6Rg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zmPEwMpPnA1f"&gt;At
June 30, 2023, the Company has outstanding exercisable warrants, as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 46%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Exercise
    Price &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expiry
Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF"&gt;
    &lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zXPpM1iVegZk" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Number"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;504,611&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$&lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230630__srt--CurrencyAxis__currency--CAD__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zYZWnTJ1Gkuk" title="Exercise price"&gt;11.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dxL_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.00Member_zggTBd5xkmG3" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expiry date::XDX::2024-06-30"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1630"&gt;June
    30, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zN1neMxZXcK2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;855,800&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C$&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220630__srt--CurrencyAxis__currency--CAD__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zz2ztmA5sLm" title="Exercise price"&gt;9.70&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dxL_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_z7Y34r2lZCWg" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expiry date::XDX::2025-02-19"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1635"&gt;February
    19, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF"&gt;
    &lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zq1a1JCJIGzh" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,789,267&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice8.94Member_zoFJ3LGfZI05" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$8.94&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F2E_zJUo8a8revY3"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;
    &lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zEnRhgpRCK7c" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,666,626&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zlfpLNP0cOWc" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$11.50&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dxL_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zCuHofnBpx1b" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Expiry date::XDX::2028-03-17"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1643"&gt;March
    17, 2028&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF"&gt;
    &lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20230630_z6TEA9T9qiLk" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,816,304&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 6pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 46%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: left; text-indent: 0in"&gt;&lt;span id="xdx_F01_zgLcDmRtSWDe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 93%; text-align: left; text-indent: 0in"&gt;&lt;span id="xdx_F17_zx4Jtucrohjg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expires
    in 12 equal monthly tranches beginning October 17, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</niobf:ScheduleOfOutstandingExercisableWarrantsTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-06-30_custom_ExercisePrice11.00Member"
      decimals="INF"
      unitRef="Shares">504611</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-06-30_currency_CAD_custom_ExercisePrice11.00Member"
      decimals="INF"
      unitRef="CADPShares">11.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-06-30_custom_ExercisePrice9.70Member"
      decimals="INF"
      unitRef="Shares">855800</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-06-30_currency_CAD_custom_ExercisePrice9.70Member"
      decimals="INF"
      unitRef="CADPShares">9.70</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-06-30_custom_ExercisePrice8.94Member"
      decimals="INF"
      unitRef="Shares">1789267</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-06-30_custom_ExercisePrice8.94Member"
      decimals="INF"
      unitRef="USDPShares">8.94</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-06-30_custom_ExercisePrice11.50Member"
      decimals="INF"
      unitRef="Shares">15666626</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-06-30_custom_ExercisePrice11.50Member"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2023-06-30" decimals="INF" unitRef="Shares">18816304</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-07-012023-06-30_custom_GXIIPublicWarrantsMember"
      decimals="INF"
      unitRef="Shares">9999959</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-07-012023-06-30_custom_GXIIPrivateWarrantsMember"
      decimals="INF"
      unitRef="Shares">5666667</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees contextRef="From2022-07-012023-06-30_us-gaap_WarrantMember">Each
NioCorp Assumed Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and the
like).</us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees>
    <us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees contextRef="From2022-07-01to2023-06-30">The
Company may elect to redeem the Public Warrants subject to certain conditions, in whole and not in part, at a price of $0.01 per
Public Warrant if (i) 30 days&#x2019; prior written notice of redemption is provided to the holders, (ii) the last reported sale
price of the Common Shares equals or exceeds approximately $16.10 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third business day prior
to the date on which the Company sends the notice of redemption to the warrant holders</us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_895_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zHGbgiqtX694" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B5_zNBGleVoOhLc"&gt;The
Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a
Black Scholes model with the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;

&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify; padding-bottom: 1pt"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 1pt"&gt;March 17, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 1pt"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-align: justify"&gt;Stock price on valuation date&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zoreS0yoSzEf" style="width: 10%; text-align: right" title="Stock price on valuation date"&gt;7.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z2HDEv33HTG8" style="width: 10%; text-align: right" title="Stock price on valuation date"&gt;5.03&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Strike price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqYzw8f2t22j" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zBewLQd8cik" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Implied volatility of Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQyAOb1pWD92" title="Volatility"&gt;19.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLgqLMNBoVT5" title="Volatility"&gt;33.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zbyJAsbavZKc" title="Risk free rate"&gt;3.47&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z3NbSUPDeekd" title="Risk free rate"&gt;4.18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zwJhckLCVLMl" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7A4lwx69S5f" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Expected warrant life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20220701__20230317__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zoLtOKC6MfC1" title="Expected warrant life in years::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1687"&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dpxL_c20220701__20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQ8kMrpiUtg6" title="Expected warrant life in years::XDX::P4Y8M23D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1689"&gt;4.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2023-03-17_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      unitRef="USDPShares">7.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      unitRef="USDPShares">5.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2023-03-17_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-07-012023-03-17_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      unitRef="Pure">0.195</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      unitRef="Pure">0.335</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2022-07-012023-03-17_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      unitRef="Pure">0.0347</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      unitRef="Pure">0.0418</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-07-012023-03-17_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-07-012023-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_89D_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zcRQoEhiDFeh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B1_zH1F9Lfrq6S1"&gt;The
change in the Private Warrants liability is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 43%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30%; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
    valuation, March 17, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt; padding-bottom: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt; padding-bottom: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20220701__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zToJ5TFGhdP3" style="font: 10pt Times New Roman, Times, Serif; width: 10%; padding-right: 2.15pt; padding-bottom: 2.15pt; text-align: right" title="Initial valuation, at begining"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,987&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-right: 2.15pt; padding-bottom: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in valuation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20220701__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zYUOPRaUUbA5" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; text-align: right" title="Change in valuation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;292&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt; padding-left: 8.65pt; text-align: justify; text-indent: -8.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Valuation
    at June 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ChangesInFairValueOfInitialValuation_iE_pn3n3_c20220701__20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zoiQANZz1QH7" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 2.15pt; padding-bottom: 2.15pt; text-align: right" title="Initial valuation, at ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,279&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock>
    <niobf:ChangesInFairValueOfInitialValuation
      contextRef="AsOf2022-06-30_us-gaap_NoteWarrantMember"
      decimals="-3"
      unitRef="USD">2987000</niobf:ChangesInFairValueOfInitialValuation>
    <us-gaap:ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs
      contextRef="From2022-07-012023-06-30_us-gaap_NoteWarrantMember"
      decimals="-3"
      unitRef="USD">292000</us-gaap:ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs>
    <niobf:ChangesInFairValueOfInitialValuation
      contextRef="AsOf2023-06-30_us-gaap_NoteWarrantMember"
      decimals="-3"
      unitRef="USD">3279000</niobf:ChangesInFairValueOfInitialValuation>
    <us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_892_eus-gaap--ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_zFIiTKoD2yAc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;&lt;span id="xdx_8B7_z2EFGHvCdVF" style="display: none; visibility: hidden"&gt;Schedule of expenses as other operating costs&lt;/span&gt;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 43%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220701__20230630__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zk3FqphoJn58" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--YorkvilleCashFee_zrPPFBqDaj78" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 30%; text-align: justify"&gt;Yorkville Cash Fee&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zOKN2XjBb37b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Fair value of Commitment Shares issued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;650&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--OtherCostAndExpenseOperating_z1H6IAYXhWZh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Legal and other related costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;496&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--OperatingCostsAndExpenses_zZoDisy4u9y" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt"&gt;Net costs expensed to other operating expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;2,646&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock>
    <niobf:YorkvilleCashFee
      contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      unitRef="USD">1500000</niobf:YorkvilleCashFee>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      unitRef="USD">650000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      unitRef="USD">496000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      unitRef="USD">2646000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_znO4NFZyAfph" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_820_z4sCjAWx41te"&gt;RELATED
PARTY TRANSACTIONS AND BALANCES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Borrowings
under the non-revolving credit facility agreement (the &#x201c;Smith Credit Facility&#x201d;) with Mark Smith, Chief Executive Officer,
President, and Executive Chairman of NioCorp, bear interest at a rate of &lt;span id="xdx_907_eus-gaap--RelatedPartyTransactionRate_pid_dp_uPure_c20220701__20230630__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_ziDTluNMFdMc" title="Interest at a rate"&gt;10&lt;/span&gt;% and drawdowns from the Smith Credit Facility are
subject to a &lt;span id="xdx_906_ecustom--LineOfCreditFacilityPrepaymentFee_pid_dp_uPure_c20220701__20230630__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zDWvTLSNJrK9" title="Prepayment fee"&gt;2.5&lt;/span&gt;% establishment fee. Amounts outstanding under the Smith Credit Facility are secured by all of the Company&#x2019;s
assets pursuant to a general security agreement. The Smith Credit Facility contains financial and non-financial covenants customary
for a facility of its size and nature. The maturity date for the Smith Credit Facility was June 30, 2023. On February 28, 2023,
the Smith Credit facility was amended to increase the borrowing limit to $&lt;span id="xdx_907_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230228__us-gaap--TypeOfArrangementAxis__custom--AmendedNonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__srt--RangeAxis__srt--MaximumMember_zb3jXltSYOMj" title="Credit agreement"&gt;4,000&lt;/span&gt; from the previous limit of $&lt;span id="xdx_909_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230228__us-gaap--TypeOfArrangementAxis__custom--AmendedNonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__srt--RangeAxis__srt--MinimumMember_zpAZNuddzkwa" title="Credit agreement"&gt;3,500&lt;/span&gt;. The Company
subsequently drew down $&lt;span id="xdx_905_ecustom--AmountPaidToRelatedParty_iI_pn3n3_c20230630_zBixtKViZtK7" title="Amount drew down"&gt;1,130&lt;/span&gt;, leaving an available balance under the Smith Credit Facility of $&lt;span id="xdx_909_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230630__us-gaap--TypeOfArrangementAxis__custom--AmendedNonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember_zDBlzT6bHeA4"&gt;52&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zT6epf8Avk78" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zehBT8sBERS1"&gt;Changes
in the Smith Credit Agreement principal balance are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ending June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left; padding-bottom: 1pt"&gt;Beginning balance&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RelatedPartyDepositLiabilities_iS_pn3n3_c20220701__20230630_zwHEezuNsSv6" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance"&gt;2,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RelatedPartyDepositLiabilities_iS_pn3n3_c20210701__20220630_zwgnGso85md4" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;2,318&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;&#160;Amounts advanced&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AmountsAdvanced_pn3n3_c20220701__20230630_zkFwglwFdpUb" style="text-align: right" title="Amounts advanced"&gt;1,130&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AmountsAdvanced_pn3n3_c20210701__20220630_zgQObPdwXnV5" style="text-align: right" title="Amounts advanced"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1732"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&#160;&#160;Repayments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_pn3n3_c20220701__20230630_zmWVPyMin6R2" style="border-bottom: Black 1pt solid; text-align: right" title="Repayments"&gt;(3,130&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_pn3n3_c20210701__20220630_zTZckqQMdsa8" style="border-bottom: Black 1pt solid; text-align: right"&gt;(318&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Balance, end of period&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RelatedPartyDepositLiabilities_iE_pn3n3_c20220701__20230630_zMTIL0qtVBd8" style="border-bottom: Black 2pt solid; text-align: right" title="Balance, end of period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1737"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RelatedPartyDepositLiabilities_iE_pn3n3_c20210701__20220630_zTxLrf98i62b" style="border-bottom: Black 2pt solid; text-align: right"&gt;2,000&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A0_zogHd5mEoNP" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 22, 2023, the Company repaid Mr. Smith $&lt;span id="xdx_901_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230322__us-gaap--TypeOfArrangementAxis__custom--NonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zEwmA6eEKUV9" title="Credit agreement"&gt;1,841&lt;/span&gt; of principal borrowed under the Smith Credit Facility. This repayment was
made out of funds transferred to the Company from the GXII trust account on the Closing Date. The Company repaid the remaining
principal balance of $&lt;span id="xdx_907_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20230531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember_zR1v5dsaih68" title="Principal amount outstanding"&gt;1,289&lt;/span&gt; on May 31, 2023. The Smith Credit Facility expired on June 30, 2023. Accounts payable and accrued
liabilities as of June 30, 2023 includes $&lt;span id="xdx_901_ecustom--EstablishmentFeesPayable_pn3n3_c20220701__20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MarkSmithMember_zX16dvpl82n3" title="Establishment fees payable"&gt;28&lt;/span&gt; of origination fees payable under the Smith Credit Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
fiscal year 2023 and 2022, the Company paid a total of $&lt;span id="xdx_903_eus-gaap--AccruedLiabilitiesCurrent_iI_pn3n3_dxL_c20230630_ziy9tdU7kGEe" title="Interest paid::XDX::252"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1746"&gt;183&lt;/span&gt;&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrent_iI_pn3n3_dxL_c20220630_zEc57w8rquI4" title="::XDX::873"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1747"&gt;252&lt;/span&gt;&lt;/span&gt;, respectively, representing accrued interest on the Smith
Credit Agreement.&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionRate
      contextRef="From2022-07-012023-06-30_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:RelatedPartyTransactionRate>
    <niobf:LineOfCreditFacilityPrepaymentFee
      contextRef="From2022-07-012023-06-30_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember"
      decimals="INF"
      unitRef="Pure">0.025</niobf:LineOfCreditFacilityPrepaymentFee>
    <us-gaap:LongTermLineOfCredit
      contextRef="AsOf2023-02-28_custom_AmendedNonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember_srt_MaximumMember"
      decimals="-3"
      unitRef="USD">4000000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LongTermLineOfCredit
      contextRef="AsOf2023-02-28_custom_AmendedNonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember_srt_MinimumMember"
      decimals="-3"
      unitRef="USD">3500000</us-gaap:LongTermLineOfCredit>
    <niobf:AmountPaidToRelatedParty contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">1130000</niobf:AmountPaidToRelatedParty>
    <us-gaap:LongTermLineOfCredit
      contextRef="AsOf2023-06-30_custom_AmendedNonRevolvingCreditFacilityAgreementMember_custom_MarkSmithMember"
      decimals="-3"
      unitRef="USD">52000</us-gaap:LongTermLineOfCredit>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_89A_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zT6epf8Avk78" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zehBT8sBERS1"&gt;Changes
in the Smith Credit Agreement principal balance are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ending June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left; padding-bottom: 1pt"&gt;Beginning balance&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RelatedPartyDepositLiabilities_iS_pn3n3_c20220701__20230630_zwHEezuNsSv6" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance"&gt;2,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RelatedPartyDepositLiabilities_iS_pn3n3_c20210701__20220630_zwgnGso85md4" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;2,318&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;&#160;Amounts advanced&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AmountsAdvanced_pn3n3_c20220701__20230630_zkFwglwFdpUb" style="text-align: right" title="Amounts advanced"&gt;1,130&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AmountsAdvanced_pn3n3_c20210701__20220630_zgQObPdwXnV5" style="text-align: right" title="Amounts advanced"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1732"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&#160;&#160;Repayments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_pn3n3_c20220701__20230630_zmWVPyMin6R2" style="border-bottom: Black 1pt solid; text-align: right" title="Repayments"&gt;(3,130&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_pn3n3_c20210701__20220630_zTZckqQMdsa8" style="border-bottom: Black 1pt solid; text-align: right"&gt;(318&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Balance, end of period&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RelatedPartyDepositLiabilities_iE_pn3n3_c20220701__20230630_zMTIL0qtVBd8" style="border-bottom: Black 2pt solid; text-align: right" title="Balance, end of period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1737"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RelatedPartyDepositLiabilities_iE_pn3n3_c20210701__20220630_zTxLrf98i62b" style="border-bottom: Black 2pt solid; text-align: right"&gt;2,000&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:RelatedPartyDepositLiabilities contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">2000000</us-gaap:RelatedPartyDepositLiabilities>
    <us-gaap:RelatedPartyDepositLiabilities contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">2318000</us-gaap:RelatedPartyDepositLiabilities>
    <niobf:AmountsAdvanced
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">1130000</niobf:AmountsAdvanced>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-3130000</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-318000</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:RelatedPartyDepositLiabilities contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">2000000</us-gaap:RelatedPartyDepositLiabilities>
    <us-gaap:LongTermLineOfCredit
      contextRef="AsOf2023-03-22_custom_NonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember"
      decimals="-3"
      unitRef="USD">1841000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LongTermLineOfCredit
      contextRef="AsOf2023-05-31_custom_MarkSmithMember"
      decimals="-3"
      unitRef="USD">1289000</us-gaap:LongTermLineOfCredit>
    <niobf:EstablishmentFeesPayable
      contextRef="From2022-07-012023-06-30_custom_MarkSmithMember"
      decimals="-3"
      unitRef="USD">28000</niobf:EstablishmentFeesPayable>
    <niobf:ExplorationExpendituresDisclosuresTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_80F_ecustom--ExplorationExpendituresDisclosuresTextBlock_z0dtcmhuBK35" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82D_zurDBRESw9od"&gt;EXPLORATION
EXPENDITURES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_89F_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zk8FIjT2avH6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zMuxKAi1HCqk" style="display: none; visibility: hidden"&gt;Schedule of exploration expenditures&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 70%; margin-left: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;&#160;Feasibility study and engineering&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zDoRPYqfL0B1" style="width: 12%; text-align: right"&gt;410&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zqyJlR7KPte4" style="width: 12%; text-align: right"&gt;334&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zdqIXbvJOf97" style="width: 12%; text-align: right"&gt;79&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;Field management and other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zEIjtm0HBAl6" style="text-align: right"&gt;738&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zcDBIKdTU0Ya" style="text-align: right"&gt;569&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zHKeiv5fbv63" style="text-align: right"&gt;656&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;Metallurgical&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__us-gaap--ExplorationAndProductionEquipmentMember_zWMnyMl6Ic2a" style="text-align: right"&gt;4,174&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__us-gaap--ExplorationAndProductionEquipmentMember_z3bptrItMw1b" style="text-align: right"&gt;2,218&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__us-gaap--ExplorationAndProductionEquipmentMember_zwRodmIVAea8" style="text-align: right"&gt;272&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;Geologists and field staff&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_zNS0ghMo89Z9" style="border-bottom: Black 1pt solid; text-align: right"&gt;26&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_zhXYrp3vCw19" style="border-bottom: Black 1pt solid; text-align: right"&gt;188&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_zSzKsYwIUAv7" style="border-bottom: Black 1pt solid; text-align: right"&gt;49&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;&#160;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630_zP6zjfAPTIgj" style="border-bottom: Black 2pt solid; text-align: right" title="Exploration expenditures"&gt;5,348&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630_zIYOyfyh2Sll" style="border-bottom: Black 2pt solid; text-align: right"&gt;3,309&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630_zND4vnhjVgr6" style="border-bottom: Black 2pt solid; text-align: right"&gt;1,056&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A5_zJl2P4EnLSs9" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

</niobf:ExplorationExpendituresDisclosuresTextBlock>
    <niobf:ScheduleOfExplorationExpendituresTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_89F_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zk8FIjT2avH6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zMuxKAi1HCqk" style="display: none; visibility: hidden"&gt;Schedule of exploration expenditures&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 70%; margin-left: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;&#160;Feasibility study and engineering&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zDoRPYqfL0B1" style="width: 12%; text-align: right"&gt;410&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zqyJlR7KPte4" style="width: 12%; text-align: right"&gt;334&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zdqIXbvJOf97" style="width: 12%; text-align: right"&gt;79&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;Field management and other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zEIjtm0HBAl6" style="text-align: right"&gt;738&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zcDBIKdTU0Ya" style="text-align: right"&gt;569&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zHKeiv5fbv63" style="text-align: right"&gt;656&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;Metallurgical&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__us-gaap--ExplorationAndProductionEquipmentMember_zWMnyMl6Ic2a" style="text-align: right"&gt;4,174&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__us-gaap--ExplorationAndProductionEquipmentMember_z3bptrItMw1b" style="text-align: right"&gt;2,218&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__us-gaap--ExplorationAndProductionEquipmentMember_zwRodmIVAea8" style="text-align: right"&gt;272&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;Geologists and field staff&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_zNS0ghMo89Z9" style="border-bottom: Black 1pt solid; text-align: right"&gt;26&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_zhXYrp3vCw19" style="border-bottom: Black 1pt solid; text-align: right"&gt;188&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_zSzKsYwIUAv7" style="border-bottom: Black 1pt solid; text-align: right"&gt;49&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;&#160;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20220701__20230630_zP6zjfAPTIgj" style="border-bottom: Black 2pt solid; text-align: right" title="Exploration expenditures"&gt;5,348&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ExplorationExpense_pn3n3_c20210701__20220630_zIYOyfyh2Sll" style="border-bottom: Black 2pt solid; text-align: right"&gt;3,309&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20200701__20210630_zND4vnhjVgr6" style="border-bottom: Black 2pt solid; text-align: right"&gt;1,056&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:ScheduleOfExplorationExpendituresTableTextBlock>
    <us-gaap:ExplorationExpense
      contextRef="From2022-07-012023-06-30_custom_FeasibilityStudyAndEngineeringMember"
      decimals="-3"
      unitRef="USD">410000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2021-07-012022-06-30_custom_FeasibilityStudyAndEngineeringMember"
      decimals="-3"
      unitRef="USD">334000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2020-07-012021-06-30_custom_FeasibilityStudyAndEngineeringMember"
      decimals="-3"
      unitRef="USD">79000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2022-07-012023-06-30_custom_FieldManagementAndOtherMember"
      decimals="-3"
      unitRef="USD">738000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2021-07-012022-06-30_custom_FieldManagementAndOtherMember"
      decimals="-3"
      unitRef="USD">569000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2020-07-012021-06-30_custom_FieldManagementAndOtherMember"
      decimals="-3"
      unitRef="USD">656000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2022-07-012023-06-30_us-gaap_ExplorationAndProductionEquipmentMember"
      decimals="-3"
      unitRef="USD">4174000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2021-07-012022-06-30_us-gaap_ExplorationAndProductionEquipmentMember"
      decimals="-3"
      unitRef="USD">2218000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2020-07-012021-06-30_us-gaap_ExplorationAndProductionEquipmentMember"
      decimals="-3"
      unitRef="USD">272000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2022-07-012023-06-30_custom_GeologistsAndFieldStaffMember"
      decimals="-3"
      unitRef="USD">26000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2021-07-012022-06-30_custom_GeologistsAndFieldStaffMember"
      decimals="-3"
      unitRef="USD">188000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2020-07-012021-06-30_custom_GeologistsAndFieldStaffMember"
      decimals="-3"
      unitRef="USD">49000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">5348000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">3309000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">1056000</us-gaap:ExplorationExpense>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_800_eus-gaap--LesseeOperatingLeasesTextBlock_z4Rp60Gt1JCf" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_822_zsmQYBEN6zid"&gt;LEASES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
February 2023, the Company entered into a &lt;span id="xdx_90F_eus-gaap--LesseeOperatingLeaseOptionToExtend_c20220701__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CorporateOfficeMember_ze67bz4beCNk" title="Other lease description"&gt;39-month corporate office lease extension and recognized the corresponding ROU asset
and lease liability of $198 associated with this extension, based on a discount rate of &lt;span id="xdx_903_ecustom--DiscountRate_dp_uPure_c20220701__20230630_zsJftga1Ki32" title="Discount rate"&gt;16&lt;/span&gt;%.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2023 and 2022, the Company had one corporate office lease with a remaining lease term of &lt;span id="xdx_909_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dxL_c20230630_zx9UWl74E3be" title="Remaining lease term::XDX::P3Y7M6D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1775"&gt;3.6&lt;/span&gt;&lt;/span&gt;
years and &lt;span id="xdx_90E_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dxL_c20220630_zbsNE9HLobVl" title="Remaining lease term::XDX::P1Y3M19D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1777"&gt;1.3&lt;/span&gt;&lt;/span&gt; years, respectively. During the year ended June 30, 2023 and 2022, operating cash flows included cash payments of $&lt;span id="xdx_905_eus-gaap--OperatingLeasePayments_c20220701__20230630_z1nSlUQphkg3" title="Cash payment"&gt;93&lt;/span&gt;
and $&lt;span id="xdx_905_eus-gaap--OperatingLeasePayments_c20210701__20220630_zipel64MjrVe"&gt;90&lt;/span&gt;, respectively related to
the measurement of lease liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;

&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;





&lt;p id="xdx_89D_eus-gaap--LeaseCostTableTextBlock_zSnfQKhwiuh3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zlbAlFFdpoHa"&gt;The
Company incurred lease costs as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20220701__20230630_zpmYZ7m6lL3d" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20210701__20220630_zXQcSgepqCo8" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20200701__20210630_zNzI0azPhXl5" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LeaseCostAbstract_iB_zoXpqvRuRPah" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -5.25pt; padding-left: 5.4pt"&gt;&#160;Operating Lease Cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--FixedRentExpense_z8AcCqN0iHUd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; text-align: left; text-indent: 3.75pt; padding-left: 5.4pt"&gt;Fixed rent expense&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;83&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;83&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;106&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--VariableLeaseCost_zr0X1jDo3W73" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 3.75pt; padding-left: 5.4pt"&gt;Variable rent expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--ShortTermLeaseCost_i_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 3.75pt; padding-left: 5.4pt"&gt;Short term lease cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--SubleaseIncome_iN_pn3n3_di_z76UFRZu2Tfa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 3.75pt; padding-left: 5.4pt"&gt;Sublease income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(33&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(26&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(18&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_zcX5cRZwenp8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 5.4pt"&gt;Net lease cost&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;73&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;85&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;108&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--OtherCostAndExpenseOperating_i_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 8.25pt; padding-left: 5.4pt"&gt;Lease cost &#x2013; other operating expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;73&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;85&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;89&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--ExplorationCosts_i_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 8.25pt; padding-left: 5.4pt"&gt;Lease cost &#x2013; exploration expenditures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1818"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1819"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;19&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--LeaseCost_iC_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 5.4pt"&gt;Net lease cost&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;73&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;85&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;108&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zKjX3tLg7oj5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zD7mmsHKNvfi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zDvJ5ophd4el"&gt;The
maturity of lease liabilities is as follows at June 30, 2023:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49C_20230630_z1QWTu6T7T0i" style="text-align: center"&gt;&#160;Fiscal Year Lease Maturities&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzI5d_zHPDhM5QUv7c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 51%; text-align: left"&gt;&#160;&#160;2024&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;$&lt;/td&gt;
    &lt;td style="width: 15%; text-align: right"&gt;71&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzI5d_z05KgwjqCgpi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;2025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;96&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPzI5d_zvTGZCZz7QY6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;2026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;98&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_maLOLLPzI5d_zqdtbyxaHpE4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;2027&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_mtLOLLPzI5d_zTaKPeQ4hDr2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;315&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--LessAmountOfPaymentsRepresentingInterest_iI_pn3n3_zKE9Pp6QS1a2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;Less amount of payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(80&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zTgELzjBCtJ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Present value of lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;235&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_z9MZvrJmbNh1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;Less current portion of operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(71&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zV9dtOQgqg4g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Noncurrent operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;164&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A5_zMOsgEKBhOac" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseOptionToExtend contextRef="From2022-07-012023-06-30_custom_CorporateOfficeMember">39-month corporate office lease extension and recognized the corresponding ROU asset
and lease liability of $198 associated with this extension, based on a discount rate of 16%.</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <niobf:DiscountRate
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">0.16</niobf:DiscountRate>
    <us-gaap:OperatingLeasePayments
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">93</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">90</us-gaap:OperatingLeasePayments>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_89D_eus-gaap--LeaseCostTableTextBlock_zSnfQKhwiuh3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zlbAlFFdpoHa"&gt;The
Company incurred lease costs as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20220701__20230630_zpmYZ7m6lL3d" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20210701__20220630_zXQcSgepqCo8" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20200701__20210630_zNzI0azPhXl5" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LeaseCostAbstract_iB_zoXpqvRuRPah" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -5.25pt; padding-left: 5.4pt"&gt;&#160;Operating Lease Cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--FixedRentExpense_z8AcCqN0iHUd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; text-align: left; text-indent: 3.75pt; padding-left: 5.4pt"&gt;Fixed rent expense&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;83&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;83&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;106&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--VariableLeaseCost_zr0X1jDo3W73" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 3.75pt; padding-left: 5.4pt"&gt;Variable rent expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--ShortTermLeaseCost_i_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 3.75pt; padding-left: 5.4pt"&gt;Short term lease cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--SubleaseIncome_iN_pn3n3_di_z76UFRZu2Tfa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 3.75pt; padding-left: 5.4pt"&gt;Sublease income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(33&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(26&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(18&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_zcX5cRZwenp8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 5.4pt"&gt;Net lease cost&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;73&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;85&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;108&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--OtherCostAndExpenseOperating_i_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 8.25pt; padding-left: 5.4pt"&gt;Lease cost &#x2013; other operating expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;73&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;85&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;89&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--ExplorationCosts_i_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 8.25pt; padding-left: 5.4pt"&gt;Lease cost &#x2013; exploration expenditures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1818"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1819"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;19&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--LeaseCost_iC_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 5.4pt"&gt;Net lease cost&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;73&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;85&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;108&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:LeaseCostTableTextBlock>
    <niobf:FixedRentExpense
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">83000</niobf:FixedRentExpense>
    <niobf:FixedRentExpense
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">83000</niobf:FixedRentExpense>
    <niobf:FixedRentExpense
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">106000</niobf:FixedRentExpense>
    <us-gaap:VariableLeaseCost
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">13000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">12000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">7000</us-gaap:VariableLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">10000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">16000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">13000</us-gaap:ShortTermLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">33000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">26000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">18000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">73000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">85000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">108000</us-gaap:LeaseCost>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">73000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">85000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">89000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:ExplorationCosts
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">19000</us-gaap:ExplorationCosts>
    <us-gaap:LeaseCost
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">73000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">85000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">108000</us-gaap:LeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_897_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zD7mmsHKNvfi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zDvJ5ophd4el"&gt;The
maturity of lease liabilities is as follows at June 30, 2023:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49C_20230630_z1QWTu6T7T0i" style="text-align: center"&gt;&#160;Fiscal Year Lease Maturities&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzI5d_zHPDhM5QUv7c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 51%; text-align: left"&gt;&#160;&#160;2024&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;$&lt;/td&gt;
    &lt;td style="width: 15%; text-align: right"&gt;71&lt;/td&gt;&lt;td style="width: 1%; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzI5d_z05KgwjqCgpi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;2025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;96&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPzI5d_zvTGZCZz7QY6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;2026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;98&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_maLOLLPzI5d_zqdtbyxaHpE4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&#160;2027&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_mtLOLLPzI5d_zTaKPeQ4hDr2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;315&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--LessAmountOfPaymentsRepresentingInterest_iI_pn3n3_zKE9Pp6QS1a2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;Less amount of payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(80&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zTgELzjBCtJ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Present value of lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;235&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_z9MZvrJmbNh1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;Less current portion of operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(71&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zV9dtOQgqg4g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Noncurrent operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;164&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">71000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">96000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">98000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">50000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">315000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <niobf:LessAmountOfPaymentsRepresentingInterest contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">-80000</niobf:LessAmountOfPaymentsRepresentingInterest>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">235000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">71000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">164000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_804_eus-gaap--IncomeTaxDisclosureTextBlock_z3QeLREfozB3" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82F_zgFxuyYK0jRi"&gt;INCOME
TAXES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zOwh96xunHZb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zHcHAOhE69tg"&gt;Domestic
and foreign components of loss before income taxes for the years ended June 30, 2023, 2022, and 2021 are as follows:&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20220701__20230630_zeb8spq4upv9" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20210701__20220630_zlF7w9Xq9dtk" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20200701__20210630_zDa3CpObDsc7" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_hus-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zK3uUy9GUwBe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%"&gt;Canada&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;34,606&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;6,918&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,362&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_hus-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zSnBYF2RA4s3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,006&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,969&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,462&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_zZFNWLHDmeR5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;40,612&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;10,887&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;4,824&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A1_zQzFBiFqZf95" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;

&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;





&lt;p id="xdx_890_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zs5HExDBoQV5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_znKJH15Ehw48"&gt;The
following table is a reconciliation of income taxes at statutory rates:&lt;/span&gt; &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20220701__20230630_znnsNMkmeHA5" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20210701__20220630_zweCFb7u7cH3" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20200701__20210630_zUDfhAo0sfv2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_z2WhkTx04cnj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Loss before income taxes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;40,612&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;10,887&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;4,824&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zd2HImnVCDA2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Combined federal and provincial statutory income tax rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_zUfrl6WI2bZg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Income tax benefit at statutory tax rates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,965&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,940&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,303&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_zG5EZlLuMTAe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Foreign rate differential&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(131&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(72&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(31&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--EarnoutSharesLiability_zatK8X6UCRIg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Earnout shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,841&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1887"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1888"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--WarrantLiability_ztPKc0T2sA0f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,518&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1891"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1892"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--GxiiTransactionCosts_zLsZii2oldF8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;GXII transaction costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(925&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1895"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1896"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_zKz7PS0iLfNa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Share based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(412&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(462&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(212&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AssetRetirementObligationAccretionExpense_iN_di_zd55MIrI4rN9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accretion expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(496&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(407&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(158&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--ExtinguishmentOfDebtGainLossIncomeTax_zyvmbEVRRo21" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Loss on debt extinguishment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(54&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1907"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1908"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--EffectOfLegislativeChanges_znHjEoUvZnG1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Capital loss rate differential&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(38&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;182&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_zt23miC8g4Lh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Change in estimates related to prior years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(274&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;739&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--IncomeTaxReconciliationOtherAdjustments_z9Za1ZpLOYbf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zjGXRlblmnE2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,341&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,713&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,841&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;Income tax benefit&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20220701__20230630_zr0eMwVRmSl3" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit::XDX::-304"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1926"&gt;304&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20210701__20220630_zYeRGCCQ4tX1" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1928"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20200701__20210630_zLlWW1B9LwUi" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1930"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A8_zLgiJwpKP3K5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z9Wm3gH6oO5e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zoPVsgiFNfqf"&gt;Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20230630_zDhU4uDzfFX" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_490_20220630_zFERGbCETe1" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0in"&gt;Deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTAGzakr_zFOs3CUB4mza" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 50%; text-align: left; text-indent: 12.45pt; padding-left: 0in"&gt;Net operating losses available for future periods&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;11,893&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;8,977&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--DeferredTaxAssetsMineralInterest_iI_pn3n3_maDTAGzakr_zO5arYDMSVR8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 12.45pt; padding-left: 0in"&gt;Mineral interests&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,477&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,477&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--DeferredTaxAssetsStartupAndOorganizationalCosts_iI_pn3n3_maDTAGzakr_znoYOjcmoRZ8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 12.45pt; padding-left: 0in"&gt;Startup and organizational costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,132&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1941"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--DeferredTaxAssetsResearchAndDevelopmentCosts_iI_pn3n3_maDTAGzakr_zKk5UOLNyXN1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 12.45pt; padding-left: 0in"&gt;Research and development costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,060&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1944"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--DeferredTaxAssetsShareIssuanceCosts_iI_pn3n3_maDTAGzakr_zQd4scgkZIE3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 12.45pt; padding-left: 0in"&gt;Share issuance costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;446&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1947"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--CapitalLossesAvailableForFuturePeriods_iI_pn3n3_maDTAGzakr_zejWCLKH9Gll" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 12.45pt; padding-left: 0in"&gt;Capital losses available for future periods&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;419&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;420&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOther_iI_maDTAGzakr_zuwwfEPG5gte" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: 12.45pt; padding-left: 0in"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;36&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iI_mtDTAGzakr_maDTALNz97R_zkKzt0D9EmG5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0in"&gt;Total deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,463&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,948&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNz97R_zkL602cJP7R1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 12.45pt; padding-left: 0in"&gt;&#160;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(25,463&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(18,948&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNz97R_zFkk3S5gNFpk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0in"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1961"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1962"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AE_zk1CTyf92846" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended June 30, 2022, we identified errors in the recognition of capital losses related to realized mineral property
write downs and foreign exchange gains and losses in Canada which resulted in changes to capital losses available for future periods
and other of $&lt;span id="xdx_90F_ecustom--IncreasesInCapitalLossesAvailableForFuturePeriods_iI_pn3n3_c20220630_zBi6QNFrDvHk"&gt;(221)&lt;/span&gt; and $&lt;span id="xdx_907_ecustom--OtherIncomeTaxes_pn3n3_c20210701__20220630_zT8rSA3tlFii"&gt;(3)&lt;/span&gt;, respectively. These changes primarily related to adjustments to deferred tax assets recorded during
fiscal year 2021. In addition, during the year ended June 30, 2022, we identified an error in the recognition of net operating
losses related to disallowed interest expense for the prior year which resulted in a decrease to net operating loss carryforwards
of $&lt;span id="xdx_90C_ecustom--CapitalLossCaryforward_iI_pn3n3_c20230630_zPeZDpsZv3Y" title="Operating loss carryforwards"&gt;19&lt;/span&gt;. After evaluation and consideration of the full valuation allowance historically applied against total deferred tax assets,
we determined that the impact of the adjustments was not material to the previously issued consolidated financial statements, nor are the out
of period adjustments material to the estimated results for the year ended June 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--SummaryOfValuationAllowanceTextBlock_zx6ddasQHuG" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B1_zhsSx74uZKO7"&gt;Changes
in the valuation allowance are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 50%; text-align: left; text-indent: -5.25pt; padding-left: 5.4pt"&gt;Valuation allowance, beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20220701__20230630_z0HmcrsxEO" style="width: 12%; text-align: right" title="Valuation allowance, beginning of year"&gt;(18,948&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20210701__20220630_zWITIePj2yUl" style="width: 12%; text-align: right" title="Valuation allowance, beginning of year"&gt;(17,235&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 4.85pt; padding-left: 5.4pt"&gt;Current year additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20220701__20230630_zwPbJS7FO6v9" style="text-align: right" title="Current year additions"&gt;(4,341&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20210701__20220630_zar3lEOTceFi" style="text-align: right"&gt;(1,713&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 4.85pt; padding-left: 5.4pt"&gt;Startup and organizational costs acquired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20220701__20230630_zWrtvp8nFv11" style="border-bottom: Black 1pt solid; text-align: right" title="Startup and organizational costs acquired"&gt;(2,174&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20210701__20220630_zwL3jCeNsFHh" style="border-bottom: Black 1pt solid; text-align: right" title="Startup and organizational costs acquired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1979"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; text-indent: -5.25pt; padding-left: 5.4pt"&gt;Valuation allowance, end of year&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20220701__20230630_zLHAnSv3xxO1" style="border-bottom: Black 2pt solid; text-align: right" title="Valuation allowance, end of year"&gt;(25,463&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20210701__20220630_zMU53NOnfclh" style="border-bottom: Black 2pt solid; text-align: right" title="Valuation allowance, end of year"&gt;(18,948&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A7_zbh27Din1iOh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;div style="text-align: center; margin-left: 0.25in"&gt;&lt;/div&gt;

&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company acquired a federal income tax payable of $&lt;span id="xdx_907_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_pn3n3_c20220701__20230630_z3PblABOZUtd" title="Federal income tax payable"&gt;406&lt;/span&gt; in connection with the GXII Transaction. As a result of a post-transaction
loss at ECRC, a partial release of the valuation allowance attributed to the reduction of the acquired federal income tax payable
of $304 has been recorded as an income tax benefit in the consolidated statement of operations and comprehensive loss for the
year ended June 30, 2023. The Company establishes a valuation allowance against future income tax assets if, based on available
information, it is more likely than not that all of the assets will not be realized. The valuation allowance of $&lt;span id="xdx_90D_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pn3n3_c20230630_zwrjHPKNexG6" title="Valuation allowance"&gt;25,463&lt;/span&gt; at June
30, 2023, relates mainly to net operating loss carryforwards in Canada and mineral interests due to deferred exploration expenditures
in the United States, where the utilization of such attributes is not more likely than not.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zt7NSQhNdB92" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company has the following cumulative net operating losses for Canadian and U.S. income tax purposes and these carryforwards will
generally expire between 2026 and 2043. As a result of the Tax Cuts and Jobs Act of 2017, U.S. tax losses incurred for tax years
ending on and after June 30, 2019, totaling $&lt;span id="xdx_900_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pn3n3_c20190630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zJv5UtZ5duE5" title="Tax losses incurred"&gt;2,510&lt;/span&gt;, have no expiration..&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8BC_zZs2rzH4nlb7" style="display: none; visibility: hidden"&gt;Schedule of cumulative net operating losses&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Jurisdiction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 20%"&gt;Canada&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zr2FLxoZyhUl" style="width: 12%; text-align: right" title="Total"&gt;40,267&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20220630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zhDi5089CG8c" style="width: 12%; text-align: right" title="Total"&gt;31,551&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zk4iV5YRgr57" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;3,491&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20220630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zyv3Wf0uaSG1" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;2,460&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630_z88s9qWFxcD1" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;43,758&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20220630_z9x1cEazGDhi" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;34,011&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zIP5noOXAsa7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, the Company has a Canadian capital loss carryforward of $&lt;span id="xdx_902_ecustom--CapitalLossCaryforward_iI_c20230630__srt--CurrencyAxis__currency--CAD_z9Q4kEAyjsb4" title="Capital loss carryforward"&gt;3,375&lt;/span&gt; as of June 30, 2023, which has no expiration date and
can be used to offset future capital gains, and U.S. state net operating loss carryforwards of $&lt;span id="xdx_903_ecustom--CapitalLossCaryforward_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z6d9xy17ptD5" title="Net operating loss carryforwards"&gt;4,943&lt;/span&gt; as of June 30, 2023 which
generally expire between 2031 and 2043.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company had no unrecognized tax benefits as of June 30, 2023 or 2022. The Company recognizes interest accrued related to unrecognized
tax benefits and penalties in its income tax provision. The Company has not recognized any interest or penalties in the fiscal
years presented in these consolidated financial statements. The Company is subject to income tax in the U.S. federal jurisdiction and Canada.
Certain years remain subject to examination but there are currently no ongoing exams in any taxing jurisdictions.&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_897_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zOwh96xunHZb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zHcHAOhE69tg"&gt;Domestic
and foreign components of loss before income taxes for the years ended June 30, 2023, 2022, and 2021 are as follows:&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20220701__20230630_zeb8spq4upv9" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20210701__20220630_zlF7w9Xq9dtk" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20200701__20210630_zDa3CpObDsc7" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_hus-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zK3uUy9GUwBe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%"&gt;Canada&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;34,606&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;6,918&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,362&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_hus-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zSnBYF2RA4s3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,006&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,969&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,462&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_zZFNWLHDmeR5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;40,612&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;10,887&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;4,824&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2022-07-012023-06-30_us-gaap_ForeignCountryMember"
      decimals="-3"
      unitRef="USD">34606000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2021-07-012022-06-30_us-gaap_ForeignCountryMember"
      decimals="-3"
      unitRef="USD">6918000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-07-012021-06-30_us-gaap_ForeignCountryMember"
      decimals="-3"
      unitRef="USD">3362000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2022-07-012023-06-30_us-gaap_DomesticCountryMember"
      decimals="-3"
      unitRef="USD">6006000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2021-07-012022-06-30_us-gaap_DomesticCountryMember"
      decimals="-3"
      unitRef="USD">3969000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-07-012021-06-30_us-gaap_DomesticCountryMember"
      decimals="-3"
      unitRef="USD">1462000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">40612000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">10887000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">4824000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_890_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zs5HExDBoQV5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_znKJH15Ehw48"&gt;The
following table is a reconciliation of income taxes at statutory rates:&lt;/span&gt; &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20220701__20230630_znnsNMkmeHA5" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20210701__20220630_zweCFb7u7cH3" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20200701__20210630_zUDfhAo0sfv2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_z2WhkTx04cnj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left"&gt;Loss before income taxes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;40,612&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;10,887&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;4,824&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zd2HImnVCDA2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Combined federal and provincial statutory income tax rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_zUfrl6WI2bZg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Income tax benefit at statutory tax rates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,965&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,940&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,303&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_zG5EZlLuMTAe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Foreign rate differential&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(131&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(72&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(31&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--EarnoutSharesLiability_zatK8X6UCRIg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Earnout shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,841&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1887"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1888"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--WarrantLiability_ztPKc0T2sA0f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,518&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1891"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1892"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--GxiiTransactionCosts_zLsZii2oldF8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;GXII transaction costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(925&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1895"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1896"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_zKz7PS0iLfNa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Share based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(412&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(462&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(212&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AssetRetirementObligationAccretionExpense_iN_di_zd55MIrI4rN9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accretion expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(496&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(407&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(158&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--ExtinguishmentOfDebtGainLossIncomeTax_zyvmbEVRRo21" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Loss on debt extinguishment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(54&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1907"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1908"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--EffectOfLegislativeChanges_znHjEoUvZnG1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Capital loss rate differential&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(38&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;182&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_zt23miC8g4Lh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Change in estimates related to prior years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(274&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;739&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--IncomeTaxReconciliationOtherAdjustments_z9Za1ZpLOYbf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zjGXRlblmnE2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,341&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,713&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,841&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;Income tax benefit&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20220701__20230630_zr0eMwVRmSl3" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit::XDX::-304"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1926"&gt;304&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20210701__20220630_zYeRGCCQ4tX1" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1928"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20200701__20210630_zLlWW1B9LwUi" style="border-bottom: Black 2pt solid; text-align: right" title="Income tax benefit"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1930"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">40612000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">10887000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">4824000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">0.27</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">0.27</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.27</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">10965000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">2940000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">1303000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-131000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-72000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-31000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <niobf:EarnoutSharesLiability
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-2841000</niobf:EarnoutSharesLiability>
    <niobf:WarrantLiability
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-1518000</niobf:WarrantLiability>
    <niobf:GxiiTransactionCosts
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-925000</niobf:GxiiTransactionCosts>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-412000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-462000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-212000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:AssetRetirementObligationAccretionExpense
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">496000</us-gaap:AssetRetirementObligationAccretionExpense>
    <us-gaap:AssetRetirementObligationAccretionExpense
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">407000</us-gaap:AssetRetirementObligationAccretionExpense>
    <us-gaap:AssetRetirementObligationAccretionExpense
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">158000</us-gaap:AssetRetirementObligationAccretionExpense>
    <us-gaap:ExtinguishmentOfDebtGainLossIncomeTax
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-54000</us-gaap:ExtinguishmentOfDebtGainLossIncomeTax>
    <niobf:EffectOfLegislativeChanges
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-2000</niobf:EffectOfLegislativeChanges>
    <niobf:EffectOfLegislativeChanges
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-38000</niobf:EffectOfLegislativeChanges>
    <niobf:EffectOfLegislativeChanges
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">182000</niobf:EffectOfLegislativeChanges>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">14000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-274000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">739000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">45000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">26000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">18000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">-4341000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-1713000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2020-07-012021-06-30"
      decimals="-3"
      unitRef="USD">-1841000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_896_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z9Wm3gH6oO5e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zoPVsgiFNfqf"&gt;Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20230630_zDhU4uDzfFX" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_490_20220630_zFERGbCETe1" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0in"&gt;Deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTAGzakr_zFOs3CUB4mza" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 50%; text-align: left; text-indent: 12.45pt; padding-left: 0in"&gt;Net operating losses available for future periods&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;11,893&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;8,977&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--DeferredTaxAssetsMineralInterest_iI_pn3n3_maDTAGzakr_zO5arYDMSVR8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 12.45pt; padding-left: 0in"&gt;Mineral interests&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,477&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,477&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--DeferredTaxAssetsStartupAndOorganizationalCosts_iI_pn3n3_maDTAGzakr_znoYOjcmoRZ8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 12.45pt; padding-left: 0in"&gt;Startup and organizational costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,132&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1941"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--DeferredTaxAssetsResearchAndDevelopmentCosts_iI_pn3n3_maDTAGzakr_zKk5UOLNyXN1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 12.45pt; padding-left: 0in"&gt;Research and development costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,060&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1944"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--DeferredTaxAssetsShareIssuanceCosts_iI_pn3n3_maDTAGzakr_zQd4scgkZIE3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 12.45pt; padding-left: 0in"&gt;Share issuance costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;446&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1947"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--CapitalLossesAvailableForFuturePeriods_iI_pn3n3_maDTAGzakr_zejWCLKH9Gll" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 12.45pt; padding-left: 0in"&gt;Capital losses available for future periods&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;419&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;420&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOther_iI_maDTAGzakr_zuwwfEPG5gte" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: 12.45pt; padding-left: 0in"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;36&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;74&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iI_mtDTAGzakr_maDTALNz97R_zkKzt0D9EmG5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0in"&gt;Total deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,463&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,948&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNz97R_zkL602cJP7R1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 12.45pt; padding-left: 0in"&gt;&#160;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(25,463&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(18,948&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNz97R_zFkk3S5gNFpk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0in"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1961"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1962"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">11893000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">8977000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <niobf:DeferredTaxAssetsMineralInterest contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">9477000</niobf:DeferredTaxAssetsMineralInterest>
    <niobf:DeferredTaxAssetsMineralInterest contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">9477000</niobf:DeferredTaxAssetsMineralInterest>
    <niobf:DeferredTaxAssetsStartupAndOorganizationalCosts contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">2132000</niobf:DeferredTaxAssetsStartupAndOorganizationalCosts>
    <niobf:DeferredTaxAssetsResearchAndDevelopmentCosts contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">1060000</niobf:DeferredTaxAssetsResearchAndDevelopmentCosts>
    <niobf:DeferredTaxAssetsShareIssuanceCosts contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">446000</niobf:DeferredTaxAssetsShareIssuanceCosts>
    <niobf:CapitalLossesAvailableForFuturePeriods contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">419000</niobf:CapitalLossesAvailableForFuturePeriods>
    <niobf:CapitalLossesAvailableForFuturePeriods contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">420000</niobf:CapitalLossesAvailableForFuturePeriods>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">36000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">74000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">25463000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">18948000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">25463000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">18948000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <niobf:IncreasesInCapitalLossesAvailableForFuturePeriods contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">-221000</niobf:IncreasesInCapitalLossesAvailableForFuturePeriods>
    <niobf:OtherIncomeTaxes
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">-3000</niobf:OtherIncomeTaxes>
    <niobf:CapitalLossCaryforward contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">19000</niobf:CapitalLossCaryforward>
    <us-gaap:SummaryOfValuationAllowanceTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_89C_eus-gaap--SummaryOfValuationAllowanceTextBlock_zx6ddasQHuG" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B1_zhsSx74uZKO7"&gt;Changes
in the valuation allowance are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 50%; text-align: left; text-indent: -5.25pt; padding-left: 5.4pt"&gt;Valuation allowance, beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20220701__20230630_z0HmcrsxEO" style="width: 12%; text-align: right" title="Valuation allowance, beginning of year"&gt;(18,948&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pn3n3_di_c20210701__20220630_zWITIePj2yUl" style="width: 12%; text-align: right" title="Valuation allowance, beginning of year"&gt;(17,235&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 4.85pt; padding-left: 5.4pt"&gt;Current year additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20220701__20230630_zwPbJS7FO6v9" style="text-align: right" title="Current year additions"&gt;(4,341&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20210701__20220630_zar3lEOTceFi" style="text-align: right"&gt;(1,713&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 4.85pt; padding-left: 5.4pt"&gt;Startup and organizational costs acquired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20220701__20230630_zWrtvp8nFv11" style="border-bottom: Black 1pt solid; text-align: right" title="Startup and organizational costs acquired"&gt;(2,174&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--CostsIncurredDevelopmentCosts_iN_pn3n3_di_c20210701__20220630_zwL3jCeNsFHh" style="border-bottom: Black 1pt solid; text-align: right" title="Startup and organizational costs acquired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1979"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt; text-indent: -5.25pt; padding-left: 5.4pt"&gt;Valuation allowance, end of year&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20220701__20230630_zLHAnSv3xxO1" style="border-bottom: Black 2pt solid; text-align: right" title="Valuation allowance, end of year"&gt;(25,463&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_pn3n3_di_c20210701__20220630_zMU53NOnfclh" style="border-bottom: Black 2pt solid; text-align: right" title="Valuation allowance, end of year"&gt;(18,948&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">18948000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">17235000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <niobf:DeferredTaxAssetsValuationAllowanceAdditions
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">4341000</niobf:DeferredTaxAssetsValuationAllowanceAdditions>
    <niobf:DeferredTaxAssetsValuationAllowanceAdditions
      contextRef="From2021-07-012022-06-30"
      decimals="-3"
      unitRef="USD">1713000</niobf:DeferredTaxAssetsValuationAllowanceAdditions>
    <us-gaap:CostsIncurredDevelopmentCosts
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">2174000</us-gaap:CostsIncurredDevelopmentCosts>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">25463000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">18948000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="From2022-07-01to2023-06-30"
      decimals="-3"
      unitRef="USD">406000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">25463000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_895_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zt7NSQhNdB92" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company has the following cumulative net operating losses for Canadian and U.S. income tax purposes and these carryforwards will
generally expire between 2026 and 2043. As a result of the Tax Cuts and Jobs Act of 2017, U.S. tax losses incurred for tax years
ending on and after June 30, 2019, totaling $&lt;span id="xdx_900_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pn3n3_c20190630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zJv5UtZ5duE5" title="Tax losses incurred"&gt;2,510&lt;/span&gt;, have no expiration..&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8BC_zZs2rzH4nlb7" style="display: none; visibility: hidden"&gt;Schedule of cumulative net operating losses&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Jurisdiction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 20%"&gt;Canada&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zr2FLxoZyhUl" style="width: 12%; text-align: right" title="Total"&gt;40,267&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20220630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zhDi5089CG8c" style="width: 12%; text-align: right" title="Total"&gt;31,551&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zk4iV5YRgr57" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;3,491&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20220630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zyv3Wf0uaSG1" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;2,460&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230630_z88s9qWFxcD1" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;43,758&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20220630_z9x1cEazGDhi" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;34,011&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock>
    <us-gaap:DeferredTaxAssetsOtherLossCarryforwards
      contextRef="AsOf2019-06-30_us-gaap_DomesticCountryMember"
      decimals="-3"
      unitRef="USD">2510000</us-gaap:DeferredTaxAssetsOtherLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-06-30_us-gaap_ForeignCountryMember"
      decimals="-3"
      unitRef="USD">40267000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2022-06-30_us-gaap_ForeignCountryMember"
      decimals="-3"
      unitRef="USD">31551000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-06-30_us-gaap_DomesticCountryMember"
      decimals="-3"
      unitRef="USD">3491000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2022-06-30_us-gaap_DomesticCountryMember"
      decimals="-3"
      unitRef="USD">2460000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">43758000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">34011000</us-gaap:OperatingLossCarryforwards>
    <niobf:CapitalLossCaryforward
      contextRef="AsOf2023-06-30_currency_CAD"
      decimals="0"
      unitRef="USD">3375</niobf:CapitalLossCaryforward>
    <niobf:CapitalLossCaryforward
      contextRef="AsOf2023-06-30_us-gaap_DomesticCountryMember"
      decimals="-3"
      unitRef="USD">4943000</niobf:CapitalLossCaryforward>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_80B_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_z2JfJREIbHPb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;16.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;&lt;span&gt;&lt;span id="xdx_823_z0Jtaq5xxBC7"&gt;FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;The Company measures the fair value of
financial assets and liabilities based on U.S. GAAP guidance which defines fair value, establishes a framework for measuring fair
value, and expands disclosures about fair value measurements.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company classifies financial assets and liabilities as held-for-trading, available-for-sale, held-to-maturity, loans and receivables,
or other financial liabilities depending on their nature. Financial assets and financial liabilities are recognized at fair value
on their initial recognition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
assets and liabilities classified as held-for-trading are measured at fair value, with gains and losses recognized in net income.
Financial assets classified as held-to-maturity, loans and receivables, and financial liabilities other than those classified
as held-for-trading are measured at amortized cost, using the effective interest method of amortization. Financial assets classified
as available-for-sale, including investments in equity securities, are measured at fair value, with unrealized gains and losses
being recognized in income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Financial
instruments including receivables, accounts payable and accrued liabilities, and related party loans are carried at amortized
cost, which management believes approximates fair value due to the short-term nature of these instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables present information about the assets and liabilities that are measured at fair value on a recurring basis as
of June 30, 2023, and June 30, 2022, respectively, and indicate the fair value hierarchy of the valuation techniques the Company
utilized to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted)
in active markets for identical instruments. Fair values determined by Level 2 inputs utilize data points that are observable,
such as quoted prices, interest rates, and yield curves. Fair values determined by Level 3 inputs are unobservable data points
for the financial instrument and include situations where there is little, if any, market activity for the instrument.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0"&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;









&lt;p style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p id="xdx_89B_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zNMgNLuWaxM2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;span id="xdx_8B5_z5Btv5rSI5I8" style="display: none; visibility: hidden"&gt;Schedule of fair values determined by level 3 inputs are unobservable data&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;As of June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Note&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 35%; text-align: left; padding-left: 9pt"&gt;Cash and cash equivalents&lt;/td&gt;
    &lt;td style="width: 9%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630_zBqcN60P3wt7" style="width: 11%; text-align: right"&gt;2,341&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIn4vwrQPf7a" style="width: 11%; text-align: right"&gt;2,341&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7zEhm2YuoQf" style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2024"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zq5aVQK3ovAl" style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2025"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;Investment in equity securities&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630_zg5N2PlFUBF4" style="border-bottom: Black 1pt solid; text-align: right"&gt;9&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zVvWu8ZiBRgi" style="border-bottom: Black 1pt solid; text-align: right"&gt;9&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhZOTDvsRkxj" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2028"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zXBuHYeUa2Dh" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2029"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20230630_zVAB7hMrEACg" style="border-bottom: Black 2pt solid; text-align: right"&gt;2,350&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zLJ84rQf7Hs2" style="border-bottom: Black 2pt solid; text-align: right"&gt;2,350&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLoa3f7lt5Q6" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2032"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoBfXWj8Caob" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2033"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Earnout Shares liability&lt;/td&gt;
    &lt;td style="text-align: center"&gt;10&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630_z0f8wg0zICOe" style="text-align: right"&gt;10,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zU38dtIrpt08" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2035"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4rJ8zi6lceg" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2036"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zsYXpvENPoBf" style="text-align: right"&gt;10,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;Warrant liabilities&lt;/td&gt;
    &lt;td style="text-align: center"&gt;9,11c&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630_zBPOAOFwAfj2" style="border-bottom: Black 1pt solid; text-align: right"&gt;4,989&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zomNPdBwqyv8" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2039"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWdcp9yPbOc5" style="border-bottom: Black 1pt solid; text-align: right"&gt;3,279&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmct4EnBaspj" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,710&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;&lt;p style="margin: 0pt 0"&gt;Total&lt;/p&gt;


&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630_zeRiRuss6wwh" style="border-bottom: Black 2pt solid; text-align: right"&gt;15,510&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z9vJ2MMgp1Cf" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2043"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zpYZRNJVy3m3" style="border-bottom: Black 2pt solid; text-align: right"&gt;3,279&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGxP1J8Qcjoe" style="border-bottom: Black 2pt solid; text-align: right"&gt;12,231&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;As of June 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 35%; text-align: left; padding-left: 9pt"&gt;Cash and cash equivalents&lt;/td&gt;
    &lt;td style="width: 9%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20220630_zQii4MSlRlr6" style="width: 11%; text-align: right" title="Cash and cash equivalents"&gt;5,280&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zPVQ35cH5Oxg" style="width: 11%; text-align: right"&gt;5,280&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhRmHXlSeHA9" style="width: 11%; text-align: right"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2049"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_ztumoy6ys8O2" style="width: 11%; text-align: right"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2050"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;Investment in equity securities&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20220630_zKuZXLiBEKi3" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents"&gt;10&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2O9RdnHokzk" style="border-bottom: Black 1pt solid; text-align: right"&gt;10&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zsoypEJ1ICUk" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2054"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoMqkyssNAE9" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2055"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20220630_zcVjOknAjGi9" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents"&gt;5,290&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z30en8wKjpu4" style="border-bottom: Black 2pt solid; text-align: right"&gt;5,290&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9RUg6IZk7dl" style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2059"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3IbVi7tAKG9" style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2060"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A7_zaS7BfaXvR81" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
&lt;span style="color: #353535"&gt;Yorkville Convertible Debt Financing &lt;/span&gt;discussed in Note 9 was initially recorded at fair value,
which represented a nonrecurring fair value measurement using a Level 3 input. At June 30, 2023, the estimated fair value of this
instrument approximated carrying value given that the instrument was issued in March 2023 and has a short time period until maturity.&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_89B_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zNMgNLuWaxM2" style="margin-top: 0; margin-bottom: 0; margin-left: 0.25in"&gt;&lt;span id="xdx_8B5_z5Btv5rSI5I8" style="display: none; visibility: hidden"&gt;Schedule of fair values determined by level 3 inputs are unobservable data&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;As of June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Note&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 35%; text-align: left; padding-left: 9pt"&gt;Cash and cash equivalents&lt;/td&gt;
    &lt;td style="width: 9%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630_zBqcN60P3wt7" style="width: 11%; text-align: right"&gt;2,341&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIn4vwrQPf7a" style="width: 11%; text-align: right"&gt;2,341&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7zEhm2YuoQf" style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2024"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zq5aVQK3ovAl" style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2025"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;Investment in equity securities&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630_zg5N2PlFUBF4" style="border-bottom: Black 1pt solid; text-align: right"&gt;9&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zVvWu8ZiBRgi" style="border-bottom: Black 1pt solid; text-align: right"&gt;9&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhZOTDvsRkxj" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2028"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zXBuHYeUa2Dh" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2029"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20230630_zVAB7hMrEACg" style="border-bottom: Black 2pt solid; text-align: right"&gt;2,350&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zLJ84rQf7Hs2" style="border-bottom: Black 2pt solid; text-align: right"&gt;2,350&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLoa3f7lt5Q6" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2032"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoBfXWj8Caob" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2033"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Earnout Shares liability&lt;/td&gt;
    &lt;td style="text-align: center"&gt;10&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630_z0f8wg0zICOe" style="text-align: right"&gt;10,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zU38dtIrpt08" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2035"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4rJ8zi6lceg" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2036"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zsYXpvENPoBf" style="text-align: right"&gt;10,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;Warrant liabilities&lt;/td&gt;
    &lt;td style="text-align: center"&gt;9,11c&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630_zBPOAOFwAfj2" style="border-bottom: Black 1pt solid; text-align: right"&gt;4,989&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zomNPdBwqyv8" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2039"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWdcp9yPbOc5" style="border-bottom: Black 1pt solid; text-align: right"&gt;3,279&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmct4EnBaspj" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,710&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;&lt;p style="margin: 0pt 0"&gt;Total&lt;/p&gt;


&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630_zeRiRuss6wwh" style="border-bottom: Black 2pt solid; text-align: right"&gt;15,510&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z9vJ2MMgp1Cf" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2043"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zpYZRNJVy3m3" style="border-bottom: Black 2pt solid; text-align: right"&gt;3,279&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGxP1J8Qcjoe" style="border-bottom: Black 2pt solid; text-align: right"&gt;12,231&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;As of June 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 35%; text-align: left; padding-left: 9pt"&gt;Cash and cash equivalents&lt;/td&gt;
    &lt;td style="width: 9%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20220630_zQii4MSlRlr6" style="width: 11%; text-align: right" title="Cash and cash equivalents"&gt;5,280&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zPVQ35cH5Oxg" style="width: 11%; text-align: right"&gt;5,280&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhRmHXlSeHA9" style="width: 11%; text-align: right"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2049"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_ztumoy6ys8O2" style="width: 11%; text-align: right"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2050"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;Investment in equity securities&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20220630_zKuZXLiBEKi3" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents"&gt;10&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2O9RdnHokzk" style="border-bottom: Black 1pt solid; text-align: right"&gt;10&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zsoypEJ1ICUk" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2054"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoMqkyssNAE9" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2055"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20220630_zcVjOknAjGi9" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents"&gt;5,290&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z30en8wKjpu4" style="border-bottom: Black 2pt solid; text-align: right"&gt;5,290&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9RUg6IZk7dl" style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2059"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3IbVi7tAKG9" style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2060"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">2341000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      unitRef="USD">2341000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">9000</niobf:AvailableForSaleSecuritiesEquitySecuritiesOther>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      unitRef="USD">9000</niobf:AvailableForSaleSecuritiesEquitySecuritiesOther>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">2350000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      unitRef="USD">2350000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">10521000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      unitRef="USD">10521000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">4989000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">3279000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      unitRef="USD">1710000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">15510000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">3279000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      unitRef="USD">12231000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">5280000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      unitRef="USD">5280000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">10000</niobf:AvailableForSaleSecuritiesEquitySecuritiesOther>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      unitRef="USD">10000</niobf:AvailableForSaleSecuritiesEquitySecuritiesOther>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">5290000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      unitRef="USD">5290000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_80D_eus-gaap--SubsequentEventsTextBlock_zlsSx7wiCx95" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;17.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;&lt;span id="xdx_82F_zpc8DItdVG3e"&gt;SUBSEQUENT
EVENTS&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--SubsequentEventDescription_c20230830__20230901__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zNuRxFnAe5v6" title="Subsequent event description"&gt;On
September 1, 2023, the Company closed a non-brokered private placement (the &#x201c;September 2023 Private Placement&#x201d;) of
units of the Company (the &#x201c;September 2023 Units&#x201d;). A total of 250,000 September 2023 Units were issued at a price per September 2023 Unit of $4.00,
for total gross proceeds to the Company of $1.0 million. Each September 2023 Unit consists of one Common Share and one Common
Share purchase warrant (&#x201c;September 2023 Warrant&#x201d;). Each September 2023 Warrant entitles the holder to acquire one
Common Share at a price of $4.60 at any time prior to September 1, 2025. Proceeds of the September 2023 Private Placement will
be used for continued advancement of the Company&#x2019;s Elk Creek Critical Minerals Project and for working capital and general
corporate purposes.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 12 and September 18, 2023, the Company issued &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20230910__20230912__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zqfBzBeSACc9" title="Shares issued and sold"&gt;70,000&lt;/span&gt; and &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20230916__20230918__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUQn6IjkDIke" title="Shares issued and sold"&gt;75,000&lt;/span&gt; Common Shares, respectively, under the Yorkville Equity
Facility Financing Agreement in exchange for $&lt;span id="xdx_90F_eus-gaap--DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds_pn5n6_c20230916__20230918__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--FinancingAgreementMember_zqNUyvCQqqJf" title="Gross cash proceeds"&gt;0.5&lt;/span&gt; million in gross cash proceeds.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SubsequentEventDescription contextRef="From2023-08-302023-09-01_us-gaap_SubsequentEventMember">On
September 1, 2023, the Company closed a non-brokered private placement (the &#x201c;September 2023 Private Placement&#x201d;) of
units of the Company (the &#x201c;September 2023 Units&#x201d;). A total of 250,000 September 2023 Units were issued at a price per September 2023 Unit of $4.00,
for total gross proceeds to the Company of $1.0 million. Each September 2023 Unit consists of one Common Share and one Common
Share purchase warrant (&#x201c;September 2023 Warrant&#x201d;). Each September 2023 Warrant entitles the holder to acquire one
Common Share at a price of $4.60 at any time prior to September 1, 2025. Proceeds of the September 2023 Private Placement will
be used for continued advancement of the Company&#x2019;s Elk Creek Critical Minerals Project and for working capital and general
corporate purposes.</us-gaap:SubsequentEventDescription>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-09-102023-09-12_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="INF"
      unitRef="Shares">70000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-09-162023-09-18_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">75000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds
      contextRef="From2023-09-162023-09-18_custom_YorkvilleConvertibleDebtFinancingAgreementMember_us-gaap_SubsequentEventMember_custom_FinancingAgreementMember"
      decimals="-5"
      unitRef="USD">500000</us-gaap:DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds>
    <dei:AuditorName contextRef="From2022-07-01to2023-06-30">BDO USA, P.C.; Spokane, Washington; PCAOB ID#</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2022-07-01to2023-06-30">Spokane, Washington</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="From2022-07-01to2023-06-30">243</dei:AuditorFirmId>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000847"
          xlink:label="Fact000847"
          xlink:type="locator"/>
        <link:footnote id="Footnote000870" xlink:label="Footnote000870" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.</link:footnote>
        <link:footnote id="Footnote000871" xlink:label="Footnote000871" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000847"
          xlink:to="Footnote000871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000847"
          xlink:to="Footnote000870"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000849"
          xlink:label="Fact000849"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000849"
          xlink:to="Footnote000871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000849"
          xlink:to="Footnote000870"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000851"
          xlink:label="Fact000851"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000851"
          xlink:to="Footnote000871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000851"
          xlink:to="Footnote000870"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000853"
          xlink:label="Fact000853"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000853"
          xlink:to="Footnote000871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000853"
          xlink:to="Footnote000870"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000855"
          xlink:label="Fact000855"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000855"
          xlink:to="Footnote000871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000855"
          xlink:to="Footnote000870"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000857"
          xlink:label="Fact000857"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000857"
          xlink:to="Footnote000871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000857"
          xlink:to="Footnote000870"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000859"
          xlink:label="Fact000859"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000859"
          xlink:to="Footnote000871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000859"
          xlink:to="Footnote000870"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000861"
          xlink:label="Fact000861"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000861"
          xlink:to="Footnote000871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000861"
          xlink:to="Footnote000870"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000863"
          xlink:label="Fact000863"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000863"
          xlink:to="Footnote000871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000863"
          xlink:to="Footnote000870"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000865"
          xlink:label="Fact000865"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000865"
          xlink:to="Footnote000871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000865"
          xlink:to="Footnote000870"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000867"
          xlink:label="Fact000867"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000867"
          xlink:to="Footnote000871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000867"
          xlink:to="Footnote000870"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000869"
          xlink:label="Fact000869"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000869"
          xlink:to="Footnote000871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000869"
          xlink:to="Footnote000870"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001084"
          xlink:label="Fact001084"
          xlink:type="locator"/>
        <link:footnote id="Footnote001094" xlink:label="Footnote001094" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes
    83,770 Common Shares issued to BTIG, LLC in exchange for Class A shares of GXII that it received as partial payment for advisory
    services.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001084"
          xlink:to="Footnote001094"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001086"
          xlink:label="Fact001086"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001086"
          xlink:to="Footnote001094"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001087"
          xlink:label="Fact001087"
          xlink:type="locator"/>
        <link:footnote id="Footnote001095" xlink:label="Footnote001095" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
    Commitment Shares (as defined in Note 11d) issued under the Yorkville Equity Facility Financing Agreement.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001087"
          xlink:to="Footnote001095"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001089"
          xlink:label="Fact001089"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001089"
          xlink:to="Footnote001095"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001264"
          xlink:label="Fact001264"
          xlink:type="locator"/>
        <link:footnote id="Footnote001267" xlink:label="Footnote001267" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
    the difference between the accrual of the minimum Consent Payment at September 25, 2022 and the actual payment made on March
    17, 2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001264"
          xlink:to="Footnote001267"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001284"
          xlink:label="Fact001284"
          xlink:type="locator"/>
        <link:footnote id="Footnote001645" xlink:label="Footnote001645" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Expires
    in 12 equal monthly tranches beginning October 17, 2023</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001284"
          xlink:to="Footnote001645"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001286"
          xlink:label="Fact001286"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001286"
          xlink:to="Footnote001645"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001288"
          xlink:label="Fact001288"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001288"
          xlink:to="Footnote001645"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001290"
          xlink:label="Fact001290"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001290"
          xlink:to="Footnote001645"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001292"
          xlink:label="Fact001292"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001292"
          xlink:to="Footnote001645"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001294"
          xlink:label="Fact001294"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001294"
          xlink:to="Footnote001645"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001296"
          xlink:label="Fact001296"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001296"
          xlink:to="Footnote001645"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001298"
          xlink:label="Fact001298"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001298"
          xlink:to="Footnote001645"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>140
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M)74?_Q6BG>TU=>#K[8WZ55YX59@'FC*/1_=A(!?GG9,."MB,9I'\QE>_LZ)
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M-&!"GZ".SSB7FQU]@>W'7Q?_ U!+ P04    " "7BT97PVB]?PP&   :&@
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M4T)LOWC[/,8O0'=Q""\B3'K.Q,OY?:68[E<]I0*0*'&36AC&-E' *B6)E0H
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M*#_..8MYH0W4[[-<S=/M%WV"W3M1XW\ 4$L#!!0    ( )>+1E=]N/;2OPH
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M#H6F,MC+>N*6]4-+O,04\1>8&A/8CXOICC$@($9LQ0+=;PY@3HU_7P0@[B+
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M\NZ^U,6F?8?L?5'7Q;K]^"02><MH&LC_/Q1%_?JE>2WM_LW(U_\'4$L#!!0
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M-Z\'PJ7;>'H)MHDWX-P&W*?C8X4/&'(L@/VEM6'SP@[Z3Z*3_P%02P,$%
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M'VGD!F!+I& J+J<'.O0D (/S)8)8[\JF*]P4 3CIMDI<3A.!-,#L^U$)!G:
MM2I)J@X1S,,9P<60+AU K1Z!NCE02[H(__!>3S,4^V?"[4%Y%1%DX"*%<'RL
M!'<4'M*V%;H6"9="6,"9%L6=L& 0AQGH[WK<;+SB8'LOO>EV6V (+!G1GIQI
M$;TC7ASS3S$E;,WU@>O5)[NU*56?HCA?V\.:TR[^L)"R;C23P8CT$C)8$Z?D
MN94@A#=**0$"?G+R8M=PTKHJ( JV8D,HL8" AS-^,.5\)/I6TAF\'^[!@A]
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M.[:GESRB@)/?4>[IEP3JQ)NJ \[QX\\<4%+ %&=0TEFTO4BX6 1($-K.;FR
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MD9^@HH$/[61$,@*1I-Q1=J" Z0=!1Q1OD(R>RI,FX7DG:B4:R\4(<'+1LY$
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M:_@OR[MK\ZNP6XD3H[A$:#HZ_9B0[:ZB;N!-$]O_QGA<)O&UPNW--BS ]]+
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M;U<TWU$[ WJ^4,KN!!>@_F(,_@)02P,$%     @ EXM&5W:1-QC;%@  UT4
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M\B<HQ?7_:4RK1]4WFLK8V'2<RS!<&UX2'DFPBY<"'03ML.D4(&#L(73CM;N
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MX >B0$C1+8VEAH\B:JH[4DDU%0M($"K]<-=V<R'O13OI0<3=Z?5[\ZCI[$R
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M<#+KA:&\>?"FY ]7"^.]R?GG4DF4)-J ]ZE!^M4/I*#]DGGY-U!+ P04
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MT5+8X -!_$80-RT$^%BT_*&="'@)Y6Y(;6BK=FJMH:BP&D@8DRJ]Q:(5>-Y
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MZ-<&&C:@]976;O?!#KK?+_-_ 5!+ P04    " "7BT97^MEH_JT'   O$@
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MV^0E?0,-@W^BK*AAQP;O724UZ%L!NZ3]SG6>P?9AE579Y/#H UQM:*5-53X
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M2GP,<+/F?2FQ &T+:,W;E_Y=WYHVTAB UJ#UG3_24^\UV%C8YEO9_#7^C*B
MT:XV5DLMM/=OKZ\<M&:#.O!R= 8.=+O*0.B3+MRNP-JE2=?:\LOSEK[:7_KJ
MY7 P (K4"ARY=HZ<> (?1FW[M4I2]7(8GP_/Z8:7D_A\-$0$]3?4-%&K"+?(
MLHP?+,9YADH9HUIO-$5^^>,QS9DZS9D>%7<(!2'0 R(U5076^E%]!@H8-@M=
MRG,<VJ*G!&#4!5"]!VO(QIJTJ-)HI-'&+>S=U[5>FTBT*;6BY601_7.M68.
M7CH!GR+F:,\!@<ET9GJM$Z9C8\BDPOUN27E^4V48QRL-IJE<9XLHL&"(!T@8
M+(9W$N1'L<6!J!.F;H=N 2LTI)-1QY[1OL*S1E-P G%;FJ B=6X:(AC4*)66
M>9Y4H(Y78&GN-5"L:VFPS%E9H0?X*:D ^^$Y2VC<2;$N -O$>%7)DD(6;MN7
M2I\FQH ,(\?J$%#D +&?K=&Y%!A[81P"$K&+5_MQC\>"M@E$J<IU%T*HCF2$
M/'$BS&Y27"3TS R(#(/EM%J"4V?OM,BJ1;/&<&O!]Y1-!;;V/BFRWTF$>>,,
M1!T@.M L$DN$& -WP2M[M>4]M#<NOAN8=0I2E97I,T1A"Y&4*LH:;4*=R%)1
M_11Z?531:%Z"F4>_4:/,X^I%69SZ"\!+(4F><91"X4LMRHPVU'J,A%1Q9S]S
MO8! EUA20"J;^,0$N)*9?H1D!,/'F*(>(:/P]I0^+^TF D KB"C!<RU@,_0
M2! KY3-09VIY]%%A,+ &'X[ZS41GMPGWH=07)0;8&-L)8B 8%"\]>#@40*:_
M-NS4W8TAZWB[H(CZ(2L;DZ.V+,H*C%OT), 6CQ]T!>+,1J1+ZL2*[&FU4Q3<
M;@:?JL=8#687TQFD,V^NU(<Z[<="R!7O&T)$O<$L!??D(DZ66U#0"-(A^ EB
MC]R4?T8S68D.;<+'E;?:@/ZAC*%#[@,1,)(!Y3(=$)&""0$T9 W%L2U:?LC>
ML$Y2TH\D< , $BF8B,OIP X]">!@?8ELK//.NBW<%)%8Z3:1N)PZ0*F/M86C
M$@SL &M5D%3M;S#S:W@70[JTAW5T!.MZ3RWI(OR'83W/4.RN"8][Y8V(('T;
M*?CE0R6XIW"5P);H6B1\\V$!IZ$4!\,-_3#,0'_7X6;#._; .^E--IL<0W))
M%W?D3(GH'?#BF)R+*6%KKO9<KSK9KG01=2F*];4=K.FU]P\W4DD"S:0W(IV$
M]-;$*GEF) AA0 EEA\!/SNS,"E9:E3E$Y49L""4Z$/!P.01,.2^)OI5T!I^'
M9["T"5@0.XY$IN<N,CT_&DO^!-\Q,8#D<H.)DNY,YH[#2'M*P$0>C+NTX4N/
M7#TQE(["9DS=SM,A406379/EYFUWW(_L622;#)+=['>X!9F,0) E*29-.T]8
M7D:4?=FBE"])D!PD666S.L@S&W*+8-[76'E"-ADN5!$;6R#Z =6D-H2Q+_&O
MW/ B]V!BR<G$T1:='N1$F^21W0Z%S&@BQ2* .P/3E9E%I4/%$%>SOWO 9RWL
M.TQD!(Y%H:C.P,&+[.^AT%?O@FJ-/(BUHV_@H0ROY>G\"Y&]QC!Y-]A,I!CF
MTFP(!R&ZB&P4R-4UM CZGC[K;U0V13&OI"C%_IR#2@RZYGEF5CH]6H"Q540I
M\\6.O6_*I$K1%;PE^2HK0_X7#!!"2R646*^QB&;K+M2VR \4K.+6=2:5%5FJ
MB8'R.ZRHR"ATBY(ET(IOF"-6@D22<]%MKL.R*1HZQ^P@*'8$L<@>I0IPR)(2
MS)%I<L[HEN R,JF*F1HT$+<E=@L4$6LEJ%MD=Q(O7 "MQ4<&DX/T?-F4Q1X9
MNZN-42C"3#Z[_62-YAZOPY8HS@+5A U#REA35JF730X>$'=68N$XX^V$M4S:
M!89QB"U(8TD^$KUF[A+4?G05JM&:JQG$1"D%!ILFL498<R!Q6;"@DDG>9J;%
MLJ;PN8Z$B1@^&*UI\6538^T1U"K:5EE=:]3PI<U7%[AE6ZD4S5\D5?6(&)%=
MHJWN*'S&//:!9(.,<&@X.9AKTDFP+;@,[T'$& 13(FH/,Y;Z))(CMGD1?@3A
MJ^K39L/ZU<E@<O*Q$@*8)->O<B [FM78D4YALZ36]X!C&)Y%@2)QKNYQZH?-
M!US^55DY?) TQ#,J$Y,\,4T4R@1P&'9O0T_8"&S05^=]T9FI3X%-@KP-RL0B
MM$$58=-48.$0KU^TXL2\S324;<0+D]L.MB&D#"Q[5M&&T)6AV$)4S5U3\@#5
M7JXLVDG\*FM-#8L=6"A2(!1;:C78DBFU'+K2;[)'F%T"FL!H3P.I5&.TQ0FF
MK51+[3H.LWR\@TPZY<Z-.;SQ6-VC#!;.K'*9G<(]:Z"B5N\@Z 6@4=>+54'I
MJ4:U"$KK744'7P$/HPVI1"VT-5-E*K5?I,&FJ2/Z%7A[A]0)%\(PC#RC,TNB
MU]BUH3!CF9=;J? B!5KRP(C*$R78\7L!2P$).C%442II1)+37B\/N-IZU8%%
M""%$!U'.640E]6H;%U^?8[,71W!;()X8;SH[;7-KB@0"6K!OZ21'(AFVW019
M1*0%144NQ+7,BIXEZ*$6HW> 91Z2+&=3SQ%=J$UB,\ "5.DI1O:/RC&6(AW;
MYB-ECK(N(RSQC!*#C>ZC('-E:<#Q)-V[4^<(J&D)B ]VF :J]43M:C<@SL7N
MY]:F9RX#F!V-WC^@;?R082QT26EF5P)P'(3N*802A5#HRBGZ:@A\Z$H<)O]=
M=F&E<R9G8X+N@50_.==]R/16@J,.VVF-')I-9PNB@Q94=,@QF ,!<B4%I]P@
M18\DMI[C"<4[[S%8%0= )7(1)+$M;7>.T6?NJ*$L-?9O!-MF2-6!)"BVKI+>
MTNH=S6J[S/V%^A%8$#'R7$6H]'Y_GJFI4T9K1U3O"PJ4 #%7:Q#N",G@FR_<
M[]#3EF%D=6S#Z-3XU*ME?@1E*T.,&^P="9T29RI;%N""!V]YBQG7LGOU*ER&
M3" ;8NH&Y_GSE'2/JE*/_8LZ>N%T].*XCF( U:F8QY];@F+2H^H+ID=1,+ER
M!_J00A*"5;^4^Z-A'^[RSK?A9A/8DEQG<+'\IK;:NR65+:G,45!"UX!R RM0
M"[FW QEP22:>>J00E"D."X6)X)PUY\Q8 NLKFO0Z+9>G8 P<5K<W7WR7L[LF
M%JB#%%5AL[22B6B40(/EASNHT"!RE'56E*GPKFA(:J?3RR4@K%5(*9<C9"WK
M /(W7Z(0/]KH?N7.:9859+JOE491/=!EP^RA(?HLZK;>B--E #:[CVP6)=>1
M3Y*\D^U!T"#O.,%4._/!*"2%LWI)FL%&?? 1(].;.L/D28+&1:5Y @'RV@I$
M&TF.T+%";!_T8==ST6>:'X;.,5%%2LE%\]#7VT @>H*VTB%EK(PG#+;M98S&
M5C;0>&@M<?4J>:#Q&,"6S!2A1HZ#3:+^#35 RL#MC5&P!ZCD**F59*$4[7'>
MFRB3K3,JZ@/IN(!NK[C -NB;]M5-6])1_D0_(NH>V"2 A=>5,F'78.TH&4P6
MBPIK7)7UIZH#[X0"3'2R\&M5-O>KLJGW! RY%B+0J0#H6"U67"LCBZR_U92T
M\=:I#!_ W_JZ$\BE*3&*?%0R^<-< MFD*%5_P\34Z(A;H!LNH)#UBG85D40L
MD9C#,9T%0\I10=6.NN%<?O95)K=?JA3LE3%"^D08.^R:IMBO6X:DMZ@^NI4$
M>*MT[E?G% I%!A-L,J'H$YBM4LSK-@L_)Q772/BBW.LM%7G"=KWUB&,;#OPD
MZ>"HB_J%G$1WU/G$H_<]99^&'#S"G@)5CR$8H]32^;K[!HPZVF>,&[?V$53>
MIH) T; =,W6Y^-JVM47"B=I2@C49Y%IE&YG@(:^!85E%^00SUZT@=>.ZE)DD
M+#[22!$Z8R-#*=P$XG(?3C79"HGO1MN <8NWY1#M^ W)"H@,0 .G'4UF$(V\
MS0QNO,D,5CL@NO<"3Y;R';4:6'SA(?6YW(!)F0W/X%&TJ&0>V'?]4Z?W5/H)
M(@.\T_EA3I@R#%RYX>)2/"NBMI*(/SK:R"0D%CUS?'Z9<94Y5$Z@!3=%I)79
M"A<#*OLT..)X^4V> "OO%JLR1UM3ICK'RP /1XNQ)U3EI;L>2ZV(;F'& \'K
MG+W$4I,0P"+KN4Z#<1E! #)TK!A(!=JV_ &R'U?+^ 9;:?F8E=AI];WCH-G
M90E)#C+S]719:>V- [JF6-J'&&&B= &Q^=)#B?*)UB*.K+E(,YPN15-&4973
M%W9IE6Y5%;"A1UV,P.Y8[BQLH26<\P$8 5.H]H@22=-=B(',;DK_G[1SIZ^;
MD5@4(1CLZJ*-#08'?"-0YC9(^X)Z3_"X:_QGMNF)\"H,0,SS"2#-N-W=/V?G
M2G8>80AU:/=-(=48;5-;:1]QR@.;<%IQU,X&$_O#H\;R'9  O36WM#JM[7$
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MW*GWMS<_J9M/[VXOZ8^Q7%Y]OO[Y^O/UNSLO*+9^(.T!(+((%I(9^<570+C
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MBI\%9EUR+(#SI;5AOV '[?0\_A=02P,$%     @ EXM&5UK2:-7@!P  3A@
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MKNF5V@P=Q"T6=@)XGJ4NM073EC/A#F]O$!?.TA4W2F^(NR1X J9)8GH+_M9
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MI74PSU="Z/W!)J@_#?$_4$L#!!0    ( )>+1E<I#A1RD04  (L/   9
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MH'8&M+]0RNXF+D#_IV+Z'5!+ P04    " "7BT97MO=LE; &  "R$@  &0
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M^R- EIZRRZ[_M#B3>QQ?=2>^>=OC\@>]L.RR])-)A'3I]"%%>H6A6NN+TA]
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MZ7%#[1QH?J/H,+8=%Z![+N=_ U!+ P04    " "7BT97KHV34*0#  #S#P
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M4=H%YOU2"+T?V WJ/G_R+U!+ P04    " "7BT97E48*T%$"  #8!   &0
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M<VAE970T,BYX;6RU6.]OFS@8_E<L-DVMU!;,[W1)I+;1:3NI4M1NMP^G^^"
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M@+J_9$P^=ZKCOO8\>/H_4$L#!!0    ( )>+1E?/HE0[Q <  #8V   9
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M-%V[3!M%I6P/TQY,<A"KCIW9#K#_?K83$)6@ZL->XKOS?9_ON_@<KZ5ZUB6
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M:1\P4"[![B^D-%O'S<CN24S^ 5!+ P04    " "7BT970V@I_#\#  !<#
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MUQ.P"+@WH?M@DFECD=A=VVWIOS_;">E;FEU0Z ?J.)['\XQGAJ<>K+AXD@F
M0L]9RN30292:G[JNC!+(B&SQ.3#]9LI%1I1^%#-7S@60V!IEJ>M[7M?-"&7.
M:&#G;L1HP!<JI0QN!)*++"-B?0XI7PT=[+Q,W-)9HLR$.QK,R0SN0/TYOQ'Z
MR2U18IH!DY0S)& Z=,[PZ07N&P.[XB\**[DU1H;*(^=/YF$2#QW/> 0I1,I
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M4HT>Y7*MID/@&J">+QF33QL]?S3S9O0/4$L#!!0    ( )>+1E?Y!7OY%@,
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M\?ERIT7NGR^W-7WI5OZ[.:]W@K>@@O)GBO[<DE1&,J("?;U3YZ"9I(GXUM+
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MM1B\.O6KBF2%.3B73*ICV!13=5$"K@>H_A5C\JVBS^+FZA7] U!+ P04
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M=R.Z29_(Q.M.S^AN8&O)AIL,D])H()]76V,U5NF7H:A;K618R[7NW-0L@V6
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MO&C]8XG?0J#= IPOE++'@7M!_W65_@-02P,$%     @ EXM&5YMZ\""' @
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MW!(O&Y*EQ8[L@DG)XN)T0\F2\KR#NK]B3'XT<@?U/R;,_P=02P,$%     @
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M_DZXHFK-A"8<5NCJ75QB<%3=>^N)D475OI;28#.LAAE^KH"R!KB_DM+L)_:
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MU$.]*X+4;%1S&FWW1.AD/MH_#^H>MYF'CDV@FH]J :J%J!91FEIF;0C$U*=
M(AD7FUPV\:O;3?G:^#DI?C><7$HUCV7\%LGU%YEWYI;UO?2N05*S4<U!-1?5
M/%03J.:C6H!J(:I%E*96=!M$,1\^<:>^<F"BT114LU'-0347U3Q4$ZCFHUJ
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M\U$M0+40U2)*4\NQS4U-]+FIP\>R:+P)U6Q4<P[L*7.N.YA%PTRH)E#-1[4
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M@&HAJD64II9NFW>::D,9!]:6T3?N7:AHN@G5G$93KC(U'0[WUY<Y;C,/'9M
M-1_5 E0+42VB-+6TVCS25)]'JMX$EX;8_F]WLONIGAH?6OI%3_<N/#2?A&H.
MJKFHYJ&:0#4?U0)4"U$MHC2UC-L<TW3"3F[16!.JV:CFH)J+:AZJ"53S42U
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M5:+\Y.)N!VC#J"HPDFV1Q&L**"$BIDR 0%)=S3G1-8=(EA=2J#_)RO$KEDE
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M6V192XO6E&B[MSZ'*]LOPE-T11U+S*B&>Z$4O-P;-+C36*K7?36JJ3O[J>T
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M_PK7G^%J?#N&#Y>H69HI^,JD9*;>'^$3J(1)5 -74W@#XD9EJ(MUJ.!(*#^
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MK^?LI*'MTE#0^-+ZY>[Q/<\YYYMLI+K3&8 A]SD7>NIEQA07OJ^3#'*J>[(
M@3M+J7)J<*I6OBX4T-0YY=P/@V#DYY0);S9Q:U=J-I&EX4S E2*ZS'.J'N;
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MSP/4_25C\OTD?T"U$;;X#U!+ P04    " "7BT978=OCZR &  !)/   &0
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MR\L"XO/;+.-?3\HG,=NGAY?_ E!+ P04    " "7BT97E[L8/-($  ")&P
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M\^UA"523AZ*9#M*H\HY=EO^YD [PC;#L4QZ37$6/T6V*<_O !*K2@])\4%H
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MYR'+$WEEGQ"6O<1#W064YH/2 E!:"$J+H&BF7S4:J^<<:<7B@4JOH#0?E!:
MTD)06@1%,]VGD5X]^[;_O58L=L;!G@*JLH+2 E!:6-,V5RSCD;,]0X$JT_2
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M4;TRIJ5[1LF,9E2M-17>^(.^L> QU7$2_;76<55*Y6.4?=M7)&#B0;)]0QJ
MWWO;:5J)5HE_NQ+N5D.0HUC8/DF"S:3\YM:S=2MV8CN0)_.GND4K.ZI'3-G?
M71*QH$SJ&LTUTNL<Z8M-E#U3.5"\L&W'C"O=Q-C'5+>9*(R!?C_G7&T&)D#=
MN$:_ 5!+ P04    " "7BT97)S_<SUT#  ":#0  &0   'AL+W=O<FMS:&5E
M=',O<VAE970W.2YX;6RU5VU/VS 0_BNG#$U,8N25T+(V$I"A,8&&>-D^H'UP
MFVL3D=B9[5+X][.=$-H2JH+"E\0O]SRY>^QSSH,YXW<B193P4.14#*U4RO+
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MF:K+$W)MH.8GC,FGCOY <QV+_@-02P,$%     @ EXM&5V.',5GD!   ?A,
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M_[E8PAB-#97@ O$5,L*/'^S ^M(F6Y]D44]D#4G=6E*WBSV\9Q*2-KE*F%?
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M(AN9/\OSBA:I?:@NA,9GKRU&0/$Z9 RP?R6$WE7,V[?\;V3Z+U!+ P04
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M!$%I_B"#()L_R"'(YP_*$)3G#RH05.8/>H2@Q_F#XA)E7!(D3; FT#HBUY'
MZXA@1P*Q(Y(="<R.B'8D4#LBVY' [8AP1P*Y(](=">R.B'<DT%M0;R'06U!O
M(=!;)@_;!'H+ZBT$>@OJ+01Z"^HM!'H+ZBT$>@OJ+01Z"^HM!'H+ZBT$>BOJ
MK01Z*^JM!'HKZJT$>NOD90F!WHIZ*X'>BGHK@=Z*>BN!WHIZ*X'>BGHK@=Z*
M>BN!W@GU3@1Z)]0[$>B=4.]$H'="O1.!WFGRLIM [X1Z)P*]$^J="/1.J'<B
MT#NAWHE [X1Z)P*]#?4V KT-]38"O0WU-@*]#?4V KT-]38"O6WRL9) ;T.]
MC4!O0[V-0&]#O8U ;T.]C4!O1[V=0&]'O9U ;T>]G4!O1[V=0&]'O9U ;T>]
MG4!OG_QL0J"WH]Y.H+>CWDZ@MZ/>3J!W1KTS@=X9]<X$>F?4.Q/HG5'O3*!W
M1KTS@=X9]<X$>F?4.Q/HG2<_"Q+HG5'O3*!W1KTS@=X%]2X$>A?4NQ#H75#O
M0J!W0;T+@=X%]2X$>A?4NQ#H75#O\IUZ#^/GH0ZWGJ\U7O\[J1XOY];;Y:_+
MKYV3>_R*<[BO&)[_ E!+ P04    " "7BT97@]&L 2X"  !$,0  $P   %M#
M;VYT96YT7U1Y<&5S72YX;6S-VTUNVS 0AN&K&-H&EBQ2I-0BSJ;MMLVB%V E
M.A:L/Y!,ZMR^E)P$:)$:"5R@[\:"37*^$0=X=K[^_CA9OSKVW>"WR3Z$Z6.6
M^7IO>^/3<;)#7-F-KC<A?G5WV63J@[FSF=AL=%:/0[!#6(>Y1G)S_=GNS'T7
M5E^.\6??CL,V<;;SR>K3:>.<M4W,-'5M;4)<SQZ&YH^4]5-"&D\N>_R^G?Q5
MW)!DKR;,*W\/>#KW[<$ZUS9V=6M<^&KZN"L[=ID/CYWUZ?D2K_0X[G9M;9NQ
MON_CD=1/SIK&[ZT-?9>>BEZ=3P[QANWI,[\X?RES+C#NO'7CY./$G'U_W/-(
MYM/K*1:R+K3G7_$E,9:^^/WL/.W&-F_,CM?[<W2'91X^6QZ7W_'O,WZI_\X^
M!*0/">FC@/2A('UH2!\EI(\*TL<'2!_YAM((1=2<0FI.,36GH)I35,TIK.84
M5W,*K#E%5D&155!D%119!45609%54&05%%D%159!D5509)44625%5DF155)D
ME119)45629%54F25%%DE1=:"(FM!D;6@R%I09"THLA8460N*K 5%UH(B:T&1
M55%D5119%45619%54615%%D5159%D5519%44635%5DV155-DU119-45639%5
M4V35%%DU159-D;6DR%I29"TILI8464N*K"5%UI(B:TF1M:3(6E)DK2BR5A19
M*XJL%476BB)K19&U^I^R_AC'PS^.7YYI;]KA.3];_CQQ\PM02P$"% ,4
M" "7BT97!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( )>+1E=H<'#Q[@   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( )>+1E>97)PC
M$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ EXM&5_9\_,O\!P  "#8  !@              ("!#0@
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( )>+1E?#:+U_
M# 8  !H:   8              " @3\0  !X;"]W;W)K<VAE971S+W-H965T
M,BYX;6Q02P$"% ,4    " "7BT97T^DI ;<"  !%!P  &
M@(&!%@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ EXM&
M5R..!Q*)!@  %1\  !@              ("!;AD  'AL+W=O<FMS:&5E=',O
M<VAE970T+GAM;%!+ 0(4 Q0    ( )>+1E<,4U-'N D  !\U   8
M      " @2T@  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M" "7BT97?;CVTK\*   E60  &               @($;*@  >&PO=V]R:W-H
M965T<R]S:&5E=#8N>&UL4$L! A0#%     @ EXM&5V"&-3[\!@  "Q   !@
M             ("!$#4  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4
M Q0    ( )>+1E?\2[0DF04  !X-   8              " @4(\  !X;"]W
M;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " "7BT97,N;*GG @  "5
M7P  &               @($10@  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL
M4$L! A0#%     @ EXM&5Y*UB #Q P  &P@  !D              ("!MV(
M 'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " "7BT97JVF3
M3E8'  #9$   &0              @('?9@  >&PO=V]R:W-H965T<R]S:&5E
M=#$Q+GAM;%!+ 0(4 Q0    ( )>+1E?/$IYO00,  +T&   9
M  " @6QN  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @
MEXM&5_C7Q>8E!0  (0L  !D              ("!Y'$  'AL+W=O<FMS:&5E
M=',O<VAE970Q,RYX;6Q02P$"% ,4    " "7BT97W@^C9<@"   ]!@  &0
M            @(% =P  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4
M Q0    ( )>+1E=VD3<8VQ8  -=%   9              " @3]Z  !X;"]W
M;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ EXM&5Q('[KYL"
MU10  !D              ("!49$  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX
M;6Q02P$"% ,4    " "7BT97,"Y?]/<2  !!,P  &0              @('T
MF0  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( )>+1E>,
M>BPLB ,  %0'   9              " @2*M  !X;"]W;W)K<VAE971S+W-H
M965T,3@N>&UL4$L! A0#%     @ EXM&5\/\MO"V @  U 4  !D
M     ("!X;   'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )>+1E>CL#AFT2$  /]H   9              "
M@<K)  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ EXM&
M5U4PVB8*!0  20L  !D              ("!TNL  'AL+W=O<FMS:&5E=',O
M<VAE970R-2YX;6Q02P$"% ,4    " "7BT976M)HU> '  !.&   &0
M        @($3\0  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0
M   ( )>+1E<*P:%EZ 0  .,+   9              " @2KY  !X;"]W;W)K
M<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ EXM&5P\XBY.* @  A@4
M !D              ("!2?X  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q0
M2P$"% ,4    " "7BT97,KD+>,D"   F!@  &0              @($* 0$
M>&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( )>+1E<I#A1R
MD04  (L/   9              " @0H$ 0!X;"]W;W)K<VAE971S+W-H965T
M,S N>&UL4$L! A0#%     @ EXM&5\!HVA=- P  $0@  !D
M ("!T@D! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " "7
MBT97MB>\HSL(  #T%P  &0              @(%6#0$ >&PO=V]R:W-H965T
M<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( )>+1E>*<N0QN@(  .@%   9
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M970S-RYX;6Q02P$"% ,4    " "7BT97KHV34*0#  #S#P  &0
M    @(%_*0$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    (
M )>+1E>51@K040(  -@$   9              " @5HM 0!X;"]W;W)K<VAE
M971S+W-H965T,SDN>&UL4$L! A0#%     @ EXM&5ZZ;&01B!   H1(  !D
M             ("!XB\! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"
M% ,4    " "7BT97N!H=Q#,$  !A#   &0              @(%[- $ >&PO
M=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( )>+1E>2\KXU/ 0
M !L6   9              " @>4X 0!X;"]W;W)K<VAE971S+W-H965T-#(N
M>&UL4$L! A0#%     @ EXM&5\^B5#O$!P  -C8  !D              ("!
M6#T! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " "7BT97
MJXXM)W4$  !K&   &0              @(%310$ >&PO=V]R:W-H965T<R]S
M:&5E=#0T+GAM;%!+ 0(4 Q0    ( )>+1E>$33X*1 (  !X%   9
M      " @?]) 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%
M  @ EXM&5T-H*?P_ P  7 P  !D              ("!>DP! 'AL+W=O<FMS
M:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " "7BT97C6UAGGX#  "1"0
M&0              @('P3P$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+
M 0(4 Q0    ( )>+1E?!(PCDJ@0  ($4   9              " @:53 0!X
M;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ EXM&5VC2B"7Y
M @  L D  !D              ("!AE@! 'AL+W=O<FMS:&5E=',O<VAE970T
M.2YX;6Q02P$"% ,4    " "7BT971621S=H"  !["@  &0
M@(&V6P$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( )>+
M1E?Y!7OY%@,  (X(   9              " @<=> 0!X;"]W;W)K<VAE971S
M+W-H965T-3$N>&UL4$L! A0#%     @ EXM&5WC-2D\K!0  X2<  !D
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M=#4V+GAM;%!+ 0(4 Q0    ( )>+1E>;>O @AP(  .4%   9
M  " @49U 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @
MEXM&5S5GE@O3!   I"   !D              ("!!'@! 'AL+W=O<FMS:&5E
M=',O<VAE970U."YX;6Q02P$"% ,4    " "7BT97\N7 [0(#   ,"0  &0
M            @($.?0$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4
M Q0    ( )>+1E?[#&:8ZQ(  #P4 0 9              " @4>  0!X;"]W
M;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ EXM&5YJD>M98!
MX!8  !D              ("!:9,! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX
M;6Q02P$"% ,4    " "7BT97+"[*9LH"  !;!@  &0              @('X
MEP$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( )>+1E<]
M/R%:N@,  /P+   9              " @?F: 0!X;"]W;W)K<VAE971S+W-H
M965T-C,N>&UL4$L! A0#%     @ EXM&5R2<.U>Y P  (PX  !D
M     ("!ZIX! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )>+1E>7NQ@\T@0  (D;   9              "
M@>&W 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @ EXM&
M5\X_'F^6 @  _04  !D              ("!ZKP! 'AL+W=O<FMS:&5E=',O
M<VAE970W,"YX;6Q02P$"% ,4    " "7BT97A+W@SIH#  #1#@  &0
M        @(&WOP$ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0
M   ( )>+1E>EQ.E1; L  -I?   9              " @8C# 0!X;"]W;W)K
M<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ EXM&5R<(Q0_? @  ^@<
M !D              ("!*\\! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q0
M2P$"% ,4    " "7BT97'(";:+<%  !O,   &0              @(%!T@$
M>&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( )>+1E?#N&@J
M8@,  +X-   9              " @2_8 0!X;"]W;W)K<VAE971S+W-H965T
M-S4N>&UL4$L! A0#%     @ EXM&5U,A,7Q1 P  H0L  !D
M ("!R-L! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4    " "7
MBT97A36] !L#   %#   &0              @(%0WP$ >&PO=V]R:W-H965T
M<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( )>+1E>3^>M080,  ,0*   9
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M970X,BYX;6Q02P$"% ,4    " "7BT97=]5($2$#   Q#@  &0
M    @(%M]@$ >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4 Q0    (
M )>+1E>8O,:6X0,  *P2   9              " @<7Y 0!X;"]W;W)K<VAE
M971S+W-H965T.#0N>&UL4$L! A0#%     @ EXM&5ZCZT8,J!0  NB(  !D
M             ("!W?T! 'AL+W=O<FMS:&5E=',O<VAE970X-2YX;6Q02P$"
M% ,4    " "7BT971(Y[8GD$   G$0  &0              @($^ P( >&PO
M=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    ( )>+1E<TBF@&9 ,
M )(6   -              "  >X' @!X;"]S='EL97,N>&UL4$L! A0#%
M  @ EXM&5Y>*NQS     $P(   L              ( !?0L" %]R96QS+RYR
M96QS4$L! A0#%     @ EXM&5X2^+Q)%!P  G#@   \              ( !
M9@P" 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( )>+1E=2-<:CB@(  +DR
M   :              "  =@3 @!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L
M<U!+ 0(4 Q0    ( )>+1E>#T:P!+@(  $0Q   3              "  9H6
K @!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !> %X R1D  /D8 @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>203</ContextCount>
  <ElementCount>443</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>73</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Shareholders' (Deficit) Equity and Redeemable Noncontrolling Interest</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest</Role>
      <ShortName>Consolidated Statements of Shareholders' (Deficit) Equity and Redeemable Noncontrolling Interest</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/DescriptionOfBusiness</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - BASIS OF PREPARATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BasisOfPreparation</Role>
      <ShortName>BASIS OF PREPARATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SignificantAccountingPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - GOING CONCERN ISSUES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/GoingConcernIssues</Role>
      <ShortName>GOING CONCERN ISSUES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - GXII TRANSACTION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/GxiiTransaction</Role>
      <ShortName>GXII TRANSACTION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - LAND AND BUILDINGS, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/LandAndBuildingsNet</Role>
      <ShortName>LAND AND BUILDINGS, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - MINERAL PROPERTIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/MineralProperties</Role>
      <ShortName>MINERAL PROPERTIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - CONVERTIBLE DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ConvertibleDebt</Role>
      <ShortName>CONVERTIBLE DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - CLASS B COMMON STOCK OF ECRC</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ClassBCommonStockOfEcrc</Role>
      <ShortName>CLASS B COMMON STOCK OF ECRC</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - COMMON SHARES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonShares</Role>
      <ShortName>COMMON SHARES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/RelatedPartyTransactionsAndBalances</Role>
      <ShortName>RELATED PARTY TRANSACTIONS AND BALANCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - EXPLORATION EXPENDITURES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ExplorationExpenditures</Role>
      <ShortName>EXPLORATION EXPENDITURES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/Leases</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FairValueMeasurements</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - BASIS OF PREPARATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BasisOfPreparationTables</Role>
      <ShortName>BASIS OF PREPARATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/BasisOfPreparation</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - GXII TRANSACTION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/GxiiTransactionTables</Role>
      <ShortName>GXII TRANSACTION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/GxiiTransaction</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - LAND AND BUILDINGS, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/LandAndBuildingsNetTables</Role>
      <ShortName>LAND AND BUILDINGS, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/LandAndBuildingsNet</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/AccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - CONVERTIBLE DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ConvertibleDebtTables</Role>
      <ShortName>CONVERTIBLE DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/ConvertibleDebt</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ClassBCommonStockOfEcrcTables</Role>
      <ShortName>CLASS B COMMON STOCK OF ECRC (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/ClassBCommonStockOfEcrc</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - COMMON SHARES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesTables</Role>
      <ShortName>COMMON SHARES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonShares</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables</Role>
      <ShortName>RELATED PARTY TRANSACTIONS AND BALANCES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/RelatedPartyTransactionsAndBalances</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - EXPLORATION EXPENDITURES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ExplorationExpendituresTables</Role>
      <ShortName>EXPLORATION EXPENDITURES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/ExplorationExpenditures</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/LeasesTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/Leases</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/IncomeTaxes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FairValueMeasurementsTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/FairValueMeasurements</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Schedule of intercompany transactions and balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails</Role>
      <ShortName>Schedule of intercompany transactions and balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative</Role>
      <ShortName>DESCRIPTION OF BUSINESS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/DescriptionOfBusiness</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - The following table sets forth the computation of the Company???s basic and diluted net loss per share attributable to common shareholders: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails</Role>
      <ShortName>The following table sets forth the computation of the Company???s basic and diluted net loss per share attributable to common shareholders: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Schedule of excluded from the dilutive securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails</Role>
      <ShortName>Schedule of excluded from the dilutive securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As of March 31, 2023 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details</Role>
      <ShortName>Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As of March 31, 2023 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Revision Impacts to the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For the Three &amp; Nine Months Ended March 31, 2023 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details</Role>
      <ShortName>Revision Impacts to the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For the Three &amp; Nine Months Ended March 31, 2023 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Revision Impacts to the Condensed Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details</Role>
      <ShortName>Revision Impacts to the Condensed Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - GOING CONCERN ISSUES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/GoingConcernIssuesDetailsNarrative</Role>
      <ShortName>GOING CONCERN ISSUES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/GoingConcernIssues</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails</Role>
      <ShortName>The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - The number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails</Role>
      <ShortName>The number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - GXII TRANSACTION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/GxiiTransactionDetailsNarrative</Role>
      <ShortName>GXII TRANSACTION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/GxiiTransactionTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Schedule of properties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfPropertiesDetails</Role>
      <ShortName>Schedule of properties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - LAND AND BUILDINGS, NET (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative</Role>
      <ShortName>LAND AND BUILDINGS, NET (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/LandAndBuildingsNetTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - MINERAL PROPERTIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/MineralPropertiesDetailsNarrative</Role>
      <ShortName>MINERAL PROPERTIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/MineralProperties</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Schedule of account payable and accrued liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>Schedule of account payable and accrued liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - Schedule of convertible debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfConvertibleDebtDetails</Role>
      <ShortName>Schedule of convertible debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - Changes in the Lind III Convertible Security are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails</Role>
      <ShortName>Changes in the Lind III Convertible Security are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - The following table summarizes the components of the initial loss on extinguishment: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails</Role>
      <ShortName>The following table summarizes the components of the initial loss on extinguishment: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - The change in the fair value of the Contingent Consent Warrants is presented below: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails</Role>
      <ShortName>The change in the fair value of the Contingent Consent Warrants is presented below: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - Schedule of valuation date and the probability calculated. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details</Role>
      <ShortName>Schedule of valuation date and the probability calculated. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - Changes in the Convertible Debentures are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails</Role>
      <ShortName>Changes in the Convertible Debentures are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ConvertibleDebtDetailsNarrative</Role>
      <ShortName>CONVERTIBLE DEBT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/ConvertibleDebtTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - The following table discloses the primary inputs into the Monte Carlo models. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details</Role>
      <ShortName>The following table discloses the primary inputs into the Monte Carlo models. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2023: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details</Role>
      <ShortName>The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2023: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative</Role>
      <ShortName>CLASS B COMMON STOCK OF ECRC (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/ClassBCommonStockOfEcrcTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - Schedule of stock option (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfStockOptionDetails</Role>
      <ShortName>Schedule of stock option (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - The following table summarizes information about stock options outstanding at June 30, 2023: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details</Role>
      <ShortName>The following table summarizes information about stock options outstanding at June 30, 2023: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - The following table summarizes the weighted average information and assumptions used to determine option costs: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails</Role>
      <ShortName>The following table summarizes the weighted average information and assumptions used to determine option costs: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details</Role>
      <ShortName>Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - At June 30, 2023, the Company has outstanding exercisable warrants, as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails</Role>
      <ShortName>At June 30, 2023, the Company has outstanding exercisable warrants, as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails</Role>
      <ShortName>The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - The change in the Private Warrants liability is presented below: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails</Role>
      <ShortName>The change in the Private Warrants liability is presented below: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - Schedule of expenses as other operating costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails</Role>
      <ShortName>Schedule of expenses as other operating costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - COMMON SHARES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesDetailsNarrative</Role>
      <ShortName>COMMON SHARES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonSharesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - Changes in the Smith Credit Agreement principal balance are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails</Role>
      <ShortName>Changes in the Smith Credit Agreement principal balance are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - Schedule of exploration expenditures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails</Role>
      <ShortName>Schedule of exploration expenditures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - The Company incurred lease costs as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails</Role>
      <ShortName>The Company incurred lease costs as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000077 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2023: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details</Role>
      <ShortName>The maturity of lease liabilities is as follows at June 30, 2023: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>00000078 - Disclosure - LEASES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/LeasesDetailsNarrative</Role>
      <ShortName>LEASES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/LeasesTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>00000079 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2023, 2022, and 2021 are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails</Role>
      <ShortName>Domestic and foreign components of loss before income taxes for the years ended June 30, 2023, 2022, and 2021 are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>00000080 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails</Role>
      <ShortName>The following table is a reconciliation of income taxes at statutory rates: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>00000081 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails</Role>
      <ShortName>Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>00000082 - Disclosure - Changes in the valuation allowance are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails</Role>
      <ShortName>Changes in the valuation allowance are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>00000083 - Disclosure - Schedule of cumulative net operating losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails</Role>
      <ShortName>Schedule of cumulative net operating losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>00000084 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/IncomeTaxesTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>00000085 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails</Role>
      <ShortName>Schedule of fair values determined by level 3 inputs are unobservable data (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="n2574_x163-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>00000086 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/SubsequentEvents</ParentRole>
      <Position>86</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="n2574_x163-10k.htm">n2574_x163-10k.htm</File>
    <File>niobf-20230630.xsd</File>
    <File>niobf-20230630_cal.xml</File>
    <File>niobf-20230630_def.xml</File>
    <File>niobf-20230630_lab.xml</File>
    <File>niobf-20230630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>n257410kimg001.jpg</File>
    <File>n257410kimg002.jpg</File>
    <File>n257410kimg003.jpg</File>
    <File>n257410kimg004.jpg</File>
    <File>n257410kimg005.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="4">http://fasb.org/srt/2022</BaseTaxonomy>
    <BaseTaxonomy items="902">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>146
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "n2574_x163-10k.htm": {
   "nsprefix": "niobf",
   "nsuri": "http://niocorp.com/20230630",
   "dts": {
    "inline": {
     "local": [
      "n2574_x163-10k.htm"
     ]
    },
    "schema": {
     "local": [
      "niobf-20230630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "niobf-20230630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "niobf-20230630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "niobf-20230630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "niobf-20230630_pre.xml"
     ]
    }
   },
   "keyStandard": 331,
   "keyCustom": 112,
   "axisStandard": 25,
   "axisCustom": 1,
   "memberStandard": 30,
   "memberCustom": 39,
   "hidden": {
    "total": 239,
    "http://niocorp.com/20230630": 61,
    "http://fasb.org/us-gaap/2022": 171,
    "http://xbrl.sec.gov/dei/2022": 7
   },
   "contextCount": 203,
   "entityCount": 1,
   "segmentCount": 73,
   "elementCount": 666,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 902,
    "http://fasb.org/srt/2022": 4,
    "http://xbrl.sec.gov/dei/2022": 40
   },
   "report": {
    "R1": {
     "role": "http://niocorp.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://niocorp.com/role/BalanceSheets",
     "longName": "00000002 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://niocorp.com/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss",
     "longName": "00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:LaborAndRelatedExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:LaborAndRelatedExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://niocorp.com/role/StatementsOfCashFlows",
     "longName": "00000005 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "From2021-07-012022-06-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:AssumptionOfEarnoutLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest",
     "longName": "00000006 - Statement - Consolidated Statements of Shareholders' (Deficit) Equity and Redeemable Noncontrolling Interest",
     "shortName": "Consolidated Statements of Shareholders' (Deficit) Equity and Redeemable Noncontrolling Interest",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "AsOf2020-06-30_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2020-06-30_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://niocorp.com/role/DescriptionOfBusiness",
     "longName": "00000007 - Disclosure - DESCRIPTION OF BUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://niocorp.com/role/BasisOfPreparation",
     "longName": "00000008 - Disclosure - BASIS OF PREPARATION",
     "shortName": "BASIS OF PREPARATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:BasisOfAccounting",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:BasisOfAccounting",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://niocorp.com/role/SignificantAccountingPolicies",
     "longName": "00000009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://niocorp.com/role/GoingConcernIssues",
     "longName": "00000010 - Disclosure - GOING CONCERN ISSUES",
     "shortName": "GOING CONCERN ISSUES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://niocorp.com/role/GxiiTransaction",
     "longName": "00000011 - Disclosure - GXII TRANSACTION",
     "shortName": "GXII TRANSACTION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://niocorp.com/role/LandAndBuildingsNet",
     "longName": "00000012 - Disclosure - LAND AND BUILDINGS, NET",
     "shortName": "LAND AND BUILDINGS, NET",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://niocorp.com/role/MineralProperties",
     "longName": "00000013 - Disclosure - MINERAL PROPERTIES",
     "shortName": "MINERAL PROPERTIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:MineralIndustriesDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:MineralIndustriesDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://niocorp.com/role/AccountsPayableAndAccruedLiabilities",
     "longName": "00000014 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://niocorp.com/role/ConvertibleDebt",
     "longName": "00000015 - Disclosure - CONVERTIBLE DEBT",
     "shortName": "CONVERTIBLE DEBT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://niocorp.com/role/ClassBCommonStockOfEcrc",
     "longName": "00000016 - Disclosure - CLASS B COMMON STOCK OF ECRC",
     "shortName": "CLASS B COMMON STOCK OF ECRC",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://niocorp.com/role/CommonShares",
     "longName": "00000017 - Disclosure - COMMON SHARES",
     "shortName": "COMMON SHARES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://niocorp.com/role/RelatedPartyTransactionsAndBalances",
     "longName": "00000018 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES",
     "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://niocorp.com/role/ExplorationExpenditures",
     "longName": "00000019 - Disclosure - EXPLORATION EXPENDITURES",
     "shortName": "EXPLORATION EXPENDITURES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:ExplorationExpendituresDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:ExplorationExpendituresDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://niocorp.com/role/Leases",
     "longName": "00000020 - Disclosure - LEASES",
     "shortName": "LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://niocorp.com/role/IncomeTaxes",
     "longName": "00000021 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://niocorp.com/role/FairValueMeasurements",
     "longName": "00000022 - Disclosure - FAIR VALUE MEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://niocorp.com/role/SubsequentEvents",
     "longName": "00000023 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://niocorp.com/role/SignificantAccountingPoliciesPolicies",
     "longName": "00000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:DevelopmentStageIssuerPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:DevelopmentStageIssuerPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://niocorp.com/role/BasisOfPreparationTables",
     "longName": "00000025 - Disclosure - BASIS OF PREPARATION (Tables)",
     "shortName": "BASIS OF PREPARATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://niocorp.com/role/SignificantAccountingPoliciesTables",
     "longName": "00000026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://niocorp.com/role/GxiiTransactionTables",
     "longName": "00000027 - Disclosure - GXII TRANSACTION (Tables)",
     "shortName": "GXII TRANSACTION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://niocorp.com/role/LandAndBuildingsNetTables",
     "longName": "00000028 - Disclosure - LAND AND BUILDINGS, NET (Tables)",
     "shortName": "LAND AND BUILDINGS, NET (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables",
     "longName": "00000029 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://niocorp.com/role/ConvertibleDebtTables",
     "longName": "00000030 - Disclosure - CONVERTIBLE DEBT (Tables)",
     "shortName": "CONVERTIBLE DEBT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://niocorp.com/role/ClassBCommonStockOfEcrcTables",
     "longName": "00000031 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)",
     "shortName": "CLASS B COMMON STOCK OF ECRC (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://niocorp.com/role/CommonSharesTables",
     "longName": "00000032 - Disclosure - COMMON SHARES (Tables)",
     "shortName": "COMMON SHARES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables",
     "longName": "00000033 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Tables)",
     "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://niocorp.com/role/ExplorationExpendituresTables",
     "longName": "00000034 - Disclosure - EXPLORATION EXPENDITURES (Tables)",
     "shortName": "EXPLORATION EXPENDITURES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:ScheduleOfExplorationExpendituresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "niobf:ExplorationExpendituresDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:ScheduleOfExplorationExpendituresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "niobf:ExplorationExpendituresDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://niocorp.com/role/LeasesTables",
     "longName": "00000035 - Disclosure - LEASES (Tables)",
     "shortName": "LEASES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://niocorp.com/role/IncomeTaxesTables",
     "longName": "00000036 - Disclosure - INCOME TAXES (Tables)",
     "shortName": "INCOME TAXES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://niocorp.com/role/FairValueMeasurementsTables",
     "longName": "00000037 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails",
     "longName": "00000038 - Disclosure - Schedule of intercompany transactions and balances (Details)",
     "shortName": "Schedule of intercompany transactions and balances (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2022-07-012023-06-30_custom_Entity0896800BCLtdMember",
      "name": "niobf:IncorporationStateCountryName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-012023-06-30_custom_Entity0896800BCLtdMember",
      "name": "niobf:IncorporationStateCountryName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative",
     "longName": "00000039 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)",
     "shortName": "DESCRIPTION OF BUSINESS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R40": {
     "role": "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
     "longName": "00000040 - Disclosure - The following table sets forth the computation of the Company\u2019s basic and diluted net loss per share attributable to common shareholders: (Details)",
     "shortName": "The following table sets forth the computation of the Company\u2019s basic and diluted net loss per share attributable to common shareholders: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-03-31",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
       "us-gaap:PriorPeriodReclassificationAdjustmentDescription",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails",
     "longName": "00000041 - Disclosure - Schedule of excluded from the dilutive securities (Details)",
     "shortName": "Schedule of excluded from the dilutive securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details",
     "longName": "00000042 - Disclosure - Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As of March 31, 2023 (Details)",
     "shortName": "Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As of March 31, 2023 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:OtherLiabilitiesNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-03-31",
      "name": "us-gaap:OtherLiabilitiesNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
       "us-gaap:PriorPeriodReclassificationAdjustmentDescription",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details",
     "longName": "00000043 - Disclosure - Revision Impacts to the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For the Three & Nine Months Ended March 31, 2023 (Details)",
     "shortName": "Revision Impacts to the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For the Three & Nine Months Ended March 31, 2023 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-03-31",
      "name": "us-gaap:OtherGeneralExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
       "us-gaap:PriorPeriodReclassificationAdjustmentDescription",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-03-31",
      "name": "us-gaap:OperatingExpenses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
       "us-gaap:PriorPeriodReclassificationAdjustmentDescription",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details",
     "longName": "00000044 - Disclosure - Revision Impacts to the Condensed Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023 (Details)",
     "shortName": "Revision Impacts to the Condensed Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-03-31",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
       "us-gaap:PriorPeriodReclassificationAdjustmentDescription",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-012023-03-31_srt_ScenarioPreviouslyReportedMember",
      "name": "niobf:AssumptionOfPrivateAndPublicWarrants",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedCashFlowStatementTableTextBlock",
       "us-gaap:PriorPeriodReclassificationAdjustmentDescription",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative",
     "longName": "00000045 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:AccruedLiabilitiesAndOtherLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:AssetRetirementObligationsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:AccruedLiabilitiesAndOtherLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:AssetRetirementObligationsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://niocorp.com/role/GoingConcernIssuesDetailsNarrative",
     "longName": "00000046 - Disclosure - GOING CONCERN ISSUES (Details Narrative)",
     "shortName": "GOING CONCERN ISSUES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-03-31",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
       "us-gaap:PriorPeriodReclassificationAdjustmentDescription",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:CashAndCashEquivalentsAtCarryingValue1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails",
     "longName": "00000047 - Disclosure - The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss: (Details)",
     "shortName": "The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails",
     "longName": "00000048 - Disclosure - The number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows: (Details)",
     "shortName": "The number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://niocorp.com/role/GxiiTransactionDetailsNarrative",
     "longName": "00000049 - Disclosure - GXII TRANSACTION (Details Narrative)",
     "shortName": "GXII TRANSACTION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "From2022-07-012023-06-30_custom_WarrantAgreementMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-012023-06-30_custom_WarrantAgreementMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://niocorp.com/role/ScheduleOfPropertiesDetails",
     "longName": "00000050 - Disclosure - Schedule of properties (Details)",
     "shortName": "Schedule of properties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentOther",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentOther",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative",
     "longName": "00000051 - Disclosure - LAND AND BUILDINGS, NET (Details Narrative)",
     "shortName": "LAND AND BUILDINGS, NET (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "From2022-10-202022-10-22_us-gaap_LandImprovementsMember",
      "name": "us-gaap:LandPurchaseOptionsDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-10-202022-10-22_us-gaap_LandImprovementsMember",
      "name": "us-gaap:LandPurchaseOptionsDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://niocorp.com/role/MineralPropertiesDetailsNarrative",
     "longName": "00000052 - Disclosure - MINERAL PROPERTIES (Details Narrative)",
     "shortName": "MINERAL PROPERTIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "From2020-07-012021-06-30",
      "name": "us-gaap:PaymentsToAcquireMineralRights",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2011-06-282011-06-30_custom_ShareExchangeAgreementMember_currency_CAD",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:MineralIndustriesDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails",
     "longName": "00000053 - Disclosure - Schedule of account payable and accrued liabilities (Details)",
     "shortName": "Schedule of account payable and accrued liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails",
     "longName": "00000054 - Disclosure - Schedule of convertible debt (Details)",
     "shortName": "Schedule of convertible debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30",
      "name": "us-gaap:ConvertibleDebtCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-06-30_custom_ConvertibleSecurityMember",
      "name": "us-gaap:ConvertibleDebtCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails",
     "longName": "00000055 - Disclosure - Changes in the Lind III Convertible Security are as follows: (Details)",
     "shortName": "Changes in the Lind III Convertible Security are as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ExtinguishmentOfDebtAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-06-30_custom_ConvertibleSecurityMember501157765",
      "name": "us-gaap:ConvertibleDebtNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails",
     "longName": "00000056 - Disclosure - The following table summarizes the components of the initial loss on extinguishment: (Details)",
     "shortName": "The following table summarizes the components of the initial loss on extinguishment: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:MinimumConsentPaymentAtInception",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfExtinguishmentOfDebtTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:MinimumConsentPaymentAtInception",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfExtinguishmentOfDebtTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails",
     "longName": "00000057 - Disclosure - The change in the fair value of the Contingent Consent Warrants is presented below: (Details)",
     "shortName": "The change in the fair value of the Contingent Consent Warrants is presented below: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfWarrantValuationTableTextblock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-06-30",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfWarrantValuationTableTextblock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details",
     "longName": "00000058 - Disclosure - Schedule of valuation date and the probability calculated. (Details)",
     "shortName": "Schedule of valuation date and the probability calculated. (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30_custom_ProbabilityOfIssuanceMember",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "NUMBER",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "niobf:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails",
     "longName": "00000059 - Disclosure - Changes in the Convertible Debentures are as follows: (Details)",
     "shortName": "Changes in the Convertible Debentures are as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "AsOf2023-03-14",
      "name": "us-gaap:ConvertibleDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-03-14",
      "name": "us-gaap:ConvertibleDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
     "longName": "00000060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)",
     "shortName": "CONVERTIBLE DEBT (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "From2021-02-162021-02-19",
      "name": "us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2021-02-162021-02-19",
      "name": "us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
     "longName": "00000061 - Disclosure - The following table discloses the primary inputs into the Monte Carlo models. (Details)",
     "shortName": "The following table discloses the primary inputs into the Monte Carlo models. (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:SharePrice",
      "unitRef": "CADPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-09-25_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember",
      "name": "us-gaap:SharePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock",
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details",
     "longName": "00000062 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2023: (Details)",
     "shortName": "The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2023: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "AsOf2023-02-28_custom_EarnoutMember",
      "name": "us-gaap:ServicingLiabilityAtFairValueAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock",
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-02-28_custom_EarnoutMember",
      "name": "us-gaap:ServicingLiabilityAtFairValueAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock",
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
     "longName": "00000063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)",
     "shortName": "CLASS B COMMON STOCK OF ECRC (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-012023-06-30_custom_EarnoutMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://niocorp.com/role/ScheduleOfStockOptionDetails",
     "longName": "00000064 - Disclosure - Schedule of stock option (Details)",
     "shortName": "Schedule of stock option (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2020-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details",
     "longName": "00000065 - Disclosure - The following table summarizes information about stock options outstanding at June 30, 2023: (Details)",
     "shortName": "The following table summarizes information about stock options outstanding at June 30, 2023: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails",
     "longName": "00000066 - Disclosure - The following table summarizes the weighted average information and assumptions used to determine option costs: (Details)",
     "shortName": "The following table summarizes the weighted average information and assumptions used to determine option costs: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details",
     "longName": "00000067 - Disclosure - Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details)",
     "shortName": "Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates. (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2020-07-012021-06-30",
      "name": "niobf:NordminWarrants",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails",
     "longName": "00000068 - Disclosure - At June 30, 2023, the Company has outstanding exercisable warrants, as follows: (Details)",
     "shortName": "At June 30, 2023, the Company has outstanding exercisable warrants, as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30_currency_CAD_custom_ExercisePrice11.00Member",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "CADPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfOutstandingExercisableWarrantsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails",
     "longName": "00000069 - Disclosure - The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details)",
     "shortName": "The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:SharePrice",
      "unitRef": "CADPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-03-17_us-gaap_FairValueInputsLevel2Member",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails",
     "longName": "00000070 - Disclosure - The change in the Private Warrants liability is presented below: (Details)",
     "shortName": "The change in the Private Warrants liability is presented below: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30_us-gaap_NoteWarrantMember",
      "name": "niobf:ChangesInFairValueOfInitialValuation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-06-30_us-gaap_NoteWarrantMember",
      "name": "niobf:ChangesInFairValueOfInitialValuation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails",
     "longName": "00000071 - Disclosure - Schedule of expenses as other operating costs (Details)",
     "shortName": "Schedule of expenses as other operating costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-012023-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember",
      "name": "niobf:YorkvilleCashFee",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://niocorp.com/role/CommonSharesDetailsNarrative",
     "longName": "00000072 - Disclosure - COMMON SHARES (Details Narrative)",
     "shortName": "COMMON SHARES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "From2023-04-262023-04-28",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-04-262023-04-28",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails",
     "longName": "00000073 - Disclosure - Changes in the Smith Credit Agreement principal balance are as follows: (Details)",
     "shortName": "Changes in the Smith Credit Agreement principal balance are as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30",
      "name": "us-gaap:RelatedPartyDepositLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-06-30",
      "name": "us-gaap:RelatedPartyDepositLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
     "longName": "00000074 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)",
     "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "niobf:AmountPaidToRelatedParty",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "niobf:AmountPaidToRelatedParty",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails",
     "longName": "00000075 - Disclosure - Schedule of exploration expenditures (Details)",
     "shortName": "Schedule of exploration expenditures (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ExplorationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfExplorationExpendituresTableTextBlock",
       "niobf:ExplorationExpendituresDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ExplorationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfExplorationExpendituresTableTextBlock",
       "niobf:ExplorationExpendituresDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails",
     "longName": "00000076 - Disclosure - The Company incurred lease costs as follows: (Details)",
     "shortName": "The Company incurred lease costs as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:FixedRentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:FixedRentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details",
     "longName": "00000077 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2023: (Details)",
     "shortName": "The maturity of lease liabilities is as follows at June 30, 2023: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://niocorp.com/role/LeasesDetailsNarrative",
     "longName": "00000078 - Disclosure - LEASES (Details Narrative)",
     "shortName": "LEASES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:DiscountRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "us-gaap:LesseeOperatingLeaseOptionToExtend",
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:DiscountRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "us-gaap:LesseeOperatingLeaseOptionToExtend",
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails",
     "longName": "00000079 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2023, 2022, and 2021 are as follows: (Details)",
     "shortName": "Domestic and foreign components of loss before income taxes for the years ended June 30, 2023, 2022, and 2021 are as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails",
     "longName": "00000080 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)",
     "shortName": "The following table is a reconciliation of income taxes at statutory rates: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails",
     "longName": "00000081 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)",
     "shortName": "Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails",
     "longName": "00000082 - Disclosure - Changes in the valuation allowance are as follows: (Details)",
     "shortName": "Changes in the valuation allowance are as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "niobf:DeferredTaxAssetsValuationAllowanceAdditions",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "unique": true
     }
    },
    "R83": {
     "role": "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails",
     "longName": "00000083 - Disclosure - Schedule of cumulative net operating losses (Details)",
     "shortName": "Schedule of cumulative net operating losses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://niocorp.com/role/IncomeTaxesDetailsNarrative",
     "longName": "00000084 - Disclosure - INCOME TAXES (Details Narrative)",
     "shortName": "INCOME TAXES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30",
      "name": "niobf:IncreasesInCapitalLossesAvailableForFuturePeriods",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-06-30",
      "name": "niobf:IncreasesInCapitalLossesAvailableForFuturePeriods",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails",
     "longName": "00000085 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)",
     "shortName": "Schedule of fair values determined by level 3 inputs are unobservable data (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://niocorp.com/role/SubsequentEventsDetailsNarrative",
     "longName": "00000086 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "From2023-08-302023-09-01_us-gaap_SubsequentEventMember",
      "name": "us-gaap:SubsequentEventDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-08-302023-09-01_us-gaap_SubsequentEventMember",
      "name": "us-gaap:SubsequentEventDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x163-10k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2024",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "us-gaap_MeasurementInputExercisePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "MeasurementInputExercisePriceMember",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Exercise Price [Member]",
        "documentation": "Measurement input using agreed upon price for exchange of underlying asset."
       }
      }
     },
     "auth_ref": [
      "r696"
     ]
    },
    "us-gaap_BuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BuildingMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Building [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrants",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails",
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r509",
      "r573",
      "r585",
      "r655",
      "r656",
      "r660",
      "r715"
     ]
    },
    "us-gaap_InvestmentInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "InvestmentInterestRate",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Interest Rate",
        "documentation": "Rate of interest on investment."
       }
      }
     },
     "auth_ref": [
      "r643",
      "r644"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash investing and financing transactions:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Warrants assumed at fair value",
        "documentation": "Amount of lease obligation assumed in business combination."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_ServicingLiabilityAtFairValueAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ServicingLiabilityAtFairValueAmount",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Fair value at beginning",
        "periodEndLabel": "Fair value at ending",
        "label": "Servicing Liability at Fair Value, Amount",
        "documentation": "Fair value of a liability representing servicing arrangements under which the estimated future revenue from contractually specified servicing fees, late charges, and other ancillary revenues are not expected to adequately compensate the servicer."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r490",
      "r491",
      "r492"
     ]
    },
    "us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued",
        "documentation": "Increase (decrease) in number of shares that would be issued upon settlement from change in fair value of share for option contract indexed to equity."
       }
      }
     },
     "auth_ref": [
      "r417"
     ]
    },
    "us-gaap_ServicingLiabilityAtFairValueAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ServicingLiabilityAtFairValueAdditions",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value",
        "label": "Servicing Liability at Fair Value, Additions",
        "documentation": "The value of new servicing liabilities, that are subsequently measured at fair value, acquired or created during the current period through assumptions of servicing obligations and servicing obligations that result from transfers of financial assets."
       }
      }
     },
     "auth_ref": [
      "r493"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r509",
      "r573",
      "r585",
      "r655",
      "r656",
      "r660",
      "r715"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total consideration",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r136",
      "r137"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total transaction related losses incurred",
        "documentation": "Amount of liabilities assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Volatility",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r132",
      "r407",
      "r577",
      "r578"
     ]
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The number of Common Shares issued and outstanding immediately following the consummation of the Transactions were as follows:",
        "documentation": "Tabular disclosure of transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancelled/expired",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Standards",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/Cover",
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r239",
      "r262",
      "r266",
      "r271",
      "r272",
      "r275",
      "r276",
      "r292",
      "r321",
      "r323",
      "r324",
      "r325",
      "r328",
      "r329",
      "r347",
      "r348",
      "r349",
      "r350",
      "r353",
      "r430",
      "r557",
      "r607",
      "r619",
      "r639"
     ]
    },
    "us-gaap_GainsLossesOnRestructuringOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "GainsLossesOnRestructuringOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total loss on debt extinguishment",
        "documentation": "For a debtor, the aggregate gain (loss) recognized on the restructuring of payables arises from the difference between the book value of the debt before the restructuring and the fair value of the payments on the debt after restructuring is complete."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative",
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r95",
      "r204",
      "r227",
      "r228",
      "r229",
      "r244",
      "r245",
      "r246",
      "r248",
      "r255",
      "r258",
      "r274",
      "r293",
      "r355",
      "r380",
      "r381",
      "r382",
      "r397",
      "r398",
      "r420",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r464",
      "r541",
      "r542",
      "r543"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "WarrantMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock price on valuation date",
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInFairValueOfEarnoutShareLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ChangeInFairValueOfEarnoutShareLiability",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation of earnout shares liability",
        "documentation": "The element represents change in fair value of earnout share liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "MeasurementInputSharePriceMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Share Price [Member]",
        "documentation": "Measurement input using share price of saleable stock."
       }
      }
     },
     "auth_ref": [
      "r696"
     ]
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "ScenarioPreviouslyReportedMember",
     "presentation": [
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r244",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r258",
      "r273",
      "r398",
      "r419",
      "r420",
      "r421",
      "r450",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r649",
      "r650",
      "r695",
      "r704",
      "r705"
     ]
    },
    "us-gaap_TransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "TransactionDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision Impacts to the Condensed Consolidated Balance Sheet (unaudited) As of March 31, 2023",
        "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r624",
      "r723"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice8.94Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ExercisePrice8.94Member",
     "presentation": [
      "http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 8.94 [Member]",
        "documentation": "The element represents exercise price 8.94 member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average shares outstanding basic and diluted",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r272"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share based compensation",
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r689",
      "r690"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r593"
     ]
    },
    "niobf_LongTermIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "LongTermIncentivePlanMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long TermIncentive Plan [Member]",
        "documentation": "The element represents long termincentive plan member."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of account payable and accrued liabilities",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_EarnoutMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "EarnoutMember",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout [Member]",
        "documentation": "The element represents earnout member."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScheduleOfCondensedFinancialStatementsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "ScheduleOfCondensedFinancialStatementsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table summarizes the elements of the GXII Transaction allocated to the Consolidated Statements of Operations and Comprehensive Loss:",
        "documentation": "Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows."
       }
      }
     },
     "auth_ref": [
      "r624",
      "r723"
     ]
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScheduleOfCondensedIncomeStatementTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "ScheduleOfCondensedIncomeStatementTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision Impacts to the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) For the Three &amp; Nine Months Ended March 31, 2023",
        "documentation": "Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r624",
      "r723"
     ]
    },
    "srt_ScheduleOfCondensedCashFlowStatementTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "ScheduleOfCondensedCashFlowStatementTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision Impacts to the Condensed Consolidated Statement of Cash Flows (unaudited) For the Nine Months Ended March 31, 2023",
        "documentation": "Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r624",
      "r723"
     ]
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RedeemableNoncontrollingInterestEquityOtherCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable noncontrolling interest",
        "documentation": "Amount of noncontrolling interests which are redeemable by the parent entity, classified as other equity."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r92",
      "r93",
      "r94"
     ]
    },
    "niobf_GXIIPublicWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "GXIIPublicWarrantsMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GXII Public Warrants [Member]",
        "documentation": "The element represents gxii public warrants member."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_GXIIPrivateWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "GXIIPrivateWarrantsMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GXII Private Warrants [Member]",
        "documentation": "The element represents gxii private warrants member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalExpenditureDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CapitalExpenditureDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/GoingConcernIssuesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital expenditure of operations",
        "documentation": "Amount of capital expenditure attributable to discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable rent expense",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r582"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r696"
     ]
    },
    "niobf_ExercisePrice8.40Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ExercisePrice8.40Member",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 8.40 [Member]",
        "documentation": "The element represents exercise price 8.40 member."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "niobf_ExercisePrice5.40Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ExercisePrice5.40Member",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 5.40 [Member]",
        "documentation": "The element represents exercise price 5.40 member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "niobf_ExercisePrice7.50Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ExercisePrice7.50Member",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 7.50 [Member]",
        "documentation": "The element represents exercise price 7.50 member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Price Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r696"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice7.50OneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ExercisePrice7.50OneMember",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 7.50 One [Member]",
        "documentation": "The element represents exercise price 7.50 one member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r696"
     ]
    },
    "niobf_ExercisePrice13.60Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ExercisePrice13.60Member",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 13.60 [Member]",
        "documentation": "The element represents exercise price 13.60 member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice11.00Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ExercisePrice11.00Member",
     "presentation": [
      "http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails",
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 11.00 [Member]",
        "documentation": "The element represents exercise price 11.00 member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r54",
      "r57"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r235"
     ]
    },
    "niobf_ExercisePrice6.95Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ExercisePrice6.95Member",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 6.95 [Member]",
        "documentation": "The element represents exercise price 6.95 member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r235"
     ]
    },
    "niobf_ExercisePrice9.70Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ExercisePrice9.70Member",
     "presentation": [
      "http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 9.70 [Member]",
        "documentation": "The element represents exercise price 9.70 member."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Change in valuation",
        "label": "Servicing Asset at Fair Value, Changes in Fair Value Resulting from Changes in Valuation Inputs",
        "documentation": "Amount of increase (decrease) in fair value from changes in the inputs used to calculate the fair value of contract to service financial assets under which the benefits of servicing are expected to more than adequately compensate the servicer."
       }
      }
     },
     "auth_ref": [
      "r495"
     ]
    },
    "us-gaap_ConversionOfStockAmountIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ConversionOfStockAmountIssued1",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Conversions",
        "label": "Conversion of Stock, Amount Issued",
        "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r62",
      "r63"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SharePrice",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Closing Common Share price",
        "verboseLabel": "Strike price",
        "terseLabel": "Stock price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party debt draws",
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Financial Statements (Unaudited)",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest paid",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_LongTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LongTermDebtTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONVERTIBLE DEBT",
        "documentation": "The entire disclosure for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined federal and provincial statutory income tax rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r388",
      "r401"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AuditorLocation",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r598",
      "r600",
      "r601"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AuditorName",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r598",
      "r600",
      "r601"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Total operating expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r577",
      "r578"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant liabilities, at fair value",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r598",
      "r600",
      "r601"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
     "presentation": [
      "http://niocorp.com/role/BasisOfPreparationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of intercompany transactions and balances",
        "documentation": "The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r151"
     ]
    },
    "us-gaap_DepositsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DepositsAssets",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposits",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future."
       }
      }
     },
     "auth_ref": [
      "r611"
     ]
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]",
        "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r151"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "MaximumMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320",
      "r364",
      "r508",
      "r540",
      "r554",
      "r555",
      "r572",
      "r579",
      "r586",
      "r659",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ServicingLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ServicingLiability",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Contingent liability",
        "label": "Servicing Liability",
        "documentation": "Aggregate amount of servicing liabilities that are subsequently measured at fair value and servicing liabilities that are subsequently measured using the amortization method."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of assets",
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r445",
      "r472"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total intrinsic value",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "MinimumMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320",
      "r364",
      "r508",
      "r540",
      "r554",
      "r555",
      "r572",
      "r579",
      "r586",
      "r659",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r445",
      "r472"
     ]
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://niocorp.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r471",
      "r473"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r445",
      "r472"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "presentation": [
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issue for acquistion",
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r445",
      "r472"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingLossCarryforwardsTable",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards [Table]",
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "us-gaap_LongTermInvestmentsAndReceivablesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LongTermInvestmentsAndReceivablesNet",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in equity securities",
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle) and amount due to the Entity from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such investments and receivables to an amount that approximates their net realizable value."
       }
      }
     },
     "auth_ref": [
      "r612"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Implied volatility of Public Warrants",
        "verboseLabel": "Expected stock price volatility (historical basis)",
        "terseLabel": "Volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares purchase",
        "documentation": "Number of shares purchased for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r688"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r365",
      "r373",
      "r374",
      "r375",
      "r376",
      "r379",
      "r383",
      "r384"
     ]
    },
    "currency_CAD": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "localname": "CAD",
     "presentation": [
      "http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails",
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details",
      "http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative",
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canada, Dollars"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r243",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r449",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r620"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherIncome",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other gains",
        "label": "Other Income",
        "documentation": "Amount of revenue and income classified as other."
       }
      }
     },
     "auth_ref": [
      "r198"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free rate",
        "verboseLabel": "Risk-free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the expected term of a nonvested share or option award issued to other than an employee."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails",
      "http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected dividend yield",
        "label": "Dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of ownership",
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PaymentsForCommissions",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash commissions",
        "documentation": "The amount of cash paid for commissions during the current period."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalances"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTY TRANSACTIONS AND BALANCES",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r465",
      "r466",
      "r468",
      "r469",
      "r470"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share issue costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r467",
      "r468"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
      "http://niocorp.com/role/GoingConcernIssuesDetailsNarrative",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/StatementsOfCashFlows",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net loss",
        "label": "Net loss for the period",
        "verboseLabel": "Net loss",
        "terseLabel": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r57",
      "r182",
      "r196",
      "r206",
      "r222",
      "r224",
      "r229",
      "r239",
      "r247",
      "r249",
      "r250",
      "r252",
      "r253",
      "r257",
      "r258",
      "r269",
      "r282",
      "r283",
      "r285",
      "r287",
      "r292",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r422",
      "r430",
      "r564",
      "r657"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r366",
      "r367"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r366",
      "r367"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value per option granted during the period",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cancelled/expired",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://niocorp.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDepositLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RelatedPartyDepositLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Balance, end of period",
        "label": "Related Party Deposit Liabilities",
        "documentation": "Amount of deposits held by the entity for a related party (entity, shareholder, employee)."
       }
      }
     },
     "auth_ref": [
      "r623"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss attributable to redeemable noncontrolling interest",
        "verboseLabel": "Adjust: net loss attributable to noncontrolling interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r149",
      "r222",
      "r224",
      "r257",
      "r258",
      "r615"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r467",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r528",
      "r529",
      "r706"
     ]
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "presentation": [
      "http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails",
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "presentation": [
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remaining lease term",
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r701"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r218",
      "r239",
      "r292",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r410",
      "r415",
      "r430",
      "r583",
      "r657",
      "r658",
      "r707"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss available to participating securities",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r250",
      "r252",
      "r253",
      "r260",
      "r261",
      "r270",
      "r272",
      "r282",
      "r283",
      "r285",
      "r287",
      "r564"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r454"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CountryRegion",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "ChiefExecutiveOfficerMember",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "documentation": "Person with designation of chief executive officer."
       }
      }
     },
     "auth_ref": [
      "r642"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CityAreaCode",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Price per unit",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "Extension",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "presentation": [
      "http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails",
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range [Axis]",
        "documentation": "Information by range of option prices pertaining to options granted."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross proceeds",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "presentation": [
      "http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails",
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "us-gaap_OfferingCostsPartnershipInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OfferingCostsPartnershipInterests",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issue price",
        "documentation": "Costs incurred in connection with the offering and selling of additional partner interest."
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "us-gaap_NoteWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NoteWarrantMember",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Warrant [Member]",
        "documentation": "A note that entitles the holder to buy stock of the company at a specified price, which is much higher than the stock price at the time of issue."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss (gain) on equity securities",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax",
        "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r220",
      "r221"
     ]
    },
    "us-gaap_ValuationTechniqueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ValuationTechniqueDomain",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of expenses as other operating costs",
        "documentation": "Tabular disclosure of each detailed component of other operating costs and expenses that are applicable to sales and revenues, but not included in the cost of sales in the income statement."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r193",
      "r535",
      "r583"
     ]
    },
    "us-gaap_ValuationTechniqueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ValuationTechniqueAxis",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Approach and Technique [Axis]",
        "documentation": "Information by valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r175",
      "r177",
      "r187",
      "r243",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r449",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r620"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrants",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r264",
      "r265",
      "r272"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Land and buildings, net",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r210"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncrementalCommonSharesAttributableToWrittenPutOptions",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of outstanding written put options using the reverse treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r272",
      "r561",
      "r562"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r164"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible debt",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r268",
      "r272"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative",
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "srt_CurrencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "CurrencyAxis",
     "presentation": [
      "http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails",
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details",
      "http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative",
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "documentation": "Information by currency."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentOther",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AcceleratedShareRepurchasesFinalPricePaidPerShare",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercisable at a price per share",
        "documentation": "Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative",
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative",
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in working capital items:"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_YorkvilleCashFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "YorkvilleCashFee",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Cash Fee",
        "documentation": "The element represents yorkville cash fee."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_CostCentreDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "CostCentreDomain",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails",
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning",
        "periodEndLabel": "Balance at ending",
        "label": "Number",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_FixedRentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "FixedRentExpense",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed rent expense",
        "documentation": "The element represents fixed rent expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign rate differential",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r690"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Lived Assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r79"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://niocorp.com/role/BalanceSheetsParenthetical",
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails",
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, outstanding",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "verboseLabel": "Common stock, shares outstanding",
        "terseLabel": "Common stock, shares, outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r95"
     ]
    },
    "niobf_YorkvilleFinancingWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "YorkvilleFinancingWarrants",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville financing warrants",
        "documentation": "The element represents yorkville financing warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amounts paid for income taxes",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "niobf_ClassOfWarrantOrRightExercisePriceExpired": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ClassOfWarrantOrRightExercisePriceExpired",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expired average price",
        "documentation": "The element represents class of warrant or right exercise price expired."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightJunePrivatePlacement": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ClassOfWarrantOrRightJunePrivatePlacement",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "June 2022 private placement",
        "documentation": "The element represents class of warrant or right june private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/Cover",
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r239",
      "r262",
      "r266",
      "r271",
      "r272",
      "r275",
      "r276",
      "r292",
      "r321",
      "r323",
      "r324",
      "r325",
      "r328",
      "r329",
      "r347",
      "r348",
      "r349",
      "r350",
      "r353",
      "r430",
      "r557",
      "r607",
      "r619",
      "r639"
     ]
    },
    "niobf_ClassOfWarrantOrRightExercisePriceJunePrivatePlacements": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ClassOfWarrantOrRightExercisePriceJunePrivatePlacements",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "June 2022 private placement average price",
        "documentation": "The element represents class of warrant or right exercise price june private placements."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "us-gaap_LeaseCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LeaseCostAbstract",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Cost:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SummaryOfOperatingLossCarryforwardsTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of cumulative net operating losses",
        "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "niobf_ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ClassOfWarrantOrRightExercisePriceWarrantsYorkvilleFinancingWarrants",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville financing warrants average price",
        "documentation": "The element represents class of warrant or right exercise price warrants yorkville financing warrants."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_GxiiWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "GxiiWarrants",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GXII warrants",
        "documentation": "The element represents gxii warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details",
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share price",
        "verboseLabel": "Common share price, per share",
        "periodStartLabel": "Balance at beginning average price",
        "periodEndLabel": "Balance at ending average price",
        "terseLabel": "Exercise price",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r354"
     ]
    },
    "niobf_ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ClassOfWarrantOrRightExercisePriceWarrantsGXIIWarrants",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GXII warrant average price",
        "documentation": "The element represents class of warrant or right exercise price warrants gxii warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in the valuation allowance are as follows:",
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "niobf_ChangesInFairValueOfInitialValuation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ChangesInFairValueOfInitialValuation",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Initial valuation, at begining",
        "periodEndLabel": "Initial valuation, at ending",
        "documentation": "The element represents changes in fair value of initial valuation.",
        "label": "Changes in Fair Value of initial Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ShareIssuanceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ShareIssuanceCost",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share issuance cost",
        "documentation": "The element represents share issuance cost."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total deferred tax assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r392"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses",
        "label": "Increase (Decrease) in Prepaid Expense",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r385",
      "r386",
      "r390",
      "r391",
      "r394",
      "r396"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental cash flow information:"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_SaleOfStockPricePerShare1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "SaleOfStockPricePerShare1",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares price",
        "documentation": "The element represents sale of stock price per share 1."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PaymentsToAcquireHeldToMaturitySecurities",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment at maturity",
        "label": "Payments to Acquire Held-to-Maturity Securities",
        "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r72"
     ]
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net lease cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r582"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r239",
      "r247",
      "r282",
      "r283",
      "r285",
      "r287",
      "r292",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r422",
      "r430",
      "r564",
      "r657"
     ]
    },
    "niobf_DescriptionOfAmendedPlan": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "DescriptionOfAmendedPlan",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of amended plan",
        "documentation": "The element represents description of amended plan."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_FairValueAssumptionsRiskFreeInterestRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "FairValueAssumptionsRiskFreeInterestRate1",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Risk-free rate",
        "documentation": "The element represents fair value assumptions risk free interest rate 1.",
        "label": "Fair Value Assumptions Risk Free Interest Rate 1"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_FairValueAssumptionsExpected1VolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "FairValueAssumptionsExpected1VolatilityRate",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility",
        "documentation": "The element represents fair value assumptions expected 1 volatility rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued exploration stage expense",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_FairValueAssumptions1ExpectedTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "FairValueAssumptions1ExpectedTerm",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected life",
        "documentation": "The element represents fair value assumptions 1 expected term.",
        "label": "Fair Value Assumptions 1 Expected Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The Company incurred lease costs as follows:",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r702"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of reportable segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange rate effect on cash and cash equivalents",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "niobf_LineOfCreditFacilityPrepaymentFee": {
     "xbrltype": "percentItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "LineOfCreditFacilityPrepaymentFee",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepayment fee",
        "documentation": "The element represents line of credit facility prepayment fee."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_AmountsAdvanced": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "AmountsAdvanced",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amounts advanced",
        "documentation": "The element represents amounts advanced."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated depreciation",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r211"
     ]
    },
    "us-gaap_SupplementalDeferredPurchasePrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SupplementalDeferredPurchasePrice",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase price",
        "documentation": "A device of credit enhancement where a part of the purchase price for the receivable/ payable is retained to serve as a cash collateral."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r62",
      "r63"
     ]
    },
    "niobf_AmountPaidToRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "AmountPaidToRelatedParty",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount drew down",
        "documentation": "The element represents amount paid to related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r188",
      "r212",
      "r239",
      "r282",
      "r284",
      "r286",
      "r292",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r410",
      "r415",
      "r430",
      "r583",
      "r657",
      "r658",
      "r707"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r38",
      "r146",
      "r464",
      "r541",
      "r542",
      "r613",
      "r614",
      "r615",
      "r625",
      "r626",
      "r627"
     ]
    },
    "us-gaap_DeferredTaxAssetsOtherLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DeferredTaxAssetsOtherLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax losses incurred",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible loss carryforwards, classified as other."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r692"
     ]
    },
    "us-gaap_PaymentsToAcquireBuildings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PaymentsToAcquireBuildings",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative",
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of land and buildings",
        "label": "Remaining balance",
        "documentation": "The cash outflow for acquisition of buildings (properties) whether for investment or use."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating losses available for future periods",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r692"
     ]
    },
    "niobf_EstablishmentFeesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "EstablishmentFeesPayable",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Establishment fees payable",
        "documentation": "The element represents establishment fees payable."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive loss",
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r38",
      "r216",
      "r536",
      "r546",
      "r550"
     ]
    },
    "niobf_CostCentreAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "CostCentreAxis",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost Centre [Axis]",
        "documentation": "The element represents"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_AssumptionOfEarnoutLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "AssumptionOfEarnoutLiability",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial valuation of earnout shares liability",
        "documentation": "The element represents assumption of earnout liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockMember",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative",
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r625",
      "r626",
      "r694"
     ]
    },
    "niobf_OtheroperatingGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "OtheroperatingGainsLosses",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other gains",
        "documentation": "The element represents otheroperating gains losses.",
        "label": "Otheroperating Gains Losses"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_LossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "LossesOnExtinguishmentOfDebt",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss on debt extinguishment",
        "documentation": "The element represents losses on extinguishment of debt.",
        "label": "Losses on Extinguishment of Debt"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RepaymentsOfNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loan repayments",
        "label": "Repayments of Notes Payable",
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "niobf_ExercisePrice11.50Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ExercisePrice11.50Member",
     "presentation": [
      "http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price11.50 [Member]",
        "documentation": "The element represents exercise price11.50 member."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss before income taxes",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax",
        "documentation": "Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/LandAndBuildingsNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LAND AND BUILDINGS, NET",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r551",
      "r552",
      "r553"
     ]
    },
    "niobf_FieldManagementAndOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "FieldManagementAndOtherMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Field Management and Other [Member]",
        "documentation": "The element represents field management and other member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_GeneralSecurityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "GeneralSecurityAgreementMember",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Security Agreement [Member]",
        "documentation": "The element represents general security agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntermediateLifePlantsUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IntermediateLifePlantsUsefulLife",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected life",
        "documentation": "Useful life of intermediate-life plants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ExtinguishmentOfDebtAmount",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on debt extinguishment",
        "verboseLabel": "Fair value increase due to debt extinguishment",
        "documentation": "Gross amount of debt extinguished."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]",
        "documentation": "Disclosure of information about allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of warrants granted",
        "verboseLabel": "Fair Value Adjustment of Warrants",
        "terseLabel": "Fair value of warrant liability",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r90"
     ]
    },
    "niobf_AmendedNonRevolvingCreditFacilityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "AmendedNonRevolvingCreditFacilityAgreementMember",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amended Non Revolving Credit Facility Agreement [Member]",
        "documentation": "The element represents amended non revolving credit facility agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative",
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss attributed to common shareholders - basic and diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r272"
     ]
    },
    "niobf_MarkSmithMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "MarkSmithMember",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mark Smith [Member]",
        "documentation": "The element represents mark smith member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in financial instrument fair value",
        "label": "Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)",
        "documentation": "Amount of unrealized gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3) and still held."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table summarizes information about stock options outstanding at June 30, 2023:",
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "niobf_NonRevolvingCreditFacilityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "NonRevolvingCreditFacilityAgreementMember",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Revolving Credit Facility Agreement [Member]",
        "documentation": "The element represents non revolving credit facility agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorizedUnlimited": {
     "xbrltype": "authorizedUnlimitedItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockSharesAuthorizedUnlimited",
     "presentation": [
      "http://niocorp.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, authorized",
        "documentation": "Indicates that the number of common shares permitted to be issued by an entity's charter and bylaws is unlimited. The acceptable value is \"Unlimited\"."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "niobf_FeasibilityStudyAndEngineeringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "FeasibilityStudyAndEngineeringMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Feasibility Study and Engineering [Member]",
        "documentation": "The element represents feasibility study and engineering member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Liabilities Fair Value Disclosure",
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LongTermDebtMaturitiesRepaymentTerms",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt term",
        "documentation": "Disclosure of timing of required repayments, sinking fund requirements, and other redeemable securities at fixed or determinable prices and dates in the five years immediately following the date of the latest balance sheet presented in the financial statements, and the amount thereafter to fully repay the principal of long-term debt. These disclosures may be made either on an individual debt or security basis, by type of debt or security basis, or on a combined basis."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r96"
     ]
    },
    "niobf_GeologistsAndFieldStaffMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "GeologistsAndFieldStaffMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geologists and Field Staff [Member]",
        "documentation": "The element represents geologists and field staff member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r289",
      "r290",
      "r346",
      "r352",
      "r418",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r645",
      "r646",
      "r647",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722"
     ]
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfShortTermDebtTable",
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Short-Term Debt [Table]",
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "niobf_CorporateOfficeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "CorporateOfficeMember",
     "presentation": [
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate Office [Member]",
        "documentation": "The element represents corporate office member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExtinguishmentOfDebtGainLossIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ExtinguishmentOfDebtGainLossIncomeTax",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss on debt extinguishment",
        "label": "Extinguishment of Debt, Gain (Loss), Income Tax",
        "documentation": "Current period income tax expense or benefit pertaining to a gain (loss) on an extinguishment of debt."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "niobf_FinancingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "FinancingAgreementMember",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Agreement [Member]",
        "documentation": "The element represents financing agreement."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DueToOfficersOrStockholdersOtherCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "DueToOfficersOrStockholdersOtherCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party loan",
        "documentation": "The element represents due to officers or stockholders other current."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_EarnoutLiabilityAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "EarnoutLiabilityAtFairValue",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout liability, at fair value",
        "documentation": "The element represents earnout liability at fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative",
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExplorationExpenditures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ExplorationExpenditures",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exploration expenditures",
        "documentation": "The element represents exploration expenditures."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://niocorp.com/role/LandAndBuildingsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of properties",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingCostsAndExpenses",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net costs expensed to other operating expense",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ForeignCurrencyTransactionGainLossBeforeTax1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax1",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign exchange loss (gain)",
        "documentation": "The element represents foreign currency transaction gain loss before tax 1."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ProfitLoss1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ProfitLoss1",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net loss",
        "label": "Net loss attributable to the company",
        "documentation": "The element represents profit loss 2."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "presentation": [
      "http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails",
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]",
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "niobf_ChangeInFairValueOfEarnoutLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ChangeInFairValueOfEarnoutLiability",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of earnout shares liability",
        "documentation": "The element represents change in fair value of earnout liability.",
        "label": "Change in Fair Value of Earnout Liability"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInFairValueOfWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ChangeInFairValueOfWarrantLiability",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of warrant liabilities",
        "negatedTerseLabel": "Change in fair value of warrant liability",
        "documentation": "The element represents change in fair value of warrant liability.",
        "label": "Change in Fair Value of Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise prices related to Canadian dollar denominated warrants were converted to U.S. dollars using end of period foreign currency exchange rates.",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r112"
     ]
    },
    "us-gaap_RelatedPartyTransactionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RelatedPartyTransactionRate",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest at a rate",
        "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "presentation": [
      "http://niocorp.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair values determined by level 3 inputs are unobservable data",
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r157"
     ]
    },
    "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_ProfitLoss1",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Loss before income taxes",
        "documentation": "The element represents income loss from continuing operations before income taxes extraordinary items noncontrolling interest 1.",
        "label": "Income Loss from Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 1"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnsecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "UnsecuredDebtMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured Debt [Member]",
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "niobf_EarningsLossPerShareBasicAndDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "EarningsLossPerShareBasicAndDiluted",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per common share, basic and diluted",
        "verboseLabel": "Loss per common share outstanding basic and diluted",
        "documentation": "The element represents earnings loss per share basic and diluted."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average common shares outstanding",
        "documentation": "The element represents total weighted average number of share outstanding basic and diluted."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_FairValueOfCommitmentSharesIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "FairValueOfCommitmentSharesIssued",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville share issuances",
        "documentation": "The element represents fair value of commitment shares issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r244",
      "r245",
      "r246",
      "r248",
      "r255",
      "r258",
      "r293",
      "r380",
      "r381",
      "r382",
      "r397",
      "r398",
      "r420",
      "r541",
      "r543"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value using a Black Scholes model with the following assumptions:",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "us-gaap_TaxesPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "TaxesPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes payable",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r176",
      "r189"
     ]
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible shares issued upon conversion",
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r10",
      "r96",
      "r97",
      "r351"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RestatementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "RestatementDomain",
     "presentation": [
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r273",
      "r294",
      "r295",
      "r398",
      "r419",
      "r420",
      "r421",
      "r422",
      "r450",
      "r463",
      "r464",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550"
     ]
    },
    "srt_ReserveQuantitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "ReserveQuantitiesLineItems",
     "presentation": [
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserve Quantities [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "RestatementAxis",
     "presentation": [
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r273",
      "r294",
      "r295",
      "r398",
      "r419",
      "r420",
      "r421",
      "r422",
      "r450",
      "r463",
      "r464",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550"
     ]
    },
    "srt_RestatementAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "RestatementAdjustmentMember",
     "presentation": [
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Adjustment [Member]",
        "documentation": "Cumulative increase (decrease) for adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r245",
      "r246",
      "r254",
      "r255",
      "r273",
      "r420",
      "r421",
      "r628",
      "r629",
      "r630",
      "r631",
      "r633",
      "r636",
      "r637"
     ]
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax benefit at statutory tax rates",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r424",
      "r429"
     ]
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in estimates related to prior years",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r690"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails",
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r424",
      "r477",
      "r478",
      "r479",
      "r568",
      "r569",
      "r574",
      "r575",
      "r576"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting currency presentation",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r690"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails",
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r477",
      "r478",
      "r479",
      "r568",
      "r569",
      "r574",
      "r575",
      "r576"
     ]
    },
    "us-gaap_LongTermDebtTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LongTermDebtTerm",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long term debt duration",
        "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r697"
     ]
    },
    "us-gaap_MineralIndustriesDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "MineralIndustriesDisclosuresTextBlock",
     "presentation": [
      "http://niocorp.com/role/MineralProperties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MINERAL PROPERTIES",
        "documentation": "The entire disclosure for mineral industries."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r510",
      "r511"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "Security12bTitle",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_DebtConversionDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DebtConversionDescription",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion, Description",
        "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "UnrealizedGainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unrealized loss (gain) on equity securities",
        "label": "Unrealized Gain (Loss) on Investments",
        "documentation": "Amount of unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "TradingSymbol",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentType",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "Security12gTitle",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r592"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional fees",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r202"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r600",
      "r601"
     ]
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r599"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r596"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss",
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net loss attributable to the Company",
        "label": "Loss for the year",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r222",
      "r224",
      "r234",
      "r239",
      "r247",
      "r257",
      "r258",
      "r282",
      "r283",
      "r285",
      "r287",
      "r292",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r409",
      "r412",
      "r413",
      "r422",
      "r430",
      "r534",
      "r564",
      "r580",
      "r581",
      "r615",
      "r657"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r602"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Environmental accruals",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r195"
     ]
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r96",
      "r98",
      "r99",
      "r100",
      "r159",
      "r160",
      "r162",
      "r185",
      "r243",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r449",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r620"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other gains and comprehensive loss",
        "documentation": "For banks, amount of all liabilities for which a financial institution is required to include in its calculation of net investment in real estate assets held for development or sale."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Total liabilities",
        "negatedLabel": "Total liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r239",
      "r292",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r411",
      "r415",
      "r416",
      "r430",
      "r563",
      "r657",
      "r707",
      "r708"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Probability of issuance",
        "verboseLabel": "Fair value",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable",
     "presentation": [
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proved Developed and Undeveloped Oil and Gas Reserve Quantities [Table]",
        "documentation": "Detailed information on net quantities of proved reserves by geographic area."
       }
      }
     },
     "auth_ref": [
      "r524",
      "r525",
      "r526",
      "r527",
      "r530",
      "r531",
      "r556",
      "r584"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities, redeemable noncontrolling interest, and shareholders\u2019 (deficit) equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r178",
      "r192",
      "r583",
      "r621",
      "r648",
      "r698"
     ]
    },
    "us-gaap_WarrantsNotSettleableInCashFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "WarrantsNotSettleableInCashFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Not Settleable in Cash, Fair Value Disclosure",
        "documentation": "Fair value portion of warrants not settleable in cash classified as equity."
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "us-gaap_DilutiveSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DilutiveSecurities",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total potentially dilutive securities",
        "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "niobf_ChangeInValuationOfWarrantLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ChangeInValuationOfWarrantLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation of warrant liabilities",
        "documentation": "The element represents change in valuation of warrant liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r156"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Initial valuation, at beginning",
        "periodEndLabel": "Valuation, at ending",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_AssumptionOfPrivateAndPublicWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "AssumptionOfPrivateAndPublicWarrants",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial valuation of warrant liabilities",
        "verboseLabel": "Assumption of Private and Public Warrants",
        "documentation": "The element represents assumption of private and public warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial loss on debt extinguishment",
        "documentation": "Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r86"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Face value",
        "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "niobf_CommonSharesWithoutParValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "CommonSharesWithoutParValueMember",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares Without Par Value [Member]",
        "documentation": "The element represents common shares without par value member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ProbabilityOfIssuanceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ProbabilityOfIssuanceMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfValuationDateAndProbabilityCalculated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Probability of Issuance [Member]",
        "documentation": "The element represents probability of issuance member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of capital stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "niobf_YorkvilleConvertibleDebtFinancingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "YorkvilleConvertibleDebtFinancingAgreementMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Convertible Debt Financing Agreement [Member]",
        "documentation": "The element represents yorkville convertible debt financing agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "WarrantsAndRightsOutstandingMaturityDate",
     "presentation": [
      "http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiry date",
        "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r697"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/AccountsPayableAndAccruedLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "niobf_LindIIIConvertibleSecurityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "LindIIIConvertibleSecurityMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lind I I I Convertible Security [Member]",
        "documentation": "The element represents lind i i i convertible security member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative",
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r693"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r691"
     ]
    },
    "niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "WarrantsEachExercisableFor1.11829212CommonSharesMember",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Each Exercisable for 1.11829212 Common Shares [Member]",
        "documentation": "The element represents warrants each exercisable for 1.11829212 common shares member."
       }
      }
     },
     "auth_ref": []
    },
    "currency_AllCurrenciesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "localname": "AllCurrenciesDomain",
     "presentation": [
      "http://niocorp.com/role/AtJune302023CompanyHasOutstandingExercisableWarrantsAsFollowsDetails",
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details",
      "http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative",
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative"
     ],
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_RedeemableNoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "RedeemableNoncontrollingInterestMember",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Noncontrolling Interest [Member]",
        "documentation": "The element represents redeemable noncontrolling interest member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_Entity0896800BCLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "Entity0896800BCLtdMember",
     "presentation": [
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity 0896800 B C Ltd [Member]",
        "documentation": "The element represents entity 0896800 b c ltd member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r238"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r278"
     ]
    },
    "niobf_ElkCreekResourcesCorpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ElkCreekResourcesCorpMember",
     "presentation": [
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elk Creek Resources Corp [Member]",
        "documentation": "The element represents elk creek resources corp member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details",
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForYearEndedJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r289",
      "r290",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r346",
      "r352",
      "r418",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r565",
      "r645",
      "r646",
      "r647",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722"
     ]
    },
    "us-gaap_ValuationTechniqueOptionPricingModelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ValuationTechniqueOptionPricingModelMember",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Technique, Option Pricing Model [Member]",
        "documentation": "Valuation technique calculating price of option."
       }
      }
     },
     "auth_ref": [
      "r696"
     ]
    },
    "niobf_ElkCreekResourcesCorpECRCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ElkCreekResourcesCorpECRCMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elk Creek Resources Corp ECRC [Member]",
        "documentation": "The element represents elk creek resources corp ecrc member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_WarrantAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "WarrantAgreementMember",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Agreement [Member]",
        "documentation": "The element represents warrant agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Authority [Member]",
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_LegacyNioCorpShareholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "LegacyNioCorpShareholdersMember",
     "presentation": [
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legacy Nio Corp Shareholders [Member]",
        "documentation": "The element represents legacy nio corp shareholders member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccountsPayableTradeCurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable, trade",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r16"
     ]
    },
    "us-gaap_AccretionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccretionExpense",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails",
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accretion of convertible debt",
        "verboseLabel": "Accretion expense",
        "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations."
       }
      }
     },
     "auth_ref": [
      "r566",
      "r654"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r208",
      "r239",
      "r292",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r411",
      "r415",
      "r416",
      "r430",
      "r583",
      "r657",
      "r707",
      "r708"
     ]
    },
    "niobf_GXIIClassAShareholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "GXIIClassAShareholdersMember",
     "presentation": [
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GXII Class A Shareholders [Member]",
        "documentation": "The element represents gxii class a shareholders member."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "RangeAxis",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320",
      "r356",
      "r364",
      "r376",
      "r377",
      "r378",
      "r480",
      "r508",
      "r540",
      "r554",
      "r555",
      "r572",
      "r579",
      "r586",
      "r653",
      "r659",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714"
     ]
    },
    "niobf_ShareExchangeAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ShareExchangeAgreementMember",
     "presentation": [
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Exchange Agreement [Member]",
        "documentation": "The element represents share exchange agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_OtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "OtherMember",
     "presentation": [
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other [Member]",
        "documentation": "The element represents other member."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "RangeMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320",
      "r356",
      "r364",
      "r376",
      "r377",
      "r378",
      "r480",
      "r508",
      "r540",
      "r554",
      "r555",
      "r572",
      "r579",
      "r586",
      "r653",
      "r659",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714"
     ]
    },
    "us-gaap_AccretionExpenseIncludingAssetRetirementObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccretionExpenseIncludingAssetRetirementObligations",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accretion expense",
        "documentation": "Amount of accretion expense, which includes, but is not limited to, accretion expense from asset retirement obligations, environmental remediation obligations, and other contingencies."
       }
      }
     },
     "auth_ref": [
      "r652"
     ]
    },
    "niobf_OptionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "OptionAgreementMember",
     "presentation": [
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option Agreement [Member]",
        "documentation": "The element represents option agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ConvertibleSecurityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ConvertibleSecurityMember",
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Security [Member]",
        "documentation": "The element represents convertible security member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransactionTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "TransactionTypeAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Type [Axis]",
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "niobf_ScheduleOfExplorationExpendituresTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ScheduleOfExplorationExpendituresTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ExplorationExpendituresTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of exploration expenditures",
        "documentation": "The element represents schedule of exploration expenditures table text block.."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendYieldRate",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair value",
        "documentation": "The element represents share based goods and nonemployee services transaction valuation method expected dividend yield rate.",
        "label": "Share-Based Goods and Nonemployee Services Transaction Valuation Method Expected Dividend Yield Rate"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityDomain",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightExercisePriceLindWarrants": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ClassOfWarrantOrRightExercisePriceLindWarrants",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lind III warrants average price",
        "documentation": "The element represents class of warrant or right exercise price lind warrants."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_IncorporationStateCountryName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "IncorporationStateCountryName",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfIntercompanyTransactionsAndBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country of incorporation",
        "documentation": "The element represents incorporation state country name."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ClassOfWarrantOrRightExercisePriceAprilPrivatePlacements",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "April 2021 private placement average price",
        "documentation": "The element represents class of warrant or right exercise price april private placements."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate obligation",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r160",
      "r342"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents, beginning of period",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r58",
      "r64"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and Diluted Per Share Disclosure",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r69"
     ]
    },
    "niobf_CashAndCashEquivalentsAtCarryingValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "CashAndCashEquivalentsAtCarryingValue1",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/GoingConcernIssuesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash",
        "documentation": "The element represents cash and cash equivalents at carrying value1."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCashCosts",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Equity Facility Financing Agreement \u2013 cash costs",
        "documentation": "The element represents business combination separately recognized transactions additional disclosures acquisition cash costs."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_EarnoutSharesAssumedAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "EarnoutSharesAssumedAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout Shares assumed at fair value",
        "documentation": "The element represents earnout shares assumed at fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r162",
      "r330",
      "r449",
      "r568",
      "r569"
     ]
    },
    "us-gaap_AmortizationOfAcquisitionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AmortizationOfAcquisitionCosts",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indirect costs",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r73"
     ]
    },
    "niobf_DeferredTaxImpacts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "DeferredTaxImpacts",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax",
        "documentation": "The element represents deferred taximpacts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "niobf_MinimumConsentPaymentAtInception": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "MinimumConsentPaymentAtInception",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum Consent Payment at inception",
        "documentation": "The element represents minimum consent payment at inception."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Change in cash and cash equivalents during period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r158"
     ]
    },
    "niobf_ASC470LossOnExtinguishment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ASC470LossOnExtinguishment",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss on debt extinguishment",
        "documentation": "The element represents as c470 loss on extinguishment.",
        "label": "AS C470 Loss on Extinguishment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r209",
      "r558"
     ]
    },
    "us-gaap_OtherLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Fair Value Disclosure",
        "documentation": "Fair value portion of other liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCostAndExpenseOperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherCostAndExpenseOperating",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal and other related costs",
        "verboseLabel": "Lease cost \u2013 other operating expense",
        "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "niobf_AdditionalConsentPaymentbooked": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "AdditionalConsentPaymentbooked",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Consent Payment booked",
        "documentation": "The element represents additional consent paymentbooked."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Add: uamortized debt issuance costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r345",
      "r448",
      "r618"
     ]
    },
    "niobf_ChangeInValuationOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ChangeInValuationOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangeInFairValueOfContingentConsentWarrantsIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation",
        "documentation": "The element represents change in valuation of warrants."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightExpired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ClassOfWarrantOrRightExpired",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expired",
        "documentation": "The element represents class of warrant or right expired."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherGeneralExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherGeneralExpense",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other operating expenses",
        "verboseLabel": "Other operating expense",
        "negatedLabel": "Other operating expense",
        "documentation": "Amount of general expenses not normally included in Other Operating Costs and Expenses."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "niobf_PrincipalAndAccruedInterestConverted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "PrincipalAndAccruedInterestConverted",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Principal and accrued interest converted",
        "documentation": "The element represents principal and accrued interest converted.",
        "label": "Principal and Accrued Interest Converted"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_TransactionCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "TransactionCost",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction costs",
        "documentation": "The element represents transaction cost."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_StockIssuedDuringPeriodSharesStockOptionsExercise": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercise",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of the convertible debentures",
        "documentation": "The element represents stock issued during period shares stock options exercise."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_StockIssuedDuringPeriodSharesStockOptionsExercise1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercise1",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of the convertible debentures",
        "documentation": "The element represents stock issued during period shares stock options exercise1.",
        "label": "Stock Issued During Period Shares Stock Options Exercise1"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DebtMaturityPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "DebtMaturityPeriod",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected life",
        "documentation": "The element represents debt maturity period.",
        "label": "Debt Maturity Period"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightExercisePriceExercised": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ClassOfWarrantOrRightExercisePriceExercised",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercised average price",
        "documentation": "The element represents class of warrant or right exercise price exercised."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ClassOfWarrantOrRightExercised",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercised",
        "documentation": "The element represents class of warrant or right exercised.",
        "label": "Class of Warrant or Right Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2": {
     "xbrltype": "dateItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesPrimaryInputsIntoMonteCarloModels.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Term (expiry)",
        "documentation": "The element represents sharebased compensation arrangement by sharebased payment award fair value assumptions expected term2."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DescriptionOfEarnOutShares": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "DescriptionOfEarnOutShares",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of earnout shares",
        "documentation": "The element represents description of earn out shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement by Share Based Payment Award Options Outstanding Intrinsic Value 1",
        "documentation": "The element represents share based compensation arrangement by share based payment award options outstanding intrinsic value 1."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_NordminWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "NordminWarrants",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nordmin warrants",
        "documentation": "The element represents nordmin warrants."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ClassOfWarrantOrRightExercisePriceWarrantsNovemberFinancing",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nordmin warrants average price",
        "documentation": "The element represents class of warrant or right exercise price warrants november financing."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightLindIIIWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ClassOfWarrantOrRightLindIIIWarrants",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lind III Warrants",
        "documentation": "The element represents class of warrant or right lind i i i warrants."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightAprilPrivatePlacement": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ClassOfWarrantOrRightAprilPrivatePlacement",
     "presentation": [
      "http://niocorp.com/role/WeightedAverageExercisePricesRelatedToCanadianDollarDenominatedWarrantsWereConvertedToU.s.DollarsUsingEndOfPeriodForeignCurrencyExchangeRates.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "April 2021 private placement",
        "documentation": "The element represents class of warrant or right april private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive loss attributable to redeemable noncontrolling interest",
        "documentation": "Amount, before tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r409",
      "r414"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in the Smith Credit Agreement principal balance are as follows:",
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParentAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive loss:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails",
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r357",
      "r362",
      "r424",
      "r478",
      "r568",
      "r569",
      "r574",
      "r575",
      "r576"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade payable accruals",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of stock option",
        "documentation": "Tabular disclosure of the change in stock options."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CapitalizedCostsMineralInterestsInUnprovedProperties",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mineral properties",
        "documentation": "Capitalized costs of unproven properties that include fee ownership or a lease, concession, or other interest representing the right to extract oil or gas subject to such terms as may be imposed by the conveyance of that interest."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r167",
      "r172"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r75"
     ]
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonShares"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMON SHARES",
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r121"
     ]
    },
    "us-gaap_SubsequentEventDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventDescription",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent event description",
        "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r357",
      "r362",
      "r424",
      "r477",
      "r574",
      "r575",
      "r576"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r424",
      "r479",
      "r568",
      "r569",
      "r574",
      "r575",
      "r576"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS\u2019 (DEFICIT) EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee related costs",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r616"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table summarizes the weighted average information and assumptions used to determine option costs:",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Translation",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r446"
     ]
    },
    "us-gaap_OciEquityMethodInvestmentBeforeTaxParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OciEquityMethodInvestmentBeforeTaxParent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Comprehensive loss attributable to the Company",
        "label": "Comprehensive loss attributable to the company",
        "documentation": "Amount, before tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r409",
      "r414"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in financial instrument fair value",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_LandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LandMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Land [Member]",
        "documentation": "Part of earth's surface not covered by water."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive (gain) loss:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LandPurchaseOptionsDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LandPurchaseOptionsDescription",
     "presentation": [
      "http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of owned land",
        "documentation": "Describes contracts, agreements and arrangements that give the entity unilateral rights to purchase the land covered by the option for a specified period of time."
       }
      }
     },
     "auth_ref": [
      "r203"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails",
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails",
      "http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected option life in years",
        "verboseLabel": "Expected warrant life in years",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions",
     "presentation": [
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares, percentage",
        "documentation": "Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails",
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FAIR VALUE MEASUREMENTS",
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r101",
      "r191",
      "r545",
      "r550",
      "r583"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table sets forth the computation of the Company\u2019s basic and diluted net loss per share attributable to common shareholders:",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic and foreign components of loss before income taxes for the years ended June 30, 2023, 2022, and 2021 are as follows:",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r622"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails",
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "documentation": "Different names of stock transactions and the different attributes of each transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ClassOfWarrantOrRightReasonForIssuingToNonemployees",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of warrants",
        "documentation": "Description of reason for issuing warrant or right."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LandImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LandImprovementsMember",
     "presentation": [
      "http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Land Improvements [Member]",
        "documentation": "Additions or improvements to real estate held."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LandAndLandImprovements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LandAndLandImprovements",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Improvements state",
        "documentation": "Amount before accumulated depreciation and depletion of real estate held for productive use and additions or improvements to real estate held for productive use, examples include, but are not limited to, walkways, driveways, fences, and parking lots. Excludes land held for sale."
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LossContingencyAccrualAtCarryingValue",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent liability",
        "documentation": "Amount of loss contingency liability."
       }
      }
     },
     "auth_ref": [
      "r316",
      "r608"
     ]
    },
    "us-gaap_SubleaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubleaseIncome",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Sublease income",
        "label": "Sublease Income",
        "documentation": "Amount of sublease income excluding finance and operating lease expense."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r582"
     ]
    },
    "niobf_LessAmountOfPaymentsRepresentingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "LessAmountOfPaymentsRepresentingInterest",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less amount of payments representing interest",
        "documentation": "The element represents less amount of payments representing interest."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "DiscountRate",
     "presentation": [
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discount rate",
        "documentation": "The element represents discount rate."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_EarnoutSharesLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "EarnoutSharesLiability",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout shares liability",
        "documentation": "The element represents earnout shares liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OffsettingAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OffsettingAssetsTable",
     "presentation": [
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offsetting Assets [Table]",
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued liabilities",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r583"
     ]
    },
    "niobf_WarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "WarrantLiability",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant liability",
        "documentation": "The element represents warrant liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r183",
      "r230",
      "r280",
      "r447"
     ]
    },
    "niobf_GxiiTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "GxiiTransactionCosts",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GXII transaction costs",
        "documentation": "The element represents gxii transaction costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total accounts payable and accrued liabilities",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangesInSmithCreditAgreementPrincipalBalanceAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments",
        "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_EffectOfLegislativeChanges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "EffectOfLegislativeChanges",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital loss rate differential",
        "documentation": "The element represents effect of legislative changes."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DeferredTaxAssetsShareIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "DeferredTaxAssetsShareIssuanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share issuance costs",
        "documentation": "The element represents deferred tax assets share issuance costs.",
        "label": "Deferred Tax Assets Share Issuance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DeferredTaxAssetsMineralInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "DeferredTaxAssetsMineralInterest",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mineral interests",
        "documentation": "The element represents deferred tax assets mineral interest."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Foreign exchange loss (gain)",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r431",
      "r433",
      "r435",
      "r436"
     ]
    },
    "niobf_DeferredTaxAssetsStartupAndOorganizationalCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "DeferredTaxAssetsStartupAndOorganizationalCosts",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Startup and organizational costs",
        "documentation": "The element represents deferred tax assets startup and oorganizational costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetRetirementObligationAccretionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AssetRetirementObligationAccretionExpense",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accretion expense",
        "label": "Asset Retirement Obligation, Accretion Expense",
        "documentation": "Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability."
       }
      }
     },
     "auth_ref": [
      "r306",
      "r307"
     ]
    },
    "niobf_DeferredTaxAssetsResearchAndDevelopmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "DeferredTaxAssetsResearchAndDevelopmentCosts",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development costs",
        "documentation": "The element represents deferred tax assets research and development costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Tax Authority [Member]",
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_CapitalLossesAvailableForFuturePeriods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "CapitalLossesAvailableForFuturePeriods",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital losses available for future periods",
        "documentation": "The element represents capital losses available for future periods."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccountsPayableAndAccruedLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan origination fees payable to related party",
        "documentation": "Fair value portion of trade and related party payables and accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DeferredTaxAssetsValuationAllowanceAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "DeferredTaxAssetsValuationAllowanceAdditions",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Current year additions",
        "documentation": "The element represents deferred tax assets valuation allowance additions.",
        "label": "Deferred Tax Assets Valuation Allowance Additions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting currency translation",
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r36",
      "r432",
      "r434",
      "r438"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_IncreasesInCapitalLossesAvailableForFuturePeriods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "IncreasesInCapitalLossesAvailableForFuturePeriods",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increases in Capital Losses Available for Future Periods",
        "documentation": "The element represents increases in capital losses available for future periods."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal income tax payable",
        "documentation": "Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r387"
     ]
    },
    "niobf_OtherIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "OtherIncomeTaxes",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income Taxes",
        "documentation": "The element represents Other Income Taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetRetirementObligationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AssetRetirementObligationsPolicy",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Retirement Obligation",
        "documentation": "Disclosure of accounting policy for legal obligation associated with retirement of long-lived asset that results from acquisition, construction, or development or from normal operation of long-lived asset. Excludes environmental remediation liability from improper or other-than-normal operation of long-lived asset, obligation arising in connection with leased property that meets definition of lease payments or variable lease payments and from plan to sell or otherwise dispose of a long-lived asset."
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "niobf_CapitalLossCaryforward": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "CapitalLossCaryforward",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating loss carryforwards",
        "documentation": "The element represents Capital Loss Caryforward."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_AvailableForSaleSecuritiesEquitySecuritiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "AvailableForSaleSecuritiesEquitySecuritiesOther",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "documentation": "The element represents available for sale securities equity securities other.",
        "label": "Available for Sale Securities Equity Securities Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OffsettingAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OffsettingAssetsLineItems",
     "presentation": [
      "http://niocorp.com/role/NumberOfCommonSharesIssuedAndOutstandingImmediatelyFollowingConsummationOfTransactionsWereAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offsetting Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementLineItems",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/Cover",
      "http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails",
      "http://niocorp.com/role/ScheduleOfPropertiesDetails",
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative",
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r204",
      "r227",
      "r228",
      "r229",
      "r244",
      "r245",
      "r246",
      "r248",
      "r255",
      "r258",
      "r274",
      "r293",
      "r355",
      "r380",
      "r381",
      "r382",
      "r397",
      "r398",
      "r420",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r464",
      "r541",
      "r542",
      "r543"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails",
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "negatedPeriodStartLabel": "Valuation allowance, beginning of year",
        "negatedPeriodEndLabel": "Valuation allowance, end of year",
        "label": "Valuation allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r393"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonUnitIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonUnitIssued",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common share purchase warrants",
        "documentation": "Number of common units issued of limited liability company (LLC)."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority [Axis]",
        "documentation": "Information by tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class B [Member]",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsIncurredDevelopmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CostsIncurredDevelopmentCosts",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Startup and organizational costs acquired",
        "label": "Costs Incurred, Development Costs",
        "documentation": "Development costs incurred, including capitalized costs and costs charged to expense, in oil and gas activities."
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune3020232022And2021AreAsFollowsDetails",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss attributable to vested shares",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r144",
      "r150",
      "r223",
      "r225",
      "r231",
      "r532",
      "r537"
     ]
    },
    "us-gaap_ExplorationCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ExplorationCosts",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease cost \u2013 exploration expenditures",
        "documentation": "The capitalized costs incurred during the period (excluded from amortization) in identifying areas that may warrant examination and in examining specific areas that are considered to have prospects of containing oil and gas reserves, including costs of drilling exploratory wells and exploratory-type stratigraphic test wells. Exploration costs may be incurred both before acquiring the related property (sometimes referred to in part as prospecting costs) and after acquiring the property. Principal types of exploration costs, which include depreciation and applicable operating costs of support equipment and facilities and other costs of exploration activities, are: costs of topographical, geographical and geophysical studies, rights of access to properties to conduct those studies, and salaries and other expenses of geologists, geophysical crews, and others conducting those studies. Collectively, these are sometimes referred to as geological and geophysical or \"G&amp;G\" costs. Exploration costs also include costs of carrying and retaining undeveloped properties, such as delay rentals, ad valorem taxes on properties, legal costs for title defense, the maintenance of land and lease records, dry hole contributions and bottom hole contributions, costs of drilling and equipping exploratory wells and costs of drilling exploratory-type stratigraphic test wells."
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubstantialDoubtAboutGoingConcernTextBlock",
     "presentation": [
      "http://niocorp.com/role/GoingConcernIssues"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GOING CONCERN ISSUES",
        "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ExplorationAndProductionEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ExplorationAndProductionEquipmentMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exploration and Production Equipment [Member]",
        "documentation": "Equipment used in the process of surveying, preparing land for the extraction of natural resources and extracting natural resources."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r169",
      "r170",
      "r171"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r180",
      "r194"
     ]
    },
    "us-gaap_ExplorationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ExplorationExpense",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exploration expenditures",
        "label": "Exploration Expense",
        "documentation": "Exploration expenses (including prospecting) related to oil and gas producing entities and would be included in operating expenses of that entity. Costs incurred in identifying areas that may warrant examination and in examining specific areas that are considered to have prospects of containing oil and gas reserves, including costs of drilling exploratory wells and exploratory-type stratigraphic test wells. Exploration costs may be incurred both before acquiring the related property (sometimes referred to in part as prospecting costs) and after acquiring the property. Principal types of exploration costs, which include depreciation and applicable operating costs of support equipment and facilities and other costs of exploration activities, are: (i) Costs of topographical, geographical and geophysical studies, rights of access to properties to conduct those studies, and salaries and other expenses of geologists, geophysical crews, and others conducting those studies. Collectively, these are sometimes referred to as geological and geophysical or \"G&amp;G\" costs. (ii) Costs of carrying and retaining undeveloped properties, such as delay rentals, ad valorem taxes on properties, legal costs for title defense, and the maintenance of land and lease records. (iii) Dry hole contributions and bottom hole contributions. (iv) Costs of drilling and equipping exploratory wells. (v) Costs of drilling exploratory-type stratigraphic test wells."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total comprehensive loss",
        "label": "Total comprehensive loss",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r223",
      "r225",
      "r232",
      "r533",
      "r538"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://niocorp.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value (in dollars per share)",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_BasisOfAccounting": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BasisOfAccounting",
     "presentation": [
      "http://niocorp.com/role/BasisOfPreparation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BASIS OF PREPARATION",
        "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, no par value, unlimited shares authorized; 31,202,131 and 27,667,060 shares outstanding as of June 30, 2023 and 2022, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r583"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "us-gaap_LongTermLineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LongTermLineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal amount outstanding",
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r81",
      "r82"
     ]
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INCOME TAXES",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r389",
      "r390",
      "r395",
      "r399",
      "r402",
      "r404",
      "r405",
      "r406"
     ]
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementTable",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/Cover",
      "http://niocorp.com/role/FollowingTableSummarizesWeightedAverageInformationAndAssumptionsUsedToDetermineOptionCostsDetails",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfCashFlowsForNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details",
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails",
      "http://niocorp.com/role/ScheduleOfPropertiesDetails",
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r245",
      "r246",
      "r274",
      "r509"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r597"
     ]
    },
    "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair value of warrants granted",
        "label": "Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r120"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares, issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_ProfitLoss1",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax benefit",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r257",
      "r258",
      "r281",
      "r387",
      "r400",
      "r403",
      "r539"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r595"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r690"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of options",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r95",
      "r101"
     ]
    },
    "us-gaap_DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross cash proceeds",
        "documentation": "The price per share or unit times the number of shares or units issued in an insurance entity stock offering in connection with its conversion from a mutual form of ownership to a stock entity. Amount is gross, before offering costs."
       }
      }
     },
     "auth_ref": [
      "r199"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r692"
     ]
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross cash proceeds, net of transaction costs incurred by GXII",
        "documentation": "For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfExtinguishmentOfDebtTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table summarizes the components of the initial loss on extinguishment:",
        "documentation": "Tabular disclosure of debt extinguished which may include, amount of gain (loss), the income tax effect and the per share amount of the aggregate gain (loss), net of the related income tax."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets",
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease liability",
        "label": "Noncurrent operating lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r452"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodValueConversionOfUnits",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered direct offering \u2013 May 2023",
        "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r95",
      "r101"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets",
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability",
        "negatedLabel": "Less current portion of operating lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r452"
     ]
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ConvertibleDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets",
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible debt, current portion",
        "verboseLabel": "Convertibled debt, current",
        "periodEndLabel": "Ending balance",
        "terseLabel": "Convertible debt liability",
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ConvertibleDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets",
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible debt",
        "verboseLabel": "Convertible debt, noncurrent",
        "periodStartLabel": "Beginning balance",
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt conversions",
        "documentation": "The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt conversions (in shares)",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r95",
      "r96",
      "r101",
      "r340"
     ]
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of convertible debt, net of costs",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitment shares issued (in shares)",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Equity Facility Financing Agreement \u2013 shares issued",
        "documentation": "The amount of financial liabilities assumed (as defined) which have been recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r134"
     ]
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RepaymentsOfRelatedPartyDebt",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Related party debt repayments",
        "label": "Repayments of Related Party Debt",
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net liabilities assumed",
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r134"
     ]
    },
    "us-gaap_ConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ConvertibleDebt",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangesInConvertibleDebenturesAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, June 30, 2023",
        "periodEndLabel": "Balance, June 30, 2023",
        "label": "Convertible Debt",
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r177",
      "r190"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails",
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of options (in shares)",
        "negatedLabel": "Exercised",
        "verboseLabel": "Exercised",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r11",
      "r95",
      "r101",
      "r369"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued and sold",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r11",
      "r95",
      "r101"
     ]
    },
    "srt_ExtractiveIndustriesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "ExtractiveIndustriesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Extractive Industries [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r109",
      "r110"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Present value of lease payments",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r452"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r132",
      "r407"
     ]
    },
    "us-gaap_LimitedPartnersCapitalAccountDescriptionOfUnits": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LimitedPartnersCapitalAccountDescriptionOfUnits",
     "presentation": [
      "http://niocorp.com/role/LandAndBuildingsNetDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of ownership of mineral rights",
        "documentation": "Description of the various rights, preferences, and privileges of the limited partners' ownership units including: redemption, conversion, liquidation, tax status of distribution per unit and the sharing in distributions."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amounts paid for interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r236",
      "r237"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitment shares issued",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodSharesReverseStockSplits",
     "presentation": [
      "http://niocorp.com/role/GxiiTransactionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post reverse stock split shares",
        "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction costs expensed",
        "documentation": "For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of any issuance related costs which have not been expensed."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets",
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedBalanceSheetAsOfMarch312023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total shareholders\u2019 (deficit) equity",
        "label": "Total shareholders\u2019 deficit",
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14",
      "r71",
      "r583",
      "r621",
      "r648",
      "r698"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Shares issue for acquistion",
        "label": "Earnout shares",
        "terseLabel": "Warrants traded prior to the closing",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r304",
      "r305",
      "r559"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash payment",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r459"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ConvertibleDebtTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in the Convertible Debentures are as follows:",
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share issuance cost",
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r700"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered direct offering May 2023 (in shares)",
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r11",
      "r95",
      "r96",
      "r101"
     ]
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LineOfCreditFacilityCommitmentFeeAmount",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitment fee",
        "label": "Line of Credit Facility, Commitment Fee Amount",
        "documentation": "Amount of the fee for available but unused credit capacity under the credit facility."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of excluded from the dilutive securities",
        "documentation": "Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r70",
      "r638"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExpensesAsOtherOperatingCostsDetails",
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share issuance costs",
        "verboseLabel": "Fair value of Commitment Shares issued",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r11",
      "r95",
      "r101"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://niocorp.com/role/DescriptionOfBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DESCRIPTION OF BUSINESS",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r279"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/RevisionImpactsToCondensedConsolidatedStatementOfOperationsAndComprehensiveLossForThreeNineMonthsEndedMarch312023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss before income taxes",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r173",
      "r181",
      "r197",
      "r282",
      "r283",
      "r285",
      "r287",
      "r534",
      "r564"
     ]
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingLeaseImpairmentLoss",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash lease activity",
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r699"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesElementsOfGxiiTransactionAllocatedToConsolidatedStatementsOfOperationsAndComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash costs associated with the Transactions:",
        "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance, value",
        "periodEndLabel": "Ending balance, value",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r141",
      "r148",
      "r204",
      "r205",
      "r228",
      "r244",
      "r245",
      "r246",
      "r248",
      "r255",
      "r293",
      "r355",
      "r380",
      "r381",
      "r382",
      "r397",
      "r398",
      "r420",
      "r439",
      "r440",
      "r444",
      "r464",
      "r542",
      "r543",
      "r621",
      "r648",
      "r698"
     ]
    },
    "us-gaap_ProceedsFromInterestReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromInterestReceived",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds",
        "documentation": "Interest received on loans and other debt instruments during the current period."
       }
      }
     },
     "auth_ref": [
      "r617"
     ]
    },
    "us-gaap_AdjustmentOfWarrantsGrantedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AdjustmentOfWarrantsGrantedForServices",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesComponentsOfInitialLossOnExtinguishmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial fair value of Contingent Consent Warrants",
        "documentation": "Adjustment for noncash service expenses paid for by granting of warrants."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The change in the Private Warrants liability is presented below:",
        "documentation": "The elements represents schedule of changes in the fair value of the private warrants table text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleOfWarrantValuationTableTextblock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ScheduleOfWarrantValuationTableTextblock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The change in the fair value of the Contingent Consent Warrants is presented below:",
        "documentation": "The element represents schedule of warrant valuation table text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireMineralRights": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PaymentsToAcquireMineralRights",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative",
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of mineral rights",
        "label": "Other amount",
        "documentation": "The cash outflow from the acquisition of a mineral right which is the right to extract a mineral from the earth or to receive payment, in the form of royalty, for the extraction of minerals."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ScheduleOfOutstandingExercisableWarrantsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "At June 30, 2023, the Company has outstanding exercisable warrants, as follows:",
        "documentation": "The element represents schedule of outstanding exercisable warrants table text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June 30, 2023:",
        "documentation": "The element represents schedule ofsummary of the changes in the fair value of the earnout share liability table text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal percentage",
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer."
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "presentation": [
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other lease description",
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability."
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table discloses the primary inputs into the Monte Carlo models.",
        "documentation": "The element represents"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The maturity of lease liabilities is as follows at June 30, 2023:",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r703"
     ]
    },
    "niobf_AccountsPayableToConvertibleDebtConversion": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "AccountsPayableToConvertibleDebtConversion",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable to note conversion",
        "documentation": "The element represents accounts payable to convertible debt conversion."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ConversionsOfDebtForCommonShares": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ConversionsOfDebtForCommonShares",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of debt for common shares",
        "documentation": "The element represents conversions of debt for common shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Granted",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "niobf_RecognitionOfOperatingLeaseLiabilities": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "RecognitionOfOperatingLeaseLiabilities",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recognition of operating lease liabilities",
        "documentation": "The element represents recognition of operating lease liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DerecognitionOfOperatingLeaseLiabilities": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "DerecognitionOfOperatingLeaseLiabilities",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derecognition of operating lease liabilities",
        "documentation": "The element represents derecognition of operating lease liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ValueOfWarrantsIssued": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ValueOfWarrantsIssued",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of warrants issued",
        "documentation": "The element represents value of warrants issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Transaction costs",
        "label": "Business Acquisition, Transaction Costs",
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_StockIssuedDuringPeriodSharesStockWarrantExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "StockIssuedDuringPeriodSharesStockWarrantExercised",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of warrants",
        "documentation": "The element represents stock issued during period shares stock warrant exercised."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_StockIssuedDuringPeriodSharesStockWarrantExercisedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "StockIssuedDuringPeriodSharesStockWarrantExercisedShares",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of warrants (in shares)",
        "documentation": "The element represents stock issued during period shares stock warrant exercised shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short term lease cost",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r456",
      "r582"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for:"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_PrivatePlacementValueMay2021": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "PrivatePlacementValueMay2021",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private placement \u2013 May 2021",
        "documentation": "The element represents private placement value may 2021."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r604"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_PrivatePlacementSharesMay2021": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "PrivatePlacementSharesMay2021",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private placement \u2013 June 2022",
        "documentation": "The element represents private placement shares may 2021."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table is a reconciliation of income taxes at statutory rates:",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r84"
     ]
    },
    "us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mortgage-Backed Securities Available-for-Sale, Fair Value Disclosure",
        "documentation": "Fair value of securitized, pay-through debt securities collateralized by real estate mortgage loans classified as available-for-sale."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_SharesIssuedUnderTheYorkvilleEquityFacility": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "SharesIssuedUnderTheYorkvilleEquityFacility",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued under the Yorkville equity facility",
        "documentation": "The element represents shares issued under the yorkville equity facility."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "niobf_PrivatePlacementSharesMay2022Sahres": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "PrivatePlacementSharesMay2022Sahres",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private placement June 2022 (in shares)",
        "documentation": "The element represents private placement shares may 2022 sahres."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_CommonSharesIssuedInTheGXIITransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "CommonSharesIssuedInTheGXIITransaction",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares issued in the GXII Transaction",
        "documentation": "The element represents common shares issued in the gxii transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "niobf_CommonSharesIssuedInTheGXIITransactionSahres": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "CommonSharesIssuedInTheGXIITransactionSahres",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares issued in the GXII Transaction (in shares)",
        "documentation": "The element represents common shares issued in the gxii transaction sahres,"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "SharesIssuedUnderTheYorkvilleEquityFacilityShares",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued under the Yorkville equity facility (in shares)",
        "documentation": "The element represents shares issued under the yorkville equity facility shares."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_RedeemableNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "RedeemableNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Redeemable noncontrolling interest",
        "documentation": "The element represents redeemable noncontrolling interest.",
        "label": "Redeemable Noncontrolling Interest [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSummarizesInformationAboutStockOptionsOutstandingAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date",
        "documentation": "Date the equity-based award expires, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r663"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "niobf_DisclosureClassBCommonStockOfEcrcAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "DisclosureClassBCommonStockOfEcrcAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Common Stock Of Ecrc"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ScheduleOfClassBCommonStockOfECRCTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CLASS B COMMON STOCK OF ECRC",
        "documentation": "The element represents schedule of class b common stock of ecrc table text block."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "us-gaap_OtherCommitment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherCommitment",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitment fee",
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total",
        "documentation": "The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "niobf_DisclosureExplorationExpendituresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "DisclosureExplorationExpendituresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Exploration Expenditures"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "niobf_ExplorationExpendituresDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ExplorationExpendituresDisclosuresTextBlock",
     "presentation": [
      "http://niocorp.com/role/ExplorationExpenditures"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EXPLORATION EXPENDITURES",
        "documentation": "The element represents exploration expenditures disclosures text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/GxiiTransaction"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GXII TRANSACTION",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r408"
     ]
    },
    "niobf_DisclosureLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "DisclosureLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "verboseLabel": "Company Incurred Lease Costs As Follows",
        "terseLabel": "Maturity Of Lease Liabilities Is As Follows At June 30 2023"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://niocorp.com/role/CompanyClassifiesPrivateWarrantsAsLevel2InstrumentsUnderFairValueHierarchyAndEstimatedFairValueUsingBlackScholesModelWithFollowingAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk free rate",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable and accrued liabilities",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "niobf_DevelopmentStageIssuerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "DevelopmentStageIssuerPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Development Stage Issuer",
        "documentation": "The element represents development stage issuer policy text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302023Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "niobf_MineralPropertiesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "MineralPropertiesPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mineral Properties",
        "documentation": "The element represents mineral properties policy text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_WarrantsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "WarrantsPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants",
        "documentation": "The element represents warrants policy text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "niobf_EarnoutSharesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "EarnoutSharesPolicy",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout Shares",
        "documentation": "The element represents earnout shares policy."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringMonteCarloTechniquesTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of valuation date and the probability calculated.",
        "documentation": "The element represents fair value assets and liabilities measured on recurring and nonrecurring monte carlo techniques table text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ScheduleOfChangesInLindIiiConvertibleSecurityOneTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in the Lind III Convertible Security are as follows:",
        "documentation": "The element represents schedule of changes in lind iii convertible security one text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ReverseStockSplitPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ReverseStockSplitPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Stock Split [Policy Text Block]",
        "documentation": "The element represents reverse stock split policy text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShortTermDebtLineItems",
     "presentation": [
      "http://niocorp.com/role/ChangesInLindIiiConvertibleSecurityAreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfConvertibleDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_RedeemableNoncontrollingInterestPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "RedeemableNoncontrollingInterestPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Noncontrolling Interest",
        "documentation": "The element represents redeemable noncontrolling interest policy text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20230630",
     "localname": "ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of convertible debt",
        "documentation": "The element represents schedule of changes in lind iii convertible security text block."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "3A",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "40",
   "URI": "https://asc.fasb.org/subtopic&trid=51888271"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a-c)",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10A",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "11",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.3)",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.6)",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "28",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "52",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "310",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "11",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "05",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=7516071&loc=d3e13374-112631"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "60",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=6402221&loc=d3e15743-112638"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "25",
   "Paragraph": "13",
   "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(12)(c)",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(16)(c)",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "14",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "15",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 4.F)",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "50",
   "Section": "S99",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "30",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=128088960&loc=d3e3913-113898"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(iii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "30",
   "Section": "35",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=126965701&loc=d3e15009-113911"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "30",
   "Paragraph": "7",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "30",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "19",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "20",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "21",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4M",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "60",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "URI": "https://asc.fasb.org/topic&trid=2155941"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "230",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "855",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "13",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61901-109447"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "14",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61926-109447"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62014-109447"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61831-109447"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "360",
   "Section": "25",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=96866604&loc=d3e64763-109465"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "360",
   "Section": "25",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=96866604&loc=d3e64867-109465"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "URI": "https://asc.fasb.org/topic&trid=2145477"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "940",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "e",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(16))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r195": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r196": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r197": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(8))",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r198": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04.4)",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r199": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "805",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124505872&loc=d3e30785-158569"
  },
  "r200": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 5.D.Q1)",
   "URI": "https://asc.fasb.org/extlink&oid=126898976&loc=d3e600348-122990"
  },
  "r201": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "220",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
  },
  "r202": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r203": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "970",
   "SubTopic": "340",
   "Section": "25",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=126944050&loc=d3e29293-110302"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "105",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "105",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "7",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "11",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(23))",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "11",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "22",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "26",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1828-109256"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "42",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2029-109256"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "15",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "272",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "272",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "272",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "40",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "323",
   "SubTopic": "10",
   "Section": "35",
   "Paragraph": "18",
   "URI": "https://asc.fasb.org/extlink&oid=126903467&loc=d3e32472-111569"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "323",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "326",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "326",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "326",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "326",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "11",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "326",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "13",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "326",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "14",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "326",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "16",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "326",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "326",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "326",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "7",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "326",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "9",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "340",
   "SubTopic": "10",
   "Section": "05",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "340",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "410",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "410",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "410",
   "SubTopic": "20",
   "URI": "https://asc.fasb.org/subtopic&trid=2175671"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "80",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "28",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "14",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "19",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "270",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "19",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "17",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "9",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "20",
   "Section": "35",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "20",
   "Section": "35",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "230",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "12",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "17",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "848",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "848",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "855",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "855",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6469459&loc=d3e122492-111745"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=6469459&loc=d3e122501-111745"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=6469459&loc=d3e122501-111745"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "905",
   "SubTopic": "360",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6471048&loc=d3e5272-110052"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "910",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "924",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "930",
   "SubTopic": "715",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6473690&loc=d3e23744-110275"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "930",
   "URI": "https://asc.fasb.org/topic&trid=2155974"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62136-109447"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61797-109447"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61831-109447"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61858-109447"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "7",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61869-109447"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "9",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61884-109447"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(25))",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "235",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "360",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(21))",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "958",
   "SubTopic": "360",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "958",
   "SubTopic": "360",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "958",
   "SubTopic": "360",
   "Section": "50",
   "Paragraph": "7",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "976",
   "SubTopic": "310",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "978",
   "SubTopic": "310",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "Item 18",
   "Subsection": "Instruction 2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "22",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "35",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2366-109256"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "36",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2398-109256"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "326",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "35",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "69B",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "69C",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "69E",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "69F",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "80",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "80",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "80",
   "Section": "55",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "53",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "852",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "10",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "55",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=34713648&loc=d3e62984-109448"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "55",
   "Paragraph": "29F",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "272",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "10",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r609": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r610": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r611": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r612": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r613": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r614": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r615": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r616": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(4))",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r617": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3337-108585"
  },
  "r618": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r619": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r620": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r621": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r622": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r623": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r624": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r625": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r626": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r627": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r628": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r629": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r630": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r631": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r632": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r633": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r634": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r635": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r636": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r637": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r638": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r639": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r640": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r641": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r642": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "310",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r643": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r644": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r645": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "321",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r646": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "321",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r647": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "321",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r648": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "323",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r649": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "326",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r650": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "326",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r651": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "326",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "13",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r652": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "410",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848"
  },
  "r653": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "410",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r654": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r656": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r657": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r658": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r659": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r660": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r661": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r662": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r663": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r664": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r665": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r666": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r667": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r668": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r669": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r670": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r671": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r672": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r673": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r674": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r675": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r676": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r677": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r678": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r679": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r680": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r681": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r682": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r683": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r684": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r685": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r686": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r687": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r688": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r689": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "740",
   "Section": "35",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944"
  },
  "r690": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r691": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r692": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r693": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "808",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r694": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r695": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r696": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r697": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r698": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r699": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957"
  },
  "r700": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r701": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r702": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r703": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r704": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "848",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r705": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "848",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r706": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r707": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "852",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r708": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "852",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r709": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r710": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r711": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r712": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r713": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r714": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r715": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "4H",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r716": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)"
  },
  "r717": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)"
  },
  "r718": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)"
  },
  "r719": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)"
  },
  "r720": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)"
  },
  "r721": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)"
  },
  "r722": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)"
  },
  "r723": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Paragraph": "(a)",
   "Subsection": "04"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>147
<FILENAME>0001539497-23-001700-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001539497-23-001700-xbrl.zip
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M@?IK?42$(. _@ !$8&(0 <DU"0*#_KL"@ BO2P00FNL%(8B("$)"20[^-T]
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MI_W_$4_5?^(98,%+$SVI.%1A'"#G;/B\^I@G)'?V(Z;#1))]?9']XOGY>IG
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MYD\'77DR;7<$+)BKEBO@W5/QC[Z3:;A6C8YHZ^;2*#SBC)Y1_;%>8'<_'N=
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M7%1MR=I%V%3J%G>E(5QU.TQ,EYF(G\9(H([#QIXV'-DKL ?EZ:'6_,RF2?"
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M-2M0?1XH!N3SHX9+L4Y/Z*S!J8QDA,S<WBDDO?XI16>Y5Q0@FD]^?'!*PL$
M@LYH_]!)\E(-%ZSW.V?MIHFP*V$&LW(SVF=86=Z?JLO\8 ,DJ55%[F2OA,X>
M3 ;]X=WJ*%/[G8:_>R,8?'_ T;VY<N_FBEL-EE09X$UV=N-56E7 /W.U,(55
M'%858:7ME%\W>L5X, WF<ATK7;T*,;P#[!?<M%"4(\1*I/=-V\^B4'DSL[%V
M.C\NFE)_2]$N=_YX -YR*WEY4V_[F?/YA)!(HLHTVEWVQF7""FDY=^5)J#7X
MO%/JC.5K\5C@SPR,WQF5F<IHYO%;PS^CA$1X,ZS7?L\E5RKYGUZ9$ THV=T!
MI-=OG9[^F2:,:4JLZX_]?G!D95]L"39&]@&=1*!L=*_EUUZ2D*_+=S:@ZMVL
M8/08TI0SXQP2-JT=$^;?<=/'Y\HBV\4J1[M4*2_;;U_T!DWM_%DF)/O\(U1M
M<%FV\)U0KVQPE@G#TM18S=IYYJZ7#*'*YA(JE;T\U1\+%$JOMZ"03Y)K@54?
MFKU:81/B%">;P1>$7?D">6MV:/,7[P#34-7(%IE$HL!'BX&MW)1609N//Y*@
M;24+,'H.UK)C?$U'!85"0&7N5SQA?Q*8/4+/PN-E6Y&BW(Y,=P G7<P[U48/
MPQ0\ELV274K9A93GT8+FL#"(9BM)!RFQY*EE:?_/<2_]JH6P4)OKF ">[3TN
M;-]C[TNDHB/]%I+=6$^SC#6WOUW@&S;#!HA.6<$+G:VXA#HR;WL%)M%M#[T@
M;VN[/W<^NR$?\2DR#A?6U>63>$O640I.I"NQM).0N'\/523I0MH@;^R2Q-LI
M]C'0@R\[0),@/:QV*GY&BZ16,D#/$Q638@EY"T/1XXA #/'V6<CH1%J%C ZY
MZ"XU"3O!_U09"2KMB(WK-O??X:9X"QA,V0_V:9D&*^&F:.MG!AZX6!Z5^RXP
MU78^?M9:,G?7JQ]^?WH])=P#OK&+Z+K)%RS4R>)1L0IWSETKN#HRK9W/.=9(
MZDZ<VVH4[!MFMZ\3U%%83PZE@N\?M=<"G75$ O2$AP@?# D]";T5Q,.JA;-C
M!:2BS@VU\"5+WVL+"2GRUBE]".$)Z]$O 2Y#1@:[[4[GA0;4DR0D^(4\?QD4
MY1BR4@=^G]S?/;.L[_A8/.@*["Y?3+J-Y;P#T"V;S26=/CC[E7*K]^-E7NT.
MRFU;7B2\B=^-ZT]M95/C=7HB+/T.P//UK,I5;IZBE])[TWXUY#1]S9=5)[&N
M\4,O(VP1EC"Y^I3W5<RLJ^[6T:3\88SBX*'<9$%I1JVG6==A23W+KOGE!WPI
M>F)E=7,)F_ EN>*W+_GBG?-2"71L?I*W360C7^*(Z \A B^A&@FYBU]M;5)Y
MU.P,G?6FQQ(Z=Y$.-@ZC,C4?"ZF@D]RF?Y:R+3)YE3ALMS;?-S3-;?.T/<JP
M4E["*D4X;;PDDJ/$:/<C'JZ?ZI5O8]L.4D!I7(.(WO*68CD2]1E#=FY^O\D%
M1QJ^P5';MZSO@?SS9?AM"_"W=9CL&^,2RN[->H*W^ =T_D35R;G6F=0'A2!2
MQ,0<V* 5*-1^D<?E.^Y5^O/G5X^W?+7,6;$Q[+)G9\MJ7;;):S6F0]1NGX1Q
M7F&)+!=:+5]L;70N)50$^*$7FF&;LHW4.E RH),U_KRV=(V_F3E%C>7#K #C
M9-N@\@!?>=OAYRP3$]9.9"(0DPI^VUX-?Q-9%B)JB>1G6AK^KCP*0@!^BD(^
M#\8CS*A'EE7#5J[5#*I08!BJG^:R#-@3C'*BIQ;\YU"K@SH5IE;90"M#SU]L
M)M$4J2VN:.&D? VV"E1A,M[CF&/PA6.^FV>H-VDG1IF<>#YPV0')T[?KAY?J
MW$P$(L!]+_^-YDGXJWD<]S]M#V[4[,;V;"_8&"4;T>@XAFW$>@,-00Z-K*Y8
MS@B$GV8,;S2FVHW@2$J$Z5YWO,?>@%W7<V8#,7#MZ,(AH_<[)K)S!=EQ*ZLH
MADT@94T4]<X:;6$DP<MOE^.B"N).C#/S79]!36[K0?-E0GGG:QBK*]U+A?2O
ML<[RFI71^Y8D7,'[J D4*G6%BI2$F2*T_KGDXFO!1@8$@/D5^WI;B +JNSPC
M4>E+"N!>W@!Y^G2T35<ANG0'![E.7-WZ@=_O1HK4N*[QT:R'0ATVX!+(17"X
M%/X!" '_%4/V9;!LZ0/(T3MX6'WKRWPFJK:&6T/>B,%^BH?"^'7M[#:BPO -
MM,(7563D^Q5(D!C4EUYX_8(9RK\,X2&WJ1 BS:*G+3N]VLPFP^M9"!TR)*5R
M)"6U=N-9^R'C_APW[&MR@@AE446OH,[;C+^[YUXL8G_\"=%_7+@FOD2[J=X]
MG,:Q= F'94^)Y:K7K(?9D3[E9^LB'0(;L6<TLE"QH888(X!.D"5I-1U JLL)
M/=GJ&''-Q,C D9;#]-D\&F*R@ [$K4,9E;5",0O=<D89R=^3\LVGI4)Z/+)!
M8K@^)65M+*2SQH*/$E=6$O?KA*W=2%G@Y=1D;EYII8\Z_2VES_+H&:_F$KBY
MQ;G%^*@Q]#A,AM2O>G$KYNM.LM]3;XN+?I&6'[!TT9G8,!",97.RBV5,G=/D
M\1!*>O8ROX8Q1I8\O+6#.#GH.UV:#W'F@A:[T>8<07;P_GXGLJ%ENN:!6#VE
M1IJ-YQC^(C/:,%O>)Q"V@ YPPUN"OH>ICX[R9<DZ'K3AYKU=0$\$MRRJ"O-9
M'H.KS4K!-H8.N/&7WSN_X5J-C+CA^W"[D5"5<)=QA3QZ?[4BAAO&R%FR2">U
MTN;VDCR_ORMCD?0DFS5?0^1:B-LMO=JBI.EWGHH2*\NMO%I>0NI51C+I@J4P
M>*8P$>CYI[T@K'#;YZ*NV-"L>D]-S$2=FJK^<*TR+'5J>;_!%Y;>?G6V:14>
M9X.$O^EVT'&2GQ(-L3)D5Q8;VG>ZGR+WH#_8Y3+L=,_6FI/++4W0Q,"XE+RX
MD[$C2+?BKVX5UA#^WBA?FK%\7R.W+-S9VZ0I?>;GP"/^.I3XB"N[DVF>M%0F
MNP33A'CGU13'.#T!$:_AL:7_K3CKJ<_CD,L2(=IC<N_RQ)4L1N&0 !TR-6T^
M\73,)XOZA(QB'8QN7-[([T ZULN/7"*&+W788(&RA2</!_2C\WI$Z^;<)1OY
M["67BECQI=6=XQF+VU3W(>I:M9]"R\M;$7:"FQ;1WT<WEGP*%DQ,K,B5!BSS
M\(6P./"8&A,UL&*@$+=-X><7[,E?%,\=PT%;(\B^7(WT;D3=HGPV$D?^AV<3
M+OK#+>U;8CGMN:4W,X/;-"1+0=/U0LI#N?P]*FQ 0*G^GD$%4.>'@I"@W67?
MO9[$-0=-ASJALK>'1S"5-'#.Z+O&(BX>*PEN$AF(%6P*YVSN0TM%46VFCZ6>
MI]?!K.[JNR:!>)X-U2@VJ3RUKC\U*24I1;?P7WF-O])G[^6)O_YXFU#?SR%\
MZU[TL\TU/LA,H _Y&QW*'H&1ZUS8-VHZT#[\&*PRG=USLOFC_]<#Q\UJ6U_3
MO84O/[NS*,SW1!"E3F$0*_TQ=/-QM#6&M%SU8\+AC;+%\/:-<C_*LWFS8>79
MQB:Q7'.1#<+:C<T8_G"QNVSE1MQ:)DW$1:<W!QE)@.V7/>/M8)[:0Y)IWVS,
ME27*A\I@DAKM>VPYK"WW=?5X@K!-^P< R&-;G3,/C$5C(^'7GTK;_#H.W'N>
M>1!^P70V]8D<&'W(M[_]M0=T#7R0$]%OWSEJ^TQP4QLT &^.T[ ]17(+6=H\
M#>P\-<U>">/Y]>$<E/]35B8S8K]9?]2XQ)C4<W8\K8'),Q#GH",85]0JS4==
MZCM(*R7)47J( _9X0\^^Q02+_2;5.'+*J]UL1MDI)/]I=<]TL)MWI7HO_=0@
M4ONM7@:IH6/KVY".$I%\IRA2/J'=!!JT5N(JON2$&G5V]@G$E8!P_Z^:_GC$
M) DZ A6V>8&T,R7=/+.">R47.C"#G[!8RI3NGP*%22\36F38F#:JQ=2I(>O?
M?<F?+=6.&"=2: SH^0!K%H-T'83U8Q1%G2DS(EP;0]^@W#Y*@XTHF2*'<*21
M&FE)W%)L7N\[FD!?KY>.J[;P#3]H;0=V7.RN,M S'9XV" Z/#(X$5$KK,2+7
M'Y1DFK%/2];+.O#I/O^.D)?R@)FD]M<F$(0CY2>;RHWCT:7838DA5\PROX"Z
MO?E5+!G[/Z^LL]RG6=R;#_#>^?F.3TSRJZBDMH_.TPC^UN!?: S=_CC/_&*Q
M?Z^U"$5K-2X=:A'4,QBCWV;M4^@R?NZH;M-('[JDS<<*]:9V!UNNYGQ,F1-K
MLZL3T!13EJ4'[,ITL$+)MR0SB]E>"$1M]TS[_Q3(AHR%I:SY4  PX [J.'B8
M]Y/)L.03&TE4!IH$P@9YRT>YZ(7KKCJB.%^/IK@!@8U6U'26LT70==CJ%)05
MOM6[/_):+T[&E5\@;=@V"7<D:[FO>*IHZW+=JTS8$<J/N?+A43XE?.\%<;RL
MPJ+&2Q.XQ5K9A!BP9'S\FDH8VE1GBC%MIZ*IC3AB!" -I $ '/*]Q;<(*M0K
M)YE;>OE[VP@Q\T64=L$*7)-MG/=5F*CI+8DG9O,YJ*[(N:";F*UO7IL*:'H'
MB(6$<.X7W580>DAO\]"M>$SBP*Y7C N;3CL02Q;"F"QA5MKWS>P71,S>]!5$
M;2S$KP4W>=6,[SO0_N@'#3YKP]5LD]9QTIH5;L>UFGTGQGI]<,3//&?(L^8J
M'1*F>EDIM3^6S<%M\]2Y7-6B6D#]@M>M589G\^&N\:@7.\FV=)H0X8S5I\(]
MZ(\@=.:ZVK($I9[>XZY,%@K%*"LA')N^R6#]RY/IK1)^[2U@6@,VT#[%[99G
MBD$H6\;9+3@C*32KOSHE]HT:S:@V+-G8^YI144>Y1.JHLW#35\RK2-+\R\'S
MG1<V^YM;]VGS=O9B$/""BB^L+I#6IO!5>/#8$Z(7/H).;B.> NLO\E514;RM
MQX;2WYA@C L';F^WG>XW&U_IY:A K[;IW.SR-)9\%X.VO&I8($\<Q+GE>?IG
MU))-L"!=F/\-7*T\(#'A8N<A?ZF%(IL3+76NB%=Z^G#NU5-1@>W?[E:1R%>5
MRX()2J6.75&TL_0]P3OODLJ:SI9A_53UJFMYB=[M458^K'8<)FO\.L;$<,T;
M5"0N.LD<:I2W]VDD=/)W>9.YX_]#VGN&-16M6Z.A0Y#>>R^A*8B %(4@0J@A
M("4@2J^A5Q&%T*L! B@U"*%(D1)"[[T::5)%Z5V* H+B=9^]S[G?.7=_]WON
M<__-'W/.9SUSO6O,,<=\W[$(OG(%UHH;M^8T<]_?I]FAJ G6#K!.Z9@5XUYT
MHTR8#(FG]!W2F4Y=JN;6TA@YY;H?=N#1=K"%6]7(N@=C'C '+NA!4GFP-BJ5
M"\-TA:K,TH[FQG?U^1 3C?O<,:*2\U)]UF80^ZR;7++3=5<W^7?@K-$6B0QZ
MVKSD9I8JO3<J3>J/3SERHT2W96=YV52)5*NTC=#3^^DM' <T78=!]/'5M4-!
ML!P?X@TR'04)#7[&]&5CP^U_Z'.M_[<^I\[@H_&A?LX8N6S@+%3>MW8R.%XG
ME2%>-]7'HG!A1)^VVKY_1IV=)K(NZV&X+JT7\(;!K%0(DK*:'0"$Z[(XBC5#
M%/BG@6LC+[FG+.Y6O.#V+N9^ 9:<4,A0RI!^;EZNJS<BJ?PCC>T7,_!64F=V
M?R<KL84*HCEB+DG?"=RV5P?.#[6*VZ3@"W$XJIU4B29-PM^_G[QX-_A8G[50
M=:QTV3%SV97*)!GP-@8Y7?"K@UN=-%U]A#'([NF@>"!U)#J1'W^BY,H75O6B
MGR)]TW,;58#&J1-ZW7S,3/KFJ<3JACN=,Y'-%+<[8>OQ?P "\\WQB,D:N 41
M343W/>_(OF<X:JNL-Q]^T)+'KJ4G1&^YJ&*C1& P)1!W3X"KQ?ZCT-7VELZ@
M=TKN\'/!1N[G*B?"*BR;'.(^LV\<^YJ*"_O2Z,UV#"Z"/D5O&'Z/%3>YYBOP
M^O'U#V#)E(4[)4BY?6 _K#4I@TD0YSZ*N^3P(2/CESMY62Q0U\$9+%G?6(=T
M,&@5H=&F>XJ%:"K X*FI0(_JRP3TD+G,9=,9@T9KH%.=/?WW$ LSZ!LJJ84'
MF3/^E:YF44(#]>O$D88<[;UI@X.&-C=B?0YVI#5A]G76NDIB^6DUB"Z)68.K
M?I*QXH<G%C/V)4]9]\&J-"#C[\41#NCY[N*4/:CS1^FBE,4KGZ[PHDRK=^ZB
MV!QT>09]E+#U/.>C\OM[-C^F:5_]4^7]5PI4ZS]2H!0^+]I+HY8H1P;M>?>#
MH68+^C7X? G_IJRT>/WY3;6=YS1H-;WC,NFY(+OFR(2F0MR [,=A/8E-!?0V
M0(0:X*:S3QZ9[/_O!.N>R#*O%[G=RXP"HW+YD7(2!.HQ:9?-6UF,J]EF&6*-
M1F2!">16Y43T/L/$W7?% 6'QXIB7_Y*BC9\M>\WG6_T.+N!V0HXV*9S=5TLT
MI2JTK2MN6JP2Q^]Y*@0(#,SF@V!&P1C-AI,W23:F!V&#TG(;Y63[]]2%,2,I
MB638[OD)E]1WRYB540V[B2XO@<077"F^T!.P7BYM/O]*,NDZ/RG1HJW;#6%P
MH@"GL%PLBJ;'6@?:F3D089I<&@NE3OGT1C7#7?.X_<!502BZM>F8F7OJ=L8N
MJWE0>2Z)=YV'1SG1?(H>[&W3WD0_G+GWF69XOLDG"7YJ@G2/Q]+ 7J_NTD6(
M%.7/K%]K'%0;92%%C)E\N8E8(-%&ATY[%59HQ$6A_6/[^FG2J>^#ZH_98;,K
M)D%.J@YUM.V2-KCF,?C#')\#<J1'=:IGO,VS]?BDCN;PV(6 +7068UNVL+3$
MU_-:#CW7KP<)K66R7L4YA51.^DO9C.L.^-7,T>H+,X=V"=AD&L"LR@6L<45P
MD7[,OS O1;X,'=(U+2T!T8DXSB@#0UR);(2%($]<N</\-%Y@Q(&4/TDC@=JK
MGZYW,.^_7\H'G=%2T2ED,6WJ7YBA"@\H?##>@==<K[GI7^MV-\&@Z)RSWP=E
MM_/B!_79,CA*T61IV&)&-?L%<;;]LIU7C4*W"MP^!I#,TE9"5<5)+1* +S2+
MP^X-;9IGYD3&?6^(VC7VH"Y[TH?)(6/:G3E,IZ9E\_IZ"]6G^H"57XNT[#8/
M#I^3/^40,8"Q58>ZH;,R>+I&D#8@*$([#MA(_&*<0FY\&/W)X-> L<RF'(<0
M"_HAQ%Q..S^C0KT1P!@ML14=36&8LHF_HN1'YX$'>Q#7"326E(E9#'/;(3[3
M7VI"ZAU+9Y@91!%MI'UB'XX_.HE3LW2,>C(^;X09(2C8C'17WF2GY\Q9/CAH
M0XJ-(F9#1'QR$4!.TYA*QLFIZN7,.PV*^@_%TG/,-^R]J&>K*G=%M<=E6VN'
M.$OLL5@&X;/'CK%I\MYJ$8\*R*P5;/X >CRKFCY["J)[@)FCQ_D@6MSIPU%7
M=5YAWM' Z=<6T./TA8+IJD50L5+,LCLW+ MJ]3@2R VK%D1)S6BH0UW?,,3[
MY*5<,J[=%"[L$R<&ZM22<M+:V7DAZCZZGDP8\8Y6:D<5L(<9-'7 [RC!,G\0
M(<RO D1)%$_90?2Y7OQKTB):'D.)( ,D*Q*&$V?R) TR93ACZ)B+P15L[P%-
M'P3ANRTW%(H^0Q.)7<0\"XYFS;]K_SVXOT,ZW3^E7$G0OGJ+5%B[[AI^D7#^
MJUX##8B,3F#V2.<ATIXFW'QL=EO)(FGTM?^ S)<9]/B:,:\)(Y^4B)QIR;*)
M1Z*0[F2&L+=0:TO[YZ756O/2EY1QC^4F%:V3'&(,0<F2'EA;N>IJH124E<Y]
MAX2?WR3T0J?(*WT=10SG<#PT)X\[&V8\J1JNQXGW V7?*)DK,I\OFS8GA4PE
MV&YQ@JTFS19=)S%243E/]@D>+STK/@8H3;\I$*?,GJP7V<O2#%J]8Y50)G\?
MY_-32;;NHC%/?XL+L3F[=UA%6V30:VB=CMD]Q'QX2.3#G?T&=NMP0"1>"K]+
M@&W7$JR4D5<)'JJFM-[!!O.9,2-UOK1WPM.*E89TT$=B7:7TN'+IX&!TXO')
MHZYFVR."C^SSST+/P'$FU4SEGE+"8O#IX/('1 -E>?]/O+54CIAZ'GCDIIR;
M]IWC8]R&7DJ#\,E(A(D;%:A);?G+F2EK25$C+[]CZS:"D\D74L.Z:L2DT:?\
M_^FFO/3'XQLJ];PI1T#$S^"S!+H5]_RNJ3,7Z6U6@S+F0^G:E(FZ$4<6W"]M
MDJ.26U5TM[:_5C58G'OS)S)T)="&MM;G;)&E#&LM>4^A%K?0KW-BV*E\ $WI
MO^64'DTRS5E[N'ZK.:0M?)5'Z_"PN"^DF6%)Q\1+'H,3#P&GZ<@S>JESTKJW
MX.5!5H<"\?<")2?)A<7D^=NX&$U8*&EV@;K?\R1!$@89GI?4-A-]]C5'#G;'
M!^3\/2]3.5+GT *97=S!A'LM+M0ED> 97OT@%#=$"[V8 "%?DM(X8="HYH^G
MX!ZU)0C=6H!FF14B0 #B1UU0/2!YY )QI/7[\;P_ &.;?F+>O)<1-2\+&ZX/
MR!(B^P.AH(6"N:H7LG\ /T<Q7AIEND\[+&B%<LG?SA960+Y-+;K=$)E(9NCP
MR(*.FE-M*F%2 [B(_#;DN28]Q85&AWIBX(P%B!3?7H]35K2[Y;ZNI];P"11"
M_IV[44!VDZW1-(VE(J#C0V*S)"-1XR)FE_PK:82O"H4CJ:K\3KJMR([W#-D)
M%FL\&\" U>*/M/7&R(B+\8Z06CTNQA\Z$!5S)XXTOBL6>/ [AV#X$\0'D@D)
M6S7[)#X@V0JPN43>3]XE^%Z_\W]IEUS1=-O;6\)//NZ#;DI<RKUYTRB\?Z7\
MY&2:U]\#F\U7JYW(5.N1==4%ER&%7$\><ILJ1S=]/9DM_%=S\E]N*?'_"$6*
M:/Y$3IK72X$"7LJQMMI6KWC<? SX,R1FCQF5CEB$);P<$%N.53?DV^P;%6YE
MPC44.UE32CJ/IKMF5$I,-GJSJ$+>V@^#%W0S.$2Z,DHAT\55(+%7OEKDFEA7
M/_:R.K]TS7X!T#-%Z:A2'2)E$ZS;X=HJIOB]QXGH</?F: ^<P;M8[WF#J/(A
M:I71W&?>4?B,]T3*A?^;VH>$ 03'*NF N4!)R W<8CQ\\M$W^W#A"R^;]["\
M641),WHBSVY T=EN;@KK[G#OX"J@_5O,'\!$@UK%YN:>TRAU/V:R.4J$53E>
M@?5;\WM)%ABM03G7(V-^A]4&69"U2Z+/=#",6[K^7;^--&=HJPO;AQ']@6X5
MR#:5=3F*VXN!CV\<9<:E 4:.3"8K?.W+IJGT3-[8[(?=HA[4].IY\CJ>BE)7
MJT$).HG41I\]PZ]I9,XLR=GU)D;3ITI?),?,_G+5EY9AIF-$L18S+5#QE'=R
M4N30<?%)YPQMU:%(K2N GBH,9IBZ*<>:FM7PHU.V=PNM56XUROPL&O\B/*""
MZYOS*Y\]?X$-(#RFINRM%W?^TP&KV_/?.6"11[ >_IKB^[U%LB:."?W7++ 6
MW)[!0?"OOKU/&?T"/#$C=\FE@@F/F>8U#DBYQQZ*=%L'+6W(OT5BCZYFHFE7
M0*R8=T8[9X_>I.4O-#<@MJ<.FVLY4Q;'3ZL\_2"61 V2,:UT;.\U9"3#C&)O
MR*W66FKG$('2&G3BL.'2Y2ZZ?'_17P'S"K7T^V',GG2IBV PK'*OUI=FFV3D
M[CCN_1?,HZQQKY5,V9^#@:'EB0E.YFJX\:1&YJRT%'$27#)/WG?&6W?'O^7&
M"MKP<7"Q]WT*.1@>5AOW$7#1:<P9[*1G>LD4B8_05;@^"WHQ-"@9HH]8M\M)
M>^P:UUWECBI&99I& U!,O?'WJL@B.@H\%6=&1[])Y<XY+VH[,GS->)80$"4R
M^FR$F7UTAW7$2;B4P\U> L;:<+*EKP/K,8HW"XI76R<\[/=/=];KZMDJ\8L/
MB$'CN*/&%2?I&C87\4AWI;R?C0E)5,-+2@-_ !2O\IQ*1-2&']3Z-WO] <AR
MOTQ6[W7QVK^W\<Q?9_N9J!%[S:PF#TBU,=N2C9L(9EH@F*:#J?\<:5WP[Q'I
M#"J^$/L'H.5^_.IO%#\F2:"T9TAY" E1'WFP@>>P?M4A7;PD=D#P8+231F"4
MHZ6G]Q "ZAE"%UU!"50 "ZA60<+@.GV4@2TC_4)O,K8OVA4>RGQS3HO\I+@8
M'IGA,!_2BX0:3$X<^>@)-0NK4AR]BZRD';G!'58R1 V%&-=YJC>K]42J+$&%
M%E.P)GXNY!O-NT!>O;J/&%<%?Q?C+%&]B!(N0)73&9O"X8]M9B_FMP\7T^Y.
M<FA& &0DD+S*L^ABX7>SS8+76 K1^==*%@8_6VT?Q#Q]2^#VP8(D)'ST&1NI
M(-"6#W&?P*/-?D=GUXPV-HYCP66SQ:6+XFG$L)N?31%P]U+_KS.2RTJ"B3??
MG18UR-WCX^QEI,^".SW("BG7[>^R0;O.>"Z:G1KX*+U!W"GV]IR:^0.8:7JY
M=_/:L.3.#WV3BM& T!^>?)>C*^DE=P*LH585*Q7>?P"S-K_R9,ME-?X EH\T
M?JK04N[?\SU?WTE^*/YYO;KV?:;A;9HQ;;M?&U<%3S[O)#_6-Q9W>C9$EB(&
M-,J:*/B59[C\4/Q\([_VNJSG#P#^\L3_8-HNVO)"3>>#MMY=@\ZH8(4 N>TL
M$5K\>TE/ 2+7>[4E=]B+LG\$!GX9XFFL*;$M6G/ ;HX]ZO=N&5E\TH;A+P?!
M_7-VVT/#W,P$$8S?72L?Z/><3$#HC^7TDEU"F<:21>5T%'QE";#T7F0ET B5
M\-,\=\&&8]/UU8*,OHGO.4D\6BOSLUKM;PX*G!M%XCO>1]X_),!23-YSY6.9
M3@_<-+64@=Q@4_G\0\$(_; (O-"ZG0,\J5,M"I)TDA_@I@Z=-%XU/OH#$*M#
M]L H:_>_82J]QJ!!;L.R@K'"/3JI5#3Y<!1^?-@CT6*G\_T\A/JIZI+']7WA
MZ!UG_I7L>]H-QE"96T5[].I_5Z.8>J+0-/1_0-;S_W^0]:P86M;Z[#96(-YR
MWY<'R/F^L.=$O3$#(8K<S1^A<Z'_9AZI1)'YEE@SB8RIBS0KU=>H7/T 6S@P
MB1,' 0%8]27ZT&YF#@(K,Z\XL52H.*OM7=O];!.O&PW$%$'MBNK1D7_CH+E@
M*>FYZPAU!GDS"#SG0\NE4(RJGW^JE4Q>Z>ZS@.R5S:I606"E92ZK45(T@UY
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M3#SYNU:#+)#G"JP5-=6$22NCHT?AG56]?P#X9J_'KY(4;3JM#KV*#OT]=/X
MI@1?B'2>DX6<A4V._-J0.C/SM&X5:*NO#F 32O)4=Z<!]#OLI+)$4S"GN(\2
M3EC7.EB*+5GWWV9YY!=Y[J=L#'2]1C7-BZ^""P*(*#V:&I]H@B9EK$]?/*X.
ME0F>T1P\%RX]CX'?J#SJ+>41E&2?H])SA&G&Z27ZN,)-&[!:6KS4I L_B*GR
MG)<9;.T=;[+PSCNM9)"UMI8/6 4K3-[LHN !SNR&9=-8RN \%1>&ZTE8BSM&
M>GU0DQ!4=#S$.1-7O2/ATZ[+RBV1@L75I?E>!9+#=! RXXXWT;?#0-1L5"U-
M2X%\9AAO;2!M:+.M]O //]=^JZ=)[HR^,DT4B3U@3C*SLY:+3_6F:];MG%O,
M&>D^^X^KWCQHGI##;^@\C*<;#/ H_T!IU$&:)W$T%YQN ]D\K4\9L72D$;SD
MTM'U]/1(M?5U2T:3$6DD=($4V7AU:?VBNSVU@[@@](](W :"AQ#E;@BC6(8*
M74Z:<C,O&#*F6G 6LWUV1/9D6C#\'U3_/RQ<;_\!]%^I7(U_B(.4"[U+B&1[
M2?[>XHJ9^^:_N?KH9&'F4R<(+J]DV_\!M'UY[LA,Y_+/7&&@HBG79C..4(%-
M;1*0'@QOT@!;BS==P[\7[1-L_H,Y61=DAT1%WG)+X+(,4S7X6+R[OS:O44?_
M5,M%VS"3F&E$YPNQ]%?6'V6*?Q&->)MFT%!;$-XI:\C?1@D@\TTC:^O@@@K&
M;/T!^)WH6.C<%]:2GEM^$-*[4"W=FTS6$DG19:('9(- 2/E$RA@\6*<_3PT6
M0B;!+ Z7T6Y"%^)2_[AK21B,NISF[G4[:+IZ53HW6*CKQY49_BO#_L2#CLNP
M!#Q94YQ#P?6X$L<+Y'M*L S<_(:^UEINSW>\I<CL[\<8E5,OG?]!*:EH(>?*
M(=0AZ)R3FEM^5-]4U#[>5YWW C\)30M[D%81UD*FHE\(Q4:+*#S8<34(WZ>3
M/"2H$@A7'\_*6#>":!=[=WZ:"S"2U^BJ;LPN-/$4NPM&.!_<+!6V\/2PO%\B
M>UC&JK%KKE<[^DPY2)X%=)Z'*OH CBEE*5<'W>.]9N9:VJ/32R-2R:2;\[WN
MPL2G[&[>EOE>C/AUST1AS)S:_0U#9E2 !8F_\E4E5GVE!=D\W7Z:?VHMDUR:
M:?_0#IBVUN' 6#3>* X'M^FU1U\\PS')_K3!C*9GNQ(K+"'C1?K+!D.%;K'!
M<G8VT+)5]TIJS\KDXF-V3OCT<ZOO2Q8,*7@Z;=B-9NK&/K."WQ7_(<\/M9;]
MJ4KB\TF.%W3QE15"B<3G"CPX$],QYE8BN"Q6O+ )DKZ#LDS>(J*3.]6B$_]9
MSRGUR XE%6R5O"TU*20K\';J #L['@_N@ADD#Y+L$L27QU^A9CUAC-\#B*D,
M$ASXSQ)HGR_'/E*,73WN/&$Q([Z'?W'@^[F5C]VS_47CTJ+VDG-S2RJ;FVQ\
M')XK;.>6=<:W]S& !TX?O_)2_ 7%#"R(N.W\"IO7W#BX.[L84"R"T&/214T6
M"JI4W_U@I;$AEP<Z!E$J/FJ55+WK'E2A<H>TQ5I&#NXX\!.AU#A=BFKT/\&%
MK2% NL?>WY@9N7=??-05;N8QTG43]@,-W[BU.E\'IW.AM3+L@$=,O;BDV5D^
M^NSG<7/]1XGA&G"]D,"X']A+]B/C2"V3N'=476^7?-Q>XDS9Y)(':4VK8Z6[
M+C#+2:<T%YS,W:<00$]CS/,9>\!> Q]JBY>2%3FTA*^J1I,XH!J651G!_1D:
M+#PVBV49H-*<0.%@+UW7P7SP5)7L75<?A(BXS?NP$.EP'>&"6B@D?::]@%/2
MJVT_JMPMC/K5YF%6CJSZ33\K$I@\&8E?3R3[KI.1!4:U@,F]JPJ1+X0L)I:<
MT;EN]N*SNY)1-J$:6" 2_%3S0^E31@2](@M!7.$.KV;/ 29UXQ!S?,;K$+[J
M8>0(F'Q-I9Q>[ERWU7-OAOS+/EFQB =:LMWUY'*:EYT,<6K_/CN_1]K^K$P(
M)*&+*Z-_+W" N>E)@8]<)/PO2LX_BX>-_\]%-L2X!-+0UB35D#^ '_\L'OYG
ME0(R?4:K8GU,"IIFHG@WR=&=ITPG+2N KFZ.S^F?O(?MD&^?.W9[X@^@R478
M/AKS\!?L_C(SX]^A$9[WKTPD+V8[UP61346CNR?$**8/W1696UR5C>)N%*V]
ME6$MU%7D,E:03L>FOT><D-3PX4A;)IUUUW;<.?P[XS:0.+(_U&0/:GQY\YHH
M^=)T);E5_2H H6JV-BC!O0Z2!+RNYS#V?!!$61.09>(HH#DMSWU*UGCK2([$
M\W#0^4[:5/#=^QEBC;S/M$G>GDAEQ=(8_$[MB:B>V\G_E,IIDO+SIY6?HPBI
M@W-)E[*V7^^K"@U;;4.%!8#.[3@*\T0AM0='#?$W Z$>]J6ALOD^/_^&LPY$
M\\.]M*MWD/9NG\F&\Y\N8K<;%*8HJ=R9:(CXA4EKYKZHM%>1JK(*T=??"DGD
M^[C9/GR."S8B^?JU%Q^Q]?KO)AV^<FIR+GY;4YK?DHJ*5UU*'/38PG%0]K5<
M%(OOZ>N9RI3UV*[F*W_:P!^?7RHO7!3>I:"G.-&C8;RWD$Q2'[CX14;[*=^U
M/ = VE=<\B)>]^'6>+^5H; ROL!Q,IH<C>IU>92%4 3R9&%2)0,TDW87 ^5'
MBXPE]9U-$X5PT43N4,F)]75G;]C;55L=TUCZQ=KI*S=';/@J2[=[S?Z:AFZ,
M V_9-]IGL.CM06]()ZU&HW<%T4L+_I&<J;96!BN9%OK%;$8977@ ]:/P$Q'1
M]GNXU?$ OUM]SLI^ G.6&QN%')LD/K#'J'#H<L](B)MY-+PUV ;[?;'%;&%+
M_$3 OY; _-E3U164]@LW:O<,>A2H,WD>)UD+^>KVH=<SY;G9MD;*_++DK3QG
MZ=>#][YF;3&@^XJ%T),<#(LN(#U8QC?(,=-Y7W8PXJ-JX/8SV64Q?8^DA_6R
M;Z+3$09#,=/?"U.K0+KH*+(Y\2A:^:/%PK7&!V_<=L9*C^O8FBP?Y)I(V'$=
M&(%9Z7%1U6>/XJ$ZI3'+=#PM L.]WY&F;[R&1_K\#6Y*SYK?%:G9S^PU4H[:
M^])0R,]D)K_X]J+JXWJNMB[V]4//D'*]R L1-93N<-WD%V!+*S%*VCT$]+7Q
MP?%B$5/D#O&4L$IFPE9N^<RNZ?I?<G O7E+Z+UD^S=:-^/&WE^:@9U)ZW ZE
M7O9)+:_/YK*G9K6A;N96KE(6+RS^"1Z.DGF>J_+/?O&O.2Y^=9KUM6D.O2$G
M9Q],%8@FP\5ROX0Q5"D:?"\YJ]JL?QR<V=0?W.(;#OVALM=W6G'WD_U:@3OT
M47$:IZ:+5<Q:(Y*X4NEL9JB[0:2_D!)NVDB#0F$@7XR>_@&8SMPPS^FS>RT-
M03'B)S*P KIF%606(OSIW7;-E'5<!>SE,BQ*7ZAT+("N'[O5Z5'R5Y[W/N%;
M..*/QTR'E=,FJXJE@;K)X^$$]4?#APWDD!P6#;'7*%,9XCA([0^:9/(!7WW\
M6WR!AX6;Q'0.D??-T,4&4][Q46&16H'N-07MF/6"&G'VP5=D SVY_,&>%9*Q
M96Z4(73R<0LKIU$GT(<5^:,YCUATU" +I[[Q [?6!G1SI?E9>2;-THLOD#HD
M,ZKBTO)D_]W89OI'!)26"_]OF57./Y@5*_.-RRG%L?,'SFWKFM"H#$'-ZI/,
M#(%!REL:+^2L0P0W7(17NKL(_LMC7LD#7.G/4^['?S'ZCH9:_!<!,P>G(P<@
M6KT?;UN4PA4!CTVX7)9X5ZACH\F^JJ%Y"0]&VEER_;.PI=:F"@WW4#?]B5;_
MP;:T3-Q2%K)9/0I%2.J&A:+)_X&L$=2I)RF:615OJCH"#DI^%2\:7<D#Q2*N
MP+T_7QCF_0$HW"'+CF2[_Q\\$7B6=>'%=X$F*/Q]"!J#*C?PCU((:40?5\1<
M<(@+*(SU#P#P\+>$U\ RIHT@O)QC1-=\=&AWDNS';DGMVI<G([\;7#@[K81U
M58M!9N&"]*[,;E^TSSV64I3=G%_J[]Q.N=A7_:K3*1#65SVLACF'^F>6: >3
MR:]:ZT9/PC 8;30\TEL1<_PX!DDNW>1JW7G'TM@TNOSJ7%E]6IP=JIV[GVE?
M-33VLW>835,9YW;/X $7]%'0KU+:N4B1V42]NS?<,D?BIM,<%?W35-$T"I/,
M;Z["&;Q^Z]"K:6FFO)Q2/^['4DF8/V6[5X/YQ*DGMX:_ DZ/E@/!E5K=?P.)
MN-)L*B)Y!#)4M[<7"'G2WO+5"G'*REJS8-30$HYQO8-68=A$5U%9N4',$1&D
M-D@%AAN-,3&9-J>9J!'&Q3,\+BJ<Q7./X#LD]WRK?+']LTG2,OMQX?2.>70&
MK=!,@P6KG(Q$WQ>Q(">$=IY)]=>O58,TLPVWYH7S3Q!6(?O?AJ74*/[+ICG?
M_6::-N;JGQ;12U/C]J-"A+!_^#+_"/P]KCJKFO;?^O)">"/W_]-#VNC.*^%7
M&F=!__1S+LT?_#O1HLH_O:9-/M@/_V,BKWV+)S.+5^C3N9/A:@EF:SWK7'N:
M7H><S#=@:-KS8@"9L_MX<W-#B:'EN+AW0.ME^57& '>F)^B68RM]!'_'$/SC
MT :).XWY9C2=F.,M-G"0D_VR*R1_36Y=B7G$ILE8Z'4!Y21YP7/HT5%G!=0^
MVVP._7:OW%_YBU6'-SIFJ861$<:X&U"6 E7VSU\\)TCGGQ%T]6[+Z;@>1379
MF$>OIF-!JE8-*>@<UQ]NR4-#J\O.XR3O.SBMK,LY850BYURZ! \46._!U1-W
M+VGRIHOQMM.OT\I[*<S2Q!MFG,BTZNEDX1U5-<,1*FHOTJR%D.=]-W4UGQ9V
ML7R+Z N7]Q&!?%'I5R*Z7?.M#Z+Y2ESK46JA)+70:RN2\%7:]%V4N$CNP%V<
M'.RKN(\N0IFQR"X*Y,#@GD)Y%?!PX.1BZS$"?3>(1T*7"6NW"P9G*J5P@J._
M:23.2_F[DF6Q%1ZRZH#C%==Z=0VN^\D;3PF6*7OK2B7S_.(Q,P-?"F@.?'H;
MZR*5YI=,3J9H2@?S0"+=/.J%XT(X=!DUU/5_D8^ +?.2XT$WQ,QV+3QZ%9Z9
M#*@(0+S+0NHC+C Z?,^!_?WO:!MB+?W(:/J5&Q/6%-Z>QA,:TN:4T07MQ@>"
MD4G_AGQQK;Y%SLP$>_.,WI'<&)2M+WI(D34<UH=/*P4^UJRJRISS,8-[KN+>
M]:Q%DQ7X;WXIY4B!>,M8%+R"%Y()P&YNT:3==17=_*Q+88.JXYHM\V,$-)/?
MCOJ-H0',;B"WKO5Q+ZM8U?\ YC!'A[FZUAN5;=$+9Z9!@T=HJ$/0/79BK&IQ
MQ(*>X2M'>4ZNSXNV/:C<2&<+,N%H@ 8;^;I5761H:X4G#EVU%$F#M=N!90+X
MN8(()HT3&]WC!;BB6K78-95LA"_X,41'/_B;:EJ'6KP/U;UVLJE)5:#Z3&H2
M$1MI6X3/Q@%&372Q;\YA]=?MEX$1#P^7E (026\MAAY:E=R.H-(K$TY+[P*X
M<'<54"EM5]S$<YFX4%K"U15TVI.W%7^5)_\!O'/^RG3N(F=Z =$U+5VD>H(S
MAGL@UA77--)$!I[@ H"\4(P+R]<56B>_^":!YAM8A9.0>MW.Q4?$EI,4!R:,
M*4\W?J7>@7OU&J=R0ZTUDU.[U1<;D\EEE&?3 TIFU_J@#_MU!F5()*-@KZ/Y
MZU*_$JDMT3F2=K@_&31:9*:X\WZM]""!)/O3\=19/[E$0)780 %>'*3&#F>J
ML=N%\DV6G!7\ ;0&(K>=^DB1IT]3#L#7XQ2O#&,^3NX=X*N7)>&PEU$$T&*<
M[44ZP5]Y<E.'U!MNFB%9<\Y+CJ3:\>S31:ZM<L2<0*3OWZB6K-I55&UD-W'3
M^L EG$#&6.SYNS SJ1%[]_7\1.5;S13YQJU>$6&LKE60294U?(,,_,N ;(4#
M/;@AN^\@^^VM/DB'5ALUWV(6[4/*27KE]MP/-?; 9/LT:L(?FZQIDT>I.+7H
M1G42]' E4<3'89W=2?/%<D83JM;GA1 ^TD/U4- OM\EW 55S$]M QD4'C\S_
M411LM_K% AD+094?39?2RV0FPA8DJ$^L Z$JT:VR'V>:A =$31)?Q[([@N A
MD6-K8L@$#[7R \R+Y \Q4-Y?D -^A:^-UYQ$H44WHC+\N/F#R&W$#DBA3LF#
MK^#@M'@@A(UBO#CPI5RDZ7@O \C$QDO:#:[DDG 9&^?=3-D81AK6"/K^]:NZ
MJ?E<VK0_UGH3C1:!&%2:!D/]*NW3S*?'E[<@5&DQQT/!Q<R%NC>XR@''DZ'O
MNNIG_KL)@-08^FI2UTI".:64M:1+5UV"3;VYZ; X#NK8Y^NN=6L!T>#'R/S6
MK*ZXJ0-@<0'QR)'H'8;J^'E_L88_3J7LX-:^W265IT5D!KM97#UZ(!3+22YJ
M0S3D9%_C7RBAJ1[,6.2 I!D)YX1)OZR1H(35!;-!8VWM$K("B'&%%5$%8=>*
MU.EA:IBS25)17_825M[3.X.:X3LA9H0*X??UQK4"SBUEPW>Y?=!3KN$-2D0^
M;\%A%6X$5IG0C*X@@EPR*_$:F7ROJRN!I9O?VKI<+/:R[W?V4X=<??YHD&PJ
MABN-444'U/G>SBUIBEQ"'BLM(@"4U"'^+ B8Z>WHQ8>;LE>\S"]!E89F8JCV
M&ZD)=CZ$1'>/.N3"13DI,=T<9IS!OG!RETO73"LA3?IE@WJ]M$#<585SRU6\
M:['#TO3J-&/J;V*=52-@FD+ G5P%L+^K@7-2"$)[-@8V=6(?\S/F ]E#*^N,
M90G#NAJ:IC-3'CK@Z:NG=DI???1,'5BDE\GZ>4CZWL[#9$*?BTYS>_W[=-\;
M+:L9[07(23;R[I*0'G">ZS2F:C(DN@:\5J&=Q-0E?.:&:3]\7-\8.;=$&'S(
MX87V6?LPN1#2&0M6DEEH?T\'1VY3 .DHF3FY'J"N$N"3)0;-+E0"D)-E<\4K
M4\Y3VDQ9$SX=,H-;JY-TCI-(+>+?;UBM5.S9IV<$O-[>5D>+Z5 1Y$L;S$'<
M5-\PWDW[998N0%XP$:;4<_9M:>#^@*:T:Z _5K+G#@\]W_[7^=4U#839/<8I
MK+X"+-BB4"QV 4/8I*,MIB_39UB7%CJ$2BU:W) [.Y,U5$\Q*ZO,8)%'0J13
M1%<CWAW-8>MBV!@RY)9_(C(G83EG<_ >I(J5N:=\E<&:O<CC+)J_HSW2&VO2
MLA'E]!8!)1HT @;%49&+Q5;1Y*FXP!&*6 Z>>_6NS/3X0"'.B3N?.%-BEIX]
MP"_#8$0P8Y$^K/!/8G7BB(>G<ZA$GU,+:S_JT=6$S"5'85*(H^:*?<7OIS+I
M2QAQ'H3605L)366FJ JB;TCQ6QS59/!C243W!K@Z35PDK[Q1^G?NX"D9<54]
MOH96XWDUB00H2X2JA8(4NT'ZJD:<ZYEDXWUSV5_=ZO_5X*GX5Z.>#%\CHXTV
M)\HHEUL7$2[F$I$I$PZ+T( OS@VIO)0[G%^BG[>VK'/07?S)$C'JE_\UP$?J
M)?GJ3?_$BUAG1[)I!$_-HXKUH<OWH2=3H02=-XU']8_I]*/&8@&3K*N,1;;+
MON("!W&RA=SHX'&13"991QJ,I> !/IAHCZ"*Z7;5G3398,44KBJ;7I,S&=^R
M*I*F5?7?3F;IEQ54<6WOT?14#+M_ 'W85U2FU!SBV$#'EX?K9V/->'<CLAS'
M1PD-Z1CUGA87N1GJ/&_LZ]0WM/>H1]^/%9R2;O]N0LRH? ,SPU6FDL._E_ST
M+'3$]SZ5>)Z$O)9P?A<C\N=5(&;KM]<2#\QPP=.AJBF./6Z2W==9U J6:1I+
MP,\4*[ \-?'DA5/+=.U&[4PX.!HN_(P[=.!#;+YY\$@I/)6CY(>?CD=PKZTI
M:[/5M;O$>5YY]G/XN1Z-V*OTOB\80GZQ$W.&)*%R%1R<9S#(Y[Y2QC^PTHK>
M*-$Q_#2BPF#\MFU)2T+.;-*T%/D)TQI:H7-T=H1I/&C_%+ED_$B(35B5J\[A
MCET6IR6;=%-ZOP1/%%3I$+,U[YGKS+O\1O]:4F'Z)IK08Y/R_;Y2;4HR *NQ
MV>JUCM$6\PH0V\B21?G=LC'1QVY4S4FX(]$F7^M'F[Z:"XKR$<TL96]A[^;J
MB=[ ]L'TM4TA8%B5.>WY7HFF4^#]1QJ6J04#I%%I*:9LS+JML?'K1R7:DC97
MNQWWQTNWH&/6Q'G6'E%G_$V[JVT+T]'1BA.<:6GY(J+XO.>WL]0F\N(6KS[)
M39D<A[[GDJ2]9&PZY0PW'VL64"<2BLDQ@VW/>4C_N':*/W7] V@N3]V9LUI_
M>94M-EYZO?F&OG;1Z+F!WB['F<6Z*EXGB-6D0@./^P. K*8ON:9N2KIZE7^<
M/5[RX1(/V?3_E6OT)=<DZ-=:IX&<R'O[;P["Y5;YG#"E-)]BP/W*Z6%@OD\'
MIC9Q:+S;T=[Q6A].&E7$"V-.7#XT9F0V*_DXJ,,=*IGM<9C9>L? /G[B4[<7
M37>L.XC-3U/VLU4A5HS[+7/,$HP1\_Q+Z-.<3R$.+M4%7@'>9ALQVA7)]\_E
MA^X[MW[^<JG'>/TDW>CWN'[D66A[K--&_*GMMX,_@$T7.2Z2YW1_ 'X/A"Y*
M.1''V3>R:AL7TM"7!O2D*W$#J:$_7Q83W-7NKY!:'+I$A=#*_P$LS0S1&9UW
M'RS5T@6=_7-QTD-)0A4 7"D<.JQ42E/N8?%W?!7NUBE.]F@LH9 F<ZE)4#Z.
M$O7#H149T4$?,,5%+WO%+R?,S#;MSS^ VP]^_EVY)0)ON->K4WFCG+\/:1U)
MH#G]SZ4O 5>6&M:]<CY;4.1]*&K/M37!TGU*/VE:"-2 &)M4(RG2#2"HK,JF
M;4)^Q*N^1G(5V3F#M_PR*@<*I:QOK4P@RJBZR/)[#\HN,2JL B!#6GZCFSI)
M<]RONJTR[U/\>K5ZB>9V_M\4B?!6D%L-:?G\QOAI;#Z?21J50!@.^IR3/&_
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M'V^LM0ZKXODH[\1ES6O9;0=16__WGG>XA?12-2>:%GIZ<OTSJLQY=F%-/U5
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M',M^?A6=U(N?G?874!>0)L*RXJ- K@9M$0^@/M7_6P-J:/J".,/A5Y?@_W)
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M=+$3!XP4 =^/M.=BY31E!B<*Q@;DMN2^.8$UW!G\C>FPH#02%X9&BRAK1(T
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MT.!YS)=C,"?DB9/$Z9A/Q)T_;DGH'BL:/,9W[5E\:2R2T8S!A,RY6?2=!OR
M?9"!\Z;VMGGI-5EHF(:^N[0XM91KR:M1B7O2Z\*ZJNMO2 10;R*4N5Y,T$F5
M+35_BHGHJDRC%J8I9"N("D/VXZ&@:@>5WW$$GGQ-"*KOK'!6=L.;:2//YE3H
M2UY=@0%5)^_3R%ELMW-D*<BZ7UC28;!#5].-$[NS%N;0%M&XS$JGSHH]Y$7
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M'><DB0@XN3W1?&A:T!K=_U;S?KE+D?L&DWER!EQ!R]<*=>]'U_S-([*:)<%
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M;X^7*5^ZZ^ :EDZ2<,D883AT6;^A^T7TO#ASQXV^LSSF(6;J8OS6+M:+!L3
MH,-8\+(*.3KC8MB^\B.UKZ#)&<15EFYV9O8#0,/:)ZLYO,U*B%N@+&D.'.K]
M^'[ D=:E[M16VL;GV8Q]WQNOGR9T8C(7+_>S&J^V X&8O.%8F4X LT@%@Y<;
M*5KB^1168M$C;4\9-&RZZG+K$PNF)TI!4?Y5#X.Z)H;#OI<HK!-/ !,3AN-C
MGSOI&+*N5Y<? 4K=]+A N;T8)5T!JK E0)GCI?J$_7WCW8SSP43<&\[T@FGZ
M:-&&C$36$6-Y>_;:G@$YGIODVJ'$D)\0)2H[?'-G+/VT QRV 2M2!5P2*-!H
M:?Z737WJW-$CM,PG?@."U$)U;BYH#[T=0)Y[12J%WZ^83K9-2G-K[=FF'YE-
MS:P3B"R=A^B$789B-X- 6U<\7OWRT4&K&/\>M"1M9^=RFV3'DU<N66RGD6#B
M*WH,]/:M1R%WDX +7>GNN(R"?G?<\P%[)O-(?F!S7LVTC=Z,\37U\9)4(GN=
MUF:Q*SX)_8,TI(29T<JK_(M+WWG1+J<5NW>:&7=1YC9?+!9\!5K7-V C%J='
M AMV%CPN(W&IB]96LR;Z9)_(E"I?"=P1T>Q\V,OJ:KW/64R)KQ#D1Q+M;;5^
M^K]+Y,*]J-PCBOA:'>_Y(\U9XXJO9'L$D I_A( I1M; _76!YGZY,Y?D!.+F
M6U:87:S<)^UG0<5B7=LS8>2L1WQ#HO.&7P+<:_O+ZTV"]1991[D7*I"''.V7
M0SRS#L$2V3R+NJ:;XI,:N\-UL]\??T>G#(0^;)\-NW-^$?[IXBG3CZQB/M]<
MH#$W/AYVCHD?7+J89=U7>_)=BI2AU%LP>SNQH_H;15#O"YI,&#OW4\UX4CLJ
MP6JICX1T0Q+2!\R"F8H:9S#8U(H\_M.:;S(XV);5-_TC6T7^BEL0-8^5]*DB
MU(_-GY.T\W/^#O)2#9/L-Y^[..](HH@2446&:2G[[:"3"KDS:-WJ5-0KTN^Z
MVM@#6/=7=D*)X7O>[C=BZQT RE73GK:D#\9"!L#BE9MC($/BZ_<NB=>^.+^T
MK2Y2H18S74JC*PSAC,8NZ03*+8VK609]WOZGHYX/VI_MO=I[1W(A^2H%&1/S
MU#@IT<MU:/FZHBY,7V9$LPY54/QAR^O7"C)C2*L&2?HE#F?<CR1C4+-MHC#0
M9FNNU6B!:E(^*:%#9(ZM.X5\P<?H!YD"&Q/,]9C;[L&NCMC9^ZK?&-/+'TH'
M;\NQ83%[)!^I7W&M\$*(3GW(S@FYL@TWT2?UV/'B>R1WSK@W7]H'QAA<IAEO
M%D@N?#XD(V66RIY?-#+NGO[&X %2#*D8&27:P+*#B)_-Q[*SR+20KJBQ_3HZ
MY1)O>EH6I9GX'"OT ^UPP>>EU\U<9+VSBZ\MW887\(8MWIV^>WF\" SGE']A
MT%Q'*OFC28CBO0C9O>K>Z'7T@[-W\8-CX+/CR_WW)?L?0#7/.'?U?V.(GN$=
MJDS<49C4G]&Y&UR9M/JV];M4'J0,+1FG1F5F_@CTO]5:0DQJI"@US.&P+\.3
MV9.-00R"2^;*3X9=7/SW+]IN75)8(@5-]$[3_UC[[.LP](LPY4@%>LX??["C
M]=5[9F6QV=VODBY*2KX'AJ@J3,,KGJ('JM#!D8785YGMCNI] SW* ]U^S'A<
M@S'A.J9.K/,4'+<BE]=</-<5->>_,6C#_'A'#.6 *0P.4O,1>XXO(3W]C=QT
MO/AR2)%'EV+H\)#X4'B*1H^[GF5'W)H#!B8;6:I+S^KD]:.SS'C,P)ATXY)]
MR[5R$]+U<+(9<(N3J%<&7NWE]% @,=UL4QILU0IGN:UAC/3X%+G4)3'FQ^-[
M0)5N"!-R.Z'N[\/7$Z0\?1!%B$9IWO]J#M02+FFDJTFCZJ7U%F#;Y!MKR(2J
M0BQLP6"U'Z6I'ODPUM@'+_W.;#1\(8^%==9E,0G<WM#Z$/#E,BR"JO>U?9"C
M)%^\*CQ_Y*V<5KN1/$LHRHS;-06#*SH4M*T]S1W-'<0U?,U'UN8KK<P6?(9@
MDOA]CV$3!M0!3YC?*9#E3/QT=+$]=&S)V.Q5/!D.HEN43C_V$]TPI[RWR3BK
M?MU>NMECK&M:]HT;G*5[K65$43K/=?5+LUC8=O<WQ@1ZK$[R%(&H#"2Q*N2"
M]'_[!LQ<,FI#M#N_9^_U0#NF"YH/3E(KW;2?P[D1A<=$E3K5Q*W,WSO[R[M-
M@H#;1JJCSC]"_#VX?F,41J=K6>;["UH@:F++H\<"K78C!N+/$'#M61%E=+/%
M1(H^Y?1,=ZY\$%[85W'ZCS[RG6-W)3<I)!<V_L/8Q5<:,J_U&!YY@:&N\ZJJ
M8OO[6,&^%B_4FHT5M!%L).<Z3ALLBPA</A$*LXN)!9O=F,[0J:_#\NQ#6F\D
MQV]M)6BC(6"B+ZHR1%A<BVJ#!TW5,'I@"%-XE'%LTQK]R]X?,Y*?#9*I'64'
MCY>J]9^6Q;E3Q/9((_I #ORR"'=ZQ&X'!.]0*IY8=I+"B='$UR=K6#B\9YUR
MO8DM8L#T[9Q]-W;RCF(%,QY;/AG.U9@Y9F/K_W=B!TOF-P:Z9_%.<BE2%>G-
M)?CVV.$_V2_ XEN\+GS^:P2W1U<>_6^!@# *:_4/%BP@;_I/=S3])3W&^IT6
MLZS.SFGR-ZE3_*;]IB@GGA]%^RDW][-</>>9Y/=;"\;^G8_3#ZQL1048YE)6
MX0C4N-Y1K*F85OYEL+GQF^\).U8E:?X3=-S2>C77C^6>3$_"YTT+F%.OL'0*
M1*TYTIZ5;J"]UAQ]5FMF\8:+F-.&@3ZNL&)8W[YR;\TNY5G%CNJD3UXD5AF+
MEW >-6I=-9H/UB66WE=+R,*0L![J<]]"]EW'GO+'ZD&KQJ-3?Y&?U] JM)R&
MDXPQ;#:@BT)%;?(H789.U_, 4PT$S\%;L]0@5-%!M6V.KE1QTBSH6\.2\JP8
M+*:*A4L0\'QV"W%4WFNH/G!@V3<6D1HUK!8:=:U-O/>MF,!SJM>SA"BDQ-KZ
M*6A<K[-S5@^31Y9KL;$V+CM>XOI,6<X*_W@SE*H\O<848=CA\7F%P .9'T\F
M7_CPRQ:HH>M@:/(["VW:U>EKU;@0"F5\#7DRU#5?$:CE//F)Q5<],JK*PLS$
MWQCB8:MYPL3\7EJ:37Q\IE,JB/GE12EO/@)O2.PS)LMFS9:'0@S<%@&#5#(>
MVQ+7@E&=\&3!-A,#)O)8)A*RQLS/:21>'[1JJ.C[HP8D-[=C"5W$HQ)HE@V8
MB7&2T82%G:CF(M%*T2)D% C-$Z76; #/ >?. .$5+'5HN<V6ZV;-UUW_[ )*
M_6].KB6T@7TJSJ8 ?*[WPGV$4'O97#6#;^3DWJUD<QJC]EI-_.9DW,&-=RW<
MBO&6:RT?G,-2-']CP)/)$)>80*O%^>?43:Y:;PIV;;KY7R"^C>W;SJ].#)6(
M < DMG-(]?&[;SEI/48XC9/A[O/.JL'\>N^>L-?7A:<E%1VIQU9VR2#'S/\\
MY12N]7^6<TK*\')7,1/",DALF<PB'(M+MJT7J,55HK8A1#8W5H23M *>\%>8
M)!8'7WSMY>YRZ)<7D_UTJBM__V]3XYDG$, M&V#Z0[S!R48U!O[F4N9=4K$S
M#X_9H9D1(3-3@BCLUYXKQ>K$D9%U->G/&X[J=$%W'LQTU8BU'8U4V;P7)Z+;
MJ)NNE2RPC1#'QLE8!-E'127Y$F;EKL Y^<+ABTI\EB29=+5^A5@J-9_UW"1'
M7C0MVJ2\P;!Z408.$);PS8IA?W'V]?3=O%8%]%;L]&>."?KR':?3%@FK5:Y:
MC%75J>'7U@7<@ ;HG8.>IXTP78J]H 2ID*LM.RCJU!Q$A-!;<-A;A)SRJ<79
M>Y8F_MW ,@P05-S->-\MQ=K(A)N%B]%^4I9F^E9;)I/3730@\ZGN!\J1?^?]
ME(6LT"X7AJ_O3D,*MIM_QH]AXRO[C;CX#S;^2K\QY)KN%)XO%F6T=YVJ '\)
M[7)>GRQEKMW-^92.G1HA[](OGMY>'5W@_<;PRG$XUV;WE?U7T=8%WM)?)#+)
MVV=HV\E79VOMDZS_4.OF;[5>L7DPULI]^HWQT>P^E_%P8OC5:@[H_)]%/JS_
MI.TWQI.V5H;[H9O(^W=O;T(^M&B+?HA<KU1.-^-8$GYI:IQYJ+ J(R(7EELU
M/AE\$&"B.0%;4EUZ/$ IUO5.X!<$NB;VDYB?EF;6F>[%MM,3SR=S^GD_];TS
M.BXSM:R3R]/%*DRC_C$KXE^*<N?W>4[#U7P1/@MY.@7]0%C8TQ)U$S(G59!"
M+(YED8]ESI)TINLJU=OOD?M=UD\8@7:M8DPFE(6D2'+(1CF VVB),Q17XV\-
M!C)\^&7I?)]UU)6OP_%S4<'/<<2Z?NVZ:L%.PH;/F1E'R<1'=6PB[Y5M Z#U
M2@?""B*K'A[ T[- PY>AWZR+3#SM=0Y9;NTD4O]\:M!ZYI#7.Z<)S46SPB-R
MB=4M ) "8#>"@Z/X<-N?SN"]NV^%!/?"@P)GQW?9,0?/;^*>SWO=NRVYE (M
M_@TBWBS>T?/'FR:&X71 D*'W3*+C-*1DR3BNHE0B"_$&-=H?W^O&,A["7F%:
M!SG^3*?PR\_%]V3[W-+LD^-O##Z7EF9!7H9Y=_,1_)$!PIA4LEUJ9B,:L+QJ
M3=W<YOUT4T.>H]-A^LO%QZ86M8 &\TSN%P&[X")6GQ;QI]^+X07^B69'YYOH
MP0SH08R8];&+1F\U16@N71!<-/3QBE8"$ 1'JA0['%UPG$<AYJ.MUV8D!SK$
MXQV,29C8 !<D+OD+2VJX\97JOJ@3](O$&NG:\(1G)#T=L@\RX&?=W7R+4G#U
ML%OP)Y?.<*BHK[NF?Y- @]B@\\_.OIYG:\[-J:*?=T">]@KR&.Q2D[6WHC]*
M=D>*5S.]WJIU^QD3_'O7^-\7@8W"KJ[>:DV1NUSAF,E]"?FQ+YBKW5]+:^(^
MGY6@[VU\&WY  JL:D2UB2GMI*B3O.:GD^?785S$5L/GYYY1LP)C'>BX^I>J#
M:>3?0OH__OM@V'>6P#)]Z%WAZT:428SB!!XQZSP\958MGC7EV !!2>=\*Y'I
M2EP9W=!W$KIH=.[AG?^>Z@IWY7GJK8MA<,R??F_O"-PR%N>'T#;F=D3"(8)6
MW1M]$?*/=8?!O4*ZZW+ZH2'V529X&)EC)K4GE]+\JPFIKWWE%F[==.9TKI-?
MG[WV6TW1/6A/F@7ZT2/^B7+\>0'[Q]__?'890YN V&PR:_UN_/9G%C0EX?::
M-V2KAIB,*I#^)ZM!>.R/)P>Z:#LI?8XG##R\A,8(=JR.!3*^6327^-C?'0\L
M;^VQ *.NNOBE.'UNSKE-#%'EFV!14[%\GMK:6%R9W8JM10E[;Y39D-M&8T]Z
MPFN4+E7)%B&T><4S,E35J&["U67&>QS7I$-H7H(JMDX'HF%EKZ>D5"/RP(."
MS.-: -CS9\0L]@]BYKYK,Y>4T->:9,E)'TFZO!,;#RL>Y1MOLP/KIV9Z6O 8
M.WGSJQ*H/A5'?M'L^C:R2A/+U4AM!%@O3VZB[RJOQ\E5 Q-0!OU!"']CS-X+
M7(1!MB0_)B-E,;KOJP;?;0F?(G"15.W3U"Y9F^_! ></GMYT\IUEC0[H, 2\
M^8WQTKK-/?T:]&#LT:N]1PTC[L\!\KZ8T7<6*=<CMAM<)/*"'\J$EB2';@L>
MAJ.<<:+=:V;%#L&)E3Q\XN!8N$3+G+8U5C^MG.1HS]F["HU58QO5?BYKJX3Y
M'=X4A5&Q'2G0-E61/;3;S[1'=;'-%65B?%E[^1LC%-U6_G 3Q<\\R0Y=K_FL
M\!6L+Y2$QW2"37KP\/U_"17F]L._6HSX>XMI%F>N;))*AE(,\.^%:I(P?EG/
M$?$?\#4'+$O&P-65N-RN[15!J0<*%4=8I<>M6-D%M9//8$F-->G*9]Q;Y=-3
M"'BRV_AN'7>_U_3&#M(M]F/#@IZ]"U^228ZV(#*KK,8PT+%$[&W$JL28R_]Q
MA_X'T!]GS4%@!1*I[M1L &2R%$4*0@0GD^WSX7&[YS;E.MK28< 2TFMU&AT7
M/BG43ZWV(O?30)2HV:+"WL2L?']K7H,IT>GI-7LX6/^[EHGQ) *-F/W)]'8,
M:FEE\0K*7YLTT#@>.K8JE$0.ET&&VXG]EZ#]!W[D^-9R)4--+UWF,YFT?EG^
M5[E9KV"U.3\G7/RA=7E[9N??&+OCMP"C-\E'7S /1?!1.4,)5(CLSJ0!%O7:
MC4<.Q&!5GHCDQ6QF_I-CV.FU'3VGW<$&Y7A6FR;(NUCDH:$Q#Q?ZF]ROGNDU
M!WRY_XX>_CLS@J0S59SKZE&'EFRAJ#C+2$.3EP"5DPC^8X9R+-GOM5;I5#;'
MDKQY(>M4DOI% '80*7GRG@'B8%^53H61_4'= 7TS,BBK1\VTFW+^#]^>K%L"
MJ[2=L/2L!EOY)P<GQ#I9"\4AR>#YUNS%IK2/78_LD/-_@Y2,#/FAAFXQ%G>+
M;84K*YVS%VUPLCZ3J&-:!)@$Y_"\"MWFN/F;57;_N554TM550Z@B^OX-G3FE
MR7IK#@R,([868/$!4:OC;24<%0>]-TB]>KYV_W3NI@X?O3EL;*YI').CRR>9
M").P?E?"AM/%AZPO4F_CR?;_8D<;F]>@E6DC9"Z:DNA4U\:C[?"'83H-UMB)
M53"K#W;_;@2 S<1]79U]*CELV@GGX()G[)I)S/C@A,*!.HEZCAM#%6L<R^(6
M+RT5_O3^@=X(9@63M6XP:_F%!$%EOMP\BM@,,'6)VA=?#O3L:*Q?_D01$GI=
M@]5IQX?D8L+!S@5RJ^)6/?[S!33ZQ (XV="@X35RE$1LKI0M_+H<IXD+GUM/
M#<:?8E1,FZO$T'@H6T<YR<3.1(Q!2/"H^*^!-[A[2:T!BLO0=^[G,3HPFBK,
MWS5I9<756$2Z2CX!@G*I1R@7/1FREQJ?<\9H*UT*?3C3*K+X^/6Z!8DHS$>^
MHX!7HDYD)>S4T >E7-.4L:A7V*N-?57,7/0I,Q!?5]A2!@4GM&^)Q0T.+9"F
M& 9(46GS6; ,H!>#@C\?Q(!.J*BHIAKI395)QQ>POI:PQB4N",SNZHC\-8!S
MTZO-"5UJ,<>XXU0A5!4'-\OM,)#TA#4*0>=<H78Z->5OE' H_"D7^ L5X9S*
MD%-3/3<\PO$]!]."Z_'NT"6&M\LJ]5J)J\CLCSLIVPO"/5KJU9^^I-!NB)9W
ME.;6UUD"+&1H7"7TZV&KT*)0[-;L\074$YARGWK:4-IWO?)D)@"/ F*B_+,4
M*8;J:VZ%A8-5CV@B<>3NOS&6$W\$G2W/]^%1<9Y4A,T+GS)$@WE=K+H4 W1S
M[).D?W5G\=CB@+Z>7V%@F'1A2R;U::WNNM!N3>+'$ Z (R$1?'4.-D_R)#R-
M=N4 G//'LE5^&.G,PD8I)#@C(/(KEIVFP]@+^,'4,$!UK".1H]NRVR.X,+AH
M?Y_F.$T,*8F4'/*_0(TN9PJ]@FP4'CY9=DG/E<'%E#_]*SA@*^ID@0J?*B%%
M%5$XOKHD[\K<:IF6SQ8D&4A3Q[#QQ]S2WA[1=1E\9A8Q!$9.OMR=!J^[(?/#
M;Y]?8W+AJ9!ZG+#<8ADZ%LZ7BC(RA&BZT'WQ4.J.NN;VW)P>@Q%)91(QM7I-
M;C%@BJV]QSR<WY&#4&?U:,)F.MBLV2]J0OELI. -B)>Q)0":I\/*]5=J$P?>
MQ\05TG\E9AAH&F*E1E_-)B&_2IY,9RMGTWK6)/I%)7XQ0CE<#*5QLA3OJ^32
MO@RB7^Z%+4G.ZUFFQG;P5,O/#]P1!>X0>PVD.V6RUVDJ/7,=#J.3-@$.WG;*
M.@9F8LPWSQIDX77XT))R+'<\;'4S#$+,NR,W'TY#'#DQ7,(*7?D9RU3' +_V
M=^J=-';\&M9!JD]F\*TE^:5I4D?0Q%^)E)$XFN#]6Z>!'J">/>($JID:EW(X
M'VF6NNRVO+,JDCGF;G/#VD1S4LK55<0J-DY-0&"GJC3#W^,',LC]Z&V8+8Z^
MRY((EBG2>"OWAH'L22U-..VC\34Q'4-#\HDRB:'"@YGZZVJERA6%X<A]9'C,
M=H]G4^,E^T!,1#D@E<$:OL(K2=^38OAM/%8]@4I;$%1-Y^<"G-6;^0LU*VCW
MM44UE'GI(APUT@8>RO2,PW?UBBD:/'',"">Z_!,M@;:*1-6D0F/C$ZIC(==D
MB!D"8L:_^Y)1_7VH\'1G=E3E8_69#PDB_]D9_PMK=B:Q/B"N2=(2</P#M.DH
M+[;_F,^O^0%Z/N=&8N$CUH\6Y//_";'XPD>,?Q&G'^7Y]Q\3_44\F_VGXK]_
M^K\+R=]4_@=(_@=4QOZ[ML_^SN++?];Y=];_SW7XGXO_VX?^7]OF^]^K_']A
MC/_R=/=(_18B*'$BM@\?^SUFY5OYHH(TL\ZX;>75<&D*#CFP_)!,CVB7\<79
M6+U(P,<U?C0Y?8GL1[=@[O_J&_'_OR*X$[A\A/P]^[\ 4$L#!!0    ( )>+
M1E?3E7(>P",! (PE 0 2    ;C(U-S0Q,&MI;6<P,#,N:G!GE'I55)M=M&UP
MBCO%W8,4+5*LN+N[6W H4MS=78J[%W<-7K2X%-= <8=+_S/N&??U[HR\[+V^
M)7/.M9(]DK>EMS\ #!D):0D %#0 8/;^ KR= C#%W$QM/0%0 %@  "#POG4&
M0!,Q<S Q!YCUON] O:T"@@'PL+"P<+#P<'#P'^#?W\B(\/"(R"A(2,A(2"@8
M*/\M#!0T= QT-!1L;!P<;&QB(B(B8K+_75 (" BH**@?,3 ^$N)BXA*2_?^N
MMUX )B)4!W0G#!0F !H3"@83ZFT0, X 0,- 04$!_G?!P$)!P\$#$*  __;_
MGX/WFF%@X> Q -!0,##0L# P\ @H\!^@$=ZW 9BP%%APGT24*;'AC9UP MAQ
M$_+K1:D0^F949CFX\$R< Q.I.<V"BP9IQ+<*&KZ:2_Z]Z'<)2A+#IU,U5:.=
M<RT<D,!\#P4-@(9%1(&#@84!P+R'PX3&@J'X9 RK[)1 :5+ @2/"+JKBG(A-
M91H$AYM?WS<S%[#5\#>0FK-_5O7BJ\O;"@ %YMT')@PF0 @PO/]R<4;?-G%/
M-:J?,$49< 26@HJ[X]JY[*C)LF7^93MW</=JD;5N\0GY#6#O,_P&N"#7LGWZ
M_ ;(TO%.8VU*.]/;F*(:/?=S3JHQ^1%63'9E=2=H:#TUW]:5*][3_+I+)5>,
M\ ;X1G9E[9V;4_!:.'EZ^0'\-+>F31RL))V(Q*$=5OI1Z-;J[@N_JI_*_JTG
M?-)Z[K;0-WH&$C]+@J-;M8VC4FO?@_>G8'VVSO2K[9I@=56Q= T;XESG&M\
MS@?NGM .GD]%1"C%]Z^_A+8+USDA7]X=;2+$6]R%M9D:<@LSVX=RXO7X=4BV
M6Z]4]RB]QR H?^J[$XZOW*?0;^DI)>F#/#89')3:"JT]K.=*I/)T^H#_%@I*
MK7G]<UC>-:>PD'1#ZF"287!SAV,$&H4^> /,1;\!3N=RYA1F_)3W;W$<?)_R
M7,?(GLO>85$_\W*/6_/LRI6((SGW-5'!IJ*R;5FGP8!Y VBDM1VM"#F]9T!X
ML$9<LT!%I5041^G''>?RKY;W?23>7$.3MMP[PF75A\:N*86Y'V4NWJ3/MLE'
M-X1O *\?D__*8UWC[8I#LTVN[Q:/<_CW]#L2OEN3IY;.N=MWL)1+#S8=X4LZ
MG-QSI>L7_^SE7V2SEG=-T7V>LN4^K5)_P%DNNDZR?IY_F5*8$?H'.8KLN:%C
MA7^&<5;;]0[,ZR3OVC5$_44R:RG@7-$9LT2IM>D-8/E.X#M&-G[_LD=X7?(.
M7.2E>A9[!<F=9;K_.!/8F"*W/F=U2EP<U=6#-$C./>OXOEM;'O]3Q_!&[A_U
M#K,X_^N=5Q#I4:E-S[L3_*R-[A/D=F"((-5<[!O@UOK7N[W#/WL*Y?,IC_J&
MW7? ^N/NR]Z5(?9>P1+/[<YZNU]RV<5+MM]D\3O(/_Y)C_+^#=!)ZL.>"&S[
M-2J"U$\]'? ">8]AU5-^Q4]X_WJQZ_P!<W<I8"8!Z@WP\Y\$Z-YC]/DU=D[V
M_!)<CWA>^3*G\-MW9_)4]BDI$U%+L0QVU>1_&/FW:6;N/;<VZB[GCZ.%>00&
MO5/XXYW"'VOOZA:M/M]TA0:,&<:=_BOKH-3J9?P=9WV?J[,H_8:TO2/)=]_O
M$#^E\?P<^7NWV>90(_4&V!M^7C'X9SO\;HO_!#KCQ[Z)NKQ.>FC\1\=3W+LM
MT=/!.F#9&>J+Y.D.V1/G>]L4_^>CTOM\'9!P8UOZ!FCYUV;_@\ORK@'K=^_L
M>%T&X3? ^KOW=]RM7]]3O^2FNA/B/*YBYX$_,E/<GWGW4WA'ZF!DN:YWY+X:
MSPUC?DF;YR;DGOR?7O\5=/6TN(;YLZ#.L7F= I&YH\_]Q.:]@-G_RD(3\GP*
M23V@)XLK);M0>RK)J3H_SCY])A7-V'BZ$\!BK%%:? .LQCTT>?W7R>KO?8GP
MQ^?H3.],AUB[(6TNZ=O+FJDN%E>3D//>;:7A;][%OETANM8OH_#<#YZX'$LZ
M%"@^DYV,#BYS39HW@M\LXS/NXMHD?J@570O]C+9]919_EUG$XP_^GR/E=W'M
M(BV_F=\ =TYO .XXM[DFH7:7#H$XNLZNZ6&Y!/N#N;B'QEJW?RWE\IX&G*&[
M=TX(6"5@VO>78,_V[)V^MZ:0ROL!\M1YG-,0OZCS_*?F?M/8=:X7G=EO\ORR
M#O,/7;F2<=V>5]0R&>,FO=)/U(=^?<7\)3GE/17O@0)'S\Y=J*I_JM> 6F;C
MKB&E[ZFEG66?35&6;I">=/@E@_%O% :%GCA?_H&WF+.\J_4TOC8SW"Z7S$W>
ME  ?]DSXK@#KJ=^\Z[DB0LV=3VE2^QT87[@_E6Q&".K.O--1>?</@8\OD#,,
M,><]!FHLVN6/*EZHW#/OD4I>RW^=7K*^5-ZI5N],"DL$IQ?6"Z$SOTO>^O7H
M_82!K+OM@4I_#M$,;8:-/I@70%2]\$_-M<?91W\ND7P.ILIU=Y%)7[.]?&TT
MW]M!\\; P3)!\JZV%=^;>&BIZX6S[@U0*?8>*?E%]SUWQM>[.^DK6B_8%2W?
M,0YOGY1_4Z#T^+U<<@S?OS[S<U6*R47=@3,20$6%^7]:_1_NXS9]#S9&'FST
M4=.]E&.$AHK?'5;X_DL=_:7UC@#A.0\&A%Y*\ 98_C>BW@'[9IF@"!EN"]/+
M?P.,OQ/H7?(N^])WOJNZG^X8"W''\$F$+/_)7IY?YK7RW0_N&^ ,O1WRZM[S
MW]C5/-/KGG^%O!\PD_6\S-LIZ*R\?*&_>:]%LLWY2?)L[6R*2H+5VR4[.#>7
M5FMHE&H<I1YL:B*41%/K\D><::T1POM8^QY.E6K#]\*_TWD/Z$)%SW0(5B@9
MOOGWT57Q,O>.!LC".VZ-(2Z.6IM"-DMP-\Z0^?KR?O8])_6G?]J$]3T]6(52
M_,UD=E(FU6N$'J#S/EWF7J;>&TC#[YMWD/5U@Z83H3X5.>E[7K+_S6;5]S.+
M_:>G=65T8$61&R@AX?+I7_'E_\6#\O,P.#9KWV-H>]K(=B>[L:E]I[+TN/,=
M_?+S<Y=SI649W)@6+Z>CAPJ?]T@]%5<= C&X=W&MS*_.9'V!D@Y/G 9'_Y<O
M7M*_=THK?\U"=1\69^.*7]6Z%M]'SC^,O:/N-%O9H\NN@BBYTD:"1(6Z2L\Z
MNQ<R?0LGN]&I9-!,,U1\OF>M+0'"W]M.X_T#I\FOU<6;(.FI-D=;'Y]:6RNN
M-4=HZ!^3YBW'>LN^Z!0E=^C<)<.T+Z_;W]X \/^>,&R]\D;:?:K,E6S8C?I&
MA/T?Q56UQ]_?IXBP8J=/+_.KBM"#]7\#>>Z_XLF0U_5.VY0E::48]\$C06\
MBW_#U^7?>$B8??TRYF?ZQ=!P\N;%_7TB#FP^"'+M^92L"? >/LD)!@7I79B6
MGEZ]UJ9Z1S)W'^V:\<$DL:[N<T'N;.^<+E^NA$ MT70\PO;,SPFZ&B:?F'",
M4.6?5(XPH8BCXN84$>0<AX89",Q_8RXU#36J6&_A *T?@$$>>5U3HM+G?W&Y
MJ==.,A,@J1B[R/3A^.1QV-+Z5L/Q3 928R'U1.T_4H"D+1_&4_;2I5I:G'9$
MSY9-%'$J&1CQ-=JX203X?ANG3M_A<^YS8]G@/)"!"ZU#; UVM:-M'#9RF]3R
MV@#?(.I)_2)\ADV/<PJ$6L1K]3IT</&!+7PYUNI\!&T34H0"V@['R_8 NK(Y
M'9DPY#*XCE<9<:685BS0'^L_.W19H\,Q1MKFB$/I(6?" *4I2]ZT=TNIJCQ]
MT?MXSE9.*AUB5 ;DU@?I-\#T;XE0#4UM7"!044>-A+G4X#<;OF2,P>0>-03_
M+\X<K)M"49!],A/Y<JTO.#P3PS&1R/6+M0:/?4(X(<]7668CE]!/B5QF/#(F
M@[7S$D?4,!-V$F?^WTJ<IDU[*BI ^9 _5GJ$2J)UA(>N>1IX-AFT*?*_9<Z$
MV!@3)S6D%I60[U4^2%(?._ANX)@A-Q]L20WQ"]>=*& H*,QM]J>CIG0IL@%(
M\.9Q]%G@8ANWP)O$PT=0)$IL,'LRZ4\BR,:_-4O'DFD%CD]&S?#P1,NKG^%P
MT@).\T"M)*\KT9^6TIBJRB]?"><TU*::&O>VO_1ROP%P9G0N5U2VO:)Y1L0A
M<VWE*25X'O#K13"ENLH*HB5<=(:_N<NW&$*F*S^I !'Z"RH6TTBRFL)LC[XR
MMR6RQD0G5&)6UO/G] B7'*QFS4[LZV>QDL+R((GX^ALV'>_H.P2O$)6U3M^0
M#"&D^1=A]5H[Y9]:9WO1SP*#R)TU!C$DOWJO9&Y9KV)3W$Z2SODQ,;2LBJ@N
M#<*M<"'G/;B?"/=[HECIXGSB3Y=U%$K:(Z%G;J*>>:R'V*?U#,NH\ZAQ2JDQ
M+"RVGCKLR.#,<\!:51UVFZO@>OO*%!LER%^<K^X3ZCP^'[+\_)GWB)-FQ8Y:
M<E +CA^*K'A5*-P3#4YP?7#+,^H<?Z(30J)DXKL]T2G22H?Q0YO'ZLZ_88%K
MFDW!K%F>':8<CH=74^&#2"N4 8YC5O=4-C75,_#@'> ;C,:/I:'4O[L#I%L-
M=CV.MJ0]8[T3/4V22#"A3#%@1.'.7/-S**)_2B;4WP$6VV]QDAA=9K]<% 8<
MU?/'@><9&^KMRALQC;ZW5%1M)4<4Q5.0JH(F;9*J[3C@!Q#)^;( \HQ=8BN+
M7\H11(9P8S^N6N'#.%&"TY!+TU FI'TF6F /;8IT2;]+=>>?>V_L&LI\/"_K
MJPJ^A4X?%W1?.]B9CI3JT_X6&PA94E5 ,>9JR/<]/BF=B)K[?-K\!GA.:GD1
MW#S]?=6SYY,V^IPV]64N+HGNRR@F$>YC!G==RV6,=\[FMN38W?+=JL=RF5EX
M>O_/NGF8NUK=8<Y29(L?71%TPJRE%W-CK4F'%I@UP B"(RHMAB<'"4W&-9VQ
M#*QQ1LQF!NZH**+JLG'^^BKIBWC$/='\#]QP$4<[$M('>P8\5*1L]7J0KD>R
M$)GN.;@&ESU0F#B5,&#VMPJ><S=Q[%.4KD)C7:LA.ZN"0?NA'[,:#E O+*8Y
MP>W%!20XIBM7XA:3QJE2\&@YAM;-6=*J!15XS?,E1H#4H/L/ZZ*.>8JIWPH]
M'^K ]6Q^]034_>[7!U&JAQ"9'8>4@43A,W;S8<Q!J4_Q<*=>:X2&B.M!06<L
MRAJ<B1])@%#Q]1N@QT&-E)2U,S%LBV%XC5UKNY$R5YA?P@ZCRJIS4I=KI!)H
M$F+.GU/9OHHPQC%1U LYQ&B@B1;QQHZ7-P?=EXWMR6%*66@D0WQ+7@'?\@BQ
MOCJBY!FVP:="7[)0B3V5BO9Z>JWQ&"*)RTD.[DEC\4',C1!Y+G"(X?6<8TV!
M+?"#,=;F&@S7E3V.Y $;O[E_9EYW3L< MVJO9D.6B)=<N!?DDF/4UOV[1LC,
M/T<!8>)&K@M7N67XFD8L>&PW]]3B&A/*(\9,)18Y6.;F;45?%SX^6R(ILE9
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ME-=P9NB5FSL+X=F,#5E+]4T<!MQ2>VLMU&2$T)<%1<&V]A4.*T7D6.WYE-F
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M9T2'VV#8"+K,#,QM!^4^A<$TW>Z'"X/ZBT>("D](A4&P$&U0FN2Y3U&)T:;
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MZ8/1 O#_QA.)(_L]ZJ"MOMR[TC-ZKVPBTP !!<,U]:_^ ?DUA'M@B%;DS^>
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MHM\ Z%P("S669+0"63KJJXUL7_AB?_#!$_P<G&V4^K"TR+R5/YLPX#1$;-W
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M?*C!SH-_Q=GZ^MDX*-7%?A, I^+."=NP+PD4UZ'OTUQ4]7$M*R")9>OB^\Y
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MD/;\^7VQ\-T-X2[J'%9E6"#+[^G?/V?32 =BNUA[7O:5)M$I2=E8!F:CG-\
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M[;(O S\L;,FZ:I"D,8WMBZ04J_Y2 RFD@'$5Z\Z^E%JOFAJ!ZJ?O:\[+&8O
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MU_$[Y8)3__8PSFD]EOY%JNR\Q?]U/8JHJR;+E.O<Z(H*N EPFN(Z;SXXVOL
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MU4G,BF8/8:XRN)&AD80F6/0A6[2+>U4WX4?N:#@)UM6M)UO19HW+V-ZL#X"
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M_YD9HL7-;J8@]EMZ34FO>L+ZU"T.R94]TBSXK&"XJ0_(YF5-"5+NNBT@V?D
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M(+HP@_8*-?!@N)"B&2)1R*@MG$AF\7/I;"7[D[7WH@9^D !L.(DLR:%2P0=
MU@_, I02_KF+=5G$R;[ (H.';<K[MMU,ZHRD#G=)>:<J9XY7D;3F/0/Q&&WD
MG8PA^6IGVU!<R)**H&+"4)YC/RR5HTF81[KPDU30YA/4>3*^!G+S"H>J H-@
MJ , .H9K@^5[!(.18MK&8#.)8V#/_+R]"FE6I(1<>[U,@^38^F"5>#\9.)XZ
MCH "0P%0LN[LU/A+0#^_[%/Z,HJ<&"+8?,]"*7Z2N9XE10Z)@/ 0(L9B _(U
M>N=J^%L( 3D05>TX+;#L';HA+P)OJCR4RJG5B_LB-,V 3^VS1/8SBSL"V6GA
MM=>4AFG?G4-]G/1IU$S1C1<4O;]-_4W?M;20H+R(]A[Q0Z+G@T@;Q\;%[M35
M;J\BQA.TY#ZO-LD8@#+ <,9<_8*1X/;R.35QEKB(.IE:L"1=\BN;EKF%83@X
MS7E#A+LT(;1M&<.20L=@\_SU<*2?*3:A*VR.=@CABV-0CN5&0.X&+61NU7Z'
M(X$I:O>+D.:),Y:.8(;CDG;4.4$E<G2+H/[#U<^(9&8X8:I>:420>>.0WIMX
M!9QPEOC\ROK)^)O"CNM[XE/W<^<T:=YDG%/*KV%=7?7//FH2;8"5[3*#X$22
MLJQ1ZW@X<]_Y!MW1AK%H;)@ QHS5V=M>B';KA03Q7W!;-L<.XWOF<.<_U@A^
ME^3>BKV$]G7$65J'Y';1S7M] )R[9QF+01C/+;Q5:YGIL33 IF"D=3!-^FU!
MN%*Z V&JH"K.CT'&IJ8?MZ+<"91]^#M!C"&=NF\I>IHA*L.%&!3=6?71G-4X
MRD+#)#L_&HC"BA':DVVX#*2(\FIG=/6%':I+:.?^VNY^BSH2'&021'?@(0\Q
M#'CY8W+K2U:BTIUW\AKL+U1+?E==/G_#=U(T0>?G\X-I:^,7N2QU//PG!0SS
M0DA9?@WG1BD&N:D4G@%4.8GODFC7YOOF\?%F:?L'8/.->%6F "-57.YE1.)3
M4&Q'K@YBM94J8KYI(&^^F0O-XN3>;'!-19G_?F^P2)"(,JI$"[CYZWI)JEBO
M KQQ) 2??$^A;7'I0IE&' K'HCC\'1O3O>F(R#J&F2/-I;6-W)^1X=^,8Z(\
M,,8-N3_1)2J<;@Y@?PP3*[CR &O><.@[$A]@L_;O4"++"3E(:NRU!O3'HG%3
M!EQ F87QJ HDWUEQ:JCU0X5MF:#DT)72KALH&VH4. CC<AASHG;1L4%91$=:
ME*:Z3_3?+U!< =1(M[^X[%-B5^#P2 7)IN5G6A-00T)>I F0G$@.1\WXL+$&
MD#SRA46Y2<D4/@#C-7<U#_)/-===F[N!"HD'M86!7@GV1)W7SI?D'/_#C.HG
MT0=G(C$B5.K=JY''I,!4P#U/L^$B_3('PIM">ZNHC@;PJ3P[^7K_H"<&.&K+
MRWI6']QCL*,1WB1"[*3SR3JF/#D8B4Y\QX 0!01/)K0O_Y/C#K&(BS>3M;FD
MWT?.PN4UYAJ+60F7V3=55'VXJ4O3HM4FW=!-:/Q=K4CNN*)MX6R>):)(2[)/
M>\O+VQV"0F'&JS,/2]:(VA$;.E:JO, +E[!+-S DBT=P0)AB@QV/MVW+Q(LP
MN(]<&>XI$Q52^_78<1&DEF4/%!G;EO?#L%.KZ3G 56"'/^7YB;>&D"^\1%4J
MCV*S_(-:&<0 -2*DE&9@Z&\SQGN$1H>CA4Z5K$41AMINKZ%K')*JKJ7B]#,I
MP),$\=.:NQ@A7@K'6QVJHJ2$@$+B(KGNVN:!'+%(R=Y]-YFIJ^NF 51;,!FC
MZF7S5X(^H+DOYEA9/HB+'Z5*&U'W@6S$;&M'"4PKRT2$@2Z4$YTC4_&9N[::
M7ITCG#NP8J_<>)?*T.M"_\OZ:.^HZ0CVA@(7^@!K=/ZJ2S>842,C"2UA"(3!
MG(^U0?4%E(4$8B.CGH2?/\6DF?VJ#OC6;P,1!,W.]>'7*G&#$Y!&S2JR; 1O
MRT0$B70;@*.$C:Y,5,?X3N^,ABRM!<H&F3NMART3VW)$$H0K.]O.*]D+0DZ#
M$P_8A\O3L(Q5U*:M=?:@![[+7W79:_MDK8^OH9A6NJ5X[5@E>833$8U90[GS
MMRF%-X9&#KX;*8;]1$*HPC;IX4(E.00A(A>+#0<O(IU*0LVBJR;X;,@=#V74
M9(O-J1#;&DU@BQ$F4EAM6-/S*T*IF<4C$/O;!;@)UZBP+QF48G-ML&A:(6X3
MX]BJZ].^1.9WWN'FU&SX;7'%34 GK3E[U-MS6%L4C; <%",X0+0_)2:%./3@
M%#25*X.7L!Z$-5[S 5!_;4Q_O!1OG2'/.9_-.7=(JW_;%\6K%,#S:U[3X73G
M%SI@4C;ABU1HYA#E%;Q0Z:429%/;95XGJNG1,4B?$=?=%.<&_*;L@C[O$<##
M%KC0G:;LE'V&%HX)DJ;DZ:EYM4:.^P!HB2G]0^?439D/ -4CD_GGA8(XG]E%
MF#TCHZ4_]ML!.H%Y 2U@(6S=,NB6_D2Y+>]P*B-I'BLN'STD.6*ATV;F0&XS
M(D=D4T%:3I0'"1>S<C*;0OBJL%%A%'*,-DBUE.VSK7E*%;, T+NS$N'006(Q
ME]"^$T.Y&2Z&9(4U'VD]_)W;U(I2#N\G/QT$GR#F73HN_UB6=K/?,. Y8,'S
M/2NN92&"]K9HN=Y)8DEAR1BBMG\A?++S!0RBPMHW\HVVZ:LK8J/7=F9Y#K.#
M[CKH&PH#NT319^!30;JUAP8(#[HV30J-DDK;SVX/KETZ=%3X#JI/.S/O-_Z^
M1W.2?M[@OL;M0$*Z/9,PLTKF#!Y4GF[OER&S*5#OY"70F8O/D,-3F?33G".T
M%+H'87TI:_CT;'NU6"7@?4M&"#,HAPN]>U\^VLY,?P^DK&T*C]LMK^@;0 I;
M*866B/EQ<.] M"=E@_T]#+@8P]E0I*R R["$\R>]X <!],HSUMJ"]*1,&.[G
M.H6A")%3:/M_\"WHXTP=L^$)*U>:BS))+.TPZ=S9W^.M;@V)09\=;4M/;6NC
M]N!>=E38E:(.!X/#S\R*A9.CF5GK$LJIMF;41T:N7&;EL)WJZ?+.?Q$1_4[2
M(O=(FB8@YXE-@_5J(D#QM_&^@Q_[[#QOO_%VYLM9B6@"0]+G:S[U-45ZDM%;
M;XBO^%@0?R9'*R(_(#F\GXJ/YGL1</B%G9N:*$&'T9=,<?T#L..X><37\ISC
M?_"_2E%)$X%$C\U61U:8!+N8>AHVIL,2;L:;7H\)-R+7;^<;G+JUW^+$*N<L
M$LMV2:+^2K<O3AENALB\HO-MCCWZ -\%RW0<4S@ORQ"Z% SM>(?+BOBSC*=5
MG,?:CNLL*G5'&@1)HEQ/\9I>[:<OUMZMLKD4K>TO'[-S+O(FYB)L8\X"<4&]
M9S23F,]Z("8D3!)'<Z$EOE6O;M1<^8,7Y8>MN1$K9:&5/QAGWM?-N86^LR].
M_\9&I?<?:E!SQ=%:W@H(CU!-DDGR9>'5E-TZ-B-5:!17(=[NUP+G;F&#O9,<
M0+.)QPAJ=^MTXW-6B=HSH[?QG!:NM)RZP2Q!(9* I4"K9VNGSC^[,)C"#M:<
M=*3Z1AU:L1(S9)?VU>U6'801AK(_==(0OVR\T" (4 YW_2RD \<B&\,JUI<0
M=QEW-[=<JH]>GF:7;N]!<T2<QSHV3OP3_J5XX%K8[""XOJ/A)/*SD^XK+4O^
M@EYPOQQ^4/_88QC7?2$5#+$Q+ B9ZOK.."8/40?KNUKC7Y/NVQI?/:;Q H60
MP1$)_@&H?!.U#T#L=V,]4^\8%>;EJ-H3@DYP:<ABN!)[Y5HD[C%%7W^$0PO>
MY_&?9<=#=[HXX0GGL4HF1W]E9V3D&YA-D<+R8;:DA%6Y! I30:B*MGQ%?1,/
MQ[Z)4,W)5I2['=;#U!VQPJBXO:P$E2R;^IS^W&L^^'MHOV!1)Z  YX3O^H+#
MGUA]A%.8NY(_=WM7A/F1IO&U[/Z*_Z:1+;6C$/>B*(M<)F$M?9TW96=W][OD
MCVH^47Z<LTJ'1FHG4F]DF*@Z=>MO1TMJ)(SK(_GY2^[(3P/ZPZCLCO.XW4?E
M8_O?GUQ0X; 4$T^CX);_-H?'B?-4I C9&L;OPN3, @>F9Y+PZ4KEYY YE*X%
MLFC!VO@Z%AP)N[#@_F+X4!=+QE'WX4B-?=?030SE-!2;X7/_,@HM<#S<(2S0
MR \QV^)9*VE-.&:6L>'G<@0B$/;D7O.BJ &O7-^QN4.IU-">C6<$JB4@^1Z@
M7_=@1!<Y;M1U-]F%]JOF'MI8)P4<('N@!^#E2 :$[!2K=)RL[A5N^.3&+2R]
ML&2<VW:6XE&*(_X!D;>*G 4A^CX$^ OYV#G[_9<4E;>,]Z!XE1.7.B?R0Y(*
M@/GI0NO\^='S>M[XX;^L*+$ZO@<^5L/ A<^6[>5:2]O^] ^V6ZOC\EZ0+J<\
M;92WAOW>:'07W?!/(."7R5HDJ+;D)+NAP)RQ7+*JH(ZXO-'L]?,7:Y!]UMR7
MN W2K1ND;4ZHXBL*P@\ 2.7^W:3X'VNR/-?W?+,S@MR<>Z@;')X*YI6$M?0[
MBJT^!:8M=J_5N,[-/L];/*0)<1N<1>6?W,8'\::UNKX*!=CEN?TS+8BMDGU;
MDVY ,^%[*L+] #0HK'%?GMV5/; (_W.9V8)L302R16'7;3^KCY7IN?R49/TJ
M6?'Y4=--*"*;K]2Y2M^U(S7-EF5UW.!JH(2FH_D$QGY)C*I]?'SQRG%A*T#%
M]V)5V6DN4AGT5Z6T&,3Q:-ST('?3?%W[\-9EE:>UA1(1T[_E*S+K?]99?/'B
M/RE:QB6>^_.!;EC#\'5#!?59KGG#X[+]I=M[9^^&M]TVQ\HZ,T]:0Z+@PN[H
M0>1?$ R][DC>G?*TX(1.-H?BW);Z6Y(/CH5>UT5_+8.XOU? TU4O]])=(XJ,
MFZ!NJ"_=L?SSU53@IYOJN17,^GVN_R].%>^%W9-SQYT5IPX$HY>P20IK'I=G
M>V1M;J+_7*=(&>4GV](=\696XES^-[GA=%;I@HPQOBJT,W/?,<KD<-Q8RCFA
M,<CS.OM-):MJ(O,)ZH\P!S<8/OGM#P%OQ!.1O5&]N?!D@Y.6[AY-QACCRAXT
M"!0-C^ ?7-:13,%FAK]2\BY2IC2?JZUMH:LA;/ EFO=MD#S4 Y=RJ'9UY62[
MNHKN7?2FQ>3X8)IMQ/A@#C;HA2/N+?/,QY\-%2CXP$+V 6 4VY_A-R:N=A$+
M"'IR^0#@P(2;C>VE+"2^?0"L\@85SRMB);_)$4&)O'&_,V+U,1-GB[9W&6),
MY"!H:<:;M->O%'U+3Y4M@+IL#)],E8$)>([WIX? ]^$M7 -P;1V$UE@^ -*8
M:5 >NP*P8,/ -N:B8/>CV7F+1T+OFU'6T15UJA5=RC(\RS>#>8/9MK)TO0RW
M74'?[\516KP5F.X_G@@ CFU2 ;[VXBON5:2*Y3/+>0"X1M-=?>*V3!UDI_[B
M(S7*@-Z$Y%^AVTIEOXF64>3S$(%6_L13WF_I07_ CJ6K$DI5#'GC%G+$TR=D
M2FN,RP#_PKTO,@-8;*PRFAL#:] 0*#)&]_VJ\65=&P"I@;HM#^S%VHO^DG'D
M4.BF^NRNBMM!G5*I@F<!-^_8"-B+NU)B'DH"SD>N!4GV;^SWK)EO\_Y9(TY+
M;#,)]G%@,&+/CL@BY[@0ZSHQGYI\2O#DU'[""P,^(/ *L'G]F]&;JO/.X /0
MLM'T^@'0Z?H D!5!_!_^MYZ.W$SH9.RB&^5<[Z[(_?8?+O;+V?PS//$P^M#A
M/1>;7P0&%GVYFS-BLF9%PJP<L#%X$CGJ#8?5X[(]>F8P\W)SNX>2P>L[A!33
MD:#2L=>-Y1JZVWXV5;FM8%7RR2M3$4N[K;FN$>HV$?KOHL+":D>.W687&:*$
M+TJ;RD<%X@211&Y+,^-A;%E) 0,$-[*UFY0]^"S9WK?97GA*C]ZGWE@R'Y >
MO(X<C@3R@)?C9QNH@;R\KQHL=9OQGS)"HCT9.AEX#3",4^9^"E[;KV^,W&\@
M^]0, ?%"22D:?A?G2MCBJF8-AIW/W;GCZ,AR'K2QF2L-[RA:[+E0CT<B^-#V
MJF@L/+M^6MGSM U,*VM'CJ2K%_CLG32:D5 42<!5VHM G\"Q^U+3F?\C=T_*
M.!8I)E=Z_-X=?ZU2V+]S"ML'<^=-LW=%G.)'OL>&Y_$$6@KN[N\>/3*R/]^N
M3L:!![(9<>"!V*]PN@H_\]1ZM!FWB+IEL!_A%-Q(!\>V'F_2,K+B[C[7=FQ#
MT9O3X9DH_8%UQ=@$$FFN<\#)?_-')DYJ^94'AY/+7ZCW/?9:.**'VH6I*=+S
MD,&^6EH(KQ%!<6ELMXZ=LF?ZE5,G?<1+I3@45IOVH2(3.7DOR',-E)V0-[)U
ME=X9:+XUFB D4IS38RD;6DY[W+-V6QA:TI871"JTFGLS>7^ "<?M?2V9:"FR
MMU(O$SNA>[S(JE31G%[>-/-^&>2UAH9Q]E3_&,O$GP[A'7Z $[XZV-YE$ 4F
M$-;R'^^H]MC8GE4R$=?PO%3M/6XH9&]?<W$8M0:R7=FNBR@(?[5=86U9W[\H
M)J;I.PHH?,G>@N_@CR7+V:_;S1+#M\[EPE9NP$=FH32Z=U#IJ,F\)U3C%B@7
M-EE/Q6L3<.@^/6 :[H_COJ$C&.;^@S6A02)S[\4!'0(>RP!TV_'[(YGUOG1X
M[ES=^)#:QVV73H<J5@O!<&P(T$0@101L*=JV'F9E3:[$8I\1+G=WY.J0K>;]
MR$Y/HCN,HUT+*N4KOVV/?R\M/3Q?YG/<]--<9T6T#(LDE;%% B'M-K5@(')'
M.D<AHJ;@"S34O/W^EBY\P#65^Q6A00RIGRTJBK@$SA8V^C.K+/0'@+#*(T6]
MO5HE9#N(#$3JC^ =R(>%1!6_&V_!JCDK_2GN=.2W/T]AJ*6;-=;$SON%P.DY
MK;(846+?V.AX* +_T^92J*(M/@Q=V6<.D3@)7S<R:+[8EK7N]FE+,S.W.#Z,
MA+,U)Q&:9U0WJGBYK5S9]UUSZ,%NVSEG_=ECT*_TW8!?+]WW77QDD>=U>2/7
MKU/4/HE6YJVQPM@)059U T'%5%T["I@>J=3^4PXVJ5]OU\:QI;\KG]36;_1F
ML*[*D=2H)4<V:\5SQAM)IQ[DBT+'A ?P07*:5R9M;JD_ .YRA50H&*"4PJ@,
MN0;8-MZG^2;#_I%49EJ85G5N[NB470/ZK\0:^#TL[6-*(S F]3&4R0GK8RN<
MT0#<<Q7?SF+$?,<O,TEM/_">#&='MQ3;OJ@#EJQ<"L[%#DO).;"#:P%$ADA8
M3T<:/Y(I*X/C9?&HYT(A,5]_ *K&7LNUW2H#&IS4BZ %\QI*&M.27LTT1K;X
M8>0*'S=.F43>6728=E2(.D'/U$\Z;)[WOH^Y>0'WJV^,#U*^ZV/Q2\<LBK78
M?;-?#8T.5ES?DWZ?!PYGW6KYP1C5\!8''CVYYZ^^]TWT#XSOB5;( K',N+_%
M1.61\@7\#><</C#.D;8=A]"[^\<&U5T7Y=':_LVQ&J>C#[&=*L/N"Q Y(PR6
M[C5XJ&)#*+P*LM^Y5B\E8R5FIYY18*[HTEGMVN:J8S'5^89MI3"#@>O<J'=M
M!8^N0"O,QDU?(,6A 3$C(K._:+I?/5"8%$@B(!Y&8^."#1.ABATRBU>HZ">]
M<RZU1XJ@4$FV58FV$/@ N+F"\N!XZ8A?7"!Z-]8H?L]) A@%\"4C/;.% >TX
M5#FF" T^-8MO3)3%#9RI>)\I-39]"!]M%4-V%=5W,C#DDQK169S6673=1$6[
MCX_V-MLWO+NSL+A0.#6I2"I+MB(/>>:8INJBA#$E5PT=Q4JJ$,M;E!S%=3D$
M QK[EZ"#KYI@G6/<N7PQ=0?)5YR7[WEXB>%9LG!]*!*'S2@,VNJ:&Z5^04M6
M7_"&57'/4SL3]VE^^ZI&T+H$4<)HB21D%M-&'1)1?V-UM$NMCZ;30Y"RWY01
M.1Y&5^D(4H#:B(FI E5+4)7&@948Q \XNT>^350ZU,L'HP1R2];]6$OXSGX[
M=?.\@G$/HR^;(Y[$=.P)&T/))JXT^>I\5=SG8WOU#9 H!" 2)[I=28D45+2P
M9!95:W'!;9N/EF+^ !B]*1UH=^^1(;+K82J5SGLL*)4Q$N&2'UWF?VJ<H=22
M$+6$?;SE9M:)^2RAS7MYXAR2'YR2,;6ZAIIZ)"&:\?_7[.C>"Z@9>4VC.D=^
MI'J IR!*-+).7,2K9?9=ZECOHO:?]N_V:P'+NM4-4=_@=@;*WA*")U@#];47
M!>JEN6CD=OT-+1.(/P#9F%[H<+D&JH)R^Y.C$U/UHZ:9CDIL080^3 WY]\:<
M@\-N74K%=<#9I0] E_Q-D&I7$-N1R9ZQ=<#C2@#;H?EGA4_ 3>/4\A&4JRP_
M]AD4<6R+OR,9E")D!O:N-J!D-L]K@M;L=DZ%.CA:T;29G(C&-[$_F\4-QELM
M__3S>D/K_<.%!D5QQ)=>*6IAE2T_Q4T?D--=UWZ6\T.0B*]&^AG7N-^[W.-H
M'1F (9#:A5)%IR:;(QV<A]81U!S+U8^TUMUIZ%P],IZ%7KA_)14EJZUTCUB@
M.!#^&+ Y_15/SHJ*::.U:[L'7>9)3+WUM[G2/PBBY5U.<WR/)[]A?]GP4_/$
MW&L*OZ =.A!0UMUR(G@$?2]+PM^+4J<@*\?N(+*W?<VAWSD2AGZ_<X@K\]AY
MXT@8^#I00;"B#BUZH9:=S^RX"&I-\-_T'J6#3^K?,I<#QZ40J]4F,91$B,F%
MX47@*8U-MYB(=&&W/K-SS/:2=2JB$F$ZL?H+U!O5FXU[#N;4I3\#94LLO[)A
M'&L:'*@8_,BIQA.]&=I/8MX9*+\S['!#C5":)-U%.C*PZ5:!2)=6V;EV=WK[
ML$HE].WQ?T]#=2A[,O0@H.6+L(R1M@I2"J-B/-DCL5V_UKKI=GFIO#&^&WW@
MUOTM=6(Q2.U=&6#S 3#]$4P4OE9U].A>[*P@9/!GL_.<"9/4UIO,:7C8^N92
ME-=38BS1!H?F'RX-?XXN.5#A33&4HG(S@8P(>.S5FX3<^B@[1Q&+:ILL8!%6
MW";R0T1$^8 S[C^=4WHNNWT=P1?98IZ!!-V'_(^7<&15CN_9*' ?  WKU)<+
MQT87]QRR51/(WM_+1WXT1.ND"/]2#5(#">Q2YD1CF^^.75_@[3CLT1#=3,>R
MUE]UF,"#4A.755D9@^;C49&4>_AF[*DL9#7XX(P5SA4<CVX7^5-P>:[&QA-Q
M*1H<JZ%/F"@S_N,-,\$%*A&SE-W(8W2D&\[OR'*@0I2PHC%;UMZC9:8R7GQ6
MW"@C9:JBU<I&3N]*(*'F>"A8S,ROG/^HS5_QG:=-V,D+XZH>PU4$7M,:=<J0
M.>),V0%B1(K6]IA+EA;)%_UW2%1(FIF@56.W678T5FNU^07+*@]&(5IA9D;J
M0E'V&WGO5NOGUE-\-\J)430N"PO9&79+L(6EB9)[BU2Q*,,EXLC0@[*]E5^1
M]5603M]+QFZNL= BTJ&B\N%^K"3X0(6D?2[+O10%^6)#!DYBN[[-Q$EZ]+H3
MV1Z/+'6NDUX2JF4I2NM[/HEOM+_L^/Y3QLW>_G1:HIK%>$IQBIIGR0.?$+8[
M3%])44RB3X9,F(K W&E3A1;5#&"V8E7&I36V:!/"G%6H">#*#5[99/0V!J1*
MGCG=SDY.!UV70?'6<]01VME(,XO9*,]BPSQ$A*Y?^*K6LC)&L48_+*Y"S2[P
M5>GW"<>8*G7W/%7IRVNGAI''Q);.F;/5@(DD4TI3T!F?CVA#%[ L'04!5'-*
M%;Y(6%JIM-M6R>16R[+7(66"[D76_#W]*;T&&#[;9'?A,A\ W.8]%4'OS2]#
M$59#7S'JI"R1H2@/FE[MT]JG.Y8&;CLNFC>/=#)XZG!%AL.=(QD]0V9F+#8-
M$X"!:3B#&P&E;$<BJ >G/MW2G'4L+D8UG)!\(W]ZP2+*_0\ (E;%[I$=CGID
MS5@H%LF$XS%&&0D]@Z^T< C=.0IDJ 6".*;"0+N*/_=7^O8RWP57 -7)'=EO
M1I9Y"G"]A@9IT0<0R&(AV;2D&80X-47R[=COO(.?="8V#S\ NL/B>N#;1QVI
M*,-*ZASH%K4'E7#-\KI(7N%X>74)X/+C@GQTF1BA#S6*;7@/7*KD#$E#];JL
M"/U(J*MVJD_\&4WF:IQ!CHUP1#T3F?(]PSQ[7?=8,%T0DON9? S:G8\*?C0G
M'VKP[6PI_'^=U$AVGG\D4T=L_,Q-GIF18^V0:9DG(\1)<$$IJCNV99*;%?4M
MZ#7()Y]P#KJP<VT?W/MV)4(=3Z:L+LF8X.'<4E>Q9.5G'ZIAN@<<;+<98\U,
M,+/CC(D;FCJ+9W;&QUVU?VNT+$F^MS N/<,&C'612'.M:LL%M)PBS#^2$7).
M_4B4[[</F,:0J&+2PT9!.;<!M+72]05?M[U\E9+8,Y<P=:[YD;\ Y>1^(B&:
MXOP!(#%X8WJ;[?)ZK6EZ(DM\FF[?%5M1UIC,'TO6M7U>.'\P^:^WHO6FX\Y7
MHB1L]N043>#4X"ZKTX;$'M37H7:F/-U XBF!>$;9? S73[39NG3=]Q95(\?"
M<MP<H^?P:ZHN.ZS,E5_'XG@YD*.P<S,,^.TC*#J9XB /CFV=? ;]'FW'XUD0
M+_N)(5;6EJ$-X0\ ;!D.?TPH7-X!U0?@:(GEW/\BKV;A ^ EUNX6Z/_<?1XR
M?4GRF'%W=O>?_??_9W9[4/::SM-Y6Q3=^J\E0U]IV^RFNEC&U[:;KL!NG;?I
M=8%-T0"3!Z ?B)-5AZ$TE@H:?R>*TFI#<HAEL:]#J(;RNG&KA8_WR<AH-<7'
M]]MJ5I;NE:@R\K:_+9\WP^O=S%'R,-.TA35P&.E]=+1S5:D:/KQL9.66"U8Q
MR$:!"/2U,]'Q?D%^.KSN3 ?#%?,Y'$=;J)S:WFTCNLJ*A.B&V#DGL()E5>ZE
MO]17UUA^</K*YHO,M\^$D-A5_\.>[7X!D>UNPY$K#%# +\JUK""F79M>I>6N
M[7&Y)^M,VG4DR@I!@ZG%Q7*BV[2^D9'!K*4H" -\8(7XJ31,>>'0=223&!6=
MJ'3<O(JL<SV2_J()H5U*^G@LC66$TF]H\;KFX+NBX$3-&'K3,I9&+J*0J_R*
MLT1\>ENU;+3.=K11!:T3;8=*RYB(% E>>'V[IKT\8O!&Q?+M8L;N$'.K1:H<
MC*)_/HP;\+(@]^"WD3MY'4SYQ77Y&,Y8&BZQC_Y.0(\'K!/+7QL.?N)J,0S+
MD=&1:(%=P*=NZ<LFI(5B-*8A.;Z*)XQ0N/E/E8X[=KK&^OAMQ KR%L^MU3U.
M-^"2340I#H=JJ7!="XR]+^<]9:H]69FH6U.N6-(PG!WA$I;,*B;!CW/C1/A@
M2ES.9;#L=Z+S5>6Y!(]87")#WE1K*Q(V]0)*U'JZDF;U$S_4I5(8G]\>,/HE
MS5CQE18-.14\S'ZJ4W6E.9R<!K0#,NC4S-(AY!NW7#5Z%M2"?YSGGF36W<LJ
M%GF] ]G(R/#/8U(#E$L5'C6K)8GS$!()B@?@-)T[(]4+3T_T9?QDQ.8J<L80
MR(,_5;(*V[W#^E,V2XF*2SQHWY?W;/RX:-$HH]*7]<%/DX:W8:EQCD@F=G;Y
M/4S&%D&X6_G;Y*!5T_G*WDEG*)=O-:!X^BK]51F7UMCPV[,?B6-BL)%KROUX
MS(/CBLF",:A 4-.+I>O !-N7Y&7UXK;,!W2FF*NJ< )D5!YGE>-RC,&==*$!
M\6F'3MJ_2CM:-;>UZ_ '3N:Q@?M[U;@SC#-5Z)/<*!(,A;"1#1WL,3Q@#F1X
M#GLR7%Y'>X2G%*X.J?HQTZ].Y=82P!WG WD<L$LY&U?WG9W^!X5KD#B^P\0N
MB$=U2Y;Z:8%<U\\0-2* [_V)A$VBDVU%$489A%(O2P-87*9X@OI\6Z"U+VBH
M04WD/<NS(^H<#A#>\;=EJ<YA0O4R[E9X:1<@X?(Y#-(=D3!S1=TI_E4P4$?;
M+^4VF_*I@6/6@B(R^ZU_S7]2LZPNBK'327W#;'ZAH7^LJC%AQN.4H>>>V]5R
M3.8LX>M"6M41##!&194[L:$"!/6@$J<FB[O+?I5%J:2GJUL.Z>'%WJIH'3GU
MDC66X6/U]W<OH>R3(-[(&JO"K^6\4RLUB-;RY@!HIP.VE@9M*?N39&AB"N,8
M<%O/)-3R-7'QR,OJ9\CK(K%@G"!'6L?.'"I;^;ES@0GJ5=4$/J8*L9>M1$;*
M,_[B7<F-0@U41'2<(F43%S'R44!'Z<CI8ML(A:'#M>]AB K5.W7!LQMP(422
M0SS($KP-&#M25MH6I-DUC22EW78$SD@48/'F$T^X[]43^@./:S-F<"]C?KG)
ML$SLO(L'Q0!)9O^>L-4F1"7P[=%:)L+MKZ#'\\TCD__4PN[_J068<ZLO#WBT
M0^1+H\EV?N>"2Y!U2+9_RS]]ZCTB2VF&R/\I]^^JN(3()V?BG_UQR%X(^*J^
M8)L*B *W6B^BS/?EH_+YS'3:ZJR(>R^V*7.NJW1*CZ%EZF\C67HA5!?U=TTF
M*!7]TO\HX#V,L?#:XSC:S9&Q$0-FD&?N+9VRX.:K;E#>US]S:MV>Q@^0#P *
MW0< A'9S^"*817Q!-^!*[$S!"D^!$$E+Y)N B5+-RJ/^53Z+77\HB(KH\X[N
M/,MTQME3.6,AUB>\^T3PY'/^?1,T_)C0YYDO?9R3YHMX,) R):OV!+\<U!+E
M3-0%]319NRNXVU!ZWJY441.PMB2."<5(,.X74@O*WKB00O(ELN%QQNX*:#D_
M %LC&6*6LDQ\7\_.UEUQW'Q*9S.I?6Z7FD;*I%X&D9K_7^9JIP+QV;=RRC#*
M+X,PY-2!335E%UHX6$?DVG\L'5%.F>'#RZU*@=Z=KHJ1"S=E )B56ZL4X?3T
MJWRC'Y/5^XQBT;&4"D#S!" FT5U[M+\4/?[CTO5 /FIH7\P,M7?KWPB,,K,U
M  H!M5P284,H2D'3[=62/#O!:9Y6YND8E3JWT^[*<QQAF8^QORX^.'4CSYOT
MH(D_NP:.!N2,N"2("27&J/V+5H,4">T/6\B,NE+1WNB T0DA IFW%F+A[6_8
M\DGK/$IU]&186' [D@?M!O<O1ZWA: ;6:P8L. # *3@(H4B;J'XM.-_IQ&D_
M6^"3),X.[ODG'M,M*H509O_AOS9:U6[I8]ICWO.1PS'+98NGPHZ+$7X.!HX[
M2I.M(=_@]Y]4PUZM"/=DM^\1_Q]1;QD4!]-$C2[!$MS=W=W=6=S='8*[N[N[
M!R>X+0[!W8.[)+C#XMP\[_?=>_^>KIJ9FJD^7=TSTX?# ?QJHYD,^A/#BDO1
M@%7:3L;:^@ %+E+5P=&^.Z1=Q1X'IR'*" (KA@I@N*P0J>A;MLR(ZQ _ 8R:
M.H[E<.4+*Z_+;_L1JE2"DWRLRHJ[P"<\'6Z))#97 ;-\.06<L]W!5JL^#?N)
MI\61LZ<I[D)*DNB8\:0S O/WN>GMCJZ:UQX_E6/PCF/?0MW!*RJ<Y6C"6@H'
M.[(LKACB=GMVX\S1UCO1/=6[_?K#BK<!DR$5DR':[HT700*36<N:O8"JC^_!
MMY,+:''"&L<^P]]<IN8'>9.WHX<+6T*8?SUKJ39.F#4-$UW^&/#J;U7H+T4N
MR;W5S^O-G$Q>!^*_;WH^,'E&/MF^9\A86+;>7P9@^%8P_WIS! MO\F[C/KA_
M3%,F<(?QQ?O],]3_SV![M;F#\-+Y7UZV-'^Y[B4<_W%TU?U_(*N:3I7_%\K[
M/Y#%7MAJQ%)J,9Z-=-?)QE'?9L]5]EZAEM%Y1%Q5X]G_Q7QWV)M/S][S$ADG
M75A<V(<)CLRDFFHS11]C#%92ZS8['%P/^C8]/^YZ\RY:5]"4I(W.U5V[09^
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MS[>#_C -F_L3#S..KG>*D9O$=Z9 7X+R4=S3%2.=*3QK,=6=.A+?RE75?NI
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MD]$?%0L(<)L143'UEYB_,!8G/*B?B(/SO_&&.3 9 <[G@-$<5?X3"XN+5JI
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M:ZBWGL.T]/R'+GUL_2>57K(P#> ':7OETX![!)E_2E]L_O<"&#6'N\!T7N>
MK#]$"'Q4R]^VJ68KY$KT/MFYY=X^M>#NEI:*3<+9AGY@*IS0Z;0+1T#[>S6L
MPQ[8^0D@A+$BQB9U(3?-<2 <C2<A)H],R6[^F+I XXP?39S)/FP8&>O=PR4_
M+[.>P$>G*-\C#CB$,Z-[IZ9@&(!:=>](AGCG&)L?F%#SS_':"DQ(&I! _P10
M[7S_-S .76@D*_%/VT\ K?3U?-B>QL'M8WYU$>1;Z\K=G!]]'$$7,MTG(*%O
M5&1/?7_6OU?$<5N">!!XS3Q_Z(:/\\00%1B1)6Y\>-&AT7'1KA(Z@)XPY2M#
M8+%8?O3;<=.H#(?'B#UZ.L;42JEBJSJZGO!#+Z+E.A9>&)\?WJ?A;&&&UCP-
M3 ;,2R!;E?E0S*G/W=.@W8VL2/9E0+SC^I*A%.Z,I'R&5=&V5X:6B<A=.'#;
M[B?%S2@ X<1V:.U\A$9KZ89M JI+]\(R+A4PE (^Q-*H"E3[^GVG-?FS6P&%
M3J>M?W]3D;JG[53[NT*3>M?Q<3YY /U&!Q4%3?G7)=QJ8CPN ;D_9%:=)9V=
M0.DG )%\0(V7Q;SWR'*CM7]YM!6'UVFI?_CPF4@<UWD9192.RG0#PGES=3TO
M-'K]7:!OM:]LL[=^GZC@]=G3G[,^$'YE)C#],9#Z5K^O\QDW-WL<F+L(S$X*
M7SAD[>"\] RT(N;<H=Z^.#"CR,;:G%D1_&F)8Z#[_S1UEF%1[=_;'T%!!$&Z
M0;JE&QD0:<FAI(:61AI&4KJD0>D:ND/:40880J1#0)".D>Y^9CR_<Y[_R[VN
M;ZQUK\^Z]S4OYMJJ>S82FGQ8#H)_R)F=N659IS"77HC$T5M7_L0=E*.62A*1
M@-B-WYY P)U>WLJ.LQK8)^[NO" M,3I-)5[,VFV#5'+8G.$/]=M[(B$YU,DR
MK\W>SL[9T>*G(4&GU.>D"+*8Z#53+ W9 GZ"GT'RV8&\AM+PP'M#*]2_-"3<
MX@A%+.,P4F%REO[RE@O%HG< I7&-Z&ZE;KM&WE)]$%-,YC4R]T&B>5\TR"%N
M:U*^,<_U4>E[Y8>:Q2LJ&6.L:E"5!)XE54Z$[+MGOPJFKB>L!4& 9SWW37N/
MK?4$,SBL8NO;[W4.I6L[>UQQ?II0)1F*IZ'N..1[4&6!K<W.^H5$)<>,A\2K
MN2<"0LX$71+TE>*F">T92"99SW\5$3.P0VWL!-."&.MY"GWS>V6[E+!<X!0,
ML-I[=WK%8?7A\I%G[856<A>^T'W_'FV_!Y04UD<4_<>"& 6SU,'5X5GJLZWP
M]=I-:5+'Q[U1QS5<"5;@EFQV5G6M/I877$J6C#*K!N!E:9+]UPK/C+@S*5[C
M=&3']<%42*OL>6 ILB)U^9_)>2BUPVH68DDGJ@-T!FN[,XQQ3S6!'T)+F>57
MK,3=4]LK+$L?1#G,Q/B5=54V6GSW\A^9>DV#FUN?\79DA:'_9-:=X6ESKBJN
MD2K!([UJV_'$=>-YSZA3IG"[!R<B9=%+("Z6W$%HW]74U/&X.=_NQC"#!8'<
MR@LFT12CU4IS&:?,3W%139O&.%UA#Q(@%K^:6J$IH]#A8"O"\!8RGD:B<D49
M)S5A9U4FDI[81'X[%KJB3"-H5O!%Z=>I,BSF']_U>NZ-)%?%0RJYEAQ=SS<8
M=8@<:![JZ?D_470M@QE1&3Q/SF&ZW.KDHG!9=3!2G_4JJWQCZ$L='GL'< /*
M8SI'ZZT29%.PIC?/Y"@PJD4Z 5E((1-?Y:$V6^_T]!H3.L(4$1OJ.IW;7'Q<
M$[@?9B?QA/B907A%C=#HGS'Q3T4WV2DPN5C%GC0D*<HZ*<-4<!)@31B^"C-K
MR6\2YAPP X7Y:9D/(*,OOU6/?%X*6)XJ&WQ7;2FXI2#IJ*U^XW72M%6_]#7)
M8IWBQ\33G%5:Z8%'HX1T0O?B^K;AG0\;\9:ET]00>;=4V*KSQG6K;A2)$3I1
M!I(#1O8Q]@$>-"6M\8?>J>F,V/+.&>^]/3X7A#6LV"@SB=8;#>>3 264)*GM
MW]\@ N,>"68 !M-6MQ&&][P P2O[4!E?COOG6[A$/$]9IUM)EA[3$VZ9<7YG
MTNS^.'KB0.M-=V.7X:TPLU%31K&I%AYB8BOR>BU/@/1X=N5$)WR\=SETMEC=
MC^C;T]@D1;7'7V:Q]"-88AE6&(:1F..&.E*DR7YA,16& ^_\A(KLY/4=#(-<
MB&GV6(ANRK+B<G"C''<#/ZQD#Q=^DD#PM(5N3YW/Z"*G.@1O5OJ;V;X/\<5L
M'=3]K-O?']M.E*.<!6"V;JM1ZS@:2BOFKN[O/V^@J4E^I*Z._^1I,G?QU+QG
M$U&1GXO+_N&[H'U*XY2/OG3YO>(%PHZNB>/C3'L[O]9^02JM*%>?MZ:&W<M-
M92/?1TCY]3MTM%)7E]$>UX%%5F93QQ\E])U6_LS"\T/@67V/V28G8,.7J9 "
MB3="8KB83H4%7]6PG@,MY?NN(A).KSN"(SY]532_KQ6N;!/KG/3 !NCK9_?#
MU';YS6&B6O\5[AR%SVA=7WK&=T2TR%-:A+V#R[#AZ]"=,5[JKH/X^&R<81_F
MK_K\5D-4Q4*'\H4O2_;"V79/*L_5[7^LY%$ZOTRZX2;LLAGH2U5]F&+K8:+6
M#]!>(I,3V#^(/'"K.[)(CQ_TBK2N_QBJ_GZWGH%Y :'J61A46ZW_J%Z69L87
MRX.2[]NS<U.B</?/(@W$K2@8Q12H:8"?:_EOULZ=G:U>2Z>(6S(DL=IV1^$&
M"4M;2)_]5)=;<N=_>VUVNJZMUL_L,^K&L;5*\:DHA>+A/2:L.X!D1@=3!&;O
MPOKI1SGXAK\B;?8C*P2[2?[$O/]4*YXP&50#OQG)=@OW=[D#:)TL-)\'JK8?
M3W^_ Z2>@E%O!Q>IDH,%A1OI HTK]'>K W:E73H7.^=ZA[W>.G(9B^^8L(C.
MOAL-7<7;T)$'+C[+CI-B@^AC,^BY/N*G_A W,A^089M85*"VL\$<YREA]*>0
M\TD#X5G\FE ]#DX.Y7/Y1$3>4KI3/W >N:*@6WK1_CJ@C<4Z+.</A7W5Y:"R
MT7R$=/\!>&3^*Z[(<$=)->R1:_K7H96#=66+C_EFZV=8OS@F%+KX G4C#OO&
MF\(4?L1)A)AY'NP<01]HL]0"3O9>R<Z':6O(X "M5<J4#@.2Z<0G51.>D01Z
MZE)L%!D$^1J^D/JFK"/-,W^3JGF"=+3X%FTA;^F;S C4YC/@CXK(KKYGA"'M
M6=QR;BCJQKH\L58M\F*P[26%:VVBH5C7^UV%.3&)#S J/=F,CGI7KK[VRR0:
M>J&W';)1+L(]S1PBN.ZE94M!-+'S/D1V(?P(_<:75=GA(YY8OQ[WJ,^6&Y.D
MYW8=!S5<!(O."C'ME'TSZ7>C61!JB7L2E[HP4#2+Z-2);+?A"]N#E&Z4I;N_
MT &7LLYZ%.?UBS*?L!UIRD:FZ=VOBH)]]"SB)L-YW\[^B[$40W%\T(4N1:%-
MBRWMX6MOX9B;.0<(U#JWS[HNT1QD'=>[CMT;JEOBH_Z,W\2&>\%E<A-R;5OP
ML&5,*%K(8 ;#J.9'0Y.;\&_=]MJM/,S?#UZ9YO=-#T;/\BG4-=N/$7) Z0W,
M1$>]R0Y:BP>MI\2Z@UV\+"$O^ _?#PZL#2 N)14*\^B$4@K))4[4$4T]E%*L
M[*FDG]]C&F3&;-L.JW #4O!_E!O*%N<F58_9'YRW:KXX7*'7G_Q\;K7W^53T
M8"JU>)Q_]=-*-MA*4L8V/DKD:?PC5GC5K@OKJZPM-G[%AV\+QR.=9)MD1K2;
MTL8&FEF(_86(Y]3*J?^0E?6MOSA8Z9<L4BX4>9_-(> =&JUTH:-,;J?M[1\T
MIC/]8,4B^AO,8#XZNE$I7;*=BE@SP=G<:P8_K)T@JB)\2]"Z.Q['-;]/L%XX
M).P>M9I2B5S**I7X!2%1&NZ3SG9P;Y)M63S +.Q9FYU[#6)#A5/TP^A:[&L2
M ">7CZI0:"*%_U5 =.FP)XR\SWK.-3 5)%$L@SL3\W@JGQX'KT2_=V9OZY.L
M%;.QKX8*U?6]KKH-B6]O/Q_Q!)$QAKL=9YY)*Y(RGQ\L*=TVR%-9<Y4"E,)G
MZ7,AI HI!!HN-F06TKI\[WL2HYTL5'N_&20>C)4*"1IDM3JYX5)K]Q\'.]#:
M]FWA5<W,K=L.BB>JO_P ]RI_$+1W8=M4U$BSN=$7"L?1P0<Z(LK ]U1 0UAX
M#W_'<IL1%=:X<:R1Z3+"O>%)XMSQ@BY/O:8U1A6)5EMP^*'=L0I7*N2UYM-@
M*@'-Z[IR11=<HYU\ QP=K+%$RA"6)?/K# O39+] _N2P@24WL=,3OI+7A7+S
M99L!GI"%1&_[=[UTF&D_TI-.;W7>%NNN]:T<?NSA!M$:*RAQ#@1^*6\I[^2G
MH7^^\X4XZNL/)?Z-,U,")IH!"U UI_^:'0"G992?F")G1>J98KOUZG[#"HVI
MGL5:PE7W_J_0>$JUMH3IIKC234J/^9JVM\^'X$>8R9[P@5Q)I$\:IPHQU>4[
M%NMYG7KD.]#"0#5WPO+S<3;"G=A=(+[:=9J7J=3HQ^!$2V-_^<8C09$TC&*G
M#U"1<Z$-\1R'Q#,%,BD?NNNZXY;BU!=*]:P_#\D$E(EV-D,G3Y-S$.MU8K?D
M<Z-,6*LMSH:.\UF*>/0.?%\^SRK7[:G&XNX:^(@,]PTM7=P?^-;GSFUPY/(J
M\M>/C7B;7VUTOR=VQCSH")+3,8R[ZJN!DRN7I@ULI:7;WZ:6A_+KL%6T?Q<)
MD[?5LKR27VT5&N3K%\K)<@V.QPL3Z5IU>K'3OF>GW^T;W-S&CR!EIIROMU9W
MWZ]GC,+L3*+$26PF!=.W@Y*6WU'/&[\*V!U<L\I]0\_]R<S*B;7+YQ=A=)R3
M%ZG8%E?#O2F\+^RN2-:M'Q8#=$]5A!SH1K8-\)M+G.]_\A2'$VETO5W&=L:7
M0#"FUO[JC*(Z0:K,-\89$?PI@1_PGD$N8"%'].#] %#T&>9<QO =X"H*N$-U
M)@GKCO^XES/M0NF7@$].IWA8OW<'..>J^.U.CG%*_KG3WDVG^@5WTF.XO+;7
M_!E3UP?F&?P9!67E!PO?F/R?E5QE"/"-)FGA"VH\E=2;UIH&V5?9J!8YA91
M<D(8D@3NUW/;4A 5T4[5%N99OW9C.\X1FWM3*O4U,\C/5K/#.$&.I!Q78-$Q
MMZ+U1WH)X]OFIW#ZI &$[)68U6Q(BTD>ZL?1\X*W6"*&Y<:%T'Y6Y,2$B:&#
M?-I;O6UJZ"5=2IW.,??#5JQ5,%0*%+QN55ZA\/5B-/)YI= ME1A$@)-41D>[
M#2!TQ6$=E\U:5^C.!=,5J;UXY&M7(Q<8[?2)"+.D5*KP-X=I:L:/J$<8.L;<
M7^DCQOLUTA,$S;\QJU$[R\!-*F7+2B(X!JS="/EZ!OW[B0U%)8@D>#9CJZ!:
MV8W,F3Z33)7BU*>)#!)IXS!YUBQU[<-+I>^+GI YPP+XF.0.UA)([LOI6,C]
MW<?M9K/JH6!967:W[!*#O ;^R; V@L\A"8=+/<=5F,;<&7W.SLK358^M-FVL
M(14< F&/&Q_J.#3Q.H"[1SC LNL/"A/*%LI!T$K(J#V!ZCV*47[M<LKW\<3.
MC:90))5]KE=7%URCOJ%"\ DNL1'"4/.$39PWNUE3FRMD9GYR]7T?N;GE;][]
M\LA:X1?N$PVV6$$>>440/P-HGP!0<:*J/7@%9)'NPS1#<J_1TW2*Q,PZ-?1U
MGK8R>W>BFV>S+&@_S*QMX*N!@[L+584*0AF!N\QD!*KNM%-)SGD/6S0*T>!,
M")>/W:TZ,U*E6\XUF+4NW$(D(OS%7 3R#J_;#!LZK3N^,W0Q2;L9W PF[S?I
M_7IU 3EN_LY_RQ O$5?IC75^H?9JV^E+W3 QQ3ZS]T%!_< &P^M[6N8SVE+8
MDJIUZEU]&EFXO.D;NNQ4S!^L7B:JE(,MD@+V$)U:>G*KEG@7'S&> ,J</$B2
MWM$9K":02D;8I_9N5]V:;,)M^]=9;#\]BIDK:[945S">[S5ZHR2? G I:]*C
M., Y#U?M6LMJF,>=L67_2L2^UA<NK(F+L3)4XS"QYN]J[&=GP<%8>U/D;>3U
MG&/@4VE#U7?K$9RTA>KTQRU;AWG#R0[X:64/ZHDT%XJXO>?)C&:$R\*G5'NW
M2*)P,09PS.YA+:/>PL';BO. =R9.+^J3$G>_3+(MC<46YKEHD((-$+VQ%09.
M?/P8OT:==0"_-AV$HRC.-P$&>C)&IQ\@Y2/5% +R012Y\AYU,*-;>T4XI>E&
M=S!?>(#8K#F3G\74TQR8M5Y3VF7_F!HSL45% HZ9<@6T1CVO.V^@L&[_0EN!
MSC/Y!0W^G%*G4$=^S.NVN1<2FED$5F]UTS4ED6I%1>Y,/B%"$,7]/[90<U\1
M3.^IJ;P/EN*.C_%SZJZ1H)>;]N_ Z;U+%]_5U7VDBVGT69:T,9\,R(]D8^)/
M',\]%J@4[["A?T[ %9*:RL6J.,$H9)KU>]'K)\O"8,T+>;O$$17C5D&W0W>6
M>,=6_#&Q?>[N*2/0MY31><]9#[:JR )#KIZ1N(?2  =UUE;?V$#-97DG:.1]
M3YC1N+6:A2OR&:85V1'#TUW,[VT>^X6<$0<MI=GIE%'\K7C/7"SL..VWQ!98
M:428:=> A6S- \6?QT&41,JLALTRI0^VNCJ=C.+_>%X%,-WN@(&WBM-O"@^S
M%%N$-\2)'@P,<S1'S7O4>"?^65F[VKGZU6%%Y_?)+)PU>?1)&F<D8?B6R"[U
M)X/;O*KU&7>5^T/IQ.PG++9]DZF,(D">5&/_]Y/C5)8)T:WWN>+%.>AR3VQ7
M_@CX'O;$I;WTQ7A-Z@V9LQ 1_?R+[ -W:O&*BQYCS4=*P^VOD9$'NYUVJJ#D
M1TFI/"?%B^RP3$5ZBTCK_F22@5S0-M9MXJF"$AWV("IH;_7!''])C$&^Z^/*
MC:3=T!4I&2)&<.!5-Q-@((J*N+W[ J+=[A%\:,1JM_:IOE.9)B(A+$9OQ L<
MIIO/A27'#M3^3;_+=&O-7<Z\LIH)YMBY60T<@G;;VI: ;_,1Y_QW ($8&<'*
M=88KIVY;'*5JS"<:V^/+FVH5D6]85QBJYOK)C^Q<3]FT+..?FOYTYOU=1W 3
M+79%-K7R=L&-MI4R<=(QL #[MH>K_O=W_H/#T-?&C</3MNYDO7A0I5%@4K>=
M*A./1O?^?1NYA+2FOB]-.?@& ^M'+7ZQU.0+>S>$NBR)09T_,D!A5N[-FG/-
MX1;8*1YTPJ\X?#\7O]0VR"2N03C!PK-4U'>ZJ4/F=?%8971E=5MXO&D]\LP:
M!JG[C,/;-@FKL3*V'W"'M?@8>7S"6[T,O1">Q78 &<?)IL8W)G/^5/C,>"QT
M3NG;6B%4?E"F"\ .V##A>6'K$T.8':PLLCMZNLU;M<OII$Z]0^(41>@Y#^TG
MWS%7.1&*=W18/-+S&%AU&UD1S>=VPW:HW]&>UEI4*663-?[R@MM.'>3LX=/5
M&S.?/$/509K'QCRV5FD;K*6Q8]*."^X4!QDZ4*7A%U''+)Q=IPP\W(^HHY5G
MZ@M\-2T1\M8;O\TP!(Y)AXPBT6]+D!7M#-MF!Y./Q5W#QFB=>W\;3.RI%<RG
MV8CT/8WQ&_.%)WI@K"_G9"O7E9%S##H&@@@?MDJ#&H.=0WI+ ;O6">+:O&78
MI>5A#]Y=DF--;4*H!IT;]Q0SY%?XX-URUM:/<6YTM]5LO>T8AEV&I778QT76
M/RAH(EJ.^\N(U@687C(-Y2-5"IGD*5BJ+)W#DPH*72VHOV.EDQ3HI@;:EW*7
M68P#Y9J[JC5[Q-I_0E7O<SL&8&1**C@J%^!P"D>1CW@(<1EG]Y[A%M[ODU%(
M]QRY*0A/]M-O?=4G$%%&;")#9^3-^G[=*<VZ_<,7:5)U/QZ*-XP"?LTWSS?/
M2:G.DUWW%=:NUY\XXC3-?X!Q_NB]_!GN,X3#+>EL*7_$<]R*M"\K%YEQ=+P@
MYEOK,"HPT_S0=4G0+Q,GE"1.[L9GOLPIXT;-T<FW0+$R'JSZ)%_'@'Y79JJA
MZF0ZKV*EGO_Q"+6#[/[] 5DJ[_U\T32)ZIN2D_8,.0,&IRG3%.$8$CULWZ:.
MQZ7"!\4/'_?^QLK>Y$X[>VKY=95(B*QY?:S"M'YQN;[%]U4+7B76:EL,W=38
MB6=:MD)^4)@R31C&UT45 KR#5$RK1I5V8^/+N+SQKEB!3@N\2'KGZ7O!8[,C
MC$@FS^T $JMM 58#RQ,*L!%IL<#W_L02_U&%GH_&I>1-]T=ZH@I7BF!V^DV1
M;=?VMH]%=IL8'C2:E=KH</M!XVH4[/<C!GL0#SXE]OS1H<Z\+ELN=PH*)$.(
M:V,$W,[A]RY7/&S\H-5/*6EADMGWL&("#"U5JG?U)107%$Z;5H[[HTP5XS/B
MXU M@.C]6#CI+Z!\/GO,*;/LUDL),<90[$U:]2043V "5[7YE>G-1B0R6P3R
MU=6'FKU+LHVL\H?= 5AW[@#=/+=#:,N<NJ9/6>[\FGOP_<C_N:_0SEG<WP^.
M#9PM.C7'1;GHGK';Q!I@L<GX.;QA7_%I =7T9HDQ)UC6YUF^L71.YRXLS=<C
M^1IL:!R5 XAJJ;2%RTB3E/-9+:\D5BJ_2SY3A+B-SQ@<'+RT^IABJZ'& 9JJ
M'2U(TM W?ZA6*41G>J+4>!+ZL0?GR'\G*)Z*E N$F^3#D'0?\-I#9)/'4N4D
MML'U8)*5E><)T@V2T58Z)N.U4UK>J<P%+7MHZF4^^YM64<[>(KV/K\,UU,+(
MAT&"&@S%.RW6M,O[W,G.WO2G*'/&X52SHP!'-[BNP^W>*:KRX"3*\A4V0MG9
M^Q&NVQZT[&\^]RO7XPUMR]M&'?:_RR1(91#AJ^_M'63,W/0DSR^J[$10V5'*
M6.!_I4":J^4,#MS6FG2'(9OPBQ;5U,08(D?7S"B"F7!3F>W4LXT89_;)R)AC
MGC5/-S'RD-@^*F.N#!\#(CJ'F+)MZE.3"3.P<,V+T\GV+LIZ_AAM\9O!6?E;
M0KFIH5>CD.ZB6-4ZVE6'S"<5DQ^OI4FJM7A5C1Y'1O*9T,9(.AQNJ9HV&8[K
M86,0O]M-4[T)TJI#ZM("V S#ZC?NM>)DU?*'/JP(*&P9+VZT\JRC^52<SA(^
MB3D>9/K58&X0,O<<SWW,NJX8+UKW?=W1\?X>2$*W220FDW965&*&4:1<>J!H
MK22..0P+*51X^=*T^WJSD#5Z9UHCLK2ITO*0QH]O^;+N]-W\UEDI)=>'%ZOE
MI)R?)\Z3>"_MO;(Q](9I:PLJ,_UEW;@A2 L[NXFXL@TKV>5?Y8.1:2-6TL^W
M\P?:$VJ%FY@]*C\C%2;3!3L::'NO/&!?]>I26[VD\-ECB"FQ7XNVQV?93)*U
M,7>;*<:TE]=>A(#L^5/"E$P^59?>:Z<+46&6SF/,KJ<%D5+)$&3_>)_[2'%5
MSG)9[69:%5D"<2/=M#G@_RS7^-24=-J$(ZW*+++@>[L.+H=00=:MEW#]LW2N
MLHM)-DL#7)J9I-ZA4D[LN$W*[SR68U/34+$?DX5JNT1\JB(A&_)$5G9OK?2L
M$Y4L<%0]QJM4C2V(QSN#S\\G!895W^!2O>K3LH&5D!^[SGX%=\H[U2CW+T<\
MQJ'"-8D?2-SA*^/<ITS_'J$&UX((\(_,4IIF+5$;?"+_(T++R56HGB_XBZ9W
M8,#CB'!9RE9<*4V4'C]#T^9@GJ06TT283HB,J$_GGJ7K5%#^@D==:QZB%Y%-
M(3W'&[6E9!ZSVS$?WF-LIF2R!GWZI @_B*J3PMWKG*9#0)6RPU&K;9YJMI?8
MCYJ2,NFIXILT;& C6YXT(]385Z1%,\M3&>NP\PHIPT]/&T5(U"LU50NSC[:@
MMK,<2URM81%(?;DW$=T):B*.L9K?NLSWIK_Q^$*<6IK)TC5P_R*E%[$C,E9<
MH8T!J&IY'82<#?GV3$>-JZ20DE'H*;%YU95IA<X.*/Z;TE.[M;<T'*S2[6I:
M2EBB= ('(KN <&DOJN0E""Z/J0"'>=S+:+SHA[X$05NG$^-3QUF)V@:ASL^H
MZ_*A^:Z"E^=D#F1Z5BU;>="7CT=V<,=F'S'N;-H?:"LQ'\\DE0*CHSMY7[A_
M2I-/$SEB V,0P)?4R8;V-.\ YIT:4Y<[BRYC"^B_@5=> %-@3.=OEBD#)V'C
MRM/(.T *9/K5TC%L/ 9?[;SA$#@= =S6!L)%<K=A^P%?)JX75:<TLL\#RA?W
MAZ\%;[[$BXZ?1*">*Q#[0P=W #V/YP%?[@"_1]<O ^HN%B.VH8%XLX$5D-/+
MJT!DX=#QC<41C&#RW2WE'2#\#M",6F9:BX[XW%(VHG8?[YV<HE>9BZ%B@ #*
MQD#0\<[):0GZ-%_4:96YX<[ 2:"'Q^75#>R1U*+&%%!R_T8+N)0&G,S=.>Y
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M#.P,JT+K99F%4K$#AO:?.\";Z;F=_RR-!C7?AL#M'["S7##*E*/@*+#1<<D
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MY#I,/IM$728QG>%:RQ&)/8X*S..^ER7 #: EJ #XET7!E?X9;?]%[O^X3+E
MM4YR17+'!?[0##,JIG:;I):83H>'J:]&/5LA=$-<2DFK:Q&S>OQR1%X!YVS+
M2.?+52[BH[3'<^%_6W#"+Q)W$>Y.A0.;+)^'.N<UJ+&/MNYZAL@"DJ^-)21[
MM(+@L P(I,ER U++=9N RC ^[&K9G:KNN,-=#/^3%K3CXOJQN>_P-NJCL\-J
M8F/Y=WXWXD24X^4/_G=MN8IWP+*;\)1,"9&K(/BY, 32XDZY;CY)H6:MB)SQ
M%3$=WTHMK#U'(KJM5CG:L/J4RMSH<]!>[?Z'SM;<)QPFTT?66=0U[XW)_F?[
MP+(<K/_CDM K8-T4)GES@/1R]0JH>044?:2^2WX&/8L 7@%MG2>!AY-XKM?7
M%YL\A&$*2!K1Q,@_EGVQ@MZA9 (T4/Y3$9(6+RS\3N$T[V/UL0]Z=-U1M:*]
M4*5]23QU5K>FG"X6KA4'1%4.G 66/FMMRTTN)0SD!(O^:I#F$968Z'HY);X@
MAC$CG3SAG$T%(@2:!^U2,;*K5C);R)_,EB+ <S0H"V$"IV<Y/!M?@9_>AWR0
M4&,4BI;'FVP/%I3'IV12X:]:EBMUBJ'D^.8P4N1Z2AKN- $:CM_8CY6[2\R(
ML6S8AORRK8;4KF7:$[J;&_CK#K%Z;)W=DZ8WF@AL-'4]Q* CD62QC#D1?/#M
MBCLBFD>HIK27SOB6U")@PZ8=6::6,8C6&-.].\19J+AK)?R6?F;_!PU;4?_?
MZ23*7 A;S=2C1L^?NEY.JK]E6;H\L3SRTZ0AI*NL1X[LRVTB[!W4MN<%"Y$2
ME:5GLZ1B5QSIPVE6P]@I)\.<0>,R;*QX5LC9!%&^]I]_B!2HVB0(]0\W*IF\
M ]$3"+4%$#4,=<0Y6ME[4C4<CT(=9IE'*.%)CLTK%KT_3VF\-^\\8R)3"=''
M=ATP$/D6*]JSEN-M.)A'JEQO2)D3X0ZM/U?J,'_11[DE,7&/ 6NZKB1D6.J+
MJ8L%D8J45_@)*7'F3N>:;N/_[(A*4#'."83U*[GD7_#]Y4S\'*:4S]EE.[?0
M?SU?8A#O4C9'N:[=3[2&CNF_$3"1[&)<YQ8N(991W#72-12K255-IPM0+$"8
M=A M]X=43'D8J+L\JL8W;J^KNN8E8:/2.8PA3EGVAZ72T#Q)-.BWO5'"V3P[
M6K8\=]8?]SBXU4MO=',%?G"D5&VUN>1B1-L?'!C)##/9Q+:VHR/$_ZG.HB+Y
ML^(6H:BJB\WH3#]]AKZ1:T:J5L!*G$6@&0_WVOB<EKTQG":;5KBMG+W-K\!/
MF]XJ>NP5X-,=',,VBY-<>>SAJ!RC.0A\D1DV<':SR]C_OFNXZCI:Q*H"1FZ:
M'/S=+,M7H!G"DZS!55Q:#<SVP?)]\.(O"Q@AF:+TSN@-'!H-X2,@&R82<^72
MC82R5EM_;93C\B6_/1&HLD@*5G6-9@X-'<%9FAQ(F5$B=<.3G6;8&:(RR9V/
M$6-0 AQ9$[<[9)G.^P3J99GFP$(;KR>RW[#W)F=&! MB,5B,#%_]1HY(LHQ5
M)PAODBGLW6D_PMRV6Z< AGFX7#>OJNFLZN^?^47ZIXP*Q>E%T5$KQA "!VBO
M>-[-E3(T6=E_;MQT(HI1E<P;L2L@74J/:M^#+[0?@]Y9PL<X^,#ECC3R7^8P
M^+-HTX!<%['M+&C2?(4MVC>[8I,RX>&?*+IHHVAZ!_9P).C*J$?(P"IH)%XO
M(%41WV/!-(-;;ZJ6K"WZW5..B(@T$!45*R>C++ZE:D)II$VB 0$X,.=S[0OG
M7Q&]HI3(_'2W4I^6;[[O=@[J:XM^N3J" M9XFE[>[+Y1V]_AV9.+Y2%=<[XB
M:=+?BZ&E^Q0J->NNXYG>P*+%]9F)AO5%^K:8980/]+L]/GPO=>?WIO>O4ECX
MN$8S\W2R8BV:N%C32=E7.?@)J_)8J?W1''1<IL\E) )XT0/"E.(Q[_Y0'F9.
MNG?$5TT6%E3+4S+K.+D XB6Z.>IO_=KW:6R9Q_F[BXLL#U_D@%'_?) Z(K<%
M&8^)2B+$J=]@VUT@T;N9=%>1O/-]_\H%?9PC^2>.,.X]_U&:W& "7IX^Q&%K
M:Q&R%[S+M"NU#S.">430PA6] D'%<O7?><M(>W^WI*(D.$\A;;E"] -@2QGR
M87\,MO"YS3ZW0WNWYM/Z1!\"->? W+U]\6:@1B)]\?BJD<>WRTN;%3K;*^=7
M -DU=DE$NK+WM'[0^R"41Z+SBKBDQH(_$C'DDJKRJ(&%3]O13KX# 1/U0%JC
MN7"H/X9@&CZ:LE?;/;(Q<G$'D22@0<\(:M@T'55F]#-C_)\12]3X0/'3ML0Q
M^PH2LA44I,Q71%>4O_0;Q*"5AGGZ"6HY;I(*6XWG5!P,!=X-/F_=A7;,S\BM
M=?25SNX?$RS$GBF&-Q<J0NH!Y(/ R@!T><VTPF3(S3S:/7FCPP// PCWR]*V
M$8.A6C>'+0)7(719M&+#8-^187_1:VHZ?7V;;I^%6VK7_BJ*ZSK J,,@@E^$
MA:<JPN?'Y;S:K*ZD:I;%,J6O#=-0/"O_*J;0Q3#AL/V 9I^S^/#OV%C+KWEW
MXL^.IV,M*G-ESR3?6E4W[#S04ZMYN6N+$]&8%MGM1"$<8U?A2Y[BC<0LG$;<
M32+*];_RJ:TB<B%,)=PR!ZN-6]WR.@P1T^\4(<T"$*=N=6S#U-VWAO,>0 $]
M=*E 5FMG[I.3F7P[%B['"14,N+VHAJI(5OYGP4[@BLOV^'1&4ASQR(#L!V\#
M1LQN>D?!:M,5<AA,[Q0W4:^";Z7Z3E,&6^*.3"F=!2R(Q!37S!XT2)JX.P^0
M_&DLTCV+@%2;+XB:M_0L;X#AWQ[_YE-J@=Y SXJ-[;ZU/]X@V@#-NO0TX?>*
M64BW+WJ,CPJ6X7S;LY3<<'Y#75ZTDTI+=[/E:?HZD9=W%X^Y\%!K/8TT1C5>
M>M2/)8.U8ZU"2C[>=G./9>THD#!,-?[[0/>UI1*"DH%TL'VIK'/D!RLNZR<V
M(J0J2&-=YF+] \3E$4LUC2,9^Y/E,!=Y[_ZGZ;>I(<5O>GO<A8_MT^_FRVHK
M<$@M#$#_#0EUK%VPKI$"=W#_[I+DDD>(\/TY'0B"U<9KNZ95_,-QMO^ 8==U
MASP#3_E4^4];B]TB#5&NF98_I!2#Q7XIKX"%]S 0!S-.YT/H<&<1Z+'A.?(?
M4AB+5<")R&)!.+2._N*YT:.S4/*O$LKQN&,[V*G^V'@..7LANWLKFG<K&*A/
M# VG3%@_+DBN]I6!0$TT*#L?JK+S:WI^&CQC\$/;@Q,0(1%RQ#BWBE>*JSN#
M;9C%5]SY",I\5VAO8Y*7WFMNG95XL,LMQJG,1_4;'Y[X19GQ\F9G]N7>:G*"
MU*8&.DJVJSN7QD7EHLM6'>$&83*\PO".-Q[[R=FTZFACB"RY,2T/$KA=/+5V
M3:AY)802ZX[R:-J?;=/ GUNN'&1"Z+5EG6G1+Z2H1 Z5\GC1T$>PJU$:OG#<
M;#0VLJ_2'A=<7SOP1I9-2@] 58664O1YH\/]O<,/&'\*JG-" ]]JWN55?YD_
M'U^Q5YZJ^PA,(\6#B)>1BRBZYHYDLY=6B@W3LML8!KFOAIMV&Q',UR3CQFBI
MS*WD':Y;YZ95?.;V9+1&6*&+8S+ZK!&Y^ I04[!*.#)+4 ^^Y,5B%?699Q/%
M-+#[1QWR,A:,:8\#LN,+W81:O6,$GA*XH:*\1)JB(HWI$EE@2%WC;15O1N:P
M4"].>+BJ7N9X:)*!MU>_LE=-46Y:O5W)QJ'T_J6#^ P.HYQ>,I^!V;0F>@CY
M-S )#S[9"<(9XK.J&E2%B0)[NA=FC[^XT_C;)JW9]YS2 )BE[4UU%QNU5X9K
MKG"E1X]&-E2<RP3J<QM27FPZOIRU2?U1AD^<5?^UDW.CT7_4:=B^.Y0(VZGM
M7G]=P&:^0 :6BN-H-[HRHF3D:;Z:=FM[<GMZM*A<TU>EK_S!+99Q@[.R1[W(
MEK-W@!B54\[6QMN0C\9*'^DW(4E0RYR;T1M*K&/_E0=?;;LQ@["P^,6#,E7K
MLN;F]?Q*VSB=JL3X9LZ'H=C!D(CZO>ZP=Y#4]Z&6UCIX**8DU61YLS[NDAS;
MQNUL=2;DSAO_HIO#Z'H#IMJ.,W!&IC/:Q6'5J,UK1Q/,5R-#I-,SE8JI3+9#
MBW S^<47)>:8.*TY+!:$,6_AW=W2K]6BQ8<+Q>U+(@A!\NXF;$#D! ^90,T\
M.";Q?6ZJK++2+?U\9 =V#Q_I&B5,MN-9!IV"EWV[.IW;K7[7O5W[.4O'$!:C
MHES57F1KD;)-;.,XT&3"82\?LXPC)35N9B2G7E.]PY,O=8O??P,HUJ^8G\.O
M!95]/CI@LQ)D,MX';A[I;2:_4_Z>)R?-8,II:^&4J[6<QSHB9CSPVTM_2V+S
M\4=+/S*X4$PY3K15H,@6B6I%U.19P9:X@4&D1IMW!%*NIM\/62LBUW&Q[ND1
M#K=3H:_9X;8/G>7?#N( )M8*_VKCUU4JK8C-+HQWLV)3*Y.969*A/JA<^='[
MX'IV<K6O!/Z12]*?AS"LFPJ:;DE2QPELK!"*);;!- N5WDG;B;[9W#.6YX6.
M.\[=Q56QQ:[[;^]3SV$U1/D.4$PAW"@3^CYYLMCE\E/&^10,;@/J28W](TA?
M 2M56L6L@@&^_8(LE\M^?JFT,98?*XA$$<>'G3"CU\28ZBJ<&@21#WQ28_:Y
MO[_(=?$(%(8Y=HJP.[.3LN8\-',/=/,+@CXYTI#%5-DMGPUHJP74<S.I<YER
M=XR;>ZQ\GY\Q9A2<JAC][<@54W_^>^#)$\7R6QK)=CP-8]+';=F?>8"!Y^?D
MD@RMK:?9?:!*3[HCJU;&WH+/;#F#?!4KX_&?6'](\G=V_?RA3Y(,(>N WU&T
MQ32*QY,0;=T%3FBISJ]%R,TU3LPEM8&GWQ.6\R5TT(DM\BHY3B<SBQ'L%JR6
M]"V[!+6UI1"ZZ$TBQ]4(8=J-KC_T>XP^VZM<C>^[40:-)(JBFNZ_ @A?8!MS
M*D]II?R4-K/ ]P FOJ464+?*/W<_^%S_]6CL%B-**0),(;QKS5TM?[5+]B48
MH2/;T6OF3P*+KK%T[V2LQ= '@;6EA\;]^%2QVKXF[E&V79YRNW4SY"1T-*OS
M8ZTZ;T,/*T(@T+:'8\&R?LX5OTZ_>%VI6!Y+L,PCDCQ ?4P(=A[V6R:94;3G
M9 Q*$:2_Y57AM4;^4K=BL6A/T;Z*7:'S*Q/]B4HW%))C6B\52_A[2)9@F#'<
MRF-Z6ADF@;[D\L10""J;M#)(3)7(=8#_W*?&]PZ&TG _+'9U)*58?IBM8T;5
M6B3WT!.X_F P4S4E8]$X73(L3!+"GT6B8:$<+(RL;&9&G3(^E*<34M'57+Z;
M&F60G3#WJV/X5IMMC.HT*%C4';^9(_#FXZ%&]*=7 ->MJ&^Z^4@8;=,;KS$5
M"5ZA3/U6,F%./O"EGF;CWH$-T(N^0/:P+:2OV89KV>-'%+AI-)4%G']=1[UN
M58=2>QS02'12_J%XCK5AQ";@+H)UFGNJ1I/BP49BAY3"5Q#?>[8WE=Q",9B?
M+.FKYOQSNT[6R!)P75!&QWIK-JE>^\+!9G-1%7OD--*%_;JD/HOC/;GWCTY[
MD_4LX69-UC,E=SK+<S5;%I'-65-!VHVK EKC'@]]$E)<870IVFW%0Z?@AK1P
MW?_)H0%I:YV7DC2O@ ^2FU]+4J%ZKP"L0+YHB_H?B<3JW KGG=9_4O'>,A4?
M*/@#4(\M)N',@(;3@".D\&3JNH(*^W1?42X[6,[!Q!!)"NAW244N,?J7Q=4@
MIQ4385)I?C<1C\QA5VXJO1ASLI'$3IE)JE= ;&V&D3%)H@"EZ(D&%,([\#&;
M_**:)RNG2OM.3G%XO=OYL_;D0XR+KNQ:W?=P.D322@3W5L0U=P]!I]XOUHY>
MGA2>'@[B:L4)/&;/+<]3!CC*L<K<Z2B6>@C@KFJ(L3_6L6,*BQ*C9>%6YMMJ
M8#.)*^>BEG <TW0E4"T)&/X'8J%WG)21_*O!<5\LRB#U+EX!;V@0[ ;Z($)D
MB&^$47%J8K49RV-8?\,[IBJ22>7F[44B:LE1<&:9N)%C:'?O<\O8=I% [J0E
M[DGN+K%GD[R82R,]$<+#ACWE=A%R=5,B;*CI&>>_1&>4_L>X[8/QN%;8H4"J
MCL'\O,A-^;8Y3WWZ C&]9:70$5_'<=A'[&GQBF7#UJ+:4I!BZ[H$\PJ]UV?9
M&D)W<=^8F/,+LF1P463\[(U;RJBF<4-HLN4JTJBW0J3H,Q=@;OIY(-_&H=@H
MN+!_]H". S5 ZVC9XT!O=Q'BJ66PO\]?RAJ?_1Y8I$Z<BKT3&A;_IVIZ"\9/
M)TG&M",646&C-JF^RJ]E;2EXGPHI(2Z^WM9":8'9GKP"Y"MY9N#(STL>:;OE
MJ:!VE3?#/\TC+#F\4@C-.3L5JF%I,=GU3][:V:6%HSKV2@&4;Y$'9W\$XG1K
MV&%+?T0)QA7_H>J%'LN']SXS..Y3&HY*%//ADQTXQ: #-U6AOGEP(S=V0UJ?
M[CTBVIN_IC#6,[CV**0#XUZ_P%X@R^G,\(QL'VMP8/H9/?XQ6]PG14A A,!7
MZ+CLCZ'IV4+3#R2O;"R!0YVA08,#.3V]XV54_U KY)T#GP)5AD"BH4&A*A"K
MK;O3/AHQTR[$JM3$__'2WN%S)DGW-RXM$K)--(G)\J(BF\8_YN*L=TWCF/>^
M"69!8:H$B%(M0O=<%[,G";J#;$[+!L)CEK#D3,6#HJI^.+^)I5NT(STN5KAS
M#?4 8=)[%]QF;>KU]!^31D9/[KM2<H,,H0U=&*3 L8\'+3Z>L/6"O:VMK;2%
M=[3U.@U9BK0,]+]9OKJ%S"ZFP^T8I)"^3\@@EZ",Q1LC&?3V <2+%MF8#^=9
MM;>W27@X.XCEB+XZ+JSHCWLE)S .9UTG/[.] M[.__83UC>=D;R(04#;3^=Z
M;P_.(L'J'W[?[F22+VRUZ*5F]#1'A-_00>#ZF%M/!2[,YN458%;A*T/=U'=;
M'ZSV0,^TF*UC.0THO4YIYPR%T?O.-_#(3I ;/-97A!_I$-#NO8VVZ%_6#_!!
M./[X#N&_U/M1=31>DGZW2-+QRU/%M&;$;FV,<[E=\<#96@V]HY.]7_!UI/YH
M\>+%WHI'$J>JV,JE&UG.>MJY:%$VUQB-SF)?_Y^9,AF#[3Z4]!U)!AWF@;">
M)I4,GB0>#(72[DC"V60GTI.&^JJU\@R+CRKN*--;S^2W95*'=Z/J7^$)J!,<
M@782NP!O);CF'3-Z9JFDV\1HC_-7Z'Z7?_&:B$Y4U3L=R#<QN<;LX+RL!/C'
M3ZJ]O$"GMQS[%L% Y>ICI\AR7DE;.T%!GZJQK_4BQ"(?^4VL/U]I1K9*N;JL
MFWNI#U[IM"5"1"/H2,61)=2<_XYVC\G6T;W@KQT5J"IN3O<5.![%'=C$KWLX
M[9/\W;:4_ZB3)8#/?(!7Y2*I53W47Q878F!D63+"4!S5[VP63Z:?;\%F=]4#
M60^M0?W;[KCE.D,RQ4'H]_@36W2/S0)*E_0*L!J+'J0S@('E"P3NW6#SPESZ
MFIZ;!:Z.^&QW"CS]C6,;2C4]X)4;K-)!-D?AM9"YR,XBI9]9>59E15:NUEL"
MVZAM7R>(?>6[E<X$#@TYU#'C5R=(,Y9^B3+N."#1)NE!-)2I%\O*'[7:'<]O
M%L;M8PM5N$<F3WG8,EV:JD\ <+EO77FBPW::-@V3OWP_9T:U*Y=1%<D[[X)L
M3$9-VJ'](WTVM1%OC_^41CF+.+%K*0!G\L'7NL+5A>OI5,;;#JDDMC93=![D
M;U K7GCUO(DRRR+@#1^2ZN5Z- 2&<ICZ04VL>"=$ L\^HQ\N5576&_%*IW3E
M;29%(A'S8A'.ZIY= ]_I9(P9])JZ#3 PGE,W7\EF<,QE"0=U.DZ8SADT#/O
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M#;2*E5< P17U-=(+$7IJQMQ_K:BK1899NEO*E=M1*P94(+P%]3#U;51\=&E
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MG>1+OPE:FVJJ1=&"C=PE+P Y[TWO1;//PN[BO[S>?I[>O]Y67>Z8]A7Z/QU
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MTDU"^Q<:YWIM\3$EN]AR'D-N$E(V[2GZ@E,_U3S>>?W9,'I1$LLW/B&C6,*
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MF0;K#IV^/QEGUZ<]77.(E\.?!UG)2=G;QYYB)(;&0F63=:$-)S%#<+@+\P.
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M%6C.5BW)'VN?$1\Q*,ZZ07GR[,G56@O&TG/*VE)K!!FG0*V4+F?5_Q*[KB6
MR1JO-S$YHSR+^;C/KVU!>-23R^=+/)SZFM 7>!O;#SOF2!-,=YDOH.B)9TA\
M_H8H]B-)2Q!5JIS[#A>V#B\0=*_9:K9NU) )VL(>9YV&HE2&[F5)0:DLC,L]
MF3[CF#NHY^\ECTAQY*/;8?9M33JJ@5J6]SND5/V5NIOLBB.#AEEA,N-7+][L
ME'G'3&U;_-JB7GGWJ1]J8LE&NTW$R!A'TH.?:URI[Y>;SY=FO"<XI>\L&,%B
M9I@!-:"6J Y<\7-] "S7WKL"JXEOLA=B;#N_/0#B;GCW+ -+:XIHN%<,=]="
M0RCA/+R,7[(@I=\;<%;?Q;EY7+*A[NC87!8EQKL2$B%(0W!'Y?O.V0JTMQQK
MMD,,,%UUDO"7]7,W1JVU$2MV4<3G<*SK;4D\NV%G'+WA3^O:VJFR:L6Z2224
M3'3D\\X)9]4L#,--IUE?5^8ZMGH\E%4,[I8=>R/TT/ZORI:6&8Q (P%FD#.6
M54%62&]1*+_+;"@3GI>1"*[/C,F;QTPS-LM/D@[PHIA/8/>"$O1Q\N&[3@;,
MVE)XIX7NG8K5[8&_AC]MN-%?-UQ%[-- ;_L,/,[7HL1:/J1)CN>[1_!-&-6_
MT;=&T@_T#,3H6;UDM.7\Y6X8NL<_??NK//6(I#PN$IK,O)63IN4S$]0Y$YFD
M',U$8,R];V4B9Y6RRCQ[944\X*SO4VNX&1WQ56ZV^<(P=KC\TU=F B'7)08!
MX^K)*^460: ?C\"[0^^?OV@] I$$[V[YR\./U$A9'&F#[H!>Y?4.MFH<=FYB
M^%T-Q>F]J BMHMG2M /#G)@$1Y3NY"_<[LQ80;Q>N90"J4?,0</:]L^H+3%3
MQ%1?9VX[B5H3V\D-B@2U"W4B H6-$P>1K78;B*1NK+RLDRFACS5/YO62NAQ/
M(];AAY@YH*NC:3F'L:BS$L<=$G\B!RLF5"NL/&>WX+81);M5_LT^SO,WA\96
MY)EAL8+DJ?=/F=Z31/[9)3])DJS,1HKOBC70WDW&V\F+V$N_/3L^5A8K6FV9
M^9B/@ -^-Y=5R1?/KSZW/0#2ZP8N ZTM5_:.FYE?*D6BW37-3[&NHV?/HY-(
MD' 73_&4,KE1-UW=(+OII.6,Q,+)G4@UA2ZN8M]WJN'O3+AF[VO+=/%O?E[Y
MZN-&ZYZX5C,=YQMJ*N;D_'^I0:@[Q_3!'@ G@@\  BS5T0OP/<W9?T;[+WRW
M>/-4X1_\S?R!RV)N3UO^ ?O)&F\>U(58Z_6PRM<G#0D?F>[P':+5![RM2U*/
MZJFZN3$WE'4 -Q-SHI6?T6EZ2=,%[B8^"3[;0CW:$3IUNP;1PGX:IW3:[1RU
MW<"K!F8L4O2_^P_]>SAWS[UP5>A&S G="&>W]CXZXNPB.K-UJH.G]3.@;\GU
MK^>3!@OS&$YI>USLR'[,#I[<E54O'Y2Q:>X?LY:'9UDKVZ%$1B]M?0[ZZSS'
ME#Q+N#$'S3;I(3R,,PZ"1/P=1&]K2-$^D[]/7HS:O?8IEQL^)>1D[85V9!Z7
M>%N_6!!^^K&ZX]?+LMD6!#G/$(P5VO"SZ[P60UP>9K%DR".J-N]O*!)CREJ6
MNJP]M;J/$O4*'MI8VP]ZS?".;,BR<IU=A.(;  :ZSAUK,4E&5]5M_9"C"</&
M&$)UXIROC1!OFF^HA;&'ORH(5"4W)'Q*?@#DV>==^1C?-1GY!0X-U :[>&;M
M4>5?_ _"O?\;X6Q?OMZ]KQM%[ A,9O&S&RYU-V.(GK>T!<?+A.E1]^H71U6)
MG)8[M&JL>*>(.W?S3\I-C:3:P%)@*EN.! BC-<]3E$)%$[V^+8L M5!QN,63
MOX"2ZNQYVW*VQ70C8I&;(^?;GO9=9_\/:J/&UF#N(RYMF KLP^!5^<X/WH_?
MWW.1;.HJPSK_G.CHO)M;_+E/)1&'&S]B47I?I*NXT71VLN)VK+6"#C%^E7LJ
MZAK-J=3XU\*+A]=Y';D%(+$*]U[_6>U-ROO(>1YX,>PQ7?6NNNA^XDLU _CC
M3IU[>YS'PCX2'#"\+G*'M;B!I%^^XQ]+0:3W'*\#24T>^7?H3!.]YBC]9I_]
M?!MAA$W9N-JU! XL?ZNT%ATZ43KCTI3)1M6U-=OFUG\68][RPZ]M$<8@+\CY
MY+E^3-W2%^+\#26P5?WK^2M]C_NZ,3YWL42Z1J,3_#'=!\!A@^1!\P- N$HN
M_&X,(]< _=4Y<)<:R$;KLTHMP?$MG=P2BNORW:; N,VL3K;"A_J"AJ-\E,OX
M46/EA^'F)\:IZCX%:6A94K\YI/7INWW1,,UFB&B(P"Y[NU[]QF@XP0]_IJCK
M"SS9AE&$M[[@$K1"*<163IR8>D]<34T/O?H)I6M%)6*RYN$1R-MHF7Q3<LM6
M4S#F?WLO[)'<V!;^YK'K[';7/M"<WC9"8?"$]\4#0/;R6+:P$O/RX^5.1'2U
M!A?8KU_SN%6O2@:MIVN+^^>#*)?8&6X8#E5MK<O*2*\^L3LLJ\(B+O/CM:+Y
M.__1ZP.OX.8.FJ2T<S-,YWRAV!:;:+2GU1)<Y#3-6*<&RA5W6+*8(7. V61]
M]:0T'J!=1?!CN05.B=EXB=/'VTO?;K>]H66O)NX=T4'P;'HVK"]YH]R1[@_O
MCK/BF\=R_LO#- 6R3]/6@%ZF*O"(6(#5IWV%NCDD_2,77XFWQ<,@X]3PB\!2
MOOPAR_2!D;UXQPL#+B$4CZ,$[!AOA8->5.*#%\X[GMCJ@L=889)*HZ3[>Q)#
MR\^V4GUSJ9ODX%P$M&08N,C5JXGRU[%??/QB1KP? ,P;^GMUX,N@O<ID0!X:
M+]- "77FI-\2TWG9*PL3U;74I@&]Y=$UCFT:[O+V)809D8I[M'[(? #D3P7(
MCK2O\MQR"G@FO$^>^M7SG>X8Q#<_D><T8-I/-<%XV^U*$\30-.^YR_4^QG&U
MLK[+" ;ZJ$KRAL?-0T-+U=W3BT*MKWNME'QWCJ/%LS"7&,7&6072:XT[*QS^
MV59M2D&0ZYLUOG")!$:P@,9X^DH_G+M-]2UCT=IWUX:Z*<^8]XV6'J1MST^!
MKG5?UOH$UK/G*Y&E_L(<BE4-^/AJA3N=*1%NBJ]5P1'9I%9!VIHO8O]_)_>C
MP%TH?;;U7W*OE)</ +!C1:OJ)*7L1,.\G!2+(]4TC@2A+W*M7(( JNM*V(N*
MJ>2T07,W;T?)X:^EM-E'8'Q)6%EE8&O].'\>ASAU_O#%O_"ME9A4=TT-]=FK
MDK1MLB26^;2:3QT,R+MCD;S2>0!LDF7W_U^#;[8'@**P,H4<\8!TD9ZGO\W=
MWZH/E7]NS6K^XI4:V1L'273;A;N&^V3D+_"?#^]Q*O1-TGYT\.]ZIO %;8+[
M.)X.H.<F^%17.+FCZA-?]")]Y)+1?"N;(] (*WM[/O8&TMOAY-<OW7P$'O7S
MG)B=):IE_4M#'/%LUX2M< VSZ'%"P2GEUB^7$VPOH[/Z )BU^?VWR^4CT ]E
M9>(K'Q=)0L/>V'=D8X9 )"CX_K(.Y:<VJ,HUOM:RK+CT96,WE5YESQV;K%^7
ML10'F]IM!QAX-3?IWP8.C/!&4V:>P?NO0CV+D.'[E 3F R\CN_&9LZ6FGGS^
M]ERRY?"L[,R5V)@-0V?-X>4)#%01D8&AU1JQUVX]?;'[&_=K:2/4)H'?EAX
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M(+1A5,.RNDG-GNS]CX_M_1E)DL,/R*?E'?YIW1OC0A::_R>_P-EN=.\;GOT
MT*:94P#J$N_+K<78_G&2N!OKCIO.LIJ[L^H=<I^$N8@9TXW4&R[E/7)K#*[2
MIIL,#&V!FJ]LYHLGZ!FG7'!QD3*(!DS#HESM N+S3^-#5%IC]OPF2?5&5F\*
MB$J_%) 5F413?#'A_ U@*O3(YA0:O:GGQ,P)77E0GF&T41\L8PC\YK+>]ZQ
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M-4A-.HHH'^-TC:VSW[3L%^)V_/EQ3:^ I=!,*$0IZ2/J6/V!-UZ3YY+""Y$
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MU'WYU5RF>$Y(5;>?\L6SJ!C![I_)REX335D3RWZUK(%<]A=S^8Q<</CZ<==
M-.*\N7A(@TFX+B[(9T]];,TN9U#;(Z(E-YT *&+TBFU#]-7V(?'=[(JVL+SU
MZ:H:X\>/QALRKF\>0JON$H-5>X/L)7>1ZDX4,]$>PS9S0]"]YA)O!9VJ*GWI
MZ*A(]G'RF(+O>YZN>X0TC:_'B[.)?2._*J=$-SJS;[@-+YV8N0>&<U()"?X.
M]TT,&=NO3;1!EQ)(*VL!>PK&.G?_7"XPGRZV*5_Q-/J(-!'V*WL2T[]^*/S%
M&D.1RHQ]<&_O)=Y=J:'RU+#TKN0Y">J\BEO/^/V-"WGIU!S?4*^J!NP%5@7?
MVT#1CX1?SPG?3'\5?0*^PR9B2#;3"=N1/:'9+VK%O01?K1EY=U\>WPE<]RCJ
M)CRMGA+O],S:AA!D0ELAOO)/?E\G_Y8:.[]XNB#M8^28^ @@YWX$H*)/<]3/
ML_+5&7__^"]HV/6O>-:?T;IJND\1X(8Z)@BMYN'BT<8#:*4;RK[_EE/W0;G'
M09.:25(ZLLA+<W-6WY*)+8U+XQ)HM>'*-T_W5 S_YO.AOB_?N_V[J&?U?[*4
MHHS42T(_V+(V]D__<;=7%0AFN];C?P34K-OHCTZ'Z/HPN(9QXCBB-!AF;U5L
M=T?4?Q^2>ZW(]*>@3S4(5>&1\M)N@3*Q+0^T*+O6Y6&/ -N*EC\QI?#:&^@5
ME'KL%"P]YR9:=&''_FTG^-=VK,L%!'7D4QN-!G>T/BR731J:'F\@Y1CVW;U1
MRM2;>8;A-H?0K_&#9.([_AIVGT6W6J3)>HH(?@0$.L_=3-&)35J^$-6P_?G&
M7=(<M$?4S%+F2N.PU=7DG9&]#P;Y!T3(S&#SE:7P)3 ?N443CV]K>',5+'34
M\G/R&&4#KWI8S%&H8,I2KM[=#!10&D/P:%:Y>GUUHU@;-DX]Z)CK2D4J[)/H
MVD43/K@V[IQ&M4$Q9%ND*R2I+- ?S32C1)J6H4*>!@>!ZF7,[<&=;_BI.E^U
MTAA0#QI6#2LO#I;OO-_<??FN[AY:=4J4F6MV\G$8\B+66\48IG5?3-$W23U5
M)AYA$YU46;6Y/IDA=&^(D/@ML#>*9K>@$RM/'1C> "T2+&3E"VK[*>R^X'Y(
M'^W:I=6^P*\P;47>%14O"*%:#-IIHZUTC]R' P6JOQRI&R;:B(&;QC"@]HO7
MTJ09MB !O!ZS;EM;UHCMS;.#6&S[DXG@->"<6CSTJ%*5>_9\JYRF.M)B?RFH
M4++$W9!A["QU28O&VD=PL=3O5S?5QXF]WA1&<8;X\G:]T]_=%O(Q_O\(7G08
M:4=O+2[A4#]IY^*)C3-4I7A>B3%8!<5]E5-_<3'IBX^EK6Q7U*_OZ3HL:Q=)
MG#EBO].7QW9-1-UZ?#_Z\F/\HA-3R"#E2X_8JFVBB\7*U"*KD?E"^DLNC1MA
M^T40XW(K]_/33Z99V$K9'^(^22O/^Y:J.MJU$K-XB(J9%EXGO<_-LO=6'BP>
M,9GPZ5HS;!F$QP,&D"@GZ+-7I@XOO5*T)6!5\R^2FW#C2V56E*A3:BG=K3)%
MBF:D K2P@[IC&R?RZ)$;D?@[A=NIM8+^EKN&.W,">G[8[98^HW[I:!4_Q,/I
MW.?V+W^>?1?N*?+/3*LHD&YA^K09H .M/QAML-<:K,2FS+'K15Z4*#:1/$&G
ME\72UEU^7N:+C[0QKV>6E+1C/5QP8]PX[Y\TNDGBV=??##K\U4LED.I-46@&
M_L&.Q(+MH"=*QBP=3&+?M@L[+["Z;'$(Z'O+N]D?!FGM;9.0]ZY%'%YZ^(7:
M="?LZH2<4=LEO9S8\Z"/$1A.K*)[>BF)&;/-?]C\^:[6H$-K=L;[)]+ NUU$
M)]6K,GRG/,UX*E:&0_2S/_VYUH0.*6A,OI&;F@NOJQ/K'ITL$U%I,T,'4:GT
M8))DSKV7E6M%-*?3C++F%UJ+=F3 :GW,&C-2/- --*B>_U=*N?\ E?:Y4<3Z
M"<=MG"5%7+7][:(8O:\MEY&;'7^\#(#KJ,:7.N+6U@AKY>(*XJD##U>+H)-C
MU9HN0KIP#<CSP! FKR2'^Q_V7^67S!WMM>9Y6@]]+J6:/Q7#L3!!?0@V">)<
M,HF34?XE6COF:-US7]S@:>(<)>"M,EXX*)%>_Q/#0/WWR"- #V8TXH[D9^ZU
MMAHNGS+S2.Q5MIDG^W-54PC&W1F]5BK_QCJ7>G/Q"$BAO'OU8[9A9!3/D!TD
M6V4JUZDQ=:+R:J'V84/T+2>BJJ7_/FW_(+VU-M>)Y&JZ7+2NG/^64_K'WCV=
M<\4,:-:1!'T0SO53[YL]9EBV;<9OTG7EJ*7G#JNOW-4]=V<EKR%X;BC=0J5T
MJ9<3$7;6/K*=!H5H5[-PV ?IB!1 MU9LCH\!*,N,BM9KIYP#RQ+/8&G, UJR
M,'!T+>BV%;^M/.))E[3<#^^Z+!$X]T@1$.1B](<T=0RP"X_J;A](5=K&K)0H
M8Z]R#%,YIU$L+(W=SV/6>LW]BOVMTQ? AQ[*=5@E>NLE6^P7GPY."6D<-'@%
MH^8:LTC5_<D 3(C,+[TR94I:*8\_Q&["\8[MS=>9>7-*^&UW2LZ&FA#<+"?P
MD["?<]ULY"43N7/2-.)NR^9HJ!W>=1&1*;Y(>DQ[RCA54A.>9:3F._ON[1TO
M/Y.(ILFND0:AM]0B=M>JG*HRXF/&F0$8%SV U@,M;EV1?NC#TZYM-)=M9.ZD
M+U%K?\M)DC5/E(J1BN$0;6,$!I??</0X/GZL<LS8Z@')[-@ '4?NY_9E6HUG
MW7<3W*@_^X6"9?R>7>*<.1T)">D:NG,[!^O<RW= 4JAJ(G5H49)8K:&/C/E-
M)5VTDEM-:-S<NS)NJR?EA]ST?%?1*:9'6BF#R?9R^H%4U+:45]())6=,KI>/
M *5W="8]=HSQ5*I=>#+V)@N*01F=*Z44?-;(_$;DZ76_/@BE$Z&,C##2H-8E
MX?VJ3AJM)DCA[14 NH62*QX<XKRE+(WE3@AU\SEN,65A+JJ&&$XT\!*PM;S9
M%( ;Y3;!E.3E'P$0UOYH_,JW*1.?W_7XV8UGM7RC=-@O()H8&#DO;.'+NQ:7
M2_*6ZHW:4WIY^+6Q!2L(C?R]'F>>MUX\6W"&_>&B>9^I!X-L+6O<+MBU6<RX
MS3"_-7L#/(&PI1QM[LJ[&_R1DC34H9-O0^WFW^ZQ)+LMLQ$NHVG^U<05IWSV
M?:S7^17KMM"V(%^JBTFU?\]\TZ0/*AV=R;KC%<+N9C+X:Q%A^L<]M4(4:I6X
MMJAU%+GH?&&:Y;S/Z:RJXYUF-[$/%%'=F VNU4Z@W9R)\" /9#1YF88][Y%2
M,Q\$-F:\_T7ZD=>HFR:\,V^8H?=I8U9JI*LH)6/O8I0EP66UU]H?C]:W3XX[
MBPLH.:?S/KG_R#C37$!\7XW:5BO).?NF-]&2Y1.Z^@@(G\(-\NG83#KE[HWZ
M2RQ JT< *]_?Z<;R]1+>N-G>7IS!VHY_2MGIF"'%IQFNW>6I.2/D'WSNUYE!
M$65\^*LM=$KLA)SP@_U_,-?_L9L3>[UE 4_KZ5#ER<6K#LQW_*84/)UH<XS@
M 9/)@MCO!,!WMO/WO->>0);.G)>:#.2Q\>DMNH1\AS>3)SSJ3)IGQ-=I2*MJ
M"QDBC,AWU%R5##-$^L_5N;VZ[*>>+6UMM_B#=O*C#'CS?01%@EW9+D953JOX
MFPVJ]/4]GJUARUKXSUZ7C,:U>F-]O,/SRHQ:NP<N9G#$#S 0L[9H[/V^=HF0
M&OGG[?"/W/]+-?(_"IV;(^J8HQNLSV</KR( ^_1_UIZ<:O%VN10O52)'1H-8
M1=IX1[D&868^;5O!1*OT3_5'!).PY%[0Y$3H"FO'D"3&$O]\P!F(!ZWE)V:[
MI(D:<9%!IM)NDBJ=9PP-1&O?WF2VI'=B1!V\4Y WLY\M?/\-"I---U>SQ?G]
M:Q*'SHVL[K+]YB7P3=+1.D2XK#>[UD BYV70'BDUW"LK;(;.K/O-'[38[X%Q
MO%LKFQHU4->R8%+W^O8V<ZLM0;845&QB5P8T6EFF<.E/W[J.]V5"'$/'7.4(
MSOB34P!)7$F5"(3>_2Y?*$1>8+_V8Q.&S_P"89#S/@?XDDB73ZM6D$4>;AQQ
M-D;A&5T9X58E'TLE4:1M\'XH^&*?DF#*\I6?+=E)68^^DSO"9)W7LVHW:^?Z
MC0$I^58%JR_=>&-U@ BTR<PK&!?W5PQWZV _>$7?HG&@HE>,)4)T?ZJ&JM;T
M9.++@*7JA?W@N/XQR55#1-/E*E4ZVV]^T<_ISCY?NI$_&M>!G1E!2]E^M:9K
M@3M 3Q+%&RW>U(GD[VM)IGQKHOH_^WVL_+C9KR#K40\A@]S]![M$Z#8>9>T
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MCA#3,&&3LKY/: A+$S]</J;U0]OMA!A=RK2%LV%'STLL2WFKW<$SR?<Y;50
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MIGSU+US>)/_&>5%NGT!?J;MT2B'3(FU6*5C]\R%ZCX3(T(F_B!@&?0'1  J
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MG11FK4VPP[ P:^YM/ZK=%#8NGB@9\Q/1/$DT3EMRY#:2;BR/\M^8K+[M&O+
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M/IM06OTNE^)OVVE<I1;:HT(T!?LD1Y;Y!'AJ\0Z? *Z<>HA-BZ]L9AL/3;Q
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MY.E\,,B[0[[E5#_WW/4G; -%6YVBU8U"U\J.KG11<JK#[D _:-V<BJM.<L;
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M(XB2*9*U,";%4><]KZ^GAYQZL*]S"Q&M6 D^LW,B]+6<_\RO_V_Q9/_EG!>
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MN/#"RYL0^@(VWU!2C;=<T))"L/M,=[5FM[.K44V(T DGH6V9^%4286T V\K
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MWQ&KG?9BN?#QDF4I_!;[^7%\65_Z9Z O,%TU=!N)MIPTA>8)8*I,22[O$V=
M<^L;:97D7E/5/J31_!@M"4Q@_<=5=,/&KZTZVF2OR1\E %YUJRL%][%^Y-]N
MCVX%%Q3M@Y2RII4_DP UKPL?G_OV/(M8'-Y(Q/1X9S;$+'=S3&2KM: BJ45
MZ.&0['_Y!61W7SI;?T"]9&BQ7!AT=S"H<W[#)LS:A%;F/W0%TI^3"7]\U>RJ
MP1O=DL3.N3EC+[:NG_,SGEP!OU:JZ95ZM0F9<PE4T0ZB(:'2+80-6N_8TKM9
M\-DT\_.T_TUSJ%8#\, W7$F[>7N/C:3;TP)8=,P&&/3D&-N=+"K1HFB^[LUP
MRO2V7:[>'@[:'/"V=4%E@!2M.>>[CX9X#U44V>E\Q[N35'N[4+@GJ8]N?^!K
M8K,%>@*L?'G,>0+,SDZ^\=#MN$X6+O:[K'OV3PWC2(DM3P"/@+L_7$#WLW><
MX#RP>RQBO7=_@J]D;V7%1,L[01#(,%6F_7MX^!.19JM4A<^>XX=/)I.D3%L3
M2 9AMEX,ZG4*H])UD 6%3%47GZZK:K^W'<8-,<_O@^'&CUB^/0##KX@RPT[[
M^6SD(]+Z\!OY>^R7J AN?"Z!"RVCQ#22S]5)+M/.:<B1N(_O;WH\F(!#BG-Z
MZ^$Q=DOACNLJ9G^D5I<PH4MW@CSF(-NR2>24K"CEH*E68'?)+%\:K'5NAX+&
M:K*\,$O$K^M8=,68TYK5(6YS:DB<;R--<$/RVGU."4E6ZF=X^/PC6IF"2QZX
M]7C7^+&^8V;\1 \^'V?[6 ]ZSF.DV@X_2,QG?P+PE.<\>/K&GG&2).HA]";O
MQ@^954_9T!$MX3DYD97\=Q\ZRNTO78Q5<=)3' LW8 DJORO4[*,_>EL6FL6)
MY-^HW5J4')69%<.,)FWD.1+U6-B_#GKOK0CS*9&%UIAA;OACZ;X)M \-LR=I
M+U+4UV]C% C@VC:182D:'6%73"]<V2==B_HLB?B4F(*]<:S=L91VX_ X O":
MM;^F?B3RJ_U,<IF&&.@()CT<QQ&H\=C<\ I3A&Y)(XMVBG?'"?.4P"=FV@V"
M"TP$@8<=/M9GB0\?A!CQ)S;6@"*)LNU8G:QOSWX^O!</<@&\[D"W]_%X:3LB
MW0"9JQRU=,WB5- 9P0\#9N2_D1+">]Z- =..E7WW+YK^F0*LW7)@O'U=)#%'
M2D$9BYU%)=N2PB#6AQ2B-;V\5FJWR\Q (?7_I?J/M$W"V"DC"R0?P:2HFH,R
M]&4*UO1ENV$TJ<JQ?%:TBK$8U5,.=L"Y4]+H[%L;/>/-4VGK::@/=;+(H%9^
MO;5ND\?#BHH\B/+#JM+)#R]X<CBU83J<3L[;<JCO8ZNE>$,225<O]LUC@+#%
MI+X;CG23M!%D8@NA>#D^<?CL=0_TI6LLD(-,OR?Y6T )'JB#[N: 9Y]"_[C=
MT<?SKZ"C9WX=VSN9SN&X>QQ:C0S(LB@.@R8A0[\GF&/(G6.:J\VI@K_L>5G'
M7X8C*QO@EC/G/6](7/N+][VFB+9/N15(]=8^;^V?HW:?I H,(58:NZ \PQS-
M4?8<7*P;@(%2\Y@H#QKB_*UL#4"&7!N&C?!Y?C#V/.]X!9!:=#?U[:N9I'D)
MVP15-5,>^9[".@['SJZ>SIYP+$RJ8()7;[&E&$OSJMZ=L2JKZ<0>[M -#"J4
M9\S$?E,B)=WE+/<B61D#?^L\P0/;3EMM_4K8,";R-NUE91?#R6:,K9.H?)L@
M&( I&M@6KE&,=:Z#&[;GY=WF?)[6O/CYKW"H2C(7D\%FL7T@P=LJFZA.7P*2
M<G.6;T0+3D7>Q0X<(F_",>6,B_<(+=TP>ZDS[S;;4U##K9K@.*4OEV8P)PQ9
M]O5?KS?$_*7IOW<$\I/\INS%#W'80@_[F1ACR2T*H.[[C5=)5;Q@TUXW)9UU
M 1LC!&EF02NP*UG]6/%$!_U/@<XU$N0-(=_I#TJ'W^[+&]DK4_#*R405MC>\
M[_RFXQFG:[/CS1T3!XFJ&?D>9R :]K)9IKJJ/E&@T_Y$'>2I10/RPBY^:$;.
MQ&V5=;.S2Z#OL) :@I G0[8P3(;ZN&G/,*T^VGH(])]^8\?(3P-^^#1SV/@7
M1NLYY>]EVM_'U&R;H4CV9M'5CY"9.J??3OE^X)-$74A3?Q"6E&C6:?T.9==_
M5U^D$73GG!HV'/:7?<"0)IZ$*8!/+M3B!W9$K6SXP]F\_SOO]I7,E<2(>D);
MZNT213KIO8:L6J</(Y13TG''K.X/]>9-8N0Z>HGVK#$9,E>"/]_UKN3Y.K4V
M=<B'3&V);L6Y?^;%T&.Z>PW\6&.X-LE@A +_8;D=P4<8L,C_BSC[@:+]6_0_
MFRK,-,TSB:_LUHD;#!O,3%!2VD_Q8FY^M6)4<7_]IEU7YC9SO;RCSS%GQ="M
M\,%F_ZAP=2IA1J.3]B^ $KFJA8'$*(-EJ+?(3/Y*M4ZYI>V$^<$>2PB6IE7M
M59AR_:7-\/&?]TA_DICZ^:9^S&[^L<BB3_L#KX#*V1]N48&[E$EW^ ><@JE-
MF[-GGY7P5W0Y^+V36T;-]^]!R\%$$X/55:^E+2P#)65_2$YBW+%EPJ(&.STY
MIN.-C,O4K%=3"XXH<'N"(H9BM+%3Q@$U>CZ<@%AS.+QL@D1G=/&O\JW/TH;"
MW8+]8C='@KZ,9;YI6)*FP&0H8^6HA> H[3Z^-J7JWUO0XIN.Q\-#U8$8LN:7
M]?_Z-SC:F,*N];PWY0JZG;',S 1DGLL_2]465RG\7A 8F\95B7,\/8LA%^_H
M8"/ARNP#!-=2_'6WWL]R($!3=94@@M8S8@[EYU+UUY/LI:K3M?ZN;BGU4U,;
MLE@3*[(X:HM:.HE:&YOOB_PG_E[2O"D]#>LK2="ZJ5E3I;_Q8SXG$1YM $VR
MG/T-Z_4*UMH>O!(_P24W(-3N!089V*?,[C8T2JV.I>+U>;(T6?7DVD(/3.6A
ML-J?>YM94[6TI.#O;Z%QIA1990'I=,3(=K'$WF-QL.,F@_NM9(55@_/L,N_(
M'/33;!9'U;1XG'YCDFL[;-72!'(E2;[J D^[<.5ZL5B?T5'P7U/1JQ<:SII^
MS28'Z2HL-'7&@'BJM[H(0U5XU?B"E3Y_07='L4$&;W!*T^?90::@C$H@EI@D
M[=2P3'U*UM/(B2(/DT 3&4IWINUO:@%YRLI^$6&]GI$+S@\2\IM"5 UP+^^%
MDR_Y\X<".;&A/%X0P&P,.WLP2H.2>DC-]T6&?LJ(XU$5Z5H)[=B_K,:%V]J*
MX;W<^%-4I\3&-:;BS1G:(<KY^IY+L#H-=D_4!??9=;62F>YN PW#^"PN4U&E
M0H%"UTQ\'$ LY;F K.L^[N+G0W@EN9>?F3IO^/[PN'@6 BP6TPSD=QGLD-7R
MXWVH1*@A"?YZF1R)Y8,O YR%US:JVL>,8_ZY=:?Y%U#U>8$)2@W\EO>K:=RM
M5)[*9Q.T6&;P%#XNK;WORN+T5+=BQ#K<,7^V0M5-5^HO,6]N!.-%P]UIE$=C
MI@8Q:R@/]IT[DN"*3O0&JX10$WR/SGG=.KR4V$?\+B82-U/C )(P.JK3G<E0
M$V>CHJ2B=^FHXYWZ=N5VR&_+W?!TTN]69R[,*TEQ7.ZDIF,IZ['^"=!/\D^-
MQIE;4Q?HR R(@2? @>'#]^-TZ*-FT!. ^ _+32RD.](7_OP?'57/>K:U6[!O
M3D[A'4(:M)H$<G-F-CR4"[E]A\1^Z:0L9C;-1T83V*O"XZ$>A!Y4+B8MCJRK
MWT$W!?/Z=DWW8POS[;=UK=J9,E[#RM)(X!HK@AGAMQ=BKAK]@VKJ.E*:A]I]
MC'A80?KT!3JVE:52UP_'M[:K70$(,[/0(\Z;3]<;$RR?O1[='AKLUWX]UB1G
MKOWN6HT6;WMV?+MZMM 1C'0W:.P5'(#N*XAY@=2QXS=D_DA$>D 7>D2"(GAS
M(3MNSNO=D@;R0M,CTK^FJSX74&47<U>.Z37,\?I&2:GW_2NJ50LO=0G!'F.C
MKTYWGH/"63 D3VSRVI:3U-+L"3#$YA<4^=@,-?;*TLPO.Z$X[KOI.$6O8WL"
M;*4(=_8^ ?3E%)WV+Z*?"SWXA3\!WM^+L3QJQS\PVE].=U\+54K]EWNP-=WW
MPYI&G],0#251N(3DIV3W%+(P:#=-CB;9:9SRS88:6%L9><KJ$O%QL]5F1;Y:
MN^=SGNO/$C4/.$_#NP>O/0%>Q3Z$P=;+QW)BA ^VCG41-W=B_]SD#G':-7EL
M-[CL6(W.%^:M]FL"D9YHD_87A4&%?OS7>\@9] TV5L#&W#+:::]=EVKKMD9K
MJ<5Z"-X8JUIF2OJU(2E':+E+_IC)Y4UFB.)(E/5JQ6)E++,WKO=O5*>$E,,+
MA$/F?+U/_8Z#[U*> +&Z':RH6Q8(H,7R(^V?I]GY\\6\A:?''L)\C0G[_CM/
MRR6A;^NI,,MVF$3>LS-K6VA_,.\N0?$TB2*)*LZ:N&J(M?^QN0=-;=B<D27:
M>3[2.TR]1L!YV-QVUX;#]03($+!XM/^#'PR\LU+)2-2#_.(G0,6P'\BO&?'L
M=JK7;_O&\!3#CSZ3@[LB]L\(2'Y<>@*XW+TX+XIX HR<=*R3/ZH+6-KK4SRV
ML"*:'@\ND'84\9\ :6M^W1(/I>[C*\V2"%>3>R?$W"[/P, -C(+>GD>J^WWE
M\?LTD@WCZ=.<-N>@KG-26-;1T+CY#0W3 N70DJLV[TM=\!:NN=@WD0BK-+(%
M3.XO$!K@\WXIXF4&];)N0@>%LJRL-?PTUPU7C24CV@K]-(TQ)M01:;J_S!$;
MY/M @PR1%TK30LJ3%V_RU^^+A_E_,!QIW=ZZ\ZKTQ#7N]AM1:])'EVP>/O_I
MIC-3L31=&E_^-J6U#$X[J.P0L:$U9YT[&;XX+_9OI(_Z9292Z(:T>O!XC+6H
MI'(QZ8^(*^:(HG4/K\#Y6V60QX=:D-+F*)6>IH9I^)C#FQBZ7>\J0(>AO>[L
M^T2/ =XT+<O)N'"91)T+^O'6LO[LSQ_]F=$M.5XYCQRM,TH:#YX!'9;N<26H
MWEY]7SCQ5GL5"5!"CABF.VLZ$K*8;\IT]H@%#]>^>5<"QEP<]'GY@S8=,&ON
MR ^1-6C('623F=("E^N3>%X01E[[+G(15]A-N0W*"7QXM9DJ9C27#7"-\_I6
MOJ=6!O(/=D?0N5^PT2XTZ)4/$OIB6IG**?N")_-E^M8:29EL-;1+5D(KUMJA
M7]N5&[OJ.Z=^@[3?R?'<6I=2?F%6I@2Z,(&RG:E;$YLDM1- O3J1"!NN_RS0
MYE\.4@[J<AU@)4RW'-WZ?W5R[N%,+V <7[?C(%8DY4[B"#D3<9YC5+H06JZ=
M(G);."X-N;39=%2H9UN;<EN,2J$8,AS,K]SE=EB$Q619S!B6S6674T_/Z8]S
M_CH]S_>?]WV_?WS_^OSQOL_SKFB')'Q=_<9VI-S4J.K5L@DU8?8[%!>2A:WR
MY,Q&UY-=OB3'PS/4T#?1PO"HF8Q5O7NG\O5K*_XI[%LS!5KS6+$29JM;6@)Q
MHF6\$G@(F[SM"E;R'D'66'UR%.T\K3OEA-0[41%^MM=F*6*DLO?^:D_)]K!!
M)N7]'E/&]'//NC*+"RZ#?1-$UY@,US>54 T&SL^?"RR+HCB!XML)B'=X.RLD
M,\L)7"'P6T-;K4 D;3;6"_;\>-I:;,4&^#-6LU@8=VVN>PONP_]UZDXN]AE?
MM_58;?"UB69WL3_4)(\]($9N\3&+"ABKQ*8=J*82S1 ^O6TJQL0PN3MG^NF)
MA[@NI V<W8KCADI6JF8KIG=<.#W8\JVY:Y%5AX[D 0<SM0/"F>\04E I;.1I
MJF8+/S[I2PIEN(2%%[NAOR33)C7PNHM21TA60@T,)T-@]+[CBFB<B;YH\FB,
M9CE%@D=.YZ1O+[&=,R3=[38N]!KN#\DUQ^YIR$\6Q):=?=UL2JVN[$%P>V>.
M*85E#NV^(=C_A IS[0:#;UYVV-?\CFS4W7CATKAY437A3KVF,LD<-W!^%3(]
MBR::B>\S2SXSA2G1_TP,*%DP2EX:!>9*)CNRBM9/?1L:MD^I&]^QHE5LW:$8
MY\]1>"5!UM%?X<V</N7;[HOG8.92)?KG!>7[<6NRMBB"K7X JBBIW\C957W,
M<1/YY9..UFON7]U2T.C%=?+ZO!0T%<]:HJ48_+@,87?ERGK8N'74P<W-*^J"
M_2%;=S)A/]C0S ;MN.5BF#A."EHRO!2>;:U47<>.YM;#\C((UM17,U6='/ 9
MAI=K36;Y<"B-E-?FZ+]\$L)UX)^;5>@.8JY1V#V&XM1+=/;UD=%#.G$&DTF[
M=)%2D-?3X$E/.-PT\'5(#$->6[8*=?=6]//"9'2M!_2W30QWA)O'Z<<:*CB#
M63>.2W$0JZ%T%V25,G(BK5)3^&?9X!\A [+5G7[P($P">?VMQ#-LT8L5A1/F
M3Y8&+/[W_O\=:JY]8BWYB-?2FO^YIYUHB"JA6/8HX@C;%'/UU&#)6NW0$,6]
M(CF?^0>.Z?4Y+PIQ'L[%JDX.,%IJNE_OHA&J (SGR;07(%@3Y$A(T#RI?#H;
M404)R@RL.>9S5#N/8-)L03<@!&?K:NG$XCB;CXM45>WB,NZR(@D6RJ=C$&EI
MCGOA0OM5Q]U'V6V2ES6;F0XKW *+!@OKD3T[ C2*BQ+5SKL2.\N#"451II9V
M-U0K5*$_R>L<Y5HM;-R3R15[3O'#T8\O+Q#-<E* M<2SSMU7JAZ:N+4A-R$*
MK%I_;Q]5AB@;'VXAW:<%LA]--5FXZ:>SVX]7;M.I*O$.^V'\4WMG1=U#[,'W
M.;N?CX[O@R7&11PP47'!S[FK3X3>-DKBRPB6Q /.L,1\Y>&KLU?^_3_KNZ1?
M!S":IKN@O!X11080I_#0&Q\3B<BWI.G51J9AUY"PR9>44';$AZ>=Y\O#KP5.
M2$'RS\;%_#-8[UM8WW,I7D <5>1%%]86_%H)_&+1(1 "2* )6L;3=IK/%N'9
MUQB=Z] QM-P6@(XWY.MAJ%>3;BXDK-.D(+^&&2&"IX9:R(>U30KB_]K[@/<"
MW3]J9XFB]$5M=/ QYPA1,?SEV!D^2HT:2I].  8*K- 9XMJU4BDH' DT;@@B
M:(R^6I89Q8^\ZH*&/^/,S<\=0:W ^.K<;2)N#=9%@,;Z+GV<E8)*!J: 6AXF
MPEYV,!=FPTIZM' *1E^<;2K#U#?A%0*.)2AD/96"<H$(<!_-UHNPT'15S.@9
MDH*\GU$NPRG@VOJTU\-R6#,IB Y(4J6@Y2&"\9L/=M+1OP%02P,$%     @
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M+FDQE+/;9Z<OHCPTJ\Q=#3+506JZ@?P4F"QV[&[3BIPG$.<SL?DM>+%23CQ
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M)UO>+[4U2O=N?>K3[CD[R67+D6GEIU(K#E>J&^;DX5T$JXL:)&62\;RAT6T
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MB3M%KT4CNP:< L*$V.1YZDX&WGD YZ&KJ=;C2^XL0B2I-8Z[V@,*7"XHSPY
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M!E^B>]G,V "-0XE<?!.LO3_/WOXJ ^S X:I*E@_<CYQUK@B1L78#X5SHOEA
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M&*]J5%:$0?H\<9A2A:U3ZPY)3YX;KN5DX37L.![4H8V6^E$Z,_-3LE&W$?0
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MQM)UKW2M7>3TW*)-50:-8D=]J@WB?'9';,C9B*FH8LR2HU^K_YH;,_K_ZS
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M<T%S[151QHWD@,$+ALO7&V<^3B;IM['"*-.1MCP4'^$8XLS;HSEE";W'.]-
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M!'N-(L_N.4J$4.4\2R+1=X7!+245E"<+5,EC%5/!]!I9%-8+U@0M!\I;O;>
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M,>OYV\%!+! K(CN&=X03_G9-*L25?ZN%7R+UZ+N$ C3TPB*?'0#HL]HA?MT
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M$3' !NM=HKH6D#_5Z_C1MIS'YI"2?NL%KL!&<W?]/E6)M1](P:9&=_T&XF#
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M"H9UX86?P^\[.I=+A=^8@@^>&0S\S!PD@*HD$?0!#U1X_^[.(!^GP>(H/9W
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MSTD.D_0#,2UZ3;Q2T?LGC-%O.$1=,4)M-D#QNV[C\M/US9GU\L-.H@?;0@+
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MKL%5#Z8%9)NB),57&S@9;.-3H9AEY"<;8@ W\ACA5E\HQD^<8MY?GJ7]P'"
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MG,A'YRW5-,P15<''&6-%@*&2K("FGH/F+4!3/CK_BCFD!G.'@[Y .6QRV"R
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M[^^OV>=&YX=TV7AHY,#+>!9+S6O;<I81? *]S6^-VZ_@L[=Y.@JX\8VOG9;
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M"'2+%Y<6@A\?S/?4CDY_$IT%E.$MNBL$FP4\%V;Q2RS=%J8#*,)-O+ZK\[1
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MIHJ3\,TIB0TO'"+IS.*4)0$6S4>-O(C^/A;1*H^'@U41O2ZA5YIF=+:'F\\
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MQ5Y1[.RX;Y>BR',%#\0B]Z?/%;DKTC:YE\Y0&W,B1KR;S;1P7LDI*I1>5WX
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MV*2U;F5C$-!RVL.?5KI,;3'E%TW2"CV9VX9?A83"?1PT/I.%W29ZPTF5SFL
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MPYR8G\_WDFXT3?@3MY(\1^!^Y&*&V\=/MI/5N5^=M5B])671]:,U0*,' 4$
MYD'GAS'U?SIK ".,G/.RB"Z:].\9 R3HNS3>):5^0^8BN@7')3G.*MRY.(,7
MU,5QI"LL BC@'#?/ZMH@ 1D'4_*VX5ZNC.9D1(QVBQI% )APP#SHD/\=01V.
M 7#D9E(]>2[-75E]%L)-5@:%8=BP.N^<M2?<KRY!Q[,@'^D4]PP<]PSF+(FB
MJ(]737H+OL8LG>"^23\P#?THY&9>CB%>K4.6Y4D [?E06X;L;-G!^W1ZA6G:
MM!L>EH@<7<RRR!J1]:IY&*):YET!(^$T7J'CXRCUB)ER/R+4J7$:$H<ES,9'
M!>,N22NQ3DW+<9=(GVC3:)OU%@M/[&N[Q#JPT\^4HQWL06NE'#*=6D"ATG0%
MNA1GIMI<W^/%(?TI)$35L[ \(=?GU1(A->Q+W"?3QM6)F]CP>D$W>/]>NNW<
M7%BZ_=T@:BNP1@GZQE;&WV,PHP_W^_2]!?/Y_#;NA*-O%X67V?[A3C99Y3,1
M]^?2H4YEGF-)YAC(T%A3U15<(OO+=8CC>_=;S898Q"$/(4UD/>2++Y0*T.A:
MLKG#_7Q8EN2DS@%I/),92H\S;Y>\4D!7_%YUY_O*H%9G,9)^/IJ4X52[9M<3
MEPE4W7>(%4'%EO.'@DQ9UD?%RNZ]DAC"._]1V\.7K]X%306O@6Y[70,UL,73
MCWE9NL_U)T,,6#HJ([6N5P^(0D)1-,R)#[(MIYA_;(-#;&J.18T\P3.(U5I/
M2-'Y<K17[S"1E\>AO]R4SF8Z$0P,=&162"?$VC7:=D=#Q].*S#31L4 8Y.%A
MF(5@ACC!@_&P54_;D*=+%G?Q4?+".\KN!^%I]6Z200K]BNF3V0GW]<0I]%U!
M^\^WZ3VV:J4.K"]4U*FT+CO'<G$'VN#<S+E$9N;O#%ONQ")^OW0@PO2[3T(;
MS%5MH#J)<&*G-&^1@]ZR&P[8)67HM.<DX/C6^\U?$C=68YIN:M^6VW-*1Y'#
MGUK+"5-B@C1N2-WA'0;#)5/38+,A8]R(/)&:'OI_:5Z>1'AW%IK*1O#[L1](
MS;;H7''@8FOW"GFOR5+YQG @7PG3#4#>=_B _/D-+P#3,G#-K&=H$!=3$]*Q
MO?Z.+5U[FG]M!$M&]$8&)P6D:LPJ;!QN8F=255O<+V>ST/(J3HG;>JQES? 8
MB!;N*TOR5TQA#IW8AH6YUPQ'F))H.U&DUPS8*9^'I2F>NT:1=#Z@TG. V@**
M)@00>&>QG0 _+2KT3\^7MNFR1#P'NA<ZB8W'WH!ELO"TW/DHF5092A 4[&^H
MOHH5^$I(HBVB086)=P^Y1E76P@D(RJG.JB3*F&& $C+#1Z,'6AQ-XUDSB4-P
M<G_!BJHK]R6NI,&DX4 O@@:/+'2X,2:FZL?W<8N^NU< .S<7/NCOTIE+?B;7
ME0W@=47P[N??^XJ)Z/8*62WY?W\HPNF%^KR>D^S5"_]-NBU,#(9.XFU^DG8%
MP0C!7!%&:B))0<TZHA<QLK:: 5.9^1<CFE=[$Y!./T)X'5RM"#P:D!\(BD;0
MDI-OM6*)K>&VB4>]6B&&IU0S_ "P&7 HC8PSIQ,JK=]UHS@L^W D=Y'4,W$<
M%;W071,//LP]"@Y6*[,]2/Y?5N9^501^M%)F8F$(7Q;%[8=YTT22CZTJZKYB
MK#J1PYXRE%$08H8@F[MI%@$31L#7>F1O3?HVF ,FO_#P$ G!^0JA$&#+SU?K
MH=A*OP^)M[3XN(8O9NP]C)?]$79OU^,[6%&34@Q@"KZ5*C;NAIIQ9F4ES*ZS
M'9?3#.J"P_%[>?9MP2+;P$2>W"F8R),]3.3;$_CL0KY],WZ U/*3HR,Z.FY<
MI?6'] 9,9@<%U6?/Q99].#AE/@MH]/L*V48TS'%]2M<P7ZTAC0U_'P4=MQ&)
M$"?[8.U7S*L!#=YURN (P_"2FG9 !T/TGBNGF)<(J9)1%[;LPTEF#_8$.*&5
M;9Y=S'4$1()&Y:2I,.99+"I?QD&FIL3\41TCQ=SHZ,XJ'!F$GB[1S*42WKT.
MS.\"+&EI$"T=#GP5=>0SA630NBD:<FB69O/Y+;%WZ#_LM\8.,M)G462N\?A_
ML4#CP<JB\"["994:9EL83:"$$B5Z!T =O@@MXGCL).B8921Q']FQ'R4>0T&;
M$(85%BC T\D.<Y/3@CD:R=%E5YP>YIP0GZ"LH.E"R\0$GH-R$9$A>C@XKRP0
MD9O)'&6_AH.LCD+ <9"#YO$N!+63GQT&8.6!YG&\>?=S\#CX11; [ 0^%+<M
MD)*I9[MDW'<7X?WWX^/_?L?K^9.C:1P+7U;NO*_S'FL"5N:E'\1/QR_>^U%$
M1XD_OWI2.(K/G=5]" 9!*S>5D8;P+ K.L'#-*<WBM,SUF-:=\ X[,?AFVR&H
MH&7I%HKQY],"^]$]XXWD!.Q^ S40]5<GN>D+UMRZ!%H:6P/^BG=:1.47@*I#
M_(N>XF\GKW(4A+9U@3N4E^?\F##E$8?++&7:&;H/X"4%K1X*&]Z;*^97)RIR
M%+*ZF.?4J$/C:A39_HY4]9CN!/N\\@R.C[25)$^DPG9E?84$E1?7=EQ VR4V
M/4E/72K@JB@@R<>1%H'QWB0*Z"32&<SJ4_H":C.LSA%)@[ODENP(#UF'Z^>A
M]TS^3TM?'@Y>2-[Z9DSE-AE9'J$94QMW23]0:Z<U$^4)4]#TU_%SY:[0:D'Q
M<DUT>%#:"!F9:-U&(!+DZV134FJU2I)[G;C(!WI@_5W0WJ.58/&(C#^AY&%6
MF9/ ^Q_5E\M3)#0!G9DC7&Z8;1H!2+B5C+%!+!CJ5JPGTCJ_06^H-5<X2 Y@
M:F )TG X*"V/7WFZ3SFN('U86_?4?HE&Y4]4GFXRCX@^5S?(0*IS7^].YR2=
MBPHNR3K#H'_F !]H)#MTT++X9/*T#1+^+'K)!M(<TRP&PW]RHFD5)GN79.K6
M<Z%AKD8XOB;[+)V&_]L6+GGX@,GN'S)[TFDJ$.B"E#%Y5NPZ.%+MY=)!\0?X
M9UFX0"9HGUAG8T(*/CI,8K3P$9J!DT,/$$0!&2^U$H-;U63*[I4OIIB4U:)D
ME$HZFY$5 V-,Q8P!3IAYJ$46A];3,60U?$M<&&_F6Z02$#'/$'&+]OC6'5HN
M.Y]$%0&6(Y *<'%&U3'"R)+.9_40A</LD]FK@G35'Q0MAXRE-_%!6)%Q*P@#
M&*DJ&YD>8VU3TI\95>5?BD].3KF"MFZYR-F )[69W;!X@1'UISY,@L/K,N-Q
MF@O>F?_>9!J-/]%(P=@5;F8,)'ZDB4NYN%X<(&9S(>^@:NXCGZ^E^<6)_"M:
MA?VMV.$)\:U8X""I4<6<.GP$R23([2BYYI2MH,[A%D98YJU!9XH,6>A9[JQZ
MN^]RO"BG_+R?K)[\A=1[B[7T$F^I.XR*]@7]7"<A*C:=!32X;IV1%Z\1L.'J
MO,RC!58-)S\BMFU8G7GC1H@?V,E750,)D1IQG"W B,G-RSDB=\YY_$.?L?0R
MZ,"JB_V5\)Y(AI6YPN)- Y7!."451Y-;N=21%&.B&N6Q[& O-^U@AAPJKBO;
MM8 #V4U/SQ&/V]_<'9Y0[&9Y/ ^..JYE58X!*ZU;Q)%H][U 5XX*KU)BM.P/
M#P[O??A.LK>3;*$&$1+-:%.5%4;%)(38!I+QYX^9F2;T=.F"..6\+D@M<;;/
M3\O<:675G3M6.Q)DZ,1+?O#QDE_*"K?]_J]E^8'%@,<1?ZJV=4?F=4U7^QO>
M;+37.)8^HF^=$,,6".;.Z1/W_RNPJWQD_%X-\Y'L0H=:&C(@)<0"':Y*=*8[
MG,L.!]2WL<6S-:LJ>RXH-5:)[Q3Y<O3DV-3;.^&;13@9:"4P'3Y[^+!;)Q7I
M[^['N\A6__3#E^M/'PY>?I3$2/2>'S:^)_YP]RT;UB K6 UB )]8A(ALY@6Y
M>M,,VQRF%;$#)/<F99Y+%6.^'%UZ^;^[>HFXVP+Q!LWGE^[F<;92=R^JZAP+
MI^!"LX,63/.T25$.$]4NY'S5<I252/%"Z[1C3(Z,^G+I;;UH1)4[H2]8Y0S*
M<UF1N\BETYOVGG1YW5,RLZ'#C;B>$ZX>X:Q9BT".IW04:;00V[]PC>55_.O^
M658?SC*Z',E+,G[I>;]8$N87:WV3'/L&#0BU:(3THV3>7+(D[[-^OCH^6HTP
M0%HBQ]9K(O4=8IP;F[SOL1,UUF#6[?NOYBQC?TJ+#Q[%W&%M]W4O__/J-[NS
MS^/E1=:LN[ZYEOZ%5G\H4']WFE92'/SWM)ZF_WHN*<C =PGGVPY-;*K38W3F
M:TO0'8>EGU<H6HT_:><NYG4Q%#V]4]"SIW<9>K;Q#.X82]'5CS-F.O8"@E'#
M4B@NP8-UJ<D:",'.3@,.#T%^WBFL8R-H]0%!9%DI0L];(M',!A.BEK,9HC2A
M!ULDEJV6V#5=!)"GN)@[<3\_U:)N?22BFP)6(!J9U<D763G.VODHJ2?T"?Z)
M[6SM(DJ#:"[[-M;O\;/-&\Z7(:1D;9\DUBO@*NV*%^I)[$//1>N6;3,!=AZ0
M"34Q?-=6*U[,YFQ2: :/E9#,Y*(U$39'[N6P_AA%1 T'.3 2-"W2TPS<=KJ9
M'F'&75[K](R#Q&I*]ZQ7[Z_[3HVMWQRU+0M0P0, Q7$L[EU;?^I9@6H:<<JX
MJ5\_73CL#BAQ;\LPG7>>S1R_27%*SI\^#\SB<G\KRD31VK)VOOXNP&PLN\7,
M".D)64J@%^7*WQ25JN5'#N#0U#?<6([A<W208SO/U?)RU203O@4-SG2:;<5<
M9ARR2>F^VN+1ER=M .)(3D[S&YUD.$Y&*T FNY$1PD;2S5F?&/ ]$7V:S6ZN
M8>IF<,>48<TN"@U=RV[U<)VX$C%>WO[AH"U0]F@KO/D$^$V9EU.7/_>^,S@?
M;2ALS'*RTE=/8EB=^?U1CFMOES)/:0<"16)VHSC:>W<[.Y^+O#O<REG%IE0#
M;QYH- #1Q$0BGPF#(E$NWMLYDQ4;O8GZ"R)&ZI%%&/37P6!?^Y,2Y/K?#P?Z
M!^YT,%W[O&^IO?H'+W/6_U S=-#_GI531NN7<A,>P''$*90&1XVUXV,=P;#0
M>M2!IX8DI+T#N)W5]Y+'NOHK5BO^E_08_7U]BC_8[^^5>N<*5'NQ?P=I4*5S
MA&\@?!F+Y\V@T :IUE+C[[@[4X4WC)UE4*>""8XV7"8H*R"57V=E?B9%G:VA
M(UDNQM!M87V5E8A4*OV+]W(&G('X^ZJ,=-$8BXC\[XB[',P78375>I.U3H21
MS#S!X>!>.:.M73^/+5-7R#G$=TZKM':;CN3ZHGN@I7QB=:^RH!37SF9TGB]X
M;OC4VI'D]?GDR0[/7+D,S(C'#$4<^*!=C NR96?TW*Z?U4^>2SO3?;]D$M#.
M,*(;8)^E,X>6%,6H]QA^QX*&&W*&HP@2OPS%WWR^9X9RL^J[C0'%@^& Z\XW
M?\)RM!>"P)"35!,@.NK=8\EF=)>525=].% D>8$V&_)SE=4?<$8+_4PH98P.
MO_8PTU;%BL,7(@[Z52O.!O9NU,W#,BTZKZ:)*N[Y8V7KJ,+(9C/'4^/83QJX
MM"[U1#E41N(N$D((7U%?KQJ@[EGX6*%$4;9.M2;]@5<GAN9S5*@$D)D^_9>+
M'"O8_R>%<?3U1?S8?_NBD%^R5<0OE)CZH-]P\(51O[;P[Y)Z^I6UBJ<F9FWD
M*G%W0Y0*YS9(]D_B/<W(FLM +X#&OL R-MZ;]MO /1RBD%[WG1=O$<*28+NX
M1%P2,48S:^/MA'V:DS4^8ES !/P:PCP.#2<G%KH@WS@4X5Z/P+=S1]LF<4@?
MKO2U.!?.R-C6&0(BQCT]F*YV\3P^R^K4A_@G22<.@,:GC]N_)V=<5(WGCQ*.
MQ(&' E!>Q_[*,C1>GF9*Q&%EX>3[N$7L5>39!UJIT[*<1K8 ;J;CH9*<7IU:
M5*,A+)&AWF6=0M[<ID:I4:7.9?613*LFGLW4C6D#+0_P?5F),R\L*)JJ$\A,
MU%0ZM#)9?7+G@>7*3;M,>%U8[>![9=6%NRQ$=]$*^*/Z/$'4H4@E.- _ RGD
M6'F\Q(&F<.3I&K*8]_=0V;(XH4GRM>DY@TQEUV'J%S6Y7/^H_@%;@"Z,%M6"
MUZ@2N3>P!<<. 6"A9_%1KM@O4"LS<._.R$"DS["L2B0W&6-CC_C#],-AJ-M#
M/#B;<[4)(G3ZK7=TD!WWL-6O'HZ2GTEZR*\.[5>_D?]^:O\^&JU_3=ZX^LVC
M\'KSN[5Q5;0HG)M8#?:)JNQ?#0_$"G^>NQ15:;KBGCWFW*4?"F%YR]9>PF1$
M -CFH63KK/-4Z1##VG,ME#6;<?,8X4ID9@0G^KCOY;8*C9 3,*&7IU/02)MX
M27H5<$!-'>"@<M'<3,'W;WYY]2(FF"RG&I6)2LA.-788JPS?JL*8'O0-2"5I
MBZ'(M(IL&2M(9*(=HUO+"M9V3?J13[ F &H9HKY#!:'FLWUQGV;AGSQ]\H.0
MHYENK=59"3DL3(UC?-8S0Z"@/9'%N*TS2?M9<LZ,U4P.%?>L,XK[Y\*Z4;4+
MB?B"0I.+UZ2W:SE;W_0H@R^!.*D&K)<UG<V.BI%8:F0R3)9C+*%TSGT>&$VC
M0"W=#&!; 8E]'CN8!A!8#=AJOZ5*NM33<'OBR19+EHJ5$/7S4=Z8*GPXT&M7
MSF9P'R+1JI3C"0SQMC)#&K@M$'&<9HN+M;?5S<@QSK@ZQ2#LJMQ8$HOE>)*7
MX]#2>$+J71.8*R\(:4OQ=L/%];$"92.AU9[*NIN+%_4]#OD$.XQ@Q,8F]%2Y
M&!+?1W6C%$;,C%<W[=1(58(>L#)=#B73,9-"'XV9/[=J89S%.##OMUD+%^?E
M5( @]\S3GK5. \)PM.BC- 1!K,KV3GA\'GE=%OY024#:2HBB(915=#O\(8Q0
M*%I?]#S 45#,Y..EW)O"(J%Q6CB^)E:''#J.>GLE=.H,ZGHCU>7:-(+*42(L
MWG5]7X<6W&0C^\OBK M6EAFQ F]\QP&@E[CBA%ZBC<9KVG2G^%:M\%42.Q/(
M-A@VN+O#>:X>2!_7;^!:-[[;WDY%,3:YM_7'\UC]R+<CCK&9D+_9W\@42I?<
MZWN3:NKZQG@ DQ%CC\3OY7GN7-#VNC+_S^Y4YO_9/O-_%S/_42SY^SCJ#)EI
MO &TO;D%AMA+SLY<1/;1Z_X$>TS\>'@ZDPFG.A!%]882GQTP?ZGQD:=CT5$+
MYF@$20A+P+:(8Q@01QG*2C)5:FSSFUHSL[F.&6W9W(3<KUJ97?>)S$JN'L6*
M7<FH].>1JPAOS2=LNT-A:G7NILA$;YS[7&\ P29II^_U"F0B*IY5FUD)WZ3<
M*MD$(2 %R\G<7)1!:#K78;%?B7EM2*PC7-N* 2!TD2ZVKE:-I[A?*1> >)/9
MA1,PS;A&&NVB8306C;:X *M=.I6?S$XS#A3#A(1NYJ+S&FF6UW/NM+OX\Y@;
M64W@7*B3X9[U0ADL8A1J%!@4(53>>=)SSB-JF)U3C+N6G?UVU17O3@5X@G)A
M"+:R,B+PVA_/JIM4\)XR/492F/P,\=#S)1^)D''@FAG'WC.WGQFM&E,D2X>#
M,Y3H1QZXXD>9\-75Y!*-%7J/#NO,)(YPJG56<A]/4ZS7F2<QMP3':N0KBE:N
M9&;(&=R<\TE^V9SMX0Q-],]QV38:SN>;95F<K#AUTH8V+*?F9WA!P% 9Y4.Z
MHPSB?BUS&779C>S1_K5<JQZ\()G"==K,L [?W(FNV)QDTM')NL<^#T0]EB3T
MR$@"DV];2Z=XQ'9>T8N'@\/C \OPO:67(<R*)X9,7UZ>W[GRIAM"P]#+2W)!
MHK03UVYPJR\JR4%K<&DB*V?7)_\[F #Q(,L%J5,-K$4F0^KO%:+/\O.%;^VR
M<(1$.^2;$VDRSE5QXK*TBRF3;5TPZ8PLKJR:M'-KB,7VI TQ!'MZ9\=RP.:F
M<M><?&6$3WW[...//1>:*HG)I-SP+G1N('F%.$96D&7!(E.?RM-L&I*\9&[B
MAI(TL$N/&!</99'#\9<_LH?-Z%'T\+Q F-Z.LWY]98E'UUB3^,C7)'J^M^'@
M50CSWH#YW":!^;M#IM#3 9R[,=/2D<URVC2+OWS__?GY^0%==G"D'$S*N12G
M=RM=.AWN$0]C5G"O52WY<'AT;_R=!U!&M7PJ,;79=ORD4$//_1LE.U2;?*Q9
M0([PW_]F8? 4XA+CNT"(WY-4KM95@<\(W=#(4!#<P2<2@]^-DO]NTZJ!F:F/
MK^/GTSA>:'A_]:]/M:B3*QL5<5+:E-"M)A>TR:RM"J&?6[05^.DX-_3.\C2'
M#^^E$F@^?'1OVK^>*WQ06K"F>SL"X%$"V]S%8,3RNB[+0GHV0CS3UP VA^LK
M19'<^Q [).'NDOUK6';<]TW2BS)=&%NC:![>[EMH]FZT7GLU'$0EI$P28;/!
M0=-N>YV*TY>>_%[T(_W"LUIP>R-)-#IE612\6*E_UK$P6._C4E(0<:(IAO,$
MPS+^1"C!8^RRF?F\&BLKY#ED,,1[T:6JW>3@I#RC"> .3J7+J8#>I)BBF%KP
M?YF H)'YUY&6X$8?S'\12&NZ)YXV,E-FM7'W) !=<G";!-AMFLN*,%[A"ADQ
M%<N"O2 18AXJJ/U,HUMN[I5>F&/V"?_AG1A-^T8Y;>X^R*$;#_E\X7FQ_N9Y
ML0[L":(&NF0F_H;UWY5SP#5R-R;_R54"TYHBM7F7[+$;,A><1(.L=@.&\=8&
M[TF@6H(D9,Y:8U2-CZ1Z "J\V<?P]@:+MA3*>C827+:QL@EK30-'HG(,\.2L
MGRB2BUVGV[$7_>=*@($3E^<+@+>*D__\TX,_\;_I<Q/[]^?9SN?9M#G%ZQ_\
M1S=7]* G5R0F?E-MO[9G" :#=D87E%[QIQ\QM>GVS](A@Q7_^V;ZXQ<]X^#I
MU6[@7\<_OGK_\C=)E%WJ_PZ/Z>R.0QN.SYO1%<^AX\8]]F[<VU?O_FN+J?UR
M_.+]Z[?OUJ;W?5/A/SC57WA9/W54]P*_;W\SH8D+;!:A6=%*!4",G-5H["H,
M*T3,)5J:_+-L?;"('@><^=+SE\6Q_H/AX%5<WA,]2G,!**] &(H4BPTV!B)9
M_WKKH=1'U"^HO&[U@"+N  J32#V*A[C.0MYKVI!QYT6./G%@B!3DB?6D\R!:
M_0X71\2)"SP!E07BX$K9!()V"O(E'^(<A8?>!9XZ-T^RN4<X<B(!/&":38A7
M0=,2XMT$6^R"0""_T"J@_)!1=QF-63SJE92)K."%D?XX@]L?ZU\!W!J&40AY
MDJ)E7"O \^LA_9"Z7#MJ[YRW>E=8KT+S7&\'A[A_<GC@R7R,N=",W;]^GZVU
M1+J9U_SZ8H97VH^FHVJ>!%6#'4>O'9\CQ]&TW=KY66W3V^C;CY;5P:7J09 $
M!32C;,>?K(/>F>G=)N7-62]2+<Y:($Z,&%[H@3]5[6 U#BANZ*EM>#CB3&D.
MJ:XD$F.DCAB]P;N>N(]9+5)<R"<[)\?7(ZT?'8G>?7J$&J[=D*;;J5V\)L@C
MJ:6[!'D\?'"7,8\W >]XQ2Q'<8XF<.Z1K;Q(&1H>(I4!VF,6LT2Z+Q0SOTMR
M*>U ^VJ4?F@(/]$4%+^;Q U,\*E6E9'+PU7YTOM#*Q%O=73I9L[E]X[OQ#M9
ME'&1?85\"D,&0V\Y[H+6"DH*&WPYQ06;1YK6:#U=]%4NPJU2D/5H.:E4UNL+
M##^U@M($GI]?H%_IP$*U(5^7-FF6-9RH$W8?UW$&AP.4Z(CO)E15IN0#?W_E
M:"#L?QHE#DU6!]0S866B#*7,T60BYUHCO\-!G>;.=^98R1A+ V74N/I*O0 (
M]5/313+0ECZJIROAL?>\0>*B*XA<"A?,*+.0@F.M0B9"K:E[RL5V^"Q3P*:)
M5M#"[(EC'B6,GTDN%$[89N^06KX:6XU(QG$=0<RL=1F[J=PYC^9G H>%7=UR
M_'S6YF).RSFUT2W2NN'<*7+D=&'&?+@A# 4-:V(0"3^.P)?#@1Q"'H[WP7G#
MV.ZJ TI1/KANUPF6\/+7XBX)Q9UQ97[GCGJY%QF?J&WO"*-.1=_>>?M&2LLN
M;HQXX:J':6<OY2)S6TTV8H3F_Z/2.@1XO?6D4?:JI6)\M;=B.!#A&ZRRR+(%
MJ& F;J-OTPX/:T8N1"E6E _K=:VOE='/4<T:RQ,[?#*MC&M:O4Z*C#*._O6+
M^=NQW[<.P-_?*2R&CJ-EV"2MN2?>GX\.'B;THGR3W8//T"#M,R-A'=1CY9_R
MJ/L4ND*]CWGL/T3_K\/7L$=P[_"$/GFDUMBLC.S6&Z)T! JF*F*W#Q3L'[D$
MF.SE/Q\>'CSU!\.0"EP37TR%K:=F_DEZ[0\'R2_&)'Y)Q';W[$>\:9IO6>TB
M'O'E\O&.+"P6RZRKT1EH$IO9)CJ%1^G<(85#%G9S:GD@CW TRQ<8'NZ R^Q*
MHZ2/;4G9? 1W!N!%L/9#(TM[]9J$'B7H5U3/EN(=-$PTQ-4XDPDXI6JP_, X
M53(#;_&3)Q)1\T#ZAZ9CPP&["0'ECD;?2EE5=HAK6#N:,FK!-/1O!8_VKF!4
MDLZ?T<["TS-M"1Q-<#BP;J5V6KQJ@X_ITDH\*CI3P+ 7UX!ING7BY=O,Y267
M*'!U@%X?,ZN@, X/'GFYH(Q>4\EI1@S6'7X7!,4Y*AWX>8*PBFL<Y2+X*-9P
M< DZIU'D/DK';OF^IBG_FOWXVWK9QL^>R9(OV3'S%&<\OU]\:/V%.;\"O7X;
MTN2OPP7A1QX^3WXU-@]UCD7!OO4<'O:YB(;*@P>0.NVPD';7Q5B-6=R_7@1N
MA=^%2J;F%J'K,1V[K;:N@6V-8R7\Y9,HN]'';R65NNCH3D=&,>CB7G-17^1:
MKQJZZE][\JQ"B0%[W]++Y(:&N<SDUNV'.AS$F.\NKMN883Q)CC3CJT$^TM@Q
M12R3:9CE2($1A'^ZGV?%!S>-V43N":R9YE9THS/?<=4V)K5@P!U,K_"\HBSN
MGY5-]!*:"\_>=U-G%LT J# F*LG9GYR&TD)#->L_:VV<,1L.7N2T^LE/PKV"
MFU]*\>_+%V]?C'Q!7Z.YHZ@6.WHD CA_2,_#U1<D%SW_8#AXWZ%;H\O"4#7L
MW\_017W$AHS*\* +XR8-#&HX0QU*2)R]XH3. I<E7MCSI*VUP-_H%WUSDTL-
M4LH,TF5HHYC"KQ.U6DE/MX81[AP*7 H5$A?F<,8WDG@Q!L/VFQ<T'!!^;'3.
M)"-9\4[Y$?*K5F*"C7]O4K&YQ'8]QJ,/!W:=ZQ:85FZ4'+__+1 FA?I4-9[0
M'K@$/D7YOSIO&R71Z6>(OE_)481U&@YL(Z6T3:R/OY<-ON*M&Z.<JY0C.*IM
M,W[\M5OL9>%E=G XB&Z_%U%Q9" @=I9!6AG*R<25]F=@J[1/4NE@S:3V6ZH6
MF+4WOQV&P&TR:@RMG6I7,JD<8A47=657;0VN!XN[ZQ;/@L'!'OEGA::9N.C2
ML6EZ1O0 #4K?CMVX32=K#00D%D_D"ZH!IO8TVIFT%5(F#-=+D& :::*LEMYI
MET#V ?C1FEDP'!3FT&NX*)^>9U.GF9QEL"J-L$U5I71>.7=1497V&N% IC'H
MC-W*Z98YKB9U8E<83("@.Y3#KFLBU-#A)G7_';^.N0Q1ONA5XRP]*RN[&>U>
MQ.[>7%[!4S(S770Z.)R#D743/#4X8^:+P8#P=D[7,)VG3<.4Y7P7.:+#]W2Y
MVAH'1?=3D@TGC@G5Q9\^(><@9+7)%&IR']D1:FSU@>S>QE]AY42?XF;U.W5R
MK@O6=7BW8%V'>UC778)U3<M)B\O/MYM!!Q4P.CTFHN=/7I&K9C=:USA/OB(J
M=)6;*7#D[Y7HSLV%K4G:V;7>$YT4B"BMF4*>ULIVV"E) ^FW464[K8@1*%8/
M,_'(JE<DQ>R?*SPR5<D]4,B]?V>XI3A]+4TQY-<Q(^_2QG.:G9QR$Q)T+CA;
M'4YYKJS-[$YS'"J1WF(,QO&O3),<G R1B=P-DIC#U8X!Q%"/?.3;)(1X,TC1
M8( R"&MD]3I.&+VU-T&51LT9>GO8"BX,7]5. BM(H!60F^9&%!/F\5^=9PK=
M@<9QFV3I&M_U4?L_5A,%@7G&9\^:%N$2%.; S,*8Z2CQSY2$%P>ZN!CLS$EB
M;49V6<U1'<[D87(63_:T%RZ<!#9&S--MBUP.JO<4^L>JHLT:_V#L_6"&X>!W
M:Z[2P50!M@'T:>([80DQDE$%!ZK+:$YT-+-<-AS!;$EMQ5&]WG'[/H,JFS/-
MGAF,J%6LR2(O!1*RFF.WU!J_V(_7C\M@*#7FO1Z)X&OH'215#OVQ=Q]A#_Z4
MA3-Z2"ZJ6)Y8#Q2,/X942I1WBV!_O$-R[C5ZXA$'51QD"]/E:$OD&&JEWW!@
M+\&97=]_@1[?)2WV[7%EY*=YZ91N;D0"J2X,'&A"E7*QXTKGRPZV3AGL5<%<
MHIKPVZ_$;3([WO6@]T<^O@EP$FL @8%S:B5BCD6HJ(LD9TTDDE-A=Q)I\EW'
MUA05P["'@S4E -G35Y%@T#L F\\BL/7Z ^2=%SQ"^#.#G&=^S?CO&X&C)M:D
M0?)<,1N?5( ^-=49;'@76I_$U>1"N^_56Z?GJMHD<^Z(I4V+><ES20U793KM
M<#19@@N*2JY=5LRJ-+*T@"RR0N.148Y%PU$JX5!?3(JAG&3R5.2)=*EMO&BJ
M0[:8\"87="37&P[C8UX4L$Y><(.-B(KY+[?CHET94\GM)BDY?,I@GBN@*CE\
M>M6,%L\>/WD6=O!SAW>Y$,)G#Y.S I=F'&E"#PX@W4:JNM52-Q(*@:5QHVB!
MEG2XX:4.C1,=H>7,%F- <QHF*@[B;A1WWNZ5?5W9%0CJU9Q0:;C%*&:", (!
M^TWG7MD+F;V0V24AH^ZG1$9,U$@(H0*@4.%2TH2A4_M'$J%&6XI\E-0?  31
M1ALCP;]<>@1J>'2%0_S2;.:3F=_J^N]OZ_ZV[NQMY?@K"@46E?26G+O<_)+O
MN4W93*]8A"[=7ZO]M;K%UXJS;DRJO\7MDM9*Q5E6E=S(3X,(XJ*'_G[X-:[;
MF?Y=3.-N$[W]A=I?J%MUH;Y 3[%OJ@7 DDYP72<U[O/5<317G<MM1N K.:2'
MIW7XW=_,_<V\73<SZIEXZ=M1+HQN5.+>*([I*+BR.DF+[-\&-,A+L-"<5&6[
MD*R]_ +M;*>>D7,;GP_MMER>+@7"P"VY-C4OW%_8_86]\Q<V]+3GFIY(><;Z
M<;2*M.!8CG:CBSIH2_U9O<V-926.6,\"31!&'L946WIM0?8V>FK2O_8W=G]C
M[_R-92* ]$209)8!L4ZW(= Y2DZ74U+!CK1NWM(9HJVG2[9<^U7GGF]C",<=
M)C6+<M_RS79M#VYZ6N4VP3Z8%5>Y+B0':)X0D,0??7_CS3Y4E*!;=Z)BAGQM
MQ&/:A;L>LJ<'^RZ&!*UP-&$HKHD,2"W V-#(64/\0N[+N))7C"'1*F: /N.O
M^,\QC0BPAE7&:/NV\-P?-" ZGO-:&T63*0E%QRG)SE*@9Z3!-.-RK<X2X3JV
ME=:IKERTB>_DY5>S2N>+^^V"Z3Q*;A$$]KY2V.;CI95&YX!L0.M&]( K*(OS
M4-7%.!5A9H@A&L-!]!6!_1J+8@^BIPL\M;K8TK,>AMV,E^3.DU?M#$U<A.6+
MH%O*Z<KHG0OPM_JQK2I4=V;FMTF._WX1*6^,Z!.8WCH,.8;T,1E1%-+RAX!E
MY"5/ 3"!?C32V"*G%PD$K/$'3'O7&H X9H52$>O2R2G#H+L/@: NI_4>%;;W
M+O;>Q:6'^><?'AP<;@68$**G3W4_V&.E]E=O?_4NOGJ'#PZ>7?W5._J68;#]
M]?N*U^_.W;[GB6[^?:9$^XL2/%ZM/CQX>O5W\G ?X_JR<5_FV>M"XR(*B:.[
M12%Q="<I)*[GF%T3<_0WHZI%Q.<201VMYI;^G&NETZ70#*[$:_E<UU).O:%.
MW;<9:1!SC8J0M;BP]A73.K)NI1C'%2HW*4\*FI*R1<^L2*TM+)!@[^AV8K57
MK!0P"FW0-*L-J5"OSVV4Q*7(4<TSJ0"+MW*XU"]H/.ACI5&E#^=++3_45_B/
MC;C:F3DRP_:@<VJHM!MU6Z4*/W516Y0&O4:S29OS7LPJOO5@A*6[#V8&5TG4
MW<>\$Z43H?%4S?UV886/$FS)HNK<*,[-.T#+Z7G!JO5Z\"Y9&"GQ2J'V41?;
M]<ZOL@W,3)%F.3_7./!Z:2U"1]I/$UM</=?T;E--[TR4]97E>S3/I%L9]>;]
MC-W:F=G=KA@R+F"W<XELF1)T+"1-4_OKCD22)-.<L-I*QQ66 I'XZ18S,X%M
ME,TKU(P&YX@GZU<<22\/HM!(UP(R$:I!EYQ4Z13E?W$B&S%BLF+F:6'=ITD!
M9+5TX"HY@RA]OX1KNEB.4&Z,+-H"A,D6CUZ<+FM^7'V:+H02)4Y9<K-K&L&X
MG"Z[3-6V>J"ZT';9FO0,?#*<EIQ*&@\3HRVH%?U2-P[_0U8KC;2=TR K?NBI
MFV,X-.HB;5KD0$]2^@<M>'V:G$,V:LP^IU?2>[)F.8J)_&D( 7^7&$N[KBKM
M >W/;%9K8^]X?#R1ADV NK.C);HBY#:K.3W<ZCX"$;('%>FY@A#@!C@=$IM
M)ASE(-D.B3.:E?8(][\QGO#C0'ED+TR88;H.F<K8(/#[&/0+2M_CCW0UB[V3
MT<;[?.5E=>7&O@Q7VA!E." 3KFJE[656,'C4+ DUML@(JZ;WA=N[=M49SBO*
M*U#=7"OI9/+J?5(OZ?;-ZR[I*IK<5:&O]F0YANW!1%=+I8\" :91NO>TGU]-
MQ@?5%XFJ:U5^7V<K;EVS'>C&"INJQ'KIA+8]G4@CQ51%;.%[!RP_\[SYP%*,
MP)C1*A1+W_,K=*,38)?SK<P8M+.4TJ+*G;1T4LN*!I:[$Z"Z^%/IQR[#DS5]
M[?3IY%$S WXF_I@.F=3C'*U\(!<Q:)E0IRU./WU_W'&H<9/3HLS+DZ79%0$L
M-DI.6YHL5+!05XU4BY4%=Z.<SUOZ019&NU&8OK!J#W(=)^IT_4R*/&O$??(;
M,R>EP'W56 ]]<H\TK0XT%!:L ^R!O7*Q3! ORC9W8F3S"+&0&I^RT93.R>7R
M?ED+.K*SK&K9J3,%7X)PMK@_)QL'KQ<@/+>@((F7UL)$2_\B_[>E,57<U,?;
M+8 \A544.D%0B3$1W257 %YM5>:<Y2>;:>+$6U4_4#^\1DDFZW$_;1I$T[SW
M7.+V'"2_"(O$O 1Q@YJ3_#(Z#(WI>6[)5"/^:P>[7ECC@?5-=7,0L9F==<&L
MC.$"[X3#K&VO\'<V_!BI)KH?0 DQ6>!"BRJ@#61ZM%]$O=2?K5_.3YTT9$A;
M8.+F$.U9V=8YERO0F88Z:=B.'O%@ \:+P7.1QMLH'T;R*+X'G1-"!Y=-)"9L
M+(0&D$%I,^F*"*EA+2/.P>9&CVS$CLT*5E=2*<6%O]&PZ!%5-*IIVJ2>462E
M[\EG*\F5GC!Z?%8Z+$I J\/8Q*:@B#1,)4E/T(RD$9[$J$X93)AS-\U2%2!R
M3VV?QLJU%Y9?KJ/LJUD=6R*C;I)"O%E!B&/PB0I&VAJQ+'R'$0,F7W0V8WK_
MA006XR.[CU=\PXX>'=,%T05TM?&;:BT\9+^Y/68%C*.V;%:X\ J*6%H76!WG
MR"(?G;*Q*+PKS9#B$R:\LCJ&4<PPPE7<I!^VH^J-.TMWQK\:Q):'<I<1)'"$
MGU$5@#K$5I%#XQQ%WO=!\KJ0/M614+,8"'>4\*3\VE5BM=$1(KB1+<337R),
MDW&(I9CE::@<"CCP*CV/IE\HM8MU8(S*][KKH"2B\48/!V&G-S9@Y&9C',1
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MC/OZ&4UWG6GZ&TSHZC$%C^X6IN#1G<84?*7SMZNWY_-1!34W/9BTM3"D)*]
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M/?N=W@T6GPC(7&NW Q.!BT\:Y>G$L]Q' _&ZZ%3@H!1*>CGW$@:DMZ$<1)_
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ME=$QF?R ^G3&B! %XR"[9J9%YTX*#ARD2F]YN?J**\SLJA1G8VL-(?'&2DK
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M/S<I''%1(I4Y4>HY57#)(-?Q';5/4A$S7?/D%'#-*WDRJ94?JGGZ9M7--^[
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M04M.-[+L S@0.8#I@^:$>RCK<51KDY7090U <1;LV_.Q.9& @[V^2LP3:'G
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M4A;<>Q!3X^A8YP41!V1<5RY0T%;'<3*6&P+>A1DJE=#[A*TJ$L.2-@YNO$7
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M![UF>>8MS]'^/XMXZ0JQT7K?I?4:N9VK];KML^9,F+NKS]J'!\WJ/*W.:XS
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M$89@%98$?O8H>1/5AQDC-5>8ESC/ DZ(]\#E)U*_;!F( 4\NEJN]V^Z)+_<
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M8C]2\9>,#\8,67"1ZC0?AFFP/U;(Y3PNHG%F67$UTGBJ=.)%JN_M7?UVY5W
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M3Q)*"2_5 YUF. NM4BQQRSRF)O1"Y%#46=[R<K1NO$"/4^V'BBK%51QX:I3
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M OX/_\&QD58-?$''"_?'X!$2O=742!]ZQ@OZ$8^3*'42\!! !MT*/QPC'*M
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M>V+H,ABP@>Q2"=_J2SYD9/G+1.1&S,-#49@.ABO=;TY87[C*'ABD/D_":,)
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M_*0WL[KW@ %0D^0UP1P=)XWBD-(Q\190O6<_$BBFW8+#1 DUMY3'4E?H6 &
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M5KU"EF0=SB^0/771Z\P"5\5H2SP,[PIW74:5HN+%5W@CJM]W9[Q #.P'VK(
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MF>B]2OAD1!6GGE$$!I^V=GM5-O2[=C1K8":Q1?8&C66;&LN!U #T[ZB(A.0
M_&#*>D6:R%DWNC^J*[G8&.+ZK;L[\K7&V)+3(2+D&#48 #G$1-1J3#=ZXPX-
M3:O1BRBT)[U),;==.:X2!F1GCD##%"8#4(2PN"L9WI=74W+>  B *-#V<\#E
M%WT)+8B7NJC3)$#EAK^KJ7ZTRNXEVW8N4.3%.&$:2<#15IVHN1O\]7:-K=*&
MKH<>D) ,_TR0C@L3&H%P24T1'\04H7G J<U'5H! U-QE;IYSJ:]QY*$K&YI/
M=G?0?PG[-=);:BBE0VP9QNC(X>QG\-G=Q>_.O7><]GS/P7A4$(0IS<+!#J41
M^5!BR/V^AN:+&OA(K3'E#1?P@PY0S8#)#)0*$H,??&,\Q'D_N<&/M[!3,(0=
M/9V1QZ#-Z0YN'"'W.B9&H!Q@#I(%-I$*=C( VW-2#$I=9J,CV;D<!!KC*%(E
MG0ASI(P143+6KP6?#JNAPRY!!NQ([ J7MJ,4-\7=S&/@OZN)HCK2H8;;J%'<
MN7B?S^\0P_.V3ZB?W7L-5+F@U>%P[K!3$N#B+S!SL&]M#<=\>[$OEX'G"]<P
M+M"'O,.'A1T9J<"QFV$Z&"+0B)>(SM+A>.1L *MH^4<32LD"H(FE7JR"GQ.*
M!Z&\$S^&'-GOEH0:XA7P%-.5_T-!T2S>7<=10&(L:1^W>>?%= T$+X\E]DFU
M8$0S#X.1N@GV @5+"[;CT#0:0CD]%D@4P9F 7@DC^@-0H=WZ66!JRFQ" ]'U
M@">S(P50^E$X BB %D 2B 0S'XC2O<"*[J4V1/]LOM3&?NW-2G%*;E&!>:/P
M XR?KY/&\Q$Q] FP,RV%%<D(<;7)CU\KZRN)4BF&@+WER&)M_3M&JN"P70]M
MD6BNC5>?^VE,/E8:#10$#[@9?9)5]%:*^&F?0 I[G*&; 5%PH^1$,)R F\H)
M3G0SB4B0H5</WX\,2TZ,/RF.IMP>HMLZ0^AIS@62.-&WEZ3)='B;+8QN3[D;
MJ,5SE >$###G9M[-F.!(\VK0()G<ZKTN #X(J+E[3%/I=#J!"?;*!3-;0$88
M*%PA)P6227!!<_/>L33P,>S< SVF+:?L$A&V+<<$2G#0V3#+CD3RRQ;1R-IF
M"Z^<,UNIL<+--IW1FP]/'BX,*ZV[G76SF&*VAF3!9OWH&=(">;+"1&2:TXFR
MP\TFS'<:^R Y@(-! GFA<AIHF(P*;>14'CY;8ZW#MR;D@+E 2[\>5_,HC5'.
MA%!QPPES?##-M0C1P1<IHN!#=>TFIZB"RC9^&^K88*"3(I<#(=01$WIO..J!
M=Z>NZG^923+<BN'%5@Y-@=QNKE$.K5D,\0V(H45Z<9UP4[!B:2Z<9T;5JLY]
MEN\JS'>]3:C_YV \F<X3K\!\Y-ABPM+LQ85B17,=@9<54\DR3";+4'#0<JSE
MV!?C6*>B!CN:TVHVVRI<ZP4Y;W\NTZ)-J[+[<&:XB-3-'Y;4^!SST?9Z)F</
M7'"ZQP<H5@)"7?"[7B0<].1I!ISY*QE&%&O/7TKF][L54L-:V=7W]EM55?<O
MX.[+U (L\#ELO%W=X>]S#V^5HAN1L%M,&YR?RG!'>::1AW,C%T@7O(^JH6Q9
M 8*YCGX-Y*.\9?  A%OB7)/J$7M)2B'27"KN5&'!"N^'K85IY)CU/1&ODL)L
M7@U'@=/M]7(K0/#8%^.]^-@4L&7)4?C-(U2&S'D.)EF@.!*#$*@RN^^%-](%
MYS!W&N*'!\_.EG]NA<YX8LC[Q2YY).?N[BC6Q=MC[L=TO9<EP/>6O^Y "T55
M%Q5S$_6M\P(J7?<UM+TU6]>&3F3>ZXR-"FZGSFB+2?[&.8K)I;KE#<BBGLC5
MIF6WR)2>TJ/KJI0$_NY.E@F+=[KWW5T74S_E4'49@1X@1?+(H_P4CE9SKL#-
M9"YEY5XV+>+A#96-(BEU.!R92X8QGQ!E.N ]41+Q%)'"]]G70!&ZN!HO6G-W
MMO,OA54",HC&..W]I1(+%I5-RW0R<_FA'HP$98@2+/H!HD,D996Q(S*H< FJ
M!F<>O@S3N8"C+D],5=H4N"JG2*8S1)C;AM5M1<#R;4^F4^X 5W0])'EC@*,S
M5?<4D]*F8:NQ'HAVQ<496],>W12S\Z;:J\@L/MAW$]ZP%T:4_[W0'?8DO]+T
M:N4Z>[&$H)?-0<?KI(CX/F&^X.#:-AL&_-LPP2U/7T35V.';=_=LT6"_SCX1
MEN&]*FD?SA038R509'H3F*8\0"U0J$REHUJV>#"/*96%,Y7=K[<_+T$>K^6(
MS$K']T^I(KFOEJGSNFJ9.J^[EFEY!_UEJY;6#6>Q%("RWA:+M^R*W93O&%&5
M6TC7+8%*R14N92(;>Z+,EV=25,D%97E$7OYIG]N3?H)JQ 5@DW95LM/H*Y+?
M,HJ9KSY240V$?0-&6;ELLD=$'I=NH5'=\&-C#8''1KV[]I3<\^NS+_>%3SKU
MF?G-:VM<MN:M_.H5^\!TS(W:Y=G5V>7_G'W\]6?XR;QQU%L1OK&,MTV,-_7?
MT3KX<-T,E^>V(\-M7TXN3GX_^W)V<:W4XM7R^_QX?G7Z_>KJ_.L%.[GX"/__
MY/._KLZOV-=/[-/YQ<G%Z?G)9W;Z]>+C^;7^#3#W]\_7]).OW\XN3_"+J^WE
M\NJ:"U-=G;Z 836@!HW&>OJ8U2N@4782<'\2@U6VIR*W7S[^)Q^-WYL",UV=
MA,%\\ -&7'5I!&-K9%;'M$Q/W.*/XMV=2/CBE@>)K.)0]5ZF2R29BZ:=JDX
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M'33J30;;];'J% O/<P6N#,LB9$WL3\U&_?B^W[74.-QL=0T-]MR:716'"2-
MJMO8]&K8]<L4RC(W%?K2.!).. @\715_QJ, >__JD8:!R^YX%&$K"=W;U<..
MFCR.0\>CXEGJVX!+_?Z_Y^?YDOI\*2V6>*N=8'L&.7 45Y<CC<=1V!?4$@,^
M[@NJFGV!0\]ZXU6X4G<AY;)["?=!@E2$>U#OZI]AGY.9WS47$BZ;I=O6 W3;
MG$NW9NG=G7R--Z6/NAZ.UZ5IW 4"!0K#ZFWFBEOAAV/JA>*$L6HF$F' ']Y)
MPV=O/< U?9=5@^=V$P;[#H^'\A?4GP";ELQL[*OL-#% WHGUR&<:IM=/L>/J
MK:!)H?AVE?=J!KW3,S3C/);M:+.W$QYQJCK."Z#AV[T$L8#YLZD7#VE?=%#X
M#;92N161G!4?41<4.?#7=.U3K][J(O72M7\HM+PXSOJWR>8Z1%)?3;.$TN]F
M0_UG6GJJ<F/A*+TI>FH>Z=DGZY2E96IN(066^9%LH!2(7/^DZ:XVA7X63^V-
M 6I?-5Y:J2L&FVV*06"Y(N&>GXW#R)IFD;I:?T.>4I#47'9YH%_RT>OJEWRT
M%?V2"TB<1==B:_/!!S<]_FI.^Y5[6JXHI_;X\.T2[5<6W<,8I]I@9;;WX_Z=
MD.NBSGN3_^&\:K7BQ@O/SB\_^Z1Z\V?=+'[M1>SG#[F>%JO -'O[L[:]+R@'
MOA\AK97Z"RR!+UGC7P1U#EQSUGM3N8VV7LM&F^O8Z.J4O^Q&'L+2VG&<$R-K
M0K(N3%T"S?G'41@_"LM/R-"[9S<(CA']'0QHSEJSOTQO,A?^G(MU];.%[YEZ
M<,$CI'QRO9R7>NB!]ZP$[]) +@M8F:%Y A4NRFB8/1?-'=(B.4:V/1N! S,1
MPO@IY!L]$D,_+8&<5JT]J^_6?%++P=$\;)0 CF:M<WCX;+2RA,1:BFR^30>:
M-\U3K=IA=T:IOA2#=[H'90&EW>U41- LB#!O&D&'M?9!MS2G56LWCLL"3+/6
M.'P^XGF2Y"F8<W.(ZZL<P3JG \:#YN']-M1#QNJRZ%]E'2WQCD!#S5#N(PS<
M:FX?]>)R?O$V[O[X>,8F>%[7YKXTV0?\F3<?KD,<0/HP.RX;C5KEW4M[L?/$
ML^HILM*S*[WVA3>H6EUL[?Y4.X8G[N^YM5SAJH3TV>F0!P/*\* !]&;RO%!I
M);%,*S%C@C=M*NRU:IVC)6S>=YL&9+\LQM.*@#R+U;T\'<W)1=J\M7G0+(W7
M] K):$V2Z;-*G*&TF&*^S.8IZ'CV J$B![=!K'16C*:]D"@ZGTJ5VGS J-U>
MT;O=)##=UE%9@&G6#@^>CV;6)'<^A1%8<!@Z<J1.HPR^O0'W@HT;':UF>0AI
M-B+P4J#L';66B%N_>[&H8[=^>)C%AI!0-F[C[#67X*O78R,#WR]!K4^GD'5=
M:N2L93,<#:@FB5*9#FQ,Z%=S@J4!9*^]A.7W<K(F,XVE1D(+6?R=4A:H<-+H
M>3RLLAQ6:;3EWA)W+>41/^>!$XX$2_@/UA.!Z'L;]ZCVV@T;U"EY4&?9*[#/
M\\J4@A!H*DBBT/<Q#J_+5::W6:6;D;U6Z[&78LMDBY5VWS.T^6KNPM:Q\Q(D
M^<U%^=QNQ#.-B(O;?U)&YGW'T%HZ"7-!>M,35]67.*HM[1*'OMX+I:W"HN[&
M:K'X)%J4'4DW@<3IY@*J?NFQ=2^5+3;]M??A5^_#)RKQV]WY5[X2_S17T2Q_
MP/3W+9Q,7QA+M/T5MQ79RQ6\S>N#<@V2W1TP<T>@W?I]K*[,"CSSQ9I8,QZ$
MIJ#SE^W PF9.U%1@>L$+<:LG ZJ[.W-.$GG2"QP_=<6C:FSEL[BDZT7P4Y;D
MNF#HM]3DA'BJ=)U[J8VELE/]-W+WW-C1(!T)MU#1*X'5*?#4&@'["H21_$Q"
M-P"G/,*\ICX0MZ">"2:+M:;#/?"EH+IEA&(<A3\FK/B[7L@C=U^_JOA=ULAC
M!-(.8..!"%,%'O:#$'$.L;IWPV/:F,SM8?*8(Z-^#+L[#ABQLO'"%QXY0]8\
MJA$@=7;" -TCK&N&(TKR.Y@IY5X[Y[\XM\P7 EFY:;Z\=+K\])%;+Y2;YFM*
M[RD]?;#<='D@EBY16W[).0=7TLY4+]B8=GWS9.=8P6LU]DY&X%TGKV"BI&6%
MLO=HWC2IOYKAJ<M'T_[C]/3L[-.G=31@[G;>;IPC?H^H4QR"2LVJJ/V5<.$)
M[,:%%DW.0IVRGWH3:N56K9Z'98-P79-+-7#-MQMF^U:MV>F6&:,OQ?EW3VZ\
MOF%>_RSB^)<*".IM VO##%D9!#Z? CY]H@+>,".>FK:0N?:3$MRY40C+M)9I
MMX=IU\V9\[*IUSKU38([)\1:@>/;-K VS);M-0V[KAI/;DJ1/IC)\BP\_*\P
MNKGU?#T&^TS>9'SBCNQC^DDF0P<#=C*(A*!<Z/_\CVZKV7S/L@[.:R+?N=D#
MI62UDH*UZ<&&M6.L(*_F69=,69>#^W.6M ITD>6MFZE7]:PM7Z\$::=VU#RL
MZEEOG\)?JXFN)BWDN7O>W)'UN]26[<O.]FN%= OXOEK.][?(NP4>EB#_*=.?
MC/?->+%D<7MYI*1@;?RBZ1CSNTN/O^HHYV?G7Y6E*$'6H\(L]Y8"K$W[T>U:
M\W@]!G?5V'<+?.8G1,Q4ZS8/V'R+G.MUI1]6%.Q-.^?8J;R:E%(=[3^-FM;"
MX5;KQQ@U3)6PYQ/*=)4 5HB*++-L0[1 &RX# [;DA+$7%!WW9YVM$>A-^PCM
MVE%G/4["B]#+3)'D2Y6$%&LMJU^8<A[L[N!QHIBIJ9JC.05=V<#4Z9&QJD(K
MC.3@5UD3%>$3<0H2S!%8W#/RTM%LK!''O'Z_VMV)DQ#X)FOHYL7X\D)=5O:Z
MK".3'.0Z59[%8A'= @1F.".!3(585(;T2BJ+UK*M9I=$V8O5%^8F112+['+D
M("L-5ZY[JP'!]'U5BGH'1GR.7.8LIX:%CL:^2 3%R/-CCV4]&_LH1B$V"9-T
M^,W7)8CX79SV8AJ[F&233>][#EYWBXB9Z#G+NSO>"/YY*WT(T0=8U:AE[MX2
MF^%2B7"& 5I*<@RR$P;AR'/@#^Y/D(W5/.1QF, JQ$.*]1&6$1\$ NRL_/#F
M\(?GPG-)N+MSX86G830F]^7H/? 7 !K01-7031U0>.#ZB#H[#U@F3^@HINH4
MM029*;64E8>$8S-%U:-V-6%?EGE>F^U=TNQE=J4J"K>/_$O.UDO:85/@WS>2
MM?NZ1K)VMV(D:S7(L"2\].9#C^>&TJNF/D:>4CGVI]S8Z"L:&]U74U3/_!MV
M&@EQP[Y%X5^@N53)-;L#5=>GL<]H5$E!>75VBJ^Y$N-$C'I@TG5(%K?J+RY)
M-F$_O[2=DI^!MKN#0]!T P2E\1YEH,Q4YFNUBFK;<;!V%G2C'"'NBP%\:DS?
MG%)%&UM6XK>;2A]_ C,'@-__;R(3J6+C@K4MEYN?()!-(N^G@4L0> ' !=8+
MF.*;L:^W51._</\./?)Q=V=JYJ/W@<3.#,UF%/VHMA)@P7*'S&47?A^1F0?6
MV^Y.+PQ2,"CY)$P3-#833F;?3[!K!KOSR9:$EZ')ZE-KC5@D6%997-4/[T#4
M"3W(<BBX2VR"5VCX2T'^Z1SC_H'=6*=QN6WEF53#WCRJ'ZTY.J3:SL19=R$F
MFPM)2D#*(5?"-'&>IVT#TV]OPTV'G@DIVRNE9#-NV=VFT.9G06N?"2G?2*B>
M,O$4,>36F/(]I];KB>1."$4]0"I(5Q]1[VF?7F#WH3GRI,8*=AZLE?H !OSR
M"VP/%N.1'^;B6*/0%2COK)BIR+;N(\KI@4J/IL:<M6<2NO;P"Q1AK<;[TY#L
M/X&]U>#?N+CY(?VD^?X=+*14GQ)_C.,UM&QLA??.^(_/@"CVNQ_VX$TG,2K6
M+SP ;X\"3>?GYS7V^?,IVU.OQ5^;Y=,Q-CL04<*]8'?'"0,)<KRH8]2?'&S$
MB!A(@VSNQ6O,I>UG/DOKL*9,X0(KZIW (@1Z'BGX@4&'!I-,6[0XTE@9XQ<@
M[]EQ%G,**(1 K\_8,D[@@Q&=F6IE1L]^ S.$(5;.X5O6!2LC$F$_;SY+%ZRH
M?HI$@I^HE+WL<*70R PG)3ZD4B/QP96%XRAI!*@8H9>'\@H?=(1IPZ4M-4EO
MXPA.5Y&C:;Z5$1";IA] .'6)IM0$!F:^D#XHX5O_.!'1:$/VOI59FY!9GZF#
MR?R17?.D%)E'IHF)I((3XWBRJP18D$<N=N=TR1 C9M>"XN3JU,B)ZW#L.>S@
MJ%';W?D(+Z_-AGT#NN/'=FAJ3L)$DY\64=-\CK()B=$\>*4>-*\EN<.!]QQA
M>&]WYZ=FLWZDW0JV9S9-'D>S46^8[U ^2Q^7C?T4H^W(C;X'0'7KAV]-%W5&
M[O"8)%N0CDS(!CE$L[N&F*33#,COV#B-XE1%_J68F_T5^Z2@F1&:GT0O2C$0
MWI2!GB;)(PX_<67_F1/\YXB4Q7\T'_>.C\)1<EF_XGZQG %08S,B&L_.O.$Y
M!;456!79%@@L/2E.7?[AJ#CO TBO)X359L,1I%FE_(G)=E%Z%T,1*.$HP@6V
M$=VQ33'S? Y2U\VS$;U<A&TJ'#)'(!="?,]@O\P+K^2V1X(;%DLCD<D]=2R%
M3J'3)V(9KB+;,A;"TK-#@!FG3 :\E%6WR2;  C1Q=GIY.G>PP?_ .FCSD\=M
MC%<5DF'A72"U5T[!6'):;EME:N'>>J"%>].V<"_K7FP+]^V6^"M> ;66O@)J
MSEX!98]2Z<.^#'C@&D [*LM+WCG*B^UL 96K)=PINRE;L1 *(5_/&'*YT L
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M.+"6 70Q1D2A!1-=(1=\+4):@HU5>AFJ^DO3;:U+J:0I\.J;&^!/X4J!8H2
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M,/3: H0=TS'T%1!R0RD4#F"2$S;], LBTA_T@[%B7Q 94"O+7J PAM9Q!RT
M<,6*3S:;#9,/"543,'"(CPUA%DSRTBC'R+6)H5E<]%*3J^DX T1+QABTF YJ
M%+8^*:"Z?;"U05.$#C*P58\I\ A;A;EHNGR-CV^# R>>LZTU?1::D8\ZI^\Q
M2E Y>X<9:IQN%R:=Z,JO>"&NQS.OA*U+PHA !1H!T]'A>1KXH<^"/=\!G_:!
M&3))U0*1R:E]&6\29;,2"A=O"(.4*.3CE=L\I.[0DU,+''T^J@X:M)EC0M7[
MU<32 ^D*=M!5Q18J 6'FA%X85P1*I13#%N:B*UZYL+VY<39.. ..NYHOO++=
M%L0OZ-6Y/6J4J-:X@J^N_AI6Q3/RW+ &2Z_?I\*>N@H6->8HV7N#/H>#5;'C
MF3!7?"3+Z;*I94E!%3B[*^)>>6:?VAFH=' L+V6#/5%>%8&:9]D:P$/F6Q94
MRNI$<.N1K=S%P)A=[ &T0R.)V]:X-BJFP(_SD=XB.,RP;(95S3D@ZM5P;06:
MB#I+M\I0-OKQ+KTA(.D0:CGL#O"9=\N.#@:H"#F@M6VL"N/U:V*9H.P#I20L
MAJ"-!7DR*6GYPC#DT5*(M/,#U%@0E]>T) BN\1(K228\#V7TG!2KBN%.[JE[
M"Q8U#Z-0L4^"+<#08'/W1%5WWZ2DM*V=A!$(UB<&%0LMICAE?2 0&1=_%A77
M]!D="ZLH!352@8W%P!9$\: @H>.RZ3VDY9G^C:FS[#K#=.=8D#[QP&0WL1,!
M:@1='XMJ*#-AR(R-/&$# OBP$RJ4/,9%+=.Y8>Q+WT19$IR-&!OS" V5MWS:
M 'IUW!:FGOB-'Q,:P#GTT(2R"H?>0ZNP/[!E>"_F*2A-@9L;TK;%M(+LN+C&
MM5VAW/*$^Q V /?9<<AL"#LF7EC%%:@.?V!59+@9U/-JY0.+Z5*WAR[!XY)9
M<1K$N P01A@GQ,\15K<9BFHIVMD8M36WKPY.1/%EI:2+ZY3T"N)$A!-T,IAZ
MU,(QD*%6:DHC"88?19"<5V [.11:,^^%F?DL33':RTZ*M26:O. X#V <^U]&
M3>F3A<0,6!>OH?_UK?97->RR94E<& KU%EH;:^+W;[@G#E\;\+E8B:],&.]8
MBHY2BZ]<,>:9SXOE$W^5"]M&6'@N>@>[)C6M<(BQ<)!CX]=%FZT(RH?X'Z;G
M@/?)4UAJ)\[H^<_J/&S(IN+^U9IV:AHR%TH/_6/PE0=!%P9[B,K.H1-19EU[
M;H]=>-OUP,IRV7&P<<O8T@LSQ\10/UB &!<>WWL$](5EY.2+6">G+(,5X[\U
MOT]X:FQDT6:XQ:%M).X9FXPYJ@J:S$,#U& SX9 T=?0W]NC)6EVUO6=;>\]F
M>;O>G>EUDKD@WB#*#;^P1EGMEY)'$PG@PF3<Q#&C:OQF9 O3\Q!#V4^G+2X8
MEH[IM$/,@\5TFI:94LMP/\])J44ZGZ!^&*KU>Q)6*:9 E%IX$!A^D@I$X0:2
M)-KGON:^22TQRJC>Q7.?"N*R!.[+<#_/B?L01U4 -"",%02NE 1]>%4P(O0O
MHZR I0Q//RU)J[$<PV_A1B.]#2-B-4)5GFJ%J$4LS& 8,7,W8&A)PEH5GY8%
M56.Z#!E>2XOJZ[NU4,C=7BY8!0J  O)^"5/4G'+W1"F8&H<'$J?-%S)'3YV;
M%Y^K-_5^(W/TAF)5PW$INM%%P%;35[#9?#, -HLE"[F/4+US/6C1ZJ-1K34B
MD,\S+2^1]F+ R(7MQH*5'W2$:6G_)YPC75>C$PYZF*) B>48(,?&4F=F6"+)
M<OH?30<?8F 3FE'3IU@!Q.E[:".R8F/ML^G=:.<]^B.#V-B]MDA7V[\G;2PW
MTDX@50ZYAU-J.T(R,F!>?OB)W6O3\NA13;&*"%87O!O\0MBT+ >5G6IWX8HC
M7B@\H>5Z'A.*6)\XQ0*@5;^LM.Y++=FG]V!!@2VK78;02BG$<(K""8;E #"[
MW"-W4RP 42C_,K:-DH)I(ZHJDH\$H=?H=;6O-3#EA]L/H3S#ZDRQB,_>-G_7
M7T45MX ^B/6K(L2!46E@H[*2]D$*H*NOE]4H&35,'&@XMJ=8 KO"2$W)J-V#
M;<3*O3&H (31,SL$^VPER@(J/5;;/QTYJ <IJ6%XG)QH^A$C;O<H1])#5"A!
MAX]\AGJ3U*\O)<+HL>M4+\G8+AFC;JE8CE_2-%*!1_T\ CWG#*Z7WZ76,FU6
M*JD ]S#<NF)#\L40#'P( C^/73%)M:YMB*7;$,6U$4&=Z<4N_G :W9D4;$4Y
M=:%VLP!N)S<3BK)7707Y#KLS>!'1%$O <J-96CQ8L0!([HCNY/I]BA5 A:*T
MI<IL?\]4""TL[DI_LIS,Q]&(/C^L4Y^%1@38(%.PNO)]CE &R+(,7-7L,94,
MVJBR7:HJ2$PAHCW+3X#IZLE2F$@/0(AI!G9 ^#KZN=?6&_KHJF(HFE=TI5?8
M7B(U9+B,>$,=W1!BK0'#O;;HP^#%X:Z5[D]D#)9RP6I3AIY(G?8!KLK0:_6&
M7JS68JUE"$"'@%>>[+;DR*J\:0;B!5#!U>VRN"]O4>%G(6N"9><*GCEV0X8
MC9Z+46-J%8?@*5UX(^\/XYT$\"\TX^P'#&O&^]+HZ>%B;2A1!!0N7]XV+[N-
MM#KJ<<S="*XL] %$\>_JVXTR&,:\R0T)T.P B0OX;IAUP$]"5+*Q_LB.!:$^
MA_I$[-]^WX8J+X]@HZ?Z2VR8H:Z!;7IJ@"43\,DE<FW60?12%0V'S/<!T,5
M>!%!P[A08 $G=7>GD4P8>'.4OJJPCAN(D8L0Z#) GL>6! 6>N"8@CQBKXZ?
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MX*:(BAWERTUW4JKJ 77.0+#I$UT85L0P4D5",[(C["A%J)B&,#K#<T(O&9Y
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M'E@XF-5-8+B,(V93:KJE7(]$BJEJI1)0KMSD)"(7D-@1 AAF?=80HD6"(#"
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M($H/!R-.'#U!Q467C=^%#A#BW3+0G2:(--9:HFO#5-:U!]"Q*OJZ99-HP,[
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M@QF(,%B!KBM:RLMK0%2&!6M8I[_U&-@U3(9PKJB($T-T89,X5 TW*;QSC(Q
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M@0/*].Y?I>V2J*99LU8.-B%;,7PVZ!DF.MN4SK0=65 4N.T;^'TX@.2,^.[
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MTL801=RQ3\$=_-IA4*_9]^G]BI]BEPR;&^G0LP-Y)01#LL\LA&8$GGRKL&V
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MCU_OC<\/>[\+W?(3VJ\,S'\X6)4GQ;KPZB-!\V-NZ8G\_6)Q5;&(ICW+K$,
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M@J\)M[Z6R#FZU-E"ZFEO-=N)FQG&T]?W^G2IDJI>*F28X%RG2E8OD)NOU8R
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M?K=R)OE9'%=N &*VV(@.TK^->]!\W$3V-L+QH$<\JYW:OF2FA&.YK>[;25<
M036C)OLR^:MR9""-V7R"M3C=UNMZ/<R:K-36$VR_Z;9>THVP-7.VK8_(!PGF
M/R-M]\K!*2$G73G;[@C*.-09VH]?S<ZA]\4__W.0BQ$G'(!"KAT8/QP>:L/R
MIYZ+/7^)S3PB(-U%O/K/",&NEL0+"S?%RO4<FI'S,G/:^RN6C,4S=#UDZ#WJ
MD:9CZ>8W[X9\Z/CV3Y)'K1[9R%/S=TK*KA@YI.RT:\\C4M.\7)F6&U[]][I8
MG)XOQQ29-T*6C U OW!C$)RA'7#Y>%J\\9OW_MG>%S,W>E:LG_X5-Z %KN:X
M >&(M[#PW!#Q"D=7*GF,KLS+@.EI'U"+JN7"XI5C,>3$;Z8]("?=[Z;GF711
MT&U/.I>/-?-#_>3PN[-GS))+61R./W(;KA'TW1U?)<,<R;RQ8@$V;.+Q@A=3
M*BW;@5LX=U9SB"LT-W>.N#!#KS7F##9P1OPG *ZG/]&?^^*;/=.[LIRMP.U3
MHG^G\7^*>I%"^*#^=%^,EI:T"61G7OUW<4TTDTJA'KVY![ >077Y&H#YT(N'
M_.05#+4%%$/@NN":^*C9L%H% 0YY&!2AE^DO.$[80A87W2D^\/^VMK0#B]B=
MM]JI>47>:>?DSX X;?)6JU7?:7AE;S5#V]H2M-2Q;M/6WJB+K$+%9&R9]'>4
MK)+W) LL(WL8WBE\#DLX?>L15EK 9RK;$AMZIUT\].DGFAZUP]KOM&-*F6S3
MQRYLKUI5O_6/^!K\"4[LWW_HQA/.H$\?L-7RB'FSU2)=UZ//-.T[\\&?<?NX
M)?6J(B]65PA+9_>R#'*G*VUQ\07*KE4H4..'2ZACBRI:KZ_MD5MBNWTD6>TH
MZ&S_^T_KO]G>M*NRQ+ED!. 9#%==NS8E/?___7_J1:/V3GN]1[I6VPK>:%"?
M%CQ@0N&,= CIH0T)61-*))YKV\"4A[).0%F?<K9G YMLB?-5;SN)JQ(X K<V
M5$JMDBF0PYW5":Z!9 M_A]<"E\W_4[WLR(IFN+C9+N(UN>_3<V*3WZBP<@<^
M/5B\A:_;Y]M:AYZGZ4$%\WV;](/-#0Q_:_36S#<SO"Y&FBC-Z3';-C==_O>*
M:A3X-Z6ZMOBW,+U*A=U+PRA?]IV24[I\W/E(C%^%\^:?6IM:68,>?=L#?O!M
M2$[:EI:6SLR^Z\],9M+, PI@,DJ[L'I4+QR3.^W,[9F.SGZA4W'E65UJ^#%"
M:L,!]WU*,>*G&-FD*%Z<X*&-3?7P97BL.CY=QP9=*4B%_[T*H9'&LL6D#H3X
MKNA3QJNWQ"V,?7?R_B8M;9XW3M<$HQZI=#5VJI=AP:&@7$:7N]3^<!T@Y.:]
MY8<?4U#J/Y->BWB7CS]:U=;N[C=WIV.MKRO3ZVI,?5UG)# MAW3V30\:'GUQ
M9P>=8.?[O;-[]:F^OK-,[VQWZCMKMMN#W@"1F$^H=0\I-JI"KXGC6[>$%3J)
M:]S_T_OI?C,?'CZ2]35F>HU[EX^MS\T?[;/#CP_'I?5AYT,MA5EA84!%[2=A
M/@E^.;EYWS\X+IJ%KZT7=84IFU16W<Y+6"RS5Y@E[FLG@\ /J,5-2>.Y<U/&
MYZG.]%H?X51'J.AW]E[N$JZ/<][CU-!>TB(&D\8LIO7ASG2X%VY@VNNSF^GL
MT@0/G]H<D#97J7;9AOQ+H58P+B\A_U*HE@IJ0R)(?![+8K:8A$TZ=3WL20P"
MSVH- I8W33;$$$7(.[MY-,^^?SK^8&23ON3QK6+];QXRC8(S)*(+17.;Q6VC
M D'T'=,&>'-=^SAPB%8JZ!H<TE2V3QAN^WL$+8[+A20])D6SN;C71EUM*E6"
M-\P@4NPAN)F^U;D<\"+J)&I(:Y:/#1=]]&\<[Z=U_7C1>:4%5@!;WY&(3"UV
MX-IK2U1"OXDSZ*0#:OP]2QO[F*,9A[$BMGHYM-.4?5.'QP=*NY0HI"V6]$JC
MJ%=JJ2$G9I,+TU'5M(2:(;VG S98$'$L1O9E2D9C)QG7]&I]<KOBFI 60$@3
M0"672$G)H=]%(D@VRI2N)D]BRI*NIIRZLB:IN4@J=61ZH6C*E<GSW=8DMMKJ
M;R'X7-7T^%QK'3<7M:0M01S3PKRLBTAR=9O)KJY()LC!5J2SATCA##68F>;X
M1UY_N']/O+;E0T7NSW[SA[7__[/WIDV)<UO_\'NK_ [Y>U_GJ>XJ]&(>NL_I
M*D2P<0 5I^XW5" !HB'!A*CPZ9^U]MZ9($" A$GNJOM<MD*RAS4/OS6X?'T(
MO$W:+,--GF13DQU5<RW.0MP@0O1^BSYMA_-TF9-DSN=*'-&GDG#_$9>S-25G
M.:)>Q^CIB_H6HK1P==&3\ ?1$9(3FHM%(^FX[V%YDWAYS=7& =W'BFYB.E!A
M(K&]M^%3:62FM'5M^]82V[>U-?#0GE-\DM.4WK&EMN9E,YWZ20^,$P.I_B=_
MJ_8(&(O#9NJ<&^I+(_4BMUY6T,7DWWQ2Z4K78SUE9Y^I@\'&#G4EAM/#GYO.
M^X>:J_6RGH83.\#E[":7\SG7(:S59HKG4I%X?/:\FTV5/8O<Q60FWP"C*1Y;
M.GRTZ8H@.Z75;]NW-@6@8%.WM@X6VC.*+VH*RP#WLICB,RRF$B]IY-KSPHNA
M]U$5VYVM]6&N_)ZI=HS'F\=%)NT%$%'"]7'O8\W=;?R/W=V]"NMH\L4?;PN!
M3I4)4REA U2HJ[UZ9V7#%)"G;=]:;ONV%C;#[-G"'^WDPC+ O%1F=GIBYD:3
MWL%IO8$7$<^5D, U/\!/UH?)HB(;B8YXWUUD\'BPX02V4JYG+I4C;>:QGQPL
M%TL(8^N)+A0F'R9U8,W37$TE8/(I&GUKJ9>Q9GAQ!!JKG+K;M08,DHE$)+G%
MIO<<A^[DUPTP:U*16'SVQ(--/7>_\CNY?;K?[];"BG]O*[?L><(GX2Q>ES*_
M39-:(G%B@\U56PX<NAHH<8W 0%9$,'QM(UBO#Q^;3YGNQ?7E[5L\Z+"!8]LC
M>(S3C2&$S7- +ZXIL9+RFUB9>>BK,8[>.W_3G5*U><N+EG$T>I(KR+#,/(WU
M&D_1="266KKL;[/4@9]0\=R280/L+1<X_-9=E3_=DHKN;/E**KHKY2MK9+ ]
M&_FDM576MIPM8:)5Q _R%S"]TL5N]+GVG.Q_AHE/[\_F(@J2 /&2;LJFJJ^V
M''C[4S9^NFYFT<1:E.Z$-AK'.)[@A,;W39$7L9TM@4C%MJ\$8G6\L^<0WV2T
MRMJ'66 2#KOI7LV# L/#YF4<W5E6"GQ/ZO,R46&GO"X*Z#:+BDX&13MK9.Y$
M\*IUJ0]6F?8N-45*1H[!-O5A1GLOG9Z>GQ7$16I,0PF'D'T=-W!C./+-VME>
M/0=GV:^(OC; J<[D,KON"\2FS!G9]JV%%8G>,UXPSO978*^PJH.\#(/"#,-@
M$JS E:KK)543X54%0]-$I3FXMT?\YA6!_$LFE&33((G1W/.?]>&S+ANYZ]Z%
M_+K(.,CE9\=--PGNQ![VT2MMKLDVQR%H/GQS;QF$1O?Q[?.K?&]M^X+0,US&
M<.3"G/;;6N!/LM$0\O&A>Z4;?)W[R_$M1E89A"_-L QN-+4E]9% ZL.GTZO.
MYU/U.2N'6^3@"10YAU['U9+1[D#NW$#DM0 U^3R I,O@TP1@":QFJ1M[7+[9
M+3RXG!T_X1G:QA8=<RK\\"'TDI'L\O5V\Y_\G)AF&WOQOEEK<1]WSUI!LM:>
M=S;F9OWR3F)Q/WFYW7E9B0EB)<8L*S$>'DKYZ^_GAZJ1J_T^#ZF?* 1D\B#;
MBI8FS6 PR$?O.I#BVE3B24T]--ZNA63 &.1S1\SG!AX/&;\D%4DG,I%<;@V2
M=1,4Y]Q0F8M5'8:#IKJ29O!8(I(-'TU\=ZEC?7#.JW=O<KE(*A;]<C;:;I')
M6L+>L4@LM32*UI<DG'7331 Z)A&)QQ)[%1.Z:[>NB.-D5.XQUVX95.[8W]+K
MXZT8O\Y(0><)M@V5.Q<"*G<HKME5YJY9/3U_?M8W FL[9D6PXJ'Z7=E,))3Z
MX_7WM0<$$QS\14SM@T\NK7XVO4@DN7U%(KZWMBN=BN%RT)Y/?!'3*JL@8G[B
MV_/!;.>J'SF^^5?+"8VUMR5N#,QV+EB8[5 LH??8ZTUSH+[P5R'"8P4,L[TJ
M<RD>345BJ>V5/2O "%ZMP93,;N]E^%4$6PBCZ7-KJ2ULGUT'"^T9Q1<UA>59
M+%(1, -F6^P_:N^MUN_<WT6R_'N8[<TBT(!1@U>K0F.[#KR72FUANZ/?K6TA
M?'C8W++G"1^$DP[+]/)2ELGI.9;IF-!#]5%*_WZ^^WQ9))NR*H!M4@Z'6UM/
M8*'H[S3C-;ZSLI1*MO=RP7_<_,D/[4#"^ %:!Q<VWC;;^UKC!\E<-A*+;J\E
M'BC4^<K,'//T$Y%,;'M!._T*]BU,0OC=6G+[MA8NQ^SYPC_QA 7GXF7PY);(
MIRR OEUJ_N;3;7GPD T\FN!J3)W#4MIY].U03*;S]O6PF7]L%!_:VX>^O2HC
M*D:,^71BQ\I65@</O-KX4C:2C>X\FE%F=U%=,EM8L+-I#+9G(Y^T%I:%/QGZ
M8S$CS8&_7?ULEV\,P8B>9M8>G]KC;R^[SM PA,-6NI,:6A)+]T%-:5=9N[S8
MW=J(+9RNOCK>V7.(;S):95%$=H9&71G^]G5;^7V;N3]M7&8W)2"RQ]\.W[)?
M)PSPBHLV(IGD]L8__,JN+9RTZ7=K6P@NOCVLMV<PGU085O70(A6386%PUT3E
MYNRZH3WFPAS0OJA9L,?@7@/=Y[;/M_*]M2T,1&\*9O-D$RY<+)(1S9/>WC&+
M&WN37_Q>_ J/58;?TS/L 2?R]N-].]'M7P\>M.8>>7N/O+WAQ^6;W19W K_X
M"2\'#SQ9SX</31>+1K+9I?.X6X<PMGK>6MRUW?-6D+RU9Y[-N5J?S)..+NX?
M!P_01NW$N&4G)L+#WA[>#X3;1N\S]=K:&NSM(!N. L3>SB^!O3UZUX&4UCY=
M/[:4YUCK,<9O'?9VR* FF4@ZG8D V^^A+\.Y\!#13U>2;(SG(M'4TMF0KTL=
MZP-57H.# T9:8OGQM5MGI.T6G:P%?#N76P/X\@Z0S;JI)@@5@S;(7L.$[]FM
M*^0XN4MRAF<W'^KD9UE[/7V[OHN+&P"]O5:HR4*P4).A^&3)UGDR^R(7ROG6
MUD!-QJT 5R)<KRR=BL02V:U-.:X )R_XJY@^@6AK[\*G<HAM8>V(WZU]I2;&
MN3FHK]H\M.<4/^2TRD()7V;2.05N'*<%5">-T9K;^E!LO#3[@T>9/UMDEGFP
M78M[+,J52HWY2&4#-&\BDMAB0\BO2-G95L9T? O+;5?)1@&KWR_!+O%5]C46
MO36PB;C(9!YQW*A)5E;N.^+Y<[GL*&2M#\]2SXW[Y# F/"^"%+!@5^)Q+'Z2
M'->]L<Q)G"A?NGB.KIY !X@"!_XV5C#B#CC'%M83R2C->](30"Y#"6'$__0^
M%#7W^I%(62&,>8XT"-3+>4YEK3&-6"232D2R\9WW#^)A^0<;L+6=;<I,Q[>P
M*=/OUG86 CT=7V438W*)E 5)I-:'C=?AQ?/?VI^X^+IVSQO%NT3::9@.8MIJ
M/8H^[C=E04]R)?J](K8^LG_3YV]BTZ7?O4YM!7D*LO.UZO!L+(@AR1OLUTWC
MW@T(AJ13(<#5;)9$3^PLA'4ZL86&87@L$W#@XRNPQBI1K$^7,':<0)H/<$MZ
M?7BN5M)B)WKVVNAL"BC3G=B6="QP$CA!TL1FGU-;+1&W8@WVN.8'6&:?6(])
MM!" -3WOE9A''[T+N?:1J+W57BWS:,JAFH>Y8@QK<B!KM9H2L60DN7R!V_;I
M@'5=PS0]$8]$HSNO*9*[6\RQC2/D5\-  1M47X-15EG+49B>27+&\!_ @M'N
M.^(?57M]EV19I-JYQ#<E&?Y;'R8KPGGN<JC>\HN 7"X/;#4KL^3.?QBX'9("
ML3;$B61'7(MM:3TF5GZAXV>&U4J,K+]&XR+1:K=N4J)E9,U]N$$DFN8^G_5F
MFZ+1K99?P5S$!MA;J>C.)_QV=TA[>F>&M ?*.@%;6E^ 158ZGCT64.C*YP"V
M[M6U^)@NM)_TETT);6W& +9D> /80C&U^LW7U^>L]IAHQ[=O -OJRGBB\6@D
MF=C>(=EKG@^U8O,KDHYN[U7YU2Z[6^"2"JO 9><9+&@C[2LP4CHL<W]A;*_9
M(]B><NG;6+[3K8EA1L+V(]A60ZFAC9$*6^U.@#6)AR$T-F7 5#J]N_7 H8T,
MWU[>65JC?DT>666)\H1V83/'<2<*HMA%J)\)0)A#_K*:_YT5Q-Q-:E."&?:B
M.<6U:DYBR]ZKV #$!(V0SJ*0C=*MD40\A%['C9$<NSM7/+V%<\5#8YO0U.JV
MLD?XXHGJP_JLIP58=!;*5<RR!K(S/.R5C61][*0ZE<O+0K7;V, Q;/OIK.&'
M_=8Y(G+%4&&13&[G X69W8VX9W8MXKX!K!<TQMA78+'L*F/QLUJ;PYK/^C>;
M:@[_YE[YS")#-T(*-^R'LJZ>V+?/'_2]M2UL:-V449Z3+;=5#F7-QK=6UVS8
M109L!VSQQ?@5'JML^8W/, *<0UFOWS[;?Z7WTYOGD*9EC>OP_7S6_7S6Y8_+
M-^?M9T@N>,++S9"<K/+#'U^4C$:BV34,0OMJ(R9SZQHQN?4G' AOA95PVK//
M!ESN2K-<DS*/RR>[%J:":=&M6,A39(OUX=O]=?.E=I%Z2009T/(Q.C8^Y^C8
M(#%M/"\K/@?/>$\NFCXZMKB:IB!>2QD=Z>%*NK0Q (MD"?//C9UP)+Z<];GG
MQH:-:1.!=T1BB:5;%Y<F'E\G'C0!^YO;MLR%ASBZ;R5I4+ &DLN#/7]=ZEC?
M/-#5.UZQ%!!+)IRYL5,ORI_IN*<37W2RGKFQRP^<VI/-.L@F4/D1C>32>_&Q
ME4;(ZFLQ8\OC BUGEC ?]5]R:/ 3_-PS7]SEM;:D'/?5W@\N^I-C_S1?%+4?
MU)OOB^XU-44\UJ-?]QV1XYM8],@K _1I%+4OZAQV,?(*Z:]H:[P,?J6&0)Z8
M.=&QK5$AVT1!S[4D!9P@"3ZDFTZ6/O?B1G=%OOS_CH^YDB3*P@_NAF^+/[F:
M^&:(X'#]X#*9GQSI6_K!Q;CC8Y.7!.G=+R<X%Y1&UWED26ETG">LW\H[N0YS
M?%?X.>*YZ](05QHESW1LR]S03^Y^T(-/Y#6^(35_<A7@0;KIBHK; ]'F^-:_
MYM?P3WAB__T7-NYQ!CUXP'%#$_G7XX8(? //Y.4/?J ON'VR)>=5N5[L7"$N
MG=[+<J1MQ@7BB51]*'4N8@7E[/7BW6[T=2R,B]+_/8FG),5]09BBEEH#V%&#
MQ:CQP8TH#L1F8>B*I!94K<>=B>^BK/8(&7-7?>'DO_\V?GFN*%\?7NNIGA2+
M9O6HM,2**H3E^BI7</)5R>*KFH.O)JPE4Q_V<XGX6:FJUSY32ZQE)$+D>)WC
M>N\,63PVKY@0G&LE\5CWJE/IOB6>VYX(*2/L0F-5=&%'OSQXF-#+F 1V,A82
M\(<D]#O(9-'_V(2$Y,G^UTF>K@UXT>A<!#6%0*)RI3IXD1^*=ZU%+^6;^(GE
M9[HY14HU=%X1=)3&#R>U$TX -<EK>N3P0/QLBCTVE0*DM\#U1(W]"TB*_VXM
MDJJ^BM$5-:GI.T\@@D+MX55JAG@T8B94^+ZAB=56%5Y)RD)T(CW,L\A&2XZP
MWOB'Z\.7])_FU?WSS5U*/EI47!!M"M0ERRP,^K\C6#;^&SB\:?[;$5&E(IF[
ME[K ?Q7Q@[M3N[P2H;^(@'36I)9;5'KJ51?E8>!Y0M@7GC#ACG'QEN7!'A<E
MW#!BE9A_\R 8:F6X,G"$15I\5Y('/V;M<DQ/Q4Y&$W36;<;/ZL//UW+G[2&6
M+ZAI3R:W.22P%9T5:X6[\LU]N5HY/*B6N-.'6KE2K-6<ZR16E?;+V[1:\,X]
MU"/5Y('MS"1DMH]1XVG>=?N77H'M@*G/PX,Q_<E]PW(;!-2/1W\6J*%)_A7[
MR:F:^0?V??:'[]P'KX.X:\*O5(VH0_!,2F)#,WAMP,4S$2Z6R\+_VM"G,O^A
M,PN5N]'4=PGM([5U>'"*R#%Z!Y2K;'0;$D\D(ZWL[<L#3B5"",%4%<XV#4@N
M(AIS"BT#W8]JBU8'\P25IDT!X(3/J[I1>;@^+=YYIB&&4NL2'*BGX>6]G4*@
MS\,5:]83.9T]\L>/Y[/G'S]BOC/JF6CNZ)>JB!8)D?\<'CB>33>*)CY["S'C
M)9W\"I8!:D96J3PF1R38%XE_[DJ*B)Z  $_4I3XYKPH\N\/EB1KA(YS> _^K
MA1)/'H ZPILHRJ]<01/%5PXNN"$9W7]K34Q9P _W4I]7X >NI^'2$*/602CV
M%^$R7\1FWZ(,66T2@L"<BVK 5W@<-Z <'E2 /'C]E3_99C[:?DF0UP\/6H:&
M\3].D'3P[IGI0LW<5(3+ ?>"A8E$%HM%D+.O>:W9X6*9")L/X908,I ;4.@9
M7+I) Q'"Y4R6<$WX!+S!:[[FX<$WD"."V,+H-=< >OX T2(!T9X_<_DF;6A!
M@D?9<\+!E[^QU^*3[-?U# T1??IHI.-[3@U8$]ADN(8&V.GD&?DVT"NR2X2C
M%GP-K#$2M#@\B*?(UN*NK4U_BOUVOJO" 3BV'*$;Q0,\E=K<';SK6M3:<. U
MHX%"U^L$S>>='![D^_1I] _NT^1E736/M&E#<,$A-OJFKZ^T==<;;-AI!V@7
M1Y 32^8W;,D.QW]X\">/IWU3B1 =$:'!AG>15A)S+9#K0,$*6.AP;0,'KG5>
M>)=T5=.Y<UEM\#)\_0:6HK9%0F_D:D<?/;I(ZV /#_ $<1\DCPKO8:C9<-W-
M#J^+-GPV?;"U"N_-T_@89P+(CNT=+PP.V[E8*B7]G!^]I;%W6G_7K0-NB$VP
MS3FQU0*Q*;V+)QP&>?HV5^C4Y._V2*3^\  V[H>H)3/PY\EJD1$ <GMAG'G*
M=R*"NXD<B2ERM1X<$@?\>7C@9M (B3YI8DO4<(I,7XW >N&19#.@63A@:<=9
M.-:@G[!#V&;YN?T: ,CM\&!LU+&DP_TB]6"XT5!(Z!#L/Q[IPV0\C9=T%ZFB
MWL#/:P(IM"!LV!:))0*V&_P%1:Q@/A*?WM. 3J6>+ )=,7,0!V>@..X3.P]^
MR2P62]@3/_H\G[^Q9"3WP Q+6'47V%45\'OV:Y@$AK_V-9$(>S=1\JA;@'K9
M P\/6(25;-F.F&I6JQF('+"K1/T$U!)N%WZ'I.XY-'K\K7A\[[S,3#4SE(4P
M=*2-C63W#P]HB4J$4U2,YW+O&#^-F#:S*?^_V9:Z/<;:DBUF]3P/2KU/.5N6
M^ ;*.XF>+:Z62AQ%[)N?8[\'@:N)-$P,2^]S<+I]%6]")DAY$7J_L+RVJ@H?
M($;005")L)04$-%M(A?9,S41STD4]N;>NIE=%Y&^9Z0$N [_+H($$!7LI@3Z
MHSX=#W=-:13X6U.X!J\C>7?XOE-)42H'FI>E(=5+R(T6#8(& 4,3*+6-+I^+
M(GEBZD@:U^0UC20X"-GKYD1V!;-)2'X&:B;X<L/4@B:I8]Q<%T7B0[4,C%P1
M\AY)@X#-Z[5I0<6$"BHSU%\<,;#L;FRZSRX_@',!=FG":]&]E=P<">=A*.3U
M8'WBH4B*(1*YZ3Z[D^TGINW? =%]EF=B11E$7@.S"R2;[85K8 TI2(DH1(FP
MTT2B-#C>:M$'JB7=^4BM)!:.), +[T09NOUKYB;#!R@S]C6C:?GRJ %$C1"G
M:@9=0=, D4]RU+ADA"7[NGP?_&N=ZF:!TXT&6LM]?):@&F"B\@UPPYT42X8G
M9GZ" J9\.)A!N!'+0G20O"#V1-+5Q1D]E?(J5?PF^_=(-31L05.[5G2"Q1(D
MO"*U@55+\!Y8AWVBE@M#7MKE4;&03UDKQ#WV4"_31^,[B.9D67!ZH""^)-!=
M^ICV^=<57'<%P6/)^E!+75VIXM.?CWYJX5 T(^LU<6/PR8-3E/G55MZRKD9R
M!WE'&&[LL_7A[9_F5?(C]OZ9C?M/'6QLTL#_*SS2"R.9!/_/FI9SF/\I9BHO
M,$J,C^4BYEQ;D(MQ1XFS\6)]6-9/LW^+^JWV6SCZ=9JOE6LT)^[K_ZHE[N:N
M>)._RV-FPQW!M<M%=B*C$1*S.7C)[T8WA>%,5MD\GL-\\<;P'!'[<_ 4V <W
MQ,NP\QEV<04!<=EN]@K)1-YTAQ&,4_@>5@!:05DK=F,9D9HA,ZM:$]L&1:FP
M4H/X\<,#>Z $^5SQ$YQ'I4WLSZZDZ\0ZQA#&[$72H"@UQEV?9K$B?22^0F/.
M:%-^@#V)^<</A5G5DB#Q&BZ)[(L'AP"+74E"#:Q@ G5L1I%<P5Q1EKH8KA6%
M$ZX (HI'U];Y ;9&S :V1(T4CF&Q$:_P\$;%+""Q(S__V+%Z\ W 8N_U9%@$
ML$=8L9;U^99@S8J?Y'A^N6IWLO7AARP9R0>CHR1CBY2D$$_ ?/:<=7">RYM6
M#IG]6N60V2TMAUR&)D:*G281;J8^3.F582=:^EVYR?DEW$G%>(W9=9'C>YJT
MM#2XO\5*JUE]4'Z?^_;5IBQM[KI)_VM-U8?Q6T',M**5/W)R^;5ZUE6.+V=J
MD>7<I93.S;FK-$&\W9]V%+'X]^%-C(\VK2Y=<.E\\0+5EPN<KZL(<]*EENK#
MZGMTF)5?"U?OKTM>:K!UF8M+A@G+HQ<R+C0"CMVXK.HK.(Y[L*2>B&E31<NF
M9AHV@QL>8Z'X2TWO2#VSK:-(TM1ZM54@)AA.^+J'19W*:O/5'0?*I5RMX2&^
MMSY\2?Z.]B\KGV_1^+)ANDTTK9U6ZP1#U3*G7::I+.E]D^ Q-2++Z@>I""#6
M(9>7Y<.#R98J/I+US#O->X<!N\VA?\9K= /N&-$IJ+[65>9R</Z@7L=L=2)(
M>D_FX5W E6#UO$NZ1"/F/SA:XW?TJ];LB((AD]R4OY,=C2!-"L$X0RZC(9E%
M_5\J@WBCKUKZ(8M!&:98L(Z#[^EP9.9/UC=9HQ5^]8CA=\P=;[ [ZC3U [?]
MOZ-%V->S;MM$UF#K3)TDQ_$VV"]G 2,%Z<:X^@@]=CT+1F7Q4S%!3!8\&+,!
M+<"8"%I9FJ0+$JO]8X$@NXR8!'X:O[P/#RAR,T@FE).Q]!_=,-^WL&!&3\0!
MH!-4A'1.A"7_[]ND$[8->R_JVO6MQT,FHP5!1.>.HR=C_UGX;$.P*:+97#H;
MC=)]G1980P4+U+$_FM&ZJ80W]T'$4XL?1 A$-M*9D;%'VI6=XIVX_ 6T9[4!
M1HV\8:%TK7]\;$E$"@%E/JZH],'^8D=[6H #-X&@;KO7M:<+Z>5S*%E='.Q5
M8VIF?,79>58<LU8<7V;%YW+7N/O[>9K ".;L%?OU#L=[]R<MX<@UNVGJOOV\
M/V:]/Q["^UFC$&4=LULH0N/D_%A=Q]B_/8UN%RO:(&>G#D_V6E)4C> J4,?4
MNN4;L/5QZ$!;/&5.;%TJ$\PSH5<W;@R-TLI2-#ULE#_$L\+CH\I;%&*_%XE$
M-1^Y1%XVLU&B9"K>Q1RWX0?48C)A^H=>8S@6QW$'D 7>/J*>C.-8_&<6[<4"
MI+VEI-.PF;MX/^_TW[*9/>T%07N^A>)*:(\9@.&:@-/P,H.SHZ,GB<RD"-((
M OUQ/$&?8-N301)047YE^HD4?=Z)NFIH&$TC#6P!68!+L8O3@ S3 LR%9P'*
MK^1TK</%LS6%UJLNJ>\/E4)4RBU@!*;#,P*G+OKA^O/U]Z-<NDJ'; =.7L7*
M3,& EF!V$T<H(SW4\D&8@&OB1=""@3;[_YO?Y>V-<FV0UOJRK"SEAZ66'!N(
MM[F91M.*S8UIC!>6Q<'(\#^4!!L#CID[VQR)VISHTW1KPXI#%0MWA8"#4)MC
ML:\N\.3%/WBT)NO_5<YNRE+VYNE>6,#T2*W6]' N_*)W=UG3GL1:]W4-YH>]
MDK6:( LNXTR4^0^0P=MLAH3L!JPTDC:+UC]NHN7<;?4I+<CKUL_S,L=J=+19
M92+SNL[E66\ZD 9"0GCK[UT@VQ&+>0P -IAJ+QL]==]ILT6=-HU-ZK1YP JR
M>?ILBF!V=K%'?]]3L\["O\.#GJ/A">[%3Q7@E&X:UHRN,Q@F LO45^%?KR(G
MFE=.ZLY D!M=.B,>X8SX/L>3VDJ&V8"=U-@/T[6J#"> AY@%A]B++JLZZ!.V
M#6SSQ==/^AY]$V[4@GR9N7F[Y]QKA>)G3U1T>+9@:";@D0.K1<3)][1#R*R6
MI*U&FCPX/! 188*<SL1S@H\3["433TPPP8XD,B2!Z_.?=+<<?19^)S(.Q^7\
M(R(,J$;_\,#Z980#PU'#WB'':=%]D^+CXP9/0;ZZN%F^;W4]F7O"O^ND5VGR
M1H#6&,H!@F7UL=S9@>J"YZA)(ID]A=]\Y^'D#)UANN 7$,J+T(S41_@G27RG
M)?T- O>AJQ3XPH9Y;$I:T^@B D$3-T,O1C=D>F\?':G9.3Q DB9_HF@BB.0!
M=(M7]V((%&'1@5I %\.,(GH"L#"#P//0)]O;(&ADSBI9!.\0)*!W? 48#1("
M$]$F+UX@<%?R@.((>  DV.<*KZ64 '*"<!IMO-)$ZZGL+2*IG6V(_0]2.>NZ
ME[ZU<FSU(DN/,,@2YR%9"! ZA9V HZ8,*PH3($1F>1Q.C(-T?7B>:U2R+Y)R
MJ\4"*IY>2?UN^$ '-;N?SP8PN $YU03.G%#UCCD#>XR9KP?4A]?QLJ0I53'Z
ME@[_!O8HS"&B,"<F(1^$S0PC( ?Y^E"+EX2>5BZ\/>2.?M7*YY5RJ5S(5^X/
M#_*%0O6A<E^NG',WU:MRH5RL>88?MM$J#!L$A4:!'-UU-73LRZ!B18UP]F""
M8$@Z*LI\?;T^O'A]3@KJ9^(FU=X<I)2]2[GKX TCLB2=J@^?^X5^Y^[OZ_G%
M"\8X+>J=P_4DA,Y12M\1T)1M]T =\%T$6QR,=NKCH(GI A37R>5)Y/*8=5\S
M&F3*4"P1C:*9>F>!-W"UXTL+O\&%Y>G <<@W^\3[B^42"0(1"](5GBM862I\
M"#[;@:M,D!AP7:21V(%LAMBBB#[9HMY/"SR(/G%+**ZGB1Y&(=/Q7UT&-":Q
M6*T%[6?YSI9SHW=40X;OOL-O#?*J'L+5"]AIUVJA)0>?1NQ,$^ ,7JO#A?&L
MZ6[,A_C$GCQP"TX.#QY@]>#E&LT.9Z\$O0A1:1,L9>+R6UAP\ ;!<*#WFO='
MW (+L W?C^D_)XB:00?@DJ51K+1^1Z0HI[)H1B DZCI-1)7'^/ [N3V7WVGM
MS/X[V0/<#T.X<P%C:)+^RE @#823PX.BGJX-6"P1A\_"HM.1;%SG[=B0M6_;
M3T+09@8G1RY+I'N!'QM$)R) I 9WBZ#W*G&H919/D10!KDX;N*!(\+OFTT0,
MON@.\$=T5D>@]SV!_@B-?X#RQ?^*RKNDJ0I^@3A_YI&@.'@5"90FO;NY\.I2
MF?KP3/JX_UTLG+=SK]ODRZT*NJ[ ZYV\(N!_BA8&KS[=;BLZVYC]?!_49:=6
M:,;DF\+MTJB!/FYA;_!MG\&W43F$48/OM#Z4>Q="YDFJG9931[^0W.>P] AZ
M%WR%<[#(WN);M\5'+Y& H>+=V!#D-KP ^0,H_@X9?$#^)2'$L_)*M+,Y[H%F
M(I!=4:4SC'8V9X:J43"R8(]@>'1Q=)B)-7YXD(MR C_0$29<!OU)3;JNJH@#
M4_.A8G>;%Q;F*P65[O(O),MN&BQDE19( 7E[_T.U<PAHX\%9]@VJ3KF\"9\
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MUWB76]FZHJIV)ND@YWFYVKH"-7(%QRWD2?YB>BBLY&AP6^1Q]>'?FO:W>/$
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ME]"7-MFV2-6'Z<_^VUFY]?EVRA_]*MFS$7U;%PZNV)L8ZS8Q[AW#V^U!(E:
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M6M</)2'Y4$WM2P_&PP>D!?E.[$LTXU6U4?\\$PBGCAC"K*_6A^F'6._)*&6
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M7 XS2$'%B@E2>*05$B,Y1*P,(B^AJ!8C*%SL,AR#:'C'_&?,UVI2PZ#(]"P
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MB0Q@_N\$X?6O:V=S<<'D\S6/=.JE9NO#5B]6>[MXC6I_$TM>ZC?Q$\<T87*
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M;X=P4D5_)^7\K>6MFX?TQ%^VC==:JYS;S3/*V&<T_)-+2.W>^<5-GU_;9L<
MJM;.>5-A"4927S,/"C2 S9#_;6C<O[\XDR\WE%8"W;^I0-C6F1KY,CL/YI)M
M'K'X..H$Y2(U8E>V/UY1%9;:JDOE>D])* FP /C/F'[S]V_644,\"2YC'/I-
M:S>^Q:/)2#R1C<13J>\>;<9,EZ92_W&?!T;H[!NA&<G42=(QE&9*+&'T^*RY
MJ!.N<_1CXTLY^O7/I(?&_^-YD].!/"8?OAO0(Z]76]1^3QR#\ 5-5)^EL@/
M]DA%0-9[X'I,.%6OX_)FNG5<Q+?0;F**2;#0)>BP;/C=Z&VDTZGE[F(L%+XK
M_! (C$TZD0V.U'T:)E["\FG"O "?4I'")SEDHKF'J5<\DW&]IVLX;LI6%LV
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M$Q6T\+UNA>)9E+.'2>4SGLXV;FOE:<P9S:37=X5)PIRPA/7KA@"]87_8MYM
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M9NK2-TN5>./SK4>1)$.^_:DJI/'2NM+?2F>UX0*&1- 7'RZJOC>^W7KN/!K
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M*YM9.V5MBF0JZ_<V@T3SHU&KW=[TK;)2V"H5&S0*XU>Q80W#WK1 JJQ=Q:Y
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M:GW"/H9IV[/$P^IK?UU)$MTF 56$*>P/,=A0%0BNALT=#,)T<$@D4!BUEQ/
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M+LI_Y]ED\5?"7N2&C/S/8\6F#W$@$-L%%?7=[/9M#,164=& Q\/OZE+!R&_
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MRMM)'VI/FF$.2.Q .G'4_?_^TV1[[5O1E*FE@8ENG@;5/[UKN=6*86JF V*
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M&G1*MDULF36PW#BNXO.3G53S^[D-F,;KN:Y>8C&NX9W.WXUO]&\_:H-"\>C
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M-0?3637ZC%=<A+=-H%S=V#FY;L)[3JT'6C E9_(S<LXC.%T,HU_1Z<'8%^X
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M9D<*H/55Z:Y4N1'>4VX>;(=H\9%,L.Q1%N;U 8_--0*[*]-MD4KR:0)P TQ
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M':K9?^0;7#<"4;++@43J:9]GG)#=;)T'3*9T(_=R%SP;2'&28V?#$UGXRND
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M-">I"8<93'#@>$0]')C3#3-TN-UX_1EF_N 2CD(_5S^ID58%!UKHC[#Z%LX
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M^'T/4+F82,)SA1U)PG>"8@W"O;#)R@6'GJ5, &5^$,AWQ8KTR_*\[78$9G'
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ML7.8G03_I!7BDY8)#CP-DK2!!33W['-3\ H.&!L0E<TD3I2TD:I3(&"J%#T
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M]W%\>A&E]P7'\^I1S]?_8:H1H@X4"UUWJ9 KPMBV#2R;8.N[KDTJ=QAX47$
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M@'KHWB6X!GQV1&;:>*RPIEK^^!S-'C2@Z 3Y$9//\7MX\6PYO63!P\8<)%V
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MULVFV)[S<GR]'[MLE0@(I\IG4_#>"7B[^D1"1(]4!\S"S\G0[\,<J,0.Q;$
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M+^Y_<^XFR2@N6W*9;6Y7#UN.D5RAY'<X[6Z,_KX@K<&<DR=HMJ,+=J!<TIP
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MHJ2&@"ER'?KP%1]NL7YIS+AT OXS1UC3!?3QTG;$7>[:.$=^G7&Q.\896 _
MKW$R)?&8,<N-AR.D2S_FSKLZ%K%8R%[]CAV0]4+WD\-89"%;NHDX9ES[*>=*
MFW@(= =P.#>#?>2I*1*G5BSD7>#\R$K#5.\E;ZD ]E^Q?TZ&P3]WN_]5B6R7
M$SX]M5=<^^ZB@\EY$02BQQVCWH73,)A6 ,)%9+8;V!W139DR@^!XNI'CY!6*
M,/HV[*F/RBQ0KCD<.D0PQ+!#.*PQ3J02,'W@^ P^/Z"^OV'?Y)E)]F (LY2?
MU>G_W@P,UPL-+!OF8U-@( 5..>S.]J( OH^Q5<97@.H/T9]*0S*P!295AP6!
MZ *Q8306!_"BD$B&2X+$-]/?DF7+.H(\ T6_X^[2SJO*.UI 6F$T@)6-+KM9
M\W)<_J">53S-Z]]^/NQW.F;PQZ?HXR;G"5:^_>P'K8>#O>B?WR\/9 68 -,$
MB83SKO<VEVX3<^D6DAGW.IY_?EK9///>3L=+G\7,=G9'YE*SUYX?.EUJ7MHR
M<]!F2#QZ5P,!E?49UG;V<,HY(8F2T6; DEQ4BD&10FI<;.9+7*FB,G- J"6+
MO]CYM5_*GP:6'SPT+Y7&/]V*?TFO84P^SJ;XU2<>52;RL:CS;S[W_#/.AK_.
M;L[8U??JZ*OSLBA@CM43#X"3/%[3<QH*> 93>V*6QM[.X7CFU8A\+(#/!:9T
MBLP)TQ 3Y?X$L'+V,.MR&MAA:#)ONK]J?VX=G%[NWQTIVLQ?4J[:,$UM^5DF
MO,P2LU,50)S B.9UMI-2-68YVPS?,?U=IWEY8[%3>W6'MXBBMM.5-UP$!YE+
M]#0+VYC(81Y+!#-,ZT=DPQFM'AN07S*/@/]GKH5L)2?CZ#$6]9<?W@T/W=.[
M2ER4;>H]>8[._8A4G;BL)3*R:JDR/R3B&@!,\E6QV8@HPPOOO^Q^;["+X/13
M?[E$-&UP_.!H^N#X3"C2)>+1JAG&]@3#C^%IY)M\*ZI=6)O9(F@^PM*^?*J[
MK;O=AX?+RF2+0-N,YQ0WW%24W!B4R*-,;$F$,S&S8QK"R;"Q\Z^UW8M+MVLY
M_9=,."N'[$TFG!F110???K;[U8,3VZW8E_W7ARP:%T;18GCLP7*B#OOPG__W
M[IUQ:C.G\YMQ9?;8>_CLCP@K0^+L*N\-)"#\V7CW3M[*CGTW+07KD]_/F?P^
M1;'4KF36FO6(YZ\_&QG3UB57]-ZX&0WAB;IOMFWKO7$!5X>O^L+#Y1U5]+=^
ME:_AGW#K_O,K+#QG#X8PP+NVS\S;=VV&P*;?X-[?FZ/@B<NG)>F4D_BP/D.<
M.I^==J)).DOL:';O\JK&*M*(KU1U]Z#^[6<MN/C9+Y]^NKB*VR(_,GYN6!26
MW/YP87L-SQ\:FN88&%_"SLY_?FV+[4XO:MS<]F%N?O.B:UU^=3]]K,YA;E[(
MT64-'69PJF &+04SF'VR-9AL]8\..^B6+_[K[#U_LCH687?\?#2ZN8X<]D[1
MCD;)$VY;ZK/ZZG" >'V'L+Z;X[[+FO]\_<$R(19:7T9-UZ\O7A/I=BR7-6<R
M7H+$NL2O]!N16-I,-V'\!LL]G7BLI[#LR[ORST/GMO'E[O:9Q_J&/0Q]%@0<
M&Q7VO2@ FX@J8'[=:>T8'8P:^XBQ@<DPW$<J/(!VTY#YXE] M>;;?&)XYJ9L
M,%SVIL^*!2Q$;;HC96X:IM%E'5%Z*ZY=;(X(-Y '1=.]+:?\U3$5K8'%A+8;
M@2XD4&?H2=2AI"E+9?>J[=2/+__Y&G:4PGDZ=G*/I8[-/K=E.H3+>>FV''N*
M*&#/=1E?U+T=]BE*_O'OLS/CQC?=@#^_8]0#.#T.Y:)JUL;0"\)W8?P(AS,:
M9F@T&]>-$CYA^M@_%_&-!$@42+5<\$P8^G8[$BA(CISL1):.JU-$-)Z$.)QQ
MM[QG]$TLR,W<&/-I(BI:?T>4UI=(S0023N'?\..>.C,!^AL 3^G#\=IWC ,;
M!;*M6!@#;=OE9;GE=6 !ZM]VT$>@=?YV"%2@ %YKLQ905KM;,MHF\C5\3Z*;
M$9_$J87PJ[BXP!B )F4X]BUS1H@== D92"!"^)[:7#[LO0V_PK^WF4*A\[GG
MS3+OPLYL&>8@2>_][Y^N?K]@#Q_W)]F",Z=SKH_Q+W#?(5%)L2#)I"2@P(BF
MM%T\K\<AO!K 'ZESD"YM:'0BE@!$@TAT/ %9)6AQQT8BB\%M7V$-\!PI9\#A
M[_M,H#^CT':$)Q'//HBP.)6\N '2&H%.<^AM1=#.Y8BZ?"S<&JQP"5#3\250
MQT%.:WF0TRF&^?8S/+AH_=&_Z!P?59_LBJ!--,K\OQ= 'BG%!\408<()%(H7
MV(H&$6^DG7.S13L(NLZVR3'FI*?F='J0;2$"EN('R,.+A1XC/@!W$.XXB$W5
MG@*.>)_>K9;W=C-B'2<+_-)H1*)5Q6>O'1AU#C.OEBL')3XAG(E*,.*A"RX%
MX??4E1HT:K=#@ ^^#)/P\YI0K!R5..@='\J(D?*CI6-RBU(K45(Y(E'R+=N:
MIQZ!&>#;X:C^8 ?: R?P9SA[JX%--OS1.1NTF?_MY^>[VM?PGUHG:M:4++K)
M+OYI93RFJAM<.>(W4D[U6^Y,YQ)NJU7RR@")C)R^B33K<7HB(;"S,V?6M_C;
MF09Z-[[]_">H^C\_[;E.^T"QE8X=#!T3AH.=8.^-.SNP*7,9?L,C7+]\D.UV
M*)5O\J7.AX*OFY18)_!V;0O>WH*WW24U+9D<^_[EP^?(MX..3>QP#=#2K[8U
MR0H@X%7TFW+K:EDH7;TBUN0.'&F[>09EYY2GC:=T';]Z^N7!^V?4U^"\5-QJ
M6K3N9!WH:4TJE-J3-^>Y.,=*U?TY-E-8/(7L/8%"JO.AD/Z)72L?'C4^'EIK
M0"'5Y5#(;J54JST.J'U"NXTE(IB(?R8\.^N$ASM:!M,;8^'=[ME_UOY[W?-K
M!V-H>NY%'9_)"1=E .Z6]H[FUG][70ISYG?J71C?'$-DH[O=O[KER&Q]K*PI
MD:69Z>*\#'M35.Q?+C!T"H4P%VA')[B&D+S96.C/P\/@Z,=?IP_6R4S$^4CM
MK 5PP'FH>[NE@]K<8'5K4-TLD4KU1/[V\^BA8C7-GQ]/^O::4L#\@)6[>Z5R
M978Q-_^Z;7O??IY=U5SO\N]Z8!Z\/G3E<J)S9VZQ$)=T"K4P/ 9GS#C8HE=
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M;PYM @HTF.\C!<)3^*^N;T:@L=R,4P8\'^C6'1G!* C9 '_[^#=+1M^[9R@
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MGNN@L+N:;C.^++F'.DL'R""C3LAQX@0&2N?;AFQ?R;+_ZML.0\Z=(-8.N_.
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MZ-X0&SQQ'%$DX.&#QE]4[_J<:CN(_A'ZC&*/?DZHEMLG)WH@]0HL,!S^VNX
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MH8II8/$,7FX1["#2WTE105,D-^,Z/;Y*)(:)^=QX5.6[7<:+0E+)S [F7J.
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M+5%>3U0)SV?.)9UK)@0*7GZ?\02JT)-UG;4JY\)UU38#.Z "@EII$,[6)79
M*QI>PHAJ7WK?@CZ**/R^JO7L>.@#A=^4A'P2$B' E'L2;FV&'!IFW.E&CI1#
MJG0C\.!PA.)3O"<+_)$0\GB;D[BZ>D!5G86[K31AG[B/%=^0XB:U74-QHV!)
MD8-]'YCBJ<[("+#^(A-G8[%A6#)ZV;J$(4K$,46Q.UC<W1OBSI?$9HEI=#TK
M"L1W4>JU@:=CDUZ<0WB/C33 ;@Q 5)!+3'PK<]2X[V!FTUDD_@BBL2/DISS$
M3!,0*CL).\I65U=Z";=LHZ6$4G['*'"N%R9JJID&48-#-=6!'MK,M?JH+% Q
M4IU8+-^F@NA"*1O \T(73=%XL3"NMLY[ _@(58_#UV2U.(T*<R8=Y=0FS=?&
M!.NQ?5 W[UW9<@:_S]4E[O=7/6=$DX4@LJR<I@Y8PUURU)*1K")TWV>D1<,&
MX7:2BI]<,2J\6N%\\0T>,3"MOLWN9(CH\98-H,(!\^VI]<&\T)6),^35\.%W
M(]YN1QP7\@SBS,!9?-8#UO^H7I\A"RPVCQ3A2_K _XD<(A>U,[B(,6>-VG;\
MM9+!;-HRSKW)BAA($\5GL/?"[,'J]UBC%>3"0\;V8@YWX):R9M,;KL_CA:)'
MP.RAPK@H:/"#\+]OL9HCKDE6=!44Y20JNFKB)F>KB&JVVO,+7!S7GG]GH%,T
M!1DA?5T0]6;211/GOU6K7^[BX,R/371 M(2%S ]S(]>ZT0=)>LU,&H,- OK>
MY>5M;0K.H(R@[]O4(3RVJ:2G1 H6;B+PRHHF[XFCPHS%@MGV[E@IH2& ).:"
M8R2[R DM25/9VXBY4(X:%*-82GZ<JL0E=O(=ONSQZA77-4#"F:*)5" T!-./
M#9_8A3C=;LIF>/#'T,;/E<BIZ3,8A>'*4IH,N>7H:5'WG>S/4* ?I,\2E4GJ
M(B6T 31;N-&2KX^A?4<EXAUL[)[<EC>>7TK"8TI\XX2_CZI6,A:\5?LC-0"7
M]3P8E!O8?>;F[>EW+PDQ,=X@V<B.04 ZPRC4J_#G;>);[FXD3; =4*PP)%#(
MG<WN\2@1DZ.7K4S0EMW5-9M$6\2M*O("%]?L=KDM42S4A[[M&)62].R.OX:\
M$Q3C%D!<(-9V+60Q3*G5D\J:@H&1Y"C455-$*S@1JA>UP(;DGR6.Q[#;$5?I
M$[X:6P0SAN8HX83F?F=._P/T"0D'5,P+@*$F7#ROBZ87BW#B:S.CT)NF2N>A
M5M-;5*_&5U==I+-YF88KY;RYT"I'4\YT!M3PE8^7 %533@G3%/&>Y3\S3(57
M2C2NT<-+M8"F*@"4LRGCX-XO_[3PFFWR62VE?M-!NAI,3OVF,>#(Q52G2=>3
MDLF"^:4^UJVVSIC9[U9S,_!765MG8MF$)Z83KDVR]303.7S"1%:62+S ?9@N
M8VX)!_*4!-Q)24*O'B(\5W\=5M%-QK"V3KN7N3BMO3IUKK(#+#Y QN,]NI",
M#D+R.TG<G=M)](XR$?_6,64OQP2*#.Q+GBEC8D93'W@BD [AH\8&Y,@ 5ODZ
MJ6 X81I2W5'&&-0J&J<YJ S09<"&SK?E$\WD\HWY>']0R:/%"$_A),N^I+*^
MN+,/NV91=H7M&MR_@!/Z;:U(;*V8UU3Y#;NO++]A=YO?L)8^FMVMC^99,R7M
MPJAS\ &9T"_$?*[47H;Y_-S"NIMC@#[#RM@DLV]K;*VQ>DZY&2Y[QQ&Y0N.D
M]'9L_$T))UJ(:'Q\2L.W!C9/F>.@8UV5UK5M4I^9.<"&W<6":?E>P+-+1'S(
M82:B=/OV< NZ>K&+ VN>ETQXA][S3K' &WELS?F7N3@RYU7RFH%U,D2U#K)
MQQBH6DT.'6</\@M5=E'S),#R([ <F!>.)PMMF$@O,"A/ZB?P2[5<.0#]C?.F
M+P@;N4'8R)F:UI5CNCLHTX ->?>N8"+>$*<;N3Q2+0$@<:T-_:,^BQ'&Z$S
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M,=?4_1H:.5QK#S;D@SF0=3*,)C\L3 BIT^E[FYT,%7&0_=,Q>*!:/XDJ(>F
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M]Q*4M PD=ZXKF]=EFYG"GA *^M7R6*8GG]C?X0^,5295J6A/QBD/Q#2UED'
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M4T'WYI0GU,!;&05R7]?^3QFJ,! W1B1!E,@7:A7Q81&^PT*W1U>P]1QL/DR
MO86:<ASRB*0LR3ETI$I8HL7G0@<)F)^J4!'V2VK7V7[-"8SL<N!=FYR\=?0!
M[ZN,3EY5G#Q7FFR6\5=?5BR&N<AZS9(>56TWY*K0DA=:1#YN"884J\U&JRHT
M6B%T%0;MP5 _#)6BU&3-4L.%@YPQ; 9R@_L"CNUT1K'3T +!#YR[MF8@J!],
M=J@9C!>Z3^#;3FG?9L8-U([,0H?JS&'L(]'XK215$6.%2UU^PE7R]4_2'?WC
M:C8] =H MH84@C1TKCV1>QCZ&BPD>,[ '688_\H9UR)LZ"$,=6%?$9_3VVB/
M$3&Y1*>;$E!!Z8<?N!^^+2RM?-)Q&7QZ4G%%$\136UPDGC(JW'S=\(SA2UG"
MY32B=H:O6#O53J<]KU/]CX755>2S'S&Y$A1+^G%(8J,J-M*""%FC(A&]TI&J
M<D<B:<(O(O/X!$NA=^!";Z\!H!AP?=)-]-*2YHPB;SZ3_EI!M].S=D*S61&+
M*=OR%UX!B^!$+\^$GY]>ABFL[5ZX4&)G_WHE8"=[=>1:FO-V?'0;AO[N<1C"
M<Y^Y"'L_UB%B3Q>^S0-<-><G]QS,D#<&%@<Q3&!5=+B],!IO4L!B@G&I2J8F
M#6?!'!L_X#>T&%IIK,;J96*2L:FR86S5>J;U4PS#,]HL 0.$7J>%4" 1I[DE
MT/FUG] ^D-\:,BS% \NP%,L,RX_8Y-CM;D\,\W:^AOGE0_]ZD7DFRK44N]WK
M366QAH%BOG8/>Y(V_O<G16B*/O?W^O</W<N;# ;E??^J^W!Y>S/XY?)N0+HW
M%^R5_@5YN._>#+H]^F:5OG-Q>=_O/=S>D\N;B_Y='_ZYZ?5+"W*'U=L#!E1\
MGPFTOT-]!F?BHUMK!OP]9?%G2WU2+&I"1.+70]5Y4?D=HV>U4"AP-#QL=VAK
M8TVQ--4^(=ZK7O>E:JAST_$1OFO#4C5X$QP?%K.:@&R!3];( Z9)8$XO)N/!
M<(9)3 ?K02*3L344W#3Z98QC1@I&E<763S982#:BBJ-BH4#ITYFN4C_K4;-!
MP% 'B<[5H6.BY06C\693\(V99<Y,]$\C0VNQ"T:Z$>C&@;6$><<FPHJ#RZ6@
M&--FN$(^!@<Z/S[2C&=3?Z:-JM@][/>B1#VZ*K\/Y"/@DRV5W1@P8Y!4T->;
MN19.C,;Y+AUU"OY@'7^_5Y^P-PL>XN#TMQ/8Q3'.BF9FT!U5^$& /0J3-=@?
M!*]_+?0H--3 X*279MYN>TL_:Y^O3,4X/GH($>://Y]II2>XVP1X;=6.CQ@X
MM8;>FD5Z$TU])'W?![ME(K-*[H 1M3&]!0S>[4T4S:(#H9SPNB#6R*U!?E4,
M5['>B$C=2TSV"<LG_+@/C'U\1$UM>L,)XDHA(_A= S'E73Q&+N_8='OL(_[=
MI)_M [+(=E'(P9.8U H N.D#Q_C.5/D&TN=9T7065N>='_SI>5-X!--3UQQZ
M_QSTN'!G^(SO)2HBX;_H@EL>IE/XB=$5&B!Z5=[$PUN!/XGD!5;AJS IQ?:R
M571M&G0_B4^73:_!IA=T+YE9ZK-FNG;PY= BCH]@%=V9I>E$#B\A>3Y4Q=!5
ML!WELU-7FYOLC4HI ?3#KZX!QR *ZQ^XX9U9Y%8F90J@BFCTBV5,HJY;,C'@
M5W]F0=8(N_9F=)( _A4>Z?@HCZ'$V%"RE\B_VJ*.C]*'PFWR0]N,\O$5J>,%
MNS^\;^P@^! R'>*+.K0H=TGM<+3J'10R-"V+F9V,5I HZCXU>IQR?)3 *B':
M>0BQ-MJ:U'5'&VUL@?"EC8"^%ZL<.[5*=)75A"'C>T*'#!6=]I]CV4>+C@ '
M;U!&+2VA/5P<=7=T&!/S(I6G)W1H'+_-$!QND#,<#I@FTT6(S$.IB^QNA5%\
MF$%E*E^1+X^/D"N ACU 7WP#I#]FYU$:Y?E]H-;UMQJH>V]*ECI3WJ:L^>?C
MW /XUUD+HJDR7H6<,\T[/K&(U/8<!!*9HMB6JW)=YBMLB-56783EXPQGBC;.
M>6.C$V26T/<",QCX["QU"DXM>GHP3\K[+!4_\L :Z<Z_"(\#7RF@#]KJ:C2R
M6#H8?WP6HCD^0B>,>K)XL-K8=P93]D)]G6F6ZNOH\'1'(R1@F_B+"DU.UY0A
M:EV-I;J'UG5\Q!8&2]+=,;S]O82]U>F.F9;VY*6=/2)ZFO?H9<LJY>)N>U$_
M#S_?@SY57^#XNYCD_8S"SB+W<-88=O&2;N]Y=.&.11?"_F1YL;CSU'J+@2OP
M8_ 2$)@>F'MD:4-,+U5U\R7J$/EW?T%\BX:$-(/,=&6DLJQ[D*M('V1FZMKH
M#2D&:&>D@H"FG_1RTKG!;WDDIH1(S(J1&#XW%$"#+_WC4@G'(F5^40X3.5XX
MJZ*<S$>TP*]4>11.K+=.Q8;7//CXZ+QWWNMB9!.E,[%<764=$_WITV('6!05
M;^@3@IP_!Y-9L[$"0'>G0PV\4-."V2B\S=^\:ZL$%Z.\0S=,_(6ZU IN#CR'
MSC6Z5;@#8*"#]B 5)H6Y;8H[X;RQ;#.P3$]BWV-C3M0SK$R>L-M:7PE-:;:\
M9H]T$WL.TCMB_TV,(.+:4*DR)S>T,C\^.C05BP9/_>@L:C[T'7A?1O]4.6PG
M6P1:XYH=(@S5L%UZQTPGH2KPR=C*Z(:'+I6MX*XY$KK%J @;E>5(XR$%DXM]
M%HG9CZ1J!H?.L!6=]_/43<6(AFZIMQ$\C[K"/$1-H[_@6?R7(Q0QTF8JUML&
M+VF;;IN_4Z"!U9F#JV2A;7S0V!RY4T8=&HN83U65'L=4,UQ'M0]+?Y9WC7G>
M-=97O6NLU1MKO&Z4_.O&N_O+F][E7?<JPX5CM]>[_?WFX?+F*_G2[[,KQT'_
M_C^7O?Z@O$N,S)O.+Y5W'\+ID(1Q&M=--K/I'TT+PROFHVK;O-VR:CV#U,.*
M6%2ZO"+VXI;\/NA6R5VM5Z/W3%/5 BOAFX'1%= ^_@>NKNY.:$(:Z'FT'=TA
MZ%7//:&IS5Y-+7PE**G%J!15#ER.ZPIH*N?%)*'K.-N/72GN.-)L.G*SIQ@&
M-BS&(D-,1*$F[",X,@9-C /GS%&9>XH"F8MR>%3RYT%Q!%_@7I(OM^,C/VH(
M/,D>3'<7O"Z==P]F]Y2IF^M[N28V3*;)FJ@'UDL>T:R/]3+0O+@/B_>X^/]8
MNC?/3!H!Y2LS&UC/^XW)[U0)SV;\R<NV"80G>R!\@.8XB4&.$Q]6PE%C$K91
MJ^-F>*\R)<M?G$]MRMF_^T*YAJWC+[S)[K.(A.?W1_PWBIF8N&)VJ'.KYF_R
MA::][9W_WFQ:UZ6Q,=R)+\"]/]ON['.%(G[ +Z3R_4FY:VF[=LIC!?'=D\K=
M6[Q[#\IK?,_D<L^64)P'@$!#'*&=JR_8.6HK+I3^%#-X"'OP9(&M,D;U88+,
MMYZ&%4FH5R49(Z.-DU3U\.Y]YN^S39Q[=V=V'B/%J]#B>[?AG0NE'\]SG6)5
M$AK55K-Q"(NEMJOTTR$L59*K<J-Y""M-.-1WB[\_)IJC'K+,DPZ!8L2V6.U(
MPB$L]8 DGEBO-AKB(:QT@<3SPX,K%\G$ R,9OKA::95T8*554EE:572X UFL
MY7R?4-D6UBH/3X>B02O]H!O*X]E>H)@%@0UUI-HVYDLZ)H9V,7C.HM@L4,V"
MV1@S_L=5+(?&U5E8.B/N0E)(>FD4O$;H0NGTH_.F5P,KCQ\$TAWE%>]_GS6;
MWJO28#AB$+ K (Q"XJ1<W6%7Z9C,Q.Z.,2K^J*NCX&8TP_C9%JKHMNFOEM\F
M>#%ZG(OMA$/U+"<APV2&;T17GS2;9R=@XH.?JU!EU^44#&V*A5;P4;KZ*L-%
MA*E6O?.GE^NLYE_+U LS?!.!6^ Z)M ?7:A=4$"'4K"N*EBW!9X5%JS1@/%*
M/TD"UF=2'UZ9PG<Z]"I3?_/$;0"J1UG I&DJJLW_/+4RS\4?UYL(@O>9;ZK7
M),#AO%8E8U<E8^#&)VKR*+:MV30?I)HJ$+/U!TBL0^3)N :[!G4L4_<E"LU"
M\01>7-1AUDS.XJZ4-@<N;;:%6N7!]'H7+"O]I!IQU(+1=6K<^.S":X\QPY)=
MW(<3!'(P(Y%7DX0F_5#-^Q1-N!O!ZT^HX_U,;G_:3J8=H)70&I-0U)+3P4SU
MP(CQ!66,BP<!FOYF,(E WF6&2,6G41GJY=FI8+15PZ-XU<]80DBA2/E' ]Q2
MN\J3/,#CM)U,!A0*,9<94;B'ZFAB(&]Y8[/:)#I'.'IFG]7(%YZ?$MB?\9*%
M+.B)\\4-#E5:$1KT28Z7%,Y"J,D]Q0!EB/F_\ 2*X_NHCE5+R8(?[EF0;%A+
M=5R+&_4+J,.?7BG]#USZU[=L:V;"R@_NDV,ZP*:RGXE[PS1.F0%5<"+?OWJ.
MGX>?[RSUU,O)/CZZPTH%D,QEN<J[4D>]0@\66F+A$T2.TYP P/WXB*6\AU$!
M8I_TX0"P3(%6NV$@S#\HE3(79:EJU"&C6F6>WR)>W?$1(B5@E\Z92EMU>BX>
M5U)FM"28AZFH*SAR,/Q&[23\J/H*3[!IG9M&OYCV8%9M1U%P]+<J5C;,;TYH
M>>,/K8]FAU(E/+\,IO6/CY:N!)[!RJ3CTYS0RB!P%:=8$LF\:&K J-%O4WO(
MGQ_ZV6@G@J%! 1NHP895E0@7A-8 3^VE$<A@!T>LU!)V-;23NN[15[!\#!Z.
M$W)C605HK #4*V&D):7A^I#$8PE5[:"E]&0ILPFIC$XJK9.*=E+IL<(B%[2[
M="J(<U5&?Q8G)S=!4NU&O<E*5VCR@5VAR86X0MLF/<U?Y6U#/:]<NK1 5JPA
MJ3)<NR,'M3O=^X?CH\O_[.6:RFJS7*K-V#8NK#EKQ&O.UD69=9\R^W_^<GE^
M^3#(4E1V<T&^7-YT;WJ7W2LR>.C"XOHW#V30^Z5_\?M5?Q CF-*7FV=6C1K"
M/Q*IGG>@((9"Z=7(,EOS4=-9IR.&G,@,1LWKV?CCWBVVB$$E5N25*)?$5JV3
M=['I\'-%F<_QSU?T#!%+\4M0";BRJ!GX20<(N^B==D(]0B%DRU[3+3 W+X1.
MH=WVNK.:\A6BX.N&\F!\X@V19!4VXTFEH4R_%QT3I SJEET=1 M^V=/F>A0H
M5NC*2[%]X8PX'8Q6VE4O)I0T%1JL&+BSF4[_QA2I"\51JE[T%=M3@9N#"@%O
MNM&E: K'1\H07/P:*3HWY5H?&W&5%-<Q?0;KT(K9N;S_%\S[7U!*ZS^2I_[B
M,]];7NO-1/HAGCLLU$0IYSY*\V9>VGRD'[8S;F-+XXIK'G=Y#4HJA6R3*C9[
M%LLR[M=>78F1F]2RTX.ECY\5,K'4QW]_^FXH".*GS_=,8Z*R"]T0W&,6%,,6
MC@)?H K[HEE3^^>A1<X^$[;X2N#=OHY?_^X(7_Y6QZIV>MIE\7$, _X]PJM_
MH26(?_^-6E=HRL+?__?K^)_'R6^/O<G5!!&_7W\T3.,&/"8+AJ2]9%^=>YSM
M%\N<XO=/A=:I(#HF/N%4:)[*H$,,>/J_/\%X/X:&^_0YHOE_(O$IMJ)3O#(9
MF%?*-%\?SL_-Z5\W@I+?-+TA/WT>S,QOBJ%6R1^*/8$M=DP##.[P*!X5_T3N
M>MW;<W)Y\5W*)^+K%*+KQ,.['">O\C^/+^?2:]U6[N7\5LD&_/19JLLI,P9#
M4MD"E\[QWGHE4C.Y*&W/!)$W1F0)22\NVM1E#]D;^2E]^AQQ4\XY^/)@HJKH
M,RN[HX[73-SUDKB+1MQRC+A#[B[V^9NI'$*2.K]8KF.I$]6PL8/#E6D?%/4G
M(RR4U+_'U%]?2/T]L-/(%]U\.2@R3\:<*,E\C\F\$25S-ILHK0]"G<MX,A2I
M7- VK<X)Z5,,7+9T5 3WX&VH4QK[NS$-7K2#Z>?@7S+<WD/BF%;),47CF.:G
MSS>FH](>>$OO* Z)UMO;H_7$^Y),X!C[??FW^4OKGS5V;XW-^-9_=]U_G6A#
MC=U"'\+]<ZXW9KD@RG+22[EOH1<]_K8G1OX%S#WQ8O_OS&?)F88Y51T?W9BU
M6&'%3EZGM>6]W.8'S='5I/U="<KMTZ:U90%&V>+&^J;2Q'%F/YZ=O;R\U&QU
M5'LRG\^ZUFBB/:OVF3I^4JPSL)J4,[$A2I+4/A,$06S(G7JG)4GP:U,4SPRI
MT:K__5J7U=>)="K6)LXT1IG\AO\[^++0[W_Z+-7$BGCRKW_]R]^,K=XK[-&V
MGKNV9J@V+RSNF=.AUS KU"J4!T+4F</Z/TH-KSGCD/5>5:8F^'DWFMDSK1FY
M4)]5W9PQ/_+*&=>JY.N?I!L4-1/\6(U<7M(OGVM/Z#RR&5S3,F@R<(?XS?@Y
M[BE]B_6Z)-3Q$.KU3OL,DT'QMDQ:@;)EH.P0VDE)UA_:3?#?-*^0WWPD7:0=
M;*4$OR\@7D;^K)4MI7RQF7(@Q:)/>27ZE$KZS&TW/8+T*70!509-::M$?7QD
M'2.]YHB\>;1$FT>+C6*1*]=K,OQ>;[3/0)W)*UD)<DT.8[F4M/K^K>PBY;$&
MH+@@Q_1E:9@8KQ48WNM@+A>+"%OM1@=S?'%'ZO4S^U$0.HW)W^IKW=O .JCN
M^K937/9FMWJF0<^=EF/3NPB&&OA&OKBL\\N<0>IW\1:;7C_RH>J\T/+\4",]
MM#&O-/CGJVX.%9UT;>RC>*T8RA/K27MY>8E=GWK%ITS)HTRII,R5=^N+:4U]
MA4P)"0B&_*%8%I;A\T9AB%Y5$/H)W$9!:G0\MU%"MU$4 A*2*XV2A%;?L)C&
M_$[DUTB>T%M!WEVH(^Y_?T3<L?$+)O-"H8Y6H\6.P*XS_=)Z4>"K')G6H]YZ
MI5E2[WNV[@]\A<,JL_PO^N:*X2).KZENS<$IZ]#N2W(+#?"0EFY46B61+MNF
MB'H>N$-L$CZ+1C!CC:==0W/FVBUC+V<&>TEA>5C;E,*2F.^B-$L26[Y-$1+C
MAI]]&!33$ 7/H)&;;$]DCW9:E79).ZMOV(UIG#X@Q/6C:BF^FWMNF=] 1R:X
M$YXB]6#"N Z-RC+$7G-"#R5#]KR7&)6"L7FOVBH-R/24F>9X< "HATV6T/UQ
MZOTH;L4Z3Z&>$-;Z$,'4:VW* *&H5CQ_H&2"^/9OGPG 9-5-=^SY6QIL!W>)
MC%&M> (\?O,+'NDJ =YZK1,&>BB%?!Z;.IAAVBAWGA U @MPYQPG=H6S]+8]
MY4J]NN0:/C*'RTMTI2@[H4D\4C#]S'EC0$5VD/Z-$TH=#Z<T JY0X"F\1WPH
M<3SMJ]X$BG4K$+I/:;8$9D0V_.L H=(I#:9E^[20@WXU$=/*\F^=.#4O8Z;H
M1=2J:2L,B5:!;W)?\1=.TH@2\\;G@( SCEE8*N:W@BMK#5$LKUA7W\PNN\ /
MHFE@HSN4;AD. V^$<(\ -7:^Q!W/R0J\ 2;5 U7A:PE/R(<D.W(%8AS!)*G0
M]U],9RH=\27&"(<T&$W4,0(5BQX;<4LLC8T69/NOT/0R0WO+^H%A\]8+@<V;
M3@E[GF"_A93S[::Z[[S@]D0AN) 6!=9G+2*G:/PZYNC;$N/7MYN9O3R#CWKU
M]/ TZI0FR4DI,#>*:V>LDL<)=H94VADY;6;8U&"+BML;A)O=:S&JT9@.Z)V'
MV4-$WST@&WN5'%&@_3*-,:_-[+^.)HKQQ,.0:S6PHT4/<^9U8:G;]^\[?ARD
M7L9!EN]3ICB(1\=YDW!?_T9Z\,1OZ)F:KH7-;>AG*X]GW\X4-GX*G9\LCI\4
M2*RWI6:SV:$'*HER1Q D41!;L-%GJB+*;;'=IMDT3Z]>8\<5;9Q&111*0;^>
M[>5W32F"/\(OHL\O7O[2(LG>,Q$L$\&@$0\"? 'BW7>1_U&F,W#&+==VO+R3
M E#_0CU<7]6>;Y8V33Y[V;5M(!!*S)RX;=N=LHPHI$\_$?5=NB+3K1,;GVF2
M;&Q!RYM09:BOX!9@-JQW-]Q]HA/VH.=<!Q0*1A[I]2U]F3;<?7S4= T6Y=>U
MACX9&^FFUJWYX]GN"'0<FF61 4LVY6S:*MDTG[U,RBDCE7#[;8Y205 XINWY
M_A.@T&YX5^FM5C0W46Q71+%T%%;>L2"CA<W^#NSUB6*G.@5^E6@S)NI72],.
M6_:: 7.G+4MC81Q\TP_E8%<.]XUV.7<<!5\M;D!3ECNQ5%NQ4Q&EDIR7;52L
M4.;&K!%:*Q-0]P+"]DL"I?J[:/JO+IKQ=S=5^E+QJ#)%=GRG_$U[ M1KDE 2
M:?9]BRCS<%'7A3H$ G/!Z$Q3[?.1L&)3F42I3"PU>_9]BU 9!YT,/",[E<3F
ML_2+2&))^=TI3:$H"4J,!$M7)M/V+K\LS-7&++@^%AN2S/;Y56PT_F;.HQVJ
M8<M(TW)%+-WS3>SU>XL.@YJQ4'YWX;!1%F^ZR,LR,M)VO:3MM6_SLD+'G2?:
ME5;I[SG7<&)3IG ??J*^U(BLJ1!TEL?.7*B!G*,E*IY'GK)=>RJ^FF*CU:J+
M+4%HUIO"F2T*;5'H %<%^7^B@(BC]9/O2DFTXHYQ.X_-?-[8N\++I0?5FN(]
M#N9 /JOD3L=IQ['M;LQG)H(Z%-NNM4OB)W_4P(Y/;XBS6)+;"GN%B"2NCI>&
MJ9?[;T24*?74TS%T?KL>3#5G4B2P$8YU1?V[>I-B78GRA+&I[!,:.!&-DM)6
MWK%Y*$2\ZK:440(2CDB)KE,2'=_"ND]T]9+HLNR81V)^A@=/^:!$!!I228;P
M9AJTZSYA H1,J5$2JCRU(T2+U0@ATH>VFD$*8+6 M?(B;K+0Y+G##<7;.I]"
M&Q6Q65)HACW+@T9%+P$O@43G*3*!4(LC1\/>OE#G>][\6YD:8V<:HM-F16R5
M=)IASY8K< ;]+OH1[!3E753*\\UM26JT6V?/]7I;;-;C9F.K(K9/_E72W8H[
M=OOXZ"C?>'ZB$A>"%.Z&^2A",YWB>M<]_%MU%!U6HI"Q]JS9/#H#KT]5B[:E
MNZ8?"%*."T&58=Q*L>7=5C4%NLDMGRS;E80K]L.DRE5V+"W[AI/KO+KFLE'V
M;,DT4GVPE-<W6*EI.1/,0;: P!BL (+-4.- +0J"<A .J[?E#H;#6G*]$7=Y
M.A5)*"ESU0U+EI?D!9P4\C!YLVW5^,UR9S,F['37>D(R(7>6.79'CDV^3H>_
M%(2\%OF'[2 ^+:!+_:]_\2H VARKI+65=N\/4W?4J>),V-P%0?Z5<*B6*$K+
M+;L+ ?GHI23Z"ISG/=19D-IS8/J]>^9._T<;.:9%KIC/\JNK&)JCD'Z-^&,?
M +$&P6U1+(GUG;N71*S]5T<U;$Z:Z40: ,K+7F#R4,DTT$!BLR&B!FJTZ]*<
M3)4J4IFWN/*.>2T-4NYAF)/#6U15R:-E3B-F(U#LM6)](S0261 Z"S%TIR%3
MAJXW)G-WRW)%*F_[5M^R=U\N!TW4"D)?"W(X5\3P0_*KE[FQN>_KP $5.N2R
ML/^/BSBK:Z[0BF?/[ERZ5L8#H0>Q!/4E\*_%1D4^9!F:8;?>D1UXH5DJM0V1
MT, YUT9@1UZ"))T:#+H[<KFS_[2W.A)T$NY0ZIXBG38K(M)I*6W7L<']Z4PW
MWX*(9G:X;4_6IF'A\.X)[%I317B#B3(Y)(+/)$20X%LEP:]O@S=+\(.1Z3CD
M%]-0C$,B^22L\H4DWRY)?GT;O%F2_U6;DH$VM0^)WIM9Z;U3TOOZ-CABB.-E
MA*6Q#/F>^:P:2AC:*3<B3:H,D<1$S_=#6RR)-3$RZ6T0S*86BY6#VEA3+(TA
MYZ>Z\_$=\<YO8XCXC0-#Q&^4B/@'@8B?S.JRQ^J2C-(H17W%9E8TR/SD'?'Z
M_2*6T\4M^7W0K9*[6F\GL\%C*Y#\,YUKU%D DR1YL:'CNE F8$R F/BJ@C7!
MTF."6BD\R9T%68BM3?8/4B[^0<IS!_D[0C_;CFF.R;5FJ!:<8^"M[,D1UOTC
MK!?_".MS1X@Y&5/X)OD*+#G;V7*:V#H:_J$UBG]HC;E#>U =2X%_1SN9C!";
M?M,_JV;QSZHY=U;=L:7!H.>6^6)X6HZ"6>P)J[7\XYLK<"_>\;7FCN\:W)FI
MANH-39,].;.V?V;MXI]9>^[,KF3,MD;T['#\8@_.K>.?6Z?XY]:9MT5TV\ZC
M^?OZ/5 A<,J%XI^4M]RP5I.^[F1187SFH>A)>OBD. <U'QKQBU#>T/@8J3.'
M#$S=Q3LD>Q\., B5B <0*Q'G@R6A>^TJN:X-1C5X['7_]/[:;W6Q#^<81$K$
M PB5B/.QDOXSXLL[Y%RSQABH[,,Y]NC-&+W0W8<S#$(EX@'$2L3Y8,FU@JRH
MZ/BXO3S!(&XB'D#@1)R/G%PKDRF&*W^;O"C_5?Q3O+C>W=J.^**">(IX  $5
M<3ZB<HU]6@URI>(E)SU"XVG_6#&(J\PC!Q;P&.<C*W^\&9C$!*?YBH8-.\3S
M\W[H*FC7SU'V,S%D<<'U;#%.,5AL#S?=3ZWGC7=Z$TT%*^=5';DT \C+Q)^Y
MENUB)E"D.>C((?<NZ%$BR@IHVHK">G2*C3'[BQ5$C<T9)LV%'S% "$X8518D
M;^2!8@T50[5/;U]U]8T^&]Z1!&'.8=A!^I%\^BFZ>Q,L=@']\&82BE[2SRI;
M*OGR1RJ^_)$^+'_$-OF]-JCU:CX9B')#6$HK':%9"%J1?%HIO*R1/BQK#HU6
M/I9(W! %+Y%8;JJODTYSI5+43K,F5MIE@6^^NSHX_8TM2I0%(51)@ D#!LVV
MNE=GIN60@3N=*M8.MGX6!;%V>3.H2*%&&WM-$'^>WU^12\-V%$S>O3!';B0G
M?ON[/>C]4K#=?E!>3<.<OH4P:/[GN[8DBC_1/J!398=VO]>].IS=[RGZR-45
M?@6U,V=PT?]R.&=PH3YJAK9K1W#5/3^<([A2AJJ^2[M_=]\_G-V_LU3;"Q?O
MSB'4B['Y6/UGT2HFL'D<%1&LT26_ %,7O"Y=)95'TYHJCM^?6\%T2%TS5$+/
M#4,Y(WBH J]$>H@"F9XD'=:"ZC->N35?HQ6M1 K5(87KCN)U29GKD)9, NNO
M0J5*8-@OI+MH]=E_71M\VS=6Q!0OQA$TXQ/?I/GW:G)#,Z(/T]5')\_JG>\B
MYQ1,(7$!^0U[K1B8L4DKL$?F= 9LSUS_&8/9PDYR['V"D#%^HX H2U"Z"JCJ
MG3154E7N5(5PG-L@JSMPEU%3'!_1X(YF$Y6+I(D"DFV()?OF5'/B8:%+1YV2
MIB!6AB<543BI:,\GK%3ZB5O !)SU*I93CR9DQ@>!L]-U>"9Y="U#LR?P3'@4
M#2GYC>Z.CU!(^@%QQ%C7;*KAW)F)_3[_<55[9;+.2GF4QHA _Y5:<.[QPEA^
M!/Q%S1BK., I_^P:RQ-+OEL3WVV)\3!^"V; \1'G-YNQ C!@ +V](@LJ)Y5&
M O?52!>,C=D;OH-@G]XS/ 9'9CP^6LR-)$]F?+^.L==40?V1,NDDZEP#G53$
M-,?EHT*N)C7P?_C?*C*.?3Y7W6.ISYKIVCJ';,0?[#1(T61@#(]0.55RT%KJ
MZ+1^LDG/M2SD$A[S!7I$U [2/OV-5*@QCJT5!$$X;31:H*+XHRF</27R?@^_
MXT/6!'.0.@R[AA*_9HPX.@U\>:):*ECMPS<@_4?XW1BIM8B$]AZQ_X<SIWZV
M[416I&1&V)2AY!,K(R3?OUM.J!>6\HAD^J39#D<Y&B"Z/3/6.=D.3D52B7P&
MR5=NM4X%46[43XCM#KD 9\.P"7 J_M75/0Q3L9F1;K=[K"N@,*SY9.=GD'4[
M-C312DH,:^,<P$;>N*B^5BQP)L06;V& <+VKD3K9@\,M^6!U/J@?-A]\48>6
MJUA\> ;O+XGOE_H;@[AJ'AC$5;.$N-JZ@Y:KX&D43/"(PNG_OE_RU-_E)NVN
M7BE5\.J<T-P13LCLC"UUP^I);I@LGTK-MB2U4CB#3>#&?&;HMZV2,PZ6,UH[
MPAE;,DYIRRE9"'RTD@L.D0O:^\H%7<-P@T3BD*'TD:ARL]0'!\L)G1WAA/PM
M)3G$$=1":H&+WTYC"=K&FH<LF.>P8O1N#PZYY(<,]YG"/C!$6IN*FL\>E<>S
M;V<*^?HGZ8[^<36;)AVSSY#+RY-5S2GQM Z:H7D25E3)@6]LIO&Q0-^.D4+)
M-1FX)B4-8+>X9HUNA=>GD;G6,I] R0F'QPE[FP>0[^T/D>HE*^PF*^1*[JF%
M*Q]-,5I[ZMJNYG>)[_(^<DWO6OO>[U[ZEK@KM_9;DMO^Y8 HTS2M5BFW"RVW
M=^6N.#.YYQP!)2*+?@HEO>\:O6_,9-_;V^*\>:'-0C@E*QPL*Z1<#Q??G+\S
M;>>T__BHLIKI[E0UQO1" 5E(]+ZUPJ6#EVV!/T'J?):;"/<)=L>+IY9^P(8-
MHUVY&L[_0BRQ@@/)493K#7%AZE"H<W99Q%%L#; K%\(+4R-2Q//J]M%9=YF%
MQ,8/R>7;D6,B!\ABF2ZQ<^R1:R7?7EP!K\\?\ R03AD(.@!BW]N;VP_8.RVI
M)2VT=V@V$!&9L=,JB7^'B']3AI"4<I%;(AOD>^$03($'8DM<@P\[Q!OCD>V6
M? \\S $V<%]71XYE4JAET">_ *4@T=5(UW&4T821=PC2SH>TL1@A*Y9*"?31
MU'7S!?O.^G!Y"(9'(?(J'-(0*PO/75LSL-LI8P3X IO'E6(\N<J3>O(CJ6@G
MG(4,6B-*R?E<T2D<\6"BJ@XPG.-7)00!'_^5K5;$M@ZL(K955L1NHR(V4="N
MK4QV^T801@^J(!N2A(-OR-JT->],9<:K'7AAJ(XM=8)2Z%DE5R8((" Z^J0W
M5;%LHH)V&D=E2BAB@1<\=/#EH_<4>T*^@"RD(P0!D2S#/"\?A:)WV11O]!]7
M<]Y2E\-FD#X8'^O&=%0[,%Y" P>M)X(I9,4<6".PZ=#4QUD9+@:.ER!CF#Q<
MRI,)%>H+H._:^?+DY4/_FNV>V(P>2*[>+GN2-O[W)T5H-G!Y=*0OM_?7@1&Y
M]$<4.)KQ;V3P^_5U]_ZO%*\FF8RRFJ;+3G9]MN?'YLU-ZCQG>&,:,<M_QR:8
MN(7+K*SV@5E9[4)861E%]H)[5;;EZ69[_B.M2:(V?8DZN/QZTWWX_;X_6,*M
MN[FJ]4C"52(*4KV6=["'8[(>'W&+"&%1-2NPOW@++:Y^9<3G%AN5\8G?3RN
M6XTT H2WQ8Y<K_*'LD KA86UR1@!_T:*:R,>8.!BTSD,56+##L [)E .S&&H
M3A3]$<,[^"07=L)B'Z"/ME37@&_1)RJN,S$M6-PX=RVPG<-9AJ*\+C?M)\)U
MRLC4=65FPX2\WY9X<$RF;OZ>'J:'+__[DY2K07%YV[N]OR,7_?_TKV[OKOLW
M#P-R]7"1,9@_MRDQ>[DA_;!A#Y8/7-_6N.L>^!UGLG?M/,[??ERXUS&S<$C-
M0M$S"_/<_S/[##ZM\/KXP429'-I9+!QEESP0=DQX1 FZ);=[DERAYK$KZ/'1
M7%O0Q5<A^7536&9X;W5SO*0C=C<F[YWONZ=VV5*C>47#.+A<0JN8]DK@MN]0
MU<T7S^8-;IQF8/MB*Q(PC9E9S#N?1"QL=D%*7QTI:"'2.<!N8+]=9E?'Z*8T
ME[=D+B^_\%B#3S[\/(!'*XYKJ3^?#3]O43>&S?:-+?Y!<_2YA;_W"GVS1M:U
M8GWC&4@U,IAJSF1'#B_?[!-;0PE136L>SV90N;,T, AFBKXCN7)X. 4^E[EC
MH'JFZX=<V/C8G!T3'OP^CL]J8FO W4KSW^N#H9>^$T6SX,.>[7%N*M88_[@
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M@56^=U:J?,\!Z.=L:([?*'5,G*D.O_P_4$L#!!0    ( )>+1E<#H'9$&0,
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M6[BWVSBCZ).KQKGJKW\!4$L#!!0    ( )>+1E<>H4RE704   H:   5
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M4IIX3 M%]"4I9,$W9E;U&A$PC"*KQA6% 3'4JO ^%11\IPF>XWE;FM\EL3*
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M:IDK=I]I'?OY)?\>8S_;_ U02P,$%     @ EXM&5Y@&+V9P!0  1QD  !4
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M+26K1LM4L>^95C4?0M(O(^8#RG]02P,$%     @ EXM&5^F!'953!0  N!H
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M#3#[OO\:?XIFHR&9X9E5*\:WC/6YP3\0@:>^#K3,EZ?\4Y3Y8O4/4$L#!!0
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MV*HUCU2T2Q*#O^7'BO[VF'R,U-\L_P902P,$%     @ EXM&5ZG06)YP!0
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MLDY;^SH] 2HY^NG4:Z#+K?<#D V+,@?VI:DU[)^[_%>>_>/W#U!+ P04
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M$!K&ZZIM7M/> N"5F?+O P S.T(8,>#C?8B8,T@FH+*NZI':L.Q6#&26-<:
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M?6KP8RZKFL]CZ?<R\UGM'U!+ P04    " "7BT97R-Y8]W<%  #/&0  %
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M^.=8CIF.UP:V&J;?MJT&$.Z;$J];![!G?'T(_6^Q..F(6US+SSU]D$GW?K&
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MD0R_= @G/GGU+"?_'<O^*7ETVV>#'G1Z@\&XW>WVAQ>GI5HI:4_&[<ZR_4)
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MA0RH++?C-"+^-;1Q5Y6(6% ;-%43GL[Q(W+#, 9F%OS)S'F1*CE@3&UZLQ3
M]^(NEN7N[!IO/FH3MA;\.+ XU:G#U-D$;8Z/$?:_3;8'?C^#ASNV_7%GYR[E
M3,AJ92JQ &,Q%N0.Q_"F5#XILWX"DHVZ8I?IS30[/LTI^"^-!IPS&@5',"4+
M>HPF?$I,K8J60J.1?^CHCR[^V):2Y=">R9A?9-&T;V<JL=>I9(=1\=;G@WX3
M51;:-XQL&BLSP[X%K6D^P63?9,RGF[\!4$L#!!0    ( )>+1E<<D5WWA@4
M )<;   4    ;C(U-S1?>#$V,V5X,C,M-BYH=&WM65MOXC@4?D?B/YQ%FE$K
M<0E0Z AH)0ITAET&V$)7FD>3..!IL#.VT\O^^CUV$@HM3.EN=]6=:1^*8_O<
MOW-\XK0^33\/3K.9UJ=>NXN_8/Y:T_YTT#MME>)?7"TERZVS4?<+3*9?!KV3
MG"^X;D#9"35,V9(J&-(;N!!+PO/Q1!XF5#(_AX1(.D[IED3.&6^ DSMMG8^&
MTW5^!9\L67#7^#[')MB]BOU)8P5RI^_Y3(7-5LDP1,W'NV0V0=-;72 !F^.C
M9/.%?DDU6F>GO=L%FS$-E6JQWBJ=_3/-4N(]J0+J&R7ZGS_"Y*)SDN.5VO$1
MO:U4ZVPY=YQR\6LXST%[,#W)[<%[BV/VB_>^)N>V+,929B+P]A#5A!4OW)HZ
M0TO"E2_DL@%1&%+I$D4W_>12KJE\R<!W1L-);SC-9D;G\/ME>] _[_>Z,.Y=
M3$;#G8[XG]KZ1'CWQ<EV@Q*MOT9*,_\NF63<HX:I4ZPQ_I*FM#W)",]FSJ2X
MX= 17$6!)EPKZ'.W" LJZ>P.7)RG9E(+T L*830+F L^"QB?@_"1O:L9;H+C
MXE&QG+<_%2 <XUK%P8$A>A]XWR+1[(AK9.JM2-Y+.WV8S2 ?LV]*W05G+@G@
M@H9":IA$2W34'6BF R1,^.S:EH=>< 4=2>D5C*7XBF+RZ)"9).J*),+@AND%
MJ@<]WS=J7%/H$DVM"K]&G$+5R4/%J6QJODMB:@$097C2I/XEOFIS'MV3" [G
M"%;T?N$WC(:T6WRF#-<[2F0V0S'4WH86U0TM5N0KL:CTD(F.D"%TZ34-1+BT
MP1IHK_C ]<N0\)6^Q1\"P3]/,I) B4>IR+B+@1>2F&0"S%5)?<PO[E)(\NEA
MPB%),I^@01DT*$3HG"D=,\IF)AH3PN!H!=E)X0,<K&^"H2A"M5HM5"J5:KEZ
M:/-]8\.*B5KC4GW$125L:D>U,A8/.ZX[]>-J/INQ#\=.[2A=,.-*.BY7ZG4K
M=O7XX1 .7!$$<5H'6 [6$F"'<F\)\4I-^3L)$2F+? .*52K811%)X&1)\R9G
M@LBS1Q?.*<1!I%;%&WL(Q+Q,(?,-BS?S&?6R&5Q1@J='R $2>-1G'%,+,VH2
MS4*"E.6JXQCY"+4H2("&I3Z48AD%<T2<9Y+4*'I9G!1-4D:2:4:5U;AWZRX(
MG]OD7#*ED/S0Z&NLY''^9C/V\#(<5D=!#/)=J6<8?^]@?8/]*S/EN;#'*H[
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MGQO\F,N:YJ L/SDS!VS_ E!+ P04    " "7BT97!VA=>X$%  !*&P  %
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MD7OX5ZBM/]H5-,08;JS:,;ZBK4\,_I7+*OI;6/)Q3']#^P=02P,$%     @
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ME 1PO(%7JGYMMS ?-W\WN8H/6N0$/^]O$UXW3HO>(?4OE?IW3_\#4$L#!!0
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M(1#9UZBI<]_L(%B=%_\'4$L#!!0    ( )>+1E=QRD$C5@0  )86   4
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MH6".M[>=LI'8K_0TV+IBE[^F.[!"@PE)[T0AWJ(O$F5B[AM]$ZL<+\*B@75
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M #7@DN1SXJOPO"PJQ#)0_+V['WELD1B#I*8O;7>+$V=+FX2B\&T_#O,&<SB
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M"X<+52)M;#DJUE06,WBRP:;SPG=9&PG%G5H*B.SRJ0!(9*3'RZWK^O:&?<K
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M'9,Z/C7A+S[$PR8Z*''+90+Q_2?=,W:WUTB%*I%M#]0C]<DV0MWN#2CQ&AA
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MU..08R)&C\4)JCP/.IX!'<^ CF= QS,@[8<3QS.@XQG0\0SH> 9T/ -ZX6=
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M9-_<#WP_)<\3W'/+BE>6[OZJ8:5 L0*IW;A8NQ.^D=O(_@!U$*Q6&Z/AX%R
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M&#@.\E'(L@%SH^$&K>+06=@$$1;FY7,C8FI[[A2%O  ,5.VF>H+DGGP9=R[
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M&72EOTRH;)&%:^C9!26BEN%B[@[8'#0F[WZ-P&?HSE<F=[*)?&%'2\PU(ML
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M<]?;G7*FYT:N:AXS/1\S/>O>?GZT3,]=[QM[9GH6[@OZ5.OL[=ID*65W1''
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M3=N/\.7N+?*4YHQD2-;5I?LF<0$7QJEF%\AE+\YNQD>:#.L,!52^457<I>#
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M\./['WA7H?_TSXMTNTV3^Z> F/U+5#RE^V(99#\'\1Y_Q-L5SGI666NY8,Q
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M#'4TX 2_FXOVF0-E^+DDK*;%Z6S(HY!UR1XMW#9]I()@^*-#UR=0)0N50;(
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M\40E!X(H!G#"/2$NWB&*IQGH*BFBXG =Q?AV+PD4DHNXXH8*7,6)_N\@N*
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MT&1!WFE2;8WCD)Z<$#,8J57;0 IAI_MK6L"=G36I)!CZ:.$)NVE4^,V*2K,
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MW>(P8@]N]V6V"9:PSMS>!>N4-/B"Z1977JH!Z'S*PN2FWF6C"**LO+9_F+7
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M3T_$M-ELE-+F45JUS_<X '6$.[[J7 99<1A\=7AX,WY(/\Q(.=7MV@!(\$'
M#4%.]UOJ\)35GV:/&>89*7;$OUM'NR"NTCIZ"'LB739.^1U^UGL)0AJ -<CM
ML6S#AY,SR#R92V/5@'?Z'H/:,"17[?#AN6S(^TC,JL326<=JP%5*NRWRJX7<
M+? K%?5.,SM\ND4H&?#H)FJ(8MH$G]9![3'Q@L6U8\,LK>.//@8%OTQI1[H1
M+;FO.CW*5+$:]:!F !%Y+'89R;>E ATY.;];%[_IRJXA.NCC=I[,[AS3<X^Z
M7MPE^4]>L-R^U_P\9*"O.[)5/Z[O4:] [@F/:A),3SF-'?U>4ZFQK<3ZF*US
MUY'=;URQI]'9@U8C+&@UPD[T92X+OV3_^^Z,M4W^]!;RG5^6,SYZ;E[H'5E\
MT+Q#9(% !I'.)3W+B\ CFO1T.WBT\8HKPX/; ]C+1AMA$X9"IR*4==KBI0=:
MW2N@P6)D0B.T/_!S;D@=IMY@RJL!B;RA:OL))W@3V:T,CFK13W<9;;J\MPQN
M#F!G&6N#,!WA#6:KDTY/(-R-25]DDPTM*4#^%6%>Y(-=$<#DX1F]4!!&Y%]I
MA BF,U;Q!6.^_;,.LNS #KFV+.\02Q?$#@/9W-1V$NFDMJD+]V28M,SV/W?[
M;,=N#547-:NF6%08U6H@U\+?(=KY<S*GLF)"2=&;6L/*W++'0YL>JXLB30@>
M148WRHS=VDK5:?\=8$RGHUKHP>F1]F -.Z;-]>2@:@$N/YOU(_%5+VAGW_#[
M%^88QT%->.'K ..DO+70A\=?>]#:/%K[+;T_3W/ATGFC.<VB:QH FZCUT?;Y
MH5VGX4.6[G<$IG5(E%'=2U23I5'2P"2#+AC"#@2L(VL3NI,W(>8A6AU0S"*#
MWE>7E.DPO$_258ZS9WZE.2@"[UR>I&P;-4_QYB=\WJLO(MA^;9,7$*0/ ],?
MI[90\)K:SSM#](G$?0H2Q)^)V$-1\]0SQ)^+Z@?75>_/T%6SIBF??H;(\]$_
M&(+_\U5V\1LRR,W)"BYW^$%;SWSM75UX?5-W]_J!7W67[UOII]M3%(C!.+KO
M*P-1Z&Y-MBM##%AMB0NZKY$=;H-M?^JUTG 79&(%O0DIT8I[9[,]1I&+3*+:
M/Z[5O4\7'Z,DI:>Q%=-K[B]Q1DN]!X_$:^;]0M&U![7@<B@?85I[8!Z@[IV8
MXS'WB=H(4JZFE;YWGMZR\B TX)!N]@8LY_$CNW^A>!4Z!9<L- -ODTXM#89C
M1HA]2MW6E5VR6@7EI8Z.6%-^%5SP(Q"Z=35KE3M^2&^)=DH&:^(C1,ECU9.D
M'VMH(_]\Y_0K/N-LE>;X1O<Q1YL@7*,,_V>?%W]NRDGWBT@GG?9X!7?2H/^1
MI?,*GH,HYO;S,D3M^]FL:K?5B[1HQ>D8-,Y$-=>-3< 9K4;A%H:PFM15"Y31
MNR K(AJ:SK:KIRX./6@/H%5ACIM/+%AL'H*7(6.=L(8[LE6WZ_B3O(+N2OVH
M)L%TB=/8H>XBO7'_F>B0=7;.LCMY[QJ=\>":4(8G8]\3 YLRC>(X0<$/G06.
M:=W;['#\*U'.&N.;!M-U3FN/L0OQS"MK7@\Q;[6"WJ 5;8@%NH113$6]=ZTJ
M"<V,YZ"IU@D\K5LK48>N PULPV4W&65>NS,,:@ ,Y<>@-J8GXI-!)['*(#Y/
MMEU)L]@2-#GMWTN<58G/6,CV)<<E;EI:*,%9^0V'W/^:5(<F?>H,3.._I9.Q
MB8S:&;M.&L2M,;FWXOV%N.\%3I;[HLQJI^@28QMS.5H=9W![V!K7$ICQZRCX
M?>J7O[X..E\$<5P")KVZRJ)QS&M2M0B.V'K3![-;WAR4$?UTI@CS=OGS*^$[
M2U>8$]-X0;G[>D/FJ!>F:14>[XVO8#CWE4V^3OZ;S)%$$9RTS.O1?8&Y9]$S
M-M);)NB2L6J@;1**4F!<!R4TX?982CB'=BEQ(6BUR?C _5X:TFRW*SSA5VBE
MT9.]_M;/CM<HNC<O0R5_Z99%PV&\X/=N7O!/_ 4G^)'FYM$-F3)P4-^SF"E9
M]KI%*4"TUH"3O_7VGM]O?_.G=V__^!=Z'RU:1]IY:,*OP#*:?< )SH*XO#LH
M^PP2,3A;(#8@A95?+]5:F8;M]7T%<&.0#B3PKU#A*&%+QW]!"-!XI,8F'XZ$
M%^]Z+N";ESP =YZTDHZ6*]4Z*XVX26NAY.K+=/O& QG;-3NU0W#+KXO2VZ+=
M>FUEXO(FH:KW18WY5*V72@7G5R]%%J19&"6T#"4-P!X4S3#I$QUO#$S]ZGJ;
M!E,]#LRX.+V-TC,52?X>".&1QH-]5S[%R+!&I3=1G;=[F<266;J)"HKOK3A9
MM7X$X"ZH,5D' ;$$'SR[H2=*:Z*>!@9[ ?@B0U#*7;EU6]-'+ZA]T'7$E\(?
M<?&4AO.$QHO175P^Q!)+U%<T;'4!?;'!D,7]Z/Z' ]C9!LX?OW?Z>0J5PZT'
M)QOKN!CZE@K^#LUZWX%_22^S2U.&CU5JIW449DFXW*_B:"T[#K77@K.-,P*S
M<&FA5J;+HJK@! U<X0T@FQ/0"?M14Q6'W:Z@XT2]_)/V*ZT"G$\W#&[_JU$M
MQ-10HT<_()CSZMEZG>UQNX01X23;O)*<%O3>B:6NRR7F('/:=+12!#,W#T$K
MC"1<MY,+/B]X*4;C'N51E\,O@OR)X*3_H9[%<Q#3>W6SXJ+,I\<ZREOIV&FK
MZNZZ^#!C6KM[5GK>F38"K.#_$2WOX]M%L(N*<KN>%SNXC/(UWR?!8;--HEJV
M6*L[O3(TT*C.<M%2USL#1P(66<C4V^4NV'WQ6L\[1<]I:3V<YV2]M*+5;6FN
M!KP+:([>^$ S!#\FM,A\NVC-+"26D#\$,7T79&E%BWC,UJ2+YNS?:2T'%:6G
M>YS++C#U2VMWF:F>!::+36Q@OTM^R.A>P)I,#VB7I6N,P_R,9U3<H*)Y1EE-
MI"XQLCJ@#W^?SR'VU^8=S4,:6;6)Z,JZ+!!*7PK!WRT4RM9S70]NE1/CUZI3
MH,F?ZKGW3O$*#9WXE(^$W)<GL%,X%2)/])_!]Y2VWV(7/9$]Y;7VO-8KFJJG
MD4=\E3VKL4MZ,-7*(!]PA<D6Y5/,_61FEWF@+A[H;@/ Q8MKM@VF?)KW'N;,
MQ'YG^S7-/C]'<8P1/^I"U\&:UVV^YD4;DL=6?4\6U_KV+]QSA5'!]E3O;$Y&
M&9INFKVLV[0HP^S"B1<,ZL>^QK6DZ25.L:94/=-[GW9LJ! [(*PCR]UM_S>\
M1_H1'](T_$+&*KFG3MH;%%3H&L0K\'&/?,$G<(%'(H#<UZ<W6W"@T^1-,T-3
M_SE=1S1\&7VA5;MIR$E[L/FZ5JWE;C<K?+I8Q=$C:\[!@D;UX%?0[T>\R*F6
MN_*GOO;^/=Q4(==O&>]2A4U4JV):U;"Y,##9&IGFH$GW17E+FS]Z5M0A(=+5
MC%''W4K5$GXW39!&P3L?AZ#L4ZG40EQM&B*!FA*NJ_*#YH">Z1_[6J<#W4N<
M:C*0/=-[UW-LZ&DV;,HD;A%YW.M=_YE.:-R>![W>KNRP!W_M'=?<7W_[F[<_
M_O 7?I&C?;2?X9@MR7CEQ/J,WWO?7&PVQ&IZ<9B;KRL9IY!UV2^T<#OW3V2"
M8#BI0R=<K*]E$1<&4\^L;\6-H1:91MXGAP38.A[5PF"YU$=HP:<;NT)94P9X
M-CG_A?2UTJ!.C;SC.TL6=RFLT$IND[$4KE3K3)*6UWOW;\JS+3+QXAS&%W7U
MX*9R45WU:+8I<#:+X_;.I.+M3? <MX6H)WI-W6K5)WX(F.%M*LO4I9!X5SNC
M>93+]OQWM;+.\6)3>;.M,__\_-#ZF\Z!&]Z,TXXRTLA./QC8!AR:CP.N*XA=
M-83:+9W1J.+6/X!Q)B5FF_Q)O8J/Y;H.O&S-+9,'0TD+D'WZR2AWTCJLQX^D
MU)V:LWVQRWU&W"@R:T1IR-VR.TP3T&+NJ.W(.E_ID@QMQ>DX.LY$(56C?1-@
M*#L.MW#XEN8%RK@T][]13N6A%$IJY3U>DA8QW4AJ+2ZX_9]V]$Y*E5%9N3 9
MT9+CFM]C3>U5\A[:#!A.C\>NRY?=.2% ^QV+&JOTO3.\*GJ"0YI3!1/?G<XD
M,WH6_LA..LX/C<@R.-!_FGT)LK*G+\G[?Z(_7:<9^V?5<''RQS@=YR=Z29V)
MX,3/ -.K)C+,M*I$NU+1>Q=;9O1&<'%8$KS%+ GIVGK'LGS0K J*MV92<DE_
M.P/:9-9K@*&F%4QQ; =0KW>V7O/=&.)^X5V&:1@BZ57DSS%FW2L)9]N4S$#_
M9O^N-%3Q8D[7O.,,+2=]*;TD+B=I&PSW3VR0)!5,U3P*6^U[[SE*0]2W,O4J
M($9BQ7U)G3P8)EJ E-QD]$ZD9A]1:8#=#K%)W<_.L)U1\AUAO2X8X@T$+$8.
M<Z4SQ-18QKQ:$<QNK](TTYZOC2*(L4^[_VO6 D-':Z@#B0AI4_@FH&DI^<*L
MK,!WB?-U%NTTETE,2BY9:&= I_:15@,,^ZQ@]IG7DF"9K[XD-/".M 2":#2P
MD/QGOMUEZ3/;:E"-=4IIU]320.YS2B(*BDQJ?'T6M45HOLC"_Y[-3;2-"KH=
ME14TP*&\4406->D^*5JL7VP^)>K#J\&M.*7;.!.[9=T&-0&'GJ-P6PQ^+!2&
M_F4;L5).**,UW_V?8]WA(+YB/:L;:5U>7_TE*IYXA.)?<4PW6B_Q,XY3YC^0
M;GP?*%<QIVC8)>E/]R+:_>#X5L%TC9.9(J]:]AA$2<X<U&&U%\;WDCPK6CV$
M_*WI'>0OU.E^ICM@S IV%^%3$E9_6T3TXOB'(+_#.<Z>\7_OB7O-WHAL97]\
M<RYZPJF,IOP_MBWOK#^1 9(%&6D2U6TRPK=:1:19]F^D852VC)JFI]T[,'0(
MP5#5/H%)V!69S8 KJJHE01#1"*]/,QES("WV)6%M/*ZX2K-1AE0L,I:!AU">
M'^(N-NV "_N8N5&->PY>/.*%&,(<1[3LO1M,8HX0N=L*R$&;-$,!>PJ(TREM
M6!W_=^)TW9-N'ZV5]W*'-@(F9%)IH'7$I- "M M*H]"_)@9++@%?I,3)#\ND
M^.R""(^MZ]?C&->$Y\OB1N,,-\"5^N &XP&@5>7V6EJ39=2Y+",W'X*7^787
MK!6Y8F5B[O+FJ$$VJ7)$&>^4,  3=\BX("WCZGU@NM_O=C';9 [B"EAUX+',
MHK7RH-ZLY_:2HZ49W4N+!B7OS!J*5%ARES)H1X6\DZT=.K786)9/,2DYC:6S
M,J 3(:?5 $,P*YC""5421AE>%^;4S%,&0/#8Z/PA+3.G?.2'#'?LC$$:_*#5
M %00UA*H?$\YV-)C&R@?Y7P?Q31I@-T'J:4A?PP1I+@3M0VBA":Z6 4Q3:7L
M?P#FAWDY,89N#Q ?-<07-!&0+N99K>$XC-D$O1>9K!('0RDS1DG\,-- .ZYR
M1G,\A?YYQ88<L4:FGEHF):<Y>:P,Z"3FT6J X9@53$DN]Q!7'$,!U0YB_^?U
M9&6%J\Y2&C!+0IJK6LLSLYI+IMD:T>::20<,VRR!BHXDJY5>4.V*=M[9INPT
M-IRS5?9;JMF6?W::8%@X"*Z0KCAYCK(TX6MM.&-?SU>@]Y $*^M,S$T5#SO/
MP[XUCQ[?4),UWJ!M4Y 8?01^H79@&B0HS:+'<M\:;7 S[J(BK9.%[H*L.+P*
MZ@]:Q.A;@$9Q^T6.3OU54=G@G:;ER-Q9"K'(H8 WU:[GYYV^S7VJ^Z<T*QYP
MMKW$*\M;<#(5/S??U.#EM]U$>3 4M "IRVO&E-Y0+435P-QIZQAS8[C'IA)V
MFT!$![B;!D0F"8=0.GABF$*//C< LM_6B7DH),V,(Y=TO$UKE?%6BU.3F8A>
MS%\59ZA<)<#X(OKEF5(8_'>10-4EC>)?)JF57O?'>>_TX^QX1%5!7/IQ'^B]
MX@.=8[*.L#WEF/"K7+W0G.+[*']BN6HV%/Z,'8+)/HM:&EZGL<#:_RC7=6DE
M6NHAHS6_4+AGBSO:B1#N-.G==6E2QQ&?C,8"<O-XY)\J(,ZDY#Y/H,D <5Q0
M:;BAX$^<@@E^I,M]\[!@0"L?NJF2K^  NK1D>7O*XK6JS<VV#+S^KT0H.1[D
M@E7M7>\=6S@UIQ?D'M*/0;'/HN)PC]?TO^IB2@/TG6;=&&J6-MQ!I0QM$!@*
M7(A&X_JT]-^VU('AP0U?\/CPW:X2BR%:B50\YPA/&)FBC#O^&"71=K^EH=$$
M397(LIBS3R0F-[%5<A>3;&M $Z%LTO"^;3$(9I\WI1HJ]5"K4T>5ZF1LFMU?
M_/Z//]RD>;Y(NEZQU$2=N#L&F4$WW%'+0G%*+'&*9TYYCHAC G'U,0O_9Y\7
M?&U5%3S^0/_7YEJ9K;+38Z5!!G6<82M-[R/8*+ABU EQ5H*X58:8[NZ3<8V2
MDPYIU1!7M>R=J!]HGH@;5L&QW^WXKL YWJ09_H5X5GBQV=!_XW<%Z&_L3BBA
M#HWH5KS.$[;ODNXG?RWM'G&RQL%TFE-;I.I7\71#OMI!"$-V;2&(NW[-*DT_
M"Y?F[50<.@I6X%O.@E;>.]\&@!0V,FHEP<_D>K"&XCN<%]E^7;"KR[P/V?0]
MJ9JW@5-CA'(\E.AXI]U H/+HD@G'KJ.I5[DCLR3D-X$DM4I[[T*OXI)R-N#;
M=-/)0SP_L\"KFB^I"\KB\<[H8GI5':M--E=>/-%:(_/DY^JYC0\M'<FU\NYF
M20O8S12I$?8^4-DB%(Y5F :*DH8QGK913]J9W1Z[6&VI6N'M?YZ?.]T8PZB5
M7 <'\S2%- MM$R+Y$0<T6CBDTR0][:>EO%FD?%;]]3S(H[PV[ &OGY+H7WMY
MPC\WCW0Y9[EX>>UN,N7SO(]Z#HV4!D6P9Z+R 6Q%,4]VI%NS^.&Z0=2T"":^
M<Z(W=F.(%)W^L5]!7Q9>HH/^? ,N#M:1H:?JUS> LD)>Q$&>UZ[?(F/^QM4+
MSM91F>*E\0O+7W-E8-2XMIS&2QUC;N=\?DQ#8#K,,>BEZ>^ )/K1.<ZM+LIZ
MZ C?6VP"RA:&RCC;55!?'PQ31X"6Y']>\=G@0 _:HO(DP3M9>X$S=N$UWLI0
MJ_9E>R(0]\;D$(5X<AZ1=(;^MB?3\_L?SA#=N_+.DGX0YCQ9QWO*?N;KW)&?
M> ]8K.+HD?D:RHB!,2VY3A0PTE1=8*U%,V"&N_'8)X_)5>[G$G\A64>[(&[N
MU%:)H<N>IS@!M5-TM\,[Q)!FJ]=&"TI$[6#$XEQ:JG:N/4>E-LTIR]7]#YN=
MQ(+744+&=M*-[!,^]E7\I7N4@U<G>^S*PQG:S" EQ_%_1ON *Y8W)&O_S6OV
MQQ&.$<!S!A7$5^(:L;B@A!ZPF\K[2B5=]F@-U#9G)&)@^J\:FRYIP4V:/+8N
MG3<-P-G?[AIFVI962ONCDW836"$*E%:F+=<>B6#MI2ZS=(UQF%^3;U7%*RXV
M=SC$>,LRTS7#[3(K8QO9I4;%JSFB/<>EH(\SNU<A>EQC8 A]K 7B*0/Q=5B8
MN'>"SPER'O9>K1?NR$I#\1Y4PBZIJ0?<YIU<$@RIM/#$P*Y*&%72Z Y"'5^6
M%/8BW6ZC0G)W2BGE/"&O"%'(P-N(@.&(')=X.;X2H.GWO%.B,UI6U,9K'#TK
M:\WI5;S-? KPRLFM)P^&1A8@^YRZQ07:E6K>&457''5J-?)?A9FBF--RWPJ0
MG7K>/1DP#%$ $Z]>)H^HH$L_MF\3[D]3:NHDZ[TF14BK;KAFA:*0=[WFT\+N
MK_JDPF!(9$(H7?DU"F>HI>*=4G1231-:GEY;)544<WN8*P?9W;3LRH"ABP*8
MS+M)$Y3SF)2J"M47*!=I9^LUCFG)/<QK3-[A"F-.-\1C%GJS#*)PB3,FH#XF
M'-J.XX/<<6;VCG&'-0*&JV.1"ZE2>$ 6SS)<H( '6:$=SCC!O=.9@3\G=H6D
MW]%#9C;!SVAG>V3'U.>'1J3*]$$Z8]@.V-QOV1B>WT7YY^L,X_8"MTSZH7C/
M[A[O-CNMVY?:S7?KYME@NJIC@X5*743CS8:H-$?H&82-FL;F#VD:YCQ>&F]W
M<7K N$IOP2K-!FMJ>AWG_!$73VE(@U?69/2[C)ZC$">A9I=PDB?YZ:XG?U7R
MGGFRQP#LA*>V39Q1N2@*2UETB'#L/UKEI,-09>3/:4R:H6&O;" *7EQ-I08
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MFR)]4S5YANI&T2;-$&\6T79!I63OOI(BW6I?R8U%VO;1+?KM&(--UW<.Z^8
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M'(1;"=)LMW<XR-.$V$B-)2@?TMLTP=M=G!ZP,G!J5$LNA] C3#4F.=8W V:
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M.PML]6K>J2C%/.WW=$ J=GN8#)A.K !FP1G\E>WZ +GN8XFR_X$^!C0C?G%
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M>0XM2TIO8(4I'_(TF6^-R0X=FB.:FBY2]J)K.,T9$53D?P4= 4+"*4,AQ#<
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M'SX^K>DK;HX":HQ2)3JL,\G#[LQ$G@7KT*95"%>'W5/@\5_6M Y4)36LZRC
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M@16]\&B.A'X=U^4<XJ +SH<\-(!8!0\"&J.BP(_AC(=^Y=:!)V+4!]-<U.9
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M2VVV,77057BDA9DA6Z[I%A1I,ZU-7'4;%?:UOC%G8,/W:)B(?1+T\M-*CG9
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M7Q7O8?QQ#>7B_D\2Q?1?(GX()X Y/8JL4, 6/"K"*M:62E;3"[8D%.>TBN8
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MPZL?WGW^7H-5Y>&JG!HLKPB$4TV"#7-5'H5QR5DD/QT=1?+#;^,D)!1R#IR
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MZ=#CYF!:X&1V\LA_H<5%K_5P!PPX&:0[!BF1"Q^^'+Q,^X/]BG?)[DR"+(0
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M8+[%9-=0TF+;TY83^8+0=S2]280J[8:K16Z'?I#$JRU!.Q+EU*>ENSFCC7&
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M,#$N:G!G4$L! A0#%     @ EXM&5QHY3V?B^   F@D! !(
M ( !31,  &XR-3<T,3!K:6UG,# R+FIP9U!+ 0(4 Q0    ( )>+1E?3E7(>
MP",! (PE 0 2              "  5\, 0!N,C4W-#$P:VEM9S P,RYJ<&=0
M2P$"% ,4    " "7BT97V5@UU$D) 0"U% $ $@              @ %/, (
M;C(U-S0Q,&MI;6<P,#0N:G!G4$L! A0#%     @ EXM&5Q=AJ[T$G0  2KP
M !(              ( !R#D# &XR-3<T,3!K:6UG,# U+FIP9U!+ 0(4 Q0
M   ( )>+1E=5=OE,"B$$ !CD)P 2              "  ?S6 P!N,C4W-%]X
M,38S+3$P:RYH=&U02P$"% ,4    " "7BT97 Z!V1!D#  !G$P  %
M        @ $V^ < ;C(U-S1?>#$V,V5X,C$M,2YH=&U02P$"% ,4    " "7
MBT97XD-4D?L"  !H#P  %               @ &!^P< ;C(U-S1?>#$V,V5X
M,C,M,2YH=&U02P$"% ,4    " "7BT97'J%,I5T%   *&@  %0
M    @ &N_@< ;C(U-S1?>#$V,V5X,C,M,3 N:'1M4$L! A0#%     @ EXM&
M5TX.6TM_!0  O1D  !4              ( !/@0( &XR-3<T7W@Q-C-E>#(S
M+3$Q+FAT;5!+ 0(4 Q0    ( )>+1E>8!B]F< 4  $<9   5
M  "  ? )" !N,C4W-%]X,38S97@R,RTQ,BYH=&U02P$"% ,4    " "7BT97
MZ8$=E5,%  "X&@  %0              @ &3#P@ ;C(U-S1?>#$V,V5X,C,M
M,3,N:'1M4$L! A0#%     @ EXM&5XV??H=@!0  L1D  !4
M ( !&14( &XR-3<T7W@Q-C-E>#(S+3$T+FAT;5!+ 0(4 Q0    ( )>+1E?N
MI(:]Q 4  +H<   5              "  :P:" !N,C4W-%]X,38S97@R,RTQ
M-2YH=&U02P$"% ,4    " "7BT97J=!8GG %  "=&@  %0
M@ &C( @ ;C(U-S1?>#$V,V5X,C,M,38N:'1M4$L! A0#%     @ EXM&5T:-
M@?0>!0  ^!,  !4              ( !1B8( &XR-3<T7W@Q-C-E>#(S+3$W
M+FAT;5!+ 0(4 Q0    ( )>+1E<IS??)LP4  %T;   4              "
M 9<K" !N,C4W-%]X,38S97@R,RTR+FAT;5!+ 0(4 Q0    ( )>+1E?(WECW
M=P4  ,\9   4              "  7PQ" !N,C4W-%]X,38S97@R,RTS+FAT
M;5!+ 0(4 Q0    ( )>+1E=D+0J%:@4  (P9   4              "  24W
M" !N,C4W-%]X,38S97@R,RTT+FAT;5!+ 0(4 Q0    ( )>+1E?R*57><04
M ,$9   4              "  <$\" !N,C4W-%]X,38S97@R,RTU+FAT;5!+
M 0(4 Q0    ( )>+1E<<D5WWA@4  )<;   4              "  61"" !N
M,C4W-%]X,38S97@R,RTV+FAT;5!+ 0(4 Q0    ( )>+1E=FN@<4>P4  &<;
M   4              "  1Q(" !N,C4W-%]X,38S97@R,RTW+FAT;5!+ 0(4
M Q0    ( )>+1E<':%U[@04  $H;   4              "  <E-" !N,C4W
M-%]X,38S97@R,RTX+FAT;5!+ 0(4 Q0    ( )>+1E>)Q9J8304  *P9   4
M              "  7Q3" !N,C4W-%]X,38S97@R,RTY+FAT;5!+ 0(4 Q0
M   ( )>+1E?X")FJC@<  ',K   4              "  ?M8" !N,C4W-%]X
M,38S97@S,2TQ+FAT;5!+ 0(4 Q0    ( )>+1E=*OIJ)?@<  (0J   4
M          "  ;M@" !N,C4W-%]X,38S97@S,2TR+FAT;5!+ 0(4 Q0    (
M )>+1E=&G,=\2 0  #86   4              "  6MH" !N,C4W-%]X,38S
M97@S,BTQ+FAT;5!+ 0(4 Q0    ( )>+1E=QRD$C5@0  )86   4
M      "  >5L" !N,C4W-%]X,38S97@S,BTR+FAT;5!+ 0(4 Q0    ( )>+
M1E?TF[&6%"H  %P# 0 4              "  6UQ" !N,C4W-%]X,38S97@T
M+3(U+FAT;5!+ 0(4 Q0    ( )>+1E>43EH=%1X  !L^ 0 2
M  "  ;.;" !N:6]B9BTR,#(S,#8S,"YX<V102P$"% ,4    " "7BT97!"OH
MXYD>   ,+P$ %@              @ 'XN0@ ;FEO8F8M,C R,S V,S!?8V%L
M+GAM;%!+ 0(4 Q0    ( )>+1E?C;AO-GDP  ,Y_!  6              "
M <78" !N:6]B9BTR,#(S,#8S,%]D968N>&UL4$L! A0#%     @ EXM&5UB1
MQQFJFP  1(L( !8              ( !ER4) &YI;V)F+3(P,C,P-C,P7VQA
M8BYX;6Q02P$"% ,4    " "7BT97VRLLH"YN  !SQ@8 %@
M@ %UP0D ;FEO8F8M,C R,S V,S!?<')E+GAM;%!+!08     (@ B ,8(  #7
%+PH    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
